PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	McLellan, T; McKinlay, A				McLellan, T.; McKinlay, A.			Sensitivity to emotion, empathy and theory of mind: Adult performance following childhood TBI	BRAIN INJURY			English	Article						Brain injury; facial expression; paediatric injury; social perception	TRAUMATIC BRAIN-INJURY; PERCEPTION DEFICITS; FACIAL EXPRESSION; RECOGNITION; CHILDREN; ABILITY	Primary objective: To examine deficits in emotion perception for adults who had experienced a traumatic brain injury (TBI) during childhood and investigate relationships between emotion perception skills, empathy and Theory of Mind (ToM). Design: Participants consisted of a random selection of individuals (n - 52) who had previously been recruited for a larger study. All participants had experienced an injury event as a child (0-17 years) (mild TBI, moderate/severe TBI or fractured limb) and were now aged between 18-30 years, with a minimum of 5 years post-injury. Methods and procedure: Each participant completed an emotion-sensitivity task, facial expression recognition task, the faux pas test (ToM) and the Interpersonal Reactivity Inventory (IRI: Empathy). Main outcomes: Individuals with moderate/severe TBI were less sensitivite to emotion and less accurate at facial expression recognition than those with mild TBI and orthopaedic controls. Difficulty with affective ToM but not empathy was also found. The emotion-sensitivity and the facial expression recognition tasks were unrelated, with only emotion sensitivity but not expression recognition related to ToM and IRI empathy. Conclusions: The current findings indicated that deficits in social skills are long lasting and raises the issue of whether intervention to improve sensitivity to genuine emotion can influence more complex social skills and improve quality of social interactions for individuals following TBI.	[McLellan, T.; McKinlay, A.] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [McKinlay, A.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia		McLellan, T (corresponding author), Univ Canterbury, Private Bag 4800, Christchurch 1, New Zealand.	traceylmclellan@gmail.com		McKinlay, Audrey/0000-0001-9846-8514	Department of Psychology, University of Canterbury, New Zealand	This research received ethical approval from the Upper South B Regional Ethics Committee, New Zealand. We acknowledge that the information in this manuscript and the manuscript itself has never been published either electronically or in print. The authors have no conflict of interest in the production of this manuscript. The current study was funded by the Department of Psychology, University of Canterbury, New Zealand.	Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Johnston L, 2008, AUST J PSYCHOL, V60, P135, DOI 10.1080/00049530701449521; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Matsumoto D., 1988, JAPANESE CAUCASIAN F; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLellan T, 2010, COGNITION EMOTION, V24, P1277, DOI 10.1080/02699930903306181; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Miles L, 2007, J NONVERBAL BEHAV, V31, P259, DOI 10.1007/s10919-007-0036-4; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543	23	22	22	1	38	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2013	27	9					1032	1037		10.3109/02699052.2013.794965			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	180HZ	WOS:000321586100007	23781878				2022-02-06	
J	Mullen, MT; Kasner, SE; Messe, SR				Mullen, Michael T.; Kasner, Scott E.; Messe, Steven R.			Seizures Do Not Increase In-Hospital Mortality After Intracerebral Hemorrhage in the Nationwide Inpatient Sample	NEUROCRITICAL CARE			English	Article						Intracerebral hemorrhage; Seizures; Anti-epileptic drugs; Outcomes; Classifications: ICH; Seizures; Stroke	ADMINISTRATIVE DATA; ANTIEPILEPTIC DRUG; ACUTE STROKE; PREDICTORS; MULTICENTER; ICH	Seizures are common after intracerebral hemorrhage (ICH) but their impact on outcome is uncertain and prophylactic anti-convulsant use is controversial. We hypothesized that seizures would not increase the risk of in-hospital mortality in a large administrative database. The study population included patients in the 2006 Nationwide Inpatient Sample over the age of 18 with a principal diagnosis of ICH (ICD9 = 431). Subjects with a secondary diagnosis of aneurysm, arterio-venous malformation, brain tumor, or traumatic brain injury were excluded. Seizures were defined by ICD9 codes (345.0x-345.5x, 345.7x-345.9x, 780.39). Logistic regression was used to quantify the relationship between seizures and in-hospital mortality. Pre-specified subgroups included age strata, length of stay, and invasive procedures. 13,033 subjects met all eligibility criteria, of which 1,430 (11.0 %) had a secondary diagnosis of seizure. Subjects with seizure were younger (64 vs. 70 years, p < 0.001), more likely to get craniectomy (2.1 vs. 1.2 %, p = 0.006), ventriculostomy (8.5 vs. 6.0 %, p < 0.001), intubation (32.2 vs. 25.9 %, p < 0.001), and tracheostomy (6.4 vs. 4.2 %, p < 0.001). Seizure patients had lower in-hospital mortality (24.3 vs. 28.0 %, p = 0.003). In a multivariable model incorporating patient and hospital level variables, seizures were associated with reduced odds of in-hospital death (OR = 0.62, 95 % CI 0.52-0.75). A secondary diagnosis of seizure after ICH was not associated with increased in-hospital death overall or in any of the pre-specified subgroups; however, there may be residual confounding by severity. These findings do not support a need for routine prophylactic anti-epileptic drug use after ICH.	[Mullen, Michael T.; Kasner, Scott E.; Messe, Steven R.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Mullen, MT (corresponding author), Univ Penn, Dept Neurol, 3400 Spruce St,3 W Gates Bldg, Philadelphia, PA 19104 USA.	michael.mullen@uphs.upenn.edu					[Anonymous], 2011, OV NAT INP SAMPL NIS; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Averill Richard F, 2002, J AHIMA, V73, P46; Battey TW, 2012, NEUROCRIT CARE; BERGER AR, 1988, NEUROLOGY, V38, P1363, DOI 10.1212/WNL.38.9.1363; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Burneo JG, 2010, EUR J NEUROL, V17, P52, DOI 10.1111/j.1468-1331.2009.02739.x; Castellanos M, 2005, J NEUROL NEUROSUR PS, V76, P691, DOI 10.1136/jnnp.2004.044347; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; De Herdt V, 2011, NEUROLOGY, V77, P1794, DOI 10.1212/WNL.0b013e31823648a6; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gilad R, 2011, EPILEPSY RES, V95, P227, DOI 10.1016/j.eplepsyres.2011.04.002; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Jette N, 2010, EPILEPSIA, V51, P62, DOI 10.1111/j.1528-1167.2009.02201.x; KILPATRICK CJ, 1990, ARCH NEUROL-CHICAGO, V47, P157, DOI 10.1001/archneur.1990.00530020053014; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Labovitz DL, 2001, NEUROLOGY, V57, P200, DOI 10.1212/WNL.57.2.200; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Messe S, 2009, NEUROCRIT CARE, V11, P38, DOI 10.1007/s12028-009-9207-y; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Naidech AM, 2009, STROKE, V40, P3810, DOI 10.1161/STROKEAHA.109.559948; Passero S, 2002, EPILEPSIA, V43, P1175, DOI 10.1046/j.1528-1157.2002.00302.x; Reddig RT, 2011, CLIN NEUROL NEUROSUR, V113, P895, DOI 10.1016/j.clineuro.2011.07.008; Reith J, 1997, STROKE, V28, P1585, DOI 10.1161/01.STR.28.8.1585; Szaflarski JP, 2008, EPILEPSIA, V49, P974, DOI 10.1111/j.1528-1167.2007.01513.x; Taylor S, 2011, NEUROCRIT CARE, V15, P80, DOI 10.1007/s12028-010-9341-6; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4	28	22	23	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	AUG	2013	19	1					19	24		10.1007/s12028-012-9791-0			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	187SP	WOS:000322140000004	23138543				2022-02-06	
J	Sitruk-Ware, R; El-Etr, M				Sitruk-Ware, R.; El-Etr, M.			Progesterone and related progestins: potential new health benefits	CLIMACTERIC			English	Article						PROGESTERONE; PROGESTIN; NESTORONE; NEUROREGENERATION; MYELIN REPAIR; STROKE; HORMONE REPLACEMENT THERAPY; LACTATION; PROGESTERONE VAGINAL RING	HORMONE REPLACEMENT THERAPY; TRAUMATIC BRAIN-INJURY; MEDROXYPROGESTERONE ACETATE; PRETERM BIRTH; VAGINAL RING; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; RECEPTORS; NESTORONE; ESTRADIOL	Progesterone is a steroid hormone that is essential for the regulation of reproductive function. The main physiological roles of this hormone have been widely described. Progesterone and progestins have been approved for a number of indications including the treatment of irregular and anovulatory menstrual cycles and, when combined with estrogen, for contraception, and the prevention of endometrial hyperplasia in postmenopausal hormonal replacement therapy (HRT) regimens. Lack of understanding between the differences in categories of the progestins as well as with the physiological hormone has resulted in considerable controversy surrounding the use of progestins for HRT regimens. Newer evidence suggests that there are distinct differences between the molecules and there is no progestin class effect, with regard to benefits or side-effects. In addition to its role in reproduction, progesterone regulates a number of biologically distinct processes in other tissues, particularly in the nervous system and the vessels. Recently, it has been shown in animal experiments that progesterone and the progestin Nestorone (R) have positive effects on neuroregeneration and repair of brain damage, as well as myelin repair. The potential benefits of natural progesterone and its related derivatives warrant further investigation. It is hoped that a better understanding of the mechanism of action of progesterone and selected progestins will help in defining better therapies for men and women.	[Sitruk-Ware, R.] Populat Council, New York, NY 10065 USA; [Sitruk-Ware, R.] Rockefeller Univ, New York, NY 10021 USA; [El-Etr, M.] INSERM, UMR 788, Le Kremlin Bicetre, France		Sitruk-Ware, R (corresponding author), Populat Council, 1230 York Ave, New York, NY 10065 USA.				USAIDUnited States Agency for International Development (USAID); NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Barrus Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5 ROI HD061106-04, 5U54HD029990]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061106, U54HD029990] Funding Source: NIH RePORTER	Some results described in this review were obtained under grants from USAID, NICHD and the Barrus Foundation. R. S. W. received support from the NIH for the work on the progesterone vaginal ring during lactation (5 ROI HD061106-04) and for the work on the action of progesterone and Nestorone on the brain (5U54HD029990).	Acs P, 2009, GLIA, V57, P807, DOI 10.1002/glia.20806; Adams MR, 1997, ARTERIOSCL THROM VAS, V17, P217, DOI 10.1161/01.ATV.17.1.217; Brinton RD, 2008, FRONT NEUROENDOCRIN, V29, P313, DOI 10.1016/j.yfrne.2008.02.001; Canonico M, 2010, ARTERIOSCL THROM VAS, V30, P340, DOI 10.1161/ATVBAHA.109.196022; Chabbert-Buffet N, 2012, MOL CELL ENDOCRINOL, V358, P232, DOI 10.1016/j.mce.2012.02.021; CHI IC, 1995, CLIN OBSTET GYNECOL, V38, P872, DOI 10.1097/00003081-199538040-00022; Cicinelli E, 2000, OBSTET GYNECOL, V95, P403, DOI 10.1016/S0029-7844(99)00542-6; Conneely OM, 2000, STEROIDS, V65, P571, DOI 10.1016/S0039-128X(00)00115-X; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; de Villiers TJ, 2013, CLIMACTERIC, V16, P203, DOI 10.3109/13697137.2013.771520; Di Renzo GC, 2012, GYNECOL ENDOCRINOL, V28, P925, DOI 10.3109/09513590.2012.730576; DIAZ S, 1991, J CLIN ENDOCR METAB, V72, P196, DOI 10.1210/jcem-72-1-196; DIAZ S, 1991, ANN NY ACAD SCI, V626, P11; Edwards HE, 2000, NEUROSCIENCE, V101, P895, DOI 10.1016/S0306-4522(00)00439-5; Fournier A, 2008, J CLIN ONCOL, V26, P1260, DOI 10.1200/JCO.2007.13.4338; Fournier A, 2008, BREAST CANCER RES TR, V107, P103, DOI 10.1007/s10549-007-9523-x; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Fraser IS, 2007, CONTRACEPTION, V76, P432, DOI 10.1016/j.contraception.2007.08.006; Frye CA, 2005, PHARMACOL BIOCHEM BE, V81, P907, DOI 10.1016/j.pbb.2005.06.016; Fu XD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-166; Garay L, 2007, J STEROID BIOCHEM, V107, P228, DOI 10.1016/j.jsbmb.2007.03.040; Gaussem P, 2011, THROMB HAEMOSTASIS, V105, P560, DOI 10.1160/TH10-05-0327; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gibson CL, 2011, BRAIN, V134, P2125, DOI 10.1093/brain/awr132; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Herkert O, 2001, CIRCULATION, V104, P2826, DOI 10.1161/hc4801.099737; Hermsmeyer RK, 2008, NAT CLIN PRACT CARD, V5, P387, DOI 10.1038/ncpcardio1234; Hussain R, 2011, ENDOCRINOLOGY, V152, P3820, DOI 10.1210/en.2011-1219; Klipping C, 2011, DRUGS R&D, V11, P159, DOI 10.2165/11591200-000000000-00000; KOENIG HL, 1995, SCIENCE, V268, P1500, DOI 10.1126/science.7770777; Kumar N, 2000, STEROIDS, V65, P629, DOI 10.1016/S0039-128X(00)00119-7; Levy T, 2000, STEROIDS, V65, P645, DOI 10.1016/S0039-128X(00)00121-5; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Liu LF, 2010, ENDOCRINOLOGY, V151, P5782, DOI 10.1210/en.2010-0005; Luo GY, 2010, REPROD SCI, V17, P532, DOI 10.1177/1933719110363618; MACLUSKY NJ, 1978, NATURE, V274, P276, DOI 10.1038/274276a0; Massai MR, 2001, CONTRACEPTION, V64, P369, DOI 10.1016/S0010-7824(01)00259-1; Massai R, 2005, CONTRACEPTION, V72, P352, DOI 10.1016/j.contraception.2005.05.004; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; MILES RA, 1994, FERTIL STERIL, V62, P485; Nath A, 2009, CLIMACTERIC, V12, P96, DOI 10.1080/13697130902905757; Nath A, 2009, EUR J CONTRACEP REPR, V14, P88, DOI 10.1080/13625180902747425; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; PARSONS B, 1982, J NEUROSCI, V2, P1446; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Sandstrom NJ, 2001, BEHAV NEUROSCI, V115, P384, DOI 10.1037//0735-7044.115.2.384; Sasagawa S, 2008, STEROIDS, V73, P222, DOI 10.1016/j.steroids.2007.10.003; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schierbeck LL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6409; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Schumacher M, 2008, CURR OPIN PHARMACOL, V8, P740, DOI 10.1016/j.coph.2008.10.002; SHAABAN MM, 1991, J STEROID BIOCHEM, V40, P705, DOI 10.1016/0960-0760(91)90294-F; Simoncini T, 2007, HUM REPROD, V22, P2325, DOI 10.1093/humrep/dem109; Sitruk-Ware R, 2007, CLIMACTERIC, V10, P358, DOI 10.1080/13697130701609121; Sitruk-Ware R, 2010, CONTRACEPTION, V82, P410, DOI 10.1016/j.contraception.2010.04.004; Sitruk-Ware R, 2008, MATURITAS, V61, P151, DOI 10.1016/j.maturitas.2004.01.001; Sivin I, 1997, CONTRACEPTION, V55, P225, DOI 10.1016/S0010-7824(97)00008-5; Smith C, 2012, INT J STROKE, DOI [10.1111/j.1747-4949.2012.00924, DOI 10.1111/J.1747-4949.2012.00924]; Stanczyk FZ, 2013, ENDOCR REV, V34, P171, DOI 10.1210/er.2012-1008; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Stuenkel CA, 2012, FERTIL STERIL, V98, P313, DOI 10.1016/j.fertnstert.2012.05.051; Tavaniotou A, 2000, HUM REPROD UPDATE, V6, P139, DOI 10.1093/humupd/6.2.139; Toner JP, 2000, HUM REPROD, V15, P166, DOI 10.1093/humrep/15.suppl_1.166; Valore EV, 2002, AM J OBSTET GYNECOL, V187, P561, DOI 10.1067/mob.2002.125280; WILLIAMS JK, 1994, J AM COLL CARDIOL, V24, P1757, DOI 10.1016/0735-1097(94)90184-8; Williams JK, 1998, AM J OBSTET GYNECOL, V179, P1288, DOI 10.1016/S0002-9378(98)70149-8; WOOLLEY CS, 1993, J COMP NEUROL, V336, P293, DOI 10.1002/cne.903360210; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Zegers-Hochschild F, 2000, HUM REPROD, V15, P2093, DOI 10.1093/humrep/15.10.2093; Zegers-Hochschild F, 1996, HUM REPROD, V11, P53; Zerr-Fouineau M, 2007, FASEB J, V21, P265, DOI 10.1096/fj.06-6840com	81	22	29	1	30	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1369-7137	1473-0804		CLIMACTERIC	Climacteric	AUG	2013	16			1			69	78		10.3109/13697137.2013.802556			10	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	183BB	WOS:000321787500010	23647429				2022-02-06	
J	Brewer, BL; Diehl, AH; Johnson, LS; Salomone, JP; Wilson, KL; Atallah, HY; Feliciano, DV; Rozycki, GS				Brewer, Brian L.; Diehl, Albert H., III; Johnson, Laura S.; Salomone, Jeffrey P.; Wilson, Kenneth L.; Atallah, Hany Y.; Feliciano, David V.; Rozycki, Grace S.			Choice of motorcycle helmet makes a difference: A prospective observational study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	26th Annual Scientific Assembly of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 15-19, 2013	Scottsdale, AZ	Eastern Assoc Surg Trauma		Motorcycle; helmet; motorcycle collision; full-face helmet	FATAL INJURIES; RIDERS; IMPACT	BACKGROUND: Although many states mandate that motorcyclists wear helmets, their laws do not indicate which type of helmet should be used. In addition, there are no prospective studies in the literature evaluating patterns of injuries as they relate to helmet type. The hypothesis in this study was that full-face helmets (FFHs) reduce craniofacial injuries associated with motorcycle collisions when compared with other helmet types. METHODS: A prospective observational study was conducted at a Level I trauma center to evaluate the efficacy of helmet types relative to craniofacial injuries. Data included patient demographics, helmet types, injuries, and outcomes. The incidences of facial fractures, skull fractures, and traumatic brain injuries (TBIs) were compared in patients wearing FFHs versus other helmet types (OH) during motorcycle crashes. RESULTS: From 2011 to 2012, 151 patients of motorcycle crashes (135 males, 16 female; mean age, 38.4 years; range, 19-74 years) whose helmet types were identified by health care providers were entered into the study. The distribution of helmets was 84 FFH and 67 OH (39 half and 28 modular). Facial fractures were present in 7% of the patients wearing FFH (95% confidence interval, 0.015-0.125) versus 27% (95% confidence interval, 0.164-0.376) of those wearing OH (p = 0.004). In addition skull fractures were present in 1% of the patients wearing FFH versus 8% in those wearing OH(p < 0.05). While there was a trend for patients wearing FFH to have a lower incidence of TBI (13% vs. 25% in those wearing OH), this was not statistically significant (p = 0.053). There were no differences in Injury Severity Score (ISS), length of stay, or mortality between the two groups. CONCLUSION: Victims of motorcycle crashes who are wearing FFH have a significant reduction in facial and skull fractures when compared with those wearing OH. Further studies will be needed to assess whether FFH will significantly decrease the incidence of TBI. Copyright (C) 2013 by Lippincott Williams & Wilkins	[Brewer, Brian L.] Sinai Hosp, Dept Surg, Baltimore, MD 21215 USA; [Diehl, Albert H., III; Atallah, Hany Y.; Rozycki, Grace S.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA; [Wilson, Kenneth L.] Morehouse Sch Med, Atlanta, GA 30310 USA; [Feliciano, David V.] Mercer Univ, Sch Med, Atlanta Med Ctr, Dept Surg, Atlanta, GA USA; [Johnson, Laura S.] Washington Hosp Ctr, Dept Surg, Washington, DC 20010 USA; [Salomone, Jeffrey P.] Univ Arizona Pheonix, Maricopa Med Ctr, Dept Surg, Phoenix, AZ USA		Brewer, BL (corresponding author), 2435 West Belvedere Ave, Baltimore, MD 21215 USA.	bbrewer@lifebridgehealth.org	Johnson, Laura S/ABE-5478-2020	Johnson, Laura S/0000-0001-6969-2648; Salomone, Jeffrey/0000-0002-1322-202X			Bledsoe GH, 2002, J TRAUMA, V53, P1078, DOI 10.1097/00005373-200212000-00009; Christian W Jay, 2003, J Ky Med Assoc, V101, P21; Croce MA, 2009, ANN SURG, V250, P390, DOI 10.1097/SLA.0b013e3181b365a2; Hitosugi M, 2004, AM J FOREN MED PATH, V25, P125, DOI 10.1097/01.paf.0000127397.67081.f5; Homer J, 2009, AM J PUBLIC HEALTH, V99, P415, DOI 10.2105/AJPH.2008.134106; Insurance Institute for Highway Safety, HIGHW SAF RES COMM; JOHNSON RM, 1995, J TRAUMA, V38, P876, DOI 10.1097/00005373-199506000-00008; Liu B. C., 2004, COCHRANE DB SYST REV; Mayrose J, 2008, J SAFETY RES, V39, P429, DOI 10.1016/j.jsr.2008.07.001; NHTSA, 2010, HSW811363 NHTSA DOT; NHTSA, 2008, MOT HELM US LAWS; O'Connor Peter J, 2005, Traffic Inj Prev, V6, P60, DOI 10.1080/15389580590903195; SARKAR S, 1995, J TRAUMA, V38, P242, DOI 10.1097/00005373-199502000-00017; SOSIN DM, 1990, JAMA-J AM MED ASSOC, V264, P2395, DOI 10.1001/jama.264.18.2395; TSAI YJ, 1995, AM J EPIDEMIOL, V142, P974, DOI 10.1093/oxfordjournals.aje.a117746	15	22	23	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2013	75	1					88	91		10.1097/TA.0b013e3182988b59			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	300EV	WOS:000330448100023	23778444				2022-02-06	
J	Ferrario, CR; Ndukwe, BO; Ren, JH; Satin, LS; Goforth, PB				Ferrario, Carrie R.; Ndukwe, Blaise O.; Ren, Jianhua; Satin, Leslie S.; Goforth, Paulette B.			Stretch injury selectively enhances extrasynaptic, GluN2B-containing NMDA receptor function in cortical neurons	JOURNAL OF NEUROPHYSIOLOGY			English	Article						traumatic brain injury; NMDA receptors; GluN2B; cortical injury	D-ASPARTATE RECEPTORS; TRAUMATIC BRAIN-INJURY; LONG-TERM DEPRESSION; CA2+-PERMEABLE AMPA RECEPTORS; SUBUNIT COMPOSITION; SYNAPTIC PLASTICITY; MECHANICAL INJURY; DIFFERENTIAL ROLES; CREB SHUTOFF; IN-VITRO	Alterations in the function and expression of NMDA receptors are observed after in vivo and in vitro traumatic brain injury. We recently reported that mechanical stretch injury in cortical neurons transiently increases the contribution of NMDA receptors to network activity and results in an increase in calcium-permeable AMPA (CP-AMPA) receptor-mediated transmission 4 h postinjury (Goforth et al. 2011). Here, we evaluated changes in the function of synaptic vs. extrasynaptic GluN2B-containing NMDA receptors after injury. We also determined whether postinjury treatment with the GluN2B-selective antagonist Ro 25-6981 or memantine prevents injury-induced increases in CP-AMPA receptor activity. We found that injury increased extrasynaptic, GluN2B-containing NMDA receptor-mediated whole cell currents. In contrast, we found no differences in synaptic NMDA receptor-mediated transmission after injury. Furthermore, treatment with Ro 25-6981 or memantine after injury prevented injury-induced increases in CP-AMPA receptor-mediated activity. Together, our data suggest that increased NMDA receptor activity after injury is predominantly due to alterations in extrasynaptic, GluN2B-containing NMDA receptors and that activation of these receptors may contribute to the appearance of CP-AMPA receptors after injury.	[Ferrario, Carrie R.; Ndukwe, Blaise O.; Ren, Jianhua; Satin, Leslie S.; Goforth, Paulette B.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48105 USA		Goforth, PB (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48105 USA.	pgoforth@umich.edu	Ferrario, Carrie/L-7372-2016	Ferrario, Carrie/0000-0002-9673-7028	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1-NS-49519, NS-069629]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049519, R01NS069629] Funding Source: NIH RePORTER	Research was supported by National Institute of Neurological Disorders and Stroke Grants RO1-NS-49519 (to L. S. Satin) and NS-069629 (to C. R. Ferrario).	Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bengtson CP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-11; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; DeRidder MN, 2006, NEUROBIOL DIS, V22, P165, DOI 10.1016/j.nbd.2005.10.011; Ferrario CR, 2011, NEUROPHARMACOLOGY, V61, P1141, DOI 10.1016/j.neuropharm.2011.01.021; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Flint AC, 1997, J NEUROSCI, V17, P2469; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Groc L, 2009, NEUROSCIENCE, V158, P4, DOI 10.1016/j.neuroscience.2008.05.029; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2009, BIOCHEM SOC T, V37, P1147, DOI 10.1042/BST0371147; Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lea PM, 2003, J NEUROTRAUM, V20, P1233, DOI 10.1089/089771503770802907; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Li JH, 1998, EUR J NEUROSCI, V10, P1704, DOI 10.1046/j.1460-9568.1998.00169.x; Li YX, 1996, NEUROSCIENCE, V71, P397, DOI 10.1016/0306-4522(95)00483-1; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; PorteraCailliau C, 1996, J NEUROCHEM, V66, P692, DOI 10.1046/j.1471-4159.1996.66020692.x; Prybylowski K, 2004, J BIOL CHEM, V279, P9673, DOI 10.1074/jbc.R300029200; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Tavalin SJ, 1995, J NEUROPHYSIOL, V74, P2767, DOI 10.1152/jn.1995.74.6.2767; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	58	22	22	0	7	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	JUL	2013	110	1					131	140		10.1152/jn.01011.2012			10	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	174ZI	WOS:000321197400014	23576693	Green Published			2022-02-06	
J	Green, L; Godfrey, C; Soo, C; Anderson, V; Catroppa, C				Green, L.; Godfrey, C.; Soo, C.; Anderson, V.; Catroppa, C.			A preliminary investigation into psychosocial outcome and quality-of-life in adolescents following childhood traumatic brain injury	BRAIN INJURY			English	Article						Adolescents; psychosocial outcome; quality-of-life; traumatic brain injury	PSYCHOMETRIC PROPERTIES; COMMUNITY INTEGRATION; HEALTH; RECOVERY; CHILDREN; SCALE; SATISFACTION; PREDICTORS; SURVIVORS	Objective: This study investigated the long-term psychosocial outcome and quality-of-life (QoL) of 15-18 year olds, sustaining childhood traumatic brain injury (TBI) between birth and 5 years. Method: Thirty-three participants (17 TBI parent-proxies, 16 control parent-proxies) were involved in the present study which compared parent-ratings for the TBI group and healthy controls on the Sydney Psychosocial Reintegration Scale-Child form (SPRS-C) and the Paediatric Quality of Life Inventory (PedsQL). Results: Despite comparable overall psychosocial reintegration scores, parents reported that their teens with TBI were more likely to experience poor QoL compared to controls. On further analysis, some aspects of psychosocial outcome appear to be compromised following childhood TBI. Conclusions: Interventions targeting childhood TBI must consider QoL in addition to symptom reduction and be extended throughout adolescence. The limitations of the sample size are cause for concern; however, preliminary results do validate the need for future research efforts.	[Green, L.; Anderson, V.; Catroppa, C.] Univ Melbourne, Melbourne, Vic, Australia; [Godfrey, C.; Soo, C.; Anderson, V.; Catroppa, C.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, V.; Catroppa, C.] Royal Childrens Hosp, Melbourne, Vic, Australia		Catroppa, C (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Murdoch Children's Research Institute; Royal Children's Hospital, Melbourne; Victorian Government's Operational Infrastructure Support Program; Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This research was supported by the Murdoch Children's Research Institute, the Royal Children's Hospital, Melbourne and the Victorian Government's Operational Infrastructure Support Program. Funding was also provided from the Australian National Health and Medical Research Council. The research reported in this thesis was conducted in accordance with the principles for the ethical treatment of human subjects as approved for this research by the University of Melbourne Human Research Ethics Committee and the Royal Children's Hospital Human Research Ethics Committee. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; Anderson V, 2010, J NEUROTRAUM, V27, P863, DOI 10.1089/neu.2009.1169; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bedell Gary M, 2002, Pediatr Rehabil, V5, P107, DOI 10.1080/1363849021000013540; Brown B.B., 1994, PERSONAL RELATIONSHI, P123; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Coghill D, 2009, J CHILD PSYCHOL PSYC, V50, P544, DOI 10.1111/j.1469-7610.2009.02008.x; Daniel A., 1983, POWER PRIVILEGE PRES; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Kuipers P, 2004, BRAIN INJURY, V18, P161, DOI 10.1080/0269905031000149524; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Reistetter Timothy A, 2005, Occup Ther Int, V12, P196; Sherer M, 2010, J HEAD TRAUMA REHAB, V25, P92, DOI 10.1097/HTR.0b013e3181c9d887; Soo C, ADAPTING SYDNE UNPUB; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; TEASDALE G, 1974, LANCET, V2, P81; Wallander JL, 1998, J CHILD PSYCHOL PSYC, V39, P29, DOI 10.1017/S0021963097001741; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541	30	22	22	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					872	877		10.3109/02699052.2013.775506			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200014	23789864				2022-02-06	
J	Gubata, ME; Piccirillo, AL; Packnett, ER; Cowan, DN				Gubata, Marlene E.; Piccirillo, Amanda L.; Packnett, Elizabeth R.; Cowan, David N.			Military Occupation and Deployment: Descriptive Epidemiology of Active Duty U.S. Army Men Evaluated for a Disability Discharge	MILITARY MEDICINE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; US ARMY; HEALTH PROBLEMS; IRAQ; AFGHANISTAN; WAR; PERSONNEL; VETERANS; INJURY; CARE	Objective: Physically demanding jobs and history of deployment put Soldiers at increased risk for injury, hospitalizations, and disability. Characterizing differences in disability outcomes by occupation and deployment history may identify specific military populations for targeted prevention and intervention programs as well as potential areas of future research. Methods: A cross-sectional analysis was conducted on U.S. Army enlisted men evaluated in the Department of Defense's Disability Evaluation System (DES) between fiscal years 2005 and 2011, comparing those assigned a Combat Arms military occupational specialty (MOS) to individuals with any other MOS (Other). Results: Among deployed Soldiers, those with Combat Arms MOS were substantially and significantly more likely to receive medical disability retirement than Other MOS and were more likely to be evaluated for conditions compatible with combat exposures, including post-traumatic stress disorder, residuals of traumatic brain injury, and paralysis. Among nondeployed Soldiers, Combat Arms MOS were only slightly more likely to receive medical disability than Other MOS, and no substantial differences in medical conditions were noted between the two MOS groups. Conclusions: Combat Arms MOS is a significant risk factor for disability retirement primarily among deployed men. Further research is needed to identify specific military occupations most at risk for disability retirement.	[Gubata, Marlene E.; Piccirillo, Amanda L.; Packnett, Elizabeth R.; Cowan, David N.] Walter Reed Army Inst Res, Div Prevent Med, Silver Spring, MD 20910 USA; [Piccirillo, Amanda L.; Packnett, Elizabeth R.; Cowan, David N.] Allied Technol Grp Inc, Rockville, MD 20850 USA		Gubata, ME (corresponding author), Walter Reed Army Inst Res, Div Prevent Med, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.				Defense Health Board	This work was funded by the Defense Health Board.	Amoroso P J, 1999, Mil Med, V164, P1; *ARM FORC HLTH SUR, 2009, MSMR, V15, P14; *ARM MED SURV ACT, 2007, MED SURVEILL MON REP, V13, P15; Bell N, 2008, TALE 2 DISABILITY CO; Bell NS, 2011, J TRAUMA STRESS, V24, P34, DOI 10.1002/jts.20612; Bell NS, 2008, DISABIL HEALTH J, V1, P163, DOI 10.1016/j.dhjo.2008.05.002; Bell NS, 2008, DISABIL HEALTH J, V1, P14, DOI 10.1016/j.dhjo.2007.11.007; Berkowitz SM, 1999, MIL MED, V164, P412, DOI 10.1093/milmed/164.6.412; Brundage JF, 2002, AM J IND MED, V41, P279, DOI 10.1002/ajim.10075; *DEP ARM, 1999, ARM PAMPHL 611 21 PE; Feuerstein M, 1997, J OCCUP ENVIRON MED, V39, P68, DOI 10.1097/00043764-199701000-00013; Friedman MJ, 2005, NEW ENGL J MED, V352, P1287, DOI 10.1056/NEJMp058028; Gubata ME, 2012, TRI SERVICE DISABILI; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hoge CW, 2005, AM J PSYCHIAT, V162, P585, DOI 10.1176/appi.ajp.162.3.585; Hollander IE, 2010, MIL MED, V175, P705, DOI 10.7205/MILMED-D-09-00214; Knapik JJ, 2012, PUBLIC HEALTH, V126, P498, DOI 10.1016/j.puhe.2012.01.031; Larson GE, 2008, AM J EPIDEMIOL, V167, P1269, DOI 10.1093/aje/kwn084; Niebuhr DW, 2011, MIL MED, V176, P170, DOI 10.7205/MILMED-D-10-00114; NIEBUHR DW, 2012, ANNUAL REPORT 2011; NIEBUHR DW, 2011, TRI SERVICE DISABILI; Packnett ER, 2012, J TRAUMA STRESS, V25, P485, DOI 10.1002/jts.21743; Songer TJ, 2000, AM J PREV MED, V18, P33, DOI 10.1016/S0749-3797(00)00107-0; Wilson J, 2009, AM J EPIDEMIOL, V169, P1362, DOI 10.1093/aje/kwp044	26	22	22	0	6	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL	2013	178	7					708	714		10.7205/MILMED-D-12-00542			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7UA	WOS:000340805300003	23820342	Bronze			2022-02-06	
J	Price, B; Arthur, AO; Brunko, M; Frantz, P; Dickson, JO; Judge, T; Thomas, SH				Price, Brian; Arthur, Annette O.; Brunko, Michael; Frantz, Pam; Dickson, Joshua O.; Judge, Tom; Thomas, Stephen H.			Hemodynamic consequences of ketamine vs etomidate for endotracheal intubation in the air medical setting	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; EMERGENCY-DEPARTMENT; PROCEDURAL SEDATION; PREHOSPITAL USE; INTRACRANIAL-PRESSURE; INDUCTION AGENT; MANAGEMENT; HYPERTENSION; COMBINATION	Objective: Recent drug shortages have required the occasional replacement of etomidate for endotracheal intubation (ETI) by helicopter emergency medical services (HEMS), with ketamine. The purpose of this study was to assess whether there was an association between ketamine vs etomidate use as the main ETI drug, with hemodynamic or clinical (airway) end points. Methods: This retrospective study used data entered into medical records at the time of HEMS transport. Subjects, 50 ketamine and 50 etomidate, were accrued from 3 US HEMS programs. The study period was from August 2011 through May 2012. Data collection included demographics, diagnostic category, ETI drugs use, ETI success, and complications. Hemodynamic parameters were assessed for up to 2 sets of vital signs before airway management and up to 5 sets of post-ETI vital signs. Significance was defined at the P < .05 level. Results: Patients on ketamine and etomidate were similar (P > .05) with respect to age, sex, scene/interfacility mission type, trauma vs nontrauma, neuromuscular blocking agent use, and rates of coadministration of fentanyl or midazolam. All patients had successful airway placement. Peri-ETI hypoxemia was seen in 10% of etomidate and 16% of ketamine cases (P =. 55). The pre-ETI and post-ETI were similar between the ketamine and etomidate groups with respect to systolic blood pressure and heart rate at every vital signs assessment after ETI. Conclusion: Initial assessment of ETI success and complication rates, as well as peri-ETI hemodynamic changes, suggests no concerning complications associated with large-scale replacement of etomidate with ketamine as the major airway management drug for HEMS. (C) 2013 Elsevier Inc. All rights reserved.	[Price, Brian] Univ Med Ctr Brackenridge, Austin, TX 78701 USA; [Price, Brian] Air Evac Lifeteam, San Marcos, TX 78666 USA; [Arthur, Annette O.; Thomas, Stephen H.] Univ Oklahoma, Sch Community Med, Dept Emergency Med, Tulsa, OK 74146 USA; [Brunko, Michael; Frantz, Pam] Flight Life Colorado, Lakewood, CO 80228 USA; [Dickson, Joshua O.; Judge, Tom] LifeFlight Maine, Bangor, ME 04843 USA; [Thomas, Stephen H.] Air Evac Oklahoma, Muskogee, OK 74401 USA		Arthur, AO (corresponding author), Univ Oklahoma, Dept Emergency Med, Tulsa, OK 74104 USA.	annette-arthur@ouhsc.edu		Thomas, Stephen/0000-0003-4153-3965			Andolfatto G, 2012, ANN EMERG MED, V59, P504, DOI 10.1016/j.annemergmed.2012.01.017; Ballow SL, 2012, J TRAUMA ACUTE CARE, V73, P1401, DOI 10.1097/TA.0b013e318270dcf5; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; BELOPAVLOVIC M, 1982, ACTA ANAESTH SCAND, V26, P458, DOI 10.1111/j.1399-6576.1982.tb01799.x; Bernhard M, 2011, ANAESTHESIST, V60, P1027, DOI 10.1007/s00101-011-1957-1; Bisanzo M, 2012, ANN EMERG MED, V59, P268, DOI 10.1016/j.annemergmed.2011.11.004; Bozeman WP, 2006, PREHOSP EMERG CARE, V10, P8, DOI 10.1080/10903120500366854; Bozeman William P, 2002, Air Med J, V21, P32, DOI 10.1067/mmj.2002.125935; Bredmose PP, 2009, EMERG MED J, V26, P62, DOI 10.1136/emj.2007.052753; Bredmose PP, 2009, ACTA ANAESTH SCAND, V53, P543, DOI 10.1111/j.1399-6576.2008.01852.x; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Davis Bradley D, 2002, Curr Opin Crit Care, V8, P571, DOI 10.1097/00075198-200212000-00015; Davis D P, 2001, Prehosp Emerg Care, V5, P163, DOI 10.1080/10903120190940065; Davis DP, 2007, RESUSCITATION, V73, P354, DOI 10.1016/j.resuscitation.2006.09.015; Deitch Sean, 2003, Prehosp Emerg Care, V7, P380, DOI 10.1080/10903120390936617; Filanovsky Y, 2010, CAN J EMERG MED, V12, P154; Gofrit ON, 1997, INJURY, V28, P41, DOI 10.1016/S0020-1383(96)00140-4; Green SM, 2011, ANN EMERG MED, V57, P449, DOI 10.1016/j.annemergmed.2010.11.030; Helm M, 1996, ANAESTHESIST, V45, P1196, DOI 10.1007/s001010050358; Kill C, 2004, ANASTH INTENSIV NOTF, V39, P668, DOI 10.1055/s-2004-826007; Kociszewski C, 2000, AM J EMERG MED, V18, P757, DOI 10.1053/ajem.2000.18033; KUZNETSOVA OY, 1984, VESTN KHIR IM GREKOV, V133, P88; Langrehr D, 1973, Acta Anaesthesiol Belg, V24, P71; Langrehr D, 1967, Anaesthesist, V16, P308; Newton A, 2008, EMERG MED J, V25, P498, DOI 10.1136/emj.2007.053421; Paal P, 2010, RESUSCITATION, V81, P148, DOI 10.1016/j.resuscitation.2009.10.023; Pallin DJ, 2010, INTENS CARE MED, V36, P1268, DOI 10.1007/s00134-010-1880-y; Pasquier M, 2012, INJURY, V43, P1377, DOI 10.1016/j.injury.2011.06.196; Podlesch I, 1967, Anaesthesist, V16, P299; Reid C, 2011, EMERG MED J, V28, P328, DOI 10.1136/emj.2010.092825; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Roberts K, 2009, EMERG MED J, V26, P128, DOI 10.1136/emj.2008.059899; Sibley A, 2011, EMERG MED J, V28, P521, DOI 10.1136/emj.2009.088237; Svenson JE, 2007, AM J EMERG MED, V25, P977, DOI 10.1016/j.ajem.2007.02.040; Swanson Eric R, 2004, Prehosp Emerg Care, V8, P273; The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563, DOI 10.1089/neu.2000.17.563; Thomas MC, 2011, AM J HEALTH-SYST PH, V68, P2248, DOI 10.2146/ajhp110136; Thomas S, 2010, PREHOSP EMERG CARE, V14, P283, DOI 10.3109/10903127.2010.481758; Tiamfook-Morgan TO, 2006, PREHOSP EMERG CARE, V10, P363, DOI 10.1080/10903120600725835; Walls RM, 2008, ANN EMERG MED, V52, P13, DOI 10.1016/j.annemergmed.2008.01.001; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Zink BJ, 2004, ANN EMERG MED, V44, P451, DOI 10.1016/j.annemergmed.2004.05.001	42	22	24	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JUL	2013	31	7					1124	1132		10.1016/j.ajem.2013.03.041			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	179VR	WOS:000321550400024	23702065				2022-02-06	
J	Bouzat, P; Millet, A; Boue, Y; Pernet-Gallay, K; Trouve-Buisson, T; Gaide-Chevronnay, L; Barbier, EL; Payen, JF				Bouzat, Pierre; Millet, Anne; Boue, Yvonnick; Pernet-Gallay, Karin; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Payen, Jean-Francois			Changes in Brain Tissue Oxygenation After Treatment of Diffuse Traumatic Brain Injury by Erythropoietin	CRITICAL CARE MEDICINE			English	Article						BOLD; brain edema; brain oxygenation; erythropoietin; MR diffusion-weighted imaging; MRI; traumatic brain injury	CEREBRAL PERFUSION; BLOOD-VOLUME; VESSEL SIZE; HEAD-INJURY; EDEMA; METABOLISM; PRESSURE; MANNITOL; PENUMBRA; HYPOXIA	Objectives: To investigate the effects of recombinant human erythropoietin on brain oxygenation in a model of diffuse traumatic brain injury. Design: Adult male Wistar rats. Setting: Neurosciences and physiology laboratories. Interventions: Thirty minutes after diffuse traumatic brain injury (impact-acceleration model), rats were intravenously administered with either a saline solution or a recombinant human erythropoietin (5000 IU/kg). A third group received no traumatic brain injury insult (sham-operated). Measurements and Main Results: Three series of experiments were conducted 2 hours after traumatic brain injury to investigate: 1) the effect of recombinant human erythropoietin on brain edema using diffusion-weighted magnetic resonance imaging and measurements of apparent diffusion coefficient (n = 11 rats per group); local brain oxygen saturation, mean transit time, and blood volume fraction were subsequently measured using a multiparametric magnetic resonance-based approach to estimate brain oxygenation and brain perfusion in the neocortex and caudoputamen; 2) the effect of recombinant human erythropoietin on brain tissue PO2 in similar experiments (n = 5 rats per group); and 3) the cortical ultrastructural changes after treatment (n = 1 rat per group). Compared with the sham-operated group, traumatic brain injury saline rats showed a significant decrease in local brain oxygen saturation and in brain tissue PO2 alongside brain edema formation and microvascular lumen collapse at H2. Treatment with recombinant human erythropoietin reversed all of these traumatic brain injury-induced changes. Brain perfusion (mean transit time and blood volume fraction) was comparable between the three groups of animals. Conclusion: Our findings indicate that brain hypoxia can be related to microcirculatory derangements and cell edema without evidence of brain ischemia. These changes were reversed with post-traumatic administration of recombinant human erythropoietin, thus offering new perspectives in the use of this drug in brain injury. (Crit Care Med 2013; 41:1316-1324)	[Bouzat, Pierre; Millet, Anne; Boue, Yvonnick; Pernet-Gallay, Karin; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Payen, Jean-Francois] INSERM, U836, Grenoble, France; [Bouzat, Pierre; Millet, Anne; Boue, Yvonnick; Pernet-Gallay, Karin; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Payen, Jean-Francois] Univ Grenoble 1, Grenoble Inst Neurosci, Grenoble, France; [Bouzat, Pierre; Boue, Yvonnick; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Payen, Jean-Francois] Hop Michallon, Pole Anesthesie Reanimat, Grenoble, France; [Millet, Anne] Hop Couple Enfant, Dept Reanimat Pediat, Grenoble, France		Payen, JF (corresponding author), INSERM, U836, Grenoble, France.	jfpayen@ujf-grenoble.fr	Bouzat, Pierre/L-6881-2014; Bouzat, Pierre/AAC-4105-2019; Barbier, Emmanuel/E-6302-2011; Payen, Jean-Francois/L-6667-2014	Bouzat, Pierre/0000-0003-4667-6738; Barbier, Emmanuel/0000-0002-4952-1240; PERNET GALLAY, Karin/0000-0003-3468-3316	Institut National de la Sante et de la Recherche Medicale (INSERM), FranceInstitut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS), FranceCentre National de la Recherche Scientifique (CNRS); Fondation des Gueules-Cassees, France; Association pour la Recherche en Neonatologie, France; Ministere de l'Education, de la Recherche et de la Technologie, France; Hutchinson Tech.; NovonordiskNovo Nordisk	Supported, in part, by grants from Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Fondation des Gueules-Cassees, Association pour la Recherche en Neonatologie, and Ministere de l'Education, de la Recherche et de la Technologie, France.; Dr. Payen consulted for Biocodex, S.A., Baxter; has received grant support from Hutchinson Tech., Novonordisk; and received payment for lectures from Abbott, LFB, GE Healthcare, and Integra Lifescience. The remaining authors have not disclosed any potential conflicts of interest.	Abate MG, 2008, NEUROCRIT CARE, V9, P319, DOI 10.1007/s12028-008-9119-2; An HY, 2009, STROKE, V40, P2165, DOI 10.1161/STROKEAHA.108.540864; Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Christen T, 2012, MAGN RESON MED, V67, P1458, DOI 10.1002/mrm.23094; Christen T, 2012, RADIOLOGY, V262, P495, DOI 10.1148/radiol.11110518; Christen T, 2011, NMR BIOMED, V24, P393, DOI 10.1002/nbm.1603; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Diringer MN, 2011, NEUROCRIT CARE, V14, P11, DOI 10.1007/s12028-010-9465-8; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Gunnarson E, 2009, P NATL ACAD SCI USA, V106, P1602, DOI 10.1073/pnas.0812708106; He X, 2007, MAGN RESON MED, V57, P115, DOI 10.1002/mrm.21108; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kroppenstedt SN, 2003, CRIT CARE MED, V31, P2211, DOI 10.1097/01.CCM.0000080482.06856.62; Lemasson B, 2011, NMR BIOMED, V24, P473, DOI 10.1002/nbm.1611; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masamoto K, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3184694; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Menon DK, 2003, ANESTHESIOLOGY, V98, P805, DOI 10.1097/00000542-200304000-00002; Moriyama M, 2010, J NEUROSCI RES, V88, P2450, DOI 10.1002/jnr.22400; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Rao KVR, 2010, GLIA, V58, P1490, DOI 10.1002/glia.21023; Robertson CS, 2013, J NEUROTRAUM, V30, P765, DOI 10.1089/neu.2012.2431; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Shimosegawa E, 2005, ANN NEUROL, V57, P495, DOI 10.1002/ana.20427; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tropres I, 2001, MAGN RESON MED, V45, P397, DOI 10.1002/1522-2594(200103)45:3<397::AID-MRM1052>3.3.CO;2-V; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Valable S, 2008, NMR BIOMED, V21, P1043, DOI 10.1002/nbm.1278; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	47	22	23	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAY	2013	41	5					1316	1324		10.1097/CCM.0b013e31827ca64e			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	126ZB	WOS:000317661000035	23591210				2022-02-06	
J	Vanderploeg, RD; Belanger, HG				Vanderploeg, Rodney D.; Belanger, Heather G.			Screening for a Remote History of Mild Traumatic Brain Injury: When a Good Idea Is Bad	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mass screening; TBI; US Department of Defense; US Veterans Administration	SERVICES TASK-FORCE; HEAD-INJURY; POSTCONCUSSION SYNDROME; PROSTATE-CANCER; SYMPTOMS; CONCUSSION; ASSOCIATIONS; METAANALYSIS; EXPECTATION; DIAGNOSIS	Background: Both the Departments of Defense and Veterans Health Administration have developed and implemented screening procedures for identification of possible deployment-related traumatic brain injury (TBI). Objective: To review population-based screening procedures for TBI, particularly mild TBIs, and discuss potential harms/costs versus benefits of such TBI screening. Methods: The principles commonly used in population-based screening for various medical conditions are identified. These principles are applied to screening for TBI. The potential harms and costs are compared with potential benefits of screening for mild TBI. Results: The core conditions essential for beneficial medical screening-progressive disease, symptoms related to the identified disease, suitable tests or examinations for accurate diagnosis, and accepted and effective treatment-are not present within the context of TBI screening. Potential harms/costs outweigh any potential benefits of population-based screening for TBI. Conclusion: On the basis of generally accepted medical screening principles and assumptions, population screening for mild TBI is unnecessary at best and potentially harmful at worst. Because nonspecific, postconcussion-like symptoms can be effectively treated in a symptom-specific manner, tying them to concussion through a screening and evaluation process is wasteful and potentially harmful.	[Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley VA Hosp, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley VA Hosp, Dept Hlth Serv Res & Dev HSR&D, Rehabil Res & Dev RR&D Ctr Excellence Maximizing, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] James A Haley VA Hosp, Dept Psychol, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Tampa, FL USA; [Vanderploeg, Rodney D.; Belanger, Heather G.] Def & Vet Brain Injury Ctr, Tampa, FL USA		Vanderploeg, RD (corresponding author), James A Haley VA Hosp, Dept Mental Hlth & Behav Sci, 13000 N Bruce B Downs Blvd, Tampa, FL 33612 USA.	rodney.vanderploeg@va.gov					Amara JH, 2011, 3 FED INT C TRAUM BR; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Belanger HG, HDB NEUROPSYCHOLOGY; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Cifu DX, 2010, VHA POL C ORL FL; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU, V2009; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Ferguson RJ, 1999, NEUROPSYCHOLOGY, V13, P582, DOI 10.1037/0894-4105.13.4.582; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Ponsford J, 2002, J NEUROL NEUROSUR PS, V73, P330, DOI 10.1136/jnnp.73.3.330; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Post-Deployment Health Group, 2012, ANN VA HLTH CAR UT O, V2012; Sayer NA, 2011, J HEAD TRAUMA REHAB, V26, P454, DOI 10.1097/HTR.0b013e3181ff393c; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Streiner DL, 2003, J PERS ASSESS, V81, P209, DOI 10.1207/S15327752JPA8103_03; Suhr JA, 2005, J INT NEUROPSYCH SOC, V11, P23, DOI 10.1017/S1355617705050010; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P279, DOI 10.1007/0-387-25610-5_16; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilson JMG, 1968, PRINCIPLES PRACTICE	36	22	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2013	28	3					211	218		10.1097/HTR.0b013e31828b50db			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	149PS	WOS:000319334000008	23661073				2022-02-06	
J	Clond, MA; Lee, BS; Yu, JJ; Singer, MB; Amano, T; Lamb, AW; Drazin, D; Kateb, B; Ley, EJ; Yu, JS				Clond, Morgan A.; Lee, Bong-Seop; Yu, Jeffrey J.; Singer, Matthew B.; Amano, Takayuki; Lamb, Alexander W.; Drazin, Doniel; Kateb, Babak; Ley, Eric J.; Yu, John S.			Reactive Oxygen Species-Activated Nanoprodrug of Ibuprofen for Targeting Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; VITAMIN-E; NEURODEGENERATIVE DISEASES; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; UNITED-STATES; CARE-UNIT	Traumatic brain injury (TBI) is an enormous public health problem, with 1.7 million new cases of TBI recorded annually by the Centers for Disease Control. However, TBI has proven to be an extremely challenging condition to treat. Here, we apply a nanoprodrug strategy in a mouse model of TBI. The novel nanoprodrug contains a derivative of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen in an emulsion with the antioxidant a-tocopherol. The ibuprofen derivative, Ibu(2)TEG, contains a tetra ethylene glycol (TEG) spacer consisting of biodegradable ester bonds. The biodegradable ester bonds ensure that the prodrug molecules break down hydrolytically or enzymatically. The drug is labeled with the fluorescent reporter Cy5.5 using nonbiodegradable bonds to 1-octadecanethiol, allowing us to reliably track its accumulation in the brain after TBI. We delivered a moderate injury using a highly reproducible mouse model of closed-skull controlled cortical impact to the parietal region of the cortex, followed by an injection of the nanoprodrug at a dose of 0.2 mg per mouse. The blood brain barrier is known to exhibit increased permeability at the site of injury. We tested for accumulation of the fluorescent drug particles at the site of injury using confocal and bioluminescence imaging of whole brains and brain slices 36 hours after administration. We demonstrated that the drug does accumulate preferentially in the region of injured tissue, likely due to an enhanced permeability and retention (EPR) phenomenon. The use of a nanoprodrug approach to deliver therapeutics in TBI represents a promising potential therapeutic modality.	[Clond, Morgan A.; Singer, Matthew B.; Lamb, Alexander W.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Lee, Bong-Seop; Yu, Jeffrey J.; Amano, Takayuki; Drazin, Doniel; Kateb, Babak; Yu, John S.] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA		Yu, JS (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA.	John.Yu@cshs.org		Yu, John/0000-0003-1230-8494; Clond, Morgan/0000-0002-3036-4193; Kateb, Babak/0000-0001-7546-7543	American Association for the Surgery of Trauma; Department of Health Services Division of Trauma Research	This study was sponsored by grants from the American Association for the Surgery of Trauma and the Department of Health Services Division of Trauma Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Afshari D, 2012, CLIN NEUROLOGY NEURO; [Anonymous], 1999, WISQARS YEARS POT LI; Bernardi A, 2012, INT J NANOMED, V7, P4927, DOI 10.2147/IJN.S35333; Bonina FP, 2001, EUR J PHARM SCI, V14, P123, DOI 10.1016/S0928-0987(01)00163-4; Botteri M, 2008, CRIT CARE MED, V36, P3089, DOI 10.1097/CCM.0b013e31818bd7df; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; BURTON GW, 1982, LANCET, V2, P327; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chassidim Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-9; Chung ES, 2012, BRAIN RES, V1451, P110, DOI 10.1016/j.brainres.2012.02.058; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Cote S, 2012, ALZHEIMERS DEMENT, V8, P219, DOI 10.1016/j.jalz.2011.03.012; Dannhardt G, 2001, EUR J MED CHEM, V36, P109, DOI 10.1016/S0223-5234(01)01197-7; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gilgun-Sherki Y, 2001, NEUROPHARMACOLOGY, V40, P959, DOI 10.1016/S0028-3908(01)00019-3; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; HALLIWELL B, 1989, ACTA NEUROL SCAND, V80, P23, DOI 10.1111/j.1600-0404.1989.tb01779.x; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hein AM, 2009, MOL NEUROBIOL, V40, P15, DOI 10.1007/s12035-009-8066-z; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Iadecola C, 2005, STROKE, V36, P182, DOI 10.1161/01.STR.0000153797.33611.d8; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Langham J., 2003, COCHRANE DATABASE SY; Lee BS, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/980720; Lee BS, 2009, INT J PHARMACEUT, V372, P112, DOI 10.1016/j.ijpharm.2008.12.037; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin Y, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/16/165101; LINDGREN S, 1966, RADIAT ENVIRON BIOPH, V3, P174, DOI DOI 10.1007/BF01191611; Liu ML, 2012, NEUROSCI LETT, V508, P31, DOI 10.1016/j.neulet.2011.12.010; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu WY, 1997, NEUROSURGERY, V41, P416, DOI 10.1097/00006123-199708000-00017; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Muehlschlegel S, 2009, NEUROCRIT CARE, V10, P103, DOI 10.1007/s12028-008-9133-4; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niki E, 2004, ACCOUNTS CHEM RES, V37, P45, DOI 10.1021/ar030069m; Nogawa S, 1997, J NEUROSCI, V17, P2746; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Rigotti A, 2007, MOL ASPECTS MED, V28, P423, DOI 10.1016/j.mam.2007.01.002; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Siskou IC, 2007, BIOORGAN MED CHEM, V15, P951, DOI 10.1016/j.bmc.2006.10.056; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; TAMMARA VK, 1993, PHARM RES-DORDR, V10, P1191, DOI 10.1023/A:1018976520391; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman DJ, 2001, EPIDEMIOLOGY EC HEAD, P1193; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Viscomi MT, 2008, CEREBELLUM, V7, P401, DOI 10.1007/s12311-008-0042-z; Wallenquist U, 2012, RESTOR NEUROL NEUROS, V30, P9, DOI 10.3233/RNN-2011-0606; Warden SJ, 2010, PHYSICIAN SPORTSMED, V38, P132, DOI 10.3810/psm.2010.04.1770; Xu J, NATL VITAL STAT REPO, V58, P19; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	75	22	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2013	8	4							e61819	10.1371/journal.pone.0061819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136DE	WOS:000318340400053	23637912	Green Published, Green Submitted, gold			2022-02-06	
J	Salido, EM; Dorfman, D; Bordone, M; Chianelli, M; Fleitas, MFG; Rosenstein, RE				Salido, Ezequiel M.; Dorfman, Damian; Bordone, Melina; Chianelli, Monica; Gonzalez Fleitas, Maria Florencia; Rosenstein, Ruth E.			Global and Ocular Hypothermic Preconditioning Protect the Rat Retina from Ischemic Damage	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GANGLION-CELLS; GLUTAMINE-SYNTHETASE; CIRCULATORY ARREST; LOCAL HYPOTHERMIA; NMDA RECEPTORS; NEURONS; MECHANISMS; INDUCTION; TOLERANCE	Retinal ischemia could provoke blindness. At present, there is no effective treatment against retinal ischemic damage. Strong evidence supports that glutamate is implicated in retinal ischemic damage. We investigated whether a brief period of global or ocular hypothermia applied 24 h before ischemia (i.e. hypothermic preconditioning, HPC) protects the retina from ischemia/reperfusion damage, and the involvement of glutamate in the retinal protection induced by HPC. For this purpose, ischemia was induced by increasing intraocular pressure to 120 mm Hg for 40 min. One day before ischemia, animals were submitted to global or ocular hypothermia (33 degrees C and 32 degrees C for 20 min, respectively) and fourteen days after ischemia, animals were subjected to electroretinography and histological analysis. Global or ocular HPC afforded significant functional (electroretinographic) protection in eyes exposed to ischemia/reperfusion injury. A marked alteration of the retinal structure and a decrease in retinal ganglion cell number were observed in ischemic retinas, whereas global or ocular HPC significantly preserved retinal structure and ganglion cell count. Three days after ischemia, a significant decrease in retinal glutamate uptake and glutamine synthetase activity was observed, whereas ocular HPC prevented the effect of ischemia on these parameters. The intravitreal injection of supraphysiological levels of glutamate induced alterations in retinal function and histology which were significantly prevented by ocular HPC. These results support that global or ocular HPC significantly protected retinal function and histology from ischemia/reperfusion injury, probably through a glutamate-dependent mechanism.	[Salido, Ezequiel M.; Dorfman, Damian; Bordone, Melina; Chianelli, Monica; Gonzalez Fleitas, Maria Florencia; Rosenstein, Ruth E.] Univ Buenos Aires, Dept Human Biochem, CEFyBO,CONICET, Lab Retinal Neurochem & Expt Ophthalmol,Sch Med, Buenos Aires, DF, Argentina		Rosenstein, RE (corresponding author), Univ Buenos Aires, Dept Human Biochem, CEFyBO,CONICET, Lab Retinal Neurochem & Expt Ophthalmol,Sch Med, Buenos Aires, DF, Argentina.	ruthr@fmed.uba.ar	Salido, Ezequiel Martin/AAF-7166-2021	Salido, Ezequiel Martin/0000-0003-3741-3389; Bordone, Melina/0000-0003-4912-228X; Gonzalez Fleitas, Maria Florencia/0000-0001-5795-8365	Agencia Nacional de Promocion Cientifica y TecnologicaANPCyT; University of Buenos AiresUniversity of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas, ArgentinaConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	This research was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica; The University of Buenos Aires; and Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 1998, EUR J PHARMACOL, V350, P53, DOI 10.1016/S0014-2999(98)00317-3; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Bhagatte Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.84; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Birnbaum Y, 1997, CIRCULATION, V96, P1641, DOI 10.1161/01.CIR.96.5.1641; BUCHAN A, 1992, NEUROL CLIN, V10, P49, DOI 10.1016/S0733-8619(18)30233-0; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Cambria RP, 1997, J VASC SURG, V25, P234, DOI 10.1016/S0741-5214(97)70365-3; Cazevieille C, 1997, BRAIN RES, V755, P91, DOI 10.1016/S0006-8993(97)00090-5; Corbett D, 2000, EXP NEUROL, V163, P200, DOI 10.1006/exnr.2000.7369; Dave KR, 2006, NEUROSCI LETT, V404, P170, DOI 10.1016/j.neulet.2006.05.037; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; FABEROWSKI N, 1989, INVEST OPHTH VIS SCI, V30, P2309; Faridar Alireza, 2011, Front Neurol, V2, P80, DOI 10.3389/fneur.2011.00080; Fernandez DC, 2009, J NEUROCHEM, V111, P488, DOI 10.1111/j.1471-4159.2009.06334.x; Franco PJ, 2008, INVEST OPHTH VIS SCI, V49, P4604, DOI 10.1167/iovs.08-2054; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; IKEDA H, 1992, EXP EYE RES, V55, P435, DOI 10.1016/0014-4835(92)90116-A; IVERSEN L L, 1991, Eye (London), V5, P194; Izumi Y, 2003, VISUAL NEUROSCI, V20, P97, DOI 10.1017/S0952523803202017; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; KATO H, 1992, NEUROSCI LETT, V139, P118, DOI 10.1016/0304-3940(92)90871-4; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Kwong JMK, 2003, BRAIN RES, V970, P119, DOI 10.1016/S0006-8993(03)02298-4; Leben J, 1997, ANN NY ACAD SCI, V813, P807, DOI 10.1111/j.1749-6632.1997.tb51785.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027; MOSINGER JL, 1991, EXP NEUROL, V113, P10, DOI 10.1016/0014-4886(91)90140-8; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NAKATA N, 1993, NEUROREPORT, V4, P695, DOI 10.1097/00001756-199306000-00023; NAYAK MS, 1995, CURR EYE RES, V14, P81, DOI 10.3109/02713689508999918; NEAL MJ, 1994, J NEUROCHEM, V62, P1025; Ning XH, 1998, AM J PHYSIOL-HEART C, V274, pH786, DOI 10.1152/ajpheart.1998.274.3.H786; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Nishio S, 2000, J NEUROSURG, V93, P845, DOI 10.3171/jns.2000.93.5.0845; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Poitry S, 2000, J NEUROSCI, V20, P1809; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Quinones-Hinojosa A, 2003, NEUROSURGERY, V52, P1178, DOI 10.1227/01.NEU.0000057836.64972.A0; RIEPE RE, 1977, NATURE, V268, P654, DOI 10.1038/268654a0; Roth S, 2004, BRAIN RES BULL, V62, P461, DOI 10.1016/j.brainresbull.2003.07.006; Roth S, 1998, INVEST OPHTH VIS SCI, V39, P777; Sakamoto K, 2004, BRAIN RES, V1015, P154, DOI 10.1016/j.brainres.2004.04.074; SARTHY PV, 1978, J CELL BIOL, V78, P675, DOI 10.1083/jcb.78.3.675; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; SOLOMON RA, 1991, NEUROSURGERY, V29, P732, DOI 10.1227/00006123-199111000-00015; Sumioka K, 2000, INVEST OPHTH VIS SCI, V41, P29; Tamai K, 1997, EXP EYE RES, V65, P733, DOI 10.1006/exer.1997.0386; THARION J, 1982, J THORAC CARDIOV SUR, V84, P66; Thoreson WB, 1999, PROG RETIN EYE RES, V18, P765, DOI 10.1016/S1350-9462(98)00031-7; Wang RB, 2010, J NEUROTRAUM, V27, P763, DOI 10.1089/neu.2009.1005; Wang XD, 2002, NEUROL RES, V24, P730, DOI 10.1179/016164102101200663; Yunoki M, 2002, J NEUROSURG, V97, P650, DOI 10.3171/jns.2002.97.3.0650	54	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61656	10.1371/journal.pone.0061656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	WOS:000318008400075	23626711	Green Published, Green Submitted, gold			2022-02-06	
J	Giacino, JT; Katz, DI; Whyte, J				Giacino, Joseph T.; Katz, Douglas I.; Whyte, John			Neurorehabilitation in Disorders of Consciousness	SEMINARS IN NEUROLOGY			English	Article						disorders of consciousness; vegetative state; minimally conscious state; rehabilitation; outcome	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; VEGETATIVE STATE; INTRATHECAL BACLOFEN; SENSORY STIMULATION; RECOVERY; COMA; ZOLPIDEM; SCALE; REHABILITATION	Survivors of severe acquired brain injury often experience prolonged disturbance in consciousness following emergence from coma. Most individuals pass through the vegetative or minimally conscious states en route to eventual recovery of consciousness, although either condition may be permanent. Rehabilitation clinicians charged with the care of these patients face numerous challenges as there are many open questions concerning diagnostic and prognostic accuracy, the natural history of recovery, and the most effective approaches to prevent medical complications and facilitate functional recovery. The last 5 years have been witness to a marked increase in well-designed empirical investigations concerning the rehabilitation of patients with disorders of consciousness. In this article, the authors review recent evidence concerning key factors that influence the course of recovery, present a model of care designed to mitigate medical complications, describe a systematic approach to assessment, and review the effectiveness of treatment interventions utilized in the rehabilitation setting.	[Giacino, Joseph T.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Katz, Douglas I.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Katz, Douglas I.] Braintree Rehabil, Acquired Brain Injury Program, Braintree, MA USA; [Whyte, John] Albert Einstein Healthcare Network, Moss Rehabil Res Inst, Elkins Pk, PA USA		Giacino, JT (corresponding author), Spaulding Rehabil Hosp, 300 1st Ave, Charlestown, MA 02129 USA.	jgiacino@partners.org	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Katz, Douglas/0000-0002-7502-8505; Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education [H133A120085, H133A070030, H133A070040]	The content of this manuscript was developed under grants from the National Institute on Disability and Rehabilitation Research, United States Department of Education H133A120085 [Spaulding Rehabilitation Hospital]; H133A070030 [JFK-Johnson Rehabilitation Institute TBI Model System]; and H133A070040 [Moss TBI Model System]. However, this content does not necessarily represent the policy of the Department of Education, and endorsement by the federal government should not be assumed.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; [Anonymous], 2006, MOHONK REPORT DISORD; [Anonymous], 2004, HEADACHE, V44, P628; [Anonymous], 2012, OCTOBER; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWAL S, 1995, NEW ENGL J MED, V333, P130, DOI 10.1056/NEJM199507133330216; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Childs NL, 1996, NEW ENGL J MED, V334, P24, DOI 10.1056/NEJM199601043340105; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; DiPasquale MC, 1996, J HEAD TRAUMA REHAB, V11, P9, DOI 10.1097/00001199-199612000-00004; Eifert B, ARCH PHYS M IN PRESS; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Formisano R, 2001, Ann Ist Super Sanita, V37, P627; Fridman EA, 2010, BRAIN INJURY, V24, P636, DOI 10.3109/02699051003610433; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Giacino JT, 2005, REHABILITATION TRAUM, P305; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Hagen C, 1979, REHABILITATION HEAD; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; Hamilton B. B., 1987, UNIFORM NATL DATA SY; JOHNSON DA, 1993, BRAIN INJURY, V7, P491, DOI 10.3109/02699059309008176; KANNO T, 1987, PACE, V10, P207, DOI 10.1111/j.1540-8159.1987.tb05949.x; Kanno T, 2009, NEUROMODULATION, V12, P33, DOI 10.1111/j.1525-1403.2009.00185.x; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kawecki Zdzislaw, 2007, Przegl Lek, V64 Suppl 2, P13; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Koeda T, 1998, BRAIN DEV-JPN, V20, P124, DOI 10.1016/S0387-7604(98)00004-7; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Leong B, 2002, BRAIN INJURY, V16, P217, DOI 10.1080/02699050110103283; Lombardi F, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD001427; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Martin RT, 2007, AM J PHYS MED REHAB, V86, P613, DOI 10.1097/PHM.0b013e3181154a84; Matsuda W, 2005, NEUROPSYCHOL REHABIL, V15, P414, DOI 10.1080/09602010443000588; McNamee S, 2012, J HEAD TRAUMA REHAB, V27, P244, DOI 10.1097/HTR.0b013e31825e12c8; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Nakase-Richardson R, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127795; Nakase-Richardson R, 2011, J NEUROTRAUM, V28, P1; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Passler MA, 2001, ARCH PHYS MED REHAB, V82, P311, DOI 10.1053/apmr.2001.20831; Patrick PD, 2006, J CHILD NEUROL, V21, P879, DOI 10.1177/08830738060210100901; Piccione F, 2011, NEUROREHAB NEURAL RE, V25, P98, DOI 10.1177/1545968310369802; PIERCE J P, 1990, Brain Injury, V4, P191, DOI 10.3109/02699059009026165; Plum F., 1982, DIAGNOSIS STUPOR COM, V3rd; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; Sara M, 2009, ARCH PHYS MED REHAB, V90, P1245, DOI 10.1016/j.apmr.2009.01.012; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schnakers C, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.124099; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Shavelle RM, 2001, AM J PHYS MED REHAB, V80, P510, DOI 10.1097/00002060-200107000-00009; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Singh R, 2008, BRAIN INJURY, V22, P103, DOI 10.1080/02699050701829704; Smart CM, 2008, NAT CLIN PRACT NEURO, V4, P448, DOI 10.1038/ncpneuro0823; Soddu A, 2009, PROG BRAIN RES, V177, P261, DOI 10.1016/S0079-6123(09)17718-X; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Taira T, 2007, ACTA NEUROCHIR SUPPL, V97, P227; Taira T, 2009, PROG BRAIN RES, V177, P317, DOI 10.1016/S0079-6123(09)17721-X; TANHEHCO J, 1982, ARCH PHYS MED REHAB, V63, P36; TEASDALE G, 1974, LANCET, V2, P81; Timmons M, 1987, J HEAD TRAUMA REHAB, V2, P64; TRESCH DD, 1991, ARCH INTERN MED, V151, P930, DOI 10.1001/archinte.151.5.930; Tsubokawa T, 1990, Brain Inj, V4, P315; Vanhaudenhuyse A, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.121624; Volker J, 2012, BIOMED TECH BERL; Wang MC, 2007, J TRAUMA, V62, P1250, DOI 10.1097/01.ta.0000215581.50234.56; Whyte J, 1999, ARCH PHYS MED REHAB, V80, P653, DOI 10.1016/S0003-9993(99)90168-5; Whyte J, 2010, DELISAS PHYS MED REH, V5, P575; Whyte J, ARCH PHYS M IN PRESS; Whyte J, 2009, AM J PHYS MED REHAB, V88, P410, DOI 10.1097/PHM.0b013e3181a0e3a0; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; Wilson SL, 1996, BRAIN INJURY, V10, P807, DOI 10.1080/026990596123927; Wood R L, 1992, Brain Inj, V6, P411, DOI 10.3109/02699059209008137; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353	101	22	22	0	14	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	APR	2013	33	2					142	156		10.1055/s-0033-1348960			15	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	188VS	WOS:000322225300008	23888398				2022-02-06	
J	Goldberg, DS				Goldberg, Daniel S.			Mild Traumatic Brain Injury, the National Football League, and the Manufacture of Doubt: An Ethical, Legal, and Historical Analysis	JOURNAL OF LEGAL MEDICINE			English	Article							SOCIAL CONDITIONS; PUBLIC-HEALTH; FUNDAMENTAL CAUSES; LONG ARM; PLAYERS; RACISM; EPIDEMIOLOGY; INEQUALITIES; CONCUSSION; EDUCATION		E Carolina Univ, Dept Bioeth & Interdisciplinary Studies, Greenville, NC 27858 USA		Goldberg, DS (corresponding author), E Carolina Univ, Dept Bioeth & Interdisciplinary Studies, Greenville, NC 27858 USA.	Goldbergd@ecu.edu					Abrams Douglas E., 2012, MISS SPORTS L REV, V2, P25; Abrams Douglas E., 2012, MISS SPORTS L REV, V2, P1; Abrams HK, 2001, J PUBLIC HEALTH POL, V22, P34, DOI 10.2307/3343553; Al Hazzouri AZ, 2011, J AGING HEALTH, V23, P1027, DOI 10.1177/0898264311421524; ALFRED LORD TENNYSON, 1964, CHARGE LIGHT BRIGADE, V1; [Anonymous], 2009, 111 C, P138; [Anonymous], 2011, BROWNS SAY COLT MCCO; [Anonymous], 2011, COMMUNICATION; Barnes LL, 2012, J INT NEUROPSYCH SOC, V18, P856, DOI 10.1017/S1355617712000628; Bashford Alison, 2007, Med Humanit, V33, P87, DOI 10.1136/jmh.2006.000251; Battista J., 2011, NY TIMES; Baugh Christine M., 2012, BOSTON U CTR STUDY T, P9; Beamon K., 2008, J NEGRO EDUC, V77, P352; Beauchamp T., 1981, HUME PROBLEM CAUSATI; BEAUCHAMP TL, 1975, AM PHILOS QUART, V12, P119; Birn A.E., 2009, SOCIAL MED, V4, P166; BRODY HOWARD, 2007, HOOKED; Buchanan Neil H., 2013, RACE EXPLOITATION FO; Caladrone Justin P., 2002, SPORTS LAW J, V9, P131; Cartwright N., 1999, DAPPLED WORLD STUDY; Chang VW, 2009, J HEALTH SOC BEHAV, V50, P245, DOI 10.1177/002214650905000301; Cranor C. F, 1993, REGULATING TOXIC SUB; Ctrs. for Disease Control& Prevention, 2012, CONC ABCS LEARN RESP; De Ville Kenneth, 2002, Account Res, V9, P17; Denner K, 2004, SETON HALL J SPORTS, V14, P209; Denner Keya, 2004, SETON HALL J SPORTS, V14, P217; DEVILLE K, 1992, MED MALPRACTICE 19 C; Edwards H, 2000, SOCIETY, V37, P9, DOI 10.1007/BF02686167; Epstein R., 2004, BROOKLYN LAW R, V69, P1421; Epstein RA, 2003, PERSPECT BIOL MED, V46, pS138, DOI 10.1353/pbm.2003.0051; ESPN.com, 2012, SCOTT FUJ CRIT ROG G; Faden R., 2006, SOCIAL JUSTICE MORAL; Fainaru-Wada Mark, 2012, NFL REPORTS REAMIN I; Fairchild AL, 2010, AM J PUBLIC HEALTH, V100, P54, DOI 10.2105/AJPH.2009.163956; Family Med. Assocs, 2012, NEW CONC GUID CHILDR; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Feinberg Kenneth R., 1987, HOUS L REV, V24, P155; Feinberg Kenneth R., 1987, HOUS L REV, V24, P160; Feyerabend P.K, 1987, FAREWELL REASON; Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296; Gatmen, 2011, SEATTLE J SOC JUSTIC, V10, P509; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gee GC, 2011, DU BOIS REV, V8, P115, DOI 10.1017/S1742058X11000130; Gee GC, 2012, AM J PUBLIC HEALTH, V102, P967, DOI 10.2105/AJPH.2012.300666; Geertz Clifford, 1973, INTERPRETATION CULTU, V412, P449; Gilbert F., 2011, AJOB NEUROSCIENCE, V2, P48, DOI [DOI 10.1080/21507740.2011.611125, https://doi.org/10.1080/21507740.2011.611125]; Glymour MM, 2008, NEUROPSYCHOL REV, V18, P194, DOI 10.1007/s11065-008-9066-x; Gol'dshtein D V, 2012, Vestn Ross Akad Med Nauk, P16; Goldberg D. S., 2013, GLOBALIZATION HLTH C, P403; Goldberg DS, 2012, PUBLIC HEALTH ETH-UK, V5, P104, DOI 10.1093/phe/phs013; Goldberg DS, 2012, AM J PUBLIC HEALTH, V102, P44, DOI 10.2105/AJPH.2011.300325; Goldberg DS, 2011, B HIST MED, V85, P1, DOI 10.1353/bhm.2011.0011; Goldberg DS, 2008, HEC FORUM, V20, P337, DOI 10.1007/s10730-008-9079-0; Grant Otis B, 2002, WHITTIER L REV, V24, P645; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gutmann A, 2002, ETHICAL DIMENSIONS H, P77; HAMLIN CHRISTOPHER, 1998, CHRISTOPHER HAMLIN P, P1800; Hayward MD, 2004, DEMOGRAPHY, V41, P87, DOI 10.1353/dem.2004.0005; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Imwinkelried EJ, 1995, IOWA LAW REV, V81, P55; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Krimsky Sheldon., 2004, SCI PRIVATE INTEREST; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Kuh D., 2004, LIFE COURSE APPROACH, V2nd; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Levy Alan H., 2003, TACKLING JIM CROW RA; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lomax ME, 1999, J SOC HIST, V33, P163, DOI 10.1353/jsh.1999.0017; Lomax ME, 2000, SOCIETY, V37, P21, DOI 10.1007/BF02686169; MacKenzie R, 2004, TOB CONTROL, V13, P79, DOI 10.1136/tc.2004.009233; Markowitz G, 2000, AM J PUBLIC HEALTH, V90, P36, DOI 10.2105/AJPH.90.1.36; Markowitz G., 2002, DECEIT DENIAL DEADLY; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; McCrory P., 2008, CONS STAT CONC SPORT, P43; McKee A, 2012, BRAIN A J NEUROL, V1, P1; Melendez MC, 2008, J BLACK PSYCHOL, V34, P423, DOI 10.1177/0095798408319874; MICHAELS DAVID, 2008, DOUBT IS THEIR PRODU, pX; Miller G, 2009, SCIENCE, V325, P670, DOI 10.1126/science.325_670; Mitten Matthew J., 2005, ST LOUIS U L J, V50, P211; Modin B, 2009, INT J EPIDEMIOL, V38, P733, DOI 10.1093/ije/dyp001; Mortensen Chris, 2011, SOURCE SYSTEM FAILUR; Munthe C, 2011, INT LIBR ETH LAW TEC, V6, P1, DOI 10.1007/978-94-007-1330-7; Najman JM, 2004, SOC SCI MED, V58, P1147, DOI 10.1016/S0277-9536(03)00286-7; NCAA, 2009 2010 STUD ATHL; NCAA, 2011, STUD ATHLET PART, P138; Noone Peter, 2009, Occup Med (Lond), V59, P209; NOWINSKI CHRISTOPHER, 2006, HEAD GAMES; Okasha S, 2001, PHILOS QUART, V51, P307, DOI 10.1111/1467-9213.00231; Overly Kathleen B., 2005, VA SPORTS ENT L J, V5, P31; Parascandola M, 2001, J EPIDEMIOL COMMUN H, V55, P905, DOI 10.1136/jech.55.12.905; Parmet W.E., 2000, ANNU REV PUBL HEALTH, V21, P445; Parmet WE, 2000, ANNU REV PUBL HEALTH, V21, P437, DOI 10.1146/annurev.publhealth.21.1.437; Phelan JC, 2010, J HEALTH SOC BEHAV, V51, pS28, DOI 10.1177/0022146510383498; Podberesky DJ, 2009, PEDIATR RADIOL, V39, P1264, DOI 10.1007/s00247-009-1359-6; Quanstrum KH, 2010, NEW ENGL J MED, V363, P1076, DOI 10.1056/NEJMsb1002538; Riis Jacob, 1890, OTHER HALF LIVES STU; ROSEN G, 1993, HIST PUBLIC HLTH; Rosner D, 1995, HIVES SICKNESS PUBLI; Rosner D, 2007, AM J IND MED, V50, P740, DOI 10.1002/ajim.20435; Schwarz Alan, 2007, NY TIMES; Sharek Z, 2012, J LAW MED ETHICS, V40, P368, DOI 10.1111/j.1748-720X.2012.00670.x; Shavers VL, 2006, J NATL MED ASSOC, V98, P386; Sherek Zahariah, 2012, J LAW MED ETHICS, V40, P376; Sloan FA, 2005, J GERONTOL B-PSYCHOL, V60, pP242, DOI 10.1093/geronb/60.5.P242; Smith S., 1911, CITY WAS; Stark Andrew., 2003, CONFLICT INTEREST AM; Starr Paul, 1982, SOCIAL TRANSFORMATIO; SZRETER SIMON, 2004, HLTH WEALTH STUDIES, P3; TAYLOR R, 1985, INT J HEALTH SERV, V15, P547, DOI 10.2190/XX9V-ACD4-KUXD-C0E5; Teplin LA, 2005, ARCH GEN PSYCHIAT, V62, P911, DOI 10.1001/archpsyc.62.8.911; Tesh Sylvia Noble, 2000, UNCERTAIN HAZARDS EN; Thompson DennisF., 2004, WHY DELIBERATIVE DEM; Wagner WE, 2004, DUKE LAW J, V53, P1619; Weed DL, 2004, J MED PHILOS, V29, P313, DOI 10.1080/03605310490500527; Wiggins David K., 2012, WAKE FOREST J LAW PO, V2, P95; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Woodlief Jennifer Lynn, 1991, ENT SPORTS L, V9, P3; [No title captured]	118	22	22	1	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0194-7648	1521-057X		J LEGAL MED	J. Legal Med.	APR 1	2013	34	2					157	191		10.1080/01947648.2013.800792			35	Law; Social Sciences, Biomedical	Social Science Citation Index (SSCI)	Government & Law; Biomedical Social Sciences	166QH	WOS:000320571700001	23781860				2022-02-06	
J	Lin, C; Wang, N; Shen, ZP; Zhao, ZY				Lin, Chao; Wang, Ning; Shen, Zhi-Peng; Zhao, Zheng-Yan			Plasma copeptin concentration and outcome after pediatric traumatic brain injury	PEPTIDES			English	Article						Copeptin; Traumatic brain injury; Functional outcome; Mortality	UMBILICAL-CORD BLOOD; STABLE PEPTIDE; VASOPRESSIN PRECURSOR; PROGNOSTIC VALUE; PRACTICAL SCALE; PRETERM INFANTS; HEART-FAILURE; SEVERITY; SHOCK; HEMORRHAGE	Higher plasma copeptin level has been associated with poor outcomes of critical illness. The present study was undertaken to investigate the plasma copeptin concentrations in children with traumatic brain injury (TBI) and to analyze the correlation of copeptin with disease outcome. Plasma copeptin concentrations of 126 healthy children and 126 children with acute severe TBI were measured by enzyme-linked immunosorbent assay. Twenty-one patients (16.7%) died and 38 patients (30.2%) had an unfavorable outcome (Glasgow Outcome Scale score of 1-3) at 6 months. Plasma copeptin level was obviously higher in patients than in healthy children (46.2 +/- 20.8 pmol/L vs. 9.6 +/- 3.0 pmol/L, P < 0.001). Plasma copeptin level was identified as an independent predictor for 6-month mortality [odds ratio (OR) 1.261, 95% confidence interval (CI) 1.112-1.538, P=0.005] and unfavorable outcome (OR 1.313, 95% CI 1.146-1.659, P=0.003). The predictive value of copeptin was similar to that of Glasgow Coma Scale (GCS) score for 6-month mortality [area under curve (AUC) 0.832, 95% CI 0.755-0.892 vs. AUC 0.873, 95% CI 0.802-0.926, P=0.412] and unfavorable outcome (AUC 0.863, 95% CI 0.790-0.918 vs. AUC 0.885, 95% CI 0.816-0.935, P=0.596). Copeptin improved the AUC of GCS score for 6-month unfavorable outcome (AUC 0.929, 95% CI 0.869-0.967, P=0.013), but not for 6-month mortality (AUC 0.887, 95% CI 0.818-0.936, P=0.600). Thus, plasma copeptin level represents a novel biomarker for predicting 6-month clinical outcome in children with TBI. (c) 2013 Elsevier Inc. All rights reserved.	[Lin, Chao; Wang, Ning; Shen, Zhi-Peng] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Zheng-Yan] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Child Hlth Care, Hangzhou 310003, Zhejiang, Peoples R China		Zhao, ZY (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Dept Child Hlth Care, 57 Zhugan Lane, Hangzhou 310003, Zhejiang, Peoples R China.	hzzzylc@163.com					Asfar P, 2006, CRIT CARE CLIN, V22, P131, DOI 10.1016/j.ccc.2005.08.007; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benzing J, 2011, J CLIN ENDOCR METAB, V96, pE982, DOI 10.1210/jc.2010-2858; Choong K, 2008, PEDIATR CRIT CARE ME, V9, P372, DOI 10.1097/PCC.0b013e318172d7c8; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; JENNETT B, 1975, LANCET, V1, P480; Jochberger S, 2009, INTENS CARE MED, V35, P489, DOI 10.1007/s00134-008-1279-1; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kelly D, 2008, J CARD FAIL, V14, P739, DOI 10.1016/j.cardfail.2008.07.231; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Koch L, 2011, HORM RES PAEDIAT, V76, P234, DOI 10.1159/000329285; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Schlapbach LJ, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-38; Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.x; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; TEASDALE G, 1974, LANCET, V2, P81; TEPAS JJ, 1987, J PEDIATR SURG, V22, P14, DOI 10.1016/S0022-3468(87)80006-4; Treschan TA, 2006, ANESTHESIOLOGY, V105, P599, DOI 10.1097/00000542-200609000-00026; Urwyler SA, 2010, STROKE, V41, P1564, DOI 10.1161/STROKEAHA.110.584649; Wellmann S, 2010, J CLIN ENDOCR METAB, V95, P5091, DOI 10.1210/jc.2010-1331; Yu GF, 2012, PEPTIDES, V33, P164, DOI 10.1016/j.peptides.2011.11.017; Zhu XD, 2011, CRIT CARE, V15, DOI 10.1186/cc10575; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	27	22	24	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781			PEPTIDES	Peptides	APR	2013	42						43	47		10.1016/j.peptides.2013.01.015			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	165OI	WOS:000320492800006	23402790				2022-02-06	
J	Al Nimer, F; Strom, M; Lindblom, R; Aeinehband, S; Bellander, BM; Nyengaard, JR; Lidman, O; Piehl, F				Al Nimer, Faiez; Strom, Mikael; Lindblom, Rickard; Aeinehband, Shahin; Bellander, Bo-Michael; Nyengaard, Jens R.; Lidman, Olle; Piehl, Fredrik			Naturally Occurring Variation in the Glutathione-S-Transferase 4 Gene Determines Neurodegeneration After Traumatic Brain Injury	ANTIOXIDANTS & REDOX SIGNALING			English	Article							NON-MHC GENES; MULTIPLE-SCLEROSIS; RHEUMATOID-ARTHRITIS; PARKINSONS-DISEASE; LIPID-PEROXIDATION; OXIDATIVE STRESS; SUSCEPTIBILITY; RATS; INFLAMMATION; EXPRESSION	Aim: Genetic factors are important for outcome after traumatic brain injury (TBI), although exact knowledge of relevant genes/pathways is still lacking. We here used an unbiased approach to define differentially activated pathways between the inbred DA and PVG rat strains. The results prompted us to study further if a naturally occurring genetic variation in glutathione-S-transferase alpha 4 (Gsta4) affects the outcome after TBI. Results: Survival of neurons after experimental TBI is increased in PVG compared to the DA strain. Global expression profiling analysis shows the glutathione metabolism pathway to be the most regulated between the strains, with increased Gsta4 in PVG among top regulated transcripts. A congenic strain (R5) with a PVG genomic insert containing the Gsta4 gene on DA background displays a reversal of the strain pattern for Gsta4 expression and increased survival of neurons compared to DA. Gsta4 is known to effectively reduce 4-hydroxynonenal (4-HNE), a noxious by-product of lipid peroxidation. Immunostaining of 4-HNE was evident in both rat and human TBI. Intracerebral injection of 4-HNE resulted in neurodegeneration with increased levels of a marker for nerve injury in cerebrospinal fluid of DA compared to R5. Innovation: These findings provide strong support for the notion that the inherent capability of coping with increased 4-HNE after TBI affects outcome in terms of nerve cell loss. Conclusion: A naturally occurring variation in Gsta4 expression in rats affects neurodegeneration after TBI. Further studies are needed to explore if genetic variability in Gsta4 can be associated to outcome also in human TBI. Antioxid. Redox Signal. 18, 784-794.	[Al Nimer, Faiez; Strom, Mikael; Lindblom, Rickard; Aeinehband, Shahin; Lidman, Olle; Piehl, Fredrik] Karolinska Univ Hosp, Neuroimmunol Unit, Dept Clin Neurosci, Stockholm, Sweden; [Bellander, Bo-Michael] Karolinska Univ Hosp, Sect Neurosurg, Dept Clin Neurosci, Stockholm, Sweden; [Nyengaard, Jens R.] Aarhus Univ Hosp, Stereol & Electron Microscopy Lab, Ctr Stochast Geometry & Adv Bioimaging, DK-8000 Aarhus, Denmark		Al Nimer, F (corresponding author), Karolinska Inst, Neuroimmunol Unit, Dept Clin Neurosci, Karolinska Univ Hosp Solna, CMM L08 04, S-17176 Stockholm, Sweden.	faiez.al.nimer@ki.se	Nimer, Faiez Al/ABB-9465-2020; Piehl, Fredrik/E-3451-2013	Lindblom, Rickard/0000-0001-7913-4981; Al Nimer, Faiez/0000-0003-0937-5995	European UnionEuropean Commission [LSHM-CT-2005-018637, LSHG-CT-2005019015, HEALTH-F4-2010-241504]; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Swedish Association of Persons with Neurological Disabilities; Villum FoundationVillum Foundation	This study was supported by the 6th Framework Program of the European Union, NeuroproMiSe, LSHM-CT-2005-018637, EURATools, LSHG-CT-2005019015, and the 7th Framework Program of the European Union, EURATrans, HEALTH-F4-2010-241504, by the Swedish Research Council, the Swedish Brain Foundation and the Swedish Association of Persons with Neurological Disabilities. Centre for Stochastic Geometry and Advanced Bioimaging is supported by Villum Foundation.	Abel EL, 2010, JNCI-J NATL CANCER I, V102, P1663, DOI 10.1093/jnci/djq392; Al Nimer F, 2011, BRAIN BEHAV IMMUN, V25, P981, DOI 10.1016/j.bbi.2010.10.017; Arakawa M, 2007, NEUROSCI RES, V57, P220, DOI 10.1016/j.neures.2006.10.011; Balogh LM, 2011, DRUG METAB REV, V43, P165, DOI 10.3109/03602532.2011.558092; Beyeen AD, 2010, J IMMUNOL, V185, P6883, DOI 10.4049/jimmunol.1001392; Coppede F, 2005, MUTAT RES-FUND MOL M, V579, P107, DOI 10.1016/j.mrfmmm.2005.02.020; Costantini D, 2012, J EXP BIOL, V215, P374, DOI 10.1242/jeb.062034; Dahlman I, 1998, EUR J IMMUNOL, V28, P2188, DOI 10.1002/(SICI)1521-4141(199807)28:07<2188::AID-IMMU2188>3.0.CO;2-B; Di Pietro G, 2010, EXPERT OPIN DRUG MET, V6, P153, DOI 10.1517/17425250903427980; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Galvani S, 2008, FREE RADICAL BIO MED, V45, P1457, DOI 10.1016/j.freeradbiomed.2008.08.026; Gillett A, 2010, J IMMUNOL, V185, P442, DOI 10.4049/jimmunol.0904101; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Gulko PS, 2007, GENES IMMUN, V8, P523, DOI 10.1038/sj.gene.6364419; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hwang JJ, 2008, J NEUROSCI, V28, P3114, DOI 10.1523/JNEUROSCI.0199-08.2008; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Lidman O, 2003, J NEUROSCI, V23, P9817; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu HL, 2004, ANN NY ACAD SCI, V1019, P346, DOI 10.1196/annals.1297.059; Lundberg C, 2001, J COMP NEUROL, V431, P75; Maes OC, 2010, NEUROBIOL AGING, V31, P34, DOI 10.1016/j.neurobiolaging.2008.03.007; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Matsuda S, 2009, J NEURAL TRANSM, V116, P395, DOI 10.1007/s00702-009-0194-0; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCracken E, 2000, J CEREBR BLOOD F MET, V20, P1529, DOI 10.1097/00004647-200011000-00002; McGlynn KA, 2003, CANCER RES, V63, P4594; Ockinger J, 2010, GENES IMMUN, V11, P142, DOI 10.1038/gene.2009.82; Perez-Pastene C, 2007, NEUROSCI LETT, V418, P181, DOI 10.1016/j.neulet.2007.03.024; Piehl F, 2009, NEUROSCIENCE, V158, P1143, DOI 10.1016/j.neuroscience.2008.08.031; Qian J, 2009, MOL CARCINOGEN, V48, P253, DOI 10.1002/mc.20478; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Reid WM, 2010, J NEUROTRAUM, V27, P1243, DOI 10.1089/neu.2010.1270; Salzer J, 2010, MULT SCLER J, V16, P287, DOI 10.1177/1352458509359725; Sawcer S, 2010, EUR J HUM GENET, V18, P746, DOI 10.1038/ejhg.2010.17; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Selley ML, 1998, FREE RADICAL BIO MED, V25, P169, DOI 10.1016/S0891-5849(98)00021-5; Selley ML, 2002, NEUROBIOL AGING, V23, P383, DOI 10.1016/S0197-4580(01)00327-X; Shao CX, 2006, FREE RADICAL BIO MED, V41, P77, DOI 10.1016/j.freeradbiomed.2006.03.007; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Strom M, 2012, NEUROMOL MED, V14, P15, DOI 10.1007/s12017-011-8164-8; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Swanberg M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005906; Tan AA, 2009, J NEUROTRAUM, V26, P539, DOI 10.1089/neu.2008.0611; Tang SC, 2007, J NEUROCHEM, V101, P729, DOI 10.1111/j.1471-4159.2006.04412.x; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Yao XM, 2009, NEUROTOXICOLOGY, V30, P121, DOI 10.1016/j.neuro.2008.11.002; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	49	22	22	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864	1557-7716		ANTIOXID REDOX SIGN	Antioxid. Redox Signal.	MAR	2013	18	7					784	794		10.1089/ars.2011.4440			11	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	076PB	WOS:000313968000005	22881716	Green Published			2022-02-06	
J	Norouzi, V; Feizi, I; Vatankhah, S; Pourshaikhian, M				Norouzi, Vadood; Feizi, Iraj; Vatankhah, Soodabe; Pourshaikhian, Majid			Calculation of the Probability of Survival for Trauma Patients Based on Trauma Score and the Injury Severity Score Model in Fatemi Hospital in Ardabil	ARCHIVES OF TRAUMA RESEARCH			English	Article						Wounds and Injuries; Survival; Mortality		Background:Trauma, in addition to economic and social costs, is the fourth cause of death in the world and in the year 2000 alone, it led to the death of more than 6000000 people. In Iran, Trauma has the first burden of disease and also needs a long medical surveillance. Objectives: The aim of this study was to evaluate the outcome of trauma cases using the trauma score and the injury severity score (TRISS) model and then comparing this with the results of a major trauma outcome study (MTOS) carried out in the US. Patients and Methods: This study is a retrospective, descriptive and analytical study on 1000 patients aged 2-82 years old with closed or penetrating traumas staying at Ardebil Fatemi hospital. In this study, injury severity score (ISS), revised trauma score (RTS), and TRISS were calculated and patients' viability ratios were obtained. Results: The results showed that 714 patients (71.4%) were male and 286 patients (28.6%) female with the mean age of 35.68 years. In this study 45 (4.5%) and 955 patients (95.5%) had penetrating and blunt traumas, respectively whereby the head and neck were the most prevalent (74%) areas of injury The most common reason for these traumas was, accident with vehicles with 670 cases (67%), which resulted in hospitalization. From this group, ninety-seven cases (9.7%) died in the hospital. From these results, calculations of ISS and RTS were15.50 +/- 11.31 and 7.49 +/- 0.79, respectively. Accord ing to the calculation of the TRISS model, 91.5% of trauma victims should be survived, while only 90.3% survived practically. Conclusions: We can conclude that the surveillance presented to our injured group probably had some defects that need to be revised in therapeutic services to enhance survival requirements.	[Norouzi, Vadood] Ardabil Univ Med Sci, Dept Anesthesia, Ardebil, Iran; [Feizi, Iraj] Ardabil Univ Med Sci, Dept Surg, Ardebil, Iran; [Vatankhah, Soodabe; Pourshaikhian, Majid] Univ Tehran Med Sci, Dept Hlth Care Serv Management, Tehran, Iran		Pourshaikhian, M (corresponding author), Univ Tehran Med Sci, Dept Hlth Care Serv Management, Tehran, Iran.	pourshaikhian@razi.tums.ac.ir	Pourshaikhian, Majid/G-1183-2017; Nourolouni, Ahmad/A-8113-2018	Pourshaikhian, Majid/0000-0003-0213-4873; Nourolouni, Ahmad/0000-0002-1433-9836	Ardabil University of Medical Sciences	This study was sponsored by the Ardabil University of Medical Sciences.	Azizi F, 2000, EPIDEMIOLOGY CONTROL; Bouillon B, 1997, J TRAUMA, V42, P652, DOI 10.1097/00005373-199704000-00012; Bouillon B, 1998, LANGENBECK ARCH SURG, V383, P228, DOI 10.1007/s004230050123; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHAMPION HR, 1989, AM J PUBLIC HEALTH, V79, P1278, DOI 10.2105/AJPH.79.9.1278; CROCE MA, 1992, J TRAUMA, V32, P380, DOI 10.1097/00005373-199203000-00017; FANISALEK MH, 1999, EMERGEN MED, V11, P155; Goel A, 2004, NATL MED J INDIA, V17, P186; Khosravi A, 2008, IRAN J EPIDEMIOL, V4, P35; Lefering R, 2002, EUR J TRAUMA, P28, DOI DOI 10.1007/S00068-002-0170-Y; Murlidhar V, 2004, INJURY, V35, P386, DOI 10.1016/S0020-1383(03)00214-6; Naghavi M, 2001, EPIDEMIOLOGY ACCIDEN; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Raftery KA, 1996, ANN EMERG MED, V27, P79, DOI 10.1016/S0196-0644(96)70300-1; Richmond TS, 2002, J AM GERIATR SOC, V50, P215, DOI 10.1046/j.1532-5415.2002.50051.x; SODERLUND N, 1995, B WORLD HEALTH ORGAN, V73, P175; Solagberu B A, 2003, West Afr J Med, V22, P177; Spence M T, 1988, Health Trends, V20, P94; Talwar S., 1999, SMJ, V40, P386; Tornetta P, 1999, J TRAUMA, V46, P702, DOI 10.1097/00005373-199904000-00024; Zafar H, 2002, EMERG MED J, V19, P391, DOI 10.1136/emj.19.5.391	22	22	24	0	1	KASHAN UNIV MEDICAL SCIENCES	KASHAN	PO BOX 87159-88141, KASHAN, REPUBLIC ISLAMIC 00000, IRAN	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	SPR	2013	2	1					30	34		10.5812/atr.940			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	V24BR	WOS:000215133000007	24396787				2022-02-06	
J	Takeuchi, S; Takasato, Y; Masaoka, H; Hayakawa, T; Yatsushige, H; Nagatani, K; Osada, H; Otani, N; Wada, K; Nawashiro, H				Takeuchi, Satoru; Takasato, Yoshio; Masaoka, Hiroyuki; Hayakawa, Takanori; Yatsushige, Hiroshi; Nagatani, Kimihiro; Osada, Hideo; Otani, Naoki; Wada, Kojiro; Nawashiro, Hiroshi			Hydrocephalus after decompressive craniectomy for hemispheric cerebral infarction	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Complication; Decompressive craniectomy; Hydrocephalus; lschemic stroke	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; SEVERE HEAD-INJURY; QUALITY-OF-LIFE; ARTERY INFARCTION; MALIGNANT INFARCTION; EVANS INDEX; HEMICRANIECTOMY; MANAGEMENT; HYPERTENSION	The aim of the present study was to investigate the risk factors for hydrocephalus after decompressive craniectomy (DC) for hemispheric cerebral infarction. This study selected 28 patients who underwent DC for malignant hemispheric cerebral infarction. The patients' clinical and radiologic findings were retrospectively reviewed. Fourteen of the 28 patients were male and 14 were female, with an age range from 34 to 80 years (mean, 63.5 years). Eighteen patients (64.3%) underwent DC within 48 hours of stroke onset. The superior limit of DC was <25 mm from the midline in 16 patients (57.1%). Twenty-two patients underwent cranioplasty, and the interval from DC to cranioplasty was within 60 days in 14 patients. Pre- and post-cranioplasty hydrocephalus were observed in 13 and nine patients, respectively. Two patients required shunt procedures for post-cranioplasty hydrocephalus. Patients with DC whose superior limit was <25 mm from the midline had a significantly increased risk of developing not only pre-cranioplasty but also post-cranioplasty hydrocephalus (p = 0.008, p = 0.010, respectively). In addition, the presence of pre-cranioplasty hydrocephalus was significantly associated with the development of post-cranioplasty hydrocephalus (p = 0.001). The presence of pre- and post-cranioplasty hydrocephalus was significantly associated with a poor outcome (p = 0.031, p = 0.049, respectively). DC with a superior limit <25 mm from the midline should be avoided to prevent the development of hydrocephalus. (C) 2012 Elsevier Ltd. All rights reserved.	[Takeuchi, Satoru; Nagatani, Kimihiro; Osada, Hideo; Otani, Naoki; Wada, Kojiro; Nawashiro, Hiroshi] Natl Def Med Coll, Dept Neurosurg, Tokorozawa, Saitama 3598513, Japan; [Takasato, Yoshio; Masaoka, Hiroyuki; Hayakawa, Takanori; Yatsushige, Hiroshi] Natl Hosp Org Disaster Med Ctr, Dept Neurosurg, Tokyo, Japan		Takeuchi, S (corresponding author), Natl Def Med Coll, Dept Neurosurg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	s.takeuchi@room.ocn.ne.jp					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Akins PT, 2008, NEUROCRIT CARE, V9, P269, DOI 10.1007/s12028-007-9033-z; Ambarki K, 2010, NEUROSURGERY, V67, P94, DOI 10.1227/01.NEU.0000370939.30003.D1; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; D'Ambrosio AL, 2005, NEUROSURGERY, V56, P12, DOI 10.1227/01.NEU.0000144820.38439.63; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Guresir E, 2009, J NEUROL NEUROSUR PS, V80, P799, DOI 10.1136/jnnp.2008.155630; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Johnson RD, 2011, J CLIN NEUROSCI, V18, P1018, DOI 10.1016/j.jocn.2010.12.021; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Marmarou A, 1996, J NEUROSURG, V85, P1026, DOI 10.3171/jns.1996.85.6.1026; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Otani N, 2008, CEREBROVASC DIS, V26, P612, DOI 10.1159/000165115; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Rahme R, 2010, NEUROSURGERY, V67, P675, DOI 10.1227/01.NEU.0000383142.10103.0B; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Schirmer CM, 2007, STROKE, V38, P987, DOI 10.1161/01.STR.0000257962.58269.e2; Takeuchi S, 2011, NEUROSURGERY, V68, pE1509, DOI 10.1227/NEU.0b013e3182124403; Toma AK, 2011, NEUROSURGERY, V68, P939, DOI 10.1227/NEU.0b013e318208f5e0; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	29	22	25	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2013	20	3					377	382		10.1016/j.jocn.2012.03.035			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	115VL	WOS:000316839900008	23266079				2022-02-06	
J	Theodore, N; Aarabi, B; Dhall, SS; Gelb, DE; Hurlbert, RJ; Rozzelle, CJ; Ryken, TC; Walters, BC; Hadley, MN				Theodore, Nicholas; Aarabi, Bizhan; Dhall, Sanjay S.; Gelb, Daniel E.; Hurlbert, R. John; Rozzelle, Curtis J.; Ryken, Timothy C.; Walters, Beverly C.; Hadley, Mark N.			Occipital Condyle Fractures	NEUROSURGERY			English	Article						Cervical immobilization; CT imaging; Occipital condyle fracture	HYPOGLOSSAL NERVE PALSY; COLLET-SICARD SYNDROME; CLOSED-HEAD-INJURY; AVULSION FRACTURE; FORGOTTEN CONDYLE; CT; IMPAIRMENT; MANAGEMENT; MORPHOLOGY; DIAGNOSIS		[Theodore, Nicholas] Barrow Neurol Inst, Div Neurol Surg, Phoenix, AZ 85013 USA; [Aarabi, Bizhan] Univ Maryland, Dept Neurosurg, Baltimore, MD 21201 USA; [Gelb, Daniel E.] Univ Maryland, Dept Orthopaed, Baltimore, MD 21201 USA; [Dhall, Sanjay S.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Hurlbert, R. John] Univ Calgary, Fac Med, Univ Calgary Spine Program, Dept Clin Neurosci, Calgary, AB, Canada; [Rozzelle, Curtis J.; Walters, Beverly C.; Hadley, Mark N.] Univ Alabama Birmingham, Childrens Hosp Alabama, Div Neurol Surg, Birmingham, AL USA; [Ryken, Timothy C.] Univ Iowa, Iowa Spine & Brain Inst, Waterloo, ON, Canada; [Walters, Beverly C.] Inova Hlth Syst, Dept Neurosci, Falls Church, VA USA		Hadley, MN (corresponding author), UAB Div Neurol Surg, 510 20th St S,FOT 1030, Birmingham, AL 35294 USA.	mhadley@uabmc.edu	Walters, Beverly/R-8411-2019	Walters, Beverly/0000-0002-5244-4282; Theodore, Nicholas/0000-0001-5355-2683			ANDERSON PA, 1988, SPINE, V13, P731, DOI 10.1097/00007632-198807000-00004; [Anonymous], 2002, NEUROSURGERY S, V50, pS114; Aulino JM, 2005, EMERG RADIOL, V11, P342, DOI 10.1007/s10140-005-0425-0; BETTINI N, 1993, SKELETAL RADIOL, V22, P187; Bloom AI, 1997, CLIN RADIOL, V52, P198, DOI 10.1016/S0009-9260(97)80273-5; BOLENDER N, 1978, AM J ROENTGENOL, V131, P729, DOI 10.2214/ajr.131.4.729; BOZBOGA M, 1992, SPINE, V17, P1119, DOI 10.1097/00007632-199209000-00019; BRIDGMAN SA, 1992, SURG NEUROL, V38, P152, DOI 10.1016/0090-3019(92)90094-4; Capuano C, 2004, ACTA NEUROCHIR, V146, P779, DOI 10.1007/s00701-004-0289-1; Caroli E, 2005, EUR SPINE J, V14, P487, DOI 10.1007/s00586-004-0832-z; CASTLING B, 1995, BRIT J ORAL MAX SURG, V33, P171, DOI 10.1016/0266-4356(95)90292-9; Cottalorda J, 1996, J PEDIATR ORTHOP B, V5, P61, DOI 10.1097/01202412-199605010-00013; Curri D, 1988, J Neurosurg Sci, V32, P157; DEEB ZL, 1988, CT-J COMPUT TOMOGR, V12, P261; Demisch S, 1998, CLIN NEUROL NEUROSUR, V100, P44, DOI 10.1016/S0303-8467(97)00111-X; DESAI SS, 1990, J TRAUMA, V30, P240, DOI 10.1097/00005373-199002000-00023; Emery E, 1995, Eur Spine J, V4, P191, DOI 10.1007/BF00298245; GOLDSTEIN SJ, 1982, SURG NEUROL, V17, P350, DOI 10.1016/0090-3019(82)90308-1; Hanson JA, 2002, AM J ROENTGENOL, V178, P1261, DOI 10.2214/ajr.178.5.1781261; HARDINGSMITH J, 1981, J BONE JOINT SURG AM, V63, P1170, DOI 10.2106/00004623-198163070-00016; HASHIMOTO T, 1988, NEUROSURGERY, V23, P367, DOI 10.1227/00006123-198809000-00015; Ide C, 1998, J NEUROSURG, V88, P773, DOI 10.3171/jns.1998.88.4.0773; JONES DN, 1990, AM J NEURORADIOL, V11, P1181; Lam CH, 1996, CAN J NEUROL SCI, V23, P145, DOI 10.1017/S0317167100038890; Legros B, 2000, J TRAUMA, V48, P342, DOI 10.1097/00005373-200002000-00031; Leone A, 2000, RADIOLOGY, V216, P635, DOI 10.1148/radiology.216.3.r00se23635; LEVENTHAL MR, 1992, ORTHOPEDICS, V15, P944; LINK TM, 1995, RADIOLOGY, V196, P741, DOI 10.1148/radiology.196.3.7644638; Malham GM, 2009, EMERG RADIOL, V16, P291, DOI 10.1007/s10140-008-0789-z; MANN FA, 1994, AM J ROENTGENOL, V163, P193, DOI 10.2214/ajr.163.1.8010212; MARIANI PJ, 1990, ANN EMERG MED, V19, P1447, DOI 10.1016/S0196-0644(05)82618-6; Maserati MB, 2009, J NEUROSURG-SPINE, V11, P388, DOI 10.3171/2009.5.SPINE08866; MASSARO F, 1993, INJURY, V24, P419, DOI 10.1016/0020-1383(93)90110-R; Maughan PH, 2005, NEUROSURGERY, V57, P600, DOI 10.1227/01.NEU.0000170989.90325.04; MODY BS, 1992, INJURY, V23, P350, DOI 10.1016/0020-1383(92)90194-W; Noble ER, 1996, AM J NEURORADIOL, V17, P507; OLSSON R, 1994, ACTA RADIOL, V35, P90; ORBAY T, 1989, SURG NEUROL, V31, P402, DOI 10.1016/0090-3019(89)90076-1; PALEY MD, 1995, BRIT J ORAL MAX SURG, V33, P239, DOI 10.1016/0266-4356(95)90008-X; RAILA FA, 1993, SKELETAL RADIOL, V22, P269; Savolaine E R, 1989, J Orthop Trauma, V3, P71, DOI 10.1097/00005131-198903010-00014; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; SPENCER JA, 1984, NEUROSURGERY, V15, P101, DOI 10.1227/00006123-198407000-00019; STROOBANTS J, 1994, J NEUROSURG, V81, P137, DOI 10.3171/jns.1994.81.1.0137; Tuli S, 1997, NEUROSURGERY, V41, P368, DOI 10.1097/00006123-199708000-00006; Urculo E, 1996, J NEUROSURG, V84, P522, DOI 10.3171/jns.1996.84.3.0522; VALASKATZIS EP, 1990, S AFR MED J, V77, P47; WANI MA, 1991, J TRAUMA, V31, P1437, DOI 10.1097/00005373-199110000-00025; WASSERBERG J, 1995, NEURORADIOLOGY, V37, P370; WESSELS LS, 1990, S AFR J SURG, V28, P155; YOUNG WF, 1994, NEUROSURGERY, V34, P257, DOI 10.1227/00006123-199402000-00008; Young WF, 1994, NEUROSURGERY, V34, P260	52	22	23	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAR	2013	72			2			106	113		10.1227/NEU.0b013e3182775527			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	103TP	WOS:000315942300012	23417183				2022-02-06	
J	Fernandez-Rodriguez, E; Lopez-Raton, M; Andujar, P; Martinez-Silva, IM; Cadarso-Suarez, C; Casanueva, FF; Bernabeu, I				Fernandez-Rodriguez, E.; Lopez-Raton, M.; Andujar, P.; Martinez-Silva, I. M.; Cadarso-Suarez, C.; Casanueva, F. F.; Bernabeu, I.			Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients	CLINICAL ENDOCRINOLOGY			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY FUNCTION; TRAUMATIC BRAIN-INJURY; GH-DEFICIENT ADULTS; GROWTH-HORMONE; CARDIOVASCULAR RISK; METABOLIC SYNDROME; CEREBROVASCULAR MORTALITY; PREMATURE MORTALITY; EXCESS MORTALITY	Introduction Hypopituitarism is associated with higher prevalence of cardiovascular risk factors and premature death. Furthermore, some clinical and therapeutic features of hypopituitarism have been associated with a worse prognosis. Objective We reviewed, retrospectively, a large series of adult patients with hypopituitarism using stringent epidemiological criteria. Prevalence, association with cardiovascular risk factors, mortality and survival have been analysed. Design and Methods Two hundred and nine adult hypopituitary patients (56.9% females) from a population of 405 218 inhabitants, followed for 10 years. Results Prevalence of hypopituitarism at the end of the study was 37.5 cases/100 000 inhabitants. Incidence of hypopituitarism was 2.07 cases/100 000 inhabitants and year. Thirty-two patients died during the period of the study. Standardized mortality rate (SMR) was 8.05, higher in males (8.92 vs 7.34) and in younger patients (84.93 vs 5.26). Diagnosis of acromegaly (P = 0.033), previous radiotherapy (P = 0.02), higher BMI (P = 0.04), diabetes mellitus (P = 0.03) and cancer (P < 0.0001) were associated with mortality. A lower survival was associated with older age at diagnosis, nontumoural causes, previous radiotherapy, diabetes mellitus with poor metabolic control and malignant disease. Conclusions Prevalence of hypopituitarism was 37.5 cases/100 000 inhabitants, and annual incidence was 2.07 cases/100 000 inhabitants. SMR was 8 times higher in hypopituitarism than in general population and was also higher in males and younger patients. Reduced survival was significantly related to cancer, nontumoural causes of hypopituitarism, older age at diagnosis, previous radiotherapy and diabetes mellitus with poor metabolic control.	[Fernandez-Rodriguez, E.; Andujar, P.; Casanueva, F. F.; Bernabeu, I.] Univ Santiago de Compostela SERGAS, Complejo Hosp, Dept Endocrinol, Santiago De Compostela, Spain; [Fernandez-Rodriguez, E.; Andujar, P.; Casanueva, F. F.; Bernabeu, I.] Univ Santiago de Compostela, Inst Invest Sanitaria Santiago Compostela IDIS, Santiago De Compostela 15706, Spain; [Lopez-Raton, M.; Martinez-Silva, I. M.; Cadarso-Suarez, C.] Univ Santiago de Compostela, Fac Med, Biostat Unit, Stat & Operat Res Dept, Santiago De Compostela 15706, Spain; [Casanueva, F. F.] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Fisiopatol Obesidad &, Santiago De Compostela, Spain		Bernabeu, I (corresponding author), Univ Santiago de Compostela, Complejo Hosp, Dept Endocrinol, Travesia de la Choupana S-N, Santiago De Compostela 15706, Spain.	ignacio.bernabeu.moron@sergas.es	Bernabeu, Ignacio/P-2049-2014	Bernabeu, Ignacio/0000-0001-8421-7394; cadarso-suarez, carmen/0000-0002-9893-9520	Spanish Ministry of Science and InnovationSpanish Government [FISS 11/00161, MTM 2008-01603, MTM2010-09213-E, MTM2011-28285-C02-00]; PfizerPfizer; NovartisNovartis; IpsenIpsen; NovonordiskNovo Nordisk	This work was supported by the Spanish Ministry of Science and Innovation under the grants FISS 11/00161 (to IB) and grants MTM 2008-01603, MTM2010-09213-E and MTM2011-28285-C02-00 (to M L-R, IM M-S and C C-S).; I. B. holds research grant from Pfizer and has received lecture fees from Novartis, Ipsen and Pfizer. F.F.C. holds research grants from Pfizer and Novartis has and received lecture fees from Pfizer, Novartis and Novonordisk. The remaining authors do not have any conflicts of interest that could be perceived as prejudicing the impartiality of the research reported.	Abdu TAM, 2001, CLIN ENDOCRINOL, V55, P209, DOI 10.1046/j.1365-2265.2001.01320.x; Abs R, 2006, EUR J ENDOCRINOL, V155, P79, DOI 10.1530/eje.1.02179; Attanasio AF, 2010, J CLIN ENDOCR METAB, V95, P74, DOI 10.1210/jc.2009-1326; Ayuk J, 2004, J CLIN ENDOCR METAB, V89, P1613, DOI 10.1210/jc.2003-031584; Bates AS, 1999, CLIN ENDOCRINOL, V50, P315, DOI 10.1046/j.1365-2265.1999.00650.x; Bates AS, 1996, J CLIN ENDOCR METAB, V81, P1169, DOI 10.1210/jc.81.3.1169; BESHYAH SA, 1995, CLIN ENDOCRINOL, V42, P179, DOI 10.1111/j.1365-2265.1995.tb01860.x; Brada M, 2002, CLIN ENDOCRINOL, V57, P713, DOI 10.1046/j.1365-2265.2002.01570.x; Bulow B, 1997, CLIN ENDOCRINOL, V46, P75, DOI 10.1046/j.1365-2265.1997.d01-1749.x; Bulow B, 1998, J CLIN ENDOCR METAB, V83, P3897, DOI 10.1210/jc.83.11.3897; COLLET D, 1994, MODELLING SURVIVAL D; COX DR, 1972, J R STAT SOC B, V34, P187; Dekkers OM, 2008, J CLIN ENDOCR METAB, V93, P61, DOI 10.1210/jc.2007-1191; Erfurth E M, 2000, Pituitary, V3, P77, DOI 10.1023/A:1009901707125; Erfurth EM, 2004, EUR J ENDOCRINOL, V150, P497, DOI 10.1530/eje.0.1500497; Fernandez-Rodriguez E, 2011, NEUROENDOCRINOLOGY, V93, P181, DOI 10.1159/000324087; FLICKINGER JC, 1989, CANCER, V63, P2404, DOI 10.1002/1097-0142(19890615)63:12<2404::AID-CNCR2820631205>3.0.CO;2-3; Gsponer J, 1999, MEDICINE, V78, P236, DOI 10.1097/00005792-199907000-00004; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Kaji H, 2007, ENDOCR J, V54, P239, DOI 10.1507/endocrj.K06-129; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; Lindholm J, 2006, CLIN ENDOCRINOL, V65, P51, DOI 10.1111/j.1365-2265.2006.02545.x; Maison P, 2004, J CLIN ENDOCR METAB, V89, P2192, DOI 10.1210/jc.2003-030840; MARKUSSIS V, 1992, LANCET, V340, P1188, DOI 10.1016/0140-6736(92)92892-J; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Nielsen EH, 2007, CLIN ENDOCRINOL, V67, P693, DOI 10.1111/j.1365-2265.2007.02947.x; Nielsen EH, 2007, PITUITARY, V10, P67, DOI 10.1007/s11102-007-0018-x; Nilsson B, 2000, J CLIN ENDOCR METAB, V85, P1420, DOI 10.1210/jc.85.4.1420; Nyenwe EA, 2009, AM J MED SCI, V338, P190, DOI 10.1097/MAJ.0b013e3181a84bde; Regal M, 2001, CLIN ENDOCRINOL, V55, P735, DOI 10.1046/j.1365-2265.2001.01406.x; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stochholm K, 2007, EUR J ENDOCRINOL, V157, P9, DOI 10.1530/EJE-07-0013; Svensson J, 2004, J CLIN ENDOCR METAB, V89, P3306, DOI 10.1210/jc.2003-031601; Swerdlow AJ, 2002, LANCET, V360, P273, DOI 10.1016/S0140-6736(02)09519-3; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tichomirowa MA, 2011, EUR J ENDOCRINOL, V165, P509, DOI 10.1530/EJE-11-0304; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009	42	22	23	0	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	FEB	2013	78	2					278	284		10.1111/j.1365-2265.2012.04516.x			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	067AT	WOS:000313264900018	22845165				2022-02-06	
J	Lam, PK; Lo, AWI; Wang, KKW; Lau, HCH; Leung, KKC; Li, KTC; Lai, PBS; Poon, WS				Lam, Ping Kuen; Lo, Anthony Wing Ip; Wang, Kevin Ka Wan; Lau, Henry Chi Ho; Leung, Kevin Kai Chung; Li, Kathy Tung Ching; Lai, Paul Bo San; Poon, Wai Sang			Transplantation of mesenchymal stem cells to the brain by topical application in an experimental traumatic brain injury model	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Mesenchymal stem cell; Topical application; Traumatic brain injury	NEUROLOGICAL DISEASES; MIGRATION; THERAPY	Mesenchymal stem cells (MSCs) have been shown in various animal models to be capable of neurorepair and neuroprotection. To carry out a therapeutic function, MSCs must be delivered to the target organ. MSCs are administered to patients via systemic infusion, which has many drawbacks, including a low engraftment rate and the migration of MSCs to non-target organs. However, other approaches such as direct intracerebral injection of MSCs might cause cerebral bleeding. In this study, a traumatic brain injury (TBI) was induced over the right parietal cerebral cortex in Sprague Dawley rats, and green fluorescent protein (GFP)-expressing MSCs (GFP-MSCs), together with a thin layer of fibrin, were applied to the external surface of the contralateral side 2 days later. Within 5 days of topical application, the GFP-MSCs had migrated from the site of application on the cortical surface, through the white matter, and had emerged at the cortical surface of the TBI site on the contralateral cerebral hemisphere, apparently following axons along the corpus callosum. In sham-injured control animals, the topically applied GFP-MSCs proliferated superficially on the cortex at the site of application, and no GFP-MSCs were found at the contralateral cortical surface. In all instances, GFP-MSCs were not detected in other organs of either the test or the control animals. Our study demonstrated that MSCs topically applied to the brain surface can migrate to a TBI site. (C) 2012 Published by Elsevier Ltd.	[Lam, Ping Kuen; Wang, Kevin Ka Wan; Lau, Henry Chi Ho; Leung, Kevin Kai Chung; Li, Kathy Tung Ching; Lai, Paul Bo San; Poon, Wai Sang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China; [Lam, Ping Kuen] Chinese Univ Hong Kong, Prince Wales Hosp, Chow Tai Fook Cheng Yu Tung Surg Stem Cell Res Ct, Shatin, Hong Kong, Peoples R China; [Lo, Anthony Wing Ip] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China; [Wang, Kevin Ka Wan] Banyan Biomarkers, Ctr Innovat Res, Alachua, FL USA; [Wang, Kevin Ka Wan] Univ Florida, Ctr Neuroprote & Biomarkers Res, Dept Psychiat & Neurosci, Gainesville, FL USA		Poon, WS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China.	wpoon@surgery.cuhk.edu.hk	Poon, Wai Sang/F-1558-2011; Lai, Paul BS/K-8556-2015; Lo, Anthony/G-5414-2015	Lai, Paul BS/0000-0002-9469-6728; Wang, Kevin/0000-0002-9343-6473; Lo, Anthony/0000-0002-9388-310X			Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Barone FC, 2006, CLIN NEUROSCI RES, V6, P329, DOI 10.1016/j.cnr.2006.09.010; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Gogel S, 2011, GENE THER, V18, P1, DOI 10.1038/gt.2010.130; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Lam PK, 2011, TRANSPLANTATION, V92, pE9, DOI 10.1097/TP.0b013e318221d3b7; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Mendick R, BABY DEATH SCANDAL S; Poon WS, 2006, ACT NEUR S, V99, P123, DOI 10.1007/978-3-211-35205-2_23; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198	15	22	26	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2013	20	2					300	303		10.1016/j.jocn.2012.03.028			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	097LX	WOS:000315476700023	23219830				2022-02-06	
J	Yokobori, S; Mazzeo, AT; Hosein, K; Gajavelli, S; Dietrich, WD; Bullock, MR				Yokobori, Shoji; Mazzeo, Anna T.; Hosein, Khadil; Gajavelli, Shyam; Dietrich, W. Dalton; Bullock, M. Ross			Preconditioning for Traumatic Brain Injury	TRANSLATIONAL STROKE RESEARCH			English	Article						Preconditioning; Traumatic brain injury; Neuroprotection; Pathophysiology	ACUTE SUBDURAL-HEMATOMA; METHYL-D-ASPARTATE; INDUCED AXONAL INJURY; REGULATED-KINASE 1/2; CLOSED-HEAD INJURY; CEREBRAL-ISCHEMIA; INDUCED NEUROPROTECTION; INTRACRANIAL-PRESSURE; NEURONAL APOPTOSIS; THERAPEUTIC TARGET	Traumatic brain injury (TBI) treatment is now focused on the prevention of primary injury and reduction of secondary injury. However, no single effective treatment is available as yet for the mitigation of traumatic brain damage in humans. Both chemical and environmental stresses applied before injury have been shown to induce consequent protection against post-TBI neuronal death. This concept termed "preconditioning" is achieved by exposure to different pre-injury stressors to achieve the induction of "tolerance" to the effect of the TBI. However, the precise mechanisms underlying this "tolerance" phenomenon are not fully understood in TBI, and therefore even less information is available about possible indications in clinical TBI patients. In this review, we will summarize TBI pathophysiology, and discuss existing animal studies demonstrating the efficacy of preconditioning in diffuse and focal type of TBI. We will also review other non-TBI preconditioning studies, including ischemic, environmental, and chemical preconditioning, which maybe relevant to TBI. To date, no clinical studies exist in this field, and we speculate on possible future clinical situations, in which pre-TBI preconditioning could be considered.	[Yokobori, Shoji; Mazzeo, Anna T.; Hosein, Khadil; Gajavelli, Shyam; Dietrich, W. Dalton; Bullock, M. Ross] Univ Miami, Miami Project Cure Paralysis, Dept Neurosurg, Miami, FL 33124 USA; [Yokobori, Shoji] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan; [Mazzeo, Anna T.] Univ Turin, Dept Anesthesia & Intens Care, Turin, Italy		Yokobori, S (corresponding author), Univ Miami, Miami Project Cure Paralysis, Dept Neurosurg, Miami, FL 33124 USA.	SYokobori@med.miami.edu	Gajavelli, Shyam/AAI-1374-2019	Gajavelli, Shyam/0000-0002-5947-6973; Mazzeo, Anna Teresa/0000-0002-8454-7243	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS 042133]; Miami Project to Cure Paralysis; General Insurance Association of Japan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042133] Funding Source: NIH RePORTER	The part of this work was supported by funds from NINDS RO1 NS 042133 and the Miami Project to Cure Paralysis. The corresponding author (S.Y.) was also partially supported by The General Insurance Association of Japan.	ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ALKHULAIFI AM, 1993, CARDIOSCIENCE, V4, P163; Badruddin A, 2011, CURR NEUROL NEUROSCI, V11, P104, DOI 10.1007/s11910-010-0156-9; Bickler PE, 2005, ANESTHESIOLOGY, V103, P532, DOI 10.1097/00000542-200509000-00016; Binder S, 2005, J HEAD TRAUMA REHAB, V20, P189, DOI 10.1097/00001199-200505000-00002; Boeck CR, 2007, AMINO ACIDS, V33, P439, DOI 10.1007/s00726-006-0455-2; BOLLI R, 1989, CIRC RES, V65, P607, DOI 10.1161/01.RES.65.3.607; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Burger R, 2004, NEUROSURGERY, V54, P701, DOI 10.1227/01.NEU.0000108784.80585.EE; Busija DW, 2008, ADV DRUG DELIVER REV, V60, P1471, DOI 10.1016/j.addr.2008.03.020; Chaudhry K, 2010, NEUROSCI LETT, V474, P109, DOI 10.1016/j.neulet.2010.03.020; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Clausen F, 2007, J NEUROTRAUM, V24, P1295, DOI 10.1089/neu.2006.0258; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cole TB, 2004, JAMA-J AM MED ASSOC, V291, P2531, DOI 10.1001/jama.291.21.2531; Correia SC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00138; Correia SC, 2010, J ALZHEIMERS DIS, V20, pS475, DOI 10.3233/JAD-2010-100669; Costa T, 2010, J NEUROSCI RES, V88, P1329, DOI 10.1002/jnr.22300; Curry A, 2010, NEUROL RES, V32, P756, DOI 10.1179/174313209X459101; Dave KR, 2005, J NEUROSCI RES, V82, P665, DOI 10.1002/jnr.20674; Davis W, 2007, NEUROL RES, V29, P382, DOI 10.1179/016164107X204701; DeFazio RA, 2009, J CEREBR BLOOD F MET, V29, P375, DOI 10.1038/jcbfm.2008.126; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Ding Y, 2004, NEUROSCIENCE, V124, P583, DOI 10.1016/j.neuroscience.2003.12.029; Ding YH, 2004, CURR NEUROVASC RES, V1, P411, DOI 10.2174/1567202043361875; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dornbos D, 2012, CURR DRUG TARGETS, V13, P247; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; FREYTAG E, 1963, ARCH PATHOL, V76, P215; Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Hu SL, 2008, ACTA NEUROCHIR SUPPL, V105, P191; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Huang YF, 2007, CELL IMMUNOL, V248, P4, DOI 10.1016/j.cellimm.2007.03.009; Jadhav V, 2009, STROKE, V40, P3139, DOI 10.1161/STROKEAHA.109.549774; JANOFF A, 1964, Int Anesthesiol Clin, V2, P251, DOI 10.1097/00004311-196402000-00008; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jung JE, 2010, MOL NEUROBIOL, V41, P172, DOI 10.1007/s12035-010-8102-z; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Kapinya KJ, 2002, STROKE, V33, P1889, DOI 10.1161/01.STR.0000020092.41820.58; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; KATO H, 1992, BRAIN RES BULL, V29, P559, DOI 10.1016/0361-9230(92)90123-F; Kawai N, 2000, J NEUROTRAUM, V17, P193, DOI 10.1089/neu.2000.17.193; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kawano T, 2007, J CEREBR BLOOD F MET, V27, P1453, DOI 10.1038/sj.jcbfm.9600449; Kersten JR, 1997, ANESTHESIOLOGY, V87, P361, DOI 10.1097/00000542-199708000-00024; KHALID MA, 1993, CIRC RES, V72, P725, DOI 10.1161/01.RES.72.4.725; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kinni H, 2011, BRAIN RES, V1388, P48, DOI 10.1016/j.brainres.2011.02.076; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; KURODA Y, 1992, NEUROSURGERY, V30, P687; Lampe JW, 2011, ANNU REV MED, V62, P79, DOI 10.1146/annurev-med-052009-150512; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Liebelt B, 2010, NEUROSCIENCE, V166, P1091, DOI 10.1016/j.neuroscience.2009.12.067; LIN BW, 1992, J NEUROCHEM, V59, P2213; LIN BW, 1993, J CEREBR BLOOD F MET, V13, P925, DOI 10.1038/jcbfm.1993.115; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Luo Y, 2008, ANESTHESIOLOGY, V109, P782, DOI 10.1097/ALN.0b013e3181895f88; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; MALONEY AFJ, 1969, BRIT J SURG, V56, P23, DOI 10.1002/bjs.1800560106; Mar J, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-46; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Moojen VKM, 2012, BRAIN RES, V1466, P82, DOI 10.1016/j.brainres.2012.05.041; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Okauchi M, 2002, J NEUROTRAUM, V19, P741, DOI 10.1089/08977150260139110; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perez-Pinzon MA, 2004, J BIOENERG BIOMEMBR, V36, P323, DOI 10.1023/B:JOBB.0000041762.47544.ff; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Perez-Pinzon MA, 2012, J CEREBR BLOOD F MET, V32, P1362, DOI 10.1038/jcbfm.2012.32; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ravati A, 2000, BRAIN RES, V866, P23, DOI 10.1016/S0006-8993(00)02210-1; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shields DC, 2000, J NEUROSCI RES, V61, P146; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Simon RP, 2006, ARCH NEUROL-CHICAGO, V63, P1368, DOI 10.1001/archneur.63.10.1368; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; Tuttolomondo A, 2009, CURR TOP MED CHEM, V9, P1317, DOI 10.2174/156802609789869646; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808; Wang YC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-134; Willis C, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003986.PUB2; Wong CHY, 2008, CURR MED CHEM, V15, P1; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yokobori S, 2011, THER HYPOTHERMIA TEM, V1, P185, DOI 10.1089/ther.2011.0012; Zhang B, 2011, J TRAUMA, V71, P1680, DOI 10.1097/TA.0b013e318231bce7; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003	111	22	23	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	FEB	2013	4	1					25	39		10.1007/s12975-012-0226-1			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	109WG	WOS:000316399900005	24323189	Green Accepted			2022-02-06	
J	Zhang, JL; Li, DB; Shen, AG; Mao, H; Jin, H; Huang, W; Xu, DW; Fan, JB; Chen, JJ; Yang, LF; Cui, ZM				Zhang, Jinlong; Li, Debao; Shen, Aiguo; Mao, Hui; Jin, Huricha; Huang, Wei; Xu, Dawei; Fan, Jianbo; Chen, Jiajia; Yang, Longfei; Cui, Zhiming			Expression of RBMX After Spinal Cord Injury in Rats	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Spinal cord injury; RBMX; Glial proliferation; Apoptosis; Rats	NUCLEAR RIBONUCLEOPROTEIN-G; ASTROGLIAL SCAR FORMATION; TRAUMATIC BRAIN-INJURY; BCL-2 FAMILY PROTEINS; FUNCTIONAL RECOVERY; BAX TRANSLOCATION; NEURONAL APOPTOSIS; COMPRESSION INJURY; NEURITE OUTGROWTH; SIGNALING PATHWAY	RBMX (RNA-binding motif gene, X chromosome) is a heterogeneous nuclear ribonucleoprotein that associates with the spliceosome, binds RNA, and influences alternative splicing. The gene encoding RBMX is located on chromosome Xq26 and is ubiquitously expressed. However, its expression and function in spinal cord injury are still unclear. In this study, we performed an acute spinal cord contusion injury (SCI) model in adult rats and investigated the dynamic changes of RBMX expression in spinal cord. Western blot and immunohistochemistry analysis revealed that RBMX was present in normal spinal cord. It gradually increased, reached a peak at 1 day, and then declined to basal levels at 14 days after spinal cord injury. Double immunofluorescence staining showed that RBMX immunoreactivity was found in neurons and astrocytes, but not in microglia. Interestingly, RBMX expression was increased predominantly in neurons and astrocytes. Moreover, colocalization of RBMX/proliferating cell nuclear antigen (PCNA) and RBMX/active caspase-3 was detected in GFAP and NeuN, respectively. We also examined the expression profiles of active caspase-3, bcl-2, Bax, and PCNA, whose changes were correlated with the expression profiles of RBMX. In conclusion, this is the first description of RBMX expression in spinal cord injury. Our results suggested that RBMX might play crucial roles in CNS pathophysiology after SCI.	[Zhang, Jinlong; Li, Debao; Jin, Huricha; Huang, Wei; Xu, Dawei; Fan, Jianbo; Chen, Jiajia; Yang, Longfei; Cui, Zhiming] Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China; [Shen, Aiguo] Nantong Univ, Coll Med, Dept Immunol, Nantong 226001, Jiangsu, Peoples R China; [Mao, Hui] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China		Cui, ZM (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China.	cuizhiming2012@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271367]	This work was supported by the National Natural Science Foundation of China (No. 81271367).	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Adhami VM, 2003, CLIN CANCER RES, V9, P3176; Bao Y, 2012, J CEREBR BLOOD F MET, V32, P1567, DOI 10.1038/jcbfm.2012.52; Barreiro-Iglesias A, 2012, ENZYME RES, V2012; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Berens HM, 2011, J VIROL, V85, P3858, DOI 10.1128/JVI.01958-10; Bhattarai G, 2012, BIOL PHARM BULL, V35, P1711, DOI 10.1248/bpb.b12-00297; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Cort A, 2012, J PHYSIOL BIOCHEM, V68, P555, DOI 10.1007/s13105-012-0173-z; FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GRUNER JA, 1992, J NEUROTRAUM, V9, P126; Harris CA, 2001, J BIOL CHEM, V276, P37754; Huan WP, 2012, J MOL HISTOL, V43, P527, DOI 10.1007/s10735-012-9411-5; Jana A, 2009, J NEUROL SCI, V278, P5, DOI 10.1016/j.jns.2008.12.010; Torres BBJ, 2010, INT J EXP PATHOL, V91, P530, DOI 10.1111/j.1365-2613.2010.00738.x; Karimi-Abdolrezaee S, 2012, MOL NEUROBIOL, V46, P251, DOI 10.1007/s12035-012-8287-4; Khalatbary AR, 2012, IRAN RED CRESCENT ME, V14, P229; Liu CJ, 2011, BRAIN RES, V1374, P100, DOI 10.1016/j.brainres.2010.11.061; Liu L, 2012, EUR J PHARMACOL, V691, P61, DOI 10.1016/j.ejphar.2012.07.031; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Liu YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000707; LIUZZI FJ, 1987, SCIENCE, V237, P642, DOI 10.1126/science.3603044; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Marriott JB, 2003, CANCER RES, V63, P593; Martin-Garabato E., 2008, Cancer Genomics & Proteomics, V5, P169; Martinez-Arribas F, 2006, J CELL BIOCHEM, V97, P1275, DOI 10.1002/jcb.20725; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Min KJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-100; Naseer MI, 2011, SYNAPSE, V65, P562, DOI 10.1002/syn.20875; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Park OH, 2007, EUR J NEUROSCI, V26, P1421, DOI 10.1111/j.1460-9568.2007.05787.x; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Rahman MA, 2012, MOL CELL BIOCHEM, V369, P95, DOI 10.1007/s11010-012-1372-1; Rong W, 2012, NEUROCHEM RES, V37, P1615, DOI 10.1007/s11064-012-0756-7; RUDGE JS, 1990, J NEUROSCI, V10, P3594; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sergeant KA, 2007, J CELL SCI, V120, P309, DOI 10.1242/jcs.03344; Shen AU, 2008, NEUROCHEM INT, V52, P1266, DOI 10.1016/j.neuint.2008.01.011; Shin KH, 2008, NITRIC OXIDE-BIOL CH, V19, P125, DOI 10.1016/j.niox.2008.04.012; Shin KH, 2008, BIOCHEM BIOPH RES CO, V372, P880, DOI 10.1016/j.bbrc.2008.05.175; Shin KH, 2007, DNA REPAIR, V6, P830, DOI 10.1016/j.dnarep.2007.01.013; Shin KH, 2006, CLIN CANCER RES, V12, P3222, DOI 10.1158/1078-0432.CCR-05-2656; Song MS, 2009, BRAIN RES, V1271, P114, DOI 10.1016/j.brainres.2009.03.032; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Sunkaria A, 2012, CHEM RES TOXICOL, V25, P1762, DOI 10.1021/tx300234n; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Ullah N, 2011, NEUROPHARMACOLOGY, V61, P1248, DOI 10.1016/j.neuropharm.2011.06.031; White RE, 2008, RESTOR NEUROL NEUROS, V26, P197; White RE, 2011, J NEUROSCI, V31, P15173, DOI 10.1523/JNEUROSCI.3441-11.2011; White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282; Wisniewski ML, 2011, J VIROL, V85, P296, DOI 10.1128/JVI.01982-10; Wu G, 2011, NEUROMOL MED, V13, P187, DOI 10.1007/s12017-011-8150-1; Wu JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042129; Wu JF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-169; Wu XM, 2012, J MOL NEUROSCI, V47, P357, DOI 10.1007/s12031-012-9761-1; Xu T, 2012, J MOL HISTOL, V43, P335, DOI 10.1007/s10735-012-9408-0; Yin X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051853, 10.1371/journal.pone.0038381]; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371; Zhao W, 2011, J MOL HISTOL, V42, P195, DOI 10.1007/s10735-011-9324-8	67	22	23	0	13	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	FEB	2013	49	2					417	429		10.1007/s12031-012-9914-2			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	070OW	WOS:000313519900020	23180094				2022-02-06	
J	Mountney, A; Leung, LY; Pedersen, R; Shear, D; Torte, F				Mountney, Andrea; Leung, Lai Yee; Pedersen, Rebecca; Shear, Deborah; Torte, Frank			Longitudinal assessment of gait abnormalities following penetrating ballistic-like brain injury in rats	JOURNAL OF NEUROSCIENCE METHODS			English	Article						TBI; CatWalk; Gait analysis; PBBI; Longitudinal profile	MODEL; STROKE; MOTOR; IMPAIRMENT; LOCOMOTION; MOVEMENT; RECOVERY; DEFICITS; NUCLEUS; LESIONS	Traumatic brain injury (TBI) results in enduring motor and cognitive dysfunction. Although gait disturbances have been documented among TBI patients, few studies have profiled gait abnormalities in animal models of TBI. We sought to obtain a comprehensive longitudinal analysis of gait function following severe penetrating ballistic-like brain injury (PBBI) in rats. Rats were subjected to either unilateral frontal PBBI, probe insertion alone, or sham surgery. Sensorimotor performance was assessed using the CatWalk automated gait analysis system. Baseline measurements were taken 3 days prior to injury and detailed analysis of gait was performed at 1, 3, 7, 14, and 28 days post-injury. Both PBBI and probe-inserted rats displayed altered static and dynamic gait parameters that were primarily evident during the early (<7 days) post-injury phase and were resolved by 1 month post-injury. PBBI produced more severe deficits compared to probe-alone which were reflected in the number, magnitude, and resolution time of abnormal gait parameters. While altered parameters were detected in all four paws, they were more apparent on the contralateral side. Gait parameters including paw pressure, print area, swing speed, and stride length were significantly decreased whereas stance, swing, and step cycle duration were increased compared to sham. Overall, altered gait patterns detected using the CatWalk system in the PBBI model were injury-severity dependent, resolved at later time points, and appeared similar to those reported in severe TBI patients. These results indicate that the CatWalk may be most useful for neuroprotection studies that focus on the acute/subacute recovery period after TBI. Published by Elsevier B.V.	[Mountney, Andrea; Leung, Lai Yee; Pedersen, Rebecca; Shear, Deborah; Torte, Frank] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Nemorestorat Branch, Silver Spring, MD 20910 USA		Mountney, A (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Nemorestorat Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Andrea.Mountney@amedd.army.mil	Leung, Lai Yee/H-8204-2013		Army Combat Casualty Care Research Program; National Research Council Research Associateship Award at Walter Reed Army Institute of Research	The authors are grateful for the technical assistance provided by Weihong Yang. This research was funded by the Army Combat Casualty Care Research Program and performed while the author held a National Research Council Research Associateship Award at Walter Reed Army Institute of Research	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Chen P, 2002, P NATL ACAD SCI USA, V99, P9031, DOI 10.1073/pnas.132076299; Chen ZY, 2012, J NEUROTRAUM, V29, P268, DOI 10.1089/neu.2011.2057; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Fanardjian V. V., 2000, Neural Plasticity, V7, P261, DOI 10.1155/NP.2000.261; Gabriel AF, 2007, J NEUROSCI METH, V163, P9, DOI 10.1016/j.jneumeth.2007.02.003; Gensel JC, 2006, J NEUROTRAUM, V23, P36, DOI 10.1089/neu.2006.23.36; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Johnk K, 1999, RESTOR NEUROL NEUROS, V14, P143; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Lorincz E, 1997, BEHAV NEUROSCI, V111, P892; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; NAUS C, 1985, EXP BRAIN RES, V59, P365; NAUS CG, 1985, J COMP NEUROL, V239, P453, DOI 10.1002/cne.902390411; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Noskin O, 2008, J NEUROL NEUROSUR PS, V79, P401, DOI 10.1136/jnnp.2007.118463; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; Shear DA, 2011, J NEUROTRAUM; Shear DA, 2011, J NEUROTRAUM, V28, P2185, DOI 10.1089/neu.2011.1916; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Terashima Anatomy T, 1995, NEUROSCI RES, V22, P139; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Vlamings R, 2007, NEUROSCIENCE, V148, P815, DOI 10.1016/j.neuroscience.2007.06.043; Vogelaar CF, 2004, BRAIN RES, V1027, P67, DOI 10.1016/j.brainres.2004.08.036; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang YG, 2008, J CEREBR BLOOD F MET, V28, P1936, DOI 10.1038/jcbfm.2008.82; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013	36	22	22	0	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	JAN 15	2013	212	1					1	16		10.1016/j.jneumeth.2012.08.025			16	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	068UB	WOS:000313390600001	22981945				2022-02-06	
J	Daggett, VS; Bakas, T; Buelow, J; Habermann, B; Murray, LL				Daggett, Virginia S.; Bakas, Tamilyn; Buelow, Janice; Habermann, Barbara; Murray, Laura L.			Needs and concerns of male combat Veterans with mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						activities of daily living; adaptation; Afghanistan; behavioral symptoms; cognitive symptoms; environment; Iraq; interpersonal interactions; needs; theoretical model; traumatic brain injury; Veterans	QUALITY-OF-LIFE; COMMUNITY REINTEGRATION; CONCEPTUAL-MODEL; HEALTH-SERVICES; MILITARY TBI; EXPERIENCES; IRAQ; AFGHANISTAN; MANAGEMENT; FAMILIES	Traumatic brain injury (TBI) has emerged as a major cause of morbidity among U.S. servicemembers who have served in Iraq and Afghanistan. Even mild TBI (mTBI) can result in cognitive impairments that can affect the community reintegration of Veterans postdeployment. The purpose of this study was to explore the needs and concerns of combat Veterans with mTBI to provide support for an mTBI-specific conceptual model (Conceptual Model in the Context of mTBI) derived from Ferrans et al.'s health-related quality of life model and the TBI literature. Content analysis of qualitative interview data was conducted using a thematic matrix with a predetermined code list. Data saturation was achieved after interviews with eight male Veterans. Six key categories and predominant themes emerged: cognitive impairments, physical symptoms, emotions and behaviors, instrumental activities of daily living, interpersonal interactions, and community reintegration. Findings provide preliminary support for a new, context-specific conceptual model that has the potential to identify areas for future interventions to enhance community reintegration of combat Veterans with mTBI.	[Daggett, Virginia S.] Richard L Roudebush VA Med Ctr, Dept Vet Affairs VA Hlth Serv Res, Indianapolis, IN 46202 USA; [Daggett, Virginia S.] Richard L Roudebush VA Med Ctr, Dev Ctr Excellence Implementing Evidence Based Pr, Indianapolis, IN 46202 USA; [Daggett, Virginia S.; Bakas, Tamilyn; Buelow, Janice; Habermann, Barbara] Indiana Univ, Sch Nursing, Indianapolis, IN 46204 USA; [Murray, Laura L.] Indiana Univ, Dept Speech & Hearing Sci, Bloomington, IN 47405 USA		Daggett, VS (corresponding author), Richard L Roudebush VA Med Ctr, VISN VA Ctr Appl Syst Engn VA CASE 11, HSR&D Mail Code 11H,1481 West 10th St, Indianapolis, IN 46202 USA.	Virginia.Daggett2@va.gov	Bakas, Tamilyn/ABC-5664-2020		VA Health Services Research and Development Center of Excellence on Implementing Evidence-Based PracticeUS Department of Veterans Affairs; Indiana University School of Nursing; Indiana University Graduate Affairs	This material is based on work supported by the VA Health Services Research and Development Center of Excellence on Implementing Evidence-Based Practice, the Indiana University School of Nursing, and Indiana University Graduate Affairs.	[Anonymous], 2008, MILD TRAUM BRAIN INJ; [Anonymous], 2008, POL BLAST REL INJ PT; Arciniegas DB, 2010, PSYCHIAT ANN, V40, P540, DOI 10.3928/00485713-20101022-05; Bakas Tamilyn, 2002, J Neurosci Nurs, V34, P242; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Carlson K, 2009, ASSESSMENT TREATMENT; Cavendish Roberta, 2007, Holist Nurs Pract, V21, P89; Ceranic BJ, 1998, J NEUROL NEUROSUR PS, V65, P523, DOI 10.1136/jnnp.65.4.523; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; Daggett VS, 2010, THESIS INDIANA U SCH; de Riesthal M, 2009, PERSPECTIVES NEUROPH, V19, P58; Doyle ME, 2005, PSYCHIAT QUART, V76, P361, DOI 10.1007/s11126-005-4972-z; Ferrans CE, 2005, J NURS SCHOLARSHIP, V37, P336, DOI 10.1111/j.1547-5069.2005.00058.x; Fraas M, 2007, BRAIN INJURY, V21, P1267, DOI 10.1080/02699050701721794; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Henry JA, 2005, J REHABIL RES DEV, V42, P95, DOI 10.1682/JRRD.2005.01.0005; Hill O, 2008, ONCOL NURS FORUM, V35, P81, DOI 10.1188/08.ONF.81-88; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Huang XY, 2008, J CLIN NURS, V17, P817, DOI 10.1111/j.1365-2702.2007.02130.x; Institute of Medicine (US) Committee on the Initial Assessment of Readjustment Needs of Military Personnel Veterans and Their Families, 2010, RET HOM IR AFGH PREL; Kilcullen N, 2007, J CLIN NURS, V16, P1029, DOI 10.1111/j.1365-2702.2007.01661.x; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Mavundla TR, 2000, J ADV NURS, V32, P1569, DOI 10.1046/j.1365-2648.2000.01661.x; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Miles MB, 1994, QUALITATIVE DATA ANA, P37; Miller NK, 2008, RURAL REMOTE HEALTH, V8; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI [DOI 10.1044/NNS1D19.2.47, 10.1044/nnsld19.2.47, DOI 10.1044/NNSLD19.2.47]; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Resnik L, 2011, J REHABIL RES DEV, V48, P89, DOI 10.1682/JRRD.2010.04.0070; Resnik L, 2009, J REHABIL RES DEV, V46, P469, DOI 10.1682/JRRD.2008.07.0082; Resnik LJ, 2007, J REHABIL RES DEV, V44, P991, DOI 10.1682/JRRD.2007.05.0071; Roehrs C, 2008, JOGNN-J OBST GYN NEO, V37, P631, DOI 10.1111/j.1552-6909.2008.00290.x; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; SANDELOWSKI M, 1993, RES NURS HEALTH, V16, P213, DOI 10.1002/nur.4770160308; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; SHUCART WA, 1981, J LARYNGOL OTOL, P166; Sloane MM, 2006, NURSING SPECTRUM; Sohlberg M., 2001, COGNITIVE REHABILITA; Street AE, 2009, CLIN PSYCHOL REV, V29, P685, DOI 10.1016/j.cpr.2009.08.007; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03	60	22	23	0	8	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	3					327	340		10.1682/JRRD.2011.09.0168			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AR1IS	WOS:000343339500006	23881759	Bronze			2022-02-06	
J	Dams-O'Connor, K; Spielman, L; Hammond, FM; Sayed, N; Culver, C; Diaz-Arrastia, R				Dams-O'Connor, K.; Spielman, L.; Hammond, F. M.; Sayed, N.; Culver, C.; Diaz-Arrastia, R.			An exploration of clinical dementia phenotypes among individuals with and without traumatic brain injury	NEUROREHABILITATION			English	Article						Dementia; traumatic brain injury (TBI); National Alzheimer's Coordinating Center (NACC)	DATA SET UDS; ALZHEIMERS-DISEASE; OLDER-ADULTS; AGE; ENCEPHALOPATHY; MORTALITY; IMPACT; RISK	OBJECTIVE: To characterize the clinical profiles of individuals with dementia who do and do not report a history of TBI. INTRODUCTION: Some evidence suggests that a history of traumatic brain injury (TBI) is associated with an increased risk of dementia later in life. The clinical features of dementia associated with TBI have not been well investigated. While there is some evidence that TBI is associated with increased risk of Alzheimer's disease (AD), there are also indications that dementia associated with TBI has prominent behavioral, affective, and motor symptoms, making it distinct from AD. METHODS: The current study involves secondary analysis of baseline data from the National Alzheimer's Coordinating Center (NACC) Uniform Data Set (UDS). RESULTS: Individuals with dementia who reported a history of TBI had higher fluency and verbal memory scores and later onset of decline, but they are on more medications, had worse cardiovascular and cerebrovascular health, were more likely to have received medical attention for depression, and were more likely to have a gait disorder, falls, and motor slowness. CONCLUSION: These findings suggest that dementia among individuals with a history of TBI may represent a unique clinical phenotype that is distinct from known dementia subtypes.	[Dams-O'Connor, K.; Spielman, L.] Ichan Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Hammond, F. M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Sayed, N.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Culver, C.; Diaz-Arrastia, R.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Dams-O'Connor, K (corresponding author), Ichan Sch Med Mt Sinai, Brain Injury Res Ctr, Dept Rehabil Med, 1 Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.	kristen.dams-o'connor@mountsinai.org		Diaz-Arrastia, Ramon/0000-0001-6051-3594	NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01 AG016976]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG016976] Funding Source: NIH RePORTER	The NACC database is funded by NIA Grant U01 AG016976.	Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Ashman TA, 2006, MT SINAI J MED, V73, P999; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breed S, 2008, J HEAD TRAUMA REHAB, V23, P149, DOI 10.1097/01.HTR.0000319931.76966.ff; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; BUTTERS N, 1987, J CLIN EXP NEUROPSYC, V9, P479, DOI 10.1080/01688638708410764; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Faul M, 2010, TRAUMATIC BRAIN INJU; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Hibbard M. R., 2005, COGNITIVE BEHAV THER, P189; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Institute of Medicine Committee on Gulf War and Health, 2009, PSYCHIATRIC OUTCOMES; Kaplan E, 1983, BOSTON NAMING TEST; Kaufer DI, 2000, J NEUROPSYCH CLIN N, V12, P233, DOI 10.1176/jnp.12.2.233; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LEZAK M, 2004, NEUROPSYCOLOGICAL AS; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Reitan RM, 1985, THE HALSTEAD REITAN; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wechsler D., 1987, WECHSLER ADULT INTEL; Wechsler D, 1987, WECHSLER MEMORY SCAL; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P655	45	22	22	0	8	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2013	32	2					199	209		10.3233/NRE-130838			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	115ZT	WOS:000316851900002	23535782	Green Accepted			2022-02-06	
J	Qureshi, JS; Ohm, R; Rajala, H; Mabedi, C; Sadr-Azodi, O; Andren-Sandberg, A; Charles, AG				Qureshi, Javeria S.; Ohm, Rebecka; Rajala, Henrik; Mabedi, Charles; Sadr-Azodi, Omid; Andren-Sandberg, Ake; Charles, Anthony G.			Head injury triage in a sub Saharan African urban population	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Head injury; Traumatic brain injury; Glasgow Coma Score; Malawi; Africa	TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; PRACTICAL SCALE; CARE; IMPACT; COUNTRIES; UGANDA; MALAWI; MODEL	Background: Injuries are the ninth leading cause of death in the world and disproportionately affect low- and middle-income countries. Head injury is the leading cause of trauma death. This study examines the epidemiology and outcomes of traumatic head injury presenting to a tertiary hospital in Malawi, in order to determine effective triage in a resource limited setting. Methods: The study was conducted at Kamuzu Central Hospital (KCH) in Lilongwe Malawi during a three-month period. Vital signs and Glasgow Coma Score (GCS) were prospectively collected for all patients that presented to the casualty department secondary to head injury. All head injury admissions were followed until death or discharge. Results: During the three-month study period, 4411 patients presented to KCH secondary to trauma and 841 (19%) had a head injury. A multivariate logistic regression model revealed that GCS and heart rate changes correlated strongly with mortality. There is a four-fold increase in the odds of mortality in moderate versus mild head injury based on GCS. Conclusion: In a resource limited setting, basic trauma tools such as GCS and heart rate can effectively triage head injury patients, who comprise the most critically ill trauma patients. Improvements in head injury outcome require multifaceted efforts including the development of a trauma system to improve pre-hospital care. (C) 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.	[Qureshi, Javeria S.; Charles, Anthony G.] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA; [Qureshi, Javeria S.; Mabedi, Charles] Kamuzu Cent Hosp, Dept Surg, Lilongwe, Malawi; [Ohm, Rebecka; Rajala, Henrik; Sadr-Azodi, Omid; Andren-Sandberg, Ake] Karolinska Univ Hosp, Dept Surg, Stockholm, Sweden		Qureshi, JS (corresponding author), Univ N Carolina, Dept Surg, 4001 Burnett Womack Bldg,CB 7050, Chapel Hill, NC 27599 USA.	jsquresh@gmail.com		Sadr Azodi, Omid/0000-0001-8093-7685	North Carolina Jaycee Burn Center; North Carolina TRACS grant	North Carolina Jaycee Burn Center.; North Carolina TRACS grant.	Ackaah W, 2010, TRAFFIC INJ PREV, V11, P522, DOI 10.1080/15389588.2010.489198; Alexander T, 2009, S AFR J SURG, V47, P120; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; Dinh-Zarr TB, 2001, AM J PREV MED, V21, P48, DOI 10.1016/S0749-3797(01)00378-6; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Hsia RY, 2010, INT J EMERG MED, V3, P165, DOI 10.1007/s12245-010-0200-1; Hyder AA, 2007, ASIA-PAC J PUBLIC HE, V19, P16, DOI 10.1177/10105395070190020401; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Jayaraman S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006955; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, LANCET, V1, P1031; Kobusingye OC, 2000, J TRAUMA, V48, P498, DOI 10.1097/00005373-200003000-00022; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; MacLeod JBA., 2003, EUR J TRAUMA, V29, P392, DOI [10.1007/s00068-003-1277-5, DOI 10.1007/S00068-003-1277-5]; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mock C, 2004, GUIDELIENS ESSENTIAL; Mock C, 2012, WORLD J SURG, V36, P959, DOI 10.1007/s00268-012-1459-6; MOCK CN, 1993, J TRAUMA, V35, P518, DOI 10.1097/00005373-199310000-00004; Murray C. J., 1996, GLOBAL HLTH STAT COM; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Odero W, 1997, TROP MED INT HEALTH, V2, P445, DOI 10.1046/j.1365-3156.1997.d01-296.x; Oginni Fadekemi O, 2007, Traffic Inj Prev, V8, P137, DOI 10.1080/15389580601058472; Oluwadiya KS, 2009, ACCIDENT ANAL PREV, V41, P294, DOI 10.1016/j.aap.2008.12.002; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Samuel JC, 2010, TROP DOCT, V40, P98, DOI 10.1258/td.2009.090009; Samuel JC, 2009, WORLD J SURG, V33, P1836, DOI 10.1007/s00268-009-0113-4; Solagberu Babatunde A, 2002, West Afr J Med, V21, P230; Stewart de Ramirez S, 2011, ANN REV PUBLIC HLTH; TEASDALE G, 1974, LANCET, V2, P81; Tiska MA, 2004, EMERG MED J, V21, P237, DOI 10.1136/emj.2002.002097; Trauma ACoSCo, 1976, RES OPT CAR INJ PAT; WHO, 2009, WHO COUNTR COOP STRA; 2001, AM J PREV MED S4, V21, P16	36	22	22	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191			INT J SURG	Int. J. Surg.		2013	11	3					265	269		10.1016/j.ijsu.2013.01.011			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	117FF	WOS:000316938200014	23380244	hybrid, Green Published			2022-02-06	
J	Sorita, E; N'Kaoua, B; Larrue, F; Criquillon, J; Simion, A; Sauzeon, H; Joseph, PA; Mazaux, JM				Sorita, Eric; N'Kaoua, Bernard; Larrue, Florian; Criquillon, Julie; Simion, Audrey; Sauzeon, Helene; Joseph, Pierre-Alain; Mazaux, Jean-Michel			Do patients with traumatic brain injury learn a route in the same way in real and virtual environments?	DISABILITY AND REHABILITATION			English	Article						Cognitive rehabilitation; topographical disorientation; transfer; virtual reality	TOPOGRAPHICAL DISORIENTATION; COGNITIVE REHABILITATION; SPATIAL INFORMATION; TRAINING PEOPLE; NAVIGATION; DEFICITS; DISABILITY; KNOWLEDGE; VALIDATION; MANAGEMENT	An increasing number of studies address the use of virtual environments (VE) in the cognitive assessment of spatial abilities. However, the differences between learning in a VE and a real environment (RE) remain controversial. Purpose: To compare the topographical behavior and spatial representations of patients with traumatic brain injury navigating in a real environment and in a virtual reproduction of this environment. Methods: Twenty-seven subjects with moderate to severe traumatic brain injury were consecutively included and allocated to one of two groups. The subjects were taught the same route in either the virtual environment or the real environment and had to recall it twice immediately after learning the route and once after a delay. At the end of these sessions, the subjects were asked to complete three representational tests: a map test, a map recognition test recognition and a scene arrangement test. Results: No significant difference was found between the two groups with regards to demographics, severity of brain injury or episodic memory. As a main result, the number of error rates did not significantly differ between the real and virtual environment [F (1, 25) = 0.679; p = 0.4176)]. Scores on the scene arrangement test were higher in the real environment [U = 32.5; p = 0.01]. Conclusions: Although spatial representations probably differ between the real and virtual environment, virtual reality remains a trusty assessment tool for spatial abilities.	[Sorita, Eric; Criquillon, Julie; Simion, Audrey; Joseph, Pierre-Alain; Mazaux, Jean-Michel] Univ Hosp Bordeaux, Rehabil Med Unit, Bordeaux, France; [Sorita, Eric; N'Kaoua, Bernard; Larrue, Florian; Sauzeon, Helene; Joseph, Pierre-Alain; Mazaux, Jean-Michel] Univ Bordeaux Segalen, Res Grp Handicap & Nervous Syst, Bordeaux, France		Sorita, E (corresponding author), Univ Hosp Pellegrin, Rehabil Med Unit, F-33076 Bordeaux, France.	eric.sorita@chu-bordeaux.fr	N'Kaoua, Bernard/T-3577-2019; Sauzeon, Helene/T-1178-2019; Sorita, eric/T-5004-2019	Sauzeon, Helene/0000-0001-5781-9891; Sorita, eric/0000-0002-5841-0972	association France Traumatisme Cranien; Fondation des Gueules Cassees, Paris, France	This study was granted by the association France Traumatisme Cranien and the Fondation des Gueules Cassees, Paris, France. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.	BARRASH J, 1993, J CLIN EXP NEUROPSYC, V15, P66; Barrash J, 1998, J CLIN EXP NEUROPSYC, V20, P807, DOI 10.1076/jcen.20.6.807.1114; Barrash J, 2000, NEUROPSYCHOLOGIA, V38, P820, DOI 10.1016/S0028-3932(99)00131-1; BOYD TM, 1993, APPL COGNITIVE PSYCH, V7, P171, DOI 10.1002/acp.2350070208; Brooks BM, 2002, DISABIL REHABIL, V24, P622, DOI 10.1080/09638280110111397; Brooks BM, 1999, NEUROPSYCHOL REHABIL, V9, P63, DOI 10.1080/713755589; Brunsdon R, 2007, NEUROPSYCHOL REHABIL, V17, P34, DOI 10.1080/09602010500505021; Carelli L, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-6; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Crosbie JH, 2007, DISABIL REHABIL, V29, P1139, DOI 10.1080/09638280600960909; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Edmans J, 2009, CLIN REHABIL, V23, P106, DOI 10.1177/0269215508095875; Farrell MJ, 2003, J EXP PSYCHOL-APPL, V9, P219, DOI 10.1037/1076-898X.9.4.219; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Foo P, 2005, J EXP PSYCHOL LEARN, V31, P195, DOI 10.1037/0278-7393.31.2.195; Foreman N, 2000, BEHAV BRAIN RES, V112, P53, DOI 10.1016/S0166-4328(00)00159-5; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Gillner S, 1998, J COGNITIVE NEUROSCI, V10, P445, DOI 10.1162/089892998562861; Golledge RG, 1999, WAYFINDING BEHAVIOR, P5; GROBER E, 1987, DEV NEUROPSYCHOL, V3, P13, DOI 10.1080/87565648709540361; Iaria G, 2009, NEUROPSYCHOLOGIA, V47, P30, DOI 10.1016/j.neuropsychologia.2008.08.021; Josman N., 2008, P 7 ICDVRAT; Kurtz MM, 2007, SCHIZOPHRENIA BULL, V33, P1162, DOI 10.1093/schbul/sbl039; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; Lloyd J, 2009, CYBERPSYCHOL BEHAV, V12, P423, DOI 10.1089/cpb.2008.0326; Lloyd J, 2009, NEUROPSYCHOL REHABIL, V19, P98, DOI 10.1080/09602010802117392; Maguire EA, 2006, BRAIN, V129, P2894, DOI 10.1093/brain/awl286; Mittelstaedt H, 1973, FORTSCHR ZOOL, V21, P46; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; Morganti F, 2007, COMPUT HUM BEHAV, V23, P1982, DOI 10.1016/j.chb.2006.02.006; Muller D, 1998, DISABIL REHABIL, V20, P97; Newman EL, 2007, COGNITION, V104, P231, DOI 10.1016/j.cognition.2006.05.013; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Reid D., 2009, TECHNOL DISABIL, V21, P43; Riva G, 1998, ST HEAL T, V58, P191; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rizzo AS, 2002, DISABIL REHABIL, V24, P567, DOI 10.1080/09638280110111315; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rose FD, 2002, DISABIL REHABIL, V24, P627, DOI 10.1080/09638280110111405; Siegle AW, 1975, ADV CHILD DEV BEHAV, P9; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Skelton RW, 2000, J CLIN EXP NEUROPSYC, V22, P157, DOI 10.1076/1380-3395(200004)22:2;1-1;FT157; Spiers HJ, 2007, HIPPOCAMPUS, V17, P618, DOI 10.1002/hipo.20298; Stanney KM, 2002, HUM PERFORM, V15, P339, DOI 10.1207/S15327043HUP1504_03; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Toglia JP, 2005, COGNITION OCCUPATION, P29; Tyndiuk F., 2005, P ACM S VIRT REAL SO, P117, DOI [10.1145/1101616.1101641, DOI 10.1145/1101616.1101641]; Waller D, 1998, PRESENCE-TELEOP VIRT, V7, P129, DOI 10.1162/105474698565631; Waller D, 2000, J EXP PSYCHOL-APPL, V6, P307, DOI 10.1037//1076-898X.6.4.307; Wallet G, 2009, J VIRT REAL BROAD, V6; Wallet G, 2011, CYBERPSYCH BEH SOC N, V14, P417, DOI 10.1089/cyber.2009.0187; Wallet G, 2010, STUD HEALTH TECHNOL, V154, P145, DOI 10.3233/978-1-60750-561-7-145; Wallet Gregory, 2008, P 2008 ACM S VIRT RE, P175, DOI 10.1145/1450579.1450616; Weniger G, 2009, NEUROPSYCHOLOGIA, V47, P59, DOI 10.1016/j.neuropsychologia.2008.08.018; Wiener JM, 2009, SPAT COGN COMPUT, V9, P152, DOI 10.1080/13875860902906496; Wiener JM, 2004, J ENVIRON PSYCHOL, V24, P475, DOI 10.1016/j.jenvp.2004.09.006; Wilson PN, 1996, DISABIL REHABIL, V18, P633, DOI 10.3109/09638289609166328; Wilson PN, 1997, DISABIL REHABIL, V19, P213, DOI 10.3109/09638289709166530; Witmer BG, 1996, INT J HUM-COMPUT ST, V45, P413, DOI 10.1006/ijhc.1996.0060; Wolbers T, 2010, TRENDS COGN SCI, V14, P138, DOI 10.1016/j.tics.2010.01.001; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X; Zimmermann P, 1995, TEST ATTENTIONAL PER	62	22	22	0	19	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2013	35	16					1371	1379		10.3109/09638288.2012.738761			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	178RN	WOS:000321465200007	23244232				2022-02-06	
J	Driscoll, DM; Dal Monte, O; Solomon, J; Krueger, F; Grafman, J				Driscoll, David M.; Dal Monte, Olga; Solomon, Jeffrey; Krueger, Frank; Grafman, Jordan			Empathic Deficits in Combat Veterans with Traumatic Brain Injury: A Voxel-Based Lesion-Symptom Mapping Study	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Article						empathy; emotion; prefrontal cortex; traumatic brain injury; voxel-based lesion-symptom mapping	GENDER-DIFFERENCES; SOCIAL-BEHAVIOR; EMOTION; SYSTEMS; MECHANISMS; RESONANCE; ABILITIES; COGNITION; PEOPLE; CORTEX	Objective: To understand better which brain regions support emotional empathy. Background: Emotional empathy, the ability to interpret and share the affective states of others, is a key component in human social interaction. Previous research has suggested that emotional empathy relies on several distinct brain regions, although further evidence from human lesion studies is needed to determine which regions are critical. Methods: We studied 192 male Vietnam combat veterans who had sustained focal penetrating traumatic brain injuries, and 54 non-brain-injured veterans. We used voxel-based lesion-symptom mapping on computed tomographic scans to elucidate the neural bases of self-reported emotional empathy as measured by the Balanced Emotional Empathy Scale. Results: Damage in several brain regions, particularly the ventrolateral prefrontal cortex, left and right posterior temporal lobes, and insula, was associated with diminished emotional empathy. Conclusions: These findings provide further insight into the neural substrates of emotional empathy, and are consistent with the notion that emotional empathy is supported by a distributed network of brain regions. Additional work may advance our understanding of the empathic deficits commonly observed in patients with neurologic and psychiatric disorders.	[Driscoll, David M.; Dal Monte, Olga] NINDS, Cognit Neurosci Sect, NIH, Bethesda, MD 20892 USA; [Driscoll, David M.; Dal Monte, Olga] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Dal Monte, Olga] Univ Turin, Dept Neuropsychol, Turin, Italy; [Solomon, Jeffrey] Expert Image Anal LLC, Potomac, MD USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA; [Grafman, Jordan] Kessler Fdn Res Ctr, Traumat Brain Injury Res Lab, W Orange, NJ USA		Driscoll, DM (corresponding author), Nebraska Western Iowa Hlth Care Syst, Dept Vet Affairs, 600 S 70th St, Lincoln, NE 68510 USA.	david.driscoll@va.gov	Dal Monte, Olga/P-3759-2018	Dal Monte, Olga/0000-0002-7823-4769; Grafman, Jordan H./0000-0001-8645-4457	US National Institute of Neurological Disorders and Stroke Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Center for Neuroscience and Regenerative Medicine via the Henry M. Jackson Foundation; National Naval Medical Center	Supported in part by the US National Institute of Neurological Disorders and Stroke Intramural Research Program and a project grant from the US Army Medical Research and Material Command administered by the Henry M. Jackson Foundation (Vietnam Head Injury Study Phase III: a 30-year post-injury follow-up study). D.M.D. and O.D.M. were supported with funding from the Center for Neuroscience and Regenerative Medicine via the Henry M. Jackson Foundation.; The authors thank all of the Vietnam veterans who participated in this study for their long-term commitment to improving the health care of veterans; the National Naval Medical Center for their support and provision of their facilities; and S. Bonifant, B. Cheon, C. Ngo, A. Greathouse, K. Reding, and G. Tasick for their invaluable help with organizing the study and testing the participants.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 1996, J NEUROSCI, V16, P7678; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 1960, ARM FORC QUAL TEST A; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Benedetti F, 2009, SCHIZOPHR RES, V114, P154, DOI 10.1016/j.schres.2009.06.021; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bora E, 2008, PSYCHIAT RES, V160, P23, DOI 10.1016/j.psychres.2007.05.017; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Decety J, 2008, DEV PSYCHOPATHOL, V20, P1053, DOI 10.1017/S0954579408000503; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Eslinger PJ, 2002, CURR OPIN NEUROL, V15, P91, DOI 10.1097/00019052-200202000-00014; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Gross JJ, 1997, PSYCHOL AGING, V12, P590, DOI 10.1037/0882-7974.12.4.590; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; Maylor EA, 2002, BRIT J PSYCHOL, V93, P465, DOI 10.1348/000712602761381358; Mcrae K, 2008, GROUP PROCESS INTERG, V11, P143, DOI 10.1177/1368430207088035; Mehrabian A., 2000, MANUAL BALANCED EMOT; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Perry RJ, 2001, NEUROCASE, V7, P145, DOI 10.1076/neur.7.2.145.16267; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rankin KP, 2006, BRAIN, V129, P2945, DOI 10.1093/brain/awl254; Rankin KP, 2005, COGN BEHAV NEUROL, V18, P28, DOI 10.1097/01.wnn.0000152225.05377.ab; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; SCHWARTZ GE, 1975, SCIENCE, V190, P286, DOI 10.1126/science.1179210; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; Shamay-Tsoory SG, 2011, NEUROSCIENTIST, V17, P18, DOI 10.1177/1073858410379268; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T., 2008, NEUROECONOMICS DECIS, P233; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Young A., 2002, FACIAL EXPRESSIONS E	55	22	23	1	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	DEC	2012	25	4					160	166		10.1097/WNN.0b013e318280cf4e			7	Behavioral Sciences; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	062TB	WOS:000312944200002	23277137				2022-02-06	
J	Hatta, T; Yoshizaki, K; Ito, Y; Mase, M; Kabasawa, H				Hatta, Takeshi; Yoshizaki, Kazuhito; Ito, Yasuhiro; Mase, Mitsuhito; Kabasawa, Hidehiro			RELIABILITY AND VALIDITY OF THE DIGIT CANCELLATION TEST, A BRIEF SCREEN OF ATTENTION	PSYCHOLOGIA			English	Article						screening test for attention; digit cancellation test; traumatic brain injury; test-reliability; test-validity	TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; TASK; PERFORMANCE; SYMPTOMS; SEARCH	The reliability and validity of a screening test called the D-CAT (Digit Cancellation Test) were evaluated across two studies. The D-CAT was developed to provide a highly practical and user-friendly assessment of various aspects of prefrontal cortex functioning, including information processing speed, the ability to focus attention, and executive functioning. Participants perform the D-CAT by deleting given target numbers on a sheet of randomly arranged possibilities. In Study 1, the reliability of the D-CAT was evaluated using a test-retest paradigm. Reasonably high correlations between scores on the two test sessions were obtained. In Study 2, construct validity was examined using a sample of participants with traumatic brain injury. TBI participants showed significantly lower D-CAT performance than age and education level matched healthy controls. On the basis of these findings, the D-CAT can be regarded as a reliable and valid screening test for attentional functioning.	[Hatta, Takeshi] Kansai Univ Welf Sci, Osaka, Japan; [Yoshizaki, Kazuhito] Aichi Shukutoku Univ, Dept Psychol, Nagakute, Aichi 4801197, Japan; [Ito, Yasuhiro] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Mase, Mitsuhito] Nagoya City Univ, Nagoya, Aichi, Japan; [Kabasawa, Hidehiro] Nagoya City Rehabil Ctr, Nagoya, Aichi, Japan		Yoshizaki, K (corresponding author), Aichi Shukutoku Univ, Dept Psychol, 9 Katahira, Nagakute, Aichi 4801197, Japan.	yoshizak@asu.aasa.ac.jp					Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Ballard JC, 1996, J CLIN EXP NEUROPSYC, V18, P843, DOI 10.1080/01688639608408307; BRICKENKAMP R, 1981, TEST D2 CONCENTRATIO; Cabeza R, 2003, NEUROPSYCHOLOGIA, V41, P390, DOI 10.1016/S0028-3932(02)00170-7; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Charter RA, 1999, J CLIN EXP NEUROPSYC, V21, P559, DOI 10.1076/jcen.21.4.559.889; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Egelko S, 1988, Arch Clin Neuropsychol, V3, P213, DOI 10.1016/0887-6177(88)90015-7; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fisk J. D., 1998, J INT NEUROPSYCH SOC, V7, P363; Geffen G. M., 1994, J CLIN NEUROPSYCHOLO, V3, P257; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; Geldmacher DS, 2000, AGING NEUROPSYCHOL C, V7, P194, DOI 10.1076/1382-5585(200009)7:3;1-Q;FT194; GELDMACHER DS, 1995, NEUROPSY NEUROPSY BE, V8, P259; Geldmacher DS, 1998, BRAIN COGNITION, V36, P346, DOI 10.1006/brcg.1997.0978; Hatta T., 2006, D CAT SCREENING TEST; Hatta T., 2004, J HUM ENV STUD, V2, P15; Hatta T., 2001, D CAT SCREENING TEST; Hatta T., 2009, TRAINING MANUALS COG; Ito Y, 2003, PSYCHOLOGIA, V46, P199, DOI 10.2117/psysoc.2003.199; Iwahara A., 2006, P 30 ANN M NEUR ASS, P121; Kabasawa H, 2008, B RES I NATL REHABIL, V28, P51; Leonards U, 2000, J COGNITIVE NEUROSCI, V12, P61, DOI 10.1162/089892900564073; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Mellers JDC, 1995, NEUROREPORT, V7, P109, DOI 10.1097/00001756-199512290-00026; Nagoya City Rehabilitation Center, 2003, REP NAT MOD PROJ SUP; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rapport LJ, 1997, J CLIN EXP NEUROPSYC, V19, P655, DOI 10.1080/01688639708403751; Rasmussen X., 1995, ARCH CLIN NEUROLOGY, V10, P21; Schretlen D, 1996, CLIN NEUROPSYCHOL, V10, P80, DOI 10.1080/13854049608406666; Smith A., 1991, SYMBOL DIGIT MODALIT; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Trenerry MR, 1990, VISUAL SEARCH ATTENT; UCHIYAMA CL, 1995, ARCH CLIN NEUROPSYCH, V10, P133, DOI 10.1016/0887-6177(94)E0034-M; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Weintraub S., 1988, ARCH NEUROL-CHICAGO, V44, P621; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; [No title captured]	42	22	23	4	27	PSYCHOLOGIA SOC	KYOTO	DEPT EDUC PSYCHOL FAC EDUC KYOTO UNIV, KYOTO, 606, JAPAN	0033-2852	1347-5916		PSYCHOLOGIA	Psychologia	DEC	2012	55	4					246	256		10.2117/psysoc.2012.246			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	063BG	WOS:000312970200002		Bronze			2022-02-06	
J	Kennedy, CH; Evans, JP; Chee, S; Moore, JL; Barth, JT; Stuessi, KA				Kennedy, Carrie H.; Evans, J. Porter; Chee, Shawnna; Moore, Jeffrey L.; Barth, Jeffrey T.; Stuessi, Keith A.			Return to Combat Duty after Concussive Blast Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Head injury; Traumatic Brain Injury; Posttraumatic stress; Disorder	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; NEUROPSYCHOLOGICAL PERFORMANCE; IRAQI FREEDOM; HEAD-INJURY; AFGHANISTAN; SYMPTOMS; SOLDIERS; OPERATIONS; DEPLOYMENT	Little data exist regarding the acute assessment of blast concussion and the course of recovery in the combat zone, as most research has examined service members long after they have returned home. This manuscript examined a case series of 377 service members seen for acute concussion evaluation following medical evacuation from the battlefield in Helmand Province, Afghanistan. Of these, 111 were assessed for concussion prior to their return to the continental USA for other severe physical injuries. Of the remainder, and when comparing those who returned to duty (RTD)/recovered from concussion in the combat zone and those who did not, data indicate that those who did not RTD were older and were more likely to endorse symptoms of combat stress. Quicker recovery times were associated with less severe headaches and fewer acute symptoms at the time of injury as well as the absence of combat stress reaction. Variables that were not associated with RTD and/or recovery were Military Acute Concussion Evaluation (MACE) cognitive scores and whether or not individuals suffered loss of consciousness. While MACE scores were not associated with recovery, they were deemed clinically useful as a part of a serial concussion evaluation if the initial MACE was given within 6 h of the blast. Implications for battlefield concussion assessment and management as well as future research directions are discussed.	[Kennedy, Carrie H.] Marine Corps Embassy Secur Grp, Dept Behav Sci, Quantico, VA 22134 USA; [Evans, J. Porter; Chee, Shawnna; Barth, Jeffrey T.] Univ Virginia, Dept Neuropsychol, Charlottesville, VA USA; [Moore, Jeffrey L.] USN, Operat Med Inst, Robert E Mitchell Prisoner War Studies Ctr, Pensacola, FL USA; [Stuessi, Keith A.] USN, Hosp Camp Pendleton, Dept Sports Med, Camp Pendleton, CA USA		Kennedy, CH (corresponding author), Marine Corps Embassy Secur Grp, Dept Behav Sci, 2007 Elliot Rd, Quantico, VA 22134 USA.	carriehillkennedy@gmail.com					Barth J., 2010, MILITARY NEUROPSYCHO, P127; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bowles SV, 2010, MIL MED, V175, P382, DOI 10.7205/MILMED-D-10-00099; Brenner LA, 2010, NEUROPSYCHOLOGY, V24, P160, DOI 10.1037/a0017966; Burgess Paula, 2010, J Emerg Trauma Shock, V3, P164, DOI 10.4103/0974-2700.62120; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cohen J., 2013, STAT POWER ANAL BEHA; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Defense and Veterans Brain Injury Center [DVBIC], 2012, MIL AC CONC EV; Defense and Veterans Brain Injury Center [DVBIC], 2009, TBI FACTS; Department of Defense Directive Type Memorandum (DTM), 2010, POL GUID MAN CONC MI; DVBIC, 2007, MIL AC CONC EV; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; FRENCH LM, 2010, MILITARY NEUROPSYCHO, P101; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Goldberg MS, 2010, MIL MED, V175, P220, DOI 10.7205/MILMED-D-09-00130; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; KAUR C, 1995, NEUROPATHOLOGY APPL, V21, P787; Kelly JP, 1997, NEUROLOGY, V48, P581; KENNEDY CH, 2010, MILITARY NEUROPSYCHO, P1; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mundie TG, 2000, J TRAUMA, V48, P1115, DOI 10.1097/00005373-200006000-00019; Nelson NW, 2010, ARCH CLIN NEUROPSYCH, V25, P713, DOI 10.1093/arclin/acq075; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Polusny MA, 2009, MIL MED, V174, P353, DOI 10.7205/MILMED-D-01-1608; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Schneiderman A. I., 2008, J HEAD TRAUMA REHAB, V24, P14; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Vanderploeg R. D., HLTH OUTCOM IN PRESS; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	50	22	22	0	20	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2012	27	8					817	827		10.1093/arclin/acs092			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	044RO	WOS:000311641000001	23059351	Bronze			2022-02-06	
J	Ok, JH; Kim, YH; Ha, KY				Ok, Ji-Hoon; Kim, Young-Hoon; Ha, Kee-Yong			Neuroprotective Effects of Hypothermia After Spinal Cord Injury in Rats Comparative Study Between Epidural Hypothermia and Systemic Hypothermia	SPINE			English	Article						spinal cord injury; epidural hypothermia; systemic hypothermia; apoptosis	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; LEUKOCYTE ACCUMULATION; CONTUSION; ACTIVATION; EXPRESSION	Study Design. An experimental comparative study on moderate epidural hypothermia (MEH) versus moderate systemic hypothermia (MSH) after spinal cord injury (SCI). Objective. To compare neuroprotective effects of hypothermia between MEH and MSH after SCI in rats. Summary of Background Data. Experimental MEH or MSH has been attempted for neuroprotection after ischemic or traumatic SCI. However, there is no comparative study on neuroprotective effect of MEH and MSH after SCI. If hypothermia is to be considered as 1 modality for treating SCI, further studies on the advantages and disadvantages of hypothermia will be mandatory. Methods. A spinal cord contusion was produced in all 32 rats, and these rats were randomly divided into 4 groups-8 rats in each group: (1) the control group (spinal cord contusion only), (2) the methylprednisolone group, (3) the MEH group (28 degrees C for 48 hr), and (4) the MSH group (32 degrees C for 48 hr). The functional recovery was assessed using Basso, Beattie, Bresnahan scale and antiapoptotic and anti-inflammatory effects were assessed. Results. The Basso, Beattie, Bresnahan scale scores in both the hypothermia groups were significantly higher than that in the control group at 6 weeks. The numbers of terminal deoxynucleotidyl transferase dUTP nick end labeling-positive cells and OX-42 positive cells were significantly lower in both the MEH and MSH groups than that in the control group. The p38 mitogen-activated protein kinases expression of the treated groups was significantly lower than that of the control group. The expression of caspase-8 and caspase-9 significantly decreased in the treated groups compared with that of the control group. However, in terms of caspase-3, only the MSH group has shown to be significantly lower than that of the control group. Conclusion. This study presented that both systemic and epidural hypothermia demonstrated neuroprotective effects after SCI. Systemic hypothermia showed more neuroprotective effect by antiapoptotic and anti-inflammatory effects.	[Ok, Ji-Hoon; Kim, Young-Hoon; Ha, Kee-Yong] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Orthoped Surg, Seoul 137701, South Korea		Ha, KY (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Orthoped Surg, 505 Banpo Dong, Seoul 137701, South Korea.	kyh@catholic.ac.kr		Kim, Young-Hoon/0000-0003-1237-4600	Catholic Medical Center Research Foundation	Catholic Medical Center Research Foundation funds were received to support this work.	Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Botel U, 1997, SPINAL CORD, V35, P420, DOI 10.1038/sj.sc.3100407; Cappuccino A, 2010, SPINE, V35, pE57, DOI 10.1097/BRS.0b013e3181b9dc28; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Dimar JR, 2000, SPINE, V25, P2294, DOI 10.1097/00007632-200009150-00006; Gebauer CM, 2006, PEDIATRICS, V117, P843, DOI 10.1542/peds.2004-1587; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Ha KY, 2008, SPINE, V33, P2059, DOI 10.1097/BRS.0b013e31818018f6; Ha KY, 2008, EUR SPINE J, V17, P864, DOI 10.1007/s00586-008-0653-6; HANSEBOUT RR, 1985, CAN J NEUROL SCI, V12, P83, DOI 10.1017/S0317167100046758; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; SAKAMOTO T, 1990, AM J PHYSIOL, V259, pH1649; Sayer Faisal T, 2006, Spine J, V6, P335, DOI 10.1016/j.spinee.2005.11.001; Shibuya S, 2004, SPINAL CORD, V42, P29, DOI 10.1038/sj.sc.3101516; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Weaver LC, 2005, J NEUROTRAUM, V22, P1375, DOI 10.1089/neu.2005.22.1375; Yenari MA, 2002, J CEREBR BLOOD F MET, V22, P29, DOI 10.1097/00004647-200201000-00004; Yu CG, 2000, J NEUROSURG, V93, P85, DOI 10.3171/spi.2000.93.1.0085; Yu WR, 2009, EUR J NEUROSCI, V29, P114, DOI 10.1111/j.1460-9568.2008.06555.x	25	22	24	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436			SPINE	SPINE	DEC 1	2012	37	25					E1551	E1559		10.1097/BRS.0b013e31826ff7f1			9	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	047MI	WOS:000311844600002	22926281				2022-02-06	
J	Oliva, AA; Kang, Y; Furones, C; Alonso, OF; Bruno, O; Dietrich, WD; Atkins, CM				Oliva, Anthony A., Jr.; Kang, Yuan; Furones, Concepcion; Alonso, Ofelia F.; Bruno, Olga; Dietrich, W. Dalton; Atkins, Coleen M.			Phosphodiesterase isoform-specific expression induced by traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						cAMP; fluid-percussion; inflammation; isoform; phosphodiesterase; traumatic brain injury	CAMP-SPECIFIC PHOSPHODIESTERASES; RAT-BRAIN; DIFFERENTIAL EXPRESSION; FUNCTIONAL RECOVERY; SPLICE VARIANTS; PDE4 INHIBITORS; TNF-ALPHA; ROLIPRAM; IV; LOCALIZATION	Traumatic brain injury (TBI) results in significant inflammation which contributes to the evolving pathology. Previously, we have demonstrated that cyclic AMP (cAMP), a molecule involved in inflammation, is down-regulated after TBI. To determine the mechanism by which cAMP is down-regulated after TBI, we determined whether TBI induces changes in phosphodiesterase (PDE) expression. Adult male Sprague Dawley rats received moderate parasagittal fluid-percussion brain injury (FPI) or sham injury, and the ipsilateral, parietal cortex was analyzed by western blotting. In the ipsilateral parietal cortex, expression of PDE1A, PDE4B2, and PDE4D2, significantly increased from 30 min to 24 h post-injury. PDE10A significantly increased at 6 and 24 h after TBI. Phosphorylation of PDE4A significantly increased from 6 h to 7 days post-injury. In contrast, PDE1B, PD4A5, and PDE4A8 significantly decreased after TBI. No changes were observed with PDE1C, PDE3A, PDE4B1/3, PDE4B4, PDE4D3, PDE4D4, PDE8A, or PDE8B. Co-localization studies showed that PDE1A, PDE4B2, and phospho-PDE4A were neuronally expressed, whereas PDE4D2 was expressed in neither neurons nor glia. These findings suggest that therapies to reduce inflammation after TBI could be facilitated with targeted therapies, in particular for PDE1A, PDE4B2, PDE4D2, or PDE10A.	[Oliva, Anthony A., Jr.; Kang, Yuan; Furones, Concepcion; Alonso, Ofelia F.; Dietrich, W. Dalton; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Bruno, Olga] Univ Genoa, Dept Pharm, Med Chem Sect, Genoa, Italy		Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, 1095 NW 14 Terrace, Miami, FL 33136 USA.	catkins@med.miami.edu		Atkins, Coleen/0000-0003-4718-7493	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS069721, AG033266, NS056072]; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069721, R01NS056072, P50NS030291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG033266] Funding Source: NIH RePORTER	This work was supported by The Miami Project to Cure Paralysis, and National Institutes of Health grants NS069721, AG033266, and NS056072. We thank Dr. Beata Frydel and Dayaris Morffi for technical assistance. The authors declare no conflicts of interest.	Ahmed T, 2005, BRAIN RES, V1041, P212, DOI 10.1016/j.brainres.2005.02.023; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Block F, 2001, NEUROREPORT, V12, P1507, DOI 10.1097/00001756-200105250-00041; Bruno O, 2011, BRIT J PHARMACOL, V164, P2054, DOI 10.1111/j.1476-5381.2011.01524.x; Bruno O, 2009, J MED CHEM, V52, P6546, DOI 10.1021/jm900977c; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; D'Sa C, 2002, J NEUROCHEM, V81, P745, DOI 10.1046/j.1471-4159.2002.00878.x; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Fatemi SH, 2008, SCHIZOPHR RES, V101, P36, DOI 10.1016/j.schres.2008.01.029; Fatemi SH, 2008, PSYCHIAT GENET, V18, P282, DOI 10.1097/YPG.0b013e3283060fb8; Giampa C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013417; Grond-Ginsbach C, 2008, J NEUROL, V255, P723, DOI 10.1007/s00415-008-0784-z; Hill EV, 2006, CELL SIGNAL, V18, P2056, DOI 10.1016/j.cellsig.2006.07.018; Iona S, 1998, MOL PHARMACOL, V53, P23, DOI 10.1124/mol.53.1.23; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Li LX, 2011, METAB BRAIN DIS, V26, P37, DOI 10.1007/s11011-011-9235-0; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; Manning CD, 1999, BRIT J PHARMACOL, V128, P1393, DOI 10.1038/sj.bjp.0702911; Medina AE, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00021; Mehats C, 2003, FASEB J, V17, P1831, DOI 10.1096/fj.03-0274com; Michibata H, 2001, BBA-GENE STRUCT EXPR, V1517, P278, DOI 10.1016/S0167-4781(00)00293-1; Miro X, 2002, SYNAPSE, V45, P259, DOI 10.1002/syn.10100; Miwa T, 2009, EUR J PHARMACOL, V602, P112, DOI 10.1016/j.ejphar.2008.10.060; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Reyes-Irisarri E, 2007, J NEUROPATH EXP NEUR, V66, P923, DOI 10.1097/nen.0b013e3181567c31; Robichaud A, 2002, BRIT J PHARMACOL, V135, P113, DOI 10.1038/sj.bjp.0704457; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Suda S, 1998, J NEUROCHEM, V71, P1554; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Temple MD, 2001, J NEUROTRAUM, V18, P47, DOI 10.1089/089771501750055767; Tilley DG, 2002, MOL PHARMACOL, V62, P497, DOI 10.1124/mol.62.3.497; VERGHESE MW, 1995, J PHARMACOL EXP THER, V272, P1313; Willette RN, 1997, J CEREBR BLOOD F MET, V17, P210, DOI 10.1097/00004647-199702000-00011; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; YAN C, 1994, J NEUROSCI, V14, P973; Zhang B, 2002, NEUROPHARMACOLOGY, V42, P262, DOI 10.1016/S0028-3908(01)00174-5; Zhang HT, 2002, NEUROPSYCHOPHARMACOL, V27, P587	50	22	22	1	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042			J NEUROCHEM	J. Neurochem.	DEC	2012	123	6					1019	1029		10.1111/jnc.12049			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	051WK	WOS:000312158500013	23057870	Green Accepted			2022-02-06	
J	Wagner, AK; Hatz, LE; Scanlon, JM; Niyonkuru, C; Miller, MA; Ricker, JH; Conley, YP; Ferrell, RE				Wagner, Amy K.; Hatz, Laura E.; Scanlon, Joelle M.; Niyonkuru, Christian; Miller, Megan A.; Ricker, Joseph H.; Conley, Yvette P.; Ferrell, Robert E.			Association of KIBRA rs17070145 polymorphism and episodic memory in individuals with severe TBI	BRAIN INJURY			English	Article						Traumatic brain injury; cognition; memory; KIBRA; genetic polymorphism	DISABILITY RATING-SCALE; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; GENE VARIANTS; PERFORMANCE; RECOVERY; MODERATE; LIFE; AGE	Background: Studies implicate single nucleotide polymorphism (SNP) rs17070145, a common T --> C polymorphism on the KIBRA gene, in mediating differences in episodic memory. In healthy adults, T-allele carriers perform better than non-carriers on episodic memory measures. However, this association is reversed in adults with subjective memory complaints and populations vulnerable to memory deficits, a problem common in traumatic brain injury (TBI). Methods: This study assessed associations between variation in the KIBRA gene and cognitive function in 129 adults with severe TBI. In addition to other executive functioning and functional/global outcomes, the Buschke Selective Reminding Test (SRT), Rey-Osterrieth Complex Figure Test and California Verbal Learning Test-II (CVLT-II) were administered 6 and 12 months post-injury. Results: T-allele non-carriers performed better than carriers on multiple episodic memory measures. At 6 months, T-allele non-carriers performed better for delayed recall measures on the SRT. At 12 months, T-allele non-carriers performed better on multiple SRT measures and on List-B learning with CVLT-II. No associations occurred with executive function or global outcome measures. Conclusion: These results suggest that rs17070145 T-allele effects are specific to episodic memory and support the hypothesis that associations between rs17070145 variation and memory are disparate between healthy and impaired populations.	[Wagner, Amy K.; Hatz, Laura E.; Scanlon, Joelle M.; Niyonkuru, Christian; Miller, Megan A.; Ricker, Joseph H.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Wagner, Amy K.; Conley, Yvette P.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; [Ferrell, Robert E.] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Ricker, Joseph/0000-0003-3415-991X; Conley, Yvette/0000-0002-1784-6067; Hatz, Laura/0000-0002-8695-8222	 [R01 HD048162];  [DODW81XWH-071-0701];  [R01NR008424];  [P01NS030318]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR008424] Funding Source: NIH RePORTER	This work was supported in part by R01 HD048162, DODW81XWH-071-0701, R01NR008424 and P01NS030318.	Almeida OP, 2008, J CELL MOL MED, V12, P1672, DOI 10.1111/j.1582-4934.2008.00229.x; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakesley RE, 2009, NEUROPSYCHOLOGY, V23, P255, DOI 10.1037/a0012850; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Burgess JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.11.004; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Chen XN, 1999, GENOME RES, V9, P492; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Delis D.C., 2000, CALIFORNIA VERBAL LE; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRANGER CV, 1986, GUIDE USE UNIFORM DA; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jacobsen LK, 2009, BIOL PSYCHIAT, V65, P671, DOI 10.1016/j.biopsych.2008.10.024; JENNETT B, 1975, LANCET, V1, P480; Johannsen S, 2008, NEUROSCIENCE, V155, P1165, DOI 10.1016/j.neuroscience.2008.06.054; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; Nacmias B, 2008, NEUROSCI LETT, V436, P145, DOI 10.1016/j.neulet.2008.03.008; Nebes RD, 2000, PSYCHOL MED, V30, P679, DOI 10.1017/S0033291799001968; Need AC, 2008, AM J MED GENET B, V147B, P667, DOI 10.1002/ajmg.b.30658; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; PANIAK CE, 1989, J CLIN EXP NEUROPSYC, V11, P631, DOI 10.1080/01688638908400921; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Preuschhof C, 2010, NEUROPSYCHOLOGIA, V48, P402, DOI 10.1016/j.neuropsychologia.2009.09.031; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reitan R, 1985, HALSTEAD REITAN NEUR; Ricker JH, 2001, J CLIN EXP NEUROPSYC, V23, P196, DOI 10.1076/jcen.23.2.196.1204; Rodriguez-Rodriguez E, 2009, NEUROBIOL AGING, V30, P322, DOI 10.1016/j.neurobiolaging.2007.07.003; Rogers E, 2009, J NEUROTRAUM, V26, pA25; Russell KC, 2011, J CLIN EXP NEUROPSYC, V33, P538, DOI 10.1080/13803395.2010.537253; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Wagner AK, 2000, AM J PHYS MED REHAB, V79, P235, DOI 10.1097/00002060-200005000-00004; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wright BD, 1997, SCAND J REHABIL MED, V29, P267; Yasuda Y, 2010, WORLD J BIOL PSYCHIA, V11, P852, DOI 10.3109/15622971003797258; Zafonte R, 2009, J NEUROTRAUM, V26, P2207, DOI 10.1089/neu.2009.1015	52	22	22	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2012	26	13-14					1658	1669		10.3109/02699052.2012.700089			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	041RU	WOS:000311419700012	22794909				2022-02-06	
J	Martin, RC; Triebel, K; Dreer, LE; Novack, TA; Turner, C; Marson, DC				Martin, Roy C.; Triebel, Kristen; Dreer, Laura E.; Novack, Thomas A.; Turner, Crystal; Marson, Daniel C.			Neurocognitive Predictors of Financial Capacity in Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognitive function; financial capacity; financial decision making; head injury; traumatic brain injury	DECISION-MAKING CAPACITY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTION; MONEY MANAGEMENT; HEAD-INJURY; COMPETENCE; DEMENTIA; RECOVERY; MODERATE	Objective: To develop cognitive models of financial capacity (FC) in patients with traumatic brain injury (TBI). Design: Longitudinal design. Setting: Inpatient brain injury rehabilitation unit. Participants: Twenty healthy controls, and 24 adults with moderate-to-severe TBI were assessed at baseline (30 days postinjury) and 6 months postinjury. Main Outcome Measures: The FC instrument (FCI) and a neuropsychological test battery. Univariate correlation and multiple regression procedures were employed to develop cognitive models of FCI performance in the TBI group, at baseline and 6-month time follow-up. Results: Three cognitive predictor models of FC were developed. At baseline, measures of mental arithmetic/working memory and immediate verbal memory predicted baseline FCI performance (R-2 = 0.72). At 6-month follow-up, measures of executive function and mental arithmetic/working memory predicted 6-month FCI performance (R-2 = 0.79), and a third model found that these 2 measures at baseline predicted 6-month FCI performance (R-2 = 0.71). Conclusions: Multiple cognitive functions are associated with initial impairment and partial recovery of FC in moderate-to-severe TBI patients. In particular, arithmetic, working memory, and executive function skills appear critical to recovery of FC in TBI. The study results represent an initial step toward developing a neurocognitive model of FC in patients with TBI.	[Marson, Daniel C.] Univ Alabama Birmingham, Dept Neurol, Sparks Ctr 650K, Birmingham, AL 35294 USA; [Martin, Roy C.; Triebel, Kristen; Turner, Crystal; Marson, Daniel C.] Univ Alabama Birmingham, Alzheimers Dis Ctr, Birmingham, AL 35294 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA		Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, Sparks Ctr 650K, 1720 7th Ave S, Birmingham, AL 35294 USA.	dmarson@uab.edu	triebel, kristen/A-6569-2019	triebel, kristen/0000-0001-9161-7847; Martin, Roy/0000-0001-9328-0846	UAB Traumatic Brain Injury Models System grant (NIDDR) [H133A980010]; related project "Medical and Financial Decision Making Following TBI"; National Institute on Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074]; National Institute on Aging (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [2RO1 AG021927]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23 EY017327-05]; EyeSight Foundation of Alabama; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Lakeshore Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23EY017327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021927] Funding Source: NIH RePORTER	Study supported primarily by a UAB Traumatic Brain Injury Models System grant (NIDDR, H133A980010) (Novack, PI) and related project "Medical and Financial Decision Making Following TBI" (Marson, Project Leader). Other sources of support include the National Institute on Child Health and Human Development (R01HD053074) (Marson, PI), National Institute on Aging (NIA, 2RO1 AG021927 (Marson, PI), the National Eye Institute (K23 EY017327-05, Dreer PI), the EyeSight Foundation of Alabama (ESFA, Dreer PI), Research to Prevent Blindness (RPB, Dreer, PI), and Lakeshore Foundation (Dreer-Malone, Co-PIs).	Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bottari C, 2011, BRAIN INJURY, V25, P1306, DOI 10.3109/02699052.2011.624570; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Crowe K. M., 2005, PSYCHIAT PSYCHOL LAW, V12, P56, DOI [10.1375/pplt.2005.12.1.56, DOI 10.1375/PPLT.2005.12.1.56, http://dx.doi.org/10.1375/pplt.2005.12.1.56]; Crowe SF, 2004, ARCH CLIN NEUROPSYCH, V19, P673, DOI 10.1016/j.acn.2003.09.002; Crowe SF, 2003, NEUROPSYCHOL REHABIL, V13, P497, DOI 10.1080/09602010343000075; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dreer LE, 2012, REHABIL PSYCHOL, V57, P5, DOI 10.1037/a0025818; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Earnst KS, 2000, J AM GERIATR SOC, V48, P919, DOI 10.1111/j.1532-5415.2000.tb06888.x; Fisk GD, 1998, BRAIN INJURY, V12, P683; Gaudette M, 2002, BRAIN INJURY, V16, P133, DOI 10.1080/02699050110102068; Hamsher K., 1989, MULTILINGUAL APHASIA; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton RK, 1991, COMPREHENSIVE NORMS; Hoskin KM, 2005, REHABIL PSYCHOL, V50, P355, DOI 10.1037/0090-5550.50.4.355; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Levin H, 1979, J NERV MENT DIS, V20, P694; LEVIN HS, 1990, NEUROBEHAVIORAL SEQU; Lillie RA, 2010, NEUROPSYCHOLOGY EVER; Mahurin RK, 2006, CLIN NEUROPSYCHOL, V20, P271, DOI 10.1080/13854040590947498; Marson D, 2001, ARCH CLIN NEUROPSYCH, V16, P754; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Marson DC, 2001, AGING NEUROPSYCHOL C, V8, P164, DOI 10.1076/anec.8.3.164.827; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; Rao S., 1990, MANUAL BRIEF REPEATA; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROYALL DR, 1992, J AM GERIATR SOC, V40, P1221, DOI 10.1111/j.1532-5415.1992.tb03646.x; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Smith A., 1982, SYMBOL DIGIT MODALIT; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); TEASDALE G, 1974, LANCET, V2, P81; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Voss SE, 2004, DEMENT GERIATR COGN, V18, P207, DOI 10.1159/000079202; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wolfson, 1993, HALSTEAD REITAN NEUR	39	22	22	2	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2012	27	6					E81	E90		10.1097/HTR.0b013e318273de49			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	039CU	WOS:000311221200008	23131973	Green Accepted			2022-02-06	
J	Turner, TH; Horner, MD; VanKirk, KK; Myrick, H; Tuerk, PW				Turner, Travis H.; Horner, Michael D.; VanKirk, Kathryn K.; Myrick, Hugh; Tuerk, Peter W.			A Pilot Trial of Neuropsychological Evaluations Conducted via Telemedicine in the Veterans Health Administration	TELEMEDICINE AND E-HEALTH			English	Article						military medicine; telepsychiatry; telemedicine	TRAUMATIC BRAIN-INJURY; SERVICES; RELIABILITY; DEMENTIA; TELEHEALTH; PROVISION; DISORDER; MEMORY; AREAS	Introduction: Many veterans live in rural areas distant from Veterans Affairs Medical Centers (VAMCs) and receive primary medical care from community-based outpatient clinics (CBOCs). These veterans often must travel great distances to the nearest VAMC for neuropsychological evaluations, resulting in poor access to care, travel reimbursement costs, fee-basis evaluations of uncontrolled quality, and driving safety concerns. Return trips for feedback compound complications. Accordingly, we initiated a pilot trial of neuropsychological evaluation and feedback via telemedicine (i.e., clinical videoconferencing). Subjects and Methods: Participants were veterans referred for neuropsychological evaluation from a rural CBOC 115 miles from the regional VAMC. All veterans were given the choice to undergo evaluation at the CBOC via telemedicine or in-person at the VAMC. Telemedicine equipment allowed presentation of digitized material with simultaneous patient observation. Testing materials were organized in numbered folders and given to veterans by CBOC clerks immediately prior to evaluation. Clerks returned completed materials via facsimile. Results: Fifteen veterans from the rural CBOC were seen for neuropsychological evaluation. Eight chose telemedicine evaluation. Groups based on evaluation modality appeared similar on demographics, referral basis, resulting neuropsychiatric diagnoses, and follow-through on recommendations. No significant technical or clinical difficulties were encountered, and veterans reported satisfaction with telemedicine. All veterans requested feedback via telemedicine. Conclusions: Neuropsychological evaluation via telemedicine is feasible and appears comparable to in-person evaluation. Experiences are encouraging and consistent with the broader literature on the acceptance of and satisfaction with clinical videoconferencing. Future studies will assess possible psychometric issues in clinical populations.	[Turner, Travis H.; Horner, Michael D.; VanKirk, Kathryn K.; Myrick, Hugh; Tuerk, Peter W.] Ralph H Johnson Dept Vet Affairs Med Ctr, Mental Hlth Serv Line, Charleston, SC USA; [Turner, Travis H.; Horner, Michael D.; VanKirk, Kathryn K.; Myrick, Hugh; Tuerk, Peter W.] Med Univ S Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Turner, Travis H.] Med Univ S Carolina, Div Neurol, Dept Neurosci, Charleston, SC 29425 USA		Turner, TH (corresponding author), Ralph H Johnson Vet Adm Med Ctr, Mental Hlth Serv Line, 109 Bee St,MH 116, Charleston, SC 29401 USA.	turnertr@musc.edu					Allott K, 2009, APPL NEUROPSYCHOL, V16, P193, DOI 10.1080/09084280903098760; Amarendran V, 2011, TELEMED E-HEALTH, V17, P223, DOI 10.1089/tmj.2010.0144; Beachler M, 2003, J RURAL HEALTH, V19, P301; BENTON A L, 1978, Archives of Neurology, V35, P364; Benton A. L., 1994, CONTROLLED ORAL WORD; Brodey BB, 2000, PSYCHIATR SERV, V51, P1305, DOI 10.1176/appi.ps.51.10.1305; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Clement PF, 2001, MIL MED, V166, P382, DOI 10.1093/milmed/166.5.382; Clemmensen P, 2010, J ELECTROCARDIOL, V43, P615, DOI 10.1016/j.jelectrocard.2010.06.012; Conners CK, 1998, J CLIN PSYCHIAT, V59, P24; Cullum CM, 2006, ASSESSMENT, V13, P385, DOI 10.1177/1073191106289065; Defense Manpower Data Center, 2009, CTS DEPL FIL BAS REP; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Elmore D, 2003, MONITOR PSYCHOL, V34, P32; Goodglass H, 1983, ASSESSMENT APHASIA R; Green P., 1996, MANUAL COMPUTERISED; Heaton K, 2003, WISCONSIN CARD SORTI; Hess DC, 2006, LANCET NEUROL, V5, P275, DOI 10.1016/S1474-4422(06)70377-5; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jacobsen SE, 2003, J INT NEUROPSYCH SOC, V9, P472, DOI 10.1017/S1355617703930128; Jamora CW, 2008, NEUROREHABILITATION, V23, P381; Kaplan E, 1983, BOSTON NAMING TEST; McEachern W, 2008, CAN J NEUROL SCI, V35, P643, DOI 10.1017/S0317167100009458; Meyers JE., 1995, REY COMPLEX FIGURE T; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Poon P, 2005, INT J GERIATR PSYCH, V20, P285, DOI 10.1002/gps.1282; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; ROGERS R, 1992, SIRS STRUCTURED INTE; Spielberger CG, 1983, MANUAL STATE ANXIETY; Tellegen A., 2003, MMPI 2 RESTRUCTURED; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TROSTER AI, 1995, J COMMUNITY PSYCHOL, V23, P85, DOI 10.1002/1520-6629(199501)23:1<85::AID-JCOP2290230108>3.0.CO;2-6; Tuerk PW, 2010, TELEMED J E-HEALTH, V16, P115, DOI 10.1089/tmj.2009.0144; Veterans Health Administration, 2010, RES IMPR CAR VET RUR; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 1997, WECHSLER MEMORY SCAL; White T, 2003, NEUROPSYCHOLOGICAL A; Wolfson, 1993, HALSTEAD REITAN NEUR; Zarate CA, 1997, J CLIN PSYCHIAT, V58, P22, DOI 10.4088/JCP.v58n0104; Zaylor C, 2000, J TELEMED TELECARE, V6, P93, DOI 10.1258/1357633001934294	44	22	22	0	17	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627			TELEMED E-HEALTH	Telemed. e-Health	NOV	2012	18	9					662	667		10.1089/tmj.2011.0272			6	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	034BX	WOS:000310846200002	23050802				2022-02-06	
J	Boyko, M; Stepensky, D; Gruenbaum, BF; Gruenbaum, SE; Melamed, I; Ohayon, S; Glazer, M; Shapira, Y; Zlotnik, A				Boyko, Matthew; Stepensky, David; Gruenbaum, Benjamin F.; Gruenbaum, Shaun E.; Melamed, Israel; Ohayon, Sharon; Glazer, Michael; Shapira, Yoram; Zlotnik, Alexander			Pharmacokinetics of Glutamate-Oxaloacetate Transaminase and Glutamate-Pyruvate Transaminase and Their Blood Glutamate-Lowering Activity in Naive Rats	NEUROCHEMICAL RESEARCH			English	Article						Glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase enzymes; Pharmacokinetics and glutamate-lowering activity; Neuroprotective activity in traumatic brain injury and stroke	ACUTE ISCHEMIC-STROKE; CLOSED-HEAD INJURY; SCAVENGING ACTIVITY; EXCESS GLUTAMATE; BRAIN-BARRIER; AMINO-ACIDS; CEREBROSPINAL-FLUID; PLASMA; MODEL; NEUROPROTECTION	Traumatic brain injury (TBI) and stroke lead to elevated levels of glutamate in the brain that negatively affect the neurological outcomes in both animals and humans. Intravenous administration of glutamate-oxaloacetate transaminase (GOT) and glutamate-pyruvate transaminase (GPT) enzymes can be used to lower the blood glutamate levels and to improve the neurological outcome following TBI and stroke. The objective of this study was to analyze the pharmacokinetics and to determine the glutamate-lowering effects of GOT and GPT enzymes in naive rats. We determined the time course of serum GOT, GPT, and glutamate levels following a single intravenous administration of two different doses of each one of the studied enzymes. Forty-six male rats were randomly assigned into one of 5 treatment groups: saline (control), human GOT at dose 0.03 and 0.06 mg/kg and porcine GPT at dose 0.6 and 1.2 mg/kg. Blood samples were collected at baseline, 5 min, and 2, 4, 8, 12, and 24 h after the drug injection and GOT, GPT and glutamate levels were determined. The pharmacokinetics of both GOT and GPT followed one-compartment model, and both enzymes exhibited substantial glutamate-lowering effects following intravenous administration. Analysis of the pharmacokinetic data indicated that both enzymes were distributed predominantly in the blood (central circulation) and did not permeate to the peripheral organs and tissues. Several-hour delay was present between the time course of the enzyme levels and the glutamate-lowering effects (leading to clock-wise hysteresis on concentration-effect curves), apparently due to the time that is required to affect the pool of serum glutamate. We conclude that the interaction between the systemically-administered enzymes (GOT and GPT) and the glutamate takes place in the central circulation. Thus, glutamate-lowering effects of GOT and GPT apparently lead to redistribution of the excess glutamate from the brain's extracellular fluid into the blood and can reduce secondary brain injury due to glutamate neurotoxicity. The outcomes of this study regarding the pharmacokinetic and pharmacodynamic properties of the GOT and GPT enzymes will be subsequently verified in clinical studies that can lead to design of effective neuroprotective treatment strategies in patients with traumatic brain diseases and stroke.	[Boyko, Matthew; Gruenbaum, Benjamin F.; Ohayon, Sharon; Glazer, Michael; Shapira, Yoram; Zlotnik, Alexander] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Anesthesiol & Crit Care, Beer Sheva, Israel; [Stepensky, David] Ben Gurion Univ Negev, Dept Pharmacol, IL-84105 Beer Sheva, Israel; [Gruenbaum, Shaun E.] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Melamed, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Neurosurg, Beer Sheva, Israel		Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Soroka Med Ctr, Dept Anesthesiol & Crit Care, Beer Sheva, Israel.	zlotnika@bgumail.bgu.ac.il	Stepensky, David/F-3277-2012	Stepensky, David/0000-0001-7206-8352; Boyko, Matthew/0000-0003-3116-1643	European Society of Anesthesiologists	The authors gratefully acknowledge Valeria Frishman (laboratory assistant at the Department of Clinical Bio-chemistry, Faculty of Health Sciences, Ben-Gurion University of the Negev) for her outstanding help with the biochemical analysis. The help of Dr. Shira Ovadia (Director of Animal Resources Unit, Faculty of Health Sciences, Ben-Gurion University of the Negev) is also gratefully acknowledged. We want to thank Dr. A. Alir and the staff of the Critical Care Unit, Soroka Medical Center, for their support and helpful discussions. This work was supported in part by grants to AZ from European Society of Anesthesiologists.	Ahlstrom C, 2011, THESIS U GOTHENBURG; Boyko M, 2011, EUR J NEUROSCI, V34, P1432, DOI 10.1111/j.1460-9568.2011.07864.x; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Castellanos M, 2008, NEUROLOGY, V71, P1862, DOI 10.1212/01.wnl.0000326064.42186.7e; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Ferrarese C, 2001, NEUROLOGY, V57, P671, DOI 10.1212/WNL.57.4.671; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; Hammarlund-Udenaes M, 2008, PHARM RES-DORDR, V25, P1737, DOI 10.1007/s11095-007-9502-2; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; JUSKO WJ, 1994, CLIN PHARMACOL THER, V56, P406, DOI 10.1038/clpt.1994.155; Klin Y, 2010, BIOCHEM BIOPH RES CO, V399, P694, DOI 10.1016/j.bbrc.2010.07.144; Koura SS, 1998, ACT NEUR S, V71, P244; Laurer HL., 2000, EUR J TRAUMA, V26, P95, DOI [10.1007/s000680050007, DOI 10.1007/S000680050007]; Liu XR, 2005, J PHARMACOL EXP THER, V313, P1254, DOI 10.1124/jpet.104.079319; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Spranger M, 1996, J NEUROL SCI, V143, P126, DOI 10.1016/S0022-510X(96)00197-9; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Teichberg VI, 2007, P NATL ACAD SCI USA, V104, P7315, DOI 10.1073/pnas.0702450104; Teichberg VI, 2011, J CEREBR BLOOD F MET, V31, P1376, DOI 10.1038/jcbfm.2011.46; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2011, J NEUROSURG ANESTH, V23, P45, DOI 10.1097/ANA.0b013e3181f82a8f; Zlotnik A, 2010, EXP NEUROL, V224, P465, DOI 10.1016/j.expneurol.2010.05.009; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	32	22	22	0	12	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	OCT	2012	37	10					2198	2205		10.1007/s11064-012-0843-9			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	004SK	WOS:000308701200016	22846966				2022-02-06	
J	Rhine, T; Wade, SL; Makoroff, KL; Cassedy, A; Michaud, LJ				Rhine, Tara; Wade, Shari L.; Makoroff, Kathi L.; Cassedy, Amy; Michaud, Linda J.			Clinical predictors of outcome following inflicted traumatic brain injury in children	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Inflicted traumatic brain injury; child abuse; outcomes	NONACCIDENTAL HEAD-INJURY; SEVERITY; HYPERGLYCEMIA; MECHANISMS; CHILDHOOD	BACKGROUND: The study aimed to determine which acute injury variables were predictors of long-term functional outcome following inflicted traumatic brain injury (iTBI). METHODS: A retrospective case review of 35 children with iTBI was performed. After controlling for age at injury and time since injury, the generalized estimation equations method was used to identify acute injury variables that were significantly related to the Glasgow Outcome Scale scores at the initial follow-up assessments. When available, functional sequelae at these and longer-term follow-ups were also examined. RESULTS: In bivariate generalized estimation equations analyses, a low Glasgow Coma Scale (GCS) eye component score, a low GCS motor component score, a low GCS verbal component score, need for neurosurgical intervention, seizures in the first week after injury, need for mechanical ventilation for more than 10 days, length of intensive care unit stay of more than 10 days, initial hyperglycemia, and neuroimaging findings of cerebral edema or loss of gray-white matter differentiation were significantly (p <= 0.05) related to having a poor outcome, as defined by their Glasgow Outcome Scale score at the initial follow-up. In multivariable analyses, considering the significant predictors while controlling for age at injury and time since injury, the presence of cerebral edema on neuroimaging (odds ratio, 27.21; 95% confidence interval, 4.40-168.22), and length of intensive care unit stay of more than 10 days (odds ratio, 21.57; 95% confidence interval, 3.09-150.48) were significantly related to having a poor outcome. CONCLUSION: Early clinical data following iTBI help predict long-term functional outcome. Further research to support these findings may help delineate acutely after injury which children with iTBI are at risk for a poor prognosis and should be more closely followed up over time. (J Trauma Acute Care Surg. 2012;73: S248-S253. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Rhine, Tara; Cassedy, Amy] Cincinnati Childrens Hosp Med Ctr, Dept Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Wade, Shari L.; Makoroff, Kathi L.; Michaud, Linda J.] Univ Cincinnati, Coll Med, Cincinnati, OH USA		Rhine, T (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Biostat & Epidemiol, 3333 Burnet Ave,ML 3008, Cincinnati, OH 45229 USA.	tara.rhine@cchmc.org					Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Chiaretti A, 1998, CHILD NERV SYST, V14, P455, DOI 10.1007/s003810050259; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; JENNETT B, 1975, LANCET, V1, P480; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; Kivlin JD, 2000, OPHTHALMOLOGY, V107, P1246, DOI 10.1016/S0161-6420(00)00161-5; KLEIN M, 1971, AM J DIS CHILD, V122, P15, DOI 10.1001/archpedi.1971.02110010051005; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Kocher M S, 2000, J Am Acad Orthop Surg, V8, P10; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Morad Y, 2003, J AAPOS, P521; Nesbitt L, 2006, ACAD EMERG MED S, V13, P171; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Salehi-Had H, 2006, PEDIATRICS, V117, pE1039, DOI 10.1542/peds.2005-0811; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; SILLS JA, 1977, DEV MED CHILD NEUROL, V19, P26; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Togioka BM, 2009, J EMERG MED, V37, P98, DOI 10.1016/j.jemermed.2008.06.022	32	22	23	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	OCT	2012	73			3			S248	S253		10.1097/TA.0b013e31826b0062			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	029OP	WOS:000310505500004	23026962				2022-02-06	
J	Scalzo, F; Hamilton, R; Asgari, S; Kim, S; Hu, X				Scalzo, Fabien; Hamilton, Robert; Asgari, Shadnaz; Kim, Sunghan; Hu, Xiao			Intracranial hypertension prediction using extremely randomized decision trees	MEDICAL ENGINEERING & PHYSICS			English	Article						Intracranial pressure; Intracranial hypertension; Cerebral autoregulation; Traumatic brain injury; Prediction; Forecast; Decision trees; Classification	APPROXIMATE ENTROPY; PRESSURE	Intracranial pressure (ICP) elevation (intracranial hypertension, IH) in neurocriticaI care is typically treated in a reactive fashion; it is only delivered after bedside clinicians notice prolonged ICP elevation. A proactive solution is desirable to improve the treatment of intracranial hypertension. Several studies have shown that the waveform morphology of the intracranial pressure pulse holds predictors about future intracranial hypertension and could therefore be used to alert the bedside clinician of a likely occurrence of the elevation in the immediate future. In this paper, a computational framework is proposed to predict prolonged intracranial hypertension based on morphological waveform features computed from the ICP. A key contribution of this work is to exploit an ensemble classifier method based on extremely randomized decision trees (Extra-Trees). Experiments on a representative set of 30 patients admitted for various intracranial pressure related conditions demonstrate the effectiveness of the predicting framework on ICP pulses acquired under clinical conditions and the superior results of the proposed approach in comparison to linear and AdaBoost classifiers. (c) 2011 IPEM. Published by Elsevier Ltd. All rights reserved.	[Scalzo, Fabien; Hamilton, Robert; Asgari, Shadnaz; Kim, Sunghan; Hu, Xiao] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neurosurg Neural Syst & Dynam Lab, Los Angeles, CA 90095 USA		Scalzo, F (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Neurosurg Neural Syst & Dynam Lab, Los Angeles, CA 90095 USA.	fabien.scalzo@gmail.com	Scalzo, Fabien/AAM-6328-2020	Scalzo, Fabien/0000-0001-9755-8104	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS066008] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS066008-04, R01 NS066008] Funding Source: Medline		Afonso VX, 1999, IEEE T BIO-MED ENG, V46, P192, DOI 10.1109/10.740882; ALLEN R, 1983, J BIOMED ENG, V5, P5, DOI 10.1016/0141-5425(83)90073-0; Asgari S, 2009, PHYSIOL MEAS, V30, P1211, DOI 10.1088/0967-3334/30/11/006; Azzerboni B, 2002, P ANN INT IEEE EMBS, P1343; Chatterjee S., 1986, STAT SCI, V1, P379; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; HAMILTON R, 2009, EMBC 2009 ANN INT C, P4331; Hornero R, 2005, IEEE T BIO-MED ENG, V52, P1671, DOI 10.1109/TBME.2005.855722; Hu X, 2008, PHYSIOL MEAS, V29, P459, DOI 10.1088/0967-3334/29/4/004; Hu X, 2008, MED ENG PHYS, V30, P631, DOI 10.1016/j.medengphy.2007.07.002; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Hu X, 2009, IEEE T BIO-MED ENG, V56, P696, DOI 10.1109/TBME.2008.2008636; McNames J, 2002, 4 INT WORKSH BIOS IN, P303; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; Price D, 1980, INTRACRANIAL PRESSUR, P395; Rosner Michael J., 1993, P57; Scalzo F, 2011, ARTIF INTEL IN PRESS; Scalzo F, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-61; Scalzo F, 2009, MED BIOL ENG COMPUT, V47, P967, DOI 10.1007/s11517-009-0505-5; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Swiercz M, 2000, ACTA NEUROCHIR, V142, P401, DOI 10.1007/s007010050449; Szewczykowski J, 1975, INTRACRANIAL PRESSUR, P392; Tsui F.-C., 1995, P 17 INT C ENG MED B, P1045; Turner J, 1976, INTRACRANIAL PRESSUR, P283; ZWEIG MH, 1993, CLIN CHEM, V39, P561	27	22	23	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	OCT	2012	34	8					1058	1065		10.1016/j.medengphy.2011.11.010			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	009MB	WOS:000309028800005	22401795	Green Accepted			2022-02-06	
J	Won, SJ; Kim, JH; Yoo, BH; Sohn, M; Kauppinen, TM; Park, MS; Kwon, HJ; Liu, JL; Suh, SW				Won, Seok Joon; Kim, Jin Hee; Yoo, Byung Hoon; Sohn, Min; Kauppinen, Tiina M.; Park, Man-Seong; Kwon, Hyung-Joo; Liu, Jialing; Suh, Sang Won			Prevention of hypoglycemia-induced neuronal death by minocycline	JOURNAL OF NEUROINFLAMMATION			English	Article						Hypoglycemia; Minocycline; Neuronal death; Microglia	ISCHEMIC BRAIN-INJURY; MICROGLIAL ACTIVATION; COGNITIVE IMPAIRMENT; TEMPORAL EVOLUTION; CEREBRAL-ISCHEMIA; AUTONOMIC FAILURE; GENE-EXPRESSION; NITRIC-OXIDE; MOUSE MODEL; RAT	Diabetic patients who attempt strict management of blood glucose levels frequently experience hypoglycemia. Severe and prolonged hypoglycemia causes neuronal death and cognitive impairment. There is no effective tool for prevention of these unwanted clinical sequelae. Minocycline, a second-generation tetracycline derivative, has been recognized as an anti-inflammatory and neuroprotective agent in several animal models such as stroke and traumatic brain injury. In the present study, we tested whether minocycline also has protective effects on hypoglycemia-induced neuronal death and cognitive impairment. To test our hypothesis we used an animal model of insulin-induced acute hypoglycemia. Minocycline was injected intraperitoneally at 6 hours after hypoglycemia/glucose reperfusion and injected once per day for the following 1 week. Histological evaluation for neuronal death and microglial activation was performed from 1 day to 1 week after hypoglycemia. Cognitive evaluation was conducted 6 weeks after hypoglycemia. Microglial activation began to be evident in the hippocampal area at 1 day after hypoglycemia and persisted for 1 week. Minocycline injection significantly reduced hypoglycemia-induced microglial activation and myeloperoxidase (MPO) immunoreactivity. Neuronal death was significantly reduced by minocycline treatment when evaluated at 1 week after hypoglycemia. Hypoglycemia-induced cognitive impairment is also significantly prevented by the same minocycline regimen when subjects were evaluated at 6 weeks after hypoglycemia. Therefore, these results suggest that delayed treatment (6 hours post-insult) with minocycline protects against microglial activation, neuronal death and cognitive impairment caused by severe hypoglycemia. The present study suggests that minocycline has therapeutic potential to prevent hypoglycemia-induced brain injury in diabetic patients.	[Liu, Jialing] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94121 USA; [Won, Seok Joon; Yoo, Byung Hoon; Kauppinen, Tiina M.; Suh, Sang Won] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; [Won, Seok Joon; Yoo, Byung Hoon; Kauppinen, Tiina M.; Liu, Jialing; Suh, Sang Won] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Yoo, Byung Hoon] Inje Univ, Inje Paik Hosp, Sch Med, Dept Anesthesiol, Seoul 139707, South Korea; [Sohn, Min] Inha Univ, Dept Nursing, Inchon 402751, South Korea; [Park, Man-Seong; Kwon, Hyung-Joo] Hallym Univ, Sch Med, Dept Microbiol, Chunchon 200702, South Korea; [Kim, Jin Hee; Suh, Sang Won] Hallym Univ, Sch Med, Dept Physiol, Chunchon 200702, South Korea		Liu, JL (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94121 USA.	jialing.liu@ucsf.edu; swsuh@hallym.ac.kr	Kauppinen, Tiina/I-1009-2019; Liu, Jialing/A-8627-2012; Park, Man-Seong/AAF-1207-2020	Liu, Jialing/0000-0003-4420-4382; SOHN, MIN/0000-0003-4021-2051; Kauppinen, Tiina/0000-0001-7219-9862	Department of Veterans AffairsUS Department of Veterans Affairs; Ministry of Health & Welfare, Republic of KoreaMinistry of Health & Welfare, Republic of Korea [A120202]	This work was supported by the Department of Veterans Affairs (JL) and by the Korea Healthcare technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120202) to SWS.	AUER RN, 1993, BAILLIERE CLIN ENDOC, V7, P611, DOI 10.1016/S0950-351X(05)80210-1; AUER RN, 1985, ACTA NEUROPATHOL, V67, P13, DOI 10.1007/BF00688120; AUER RN, 1984, DIABETES, V33, P1090, DOI 10.2337/diabetes.33.11.1090; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Ben-Ami H, 1999, ARCH INTERN MED, V159, P281, DOI 10.1001/archinte.159.3.281; BIAGAS KV, 1992, J NEUROTRAUM, V9, P363, DOI 10.1089/neu.1992.9.363; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; Cryer PE, 2001, AM J PHYSIOL-ENDOC M, V281, pE1115, DOI 10.1152/ajpendo.2001.281.6.E1115; Cryer PE, 2004, NEW ENGL J MED, V350, P2272, DOI 10.1056/NEJMra031354; Davis EA, 1998, J PEDIATR ENDOCR MET, V11, P177; DERESKI MO, 1993, ACTA NEUROPATHOL, V85, P327; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Elewa HF, 2006, PHARMACOTHERAPY, V26, P515, DOI 10.1592/phco.26.4.515; Ennis K, 2008, BRAIN RES, V1224, P119, DOI 10.1016/j.brainres.2008.06.003; Fan R, 2007, J NEUROSCI, V27, P3057, DOI 10.1523/JNEUROSCI.4371-06.2007; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; GOLDEN MP, 1989, DIABETES CARE, V12, P89, DOI 10.2337/diacare.12.2.89; Hershey T, 2005, DIABETES CARE, V28, P2372, DOI 10.2337/diacare.28.10.2372; Hunter CL, 2004, ANN NEUROL, V56, P675, DOI 10.1002/ana.20250; Iadecola C, 1997, J NEUROSCI, V17, P9157; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; KALIMO H, 1980, ACTA NEUROL SCAND, V62, P345; Kauppinen TM, 2008, J NEUROSCI, V28, P5827, DOI 10.1523/JNEUROSCI.1236-08.2008; Keck T, 2002, GASTROENTEROLOGY, V122, P188, DOI 10.1053/gast.2002.30348; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; LANGAN SJ, 1991, DIABETOLOGIA, V34, P337, DOI 10.1007/BF00405006; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; MALOUF R, 1985, ANN NEUROL, V17, P421, DOI 10.1002/ana.410170502; MATSUO Y, 1994, STROKE, V25, P1469, DOI 10.1161/01.STR.25.7.1469; Metz LM, 2004, ANN NEUROL, V55, P756, DOI 10.1002/ana.20111; Mizoguchi H, 2008, PSYCHOPHARMACOLOGY, V196, P233, DOI 10.1007/s00213-007-0955-0; Moller JC, 1996, GLIA, V17, P121; Nogawa S, 1997, J NEUROSCI, V17, P2746; Rovet J, 1997, DIABETES CARE, V20, P803, DOI 10.2337/diacare.20.5.803; RYAN CM, 1990, J PEDIATR-US, V117, P32, DOI 10.1016/S0022-3476(05)82440-0; Ryu JK, 2004, GLIA, V48, P85, DOI 10.1002/glia.20051; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Shin BS, 2010, J CEREBR BLOOD F MET, V30, P390, DOI 10.1038/jcbfm.2009.229; Suh SW, 2008, J CEREBR BLOOD F MET, V28, P1697, DOI 10.1038/jcbfm.2008.61; Suh SW, 2007, GLIA, V55, P1280, DOI 10.1002/glia.20440; Suh SW, 2007, J CLIN INVEST, V117, P910, DOI 10.1172/JCI30077; Suh SW, 2004, NEUROBIOL DIS, V16, P538, DOI 10.1016/j.nbd.2004.04.017; Suh SW, 2003, J NEUROSCI, V23, P10681; Takizawa S, 2002, J CEREBR BLOOD F MET, V22, P50, DOI 10.1097/00004647-200201000-00006; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Zemke D, 2004, CLIN NEUROPHARMACOL, V27, P293, DOI 10.1097/01.wnf.0000150867.98887.3e	55	22	22	0	10	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	SEP 22	2012	9								225	10.1186/1742-2094-9-225			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	045YW	WOS:000311733700001	22998689	Green Published, gold			2022-02-06	
J	Ruseckaite, R; Gabbe, B; Vogel, AP; Collie, A				Ruseckaite, R.; Gabbe, B.; Vogel, A. P.; Collie, A.			Health care utilisation following hospitalisation for transport-related injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Compensation; Road traffic injury; Hospitalization; Health service use	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; COMPENSATION; FATALITIES; SERVICES; CHILDREN; ONTARIO; COSTS	Background: Transport injuries are a substantial cause of disability and death internationally. There is little published information regarding patterns of healthcare utilisation following transport injury. Aims: To investigate patterns of in-hospital and post-discharge healthcare use following transport injury. Methods: Analysis of all accepted adult claims from the database of the transport accident compensation regulator in Victoria, Australia between 1995 and 2008. The analyses focused on injuries resulting in hospitalisation. Indicators of in-hospital and post-discharge healthcare utilisation (e. g. number of services per practitioner group) within the first 12-months were summarised. Results: More than a third (33.6%, n = 68,639) of all accepted compensable transport injuries resulted in admission to an acute care facility within 28 days of injury. In this group, the compensation authority paid for a total of 4.5 million healthcare services in the 12 months post-discharge (median of 19 services per claim). Services provided by medical practitioners were accessed by nearly all claimants (95.7%) at a median of 11 (5-26) per claimant. Less than half of claimants (46.7%) accessed paramedical or allied health services but the median number of services accessed was higher at 29 (9-82) per claimant. Conclusion: Transport-related injury cases require a substantial interaction with multiple components of the healthcare system in the year following hospital discharge. Compensation system datamay provide adetailed understanding of healthcare utilisation, a key element of injury burden. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.	[Ruseckaite, R.; Vogel, A. P.; Collie, A.] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic 3004, Australia; [Gabbe, B.; Collie, A.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia		Collie, A (corresponding author), Monash Univ, Inst Safety Compensat & Recovery Res, Level 11,499 St,Kilda Rd, Melbourne, Vic 3004, Australia.	alex.collie@monash.edu	Vogel, Adam/ABD-7685-2020; Ruseckaite, Rasa/H-4060-2014	Vogel, Adam/0000-0002-3505-2631; Ruseckaite, Rasa/0000-0002-9078-2696; Collie, Alex/0000-0003-2617-9339; Gabbe, Belinda/0000-0001-7096-7688	Transport Accident Commission (TAC); WorkSafe Victoria; National Health and Medical Research Council (NHMRC) of AustraliaNational Health and Medical Research Council of Australia	The authors would like to acknowledge the assistance provided by the Transport Accident Commission in interpreting the compensation data presented in this report. The Institute for Safety Compensation and Recovery Research (ISCRR) is partly funded by an establishment grant from the Transport Accident Commission (TAC) and WorkSafe Victoria. Dr. Gabbe's involvement in this study was supported by a National Health and Medical Research Council (NHMRC) of Australia Career Development Award.	Access Economics, 2009, EC COST SPINAL CORD; AIHW, 1997, HLTH SERV SER, V33; AIIIW, 2009, HLTH SERV SER, V33; Boufous S, 2003, AUST NZ J PUBL HEAL, V27, P352, DOI 10.1111/j.1467-842X.2003.tb00406.x; Brown J, 2007, HEALTHC POLICY, V2; BULL JP, 1975, ACCIDENT ANAL PREV, V7, P249, DOI 10.1016/0001-4575(75)90026-3; BULL JP, 1985, ACCIDENT ANAL PREV, V17, P387, DOI 10.1016/0001-4575(85)90093-4; Butler DJ, 1999, AM FAM PHYSICIAN, V60, P524; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; D.o. Health, 2010, VICT HOSP ADM POL; Driscoll T, 2003, OCCUP ENVIRON MED, V60, P195, DOI 10.1136/oem.60.3.195; Dryden DM, 2005, J TRAUMA, V59, P441, DOI 10.1097/01.ta.0000174732.90517.df; Gabbe BJ, 2007, AUST HEALTH REV, V31, P628, DOI 10.1071/AH070628; Guilcher SJT, 2010, SPINAL CORD, V48, P45, DOI 10.1038/sc.2009.78; Harris IA, 2009, MED J AUSTRALIA, V190, P619, DOI 10.5694/j.1326-5377.2009.tb02589.x; Henley G., 2009, SERIUOS INJURY DUE L; Katz SJ, 1996, AM J PUBLIC HEALTH, V86, P520, DOI 10.2105/AJPH.86.4.520; Li L, 1998, TRENDS ROAD TRAFFIC; Littleton S, 2010, INJURY, V41, P904, DOI DOI 10.1016/J.INJURY.2010.02.011; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; Munce SEP, 2009, SPINAL CORD, V47, P470, DOI 10.1038/sc.2008.173; Parry WR, 2009, J CLIN PATHOL, V62, P561, DOI 10.1136/jcp.2009.065318; Petersen C, 2006, BRAIN INJURY, V20, P321, DOI 10.1080/02699050500488108; Rainville J, 1997, SPINE, V22, P2016, DOI 10.1097/00007632-199709010-00016; REDELMEIER DA, 1993, J GEN INTERN MED, V8, P199, DOI 10.1007/BF02599267; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sluys K, 2005, J TRAUMA, V59, P223, DOI 10.1097/01.TA.0000173832.01547.CB; State Government of Victoria, 2009, 2008 VICT ROAD TOLL; TAC, 2009, TAC ANN REP; Vangel SJ, 2005, AM J PHYS MED REHAB, V84, P153, DOI 10.1097/01.PHM.0000154896.55045.E7; Willemse-van Son AHP, 2009, J REHABIL MED, V41, P59, DOI 10.2340/16501977-0294; Winston FK, 2004, ACCIDENT ANAL PREV, V36, P507, DOI 10.1016/S0001-4575(03)00056-3	33	22	22	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2012	43	9					1600	1605		10.1016/j.injury.2011.03.011			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	977MK	WOS:000306666100048	21466883				2022-02-06	
J	Feyen, BFE; Sener, S; Jorens, PG; Menovsky, T; Maas, AIR				Feyen, B. F. E.; Sener, S.; Jorens, P. G.; Menovsky, T.; Maas, A. I. R.			Neuromonitoring in traumatic brain injury	MINERVA ANESTESIOLOGICA			English	Article						Brain injuries; Monitoring; Intensive Care Unit	CEREBRAL PERFUSION-PRESSURE; TISSUE OXYGEN-TENSION; INTRACRANIAL-PRESSURE; BLOOD-FLOW; CEREBROSPINAL-FLUID; HEAD-INJURY; AUTOREGULATION; REACTIVITY; GLUCOSE; MICRODIALYSIS	Current approaches to monitoring in severe traumatic brain injury (TBI) include a wide array of modalities, providing insight into pressure parameters, oxygenation, perfusion, electrophysiology and metabolism of the brain. The intent of "multimodality monitoring" is to obtain a better understanding of what is going on within the brain of an individual patient in order to target treatment more appropriately,. In this review we highlight the current status of neuromonitoring for TBI with a specific focus on how advanced analysis and integration of these parameters may be used to implement more personalized treatment approaches. In particular, combining information from different parameters and performing dynamic testing offers the potential to better understand the pathophysiological mechanisms active in the brain of a particular patient. Rather than persisting in a standardized "one size fits all" approach to therapy or continuing down the separate tracts of goal directed therapy, we suggest to think more in terms of "individualized therapeutic strategies" more focused on the specific requirements of each patient. Given the considerable data overload in multimodality monitoring and the complexity in interpretation of signals from multiple sources, specific attention needs to be directed to data processing and user-friendly displays. Intense collaboration and interaction between clinicians, basic researchers, IT-experts, nurses and industry will be required to further advance the fields towards more personalized approaches. (Minerva Anestesiol 2012;78:949-58)	[Feyen, B. F. E.; Sener, S.; Menovsky, T.; Maas, A. I. R.] Univ Antwerp Hosp, Dept Neurosurg, Antwerp, Belgium; [Feyen, B. F. E.; Sener, S.; Jorens, P. G.; Menovsky, T.; Maas, A. I. R.] Univ Antwerp, B-2020 Antwerp, Belgium; [Jorens, P. G.] Univ Antwerp Hosp, Dept Intens Care Med, Antwerp, Belgium		Maas, AIR (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	andrew.maas@uza.be	Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264	IWT-TBMInstitute for the Promotion of Innovation by Science and Technology in Flanders (IWT) [80660]	The work of the authors on multimodality monitoring was supported by a grant from the IWT-TBM funding: IWT project number 80660: "Individualized Targeted Management in Neurocritical Care".	Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P103, DOI 10.1111/j.1399-6576.1995.tb04285.x; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Bechir M, 2010, MINERVA ANESTESIOL, V76, P896; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Bouras TIM, 2011, J NEUROTRAUMA; Brain Trauma Foundation, 2001, J NEUROTRAUMA S2, V51, pS1; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 2007, J NEUROTRAUMA SUPPL, V24, P1; Bullock R., 1996, EUR J EMERG MED, V3, P109, DOI 10.1097/00063110-199606000-00010; Chieregato A, 2003, J NEUROL NEUROSUR PS, V74, P784, DOI 10.1136/jnnp.74.6.784; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dings J, 1996, ACTA NEUROCHIR, V138, P425, DOI 10.1007/BF01420305; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; GUILLAUME J, 1951, REV NEUROL, V84, P131; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Jaeger M, 2005, ACTA NEUROCHIR, V147, P51, DOI 10.1007/s00701-004-0408-z; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kim DH, 2006, NEUROCRIT CARE, V4, P83, DOI 10.1385/NCC:4:1:083; Kim MN, 2010, NEUROCRIT CARE, V12, P173, DOI 10.1007/s12028-009-9305-x; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Longhi L, 2002, ACT NEUR S, V81, P315; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MAAS AIR, 1993, ACTA NEUROCHIR, P50; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, INTENS CARE MED, V36, P1283, DOI 10.1007/s00134-010-1921-6; Magnoni S, 2011, BRAIN; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Meierhans R, 2010, CRIT CARE, V14, DOI 10.1186/cc8869; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Miller JD, 1972, INTRACRANIAL PRESSUR, P270; Nangunoori R, NEUROCRIT CARE; Owen-Reece H, 1999, BRIT J ANAESTH, V82, P418, DOI 10.1093/bja/82.3.418; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; Radolovich DK, 2009, NEUROCRIT CARE, V10, P274, DOI 10.1007/s12028-009-9190-3; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sahuquillo J, 2008, EUR J ANAESTH, V25, P83, DOI 10.1017/S0265021507003353; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stocchetti N, 2010, CRIT CARE MED, V38, P318, DOI 10.1097/CCM.0b013e3181b9d5ac; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2008, CRIT CARE, V12, DOI 10.1186/cc6986; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wong GKC, 2010, J NEUROL NEUROSUR PS, V81, P1064, DOI 10.1136/jnnp.2009.198523; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	71	22	22	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	AUG	2012	78	8					949	958					10	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	010FN	WOS:000309080200012	22643541				2022-02-06	
J	Masel, BE; Bell, RS; Brossart, S; Grill, RJ; Hayes, RL; Levin, HS; Rasband, MN; Ritzel, DV; Wade, CE; DeWitt, DS				Masel, Brent E.; Bell, Randy S.; Brossart, Shawn; Grill, Raymond J.; Hayes, Ronald L.; Levin, Harvey S.; Rasband, Matthew N.; Ritzel, David V.; Wade, Charles E.; DeWitt, Douglas S.			Galveston Brain Injury Conference 2010: Clinical and Experimental Aspects of Blast Injury	JOURNAL OF NEUROTRAUMA			English	Article						blast injury; blast-induced neurotrauma; neurocritical care; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; AMYLOID PRECURSOR PROTEIN; CONTROLLED CORTICAL IMPACT; COMBAT-CASUALTY-CARE; MILD HEAD-INJURY; PERSISTENT POSTCONCUSSIVE SYMPTOMS; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CENTRAL-NERVOUS-SYSTEM; AXON INITIAL SEGMENT; LONG-TERM SURVIVAL	Blast injury is the most prevalent source of mortality and morbidity among combatants in Operations Iraqi and Enduring Freedom. Blast-induced neurotrauma (BINT) is a common cause of mortality, and even mild BINT may be associated with chronic cognitive and emotional deficits. In addition to military personnel, the increasing use of explosives by terrorists has resulted in growing numbers of blast injuries in civilian populations. Since the medical and rehabilitative communities are likely to be faced with increasing numbers of patients suffering from blast injury, the 2010 Galveston Brain Injury Conference focused on topics related to the diagnosis, treatment, and mechanisms of BINT. Although past military actions have resulted in large numbers of blast casualties, BINT is considered the signature injury of the conflicts in Iraq and Afghanistan. The attention focused on BINT has led to increased financial support for research on blast effects, contributing to the development of better experimental models of blast injury and a clearer understanding of the mechanisms of BINT. This more thorough understanding of blast injury mechanisms will result in novel and more effective therapeutic and rehabilitative strategies designed to reduce injury and facilitate recovery, thereby improving long-term outcomes in patients suffering from the devastating and often lasting effects of BINT. The following is a summary of the 2010 Galveston Brain Injury Conference, that included presentations related to the diagnosis and treatment of acute BINT, the evaluation of the long-term neuropsychological effects of BINT, summaries of current experimental models of BINT, and a debate about the relative importance of primary blast effects on the acute and long-term consequences of blast exposure.	[DeWitt, Douglas S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Masel, Brent E.] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Bell, Randy S.] Natl Naval Med Ctr, Dept Neurosurg, Bethesda, MD USA; [Brossart, Shawn] Transit Learning Ctr, Project Victory, Galveston, TX USA; [Grill, Raymond J.] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX USA; [Hayes, Ronald L.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Levin, Harvey S.] Banyan Biomarkers, Alachua, FL USA; [Rasband, Matthew N.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ritzel, David V.] Dyn Fx Consulting Ltd, Amherstburg, ON, Canada; [Wade, Charles E.] Univ Texas Houston, Sch Med, Dept Surg, Houston, TX USA		DeWitt, DS (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd,Suite 2A, Galveston, TX 77555 USA.	ddewitt@utmb.edu		Rasband, Matthew/0000-0001-8184-2477	Transitional Learning Center; Moody Endowment; Center for Rehabilitation Sciences, School of Health Professions at University of Texas Medical Branch Health	The 2010 Galveston Brain Injury Conference was supported by the Transitional Learning Center, the Moody Endowment, and the Center for Rehabilitation Sciences, School of Health Professions at University of Texas Medical Branch Health, with assistance from the Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect. The authors are grateful for the skilled and indispensable assistance of Ms. Georgina Eastmond with the conference organization. We are especially indebted to Mr. Robert Moody for his many years of generous support for research on traumatic brain injury.	AARABI B, 1990, NEUROSURGERY, V27, P692, DOI 10.1227/00006123-199011000-00004; ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Alvarez L., 2008, NY TIMES        0829; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Benzinger T., 1950, GERMAN AVIATION MED, V2, P1225; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bolander R., 2012, MULTISPECIES ANAL BI; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; Bowen I.G., 1962, TRANSLATIONAL EFFECT; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Brewin CR, 2010, PSYCHOL REV, V117, P210, DOI 10.1037/a0018113; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 1996, CHINESE J TRAUMATOL, V12, P28; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Chiffelle T. L., 1966, DA49146XY055 DEP DEF; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cushing H, 1918, BRIT J SURG, V5, P558; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; EDWARDS OM, 1986, MEDICINE, V65, P281; Engel T, 2011, J CEREBR BLOOD F MET, V31, P1196, DOI 10.1038/jcbfm.2011.26; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Freidlander F.G., 1946, P ROY SOC LOND A MAT, VA186, P322; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Hai T, 1999, GENE EXPRESSION, V7, P321; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hayes RL, 2009, METHODS MOL BIOL, V566, P303, DOI 10.1007/978-1-59745-562-6_20; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Institute of Medicine, 2009, GULF WAR HLTH, V7; Irwin RJ, 1999, J TRAUMA, V47, P105, DOI 10.1097/00005373-199907000-00023; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kim KA, 2005, NEUROSURGERY, V57, P737, DOI [10.1227/01.NEU.0000175727.76530.94, 10.1227/01.NEU.0000164174.07281.F9]; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MATSON D, 1958, MANAGEMENT ACUTE CRA; MAYHEW TM, 1990, J ANAT, V172, P191; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; Menascu S, 2010, PEDIATR NEUROSURG, V46, P82, DOI 10.1159/000319004; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Park E, 2011, J NEUROTRAUM, V28, P343, DOI 10.1089/neu.2009.1050; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rice D, 2000, TACTICAL EDGE J  SUM, P53; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Ritenour AE, 2010, ANN SURG, V251, P1140, DOI 10.1097/SLA.0b013e3181e01270; Ritzel D.V., 1997, 21 INT S SHOCK WAV G; Ritzel D.V., 2011, NATO RTO HFM 207 S H; Ritzel D.V., 2007, 26 INT S SHOCK WAV G; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sahin B., 2001, IMAGE ANAL STEREOL, V20, P9, DOI [10.5566/ias.v20.p9-13, DOI 10.5566/IAS.V20.P9-13]; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; SCHMIDT RH, 1993, J NEUROTRAUM, V10, P415, DOI 10.1089/neu.1993.10.415; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Sisodiya S, 1996, J ANAT, V188, P425; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Stuhmiller J., 2008, BLAST INJURY TRANSLA, P1; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Unterberg AW, 1997, ACT NEUR S, V70, P106; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Wade C.E., 2008, EXPLOSIONS BLAST REL; Wang ZG, 1998, CHINESE MED J-PEKING, V111, P109; Whalen MJ, 1998, ACT NEUR S, V71, P212; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	169	22	22	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2012	29	12					2143	2171		10.1089/neu.2011.2258			29	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	993KZ	WOS:000307859900004	22655746				2022-02-06	
J	Mo, SJ; Zhong, Q; Zhou, YF; Deng, DB; Zhang, XQ				Mo, Shi-Jing; Zhong, Qian; Zhou, Yan-Fang; Deng, David B.; Zhang, Xiu-Quan			Bone marrow-derived mesenchymal stem cells prevent the apoptosis of neuron-like PC12 cells via erythropoietin expression	NEUROSCIENCE LETTERS			English	Article						Bone marrow-derived mesenchymal stem cells; PC12 cells; Erythropoietin; Apoptosis; Neuronal stress	TRAUMATIC BRAIN-INJURY; SIGNALING PATHWAY; MECHANISMS; PROTECTION; HYPOXIA; ACTIVATION; LINES	It is known that bone marrow-derived mesenchymal stem cells (BM-MSCs) are able to improve neuronal function through secretion of trophic factors in animal models of middle cerebral artery occlusion (MCAo). In this study, we demonstrated that incubation of BM-MSCs protects PC12 cells against apoptosis induced by CoCl2 via the production of erythropoietin (EPO). Addition of CoCl2 to BM-MSCs cultures induced the expression of EPO in a time-dependent manner. Additionally, BM-MSCs co-culture protected PC12 cells against apoptosis induced by CoCl2 in a ratio-dependent manner. To explore whether expression of EPO induced by CoCl2 is required for BM-MSCs-mediated cytoprotection, we transfected BM-MSCs with EPO small interfering RNA (siRNA). Knocking-down EPO abrogated increases in EPO expression induced by CoCl2, and the cytoprotective effect of BM-MSCs. Reverse transcriptase polymerase chain reaction results showed that EPO siRNA reversed upregulation of Bcl-2, BcI-X-L expression and downregulation of Bax. Bak, caspase-9, and caspase-3 expression. Our results revealed that the protective effect of BM-MSCs against PC12 cell apoptosis induced by CoCl2 might be dependent on EPO expression, at least in part, via the regulation of Bcl-2 family members and caspases. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Mo, Shi-Jing; Zhou, Yan-Fang; Deng, David B.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Guangzhou 510089, Guangdong, Peoples R China; [Zhong, Qian] Sun Yat Sen Univ, Dept Res Lab, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China; [Deng, David B.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Translat Med Lab,Affiliated Hosp 1, Guangzhou 510089, Guangdong, Peoples R China; [Zhang, Xiu-Quan] Univ Utah, Dept Surg, Salt Lake City, UT 84132 USA		Deng, DB (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Translat Med Lab,Affiliated Hosp 1, Guangzhou 510089, Guangdong, Peoples R China.	dengyub@mail.sysu.edu.cn			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30973093, 801171711]; Ministry of Education Fund for the Doctoral [01711100480]; Natural Science Foundation of Guangdong Province in ChinaNational Natural Science Foundation of Guangdong Province [2009B050200010]	This work was financially supported by the Natural Science Foundation of China (Nos. 30973093, 801171711), Ministry of Education Fund for the Doctoral (No. 01711100480) and the Natural Science Foundation of Guangdong Province in China (No. 2009B050200010).	Bernaudin M, 2000, GLIA, V30, P271, DOI 10.1002/(SICI)1098-1136(200005)30:3<271::AID-GLIA6>3.0.CO;2-H; Bin Deng Y, 2010, NEUROL RES, V32, P148, DOI 10.1179/174313209X414434; Crispo JAG, 2010, CAN J PHYSIOL PHARM, V88, P429, DOI [10.1139/Y09-137, 10.1139/y09-137]; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; GOLDBERG MA, 1987, P NATL ACAD SCI USA, V84, P7972, DOI 10.1073/pnas.84.22.7972; Guo LX, 2009, CHINESE MED J-PEKING, V122, P2886, DOI 10.3760/cma.j.issn.0366-6999.2009.23.016; Hillion JA, 2005, J CEREBR BLOOD F MET, V25, P154, DOI 10.1038/sj.jcbfm.9600003; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Jin W, 2011, J TRAUMA, V71, P680, DOI 10.1097/TA.0b013e3181f6b984; Jung JY, 2007, LIFE SCI, V80, P1355, DOI 10.1016/j.lfs.2006.11.033; Li G, 2008, NEUROSCI LETT, V442, P143, DOI 10.1016/j.neulet.2008.07.007; Lu YR, 2010, CELL BIOCHEM FUNCT, V28, P637, DOI 10.1002/cbf.1701; Lykissas MG, 2007, CLIN NEUROL NEUROSUR, V109, P639, DOI 10.1016/j.clineuro.2007.05.013; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Minano A, 2008, J NEUROSCI RES, V86, P1734, DOI 10.1002/jnr.21633; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pereira WO, 2011, SCAND J IMMUNOL, V73, P401, DOI 10.1111/j.1365-3083.2011.02513.x; POLAK M, 1993, P NATL ACAD SCI USA, V90, P5781, DOI 10.1073/pnas.90.12.5781; Rabie T, 2008, PHYSIOLOGY, V23, P263, DOI 10.1152/physiol.00016.2008; Tang XQ, 2005, BRAIN RES, V1057, P57, DOI 10.1016/j.brainres.2005.07.072; van der Kooij MA, 2008, BRAIN RES REV, V59, P22, DOI 10.1016/j.brainresrev.2008.04.007; Wang XF, 2010, LEUKEMIA RES, V34, P1325, DOI 10.1016/j.leukres.2010.05.006; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Wenger RH, 1998, INT J MOL MED, V2, P317; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Zaman K, 1999, J NEUROSCI, V19, P9821; Zhong Q., 2012, STEM CELLS DEV	27	22	29	1	9	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 1	2012	522	2					92	97		10.1016/j.neulet.2012.06.002			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	982IG	WOS:000307035800003	22698588				2022-02-06	
J	Obirieze, AC; Gaskin, DJ; Villegas, CV; Bowman, SM; Schneider, EB; Oyetunji, TA; Haut, ER; Efron, DT; Cornwell, EE; Haider, AH				Obirieze, Augustine C.; Gaskin, Darrell J.; Villegas, Cassandra V.; Bowman, Stephen M.; Schneider, Eric B.; Oyetunji, Tolulope A.; Haut, Elliott R.; Efron, David T.; Cornwell, Edward E., III; Haider, Adil H.			Regional variations in cost of trauma care in the United States: Who is paying more?	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Cost of trauma care; regional variations; trauma outcomes	HEALTH-CARE; ADMINISTRATIVE DATA; MEDICARE; QUALITY; VALIDATION; REFORM	BACKGROUND: The study of regional variations in costs of care has been used to identify areas of savings for several diseases and conditions. This study investigates similar potential regional differences in the cost of adult trauma care using an all-payer, nationally representative sample. METHODS: Trauma patients aged 18 to 64 years in the 2006-2008 Nationwide Inpatient Sample were identified using International Classification of Diseases, 9th Revision, Clinical Modification codes. Those with isolated diagnoses for five index conditions (ICs): blunt splenic injury, liver injury, tibia fracture, moderate traumatic brain injury, and pneumothorax/hemothorax were selected. Cost was estimated from charges using a cost-to-charge ratio. Generalized linear modeling was used to compare the mean cost for treating these ICs between US regions (Northeast, South, Midwest, and West), adjusting for hospital factors (size, teaching status, and location), patient demographics, injury severity, length of stay, Charlson comorbidity index, local wage index, and payer. Relative mean cost (RC) was calculated using Northeast as the reference, and sampling weights were applied to obtain regional estimates. Differences in adjusted mortality between regions were also assessed. RESULTS: Adjusted relative costs were estimated for 62,678 patients (South: 28,536; West: 12,975; Midwest: 11,450; and Northeast: 9,717). Mean costs for liver injury were 22% higher in the Midwest compared with the Northeast (RC: 1.22; 95% confidence interval [CI]: 1.10-1.35). Similarly higher costs were seen with other regions and ICs (RC for blunt splenic injury in the South: 1.18; 95% CI: 1.07-1.31; RC for pneumothorax/hemothorax in the West: 1.31; 95% CI: 1.22-1.41). No differences in adjusted mortality by region were noted overall. CONCLUSION: Even after controlling for factors known to influence medical care cost, as well as controlling for geographic differences in pricing, significant regional differences exist in the cost of trauma care. Exploring these variations may assist in identifying potential areas for cost savings. (J Trauma Acute Care Surg. 2012; 73: 516-522. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Villegas, Cassandra V.; Schneider, Eric B.; Haut, Elliott R.; Efron, David T.; Haider, Adil H.] Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, Baltimore, MD 21212 USA; [Obirieze, Augustine C.; Oyetunji, Tolulope A.; Cornwell, Edward E., III] Howard Univ, Coll Med, Outcomes Res Ctr, Dept Surg, Washington, DC USA; [Gaskin, Darrell J.; Bowman, Stephen M.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA		Haider, AH (corresponding author), Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Dept Surg, 600 N Wolfe St,Halsted 610, Baltimore, MD 21212 USA.	ahaider1@jhmi.edu	Bowman, Stephen/AAF-2154-2019; Haut, Elliott R./J-3948-2019	Haut, Elliott/0000-0001-7075-771X; Oyetunji, Tolulope/0000-0003-3039-7195	National Institutes of Health/NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093112-01]; American College of Surgeons C. James Carrico Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM093112] Funding Source: NIH RePORTER	Supported by National Institutes of Health/NIGMS K23GM093112-01; American College of Surgeons C. James Carrico Fellowship for the study of Trauma and Critical Care.	[Anonymous], 2006, HEALTHC COST UT PROJ; Briggs A, 1998, J Health Serv Res Policy, V3, P233; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper RA, 2009, HEALTH AFFAIR, V28, pW103, DOI 10.1377/hlthaff.28.1.w103; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cutler DM, 1999, AM ECON REV, V89, P228, DOI 10.1257/aer.89.2.228; Deb P., 2010, AM SOC HLTH EC C COR; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Gawande A., 2009, NEW YORKER; Glance LG, 2010, ANN SURG, V252, P217, DOI 10.1097/SLA.0b013e3181e623f6; HCUP Nationwide Inpatient Sample (NIS), 2008, HEALTHC COST UT PROJ; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Makarov DV, 2010, J UROLOGY, V183, P1504, DOI 10.1016/j.juro.2009.12.014; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Quan HD, 2002, MED CARE, V40, P675, DOI 10.1097/00005650-200208000-00007; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rettenmaier AJ, 2012, HEALTH ECON, V21, P67, DOI 10.1002/hec.1700; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Skinner J, 2000, NBER FR HLTH POL RES, V3, P69, DOI 10.1162/109623100300091078; Skinner J, 1997, NATL TAX J, V50, P413; Weir S, 2010, EXPERT REV PHARM OUT, V10, P187, DOI [10.1586/erp.10.8, 10.1586/ERP.10.8]; Wennberg J. E., 1998, DARTMOUTH ATLAS HLTH; WHO, 2009, WORLD HLTH STAT 2009; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	28	22	22	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	AUG	2012	73	2					516	522		10.1097/TA.0b013e31825132a0			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	992VG	WOS:000307807400056	23019681				2022-02-06	
J	Walter, KH; Barnes, SM; Chard, KM				Walter, Kristen H.; Barnes, Sean M.; Chard, Kathleen M.			The influence of comorbid MDD on outcome after residential treatment for veterans with PTSD and a history of TBI	JOURNAL OF TRAUMATIC STRESS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; DIAGNOSIS; SYMPTOMS; IRAQ; ASSOCIATIONS; AFGHANISTAN; DEPLOYMENT; VICTIMS	Among military personnel, posttraumatic stress disorder (PTSD), major depressive disorder (MDD), and a history of traumatic brain injury (TBI) are frequently reported, highlighting the need for treatment outcome research with this population. This study examined the influence of the presence or absence of comorbid MDD on the outcome of a residential treatment program at the midpoint and end of the program for 47 male veterans with PTSD and a history of TBI. Results demonstrated significant decreases of self-reported symptoms on the PTSD Checklist-Stressor Specific Version (PCL-S; MDD, d = 1.19; No MDD, d = 1.17) and the Beck Depression InventoryII (BDI-II; MDD, d = 0.98; No MDD, d = 1.09) following treatment for both groups. There were no differences in the rate of symptom reduction between groups. Individuals who also met criteria for MDD at pretreatment, however, evidenced higher scores on symptom measures at all assessment time points (ds = 0.601.25).	[Walter, Kristen H.; Barnes, Sean M.; Chard, Kathleen M.] Cincinnati VA Med Ctr, PTSD & Anxiety Disorders Clin, Cincinnati, OH 45220 USA; [Chard, Kathleen M.] Univ Cincinnati, Sch Med, Dept Psychiat, Cincinnati, OH USA; [Barnes, Sean M.] VA Eastern Colorado Hlth Care Syst, VISN Mental Illness Res Educ & Clin Ctr 19, Denver, CO USA		Chard, KM (corresponding author), Cincinnati VA Med Ctr, PTSD & Anxiety Disorders Clin, 3200 Vine St, Cincinnati, OH 45220 USA.	Kathleen.Chard@va.gov	Walter, Kristen H/S-1827-2019				American Psychiatric Association, 2000, DIAGN STAT MAN MENT, DOI [DOI 10.1176/APPI.BOOKS.9780890423349, 10.1176/appi.books.9780890423349]; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Blake D. D., 1990, CLIN ADM PTSD SCALE, VIV; BLANCHARD EB, 1995, BEHAV RES THER, V33, P471, DOI 10.1016/0005-7967(94)00064-Q; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Chard KM, 2008, COGNITIVE PROCESSING; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehlers A, 1995, Behav Cogn Psychother, V23, P217, DOI 10.1017/S135246580001585X; First M.B., 1996, STRUCTURED CLIN INTE; Foa E.B., 2007, PROLONGED EXPOSURE T; FOA EB, 1989, BEHAV THER, V20, P155, DOI 10.1016/S0005-7894(89)80067-X; Henning KR, 1997, J CLIN PSYCHOL, V53, P801, DOI 10.1002/(SICI)1097-4679(199712)53:8<801::AID-JCLP3>3.3.CO;2-V; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Jaycox, 2008, INVISIBLE WOUNDS WAR; Karlin BE, 2010, J TRAUMA STRESS, V23, P663, DOI 10.1002/jts.20588; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Linehan MM., 1993, COGNITIVE BEHAV TREA; Lobbestael J, 2011, CLIN PSYCHOL PSYCHOT, V18, P75, DOI 10.1002/cpp.693; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Monson C. M., 2007, COGNITIVE PROCESSING; Nixon RDV, 2011, J TRAUMA STRESS, V24, P451, DOI 10.1002/jts.20654; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Rizvi SL, 2009, BEHAV RES THER, V47, P737, DOI 10.1016/j.brat.2009.06.003; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shear MK, 2000, AM J PSYCHIAT, V157, P581, DOI 10.1176/appi.ajp.157.4.581; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Twamley E. W., 2008, COGNITIVE SYMP UNPUB; United States Department of Veterans Affairs & Department of Defense, 2009, VA DOD CLIN PRACT GU; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Weathers F.W., 1991, PTSD CHECKLIST MILIT; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Williams AD, 2007, BEHAV RES THER, V45, P1141, DOI 10.1016/j.brat.2006.09.005	37	22	22	0	5	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-9867			J TRAUMA STRESS	J. Trauma Stress	AUG	2012	25	4					426	432		10.1002/jts.21722			7	Psychology, Clinical; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Psychiatry	983HI	WOS:000307110000009	22821663				2022-02-06	
J	Hunter, JM; Cirrito, JR; Restivo, JL; Kinley, RD; Sullivan, PM; Holtzman, DM; Koger, D; Delong, C; Lin, SZ; Zhao, LZ; Liu, F; Bales, K; Paul, SM				Hunter, Jesse M.; Cirrito, John R.; Restivo, Jessica L.; Kinley, Robert D.; Sullivan, Patrick M.; Holtzman, David M.; Koger, Deanna; Delong, Cynthia; Lin, Suizhen; Zhao, Lingzhi; Liu, Feng; Bales, Kelly; Paul, Steven M.			Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice	BRAIN RESEARCH			English	Article						Apolipoprotein E; Alzheimer; Epilepsy; Seizure; Amyloid beta	TEMPORAL-LOBE EPILEPSY; ALZHEIMERS-DISEASE RELATION; EVENT-RELATED POTENTIALS; TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; E POLYMORPHISM; POSTTRAUMATIC SEIZURES; RECEPTOR-BINDING; EEG ALTERATIONS; ONSET SEIZURES	The apolipoprotein 64 allele is the strongest genetic risk factor for late-onset Alzheimer's disease (AD) and is associated with earlier age of onset. The incidence of spontaneous seizures has been reported to be increased in sporadic AD as well as in the early onset autosomal dominant forms of AD. We now report the emergence of a seizure phenotype in aged apolipoprotein E4 (apoE4) targeted replacement (TR) mice but not in age-matched apoE2 TR or apoE3-TR mice. Tonic-clonic seizures developed spontaneously after 5 months of age in apoE4 TR mice and are triggered by mild stress. Female mice had increased seizure penetrance compared to male mice, but had slightly reduced overall seizure severity. The majority of seizures were characterized by head and neck jerks, but 25% of aged apoE4 TR mice had more severe tonic-clonic seizures which occasionally progressed to tonic extension and death. Aged apoE4 TR mice progressed through pentylenetetrazol-induced seizure stages more rapidly than did apoE3 TR and apoE2 TR mice. Electroencephalographic (EEG) recordings revealed more frequent bursts of synchronous theta activity in the hippocampus of apoE4 TR mice than in apoE2 TR or apoE3 TR mice. Cortical EEG recordings also revealed sharp spikes and other abnormalities in apoE4 TR mice. Taken together, these findings demonstrate the emergence of an age-dependent seizure phenotype in old apoE4 TR mice in the absence of human amyloid-beta peptide (A beta) overexpression, suggesting increased central nervous system neural network excitability. (c) 2012 Published by Elsevier B.V.	[Paul, Steven M.] Cornell Univ, Weill Cornell Med Coll, Helen & Robert Appel Alzheimers Dis Res Inst, New York, NY 10065 USA; [Hunter, Jesse M.; Kinley, Robert D.; Koger, Deanna; Delong, Cynthia; Lin, Suizhen; Zhao, Lingzhi; Liu, Feng; Bales, Kelly] Eli Lilly & Co, Neurosci Discovery, Indianapolis, IN 46285 USA; [Cirrito, John R.; Restivo, Jessica L.; Holtzman, David M.] Washington Univ, Hope Ctr Neurol Disorders, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Sullivan, Patrick M.] Duke Univ, Durham VA Med Ctr, Div Geriatr, Durham, NC 27710 USA		Paul, SM (corresponding author), Cornell Univ, Weill Cornell Med Coll, Helen & Robert Appel Alzheimers Dis Res Inst, 1300 York Ave,8th Floor,LC 802, New York, NY 10065 USA.	jeshnt@gmail.com; cirritoj@neuro.wustl.edu; restivoj@neuro.wustl.edu; KINLEY_ROBERT@lilly.com; p.sullivan@duke.edu; holtzman@neuro.wustl.edu; koger_deanna@lilly.com; DELONG_CYNTHIA_A@lilly.com; LIN_SUIZHEN@lilly.com; liz2010@med.cornell.edu; liu_feng_fl@lilly.com; Kelly.Bales@Pfizer.com; smpaulmd@gmail.com	Paul, Steve/ABE-5400-2020				Alexander DM, 2007, BIOL PSYCHOL, V75, P229, DOI 10.1016/j.biopsycho.2007.03.001; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Anderson GD, 2009, EPILEPSY BEHAV, V16, P501, DOI 10.1016/j.yebeh.2009.08.025; Arab L, 2010, J ALZHEIMERS DIS, V20, P785, DOI 10.3233/JAD-2010-091573; Baker N. L., 2010, ALZH ASS INT C ALZH, pS469; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Bales KR, 2002, MOL INTERV, V2, P339, DOI DOI 10.1124/MI.2.6.363; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Blumcke I, 1997, NEUROREPORT, V8, P1235; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Briellmann RS, 2000, NEUROLOGY, V55, P435, DOI 10.1212/WNL.55.3.435; Busch RM, 2007, NEUROLOGY, V68, P409, DOI 10.1212/01.wnl.0000253021.60887.db; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Colom LV, 2006, J NEUROPHYSIOL, V95, P3645, DOI 10.1152/jn.00040.2006; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Diaz-Arrastia R, 2006, J HEAD TRAUMA REHAB, V21, P361, DOI 10.1097/00001199-200607000-00007; Espeseth T, 2009, NEUROSCI LETT, V459, P91, DOI 10.1016/j.neulet.2009.04.053; FRANDSEN A, 1987, EPILEPSY RES, V1, P107, DOI 10.1016/0920-1211(87)90015-5; Frye Cheryl A, 2006, Expert Rev Neurother, V6, P1061, DOI 10.1586/14737175.6.7.1061; Frye CA, 2008, INT REV NEUROBIOL, V83, P27, DOI 10.1016/S0074-7742(08)00003-2; Gambardella T, 2005, EPILEPSIA, V46, P110, DOI 10.1111/j.0013-9580.2005.15804.x; Garcia-Hernandez A, 2010, EXP NEUROL, V222, P86, DOI 10.1016/j.expneurol.2009.12.010; Gilby KL, 2007, EPILEPSIA, V48, P114, DOI 10.1111/j.1528-1167.2007.01298.x; Gouras GK, 1997, ANN NEUROL, V41, P402, DOI 10.1002/ana.410410317; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; Hirsch Lawrence J, 2007, Epilepsy Curr, V7, P149, DOI 10.1111/j.1535-7511.2007.00208.x; Irizarry MC, 2012, ARCH NEUROL-CHICAGO, V69, P368, DOI 10.1001/archneurol.2011.830; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Korwek KM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-21; Kramer G, 2008, CLIN NEUROPHYSIOL, V119, P2727, DOI 10.1016/j.clinph.2008.08.019; Kurschner VC, 1998, BRAIN RES, V780, P1, DOI 10.1016/S0006-8993(97)01081-0; Larner AJ, 2011, EPILEPSY BEHAV, V21, P20, DOI 10.1016/j.yebeh.2011.03.022; Lehtovirta M, 1996, NEUROBIOL AGING, V17, P523; Lehtovirta M, 2000, DEMENT GERIATR COGN, V11, P29, DOI 10.1159/000017210; Lehtovirta M, 1996, NEUROLOGY, V46, P413, DOI 10.1212/WNL.46.2.413; LERMA J, 1984, ELECTROEN CLIN NEURO, V57, P532, DOI 10.1016/0013-4694(84)90089-0; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Loscher W, 2009, EUR J PHARMACOL, V610, P1, DOI 10.1016/j.ejphar.2009.03.025; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Mendez MF, 2003, DRUG AGING, V20, P791, DOI 10.2165/00002512-200320110-00001; MILLER JW, 1994, EPILEPSY RES, V18, P195, DOI 10.1016/0920-1211(94)90040-X; Murphy C, 2009, ANN NY ACAD SCI, V1170, P647, DOI 10.1111/j.1749-6632.2009.04486.x; Nakken KO, 2005, EPILEPSY BEHAV, V6, P85, DOI 10.1016/j.yebeh.2004.11.003; PALAYOOR ST, 1986, J NEUROCHEM, V46, P1370, DOI 10.1111/j.1471-4159.1986.tb01749.x; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pinikahana J, 2009, EPILEPSY BEHAV, V15, P513, DOI 10.1016/j.yebeh.2009.06.004; Ponomareva NV, 2008, NEUROBIOL AGING, V29, P819, DOI 10.1016/j.neurobiolaging.2006.12.019; Ponomareva NV, 2003, NEUROPSYCHOBIOLOGY, V48, P152, DOI 10.1159/000073633; Raber J, 2008, HORM BEHAV, V53, P706, DOI 10.1016/j.yhbeh.2008.02.012; Rabinowicz AL, 2000, ALZ DIS ASSOC DIS, V14, P231, DOI 10.1097/00002093-200010000-00008; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; ROMANELLI MF, 1990, ARCH NEUROL-CHICAGO, V47, P847, DOI 10.1001/archneur.1990.00530080029006; Roses AD, 1996, ANN NY ACAD SCI, V777, P146, DOI 10.1111/j.1749-6632.1996.tb34413.x; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; Spatt J, 1998, SEIZURE-EUR J EPILEP, V7, P391, DOI 10.1016/S1059-1311(05)80008-1; Sporis D, 2005, J CELL MOL MED, V9, P698, DOI 10.1111/j.1582-4934.2005.tb00500.x; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.002, 10.1016/j.jalz.2011.02.004]; Trommer BL, 2005, NEUROBIOL DIS, V18, P75, DOI 10.1016/j.nbd.2004.08.011; Trommer BL, 2004, NEUROREPORT, V15, P2655, DOI 10.1097/00001756-200412030-00020; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Yeni SN, 2005, EUR J NEUROL, V12, P103, DOI 10.1111/j.1468-1331.2004.00956.x; Yun SH, 2005, J NEUROSCI RES, V82, P771, DOI 10.1002/jnr.20684; Yun SH, 2007, HIPPOCAMPUS, V17, P1153, DOI 10.1002/hipo.20357; ZANNIS VI, 1981, BIOCHEMISTRY-US, V20, P1033, DOI 10.1021/bi00507a059	76	22	23	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 27	2012	1467						120	132		10.1016/j.brainres.2012.05.048			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	994CT	WOS:000307909200013	22682924				2022-02-06	
J	Schober, ME; Block, B; Requena, DF; Hale, MA; Lane, RH				Schober, Michelle Elena; Block, Benjamin; Requena, Daniela F.; Hale, Merica A.; Lane, Robert H.			Developmental traumatic brain injury decreased brain derived neurotrophic factor expression late after injury	METABOLIC BRAIN DISEASE			English	Article						Anesthesia; Controlled cortical impact; Brain derived neurotrophic factor; Developmental; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; DEVELOPING RAT-BRAIN; GENE-EXPRESSION; MATERNAL-DEPRIVATION; HIPPOCAMPAL-NEURONS; SYNAPTIC PLASTICITY; SPATIAL MEMORY; BDNF; DEATH; PERFORMANCE	Pediatric traumatic brain injury (TBI) is a major cause of acquired cognitive dysfunction in children. Hippocampal Brain Derived Neurotrophic Factor (BDNF) is important for normal cognition. Little is known about the effects of TBI on BDNF levels in the developing hippocampus. We used controlled cortical impact (CCI) in the 17 day old rat pup to test the hypothesis that CCI would first increase rat hippocampal BDNF mRNA/protein levels relative to SHAM and Na < ve rats by post injury day (PID) 2 and then decrease BDNF mRNA/protein by PID14. Relative to SHAM, CCI did not change BDNF mRNA/protein levels in the injured hippocampus in the first 2 days after injury but did decrease BDNF protein at PID14. Surprisingly, BDNF mRNA decreased at PID 1, 3, 7 and 14, and BDNF protein decreased at PID 2, in SHAM and CCI hippocampi relative to Na < ve. In conclusion, TBI decreased BDNF protein in the injured rat pup hippocampus 14 days after injury. BDNF mRNA levels decreased in both CCI and SHAM hippocampi relative to Na < ve, suggesting that certain aspects of the experimental paradigm (such as craniotomy, anesthesia, and/or maternal separation) may decrease the expression of BDNF in the developing hippocampus. While BDNF is important for normal cognition, no inferences can be made regarding the cognitive impact of any of these factors. Such findings, however, suggest that meticulous attention to the experimental paradigm, and possible inclusion of a Na < ve group, is warranted in studies of BDNF expression in the developing brain after TBI.	[Schober, Michelle Elena; Block, Benjamin; Requena, Daniela F.; Hale, Merica A.; Lane, Robert H.] Univ Utah, Salt Lake City, UT 84112 USA		Schober, ME (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	michelle.schober@hsc.utah.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001410] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD001410] Funding Source: Medline		Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Aisa B, 2009, HIPPOCAMPUS, V19, P1222, DOI 10.1002/hipo.20586; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Cook JL, 1998, BRAIN RES PROTOC, V3, P1, DOI 10.1016/S1385-299X(98)00012-9; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Griesbach GS, 2009, J NEUROSCI RES, V87, P795, DOI 10.1002/jnr.21893; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hamatake M, 2011, J BIOL CHEM, V286, P21478, DOI 10.1074/jbc.M110.195859; Hellmich HL, 2005, ANESTHESIOLOGY, V102, P806, DOI 10.1097/00000542-200504000-00017; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Kikusui T, 2009, PSYCHONEUROENDOCRINO, V34, P762, DOI 10.1016/j.psyneuen.2008.12.009; Kim JK, 2007, NEUROSCIENCE, V146, P1128, DOI 10.1016/j.neuroscience.2007.02.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lessmann V, 1998, GEN PHARMACOL-VASC S, V31, P667; LINDHOLM D, 1994, J NEUROBIOL, V25, P1362, DOI 10.1002/neu.480251105; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Liu Y, 2001, DEV BRAIN RES, V127, P51, DOI 10.1016/S0165-3806(01)00111-0; Lu LX, 2006, APOPTOSIS, V11, P1603, DOI 10.1007/s10495-006-8762-3; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Ming Z, 2001, BRAIN RES, V920, P117, DOI 10.1016/S0006-8993(01)03044-X; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Roceri M, 2002, MOL PSYCHIATR, V7, P609, DOI 10.1038/sj.mp.4001036; Schober ME, 2010, J NEUROTRAUMA; Shah SA, 2006, EXP GERONTOL, V41, P1201, DOI 10.1016/j.exger.2006.07.006; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Stansberg C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-94; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; ZAFRA F, 1991, P NATL ACAD SCI USA, V88, P10037, DOI 10.1073/pnas.88.22.10037	38	22	28	0	15	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	JUN	2012	27	2					167	173		10.1007/s11011-012-9309-7			7	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	940BO	WOS:000303865200008	22527999	Green Accepted			2022-02-06	
J	Le, K; Coelho, C; Mozeiko, J; Krueger, F; Grafman, J				Le, Karen; Coelho, Carl; Mozeiko, Jennifer; Krueger, Frank; Grafman, Jordan			Predicting Story Goodness Performance From Cognitive Measures Following Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article						discourse analysis; cognition; brain injury; narratives; executive function	CLOSED-HEAD-INJURY; WORKING-MEMORY; DISCOURSE; CHILDREN; ADULTS; REPRESENTATIONS; INFORMATION; NARRATIVES; ABILITIES; LANGUAGE	Purpose: This study examined the prediction of performance on measures of the Story Goodness Index (SGI; Le, Coelho, Mozeiko, & Grafman, 2011) from executive function (EF) and memory measures following traumatic brain injury (TBI). It was hypothesized that EF and memory measures would significantly predict SGI outcomes. Method: One hundred sixty-seven individuals with TBI participated in the study. Story retellings were analyzed using the SGI protocol. Three cognitive measures-Delis-Kaplan Executive Function System (D-KEFS; Delis, Kaplan, & Kramer, 2001) Sorting Test, Wechsler Memory Scale-Third Edition (WMS-III; Wechsler, 1997) Working Memory Primary Index (WMI), and WMS-III Immediate Memory Primary Index (IMI)-were entered into a multiple linear regression model for each discourse measure. Two sets of regression analyses were performed, the first with the Sorting Test as the first predictor and the second with it as the last. Results: The first set of regression analyses identified the Sorting Test and IMI as the only significant predictors of performance on measures of the SGI. The second set identified all measures as significant predictors when evaluating each step of the regression function. Conclusion: The cognitive variables predicted performance on the SGI measures, although there were differences in the amount of explained variance. The results (a) suggest that storytelling ability draws on a number of underlying skills and (b) underscore the importance of using discrete cognitive tasks rather than broad cognitive indices to investigate the cognitive substrates of discourse.	[Grafman, Jordan] Kessler Fdn Res Ctr, W Orange, NJ USA; [Krueger, Frank] George Mason Univ, Fairfax, VA 22030 USA; [Le, Karen; Coelho, Carl; Mozeiko, Jennifer] Univ Connecticut, Storrs, CT USA		Grafman, J (corresponding author), Kessler Fdn Res Ctr, W Orange, NJ USA.	jgrafman@kesslerfoundation.org					Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1986, WORKING MEMORY; Barrett J., 1998, OLD MCDONALD HAD APA, V2nd; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; Chapman SB, 2004, DEV NEUROPSYCHOL, V25, P37, DOI 10.1207/s15326942dn2501&2_4; Cherney L. R., 1998, ANAL DISCOURSE COMMU; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Cohen, 2001, CONDITIONING CONSCIO; COWAN N, 1988, PSYCHOL BULL, V104, P163, DOI 10.1037/0033-2909.104.2.163; Cowan N, 2010, DEV NEUROPSYCHOL, V35, P447, DOI 10.1080/87565641.2010.494985; Delis DC., 2001, DELIS KAPLAN EXECUTI; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Dimitrov M, 1999, NEUROPSYCHOLOGY, V13, P135, DOI 10.1037/0894-4105.13.1.135; Duff MC, 2008, APHASIOLOGY, V22, P866, DOI 10.1080/02687030701844196; Edgin JO, 2010, J INTELL DISABIL RES, V54, P406, DOI 10.1111/j.1365-2788.2010.01278.x; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; FREDERIKSEN CH, 1975, COGNITIVE PSYCHOL, V7, P371, DOI 10.1016/0010-0285(75)90016-X; Gernsbacher M.A, 1990, LANGUAGE COMPREHENSI; Gernsbacher M. A., 1995, MODELS TEXT UNDERSTA, P289; Gernsbacher Morton Ann, 1999, Discourse Stud, V1, P355, DOI 10.1177/1461445699001003004; Grafman J., 1987, NEUROBEHAVIORAL RECO, P43; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); Healon R. K, 1993, WISCONSIN CARD SORTI; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Hunt K., 1965, 3 NCTE; Jennekens N, 2010, J CLIN NURS, V19, P1198, DOI 10.1111/j.1365-2702.2009.03114.x; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kaplan E, 1983, BOSTON NAMING TEST; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kurczek J, 2011, APHASIOLOGY, V25, P700, DOI 10.1080/02687038.2010.537345; Le K, 2011, APHASIOLOGY, V25, P748, DOI 10.1080/02687038.2010.539696; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); MANDLER JM, 1977, COGNITIVE PSYCHOL, V9, P111, DOI 10.1016/0010-0285(77)90006-8; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; MERRITT DD, 1987, J SPEECH HEAR RES, V30, P539, DOI 10.1044/jshr.3004.539; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Moran C. A, 2010, EXPOSITORY DISCOURSE, P275; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Oberauer Klaus., 2005, HDB UNDERSTANDING ME, P393, DOI [10.4135/9781452233529, DOI 10.4135/9781452233529, DOI 10.4135/9781452233529.N22]; Pickens S, 2010, INT J EVID-BASED HEA, V8, P110, DOI 10.1111/j.1744-1609.2010.00170.x; PLAG JA, 1967, PERS PSYCHOL, V20, P323, DOI 10.1111/j.1744-6570.1967.tb01527.x; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Stein N. L., 1979, NEW DIRECTIONS DISCO, P53; Tulving Endel, 1995, P839; U. S. Department of Defense, 1984, TEST MAN ARM SERV VO; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vietnam Head Injury Study-Phase III, 2011, VIETNAM HEAD INJURY; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilhelm K L, 1995, Appl Neuropsychol, V2, P42, DOI 10.1207/s15324826an0201_8; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	57	22	22	0	7	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY 1	2012	21	2					S115	S125		10.1044/1058-0360(2012/11-0114)			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	019SZ	WOS:000309760900008	22294408				2022-02-06	
J	Sise, MJ; Sise, CB; Thorndike, JF; Kahl, JE; Calvo, RY; Shackford, SR				Sise, Michael J.; Sise, C. Beth; Thorndike, Jonathan F.; Kahl, Jessica E.; Calvo, Richard Y.; Shackford, Steven R.			Withdrawal of care: A 10-year perspective at a Level I trauma center	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	70th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery	SEP 14-17, 2011	Chicago, IL	Amer Assoc Surg Trauma		End-of-life care; futility; limitation of care; withdrawal of care; trauma center	OF-LIFE CARE; SUSTAINING TREATMENT; PALLIATIVE CARE; UNIT; DECISIONS; THERAPY; PATIENT; ICU; COMMUNICATION; SUPPORT	BACKGROUND: Withdrawal or limitation of care (WLC) in trauma patients has not been well studied. We reviewed 10 years of deaths at our adult Level I trauma center to identify the patients undergoing WLC and to describe the process of trauma surgeon-managed WLC. METHODS: This is a retrospective review of WLC. Each patient was assigned to one of three modes of WLC: care withdrawn, limited or no resuscitation, or organ harvest. Frequency, timing, and circumstances of WLC, including family involvement, ethics committee consultation, palliative care, and hospice, were reviewed. RESULTS: From 2000 through 2009, 375 patients died with WLC (54% of all deaths; 93% at >= 24 hours). For age >= 65 years, 80% were WLC. Overall, 15% had advance directive documents. Traumatic brain or high cervical spine injury was the cause of death in 63%. Factors associated with WLC included age, comorbidities, injury mechanism and severity, and nontrauma activation status. At time of death, 316 (84%) WLC were under trauma surgeon management. In this group, mode of WLC was care withdrawn in 74%, organ harvest in 20%, and limited or no resuscitation in 6%. Rationale for WLC in non-organ harvest patients was poor neurologic prognosis in 86% and futility in 76%. When family was identified, end-of-life discussions with physicians occurred in 100%. Conflicts over WLC occurred in 6.6% and were not associated with any demographic group. Ethics committee was involved in 2.8%. For care-withdrawn patients, median time to death from first WLC order was 6.6 hours. Palliative care and hospice consults (6% and 9%) increased yearly. CONCLUSIONS: WLC occurred in over 50% of all trauma deaths and exceeded 90% at >= 24 hours. Hospice and palliative care were increasingly important adjuncts to WLC. Guidelines for WLC should be developed to ensure quality end-of-life care for trauma patients in whom further care is futile. (J Trauma. 2012; 72: 1186-1193. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Sise, Michael J.; Sise, C. Beth; Thorndike, Jonathan F.; Kahl, Jessica E.; Calvo, Richard Y.; Shackford, Steven R.] Scripps Mercy Hosp, Trauma Serv, San Diego, CA 92103 USA		Sise, MJ (corresponding author), Scripps Mercy Hosp, Trauma Serv, 4077 5th Ave, San Diego, CA 92103 USA.	sise.mike@scrippshealth.org		Calvo, Richard/0000-0001-9147-2668			Abbott KH, 2001, CRIT CARE MED, V29, P197, DOI 10.1097/00003246-200101000-00040; Barnato AE, 2011, CRIT CARE MED, V39, P1663, DOI 10.1097/CCM.0b013e3182186e98; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Breen CM, 2001, J GEN INTERN MED, V16, P283, DOI 10.1046/j.1525-1497.2001.00419.x; Burns KJ, 2011, J TRAUMA NURS, V18, P97; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper Z, 2009, J TRAUMA, V66, P1327, DOI 10.1097/TA.0b013e31819ea047; Cronin M, 2006, 2 TRAUMA PROGRAM ART; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Dunn Geoffrey P, 2010, Bull Am Coll Surg, V95, P16; dunn gp, 2009, SURG PALLIATIVE CARE; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Gay EB, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.10.003; Hamel MB, 1999, ANN INTERN MED, V130, P116, DOI 10.7326/0003-4819-130-2-199901190-00005; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Kwak J, 2005, GERONTOLOGIST, V45, P634, DOI 10.1093/geront/45.5.634; Mack JW, 2010, ARCH INTERN MED, V170, P1533, DOI 10.1001/archinternmed.2010.322; Mosenthal AC, 2008, J TRAUMA, V64, P1587, DOI 10.1097/TA.0b013e318174f112; Muni S, 2011, CHEST, V139, P1025, DOI 10.1378/chest.10-3011; Nathens AB, 2008, J TRAUMA, V64, P81, DOI 10.1097/TA.0b013e31815dd4d7; Nelson JE, 2006, QUAL SAF HEALTH CARE, V15, P264, DOI 10.1136/qshc.2005.017707; Nelson JE, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.02.007; Nelson JE, 2010, CRIT CARE MED, V38, P1765, DOI 10.1097/CCM.0b013e3181e8ad23; OCALLAHAN JG, 1995, CRIT CARE MED, V23, P1567, DOI 10.1097/00003246-199509000-00018; Plaisier BR, 2002, AM SURGEON, V68, P159; Qaseem A, 2009, ANN INTERN MED, V150, P148; SHACKFORD SR, 1987, J TRAUMA, V27, P866, DOI 10.1097/00005373-198708000-00004; Trunkey DD, 2000, ARCH SURG-CHICAGO, V135, P34, DOI 10.1001/archsurg.135.1.34; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Watch LS, 2005, J TRAUMA, V59, P1320, DOI 10.1097/01.ta.0000196003.41799.41	31	22	22	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1186	1191		10.1097/TA.0b013e31824d0e57			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	944JD	WOS:000304195100015	22673244				2022-02-06	
J	Amyot, F; Zimmermann, T; Riley, J; Kainerstorfer, JM; Chernomordik, V; Mooshagian, E; Najafizadeh, L; Krueger, F; Gandjbakhche, AH; Wassermann, EM				Amyot, Franck; Zimmermann, Trelawny; Riley, Jason; Kainerstorfer, Jana M.; Chernomordik, Victor; Mooshagian, Eric; Najafizadeh, Laleh; Krueger, Frank; Gandjbakhche, Amir H.; Wassermann, Eric M.			Normative database of judgment of complexity task with functional near infrared spectroscopy-Application for TBI	NEUROIMAGE			English	Article						Near infrared spectroscopy; Frameless stereotaxy; Frontal cortex; Group study	TRAUMATIC BRAIN-INJURY; VIETNAM HEAD-INJURY; ACTIVATION; TECHNOLOGY; LOCATIONS	The ability to assess frontal lobe function in a rapid, objective, and standardized way, without the need for expertise in cognitive test administration might be particularly helpful in mild traumatic brain injury (TBI), where objective measures are needed. Functional near infrared spectroscopy (fNIRS) is a reliable technique to noninvasively measure local hemodynamic changes in brain areas near the head surface. In this paper, we are combining fNIRS and frameless stereotaxy which allowed us to co-register the functional images with previously acquired anatomical MRI volumes. In our experiment, the subjects were asked to perform a task, evaluating the complexity of daily life activities, previously shown with fMRI to activate areas of the anterior frontal cortex. We reconstructed averaged oxyhemoglobin and deoxyhemoglobin data from 20 healthy subjects in a spherical coordinate. The spherical coordinate is a natural representation of surface brain activation projection. Our results show surface activation projected from the medial frontopolar cortex which is consistent with previous fMRI results. With this original technique, we will construct a normative database for a simple cognitive test which can be useful in evaluating cognitive disability such as mild traumatic brain injury. Published by Elsevier Inc.	[Amyot, Franck; Riley, Jason; Kainerstorfer, Jana M.; Chernomordik, Victor; Najafizadeh, Laleh; Gandjbakhche, Amir H.] Eunice Kennedy Shriver NICHD, NIH, Program Pediat Imaging & Tissue Sci, Sect Analyt & Funct Biophoton, Bethesda, MD 20892 USA; [Amyot, Franck; Mooshagian, Eric; Najafizadeh, Laleh] Henry M Jackson Fdn, Rockville, MD 20852 USA; [Amyot, Franck; Zimmermann, Trelawny; Mooshagian, Eric; Wassermann, Eric M.] Natl Inst Neurol Disorders & Stroke, Behav Neurol Unit, NIH, Bethesda, MD USA; [Krueger, Frank] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA		Gandjbakhche, AH (corresponding author), Eunice Kennedy Shriver NICHD, NIH, Program Pediat Imaging & Tissue Sci, Sect Analyt & Funct Biophoton, Bethesda, MD 20892 USA.	amir@helix.nih.gov	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210; Mooshagian, Eric/0000-0001-5998-8445	Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [ZIAHD008882, ZIAHD000261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER	We thank Dr. Jordan Grafman for his valuable suggestions and comments on this project. We also acknowledge the funding of the intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Institute of Neurological Disorders and Stroke and Center for Neuroscience and Regenerative Medicine.	Ayaz Hasan, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P2671; Benaron DA, 2000, J CEREBR BLOOD F MET, V20, P469, DOI 10.1097/00004647-200003000-00005; Boas DA, 2004, OPT LETT, V29, P1506, DOI 10.1364/OL.29.001506; Boas DA, 2003, PHYS MED BIOL, V48, P2405, DOI 10.1088/0031-9155/48/15/311; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Dubroff JG, 2008, SEMIN NEUROL, V28, P548, DOI 10.1055/s-0028-1083698; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Fonov V, 2011, NEUROIMAGE, V54, P313, DOI 10.1016/j.neuroimage.2010.07.033; Hanna-Pladdy B, 2007, J Neurol Phys Ther, V31, P119; Hillary FG, 2002, J HEAD TRAUMA REHAB, V17, P411, DOI 10.1097/00001199-200210000-00004; Izzetoglu M, 2007, IEEE ENG MED BIOL, V26, P38, DOI 10.1109/MEMB.2007.384094; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Krueger F, 2009, NEUROREPORT, V20, P1093, DOI 10.1097/WNR.0b013e32832e7ea5; Laatsch Linda, 2007, Phys Med Rehabil Clin N Am, V18, P69, DOI 10.1016/j.pmr.2006.11.004; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Okamoto M, 2005, NEUROIMAGE, V26, P18, DOI 10.1016/j.neuroimage.2005.01.018; Okamoto M, 2004, NEUROIMAGE, V21, P99, DOI 10.1016/j.neuroimage.2003.08.026; Okamoto M, 2009, CLIN NEUROPHYSIOL, V120, P1320, DOI 10.1016/j.clinph.2009.01.023; Ptito A, 2007, NEUROREHABILITATION, V22, P217; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; SALAZAR AM, 1995, NEUROSURG CLIN N AM, V6, P715; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Sparing R, 2008, HUM BRAIN MAPP, V29, P82, DOI 10.1002/hbm.20360; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; Whalen C, 2008, HUM BRAIN MAPP, V29, P1288, DOI 10.1002/hbm.20465; Wishart Heather A, 2002, Curr Psychiatry Rep, V4, P338, DOI 10.1007/s11920-002-0081-y; Wylie GR, 2009, NEUROIMAGE, V47, P473, DOI 10.1016/j.neuroimage.2009.04.056	29	22	22	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	APR 2	2012	60	2					879	883		10.1016/j.neuroimage.2012.01.104			5	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	932ED	WOS:000303272300005	22306800	Green Accepted			2022-02-06	
J	Zhang, JY; Si, YL; Liao, J; Yan, GT; Deng, ZH; Xue, H; Wang, LH; Zhang, K				Zhang, Jin-Ying, Jr.; Si, Yi-Ling; Liao, Jie; Yan, Guang-Tao; Deng, Zi-Hui; Xue, Hui; Wang, Lu-Huan; Zhang, Kai			Leptin administration alleviates ischemic brain injury in mice by reducing oxidative stress and subsequent neuronal apoptosis	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Leptin; reperfusion injury; brain; oxidative stress; neuronal apoptosis	CEREBRAL-ISCHEMIA; REPERFUSION INJURY; RATS; PROTEIN; MECHANISMS	BACKGROUND: Recent research has indicates that leptin plays a protective role in traumatic brain injury. We studied the protective effect of leptin on cerebral ischemia/reperfusion injury by using mice transient focal cerebral ischemia/reperfusion injury model. METHODS: The distribution of I-125-leptin in the mouse brain was assessed by radioimmunoassay method. Mouse models of transient focal cerebral ischemia were established by occlusion of the right middle cerebral artery for two hours followed by 24 hours reperfusion. The neurologic deficits and infarct volume were determined using the Longa's score and 2,3,5-triphenyltetrazolium chloride staining, respectively. Regional cerebral blood flow was monitored by a laser-Doppler blood flowmeter. The levels of malondialdehyde, nitric oxide, nitric oxide synthase, and superoxide dismutase were detected according to respective assay kit. The histologic changes and neuronal apoptosis were observed with hematoxylin and eosin and transferase-mediated dUTP-biotin nick end labeling staining, respectively. The expression of B-cell lymphoma/lewkmia-2 (Bcl-2) and cysteineasparateprotease-3 (caspase-3) were investigated by Western blot and real-time polymerase chain reaction assay. RESULTS: Leptin decreased infarct volume and neurologic defects and improved regional cerebral blood flow and microvascular branch blood flow after injury. The malondialdehyde and nitric oxide levels were reduced, and superoxide dismutase level was increased after leptin treatment, which also minimized histologic changes and neuronal apoptosis, led to the upregulation of Bcl-2 and downregulation of caspase-3 expression after injury. CONCLUSIONS: Peripherally administered leptin crossed the blood-brain barrier and was distributed into multiple regions of the brain; in the brain, leptin directly alleviated the injury-evoked damages by reducing oxidative stress and neuronal apoptosis. (J Trauma. 2012;72:982-991. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Zhang, Jin-Ying, Jr.; Yan, Guang-Tao; Deng, Zi-Hui; Xue, Hui; Wang, Lu-Huan; Zhang, Kai] Chinese Gen Hosp PLA, Basic Med Inst, Biochem Res Lab, Beijing 100853, Peoples R China; [Si, Yi-Ling] Chinese Gen Hosp PLA, Basic Med Inst, Res Lab Mol Biol, Beijing 100853, Peoples R China; [Liao, Jie] Chinese Gen Hosp PLA, Basic Med Inst, Res Lab Med Expt & Test Ctr, Beijing 100853, Peoples R China		Zhang, JY (corresponding author), Chinese Gen Hosp PLA, Basic Med Inst, Biochem Res Lab, 28 Fuxing Rd, Beijing 100853, Peoples R China.	yan301@263.net			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30670821]	Supported by the National Natural Science Foundation of China (No. 30670821).	Avraham Y, 2010, CURR NEUROVASC RES, V7, P136, DOI 10.2174/156720210791184943; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Eguchi M, 2008, FEBS J, V275, P3136, DOI 10.1111/j.1742-4658.2008.06465.x; Erkasap N, 2003, PEPTIDES, V24, P1181, DOI 10.1016/j.peptides.2003.06.007; Fliedner S, 2006, ENDOCRINOLOGY, V147, P2088, DOI 10.1210/en.2005-1016; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li Q, 2009, J MOL NEUROSCI, V37, P67, DOI 10.1007/s12031-008-9121-3; Lin J, 2005, WORLD J GASTROENTERO, V11, P1000, DOI 10.3748/wjg.v11.i7.1000; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Maness LM, 1998, ENDOCRINOLOGY, V139, P4556, DOI 10.1210/en.139.11.4556; Martijn C, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-27; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Nakka VP, 2008, MOL NEUROBIOL, V37, P7, DOI 10.1007/s12035-007-8013-9; Signore AP, 2008, J NEUROCHEM, V106, P1977, DOI 10.1111/j.1471-4159.2008.05457.x; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Woitzik J, 2008, FRONT BIOSCI-LANDMRK, V13, P1500, DOI 10.2741/2776; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Yan GT, 2009, EUR J PHARMACOL, V616, P244, DOI 10.1016/j.ejphar.2009.06.039; Yanagida T, 2009, OXID MED CELL LONGEV, V2, P36, DOI 10.4161/oxim.2.1.7985; Zhang F, 2008, J NEUROCHEM, V107, P578, DOI 10.1111/j.1471-4159.2008.05645.x; Zhang F, 2007, STROKE, V38, P2329, DOI 10.1161/STROKEAHA.107.482786; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	24	22	23	1	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	2163-0755			J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2012	72	4					982	991		10.1097/TA.0b013e3182405459			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	925TO	WOS:000302784600041	22491615				2022-02-06	
J	Zhao, TF; Qi, YY; Li, Y; Xu, K				Zhao, Tengfei; Qi, Yiying; Li, Yan; Xu, Kan			PI3 Kinase regulation of neural regeneration and muscle hypertrophy after spinal cord injury	MOLECULAR BIOLOGY REPORTS			English	Article						PI3 Kinase pathway; Axon regeneration; Muscle atrophy; Spinal cord injury	TUBEROUS SCLEROSIS GENE; SKELETAL-MUSCLE; SIGNALING PATHWAY; CELL-GROWTH; AXON GROWTH; TRANSLATION INITIATION; MYOTUBE HYPERTROPHY; NEURONAL POLARITY; PROTEIN-SYNTHESIS; RAPAMYCIN TOR	Spinal cord injury (SCI) is a serious neurotrauma that can lead to life-long disability; to date, no suitable therapeutic strategy exists. Axons do not regenerate after SCI in adult mammals and loss of skeletal muscle mass occurs very rapidly after SCI. Promotion of neurite growth through improving the extracellular environment allows only a limited degree of axon regeneration. The phosphatidylinositol-3 kinase (PI3K)/Akt pathway and its downstream targets ("mammalian target of rapamycin," mTOR, and glycogen synthase kinase-3), which regulate cell growth and proliferation in many tissues, have been suggested to play an important role in regulation of the intrinsic axonal regeneration and muscle hypertrophy. This review is focused on recent progress in our understanding of the PI3K pathway in the modulation of axonal regeneration and muscle hypertrophy after SCI.	[Zhao, Tengfei; Qi, Yiying; Li, Yan; Xu, Kan] Zhejiang Univ, Dept Orthoped Surg, Affiliated Hosp 2, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China		Xu, K (corresponding author), Zhejiang Univ, Dept Orthoped Surg, Affiliated Hosp 2, Sch Med, Jiefang Rd 88, Hangzhou 310009, Zhejiang, Peoples R China.	xukanzju@gmail.com					Alabed YZ, 2010, J NEUROSCI, V30, P5635, DOI 10.1523/JNEUROSCI.6154-09.2010; Asante CO, 2010, J PAIN, V11, P1356, DOI 10.1016/j.jpain.2010.03.013; Bauman W A, 2000, Phys Med Rehabil Clin N Am, V11, P109; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BRENES G, 1986, ARCH PHYS MED REHAB, V67, P445; Chen W, 2010, AM J PHYSIOL-GASTR L, V299, pG293, DOI 10.1152/ajpgi.00005.2010; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cyranoski D, 2007, NATURE, V446, P476, DOI 10.1038/446476b; Dann SG, 2006, FEBS LETT, V580, P2821, DOI 10.1016/j.febslet.2006.04.068; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Dreyer HC, 2008, J APPL PHYSIOL, V104, P27, DOI 10.1152/japplphysiol.00736.2007; Dudley GA, 1999, EUR J APPL PHYSIOL O, V80, P394, DOI 10.1007/s004210050609; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Garshick E, 2005, SPINAL CORD, V43, P408, DOI 10.1038/sj.sc.3101729; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Goswami R, 1999, J NEUROSCI RES, V57, P884, DOI 10.1002/(SICI)1097-4547(19990915)57:6<884::AID-JNR14>3.3.CO;2-1; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Hu LY, 2010, NEUROSCIENCE, V169, P1046, DOI 10.1016/j.neuroscience.2010.05.046; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kimball SR, 2002, J APPL PHYSIOL, V93, P1168, DOI 10.1152/japplphysiol.00221.2002; KRAUS JF, 1983, J CHRON DIS, V36, P297, DOI 10.1016/0021-9681(83)90065-6; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lee SW, 2004, J AM SOC NEPHROL, V15, P1537, DOI 10.1097/01.ASN.0000127211.86206.E1; Leger B, 2006, FASEB J, V20, P583, DOI 10.1096/fj.05-5249fje; Leger B, 2009, MUSCLE NERVE, V40, P69, DOI 10.1002/mus.21293; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu M, 2008, SPINAL CORD, V46, P488, DOI 10.1038/sj.sc.3102169; Lohmeyer JA, 2008, LANGENBECK ARCH SURG, V393, P317, DOI 10.1007/s00423-008-0289-3; Lynch G S, 2001, Exerc Sport Sci Rev, V29, P141, DOI 10.1097/00003677-200110000-00002; Mao XB, 2011, MOL BIOL REP, V38, P3201, DOI 10.1007/s11033-010-9992-6; NELLIST M, 1993, CELL, V75, P1305; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Reiling JH, 2008, MOL CELL, V29, P533, DOI 10.1016/j.molcel.2008.02.011; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Welsh GI, 1997, FEBS LETT, V410, P418, DOI 10.1016/S0014-5793(97)00579-6; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	72	22	23	0	13	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0301-4851			MOL BIOL REP	Mol. Biol. Rep.	APR	2012	39	4					3541	3547		10.1007/s11033-011-1127-1			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	903HZ	WOS:000301108500020	21720761				2022-02-06	
J	Archambault, PM; Bilodeau, A; Gagnon, MP; Aubin, K; Lavoie, A; Lapointe, J; Poitras, J; Croteau, S; Pham-Dinh, M; Legare, F				Archambault, Patrick Michel; Bilodeau, Andrea; Gagnon, Marie-Pierre; Aubin, Karine; Lavoie, Andre; Lapointe, Jean; Poitras, Julien; Croteau, Sylvain; Pham-Dinh, Martin; Legare, France			Health Care Professionals' Beliefs About Using Wiki-Based Reminders to Promote Best Practices in Trauma Care	JOURNAL OF MEDICAL INTERNET RESEARCH			English	Article						Wiki; Collaborative writing applications; Web 2.0; traumatic brain injury; interprofessional collaboration; reminders; computerized clinical decision-support system; knowledge translation; evidence-based medicine; theory of planned behavior	CLINICAL DECISION-SUPPORT; BRAIN-INJURY GUIDELINES; INFORMATION-TECHNOLOGY; PATIENT OUTCOMES; PLANNED BEHAVIOR; AUDIT FILTERS; RESOURCE UTILIZATION; LONGITUDINAL-FIELD; AMERICAN-COLLEGE; USER ACCEPTANCE	Background : Wikis are knowledge translation tools that could help health professionals implement best practices in acute care. Little is known about the factors influencing professionals' use of wikis. Objectives : To identify and compare the beliefs of emergency physicians (EPs) and allied health professionals (AHPs) about using a wiki-based reminder that promotes evidence-based care for traumatic brain injuries. Methods : Drawing on the theory of planned behavior, we conducted semistructured interviews to elicit EPs' and AHPs' beliefs about using a wiki-based reminder. Previous studies suggested a sample of 25 EPs and 25 AHPs. We purposefully selected participants from three trauma centers in Quebec, Canada, to obtain a representative sample. Using univariate analyses, we assessed whether our participants' gender, age, and level of experience were similar to those of all eligible individuals. Participants viewed a video showing a clinician using a wiki-based reminder, and we interviewed participants about their behavioral, control, and normative beliefs-that is, what they saw as advantages, disadvantages, barriers, and facilitators to their use of a reminder, and how they felt important referents would perceive their use of a reminder. Two reviewers independently analyzed the content of the interview transcripts. We considered the 75% most frequently mentioned beliefs as salient. We retained some less frequently mentioned beliefs as well. Results : Of 66 eligible EPs and 444 eligible AHPs, we invited 55 EPs and 39 AHPs to participate, and 25 EPs and 25 AHPs (15 nurses, 7 respiratory therapists, and 3 pharmacists) accepted. Participating AHPs had more experience than eligible AHPs (mean 14 vs 11 years; P =.04). We noted no other significant differences. Among EPs, the most frequently reported advantage of using a wiki-based reminder was that it refreshes the memory (n = 14); among AHPs, it was that it provides rapid access to protocols (n = 16). Only 2 EPs mentioned a disadvantage (the wiki added stress). The most frequently reported favorable referent was nurses for EPs (n = 16) and EPs for AHPs (n = 19). The most frequently reported unfavorable referents were people resistant to standardized care for EPs (n = 8) and people less comfortable with computers for AHPs (n = 11). The most frequent facilitator for EPs was ease of use (n = 19); for AHPs, it was having a bedside computer (n = 20). EPs' most frequently reported barrier was irregularly updated wiki-based reminders (n = 18); AHPs'was undetermined legal responsibility (n = 10). Conclusions : We identified EPs' and AHPs' salient beliefs about using a wiki-based reminder. We will draw on these beliefs to construct a questionnaire to measure the importance of these determinants to EPs' and AHPs' intention to use a wiki-based reminder promoting evidence-based care for traumatic brain injuries.	[Archambault, Patrick Michel; Bilodeau, Andrea; Aubin, Karine; Lapointe, Jean; Poitras, Julien] Ctr Hosp Affilie Univ Levis, Ctr Sante & Serv Sociaux Alphonse Desjardins, Levis, PQ G6V 3Z1, Canada; [Archambault, Patrick Michel; Poitras, Julien; Legare, France] Univ Laval, Fac Med, Dept Med Familiale & Med Urgence, Quebec City, PQ G1K 7P4, Canada; [Archambault, Patrick Michel; Lavoie, Andre; Poitras, Julien] CHA Univ Quebec, Ctr Rech FRQS, Quebec City, PQ, Canada; [Archambault, Patrick Michel; Gagnon, Marie-Pierre; Legare, France] Ctr Hosp Univ Quebec CRCHUQ, Ctr Rech, Quebec City, PQ, Canada; [Bilodeau, Andrea; Gagnon, Marie-Pierre; Aubin, Karine] Univ Laval, Fac Sci Infirmieres, Quebec City, PQ, Canada; [Lapointe, Jean] Inst Natl Excellence Sante & Serv Sociaux, Montreal, PQ, Canada; [Croteau, Sylvain; Pham-Dinh, Martin] Hop Gatineau, Gatineau, PQ, Canada		Archambault, PM (corresponding author), Ctr Hosp Affilie Univ Levis, Ctr Sante & Serv Sociaux Alphonse Desjardins, 143 Rue Wolfe, Levis, PQ G6V 3Z1, Canada.	patrick.m.archambault@gmail.com	Gagnon, Marie-Pierre/I-3013-2019	Gagnon, Marie-Pierre/0000-0002-0782-5457	CADRE [PDA 1850]; Canadian Health Services Research Foundation; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); KT Canada; Departement de medecine familiale et medecine d'urgence at Universite Laval; CSSS Alphonse-Desjardins (CHAU de Levis)	Funding for this project was provided by a CADRE program (reference number: PDA 1850) (supported by a partnership between the Canadian Health Services Research Foundation and the Canadian Institutes of Health Research). KT Canada, the Departement de medecine familiale et medecine d'urgence at Universite Laval and CSSS Alphonse-Desjardins (CHAU de Levis) also contributed funding. The funding agencies and organizations did not influence the content of the manuscript. France Legare holds the Canada Research Chair in Implementation of Shared Decision Making in Primary Care and is a member of KT Canada. Marie-Pierre Gagnon holds the Tier 2 Canada Research Chair in Technologies and Practices in Health and is a KT Canada member. We thank Jennifer Petrela for editing the manuscript, Yves Lessard for drawing the cartoons for the video, Alain Audet for filming the video, and Amelie Bourassa for sharing parts of a video she produced. We also thank Lee LeFever and Common Craft for permitting us to adapt the original Wikis in Plain English video for our study. We thank all the actors in the video: Isabelle Bertrand, Marie-Maude Couture, Renee Turgeon, Amelie Bourassa, Mathieu Simon, Robert Doucet, and Andre Villeneuve. We also thank Jean-Francois Rancourt, Luc Genier, Marcel Emond, Alexis Turgeon, Natalie Lesage, Manon Vallieres, Caroline Boutin, and Cynthia Fournier for their help in organizing this project. We are also very grateful to all the emergency physicians, nurses, respiratory therapists, and pharmacists who volunteered to answer our survey.	Agha Riaz, 2006, Int J Surg, V4, P140, DOI 10.1016/j.ijsu.2006.07.002; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I., 1988, ATTITUDES PERSONALIT; Alch ML, 2000, FUTURIST, V34, P42; Ammenwerth Elske, 2006, BMC Med Inform Decis Mak, V6, P3, DOI 10.1186/1472-6947-6-3; [Anonymous], 1996, PREDICTING HLTH BEHA; [Anonymous], 2005, QUICKCALCS ONLINE CA; Archambault PM, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-45; Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Barwick MA, 2009, J CAN ACAD CHILD ADO, V18, P16; Berner E.S, 2009, CLIN DECISION SUPPOR; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Boulos Maged N Kamel, 2006, BMC Med Educ, V6, P41, DOI 10.1186/1472-6920-6-41; BUNTINX F, 1993, FAM PRACT, V10, P219, DOI 10.1093/fampra/10.2.219; COPES WS, 1995, J TRAUMA, V38, P432, DOI 10.1097/00005373-199503000-00027; Cresswell KM, 2011, BMJ QUAL SAF, V20, P625, DOI 10.1136/bmjqs.2010.048934; Croskerry P, 2011, J ROY COLL PHYS EDIN, V41, P155, DOI 10.4997/JRCPE.2011.208; Cryer HG, 1996, J TRAUMA, V41, P389, DOI 10.1097/00005373-199609000-00003; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Deshpande Amol, 2009, Open Med, V3, pe69; Dijkstra R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-53; Eichner J. S., 2010, CHALLENGES BARRIERS; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Eysenbach G, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1030; Faber MJ, 2011, MED 2 0 SEP 17 18 20; Francis J., 2004, CONSTRUCTING QUESTIO; Gagnon Marie-Pierre, 2007, Inform Prim Care, V15, P83; Gagnon MP, 2012, J MED SYST, V36, P241, DOI 10.1007/s10916-010-9473-4; Gagnon MP, 2003, INT J MED INFORM, V71, P103, DOI 10.1016/S1386-5056(03)00094-7; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; GODIN G, 1992, MED CARE, V30, P199, DOI 10.1097/00005650-199203000-00002; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Graham ID, 2007, ACAD EMERG MED, V14, P936, DOI 10.1197/j.aem.2007.07.004; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Gupta S, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1833; HARTWICK J, 1994, MANAGE SCI, V40, P440, DOI 10.1287/mnsc.40.4.440; Heilman JM, 2011, J MED INTERNET RES, V13, P153, DOI 10.2196/jmir.1589; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hoffmann R, 2008, NAT GENET, V40, P1047, DOI 10.1038/ng.f.217; Hughes B, 2009, INT J MED INFORM, V78, P645, DOI 10.1016/j.ijmedinf.2009.04.008; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; JOHNSTON ME, 1994, ANN INTERN MED, V120, P135, DOI 10.7326/0003-4819-120-2-199401150-00007; Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Lapointe L, 2006, CAN MED ASSOC J, V174, P1573, DOI 10.1503/cmaj.050281; LeFever L, WIKIS PLAIN ENGLISH; Liabsuetrakul T, 2003, SOC SCI MED, V57, P1665, DOI 10.1016/S0277-9536(02)00550-6; Lupianez-Villanueva F, 2009, INFORM HEALTH SOC CA, V34, P117, DOI 10.1080/17538150903102265; MANDELBLATT J, 1995, J FAM PRACTICE, V40, P162; Masters K, 2008, INT J MED INFORM, V77, P4, DOI 10.1016/j.ijmedinf.2006.10.002; Mavergames C, 2009, WEB 2 0 COCHRANE COL; McDermott FT, 2001, BRIT J SURG, V88, P1099, DOI 10.1046/j.0007-1323.2001.01835.x; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; Mcgowan B, 2011, MED 2 0 SEP 17 18 20; Millstein SG, 1996, HEALTH PSYCHOL, V15, P398, DOI 10.1037/0278-6133.15.5.398; Morris MG, 2000, PERS PSYCHOL, V53, P375, DOI 10.1111/j.1744-6570.2000.tb00206.x; NAYDUCH D, 1994, J TRAUMA, V37, P565, DOI 10.1097/00005373-199410000-00008; O'Keefe GE, 1999, J TRAUMA, V46, P473, DOI 10.1097/00005373-199903000-00023; Overhage JM, 1997, J AM MED INFORM ASSN, V4, P364, DOI 10.1136/jamia.1997.0040364; Ovretveit J, 2007, INT J QUAL HEALTH C, V19, P259, DOI 10.1093/intqhc/mzm031; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Park ER, 2003, ANN BEHAV MED, V25, P120, DOI 10.1207/S15324796ABM2502_08; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Renold E., 2002, BUILD RES CAPACITY, V3, P3; RHODES M, 1990, J TRAUMA, V30, P724, DOI 10.1097/00005373-199006000-00012; Rogers EM., 2003, DIFFUSION INNOVATION, V5; Rutter D., 2002, CHANGING HLTH BEHAV, P1; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Sandars J, 2007, POSTGRAD MED J, V83, P759, DOI 10.1136/pgmj.2007.063123; Shojania KG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001096.pub2; Sittig DF, 2008, J BIOMED INFORM, V41, P387, DOI 10.1016/j.jbi.2007.09.003; Sittig Dean F, 2006, BMC Med Inform Decis Mak, V6, P6, DOI 10.1186/1472-6947-6-6; Sittig DF, 2010, INT J MED INFORM, V79, P44, DOI 10.1016/j.ijmedinf.2009.09.003; TAYLOR S, 1995, INFORM SYST RES, V6, P144, DOI 10.1287/isre.6.2.144; Teich JM, 2000, ARCH INTERN MED, V160, P2741, DOI 10.1001/archinte.160.18.2741; THOMPSON RL, 1991, MIS QUART, V15, P125, DOI 10.2307/249443; Tierney WM, 2003, J GEN INTERN MED, V18, P967, DOI 10.1111/j.1525-1497.2003.30635.x; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 2003, MIS QUART, V27, P425, DOI 10.2307/30036540; Venkatesh V, 2000, ORGAN BEHAV HUM DEC, V83, P33, DOI 10.1006/obhd.2000.2896; Verhoeven F, 2009, INT J MED INFORM, V78, P663, DOI 10.1016/j.ijmedinf.2009.06.001; Walker AE, 2001, BRIT J HEALTH PSYCH, V6, P347, DOI 10.1348/135910701169250; WARSHAW PR, 1980, J MARKETING RES, V17, P153, DOI 10.2307/3150927; Webb TL, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1376; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625; Wensing M, 1994, Int J Qual Health Care, V6, P115; Wright A, 2009, J BIOMED INFORM, V42, P334, DOI 10.1016/j.jbi.2008.09.003; Yusof MM, 2008, INT J MED INFORM, V77, P386, DOI 10.1016/j.ijmedinf.2007.08.011	90	22	22	0	29	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1438-8871			J MED INTERNET RES	J. Med. Internet Res.	MAR-APR	2012	14	2							e49	10.2196/jmir.1983			22	Health Care Sciences & Services; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Medical Informatics	948VL	WOS:000304530800022	22515985	gold, Green Published			2022-02-06	
J	Hyde, P; Mackenzie, R; Ng, G; Reid, C; Pearson, G				Hyde, Philip; Mackenzie, Rod; Ng, Gail; Reid, Cliff; Pearson, Gale			Availability and utilisation of physician-based pre-hospital critical care support to the NHS ambulance service in England, Wales and Northern Ireland	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC BRAIN-INJURY; ADVANCED LIFE-SUPPORT; HEAD-INJURY; MORTALITY; SURVIVAL; IMPACT; TEAM	Background Every day throughout the UK, ambulance services seek medical assistance in providing critically ill or injured patients with pre-hospital care. Objective To identify the current availability and utilisation of physician-based pre-hospital critical care capability across England, Wales and Northern Ireland. Design A postal and telephone survey was undertaken between April and December 2009 of all 13 regional NHS ambulance services, 17 air ambulance charities, 34 organisations affiliated to the British Association for Immediate Care and 215 type 1 emergency departments in England, Wales and Northern Ireland. The survey focused on the availability and use of physician-based pre-hospital critical care support. Results The response rate was 100%. Although nine NHS ambulance services recorded physician attendance at 6155 incidents, few could quantify doctor availability and utilisation. All but one of the British Association for Immediate Care organisations deployed 'only when available' and only 45% of active doctors could provide critical care support. Eleven air ambulance services (65%) operated with a doctor but only 5 (29%) operated 7 days a week. Fifty-nine EDs (27%) had a pre-hospital team but only 5 (2%) had 24 h deployable critical care capability and none were used regularly. Conclusion There is wide geographical and diurnal variability in availability and utilisation of physician-based pre-hospital critical care support. Only London ambulance service has access to NHS-commissioned 24 h physician-based pre-hospital critical care support. Throughout the rest of the UK, extensive use is made of volunteer doctors and charity sector providers of varying availability and capability.	[Hyde, Philip] Southampton Gen Hosp, Paediat Intens Care Unit, Southampton SO16 6YD, Hants, England; [Mackenzie, Rod] Univ Leicester, Leicester, Leics, England; [Ng, Gail] Leicester Royal Infirm, Emergency Dept, Leicester, Leics, England; [Reid, Cliff] Ambulance Serv New S Wales, Helicopter Retrieval Serv, Sydney, NSW, Australia; [Pearson, Gale] Birmingham Childrens Hosp, Paediat Intens Care Unit, Birmingham, England		Hyde, P (corresponding author), Southampton Gen Hosp, Paediat Intens Care Unit, Tremona Rd, Southampton SO16 6YD, Hants, England.	prhyde@doctors.org.uk		Reid, Clifford/0000-0002-1152-8551			[Anonymous], 2010, NHS CLIN ADV GROUPS; *ASS AN GREAT BRIT, 2009, AAGBI SAF GUID PREH; BAXT WG, 1987, JAMA-J AM MED ASSOC, V257, P3246, DOI 10.1001/jama.257.23.3246; BAXT WG, 1987, J TRAUMA, V27, P365, DOI 10.1097/00005373-198704000-00004; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Botker MT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-12; Department of Health, 2009, NAT HLTH SERV CONST; Department of Health, 2009, NHS EM PLANN GUID PL; Department of Health, 2000, COMPR CRIT CAR REV A; Findlay G, 2007, TRAUMA WHO CARES REP; Garner A, 2001, INJURY, V32, P455, DOI 10.1016/S0020-1383(01)00013-4; Hyde P, 2009, PAEDIAT CHILD HLTH, V19, P487; Intercollegiate Group of Trauma Standards, 2009, REG TRAUM SYST INT G; Klemen P, 2006, ACTA ANAESTH SCAND, V50, P1250, DOI 10.1111/J.1399-6576.2006.01039.X; Lossius HM, 2002, ACTA ANAESTH SCAND, V46, P771, DOI 10.1034/j.1399-6576.2002.460703.x; Mackenzie R, 2009, EMERG MED J, V26, P365, DOI 10.1136/emj.2008.062588; National Audit Office, 2010, MAJ TRAUM CAR ENGL; Nicholl J, 2003, REV COSTS BENEFITS H; Oppe S, 2001, ACCIDENT ANAL PREV, V33, P129, DOI 10.1016/S0001-4575(00)00023-3; Osterwalder JJ, 2003, J TRAUMA, V55, P355, DOI 10.1097/01.TA.0000034231.94460.1F; Royal College of Surgeons of England and the British Orthopaedic Society, 2000, BETT CAR SEV INJ; Secretary of State for Health, 2008, HIGH QUAL CAR ALL NH; WILDEN JN, 1993, LANCET, V342, P1378, DOI 10.1016/0140-6736(93)92750-N	23	22	22	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	MAR	2012	29	3					177	181		10.1136/emj.2010.106963			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	897GV	WOS:000300637000003	21427108	Green Published, Green Submitted, hybrid			2022-02-06	
J	Turner-Stokes, L; Sutch, S; Dredge, R; Eagar, K				Turner-Stokes, Lynne; Sutch, Stephen; Dredge, Robert; Eagar, Kathy			International casemix and funding models: lessons for rehabilitation	CLINICAL REHABILITATION			English	Article							PROSPECTIVE-PAYMENT SYSTEM; TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; MEDICAL REHABILITATION; CARE; CHALLENGES; DISABILITY; EFFICIENCY; SERVICES	Background: Payment for treatment in healthcare systems around the world is increasingly based on fixed tariff models to drive up efficiency and contain costs. Casemix classifications, however, must account adequately for the resource implications of varying case complexity. Rehabilitation poses some particular challenges for casemix development. Objective: The objectives of this educational narrative review are (a) to provide an overview of the development of casemix in rehabilitation, (b) to describe key characteristics of some well-established casemix and payment models in operation around the world and (c) to explore opportunities for future development arising from the lessons learned. Results: Diagnosis alone does not adequately describe cost variation in rehabilitation. Functional dependency is considered a better cost indicator, and casemix classifications for inpatient rehabilitation in the United States and Australia rely on the Functional Independence Measure (FIM). Fixed episode-based prospective payment systems are shown to contain costs, but at the expense of poorer functional outcomes. More sophisticated models incorporating a mixture of episode and weighted per diem rates may offer greater flexibility to optimize outcome, while still providing incentive for throughput. Conclusion: The development of casemix in rehabilitation poses similar challenges for healthcare systems all around the world. Well-established casemix systems in the United States and Australia have afforded valuable lessons for other countries to learn from, but have not provided all the answers. A range of casemix and payment models is required to cater for different healthcare cultures, and casemix tools must capture all the key cost-determinants of treatment for patients with complex needs.	[Turner-Stokes, Lynne] Kings Coll London, Sch Med, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Harrow HA1 3UJ, Middx, England; [Sutch, Stephen] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Dredge, Robert] Keele Univ, Sch Publ Policy, Keele ST5 5BG, Staffs, England; [Eagar, Kathy] Univ Wollongong, Ctr Hlth Serv Dev, Wollongong, NSW, Australia		Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Watford Rd, Harrow HA1 3UJ, Middx, England.	lynne.turner-stokes@dial.pipex.com	Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462; Eagar, Kathy/0000-0001-5802-8995; Sutch, Stephen/0000-0003-3202-6718	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding schemeNational Institute for Health Research (NIHR) [RP-PG-0407-10185]; Dunhill Medical TrustDunhill Medical Trust; Luff Foundation; National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0407-10185] Funding Source: researchfish	This article presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10185). The views expressed in this article are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Financial support for the preparation of this manuscript was also provided by the Dunhill Medical Trust, the Luff Foundation.	[Anonymous], 2009, NAT DEF SET SPEC SER; Arling G, 2007, HEALTH SERV RES, V42, P827, DOI 10.1111/j.1475-6773.2006.00627.x; BATAVIA AI, 1988, ARCH PHYS MED REHAB, V69, P377; Bjorkgren MA, 1999, SCAND J PUBLIC HEALT, V27, P228, DOI 10.1177/14034948990270030201; Boyle S., 2005, EURO OBSERVER, V7, P1; Braddom RL, 2005, ARCH PHYS MED REHAB, V86, P1287, DOI 10.1016/j.apmr.2005.01.004; CARPENTER GI, 1995, AGE AGEING, V24, P5, DOI 10.1093/ageing/24.1.5; *DEP HLTH, 2007, OPT FUT PAYM RES 200; Department of Health, 2002, REF NHS FIN FLOWS IN; DISLER PB, 1993, ARCH PHYS MED REHAB, V74, P139; Duckett SJ, 1998, MED J AUSTRALIA, V169, pS17, DOI 10.5694/j.1326-5377.1998.tb123470.x; Eagar K, 1999, Aust Health Rev, V22, P180; Eagar K, 1997, Aust Health Rev, V20, P26; Evans R L, 1990, Int J Rehabil Res, V13, P27, DOI 10.1097/00004356-199003000-00003; Fetter RB, 1991, DRGS THEIR DESIGN DE; FRIES BE, 1994, MED CARE, V32, P668, DOI 10.1097/00005650-199407000-00002; Green J, 2007, AUST HEALTH REV, V31, pS68; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; Hirdes J P, 1996, Healthc Manage Forum, V9, P40; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; Information Standards Board for Health and Social Care, 2008, HEALTHC RES GROUP 4, V4; Lee LA, 1998, MED J AUSTRALIA, V169, P19; Nyein K, 2007, J HEAD TRAUMA REHAB, V22, P239, DOI 10.1097/01.HTR.0000281840.85096.1f; Office of Population, 2006, CENS SURV CLASS SURG; Royal College of Physicians, 1986, PHYS DIS 1986; Saitto C, 2005, MED CARE, V43, P844, DOI 10.1097/01.mlr.0000173567.80190.32; Saitto C, 2005, MED CARE, V43, P856, DOI 10.1097/01.mlr.0000173568.67805.70; Schreyogg J, 2005, Eur J Health Econ, VSuppl, P2; Stineman MG, 2005, MED CARE, V43, P841, DOI 10.1097/01.mlr.0000178392.96014.cf; Stineman MG, 1997, HEALTH SERV RES, V32, P529; Sutherland JM, 2008, HEALTH POLICY, V85, P336, DOI 10.1016/j.healthpol.2007.09.006; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2010, CLIN REHABI IN PRESS; Turner-Stokes L, 2007, CLIN MED, V7, P593, DOI 10.7861/clinmedicine.7-6-593; Turner-Stokes L, 2007, BRAIN INJURY, V21, P1015, DOI 10.1080/02699050701591445; Turner-Stokes L, 2010, J NEUROL NEUROSUR PS, V81, P146, DOI 10.1136/jnnp.2009.173716; VLADECK BC, 1988, ANNU REV PUBL HEALTH, V9, P333, DOI 10.1146/annurev.pu.09.050188.002001; Webster F, 1996, Aust Health Rev, V19, P81; Wikipedia, CAS MIX; World Health Organization, 2016, INT STAT CLASS DIS R; Zorowitz RD, 2009, EUR J PHYS REHAB MED, V45, P259	44	22	22	3	12	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAR	2012	26	3					195	208		10.1177/0269215511417468			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	260GN	WOS:000327583100002	22070989				2022-02-06	
J	Vranova, HP; Mares, J; Hlustik, P; Nevrly, M; Stejskal, D; Zapletalova, J; Obereigneru, R; Kanovsky, P				Vranova, Hana Prikrylova; Mares, Jan; Hlustik, Petr; Nevrly, Martin; Stejskal, David; Zapletalova, Jana; Obereigneru, Radko; Kanovsky, Petr			Tau protein and beta-amyloid(1-42) CSF levels in different phenotypes of Parkinson's disease	JOURNAL OF NEURAL TRANSMISSION			English	Article						Parkinson's disease subgroups; Tau protein; Beta-amyloid(1-42); Index tau/beta; CSF	MILD-COGNITIVE-IMPAIRMENT; TRAUMATIC BRAIN-INJURY; DATA-DRIVEN APPROACH; CEREBROSPINAL-FLUID; ALZHEIMER-DISEASE; ALPHA-SYNUCLEIN; AMYLOID-BETA; LEWY BODIES; MOTOR SUBTYPE; DEMENTIA	Parkinson's disease (PD) is a neurodegenerative disorder with highly heterogeneous clinical manifestations. This fact has prompted many attempts to divide PD patients into clinical subgroups. This could lead to a better recognition of pathogenesis, improving targeted treatment and the prognosis of PD patients. The aim of the present study was to obtain cerebrospinal fluid (CSF) samples in PD patients and to search for a relationship between neurodegenerative CSF markers (tau protein, beta-amyloid(1-42) and index tau protein/beta-amyloid(1-42)) and the clinical subtypes. PD patients were divided into three subgroups: early disease onset (EDO), tremor-dominant PD (TD-PD), and non-tremor dominant PD (NT-PD) according to the previously published classification. Neurodegenerative markers in the CSF were assessed in these three groups of patients suffering from PD (EDO-17, TD-15, NT-16 patients) and in a control group (CG) of 19 patients suffering from non-degenerative neurological diseases and 18 patients with Alzheimer's disease (AD). The NT-PD patients were found to have significantly higher levels of CSF tau protein and index tau/beta than the control subjects and other Parkinsonian subgroups, but no significant differences in these markers were found between AD and NT-PD patients. In the context of more rapid clinical progression and more pronounced neuropathological changes in the NT-PD patient group, our results corroborate the opinion that CSF level of tau protein may be regarded as a potential laboratory marker of the presence and severity of neurodegeneration.	[Vranova, Hana Prikrylova; Mares, Jan; Hlustik, Petr; Nevrly, Martin; Kanovsky, Petr] Palacky Univ, Univ Hosp Olomouc, Fac Med & Dent, Dept Neurol, Olomouc 77520, Czech Republic; [Stejskal, David] Palacky Univ, Univ Hosp Olomouc, Fac Med & Dent, Dept Biochem, Olomouc 77520, Czech Republic; [Zapletalova, Jana] Palacky Univ, Fac Med & Dent, Dept Med Biophys, Olomouc 77520, Czech Republic; [Obereigneru, Radko] Palacky Univ, Dept Psychol, Philosoph Fac, Olomouc 77520, Czech Republic		Vranova, HP (corresponding author), Palacky Univ, Univ Hosp Olomouc, Fac Med & Dent, Dept Neurol, IP Pavlova 6, Olomouc 77520, Czech Republic.	vranovaha@seznam.cz	Hlustik, Petr/AAN-7342-2021; Stejskal, David/AAN-6236-2021; Stejskal, David/D-6125-2018; Hlustik, Petr/B-9411-2008; OBEREIGNERu, Radko/Q-5239-2016	Hlustik, Petr/0000-0002-1951-0671; Stejskal, David/0000-0003-1204-0395; Stejskal, David/0000-0003-1204-0395; Mares, Jan/0000-0003-4760-9123	 [IGA MHCZ NT1222-5/2010]	The study was supported by grant IGA MHCZ NT1222-5/2010.	Alves G, 2010, J NEUROL NEUROSUR PS, V81, P1080, DOI 10.1136/jnnp.2009.199950; Arima K, 1999, BRAIN RES, V843, P53, DOI 10.1016/S0006-8993(99)01848-X; Bibl M, 2006, BRAIN, V129, P1177, DOI 10.1093/brain/awl063; Blennow K, 2004, NEUROLOGY, V62, P159, DOI 10.1212/WNL.62.1.159; Burn DJ, 2006, J NEUROL NEUROSUR PS, V77, P585, DOI 10.1136/jnnp.2005.081711; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Compta Y, 2009, MOVEMENT DISORD, V24, P2203, DOI 10.1002/mds.22594; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; GOEL V, 1995, NEUROPSYCHOLOGIA, V33, P623, DOI 10.1016/0028-3932(95)90866-P; Graham JM, 1999, MOVEMENT DISORD, V14, P10; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hu WT, 2010, ACTA NEUROPATHOL, V120, P385, DOI 10.1007/s00401-010-0723-9; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jellinger KA, 2002, J NEURAL TRANSM, V109, P329, DOI 10.1007/s007020200027; Jellinger KA, 2008, NEURODEGENER DIS, V5, P118, DOI 10.1159/000113679; Jellinger KA, 2009, BBA-MOL BASIS DIS, V1792, P730, DOI 10.1016/j.bbadis.2008.07.006; Lashley T, 2008, ACTA NEUROPATHOL, V115, P417, DOI 10.1007/s00401-007-0336-0; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Lyros E, 2008, EUR J NEUROL, V15, P262, DOI 10.1111/j.1468-1331.2007.02046.x; Mattila PM, 1998, ACTA NEUROPATHOL, V96, P417, DOI 10.1007/s004010050913; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Mollenhauer B, 2006, DEMENT GERIATR COGN, V22, P200, DOI 10.1159/000094871; Obereigneru R, 2010, EUR J NEUROL, V17, P482; Okonkwo OC, 2010, ARCH NEUROL-CHICAGO, V67, P688, DOI 10.1001/archneurol.2010.118; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Pan S, 2007, MOL CELL PROTEOMICS, V6, P1818, DOI 10.1074/mcp.M700158-MCP200; PAULUS W, 1991, J NEUROPATH EXP NEUR, V50, P743, DOI 10.1097/00005072-199111000-00006; Qureshi HY, 2011, J BIOL CHEM, V286, P5055, DOI 10.1074/jbc.M110.178905; Rajput A, 2006, NEUROLOGY, V67, P1506, DOI 10.1212/01.wnl.0000240220.33950.0c; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Siderowf A, 2010, NEUROLOGY, V75, P1055, DOI 10.1212/WNL.0b013e3181f39a78; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stejskal David, 2005, Biomedical Papers (Olomouc), V149, P265; Sunderland T, 2003, JAMA-J AM MED ASSOC, V289, P2094, DOI 10.1001/jama.289.16.2094; van Rooden SM, 2011, MOVEMENT DISORD, V26, P51, DOI 10.1002/mds.23346; van Rooden SM, 2010, MOVEMENT DISORD, V25, P969, DOI 10.1002/mds.23116; Vranova HP, 2010, J NEURAL TRANSM, V117, P1177, DOI 10.1007/s00702-010-0462-z; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; Williams DR, 2009, INTERN MED J, V39, P7, DOI 10.1111/j.1445-5994.2008.01635.x; Yao CP, 2008, BRAIN INJURY, V22, P723, DOI 10.1080/02699050802304706	45	22	23	1	18	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564			J NEURAL TRANSM	J. Neural Transm.	MAR	2012	119	3					353	362		10.1007/s00702-011-0708-4			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	896RM	WOS:000300587900007	21892760				2022-02-06	
J	Zhang, MY; Shan, HY; Gu, ZY; Wang, DL; Wang, T; Wang, ZW; Tao, LY				Zhang, Mingyang; Shan, Haiyan; Gu, Zhenyong; Wang, Donglin; Wang, Tao; Wang, Zhiwei; Tao, Luyang			Increased Expression of Calcium/Calmodulin-Dependent Protein Kinase Type II Subunit Delta after Rat Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Calcium/calmodulin-dependent protein kinase type II subunit delta; Traumatic brain injury; Apoptosis; Rat	IN-VIVO; NEUROTROPHIC FACTOR; ISOFORM REGULATION; MESSENGER-RNAS; HEART-FAILURE; CELL-DEATH; ACTIVATION; APOPTOSIS; DIFFERENTIATION; HYPERTROPHY	Many cellular responses to Ca2+ signals are mediated by Ca2+/calmodulin-dependent enzymes, among which is the Ca2+/calmodulin-dependent protein kinase II (CaMKII). CaMKII was originally described in rat brain tissue. In rat brain, four different subunits of the kinase have been identified: alpha, beta, gamma, and delta. This study aims to investigate changes of CaMKII delta after traumatic brain injury and its possible role. Rat traumatic brain injury (TBI) model was established by controlled cortical injury system. In the present study, we mainly investigated the expression and cellular localization of CaMKII delta after traumatic brain injury. Western blot analysis revealed that CaMKII delta was present in normal rat brain cortex. It gradually increased, reached a peak at the third day after TBI, and then decreased. Importantly, more CaMKII delta was colocalized with neuron. In addition, Western blot detection showed that the third day postinjury was also the apoptosis peak indicated by the elevated expression of caspase-3.Importantly, immunohistochemistry analysis revealed that injury-induced expression of CaMKII delta was colabeled by caspase-3 (apoptosis cells marker). Moreover, pretreatment with the CaMKII inhibitor (KN62) reduced the injury-induced activation of caspase-3. Noticeably, the CaMKII inhibitor KN-62 could reduce TBI-induced cell injury assessed with lesion volume and attenuate behavioral outcome evaluated by motor test. These data suggested that CaMKII delta may be implicated in the apoptosis of neuron and the recovery of neurological outcomes. However, the inherent mechanisms remained unknown. Further studies are needed to confirm the exact role of CaMKII delta after brain injury.	[Zhang, Mingyang; Wang, Tao; Tao, Luyang] Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China; [Zhang, Mingyang; Gu, Zhenyong; Wang, Donglin] Nantong Univ, Coll Med, Dept Forens Sci, Nantong 226001, Jiangsu, Peoples R China; [Shan, Haiyan; Wang, Zhiwei] Nantong Univ, Affiliated Hosp, Dept Gen Surg, Nantong 226001, Jiangsu, Peoples R China		Tao, LY (corresponding author), Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China.	ghost8469@gmail.com	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30872666, 81172911]; Natural Science Foundation of Medical College of Nantong University [Y200905, Y201003]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No.30872666, No.81172911); Natural Science Foundation of Medical College of Nantong University (No.Y200905, No.Y201003); A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Banno Y, 2008, J NEUROCHEM, V104, P1372, DOI 10.1111/j.1471-4159.2007.05085.x; Chang L, 2007, CIRCULATION, V116, P2976, DOI 10.1161/CIRCULATIONAHA.107.707257; Chen JA, 2011, CELL MOL NEUROBIOL, V31, P269, DOI 10.1007/s10571-010-9617-6; Chen YJ, 2008, NEUROCHEM RES, V33, P2092, DOI 10.1007/s11064-008-9690-0; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 1997, J NEUROSCI, V17, P9172; Currie S, 2011, PHARMACOL THERAPEUT, V131, P204, DOI 10.1016/j.pharmthera.2011.02.006; Donai H, 2000, MOL BRAIN RES, V85, P189, DOI 10.1016/S0169-328X(00)00221-7; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Erhardt L, 1996, EUR HEART J, V17, P1781; Garic A, 2011, J NEUROCHEM, V118, P646, DOI 10.1111/j.1471-4159.2011.07273.x; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Houston CM, 2008, J NEUROSCI, V28, P7574, DOI 10.1523/JNEUROSCI.5531-07.2008; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jackson KJ, 2009, J PHARMACOL EXP THER, V330, P541, DOI 10.1124/jpet.109.153171; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kamata A, 2006, J NEUROCHEM, V96, P195, DOI 10.1111/j.1471-4159.2005.03531.x; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; KONIGSMARK BW, 1970, METHODS COUNTING NEU, P315; Li WW, 2011, J BIOL CHEM, V286, P7990, DOI 10.1074/jbc.M110.163006; LOGAN A, 1992, J NEUROSCI, V12, P3828; Ma Y, 2009, BRIT J PHARMACOL, V157, P705, DOI 10.1111/j.1476-5381.2009.00212.x; Maier LS, 2005, BRAZ J MED BIOL RES, V38, P1293, DOI 10.1590/S0100-879X2005000900002; Moreno-Delgado D, 2009, NEUROSCIENCE, V164, P1244, DOI 10.1016/j.neuroscience.2009.08.068; Mouton-Liger F, 2011, J COMP NEUROL, V519, P2779, DOI 10.1002/cne.22651; Nomura K, 2003, J NEUROSCI RES, V72, P384, DOI 10.1002/jnr.10581; Nozawa Y, 2004, J PHARMACOL SCI, V94, P233, DOI 10.1254/jphs.94.233; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Qin Y, 2011, BIOCHEM BIOPH RES CO, V409, P287, DOI 10.1016/j.bbrc.2011.05.003; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Reshef A, 2008, J NEUROTRAUM, V25, P569, DOI 10.1089/neu.2007.0341; Rochlitz H, 2000, DIABETOLOGIA, V43, P465, DOI 10.1007/s001250051330; Rokita AG, 2011, HERZ, V36, P94, DOI 10.1007/s00059-010-3415-2; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Schnabel R, 1999, NEUROPHARMACOLOGY, V38, P605, DOI 10.1016/S0028-3908(98)00229-9; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Shen GF, 2010, NEUROPSYCHOPHARMACOL, V35, P1897, DOI 10.1038/npp.2010.61; Takeuchi Y, 1999, J NEUROCHEM, V72, P815, DOI 10.1046/j.1471-4159.1999.0720815.x; Tan SE, 1996, BRAIN RES, V711, P234, DOI 10.1016/0006-8993(95)01411-X; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; Toko H, 2010, CIRCULATION, V122, P891, DOI 10.1161/CIRCULATIONAHA.109.935296; Tombes RM, 1999, BBA-MOL CELL RES, V1452, P1, DOI 10.1016/S0167-4889(99)00113-5; Torkkeli PH, 2011, EUR J NEUROSCI, V33, P1186, DOI 10.1111/j.1460-9568.2011.07624.x; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Yang CX, 2011, NEUROSURGERY, V68, P691, DOI 10.1227/NEU.0b013e3182098a8a; Zhang T, 2004, RECENT PROG HORM RES, V59, P141, DOI 10.1210/rp.59.1.141; Zhao W, 2011, J MOL HISTOL, V42, P195, DOI 10.1007/s10735-011-9324-8	54	22	26	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	MAR	2012	46	3					631	643		10.1007/s12031-011-9651-y			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	893HE	WOS:000300346100022	22048920				2022-02-06	
J	Hoffman, JM; Dikmen, S; Temkin, N; Bell, KR				Hoffman, Jeanne M.; Dikmen, Sureyya; Temkin, Nancy; Bell, Kathleen R.			Development of Posttraumatic Stress Disorder After Mild Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Traumatic brain injury; Posttraumatic stress disorders; Rehabilitation	HEAD-INJURY; PRACTICAL SCALE; SYMPTOMS; PERSONALITY; PTSD	Hoffman JM, Dikmen S, Temkin N, Bell KR. Development of posttraumatic stress disorder after mild traumatic brain injury. Arch Phys Med Rehabil 2012;93:287-92. Objective: To examine the incidence of and factors associated with the development of posttraumatic stress disorder (PTSD) 6 months after civilian mild traumatic brain injury (MTBI). Design: Secondary analysis of a randomized controlled trial of telephone follow-up versus usual care to reduce MTBI symptoms and improve function. Setting: In-person and telephone interviews. Participants: Prospectively studied participants (N=239) with MTBI enrolled in the emergency department. Interventions: Not applicable. Main Outcome Measures: Secondary analysis with main outcome measure of Posttraumatic Stress Disorder Checklist Civilian Version. Results: At 6 months after MTBI, 17% of participants met criteria for diagnosis of PTSD. Logistic regression predicting PTSD from baseline characteristics showed that participants who were Hispanic versus white, non-Hispanic and who, at the time of injury, described themselves as less happy and believed they would be more affected by their injury were significantly more likely to have PTSD. Conclusions: Rates of PTSD in civilian MTBI in this study are consistent with prior research. Results suggest that personality characteristics and attribution regarding the injury may impact the development of PTSD. Early interventions addressing risk factors may prevent or reduce the likelihood of developing PTSD.	[Hoffman, Jeanne M.; Dikmen, Sureyya; Temkin, Nancy; Bell, Kathleen R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Dikmen, Sureyya] Univ Washington, Dept Psychiat & Behav Med, Seattle, WA 98195 USA; [Dikmen, Sureyya; Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA		Hoffman, JM (corresponding author), Univ Washington, Dept Rehabil Med, Box 356490, Seattle, WA 98195 USA.	jeanneh@u.washington.edu		Bell, Kathleen/0000-0002-0928-2046	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CCR023226]	Supported by the Centers for Disease Control and Prevention (grant no. R49/CCR023226).	[Anonymous], 2011, ASS ONG EFF TREATM P; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; De Silva M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006422.pub3; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Gaylord KM, 2008, J TRAUMA, V64, pS200, DOI 10.1097/TA.0b013e318160ba42; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Hatcher MB, 2009, BRIT J HEALTH PSYCH, V14, P541, DOI 10.1348/135910708X373445; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaloupek DG, 2010, ARCH PHYS MED REHAB, V91, P1684, DOI 10.1016/j.apmr.2010.06.032; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mezuk B, 2010, AM J EPIDEMIOL, V172, P1238, DOI 10.1093/aje/kwq283; Mulligan K, 2011, PSYCHOL MED, V41, P673, DOI 10.1017/S003329171000125X; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nayback AM, 2008, J PSYCHOSOC NURS MEN, V46, P43; Norris FH., 2004, ASSESSING PSYCHOL TR; Paris J, 2000, HARVARD REV PSYCHIAT, V8, P175, DOI 10.1093/hrp/8.4.175; Rademaker AR, 2011, J ABNORM PSYCHOL, V120, P299, DOI 10.1037/a0021806; Roberts NP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006869.pub2; Rush BK, 2006, REHABIL PSYCHOL, V51, P257, DOI 10.1037/0090-5550.51.3.257; Santos MR, 2008, PSYCHIATRY, V71, P234, DOI 10.1521/psyc.2008.71.3.234; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; TEASDALE G, 1974, LANCET, V2, P81; Terhakopian A, 2008, J TRAUMA STRESS, V21, P290, DOI 10.1002/jts.20341; van Veldhoven LM, 2011, J NEUROL NEUROSUR PS, V82, P782, DOI 10.1136/jnnp.2010.228254; van Zuiden M, 2011, J PSYCHIATR RES, V45, P713, DOI 10.1016/j.jpsychires.2010.11.013; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Weathers F.W., 1993, 9 ANN C ISTSS; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Williams AE, 2008, J TRAUMA, V65, P1054, DOI 10.1097/TA.0b013e318184a9ec; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026	42	22	23	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2012	93	2					287	292		10.1016/j.apmr.2011.08.041			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	893ER	WOS:000300338900016	22289239				2022-02-06	
J	Hsieh, MY; Ponsford, J; Wong, D; Schonberger, M; McKay, A; Haines, K				Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; Schoenberger, Michael; McKay, Adam; Haines, Kerrie			A cognitive behaviour therapy (CBT) programme for anxiety following moderate-severe traumatic brain injury (TBI): Two case studies	BRAIN INJURY			English	Article						Anxiety; cognitive behaviour therapy; psychiatric disorders; psychological treatment; traumatic brain injury	HOSPITAL ANXIETY; DEPRESSION SCALE; REHABILITATION; DISORDERS; PATIENT; NEUROREHABILITATION; INTERVENTION; INDIVIDUALS; SUITABILITY; OUTCOMES	Background: CBT is a potentially effective treatment for anxiety disorders following TBI; however, empirical evidence has mainly come from clients with mild TBI. This paper describes a CBT-based anxiety treatment programme adapted for clients with more severe injuries. Two case studies are provided to illustrate the implementation of the programme, as a step toward larger scale testing of the programme's feasibility. Methods and procedures: A manualised adapted CBT treatment manual was used to deliver CBT in a standardised manner to two clients, one with severe and one with moderate TBI. Outcome was evaluated using a single-subject design with repeated measures of anxiety, mood and coping style at pre- and post-CBT. Results: The two clients demonstrated positive treatment response on either a measure of anxiety or a continuous measure of distress. Although neither demonstrated a clinically significant change according to the primary outcome measure (Hospital Anxiety and Depression Scale), they showed significant change in at least one corroborated measure of anxiety. Conclusions: This study suggests the potential utility of the adapted CBT programme for clients with moderate-severe TBI. Limitations of the single case studies were discussed, while noting how they would be addressed in a follow-up randomised controlled trial.	[Hsieh, Ming-Yun; Ponsford, Jennie; Wong, Dana; McKay, Adam; Haines, Kerrie] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia; [Hsieh, Ming-Yun; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Hsieh, Ming-Yun] Victorian Rehabil Ctr, Melbourne, Vic, Australia; [Ponsford, Jennie] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Schoenberger, Michael] Univ Freiburg, Inst Psychol, Dept Rehabil Psychol & Psychotherapy, Freiburg, Germany; [McKay, Adam] Epworth Med Fdn, Melbourne, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol & Psychiat, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Wong, Dana/AAD-3410-2020; McKay, Adam JD/M-6003-2017	McKay, Adam JD/0000-0002-0479-7681; Wong, Dana/0000-0001-9619-1929	National Health Medical Research Council (NHMRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council of Australia; Monash UniversityMonash University; Victorian Brain Injury Recovery Association	This study is part of a randomised controlled trial funded by the National Health Medical Research Council (NHMRC) and Monash University Strategic Grant. The first author received a scholarship provided by the Victorian Brain Injury Recovery Association, for attendance of professional development activities. The funding sources had no role in study design, data collection and analysis. The authors alone are responsible for the content and writing of the paper.	Andrews G., 2003, TREATMENT ANXIETY DI; Anson K, 2006, BRAIN INJURY, V20, P1, DOI 10.1080/02699050500309791; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Beck JS, 1995, COGNITIVE THERAPY BB; Borckardt JJ, 2008, AM PSYCHOL, V63, P77, DOI 10.1037/0003-066X.63.2.77; Borckardt JJ, 2006, SMA SIMULATION MODEL; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Burgess P.W., 1997, HAYLING BRIXTON TEST; Callahan CD, 2005, REHABIL PSYCHOL, V50, P24, DOI 10.1037/0090-5550.50.1.24; Coughlin A, 2007, MEMORY INFORM PROCES; Dahm J, 2009, APS ANN C PERTH AUST; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Devilly GJ, 2005, RELIABLE CLIN CHANGE, V4.0; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; First M, 2007, STRUCTURED CLIN INTE; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Frydenberg E., 1996, COPING SCALE ADULTS; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Hawton K., 1989, COGNITIVE BEHAV TREA; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kazdin A., 1982, SINGLE CASE RES DESI; Kendall E, 2001, BRAIN IMPAIR, V2, P81; Kendall PC, 2008, J AM ACAD CHILD PSY, V47, P987, DOI 10.1097/CHI.0b013e31817eed2f; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; Kroese B. S., 1997, COGNITIVE BEHAV THER; Leathem J, 2007, HDB HOMEWORK ASSIGNM, P389; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lux WE, 2007, J REHABIL RES DEV, V44, P951, DOI 10.1682/JRRD.2007.01.0009; Manchester D, 2001, BRAIN DAM B, P157; Mathias JL, 2007, AUST PSYCHOL, V42, P49, DOI 10.1080/00050060600827599; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Myhr G, 2007, J COGN PSYCHOTHER, V21, P334, DOI 10.1891/088983907782638743; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Newburn G, 1998, CNS DRUGS, V9, P441, DOI 10.2165/00023210-199809060-00003; O'Leary CA, 2000, BEHAV INTERVENT, V15, P205, DOI 10.1002/1099-078X(200007/09)15:3<205::AID-BIN56>3.3.CO;2-B; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; Page AC, 2007, BRIT J CLIN PSYCHOL, V46, P283, DOI 10.1348/014466506X158996; Perna R, 2006, J HEAD TRAUMA REHAB, V21, P82, DOI 10.1097/00001199-200601000-00009; Perna RB, 2001, J COGNITIVE REHABILI, V19, P7; Rasquin SMC, 2009, NEUROPSYCHOL REHABIL, V19, P208, DOI 10.1080/09602010802091159; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; SAFRAN JD, 1993, COGNITIVE THER RES, V17, P23, DOI 10.1007/BF01172738; Sanderson WC, 2006, PRAGMATIC CASE STUDI, V2, P1; Scheutzow MH, 1999, BRAIN INJURY, V13, P705; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Snaith R., 1994, HOSP ANXIETY DEPRESS; SNAITH RP, 1986, BRIT MED J, V292, P344, DOI 10.1136/bmj.292.6516.344; Soo C, 2007, COCHRANE DATABASE SY, P3; Stanley MA, 2004, BEHAV MODIF, V28, P73, DOI 10.1177/0145445503259259; Tate RL, 2003, NEUROPSYCHOL REHABIL, V13, P43, DOI 10.1080/09602010244000372; Tate RL, 1998, NEUROPSYCHOL REHABIL, V8, P1, DOI 10.1080/713755554; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Whyte J, 2009, ARCH PHYS MED REHAB, V90, pS3, DOI 10.1016/j.apmr.2009.07.008; Williams W H, 2003, Cogn Neuropsychiatry, V8, P1, DOI 10.1080/713752238; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P133, DOI 10.1080/09602010244000417; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	71	22	23	1	28	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2012	26	2					126	138		10.3109/02699052.2011.635365			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	897NP	WOS:000300658200002	22360519				2022-02-06	
J	Verkade, MA; Epker, JL; Nieuwenhoff, MD; Bakker, J; Kompanje, EJO				Verkade, Martijn A.; Epker, Jelle L.; Nieuwenhoff, Mariska D.; Bakker, Jan; Kompanje, Erwin J. O.			Withdrawal of Life-Sustaining Treatment in a Mixed Intensive Care Unit: Most Common in Patients with Catastropic Brain Injury	NEUROCRITICAL CARE			English	Article						Intensive care; End-of-life; Withdrawal of treatment; Subarachnoid haemorrhage; Traumatic brain injury	CRITICALLY-ILL PATIENTS; MECHANICAL VENTILATION; SUPPORT; DEATH; ADMISSION; DECISIONS; DOCUMENTATION; EPIDEMIOLOGY; MORTALITY; ETHICUS	To determine the incidence of withdrawal of life-sustaining treatment in various groups of patients in a mixed intensive care unit (ICU). Observational retrospective. Setting: University hospital mixed medical, neurological, neurosurgical and surgical ICU. All patients admitted to the ICU between 1 November 2006, and 31 October 2007. 1,353 Patients were admitted to our ICU between 1 November 2006, and 31 October 2007. During this period, 218 (16.1%) patients died in the ICU, 10 of which were excluded for further analysis. In 174 (83.7%) of the remaining 208 patients, life-sustaining treatment was withdrawn. Severe CNS injury was in 86 patients (49.4%) being the reason for withdrawal of treatment, followed by MODS in 67 patients (38.5%). Notably, treatment was withdrawn in almost all patients (95%) who died of CNS failure. Patients who died in the ICU were significantly older, more often admitted for medical than surgical reasons, and had higher SOFA and APACHE II scores compared with those who survived their ICU stay. Also, SOFA scores before discharge/death were significantly different from admission scores. Of the 1,135 patients who survived their ICU stay, only 51 patients (4.5%) died within 28 days after ICU discharge. In 83, 7% of patients who die in the mixed ICU life-sustaining treatment is withdrawn. Severe cerebral damage was the leading reason to withdraw life-sustaining treatment.	[Verkade, Martijn A.; Epker, Jelle L.; Nieuwenhoff, Mariska D.; Bakker, Jan; Kompanje, Erwin J. O.] Erasmus Univ, Dept Intens Care Med, Med Ctr Rotterdam, NL-3000 CA Rotterdam, Netherlands		Kompanje, EJO (corresponding author), Erasmus Univ, Dept Intens Care Med, Med Ctr Rotterdam, Room H 324,POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl	Bakker, Jan/A-4011-2009	Bakker, Jan/0000-0003-2236-7391			Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; Conlon N, 2008, BRIT J ANAESTH, V100, P219, DOI 10.1093/bja/aem372; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; Cook DJ, 2001, LANCET, V358, P1941, DOI 10.1016/S0140-6736(01)06960-4; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Epker JL, 2011, ANESTH ANALG, V112, P628, DOI 10.1213/ANE.0b013e31820ad4d9; Estenssoro E, 2006, CRIT CARE, V10, DOI 10.1186/cc4941; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Laupland KB, 2006, CHEST, V129, P954, DOI 10.1378/chest.129.4.954; Levin PD, 2005, CRIT CARE, V9, P230, DOI 10.1186/cc3487; Luce JM, 2000, AM J RESP CRIT CARE, V162, P2029, DOI 10.1164/ajrccm.162.6.1-00; Mayr VD, 2006, CRIT CARE, V10, DOI 10.1186/cc5086; McLean RF, 2000, CRIT CARE MED, V28, P100, DOI 10.1097/00003246-200001000-00016; Metnitz PGH, 2003, INTENS CARE MED, V29, P241, DOI 10.1007/s00134-002-1584-z; Moselli NM, 2006, ACTA ANAESTH SCAND, V50, P1177, DOI 10.1111/j.1399-6576.2006.01150.x; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 1997, AM J RESP CRIT CARE, V155, P15, DOI 10.1164/ajrccm.155.1.9001282; Richter J, 2001, J MED ETHICS, V27, P186, DOI 10.1136/jme.27.3.186; Rosenberg AL, 2000, CHEST, V118, P492, DOI 10.1378/chest.118.2.492; Spronk PE, 2009, ANESTH ANALG, V109, P841, DOI 10.1213/ane.0b013e3181acc64a; Sprung CL, 2008, INTENS CARE MED, V34, P271, DOI 10.1007/s00134-007-0927-1; Sprung CL, 2007, INTENS CARE MED, V33, P1732, DOI 10.1007/s00134-007-0693-0; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; Vincent JL, 2002, CHEST, V121, P1602, DOI 10.1378/chest.121.5.1602; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042	28	22	22	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	FEB	2012	16	1					130	135		10.1007/s12028-011-9567-y			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	881QW	WOS:000299502500018	21660623				2022-02-06	
J	Ye, Z; Wang, N; Xia, PP; Wang, E; Yuan, YJ; Guo, QL				Ye, Zhi; Wang, Na; Xia, Pingping; Wang, E.; Yuan, Yajing; Guo, Qulian			Delayed Administration of Parecoxib, a Specific COX-2 Inhibitor, Attenuated Postischemic Neuronal Apoptosis by Phosphorylation Akt and GSK-3 beta	NEUROCHEMICAL RESEARCH			English	Article						Parecoxib; Apoptosis; Cyclooxygenase-2 (COX-2); Akt/glycogen synthase kinase 3 beta (GSK-3 beta); Cerebral ischemic reperfusion injury	GLYCOGEN-SYNTHASE KINASE-3-BETA; TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; CYTOCHROME-C; CELL-DEATH; RAT-BRAIN; ISCHEMIA; CYCLOOXYGENASE-2; MODEL; NEUROPROTECTION	Parecoxib is a recently described novel COX-2 inhibitor whose functional significance and neuroprotective mechanisms remain elusive. Therefore, in this study, we aimed to investigate whether delayed administration of parecoxib inhibited mitochondria-mediated neuronal apoptosis induced by ischemic reperfusion injury via phosphorylating Akt and its downstream target protein, glycogen synthase kinase 3 beta (GSK-3 beta). Adult male Sprague-Dawley rats were administered parecoxib (10 or 30 mg kg(-1), IP) or isotonic saline twice a day starting 24 h after middle cerebral artery occlusion (MCAO) for three consecutive days. Cerebral infarct volume, apoptotic neuron, caspase-3 immunoreactivity and the protein expression of p-Akt, p-GSK-3 beta and Cytochrome C in cerebral ischemic cortex were evaluated at 96 h after reperfusion. Parecoxib significantly diminished infarct volume and attenuated neuron apoptosis in a dose-independent manner, compared with MCAO group alone. Increased p-Akt and p-GSK-3 beta was observed in the ischemic penumbra of parecoxib group after stroke. Moreover, parecoxib also reduced the release of Cytochrome C from mitochondrial into cytosol and attenuated the caspase-3 immunoreactivity in the penumbra. Taken together, these results suggested that parecoxib ameliorated postischemic mitochondria-mediated neuronal apoptosis induced by focal cerebral ischemia in rats and this neuroprotective potential is involved in phosphorylation of Akt and GSK-3 beta.	[Ye, Zhi; Wang, Na; Xia, Pingping; Wang, E.; Yuan, Yajing; Guo, Qulian] Ctr S Univ, Dept Anesthesiol, Affiliated Xiangya Hosp, Changsha 410078, Hunan, Peoples R China		Guo, QL (corresponding author), Ctr S Univ, Dept Anesthesiol, Affiliated Xiangya Hosp, Changsha 410078, Hunan, Peoples R China.	guoqulian7411@live.cn					Abbate A, 2007, J CARDIOVASC PHARM, V49, P416, DOI 10.1097/FJC.0b013e31804a5e50; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Brywe KG, 2005, EUR J NEUROSCI, V21, P1489, DOI 10.1111/j.1460-9568.2005.03982.x; Candelario-Jalil E, 2004, BRAIN RES, V1007, P98, DOI 10.1016/j.brainres.2004.01.078; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Candelario-Jalil E, 2008, CURR PHARM DESIGN, V14, P1401, DOI 10.2174/138161208784480216; Candelario-Jalil E, 2008, PHARMACOL RES, V57, P266, DOI 10.1016/j.phrs.2008.03.003; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926, DOI 10.1097/01.WCB.0000130866.25040.7D; Cimarosti H, 2005, NEUROCHEM RES, V30, P191, DOI 10.1007/s11064-004-2441-y; Clodfelder-Miller B, 2005, J BIOL CHEM, V280, P39723, DOI 10.1074/jbc.M508824200; Dembo G, 2005, ANESTHESIOLOGY, V102, P409, DOI 10.1097/00000542-200502000-00026; Dirnagl U, 2004, E SCHERING RES FDN W, V47, P87; Dore S, 2003, ANN NEUROL, V54, P155, DOI 10.1002/ana.10612; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Hirai K, 2004, MOL BRAIN RES, V124, P51, DOI 10.1016/j.molbrainres.2004.02.009; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kelsen J, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-31; Kelso ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-108; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Leclerc S, 2001, J BIOL CHEM, V276, P251, DOI 10.1074/jbc.M002466200; Li J, 2008, NEUROSCI LETT, V438, P210, DOI 10.1016/j.neulet.2008.04.054; Li LL, 2008, EUR J PHARMACOL, V586, P106, DOI 10.1016/j.ejphar.2008.02.073; Nishimoto T, 2008, J NEUROSCI RES, V86, P1096, DOI 10.1002/jnr.21567; Nogawa S, 1997, J NEUROSCI, V17, P2746; Norregaard R, 2010, AM J PHYSIOL-REG I, V298, pR1017, DOI 10.1152/ajpregu.00336.2009; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Ohtsuki T, 1996, BRAIN RES, V736, P353, DOI 10.1016/0006-8993(96)00948-1; Patel NSA, 2007, EUR J PHARMACOL, V562, P148, DOI 10.1016/j.ejphar.2007.01.079; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Polascheck N, 2010, EXP NEUROL, V224, P219, DOI 10.1016/j.expneurol.2010.03.014; Raphael J, 2006, J PHARMACOL EXP THER, V318, P186, DOI 10.1124/jpet.105.100537; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Salloum FN, 2009, J CARDIOVASC PHARM, V53, P495, DOI 10.1097/FJC.0b013e3181a7b5b6; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Sugimoto K, 2003, BRAIN RES, V960, P273, DOI 10.1016/S0006-8993(02)03805-2; Wang HY, 2009, BRAIN RES, V1297, P177, DOI 10.1016/j.brainres.2009.08.054; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wu T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-22; Xiang Z, 2007, CURR NEUROVASC RES, V4, P274, DOI 10.2174/156720207782446342; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zheng Z, 2004, NEUROL RES, V26, P884, DOI 10.1179/016164104X2357	49	22	28	0	5	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	FEB	2012	37	2					321	329		10.1007/s11064-011-0615-y			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	920KU	WOS:000302404100012	21964800				2022-02-06	
J	Alston, M; Jones, J; Curtin, M				Alston, Margaret; Jones, Jennifer; Curtin, Michael			Women and Traumatic Brain Injury: "It's not visible damage''	AUSTRALIAN SOCIAL WORK			English	Article						Women; Acquired Brain Injury; Poststructural Feminism; Embodied Self; Caring		With advances in medical technology, more people are surviving major trauma experiences. Those with a traumatic brain injury are one such group who may survive for several decades with significant health consequences including physical, cognitive, and psychosocial sequelae. Traumatic brain injury sufferers are typically young males with a premorbid history of risk taking. Consequently, the differential needs of female traumatic brain injury survivors are less likely to be acknowledged in the literature or by allied health workers. A large quantitative and qualitative study of people with traumatic brain injury was conducted in rural areas of New South Wales, Australia in 2004-2005. The qualitative component of the study included in-depth interviews with 11 women and 21 men. This paper focuses on the interviews with the 11 women who live in two rural areas of New South Wales. These data illustrate the psychosocial consequences of traumatic brain injury for women. They reveal that women are particularly vulnerable to isolation, disempowerment, and in extreme cases, abuse, and are less likely to have a carer. The need for gender to be a factor in ongoing social work and allied health treatment and support of traumatic brain injury sufferers and their carers is evident from this research.	[Alston, Margaret] Monash Univ, Melbourne, Vic 3004, Australia; [Jones, Jennifer; Curtin, Michael] Charles Sturt Univ, Albury, NSW, Australia		Alston, M (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.	margaret.alston@monash.edu	Jones, Jennifer/N-1940-2015; Curtin, Michael/G-2650-2014	Jones, Jennifer/0000-0003-1855-2674; Curtin, Michael/0000-0002-2152-7501; Alston, Margaret/0000-0001-9057-7767			ABS (Australian Bureau of Statistics), 1993, DIS AG CAR AUSTR BRA; Alston M., 2008, PARTICIPATION FOLLOW; Australian Bureau of Statistics [ABS], 2000, CAR COMM; Australian Bureau of Statstics [ABS], 2003, ABS YB AUSTR; Bartky S., 1990, FEMININITY DOMINATIO; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bourdieu P., 1977, OUTLINE THEORY PRACT; Bourdieu P, 1992, INVITATION REFLEXIVE; Brookshire R. H., 2003, INTRO NEUROGENIC COM; Butler J., 1990, GENDER TROUBLE SUBVE; Callaway L., 2005, AUSTR OCCUPATIONAL T, V52, P257, DOI [10.1111/j.1440-1630.2005.00492, DOI 10.1111/J.1440-1630.2005.00492]; Connell R.W., 2002, GENDER; Cunningham JM, 1999, HLTH CARE DISABILITY, P475; Curtin M., 2008, PARTICIPATION FOLLOW; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Fine M, 2005, AGEING SOC, V25, P601, DOI 10.1017/S0144686X05003600; Foucault Michel, 1995, DISCIPLINE PUNISH BI; Graham H., 1983, LABOUR LOVE WOMEN WO, P13; Gwynn R., 2003, DISCOURSE BODY IDENT, P209; Howes H, 2005, PSYCHOL HEALTH, V20, P129, DOI 10.1080/0887044042000272903; Jones J, 2010, QUAL HEALTH RES, V20, P942, DOI 10.1177/1049732310365501; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Lupton D, 2003, DISCOURSE BODY IDENT, P246; Mukherjee D, 2003, WOMEN THER, V26, P3, DOI 10.1300/J015v26n01_01; O'Rance L., 2007, B AIHW, V55; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; *QSR INT, 2006, NVIVO 7 COMP SOFTW; Rees RJ, 1996, AUST J SOC ISSUES, V31, P392, DOI 10.1002/j.1839-4655.1996.tb01286.x; Reichard AA, 2007, J HEAD TRAUMA REHAB, V22, P390, DOI 10.1097/01.HTR.0000300234.36361.b1; Reidpath DD, 2005, SOCIOL HEALTH ILL, V27, P468, DOI 10.1111/j.1467-9566.2005.00452.x; Shildrick M., 1997, LEAKY BODIES BOUNDAR; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808	32	22	22	0	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1447-0748			AUST SOC WORK	Aust. Soc. Work		2012	65	1					39	53		10.1080/0312407X.2011.594898			15	Social Work	Social Science Citation Index (SSCI)	Social Work	910VO	WOS:000301671500004					2022-02-06	
J	Barden, AE; Corcoran, TB; Mas, E; Durand, T; Galano, JM; Roberts, LJ; Paech, M; Muchatuta, NA; Phillips, M; Mori, TA				Barden, Anne E.; Corcoran, Tomas B.; Mas, Emilie; Durand, Thierry; Galano, Jean-Marie; Roberts, L. Jackson, II; Paech, Michael; Muchatuta, Neil A.; Phillips, Michael; Mori, Trevor A.			Is There a Role for Isofurans and Neuroprostanes in Pre-Eclampsia and Normal Pregnancy?	ANTIOXIDANTS & REDOX SIGNALING			English	Article							TRAUMATIC BRAIN-INJURY; LIPID-PEROXIDATION; OXIDATIVE STRESS; PLASMA	Pre-eclampsia is a complex disorder of pregnancy that adversely affects the mother and baby. Arachidonic acid and docosahexaenoic acid are essential for fetal development and can undergo free radical oxidation to F(2)-isoprostanes (F(2)-IsoPs) and isofurans (IsoFs); and F(4)-neuroprostanes (F(4)-NeuroPs), respectively. These metabolites may be relevant to pre-eclampsia and fetal development. We examined IsoFs, F(4)-NeuroPs, and F(2)-IsoPs in maternal plasma and cord blood plasma of 23 women with pre-eclampsia and 21 normal pregnancies. Women with pre-eclampsia had significantly elevated maternal IsoFs and F(4)-NeuroPs, but not F(2)-IsoPs. Cord blood F(4)-NeuroPs were elevated among neonates of women with pre-eclampsia. In women with pre-eclampsia, birth weight was predicted by gestation at delivery. The latter was also true in normal pregnancy, but birth weight was negatively related to maternal F(2)-IsoPs, IsoFs, and F(4)-NeuroPs. We have shown that in women with pre-eclampsia, IsoFs and F(4)-NeuroPs are elevated, and cord blood F(4)-NeuroPs are increased. The inverse relationship between maternal F(2)-IsoPs, IsoFs, and F(4)-NeuroPs and birth weight may be relevant as predictors of low birth weight in normal pregnancy. Future studies should examine whether these markers in maternal blood at early stages of pregnancy relate to subsequent maternal, fetal, and neonatal complications. Antioxid. Redox Signal. 16, 165-169.	[Barden, Anne E.; Corcoran, Tomas B.; Mas, Emilie; Paech, Michael; Mori, Trevor A.] Univ Western Australia, Sch Med & Pharmacol, Cardiovasc Res Ctr, Perth, WA 6847, Australia; [Corcoran, Tomas B.] Royal Perth Hosp, Dept Anaesthesia & Pain Med, Perth, WA, Australia; [Durand, Thierry; Galano, Jean-Marie] UM II, UM 1, CNRS, Fac Pharm,IBMM,UMR 5247, Montpellier, France; [Roberts, L. Jackson, II] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Paech, Michael; Muchatuta, Neil A.] King Edward Mem Hosp Women, Dept Anaesthesia & Pain Med, Perth, WA, Australia; [Phillips, Michael] Univ Western Australia, Western Australian Inst Med Res, Perth, WA 6847, Australia		Barden, AE (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Cardiovasc Res Ctr, GPO Box X 2213, Perth, WA 6847, Australia.	anne.barden@uwa.edu.au	Mori, Trevor/H-5485-2014	Mori, Trevor/0000-0002-5264-9229; PAECH, MICHAEL/0000-0001-9023-6575; Barden, Anne/0000-0001-7631-0767; Phillips, Michael/0000-0002-0252-9085	National Heart Foundation of AustraliaNational Heart Foundation of Australia; West Australian Institute of Medical Research; University of Western Australia; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM42056]; University Montpellier 1 [BQR-2008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R37GM042056, R01GM042056] Funding Source: NIH RePORTER	The study was supported by grants from the National Heart Foundation of Australia, and by a grant from the Neurotrauma Research Program of the West Australian Institute of Medical Research and the University of Western Australia. The synthesis of the IsoFs (Prof Roberts II LJ) was supported by a National Institutes of Health Grant GM42056. The synthesis of the neuroprostanes (Dr Durand T) was supported by a University Montpellier 1 Grant BQR-2008.	Barden A, 1996, CLIN SCI, V91, P711, DOI 10.1042/cs0910711; Barden A, 2001, HYPERTENSION, V38, P803, DOI 10.1161/hy1101.092969; Corcoran TB, 2011, ANTIOXID REDOX SIGN, V15, P2663, DOI 10.1089/ars.2011.4125; Harsem NK, 2006, EUR J OBSTET GYN R B, V128, P209, DOI 10.1016/j.ejogrb.2005.11.014; Harsem NK, 2008, HYPERTENS PREGNANCY, V27, P374, DOI 10.1080/10641950802000968; Ishihara O, 2004, FREE RADICAL RES, V38, P913, DOI 10.1080/10715760412331273421; Roberts LJ, 2004, CHEM PHYS LIPIDS, V128, P173, DOI 10.1016/j.chemphyslip.2003.09.016; Stein TP, 2008, FREE RADICAL RES, V42, P841, DOI 10.1080/10715760802510069; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005	9	22	23	0	5	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1523-0864			ANTIOXID REDOX SIGN	Antioxid. Redox Signal.	JAN	2012	16	2					165	169		10.1089/ars.2011.4214			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	852DK	WOS:000297327800006	21827297	Green Published			2022-02-06	
J	Donovan, V; Bianchi, A; Hartman, R; Bhanu, B; Carson, MJ; Obenaus, A				Donovan, Virginia; Bianchi, Anthony; Hartman, Richard; Bhanu, Bir; Carson, Monica J.; Obenaus, Andre			Computational analysis reveals increased blood deposition following repeated mild traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Edema; Hemorrhagic progression; Histogram; T2; Quantitative magnetic resonance imaging		Mild traumatic brain injury (mTBI) has become an increasing public health concern as subsequent injuries can exacerbate existing neuropathology and result in neurological deficits. This study investigated the temporal development of cortical lesions using magnetic resonance imaging (MRI) to assess two mTBIs delivered to opposite cortical hemispheres. The controlled cortical impact model was used to produce an initial mTBI on the right cortex followed by a second injury induced on the left cortex at 3 (rmTBI 3d) or 7 (rmTBI 7d) days later. Histogram analysis was combined with a novel semi-automated computational approach to perform a voxel-wise examination of extravascular blood and edema volumes within the lesion. Examination of lesion volume 1d post last injury revealed increased tissue abnormalities within rmTBI 7d animals compared to other groups, particularly at the site of the second impact. Histogram analysis of lesion T2 values suggested increased edematous tissue within the rmTBI 3d group and elevated blood deposition in the rm TBI 7d animals. Further quantification of lesion composition for blood and edema containing voxels supported our histogram findings, with increased edema at the site of second impact in rmTBI 3d animals and elevated blood deposition in the rmTBI 7d group at the site of the first injury. Histological measurements revealed spatial overlap of regions containing blood deposition and microglial activation within the cortices of all animals. In conclusion, our findings suggest that there is a window of tissue vulnerability where a second distant mTBI, induced 7d after an initial injury, exacerbates tissue abnormalities consistent with hemorrhagic progression. (C) 2012 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.	[Donovan, Virginia; Carson, Monica J.; Obenaus, Andre] Univ Calif Riverside, Cell Mol & Dev Biol Program, Riverside, CA 92521 USA; [Donovan, Virginia; Carson, Monica J.; Obenaus, Andre] Univ Calif Riverside, Sch Med, Ctr Glial Neuronal Interact, Riverside, CA 92521 USA; [Bianchi, Anthony; Bhanu, Bir] Univ Calif Riverside, Ctr Res Intelligent Syst, Riverside, CA 92521 USA; [Hartman, Richard] Loma Linda Univ, Dept Psychol, Loma Linda, CA 92354 USA; [Carson, Monica J.] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA; [Obenaus, Andre] Loma Linda Univ, Dept Pediat, Loma Linda, CA 92354 USA		Obenaus, A (corresponding author), Loma Linda Univ, Dept Pediat, 11175 Campus St,Rm A1120, Loma Linda, CA 92354 USA.	aobenaus@llu.edu		Bhanu, Bir/0000-0001-8971-6416	Department of Defense (DCMRP) [DR080470]; National Science Foundation Integrative Graduate Education and Research Traineeship (IGERT)National Science Foundation (NSF) [DGE 0903667]	This study was supported by funding from Department of Defense (DCMRP #DR080470 to AO) and in part by National Science Foundation Integrative Graduate Education and Research Traineeship (IGERT) in Video Bioinformatics (DGE 0903667 to VD, AB and BB).	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Colgan NC, 2010, J NEUROTRAUM, V27, P1265, DOI 10.1089/neu.2009.1267; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; del Zoppo GJ, 2012, J CEREBR BLOOD F MET, V32, P919, DOI 10.1038/jcbfm.2012.11; Ding JY, 2009, BRAIN RES, V1268, P125, DOI 10.1016/j.brainres.2009.02.060; Emblem KE, 2008, AM J NEURORADIOL, V29, P1664, DOI 10.3174/ajnr.A1182; Faul M, 2010, TRAUMATIC BRAIN INJU; Fukuda S, 2004, STROKE, V35, P998, DOI 10.1161/01.STR.0000119383.76447.05; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Gidday JM, 2005, AM J PHYSIOL-HEART C, V289, pH558, DOI 10.1152/ajpheart.01275.2004; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Gupta RK, 2012, NEURORADIOLOGY, V54, P565, DOI 10.1007/s00234-011-0952-1; HAMANN GF, 1995, STROKE, V26, P2120, DOI 10.1161/01.STR.26.11.2120; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kopelman R, 2005, J MAGN MAGN MATER, V293, P404, DOI 10.1016/j.jmmm.2005.02.061; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nevo U, 2001, MAGN RESON MED, V45, P1, DOI 10.1002/1522-2594(200101)45:1<1::AID-MRM1001>3.0.CO;2-I; Obenaus A, 2008, RADIAT RES, V169, P149, DOI 10.1667/RR1135.1; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Obenaus A, 2011, ANN NEUROL, V69, P282, DOI 10.1002/ana.22168; Oehmichen M, 2003, J NEUROTRAUM, V20, P87, DOI 10.1089/08977150360517218; Rosidi NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026612; Schmued LC, 2000, TOXICOL PATHOL, V28, P91, DOI 10.1177/019262330002800111; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; THULBORN KR, 1990, AM J ROENTGENOL, V154, P1053, DOI 10.2214/ajr.154.5.2108542; VA/DoD, 2009, MAN CONC MILD TRAUM; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Veltkamp R, 2005, BRAIN RES, V1037, P134, DOI 10.1016/j.brainres.2005.01.006; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X	56	22	22	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2012	1	1					18	28		10.1016/j.nicl.2012.08.001			11	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V37LG	WOS:000209276700003	24179733	Green Published, gold			2022-02-06	
J	Gardner, A; Shores, EA; Batchelor, J; Honan, CA				Gardner, Andrew; Shores, E. Arthur; Batchelor, Jennifer; Honan, Cynthia A.			Diagnostic Efficiency of ImPACT and CogSport in Concussed Rugby Union Players Who Have Not Undergone Baseline Neurocognitive Testing	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						CogSport; computerized neuropsychological testing; ImPACT; sports-related concussion	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; PROCESSING SPEED; FOOTBALL; SCHOOL; SPECIFICITY; RELIABILITY; SENSITIVITY; HISTORY	The current study endeavored to replicate the approach to sports-related concussion management adopted by some community-based sporting organizations by examining the diagnostic efficiency of CogSport and ImPACT in athletes without baseline test data and assessed only once postinjury. Recently concussed nonelite-level rugby union players (N = 51) were tested within 72 hours of sustaining a concussion and were compared to nonconcussed matched controls (N = 41). Demographic information and history of recent concussion were also collected. Logistic regression analysis and receiver-operating characteristic curve analysis were conducted to evaluate the most accurate scores at identifying group membership. Overall, the classification accuracy of CogSport and ImPACT represented only very minimal improvements over a demographic-only (age, estimated premorbid Full-Scale IQ, and number of previous concussions) model. Positive predictive power and negative predictive power of composite scores were modest. The ImPACT postconcussion symptoms total (severity) score was most accurate at classifying concussed athletes. Where neuropsychological tests are utilized on a single occasion postconcussion and in the absence of baseline testing, postinjury testing does not improve diagnostic utility beyond the demographic model. These results do not validate this approach as a useful method of managing sports-related concussion.	[Gardner, Andrew; Shores, E. Arthur; Batchelor, Jennifer; Honan, Cynthia A.] Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia		Shores, EA (corresponding author), Macquarie Univ, Dept Psychol, N Ryde, NSW 2109, Australia.	arthur.shores@mq.edu.au	Gardner, Andrew/J-5162-2013; Honan, Cynthia/O-6332-2017	Shores, Edwin A/0000-0003-1553-5131; Honan, Cynthia/0000-0001-5735-4270; Batchelor, Jennifer/0000-0003-4438-4993; Gardner, Andrew/0000-0001-5031-5586			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barth JT, 1989, MILD HEAD INJURY, P257; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Diaz-Asper CM, 2004, J INT NEUROPSYCH SOC, V10, P82; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell M.R., 2007, CLIN INTERPRETATION; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT	29	22	22	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2012	19	2					90	97		10.1080/09084282.2011.643945			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	949SL	WOS:000304596100003	23373575				2022-02-06	
J	Hayes, A; Chen, CS; Clarke, G; Thompson, A				Hayes, Allison; Chen, Celia S.; Clarke, Gayle; Thompson, Annette			Functional improvements following the use of the NVT Vision Rehabilitation program for patients with hemianopia following stroke	NEUROREHABILITATION			English	Article						Neurological vision deficits; acquired brain injury; hemianopia; stroke; traumatic brain injury; mobility; activities of daily living; quality of life; compensatory visual scanning	QUALITY-OF-LIFE; HOMONYMOUS HEMIANOPIA; VISUAL FUNCTION; OUTCOMES; NEGLECT	The incidence of visual deficits following stroke ranges from 20%-68% and has significant impact on activities of daily living. The NVT system is a compensatory visual scanning training program that consists of combined static and mobility training and transfer to activities of daily living. The study aims to evaluate functional changes following the NVT program for people who have homonymous hemianopia (HH) following stroke. Method: Interventional case series of 13 consecutive participants with HH undergoing NVT vision rehabilitation. The primary outcome measure was the number of targets missed on a standardized Mobility Assessment Course (MAC). Other outcome measures included assessment of visual scanning, vision specific Quality of Life questionnaires and reading performance. Results: The average number of targets (sd) missed on the MAC course was 39.6 +/- 20.9% before intervention, 27.5 +/- 16.3% immediately post intervention and 20.8 +/- 15.5% at 3 months post rehabilitation. The study showed a statistically significant trend in improvement in mobility related subscales of National Eye Institute Visual Function Questionnaire-NEI VFQ-25 (p = 0.003) and the Veteran Affairs Low Vision Visual Function Questionnaire-VA LVFQ-48 (p = 0.036) at 3 months post rehabilitation. Discussion: The NVT intervention resulted in functional improvements in mobility post rehabilitation. The NVT training showed improvement in vision specific quality of life. There is a need for standardised vision therapy intervention, in conjunction with existing rehabilitation services, for patients with stroke and traumatic brain injury.	[Hayes, Allison; Clarke, Gayle] NVT Syst, Torrensville, SA 5031, Australia; [Chen, Celia S.] Flinders Univ S Australia, Bedford Pk, SA 5042, Australia; [Chen, Celia S.] Flinders Med Ctr, Dept Ophthalmol, Bedford Pk, SA, Australia; [Thompson, Annette] Royal Soc Blind, Adelaide, SA, Australia		Hayes, A (corresponding author), NVT Syst, POB 131, Torrensville, SA 5031, Australia.	ahayes@nvtsystems.com.au	Chen, Celia/AAM-7110-2020; Chen, Celia/ABD-7054-2020	Chen, Celia/0000-0002-7723-4812			CHEDRU F, 1973, Cortex, V9, P94; Chen CS, 2009, TOP STROKE REHABIL, V16, P445, DOI 10.1310/tsr1606-445; Coupar F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006432.pub2; DENES G, 1982, BRAIN, V105, P543, DOI 10.1093/brain/105.3.543; Faul M, 2010, TRAUMATIC BRAIN INJU; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GASSEL MM, 1963, BRAIN, V86, P1, DOI 10.1093/brain/86.1.1; GIANUTSOS R, 1988, ARCH PHYS MED REHAB, V69, P573; Haymes SA, 2006, INVEST OPHTH VIS SCI, V47, P2739, DOI 10.1167/iovs.05-1419; ISHIAI S, 1987, NEUROPSYCHOLOGIA, V25, P675, DOI 10.1016/0028-3932(87)90058-3; Kerkhoff G, 1999, RESTOR NEUROL NEUROS, V15, P255; Kerkhoff G, 2000, J NEUROL NEUROSUR PS, V68, P691, DOI 10.1136/jnnp.68.6.691; Kingston J, 2010, J VISUAL IMPAIR BLIN, V104, P603, DOI 10.1177/0145482X1010401006; Kinsella G, 1985, Int Rehabil Med, V7, P102; Koons P, 2010, EYE BRAIN, V2, P47; Landers J, 2010, CLIN EXP OPHTHALMOL, V38, P273, DOI 10.1111/j.1442-9071.2010.02246.x; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Margolis MK, 2002, PHARMACOECONOMICS, V20, P791, DOI 10.2165/00019053-200220120-00001; McInnes JK., 2000, VIS IMPAIR RES, V2, P129, DOI DOI 10.1076/VIMR.2.3.129.4422; Pambakian ALM, 1997, BRIT J OPHTHALMOL, V81, P324, DOI 10.1136/bjo.81.4.324; Parton A, 2004, J NEUROL NEUROSUR PS, V75, P13; Rowe F, 2009, AGE AGEING, V38, P188, DOI 10.1093/ageing/afn230; STELMACK J, 1987, AM J OPTOM PHYS OPT, V64, P829; Stelmack JA, 2002, INVEST OPHTH VIS SCI, V43, P2859; Stelmack JA, 2007, OPTOMETRY VISION SCI, V84, P705, DOI 10.1097/OPX.0b013e3181339f1a; Stelmack JA, 2006, INVEST OPHTH VIS SCI, V47, P3253, DOI 10.1167/iovs.05-1319; STONE SP, 1993, AGE AGEING, V22, P46, DOI 10.1093/ageing/22.1.46; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Zihl, 1999, VIS IMPAIR RES, V1, P23, DOI [10.1076/vimr.1.1.23.4450, DOI 10.1076/VIMR.1.1.23.4450]; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A; ZIHL J, 1994, LOW VISION	33	22	22	2	14	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	1					19	30		10.3233/NRE-2012-0771			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	976SU	WOS:000306605900003	22523012				2022-02-06	
J	Laursen, B; Helweg-Larsen, K				Laursen, Bjarne; Helweg-Larsen, Karin			Health service use in adults 20-64 years with traumatic brain injury, spinal cord injury or pelvic fracture. A cohort study with 9-year follow-up	BMJ OPEN			English	Article							CARE UTILIZATION; DISABILITY; REGISTER	Objectives: To estimate the health service use over 9 years after the injury year for patients with traumatic brain injury (TBI), spinal cord injury (SCI) and pelvic fracture (PF), and compare with non-injured. Design: A register-based cohort design with a 9-year follow-up period. Setting: The Danish population. Participants: The study included 434, 100 and 278 hospital-treated incident patients with TBI, SCI and PF, respectively, among 20-year-olds to 64-year-olds identified using the National Patient Register. Controls for each patient group were drawn from the population register, matched by age, sex and health service use during 1995. All were followed during 1996-2005 by linkage to national health registers. The observations were excluded when the patients left Denmark or died. Outcome measures: The use of hospital treatments, contacts with general practitioners and the use of physiotherapy. Results: Compared to the controls, more patients with TBI and SCI were hospital admitted all 9 years after the injury year, on average 0.36 and 0.50 times annually, respectively. For patients with PF hospital admissions returned to baseline year 2 after the injury year. For patients with SCI the use of general practitioner services remained at an increased level year 9 after the injury year, while it returned to baseline level year 4 after the injury year for patients with TBI and year 2 for patients with PF. For patients with SCI physiotherapy use remained increased over 9 years after the injury year, while it returned to baseline the fifth year for patients with TBI and the third year after for patients with PF. Conclusions: TBI and SCI increase the use of health services over 9 years after the injury year, while most health service use after PF returned to baseline 2 years after the injury year.	[Laursen, Bjarne; Helweg-Larsen, Karin] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark		Laursen, B (corresponding author), Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	bla@niph.dk		Laursen, Bjarne/0000-0003-0121-9891	TrygFonden [7585-07]	This work was supported by TrygFonden, grant no. 7585-07.	Becker DJ, 2010, J GERONTOL A-BIOL, V65, P1012, DOI 10.1093/gerona/glq093; Borg T, 2010, INJURY, V41, P400, DOI 10.1016/j.injury.2009.11.006; Braithwaite IJ, 1998, INJURY, V29, P55; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dryden DM, 2004, SPINAL CORD, V42, P513, DOI 10.1038/sj.sc.3101629; Guilcher SJT, 2010, SPINAL CORD, V48, P45, DOI 10.1038/sc.2009.78; Haagsma JA, 2012, B WORLD HEALTH ORGAN, V90, P513, DOI 10.2471/BLT.11.095109; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1507, DOI 10.1016/S0003-9993(99)90265-4; Kiely N, 1996, INJURY, V27, P45, DOI 10.1016/0020-1383(95)00161-1; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Munce SEP, 2009, SPINAL CORD, V47, P470, DOI 10.1038/sc.2008.173; NAAM NH, 1983, ARCH SURG-CHICAGO, V118, P610; National Board of Health Denmark, ACTIVITY AT HOSPITAL; Nickelsen T N, 2001, Ugeskr Laeger, V164, P33; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; SAHL AJ, 2011, SCAND J PUBLIC HLT S, V39, P34, DOI DOI 10.1177/1403494810394718; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Toft AMH, 2010, J TRAUMA, V69, P26, DOI 10.1097/TA.0b013e3181d3cbf2; Wrona RM, 2010, DISABIL REHABIL, V32, P650, DOI 10.3109/09638280903186327	20	22	22	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2012	2	5							e001521	10.1136/bmjopen-2012-001521			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	091MN	WOS:000315053900080	23103605	Green Published, gold			2022-02-06	
J	Macera, CA; Aralis, HJ; MacGregor, AJ; Rauh, MJ; Galarneau, MR				Macera, Caroline A.; Aralis, Hilary J.; MacGregor, Andrew J.; Rauh, Mitchell J.; Galarneau, Michael R.			Postdeployment symptom changes and traumatic brain injury and/or posttraumatic stress disorder in men	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blasts; deployment; males; military; odds ratio; percent change; Post-Deployment Health Assessment; posttraumatic stress disorder; symptoms; traumatic brain injury	HEALTH PROBLEMS; MILITARY; IRAQ; DEPLOYMENT; AFGHANISTAN; VETERANS; CHALLENGES; OUTCOMES; HISTORY; CARE	In Operation Iraqi Freedom and Operation Enduring Freedom, blast-related injuries associated with combat are frequent and can result in traumatic brain injury (TBI) symptoms that may be difficult to distinguish from psychological problems. Using data from the Post-Deployment Health Assessment and Reassessment, we identified 12,046 male U.S. Navy sailors and Marines with reported combat exposure from 2008 to 2009. Symptoms potentially associated with blast-related TBI and posttraumatic stress disorder (PTSD) that were reported immediately after deployment were compared with symptoms present several months later. Our study supports others that have found that subjects with blast-related injuries may experience the development or worsening of symptoms during the months following deployment. Additionally, our study found that those who screened positive for PTSD and TBI formed a unique group, with the presence of TBI exacerbating development of PTSD symptoms at reassessment. Providers should recognize the late development of symptoms, consider the possibility of comorbidity, and be prepared to treat multiple symptoms rather than a specific diagnostic category.	[Macera, Caroline A.; Aralis, Hilary J.; Rauh, Mitchell J.] USN, Hlth Res Ctr, Warfighter Performance Dept, San Diego, CA 92106 USA; [MacGregor, Andrew J.; Galarneau, Michael R.] USN, Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, San Diego, CA 92106 USA		Aralis, HJ (corresponding author), USN, Hlth Res Ctr, Warfighter Performance Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.	Hilary.Aralis@gmail.com		MacGregor, Andrew/0000-0003-1020-7390	U.S. Navy Bureau of Medicine and Surgery [60818]	This material was based on work supported by the U.S. Navy Bureau of Medicine and Surgery, under Work Unit No. 60818.	Bahraini NH, 2009, MIL MED, V174, P1005, DOI 10.7205/MILMED-D-00-9509; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Deployment Health Clinical Center, POSTD HLTH ASS PDHA; Deployment Health Clinical Center, POSTD HLTH REASS PDH; Helmick KM, 2007, FEDERAL PRACTITIONER, V24, P58; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Mernoff Stephen T, 2010, Med Health R I, V93, P16; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; PRINS A, 2003, PRIMARY CARE PSYCHIA, V0009, P00009, DOI DOI 10.1185/135525703125002360; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sharkey JM, 2011, MIL MED, V176, P915, DOI 10.7205/MILMED-D-10-00366; Smith TC, 2009, PUBLIC HEALTH REP, V124, P90, DOI 10.1177/003335490912400112; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielian T, 2008, INVISIBLE WOUNDS WAR, P96; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	33	22	22	0	6	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2012	49	8					1197	1208		10.1682/JRRD.2011.07.0131			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149FA	WOS:000319303200007	23341312	Bronze			2022-02-06	
J	Mills, PH; Hitchens, TK; Foley, LM; Link, T; Ye, Q; Weiss, CR; Thompson, JD; Gilson, WD; Arepally, A; Melick, JA; Kochanek, PM; Ho, C; Bulte, JWM; Ahrens, ET				Mills, Parker H.; Hitchens, T. Kevin; Foley, Lesley M.; Link, Thomas; Ye, Qing; Weiss, Clifford R.; Thompson, Joe D.; Gilson, Wesley D.; Arepally, Aravind; Melick, John A.; Kochanek, Patrick M.; Ho, Chien; Bulte, Jeff W. M.; Ahrens, Eric T.			Automated detection and characterization of SPIO-labeled cells and capsules using magnetic field perturbations	MAGNETIC RESONANCE IN MEDICINE			English	Article						SPIO; magnetic moment; MRI; cell tracking; magnetocapsules; susceptibility	POSITIVE-CONTRAST VISUALIZATION; IN-VIVO MRI; IRON-OXIDE; STEM-CELLS; RESONANCE; SUSCEPTIBILITY; TRACKING; MIGRATION; AGENTS; MACROPHAGES	Understanding how individual cells behave inside living systems will help enable new diagnostic tools and cellular therapies. Superparamagnetic iron oxide particles can be used to label cells and theranostic capsules for noninvasive tracking using MRI. Contrast changes from superparamagnetic iron oxide are often subtle relative to intrinsic sources of contrast, presenting a detection challenge. Here, we describe a versatile postprocessing method, called Phase map cross-correlation Detection and Quantification (PDQ), that automatically identifies localized deposits of superparamagnetic iron oxide, estimating their volume magnetic susceptibility and magnetic moment. To demonstrate applicability, PDQ was used to detect and characterize superparamagnetic iron oxide-labeled magnetocapsules implanted in porcine liver and suspended in agarose gel. PDQ was also applied to mouse brains infiltrated by MPIO-labeled macrophages following traumatic brain injury; longitudinal, in vivo studies tracked individual MPIO clusters over 3 days, and tracked clusters were corroborated in ex vivo brain scans. Additionally, we applied PDQ to rat hearts infiltrated by MPIO-labeled macrophages in a transplant model of organ rejection. PDQ magnetic measurements were signal-to-noise ratio invariant for images with signal-to-noise ratio > 11. PDQ can be used with conventional gradient-echo pulse sequences, requiring no extra scan time. The method is useful for visualizing biodistribution of cells and theranostic magnetocapsules and for measuring their relative iron content. Magn Reson Med, 2011. (C) 2011 Wiley-Liss, Inc.	[Mills, Parker H.; Hitchens, T. Kevin; Foley, Lesley M.; Ye, Qing; Ho, Chien; Ahrens, Eric T.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Mills, Parker H.; Hitchens, T. Kevin; Foley, Lesley M.; Ye, Qing; Ho, Chien; Ahrens, Eric T.] Carnegie Mellon Univ, Pittsburgh NMR Ctr Biomed Res, Pittsburgh, PA 15213 USA; [Link, Thomas; Weiss, Clifford R.; Arepally, Aravind; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Link, Thomas; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Link, Thomas; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Cellular Imaging Sect, Baltimore, MD USA; [Link, Thomas; Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Biol Program, Baltimore, MD USA; [Thompson, Joe D.] Los Alamos Natl Lab, Div Mat Sci & Technol, Grp 10, Los Alamos, NM 87545 USA; [Gilson, Wesley D.] Siemens Corp Res, Baltimore, MD USA; [Melick, John A.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bulte, Jeff W. M.] Johns Hopkins Univ, Sch Med, Dept Chem & Biomol Engn, Baltimore, MD USA		Ahrens, ET (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	eta@andrew.cmu.edu	Mills, Parker Henry/I-4563-2012; Kochanek, Patrick M/D-2371-2015; Ho, Chien/O-6112-2016; Bulte, Jeff W.M./A-3240-2008	Mills, Parker Henry/0000-0002-0715-3531; Kochanek, Patrick M/0000-0002-2627-913X; Ho, Chien/0000-0002-4094-9232; Bulte, Jeff W.M./0000-0003-1202-1610	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-EB005740, R01-CA134633, R01-EB003453, R01-HL081349, R01-EB007825, P41-EB001977]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA134633] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL081349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB003453, P41EB001977, R01EB007825, R01EB005740] Funding Source: NIH RePORTER	Grant sponsor: National Institutes of Health; Grant numbers: R01-EB005740, R01-CA134633, R01-EB003453, R01-HL081349, R01-EB007825, P41-EB001977.	Bakker CJG, 2008, PHYS MED BIOL, V53, pN349, DOI 10.1088/0031-9155/53/18/N02; Bakker CJG, 2006, MAGN RESON MED, V56, P1107, DOI 10.1002/mrm.21069; Bakker CJG, 2006, MAGNET RESON MED, V55, P92, DOI 10.1002/mrm.20733; BANKS MA, 1991, COMP BIOCHEM PHYS B, V100, P795, DOI 10.1016/0305-0491(91)90292-L; Barnett BP, 2007, NAT MED, V13, P986, DOI 10.1038/nm1581; Bomati-Miguel O, 2005, BIOMATERIALS, V26, P5695, DOI 10.1016/j.biomaterials.2005.02.020; Bos C, 2003, MAGNET RESON MED, V50, P400, DOI 10.1002/mrm.10505; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256; Chavez S, 2002, IEEE T MED IMAGING, V21, P966, DOI 10.1109/TMI.2002.803106; Cunningham CH, 2005, MAGNET RESON MED, V53, P999, DOI 10.1002/mrm.20477; Dixon WT, 2009, MAGN RESON MED, V61, P1132, DOI 10.1002/mrm.21930; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Foster-Gareau P, 2003, MAGN RESON MED, V49, P968, DOI 10.1002/mrm.10417; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Griffiths DJ, 1999, INTRO ELECTRODYNAMIC, P269; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Jenkinson M, 2003, MAGNET RESON MED, V49, P193, DOI 10.1002/mrm.10354; Lai S, 1996, MAGNET RESON MED, V36, P781, DOI 10.1002/mrm.1910360518; Mani V, 2006, MAGN RESON MED, V55, P126, DOI 10.1002/mrm.20739; McAuley G, 2010, MAGN RESON MED, V63, P106, DOI 10.1002/mrm.22185; MENDONCADIAS MH, 1983, SEMIN NUCL MED, V13, P364, DOI 10.1016/S0001-2998(83)80048-8; Mills PH, 2008, MAGN RESON IMAGING, V26, P618, DOI 10.1016/j.mri.2008.01.007; Mills PH, 2009, MAGN RESON MED, V62, P1349, DOI 10.1002/mrm.22127; Mowat P, 2007, NMR BIOMED, V20, P21, DOI 10.1002/nbm.1084; Muja N, 2009, PROG NUCL MAG RES SP, V55, P61, DOI 10.1016/j.pnmrs.2008.11.002; Nieman BJ, 2010, NEUROIMAGE, V50, P456, DOI 10.1016/j.neuroimage.2009.12.107; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Qiu BS, 2010, MAGN RESON MED, V63, P1437, DOI 10.1002/mrm.22348; Robson MD, 2003, J COMPUT ASSIST TOMO, V27, P825, DOI 10.1097/00004728-200311000-00001; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Seppenwoolde JH, 2003, MAGNET RESON MED, V50, P784, DOI 10.1002/mrm.10574; SHEN T, 1993, MAGN RESON MED, V29, P599, DOI 10.1002/mrm.1910290504; Stuber M, 2007, MAGN RESON MED, V58, P1072, DOI 10.1002/mrm.21399; Walczak P, 2005, MAGN RESON MED, V54, P769, DOI 10.1002/mrm.20701; Warren WS, 1998, SCIENCE, V281, P247, DOI 10.1126/science.281.5374.247; Williams JB, 2007, J MAGN RESON IMAGING, V25, P1210, DOI 10.1002/jmri.20930; Wu YL, 2006, P NATL ACAD SCI USA, V103, P1852, DOI 10.1073/pnas.0507198103; Yang JX, 2010, CYTOTHERAPY, V12, P251, DOI 10.3109/14653240903446910; Ye Q, 2008, CIRCULATION, V118, P149, DOI 10.1161/CIRCULATIONAHA.107.746354	40	22	22	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0740-3194	1522-2594		MAGN RESON MED	Magn. Reson. Med.	JAN	2012	67	1					278	289		10.1002/mrm.22998			12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	867VL	WOS:000298482800032	21656554	Green Accepted, Bronze, Green Submitted			2022-02-06	
S	North, SH; Shriver-Lake, LC; Taitt, CR; Ligler, FS		Cooks, RG; Yeung, ES		North, Stella H.; Shriver-Lake, Lisa C.; Taitt, Chris R.; Ligler, Frances S.			Rapid Analytical Methods for On-Site Triage for Traumatic Brain Injury	ANNUAL REVIEW OF ANALYTICAL CHEMISTRY, VOL 5	Annual Review of Analytical Chemistry		English	Article; Book Chapter						TBI; biomarkers; biosensors; pathophysiology; rapid detection	OF-CARE TESTS; CEREBROSPINAL-FLUID; BIOMARKER DISCOVERY; CELL-DEATH; DIAGNOSING INFECTIONS; PROTEIN BIOMARKERS; PLASMA PROTEOME; SERUM; NEUROPROTEOMICS; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) results from an event that causes rapid acceleration and deceleration of the brain or penetration of the skull with an object. Responses to stimuli and questions, loss of consciousness, and altered behavior are symptoms currently used to justify brain imaging for diagnosis and therapeutic guidance. Tests based on such symptoms are susceptible to false-positive and false-negative results due to stress, fatigue, and medications. Biochemical markers of neuronal damage and the physiological response to that damage are being identified. Biosensors capable of rapid measurement of such markers in the circulation offer a solution for on-site triage, as long as three criteria are met: (a) Recognition reagents can be identified that are sufficiently sensitive and specific, (b) the biosensor can provide quantitative assessment of multiple markers rapidly and simultaneously, and (c) both the sensor and reagents are designed for use outside the laboratory.	[North, Stella H.; Shriver-Lake, Lisa C.; Taitt, Chris R.; Ligler, Frances S.] USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA		North, SH (corresponding author), USN, Res Lab, Ctr Biomol Sci & Engn, Washington, DC 20375 USA.	stella.north@nrl.navy.mil; lisa.shriverlake@nrl.navy.mil; chris.taitt@nrl.navy.mil; frances.ligler@nrl.navy.mil		Taitt, Chris/0000-0002-0125-9239			Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; Bele S, 2009, NEUROTRAUMA CRITICAL, P42; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Berger RP, 2006, CLIN PEDIATR EMERG M, V7, P186, DOI 10.1016/j.cpem.2006.06.001; Bissonnette L, 2010, CLIN MICROBIOL INFEC, V16, P1044, DOI 10.1111/j.1469-0691.2010.03282.x; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; Brain Inj. Assoc. Am, 2011, LIV BRAIN INJ; Brain Trauma Found. n.d, TBI STAT FACTS TBI U; Brewin B., 2011, BATTL BRAIN INJ ASS; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Centers for Disease Control and Prevention (CDC), 2011, INJ PREV CONTR TRAUM; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cheng CM, 2009, LAB CHIP, V9, P2339, DOI 10.1039/b907860f; Clerc O, 2010, CLIN MICROBIOL INFEC, V16, P1054, DOI 10.1111/j.1469-0691.2010.03281.x; Conrads TP, 2006, BIOTECHNIQUES, V40, P799, DOI 10.2144/000112196; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Davidsson P, 2002, NEUROREPORT, V13, P611, DOI 10.1097/00001756-200204160-00015; Def. Cent. Excell, 2011, AUT NEUR ASS METR; Def. Veterans Brain Inj. Cent, 2007, MIL AC CONC EV MACE; Defense and Veterans Brain Injury Center, 2009, MIL AC CONC EV MACE; Defense and Veterans Brain Injury Center, 2011, DOD WORLDW NUMB TRAU; Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56; Emanuel P, 2011, CHEM BIOL RAD TECHN; Frink M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/797383; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Gouix E, 2009, MOL CELL NEUROSCI, V40, P463, DOI 10.1016/j.mcn.2009.01.002; Griesmaier E, 2009, FUTUR NEUROL, V4, P469, DOI 10.2217/FNL.09.28; Halamek J, 2010, MOL BIOSYST, V6, P2554, DOI 10.1039/c0mb00153h; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Haskins WE, 2005, J NEUROTRAUM, V22, P629, DOI 10.1089/neu.2005.22.629; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holder S., 2008, MRI VERSUS CT SCAN D; Holder S., 2008, GLASGOW COMA SCALE; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; ImPACT Appl, 2011, OV FEAT IMPACT TEST; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Inst. Med. Natl. Acad, 2008, GULF WAR HLTH, V7; Int. Brain Inj. Assoc, 2010, BRAIN INJ FACTS; JANKOVIC BD, 1991, INT J NEUROSCI, V60, P119, DOI 10.3109/00207459109082042; JANKOVIC BD, 1991, INT J NEUROSCI, V58, P113, DOI 10.3109/00207459108987188; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kingsmore SF, 2006, NAT REV DRUG DISCOV, V5, P310, DOI 10.1038/nrd2006; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Korfias S, 2009, MINI-REV MED CHEM, V9, P227, DOI 10.2174/138955709787315994; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Leland A, 2010, FK32492 C REP SERV; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Manesh KM, 2009, BIOSENS BIOELECTRON, V24, P3569, DOI 10.1016/j.bios.2009.05.019; Matt P, 2008, PHYSIOL GENOMICS, V33, P12, DOI 10.1152/physiolgenomics.00282.2007; Mehta SS., 2009, CLIN NEUROSURG, V57, P134; Melo MR, 2011, CLIN CHEM LAB MED, V49, P581, DOI 10.1515/CCLM.2011.092; Mohammed MI, 2011, LAB CHIP, V11, P569, DOI 10.1039/c0lc00204f; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; North SH, 2011, FED INT C TRAUM BRAI; Olivecrona M, 2009, J NEUROL NEUROSUR PS, V80, P1241, DOI 10.1136/jnnp.2008.158196; Ottens AK, 2006, MASS SPECTROM REV, V25, P380, DOI 10.1002/mas.20073; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pedersen BK, 2000, IMMUNOL CELL BIOL, V78, P532, DOI 10.1046/j.1440-1711.2000.00962.x; Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x; Petzold A, 2007, NEUROL RES, V29, P691, DOI 10.1179/016164107X240080; Poletaev AB, 2000, AUTOIMMUNITY, V32, P33, DOI 10.3109/08916930008995985; Radi R., 2000, NITRIC OXIDE BIOL PA, P57; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Ryan L., 2005, TRAUMATIC BRAIN INJU; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salisbury D, 2005, TBI INFORM TRAUMATIC; Sande A, 2010, J VET EMERG CRIT CAR, V20, P177, DOI 10.1111/j.1476-4431.2010.00527.x; Sanfilippo Filippo, 2010, Front Biosci (Schol Ed), V2, P623; Sharma Pushpa, 2009, J Emerg Trauma Shock, V2, P67, DOI 10.4103/0974-2700.50739; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Streeter J, 2011, P SOC PHOTO-OPT INS, V8029; Sun FN, 2010, MOL CELL PROTEOMICS, V9, P963, DOI 10.1074/mcp.R900003-MCP200; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Dep. Def, 2011, DOD REP C EXP ACT TR; Venkatasubbarao S, 2011, P SOC PHOTO-OPT INS, V8029; Vista Life Sci, 2011, AUT NEUR ASS METR AN; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yeo LY, 2011, SMALL, V7, P12, DOI 10.1002/smll.201000946; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505; Zupanc GKH, 2007, PROTEOM CLIN APPL, V1, P1362, DOI 10.1002/prca.200700420	109	22	23	0	38	ANNUAL REVIEWS	PALO ALTO	4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA	1936-1327		978-0-8243-4405-4	ANNU REV ANAL CHEM	Annu. Rev. Anal. Chem.		2012	5						35	56		10.1146/annurev-anchem-062011-143105			22	Chemistry, Analytical; Spectroscopy	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Spectroscopy	BBR12	WOS:000307956200004	22462400				2022-02-06	
J	Urakami, Y				Urakami, Yuko			Relationship Between Sleep Spindles and Clinical Recovery in Patients With Traumatic Brain Injury: A Simultaneous EEG and MEG Study	CLINICAL EEG AND NEUROSCIENCE			English	Article						diffuse axonal injury; electroencephalography; magneoencephalography; recovery; sleep spindles		Few methods can predict the prognosis and outcome of traumatic brain injury. Electroencephalographic (EEG) examinations have prognostic significance in the acute stage of posttraumatic coma, and some EEG variables have been correlated with outcome. Furthermore, spindle activity and reactivity in the acute stage have been associated with good recovery. Assessments of consciousness based on EEG and magnetoencephalographic (MEG) recordings provide valuable information for evaluating residual function, forming differential diagnoses and estimating prognosis. This study objectively investigated how fast spindles could relate to the recovery of consciousness and cognitive function during the post-acute to chronic stages of diffuse axonal injuries (DAIs). Sleep stage 2 was examined in 7 healthy participants and 8 patients with DAIs. Simultaneous EEG and MEG recordings were performed in the post-acute (mean 80 days) and chronic (mean 151 days) stages of recovery. Magnetoencephalography enabled equivalent current dipole estimates of fast spindle sources. Clinical recovery was evaluated by consciousness, neuropsychological examination, and outcome. Six severe and two moderate injuries were studied in patients with favorable 1-year outcomes. In the sub-acute stage, significant decreases were detected in the frequency, amplitude, and cortical activation source strengths of spindle activities, but these recovered during the chronic stage. In the chronic stage, the Wechsler adult intelligence factor scale and subset patterning revealed significant improvement in cognitive function. These results suggested that spindles may reflect recovery of consciousness and cognitive function following a DAI.	Natl Rehabil Ctr Persons Disabil, Dept Med Treatment 1, Tokorozawa, Saitama 3598555, Japan		Urakami, Y (corresponding author), Natl Rehabil Ctr Persons Disabil, Dept Med Treatment 1, 4-1 Namiki, Tokorozawa, Saitama 3598555, Japan.	urakami-yuko@rehab.go.jp					ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BRICOLO A, 1976, CLIN ELECTROENCEPHAL, V7, P184, DOI 10.1177/155005947600700402; CHATRIAN GE, 1990, CURRENT PRACTICE CLI, P425; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; Gibbs FA, 1964, ATLAS ELECTROENCEPHA, V3, P90; Gottselig JM, 2002, BRAIN, V125, P373, DOI 10.1093/brain/awf021; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Ilonka M, 2003, CLIN NEUROPHYSIOL, V113, P1937; Kaplan PW, 2004, J CLIN NEUROPHYSIOL, V21, P307; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Merrit HH, 1990, MERRITS PRACTICE CLI, P425; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Morel A, 2005, EUR J NEUROSCI, V21, P1007, DOI 10.1111/j.1460-9568.2005.03921.x; Niedermeyer F., 2005, ELECTROENCEPHALOGRAP, P107; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Reilly E. L., 2005, ELECTROENCEPHALOGRAP, P139; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P420, DOI 10.1016/0013-4694(83)90224-9; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Urakami Y, 2008, J CLIN NEUROPHYSIOL, V25, P13, DOI 10.1097/WNP.0b013e318162a8a4; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031	26	22	23	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	JAN	2012	43	1					39	47		10.1177/1550059411428718			9	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	952FT	WOS:000304777400007	22423550				2022-02-06	
J	Yu, GF; Huang, Q; Dai, WM; Jie, YQ; Fan, XF; Wu, A; Lv, Y; Li, YP; Yan, XJ				Yu, Guo-Feng; Huang, Qiang; Dai, Wei-Min; Jie, Yuan-Qing; Fan, Xiao-Feng; Wu, An; Lv, Yao; Li, Yun-Ping; Yan, Xin-Jiang			Prognostic value of copeptin: One-year outcome in patients with traumatic brain injury	PEPTIDES			English	Article						Copeptin; Traumatic brain injury; 1-Year outcome	VASOPRESSIN PRECURSOR; STABLE PEPTIDE; CEREBRAL-ISCHEMIA; V-2 RECEPTORS; HEART-FAILURE; MORTALITY; DAMAGE; STROKE	High plasma copeptin level has been associated with one-month mortality after traumatic brain injury. However, not much is known regarding its relation with long-term outcome. Thus, we investigated the ability of copeptin to predict 1-year outcome in patients with traumatic brain injury. One hundred and six healthy controls and 106 patients with acute severe traumatic brain injury were included. Plasma samples were obtained on admission. Its concentration was measured by enzyme-linked immunosorbent assay. Forty-eight patients (45.3%) suffered from unfavorable outcome (Glasgow Outcome Scale score of 1-3) and 31 patients (29.2%) died in 1 year after traumatic brain injury. Upon admission, plasma copeptin level in patients was substantially higher than that in healthy controls. A forward stepwise logistic regression selected plasma copeptin level as an independent predictor for 1-year unfavorable outcome and mortality of patients. A receiver operating characteristic curve analysis showed plasma copeptin level predicted 1-year unfavorable outcome and mortality obviously. The predictive value of the copeptin concentration was thus similar to that of Glasgow Coma Scale score for the prediction of unfavorable outcome and mortality after 1 year. In a combined logistic-regression model, copeptin improved the area under curve of Glasgow Coma Scale score for the prediction of unfavorable outcome and mortality after 1 year, but the differences were not significant. Thus, copeptin level is a useful, complementary tool to predict functional outcome and mortality 1 year after traumatic brain injury. (C) 2011 Elsevier Inc. All rights reserved.	[Yu, Guo-Feng; Huang, Qiang; Dai, Wei-Min; Jie, Yuan-Qing; Fan, Xiao-Feng; Wu, An; Lv, Yao; Li, Yun-Ping; Yan, Xin-Jiang] Quzhou Peoples Hosp, Dept Neurosurg, Quzhou 324000, Peoples R China		Huang, Q (corresponding author), Quzhou Peoples Hosp, Dept Neurosurg, 2 Zhongloudi Rd, Quzhou 324000, Peoples R China.	quzhouhuangqiang@163.com					Asfar P, 2006, CRIT CARE CLIN, V22, P131, DOI 10.1016/j.ccc.2005.08.007; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Dong XQ, 2011, PEPTIDES, V32, P253, DOI 10.1016/j.peptides.2010.11.021; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; JENNETT B, 1975, LANCET, V1, P480; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Katan M, 2008, NEUROENDOCRINOL LETT, V29, P341; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kelly D, 2008, J CARD FAIL, V14, P739, DOI 10.1016/j.cardfail.2008.07.231; Kleindienst A, 2010, ACTA NEUROCHIR SUPPL, V106, P221, DOI 10.1007/978-3-211-98811-4_41; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Molnar AH, 2008, ACTA NEUROCHIR, V150, P265, DOI 10.1007/s00701-007-1400-1; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Stoiser B, 2006, EUR J CLIN INVEST, V36, P771, DOI 10.1111/j.1365-2362.2006.01724.x; Struck J, 2005, PEPTIDES, V26, P2500, DOI 10.1016/j.peptides.2005.04.019; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Urwyler SA, 2010, STROKE, V41, P1564, DOI 10.1161/STROKEAHA.110.584649; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Xu Miao, 2007, Chin J Traumatol, V10, P90; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	23	22	25	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	JAN	2012	33	1					164	169		10.1016/j.peptides.2011.11.017			6	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	889KR	WOS:000300073100022	22138140				2022-02-06	
J	Zampolini, M; Zaccaria, B; Tolli, V; Frustaci, A; Franceschini, M				Zampolini, M.; Zaccaria, B.; Tolli, V.; Frustaci, A.; Franceschini, M.		GISCAR Grp	Rehabilitation of traumatic brain injury in Italy: A multi-centred study	BRAIN INJURY			English	Article						Closed head injury; rehabilitation; persistent vegetative state; outcome	LENGTH-OF-STAY; EPIDEMIOLOGY; PREDICTORS; OUTCOMES; IMPACT	Objectives: The aims of this study were to analyse TBI rehabilitation in Italy, identifying the main factors conditioning motor and functional recovery and destination upon discharge of traumatic severe acquired brain injury (sABI) patients who had undergone intensive rehabilitative treatment. Design: An observational prospective study of 863 consecutive patients admitted to 52 Rehabilitation Centres from January 2001 to December 2003. Results: The main cause of trauma was road accidents (79.8%), the mean length of stay was 87.31 +/- 77.26 days and 40.4% access to rehabilitation facilities after a month. Pressure sore rates fell from 26.1% to 6.6% during the rehabilitation programme. After discharge 615 patients returned home, whilst 212 were admitted to other health facilities. Discussion: This study highlights some major criticisms of rehabilitation of TBI. The delay of admission and evitable complications such as pressure sores are correlated to a worse outcome. While LOS causes a problem of cost-effectiveness, the rate of home discharge is prevalent and very high compared with other studies.	[Zampolini, M.] ASL N 3, Dept Rehabil, Umbria, Italy; [Zaccaria, B.] Univ Hosp, Dept Rehabil, Parma, Italy; [Tolli, V.] Inst San Raffaele Velletri, Rehabil Unit, Rome, Italy; [Franceschini, M.] IRCCS San Raffaele Pisana, Dept Neurorehabil, Rome, Italy		Zampolini, M (corresponding author), Foligno Hosp, Via M Arcamone, I-06034 Foligno, PG, Italy.	mauro.zampolini@tin.it	Zampolini, Mauro/B-7749-2009; Frustaci, Alessandra/I-9378-2012; Castelli, Enrico/J-1887-2012	Franceschini, Marco/0000-0002-2131-1583	'La Regione d'Umbria', Italy	Financial disclosure statements have been obtained and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article. This study has been carried out with funds provided by 'La Regione d'Umbria', Italy. The authors do not have economic benefits from this study. Preliminary data from this study has been presented at various meetings and congresses.	Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Mammi P, 2006, Eura Medicophys, V42, P17; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Ottenbacher KJ, 2004, JAMA-J AM MED ASSOC, V292, P1687, DOI 10.1001/jama.292.14.1687; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Sirois MJ, 2004, ARCH PHYS MED REHAB, V85, P184, DOI 10.1016/j.apmr.2003.06.009; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; von Wild K R, 2000, Neurol Neurochir Pol, V34, P138; Zampolini M, 2003, GIORNALE ITALIANO ME, V17, P15; ZAMPOLINI M, 2001, 4 WORLD C BRAIN INJ, P427	20	22	22	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2012	26	1					27	35		10.3109/02699052.2011.635358			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858HY	WOS:000297787900003	22149442				2022-02-06	
J	Peterson, EC; Chesnut, RM				Peterson, Eric Cecala; Chesnut, Randall M.			Talk and Die Revisited: Bifrontal Contusions and Late Deterioration	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Traumatic Brain Injury; Bifrontal Contusions; Late Deterioration	PROGRESSION; HEMORRHAGE	Background: Severe bifrontal contusions in an awake traumatic brain injury (TBI) patient is a challenging clinical picture, as they are prone to late deterioration. We evaluated our series of patients with severe bifrontal contusions, characterizing their clinical course and suggestions for management. Methods: We examined a prospectively collected database of TBIs for patients with severe bifrontal contusions, defined as >30 cm(3). Only patients with Glasgow Coma Scale score of 10 or greater were included. Patients were divided into two groups: deterioration and nondeterioration. Clinical variables were compared between the two groups. Results: Thirteen patients met the above criteria. The mean Glasgow Coma Scale score was 13, and all were low mechanism injuries. All patients were managed with intensive care unit observation and hyperosmolar therapy to maintain serum osmolarity >300. Overall, 7 of 13 (54%) suffered an acute clinical deterioration a mean of 4.5 days postinjury. Of those managed with immediate surgical decompression, all had good outcomes and returned to work. There was no difference in contusion or edema volumes between the two groups. Conclusions: Awake patients with bifrontal contusions represent a unique cohort of TBI patients who are prone to rapid deterioration late in their clinical course. They have extensive frontal edema and mass effect, yet we were unable to find a correlation between edema volumes and incidence of deterioration. Based on this series and our experience in other TBI patients, we no longer utilize prophylactic infusions of hypertonic saline in the setting of TBI. We recommend managing these patients with intensive care unit admission and early intracranial pressure monitoring. If they do deteriorate despite these measures, rapid bifrontal decompression can lead to good functional outcomes.	[Peterson, Eric Cecala; Chesnut, Randall M.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Peterson, EC (corresponding author), Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.	ericpete@uw.edu		Chesnut, Randall/0000-0001-6377-3666			Alahmadi H, 2009, J NEUROSURG; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; KATAYAMA Y, 1990, ACT NEUR S, V51, P308; Lee TT, 1997, SURG NEUROL, V48, P333, DOI 10.1016/S0090-3019(96)00483-1; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Rehman Tausif, 2008, Cases J, V1, P203, DOI 10.1186/1757-1626-1-203; STATHAM PF, 1989, J NEUROL NEUROSUR PS, V52, P351, DOI 10.1136/jnnp.52.3.351; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f	13	22	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1588	1592		10.1097/TA.0b013e31822b791d			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	869RT	WOS:000298616400025	22182868				2022-02-06	
J	Stewart, TC; Polgar, D; Gilliland, J; Tanner, DA; Girotti, MJ; Parry, N; Fraser, DD				Stewart, Tanya Charyk; Polgar, Denise; Gilliland, Jason; Tanner, David A.; Girotti, Murray J.; Parry, Neil; Fraser, Douglas D.			Shaken Baby Syndrome and a Triple-Dose Strategy for Its Prevention	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Shaken Baby Syndrome; Epidemiology; Evaluation; Geographic information systems	NONACCIDENTAL HEAD-INJURY; TRAUMATIC BRAIN-INJURY; CHANGE KNOWLEDGE; YOUNG-CHILDREN; INFANTS; MALTREATMENT	Objectives: Inflicted traumatic brain injury associated with Shaken Baby Syndrome (SBS) is a leading cause of injury mortality and morbidity in infants. A triple-dose SBS prevention program was implemented with the aim to reduce the incidence of SBS. The objectives of this study were to describe the epidemiology of SBS, the triple-dose prevention program, and its evaluation. Methods: Descriptive and spatial epidemiologic profiles of SBS cases treated at Children's Hospital, London Health Sciences Centre, from 1991 to 2010 were created. Dose 1 (in-hospital education): pre-post impact evaluation of registered nurse training, with a questionnaire developed to assess parents' satisfaction with the program. Dose 2 (public health home visits): process evaluation of additional education given to new parents. Dose 3 (media campaign): a questionnaire developed to rate the importance of factors on a 7-point Likert scale. These factors were used to create weights for statistical modeling and mapping within a geographic information system to target prevention ads. Results: Forty-three percent of severe infant injuries were intentional. A total of 54 SBS cases were identified. The mean age was 6.7 months (standard deviation, 10.9 months), with 61% of infant males. The mean Injury Severity Score was 26.3 (standard deviation, 5.5) with a 19% mortality rate. Registered nurses learned new information on crying patterns and SBS, with a 47% increase in knowledge posttraining (p < 0.001). Over 10,000 parents were educated in-hospital, a 93% education compliance rate. Nearly all parents (93%) rated the program as useful, citing "what to do when the crying becomes frustrating" as the most important message. Only 6% of families needed to be educated during home visits. Locations of families with a new baby, high population density, and percentage of lone parents were found to be the most important factors for selecting media sites. The spatial analysis revealed six areas needed to be targeted for ad locations. Conclusions: SBS is a devastating intentional injury that often results in poor outcomes for the child. Implementing a triple-dose prevention program that provides education on crying patterns, coping strategies, and the dangers of shaking is key to SBS prevention. The program increased knowledge. Parents rated the program as useful. The media campaign allowed us to extend the primary prevention beyond new parents to help create a cultural change in the way crying, the primary trigger for SBS, is viewed. Targeting our intervention increased the likelihood that our message was reaching the population in greatest need.	[Stewart, Tanya Charyk; Polgar, Denise; Tanner, David A.; Girotti, Murray J.] London Hlth Sci Ctr, Trauma Program, London, ON, Canada; Childrens Hosp, London, ON, Canada; [Stewart, Tanya Charyk; Girotti, Murray J.; Parry, Neil] Univ Western Ontario, Dept Surg, Schulich Sch Med & Dent, London, ON N6A 3K7, Canada; [Gilliland, Jason] Univ Western Ontario, Dept Geog, Human Environm Anal Lab, London, ON N6A 5C2, Canada; [Gilliland, Jason; Fraser, Douglas D.] Univ Western Ontario, Schulich Sch Med & Dent, Childrens Hlth Res Inst, London, ON, Canada; [Gilliland, Jason; Fraser, Douglas D.] Univ Western Ontario, Schulich Sch Med & Dent, Lawson Hlth Res Inst, London, ON, Canada; [Parry, Neil] Univ Western Ontario, Schulich Sch Med & Dent, Div Crit Care Med, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, Schulich Sch Med & Dent, Ctr Crit Illness Res, London, ON, Canada; [Fraser, Douglas D.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada		Stewart, TC (corresponding author), London Hlth Sci Ctr, Trauma Program, London, ON, Canada.	tanya.charyk@lhsc.on.ca	University, HEAL Western/T-1323-2019; Gilliland, Jason A/E-3393-2019; El-Bagdady, Moe/S-8621-2019	Gilliland, Jason A/0000-0002-2909-2178; 	Children's Health Foundation; Middlesex-London Health Unit for media campaign; LHSC	Supported by The Children's Health Foundation, whose grant has allowed our team to increase the injury prevention programming for children in Southwestern Ontario. Supported also by the Middlesex-London Health Unit for media campaign and donated media time from 1031 FRESH FM in London, Ontario, Canada.; We thank Bonnie Wooten for her involvement in this endeavor. We appreciate the collaborative efforts of the National Center for Shaken Baby Syndrome throughout this project. We also thank Joyce Williamson, Cynthia Dettloff, and Jane Harrington of the Trauma Program, LHSC for providing data and support for the preparation of this manuscript.	ALEXANDER R, 1990, AM J DIS CHILD, V144, P724, DOI 10.1001/archpedi.1990.02150300124032; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr R.G, 2004, PERIOD PURPLE CRYING; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Barr RG, 2009, PEDIATRICS, V123, P972, DOI 10.1542/peds.2008-0908; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; Brewster AL, 1998, CHILD ABUSE NEGLECT, V22, P91, DOI 10.1016/S0145-2134(97)00132-4; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Canada Health, 2001, JOINT STAT SHAK BAB; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Charyk Stewart T, 2010, CHILDRENS HLTH ENV; Cusimano MD, 2007, INJURY PREV, V13, P51, DOI 10.1136/ip.2006.012468; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DYKES LJ, 1986, CHILD ABUSE NEGLECT, V10, P211, DOI 10.1016/0145-2134(86)90082-7; Ernst JS, 2000, CHILD WELFARE, V79, P555; Ettaro L, 2004, CHILD ABUSE NEGLECT, V28, P1099, DOI 10.1016/j.chiabu.2004.06.006; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Goulet C, 2009, JOGNN-J OBST GYN NEO, V38, P7, DOI 10.1111/j.1552-6909.2008.00301.x; Kairys SW, 2001, PEDIATRICS, V108, P206; Karandikar S., 2004, CHILD ABUSE REV, V13, P178, DOI DOI 10.1002/CAR.850; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WJ, 2003, CAN MED ASSOC J, V168, P155; Levitt CJ, 1994, CHILD ABUSE MED DIAG, P1; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; Minns RA, 2008, AM J PREV MED, V34, pS126, DOI 10.1016/j.amepre.2008.01.016; Nagler J, 2002, CURR OPIN PEDIATR, V14, P251, DOI 10.1097/00008480-200204000-00019; Noar SM, 2006, J HEALTH COMMUN, V11, P21, DOI 10.1080/10810730500461059; Reece RM, 2010, WHITE PAPER SHAKEN B; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Runyan DK, 2008, AM J PREV MED, V34, pS112, DOI 10.1016/j.amepre.2008.01.011; Runyan DK, 2009, SOC MARK Q, V15, P2, DOI 10.1080/15245000903304635; Russell BS, 2008, CHILD ABUSE NEGLECT, V32, P949, DOI 10.1016/j.chiabu.2008.05.002	34	22	22	1	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1801	1807		10.1097/TA.0b013e31823c484a			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	869RT	WOS:000298616400066	22182892				2022-02-06	
J	Baker, AJ; Topolovec-Vranic, J; Michalak, A; Pollmann-Mudryj, MA; Ouchterlony, D; Cheung, B; Tien, HC				Baker, Andrew J.; Topolovec-Vranic, Jane; Michalak, Alicja; Pollmann-Mudryj, Mary-Ann; Ouchterlony, Donna; Cheung, Bob; Tien, Homer C.			Controlled Blast Exposure During Forced Explosive Entry Training and Mild Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Adult; Blast injuries; Humans; Traumatic brain injury	POSTURAL STABILITY; HEAD-INJURY; PERFORMANCE; HISTORY	Background: There is a paucity of data regarding the pathophysiology and short- and long-term neurologic consequences of primary blast injury in humans. The purpose of this investigation was to test the feasibility of implementing a research protocol in the context of a forced explosive entry training course. Methods: Instructors (n = 4) and students (n = 10) completing the Police Explosives Technicians-Forced Entry Instructors course were recruited to participate in the study. Participants underwent a physical examination, tests of postural stability and vestibular ataxia, and a neurocognitive battery 1 day before and 10 days following practical forced explosive entry exercises. Results: The instructors reported significantly more blast exposures in their careers than the students (p < 0.05). Seventy-five percent of the instructors and 50% of the students reported a history of trauma to the head. A minority of the participants had deficits on cranial nerve, vestibular ataxia, and neurocognitive tests which did not change significantly postexposure. All the instructors and most of the students (90%) demonstrated postural stability deficits at baseline which did not change significantly postexposure. Conclusions: Studying the effects of blast exposure on the human brain in a controlled experimental setting is not possible. Forced explosive entry training courses afford an opportunity to begin examining this issue in real time in a controlled setting. This study underscores the importance of baseline testing of troops, of the consideration of subclinical implications of blast exposure, and of continued studies of the effects of blast exposures, including repeated exposures on the human brain.	[Tien, Homer C.] Sunnybrook Hlth Sci Ctr, Trauma Program, Dept Surg, Toronto, ON M4N 3M5, Canada; [Baker, Andrew J.] Univ Toronto, Dept Anesthesia, Interdept Div Crit Care Med, Toronto, ON, Canada; [Baker, Andrew J.] St Michaels Hosp, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane; Michalak, Alicja; Pollmann-Mudryj, Mary-Ann; Ouchterlony, Donna] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Cheung, Bob] Def Res & Dev Canada, Toronto, ON, Canada		Tien, HC (corresponding author), Sunnybrook Hlth Sci Ctr, Trauma Program, Dept Surg, H186-2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	homer.tien@sunnybrook.ca	Pollmann-Mudryj, Mary Ann/AAC-9047-2019; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212; Pollmann-Mudryj, Mary Ann/0000-0003-2244-8116	Canadian Forces Health Services	Supported by Canadian Forces Health Services.	ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Benton AL, 1994, MULTILINGUAL APHASIA; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; CAEYENBERGHS K, 2009, HUM BRAIN MAPP; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Coupland RM, 1999, BRIT MED J, V319, P407, DOI 10.1136/bmj.319.7207.407; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Graybiel A, 1966, Acta Otolaryngol, V61, P292, DOI 10.3109/00016486609127066; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Heaton R. K., 2004, REVISED COMPREHENSIV; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; McHugh T, 2006, BRAIN COGNITION, V60, P209; McMinn M. R., 1988, CLIN NEUROPSYCHOL, V2, P67, DOI [10.1080/13854048808520087, DOI 10.1080/13854048808520087]; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Reitan RM, 1985, HALSTEADREITAN NEURO; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Smith A., 1991, SYMBOL DIGIT MODALIT; Spreen, 2006, COMPENDIUM NEUROPSYC; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Westerman R., 2001, ADF HLTH, V2, P29	32	22	22	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71			1			S472	S477		10.1097/TA.0b013e318232e7da			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	849GE	WOS:000297112800015	22072006				2022-02-06	
J	Bechtel, K; Le, K; Martin, KD; Shah, N; Leventhal, JM; Colson, E				Bechtel, Kirsten; Le, Kim; Martin, Kimberly D.; Shah, Niyati; Leventhal, John M.; Colson, Eve			Impact of an Educational Intervention on Caregivers' Beliefs About Infant Crying and Knowledge of Shaken Baby Syndrome	ACADEMIC PEDIATRICS			English	Article						abusive head trauma; infant crying; parent education; shaken baby syndrome	TRAUMATIC BRAIN-INJURY; ABUSIVE HEAD TRAUMA; ADMISSIONS	OBJECTIVE: Shaken baby syndrome (SBS) is the leading cause of traumatic infant death. We examined whether the message about not shaking an infant should be included in the newborn anticipatory guidance provided by pediatric residents. The aim of this study was to determine the impact of an educational intervention (Take 5 Safety Plan for Crying) delivered by pediatric residents at newborn hospital discharge on beliefs about infant crying and knowledge of SBS among caregivers of young infants being treated in an urban primary care center. METHODS: Structured interviews were done in one convenience sample of caregivers before (historical control group) and in a second set of different caregivers after (intervention group) an educational intervention was implemented at hospital discharge. Logistic regression was used to calculate adjusted associations between the intervention and caregivers' beliefs/knowledge. RESULTS: One hundred ten caregivers were in the historical control group and 112 in the intervention group. The intervention group had more mothers and the infants were younger. Controlling for these differences, intervention group caregivers were more likely to state they would take a break if frustrated with infant crying (OR 3.10, 95% CI, 1.62-5.93), were more likely to state frustration caused infant shaking (OR 2.21, 95% CI, 1.20-4.20), and to state their knowledge of SBS was from hospital staff (OR 3.39, 95% CI, 1.61-4.20). CONCLUSION: This targeted postpartum intervention incorporated into newborn anticipatory guidance can influence caregivers' beliefs about infant crying and knowledge of SBS.	[Bechtel, Kirsten; Le, Kim; Shah, Niyati; Leventhal, John M.; Colson, Eve] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Martin, Kimberly D.] Yale Univ, Sch Publ Hlth, New Haven, CT 06510 USA		Bechtel, K (corresponding author), Yale New Haven Childrens Hosp, Sect Pediat Emergency Med, 100 York St,Suite 1F, New Haven, CT 06504 USA.	kirsten.bechtel@yale.edu	Bechtel, Kirsten/K-2147-2019		Connecticut Children's Trust, Hartford, Connecticut	This study was funded by the Connecticut Children's Trust Fund, Hartford, Connecticut (principal investigators John M. Leventhal and Kirsten Bechtel).	Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Barr RG, 2009, CAN MED ASSOC J, V180, P727, DOI 10.1503/cmaj.081419; Barr RG, 2009, PEDIATRICS, V123, P972, DOI 10.1542/peds.2008-0908; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; Colson ER, 2002, ARCH PEDIAT ADOL MED, V156, P717, DOI 10.1001/archpedi.156.7.717; Dias MS, 2005, PEDIATRICS, V115, DOI 10.1542/peds.2004-1896; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ellingson KD, 2008, AM J PREV MED, V34, pS157, DOI 10.1016/j.amepre.2007.12.021; HELFER RE, 1987, CHILD ABUSE NEGLECT, V11, P11, DOI 10.1016/0145-2134(87)90028-7; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kesler H, 2008, J NEUROSURG-PEDIATR, V1, P351, DOI 10.3171/PED/2008/1/5/351; Lee C, 2007, J DEV BEHAV PEDIATR, V28, P288, DOI 10.1097/DBP.0b013e3180327b55; McRury JM, 2010, J AM BOARD FAM MED, V23, P315, DOI 10.3122/jabfm.2010.03.090142; Reijneveld SA, 2004, LANCET, V364, P1340, DOI 10.1016/S0140-6736(04)17191-2; Russell BS, 2008, CHILD ABUSE NEGLECT, V32, P949, DOI 10.1016/j.chiabu.2008.05.002; Schnitzer PG, 2005, PEDIATRICS, V116, pE687, DOI 10.1542/peds.2005-0296; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454	18	22	23	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1876-2859	1876-2867		ACAD PEDIATR	Acad. Pediatr.	NOV-DEC	2011	11	6					481	486		10.1016/j.acap.2011.08.001			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	851MU	WOS:000297276000009	21940233				2022-02-06	
J	Meoded, A; Singhi, S; Poretti, A; Tekes, A; Tekes, A; Huisman, TAGM				Meoded, A.; Singhi, S.; Poretti, A.; Eran, A.; Tekes, A.; Huisman, T. A. G. M.			Tectorial Membrane Injury: Frequently Overlooked in Pediatric Traumatic Head Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							RETROCLIVAL EPIDURAL HEMATOMA; EXTRADURAL HEMATOMA; CLIVUS; TOMOGRAPHY; CHILDREN	REHs and tectorial membrane injuries are rare complications of pediatric head and neck injuries. We aim to describe the neuroimaging findings in pediatric REHs, to summarize the mechanism of injury, and to correlate the imaging findings with the clinical presentation. We retrospectively evaluated CT and/or MR imaging studies of 10 children with traumatic REH. Most patients were involved in MVAs. The tectorial membrane was injured in 70% of patients, and REHs were medium to large in 80%. None of the patients had a focal spinal cord or brain stem injury, craniocervical junction dislocation, or vertebral fractures. Tectorial membrane disruption was diagnosed in most patients without craniocervical junction related symptoms. Tectorial membrane lesions and REHs were seen in young children who sustained high-speed head and neck injuries. Clinical symptoms may be minimal or misleading. The radiologist should be aware of these injuries in children, MR imaging appears to be more sensitive than CT.	[Huisman, T. A. G. M.] Johns Hopkins Univ Hosp, Div Pediat Radiol, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; Johns Hopkins Univ Hosp, Div Neuroradiol, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA		Huisman, TAGM (corresponding author), Johns Hopkins Univ Hosp, Div Pediat Radiol, Russell H Morgan Dept Radiol & Radiol Sci, 600 N Wolfe St,B-173, Baltimore, MD 21287 USA.	thuisma1@jhmi.edu	Poretti, Andrea/H-6269-2019	Poretti, Andrea/0000-0002-9594-3858			Agrawal D, 2006, CHILD NERV SYST, V22, P670, DOI 10.1007/s00381-006-0059-x; Benedetti PF, 2000, AM J ROENTGENOL, V175, P661, DOI 10.2214/ajr.175.3.1750661; Coleman CC, 1941, ANN SURG, V113, P712, DOI 10.1097/00000658-194105000-00008; CORDOBES F, 1981, J NEUROSURG, V54, P179, DOI 10.3171/jns.1981.54.2.0179; HOOPER R, 1959, BRIT J SURG, V47, P71, DOI 10.1002/bjs.18004720114; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; Kwon TH, 2008, NEUROL MED-CHIR, V48, P347, DOI 10.2176/nmc.48.347; MCKISSOCK W, 1960, BRIT J SURG, V48, P155, DOI 10.1002/bjs.18004820814; Mizushima H, 1998, J NEUROSURG, V88, P590, DOI 10.3171/jns.1998.88.3.0590; Ratilal B, 2006, SURG NEUROL, V66, P200, DOI 10.1016/j.surneu.2005.11.030; Sun PP, 2000, J NEUROSURG, V93, P28, DOI 10.3171/spi.2000.93.1.0028; Tubbs RS, 2010, NEUROSURGERY, V67, P404, DOI 10.1227/01.NEU.0000372085.70895.E7; WERNE SVEN, 1957, ACTA ORTHOPAED SCAND SUPPL, V23, P1; Yama N, 2007, J TRAUMA, V62, P898, DOI 10.1097/01.ta.0000221058.72995.c9	14	22	23	0	2	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	NOV	2011	32	10					1806	1811		10.3174/ajnr.A2606			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	859PM	WOS:000297888300009	21852371	Green Published, hybrid			2022-02-06	
J	Tlustos, SJ; Chiu, CYP; Walz, NC; Taylor, HG; Yeates, KO; Wade, SL				Tlustos, Sarah J.; Chiu, C. -Y. Peter; Walz, Nicolay Chertkoff; Taylor, H. Gerry; Yeates, Keith Owen; Wade, Shari L.			Emotion Labeling and Socio-Emotional Outcomes 18 Months after Early Childhood Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Head injury; Emotion; Longitudinal studies; Social adjustment; Pediatric; Chronic brain injury	NONVERBAL-COMMUNICATION; FUNCTIONAL RECOVERY; READING EMOTIONS; SOCIAL OUTCOMES; HEAD-INJURY; SHORT-TERM; RECOGNITION; CHILDREN; VULNERABILITY; PREDICTORS	A growing body of literature has documented evidence for emotion labeling (EL) deficits after traumatic brain injury (TBI); however, long-term effects of TBI on EL abilities, particularly among young children, are unclear. We investigated EL abilities and socio-emotional outcomes in 32 children with moderate-severe TBI, 23 with complicated-mild TBI, and 82 children with orthopedic injuries (OI), shortly after injury and at 18 months post-injury. All children were between 3: 0 and 6: 11 years of age at the time of injury. Repeated measures analyses indicated that all groups showed improved EL performance between acute and 18-month assessments, but that the moderate-severe TBI group improved at a slower rate than the OI group, so that the two groups showed significantly different performance at 18 months. Emotion labeling ability did not significantly contribute to the prediction of socio-emotional outcomes after controlling for pre-injury functioning. These results provide preliminary evidence of emerging EL deficits after early childhood TBI that are related to injury severity but that do not predict social and behavioral outcomes. (JINS, 2011, 17, 1132-1142)	[Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA; [Tlustos, Sarah J.; Chiu, C. -Y. Peter] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Chiu, C. -Y. Peter] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH USA; [Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Dept Pediat, Cincinnati, OH 45229 USA; [Walz, Nicolay Chertkoff; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Yeates, Keith Owen] Ohio State Univ, Dept Pediat, Div Psychol, Columbus, OH 43210 USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA		Wade, SL (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Rehabil, 3333 Burnet Ave,MLC 4009, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; State of Ohio Emergency Medical Services; NIH/NCRRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [1UL1RR026314]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR026314] Funding Source: NIH RePORTER	This work is supported by grant R01 HD42729 from NICHD and by Trauma Research grants from the State of Ohio Emergency Medical Services. This publication was also supported by an Institutional Clinical and Translational Science Award, NIH/NCRR Grant Number 1UL1RR026314. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Portions of this work have been presented at the 8th World Congress on Brain Injury in Washington, DC (March 2010). The information in this manuscript is an original contribution to the literature and has not previously been published, electronically or in print. The authors certify that we know of no conflict of interest, and we adhere to the ethical guidelines of the Helsinki Declaration.	Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Crick NR, 1996, CHILD DEV, V67, P993, DOI 10.1111/j.1467-8624.1996.tb01778.x; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Denham SA, 2003, CHILD DEV, V74, P238, DOI 10.1111/1467-8624.00533; Eisenberg N, 2009, DEV PSYCHOL, V45, P988, DOI 10.1037/a0016213; Elliott C. D., 1990, DIFFERENTIAL ABILITI; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gouick J, 2004, TRAUMA, V6, P285, DOI DOI 10.1191/1460408604TA3230A; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Leerkes EM, 2008, MERRILL PALMER QUART, V54, P102, DOI 10.1353/mpq.2008.0009; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Merrell K. W., 2002, PRESCHOOL KINDERGART; Merrell KM., 2002, HOME COMMUNITY SOCIA; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Saarni C., 2006, HDB CHILD PSYCHOL SO, V3, P226, DOI DOI 10.1002/9780470147658.CHPSY0305; Schmidt AT, 2010, NEUROPSYCHOLOGIA, V48, P2869, DOI 10.1016/j.neuropsychologia.2010.05.029; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; TEASDALE G, 1974, LANCET, V2, P81; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; Tonks J, 2007, BRAIN INJURY, V21, P731, DOI 10.1080/02699050701426899; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Wetherington C. E., 2006, EXCEPTIONALITY, V14, P155, DOI [10.1207/s15327035-x1403_4, DOI 10.1207/S15327035-X1403_4]; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; [No title captured]	48	22	22	0	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2011	17	6					1132	1142		10.1017/S1355617711001202			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	848DF	WOS:000297028500020	21923972	Green Accepted			2022-02-06	
J	Liu, AA; Voss, HU; Dyke, JP; Heier, LA; Schiff, ND				Liu, A. A.; Voss, H. U.; Dyke, J. P.; Heier, L. A.; Schiff, N. D.			Arterial spin labeling and altered cerebral blood flow patterns in the minimally conscious state	NEUROLOGY			English	Article							ROUTINE CLINICAL-PRACTICE; BRAIN-FUNCTION; PERFUSION MRI; PARKINSONS-DISEASE; GLUCOSE-METABOLISM; ALZHEIMERS-DISEASE; VEGETATIVE STATE; DEFAULT MODE; AGE; HYPERPERFUSION	Objective: To use arterial spin labeling (ASL) to compare cerebral blood flow (CBF) patterns in minimally conscious state (MCS) patients with those in normal controls in an observational study design. Methods: Subjects meeting MCS criteria and normal controls were identified. A pseudocontinuous ASL sequence was performed with subjects and controls in the resting awake state. Multiple CBF values for 10 predetermined regions of interest were sampled and average CBF was calculated and compared between controls and subjects. Results: Ten normal controls were identified, with ages ranging from 26 to 54 years. Four subjects met the MCS criteria and received an ASL study, with one patient receiving a second study at a later date. Subjects ranged in age from 19 to 58 years and had traumatic brain injury, stroke, or hypoxic-ischemic encephalopathy. Regional CBF for controls ranged from 21.6 to 57.2 mL/100 g/min, with a pattern of relatively increased blood flow posteriorly including the posterior cingulate, parietal, and occipital cortices. CBF patterns for MCS subjects showed greater variability (from 7.7 to 33.1 mL/100 g/min), demonstrating globally decreased CBF in gray matter compared with that in normal controls, especially in the medial prefrontal and midfrontal regions. In the one subject studied longitudinally, global CBF values increased over time, which correlated with clinical improvement. Conclusions: We identified globally decreased CBF and a selective reduction of CBF within the medial prefrontal and midfrontal cortical regions as well as gray matter in MCS patients. ASL may serve as an adjunctive method to assess functional reserve in patients recovering from severe brain injuries. Neurology (R) 2011;77:1518-1523	[Liu, A. A.; Heier, L. A.; Schiff, N. D.] New York Presbyterian Cornell, Dept Neurol, New York, NY USA; [Voss, H. U.; Dyke, J. P.] Weill Cornell Med Coll, Dept Radiol, New York, NY USA		Liu, AA (corresponding author), Beth Israel Deaconess Harvard Univ, Kirstein 2,330 Brookline Ave, Boston, MA 02215 USA.	aaliu@bidmc.harvard.edu	Dyke, Jonathan P/AAX-4362-2020; Voss, Henning/C-2194-2009	Dyke, Jonathan P/0000-0001-7170-488X; Voss, Henning/0000-0003-2811-2074; Liu, Anli/0000-0002-1118-981X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD51912]; James S. McDonnell Foundation; NSFNational Science Foundation (NSF); NIH/NCCFUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH (NINDS, NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)NIH National Institute of Neurological Disorders & Stroke (NINDS); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD051912] Funding Source: NIH RePORTER	The authors thank David Alsop for providing the ASL pulse sequence for our MRI scanner and acknowledge the support of the NIH (HD51912) and the James S. McDonnell Foundation.; Dr. Liu reports no disclosures. Dr. Voss receives research support from the NIH and the NSF. Dr. Dyke reports no disclosures. Dr. Heier receives research support from the NIH/NCCF. Dr. Schiff has received travel support from and serves as a scientific consultant for Boston Scientific; receives publishing royalties for Plum and Posner's Diagnosis of Stupor and Coma 4th Edition (Oxford University Press, 2007); receives research support from the NIH (NINDS, NICHD) and the James S. McDonnell Foundation; is listed as an author on numerous patents re: Deep brain stimulation technology; and receives royalties for patents issued to Cornell University and licensed to Boston Scientific.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Alsop DC, 2008, NEUROIMAGE, V42, P1267, DOI 10.1016/j.neuroimage.2008.06.006; Balkin TJ, 2002, BRAIN, V125, P2308, DOI 10.1093/brain/awf228; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Deibler AR, 2008, AM J NEURORADIOL, V29, P1428, DOI 10.3174/ajnr.A1034; Deibler AR, 2008, AM J NEURORADIOL, V29, P1228, DOI 10.3174/ajnr.A1030; Deibler AR, 2008, AM J NEURORADIOL, V29, P1235, DOI 10.3174/ajnr.A1033; DEVOLDER AG, 1990, ARCH NEUROL-CHICAGO, V47, P197, DOI 10.1001/archneur.1990.00530020103022; Dupui P, 1984, Monogr Neural Sci, V11, P131; Dyke JP, 2007, AM J NEURORADIOL, V28, P1232, DOI 10.3174/ajnr.A0551; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; Giacino JT, 2005, PROG BRAIN RES, V150, P381, DOI 10.1016/S0079-6123(05)50027-X; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Jiang L, 2010, MAGN RESON IMAGING, V28, P1283, DOI 10.1016/j.mri.2010.05.002; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Lee C, 2009, J NEUROIMAGING, V19, P344, DOI 10.1111/j.1552-6569.2008.00277.x; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; Ma Y, 2007, MOL IMAGING BIOL, V9, P223, DOI 10.1007/s11307-007-0085-4; Ma YL, 2010, J CEREBR BLOOD F MET, V30, P505, DOI 10.1038/jcbfm.2009.256; MAMO H, 1983, ARCH NEUROL-CHICAGO, V40, P626, DOI 10.1001/archneur.1983.04050090062010; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schiff ND, 2005, PROG BRAIN RES, V150, P473, DOI 10.1016/S0079-6123(05)50033-5; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; Tshibanda L, 2010, NEURORADIOLOGY, V52, P15, DOI 10.1007/s00234-009-0614-8; TSUDA Y, 1989, STROKE, V20, P1667, DOI 10.1161/01.STR.20.12.1667; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; WILLIAMS S, 2009, ABSTR SOC NEUR; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462	37	22	25	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	OCT	2011	77	16					1518	1523		10.1212/WNL.0b013e318233b229			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	839TL	WOS:000296392000007	21940616	Green Published			2022-02-06	
J	Su, TM; Lee, TH; Huang, YH; Su, FW; Chen, WF				Su, Tsung-Ming; Lee, Tsung-Han; Huang, Yu-Hua; Su, Feng-Wen; Chen, Wu-Fu			Contralateral Subdural Effusion After Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury: Clinical Features and Outcome	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Contralateral subdural effusion; Decompressive craniectomy; Traumatic brain injury	HEAD-INJURY; COMPLICATIONS; SURGERY	Background: Contralateral subdural effusion (SDE) is usually considered as an uncommon complication after decompressive craniectomy (DC) for head trauma. This complication may need more aggressive treatment because of its tendency to cause midline shift and neurologic deterioration. In this article, we present our experience with this group of patients and discuss the diagnosis and management of this entity. Methods: This study included 13 patients with severe traumatic brain injury who developed contralateral SDE after DC. Clinical and radiographic information was obtained through a retrospective review of the medical records and the radiographs. Results: The average time from the procedure of DC to the diagnosis of contralateral SDE was 13 days. Deterioration of clinical condition or appearance of new symptoms/signs related to the contralateral SDE was noted in four patients. In the remaining nine patients without apparent clinical deterioration, the contralateral SDE was discovered on routine computed tomography scan. Six patients were treated conservatively and the contralateral SDE resolved gradually. In six patients who underwent burr hole craniectomy to evacuate the SDE, the operation had successfully drained the SDE in four patients. Two patients received subsequent subduroperitoneal shunt to manage the reaccumulation of SDE. In one patient, subduroperitoneal shunt and cranioplasty were performed simultaneously to treat the SDE. Subsequently, six patients (46.2%) developed hydrocephalus and underwent ventriculoperitoneal shunt operation. Conclusions: Contralateral SDE may not be a rare complication after DC. Its diagnosis may be delayed or missed when it is asymptomatic or the clinical condition of the patient masks its clinical manifestations. It may be reasonable to repeat a computed tomography scan to detect contralateral SDE 2 weeks to 3 weeks after DC, irrespective of the clinical condition. In addition, posttraumatic hydrocephalus is a common late consequence in these patients. Close surveillance in these patients is indicated to prompt appropriate management.	[Su, Tsung-Ming; Lee, Tsung-Han; Huang, Yu-Hua; Su, Feng-Wen; Chen, Wu-Fu] Chang Gung Univ, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Neurosurg,Coll Med, Kaohsiung Hsien, Taiwan; [Chen, Wu-Fu] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan		Chen, WF (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Kaohsiung Med Ctr, Dept Neurosurg,Coll Med, 123 Ta Pei Rd, Kaohsiung Hsien, Taiwan.	wfchen@ms29.hinet.net					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0947; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; JENNETT B, 1975, LANCET, V1, P480; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su FW, 2008, J CLIN NEUROSCI, V15, P305, DOI 10.1016/j.jocn.2006.08.019; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Yang XF, 2009, MED PRIN PRACT, V18, P16, DOI 10.1159/000163040	13	22	31	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2011	71	4					833	837		10.1097/TA.0b013e31821b092a			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	833ZT	WOS:000295925700017	21610528				2022-02-06	
J	Mannix, RC; Zhang, J; Park, J; Lee, C; Whalen, MJ				Mannix, Rebekah C.; Zhang, Jimmy; Park, Juyeon; Lee, Christopher; Whalen, Michael J.			Detrimental Effect of Genetic Inhibition of B-Site App-Cleaving Enzyme 1 on Functional Outcome after Controlled Cortical Impact in Young Adult Mice	JOURNAL OF NEUROTRAUMA			English	Article						beta-amyloid; traumatic brain injury	TRAUMATIC BRAIN-INJURY; AMYLOID PROTEIN DEPOSITION; ALZHEIMERS-DISEASE; BETA-SECRETASE; HEAD-INJURY; RISK-FACTOR; AGE; ASSOCIATION; PEPTIDE	beta-Amyloid (A beta) peptides, most notably associated with Alzheimer's disease, have been implicated in the pathogenesis of secondary injury after traumatic brain injury (TBI). A prior study has demonstrated that blocking the beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (Bace1) required for production of A beta from APP improved functional and histologic outcomes after controlled cortical impact (CCI) in aged mice. However, the majority of patients with severe TBI are young adults under the age of 40. Prior experimental models have suggested age-dependent differences in A beta clearance, and a recent study in our lab suggests that young animals remediate acute elevations in A beta after CCI better than older animals. We therefore tested the hypothesis that Bace1 deletion in young adult mice would not be protective after CCI. Male Bace1 knockout (Bace1(-/-)) and wild-type Bace1(+/+) (C57BL/6) mice (2-3 months old) were subjected to CCI (n=18-23/group) or sham injury (n=10-12/group). Functional outcomes were assessed with wire grip (motor) and the Morris water maze (MWM; spatial memory). Soluble A beta levels were assessed at 48 h after CCI. Histopathological outcomes were assessed by lesion and hippocampal volume. Clustered ordinal logistic regression showed overall significant impairment in motor performance in injured Bace1(-/-) versus Bace1(+/+) animals (p=0.003). No significant differences in MWM performance were found on repeated-measures ANOVA (p=0.11) between groups. Probe scores were significantly worse in injured Bace1(-/-) versus Bace1(+/+) mice (p=0.0009). Soluble A beta(40) was significantly lower in ipsilateral hemispheres of Bace1(-/-) than in Bace1(+/+) animals after CCI (0.9 [IQR 0.88-0.94] pmol/g protein versus 3.8 [IQR 2.4-6.0] pmol/g protein; p=0.005). Lesion and hippocampal volumes did not differ between injured groups. The data suggest that therapies targeting Bace1 may need to be tailored according to age and injury severity, as their use may exacerbate functional deficits after TBI in younger or less severely injured patients.	[Mannix, Rebekah C.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Emergency Med,Dept Med, Boston, MA 02115 USA; [Mannix, Rebekah C.; Zhang, Jimmy; Park, Juyeon; Lee, Christopher; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Neurosci, Charlestown, MA USA; [Zhang, Jimmy; Park, Juyeon; Lee, Christopher; Whalen, Michael J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pediat, Charlestown, MA USA		Mannix, RC (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Div Emergency Med,Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	Rebekah.Mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		National Institute of Child Health & Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K12HD052896]; Charles Hood Foundation; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5RO1NS047447]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD052896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047447] Funding Source: NIH RePORTER	This work was supported by grants from the National Institute of Child Health & Human Development 5K12HD052896 (R.C.M.), the Charles Hood Foundation (R.C.M.), and the National Institute of Neurological Disorders and Stroke 5RO1NS047447 (M.J.W.).	Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Brewer GJ, 1998, NEUROBIOL AGING, V19, P561, DOI 10.1016/S0197-4580(98)00091-8; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Marklund N, 2009, J NEUROSURG, V110, P1227, DOI 10.3171/2008.9.JNS08584; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Miners JS, 2010, BRAIN PATHOL, V20, P794, DOI 10.1111/j.1750-3639.2010.00375.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Placanica L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005088; Plant LD, 2003, J NEUROSCI, V23, P5531; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Venkitaramani DV, 2007, J NEUROSCI, V27, P11832, DOI 10.1523/JNEUROSCI.3478-07.2007	38	22	23	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2011	28	9					1855	1861		10.1089/neu.2011.1759			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	821AK	WOS:000294947000016	21639727	Green Published			2022-02-06	
J	Sutton, GP; Barchard, KA; Bello, DT; Thaler, NS; Ringdahl, E; Mayfield, J; Allen, DN				Sutton, Griffin P.; Barchard, Kimberly A.; Bello, Danielle T.; Thaler, Nicholas S.; Ringdahl, Erik; Mayfield, Joan; Allen, Daniel N.			Beery-Buktenica Developmental Test of Visual-Motor Integration Performance in Children With Traumatic Brain Injury and Attention-Deficit/Hyperactivity Disorder	PSYCHOLOGICAL ASSESSMENT			English	Article						Beery; Beery-Buktenica Developmental Test of Visual-Motor Integration; traumatic brain injury; attention-deficit/hyperactivity disorder; ADHD	TERM; RECOVERY	Evaluation of visuoconstructional abilities is a common part of clinical neuropsychological assessment, and the Beery-Buktenica Developmental Test of Visual-Motor Integration (VMI; K. E. Beery & N. A. Beery, 2004) is often used for this purpose. However, few studies have examined its psychometric properties when used to assess children and adolescents with traumatic brain injury (TBI) or attention-deficit/hyperactivity disorder (ADHD), even though these are among the most common acquired and neurodevelopmental forms of brain dysfunction in children. This study examined the validity of VMI scores in 123 children with TBI and 65 with ADHD. The TBI and ADHD groups performed significantly worse than the standardization sample, obtaining VMI mean scores of 87.2 (SD = 13.7) and 93.5 (SD = 11.27). Previous research has noted decrements in visuoconstructional abilities in TBI but relative sparing in ADHD. To examine the criterion validity of VMI scores, the authors therefore compared these 2 groups. As anticipated, the TBI group performed significantly worse than the ADHD group, but receiver operator characteristic analysis indicated that VMI scores were poor at discriminating between groups. Nonetheless, convergent validity evidence supported interpretation of VMI scores as measuring perceptual organization in both groups. In particular, principal components analysis indicated that VMI total scores loaded with perceptual organization tests from the Wechsler Intelligence Scale for Children, 3rd ed. (WISC-III; D. Wechsler, 1997), and its highest correlation was with the WISC-III Perceptual Organization Index. Also, the VMI correlated significantly with the Grooved Pegboard test for the group with TBI. These findings suggest that VMI scores are sensitive to visuoconstructional and motor deficits in children with developmental and acquired brain dysfunction.	[Sutton, Griffin P.; Barchard, Kimberly A.; Bello, Danielle T.; Thaler, Nicholas S.; Ringdahl, Erik; Allen, Daniel N.] Univ Nevada, Dept Psychol, Neuropsychol Res Program, Las Vegas, NV 89154 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, Neuropsychol Res Program, Las Vegas, NV 89154 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Beery K.E., 2004, BEERY BUKTENICA DEV; Brosseau-Lachaine O, 2008, BRAIN INJURY, V22, P657, DOI 10.1080/02699050802203353; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; GOLDSTEIN DJ, 1986, J CLIN PSYCHOL, V42, P890, DOI 10.1002/1097-4679(198611)42:6<890::AID-JCLP2270420611>3.0.CO;2-Y; Hall S, 1996, J CLIN PSYCHOL, V52, P449, DOI 10.1002/(SICI)1097-4679(199607)52:4<449::AID-JCLP10>3.0.CO;2-G; Hosmer D.W., 2000, APPL LOGISTIC REGRES, P375, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Kaplan BJ, 1998, HUM MOVEMENT SCI, V17, P471, DOI 10.1016/S0167-9457(98)00010-4; Kooistra L, 2005, J LEARN DISABIL-US, V38, P195, DOI 10.1177/00222194050380030201; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Piek JP, 1999, DEV MED CHILD NEUROL, V41, P159, DOI 10.1017/S0012162299000341; Pitcher TM, 2003, DEV MED CHILD NEUROL, V45, P525, DOI 10.1111/j.1469-8749.2003.tb00952.x; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLIAMS J, 1994, DEV NEUROPSYCHOL, V10, P19, DOI 10.1080/87565649409540563; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514; [No title captured]	20	22	23	1	55	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	2011	23	3					805	809		10.1037/a0023370			5	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	816TD	WOS:000294624100021	21875221				2022-02-06	
J	Genet, F; Jourdan, C; Lautridou, C; Chehensse, C; Minooee, K; Denormandie, P; Schnitzler, A				Genet, Francois; Jourdan, Claire; Lautridou, Christine; Chehensse, Clement; Minooee, Kambiz; Denormandie, Philippe; Schnitzler, Alexis			The Impact of Preoperative Hip Heterotopic Ossification Extent on Recurrence in Patients with Head and Spinal Cord Injury: A Case Control Study	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; BONE-FORMATION; EARLY EXCISION; RESECTION; ELBOW; HEMIPLEGIA; ANTIGENS; COMA; KNEE	Background: The preoperative Heterotopic Ossification (HO) extent is usually one of the main used criteria to predict the recurrence before excision. Brooker et al built a radiologic scale to assess this pre operative extent around the hip. The aim of this study is to investigate the relationship between the recurrence risk after hip HO excision in Traumatic Brain Injury (TBI) and Spinal Cord Injury (SCI) patients and the preoperative extent of HO. Methodology/Principal Findings: A case control study including TBI or SCI patients following surgery for troublesome hip HO with (case, n = 19) or without (control, n = 76) recurrence. Matching criteria were: sex, pathology (SCI or TBI) and age at the time of surgery (+/-4.5 years). For each etiology (TBI and SCI), the residual cognitive and functional status (Garland classification), the preoperative extent (Brooker status), the modified radiological and functional status (GCG-BD classification), HO localization, side, mean age at the CNS damage, mean delay for the first HO surgery, and for the case series, the mean operative delay for recurrence after the first surgical intervention were noted. Conclusions/Significance: The median delay for first HO surgery was 38.6 months (range 4.5 to 414.5;) for the case subgroup and 17.6 months (range 5.7 to 339.6) for the control group. No significant link was found between recurrence and operative delay (p = 0.51); the location around the joint (0.07); the Brooker (p = 0.52) or GCG-BD status (p = 0.79). Including all the matching factors, no significant relationship was found between the recurrence HO risk and the preoperative extent of troublesome hip HO using Brooker status (OR = 1.56(95% CI: 0.47-5.19)) or GCG-BD status (OR class 3 versus 2 = 0.67(95% CI: 0.11-4.24) and OR class 4 versus 2 = 0.79(95% CI: 0.09-6.91)). Until the pathophysiology of HO development is understood, it will be difficult to create tools which can predict HO recurrence.	[Genet, Francois; Jourdan, Claire; Chehensse, Clement; Schnitzler, Alexis] CHU R Poincare, Serv Med Phys & Readaptat, Garches, France; [Lautridou, Christine; Denormandie, Philippe] CHU R Poincare, Serv Chirurg Orthoped, Garches, France; [Minooee, Kambiz] CHU Erasme, Serv Rhumatol & Med Phys, Brussels, Belgium		Genet, F (corresponding author), CHU R Poincare, Serv Med Phys & Readaptat, Garches, France.	francois.genet@rpc.aphp.fr					BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chalidis B, 2007, J NEUROTRAUM, V24, P1675, DOI 10.1089/neu.2007.0342; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Denormandie P, 1999, Chir Main, V18, P99; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; Frischhut B, 1993, Acta Neurol (Napoli), V15, P114; Fuller DA, 2005, CLIN ORTHOP RELAT R, P197, DOI 10.1097/01.blo.0000170718.86747.da; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P531; GARLAND DE, 1989, CLIN ORTHOP RELAT R, P169; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; HAJEK VE, 1987, ARCH PHYS MED REHAB, V68, P313; Hendricks HT, 2010, EUR J NEUROL, V17, P1172, DOI 10.1111/j.1468-1331.2010.02989.x; Ippolito E, 1999, J HAND SURG-AM, V24A, P546; Ippolito E, 1999, CLIN ORTHOP RELAT R, P130, DOI 10.1097/00003086-199908000-00018; Lazarus MD, 1999, NEUROREHABILITATION, V12, P145; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; MINAIRE P, 1980, ARCH PHYS MED REHAB, V61, P214; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; ROSIN AJ, 1975, ANN RHEUM DIS, V34, P499, DOI 10.1136/ard.34.6.499; Sarafis KA, 1999, J TRAUMA, V46, P104, DOI 10.1097/00005373-199901000-00017; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; Seegenschmiedt MH, 2008, MED RADIOL RADIAT ON, P333, DOI 10.1007/978-3-540-68943-0_18; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Sorriaux G, 2005, REV CHIR ORTHOP, V91, P415, DOI 10.1016/S0035-1040(05)84358-2; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	33	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2011	6	8							e23129	10.1371/journal.pone.0023129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	827UM	WOS:000295454200044	21853078	Green Submitted, Green Published, gold			2022-02-06	
J	Legarda, SB; McMahon, D; Othmer, S; Othmer, S				Legarda, Stella B.; McMahon, Doreen; Othmer, Siegfried; Othmer, Sue			Clinical Neurofeedback: Case Studies, Proposed Mechanism, and Implications for Pediatric Neurology Practice	JOURNAL OF CHILD NEUROLOGY			English	Article						neurology; epilepsy; neurofeedback; electroencephalogram	OSCILLATIONS; EEG; STIMULATION; BIOFEEDBACK; CHILDREN	Trends in alternative medicine use by American health care consumers are rising substantially. Extensive literature exists reporting on the effectiveness of neurofeedback in the treatment of autism, closed head injury, insomnia, migraine, depression, attention deficit hyperactivity disorder, epilepsy, and posttraumatic stress disorder. We speculated that neurofeedback might serve as a therapeutic modality for patients with medically refractory neurological disorders and have begun referring patients to train with clinical neurofeedback practitioners. The modality is not always covered by insurance. Confident their child's medical and neurological needs would continue to be met, the parents of 3 children with epilepsy spectrum disorder decided to have their child train in the modality. The children's individual progress following neurofeedback are each presented here. A proposed mechanism and practice implications are discussed.	[Legarda, Stella B.] Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA; [Legarda, Stella B.] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [McMahon, Doreen] NOVA Neurointegrat Med, Maclean, VA USA; [Othmer, Siegfried; Othmer, Sue] BCIAC, EEG Inst, Biofeedback Certificat Inst Amer, Woodland Hills, CA USA		Legarda, SB (corresponding author), Georgetown Univ Hosp, Pasquerilla Healthcare Ctr, 3800 Reservoir Rd NW,2nd Floor, Washington, DC USA.	m.stella.legarda@gunet.georgetown.edu					ALADJALOVA NA, 1957, NATURE           MAY, P957; Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Boison D, 2010, EPILEPSIA, V51, P97, DOI 10.1111/j.1528-1167.2010.02883.x; Boulet SL, 2009, ARCH PEDIAT ADOL MED, V163, P19, DOI 10.1001/archpediatrics.2008.506; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; FEINSTEIN B, 1974, SLEEP RES, V3, P134; Fernandez T, 2003, CLIN ELECTROENCEPHAL, V34, P145, DOI 10.1177/155005940303400308; Gevensleben H, 2009, J CHILD PSYCHOL PSYC, V50, P780, DOI 10.1111/j.1469-7610.2008.02033.x; GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x; Kwon JS, 1996, J AFFECT DISORDERS, V40, P169, DOI 10.1016/0165-0327(96)00057-2; LEGARDA S, 2010, AM EP SOC 64 ANN M; Li TF, 2008, J CLIN INVEST, V118, P571, DOI 10.1172/JCI33737; Lorincz ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004447; LUDERS HO, 2004, DEEP BRAIN STIMULATI; Lundgren J, 1998, EPILEPSIA, V39, P809, DOI 10.1111/j.1528-1157.1998.tb01173.x; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Monto S, 2008, J NEUROSCI, V28, P8268, DOI 10.1523/JNEUROSCI.1910-08.2008; OTHMER S, 2008, PROTOCOL GUIDE NEURO; Parri HR, 2001, NEUROREPORT, V12, P3897, DOI 10.1097/00001756-200112210-00008; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Peniston E. G., 1991, MED PSYCHOTHERAPY, V4, P47, DOI DOI 10.1021/MA0483701; Price J, 2009, INTRODUCTION TO QUANTITATIVE EEG AND NEUROFEEDBACK: ADVANCED THEORY AND APPLICATIONS, 2ND EDITION, P453, DOI 10.1016/B978-0-12-374534-7.00017-4; Robbins Jim, 2008, SYMPHONY BRAIN EVOLU; Schrader LM, 2006, CLIN NEUROPHYSIOL, V117, P781, DOI 10.1016/j.clinph.2005.12.010; Sterman MB, 2006, APPL PSYCHOPHYS BIOF, V31, P21, DOI 10.1007/s10484-006-9002-x; STERMAN MB, 1974, EPILEPSIA, V15, P395, DOI 10.1111/j.1528-1157.1974.tb04016.x; STERMAN MB, 1969, ANN NY ACAD SCI, V157, P723, DOI 10.1111/j.1749-6632.1969.tb12916.x; STERMAN MB, 1978, EPILEPSIA, V19, P207, DOI 10.1111/j.1528-1157.1978.tb04483.x; Strehl U, 2006, PEDIATRICS, V118, pE1530, DOI 10.1542/peds.2005-2478; Tan G, 2009, CLIN EEG NEUROSCI, V40, P173, DOI 10.1177/155005940904000310; Thatcher RW, 2000, CLIN ELECTROENCEPHAL, V31, P38, DOI 10.1177/155005940003100110; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Walker J. E., 2002, J NEUROTHER, V6, P31, DOI DOI 10.1300/J184v06n02_05; WALKER JE, 2005, CHILD ADOLESC PSYCHI, V14, P153; Walker JE, 2011, CLIN EEG NEUROSCI, V42, P59, DOI 10.1177/155005941104200112; 2009, DYESS D HLTH NE 0731	36	22	23	1	21	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	AUG	2011	26	8					1045	1051		10.1177/0883073811405052			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	796WY	WOS:000293085400021	21576401				2022-02-06	
J	Morrison, LJ; Baker, AJ; Rhind, SG; Kiss, A; MacDonald, RD; Schwartz, B; Perreira, T; Simitciu, M; Trompeo, A; Black, SE; Stuss, DT; Rizoli, SB				Morrison, Laurie J.; Baker, Andrew J.; Rhind, Shawn G.; Kiss, Alex; MacDonald, Russell D.; Schwartz, Brian; Perreira, Tyrone; Simitciu, Merita; Trompeo, Anna; Black, Sandra E.; Stuss, Donald T.; Rizoli, Sandro B.			The Toronto prehospital hypertonic resuscitation-head injury and multiorgan dysfunction trial: Feasibility study of a randomized controlled trial	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Hypertonic saline; Emergency medical services; Organ failure; Neurofunctional and neurocognitive outcomes; Immune modulation; Neuro Imaging; Feasibility	7.5-PERCENT SODIUM-CHLORIDE; TRAUMATIC BRAIN-INJURY; SALINE RESUSCITATION; ORGAN DYSFUNCTION; FLUID RESUSCITATION; HEMORRHAGIC-SHOCK; MULTICENTER TRIAL; DEXTRAN; HYPOTENSION; RECOMMENDATIONS	Objective: The aim of the study was to evaluate the feasibility of a prehospital trial comparing hypertonic saline and dextran (HSD) with normal saline (NS) in blunt head injury patients. Design: The study used a double blind randomized trial. Setting: The study was conducted in air and land emergency medical services and 2 trauma centers serving a population of 4 million people. Patients: The study population consisted of head injured, blunt trauma adult patients with a Glasgow Coma Scale of lower than 9. Interventions: We used 250 mL of HSD vs NS given within 4 hours of the accident. Measurements: The specific objectives were to assess protocol-related logistical issues, randomization, HSD safety, and follow up rates and to obtain survival and neurocognitive end point estimates. Main Results: Of 132 eligible patients, 113 were randomized. Nineteen eligible patients were missed because of lack of time (9 [22%]), paramedic discretion (3 [7%]), the paramedic forgot (6 [15%]), and the paramedic refused (1 [2%]). Randomization compliance was 96% (109/113). Four randomized cases met exclusion criteria: penetrating trauma (1), cardiac arrest (2), and fall from standing (1). Three randomized patients were excluded from the final analysis: 2 patients received less than 50 mL of study solution due to an interstitial intravenous line and 1 lost randomization identification. Fifty patients (47%) were randomized to HSD and 56 (53%) to NS. Mean injury severity score was 32.7 for HSD and 32.6 for NS. There was no difference in length of stay, Sequential Organ Failure Assessment maximum, Multiple Organ Dysfunction Score maximum, delta Multiple Organ Dysfunction Score, or Apache scores. Initial head scans scored 3 or higher by Marshall classification for 12 HSD and 11 NS patients. Zero adverse events occurred, and follow-up for the primary outcome was 100%. Alive at 30 days for HSD and NS, respectively, was 70% (35/50) and 75% (42/56) and at discharge was 68% (34/50) and 73% (41/56). Only 49.3% (37/77) of surviving patients consented to follow-up at 4 months and 89% (33/37) completed the assessment. Disability rating scale (median, interquartile range) was 3 (0, 6) for HSD and was 0 (0, 6) for NS. Glasgow Outcome Scale Evaluation was higher than 4 for HSD (12/12 [100%]) and NS (15/21 [72%]). Functional Independence Measure (mean, SD) was 62 (37) for HSD and 80 (32) for NS. Conclusions: It is feasible to conduct a prehospital randomized controlled trial with HSD for treatment of blunt trauma patients with head injuries; however, consent for neurofunctional outcomes in this cohort is problematic and threatens the feasibility of definitive trials using these potentially meaningful end points. (C) 2011 Elsevier Inc. All rights reserved.	[Morrison, Laurie J.; Baker, Andrew J.; Perreira, Tyrone] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Rescu, Toronto, ON M5B 1W8, Canada; [Morrison, Laurie J.; MacDonald, Russell D.] Univ Toronto, Dept Med, Div Emergency Med, Toronto, ON, Canada; [Baker, Andrew J.; Simitciu, Merita] Univ Toronto, St Michaels Hosp, Dept Anaesthesia, Toronto, ON M5B 1W8, Canada; [Baker, Andrew J.; Rizoli, Sandro B.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON M5B 1W8, Canada; [Rhind, Shawn G.] Def Res & Dev Canada, Toronto, ON, Canada; [Kiss, Alex] Univ Toronto, Inst Clin & Evaluat Sci, Toronto, ON, Canada; [MacDonald, Russell D.] Ornge Transport Med, Toronto, ON, Canada; [Kiss, Alex; MacDonald, Russell D.; Schwartz, Brian; Black, Sandra E.; Rizoli, Sandro B.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Schwartz, Brian] Sunnybrook Osler Ctr Prehosp Care, Toronto, ON, Canada; [Schwartz, Brian] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Trompeo, Anna] Univ Turin, Turin, Italy; [Stuss, Donald T.] Rotman Res Inst, Toronto, ON, Canada; [Rizoli, Sandro B.] Univ Toronto, Dept Surg, Toronto, ON, Canada		Morrison, LJ (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Rescu, 30 Bond St, Toronto, ON M5B 1W8, Canada.	morrisonl@smh.ca	morrison, laurie J/A-6325-2012	morrison, laurie J/0000-0001-8369-9774; Black, Sandra/0000-0001-7093-8289; Rhind, Shawn/0000-0003-2300-0620	DRDC (Government of Canada) [w7711-027801/001/TOR]	Funding for this study was provided in part from the DRDC grant no. w7711-027801/001/TOR (Government of Canada). The investigators would like to acknowledge the assistance of Sandy Malhi, Vincenza Notarangelo, Jennifer Long, Boris Bojilov, Amanda White-McFarlan, and Jane Topolovec-Vranic for the trial coordination and data abstraction. In addition, the investigators acknowledge the outstanding contribution by the Ornge Transport Medicine critical care air medics and staff and Toronto Emergency Medical Services and the advance life support paramedics and staff in the implementation and completion of the study.	*AM ASS NEUR SURG, 2000, J NEUROTRAUM, V17, P591; BEAL AL, 1994, JAMA-J AM MED ASSOC, V271, P226, DOI 10.1001/jama.271.3.226; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Holcroft J W, 1989, Prog Clin Biol Res, V299, P331; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; MANINGAS PA, 1989, AM J SURG, V157, P528, DOI 10.1016/0002-9610(89)90654-5; MANINGAS PA, 1989, AM J SURG, V157, P533; MARSHALL JC, 1995, CRIT CARE MED, V23, P1638, DOI 10.1097/00003246-199510000-00007; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Morrison LJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-105; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Rizoli SB, 2006, ANN SURG, V243, P47, DOI 10.1097/01.sla.0000193608.93127.b1; RIZOLI SB, 2002, 2002 YB INTENSIVE CA, P446; SAMPALIS J, 2002, HLTH INFRASTRUCTURE; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Sosin DM, 1996, BRAIN INJURY, V10, P47; Tremblay LN, 2001, CAN J SURG, V44, P172; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1011; VASSAR MJ, 1993, J TRAUMA, V34, P632	26	22	23	0	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441			J CRIT CARE	J. Crit. Care	AUG	2011	26	4					363	372		10.1016/j.jcrc.2010.08.021			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	816NG	WOS:000294608400007	21106341				2022-02-06	
J	Yeoman, P; Pattani, H; Silcocks, P; Owen, V; Fuller, G				Yeoman, Paddy; Pattani, Hina; Silcocks, Paul; Owen, Victoria; Fuller, Gordon			Validation of the IMPACT Outcome Prediction Score Using the Nottingham Head Injury Register Dataset	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Glasgow outcome scale; Mortality; Prognosis; Statistical models; Traumatic brain injury; Validation studies	TRAUMATIC BRAIN-INJURY; GUIDELINES; ADMISSIONS; MANAGEMENT; CARE	Background: Comparison of traumatic brain injury (TBI) outcomes is severely limited by the absence of a universally accepted and validated outcome prediction score. The IMPACT group recently reported models predicting mortality and unfavorable outcome after TBI, based on the outcomes of patients with moderate and severe head injury reported in two large clinical trials. Methods: We have used prospectively collected data from 1,276 adult patients from the Nottingham Head Injury Register admitted to a single UK neurosurgical unit during a 10-year period to validate the IMPACT score models. The two models were validated for discrimination, calibration, and accuracy, using multiple imputation to adjust for missing data. Results: One thousand sixty-one patients (83%) had a complete set of data. For the multiply imputed analysis, the IMPACT prognostic models showed satisfactory discrimination (area under the receiver operator curve for mortality, 0.835; 95% confidence interval, 0.811-0.858; unfavorable outcome, 0.828; 95% confidence interval, 0.805-0.851) and accuracy (Brier Accuracy Score for mortality, 0.403, p < 0.01; unfavorable outcome, 0.371, p < 0.01). Good calibration was evident for unfavorable outcome, but mortality risk was underestimated by the scoring system in our sample (Hosmer-Lemeshow test: mortality: p < 0.01; unfavorable outcome: p = 0.6). These results were not significantly changed when repeated using patients with complete data only. Conclusion: The 2005 IMPACT model for unfavorable outcome performs well when used to predict outcome in adults with moderate and severe TBI presenting to a British neurosurgical center. However, the model for mortality fitted less well, slightly overestimating mortality in the higher-risk groups.	[Yeoman, Paddy; Pattani, Hina; Fuller, Gordon] Nottingham Univ Hosp NHS Trust, Intens Care Unit, Nottingham, England; [Silcocks, Paul] Univ Nottingham, Sch Med, Sch Community Hlth Sci, Nottingham Clin Trials Unit, Nottingham, England; [Owen, Victoria] Univ Nottingham, NIHR Res Design Serv E Midlands, Nottingham NG7 2RD, England		Fuller, G (corresponding author), 85 Main St, Loughborough LE12 5PE, Leics, England.	gordonwfuller@doctors.net.uk		Fuller, Gordon Ward/0000-0001-8532-3500			*AM COLL SURG COMM, 1997, ADV TRAUM LIF SUPP D, P1; Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hyam JA, 2006, CRIT CARE, V10, DOI 10.1186/cc5066; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1975, LANCET, V1, P480; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Royston P, 2005, STATA J, V5, P279, DOI 10.1177/1536867X0500500212; Rubin D.B., 1987, MULTIPLE IMPUTATION; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14; Stranjalis G, 2008, J TRAUMA, V65, P789, DOI 10.1097/TA.0b013e3181469e26; TEASDALE G, 1974, LANCET, V2, P81; TWEEDIE IE, 2008, CARE CRITICALLY ILL, V24, P143; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e	34	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2011	71	2					387	392		10.1097/TA.0b013e31820ceadd			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	806XH	WOS:000293850200037	21427619				2022-02-06	
J	Charash, WE; Caputo, MP; Clark, H; Callas, PW; Rogers, FB; Crookes, BA; Alborg, MS; Ricci, MA				Charash, William E.; Caputo, Michael P.; Clark, Harry; Callas, Peter W.; Rogers, Frederick B.; Crookes, Bruce A.; Alborg, Monica S.; Ricci, Michael A.			Telemedicine to a Moving Ambulance Improves Outcome After Trauma in Simulated Patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	66th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 27-29, 2007	Las Vegas, NV	Amer Assoc Surg Trauma		Telemedicine; Mobile; Simulation; Outcomes	CARE	Background: Rural trauma victims often require prolonged transport by s with limited scopes of practice. We evaluated the impact of telemedicine (TM) to a moving ambulance on outcomes in simulated trauma patients. Methods: This is an institutional review board approved, prospective double-blind study. Three trauma scenarios (blunt torso trauma, epigastric stab wound, and closed head injury) were created for a human patient simulator. Intermediate emergency medical technicians (EMTs; n = 20) managed the human patient simulator, in a moving ambulance. In the TM group, physicians (n = 12) provided consultation. In the non-TM group, EMTs communicated with medical control by radio, as necessary. We tabulated the fraction of 13 key signs, 5 pathologic processes, and 12 key interventions that were performed. Vital signs and SaO(2) (%) were recorded. Data were compared using the Wilcoxon rank-sum test. Results: Lowest SaO(2) (84 +/- 0.7 vs. 78 +/- 0), lowest systolic blood pressure (70 +/- 1 vs. 53 +/- 1), and highest heart rate (144 +/- 0.9 vs. 159 +/- 0.5) were significantly improved in the TM group (p < 0.001). Recognition rates for key signs (0.96 +/- 0.01 vs. 0.79 +/- 0.05), processes (0.98 +/- 0.02 vs. 0.75 +/- 0.05), and critical interventions (0.92 +/- 0.02 vs. 0.49 +/- 0.03) were higher in the TM group (p < 0.003). EMTs were successfully guided through needle decompression procedures in 22 of 24 cases (zero in the non-TM group). Conclusion: TM to a moving ambulance improved the care of simulated trauma patients. Furthermore, procedurally naive EMTs were able to perform needle thoracostomy and pericardiocentesis with TM guidance.	[Charash, William E.; Clark, Harry] Fletcher Allen Hlth Care, Burlington, VT 05401 USA; [Charash, William E.; Callas, Peter W.; Crookes, Bruce A.; Alborg, Monica S.; Ricci, Michael A.] Univ Vermont, Coll Med, Burlington, VT USA; [Rogers, Frederick B.] Lancaster Gen Hosp, Lancaster, PA USA; [Caputo, Michael P.] Washington Univ, Sch Med, St Louis, MO USA		Charash, WE (corresponding author), Fletcher Allen Hlth Care, 111 Colchester Ave,MCHV Campus,Fletcher 466, Burlington, VT 05401 USA.	bill.charash@vtmednet.org					CAPUTO MP, 2004, TELEHEALTH PRACTICE, V9, P7; CERTO TF, 1983, J TRAUMA, V23, P559, DOI 10.1097/00005373-198307000-00003; Esposito TJ, 1999, J TRAUMA, V47, P243, DOI 10.1097/00005373-199908000-00004; Hobbs F, 2002, CENSR4 US CENS BUR; ILLI OJ, 2001, TELEMED J E-HEALTH, V7, P148; Muelleman RL, 2007, J TRAUMA, V62, P221, DOI 10.1097/01.ta.0000231696.65548.06; *NAT HIGHW TRAFF S, 810657 NHTSA DOT HS; *NAT HIGHW TRAFF S, 809524 NHTSA DOT HS; *NAT HIGHW TRAFF S, 808806 NHTSA DOT HS; Ricci MA, 2003, TELEMED J E-HEALTH, V9, P3, DOI 10.1089/153056203763317602; Robertson R, 1996, AM J SURG, V172, P564, DOI 10.1016/S0002-9610(96)00247-4; Rogers FB, 1999, J TRAUMA, V47, P802, DOI 10.1097/00005373-199910000-00038; Rogers FB, 2001, J TRAUMA, V51, P1037, DOI 10.1097/00005373-200112000-00002; Sibert K, 2008, TELEMED J E-HEALTH, V14, P266, DOI 10.1089/tmj.2007.0050; *US C OFF TECHN AS, 1989, OTAH445 US C OFF TEC; Xiao Y, 2000, J HIGH SPEED NETW, V9, P47	16	22	23	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					49	54		10.1097/TA.0b013e31821e4690			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	790RR	WOS:000292607400017	21818014				2022-02-06	
J	Chiou, KS; Carlson, RA; Arnett, PA; Cosentino, SA; Hillary, FG				Chiou, Kathy S.; Carlson, Richard A.; Arnett, Peter A.; Cosentino, Stephanie A.; Hillary, Frank G.			Metacognitive Monitoring in Moderate and Severe Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Awareness; Brain injury; Metacognition; Confidence judgments; Self-monitoring; Executive functioning	IMPAIRED SELF-AWARENESS; EXECUTIVE FUNCTION; COGNITIVE DEFICIT; METAMEMORY; METACOMPREHENSION; ACCURACY; JUDGMENTS; MEMORY; ANOSOGNOSIA; PREDICTIONS	The ability to engage in self-reflective processes is a capacity that may be disrupted after neurological compromise; research to date has demonstrated that patients with traumatic brain injury (TBI) show reduced awareness of their deficits and functional ability compared to caretaker or clinician reports. Assessment of awareness of deficit, however, has been limited by the use of subjective measures (without comparison to actual performance) that are susceptible to report bias. This study used concurrent measurements from cognitive testing and confidence judgments about performance to investigate in-the-moment metacognitive experiences after moderate and severe traumatic brain injury. Deficits in metacognitive accuracy were found in adults with TBI for some but not all indices, suggesting that metacognition may not be a unitary construct. Findings also revealed that not all indices of executive functioning reliably predict metacognitive ability. (JINS, 2011, 17, 720-731)	[Chiou, Kathy S.; Carlson, Richard A.; Arnett, Peter A.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Cosentino, Stephanie A.] Columbia Univ, Gertrude H Sergievsky Ctr, Med Ctr, Cognit Neurosci Div, New York, NY 10027 USA		Chiou, KS (corresponding author), Penn State Univ, Dept Psychol, 610 Moore Bldg, University Pk, PA 16802 USA.	ksc167@psu.edu	Hillary, Frank/AAN-8622-2021		New Jersey Commission on Brain Injury Research [0120090178]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG032899] Funding Source: NIH RePORTER	Much appreciation to Philip Schatz, Ph.D., for his consultation and to Neal Fitzpatrick, Tia Bochnakova, Julia Slocomb, and Britney Wardecker for their assistance in recruitment and data collection. The authors declare that there are no conflicts of interest associated with this study and manuscript. This research was funded in part by a grant from the New Jersey Commission on Brain Injury Research (grant number 0120090178).	ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; AMADOR XF, 1993, AM J PSYCHIAT, V150, P873; Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; Augustyn JS, 2005, PSYCHON B REV, V12, P911, DOI 10.3758/BF03196785; Babinski J, 1914, REV NEUROL, V27; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barrett AM, 2005, NEUROLOGY, V64, P693, DOI 10.1212/01.WNL.0000151959.64379.1B; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Chen Q, 2006, J COGNITIVE NEUROSCI, V18, P1937, DOI 10.1162/jocn.2006.18.11.1937; Chua EF, 2006, NEUROIMAGE, V29, P1150, DOI 10.1016/j.neuroimage.2005.09.058; Chua EF, 2009, J COGNITIVE NEUROSCI, V21, P1751, DOI 10.1162/jocn.2009.21123; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Cosentino S, 2005, J INT NEUROPSYCH SOC, V11, P910, DOI 10.1017/S1355617705050964; COSENTINO SA, NEUROPSYCHO IN PRESS; de Frias CM, 2006, NEUROPSYCHOLOGY, V20, P206, DOI 10.1037/0894-4105.20.2.206; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Dunlosky J., 2009, METACOGNITION; Dunlosky J, 2006, PSYCHOL AGING, V21, P390, DOI 10.1037/0882-7974.21.2.390; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Faul M, 2010, TRAUMATIC BRAIN INJU; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming JM, 1996, BRAIN INJURY, V10, P1; GALLUP GG, 1991, J COMP PSYCHOL, V105, P376, DOI 10.1037/0735-7036.105.4.376; Garmoe W, 2005, J HEAD TRAUMA REHAB, V20, P348, DOI 10.1097/00001199-200507000-00006; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; GOLDENBERG G, 1995, NEUROPSYCHOLOGIA, V33, P1373, DOI 10.1016/0028-3932(95)00070-J; Gonzalez R, 1996, PSYCHOL BULL, V119, P159, DOI 10.1037/0033-2909.119.1.159; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Griffin TD, 2008, MEM COGNITION, V36, P93, DOI 10.3758/MC.36.1.93; Griffin TD, 2009, MEM COGNITION, V37, P1001, DOI 10.3758/MC.37.7.1001; HAGER W, 1992, PSYCHOL RES-PSYCH FO, V54, P110, DOI 10.1007/BF00937139; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Heilman KM, 1998, PHILOS T R SOC B, V353, P1903, DOI 10.1098/rstb.1998.0342; HERTZOG C, 1990, PSYCHOL AGING, V5, P215, DOI 10.1037/0882-7974.5.2.215; Howell D. C., 1987, STAT METHODS PSYCHOL; Karpicke JD, 2009, J EXP PSYCHOL GEN, V138, P469, DOI 10.1037/a0017341; Kaszniak AW, 1996, LEARN INDIVID DIFFER, V8, P355, DOI 10.1016/S1041-6080(96)90023-0; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Kervick RB, 2005, BRAIN INJURY, V19, P881, DOI 10.1080/02699050400025273; Kikyo H, 2002, NEURON, V36, P177, DOI 10.1016/S0896-6273(02)00939-X; Koren D, 2004, SCHIZOPHR RES, V70, P195, DOI 10.1016/j.schres.2004.02.004; Koriat A, 2007, EVERYDAY MEMORY, P251; LEBRUN Y, 1987, CORTEX, V23, P251, DOI 10.1016/S0010-9452(87)80035-7; Lefevre N, 2004, MEM COGNITION, V32, P1238, DOI 10.3758/BF03206315; LEONESIO RJ, 1990, J EXP PSYCHOL LEARN, V16, P464, DOI 10.1037/0278-7393.16.3.464; Leritz E, 2004, CLIN NEUROPSYCHOL, V18, P352, DOI 10.1080/1385404049052412; MAKI RH, 1984, J EXP PSYCHOL LEARN, V10, P663, DOI 10.1037/0278-7393.10.4.663; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; McAvinue L, 2005, NEUROPSYCHOL REHABIL, V15, P569, DOI 10.1080/09602010443000119; McDonaldMiszczak L, 1995, PSYCHOL AGING, V10, P553, DOI 10.1037/0882-7974.10.4.553; McGlynn SM, 1997, PSYCHIAT ANN, V27, P806, DOI 10.3928/0048-5713-19971201-10; Metcalfe J, 2009, CURR DIR PSYCHOL SCI, V18, P159, DOI 10.1111/j.1467-8721.2009.01628.x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Nelson T. O., 1992, METACOGNITION CORE R; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Norman DA., 1986, CONSCIOUSNESS SELF R, P1, DOI [10.1007/978-1-4757-0629-1_1, DOI 10.1007/978-1-4757-0629-1_1]; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Perrotin A, 2006, ACTA PSYCHOL, V122, P58, DOI 10.1016/j.actpsy.2005.10.003; Perrotin A, 2008, BRAIN COGNITION, V67, P76, DOI 10.1016/j.bandc.2007.11.006; Perrotin A, 2007, NEUROPSYCHOLOGIA, V45, P2811, DOI 10.1016/j.neuropsychologia.2007.05.003; Pia L, 2006, PSYCHIAT CLIN NEUROS, V60, P531, DOI 10.1111/j.1440-1819.2006.01576.x; Prigatano G.P, 1997, NEUROPSYCHOLOGICAL R; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRINGLE RK, 1971, J CLIN PSYCHOL, V27, P479, DOI 10.1002/1097-4679(197110)27:4<479::AID-JCLP2270270422>3.0.CO;2-C; Rawson KA, 2000, MEM COGNITION, V28, P1004, DOI 10.3758/BF03209348; Redford JS, 2010, J EXP PSYCHOL LEARN, V36, P248, DOI 10.1037/a0017809; Reitan RM, 1985, HALSTEADREITAN NEURO; Rickelman Bonnie L, 2004, Issues Ment Health Nurs, V25, P227, DOI 10.1080/01612840490274741; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; Shipley W. C., 1946, I LIVING SCALE; Souchay C, 2004, EXP AGING RES, V30, P47, DOI 10.1080/03610730490251478; Souchay C, 2000, NEUROPSYCHOLOGY, V14, P299, DOI 10.1037/0894-4105.14.2.299; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; THIEDE KW, 2010, BRIT J ED PSYCHOL; Tiede HL, 2009, MEMORY, V17, P288, DOI 10.1080/09658210802665837; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Wagner MT, 1997, ALZ DIS ASSOC DIS, V11, P125, DOI 10.1097/00002093-199709000-00004; *WARD DEP ADJ GEN, 1944, MAN DIR SCOR; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whyte J, 1993, REHABILITATION MED P, P825	100	22	22	0	13	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2011	17	4					720	731		10.1017/S1355617711000658			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	781NL	WOS:000291939900016	21554787				2022-02-06	
J	Sehgal, N; Agarwal, V; Valli, RK; Joshi, SD; Antonovic, L; Strobel, HW; Ravindranath, V				Sehgal, Neha; Agarwal, Varsha; Valli, Rupanagudi Khader; Joshi, Shanker Dutt; Antonovic, Leposava; Strobel, Henry W.; Ravindranath, Vijayalakshmi			Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation	BIOCHEMICAL PHARMACOLOGY			English	Article						Neuroinflammation; Microglia; Cytokines; Cytochrome P450; Leukotriene	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; DORSAL-ROOT GANGLION; LEUKOTRIENE B4; RAT-BRAIN; INFLAMMATION; EXPRESSION; DISEASE; INVOLVEMENT; METABOLISM	Inflammatory processes are involved in the pathogenesis and/or progression of acute central nervous system (CNS) infection, traumatic brain injury and neurodegenerative disorders among others indicating the need for novel strategies to limit neuroinflammation. Eicosanoids including leukotrienes, particularly leukotriene B-4 (LTB4) are principle mediator(s) of inflammatory response, initiating and amplifying the generation of cytokines and chemokines. Cytochrome P450 (Cyp), a family of heme proteins mediate metabolism of xenobiotics and endogenous compounds, such as eicosanoids and leukotrienes. Cytochrome P4504F (Cyp4f) subfamily includes five functional enzymes in mouse. We cloned and expressed the mouse Cyp4f enzymes, assayed their relative expression in brain and examined their ability to hydroxylate the inflammatory cascade prompt LTB4 to its inactive 20-hydroxylated product. We then examined the role of Cyp4fs in regulating inflammatory response in vitro, in microglial cells and in vivo, in mouse brain using lipopolysacharide (LPS), as a model compound to generate inflammatory response. We demonstrate that mouse brain Cyp4fs are expressed ubiquitously in several cell types in the brain, including neurons and microglia, and modulate inflammatory response triggered by LPS, in vivo and in microglial cells, in vitro through metabolism of LTB4 to the inactive 20-hydroxy LTB4. Chemical inhibitor or shRNA to Cyp4fs enhance and inducer of Cyp4fs attenuates inflammatory response. Further, induction of Cyp4f expression lowers LTB4 levels and affords neuroprotection in microglial cells or mice exposed to LPS. Thus, catalytic activity of Cyp4fs is a novel target for modulating neuroinflammation through hydroxylation of LTB4. (C) 2011 Elsevier Inc. All rights reserved.	[Sehgal, Neha; Agarwal, Varsha; Valli, Rupanagudi Khader; Joshi, Shanker Dutt; Ravindranath, Vijayalakshmi] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar 122050, Haryana, India; [Antonovic, Leposava; Strobel, Henry W.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA		Ravindranath, V (corresponding author), Indian Inst Sci, Ctr Neurosci, Bangalore 560012, Karnataka, India.	viji@cns.iisc.emet.in			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH 70054]; Bose National Fellowship; CSIRCouncil of Scientific & Industrial Research (CSIR) - India; NBRCDepartment of Biotechnology (DBT) India; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH070054] Funding Source: NIH RePORTER	The authors thank Smitha Karunakaran, Lalitha Durgadoss, Uzma Saeed and Manoj Kumar Mishra for their help in this study. This work was supported by National Institutes of Health grant MH 70054 to H.W.S. & V.R., J.C. Bose National Fellowship to V.R., Senior Research fellowship from CSIR to N.S., and CORE grant from NBRC.	Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Andoh T, 2005, MOL BRAIN RES, V137, P263, DOI 10.1016/j.molbrainres.2005.02.029; Azab AN, 2004, PROSTAG LEUKOTR ESS, V70, P67, DOI 10.1016/j.plefa.2003.08.005; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chinta SJ, 2005, MOL BRAIN RES, V135, P81, DOI 10.1016/j.molbrainres.2004.12.014; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Crooks SW, 1998, INT J BIOCHEM CELL B, V30, P173, DOI 10.1016/S1357-2725(97)00123-4; Deplanque D, 2003, J NEUROSCI, V23, P6264; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; Kalsotra A, 2007, ARCH BIOCHEM BIOPHYS, V461, P104, DOI 10.1016/j.abb.2007.02.027; Kalsotra A, 2006, PHARMACOL THERAPEUT, V112, P589, DOI 10.1016/j.pharmthera.2006.03.008; Kikuta Y, 2000, ARCH BIOCHEM BIOPHYS, V383, P225, DOI 10.1006/abbi.2000.2078; Kipp M, 2008, J MOL NEUROSCI, V35, P235, DOI 10.1007/s12031-008-9057-7; KOLLER H, 1993, BRAIN RES, V628, P313, DOI 10.1016/0006-8993(93)90971-O; Kreisler A, 2007, BRAIN RES, V1135, P77, DOI 10.1016/j.brainres.2006.12.011; Kroetz DL, 2005, ANNU REV PHARMACOL, V45, P413, DOI 10.1146/annurev.pharmtox.45.120403.100045; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Morgan D M, 1998, Methods Mol Biol, V79, P179; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; Okubo M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-57; Okubo M, 2010, GLIA, V58, P599, DOI 10.1002/glia.20948; Pai HV, 2004, J BIOL CHEM, V279, P27383, DOI 10.1074/jbc.M402337200; Paul L, 1999, AM J PHYSIOL-REG I, V276, pR52, DOI 10.1152/ajpregu.1999.276.1.R52; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Ravindranath V, 1998, BIOCHEM PHARMACOL, V56, P547, DOI 10.1016/S0006-2952(97)00671-0; Ravindranath V, 2006, J NEURAL TRANSM-SUPP, P167; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Saiwai H, 2010, AM J PATHOL, V176, P2352, DOI 10.2353/ajpath.2010.090839; SOBERMAN RJ, 1990, METHOD ENZYMOL, V187, P319; Soldan SS, 2004, J NEUROIMMUNOL, V146, P209, DOI 10.1016/j.jneuroim.2003.10.033; Toda A, 2002, PROSTAG OTH LIPID M, V68-9, P575, DOI 10.1016/S0090-6980(02)00056-4; Tremblay RG, 2010, J NEUROSCI METH, V186, P60, DOI 10.1016/j.jneumeth.2009.11.004; van Neerven S, 2008, PROG NEUROBIOL, V85, P433, DOI 10.1016/j.pneurobio.2008.04.006; Wang Y, 2008, J NEUROTRAUM, V25, P1187, DOI 10.1089/neu.2008.0542; Wendt W, 2009, J NEUROCHEM, V110, P1931, DOI 10.1111/j.1471-4159.2009.06283.x; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484	45	22	22	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0006-2952	1873-2968		BIOCHEM PHARMACOL	Biochem. Pharmacol.	JUL 1	2011	82	1					53	64		10.1016/j.bcp.2011.03.025			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	774IX	WOS:000291380000007	21466787				2022-02-06	
J	Contreras, R; Ghajar, J; Bahar, S; Suh, M				Contreras, R.; Ghajar, J.; Bahar, S.; Suh, M.			Effect of cognitive load on eye-target synchronization during smooth pursuit eye movement	BRAIN RESEARCH			English	Article						Mild traumatic brain injury (mTBI); Smooth pursuit eye movement; Phase synchronization; Diffuse axonal injury; Eye tracking	BRAIN; ATTENTION; DEFICITS	In mild traumatic brain injury (mTBI), the fiber tracts that connect the frontal cortex with the cerebellum may suffer shear damage, leading to attention deficits and performance variability. This damage also disrupts the enhancement of eye-target synchronization that can be affected by cognitive load when subjects are tested using a concurrent eye-tracking test and word-recall test. We investigated the effect of cognitive load on eye-target synchronization in normal and mTBI patients using the nonlinear dynamical technique of stochastic phase synchronization. Results demonstrate that eye-target synchronization was negatively affected by cognitive load in mTBI subjects. In contrast, eye-target synchronization improved under intermediate cognitive load in young (<= 40 years old) normal subjects. (C) 2011 Elsevier B.V. All rights reserved.	[Contreras, R.; Bahar, S.] Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA; [Contreras, R.; Bahar, S.] Univ Missouri, Ctr Neurodynam, St Louis, MO 63121 USA; [Ghajar, J.] Brain Trauma Fdn, New York, NY USA; [Ghajar, J.] Weill Cornell Med Coll, Dept Neurol Surg, New York, NY USA; [Suh, M.] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Suh, M.] Sungkyunkwan Univ, Sch Med, Samsung Adv Inst Hlth Sci & Technol, Grad Program Hlth Sci & Technol, Seoul, South Korea		Bahar, S (corresponding author), Univ Missouri, Dept Phys & Astron, St Louis, MO 63121 USA.	bahars@umsl.edu; minahsuh@skku.edu			James S. McDonnell Foundation; NSFNational Science Foundation (NSF) [PHY-0547647]; National Research Foundation (NRF) [2010-0000571]	This work was supported by James S. McDonnell Foundation grant for the Cognitive Neurobiological Research Consortium in Traumatic Brain Injury. The authors thank Rachel Kolster and Ranjeeta Sarkar for technical assistance with eye movement and cognitive testing. SB and RC acknowledge NSF CAREER Grant No. PHY-0547647 (to SB) for additional support. MS also acknowledge the National Research Foundation (NRF) Grant No. 2010-0000571 (to MS) by the Korean government (MEST).	Bahar S, 2004, FLUCT NOISE LETT, V4, pL87, DOI 10.1142/S0219477504001690; Chen Y, 2002, PROG BRAIN RES, V140, P255; COLLEWIJN H, 1984, J PHYSIOL-LONDON, V351, P217, DOI 10.1113/jphysiol.1984.sp015242; Contreras R, 2008, J BIOL PHYS, V34, P381, DOI 10.1007/s10867-008-9092-1; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Gross J, 2000, J PHYSIOL-LONDON, V527, P623, DOI 10.1111/j.1469-7793.2000.00623.x; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hultsch D. F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; Hutton SB, 2005, EXP BRAIN RES, V163, P306, DOI 10.1007/s00221-004-2171-z; KOWLER E, 1989, VISION RES, V29, P1049, DOI 10.1016/0042-6989(89)90052-7; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Pikovsky A., 2001, CAMBRIDGE NONLINEAR, P1; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Suh M, 2008, J KOREAN PHYS SOC, V53, P3468, DOI 10.3938/jkps.53.3468; Takeshita D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051925; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tass PA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088101; Van Donkelaar P, 2002, PROG BRAIN RES, V140, P267; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289	23	22	22	2	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 29	2011	1398						55	63		10.1016/j.brainres.2011.05.004			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	788GZ	WOS:000292434700006	21620377				2022-02-06	
J	Bales, JW; Yan, HQ; Ma, XC; Li, YM; Samarasinghe, R; Dixon, CE				Bales, James W.; Yan, Hong Q.; Ma, Xiecheng; Li, Youming; Samarasinghe, Ranmal; Dixon, C. Edward			The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: A novel therapeutic target in traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						DARPP-32; TBI; Striatum; Amantadine; Dopamine	WATER MAZE PERFORMANCE; CORTICAL IMPACT MODEL; PROTEIN PHOSPHATASE-1; PARKINSONS-DISEASE; SYNAPTIC PLASTICITY; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; GLUTAMATE SIGNALS; RAT; DEPHOSPHORYLATION	Traumatic brain injury (TBI) causes persistent neurologic deficits. Current therapies, predominantly focused upon cortical and hippocampal cellular survival, have limited benefit on cognitive outcomes. Striatal damage is associated with deficits in executive function, learning, and memory. Dopamine and cAMP regulated phosphoprotein 32 (DARPP-32) is expressed within striatal medium spiny neurons and regulates striatal function. We found that controlled cortical impact injury in rats produces a chronic decrease in DARPP-32 phosphorylation at threonine-34 and an increase in protein phosphatase-1 activity. There is no effect of injury on threonine-75 phosphorylation or on DARPP-32 protein. Amantadine, shown to be efficacious in treating post-TBI cognitive deficits, given daily for two weeks is able to restore the loss of DARPP-32 phosphorylation and reduce protein phosphatase-1 activity. Amantadine also decreases the phosphorylation of threonine-75 consistent with activity as a partial N-methyl-D-aspartate (NMDA) receptor antagonist and partial dopamine agonist. These data demonstrate that targeting the DARPP-32 signaling cascade represents a promising novel therapeutic approach in the treatment of persistent deficits following a TBI. Published by Elsevier Inc.	[Bales, James W.; Yan, Hong Q.; Ma, Xiecheng; Li, Youming; Dixon, C. Edward] Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Bales, James W.; Samarasinghe, Ranmal; Dixon, C. Edward] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Bales, James W.; Samarasinghe, Ranmal] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Brain Trauma Res Ctr, 201 Hill Bldg,3434 5th Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu			NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS060672-02, 2P50NS030318]; Veterans AffairsUS Department of Veterans Affairs [B6761R]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060672, P50NS030318] Funding Source: NIH RePORTER	We acknowledge the support of NIH/NINDS grant 5R01NS060672-02; NIH/NINDS grant 2P50NS030318; and the Veterans Affairs grant B6761R. We also thank Kristin Macfarlane for her assistance in preparing the data for this study.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Baldo BA, 2007, PSYCHOPHARMACOLOGY, V191, P439, DOI 10.1007/s00213-007-0741-z; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; BRENNER M, 1989, J NEUROL, V236, P153, DOI 10.1007/BF00314331; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Choe ES, 2004, J NEUROCHEM, V89, P383, DOI 10.1111/j.1471-4159.2003.02334.x; Coccurello R, 2004, NEUROPSYCHOPHARMACOL, V29, P1451, DOI 10.1038/sj.npp.1300444; DEKOSKY ST, 1998, SEMIN CLIN NEUROPSYC, V3, P176; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; DUNNMEYNELL A, 1994, BRAIN RES, V660, P88, DOI 10.1016/0006-8993(94)90842-7; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GREENAMYRE JT, 1991, ARCH NEUROL-CHICAGO, V48, P977, DOI 10.1001/archneur.1991.00530210109030; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Hakansson K, 2004, PARKINSONISM RELAT D, V10, P281, DOI 10.1016/j.parkreldis.2004.02.010; HALPAIN S, 1990, NATURE, V343, P369, DOI 10.1038/343369a0; Hamada M, 2005, J PHARMACOL EXP THER, V315, P872, DOI 10.1124/jpet.105.090852; HEMMINGS HC, 1986, PROG BRAIN RES, V69, P149; HEMMINGS HC, 1990, J BIOL CHEM, V265, P20369; HOVDA DA, 1990, ACT NEUR S, V51, P331; HUGER F, 1979, J NEUROCHEM, V33, P89, DOI 10.1111/j.1471-4159.1979.tb11710.x; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Koch K, 2008, NEUROSCIENCE, V153, P54, DOI 10.1016/j.neuroscience.2008.01.063; Kochanek P M, 1993, Crit Care Med, V21, pS333, DOI 10.1097/00003246-199309001-00016; Kopnisky KL, 2003, NEUROSCIENCE, V116, P425, DOI 10.1016/S0306-4522(02)00573-0; Kraus MF, 2005, BRAIN INJURY, V19, P471, DOI 10.1080/02699050400025059; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Mcallister TW, 2004, BRAIN INJURY, V18, P331, DOI 10.1080/02699050310001617370; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Merims D, 2008, INT REV PSYCHIATR, V20, P364, DOI 10.1080/09540260802095123; Nairn AC, 2004, NEUROPHARMACOLOGY, V47, P14, DOI 10.1016/j.neuropharm.2004.05.010; Nishi A, 2002, J NEUROCHEM, V81, P832, DOI 10.1046/j.1471-4159.2002.00876.x; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Peinemann A, 2005, J NEUROL SCI, V239, P11, DOI 10.1016/j.jns.2005.07.007; PENNARTZ CMA, 1991, J NEUROSCI, V11, P2838; Ridley RM, 2006, BEHAV BRAIN RES, V166, P253, DOI 10.1016/j.bbr.2005.08.007; Sawamoto N, 2007, NEUROLOGY, V68, P1062, DOI 10.1212/01.wnl.0000257821.28992.db; SHAPIRA Y, 1989, Neurological Research, V11, P169; SHIMA H, 1993, BIOCHEM BIOPH RES CO, V192, P1289, DOI 10.1006/bbrc.1993.1556; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Vertes RP, 2006, NEUROSCIENCE, V142, P1, DOI 10.1016/j.neuroscience.2006.06.027; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X	60	22	22	1	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2011	229	2					300	307		10.1016/j.expneurol.2011.02.013			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	774XF	WOS:000291419400014	21376040	Green Accepted			2022-02-06	
J	Shadli, RM; Pieter, MS; Yaacob, MJ; Rashid, FA				Shadli, Rahida Mohd; Pieter, Maria Socorro; Yaacob, Mohd Jamil; Rashid, Faridah Abdul			APOE genotype and neuropsychological outcome in mild-to-moderate traumatic brain injury: A pilot study	BRAIN INJURY			English	Article						APOE; APOE epsilon 4; neuropsychology; TBI	APOLIPOPROTEIN-E POLYMORPHISM; HEAD-INJURY; ASSOCIATION; GENE; RECOVERY; E-EPSILON-4; EPSILON-4; IMPACT; ALLELE; VOLUME	Primary objective: The influence of apolipoprotein (APOE) on neuropsychological outcome was investigated in 19 patients (25.79 +/- 7.22 years) with mild-to-moderate traumatic brain injury and 14 matched healthy control subjects (27.43 +/- 6.65 years). Research design: Within- and between-group comparisons were employed. Methods and procedure: APOE genotype was determined using the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism method. Verbal learning and memory, speed of processing and executive function were assessed at 6 weeks and 6 months post-injury. A three-way [Group(star)Type(star)Time] ANOVA with repeated measures on the third factor was employed to determine the differences between groups and APOE genotype. Main outcomes and results: No Group(star)APOE Genotype(star)Time interaction was found for all neuropsychological measures, Auditory Verbal Learning Test (p = 0.484, eta(2) = 0.017), Trail Making Test-B (p = 0.454, eta(2) = 0.019), Controlled Oral Word Association (p = 0.107, eta(2) = 0.087) and Wisconsin Card Sorting Test-64 (p = 0.291, eta(2) = 0.038). The results of this pilot study support earlier findings that showed no relationship between APOE epsilon 4 and poor recovery in the same population. Conclusion: The preliminary findings suggest no clear APOE genotype influence on neuropsychological outcome in mild and moderate TBI patients. Large-scale studies with longer follow-up duration are warranted.	[Pieter, Maria Socorro] Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia		Pieter, MS (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Neurosci, Kubang Kerian 16150, Kelantan, Malaysia.	maria@kb.usm.my	Yaacob, Mohd Jamil/B-4378-2014; Rashid, Faridah Abdul/N-9768-2019; Abdul Rashid, Faridah/B-8667-2011	Yaacob, Mohd Jamil/0000-0001-6194-6551; Abdul Rashid, Faridah/0000-0003-0701-9559	university grant	Initial data from this research were presented at the 7th International Congress on Brain Injury, April 2008, Lisbon, Portugal. This project was funded by a university grant.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Blackman JA, 2005, DEV MED CHILD NEUROL, V47, P64, DOI 10.1017/S0012162205000113; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Collie A, 2004, NEUROLOGY, V63, P2460, DOI 10.1212/WNL.63.12.2460; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Goldberg D., 1988, USERS GUIDE GEN HLTH; Golden C, 2000, NEUROPSYCHOLOGICAL I; GOLDSTEIN FC, 2004, 32 ANN M INT NEUR SO; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Heaton R., 2000, WISCONSIN CARD SORTI; HIXSON JE, 1990, J LIPID RES, V31, P545; Hodgkinson A, 2009, BRAIN IMPAIR, V10, P162, DOI 10.1375/brim.10.2.162; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; KEYS B, 2004, 32 ANN M INT NEUR SO; Levi O, 2003, NEUROBIOL DIS, V13, P273, DOI 10.1016/S0969-9961(03)00045-7; Levi O, 2007, J NEUROCHEM, V100, P202, DOI 10.1111/j.1471-4159.2006.04189.x; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Maezawa I, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-10; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Mitrushina MN, 1999, HDB NORMATIVE DATA N; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Nicoll JAR, 1996, ANN NY ACAD SCI, V777, P271, DOI 10.1111/j.1749-6632.1996.tb34431.x; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; Raven J. C., 1991, MANUAL RAVENS PROGRE; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Samatovicz RA, 2000, J HEAD TRAUMA REHAB, V15, P869, DOI 10.1097/00001199-200006000-00002; SCHMIDT M, 2004, AUDITORY VERBAL LEAR; SmithSeemiller L, 1997, BRAIN INJURY, V11, P191; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stengard JH, 2002, AM J HUM GENET, V71, P501, DOI 10.1086/342217; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8; TEASDALE G, 1974, LANCET, V2, P81; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Teasdale TW, 2008, J NEUROL NEUROSUR PS, V79, P364, DOI 10.1136/jnnp.2007.138081; Tzourio C, 2008, NEUROLOGY, V70, P1322, DOI 10.1212/01.wnl.0000308819.43401.87; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	60	22	22	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2011	25	6					596	603		10.3109/02699052.2011.572947			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	758FF	WOS:000290146300006	21534737				2022-02-06	
J	Bauer, DF; McGwin, G; Melton, SM; George, RL; Markert, JM				Bauer, David F.; McGwin, Gerald, Jr.; Melton, Sherry M.; George, Richard L.; Markert, James M.			The Relationship Between INR and Development of Hemorrhage With Placement of Ventriculostomy	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	Meeting of the American-College-of-Surgeons-Committee-on-Trauma	NOV, 2009	New Orleans, LA	Amer Coll Surg Comm Trauma		Hemorrhage; ICP; INR; Trauma; Ventriculostomy	INTRACRANIAL-PRESSURE MONITORS; BRAIN-INJURY; COMPLICATIONS; COAGULOPATHY	Background: This study seeks to evaluate the relationship between the risk of symptomatic hemorrhage from ventriculostomy placement and International Normalized Ratio (INR) in patients who received a ventriculostomy after traumatic brain injury. Methods: Patients who received a ventriculostomy after traumatic brain injury between June 2007 and July 2008 were identified and their medical records were abstracted for information. Results: At the time of ventriculostomy placement, 32 patients had an INR <1.2, 26 patients had an INR 1.2 to 1.4, 12 patients had an INR 1.4 to 1.6, and one patient had an INR >1.6 (INR = 1.61). No significant difference in the risk of hemorrhage between the groups was observed: 9.4%, 3.9%, 8.3%, and 0%, respectively (p = 0.73). In a subgroup analysis of patients who received ventriculostomy in the Neurosurgical Intensive Care Unit within 24 hours of admission (n = 54), the average time between admission and ventriculostomy placement in patients who did not receive fresh frozen plasma was 6.8 hours compared with 9.3 hours (p = 0.03) for those who did. Conclusions: In this retrospective study, INRs between 1.2 and 1.6 appeared to be acceptable for a neurosurgeon to place an emergent ventriculostomy in a patient with traumatic brain injury.	[Bauer, David F.; Markert, James M.] Univ Alabama Birmingham, Div Neurosurg, Birmingham, AL 35294 USA; [McGwin, Gerald, Jr.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [McGwin, Gerald, Jr.; Melton, Sherry M.; George, Richard L.] Univ Alabama Birmingham, Dept Surg, Sect Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA		Markert, JM (corresponding author), Univ Alabama Birmingham, Div Neurosurg, FOT 1060,1530 3rd Ave S, Birmingham, AL 35294 USA.	markert@uab.edu		Bauer, David/0000-0003-3548-0887			Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; BRAIN TRAUM FD, 2000, J NEUROTRAUM, V17, P457; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; *BRIT COMM STAND H, 2004, J BR SOC HAEMATOL, V126, P11; BULLOCK MR, 2006, NEUROSURGERY S, V58; CIAVARELLA D, 1987, BRIT J HAEMATOL, V67, P365, DOI 10.1111/j.1365-2141.1987.tb02359.x; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Greenberg M, 2006, HDB NEUROSURGERY; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; HEYMANN CV, 2006, ANESTH ANALG, V103, P969; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kakarla UK, 2008, NEUROSURGERY S1, V63; KELLY DF, 1995, OPERATIVE NEUROSURGI, P47; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Reiss R F, 2000, Am J Crit Care, V9, P158; Roitberg BZ, 2001, BRIT J NEUROSURG, V15, P324; SCHMIDEK HH, 2005, SCHMIDEK SWEETS OPER; Segal JB, 2005, TRANSFUSION, V45, P1413, DOI 10.1111/j.1537-2995.2005.00546.x; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; VESPA PM, 2000, OPERATIVE NEUROSURGE, P1205; Wiesmann M, 2001, J CLIN NEUROSCI, V8, P126, DOI 10.1054/jocn.2000.0749; 2006, NATL NEUROSURGICAL P	29	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2011	70	5					1112	1117		10.1097/TA.0b013e3181e7c2ae			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	762LQ	WOS:000290480300030	20805772				2022-02-06	
J	de Groot, YJ; Wijdicks, EFM; van der Jagt, M; Bakker, J; Lingsma, HF; IJzermans, JNM; Kompanje, EJO				de Groot, Yorick J.; Wijdicks, Eelco F. M.; van der Jagt, Mathieu; Bakker, Jan; Lingsma, Hester F.; IJzermans, Jan N. M.; Kompanje, Erwin J. O.			Donor conversion rates depend on the assessment tools used in the evaluation of potential organ donors	INTENSIVE CARE MEDICINE			English	Article						Brain death; Critical care organisation; Ethics; Neurotrauma; Stroke; Transplantation	ANEURYSMAL SUBARACHNOID HEMORRHAGE; UNITED-STATES; BRAIN-DEATH; COMA SCALE; 4 SCORE; DONATION; CARE; VALIDATION; AUDIT	Purpose: It is desirable to identify a potential organ donor (POD) as early as possible to achieve a donor conversion rate (DCR) as high as possible which is defined as the actual number of organ donors divided by the number of patients who are regarded as a potential organ donor. The DCR is calculated with different assessment tools to identify a POD. Obviously, with different assessment tools, one may calculate different DCRs, which make comparison difficult. Our aim was to determine which assessment tool can be used for a realistic estimation of a POD pool and how they compare to each other with regard to DCR. Methods: Retrospective chart review of patients diagnosed with a subarachnoid haemorrhage, traumatic brain injury or intracerebral haemorrhage. We applied three different assessment tools on this cohort of patients. Results: We identified a cohort of 564 patients diagnosed with a subarachnoid haemorrhage, traumatic brain injury or intracerebral haemorrhage of whom 179/564 (31.7%) died. After applying the three different assessment tools the number of patients, before exclusion of medical reasons or age, was 76 for the IBD-FOUR definition, 104 patients for the IBD-GCS definition and 107 patients based on the OPTN definition of imminent neurological death. We noted the highest DCR (36.5%) in the IBD-FOUR definition. Conclusion: The definition of imminent brain death based on the FOUR-score is the most practical tool to identify patients with a realistic chance to become brain dead and therefore to identify the patients most likely to become POD.	[de Groot, Yorick J.; van der Jagt, Mathieu; Bakker, Jan; Kompanje, Erwin J. O.] Erasmus MC Univ, Med Ctr, Dept Intens Care, NL-3000 CA Rotterdam, Netherlands; [Wijdicks, Eelco F. M.] Mayo Clin, Div Crit Care Neurol, Rochester, MN USA; [Lingsma, Hester F.] Erasmus MC Univ, Med Ctr Rotterdam, Dept Publ Hlth, Ctr Med Decis Making, NL-3000 CA Rotterdam, Netherlands; [IJzermans, Jan N. M.] Erasmus MC Univ, Med Ctr Rotterdam, Dept Surg, NL-3000 CA Rotterdam, Netherlands		Kompanje, EJO (corresponding author), Erasmus MC Univ, Med Ctr, Dept Intens Care, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl	Bakker, Jan/A-4011-2009; van der Jagt, Mathieu/G-1905-2017	Bakker, Jan/0000-0003-2236-7391; van der Jagt, Mathieu/0000-0003-2566-8325			Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Connolly E S Jr, 1999, J Stroke Cerebrovasc Dis, V8, P248, DOI 10.1016/S1052-3057(99)80074-3; Cuende N, 2007, AM J TRANSPLANT, V7, P1526, DOI 10.1111/j.1600-6143.2007.01792.x; de Groot YJ, 2010, INTENS CARE MED, V36, P1488, DOI 10.1007/s00134-010-1848-y; Goldacre MJ, 2008, STROKE, V39, P2197, DOI 10.1161/STROKEAHA.107.509695; Gortmaker SL, 1996, CRIT CARE MED, V24, P432, DOI 10.1097/00003246-199603000-00012; Jansen NE, 2009, TRANSPL INT, V22, P1064, DOI 10.1111/j.1432-2277.2009.00930.x; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; KOMPANJE EJO, 2010, HUMAN RIGHTS BIOMEDI, P235; Lytle FT, 2009, AM J TRANSPLANT, V9, P1446, DOI 10.1111/j.1600-6143.2009.02575.x; Jimenez-Yepes CM, 2008, STROKE, V39, P1344, DOI 10.1161/STROKEAHA.107.504019; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Opdam HI, 2004, INTENS CARE MED, V30, P1390, DOI 10.1007/s00134-004-2185-9; Raja PV, 2008, NEUROSURGERY, V62, P1187, DOI 10.1227/01.neu.0000333291.67362.0b; Rodrigue JR, 2006, AM J TRANSPLANT, V6, P190, DOI 10.1111/j.1600-6143.2005.01130.x; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; Tuttle-Newhall JE, 2009, AM J TRANSPLANT, V9, P879, DOI 10.1111/j.1600-6143.2009.02565.x; Wesslau C, 2007, TRANSPL INT, V20, P147, DOI 10.1111/j.1432-2277.2006.00413.x; Wijdicks EFM, 2008, NEUROLOGY, V70, P1234, DOI 10.1212/01.wnl.0000289762.50376.b6; Wijdicks Eelco F M, 2006, Rev Neurol Dis, V3, P109; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wijdicks EFM, 2005, MAYO CLIN PROC, V80, P550, DOI 10.4065/80.4.550; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	24	22	22	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	APR	2011	37	4					665	670		10.1007/s00134-011-2131-6			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747FM	WOS:000289305700016	21267542	Green Published, hybrid, Green Submitted			2022-02-06	
J	Gebauer, DP; Williamson, RA; Wallman, KE; Dawson, BT				Gebauer, Dieter P.; Williamson, Raymond A.; Wallman, Karen E.; Dawson, Brian T.			The Effect of Mouthguard Design on Respiratory Function in Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						mouthguard; ventilation; oxygen uptake; respiration; athlete	INJURIES; CONCUSSIONS; ABSORPTION; CAPACITY; PLAYERS; FLOW	Objective: To test the hypothesis that 2 types of custom-made mouthguards will have no effect on ventilation ((V) over dot(E), L.min(-1)), oxygen uptake ((V) over dotO(2), mL.kg(-1).min(-1)), and heart rate (beats per minutes) at varying exercise intensities (10 km.h(-1) and 12 km.h(-1)) and at subjective maximal effort ((V) over dotO(2)peak) in male field hockey and water polo players. Design: A randomized, prospective, crossover study. Setting: The Physiology Testing Laboratory, School of Sports Science, Exercise and Health at the University of Western Australia, a tertiary educational institution. Participants: Twenty-seven male team-sport athletes. Interventions: Each athlete participated in 3 experimental exercise sessions separated by 1-week intervals. Testing involved a graded exercise test (GXT) performed on a treadmill wearing either a custom laminated mouthguard with normal palatal surface, a custom laminated mouthguard with palatal coverage up to the gingival margin, or no mouthguard. The experimental trials were performed in a random counterbalanced order. Main Outcome Measures: (V) over dot(E) (L.min(-1)) and (V) over dotO(2) (mL.kg(-1).min(-1)) were measured during the GXTat intensities that equated to 10 km.h(-1), 12 km.h(-1) and subjective maximal effort ((V) over dotO(2)peak). Results: There were no significant differences between trials for (V) over dot(E) (L.min(-1)) and (V) over dotO(2) (mL.kg(-1).min(-1)) at any of the intensities assessed (P < 0.05). Conclusions: The wearing of 2 different custom-made mouthguards during a GXT did not impair (V) over dot(E) or (V) over dotO(2) during varying levels of exercise intensity in team sport athletes.	[Gebauer, Dieter P.; Williamson, Raymond A.] Univ Western Australia, Sch Dent, Crawley, WA 6009, Australia; [Gebauer, Dieter P.; Williamson, Raymond A.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA 6009, Australia; [Wallman, Karen E.; Dawson, Brian T.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA 6009, Australia		Williamson, RA (corresponding author), Univ Western Australia, Sch Dent, 35 Stirling Highway, Crawley, WA 6009, Australia.	raymond.williamson@uwa.edu.au			Australian and New Zealand Association of Oral and Maxillofacial Surgery	Supported by the Australian and New Zealand Association of Oral and Maxillofacial Surgery.	ADA, 2006, J AM DENT ASSOC, V137, P1712; Amis T, 2000, MED SCI SPORT EXER, V32, P284, DOI 10.1097/00005768-200002000-00006; Bemelmanns P, 2001, INT J SPORTS MED, V22, P149, DOI 10.1055/s-2001-11342; Berry DC, 2005, J PUBLIC HEALTH DENT, V65, P71, DOI 10.1111/j.1752-7325.2005.tb02789.x; Bourdin M, 2006, MED SCI SPORT EXER, V38, P1500, DOI 10.1249/01.mss.0000228952.44850.eb; Braham RA, 2004, J SCI MED SPORT, V7, P216, DOI 10.1016/S1440-2440(04)80011-2; Chatterjee Mahua, 2007, Prim Dent Care, V14, P111, DOI 10.1308/135576107781327151; Craig RG, 2002, J ORAL REHABIL, V29, P146, DOI 10.1046/j.1365-2842.2002.00831.x; Delaney JS, 2005, CLIN J SPORT MED, V15, P154, DOI 10.1097/01.jsm.0000158256.85664.8d; Duhaime CF, 2006, DENT TRAUMATOL, V22, P186, DOI 10.1111/j.1600-9657.2006.00360.x; Francis K T, 1991, Br J Sports Med, V25, P227; Gardiner D M, 2000, Dent Clin North Am, V44, P53; Hendrick K, 2008, DENT TRAUMATOL, V24, P189, DOI 10.1111/j.1600-9657.2007.00527.x; Kececi AD, 2005, DENT TRAUMATOL, V21, P276, DOI 10.1111/j.1600-9657.2005.00354.x; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Kumamoto David P, 2004, Gen Dent, V52, P270; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lieger O, 2006, DENT TRAUMATOL, V22, P1, DOI 10.1111/j.1600-9657.2006.00328.x; Lim D, 2005, CLIN J SPORT MED, V15, P313, DOI 10.1097/01.jsm.0000180019.22018.3c; Low Danny, 2002, Ann R Australas Coll Dent Surg, V16, P153; Luke R, 1982, Diastema, V10, P56; Maeda Y, 2006, BRIT J SPORT MED, V40, P1006, DOI 10.1136/bjsm.2006.030874; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Newsome P R, 2001, Int J Paediatr Dent, V11, P396, DOI 10.1046/j.0960-7439.2001.00304.x; Schwartz R, 2000, CRANIO, V18, P23, DOI 10.1080/08869634.2000.11746110; *SPORTS MED AUSTR, 2001, W AUSTR SPORTS INJ S; von Arx T, 2008, INT J SPORTS MED, V29, P435, DOI 10.1055/s-2007-965341; Westerman B, 1995, AUST DENT J, V40, P389, DOI 10.1111/j.1834-7819.1995.tb04838.x; Westerman B, 2000, AUST DENT J, V45, P21, DOI 10.1111/j.1834-7819.2000.tb00237.x; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Yamada J, 2006, DENT TRAUMATOL, V22, P139, DOI 10.1111/j.1600-9657.2006.00393.x; Yamanaka Takuto, 2002, Journal of Medical and Dental Sciences, V49, P129	32	22	23	1	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2011	21	2					95	100		10.1097/JSM.0b013e31820428b0			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	728AB	WOS:000287844100004	21358498				2022-02-06	
J	Numminen, HJ				Numminen, H. J.			The incidence of traumatic brain injury in an adult population - how to classify mild cases?	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						adult; incidence; population; risk factor; traumatic brain injury	TASK-FORCE; EPIDEMIOLOGY; ACCURACY	Background: The incidence of traumatic brain injury (TBI) varies considerably between reports mainly because of variable methods used in recruiting of cases and especially in defining mild TBI. This study was carried out to evaluate the incidence in a given population according to published criteria for mild TBIs. Methods: All cases with symptoms of brain injury after a head trauma were collected from the health centres serving a defined population in South East Finland and from the one hospital taking care of all corresponding TBI cases. After reviewing the health records, the author classified the TBIs according to the guidelines of European Federation of Neurological Societies (EFNS). Results: A total of 370 patients were enrolled. The total crude annual incidence rate was 221 per 100.000 (95% CI: 176-265). A mild TBI was defined in 71% of the patients. According to the EFNS criteria, one-third of them should be classified only with head traumas because of the lack of either loss consciousness (LOC) or post-traumatic amnesia (PTA). This would reduce the total crude incidence rate to 137 per 100.000(95% CI: 101-172), an effect of the same magnitude as excluding mild TBIs treated out of hospital. Conclusions: The incidence rate falls within the wide range of previous published figures. Use of LOC or PTA as a criterion for mild TBI affects the incidence rate considerably as does the exclusion of mild cases treated out of hospital.	Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere 33521, Finland		Numminen, HJ (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, PL 2000, Tampere 33521, Finland.	heikki.numminen@pshp.fi			Maire Tapola Foundation; South Karelia Central Hospital	I thank Sirpa Valpas for collecting the patient data. This work was supported by the Maire Tapola Foundation and by South Karelia Central Hospital.	Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Engberg AW, 2001, EUR J EPIDEMIOL, V17, P437, DOI 10.1023/A:1013733107520; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; WINQVIST S, 2006, J ADOLESC HLTH, V39; Yates PJ, 2006, J NEUROL NEUROSUR PS, V77, P699, DOI 10.1136/jnnp.2005.081901	13	22	22	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	MAR	2011	18	3					460	464		10.1111/j.1468-1331.2010.03179.x			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	722RB	WOS:000287450900017	20722703				2022-02-06	
J	Piras, F; Borella, E; Incoccia, C; Carlesimo, GA				Piras, F.; Borella, E.; Incoccia, C.; Carlesimo, G. A.			Evidence-based practice recommendations for memory rehabilitation	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Memory disorders; Rehabilitation; Practice guidelines as topic	TRAUMATIC BRAIN-INJURY; FACE-NAME ASSOCIATIONS; CLOSED-HEAD INJURY; ALZHEIMERS-DISEASE; IMPAIRED PATIENTS; COGNITIVE REHABILITATION; ELECTRONIC MEMORY; PAGING SYSTEM; NEUROPSYCHOLOGICAL REHABILITATION; OLDER-ADULTS	Memory impairment is a common consequence of neurological injury or disease, causing significant disability in everyday life, and is therefore a critical target for rehabilitation intervention. Here we report a review of the available evidence on the efficacy of restitution-oriented therapies and compensatory approaches for memory rehabilitation. A total of 110 studies was systematically classified and analyzed in order to generate evidence-based clinical recommendations for treatment providers. Different key aspects, such as types of brain damage, treatments characteristics and outcome measurements guided the evaluation of the literature as to appraise the potential interaction between patients characteristics, interventions and outcomes. The general conclusion is that memory re-training programs and compensatory approaches are probably effective in ameliorating memory disorders in patients with focal brain lesions, with some evidences of changes in memory functioning extending beyond the trained skills. Externally directed assistive devices and specific learning strategies are effective (with a level D and B of evidence, respectively) in retaining information relevant for daily needs also in patients with degenerative diseases. Some methodological concerns, such as the heterogeneity of subjects, interventions and outcomes studied, may limit the generalization of the present recommendations.	[Piras, F.] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, D-72074 Tubingen, Germany; [Piras, F.; Incoccia, C.; Carlesimo, G. A.] Santa Lucia Fdn, Rome, Italy; [Borella, E.] Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy; [Carlesimo, G. A.] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy		Piras, F (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Gartenstr 29, D-72074 Tubingen, Germany.	PirasFPhD@gmail.com	Borella, Erika/D-1278-2014	Borella, Erika/0000-0001-5481-6601; Incoccia, Chiara/0000-0003-4068-6548	European CommissionEuropean CommissionEuropean Commission Joint Research Centre [PITN-G-2008-214570]	FP was funded by a three year European Commission fellowship, PITN-G-2008-214570.	Abrisqueta-Gomez J, 2004, ARQ NEURO-PSIQUIAT, V62, P778, DOI 10.1590/S0004-282X2004000500007; Allen DN, 1998, J REHABIL RES DEV, V35, P405; Avila R, 2004, BRAZ J MED BIOL RES, V37, P1721, DOI 10.1590/S0100-879X2004001100018; BACKMAN L, 1991, PSYCHOL AGING, V6, P489; Baddeley, 1990, HUMAN MEMORY THEORY; Bakke B. L., 2004, CLIN GERONTOLOGIST, V27, P159, DOI DOI 10.1300/J018V27N01_12; Belleville S, 2006, DEMENT GERIATR COGN, V22, P486, DOI 10.1159/000096316; BENEDICT RHB, 1993, NEUROPSYCHOL REHABIL, V3, P37; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Berry E, 2007, NEUROPSYCHOL REHABIL, V17, P582, DOI 10.1080/09602010601029780; Bjork R., 1988, PRACT ASP MEM, V2; Boman IL, 2007, DISABIL REHABIL-ASSI, V2, P23, DOI 10.1080/17483100600856213; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Bourgeois MS, 2003, J COMMUN DISORD, V36, P361, DOI 10.1016/S0021-9924(03)00051-0; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; Burke DT, 2001, J HEAD TRAUMA REHAB, V16, P284, DOI 10.1097/00001199-200106000-00007; Cahn-Weiner DA, 2003, APPL NEUROPSYCHOL, V10, P215, DOI 10.1207/s15324826an1004_3; CAMP CJ, 1992, EVERYDAY MEMORY AGIN, P155; Cappa SF, 2005, EUR J NEUROL, V12, P665; CARLESIMO GA, 1996, MANUALE NEUROPSICOLO, P1156; Cavaco S, 2005, BRAIN INJURY, V19, P853, DOI 10.1080/01449290500109917; Cherry K.E., 1999, J CLIN GEROPSYCHOLOG, V5, P159, DOI DOI 10.1023/A:1022983131186; Cherry KE, 2005, EXP AGING RES, V31, P261, DOI 10.1080/03610730590948186; CHERRY KE, 2004, CLIN GERONTOLOGIST, V27, P139, DOI DOI 10.1300/J018V27N01_11; Chiaravalloti ND, 2005, MULT SCLER, V11, P58, DOI 10.1191/1352458505ms1118oa; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cipriani G, 2006, ARCH GERONTOL GERIAT, V43, P327, DOI 10.1016/j.archger.2005.12.003; Clare L, 2001, NEUROPSYCHOL REHABIL, V11, P477, DOI 10.1080/09602010042000213; Clare L, 2000, J CLIN EXP NEUROPSYC, V22, P132, DOI 10.1076/1380-3395(200002)22:1;1-8;FT132; Clare L, 1999, NEUROCASE, V5, P37, DOI 10.1080/13554799908404063; CLARE L, 2004, Z GERONTOPSYCHOLOGIE, V17, P109, DOI DOI 10.1024/1011-6877.17.2.109; Cowles A, 2003, NEUROCASE, V9, P493, DOI 10.1076/neur.9.6.493.29378; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; CROVITZ HF, 1979, CORTEX, V15, P225, DOI 10.1016/S0010-9452(79)80027-1; DAVIS RN, 2001, ALZ DIS ASSOC DIS, V5, P1; Donaghy S, 1998, BRAIN INJURY, V12, P1061, DOI 10.1080/026990598121963; Doornhein K, 1998, NEUROPSYCHOL REHABIL, V8, P393, DOI 10.1080/713755579; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; DOUGAN DR, 1984, INT J NEUROSCI, V23, P215, DOI 10.3109/00207458408985365; Ehlhardt LA, 2005, BRAIN INJURY, V19, P569, DOI 10.1080/002699050400013550; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Evans J, 1992, CLIN REHABIL, V6, P75, DOI DOI 10.1177/026921559200600110; Fernandez AL, 2006, NEUROPSYCHOL REHABIL, V16, P96, DOI 10.1080/09602010443000164; Fillingham JK, 2003, NEUROPSYCHOL REHABIL, V13, P337, DOI 10.1080/09602010343000020; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Fluharty George, 1993, Brain Injury, V7, P85, DOI 10.3109/02699059309008160; FRAAS M, 2006, INT J COGNIT TECH, V11, P10; GIANUTSOS R, 1981, Journal of Clinical Neuropsychology, V3, P143, DOI 10.1080/01688638108403119; GIANUTSOS R, 1979, J CLIN NEUROPSYCHOL, V14, P117; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; GLISKY EL, 1986, NEUROPSYCHOLOGIA, V24, P313, DOI 10.1016/0028-3932(86)90017-5; GLISKY EL, 1987, NEUROPSYCHOLOGIA, V25, P893, DOI 10.1016/0028-3932(87)90094-7; GLISKY EL, 1992, NEUROPSYCHOLOGIA, V30, P899, DOI 10.1016/0028-3932(92)90034-J; GLISKY EL, 1986, J CLIN EXP NEUROPSYC, V8, P292, DOI 10.1080/01688638608401320; GLISKY EL, 1995, NEUROPSYCHOL REHABIL, V5, P299, DOI 10.1080/09602019508401474; GLISKY EL, 1988, NEUROPSYCHOLOGIA, V26, P173, DOI 10.1016/0028-3932(88)90041-3; GODFREY HPD, 1985, J CONSULT CLIN PSYCH, V53, P555, DOI 10.1037/0022-006X.53.4.555; Goldstein G, 1998, J REHABIL RES DEV, V35, P238; Gupta A, 2003, BRAIN INJURY, V17, P161, DOI 10.1080/0269905021000010195; Hannon R, 1989, Arch Clin Neuropsychol, V4, P227, DOI 10.1016/0887-6177(89)90015-2; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Haslam C, 2006, NEUROPSYCHOL REHABIL, V16, P505, DOI 10.1080/09602010500231867; Hawley KS, 2004, BEHAV MODIF, V28, P276, DOI 10.1177/0145445503259283; Heinrichs R.W, 1992, NEUROPSYCHOL REHABIL, V2, P43, DOI [10.1080/09602019208401394, DOI 10.1080/09602019208401394]; HEISS WD, 1994, DEMENTIA, V5, P88, DOI 10.1159/000106702; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; Hildebrandt H, 2007, RESTOR NEUROL NEUROS, V25, P33; HILL RD, 1987, PSYCHOL AGING, V2, P204, DOI 10.1037/0882-7974.2.2.204; HT P, 2001, BRAIN INJURY, V15, P787; HUNKIN NM, 1995, NEUROPSYCHOLOGIA, V33, P1255, DOI 10.1016/0028-3932(95)00061-7; Hux K, 2000, BRAIN INJURY, V14, P907; Inzitari D, 2006, NEUROL SCI, V27, pS225, DOI 10.1007/s10072-006-0622-y; Jennett S M, 1991, Int Disabil Stud, V13, P83; JONSSON A, 1993, ACTA NEUROL SCAND, V88, P394, DOI 10.1111/j.1600-0404.1993.tb05366.x; Kapur N, 2004, NEUROPSYCHOL REHABIL, V14, P41, DOI 10.1080/09602010343000138; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Kime SK, 1996, BRAIN INJURY, V10, P17; Kirsch NL, 2004, REHABIL PSYCHOL, V49, P200, DOI 10.1037/0090-5550.49.3.200; Kirsch NL, 2004, BRAIN INJURY, V18, P725, DOI 10.1080/02699050310001646161; Koltai DC, 2001, NEUROPSYCHOL REHABIL, V11, P455, DOI 10.1080/09602010042000097; KOVNER R, 1983, J CLIN NEUROPSYCHOL, V5, P65, DOI 10.1080/01688638308401151; MALEC J, 1983, ARCH PHYS MED REHAB, V64, P436; Malone M. L., 2007, ALZHEIMERS CARE Q, V8, P65; Manasse NJ, 2005, BRAIN INJURY, V19, P633, DOI 10.1080/02699050400013667; McKerracher G, 2005, NEUROPSYCHOL REHABIL, V15, P115, DOI 10.1080/09602010443000056; MCKITRICK LA, 1992, J GERONTOL, V47, pP337, DOI 10.1093/geronj/47.5.P337; McMahon C.M., 2003, CLIN PSYCHOL, V7, P50, DOI [https://doi.org/10.1080/13284200410001707483, DOI 10.1080/13284200410001707483]; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; Miotto EC, 2007, NEUROPSYCHOL REHABIL, V17, P551, DOI 10.1080/09602010701202188; Moore S, 2001, NEUROPSYCHOL REHABIL, V11, P245, DOI 10.1080/09602010042000222; MOSCOVITCH M, 1982, HUMAN MEMORY AMNESIA; Mount J, 2007, NEUROREHABILITATION, V22, P123; Oriani M, 2003, AGING MENT HEALTH, V7, P22, DOI 10.1080/1360786021000045863; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Paivio A., 1971, IMAGERY VERBAL PROCE; Pitel AL, 2006, BRAIN INJURY, V20, P1099, DOI 10.1080/02699050600909961; QOCARROLL RE, 1999, PSYCHOL MED, V29, P105; QSQUIRES EJ, 1996, NEUROPSYCHOL REHABIL, V6, P55; Quittre A, 2005, ACTA NEUROL BELG, V105, P30; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Solari A, 2004, J NEUROL SCI, V224, P113, DOI 10.1016/j.jns.2004.07.001; Stapleton S, 2007, BRAIN INJURY, V21, P401, DOI 10.1080/02699050701252030; STEINGASS HP, 1994, NEUROPSYCHOL REHABIL, V4, P49, DOI 10.1080/09602019408401455; Sykes, 1978, PRACTICAL ASPECTS ME, P625; Tam SF, 2004, BRAIN INJURY, V18, P461, DOI 10.1080/02699050310001646099; Tam Sing-Fai, 2003, Occup Ther Int, V10, P20, DOI 10.1002/oti.175; Tesar N, 2005, WIEN KLIN WOCHENSCHR, V117, P747, DOI 10.1007/s00508-005-0470-4; Thickpenny-Davis KL, 2007, J HEAD TRAUMA REHAB, V22, P303, DOI 10.1097/01.HTR.0000290975.09496.93; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; TOPPINO TC, 1991, MEM COGNITION, V19, P159, DOI 10.3758/BF03197112; Tulving E., 1983, ELEMENTS EPISODIC ME; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Van Hulle A, 2006, BRAIN INJURY, V20, P101, DOI 10.1080/02699050500309684; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2003, NEUROREHABILITATION, V18, P3; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239; YOHMAN JR, 1988, J CONSULT CLIN PSYCH, V56, P67	129	22	23	0	43	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	MAR	2011	47	1					149	175					27	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	751CO	WOS:000289595300013	21448125				2022-02-06	
J	Alla, S; Sullivan, SJ; McCrory, P; Hale, L				Alla, Sridhar; Sullivan, S. John; McCrory, Paul; Hale, Leigh			Spreading the word on sports concussion: citation analysis of summary and agreement, position and consensus statements on sports concussion	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							2ND INTERNATIONAL-CONFERENCE; NOVEMBER 2008; ZURICH; MANAGEMENT; RECOMMENDATIONS; SCIENCE	Background The growing concern over concussion in sports has led to the publication of five major summary and agreement, position and consensus statements since 2000. The dissemination of information from these statements is largely unknown and difficult to quantify, but their impact on the research community can be quantified by analysing the number of citations to these key publications. The purpose of this review is to report the number and pattern of citations to the key published statements on sports concussion. Methods Web of Science, Scopus and PubMed were searched from 2000 to mid-December 2009 using two different search strategies. The first strategy used the search terms 'concussion' and 'first author' of the statement article, while the second used the 'title' of the target article as the key search term. Results The publications resulting from the three 'Concussion in Sport' (CIS) group conferences were cited by 532 journal articles, while the National Athletic Trainers' Association position statement was cited 123 times. The highest number of citations to each of the five identified statements was seen in 2009. British Journal of Sports Medicine was the most frequently cited journal. Conclusion The citation analysis of the key statements on sports concussion has shown that the target papers have been widely cited in the research literature, with the highest number of citations being from the publications arising from the CIS group conferences. The authors have shown their preference to cite source articles published in the British Journal of Sports Medicine.	[Alla, Sridhar] Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, Dunedin 9054, New Zealand; [McCrory, Paul] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia		Alla, S (corresponding author), Univ Otago, Sch Physiotherapy, Ctr Physiotherapy Res, POB 56, Dunedin 9054, New Zealand.	allsr357@student.otago.ac.nz	McCrory, Paul/Q-8688-2019	McCrory, Paul/0000-0003-4850-0568	International Rugby Board	The authors would like to thank G Forsyth, for assisting with the literature search, and the International Rugby Board, for financial support.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Aubry Mark, 2002, Phys Sportsmed, V30, P57, DOI 10.3810/psm.2002.02.176; Bakkalbasi Nisa, 2006, Biomed Digit Libr, V3, P7, DOI 10.1186/1742-5581-3-7; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Cantu Robert C, 2006, Neurosurg Focus, V21, pE3; Cantu RC, 2009, NEUROSURGERY, V64, P786, DOI 10.1227/01.NEU.0000348539.13887.D3; Dvorak J, 2009, BRIT J SPORT MED, V43, pI1, DOI 10.1136/bjsm.2009.059360; Guskiewicz KM, 2006, BRIT J SPORT MED, V40, P6, DOI 10.1136/bjsm.2005.021683; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; HERRING S, 2006, MED SCI SPORTS EXERC, V38, P395, DOI DOI 10.1249/01.MSS.0000202025.48774.31; HERRING SA, 2005, MED SCI SPORTS EXERC, V37, P2012; McCrory P, 2005, PHYSICIAN SPORTSMED, V33, P29, DOI 10.3810/psm.2005.04.76; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory Paul, 2009, Scand J Med Sci Sports, V19, P452, DOI 10.1111/j.1600-0838.2009.00978.x; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Noruzi A, 2005, LIBRI, V55, P170, DOI 10.1515/LIBR.2005.170; Perneger TV, 2010, J CLIN EPIDEMIOL, V63, P660, DOI 10.1016/j.jclinepi.2009.09.012; Renear AH, 2009, SCIENCE, V325, P828, DOI 10.1126/science.1157784; Roth DL, 2005, CURR SCI INDIA, V89, P1531; Schmoch U, 2008, SCIENTOMETRICS, V74, P361, DOI 10.1007/s11192-007-1818-5; WADE N, 1975, SCIENCE, V188, P429, DOI 10.1126/science.188.4187.429	28	22	22	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	FEB	2011	45	2					132	135		10.1136/bjsm.2010.074088			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	709FJ	WOS:000286423000012	21081639				2022-02-06	
J	Cullen, NK; Weisz, K				Cullen, Nora K.; Weisz, Karen			Cognitive correlates with functional outcomes after anoxic brain injury: A case-controlled comparison with traumatic brain injury	BRAIN INJURY			English	Article						Brain injuries; hypoxia; brain; rehabilitation	DISABILITY RATING-SCALE; NEUROPSYCHOLOGICAL ASSESSMENT; REHABILITATION; VALIDITY; PERFORMANCE; SEQUELAE	Objectives: To assess the effectiveness of inpatient rehabilitation in adults who have sustained an anoxic brain injury (AnBI). Secondly, to identify areas of cognition that predict functional outcomes at discharge. Design: Retrospective, matched case-controlled study. Methods: Ten patients with moderate-to-severe AnBI and 10 patients with traumatic brain injury (TBI), treated in an inpatient neurorehabilitation programme, were matched on age, acute care length of stay and admission Functional Independence Measure (FIM). Functional outcome was assessed using the FIM and Disability Rating Scale (DRS). Results: Patients with AnBI performed worse on all measures of functional outcome relative to patients with TBI. Patients with AnBI achieved significantly lower FIM motor and cognitive gain compared with patients with TBI (11.5, SD 13.6 vs. 31.0, SD 19.7 and 2.4, SD 3.9 vs. 7.5, SD 4.2, respectively (p < 0.02)). DRS data showed similar trends of functional improvement between the groups. Several neuropsychometric tests correlated with functional outcome (p < 0.01). Conclusions: Patients with AnBI had worse functional outcomes following rehabilitation than patients with TBI, confirming the results of previous reports. Poor cognitive function predicted poor functional outcomes on the FIM and somewhat on the DRS. Research is needed to assess why these differences occur and to improve or develop new effective rehabilitation treatments for AnBI.	[Cullen, Nora K.] Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Cullen, Nora K.] Univ Toronto, Div Physiatry, Toronto, ON, Canada; [Weisz, Karen] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada		Cullen, NK (corresponding author), Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	cullen.nora@torontorehab.on.ca		Cullen, Nora/0000-0001-6359-9418	Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; Physicians' Services Foundation Inc. [06-43]; Canada Foundation for Innovation and the Province of Ontario	Thank you to the Physicians' Services Incorporated Foundation for funding this study. The Clinical Team at Toronto Rehabilitation Institute is greatly appreciated for their assistance in collection of data for this study. The authors also acknowledge the support of Toronto Rehabilitation Institute which receives funding under the Provincial Rehabilitation Research Program from the Ontario Ministry of Health and Long-Term Care. The views expressed herein do not necessarily reflect those of the Ministry.; Declaration of Interest: This study was supported by the Physicians' Services Foundation Inc. (grant no. 06-43). Equipment and space have been funded with grants from the Canada Foundation for Innovation and the Province of Ontario. The authors report no conflicts of interest.	Ashley MJ, 1997, BRAIN INJURY, V11, P677; Blum L, 2008, PHYS THER, V88, P559, DOI 10.2522/ptj.20070205; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; Burke DT, 2005, BRAIN INJURY, V19, P675, DOI 10.1080/02699050400024953; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; DAMS JH, 2000, BRAIN, V123, P1327; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Gualtieri CT, 2002, BRAIN INJURY MENTAL; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Hopkins RO, 2004, J INT NEUROPSYCH SOC, V10, P957, DOI 10.1017/S1355617704107108; Kaplan CP, 1999, BRAIN INJURY, V13, P305, DOI 10.1080/026990599121674; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Neese LE, 2000, BRAIN INJURY, V14, P719; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, pS16, DOI 10.1016/S0003-9993(98)90115-0; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ravaud JF, 1999, SCAND J REHABIL MED, V31, P31; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; SCHURR A, 1992, HIPPOCAMPUS, V2, P221, DOI 10.1002/hipo.450020303; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; UDS Data Management Service, 1995, GUID UN DAT SYST MED; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	32	22	22	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2011	25	1					35	43		10.3109/02699052.2010.531691			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JI	WOS:000288101700005	21121706				2022-02-06	
J	Honeybul, S; O'Hanlon, S; Ho, KM				Honeybul, Stephen; O'Hanlon, Susan; Ho, Kwok M.			Decompressive Craniectomy for Severe Head Injury: Does an Outcome Prediction Model Influence Clinical Decision-Making?	JOURNAL OF NEUROTRAUMA			English	Article						decision making; decompressive craniectomy; outcome	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY INFARCTION; SURGICAL DECOMPRESSION; MULTICENTER; SURGERY; MANAGEMENT; RECOVERY; TRIAL	The use of a prognostic model to aid clinician decision-making with regard to decompressive craniectomy for patients with severe neurotrauma has not been examined. Thus in this study we assessed whether an internationally validated prediction model would influence clinician decision-making about craniectomy. A two-part structured interview, given before and after knowing the predicted risks of unfavorable neurological outcomes at 6 months, was used to assess the participants' recommendations about performing decompressive craniectomy in three patients with severe traumatic brain injury. The participants rated their preferences when there was no surrogate decision maker available, when the next of kin requested surgical intervention, when the patient had an advance directive, and when the participant was the injured party. A visual analogue scale (1-10) was used to assess the strength of their opinions. A total of 50 neurosurgeons and intensive care physicians participated in this study. The participants were significantly more likely to recommend decompressive craniectomy for their patients than for themselves, especially when the next of kin of the patient demanded the procedure, and were more similar in their own preferences to patients who had advance directives. Clinicians' preferences to perform the procedure for both themselves and their patients was significantly reduced after knowing the predicted risks of unfavorable outcomes, and these changes in attitude were consistent across those with different specialties, regardless of the amount of experience caring for similar patients, or religious background. In conclusion, the predicted risks of unfavorable outcomes influenced clinician decision-making about recommending decompressive craniectomy for patients with very severe neurotrauma.	[Honeybul, Stephen; O'Hanlon, Susan] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Honeybul, Stephen; O'Hanlon, Susan] Royal Perth Hosp, Perth, WA, Australia; [Ho, Kwok M.] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok M.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Ho KM, 2010, CRIT CARE MED, V38, P1562, DOI 10.1097/CCM.0b013e3181e2ccd8; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Woischneck D, 2010, Z ORTHOP UNFALLCHIR, V148, P548, DOI 10.1055/s-0030-1249913; Zheng WB, 2007, NEURORADIOLOGY, V49, P271, DOI 10.1007/s00234-006-0187-8	24	22	23	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2011	28	1					13	19		10.1089/neu.2010.1584			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	710DT	WOS:000286491800002	20979568				2022-02-06	
B	Iverson, GL; Lange, RT		Schoenberg, MR; Scott, JG		Iverson, Grant L.; Lange, Rael T.			Moderate and Severe Traumatic Brain Injury	LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; DIFFUSE AXONAL INJURY; MILD HEAD-INJURY; SAN-DIEGO-COUNTY; MAJOR DEPRESSION; AXIS-I; PSYCHIATRIC-DISORDERS; MOTOR-PERFORMANCE; NATURAL-HISTORY; DAMAGE	Traumatic brain injuries arise from open or closed head injuries. Most traumatic brain injuries result from closed head injuries (an example of an open head injury is an object penetrating the skull). Brain injuries occur as the result of acceleration-deceleration forces (linear or angular), blunt trauma, or both. Traumatic brain injuries occur on a broad continuum of severity, from very mild transient injuries to catastrophic injuries resulting in death or severe disability. The continuum of severity of traumatic brain injury is illustrated in Fig. 21.1.	[Iverson, Grant L.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Iverson, Grant L.; Lange, Rael T.] British Columbia Mental Hlth & Addict Serv, Coquitlam, BC, Canada		Iverson, GL (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	giverson@interchange.ubc.ca; rlange@dvbic.org					AbdelMalik P, 2003, ARCH GEN PSYCHIAT, V60, P231, DOI 10.1001/archpsyc.60.3.231; ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 2005, STRUCTURAL IMAGING; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Breslau N, 2003, NEUROLOGY, V60, P1308, DOI 10.1212/01.WNL.0000058907.41080.54; *BRIT MED ASS MED, 1992, DISC PAP PAT PERS VE; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Campbell M, 2005, BRAIN INJURY, V19, P1095, DOI 10.1080/02699050500188898; CAVALLO MM, 2005, TXB TRAUMATIC BRAIN, P533; CELESIA, 1993, ANN NEUROL, V33, P386; CHARNESS ME, 1993, ALCOHOL CLIN EXP RES, V17, P2, DOI 10.1111/j.1530-0277.1993.tb00718.x; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; CORCORAN C, 2005, TXB TRAUMATIC BRAIN, P213; Corrigan J.D., 2003, TECHNICAL REPORT PRO; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CORRIGAN JD, 2007, BRAIN INJURY MED, P1105; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; ERB DE, 1991, EXP BRAIN RES, V83, P253; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Fellus J, 2007, BRAIN INJURY MED, P545; Flashman L., 2005, TXB TRAUMATIC BRAIN, P353; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; GEAN AD, 1994, IMAGING HEAD TRAUMA, P207; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Gorrie C, 2001, J NEUROTRAUM, V18, P849, DOI 10.1089/089771501750451776; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; GUREJE O, 1994, AM J PSYCHIAT, V151, P368; HARRIS JH, 2000, RADIOLOGY EMERGENCY; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HILLBOM E, 1960, Acta Psychiatr Scand Suppl, V35, P1; Hillier SL, 1997, BRAIN INJURY, V11, P661; Horner MD, 2005, J INT NEUROPSYCH SOC, V11, P322, DOI 10.1017/S135561770505037X; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JAGGER J, 1984, J TRAUMA, V24, P40, DOI 10.1097/00005373-198401000-00006; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1996, CATASTROPHIC BRAIN I; JONES GA, 1989, ALCOHOL HEALTH RES W, V13, P104; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KAPOOR N, 2005, TXB TRAUMATIC BRAIN, P405; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KNEIPP S, 2007, BRAIN INJURY MED, P1085; Kochanek PM, 2007, BRAIN INJURY MED PRI, P81; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; KRAUSS J, 2007, BRAIN INJURY MED PRI, P469; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; LAHMEYER HW, 1987, J PSYCHIAT RES, V21, P1, DOI 10.1016/0022-3956(87)90004-5; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; LEVIN HS, 1990, J NEUROSURG, V73, P77, DOI 10.3171/jns.1990.73.1.0077; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; LUCAS JA, 1998, CLIN NEUROPSYCHOLOGY, P243; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; MacKenzie E J, 1989, Md Med J, V38, P725; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; Mayou RA, 2000, BRIT J PSYCHIAT, V177, P540, DOI 10.1192/bjp.177.6.540; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; MEARNS J, 1993, J CLIN PSYCHOL, V49, P714, DOI 10.1002/1097-4679(199309)49:5<714::AID-JCLP2270490515>3.0.CO;2-H; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; MILLER NS, 1991, PHARM ALCOHOL DRUGS; Mitsikostas DD, 1999, CEPHALALGIA, V19, P211, DOI 10.1046/j.1468-2982.1999.019004211.x; Morales D., 2007, BRAIN CONTUSION; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; OSHANICK GJ, 2005, TXB TRAUMATIC BRAIN, P245; PADULA W, 2007, BRAIN INJURY MED, P511; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pine DS, 1996, J CHILD ADOL PSYCHOP, V6, P153, DOI 10.1089/cap.1996.6.153; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RAO V, 2005, TXB TRAUMATIC BRAIN, P369; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Robinson RG, 2005, TXB TRAUMATIC BRAIN, P201; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; SANDEL ME, 2007, BRAIN INJURY MED PRI, P673; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; SCHWARTZ JH, 1991, PRINCIPLES NEURAL SC, P49; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; STAMBROOK M, 1990, Brain Injury, V4, P183, DOI 10.3109/02699059009026164; STRICH SJ, 1961, LANCET, V2, P443; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; THAXTON L, 2007, BRAIN INJURY MED PRI, P557; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; UZZELL BP, 1987, SURG NEUROL, V27, P419, DOI 10.1016/0090-3019(87)90247-3; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; WARDEN DL, 2005, TXB TRAUMATIC BRAIN, P231; West M., 2007, BRAIN INJURY MED PRI, P1131; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; ZASLER ND, 2007, BRAIN INJURY MED PRI, P697; Zwart JA, 2003, EUR J NEUROL, V10, P147, DOI 10.1046/j.1468-1331.2003.00551.x; [No title captured]; [No title captured]	165	22	22	0	8	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-0-387-70703-7				2011							663	696		10.1007/978-0-387-76978-3_21	10.1007/978-0-387-76978-3		34	Clinical Neurology; Neurosciences; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BTF43	WOS:000286799800021					2022-02-06	
J	Jung, CS; Zweckberger, K; Schick, U; Unterberg, AW				Jung, Carla S.; Zweckberger, Klaus; Schick, Uta; Unterberg, Andreas W.			Helmet use in winter sport activities-attitude and opinion of neurosurgeons and non-traumatic-brain-injury-educated persons	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Sport injury; Protective helmets	BICYCLE SAFETY HELMETS; WESTERN NORTH-AMERICA; HEAD-INJURIES; SKI AREAS; SNOWBOARDERS; PREVALENCE; CHILDREN	During the last winter season, some fatal sport injuries with severe traumatic brain injury (TBI) prompted major discussions about protective helmet use. Although ski helmets reportedly lead to a 60% decrease of risk to incur TBI, little is known about the distribution of helmet users and which factors are crucial for the decision to wear a helmet. Especially, it is unknown whether knowledge or experience concerning TBI in winter sports influences the use of helmets, as well as the attitude and opinion of people. Since treatment of TBI is a major field in neurosurgery, 55 neurosurgical departments (NS) in Germany, Switzerland and Austria were addressed and asked to answer anonymous questionnaires. A "non-trauma-educated" control cohort (NTP) was interviewed in ski resorts in Austria as well as sports equipment stores in Germany. Questionnaires were returned by 465 NS and 546 NTP. Half of NS and NTP wore helmets in winter sports. Although some interviewees showed cognitive dissonant behaviour, experience in TBI after ski or snowboard accidents significantly affected the decision to wear helmets. After the fatal ski accidents, and increased media coverage 15.4% NS and 13.2% NTP bought their helmet. Furthermore, incidence of helmet use in children was correlated with the actual use and disposition of their parents to make the use of helmet compulsory. This study indicates that brain-trauma education affects ones attitude and opinion concerning protective helmet use in winter sports. However, without neglecting educational measures, emotional arguments should be added in the promotion of helmets to make them a popular integral part of winter sport outfits.	[Jung, Carla S.; Zweckberger, Klaus; Schick, Uta; Unterberg, Andreas W.] Univ Heidelberg, Dept Neurosurg, D-69121 Heidelberg, Germany		Jung, CS (corresponding author), Univ Heidelberg, Dept Neurosurg, Neuenheimer Feld 400, D-69121 Heidelberg, Germany.	carla.jung@med.uni-heidelberg.de					Alexander Mary H, 2003, J Emerg Nurs, V29, P461, DOI 10.1016/S0099-1767(03)00178-8; Andersen PA, 2004, INJURY PREV, V10, P358, DOI 10.1136/ip.2004.005967; Buller DB, 2003, J TRAUMA, V55, P939, DOI 10.1097/01.TA.0000078694.53320.CA; Burtscher M, 2008, CLIN J SPORT MED, V18, P355, DOI 10.1097/MJT.0b013e31815fd0fe; Ehrlich PF, 2001, J PEDIATR SURG, V36, P763, DOI 10.1053/jpsu.2001.22955; Evans B, 2009, INT J INJ CONTROL SA, V16, P9, DOI 10.1080/17457300902732045; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; Hennessey T, 2002, AM J PREV MED, V22, P110, DOI 10.1016/S0749-3797(01)00411-1; Jung CS, 2010, J NEUROTRAUM, V27, P871, DOI 10.1089/neu.2009.1130; Lawrence L, 2008, PEDIATR EMERG CARE, V24, P219, DOI 10.1097/PEC.0b013e31816a9f0a; Levy AS, 2007, HEALTH PROMOT PRACT, V8, P257, DOI 10.1177/1524839906292178; Levy AS, 2002, J TRAUMA, V53, P695, DOI 10.1097/00005373-200210000-00013; McDonah M R, 2000, J Am Acad Nurse Pract, V12, P517; Meyers MC, 2007, SPORTS MED, V37, P485, DOI 10.2165/00007256-200737060-00003; MORROW PL, 1988, J TRAUMA, V28, P95, DOI 10.1097/00005373-198801000-00014; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101	19	22	22	0	7	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JAN	2011	153	1					101	106		10.1007/s00701-010-0704-8			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	700YD	WOS:000285780600016	20532575				2022-02-06	
J	Martinon, C; Duracher, C; Blanot, S; Escolano, S; De Agostini, M; Perie-Vintras, AC; Orliaguet, G; Carli, PA; Meyer, PG				Martinon, Claire; Duracher, Caroline; Blanot, Stephane; Escolano, Sylvie; De Agostini, Maria; Perie-Vintras, Anne Catherine; Orliaguet, Gilles; Carli, Pierre A.; Meyer, Philippe G.			Emergency tracheal intubation of severely head-injured children: Changing daily practice after implementation of national guidelines	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injury; children; emergency tracheal intubation; rapid sequence induction; guidelines	RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; PEDIATRIC-PATIENTS; PREHOSPITAL CARE; TRAUMA; VENTILATION; HYPOTENSION; MANAGEMENT; CAPNOGRAPHY; PARAMEDICS	Objective: To report daily practice of scene emergency tracheal intubation performed by physicians and changes induced by implementation of national guidelines, with special attention to rapid sequence induction (RSI) and control of assisted ventilation. Design: Observational study. Setting: Pediatric intensive care unit of a university hospital. Patients: A total of 296 children (age, 2-15 yrs old) referred to our center for severe traumatic brain injury (Glasgow Coma Scale score of <= 8), with spontaneous cardiac rhythm. Interventions: Scene RSI practice by field physicians was compared before (n = 188), and after (n = 108) publication of national guidelines. Emergency tracheal intubation conditions, RSI use, immediate complications, assisted ventilation efficiency on blood gases measurements upon arrival, and, in the later period, physician's knowledge, and observance to published guidelines were analyzed. Measurements and Main Results: After publication of guidelines, tracheal intubation was performed at the scene in 100% of the cases (vs. 88%, p = .05); RSI practice was more standardized, with an increased use of succinylcholine (10% to 80%, p = .0001), and a concomitant decreased use of nondepolarizing muscle relaxant (20% vs. 0%, p = .005), and opioids (70% vs. 36%, p = .05). Recommended RSI protocol (etomidate and succinylcholine) was effectively used by 64% of the physicians (vs. 2.8%, p = .001), and rate of immediate complications upon tube insertion (mainly cough reflex) decreased to 8% (vs. 25%, p = .0015). Scene emergency tracheal intubation, when ordered, resulted in a 100% success rate and adequate oxygenation within the two groups. Despite increasing the use of portable capnograph in the later period, PaCO2 was measured outside the tight target range (35-40 torr, 4.6-5.3 kPa) in 70% of the cases upon arrival. Conclusions: Scene emergency tracheal intubation was effectively performed by trained careproviders in children with traumatic brain injury. Implementation of guidelines led to a more standardized practice of RSI, decreased rate of immediate complications, but insufficient control of PaCO2 during transport. (Pediatr Crit Care Med 2011; 12:65-70)	[Martinon, Claire; Duracher, Caroline; Blanot, Stephane; Perie-Vintras, Anne Catherine; Orliaguet, Gilles; Carli, Pierre A.; Meyer, Philippe G.] CHU Necker Enfants Malad, Fac Med Descartes Paris 5, Dept Pediat Anesthesiol, Pediat Surg Crit Care Unit, Villejuif, France; [Escolano, Sylvie; De Agostini, Maria] INSERM, U780, Villejuif, France; CHU Necker Enfants Malad, Fac Med Descartes Paris 5, SAMU Paris, Villejuif, France		Martinon, C (corresponding author), CHU Necker Enfants Malad, Fac Med Descartes Paris 5, Dept Pediat Anesthesiol, Pediat Surg Crit Care Unit, Villejuif, France.	philippe.meyer@nck.aphp.fr	Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; Orliaguet, Gilles/0000-0003-0930-2251; escolano, sylvie/0000-0003-0864-4321	Direction Regionale de la Recherche Clinique (DRCC)-Assistance Publique Hopitaux de Paris [PHRC 2003/AOM-03018]	This study was supported, in part, by Grant PHRC 2003/AOM-03018 from the "Direction Regionale de la Recherche Clinique (DRCC)-Assistance Publique Hopitaux de Paris" (PGM).	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; [Anonymous], 1999, Ann Fr Anesth Reanim, V18, P36; APPLEBAUM D, 1985, ANN EMERG MED, V14, P656, DOI 10.1016/S0196-0644(85)80882-9; Baisch Steven D, 2005, Pediatr Crit Care Med, V6, P312, DOI 10.1097/01.PCC.0000161119.05076.91; Boswell W C, 1995, Air Med J, V14, P125, DOI 10.1016/1067-991X(95)90513-8; Brownstein D, 1996, ANN EMERG MED, V28, P34, DOI 10.1016/S0196-0644(96)70136-1; Chen L, 2008, PEDIATRICS, V122, pE294, DOI 10.1542/peds.2008-0103; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper A, 2001, Semin Pediatr Surg, V10, P3, DOI 10.1053/spsu.2001.19379; Dunning J, 2004, ARCH DIS CHILD, V89, P763, DOI 10.1136/adc.2003.042523; Ehrlich PF, 2004, J PEDIATR SURG, V39, P1376, DOI 10.1016/j.jpedsurg.2004.05.010; Gausche M, 1998, JEMS, V23, P74; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gerritse BM, 2008, RESUSCITATION, V79, P225, DOI 10.1016/j.resuscitation.2008.05.016; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Meyer PG, 2000, PAEDIATR ANAESTH, V10, P253, DOI 10.1046/j.1460-9592.2000.00496.x; NAKAYAMA DK, 1990, ANN SURG, V211, P218, DOI 10.1097/00000658-199002000-00015; Orliaguet C, 2000, ANN FR ANESTH, V19, P164; Pierrot M, 2003, ANN FR ANESTH, V22, P12, DOI 10.1016/S0750-7658(02)00003-5; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Prause, 1997, Crit Care, V1, P79, DOI 10.1186/cc108; Reed David B, 2002, Prehosp Emerg Care, V6, P50, DOI 10.1080/10903120290938779; Sagarin MJ, 2002, PEDIATR EMERG CARE, V18, P417, DOI 10.1097/00006565-200212000-00004; SEIDEL JS, 1991, PEDIATRICS, V88, P681; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; SILVERSTON P, 1989, BRIT MED J, V298, P711, DOI 10.1136/bmj.298.6675.711; Sokolove PE, 2000, PEDIATR EMERG CARE, V16, P18, DOI 10.1097/00006565-200002000-00005; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Warner KJ, 2009, J TRAUMA, V66, P26, DOI 10.1097/TA.0b013e3181957a25	31	22	23	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2011	12	1					65	70		10.1097/PCC.0b013e3181e2a244			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	703FT	WOS:000285964500022	20473241				2022-02-06	
J	Solomon, GS; Ott, SD; Lovell, MR				Solomon, Gary S.; Ott, Summer D.; Lovell, Mark R.			Long-term Neurocognitive Dysfunction in Sports: What Is the Evidence?	CLINICS IN SPORTS MEDICINE			English	Article						Neurocognitive dysfunction; Computerized assessment; Athletes; Concussive injury	TRAUMATIC BRAIN-INJURY; SELF-REPORTED CONCUSSIONS; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL PERFORMANCE; RECURRENT CONCUSSION; HIGH-SCHOOL; HISTORY; RISK; DEMENTIA; ENCEPHALOPATHY	Although the immediate neurocognitive effects of sports-related concussion are well known, less is known about the intermediate or long-term effects of sports-related concussions. A sample of selected studies of high-school and collegiate athletes is reviewed and the intermediate effects of concussive injuries are discussed, because no long-term empiric data are available with these populations. The evidence for intermediate neurocognitive effects is mixed and not convincing at present in these groups of athletes. Selected studies of professional boxers and American professional football players are also reviewed, and the available data regarding long-term neurocognitive and neuropathologic effects are assessed. The evidence for long-term adverse neurocognitive effects in professional boxers is compelling. Suggestions for future research on relevant biopsychosocial variables affecting response to concussive injury are presented.	[Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37232 USA; [Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37232 USA; [Ott, Summer D.] Methodist Hosp, Neurol Inst, Concuss Ctr, Houston, TX 77027 USA; [Lovell, Mark R.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15203 USA		Solomon, GS (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, T-4224 MCN, Nashville, TN 37232 USA.	gssolomon1@yahoo.com	Solomon, Gary/K-9011-2019				Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; CAJIGAL S, 2007, NEUROLOGY TODAY, V7, P6; Casson I, 2010, NEUROLOGY TODAY, V10, P6, DOI DOI 10.1097/01.NT.0000380917.17552.b7; CASSON IR, 2006, NEUROSURGERY, V58, P1003; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DEBEAUMONT L, 2010, BRAIN INJURY, V21, P631; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; MILLSPAUGH JA, 1937, DEMENTIA, V35, P297; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Plassman BL, 2008, ANN INTERN MED, V148, P427, DOI 10.7326/0003-4819-148-6-200803180-00005; Roberts AH, 1969, BRAIN DAMAGE BOXERS; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; THEIRAULT M, 2010, J CLIN EXP NEUROPSYC, V17, P1; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1167, DOI 10.1016/S0895-4356(98)00108-5; Weir DR., 2009, NATL FOOTBALL LEAGUE	42	22	22	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	JAN	2011	30	1					165	+		10.1016/j.csm.2010.09.002			15	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	691XR	WOS:000285114800015	21074090				2022-02-06	
J	Westermaier, T; Jauss, A; Eriskat, J; Kunze, E; Roosen, K				Westermaier, Thomas; Jauss, Alina; Eriskat, Joerg; Kunze, Ekkehard; Roosen, Klaus			The Temporal Profile of Cerebral Blood Flow and Tissue Metabolites Indicates Sustained Metabolic Depression After Experimental Subarachnoid Hemorrhage in Rats	NEUROSURGERY			English	Article						Cerebral blood flow and oxidative metabolism; Microdialysis; Subarachnoid hemorrhage; Vasospasm	PYRUVATE-DEHYDROGENASE; PERFUSION-PRESSURE; ENERGY-METABOLISM; OXYGEN-METABOLISM; TIME-COURSE; ISCHEMIA; BRAIN; MICRODIALYSIS; VASOSPASM; MODELS	BACKGROUND: Derangement of cerebral metabolism occurs after various insults such as ischemia, traumatic brain injury, and subarachnoid hemorrhage (SAH). OBJECTIVE: To investigate the course of cerebral blood flow and metabolic parameters in the first hours after experimental SAH. METHODS: Sixteen Sprague-Dawley rats were subjected to SAH using the endovascular filament model or served as controls (8 rats in each group). Local cerebral blood flow and intracranial pressure were measured continuously. Microdialysis samples were acquired in 30-minute intervals for 6 hours after SAH. Concentrations of glucose, lactate, pyruvate, and glutamate were determined. RESULTS: After induction of SAH, cerebral perfusion pressure and local cerebral blood flow sharply decreased. The decrease in local cerebral blood flow exceeded the decrease in cerebral perfusion pressure throughout the observation period. Glutamate concentrations in microdialysis samples increased sixfold and recovered to baseline levels. Lactate concentrations immediately increased after SAH, recovered incompletely, and remained above the levels of control animals until the end of the sampling period. Pyruvate concentrations showed a delayed increase starting 2 hours after SAH. CONCLUSION: The course of cerebral blood flow after SAH resembles global ischemia followed by a continuous low-flow state caused by a sudden decrease in cerebral perfusion pressure and acute vasoconstriction. The courses of lactate and pyruvate concentrations indicate a persistently deranged aerobic metabolism.	[Westermaier, Thomas; Jauss, Alina; Eriskat, Joerg; Kunze, Ekkehard; Roosen, Klaus] Univ Wurzburg, Dept Neurosurg, D-97080 Wurzburg, Germany		Westermaier, T (corresponding author), Univ Wurzburg, Dept Neurosurg, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	Westermaier.T@nch.uni-wuerzburg.de	Westermaier, Thomas/AAE-2701-2019; Kunze, Ekkehard/AAE-6926-2019				Audebert HJ, 2005, DEUT MED WOCHENSCHR, V130, P2495, DOI 10.1055/s-2005-918593; Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Bianchi MC, 2003, AM J NEURORADIOL, V24, P1958; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; CARPENTER DA, 1991, J CEREBR BLOOD F MET, V11, P837, DOI 10.1038/jcbfm.1991.143; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; CHOPP M, 1988, STROKE, V19, P1383, DOI 10.1161/01.STR.19.11.1383; CORBETT RJT, 1990, J NEUROCHEM, V54, P1208, DOI 10.1111/j.1471-4159.1990.tb01950.x; DELGADO TJ, 1985, STROKE, V16, P595, DOI 10.1161/01.STR.16.4.595; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; HEISS WD, 1992, STROKE, V23, P1668, DOI 10.1161/01.STR.23.11.1668; HOFFMAN TL, 1994, J NEUROSURG, V81, P567, DOI 10.3171/jns.1994.81.4.0567; JACKOWSKI A, 1990, J CEREBR BLOOD F MET, V10, P835, DOI 10.1038/jcbfm.1990.140; JAKOBSEN M, 1990, ACTA NEUROL SCAND, V82, P174, DOI 10.1111/j.1600-0404.1990.tb04485.x; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Karaszewski B, 2009, BRAIN, V132, P955, DOI 10.1093/brain/awp010; LIN BW, 1995, STROKE, V26, P1634, DOI 10.1161/01.STR.26.9.1634; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Martin E, 2005, J NEUROSCI RES, V79, P240, DOI 10.1002/jnr.20293; MARTIN WRW, 1984, ACTA NEUROCHIR, V70, P3, DOI 10.1007/BF01406037; Miyazaki T, 2006, SURG NEUROL, V65, P360, DOI 10.1016/j.surneu.2005.10.025; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; PEERLESS SJ, 1982, STROKE, V13, P473, DOI 10.1161/01.STR.13.4.473; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Prunell GF, 2003, NEUROSURGERY, V52, P165, DOI 10.1097/00006123-200301000-00022; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Robertson CS, 1998, NEUROL RES, V20, pS91; Sarrafzadeh A, 2005, J NEURORADIOLOGY, V32, P348, DOI 10.1016/S0150-9861(05)83168-2; SARRAFZADEH AS, 2005, ACTA NEUROCHIR SUPP, P9589; Sato M, 2006, ACTA NEUROCHIR, V148, P623, DOI 10.1007/s00701-005-0717-x; Schwartz AY, 2000, J NEUROSCI METH, V96, P161, DOI 10.1016/S0165-0270(00)00156-4; SIESJO BK, 1992, J NEUROSURG, V77, P169, DOI 10.3171/jns.1992.77.2.0169; Staub F, 2000, NEUROSURGERY, V47, P1106, DOI 10.1097/00006123-200011000-00016; SUGI T, 1975, STROKE, V6, P715, DOI 10.1161/01.STR.6.6.715; SVENDGAARD NA, 1985, STROKE, V16, P602, DOI 10.1161/01.STR.16.4.602; VEELKEN JA, 1995, STROKE, V26, P1279, DOI 10.1161/01.STR.26.7.1279; VILLA RF, 1983, NEUROCHEM RES, V8, P269, DOI 10.1007/BF00963926; VOLDBY B, 1985, J NEUROSURG, V62, P48, DOI 10.3171/jns.1985.62.1.0048; Westermaier T, 2009, J CEREBR BLOOD F MET, V29, P771, DOI 10.1038/jcbfm.2008.169; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	41	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JAN	2011	68	1					223	229		10.1227/NEU.0b013e3181fe23c1			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	694IE	WOS:000285288200063	21099709				2022-02-06	
J	Dams-O'Connor, K; Gordon, WA				Dams-O'Connor, Kristen; Gordon, Wayne A.			Role and Impact of Cognitive Rehabilitation	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Cognitive rehabilitation; Cognitive impairment; Brain injury	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; NEUROPSYCHOLOGIC REHABILITATION; SELF-AWARENESS; EVERYDAY MEMORY; CHRONIC APHASIA; PAGING SYSTEM; INDIVIDUALS; DEPRESSION; MANAGEMENT	Cognitive rehabilitation interventions are theoretically based and empirically validated treatments designed to ameliorate the cognitive, behavioral, and emotional impairments commonly experienced by individuals with traumatic brain injury (TBI) Cognitive rehabilitation can play many roles in facilitating recovery after TBI such as improving impaired cognitive functions increasing awareness of injury-related deficits improving mood facilitating vocational and community involvement, and reducing the probability of secondary disability The considerable evidence documenting the impact of cognitive rehabilitation on improving the day-to-day function of individuals with TBI is described	[Dams-O'Connor, Kristen; Gordon, Wayne A.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA		Dams-O'Connor, K (corresponding author), Mt Sinai Sch Med, Dept Rehabil Med, 1 Gustave L Levy Pl,Box 1240, New York, NY 10029 USA.				NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE001171] Funding Source: NIH RePORTER; NCIPC CDC HHS [5R49-CE-001171] Funding Source: Medline		[Anonymous], 1999, JAMA, V282, P974; Ashman TA, 2006, MT SINAI J MED, V73, P999; Beck AT., 1979, COGNITIVE THERAPY DE; BENYISHAY Y, 1985, SEMIN NEUROL, V5, P252, DOI 10.1055/s-2008-1041522; BENYISHAY Y, 1993, ARCH PHYS MED REHAB, V74, P204; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Brain Injury Association of America, SUBST AB ISS TRAUM B; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dams-O Connor K, 2009, AM C REH MED DENV CO; Dams-O Connor K, ENCY CLIN N IN PRESS; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Ehlhardt LA, 2005, BRAIN INJURY, V19, P569, DOI 10.1080/002699050400013550; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2003, PSYCHOSOMATICS, V44, P161; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Hibbard M. R., 2005, COGNITIVE BEHAV THER, P189; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kasten E, 2001, J CLIN EXP NEUROPSYC, V23, P297, DOI 10.1076/jcen.23.3.297.1180; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Lebowitz M, 2009, AM C REH MED DENV CO; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; LEZAK M, 2004, NEUROPSYCOLOGICAL AS; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Meinzer M, 2005, STROKE, V36, P1462, DOI 10.1161/01.STR.0000169941.29831.2a; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; Merzenich MM, 1999, RES PER NEUROSCI, P169; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Ownsworth TL, 2002, BRAIN INJURY, V16, P291, DOI 10.1080/02699050110103986; Poggel DA, 2004, NEUROLOGY, V63, P2069, DOI 10.1212/01.WNL.0000145773.26378.E5; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Sherer M, 2010, J HEAD TRAUMA REHAB, V25, P92, DOI 10.1097/HTR.0b013e3181c9d887; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tsaousides T, 2010, 8 WORLD C BRAIN INJ; Waldmann C, 2007, APHA 135 ANN M EXP P; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wilson BA, 2008, ANNU REV CLIN PSYCHO, V4, P141, DOI 10.1146/annurev.clinpsy.4.022007.141212; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P655; [No title captured]	78	22	22	2	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	DEC	2010	33	4					893	+		10.1016/j.psc.2010.08.002			13	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	694TA	WOS:000285320700010	21093684				2022-02-06	
J	Haney, SB; Starling, SP; Heisler, KW; Okwara, L				Haney, Suzanne B.; Starling, Suzanne P.; Heisler, Kurt W.; Okwara, Leonore			Characteristics of Falls and Risk of Injury in Children Younger Than 2 Years	PEDIATRIC EMERGENCY CARE			English	Article						falls; injury patterns; accident	CARE CENTERS; INFANTS; BED	Introduction: Although many studies have shown that short falls by children rarely result in serious injury, no recent study in the United States has assessed the prevalence and the characteristics of such falls. Because the history of a short fall often is given in the instance of suspected child abuse, data addressing the characteristics, the frequency, and the severity of such falls would assist in abuse investigations. Methods: Anonymous questionnaires were distributed at primary care offices to parents of children younger than 5 years. Parents answered a series of questions regarding any falls their children had sustained before the age of 2 years. Information gathered included the age of the child at the time of the fall, the details about the fall, the medical attention sought, and any injuries sustained. Results: We received a total of 307 eligible surveys. There were 209 falls reported for 122 children. Only 24% of those children sustained any injury as a result of the fall. Most (85%) of the children who sustained injuries had a bruise or a bump. Of the 20% (40 children) who were brought for medical care, only 13 children received medical treatment. The most severe injuries were in 2 children who sustained concussions; only 4 children had permanent injury (cutaneous scars). Children who fell on a hard surface were 6 times more likely to have an injury compared with children who fell on a soft surface (P = 0.001) In addition, for every 1 unit increase in fall height, risk of injury increased by a factor of 2.3. Conclusions: In short falls, ground surface and fall height were significant predictors of injury risk. The results of this study also support the opinion that short falls rarely cause injury. Therefore, a history of a short fall in a seriously injured child should raise the suspicion of child abuse.	[Haney, Suzanne B.; Starling, Suzanne P.] Childrens Hosp Kings Daughters, Norfolk, VA USA; [Haney, Suzanne B.; Starling, Suzanne P.; Heisler, Kurt W.; Okwara, Leonore] Eastern Virginia Med Sch, Norfolk, VA USA		Haney, SB (corresponding author), Project Harmony, 7110 F St, Omaha, NE 68117 USA.	shaneymd@projectharmony.com					ALKON A, 1994, PEDIATRICS, V94, P1043; Alkon A, 1999, ARCH PEDIAT ADOL MED, V153, P1248, DOI 10.1001/archpedi.153.12.1248; BARLOW B, 1983, J PEDIATR SURG, V18, P509, DOI 10.1016/S0022-3468(83)80210-3; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; HELFER RE, 1977, PEDIATRICS, V60, P533; Hoke JR, 1988, RAMSEY SLEEPER ARCHI; Kotch J B, 1997, Inj Prev, V3, P267, DOI 10.1136/ip.3.4.267; KRAVITZ H, 1969, PEDIATRICS, V44, P869; Lallier M, 1999, J PEDIATR SURG, V34, P1060, DOI 10.1016/S0022-3468(99)90564-X; LYONS TJ, 1993, PEDIATRICS, V92, P125; Macarthur C, 2000, ACCIDENT ANAL PREV, V32, P377, DOI 10.1016/S0001-4575(99)00079-2; NIMITYONGSKUL P, 1987, J PEDIATR ORTHOPED, V7, P184, DOI 10.1097/01241398-198703000-00014; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Warrington SA, 2001, ARCH DIS CHILD, V85, P104, DOI 10.1136/adc.85.2.104; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005	16	22	22	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	DEC	2010	26	12					914	918		10.1097/PEC.0b013e3181fe9139			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	689QP	WOS:000284943800008	21088634				2022-02-06	
J	Arango-Lasprilla, JC; Ketchum, JM; Cifu, D; Hammond, F; Castillo, C; Nicholls, E; Watanabe, T; Lequerica, A; Deng, XY				Arango-Lasprilla, Juan Carlos; Ketchum, Jessica M.; Cifu, David; Hammond, Flora; Castillo, Camilo; Nicholls, Elizabeth; Watanabe, Thomas; Lequerica, Anthony; Deng, Xiaoyan			Predictors of Extended Rehabilitation Length of Stay After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Length of stay; Prognosis; Rehabilitation	FUNCTIONAL INDEPENDENCE MEASURE; INPATIENT REHABILITATION; VIOLENCE; COMPLICATIONS; OUTCOMES; MODEL	Objective: To develop a prediction rule for acutely identifying patients at risk for extended rehabilitation length of stay (LOS) after traumatic brain injury (TBI) by using demographic and injury characteristics. Design: Retrospective cohort study. Setting: Traumatic Brain Injury Model Systems. Participants: Sample of TBI survivors (N=7284) with injuries occurring between 1999 and 2009. Interventions: Not applicable. Main Outcome Measures: Extended rehabilitation LOS defined as 67 days or longer. Results: A multivariable model was built containing FIM motor and cognitive scores at admission, preinjury level of education, cause of injury, punctate/petechial hemorrhage, acute-care LOS, and primary payor source. The model had good calibration, excellent discrimination (area under the receiver operating characteristic curve = .875). and validated well. Based on this model, a formula for determining the probability of extended rehabilitation LOS and a prediction rule that classifies patients with predicted probabilities greater than 4.9% as at risk for extended rehabilitation LOS were developed. Conclusions: The current predictor model for TBI survivors who require extended inpatient rehabilitation may allow for enhanced rehabilitation team planning, improved patient and family education, and better use of health care resources. Cross-validation of this model with other TBI populations is recommended.	[Arango-Lasprilla, Juan Carlos; Cifu, David; Castillo, Camilo; Nicholls, Elizabeth] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; [Ketchum, Jessica M.; Deng, Xiaoyan] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Arango-Lasprilla, Juan Carlos; Ketchum, Jessica M.; Cifu, David; Castillo, Camilo; Nicholls, Elizabeth; Deng, Xiaoyan] Virginia Commonwealth Univ, Ctr Rehabil Sci & Engn, Richmond, VA 23298 USA; [Hammond, Flora] Indiana Univ Sch Med, Indianapolis, IN USA; [Hammond, Flora] Carolinas Rehabil, Charlotte, NC USA; [Watanabe, Thomas] Moss Rehab Albert Einstein Med Ctr, Philadelphia, PA USA; [Lequerica, Anthony] Univ Med & Dent New Jersey, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; [Lequerica, Anthony] Kessler Fdn, W Orange, NJ USA; [Cifu, David] Richmond Vet Adm Med Ctr, Phys Med & Rehabil Serv, Richmond, VA USA		Arango-Lasprilla, JC (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, VCU W Hosp, 3rd Fl,Rm 3-102,1200 E Broad St, Richmond, VA 23298 USA.	jcarangolasp@vcu.edu	Ketchum, Jessica/AAE-8200-2020	Ketchum, Jessica/0000-0002-5566-3691; Cifu, David/0000-0003-1600-9387	National Institute on Disability and Rehabilitation Research; U.S. Department of EducationUS Department of Education [HI33A070036, HI33A21943-16, HI33A07003]	Supported by the National Institute on Disability and Rehabilitation Research, U.S. Department of Education (grant nos. HI33A070036, HI33A21943-16 and HI33A07003).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Englander JS, 1996, J HEAD TRAUMA REHAB, V11, P15, DOI 10.1097/00001199-199610000-00003; Esselman PC, 2004, ARCH PHYS MED REHAB, V85, P1445, DOI 10.1016/j.apmr.2003.10.018; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Highhouse S, 1996, J BUS PSYCHOL, V11, P85, DOI 10.1007/BF02278258; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Ottenbacher KJ, 2000, AM J PUBLIC HEALTH, V90, P1920, DOI 10.2105/AJPH.90.12.1920; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Valach L, 2004, INT J REHABIL RES, V27, P135, DOI 10.1097/01.mrr.0000131577.55940.80	20	22	25	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2010	91	10					1495	1504		10.1016/j.apmr.2010.07.010			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	661IT	WOS:000282720300002	20875505				2022-02-06	
J	Berry, C; Ley, EJ; Mirocha, J; Salim, A				Berry, Cherisse; Ley, Eric J.; Mirocha, James; Salim, Ali			Race Affects Mortality After Moderate to Severe Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	5th Annual Academic Surgical Congress	FEB 03-05, 2010	San Antonio, TX	Assoc Acad Surg (AAS), Soc Univ Surg (SUS)		traumatic brain injury; outcome; mortality; race; insurance	INSURANCE STATUS; RACIAL DISPARITIES; EMERGENCY-DEPARTMENT; CARE; OUTCOMES; HEALTH; IMPACT; RISK	Background. Traumatic brain injury (TB!) is the most common cause of death and disability in trauma patients, affecting over 1 million Americans per year. Minorities are at disproportionate risk for TBI, and they account for nearly half of all brain injury hospitalizations. Little is known regarding racial disparities in TBI patients. The objective of this study was to investigate the association of race on mortality in patients with moderate to severe isolated TBI. Methods. The Los Angeles County Trauma System database, consisting of admissions from five Level I and eight Level II trauma centers, was queried for all patients with isolated moderate to severe TBI admitted between 1998 and 2005. Demographics and mortality were compared between races: Asian, African American, Hispanic, White, and Other. Multivariate logistic regression was used to determine the relationship between race and mortality. Results. A total of 17,977 (23.8% female, 76.2% male) severe TBI patients were evaluated. Of this study population, 7.1% were Asian, 13.5% were African American, 42.3% were Hispanic, 32.5% were White, and 4.7% where classified as Other. Overall, Asians (adjusted Odds Ratio [AOR] 1.4; 95% CI: 1.14-1.71, P = 0.001) had a significantly higher risk in mortality when compared with Whites. Surprisingly, neither African Americans (AOR 1.02; 95% CI: 0.87-1.2, P = 0.82), nor Hispanics (AOR 1.00; 95% CI: 0.89-1.13, P > 0.9) were at increased risk of death compared to their White counterparts. Conclusion. This data supports the hypothesis that race may play a role in mortality in moderate to severe TBI. However, only Asians were at higher risk for death. (C) 2010 Elsevier Inc. All rights reserved.	[Berry, Cherisse; Ley, Eric J.; Mirocha, James; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020				Arthur M, 2008, MED CARE, V46, P192, DOI 10.1097/MLR.0b013e31815b9d8e; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; *I MED, 2002, UN TREATM WHAT HEALT; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Rosen H, 2009, ARCH SURG-CHICAGO, V144, P1006, DOI 10.1001/archsurg.2009.195; Sabharwal S, 2007, J PEDIATR ORTHOPED, V27, P690, DOI 10.1097/BPO.0b013e3181425653; Salim A, 2010, J TRAUMA, V68, P211, DOI 10.1097/TA.0b013e3181a0e659; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Wall SP, 2005, ACAD EMERG MED, V12, P862, DOI 10.1197/j.aem.2005.05.003; Wallace LS, 2007, J SURG RES, V140, P208, DOI 10.1016/j.jss.2007.01.029; White FA, 2007, J EMERG MED, V32, P159, DOI 10.1016/j.jemermed.2006.05.043; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	21	22	22	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	OCT	2010	163	2					303	308		10.1016/j.jss.2010.03.018			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	653SB	WOS:000282115900024	20605614				2022-02-06	
J	Eckroth-Bucher, M				Eckroth-Bucher, Margie			Self-Awareness A Review and Analysis of a Basic Nursing Concept	ADVANCES IN NURSING SCIENCE			English	Article						convictions; intrapersonal; introspection; presence; process; self-awareness; understanding; values	TRAUMATIC BRAIN-INJURY; EDUCATION	Self-awareness has long been addressed as fundamental for the professional nurse with the accepted view that self-awareness will lead to greater competence. Therefore, it is important to understand the historical evolution of the concept, attributes, antecedents, and consequences. Rodgers' evolutionary method was used for critical analysis of nursing, social sciences, and education literature. Analysis indicates that self-awareness is a dynamic, transformative process of self. Ultimately, self-awareness is the use of self-insights and presence knowingly to guide behavior that is genuine and authentic to create a healing interpersonal environment. Future research areas within practice and education are identified.	Bloomsburg Univ, Dept Nursing, McCormick Ctr Human Serv 3203, Bloomsburg, PA 17815 USA		Eckroth-Bucher, M (corresponding author), Bloomsburg Univ, Dept Nursing, McCormick Ctr Human Serv 3203, 400 E 2nd St, Bloomsburg, PA 17815 USA.	meckroth@bloomu.edu					Abu Baker K, 1999, FAM PROCESS, V38, P55, DOI 10.1111/j.1545-5300.1999.00055.x; ARNOLD EC, 2007, INTERPERSONAL RELATI, P91; Baumeister R. F., 1995, ADV SOCIAL PSYCHOL, P51; Burnard P, 1984, Nurs Mirror, V158, P30; BURNARD P, 1986, SELF AWARENESS NURSE; Campbell J, 1980, ANS Adv Nurs Sci, V2, P15; Cook SH, 1999, J ADV NURS, V29, P1292, DOI 10.1046/j.1365-2648.1999.01014.x; Demaree HA, 1997, NEUROPSYCHOL REV, V7, P171, DOI 10.1023/B:NERV.0000005908.72548.10; Dirette DK, 2007, BRAIN INJURY, V21, P1131, DOI 10.1080/02699050701687326; Drew N, 1997, J Holist Nurs, V15, P406, DOI 10.1177/089801019701500407; Duval TS., 1972, THEORY OBJECTIVE SEL; Eckroth-Bucher M, 2001, J Psychosoc Nurs Ment Health Serv, V39, P32; Engin E, 2009, ARCH PSYCHIAT NURS, V23, P148, DOI 10.1016/j.apnu.2008.05.003; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Ferrari M, 1998, SELF-AWARENESS, P387; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Foster Tom, 2005, Br J Nurs, V14, P698; Freshwater Dawn, 2004, Nurs Inq, V11, P91, DOI 10.1111/j.1440-1800.2004.00198.x; Gooch Sally, 2006, Nurs Stand, V20, P20; Harris MS, 1997, SMITH COLL STUD SOC, V67, P587, DOI 10.1080/00377319709517508; Jarvis P, 1995, NURS EDUC TODAY, V15, P414, DOI 10.1016/S0260-6917(95)80052-2; Jerome A M, 1992, Pediatr Nurs, V18, P153; Kondrat ME, 1999, SOC SERV REV, V73, P451, DOI 10.1086/514441; Lauterbach S. S., 2005, INT J HUMAN CARING, V9, P29; Maslow Abraham., 1954, MOTIVATION PERSONALI; MILLER JK, 2008, MENT HLTH PRACT, V12, P31; Moch S D, 1990, Sch Inq Nurs Pract, V4, P155; Moore C, 2007, INFANCY, V11, P157, DOI 10.1111/j.1532-7078.2007.tb00220.x; Morrison J, 2008, J NURS MANAGE, V16, P974, DOI 10.1111/j.1365-2834.2008.00876.x; Parks P, 1997, J HUMANIST PSYCHOL, V37, P67, DOI 10.1177/00221678970372010; Peplau H. E., 1952, INTERPERSONAL RELATI; Rawlinson J W, 1990, Nurse Educ Today, V10, P111, DOI 10.1016/0260-6917(90)90205-5; RIDLEY DS, 1991, J EXP EDUC, V60, P31; Rodgers B. L., 2000, CONCEPT DEV NURSING, V2nd, P77; Rogers CR, 2007, PSYCHOTHERAPY, V44, P240, DOI 10.1037/0033-3204.44.3.240; Rungapadiachy D. M., 1999, INTERPERSONAL COMMUN; *SIGM THET TAU INT, 2005, SCHOL REFL PRACT; SMITH J, 2007, NURSING STANDARD, V21, P47; SMOYAK S, 1999, INTERPERSONAL RRELAT, P41; SORENSEN KC, 1979, BASIC NURSING PSYCHO; Stolder ME, 2007, J TRANSCULT NURS, V18, P265, DOI 10.1177/1043659607301295; Stumpf S.E., 1994, PHILOS HIST PROBLEMS; SWEENEY NM, 1994, J ADV NURS, V20, P917, DOI 10.1046/j.1365-2648.1994.20050917.x; TAYLOR CM, 1990, ESSENTIALS PSYCHIAT, P41; Tiuraniemi J, 2008, ADMIN SOC WORK, V32, P23, DOI 10.1080/03643100802293824; Vorauer JD, 1999, J EXP SOC PSYCHOL, V35, P415, DOI 10.1006/jesp.1999.1388; WANSOR CT, 1991, ENGL J, V21, P41; WARELOW E, 2008, HOLIST NURS PRACT, V22, P146; Weierter SJM, 1999, J APPL SOC PSYCHOL, V29, P1246, DOI 10.1111/j.1559-1816.1999.tb02038.x; Wertz FJ, 1998, J HUMANIST PSYCHOL, V38, P42, DOI 10.1177/00221678980381006	50	22	24	4	30	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0161-9268	1550-5014		ADV NURS SCI	Adv. Nurs. Sci.	OCT-DEC	2010	33	4					297	309		10.1097/ANS.0b013e3181fb2e4c			13	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	678SY	WOS:000284102100007	21068551				2022-02-06	
J	Engel, T; Caballero-Caballero, A; Schindler, CK; Plesnila, N; Strasser, A; Prehn, JHM; Henshall, DC				Engel, Tobias; Caballero-Caballero, Aurelien; Schindler, Clara K.; Plesnila, Nikolaus; Strasser, Andreas; Prehn, Jochen H. M.; Henshall, David C.			BH3-only protein Bid is dispensable for seizure-induced neuronal death and the associated nuclear accumulation of apoptosis-inducing factor	JOURNAL OF NEUROCHEMISTRY			English	Article						AIF; Bax; Bcl-2; hippocampus; neuroprotection; epilepsy	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; CYTOCHROME-C RELEASE; PROGRAMMED CELL-DEATH; STATUS-EPILEPTICUS; HIPPOCAMPAL-NEURONS; DEFICIENT MICE; KAINIC ACID; CALPAIN-I	P>Prolonged seizures activate members of the Bcl-2 homology domain 3-only sub-group of the Bcl-2 protein family, which are essential for initiation of apoptosis signaling. Bid is a potent pro-apoptotic Bcl-2 homology domain 3-only protein, which upon proteolytic activation translocates to mitochondria to promote activation of the Bax/Bak sub-group of the pro-apoptotic Bcl-2 family and thereby contributes to release of apoptogenic molecules, such as cytochrome c and possibly apoptosis-inducing factor (AIF). Bid-deficient mice have been reported to show reduced lesion volumes after ischemia and trauma in vivo but a causal role for Bid in the setting of seizure-induced neuronal death has not been investigated. In this study, we studied Bid activation following status epilepticus in mice and compared hippocampal damage between wild-type and Bid-deficient animals. Full-length Bid was detected in normal mouse hippocampus and the cleaved (activated) p15 fragment of Bid was detected shortly after status epilepticus. Bid-deficient mice underwent equivalent electrographic seizure responses during status epilepticus as wild-type animals. Hippocampal counts of degenerating neurons and surviving neuron-specific nuclear protein-positive cells were not significantly different between wild-type and Bid-deficient mice. Additionally, nuclear translocation of AIF was not reduced in Bid-deficient compared with wild-type animals subjected to status epilepticus. The present study demonstrates that AIF is not dependent on Bid for mitochondrial release and nuclear import in this model and that while Bid is cleaved during seizure-induced neuronal death, it may be functionally redundant or even not essential.	[Engel, Tobias; Caballero-Caballero, Aurelien; Plesnila, Nikolaus; Prehn, Jochen H. M.; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Schindler, Clara K.] Robert S Dow Neurobiol Labs, Portland, OR USA; [Strasser, Andreas] Univ Melbourne, Dept Mol Med, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia		Henshall, DC (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, 123 St Stephens Green, Dublin 2, Ireland.	dhenshall@rcsi.ie	Plesnila, Nikolaus/T-7522-2019; Strasser, Andreas/C-7581-2013; Henshall, David/C-3364-2012; Prehn, Jochen HM/A-3928-2010	Strasser, Andreas/0000-0002-5020-4891; Prehn, Jochen HM/0000-0003-3479-7794; Engel, Tobias/0000-0001-9137-0637; Henshall, David/0000-0001-6237-9632	Health Research Board Ireland [RP/2005/24, RP/2007/37]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [08/IN1/B1875, 08/RFP/NSC1745]; Irish Research Council for Science Engineering and TechnologyIrish Research Council for Science, Engineering and TechnologyCGIAR; Health Research Board; NHMRCNational Health and Medical Research Council of Australia	This work was supported by Health Research Board Ireland (RP/2005/24, RP/2007/37), Science Foundation Ireland (08/IN1/B1875 and 08/RFP/NSC1745), post-doctoral fellowships from the Irish Research Council for Science Engineering and Technology and Health Research Board (to T. E.) and the NHMRC (AS).	Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Bossy-Wetzel E, 1999, J BIOL CHEM, V274, P17484, DOI 10.1074/jbc.274.25.17484; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Cheung ECC, 2005, J NEUROSCI, V25, P1324, DOI 10.1523/JNEUROSCI.4261-04.2005; Culmsee C, 2006, BIOCHEM SOC T, V34, P1334, DOI 10.1042/BST0341334; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Engel T, 2010, NEUROSCIENCE, V168, P443, DOI 10.1016/j.neuroscience.2010.03.057; Engel T, 2010, FASEB J, V24, P853, DOI 10.1096/fj.09-145870; Engel Tobias, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P97; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Henshall DC, 2002, J NEUROSCI, V22, P8458; Henshall DC, 2004, ANN NEUROL, V55, P485, DOI 10.1002/ana.20001; Henshall DC, 2001, NEUROBIOL DIS, V8, P568, DOI 10.1006/nbdi.2001.0415; Ju KL, 2008, EXP NEUROL, V210, P602, DOI 10.1016/j.expneurol.2007.12.008; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Konig HG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-7; Krajewska M, 2002, CELL DEATH DIFFER, V9, P145, DOI 10.1038/sj/cdd/4400934; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li Tian-Fu, 2005, Shengli Xuebao, V57, P310; Li TF, 2006, BRAIN RES, V1098, P204, DOI 10.1016/j.brainres.2006.04.131; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; MELDRUM BS, 1994, NEUROLOGY, V44, P14; Mouri G, 2008, BRAIN RES, V1213, P140, DOI 10.1016/j.brainres.2008.03.061; Murphy BM, 2010, CELL DEATH DIFFER, V17, P459, DOI 10.1038/cdd.2009.134; Murphy B, 2007, AM J PATHOL, V171, P1258, DOI 10.2353/ajpath.2007.070269; NEDERGAARD M, 1988, ACTA NEUROL SCAND, V77, P81, DOI 10.1111/j.1600-0404.1988.tb05878.x; Noh HS, 2006, J NEUROSCI RES, V84, P1829, DOI 10.1002/jnr.21057; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Plesnila N, 2001, P NATL ACAD SCI USA, V98, P15318, DOI 10.1073/pnas.261323298; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Schindler CK, 2006, J CEREBR BLOOD F MET, V26, P583, DOI 10.1038/sj.jcbfm.9600219; Shinoda S, 2004, J NEUROSCI RES, V76, P121, DOI 10.1002/jnr.20064; Shinoda S, 2004, J CLIN INVEST, V113, P1059, DOI 10.1172/JCI200419971; Shinoda S, 2003, EUR J NEUROSCI, V17, P2065, DOI 10.1046/j.1460-9568.2003.02655.x; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Upton JP, 2008, MOL CELL BIOL, V28, P3943, DOI 10.1128/MCB.00013-08; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang SH, 2008, BRAIN RES BULL, V76, P90, DOI 10.1016/j.brainresbull.2007.12.006; Ward MW, 2006, J BIOL CHEM, V281, P5837, DOI 10.1074/jbc.M511562200; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; Yin XM, 2002, J BIOL CHEM, V277, P42074, DOI 10.1074/jbc.M204991200; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao SP, 2010, J NEUROSCI RES, V88, P1727, DOI 10.1002/jnr.22338	52	22	22	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	OCT	2010	115	1					92	101		10.1111/j.1471-4159.2010.06909.x			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	650DF	WOS:000281828200009	20646170	Bronze			2022-02-06	
J	Kelley-Quon, L; Min, L; Morley, E; Hiatt, JR; Cryer, H; Tillou, A				Kelley-Quon, Lorraine; Min, Lillian; Morley, Eric; Hiatt, Jonathan R.; Cryer, Henry; Tillou, Areti			Functional Status after Injury: A Longitudinal Study of Geriatric Trauma	AMERICAN SURGEON			English	Article							PROSPECTIVE MULTICENTER TRIAL; LIVING OLDER PERSONS; FOLLOW-UP; UNITED-STATES; BRAIN-INJURY; RESOURCE USE; CARE; DISABILITY; COMMUNITY; OUTCOMES	We evaluated self-rated functional status measured longitudinally in the year after injury in a geriatric trauma population. The longitudinal (L) group included 37 of 60 eligible trauma patients aged 65 years or older admitted December 2006 to November 2007 for greater than 24 hours who completed a Short Functional Status questionnaire (SFS) at 3, 6, and 12 months after injury. The SFS yields scores of 0 to 5 (5 = independent in all five activities of daily living [ADLs]) and has been validated among community-dwelling elders. The control (C) group included 63 trauma patients aged 65 years or older admitted December 2007 to July 2009 for greater than 24 hours who reported their preinjury functional status using the SFS at hospital admission. We used characteristics and scores of the C group to impute preinjury ADL scores for the L group. The groups were similar in baseline characteristics (age, ethnicity, Injury Severity Score, Charlson Comorbidity Index, and living arrangement; P > 0.05). For the C group, the preinjury ADL score was 4.6 (SD = 0.9). For the L group, ADL scores declined at all intervals reaching statistical significance at 12 months. We conclude that in the year after traumatic injury, geriatric patients lost the equivalent of approximately one ADL, increasing their risk of further functional decline, loss of independence, and death.	[Kelley-Quon, Lorraine; Min, Lillian; Morley, Eric; Hiatt, Jonathan R.; Cryer, Henry; Tillou, Areti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA		Tillou, A (corresponding author), 10833 Le Conte Ave,CHS Room 72-231, Los Angeles, CA 90095 USA.	atillou@mednet.ucla.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG024824] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG024824] Funding Source: NIH RePORTER		Battistella FD, 1998, J TRAUMA, V44, P618, DOI 10.1097/00005373-199804000-00010; CARRILLO EH, 1993, SURG GYNECOL OBSTET, V176, P559; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Covinsky KE, 2003, J AM GERIATR SOC, V51, P492, DOI 10.1046/j.1532-5415.2003.51157.x; DEMARIA EJ, 1987, J TRAUMA, V27, P1200; Fallon WF, 2006, J TRAUMA, V61, P1040, DOI 10.1097/01.ta.0000238652.48008.59; Gill TM, 1997, J GEN INTERN MED, V12, P757, DOI 10.1046/j.1525-1497.1997.07161.x; Gill TM, 1998, ANN INTERN MED, V128, P96, DOI 10.7326/0003-4819-128-2-199801150-00004; Gill TM, 2002, J AM GERIATR SOC, V50, P1492, DOI 10.1046/j.1532-5415.2002.50403.x; Inaba K, 2003, J TRAUMA, V54, P486, DOI 10.1097/01.TA.0000051588.05542.D6; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; McKevitt EC, 2003, CAN J SURG, V46, P211; Min LC, 2008, J AM GERIATR SOC, V56, P1932, DOI 10.1111/j.1532-5415.2008.01921.x; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; ORESKOVICH MR, 1984, J TRAUMA, V24, P565, DOI 10.1097/00005373-198407000-00003; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Rzepka SG, 2001, J CLIN EPIDEMIOL, V54, P627, DOI 10.1016/S0895-4356(00)00337-1; Saliba D, 2000, J GERONTOL A-BIOL, V55, pM750, DOI 10.1093/gerona/55.12.M750; Stenvall M, 2007, J REHABIL MED, V39, P232, DOI 10.2340/16501977-0045; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; TSUJI I, 1994, J AM GERIATR SOC, V42, P153, DOI 10.1111/j.1532-5415.1994.tb04944.x; VANAALST JA, 1991, J TRAUMA, V31, P1096	25	22	22	0	1	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	OCT	2010	76	10					1055	1058					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	663AO	WOS:000282855600006	21105608				2022-02-06	
J	Dooley, JJ; Beauchamp, M; Anderson, VA				Dooley, Julian J.; Beauchamp, Miriam; Anderson, Vicki A.			The Measurement of Sociomoral Reasoning in Adolescents With Traumatic Brain Injury: A Pilot Investigation	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; moral reasoning; aggression		Moral reasoning skills are crucial for appropriate and adaptive social functioning. Impairments in moral reasoning have been associated with aggressive and violent behaviours. Traditional measures of moral reasoning may provide limited insight into daily behavioural functioning as these measures are dependent on several higher order cognitive skills and, as such, may be limited in their utility with certain clinical populations. In Study 1, new measures of sociomoral reasoning and maturity, the So-Moral and So-Mature, were described. Further, the psychometric properties of the So-Moral and So-Mature were investigated in a sample of 50 adolescents aged 11 to 19 (mean age = 14.5, SD = 2.6 years, 25 male). Preliminary support was found for the validity and reliability of both tasks. In Study 2, the clinical applicability of the So-Moral and So-Mature were examined in a sample 25 adolescents with traumatic brain injury (TBI; mean age = 13.8, SD = 2.3 years, 15 male). Response trends suggested that adolescents with TBI generated less developmentally mature responses to sociomoral dilemmas and those with more severe injuries performed most poorly. The sociomoral reasoning tasks described promote participant's emotional involvement and investment as well as being appropriate for use with clinical populations.	[Dooley, Julian J.] Edith Cowan Univ, Child Hlth Promot Res Ctr, Mt Lawley, WA 6050, Australia; [Beauchamp, Miriam] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Anderson, Vicki A.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Anderson, Vicki A.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Anderson, Vicki A.] Univ Melbourne, Melbourne, Vic 3010, Australia		Dooley, JJ (corresponding author), Edith Cowan Univ, Child Hlth Promot Res Ctr, 2 Bradford St, Mt Lawley, WA 6050, Australia.	j.dooley@ecu.edu.au					Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Beauchamp M., 2010, PRINCIPLES PRACTICE, P315, DOI 10.1017/CBO9780511674815.024; Bigler E. D., 1997, CHILDHOOD TRAUMATIC, P7; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; BRYANT BK, 1982, CHILD DEV, V53, P413, DOI 10.2307/1128984; Couper E., 2002, BRAIN IMPAIR, V3, P105, DOI [DOI 10.1375/BRIM.3.2.105, 10.1375/brim.3.2.105]; de Castro BO, 2002, CHILD DEV, V73, P916, DOI 10.1111/1467-8624.00447; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Eslinger PJ, 2009, J CLIN EXP NEUROPSYC, V31, P158, DOI 10.1080/13803390802298064; Eslinger PJ, 2004, BRAIN COGNITION, V55, P84, DOI 10.1016/s0278-2626(03)00281-1; Gibbs J.C., 1992, MORAL MATURITY MEASU; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; KOHLBERG L, 1974, AM J MENT DEF, V79, P142; Kohlberg L., 1981, ESSAYS MORAL DEV, VI; Kohlberg Lawrence., 1958, THESIS U CHICAGO; Little TD, 2003, MERRILL PALMER QUART, V49, P343, DOI 10.1353/mpq.2003.0014; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Moll J, 2005, COGN BEHAV NEUROL, V18, P68, DOI 10.1097/01.wnn.0000152236.46475.a7; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Oliveira-Souza R., 2000, NEUROLOGY S3, V54, P252; Piaget Jean, 1965, MORAL JUDGMENT CHILD; Pujol J, 2008, HUM BRAIN MAPP, V29, P910, DOI 10.1002/hbm.20436; Roberts J.R., 1990, J ABNORMAL CHILD PSY, V18, P231; Stams GJ, 2006, J ABNORM CHILD PSYCH, V34, P697, DOI 10.1007/s10802-006-9056-5; TEASDALE G, 1974, LANCET, V2, P81; THOMSON JJ, 1985, YALE LAW J, V94, P1395, DOI 10.2307/796133; Wall S., CLIN CHILD IN PRESS; Wechsler D., 1999, MANUAL WASI; [No title captured]	37	22	22	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646			BRAIN IMPAIR	Brain Impair.	SEP	2010	11	2			SI		152	161		10.1375/brim.11.2.152			10	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	V24IS	WOS:000208404700006					2022-02-06	
J	Griffen, JA; Hanks, RA; Meachen, SJ				Griffen, Julie A.; Hanks, Robin A.; Meachen, Sarah-Jane			The Reliability and Validity of the Community Integration Measure in Persons With Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						community integration; brain injury; reliability; validity; rehabilitation	PARTICIPATION; SATISFACTION	Objective: To investigate the psychometric properties of the Community Integration Measure (CIM), a scale that assesses self-perceived quality of community integration, among persons with traumatic brain injury (TB I). Method: Persons (N = 279) with TBI completed the CIM, as well as other measures of community integration and quality of life, and were followed up to 15 years postinjury. Results: The CIM was found to be a reliable instrument with adequate internal consistency. Validity was demonstrated in its relationship to other measures of community integration and life satisfaction. Utility was evident in its prediction of perceived social support. Conclusion: Results suggest that the CIM is an adequate measure of community integration for persons with histories of TBI of up to 15 years.	[Griffen, Julie A.; Meachen, Sarah-Jane] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Hanks, Robin A.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Detroit, MI 48202 USA		Griffen, JA (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave,7th Floor, Detroit, MI 48202 USA.	jgriffen@wayne.edu					Bodenheimer CF, 2004, ARCH PHYS MED REHAB, V85, pS23, DOI 10.1016/j.apmr.2004.03.009; Brown M, 2006, PARTICIPATION OBJECT; Cutrona EC., 1987, ADV PERSONAL RELATIO, V1, P37, DOI DOI 10.1037/0882-7974.1.1.47; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; GLASS TA, 1992, SOC SCI MED, V34, P1249, DOI 10.1016/0277-9536(92)90317-J; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McGrew K. S., 1994, CHALLENGES SERVICE S, P65; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Ostir GV, 2005, AGING CLIN EXP RES, V17, P35, DOI 10.1007/BF03337718; Reistetter TA, 2005, NEUROREHABILITATION, V20, P139; Salter K, 2008, BRAIN INJURY, V22, P820, DOI 10.1080/02699050802425428; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; Ware J., 1998, SF 12 SCORE SF 12 PH, V2nd Ed; Whiteneck G., 1997, ASSESSING MED REHABI, P91; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002; Zabora J, 2001, PSYCHOSOMATICS, V42, P241, DOI 10.1176/appi.psy.42.3.241	20	22	22	0	5	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2010	55	3					292	297		10.1037/a0020503			6	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	642ND	WOS:000281220800010	20804273				2022-02-06	
J	Immonen, R; Heikkinen, T; Tahtivaara, L; Nurmi, A; Stenius, TK; Puolivali, J; Tuinstra, T; Phinney, AL; Van Vliet, B; Yrjanheikki, J; Grohn, O				Immonen, Riikka; Heikkinen, Taneli; Tahtivaara, Leena; Nurmi, Antti; Stenius, Taina-Kaisa; Puolivali, Jukka; Tuinstra, Tinka; Phinney, Amie L.; Van Vliet, Bernard; Yrjanheikki, Juha; Grohn, Olli			Cerebral blood volume alterations in the perilesional areas in the rat brain after traumatic brain injury-comparison with behavioral outcome	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						cerebral blood volume; iron oxide MRI contrast agent; traumatic brain injury	CONTROLLED CORTICAL IMPACT; FLOW; DIFFUSION; EDEMA; MODEL; NEUROTRAUMA; METABOLISM; HYPEREMIA; PERFUSION; ISCHEMIA	In the traumatic brain injury (TBI) the initial impact causes both primary injury, and launches secondary injury cascades. One consequence, and a factor that may contribute to these secondary changes and functional outcome, is altered hemodynamics. The relative cerebral blood volume (CBV) changes in rat brain after severe controlled cortical impact injury were characterized to assess their interrelations with motor function impairment. Magnetic resonance imaging (MRI) was performed 1, 2, 4 h, and 1, 2, 3, 4, 7, and 14 days after TBI to quantify CBV and water diffusion. Neuroscore test was conducted before, and 2, 7, and 14 days after the TBI. We found distinct temporal profile of CBV in the perilesional area, hippocampus, and in the primary lesion. In all regions, the first response was drop of CBV. Perifocal CBV was reduced for over 4 days thereafter gradually recovering. After the initial drop, the hippocampal CBV was increased for 2 weeks. Neuroscore demonstrated severely impaired motor functions 2 days after injury (33% decrease), which then slowly recovered in 2 weeks. This recovery parallelled the recovery of perifocal CBV. CBV MRI can detect cerebrovascular pathophysiology after TBI in the vulnerable perilesional area, which seems to potentially associate with time course of sensory-motor deficit. Journal of Cerebral Blood Flow & Metabolism (2010) 30, 1318-1328; doi:10.1038/jcbfm.2010.15; published online 10 February 2010	[Immonen, Riikka; Grohn, Olli] Univ Eastern Finland, Biomed NMR Grp, Dept Neurobiol, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Heikkinen, Taneli; Tahtivaara, Leena; Nurmi, Antti; Stenius, Taina-Kaisa; Puolivali, Jukka; Yrjanheikki, Juha] Cerebricon Ltd, Kuopio, Finland; [Tuinstra, Tinka; Phinney, Amie L.; Van Vliet, Bernard] Solvay Pharmaceut BV, Cp Weesp, Netherlands		Immonen, R (corresponding author), Univ Kuopio, Biomed NMR Grp, Dept Neurobiol, AI Virtanen Inst Mol Sci, POB 1627, FIN-70211 Kuopio, Finland.	riikka.immonen@uku.fi			Solvay PharmaceuticalsSolvay SA	The data have been collected as a part of contract-based study by Cerebricon Ltd, funded by Solvay Pharmaceuticals.	Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dunn JF, 2004, MAGN RESON MED, V51, P55, DOI 10.1002/mrm.10660; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Grohn OHJ, 2000, J CEREBR BLOOD F MET, V20, P1457; Henninger N, 2007, CRIT CARE MED, V35, P2607, DOI 10.1097/01.CCM.0000286395.79654.8D; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Plesnila N, 2003, NEUROSCI LETT, V345, P85, DOI 10.1016/S0304-3940(03)00396-3; Prat R, 1997, NEUROL RES, V19, P393, DOI 10.1080/01616412.1997.11740832; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Soares HD, 1995, J NEUROSCI, V15, P8223; Soustiel JF, 2005, J NEUROTRAUM, V22, P955, DOI 10.1089/neu.2005.22.955; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Wu EX, 2003, MAGNET RESON MED, V49, P765, DOI 10.1002/mrm.10425	40	22	23	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUL	2010	30	7					1318	1328		10.1038/jcbfm.2010.15			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	619CY	WOS:000279408000007	20145657	Green Published, Bronze			2022-02-06	
J	McLellan, T; Bishop, A; McKinlay, A				McLellan, T.; Bishop, A.; McKinlay, A.			Community attitudes toward individuals with traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						TBI. Head injury; Brain injuries; Public attitudes; Stigmatization; Stereotype; Social Discrimination	IMPLICIT ASSOCIATION TEST; SOCIAL DISTANCE; MENTAL-ILLNESS; PEOPLE; FAMILIARITY; DEPRESSION; PREJUDICE; OUTCOMES; STIGMA	Explicit and implicit attitudes toward people who have sustained traumatic brain injury (TBI) were investigated to determine if negative attitudes exist and if the terminology used (brain vs. head injury) exacerbated predicted negativity. Participants (n = 103) rated Tony (brain/head injury) and Peter (limb-injury) on 10 characteristics using a 7-point scale. Familiarity with brain injury was also measured. Implicit Association Tests (IAT) assessed potential negative bias. Tony (M = 36.84) was judged more negatively than Peter (M = 31.69). The term "brain" versus "head" injury resulted in more negative evaluations (Ms = 38.72 vs. 34.78). Participants familiar with TBI were more positive toward Tony than those unfamiliar (Ms = 34.98 vs. 39.80). Only those unfamiliar with TBI demonstrated implicit negative bias. Negative attitudes toward TBI are expressed explicitly with individuals openly endorsing less desirable characteristics. When people have more knowledge about or experience with brain injury, they are less likely to endorse negative stereotypes. (JINS, 2010, 16, 705-710.)	[McLellan, T.; Bishop, A.; McKinlay, A.] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand		McKinlay, A (corresponding author), Univ Canterbury, Dept Psychol, Private Bag 4800, Christchurch 1, New Zealand.	audrey.mckinlay@canterbury.ac.nz		McKinlay, Audrey/0000-0001-9846-8514	Health Research Council of New ZealandHealth Research Council of New Zealand; Accident Compensation Corporation; University of Canterbury; Tertiary Education Commission of New Zealand (TEC)	The research was conducted during tenure of an ACC Post-Doctoral Research Career Development Award from the Health Research Council of New Zealand and the Accident Compensation Corporation awarded to Audrey McKinlay. Alana Bishop was supported by a Summer Scholarship 2009-2010 jointly funded by the University of Canterbury and the Tertiary Education Commission of New Zealand (TEC). This research received ethical approval from the Human Ethics Committee, University of Canterbury, New Zealand. We acknowledge that the information in this manuscript and the manuscript itself has never been published either electronically or in print. The authors have no conflict of interest in the production of this manuscript.	Angermeyer MC, 2004, SCHIZOPHR RES, V69, P175, DOI 10.1016/S0920-9964(03)00186-5; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bessenoff GR, 2000, SOC COGNITION, V18, P329, DOI 10.1521/soco.2000.18.4.329; Corrigan PW, 2001, SCHIZOPHRENIA BULL, V27, P219, DOI 10.1093/oxfordjournals.schbul.a006868; Fogel J, 2004, J PSYCHOSOM RES, V56, P75, DOI 10.1016/S0022-3999(03)00563-4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Linden MA, 2006, ARCH CLIN NEUROPSYCH, V21, P763, DOI 10.1016/j.acn.2006.08.010; Link BG, 2006, LANCET, V367, P528, DOI 10.1016/S0140-6736(06)68184-1; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; MCKINLAY A, CHANGING TE IN PRESS; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Rydell RJ, 2007, EUR J SOC PSYCHOL, V37, P867, DOI 10.1002/ejsp.393; Teachman BA, 2006, J SOC CLIN PSYCHOL, V25, P75, DOI 10.1521/jscp.2006.25.1.75; Wolkenstein L, 2009, INT J SOC PSYCHIATR, V55, P124, DOI 10.1177/0020764008092410	21	22	22	0	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2010	16	4					705	710		10.1017/S1355617710000524			6	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	619HE	WOS:000279419100015	20478103				2022-02-06	
J	Dorsi, MJ; Hsu, W; Belzberg, AJ				Dorsi, Michael J.; Hsu, Wesley; Belzberg, Allan J.			Epidemiology of brachial plexus injury in the pediatric multitrauma population in the United States Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						brachial plexus injury; trauma; prevalence; nerve injury; National Pediatric Trauma Registry	BROWN-SEQUARD-SYNDROME; SUBCLAVIAN PSEUDOANEURYSM; CLAVICULAR FRACTURE; LESIONS; TRAUMA; COMPLICATIONS; PARALYSIS; AVULSION; CHILDREN; REPAIR	Object. The aim of this study was to estimate the prevalence of brachial plexus injury (BPI) in pediatric multitrauma patients. Methods. The National Pediatric Trauma Registry was queried using the ICD-9 code 953.4, injury to brachial plexus, to identify cases of BPI. The patient demographics, mechanism of trauma, and associated ICD-9 diagnoses were analyzed. Results. Brachial plexus injuries were identified in 113 (0.1%) of the 103,434 injured children entered in the registry between April 1, 1985, and March 31, 2002. Sixty-nine patients (61%) were male. Injuries were most often caused by motor vehicle accidents involving passengers (36 cases [32%]) or pedestrians (19 cases [17%]). Head injuries were diagnosed in 47% of children and included concussion in 27%, intracranial bleeds in 21%, and skull fractures in 14%. Upper-extremity vascular injury occurred in 16%. The most common musculoskeletal injuries were fractures of the humerus (16%), ribs (16%), clavicle (13%), and scapula (11%). Spinal fractures occurred in 12% of patients, and spinal cord injury occurred in 4%. The Injury Severity Score ranged from 1 to 75, with a mean score of 10, and 6 patients (5%) died as a result of injuries sustained during a traumatic event. Conclusions. Brachial plexus injuries occur in 0.1% of pediatric multitrauma patients. Motor vehicle accidents and pedestrians struck by a motor vehicle are the most common reasons for BPIs in this population. Common associated injuries include head injuries, upper-extremity vascular injuries, and fractures of the spine, humerus, ribs, scapula, and clavicle. (DOI: 10.3171/2010.3.PEDS09538)	[Dorsi, Michael J.; Hsu, Wesley; Belzberg, Allan J.] Johns Hopkins Med Inst, Dept Neurosurg, Baltimore, MD 21205 USA		Dorsi, MJ (corresponding author), Univ Calif Los Angeles, 635 Charles E Young Dr S,NRB 404, Los Angeles, CA 90095 USA.	mdorsi@jhmi.edu					ALNOT JY, 1986, CHIRURGIE, V112, P674; AYCOCK TM, 1971, SOUTHERN MED J, V64, P1165, DOI 10.1097/00007611-197110000-00002; Battiston B, 2006, MICROSURG, V26, P311, DOI 10.1002/micr.20244; Birch R, 1998, SURG DISORDERS PERIP, P157; Brown KR, 2001, ANN VASC SURG, V15, P43, DOI 10.1007/BF02693799; BRUNELLI GA, 1995, MICROSURG, V16, P17, DOI 10.1002/micr.1920160107; D'Aubigne M, 1967, Rev Chir Orthop Reparatrice Appar Mot, V53, P23; Diamond S, 2003, AM SURGEON, V69, P848; DUMONTIER C, 1990, Annales de Chirurgie de la Main et du Membre Superieur, V9, P351, DOI 10.1016/S0753-9053(05)80508-3; El-Gammal TA, 2003, MICROSURG, V23, P14, DOI 10.1002/micr.10084; Fields CE, 2002, SURG CLIN N AM, V82, P105, DOI 10.1016/S0039-6109(03)00143-9; Fletcher I, 1969, HAND, V1, P129; Gilbert A, 2006, MICROSURG, V26, P334, DOI 10.1002/micr.20248; Gupta KS, 2000, GROWING HAND DIAGNOS, P653; HANSKY B, 1993, EUR J CARDIO-THORAC, V7, P497, DOI 10.1016/1010-7940(93)90281-F; HOULDEN DA, 1992, J TRAUMA, V33, P244, DOI 10.1097/00005373-199208000-00014; HOWARD FM, 1965, J BONE JOINT SURG AM, VA 47, P1335, DOI 10.2106/00004623-196547070-00005; KAY SP, 1986, CLIN ORTHOP RELAT R, P219; Kim DH, 2003, J NEUROSURG, V98, P1005, DOI 10.3171/jns.2003.98.5.1005; Kitsis CK, 2003, INJURY, V34, P69, DOI 10.1016/S0020-1383(02)00169-9; MANSKE DJ, 1985, J BONE JOINT SURG AM, V67A, P1367, DOI 10.2106/00004623-198567090-00010; McGowin J F, 1989, J Spinal Disord, V2, P104; Midha R, 1997, NEUROSURGERY, V40, P1182, DOI 10.1097/00006123-199706000-00014; Nordin L, 2009, J BONE JOINT SURG BR, V91B, P88, DOI 10.1302/0301-620X.91B1.21668; Rigault P, 1969, Rev Chir Orthop Reparatrice Appar Mot, V55, P125; Stephen AB, 1997, INJURY, V28, P557, DOI 10.1016/S0020-1383(97)83474-2; Watanabe K, 2005, J TRAUMA, V58, P1073, DOI 10.1097/01.TA.0000087649.78376.1B	27	22	22	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2010	5	6					573	577		10.3171/2010.3.PEDS09538			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	600YF	WOS:000278024200007	20515329				2022-02-06	
J	Palijan, TZ; Radeljak, S; Kovac, M; Kovacevic, D				Palijan, Tija Zarkovic; Radeljak, Sanja; Kovac, Marina; Kovacevic, Drazen			RELATIONSHIP BETWEEN COMORBIDITY AND VIOLENCE RISK ASSESMENT IN FORENSIC PSYCHIATRY - THE IMPLICATON OF NEUROIMAGING STUDIES	PSYCHIATRIA DANUBINA			English	Article; Proceedings Paper	24th Danube Congress of Psychiatry	MAY 05-08, 2010	Zagreb, CROATIA	Danubian Psychiat Assoc		comorbidity; violence risk assessment; neuroimaging; forensic psychiatry	DOUBLE-BLIND; DEPRESSION; PREVALENCE; ADULTS; THERAPY	Violence is an important social problem. Violence in the community has important social relevance for the political, criminal justice, and health care systems. Studies of homicide offenders have suggested a high prevalence of neurologic dysfunction due to organic brain damage such as traumatic brain injury, epilepsy and dementia have been observed to exhibit excessive violence. Moreover, violence in the mentally ill can be viewed as an important medical and mental health problem with significant implications for forensic psychiatry and the community. Although numerous previous studies showed that rate of violent behavior in the community is not much higher in patients with serious mental disorders (schizophrenia) than in healthy controls, that rate is substantially higher in patients with psychiatric comorbidity and substance abuse. A high proportion of patients in forensic psychiatric facilities are diagnosed with comorbidity, most often with schizophrenia, paranoid psychosis, organic brain syndrome, various personality disorders and comorbid substance abuse. These patients represent a high risk group for violence within forensic psychiatric facilities, and repetitive violent behavior in the community. Understanding the neurobiological basis of aggressive behavior clearly has important social and clinical implications. By introduction of neuroimaging studies (MU, fMRI, PET, SPECT) as a useful tool in forensic psychiatry, the neurobiological aspect of violence is better understood. Previous studies have shown that individuals with frontotemporal brain dysfunction are frequently displaying antisocial behavior (disinhibition, impulsivity, lack of empathy) that justify the diagnosis of "acquired sociopathy/psychopathy". A correlation between the potential for impulsive aggression mediated by limbic brain structures, and the control of the aggression by frontotemporal brain regions has been shown. The individuals with such brain dysfunction have an increased risk of violent behavior and scored high on the Webster's and Hare's violence risk assessment scale. This article reviews the relationship between psychiatric comorbidity, violence risk assessment and neuro imaging in forensic psychiatry and showing the useful directions for future research, screening and prevention of violent behavior among mentally ill criminal offenders.	[Palijan, Tija Zarkovic; Radeljak, Sanja; Kovac, Marina; Kovacevic, Drazen] Neuropsychiat Hosp Dr Ivan Barbot, Dept Forens Psychiat, Popovaca 44317, Croatia		Palijan, TZ (corresponding author), Neuropsychiat Hosp Dr Ivan Barbot, Dept Forens Psychiat, Jelengradska 1, Popovaca 44317, Croatia.	tija.zarkovic-palijan@npbp.hr	Askitas, Nikolaos/O-1065-2019; Askitas, Nikolaos/L-8362-2016; Palijan, Tija Zarkovic/D-4801-2017	Askitas, Nikolaos/0000-0002-3134-6616; Askitas, Nikolaos/0000-0002-3134-6616; Palijan, Tija Zarkovic/0000-0002-4113-2726			Anderson RJ, 2000, DIABETES, V49, pA64; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Brown LC, 2008, DIABETES RES CLIN PR, V79, P61, DOI 10.1016/j.diabres.2007.07.009; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; Egede LE, 2005, PSYCHOSOM MED, V67, P46, DOI 10.1097/01.psy.0000149260.82006.fb; Egede LE, 2004, DIABETES CARE, V27, P421, DOI 10.2337/diacare.27.2.421; Egede LE, 2002, DIABETES EDUCATOR, V28, P258, DOI 10.1177/014572170202800211; Filakovic P., 2004, MEDICUS, V13, P59; Filipcic I, 2007, COLLEGIUM ANTROPOL, V31, P139; Gonzalez JS, 2007, DIABETES CARE, V30, P2222, DOI 10.2337/dc07-0158; Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914; Katon WJ, 2005, DIABETES CARE, V28, P2668, DOI 10.2337/diacare.28.11.2668; Lustman Patrick J, 2007, Curr Diab Rep, V7, P114, DOI 10.1007/s11892-007-0020-8; Lustman PJ, 2006, ARCH GEN PSYCHIAT, V63, P521, DOI 10.1001/archpsyc.63.5.521; Lustman PJ, 1997, PSYCHOSOM MED, V59, P241, DOI 10.1097/00006842-199705000-00007; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Paile-Hyvarinen M, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-34; Pibernik-Okanovic M, 2005, DIABETIC MED, V22, P942, DOI 10.1111/j.1464-5491.2005.01528.x; Pibernik-Okanovic M, 1998, PHARMACOECONOMICS, V14, P201, DOI 10.2165/00019053-199814020-00008	19	22	24	1	40	MEDICINSKA NAKLADA	ZAGREB	VLASKA 69, HR-10000 ZAGREB, CROATIA	0353-5053			PSYCHIAT DANUB	Psychiatr. Danub.	JUN	2010	22	2					253	256					4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Conference Proceedings Citation Index - Science (CPCI-S)	Psychiatry	616JT	WOS:000279206200019	20562756				2022-02-06	
J	Fang, R; Dorlac, GR; Allan, PF; Dorlac, WC				Fang, Raymond; Dorlac, Gina R.; Allan, Patrick F.; Dorlac, Warren C.			Intercontinental aeromedical evacuation of patients with traumatic brain injuries during Operations Iraqi Freedom and Enduring Freedom	NEUROSURGICAL FOCUS			English	Article						critical care; traumatic brain injury; military medicine; war; wounds and injuries	PROPOFOL INFUSION SYNDROME	Traumatic brain injury contributes significantly to military combat morbidity and mortality. No longer maintaining comprehensive medical care facilities throughout the world, the US military developed a worldwide trauma care system making the patient the moving part of the system. Life-saving interventions are performed early, and essential care is delivered at forward locations. Patients then proceed successively through increasingly capable levels of care culminating with arrival in the US. Proper patient selection and thorough mission preparation are crucial to the safe and successful intercontinental aeromedical evacuation of critical brain-injured patients during Operations Iraqi Freedom and Enduring Freedom. (DOI: 10.3171/2010.2.FOCUS1043)	[Fang, Raymond] Landstuhl Reg Med Ctr, Div Surg, APO, AE 09180 USA; [Dorlac, Gina R.; Dorlac, Warren C.] Univ Cincinnati, USAF, Ctr Sustainment Trauma & Readiness Skills, Cincinnati, OH 45221 USA		Fang, R (corresponding author), Landstuhl Reg Med Ctr, Div Surg, 402 Box 506, APO, AE 09180 USA.	Raymond.Fang@amedd.army.mil					Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Beninati W, 2008, CRIT CARE MED, V36, pS370, DOI 10.1097/CCM.0b013e31817e3143; CAMPION EM, 2010, J SURG RES, V158, P214; Carlton PK, 2008, CRIT CARE MED, V36, pS255, DOI 10.1097/CCM.0b013e31817da609; GOODMAN MD, 2009, J SURG RES; Grant GA, 2007, J TRAUMA, V62, pS100, DOI 10.1097/TA.0b013e318065b42c; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; *PUBL AFF OFF AIR, 2008, C17 US AIR FORC PUBL; Rosen DJ, 2007, J TRAUMA, V63, P443, DOI 10.1097/TA.0b013e31809fe910; *US DEP DEF, 2004, EM WAR SURG 3 US REV, P5; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x	11	22	24	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2010	28	5							E11	10.3171/2010.2.FOCUS1043			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	589ZU	WOS:000277193600011	20568927				2022-02-06	
J	Nordstrom, CH				Nordstrom, Carl-Henrik			Cerebral energy metabolism and microdialysis in neurocritical care	CHILDS NERVOUS SYSTEM			English	Article						Microdialysis; Cerebral metabolism; Traumatic brain injury; Monitoring	VOLUME-TARGETED THERAPY; SEVERE BRAIN TRAUMA; INJURED HUMAN BRAIN; INTRACEREBRAL MICRODIALYSIS; RAT HIPPOCAMPUS; LUND CONCEPT; PRINCIPLES; TRANSPORT; PRESSURE; MORPHINE	It is of obvious clinical importance to monitor cerebral metabolism-in particular, cerebral energy metabolism and indicators of cellular damage-online at the bedside. The technique of cerebral microdialysis provides the opportunity for continuous monitoring of metabolic changes in the tissue before they are reflected in peripheral blood chemistry or in systemic physiological parameters. The basic idea of microdialysis is to mimic the function of a blood capillary by positioning a thin dialysis tube in the tissue and to be used to analyze the chemical composition of the interstitial fluid. The biochemical variables used during routine monitoring were chosen to cover important aspects of cerebral energy metabolism (glucose, pyruvate and lactate), to indicate excessive interstitial levels of excitatory transmitter substance (glutamate) and to give indications of degradation of cellular membranes (glycerol). Furthermore, pharmokinetic studies can be conducted using microdialysis. This article discusses technical and physiological aspects of microdialysis, and its clinical applications in brain injury.	Univ Lund Hosp, Dept Clin Sci, Div Neurosurg, SE-22185 Lund, Sweden		Nordstrom, CH (corresponding author), Univ Lund Hosp, Dept Clin Sci, Div Neurosurg, SE-22185 Lund, Sweden.	carl-henrik.nordstrom@med.lu.se					Amer-Wahlin I, 2009, J MATERN-FETAL NEO M, V10, P1, DOI [10.1080/14767050903067360, DOI 10.1080/14767050903067360]; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Ederoth P, 2004, BRIT J CLIN PHARMACO, V57, P427, DOI 10.1046/j.1365-2125.2003.02032.x; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Gardenfors A, 2002, ACTA NEUROCHIR, V144, P601, DOI 10.1007/s00701-002-0954-1; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; HAGSTROMTOFT E, 1993, J CLIN ENDOCR METAB, V76, P392, DOI 10.1210/jc.76.2.392; HAMBERGER A, 1984, NEUROCHEM RES, V9, P1181, DOI 10.1007/BF00973033; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Nordstrom CH, 2005, NEUROCRIT CARE, V2, P83, DOI 10.1385/NCC:2:1:083; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; NORDSTROM CH, 2003, NEUROSURG FOCUS, V15; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rosdahl H, 2000, INT J BIOL MACROMOL, V28, P69, DOI 10.1016/S0141-8130(00)00148-3; Siesj? BK., 1978, BRAIN ENERGY METABOL; Stahl N, 2003, ACTA NEUROL SCAND, V108, P211, DOI 10.1034/j.1600-0404.2003.00095.x; Tunblad K, 2004, ACTA ANAESTH SCAND, V48, P294, DOI 10.1111/j.0001-5172.2003.0311.x; Ungerstedt U, 1997, PHYSIOLOGY, STRESS, AND MALNUTRITION, P361; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Ungerstedt U., 1974, B SCHWEIZ AKAD MED, V1278, P1	25	22	23	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	APR	2010	26	4					465	472		10.1007/s00381-009-1035-z			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	568QI	WOS:000275537100008	19937248				2022-02-06	
J	Mann, CM; Lee, JHT; Hillyer, J; Stammers, AMT; Tetzlaff, W; Kwon, BK				Mann, Cody M.; Lee, Jae H. T.; Hillyer, Jessica; Stammers, Anthea M. T.; Tetzlaff, Wolfram; Kwon, Brian K.			Lack of robust neurologic benefits with simvastatin or atorvastatin treatment after acute thoracic spinal cord contusion injury	EXPERIMENTAL NEUROLOGY			English	Article						Simvastatin; Atorvastatin; Neuroprotection; Spinal cord injury	NITRIC-OXIDE SYNTHASE; TRAUMATIC BRAIN-INJURY; MORPHOLOGICAL CONSEQUENCES; NEUROPROTECTIVE AGENT; INFLAMMATORY RESPONSE; LOCOMOTOR RECOVERY; ISCHEMIC BRAIN; STATINS; RATS; ERYTHROPOIETIN	Although much progress has been made in the clinical care of patients with acute spinal cord injuries, there are no reliably effective treatments, which minimize secondary damage and improve neurologic Outcome. The time and expense needed to establish de novo pharmacologic or biologic therapies for acute SCI has encouraged the development of neuroprotective treatments based oil drugs that are already in clinical use and, therefore, have the advantage of a well-characterized safety and pharmacokinetic profile in humans. Statins are the most commonly prescribed class of lipid-lowering drugs, and recently, it has been recognized that statins also have powerful immunomodulatory and anti-inflammatory effects. This paper describes a series of experiments that were performed to evaluate the comparative neuroprotective effects of simvastatin and atorvastatin. We observed a promising signal of neurologic benefit with simvastatin in our first experiment, but in repeated attempts to replicate that effect in three subsequent experiments, we failed to reveal any behavioral OF histologic improvements. We Would conclude that simvastatin given orally or subcutaneously at doses previously reported by other investigators to be effective in different neurologic conditions does not confer a significant neurologic benefit in a thoracic contusion injury model (OSU Impactor) when administered with a I-h delay in intervention. We contend that further preclinical investigation of atorvastatin and simvastatin is warranted before considering their translation into human SCI. (C) 2009 Elsevier Inc. All rights reserved.	[Mann, Cody M.; Lee, Jae H. T.; Hillyer, Jessica; Stammers, Anthea M. T.; Tetzlaff, Wolfram; Kwon, Brian K.] Univ British Columbia, ICORD, Vancouver, BC V5Z 1M9, Canada; [Kwon, Brian K.] Univ British Columbia, Dept Orthopaed, CNOSP, Vancouver, BC V5Z 1M9, Canada; [Tetzlaff, Wolfram] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada		Kwon, BK (corresponding author), Univ British Columbia, Dept Orthopaed, Vancouver Gen Hosp, D6 Heather Pavil,2733 Heather St, Vancouver, BC V5Z 3J5, Canada.	brian.kwon@vch.ca	Tetzlaff, Wolfram/AAY-4430-2020		Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); UBC; Wings for Life Spinal Cord Injury Foundation; Scoliosis Research Society	BKK holds a New Investigator Award from the Canadian Institutes for Health Research and WT is the Rick Hansen Man in Motion Chair of Spinal Cord Injury Research, UBC. This research was supported by the Wings for Life Spinal Cord Injury Foundation and Scoliosis Research Society.	Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Balduini W, 2001, STROKE, V32, P2185, DOI 10.1161/hs0901.094287; Bartesaghi S, 2005, NEUROTOXICOLOGY, V26, P923, DOI 10.1016/j.neuro.2005.01.016; Basso DM, 2004, J NEUROTRAUM, V21, P395, DOI 10.1089/089771504323004548; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Cimino A, 2005, NEUROTOXICOLOGY, V26, P929, DOI 10.1016/j.neuro.2005.03.009; Cimino M, 2007, NEUROSCIENTIST, V13, P208, DOI 10.1177/1073858406297121; Dery MA, 2009, NEUROSCI LETT, V453, P73, DOI 10.1016/j.neulet.2009.01.062; Domercq M, 2004, TRENDS PHARMACOL SCI, V25, P609, DOI 10.1016/j.tips.2004.10.001; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; HOLMBERG E, 2008, EXP NEUROL; Holmberg E, 2006, J NEUROTRAUM, V23, P1366, DOI 10.1089/neu.2006.23.1366; Hurlbert RJ, 2008, CAN J NEUROL SCI, V35, P41, DOI 10.1017/S031716710000754X; Igel M, 2001, EUR J CLIN PHARMACOL, V57, P357, DOI 10.1007/s002280100329; Igel M, 2002, J CLIN PHARMACOL, V42, P835, DOI 10.1177/009127002401102731; Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y; Kugi M, 2002, CARDIOVASC DRUG THER, V16, P203, DOI 10.1023/A:1020692220701; KWON BK, 2009, J NEUROTRAUMA; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; McGirt MJ, 2002, STROKE, V33, P2950, DOI 10.1161/01.STR.0000038986.68044.39; Pannu R, 2005, J NEUROSCI RES, V79, P340, DOI 10.1002/jnr.20345; Pannu R, 2007, J NEUROCHEM, V101, P182, DOI 10.1111/j.1471-4159.2006.04354.x; Pinzon A, 2008, EXP NEUROL, V213, P129, DOI 10.1016/j.expneurol.2008.05.018; Pinzon A, 2008, BRAIN RES, V1243, P146, DOI 10.1016/j.brainres.2008.09.047; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Romano M, 2000, LAB INVEST, V80, P1095, DOI 10.1038/labinvest.3780115; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Stuve O, 2003, CURR OPIN NEUROL, V16, P393, DOI 10.1097/01.wco.0000073942.19076.d1; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wells JEA, 2003, BRAIN, V126, P1628, DOI 10.1093/brain/awg178; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158; Zacco A, 2003, J NEUROSCI, V23, P11104	40	22	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2010	221	2					285	295		10.1016/j.expneurol.2009.11.006			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	556BD	WOS:000274560800003	19931252				2022-02-06	
J	Dong, XQ; Yang, SB; Zhu, FL; Lv, QW; Zhang, GH; Huang, HB				Dong, Xiao-Qiao; Yang, Song-Bin; Zhu, Fang-Long; Lv, Qing-Wei; Zhang, Guo-Hai; Huang, Hang-Bin			Resistin is associated with mortality in patients with traumatic brain injury	CRITICAL CARE			English	Article							ADIPOKINE GENE-EXPRESSION; HEAD-INJURY; IN-VITRO; MACROPHAGES; ALPHA	Introduction: Recently, we reported that high levels of resistin are present in the peripheral blood of patients with intracerebral hemorrhage and are associated with a poor outcome. However, not much is known regarding the change in plasma resistin and its relation with mortality after traumatic brain injury (TBI). Thus, we sought to investigate change in plasma resistin level after TBI and to evaluate its relation with disease outcome. Methods: Fifty healthy controls and 94 patients with acute severe TBI were included. Plasma samples were obtained on admission and at days 1, 2, 3, 5 and 7 after TBI. Its concentration was measured by enzyme-linked immunosorbent assay. Results: Twenty-six patients (27.7%) died from TBI within 1 month. After TBI, plasma resistin level in patients increased during the 6-hour period immediately after TBI, peaked within 24 hours, plateaued at day 2, decreased gradually thereafter and was substantially higher than that in healthy controls during the 7-day period. A forward stepwise logistic regression selected plasma resistin level (odds ratio, 1.107; 95% confidence interval, 1.014-1.208; P = 0.023) as an independent predictor for 1-month mortality of patients. A multivariate linear regression showed that plasma resistin level was negatively associated with Glasgow Coma Scale score (t = -6.567, P < 0.001). A receiver operating characteristic curve identified plasma resistin cutoff level (30.8 ng/mL) that predicted 1-month mortality with the optimal sensitivity (84.6%) and specificity (75.0%) values (area under curve, 0.854; 95% confidence interval, 0.766-0.918; P < 0.001). Conclusions: Increased plasma resistin level is found and associated with Glasgow Coma Scale score and mortality after TBI.	[Dong, Xiao-Qiao] First Hangzhou Municipal Peoples Hosp, Dept Neurosurg, Hangzhou 310000, Zhejiang, Peoples R China; [Yang, Song-Bin; Zhu, Fang-Long; Lv, Qing-Wei; Zhang, Guo-Hai; Huang, Hang-Bin] Shengzhou Peoples Hosp, Dept Neurosurg, Shenzhou 312400, Peoples R China		Dong, XQ (corresponding author), First Hangzhou Municipal Peoples Hosp, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310000, Zhejiang, Peoples R China.	dxqhyy@163.com					Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Dong XQ, 2010, J CRIT CARE, V25, P243, DOI 10.1016/j.jcrc.2009.09.008; Efstathiou SP, 2007, CLIN CHIM ACTA, V378, P78, DOI 10.1016/j.cca.2006.10.023; Fasshauer M, 2001, BIOCHEM BIOPH RES CO, V288, P1027, DOI 10.1006/bbrc.2001.5874; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Kim KH, 2001, J BIOL CHEM, V276, P11252, DOI 10.1074/jbc.C100028200; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lu SC, 2002, FEBS LETT, V530, P158, DOI 10.1016/S0014-5793(02)03450-6; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Pang SS, 2006, CELL MOL IMMUNOL, V3, P29; Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3; Reilly MP, 2005, CIRCULATION, V111, P932, DOI 10.1161/01.CIR.0000155620.10387.43; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Wiesner G, 2006, NEUROREPORT, V17, P1195, DOI 10.1097/01.wnr.0000224776.12647.ba; Wilkinson M, 2007, NEUROENDOCRINOLOGY, V86, P191, DOI 10.1159/000108635	21	22	22	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X			CRIT CARE	Crit. Care		2010	14	5							R190	10.1186/cc9307			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	685AN	WOS:000284596500029	21029428	Green Published, gold			2022-02-06	
S	Kabadi, SV; Maher, TJ		Andrews, RJ; Slikker, W; Trembly, B; Patterson, TA		Kabadi, Shruti V.; Maher, Timothy J.			Posttreatment with uridine and melatonin following traumatic brain injury reduces edema in various brain regions in rats	NEUROPROTECTIVE AGENTS	Annals of the New York Academy of Sciences		English	Article; Proceedings Paper	9th International Conference on Neuroprotective Agents	SEP 07-11, 2008	Marine Biol Lab, Woods Hole, MA		Marine Biol Lab	uridine; melatonin; edema; traumatic brain injury (TBI)	CEREBRAL-ARTERY OCCLUSION; CDP-CHOLINE; ANTIOXIDANT ENZYMES; NEURONAL DEATH; STROKE MODEL; HEAD TRAUMA; DAMAGE; CITICOLINE; ISCHEMIA; VOLUME	Traumatic brain injury (TBI) is a major health problem and a significant cause of death, disability, and neurobehavioral deficits. We investigated the effect of posttreatment with uridine and melatonin, separate and in combination, on edema in various brain regions following TBI via lateral fluid percussion. Uridine (16 and 32 mg/kg, i.p.) and melatonin (200 mg/kg, i.p.), individually reduced edema in impacted striatum versus TBI. Combination treatment of uridine (32) and melatonin (200) decreased edema in impacted as well as non-impacted hippocampus (75.7 +/- 0.5% and 75.4 +/- 0.3%) and striatum (69.7 +/- 1.2% and 72.6 +/- 0.5%) respectively, as compared to the group that received vehicle following TBI. Combination of uridine (16) and melatonin (200) attenuated edema levels in impacted hippocampus (76.6 +/- 0.4%) and striatum (71.7 +/- 0.5% and 74 +/- 0.3%, respectively). Combination of uridine and melatonin may be a possible treatment strategy for the damage caused by TBI and its neuroprotective potential needs to be evaluated further.	[Kabadi, Shruti V.; Maher, Timothy J.] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Boston, MA 02115 USA		Maher, TJ (corresponding author), Massachusetts Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 179 Longwood Ave, Boston, MA 02115 USA.	Timothy.Maher@mcphs.edu					Alvarez XA, 1997, METHOD FIND EXP CLIN, V19, P201; Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165; Baranova AI, 2006, J NEUROTRAUM, V23, P1233, DOI 10.1089/neu.2006.23.1233; Baskaya MK, 2000, J NEUROSURG, V92, P448, DOI 10.3171/jns.2000.92.3.0448; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; BETZ A L, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P133; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Browne KD, 2006, EXP NEUROL, V201, P301, DOI 10.1016/j.expneurol.2006.04.008; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Cansev M, 2005, BRAIN RES, V1058, P101, DOI 10.1016/j.brainres.2005.07.054; Cansev M, 2006, BRAIN RES REV, V52, P389, DOI 10.1016/j.brainresrev.2006.05.001; Cirak B, 1999, PEDIATR NEUROSURG, V31, P298, DOI 10.1159/000028879; Clark W, 1998, STROKE, V29, P2136, DOI 10.1161/01.STR.29.10.2136; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Dempsey RJ, 2003, J NEUROSURG, V98, P867, DOI 10.3171/jns.2003.98.4.0867; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1992, J NEUROTRAUMA, V9, P475; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; FARABEGOLI C, 1988, ACTA PHYSIOL SCAND, V132, P209, DOI 10.1111/j.1748-1716.1988.tb08319.x; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Gupta YK, 2002, CAN J PHYSIOL PHARM, V80, P210, DOI 10.1139/Y02-052; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar AR, 2008, J BIOL CHEM, V283, P33874, DOI 10.1074/jbc.M804016200; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kong XY, 2008, CELL MOL NEUROBIOL, V28, P569, DOI 10.1007/s10571-007-9212-7; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; Lopez-Burillo S, 2003, J PINEAL RES, V34, P269, DOI 10.1034/j.1600-079X.2003.00041.x; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; Mor M, 2004, J PINEAL RES, V36, P95, DOI 10.1046/j.1600-079X.2003.00102.x; MYERS CS, 1995, PHARMACOL BIOCHEM BE, V52, P749, DOI 10.1016/0091-3057(95)00169-W; Norenberg MD, 2007, METAB BRAIN DIS, V22, P219, DOI 10.1007/s11011-007-9062-5; Ozdemir D, 2005, PHYSIOL RES, V54, P631; Pei Z, 2002, J PINEAL RES, V32, P168, DOI 10.1034/j.1600-079x.2002.1o847.x; Pei Z, 2003, STROKE, V34, P770, DOI 10.1161/01.STR.0000057460.14810.3E; PETERS GJ, 1987, CANCER CHEMOTH PHARM, V20, P101, DOI 10.1007/BF00253962; Plataras C, 2003, Z NATURFORSCH C, V58, P277; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Richardson UI, 2003, BRAIN RES, V971, P161, DOI 10.1016/S0006-8993(03)02333-3; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Sarrafzadeh AS, 2000, ACTA NEUROCHIR, V142, P1293, DOI 10.1007/s007010070028; Schabitz WR, 1999, STROKE, V30, P427, DOI 10.1161/01.STR.30.2.427; Sinha K, 2001, EUR J PHARMACOL, V428, P185, DOI 10.1016/S0014-2999(01)01253-5; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Winiarska K, 2006, J PINEAL RES, V40, P168, DOI 10.1111/j.1600-079X.2005.00295.x; Wurtman RJ, 2000, BIOCHEM PHARMACOL, V60, P989, DOI 10.1016/S0006-2952(00)00436-6	56	22	23	0	2	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN STREET, MALDEN 02148, MA USA	0077-8923		978-1-57331-777-1	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2010	1199						105	113		10.1111/j.1749-6632.2009.05352.x			9	Multidisciplinary Sciences; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology	BRJ59	WOS:000282838900012	20633115				2022-02-06	
J	Kilts, JD; Tupler, LA; Keefe, FJ; Payne, VM; Hamer, RM; Naylor, JC; Calnaido, RP; Morey, RA; Strauss, JL; Parke, G; Massing, MW; Youssef, NA; Shampine, LJ; Marx, CE				Kilts, Jason D.; Tupler, Larry A.; Keefe, Francis J.; Payne, Victoria M.; Hamer, Robert M.; Naylor, Jennifer C.; Calnaido, Rohana P.; Morey, Rajendra A.; Strauss, Jennifer L.; Parke, Gillian; Massing, Mark W.; Youssef, Nagy A.; Shampine, Lawrence J.; Marx, Christine E.		Vet Affairs MidAtlantic Mental	Neurosteroids and Self-Reported Pain in Veterans Who Served in the U.S. Military after September 11, 2001	PAIN MEDICINE			English	Article						Neuroactive Steroid; Allopregnanolone; Pregnenolone; DHEA; Nociception; Pain; Neurosteroid	TRAUMATIC BRAIN-INJURY; PROGESTERONE METABOLITE 5-ALPHA-PREGNAN-3-ALPHA-OL-20-ONE; STEROID-HORMONE METABOLITES; GABA-A RECEPTOR; PREGNENOLONE-SULFATE; ANTINOCICEPTIVE PROPERTIES; NEUROACTIVE STEROIDS; MENTAL-HEALTH; ANXIOLYTIC ACTIVITY; ALZHEIMERS-DISEASE	Objective. Nearly half of Operation Enduring Freedom/Operation Iraqi Freedom veterans experience continued pain post-deployment. Several investigations report analgesic effects of allopregnanolone and other neurosteroids in animal models, but few data are currently available focusing on neurosteroids in clinical populations. Allopregnanolone positively modulates GABA(A) receptors and demonstrates pronounced analgesic and anxiolytic effects in rodents, yet studies examining the relationship between pain and allopregnanolone in humans are limited. We thus hypothesized that endogenous allopregnanolone and other neurosteroid levels may be negatively correlated with self-reported pain symptoms in humans. Design. We determined serum neurosteroid levels by gas chromatography/mass spectrometry (allopregnanolone, pregnenolone) or radioimmunoassay (dehydroepiandrosterone [DHEA], progesterone, DHEA sulfate [DHEAS]) in 90 male veterans who served in the U.S. military after September 11, 2001. Self-reported pain symptoms were assessed in four areas (low back pain, chest pain, muscle soreness, headache). Stepwise linear regression analyses were conducted to investigate the relationship between pain assessments and neurosteroids, with the inclusion of smoking, alcohol use, age, and history of traumatic brain injury as covariates. Setting. Durham VA Medical Center. Results. Allopregnanolone levels were inversely associated with low back pain (P = 0.044) and chest pain (P = 0.013), and DHEA levels were inversely associated with muscle soreness (P = 0.024). DHEAS levels were positively associated with chest pain (P = 0.001). Additionally, there was a positive association between traumatic brain injury and muscle soreness (P = 0.002). Conclusions. Neurosteroids may be relevant to the pathophysiology of self-reported pain symptoms in this veteran cohort, and could represent future pharmacological targets for pain disorders.	[Kilts, Jason D.; Tupler, Larry A.; Keefe, Francis J.; Payne, Victoria M.; Naylor, Jennifer C.; Morey, Rajendra A.; Strauss, Jennifer L.; Shampine, Lawrence J.; Marx, Christine E.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA; [Hamer, Robert M.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Hamer, Robert M.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA		Marx, CE (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, 508 Fulton St,Mental Hlth Serv Line 116A, Durham, NC 27705 USA.	marx0001@mc.duke.edu	Morey, Rajendra A/P-3079-2018; Youssef, Nagy A/F-5869-2019	Morey, Rajendra A/0000-0002-6517-6969; Youssef, Nagy A/0000-0002-1922-9396	VA Mid-Atlantic MIRECC [K23 MH 65080]; VA Advanced Research Career Development Award; VA Career Development Award; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH065080] Funding Source: NIH RePORTER	This work was supported by the following sources: VA Mid-Atlantic MIRECC, K23 MH 65080 (C.E.M.), VA Advanced Research Career Development Award (C.E.M.), VA Career Development Award (J.L.S.). Dr Marx discloses that she is a co-applicant on pending U.S. patent applications on the use of neurosteroids and derivatives for the treatment of central nervous system disorders and for lowering cholesterol, and she is an unpaid scientific advisor and unpaid board member of NeuroScience Pharmaceuticals. The remaining authors have no potential conflicts of interest to disclose. The views expressed in this presentation are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the National Institutes of Health.	Ahmad I, 2005, J NEUROSCI RES, V82, P811, DOI 10.1002/jnr.20685; Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513; BELELLI D, 1989, EUR J PHARMACOL, V166, P325, DOI 10.1016/0014-2999(89)90077-0; Bitran D, 2000, PSYCHOPHARMACOLOGY, V151, P31, DOI 10.1007/s002130000472; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Chen SC, 2004, BRAIN RES, V1027, P196, DOI 10.1016/j.brainres.2004.08.053; Chen SC, 2006, BIOCHEM BIOPH RES CO, V349, P626, DOI 10.1016/j.bbrc.2006.08.076; CRAWLEY JN, 1986, BRAIN RES, V398, P382, DOI 10.1016/0006-8993(86)91500-3; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; DEVAUD LL, 1995, ALCOHOL CLIN EXP RES, V19, P350, DOI 10.1111/j.1530-0277.1995.tb01514.x; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Enna SJ, 2006, ADV PHARMACOL, V54, P1, DOI 10.1016/S1054-3589(06)54001-3; Finckh A, 2005, J RHEUMATOL, V32, P1336; Finset A, 2004, PSYCHONEUROENDOCRINO, V29, P49, DOI 10.1016/S0306-4530(02)00134-8; FRYE CA, 1994, BRAIN RES, V643, P194, DOI 10.1016/0006-8993(94)90025-6; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Genazzani A R, 2004, Aging Male, V7, P133; Genazzani AD, 2002, EUR J ENDOCRINOL, V146, P347, DOI 10.1530/eje.0.1460347; Genazzani AR, 1998, J CLIN ENDOCR METAB, V83, P2099, DOI 10.1210/jc.83.6.2099; Ghezzi P, 2000, EUR CYTOKINE NETW, V11, P464; Ghoumari AM, 2003, J NEUROCHEM, V86, P848, DOI 10.1046/j.1471-4159.2003.01881.x; Gilron I, 1996, ANESTHESIOLOGY, V84, P572, DOI 10.1097/00000542-199603000-00013; Girdler SS, 2001, BIOL PSYCHIAT, V49, P788, DOI 10.1016/S0006-3223(00)01044-1; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Goodchild CS, 2001, BRIT J ANAESTH, V86, P528, DOI 10.1093/bja/86.4.528; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Imamura M, 1998, BIOCHEM BIOPH RES CO, V243, P771, DOI 10.1006/bbrc.1998.8177; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jain NS, 2005, NEUROPHARMACOLOGY, V48, P627, DOI 10.1016/j.neuropharm.2004.11.016; KAVALIERS M, 1988, PSYCHOPHARMACOLOGY, V95, P488; KAVALIERS M, 1987, BRAIN RES, V415, P393, DOI 10.1016/0006-8993(87)90228-9; Kavaliers M, 2000, NEUROSCIENCE, V95, P807; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Khoromi S, 2006, J CLIN ENDOCR METAB, V91, P4313, DOI 10.1210/jc.2006-1122; Kokate TG, 1996, NEUROPHARMACOLOGY, V35, P1049, DOI 10.1016/S0028-3908(96)00021-4; KOKATE TG, 1994, J PHARMACOL EXP THER, V270, P1223; Korneyev A, 1996, HORM BEHAV, V30, P37, DOI 10.1006/hbeh.1996.0006; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; LANDGREN S, 1987, ACTA PHYSIOL SCAND, V131, P33, DOI 10.1111/j.1748-1716.1987.tb08202.x; MAJEWSKA MD, 1990, EUR J PHARM-MOLEC PH, V189, P307, DOI 10.1016/0922-4106(90)90124-G; MAJEWSKA MD, 1987, BRAIN RES, V404, P355; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; MAJEWSKA MD, 1990, BRAIN RES, V526, P143, DOI 10.1016/0006-8993(90)90261-9; Marx CE, 2006, PSYCHOPHARMACOLOGY, V186, P462, DOI 10.1007/s00213-005-0226-x; Marx CE, 2006, BIOL PSYCHIAT, V60, P1287, DOI 10.1016/j.biopsych.2006.06.017; Mechlin B, 2007, PAIN, V131, P142, DOI 10.1016/j.pain.2006.12.027; Mellon S, 2004, ENDOCR RES, V30, P727, DOI 10.1081/ERC-200044016; MOK WM, 1990, BRAIN RES, V533, P42, DOI 10.1016/0006-8993(90)91792-F; MORROW AL, 1987, EUR J PHARMACOL, V142, P483, DOI 10.1016/0014-2999(87)90094-X; Nadeson R, 2001, BRIT J ANAESTH, V86, P704, DOI 10.1093/bja/86.5.704; Park-Chung M, 1999, BRAIN RES, V830, P72, DOI 10.1016/S0006-8993(99)01381-5; Pathirathna S, 2005, PAIN, V114, P429, DOI 10.1016/j.pain.2005.01.009; Peebles JE, 2001, SPINE, V26, P766, DOI 10.1097/00007632-200104010-00014; Pinna G, 2003, P NATL ACAD SCI USA, V100, P2035, DOI 10.1073/pnas.0337642100; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Smith CD, 2006, PSYCHOPHARMACOLOGY, V186, P481, DOI 10.1007/s00213-005-0186-1; Tanielian T., 2008, INVISIBLE WOUNDS WAR; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; *VHA OFF PUBL HLTH, 2008, REP RET COMB VET; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; WIELAND S, 1991, BRAIN RES, V565, P263, DOI 10.1016/0006-8993(91)91658-N; WINFREE CJ, 1992, LIFE SCI, V50, P1007, DOI 10.1016/0024-3205(92)90095-7; Winter L, 2003, ANESTH ANALG, V97, P798, DOI 10.1213/01.ANE.0000075835.73967.F3; Yokoro CM, 2001, BRAZ J MED BIOL RES, V34, P397, DOI 10.1590/S0100-879X2001000300015; Zou XJ, 2002, BRAIN RES, V958, P322, DOI 10.1016/S0006-8993(02)03621-1	71	22	22	0	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1526-2375			PAIN MED	Pain Med.		2010	11	10					1469	1476		10.1111/j.1526-4637.2010.00927.x			8	Anesthesiology; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	656YA	WOS:000282375800006	20735755	Bronze, Green Submitted, Green Accepted			2022-02-06	
J	McDonald, S; Hunt, C; Henry, JD; Dimoska, A; Bornhofen, C				McDonald, Skye; Hunt, Christopher; Henry, Julie D.; Dimoska, Aneta; Bornhofen, Cristina			Angry responses to emotional events: The role of impaired control and drive in people with severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Emotion; Control; Drive; Frontal lobes	BLUNT HEAD-INJURY; ECOLOGICAL VALIDITY; HIGHER COGNITION; BEHAVIOR; NEUROBIOLOGY; PERCEPTION; DEFICITS; AMYGDALA; LESIONS; REHABILITATION	Emotional and behavioral changes (e.g., irritability and anger or alternatively passivity and inertia) are common after traumatic brain injury (TBI). These changes have been conceptualized as reflecting a loss of regulation, specifically control (loss of inhibition) and/or drive (self-initiation). However, no empirical studies have examined the relationship between neuropsychological measures of these constructs and emotional responsivity in situ. In this study, 29 individuals with severe, chronic TBI and 32 matched control participants were shown emotionally evocative films selected to elicit anger and were asked to rate their emotions before and after. They were also given measures of executive function to assess inhibition and flexibility as indices of control and drive, respectively. Both groups had heightened anxiety after the films. An increase in anger and confusion correlated with impaired control (Haylings Test score, Trails B errors) in the TBI group but not in controls. No association was found between reduced emotional responsivity and drive (Controlled Oral Word Association Test, Matrix Reasoning Scaled Score, Trails A/B time difference). This study provides support for the use of formal measures of disinhibition on neuropsychological tests as a corollary for emotion disinhibition. As with previous work, operationalization of loss of drive was more difficult to achieve.	[McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		McDonald, S (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	s.mcdonald@unsw.edu.au	McDonald, Skye/G-4118-2014	McDonald, Skye/0000-0003-0723-6094; Hunt, Christopher/0000-0001-5648-1139; Henry, Julie/0000-0002-2081-3717	National Health & Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Australian Research CouncilAustralian Research Council	This research was funded with grants from the National Health & Medical Research Council of Australia and the Australian Research Council. We are grateful to the Sydney metropolitan brain injury units-Royal Rehabilitation Centre, Westmead Brain Injury Unit, and Liverpool Brain Injury Unit-who assisted with recruitment. We are particularly grateful to the people with traumatic brain injuries and our control participants who gave willingly of their time to assist this research.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Andrewes D., 2001, NEUROPSYCHOLOGY THEO; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BOND MR, 1976, SCAND J REHABIL MED, V8, P127; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; CROWE SF, 1992, J CLIN EXP NEUROPSYC, V14, P327, DOI 10.1080/01688639208402832; Cummings J, 1985, CLIN NEUROPSYCHIATRY; Darby D, 2005, WALSHS NEUROPSYCHOLO; Emery NJ, 2001, BEHAV NEUROSCI, V115, P515, DOI 10.1037/0735-7044.115.3.515; Eslinger PJ, 2008, NEUROPSYCHOLOGICAL RESEARCH: A REVIEW, P379; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Grattan LM, 1989, NEUROPSYCHOLOGY, V3, P175, DOI 10.1037//0894-4105.3.3.175; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Hauser MD, 1999, CURR OPIN NEUROBIOL, V9, P214, DOI 10.1016/S0959-4388(99)80030-0; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Hosie JA, 2005, PSYCHOLOGIA, V48, P288, DOI 10.2117/psysoc.2005.288; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; LOVIBOND PF, 1995, MANUAL DEPRESSION AN; Luria A.R., 1973, WORKING BRAIN; Machado CJ, 2008, BEHAV NEUROSCI, V122, P251, DOI 10.1037/0735-7044.122.2.251; Marsh NV, 1991, NEUROPSYCHOLOGY, V5, P107, DOI 10.1037/0894-4105.5.2.107; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BRIT J PSYCHIAT, V182, P190, DOI 10.1192/bjp.182.3.190; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Reitan RM, 1992, TRAIL MAKING TEST; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Soussignan R, 2005, NEUROCASE, V11, P114, DOI 10.1080/13554790590922513; Spreen O, 1991, COMPENDIUM NEUROPSYC; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Terry PC, 1999, J SPORT SCI, V17, P861, DOI 10.1080/026404199365425; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Yochim BP, 2009, J CLIN EXP NEUROPSYC, V31, P658, DOI 10.1080/13803390802448669	67	22	22	1	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	8					855	864	PII 921771147	10.1080/13803391003596405			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	659RO	WOS:000282584800006	20432104				2022-02-06	
J	Medley, AR; Powell, T; Worthington, A; Chohan, G; Jones, C				Medley, Andrew R.; Powell, Theresa; Worthington, Andrew; Chohan, Gagandeep; Jones, Chris			Brain injury beliefs, self-awareness, and coping: A preliminary cluster analytic study based within the self-regulatory model	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Rehabilitation; Illness perceptions; Coping; Self-awareness	QUALITY-OF-LIFE; ILLNESS REPRESENTATIONS; PERCEPTION QUESTIONNAIRE; EMOTIONAL ADJUSTMENT; RHEUMATOID-ARTHRITIS; REHABILITATION; EXPERIENCE; DISEASE; MOOD; ASSOCIATION	The interplay between individuals' subjective beliefs about traumatic brain injury, their coping style and their self-awareness might provide a more helpful guide to rehabilitation goals than looking at these factors in isolation. We therefore conducted a preliminary study to determine whether the Self-Regulatory Model can identify different clusters of individuals according to belief schemata, and to explore whether clusters differed across measures of coping and self-awareness. The Illness Perception Questionnaire-Revised was administered to 37 participants with severe traumatic brain injury (TBI), along with the Ways of Coping Checklist-Revised and the European Brain Injury Questionnaire. Clinicians also rated clients' level of difficulties using the latter scale, and the discrepancy between client and clinician scores was used as a measure of self-awareness. Hierarchical cluster analysis distinguished three groups based on profiles of subjective beliefs about TBI, labelled olow control/ambivalento, ohigh salienceo, and ohigh optimismo. The high salience group was characterised by beliefs about serious consequences of the injury and greater self-awareness, and reported a greater range of coping strategies. The other two groups showed lower levels of awareness but differed in coping styles, with the low control/ambivalent group showing a trend towards more avoidance coping against a background of lower perceived control.	[Medley, Andrew R.; Powell, Theresa; Chohan, Gagandeep; Jones, Chris] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Worthington, Andrew] Brain Injury Rehabil Trust, Birmingham, W Midlands, England		Medley, AR (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	a_medley@o2.co.uk		Powell, Theresa/0000-0002-3351-9453			Ajzen I., 1988, ATTITUDES PERSONALIT; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bains B, 2007, NEUROPSYCHOL REHABIL, V17, P174, DOI 10.1080/09602010600562468; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; BUICK DL, 1997, PERCEPTIONS HLTH ILL; Carlisle ACS, 2005, BRIT J HEALTH PSYCH, V10, P571, DOI 10.1348/135910705X52309; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; CICERONE KD, 1991, J HEAD TRAUMA REHAB, V6, P30, DOI DOI 10.1097/00001199-199112000-00007; Clare L, 2006, INT J GERIATR PSYCH, V21, P761, DOI 10.1002/gps.1558; Clatworthy J, 2007, PSYCHOL HEALTH, V22, P123, DOI 10.1080/14768320600774496; COETZER BR, 2001, J COGNITIVE REHA WIN, P8; Coetzer R, 2008, NEUROPSYCHOL REHABIL, V18, P766, DOI 10.1080/09602010701860266; Cooper A, 1999, HEART, V82, P234, DOI 10.1136/hrt.82.2.234; Finset A, 2000, BRAIN INJURY, V14, P887; FOLKMAN S, 1988, SOC SCI MED, V26, P309, DOI 10.1016/0277-9536(88)90395-4; Folkman S., 1984, STRESS; Goldstein LH, 2005, EPILEPSY RES, V67, P1, DOI 10.1016/j.eplepsyres.2005.06.008; Groarke AM, 2005, PSYCHOL HEALTH, V20, P597, DOI 10.1080/14768320500094177; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Harman G, 2006, QUAL HEALTH RES, V16, P484, DOI 10.1177/1049732306286851; Hart T, 2007, REHABIL PSYCHOL, V52, P152, DOI 10.1037/0090-5550.52.2.152; Heijmans M, 1999, BRIT J HEALTH PSYCH, V4, P137, DOI 10.1348/135910799168533; Helder DI, 2002, BRIT J HEALTH PSYCH, V7, P449, DOI 10.1348/135910702320645417; Hobro N, 2004, PAIN, V108, P276, DOI 10.1016/j.pain.2003.12.027; Jessop DC, 2003, PSYCHOL HEALTH, V18, P595, DOI 10.1080/0887044031000097009; Jopson NM, 2003, J PSYCHOSOM RES, V54, P503, DOI 10.1016/S0022-3999(02)00455-5; Kendall E, 2001, BRAIN IMPAIR, V2, P81; KING NS, 2003, HDB CLIN NEUROPSYCHO; Kline P., 2000, PSYCHOMETRICS PRIMER; Krpan KM, 2007, J CLIN EXP NEUROPSYC, V29, P36, DOI 10.1080/13803390500376816; Leventhal H., 1980, CONTRIB MED PSYCHOL, V2, P7; Leventhal H, 1984, HDB PSYCHOL HLTH; Leventhal H., 2003, SELF REGULATION HLTH, DOI DOI 10.4324/9780203553220; Llewellyn CD, 2003, PSYCHOL HEALTH, V18, P185, DOI 10.1080/0887044031000098198; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; Maclean N, 2000, BMJ-BRIT MED J, V321, P1051, DOI 10.1136/bmj.321.7268.1051; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; MALIA K, 1997, J COGNITIVE REHA MAY, P10; Manchester D, 2001, BRAIN DAM B, P157; Miglioretti M, 2008, J PSYCHOSOM RES, V65, P603, DOI 10.1016/j.jpsychores.2008.05.012; Miller W.R., 2002, MOTIVATIONAL INTERVI; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; MOSSMORRIS R, 1997, PERCEPTIONS HLTH ILL; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Petrie KJ, 2002, PSYCHOSOM MED, V64, P580, DOI 10.1097/00006842-200207000-00007; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Prigatano G. P, 2005, REHABILITATION TRAUM; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Saltapidas H, 2008, BRAIN IMPAIR, V9, P1, DOI 10.1375/brim.9.1.1; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Searle A, 2007, BRIT J HEALTH PSYCH, V12, P621, DOI 10.1348/135910706X164935; Shotton L, 2007, BRAIN INJURY, V21, P857, DOI 10.1080/02699050701481621; Spain LA, 2007, ACTA NEUROL SCAND, V116, P293, DOI 10.1111/j.1600-0404.2007.00895.x; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Tennen H, 2000, AM PSYCHOL, V55, P626, DOI 10.1037//0003-066X.55.6.626; Toglia J, 2000, NEUROREHABILITATION, V15, P57; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Vaughan R, 2003, BRIT J HEALTH PSYCH, V8, P287, DOI 10.1348/135910703322370860; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Whitmarsh A, 2003, BRIT J HEALTH PSYCH, V8, P209, DOI 10.1348/135910703321649178; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026; [No title captured], DOI DOI 10.1080/09602019108520164; [No title captured]; [No title captured]	74	22	22	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	6					899	921	PII 928656316	10.1080/09602011.2010.517688			23	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	684GB	WOS:000284537300007	20981622				2022-02-06	
J	Wade, SL; Walz, NC; Cassedy, A; Taylor, HG; Stancin, T; Yeates, KO				Wade, Shari L.; Walz, Nicolay C.; Cassedy, Amy; Taylor, H. Gerry; Stancin, Terry; Yeates, Keith Owen			Caregiver functioning following early childhood TBI: Do moms and dads respond differently?	NEUROREHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; GENDER DIFFERENCES; SOCIAL SUPPORT; FAMILY BURDEN; INITIAL YEAR; HEAD-INJURY; SHORT-TERM; CHILDREN; PREDICTORS; DISTRESS	Introduction: Research suggests that pediatric TBI results in injury-related stress and burden and psychological distress for parents. However, existing studies have focused almost exclusively on mothers, so that we know relatively little about the impact of childhood TBI on fathers. Specific aims: The aims were to prospectively examine differences in maternal and paternal response to early childhood TBI over time relative to a comparison cohort of mothers and fathers of children with orthopedic injuries (OI). Methods: The concurrent cohort/prospective research design involved repeated assessments of children aged 3-6 years with TBI or OI requiring hospitalization and their families. Shortly after injury and at 6, 12, and 18 months post injury, parents of 48 children with TBI (11 severe and 37 moderate) and 89 with OI completed standardized assessments of injury-related stress and burden, parental distress, and coping strategies. Mixed models analyses and Generalized Estimating Equations examined differences in maternal versus paternal burden, distress, and coping over time. The analyses included interactions of parent sex with group (severe TBI, moderate TBI, OI) and time since injury, to examine the moderating effects of injury severity on parental response to injury over time. Results: Fathers were more likely than mothers to use denial to cope following moderate and severe TBI, but not OI. Conversely, mothers were more likely to prefer acceptance and emotion-focused strategies than fathers regardless of the type of injury. The use of active coping strategies varied as a function of injury type, parent sex, and time since injury. Fathers reported greater injury-related stress and distress than mothers over time, with pronounced differences in the severe TBI and OI groups. Conclusions: Mothers and fathers appear to respond differently following TBI. The different types of responses may serve to exacerbate emerging family dysfunction.	[Wade, Shari L.] Univ Cincinnati, Div Pediat Phys Med & Rehabil, Cincinnati Childrens Hosp Med Ctr, Coll Med, Cincinnati, OH 45229 USA; [Taylor, H. Gerry] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Taylor, H. Gerry; Stancin, Terry] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Stancin, Terry] Metrohlth Med Ctr, Cleveland, OH USA; [Yeates, Keith Owen] Nationwide Childrens Hosp, Columbus, OH USA; [Yeates, Keith Owen] Ohio State Univ, Columbus, OH 43210 USA		Wade, SL (corresponding author), Univ Cincinnati, Div Pediat Phys Med & Rehabil, Cincinnati Childrens Hosp Med Ctr, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shari.wade@cchmc.org	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR08084, M01 RR008084] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD042729, R01 HD42729] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER		ALDWIN CM, 1987, J PERS SOC PSYCHOL, V53, P337, DOI 10.1037/0022-3514.53.2.337; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Benn KM, 2004, BRAIN INJURY, V18, P239, DOI 10.1080/02699050310001617343; Burgess ES, 1999, J HEAD TRAUMA REHAB, V14, P394, DOI 10.1097/00001199-199908000-00008; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; DEROGATIS L, 1982, CLIN PSYCHOL RES; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerhardt CA, 2003, J PEDIATR PSYCHOL, V28, P5, DOI 10.1093/jpepsy/28.1.5; HOLAHAN CJ, 1985, J PERS SOC PSYCHOL, V49, P739, DOI 10.1037/0022-3514.49.3.739; Holmbeck GN, 1997, J PEDIATR PSYCHOL, V22, P167; Macias MM, 2007, CHILD HEALTH CARE, V36, P99, DOI 10.1080/02739610701334558; PORTER LS, 1995, J SOC CLIN PSYCHOL, V14, P184, DOI 10.1521/jscp.1995.14.2.184; PTACEK JT, 1994, PERS SOC PSYCHOL B, V20, P421, DOI 10.1177/0146167294204009; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; Seiffge-Krenke I, 2002, J PEDIATR PSYCHOL, V27, P439, DOI 10.1093/jpepsy/27.5.439; Simons L, 2007, PEDIATR TRANSPLANT, V11, P781, DOI 10.1111/j.1399-3046.2007.00726.x; Sloper P, 2000, J PEDIATR PSYCHOL, V25, P79, DOI 10.1093/jpepsy/25.2.79; Stancin T, 2008, J DEV BEHAV PEDIATR, V29, P253, DOI 10.1097/DBP.0b013e31816b6b0f; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750; Wade SL, 2008, REHABIL PSYCHOL, V53, P180, DOI 10.1037/0090-5550.53.2.180; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	27	22	22	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2010	27	1					63	72		10.3233/NRE-2010-0581			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	629GA	WOS:000280182000006	20634601	Green Accepted			2022-02-06	
J	Elliott, MB; Jallo, JJ; Barbe, MF; Tuma, RF				Elliott, Melanie B.; Jallo, Jack J.; Barbe, Mary F.; Tuma, Ronald F.			Hypertonic saline attenuates tissue loss and astrocyte hypertrophy in a model of traumatic brain injury	BRAIN RESEARCH			English	Article						Hypertonic saline; Traumatic brain injury; Cortical contusion injury; Tissue loss; Astrocyte; Gliosis	POSTTRAUMATIC INTRACRANIAL HYPERTENSION; SEVERE HEAD-INJURY; SPINAL-CORD; SODIUM-CHLORIDE; CEREBRAL EDEMA; RESUSCITATION; MANNITOL; IMPACT; PRESSURE; VOLUME	Hypertonic saline is currently being used in the treatment of patients with post-traumatic cerebral edema and elevated intracranial pressure resulting from TBI. A limited number of studies show the cellular effects of hypertonic saline and no studies, to our knowledge, have investigated the effects on astrocytes. The role of astrocyte responses after traumatic brain injury remains unclear. There is evidence that reduced astrocyte proliferation is detrimental while increased hypertrophy and proliferation are signs of increased injury severity. Therefore, this study focused on the hypothesis that hypertonic saline-induced improvements in histological outcome are time dependent and may be associated with alterations in astrocyte hypertrophy after cortical contusion injury. Histopathological changes at 7 days after controlled cortical impact (CCI) injury were examined. Brain tissue loss determined using cresyl violet staining and astrocyte hypertrophy and proliferation were assessed using glial fibrillary acidic protein immunostaining in hypertonic saline and normal saline treated rats, and untreated, injured controls. Effects of the timing of hypertonic saline treatment administration on tissue loss were also examined. Plasma osmolarity and sodium levels were measured over 4 h and again at 24 h following hypertonic saline administration. Results show that hypertonic saline treatment reduced tissue loss that correlated with attenuated astrocyte hypertrophy characterized by reductions in astrocyte immunoreactivity without changes in the number of astrocytes after CCI injury. Delayed treatment of hypertonic saline resulted in the greatest reduction in tissue loss compared to all other treatments indicating that there is a therapeutic window for hypertonic saline use after traumatic brain injury. (C) 2009 Elsevier B.V. All rights reserved.	[Elliott, Melanie B.; Jallo, Jack J.] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Tuma, Ronald F.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; [Barbe, Mary F.] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA		Elliott, MB (corresponding author), Thomas Jefferson Univ, Dept Neurosurg, 1025 Walnut St, Philadelphia, PA 19107 USA.	melaniedion@comcast.net; jack.jallo@jefferson.edu; mbarbe@temple.edu; ronald.tuma@temple.edu		Jallo, Jack/0000-0002-5512-1729	PA Department of Health; AHAAmerican Heart Association [0415405U]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01HD042738] Funding Source: NIH RePORTER	Support for this research was provided by the PA Department of Health and AHA (0415405U).	Al-Shatti T, 2005, J NEUROIMMUNOL, V167, P13, DOI 10.1016/j.jneuroim.2005.06.013; Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Boycott HE, 2008, GLIA, V56, P998, DOI 10.1002/glia.20673; Chang YC, 2008, NEUROCHEM RES, V33, P2318, DOI 10.1007/s11064-008-9731-8; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Elliott MB, 2008, BRAIN RES, V1218, P103, DOI 10.1016/j.brainres.2008.04.029; Elliott MB, 2008, J NEUROSCI METH, V168, P320, DOI 10.1016/j.jneumeth.2007.10.019; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; Horn P, 1999, NEUROL RES, V21, P758, DOI 10.1080/01616412.1999.11741010; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levene Howard B, 2007, Clin Neurosurg, V54, P213; Mouton P. R., 2002, PRINCIPLES PRACTICES; Munar F, 2000, J NEUROTRAUM, V17, P41, DOI 10.1089/neu.2000.17.41; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Okuno S, 2001, NEUROL RES, V23, P657, DOI 10.1179/016164101101198983; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Phillis JW, 1999, BRAIN RES, V828, P1, DOI 10.1016/S0006-8993(99)01235-4; Prow NA, 2008, J NEUROCHEM, V105, P1276, DOI 10.1111/j.1471-4159.2008.05230.x; Qureshi AI, 2002, CRIT CARE MED, V30, P435, DOI 10.1097/00003246-200202000-00028; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; Rotstein OD, 2000, J TRAUMA, V49, P580, DOI 10.1097/00005373-200010000-00002; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sama MA, 2008, J BIOL CHEM, V283, P21953, DOI 10.1074/jbc.M800148200; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Shackford SR, 1997, J TRAUMA, V42, pS48, DOI 10.1097/00005373-199705001-00009; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Spera PA, 1998, SPINE, V23, P2444, DOI 10.1097/00007632-199811150-00018; Spera PA, 2000, ACTA NEUROCHIR, V142, P811, DOI 10.1007/s007010070097; Sumas ME, 2001, NEUROSURGERY, V48, P167; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Tuma RF, 1997, J TRAUMA, V42, pS54, DOI 10.1097/00005373-199705001-00010; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Wenham TN, 2008, ANAESTHESIA, V63, P558, DOI 10.1111/j.1365-2044.2008.05532.x; White RE, 2008, RESTOR NEUROL NEUROS, V26, P197; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; Ziai WC, 2007, J NEUROL SCI, V261, P157, DOI 10.1016/j.jns.2007.04.048	52	22	24	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 11	2009	1305						183	191		10.1016/j.brainres.2009.09.104			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	538EQ	WOS:000273167500018	19804766				2022-02-06	
J	Gould, TE; Piland, SG; Shin, J; McNair, O; Hoyle, CE; Nazarenko, S				Gould, Trenton E.; Piland, Scott G.; Shin, Junghwan; McNair, Olivia; Hoyle, Charles E.; Nazarenko, Sergei			Characterization of mouthguard materials: Thermal properties of commercialized products	DENTAL MATERIALS			English	Article						Mouthguard materials; Differential scanning calorimetry; Dynamic mechanical analysis; Ethylene vinyl acetate; Dental materials; Material characterization	CONCUSSION; PREVENTION	Objectives. Several mechanisms have been purported to describe how mouthguards protect the orofacial complex against injury. As the properties needed for these mechanisms to be effective are temperature and frequency dependent, the specific aim of this study was to provide a comprehensive thermal characterization of commercial mouthguard materials. Methods. Five commercially representative thermoplastic mouthguard materials (Essix(TM) Resin, Erkoflex(TM), Proform(TM)-regular, Proform(TM)-laminate, and Polyshok(TM)) were tested. Differential scanning calorimetry (DSC) and dynamic mechanical analysis (DMA) techniques were implemented to measure thermal transitions and mechanical properties. Measurements were conducted three times per sample. One-way ANOVA and one-sample t-tests were used to test for differences between commercial products on selected mean thermal property values. Results. The DSC measurements indicated no differences between commercial materials for mean glass transition (p = 0.053), onset melt (p = 0.973), or peak melt (p = 0.436) temperatures. Likewise, DMA measurements revealed no differences between commercial materials for the mean glass transition (p = 0.093), storage modulus (p = 0.257), or loss modulus (p = 0.172) properties, respectively. The one-sample t-tests revealed that glass transition temperatures were different from intra-oral temperature (p < 0.005) for all materials. Significance. Commercialized mouthguard materials are sensitive to repetitive heating and cooling cycles, prolonged thermal treatment, and have glass transitions well below their end-use intra-oral temperature. As such, these materials are functioning as elastomers and not optimal mechanical damping materials. Dental clinicians, healthcare practitioners, or end-users should be aware that these materials are at best problematic with respect to this protective mechanism. Published by Elsevier Ltd on behalf of Academy of Dental Materials.	[Gould, Trenton E.] Univ So Mississippi, Sport & High Performance Mat Program, Sch Human Performance, Hattiesburg, MS 39406 USA; [Shin, Junghwan; McNair, Olivia; Hoyle, Charles E.; Nazarenko, Sergei] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA		Gould, TE (corresponding author), Univ So Mississippi, Sport & High Performance Mat Program, Sch Human Performance, 118 Coll Dr,5142, Hattiesburg, MS 39406 USA.	Trent.Gould@usm.edu	, scott/ABB-2057-2021		Alliance for Graduate Education in Mississippi (AGEM); National Science FoundationNational Science Foundation (NSF)	Ms. Olivia McNair was supported by the Alliance for Graduate Education in Mississippi (AGEM), a National Science Foundation funded grant designed to increase the number of under represented minorities that pursue graduate education in science, technology, engineering, and mathematics. Additionally, in the course of completing this article for print, our dear colleague, Dr. Charles E. Hoyle, suddenly and tragically passed away. Charlie, as most referred to him, was an internationally renowned polymer scientist, a dedicated teacher, and beloved mentor. This manuscript is dedicated in his memory.	*AM NAT STAND I AM, 2001, 99 AM NAT STAND I AM; *ASTM INT, 2000, 69700 ASTM INT; *AUSTR IND, 2003, STAND; Currel B.R, 1987, THERMAL METHODS; GOULD TE, 2007, MAT SPORTS EQUIPMENT; Gould TE, 2009, DENT MATER, V25, P771, DOI 10.1016/j.dental.2008.12.005; KIM ST, 1997, IDW 97 SID NAG, P155; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; Meng FH, 2007, DENT MATER, V23, P1492, DOI 10.1016/j.dental.2007.01.006; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Moly KA, 2005, EUR POLYM J, V41, P1410, DOI 10.1016/j.eurpolymj.2004.10.016; Seymour RB, 1981, POLYM CHEM INTRO; STENGER JM, 1964, J AM DENT ASSOC, V69, P273, DOI 10.14219/jada.archive.1964.0290; Winters JE, 2001, J ATHL TRAINING, V36, P339; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x	17	22	23	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0109-5641	1879-0097		DENT MATER	Dent. Mater.	DEC	2009	25	12					1593	1602		10.1016/j.dental.2009.08.003			10	Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Materials Science	515LN	WOS:000271472400017	19796800				2022-02-06	
J	Shen, YX; Fan, ZH; Zhao, JG; Zhang, P				Shen, Yi-Xin; Fan, Zhi-Hai; Zhao, Jia-Guo; Zhang, Peng			The application of platelet-rich plasma may be a novel treatment for central nervous system diseases	MEDICAL HYPOTHESES			English	Article							EPIDERMAL-GROWTH-FACTOR; SPINAL-CORD-INJURY; IN-VITRO; FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; DEGENERATIVE DISEASES; DOPAMINERGIC-NEURONS; FUNCTIONAL RECOVERY; STEM-CELLS; RECEPTOR	As a potential biological product, platelet-rich plasma (PRP) has been widely utilized in the areas of oral and maxillofacial reconstruction, bone and soft tissue restoration and wound healing. A recent study reported that the application of PRP on interrupted sciatic nerve could promote remyelinization of peripheral nerve. This renovated a notion that the application of PRP might extend to the nervous system. Most central nervous system (CNS) diseases have a series of common pathological changes in the later period of diseases which induce neurons and glia apoptosis and aggravate neurological dysfunction. It has been demonstrated that the potent restorative function of PRP is mainly based on neurotrophic capacity of preparation rich in growth factors (PRGFs) and scaffolding effect of platelet-rich gel (PRG), all of which could be certified to ameliorate the pathological process of CNS diseases. In view of this, we propose a hypothesis that the application of PRP and its derivatives might provide a novel therapeutic approach for CNS diseases, especially for traumatic brain or spinal cord injury, autoimmune diseases and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. (C) 2009 Elsevier Ltd. All rights reserved.	[Shen, Yi-Xin; Fan, Zhi-Hai; Zhang, Peng] Soochow Univ, Affiliated Hosp 2, Dept Orthopaed, Suzhou 215004, Jiangsu, Peoples R China; [Zhao, Jia-Guo] Tianjin Hosp, Dept Orthopaed, Tianjin 300211, Peoples R China; [Zhao, Jia-Guo] China Med Univ, Shengjing Hosp, Dept Orthopaed, Shenyang 110004, Liaoning, Peoples R China		Zhao, JG (corresponding author), Tianjin Hosp, Dept Orthopaed, Tianjin 300211, Peoples R China.	pcrole@foxmail.com; tyb0423@yahoo.com.cn					Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037; Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491; Bogaert E, 2006, MUSCLE NERVE, V34, P391, DOI 10.1002/mus.20609; Carmeliet P, 2002, SEMIN CELL DEV BIOL, V13, P39, DOI 10.1006/scdb.2001.0290; CHENG B, 1995, J NEUROSCI, V15, P7095; Egawa-Tsuzuki T, 2004, EXP NEUROL, V186, P89, DOI 10.1016/j.expneurol.2003.11.001; Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009; Eppley BL, 2006, PLAST RECONSTR SURG, V118, p147E, DOI 10.1097/01.prs.0000239606.92676.cf; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Flanders KC, 1998, PROG NEUROBIOL, V54, P71, DOI 10.1016/S0301-0082(97)00066-X; Froestl W, 2000, Pharm Acta Helv, V74, P247, DOI 10.1016/S0031-6865(99)00035-7; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; HEFTI F, 1994, J NEUROBIOL, V25, P1418, DOI 10.1002/neu.480251109; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Kojima A, 2002, J NEUROTRAUM, V19, P223, DOI 10.1089/08977150252806974; Kwon YK, 2002, J BIOCHEM MOL BIOL, V35, P87; Lippa CF, 1995, NEURODEGENERATION, V4, P425, DOI 10.1006/neur.1995.0051; MAIESE K, 1995, J CEREBR BLOOD F MET, V15, P440, DOI 10.1038/jcbfm.1995.55; Mattson MP, 2006, ANTIOXID REDOX SIGN, V8, P1997, DOI 10.1089/ars.2006.8.1997; McTigue DM, 2000, EXP NEUROL, V163, P220, DOI 10.1006/exnr.2000.7372; Mehta S, 2008, J ORTHOP TRAUMA, V22, P433, DOI 10.1097/BOT.0b013e31817e793f; Nakao Y, 2001, J THORAC CARDIOV SUR, V122, P136, DOI 10.1067/mtc.2001.114101; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Peng H, 1998, J CEREBR BLOOD F MET, V18, P349, DOI 10.1097/00004647-199804000-00002; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Roussa E, 2006, STEM CELLS, V24, P2120, DOI 10.1634/stemcells.2005-0514; Sariguney Y, 2008, J RECONSTR MICROSURG, V24, P159, DOI 10.1055/s-2008-1076752; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P95, DOI 10.1196/annals.1403.007; Skold M, 2000, EUR J NEUROSCI, V12, P3675, DOI 10.1046/j.1460-9568.2000.00263.x; Stoll G, 2004, BRAIN PATHOL, V14, P51, DOI 10.1111/j.1750-3639.2004.tb00497.x; Tirassa P, 2003, J NEUROSCI RES, V72, P557, DOI 10.1002/jnr.10614; Valenzuela CF, 1996, J BIOL CHEM, V271, P16151, DOI 10.1074/jbc.271.27.16151; Vincent AM, 2002, GROWTH HORM IGF RES, V12, P193, DOI 10.1016/S1096-6374(02)00017-5; Wang JM, 2000, BRAIN RES, V859, P381, DOI 10.1016/S0006-8993(00)02008-4; Wang K, 2004, NEUROSCI LETT, V364, P154, DOI 10.1016/j.neulet.2004.04.086; Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jcms.2002.0285; WERNER MH, 1988, J HISTOCHEM CYTOCHEM, V36, P81, DOI 10.1177/36.1.3275713; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrotniak Maciej, 2007, Ortop Traumatol Rehabil, V9, P227; WYSSCORAY T, 1995, AM J PATHOL, V147, P53	46	22	24	0	10	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	DEC	2009	73	6					1038	1040		10.1016/j.mehy.2009.05.021			3	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	534UN	WOS:000272923000043	19767153				2022-02-06	
J	Lancioni, GE; Singh, NN; O'Reilly, MF; Sigafoos, J; Buonocunto, F; Sacco, V; Colonna, F; Navarro, J; Oliva, D; Signorino, M; Megna, G				Lancioni, Giulio E.; Singh, Nirbhay N.; O'Reilly, Mark F.; Sigafoos, Jeff; Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge; Oliva, Doretta; Signorino, Mario; Megna, Gianfranco			Microswitch- and VOCA-assisted programs for two post-coma persons with minimally conscious state and pervasive motor disabilities	RESEARCH IN DEVELOPMENTAL DISABILITIES			English	Article						Microswitch; VOCA; Learning principles; Post-coma; Minimally conscious state; Motor disabilities	PROFOUND MULTIPLE DISABILITIES; TRAUMATIC BRAIN-INJURY; VEGETATIVE STATE; RECOVERY SCALE; REHABILITATION; TECHNOLOGY; DISORDERS; PEOPLE; ADULTS	Intervention programs, based on learning principles and assistive technology, were assessed in two studies with two post-coma men with minimally conscious state and pervasive motor disabilities. Study I assessed a program that included (a) an optic microswitch, activated via double blinking, which allowed a man direct access to brief music intervals, and (b) a voice output communication aid (VOCA) with two channels, activated via different hand-closure movements, which allowed the man to call his mother and a research assistant who provided stimulation events. Study H assessed a program that included (a) a pressure microswitch, activated via head movements, which allowed a man direct access to video-clips and music, and (b) a VOCA device, activated via prolonged eyelid closure, which allowed the man to call the caregiver (i.e., a research assistant) who provided attention and sang to him. Each of the two participants had significant increases in both microswitch- and VOCA-related responses during the intervention phases of the studies. Moreover, purposeful choice seemed to occur between the two VOCA responses in Study 1. Implications of the findings for improving the situation of post-coma persons with minimally conscious state and pervasive motor disabilities are discussed. (C) 2009 Elsevier Ltd. All rights reserved.	[Lancioni, Giulio E.] Univ Bari, Dept Psychol, I-70100 Bari, Italy; [Singh, Nirbhay N.] ONE Res Inst, Midlothian, VA USA; [O'Reilly, Mark F.] Univ Texas Austin, Meadows Ctr Preventing Educ Risk, Austin, TX 78712 USA; [Sigafoos, Jeff] Victoria Univ Wellington, Wellington, New Zealand; [Buonocunto, Francesca; Sacco, Valentina; Colonna, Fabio; Navarro, Jorge] S Raffaele Rehabil Ctr, Ceglie Messapica, Italy; [Oliva, Doretta; Signorino, Mario] Lega F DOro Res Ctr, Osimo, Italy		Lancioni, GE (corresponding author), Univ Bari, Dept Psychol, Via Quintino Sella 268, I-70100 Bari, Italy.	g.lancioni@psico.uniba.it	Singh, Nouratan/N-9377-2017	Singh, Nouratan/0000-0002-8063-8375; Navarro solano, Jorge/0000-0003-1508-6727; Lancioni, Giulio/0000-0002-6515-5690			Avesani R, 2006, BRAIN INJURY, V20, P333, DOI 10.1080/02699050500487605; Baker PMA, 2008, ASSIST TECHNOL, V20, P149, DOI 10.1080/10400435.2008.10131942; BARLOW D, 2009, SINGLE CASE EXPT DES; Bekinschtein T, 2005, NEUROPSYCHOL REHABIL, V15, P307, DOI 10.1080/09602010443000443; Bernat JL, 2007, NEUROLOGY, V68, P885, DOI 10.1212/01.wnl.0000258973.95355.68; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Coleman MR, 2005, NEUROPSYCHOL REHABIL, V15, P161, DOI 10.1080/09602010443000669; Elliott L, 2005, NEUROPSYCHOL REHABIL, V15, P480, DOI 10.1080/09602010443000506; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, NEUROREHABILITATION, V19, P293; Giacino JT, 2004, J HEAD TRAUMA REHAB, V19, P254, DOI 10.1097/00001199-200405000-00006; Holburn S, 2004, BEHAV INTERVENT, V19, P25, DOI 10.1002/bin.147; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; KAZDIN AE, 2001, BEHAV MODIFICATION A; Kennedy K, 2005, SINGLE CASE DESIGNS; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Lancioni GE, 2008, EUR J PHYS REHAB MED, V44, P449; Lancioni GE, 2007, PERCEPT MOTOR SKILL, V104, P1027, DOI 10.2466/PMS.104.3.1027-1034; Lancioni G E, 2006, Pediatr Rehabil, V9, P137, DOI 10.1080/13638490500235466; LANCIONI GE, DISABILITY IN PRESS; Lancioni GE, 2007, DISABIL REHABIL-ASSI, V2, P293, DOI 10.1080/17483100701308635; Lancioni GE, 2008, J DEV PHYS DISABIL, V20, P379, DOI 10.1007/s10882-008-9104-x; Lancioni GE, 2008, PERCEPT MOTOR SKILL, V106, P355, DOI 10.2466/PMS.106.2.355-370; Lancioni GE, 2008, J DEV PHYS DISABIL, V20, P209, DOI 10.1007/s10882-008-9105-9; Lancioni Giulio E, 2005, Cogn Process, V6, P177, DOI 10.1007/s10339-005-0003-0; Lancioni GE, 2009, DEV NEUROREHABIL, V12, P24, DOI 10.1080/17518420902776995; Lancioni GE, 2009, RES DEV DISABIL, V30, P1034, DOI 10.1016/j.ridd.2009.02.006; Leong B, 2002, BRAIN INJURY, V16, P217, DOI 10.1080/02699050110103283; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Mcnaughton D, 2007, AUGMENT ALTERN COMM, V23, P217, DOI 10.1080/07434610701573856; Naude K, 2005, NEUROPSYCHOL REHABIL, V15, P514, DOI 10.1080/09602010443000470; Noda R, 2004, BRAIN INJURY, V18, P509, DOI 10.1080/02699050310001645810; Petry K, 2005, J APPL RES INTELLECT, V18, P35, DOI 10.1111/j.1468-3148.2004.00209.x; Siegel S., 1988, NONPARAMETRIC STAT; Tsuchiya N, 2007, TRENDS COGN SCI, V11, P158, DOI 10.1016/j.tics.2007.01.005; Wales L., 2005, BRIT J OCCUPATIONAL, V68, P486; Wilson FC, 2007, DISABIL REHABIL, V29, P1751, DOI 10.1080/09638280601118432	38	22	22	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-4222			RES DEV DISABIL	Res. Dev. Disabil.	NOV-DEC	2009	30	6					1459	1467		10.1016/j.ridd.2009.07.006			9	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	511ZT	WOS:000271212100038	19660902				2022-02-06	
J	Lundblad, C; Grande, PO; Bentzer, P				Lundblad, Cornelia; Grande, Per-Olof; Bentzer, Peter			Hemodynamic and Histological Effects of Traumatic Brain Injury in eNOS-Deficient Mice	JOURNAL OF NEUROTRAUMA			English	Article						blood flow; brain trauma; edema; endothelial nitric oxide synthase; permeability	NITRIC-OXIDE SYNTHASE; CEREBRAL-BLOOD-FLOW; CONTROLLED CORTICAL IMPACT; L-ARGININE; HEAD-INJURY; MICROVASCULAR PERMEABILITY; MOUSE; RAT; ISCHEMIA; INHIBITION	Microvascular dysfunction in the brain, characterized by vasoconstriction, vascular occlusion, and disruption of the blood brain barrier, may adversely affect outcome following traumatic brain injury (TBI). Because of its vasodilating and antiaggregative properties, nitric oxide (NO) produced by nitric oxide synthase in the endothelium (eNOS) is a key regulator of vascular homeostasis. The objective of the present study was to evaluate the role of eNOS in vascular disturbances and histological outcome in the brain following TBI. Cortical blood flow ([C-14]-iodoantipyrine technique), number of perfused capillaries (FITC-dextran technique), brain water content (wet vs. dry weight), and the transfer constant (K-i) for [Cr-51]-EDTA, reflecting permeability, were analyzed 3 h and 24 h after a controlled cortical impact injury (CCI) in eNOS-deficient (eNOS-KO) and wild-type (WT) mice. Cortical contusion volume and cell count in the hippocampus were evaluated 3 weeks after injury. Blood flow in the injured cortex decreased in both groups following trauma. There were no significant differences between the groups at 3 h, but blood flow was lower in eNOS-KO mice than in WT mice 24 h after trauma. Brain water content was higher in the WT mice than in eNOS-KO mice at 24 h. Number of perfused capillaries, K-i, and histological outcome were similar in both groups. We conclude that eNOS is important for maintenance of cerebral blood flow after trauma and that eNOS promotes edema formation by mechanisms other than increased permeability. The vascular effects of eNOS do not, however, influence histological outcome.	[Bentzer, Peter] Univ Lund Hosp, Dept Anesthesiol & Intens Care, SE-22185 Lund, Sweden; Lund Univ, Dept Anesthesiol & Intens Care, S-22100 Lund, Sweden		Bentzer, P (corresponding author), Univ Lund Hosp, Dept Anesthesiol & Intens Care, SE-22185 Lund, Sweden.	peter.bentzer@med.lu.se		Lundblad, Cornelia/0000-0001-9686-2112	Swedish Research CouncilSwedish Research CouncilEuropean Commission [11581]; Medical Faculty of Lund University; Region Skane (ALF)	We would like to thank Assoc. Prof. Bo Holmqvist (Dept. of Experimental Oncology, Lund University) for his generous help with the PCR experiments. The skillful technical assistance by Helen Davidsson is gratefully acknowledged. This study was supported by grants from the Swedish Research Council (grant no. 11581), from the Medical Faculty of Lund University, and from Region Skane (ALF).	Al-Shabrawey M, 2003, MOL VIS, V9, P549; Atochin DN, 2003, J CEREBR BLOOD F MET, V23, P1219, DOI 10.1097/01.WCB.0000089601.87125.E4; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cherian L, 2003, J PHARMACOL EXP THER, V304, P617, DOI 10.1124/JPET.102.043430; Cobbs CS, 1997, BRAIN RES, V751, P336, DOI 10.1016/S0006-8993(96)01429-1; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Foley LM, 2008, J NEUROTRAUM, V25, P299, DOI 10.1089/neu.2007.0471; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Han F, 2006, J NEUROCHEM, V99, P97, DOI 10.1111/j.1471-4159.2006.04048.x; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; JAY TM, 1988, J CEREBR BLOOD F MET, V8, P121, DOI 10.1038/jcbfm.1988.16; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/neu.2004.21.1756; Lundblad C, 2007, MICROVASC RES, V74, P1, DOI 10.1016/j.mvr.2007.03.001; Lundblad C, 2004, J NEUROTRAUM, V21, P741, DOI 10.1089/0897715041269614; Maeda K, 2000, J CEREBR BLOOD F MET, V20, P10, DOI 10.1097/00004647-200001000-00003; Mayhan WG, 2000, BRAIN RES, V855, P143, DOI 10.1016/S0006-8993(99)02389-6; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MONCADA S, 1991, PHARMACOL REV, V43, P109; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stefanovic B, 2007, J CEREBR BLOOD F MET, V27, P741, DOI 10.1038/sj.jcbfm.9600377; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WANIEWSKI J, 1992, NEPHROL DIAL TRANSPL, V7, P50; Wei G, 1999, BBA-MOL BASIS DIS, V1455, P23, DOI 10.1016/S0925-4439(99)00051-4	35	22	26	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1953	1962		10.1089/neu.2009.0955			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600011	19929218				2022-02-06	
J	Slawik, H; Salmond, CH; Taylor-Tavares, JV; Williams, GB; Sahakian, BJ; Tasker, RC				Slawik, Helen; Salmond, Claire H.; Taylor-Tavares, Joana V.; Williams, Guy B.; Sahakian, Baraba J.; Tasker, Robert C.			Frontal Cerebral Vulnerability and Executive Deficits from Raised Intracranial Pressure in Child Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						child; frontal lobe; intracranial pressure; traumatic brain injury; white matter	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CLOSED-HEAD INJURY; DECISION-MAKING; PREFRONTAL CORTEX; DECOMPRESSIVE CRANIECTOMY; SPATIAL NORMALIZATION; WORKING-MEMORY; RESPONSE-INHIBITION; CLINICAL-TRIALS; OUTCOME-SCALE	In severe pediatric traumatic brain injury (TBI), a common focus of treatment is raised intracranial pressure (ICP). The aim of this investigation was to test whether raised ICP is associated with later prefrontal executive deficits and regional brain tissue loss, consistent with an anterior vascular compartment syndrome. Thirty-three participants were assigned to one of two severe TBI groups based on whether or not they had increased ICP complicating their critical illness. At follow-up (average 3.9 years), the participants underwent magnetic resonance imaging and a battery of neuropsychological testing focused on prefrontal function. The ICP group had white matter loss that was diffuse as well as regional in the corpus callosum, periventricular tissue, and frontal region. Loss of gray matter in the ICP group was more regionally specific, with bilateral loss in the caudate nuclei and frontal regions, including the right dorsolateral region, right supplementary motor area, and the left orbitofrontal cortex. Both groups had normal intelligence quotients (IQs), but the ICP group showed long-term deficits on various measures of attention and executive function such as working memory, decision-making, and impulsivity. These findings suggest that raised ICP leads to diffuse brain injury and a predilection to hypo-perfusion in, at least, the distribution of the anterior cerebral artery. Furthermore, since voxel-based morphometry (VBM) and measures of attention and executive function are sensitive to the phenomenon of raised ICP, we consider that these techniques warrant inclusion in trials assessing ICP-directed therapy.	[Tasker, Robert C.] Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Sch Clin,Paediat Intens Care Unit, Cambridge CB2 2QQ, England; [Slawik, Helen; Tasker, Robert C.] Univ Cambridge, Sch Clin Med, Dept Paediat, Cambridge CB2 2QQ, England; [Salmond, Claire H.; Sahakian, Baraba J.] Univ Cambridge, Sch Clin Med, Dept Psychiat, Cambridge CB2 2QQ, England; [Sahakian, Baraba J.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 2QQ, England; [Salmond, Claire H.; Taylor-Tavares, Joana V.; Williams, Guy B.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; [Slawik, Helen] Tech Univ Muenchen, Dept Psychiat, Munich, Germany		Tasker, RC (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Sch Clin,Paediat Intens Care Unit, Box 116,Hills Rd, Cambridge CB2 2QQ, England.	rct31@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020; Tasker, Robert C/R-5837-2019	Sahakian, Barbara/0000-0001-7352-1745; Tasker, Robert/0000-0003-3647-8113	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390]; Addenbrooke's Charitable Trust; Evelyn Trust; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0600986, G0001237] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0508-10327] Funding Source: researchfish	We wish to thank the patients and families who participated in this study, and the staff in the Department of Paediatrics and Radiographers at the Wolfson Brain Imaging Centre. The Medical Research Council (G9439390), the Addenbrooke's Charitable Trust, and the Evelyn Trust supported this work.	Achenbach TM, 1991, MANUAL CHILD BEHAV C; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; BRUST JCM, 2004, STROKE PATHOPHYSIOLO, P101; Castellanos FX, 1997, CLIN PEDIATR, V36, P381, DOI 10.1177/000992289703600702; CLARIZIO H, 1984, PSYCHOL SCHOOLS, V21, P154, DOI 10.1002/1520-6807(198404)21:2<154::AID-PITS2310210205>3.0.CO;2-P; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Clark L, 2003, NEUROPSYCHOLOGIA, V41, P1474, DOI 10.1016/S0028-3932(03)00081-2; Clark L, 2007, BIOL PSYCHIAT, V61, P1395, DOI 10.1016/j.biopsych.2006.07.020; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Conners CK, 2003, CONNERS RATING SCALE; Cremer OL, 2008, EUR J ANAESTH, V25, P87, DOI 10.1017/S0265021507003237; Crouchman M, 2001, ARCH DIS CHILD, V84, P120, DOI 10.1136/adc.84.2.120; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dalton CM, 2002, J NEUROL NEUROSUR PS, V73, P141, DOI 10.1136/jnnp.73.2.141; DeVito EE, 2007, ACTA NEUROL SCAND, V116, P328, DOI 10.1111/j.1600-0404.2007.00906.x; DeVito EE, 2008, BIOL PSYCHIAT, V64, P636, DOI 10.1016/j.biopsych.2008.04.017; Eriksson SH, 2001, BRAIN, V124, P617, DOI 10.1093/brain/124.3.617; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Garth J, 1997, Pediatr Rehabil, V1, P99; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; Jolly, 2001, MANUAL BECK YOUTH IN; Kelly T P, 1999, Pediatr Rehabil, V3, P187; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Konrad KN, 2000, BRAIN INJURY, V14, P859; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2004, J CLIN EXP NEUROPSYC, V26, P589, DOI 10.1080/13803390490504434; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Logan Gordon D., 1994, P189; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; Maas AIR, 2004, ACT NEUR S, V89, P113; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Mavaddat N, 2000, BRAIN, V123, P2109, DOI 10.1093/brain/123.10.2109; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Owen AM, 1996, CEREB CORTEX, V6, P31, DOI 10.1093/cercor/6.1.31; Pearson GA, 2001, ARCH DIS CHILD, V84, P125, DOI 10.1136/adc.84.2.125; PRAYER L, 1993, ACTA RADIOL, V34, P593; Rahman S, 2001, TRENDS COGN SCI, V5, P271, DOI 10.1016/S1364-6613(00)01650-8; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; TEASDALE G, 1974, LANCET, V2, P81; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Turner DC, 2003, PSYCHOPHARMACOLOGY, V165, P260, DOI 10.1007/s00213-002-1250-8; VANDENBERGH R, 1969, RES CEREBRAL CIRCULA, P52; VANDEREECKEN H, 1969, RESEARCH CEREBRAL CI, P42; VanPaesschen W, 1997, ANN NEUROL, V41, P41, DOI 10.1002/ana.410410109; Wechsler D., 1997, MANUAL WECHSLER ADUL; Wechsler D., 1992, MANUAL WECHSLER INTE; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilke M, 2003, MAGN RESON MED, V50, P749, DOI 10.1002/mrm.10606; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Wilson BA, 2003, RIVERMEAD BEHAV MEMO; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799	75	22	22	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2009	26	11					1891	1903		10.1089/neu.2009.0942			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	523CO	WOS:000272049600004	19929215				2022-02-06	
J	Lanska, DJ				Lanska, Douglas J.			Historical Perspective: Neurological Advances from Studies of War Injuries and Illnesses	ANNALS OF NEUROLOGY			English	Article							SPINAL-CORD; HEAD-INJURY; CUSHING,HARVEY; REPRESENTATION; HOLMES,GORDON; MOVEMENT; LESIONS; VISION; WOUNDS; CORTEX	Early in the 20th century during the Russo-Japanese War and World War I (WWI), some of the most important, lasting contributions to clinical neurology were descriptive clinical studies, especially those concerning war-related peripheral nerve disorders (eg, Hoffmann-Tinel sign, Guillain-Barre-Strohl syndrome [GBS]) and occipital bullet wounds (eg, the retinal projection on the cortex by Inouye and later by Holmes and Lister, and the functional partitioning of visual processes in the occipital cortex by Riddoch), but there were also other important descriptive studies concerning war-related aphasia, cerebellar injuries, and spinal cord injuries (eg, cerebellar injuries by Holmes, and autonomic dysreflexia by Head and Riddoch). Later progress, during and shortly after World War II (WWII), included major progress in understanding the pathophysiology of traumatic brain injuries by Denny-Brown, Russell, and Holbourn, pioneering accident injury studies by Cairns and Holbourn, promulgation of helmets to prevent motorcycle injuries by Cairns, development of comprehensive multidisciplinary neurorehabilitation by Rusk, and development of spinal cord injury care by Munro, Guttman, and Bors. These studies and developments were possible only because of the large number of cases that allowed individual physicians the opportunity to collect, collate, and synthesize observations of numerous cases in a short span of time. Such studies also required dedicated, disciplined, and knowledgeable investigators who made the most out of their opportunities to systematically assess large numbers of seriously ill and injured soldiers under stressful and often overtly dangerous situations.	Vet Affairs Med Ctr, Dept Neurol, Tomah, WI 54660 USA		Lanska, DJ (corresponding author), Vet Affairs Med Ctr, Dept Neurol, 500 E Vet St, Tomah, WI 54660 USA.	Douglas.Lanska@med.va.gov					Adams GW, 1952, MED HIST UNION ARMY; Allen D., 1964, CORD, V17, P14; [Anonymous], 1941, BR MED J, P481; ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; Bors E, 1967, Paraplegia, V5, P126; Bors E., 1971, NEUROLOGICAL UROLOGY; CAIRNS H, 1946, BRIT MED J, V2, P322, DOI 10.1136/bmj.2.4470.322; Cairns H, 1941, BRIT MED J, V1941, P465, DOI 10.1136/bmj.2.4213.465; Cairns H, 1943, BRIT MED J, V1, P592; Comarr A E, 1984, J Am Paraplegia Soc, V7, P10; COVALT DA, 1953, JAMA-J AM MED ASSOC, V151, P89; CRANE A, 1927, MED DEP US ARMY WORL, V13, P135; Cushing H., 1927, MED DEP UNITED STATE, VXI, P749; Cushing H., 1936, SURG J 1915 1918; Dean B., 1927, MED DEP US ARMY WORL, V9, P1; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Donovan WH, 2007, J SPINAL CORD MED, V30, P85, DOI 10.1080/10790268.2007.11753918; ELTORAI IM, 2003, SPINAL CORD MED PRIN, P3; Fishman RS, 1997, DOC OPHTHALMOL, V93, P9, DOI 10.1007/BF02569044; FRAZER CH, 1918, SURG SPINE SPINAL CO; Fulton J.F., 1946, HARVEY CUSHING BIOGR; GLICKSTEIN M, 1987, TRENDS NEUROSCI, V10, P350, DOI 10.1016/0166-2236(87)90066-X; GUILLAIN G, 1968, ARCH NEUROL-CHICAGO, V18, P450; GUILLAIN G, 1939, B ACAD NAD MED PARIS, V122, P582; Gulllain G, 1936, ARCH NEURO PSYCHIATR, V36, P975; Guttmann L., 1973, SPINAL CORD INJURIES; HAYMAKER W, 1949, MEDICINE, V28, P59, DOI 10.1097/00005792-194902000-00003; Head H, 1917, BRAIN, V40, P188, DOI 10.1093/brain/40.2-3.188; Hoffmann P., 1915, MED KLIN, V11, P856; Hoffmann P., 1915, MED KLIN, V11, P359; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; Holmes G, 1916, BRAIN, V39, P34, DOI 10.1093/brain/39.1-2.34; Holmes G, 1918, Br J Ophthalmol, V2, P353, DOI 10.1136/bjo.2.7.353; Holmes G, 1919, BMJ-BRIT MED J, V1919, P230; Holmes G, 1915, BRIT MED J, V1915, P769; HOLMES G, 1945, PROC R SOC SER B-BIO, V132, P348, DOI 10.1098/rspb.1945.0002; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Hughes J T, 2001, J Med Biogr, V9, P236; Hull AJ, 1917, J ROY ARMY MED CORPS, V28, P66; Inouye T, 2000, BRAIN, V123, P1; Jones MM, 2007, AM J PUBLIC HEALTH, V97, P208, DOI 10.2105/AJPH.2005.083204; Koehler Peter J, 2004, J Hist Neurosci, V13, P326, DOI 10.1080/09647040490510498; LANDRY N, 1859, GAZ HEBD MED CHIR, V6, P472; Lanska DJ, 2009, STROKE RECOVERY REHA, P1; LEPORE FE, 1994, ARCH NEUROL-CHICAGO, V51, P711, DOI 10.1001/archneur.1994.00540190095022; Lister W T, 1916, Proc R Soc Med, V9, P57; Maartens NF, 2002, NEUROSURGERY, V50, P176; MARIE P, 1916, REV NEUROL PARIS, V23, P564; McDonald I, 2007, BRAIN, V130, P288, DOI 10.1093/brain/awl335; *MED RES COUNC, 1943, 7 MRC; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Pitres A, 1925, NERFS SCHEMAS ANATOM; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; REICH SG, 1987, NEUROSURGERY, V21, P135, DOI 10.1227/00006123-198708000-00001; Riddoch G, 1917, BRAIN, V40, P15, DOI 10.1093/brain/40.1.15; Riddoch G, 1917, BRAIN, V40, P264, DOI 10.1093/brain/40.2-3.264; Riddoch G, 1917, Proc R Soc Med, V10, P13; Rusk H A, 1969, Arch Phys Med Rehabil, V50, P463; Rusk H A, 1977, Med Times, V105, P64; Rusk H. A., 1972, WORLD CARE AUTOBIOGR; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Silver J. R., 2003, HIST TREATMENT SPINA; SIX E, 1979, SOUTHERN MED J, V72, P699, DOI 10.1097/00007611-197906000-00020; SPALDING JMK, 1952, J NEUROL NEUROSUR PS, V15, P169, DOI 10.1136/jnnp.15.3.169; The Editorial Commitee for the Guarantors of Brain, 1986, AIDS EX PER NERV SYS; TINEL J, 1971, ARCH NEUROL-CHICAGO, V24, P574; Tinel J, 1917, NERVE WOUNDS; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25; ZEKI S, 1991, BRAIN, V114, P811, DOI 10.1093/brain/114.2.811; Zeki S., 1993, VISION BRAIN; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313; 1943, J NEUROL PSYCHIAT, V6, P81; 2004, J SPINAL CORD MED, V27, P287	75	22	22	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0364-5134	1531-8249		ANN NEUROL	Ann. Neurol.	OCT	2009	66	4					444	459		10.1002/ana.21822			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507SJ	WOS:000270874700005	19847911				2022-02-06	
J	Zhu, L; Wang, HD; Yu, XG; Jin, W; Qiao, L; Lu, TJ; Hu, ZL; Zhou, J				Zhu, Lin; Wang, Han-dong; Yu, Xin-guang; Jin, Wei; Qiao, Liang; Lu, Ting-jia; Hu, Ze-lan; Zhou, Jing			Erythropoietin prevents zinc accumulation and neuronal death after traumatic brain injury in rat hippocampus: In vitro and in vivo studies	BRAIN RESEARCH			English	Article						Hippocampus; Erythropoietin; Rat; Traumatic brain injury; Zinc	CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; ZN2+ ENTRY; APOPTOSIS; CELLS; NEUROPROTECTION; EXPRESSION; TRANSLOCATION; ACTIVATION; PROTECTS	Erythropoietin (Epo) has been gaining great interest for its potential neuroprotective effect in various neurological insults. However, the molecular mechanism underlying how Epo exerts the function is not clear. Recent studies have indicated that Zn2+ may have a key role in selective cell death in excitotoxicity after injury, In the present study, we studied the effect of recombinant human Epo (rhEpo) in zinc-induced neurotoxicity both in vitro and in vivo. Exposure of cultured hippocampal neurons to 200 mu M ZnCl2 for 20 min resulted in remarkable neuronal injury, revealed by assessing neuronal morphology. By measuring mitochondrial function using MTT assay, we found that application of rhEpo (0.1 U/ml) 24 h before zinc exposure resulted in a significant increase of neuronal survival (0.6007 +/- 0.2280 Epo group vs 0.2333 +/- 0.1249 in control group; n=4, p<0.01). Furthermore, we demonstrated that administration of rhEpo (5,000 IU/kg, intraperitoneal) 30 min after traumatic brain injury (TBI) in rats dramatically protected neuronal death indicated by ZP4 staining, a new zinc-specific fluorescent sensor which has been widely used to indicate neuronal damage after excitotoxic injury (n=5/group, p<0.05). Neuronal damage was also assessed by Fluoro-Jade B (FJB) staining, a highly specific fluorescent marker for the degenerating neurons. Consistent with ZP4 staining, we found the beneficial effects of rhEpo on neuronal survival in hippocampus after TBI (n=5/group, p<0.05). Our results suggest that rhEpo can significantly reduce the pathological Zn2+ accumulation in rat hippocampus after TBI as well as zinc-induced cell death in cultured cells, which may potentially contribute to its neuronal protection after excitotoxic brain damage. (C) 2009 Elsevier B.V. All rights reserved.	[Zhu, Lin; Wang, Han-dong; Jin, Wei; Qiao, Liang] Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu Prov, Peoples R China; [Lu, Ting-jia; Hu, Ze-lan; Zhou, Jing] Chinese Acad Sci, Inst Neurosci Shanghai, Shanghai, Peoples R China; [Yu, Xin-guang] Gen Hosp Peoples Liberat Army, Dept Neurosurg, Beijing 100853, Peoples R China		Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu Prov, Peoples R China.	wanghandong61@126.com			Jinling Hospital of Nanjing, Jiangsu Province, China [Q2008033]	The authors gratefully acknowledge Professor Yu-Qiang Ding (Institute of Neuroscience of Shanghai, Chinese Academy of Science, Shanghai, China) and Professor Zhi-Qi Xiong (Institute of Neuroscience of Shanghai, Chinese Academy of Science, Shanghai, China) for technical assistance. This work was financially supported by grants from Jinling Hospital of Nanjing (Grant No Q2008033), Jiangsu Province, China.	Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; BUHRER C, 1991, PEDIATR HEMAT ONCOL, V8, P243, DOI 10.3109/08880019109033458; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; Chong ZZ, 2003, J NEUROSCI RES, V71, P659, DOI 10.1002/jnr.10528; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Cuajungco MP, 1998, BRAIN RES, V799, P118, DOI 10.1016/S0006-8993(98)00463-6; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; DITTMER J, 1992, BIOCHEM J, V285, P113, DOI 10.1042/bj2850113; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2004, J NEUROSCI METH, V139, P79, DOI 10.1016/j.jneumeth.2004.04.033; Frederickson CJ, 2002, NEUROSCIENCE, V115, P471, DOI 10.1016/S0306-4522(02)00399-8; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Grasso G, 2006, J NEUROSURG ANESTH, V18, P91, DOI 10.1097/00008506-200604000-00001; Grasso G, 2001, J Neurosurg Sci, V45, P7; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Kay AR, 2006, J NEUROPHYSIOL, V95, P1949, DOI 10.1152/jn.00959.2005; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Lee JM, 2002, NEUROSCIENCE, V115, P871, DOI 10.1016/S0306-4522(02)00513-4; Liang Zhang, 2007, Genomics Proteomics & Bioinformatics, V5, P25, DOI 10.1016/S1672-0229(07)60011-4; Manev H, 1997, EXP NEUROL, V146, P171, DOI 10.1006/exnr.1997.6510; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; PerezClausell J, 1996, J CHEM NEUROANAT, V11, P99, DOI 10.1016/0891-0618(96)00131-7; Renzi MJ, 2002, MOL BRAIN RES, V104, P86, DOI 10.1016/S0169-328X(02)00323-6; Roesler R, 2004, NEW ENGL J MED, V351, P1465; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wei G, 2004, NEUROSCIENCE, V125, P867, DOI 10.1016/j.neuroscience.2004.03.011; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Wen TC, 2002, J NEUROSCI RES, V67, P795, DOI 10.1002/jnr.10166; Yang J, 2007, ACTA NEUROBIOL EXP, V67, P141; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	49	22	24	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 15	2009	1289						96	105		10.1016/j.brainres.2009.07.015			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	493YP	WOS:000269776000011	19615349				2022-02-06	
J	Datta, SGS; Pillai, SV; Rao, SL; Kovoor, JME; Chandramouli, BA				Datta, S. G. S.; Pillai, S. V.; Rao, S. L.; Kovoor, J. M. E.; Chandramouli, B. A.			Post-concussion syndrome: Correlation of neuropsychological deficits, structural lesions on magnetic resonance imaging and symptoms	NEUROLOGY INDIA			English	Article						Minimal traumatic brain injury; post-concussion syndrome; magnetic resonance imaging; neuropsychological deficits	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; MILD; MODERATE; SCALE; MRI; TOMOGRAPHY; RECOVERY	Background : Post-concussion syndrome (PCS) associated with mild traumatic brain injury (MTBI) can cause long-lasting disabilities. Magnetic resonance imaging (MRI) evaluation in these patients may demonstrate structural lesions that correlate with functional deficits on neuropsychological testing. However, little is known about the significance of the relationship between structureal lesions on MRI, functional deficits on neuropsychological evaluation and outcome in patients with MTBI. Aims: To assess neuropsychological deficits and structural lesions on MRI in patients with PCS following MTBI, and to find correlation between these findings and PCS. Settings and Design : Prospective, observational, cohort study in a tertiary hospital. Materials and Methods : The study cohort included consecutive patients with MTBI (three months or more duration) and PCS. All the patients in the cohort had neuropsychological testing using the National Institute of Mental Health and Neurological Sciences Neuropsychological Battery for head injury and also MRI using T1, T2 and FLAIR sequences. Statistical analysis was done using Fishers Exact test of significance. Results : All the 20 patients evaluated had neuropsychological deficits. Eleven patients had lesions on MRI. Disturbances of sleep, behavior and memory and abnormalties in tests for mental speed were more frequent in patients with lesions on MRI, but were not statically significant (P=0.08). Both the test modalities localized lesions predominantly to the frontal and temporal lobes. All the symptoms observed in the patients were associated with prefrontal dysfunction on neuropsychological testing. Conclusions : Prefrontal dysfunction is invariably associated with PCS following MTBI. Structural lesions on MRI may not always be present but when present may influence the degree or severity of the symptoms.	[Datta, S. G. S.; Pillai, S. V.; Chandramouli, B. A.] Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India; [Rao, S. L.] Natl Inst Mental Hlth & Neurosci, Dept Clin Psychol, Bangalore 560029, Karnataka, India; [Kovoor, J. M. E.] Natl Inst Mental Hlth & Neurosci, Dept Neuroimaging & Intervent Radiol, Bangalore 560029, Karnataka, India		Pillai, SV (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 560029, Karnataka, India.	drshibupillai@hotmail.com					Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Flanagan S, 1999, MT SINAI J MED, V66, P152; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; JENNETT B, 1975, LANCET, V1, P480; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; KURTZKE JF, 1993, CLIN NEUROLOGY; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rao S. L., 2004, NIMHANS NEUROPSYCHOL; Ruchinskas R A, 1997, Appl Neuropsychol, V4, P43, DOI 10.1207/s15324826an0401_5; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391	20	22	22	0	9	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	SEP-OCT	2009	57	5					594	598		10.4103/0028-3886.57810			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	531OU	WOS:000272678200011	19934558	Green Submitted			2022-02-06	
J	Greve, KW; Curtis, KL; Bianchini, KJ; Ord, JS				Greve, Kevin W.; Curtis, Kelly L.; Bianchini, Kevin J.; Ord, Jonathan S.			Are the Original and Second Edition of the California Verbal Learning Test Equally Accurate in Detecting Malingering?	ASSESSMENT			English	Article						California Verbal Learning Test; memory; malingering; traumatic brain injury; chronic pain; assessment	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DIGIT RECOGNITION TEST; NEUROCOGNITIVE DYSFUNCTION; CLASSIFICATION ACCURACY; SPECIFICITY; INDICATORS; SENSITIVITY; MMPI-2	This two-part study sought to determine the equivalence of the California Verbal Learning Tests (CVLT-1 and CVLT-2) in the detection of malingering in traumatic brain injury (TB1) and chronic pain. Part 1 compared a variety of scores from the two versions in carefully matched patient groups. Part 2 used criterion groups (known-groups) methodology to examine the relative rates of false positive (FP) errors across the two versions. Participants were 442 TBI (CVLT-1 = 3 10; CVLT-2 = 132) and 378 chronic pain patients (CVLT-1 = 250; CVLT-2 = 128). Overall, the CVLT-2 was more difficult than the CVLT-1, with the chronic pain patients showing larger version effects than the TBI patients. The two versions of the CVLT were equally accurate in detecting malingering in TBI and chronic pain. However, they were not interchangeable. The use of CVLT-1 cutoffs with the CVLT-2 may result in an increased risk of FP error. Appropriate cutoff adjustment in clinical practice is recommended.	[Greve, Kevin W.; Bianchini, Kevin J.] Univ New Orleans, Jefferson Neurobehav Grp, Los Angeles, CA USA		Greve, KW (corresponding author), Univ New Orleans Lakefront, Dept Psychol, New Orleans, LA 70148 USA.	kgreve@uno.edu					Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; BINDER LM, 1993, PORTLAND DIGIT RECOG; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; DELIS D, 1987, CALIFORNIA VERBAL LE; DELIS DC, 2000, CALIFORNIA VERBAL LE; Doane BM, 2005, CLIN NEUROPSYCHOL, V19, P99, DOI 10.1080/13854040490524100; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P816, DOI 10.1080/13854040500346610; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Millis SR, 2001, J CLIN EXP NEUROPSYC, V23, P809, DOI 10.1076/jcen.23.6.809.1017; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; MILLIS SR, 2007, J INT NEUROPSYCH SOC, V13, P193; MILLIS SR, 1997, CVLT ASSESSMENT FINA; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	32	22	23	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911			ASSESSMENT	Assessment	SEP	2009	16	3					237	248		10.1177/1073191108326227			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	482YS	WOS:000268927400002	19098280				2022-02-06	
J	McFadyen, BJ; Cantin, JF; Swaine, B; Duchesneau, G; Doyon, J; Dumas, D; Fait, P				McFadyen, Bradford J.; Cantin, Jean-Francois; Swaine, Bonnie; Duchesneau, Guylaine; Doyon, Julien; Dumas, Denyse; Fait, Philippe			Modality-Specific, Multitask Locomotor Deficits Persist Despite Good Recovery After a Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Attention; Gait; Locomotion; Rehabilitation	GAIT; ATTENTION; STABILITY; WALKING; OLDER; OBSTACLES; PATTERNS; DEMANDS; STEP	Objective: To study the effects of sensory modality of simultaneous tasks during walking with and without obstacles after moderate to severe traumatic brain injury (TBI). Design: Group comparison study. Setting: Gait analysis laboratory within a postacute rehabilitation facility. Participants: Volunteer sample (N=18). Persons with moderate to severe TBI (n=11) (9 men, 3 women; age, 37.56 13.79y) and a comparison group (n=7)of subjects without neurologic problems matched on average for body mass index and age (4 men, 3 women; age, 39.19 +/- 17.35y). Interventions: Not applicable. Main Outcome Measures: Magnitudes and variability for walking speeds, foot clearance margins (ratio of foot clearance distance to obstacle height), and response reaction times (both direct and as a relative cost because of obstacle avoidance). Results: The TBI group had well-recovered walking speeds and a general ability to avoid obstacles. However, these subjects did show lower trail limb toe clearances (P=.003) across all conditions. Response reaction times to the Stroop tasks were longer in general for the TBI group (P=.017), and this group showed significant increases in response reaction times for the visual modality within the more challenging obstacle avoidance task that was not observed for control subjects. A measure of multitask costs related to differences in response reaction times between obstructed and unobstructed trials also only showed increased attention costs for the visual over the auditory stimuli for the TBI group (P=.002). Conclusions: Mobility is a complex construct, and the present results provide preliminary findings that, even after good locomotor recovery, subjects with moderate to severe TBI show residual locomotor deficits in multitasking. Furthermore, our results suggest that sensory modality is important,	[McFadyen, Bradford J.; Fait, Philippe] Univ Laval, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ G1M 2S8, Canada; [McFadyen, Bradford J.; Fait, Philippe] Univ Laval, Fac Med, Dept Rehabil, Quebec City, PQ G1M 2S8, Canada; [Swaine, Bonnie] Ctr Interdisciplinary Res Rehabil Greater Montrea, Montreal, PQ, Canada; [Swaine, Bonnie] Montreal Rehabil Inst, Montreal, PQ, Canada; [Swaine, Bonnie] Univ Montreal, Sch Rehabil, Montreal, PQ, Canada; [Doyon, Julien] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Cantin, Jean-Francois; Duchesneau, Guylaine; Dumas, Denyse] Quebec Rehabil Inst, Quebec City, PQ, Canada		McFadyen, BJ (corresponding author), Univ Laval, Ctr Interdisciplinary Res Rehabil & Social Integr, 525 Hamel, Quebec City, PQ G1M 2S8, Canada.	brad.mcfadyen@rea.ulaval.ca		Fait, Philippe/0000-0002-2554-9273; McFadyen, Bradford/0000-0003-1992-4927	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [64408]	Supported by the Canadian Institutes of Health Research (grant no. 64408).	Bruggeman H, 2007, CURR BIOL, V17, P2035, DOI 10.1016/j.cub.2007.10.059; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Gadoury M, 2001, CADRE REFERENCE CLIN; Gerin-Lajoie M, 2005, MOTOR CONTROL, V9, P242, DOI 10.1123/mcj.9.3.242; Gerin-Lajoie M, 2006, GAIT POSTURE, V24, P364, DOI 10.1016/j.gaitpost.2005.11.001; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; KUROSAWA K, 1994, PERCEPT MOTOR SKILL, V78, P768, DOI 10.2466/pms.1994.78.3.768; LAJOIE Y, 1993, EXP BRAIN RES, V97, P139; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Niechwiej-Szwedo E, 2007, GAIT POSTURE, V25, P70, DOI 10.1016/j.gaitpost.2006.01.002; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Patla AE, 1996, J MOTOR BEHAV, V28, P35, DOI 10.1080/00222895.1996.9941731; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Redfern MS, 2002, J GERONTOL A-BIOL, V57, pB298, DOI 10.1093/gerona/57.8.B298; Rees G, 2001, NEUROPSYCHOLOGIA, V39, P937, DOI 10.1016/S0028-3932(01)00016-1; ShumwayCook A, 1997, J GERONTOL A-BIOL, V52, pM232, DOI 10.1093/gerona/52A.4.M232; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Woollacott M, 2008, BRAIN RES, V1208, P95, DOI 10.1016/j.brainres.2008.03.005; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720	26	22	24	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2009	90	9					1596	1606		10.1016/j.apmr.2009.03.010			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	496AA	WOS:000269938100019	19735789				2022-02-06	
J	Venturi, L; Miranda, M; Selmi, V; Vitali, L; Tani, A; Margheri, M; De Gaudio, AR; Adembri, C				Venturi, Luna; Miranda, Marco; Selmi, Valentina; Vitali, Luca; Tani, Alessia; Margheri, Martina; De Gaudio, Angelo Raffaele; Adembri, Chiara			Systemic Sepsis Exacerbates Mild Post-Traumatic Brain Injury in the Rat	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assessments; glial cell response to injury; inflammation; secondary insult; traumatic brain injury	CONTROLLED CORTICAL IMPACT; CECAL LIGATION; EXPERIMENTAL-MODELS; ANIMAL-MODELS; MICROGLIA; MEMORY; DEFICITS; PUNCTURE; CNS; COMPLICATIONS	The development of sepsis in patient suffering from traumatic brain injury (TBI) represents a frequent complication that has been associated with worsened global and neurological outcome. In an effort to better characterize the influence of sepsis following TBI, we developed an in vivo model of combined TBI and sepsis in the rat by coupling two validated models: (1) Controlled Cortical Impact (CCI) and (2) Cecal Ligation and Puncture (CLP). Possible contributing effects of sepsis on post-traumatic outcome were evaluated as mortality rate, body weight change, neurological motor (beam balance), cognitive (Morris water maze [MWM] for memory and learning) function, histopathological damage (lesion volume, cell counts in the CA1 and CA3 hippocampal areas), and morphological indices of inflammation (activated microglia and astrocytes) for the 14-day study period. In this study, we produced a mild TBI characterized by a low mortality rate, a transient delay in weight gain, and a transient impairment in motor and cognitive functions. The histological counterpart was represented by a cortical lesion in the area of impact at 14 days post-injury, associated with cell loss in the CA1 and CA3 hippocampal regions, and scarce infiltration of microglia. The superimposition of sepsis on this mild TBI model resulted in worsening of post-injury mortality and weight loss, significant exacerbation of post-injury motor deficit and cognitive impairments, and further exacerbation of neuronal cell death in the CA3 area together with over-expression and activation of microglial cells in the peri-lesional area. Altogether, our findings indicate that sepsis, when superimposed on TBI, exerts a negative effect on the evolution of post-traumatic damage.	[Venturi, Luna; Miranda, Marco; Selmi, Valentina; Vitali, Luca; De Gaudio, Angelo Raffaele; Adembri, Chiara] Univ Florence, Crit Care Dept, Sect Anesthesiol & IC, I-50134 Florence, Italy; [Tani, Alessia; Margheri, Martina] Univ Florence, Dept Anat Histol & Forens Med, I-50134 Florence, Italy		Adembri, C (corresponding author), Univ Florence, Crit Care Dept, Sect Anesthesiol & IC, Viale Morgagni 85, I-50134 Florence, Italy.	chiara.adembri@unifi.it			University of Florence; Ente Cassa di Risparmio di FirenzeFondazione Cassa Risparmio Firenze	We thank D. M. Morales for the initial setup of the CCI device and Prof. T. K. McIntosh for helpful discussion and suggestions. This work was partly supported by a University of Florence grant to C. A. The CCI device was purchased with a "Ente Cassa di Risparmio di Firenze'' grant.	Ashman TA, 2006, MT SINAI J MED, V73, P999; Bae JS, 2005, WORLD J GASTROENTERO, V11, P810, DOI 10.3748/wjg.v11.i6.810; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Barichello T, 2007, CRIT CARE MED, V35, P2186, DOI 10.1097/01.CCM.0000281452.60683.96; Brooks HF, 2007, METAB BRAIN DIS, V22, P353, DOI 10.1007/s11011-007-9058-1; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Danton GH, 2004, AM J NEURORADIOL, V25, P181; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Fabregas N, 2002, Minerva Anestesiol, V68, P285; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GEHRMANN J, 1994, NEUROPATH APPL NEURO, V20, P180; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hang CH, 2004, BRAIN RES, V1026, P23, DOI 10.1016/j.brainres.2004.07.090; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hoover L, 2006, J TRAUMA, V61, P310, DOI 10.1097/01.ta.0000229052.75460.c2; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Maier S, 2004, SHOCK, V21, P505, DOI 10.1097/01.shk.0000126906.52367.dd; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Messaris E, 2004, CRIT CARE MED, V32, P1764, DOI 10.1097/01.CCM.0000135744.30137.B4; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nau R, 2004, NEUROLOGY, V62, P509, DOI 10.1212/01.WNL.0000106826.82670.30; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Singleton KD, 2003, EUR SURG RES, V35, P486, DOI 10.1159/000073387; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Streck EL, 2008, NEUROCHEM RES, V33, P2171, DOI 10.1007/s11064-008-9671-3; Taoufik E, 2008, P NATL ACAD SCI USA, V105, P6185, DOI 10.1073/pnas.0801447105; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thompson HJ, 2005, J CEREBR BLOOD F MET, V25, P163, DOI 10.1038/sj.jcbfm.9600008; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0	48	22	25	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2009	26	9					1547	1556		10.1089/neu.2008.0723			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	489NG	WOS:000269426200011	19257801				2022-02-06	
J	Hostler, D; Northington, WE; Callaway, CW				Hostler, David; Northington, William E.; Callaway, Clifton W.			High-dose diazepam facilitates core cooling during cold saline infusion in healthy volunteers	APPLIED PHYSIOLOGY NUTRITION AND METABOLISM-PHYSIOLOGIE APPLIQUEE NUTRITION ET METABOLISME			English	Article						therapeutic hypothermia; diazepam; shivering; oxygen consumption	HEAT-STROKE; CARDIAC-ARREST; HYPOTHERMIA; HEATSTROKE; TEMPERATURE; HUMANS	Studies have suggested that inducing mild hypothermia improves neurologic outcomes after traumatic brain injury, major stroke, cardiac arrest, or exertional heat illness. While infusion of cold normal saline is a simple and inexpensive method for reducing core temperature, human cold-defense mechanisms potentially make this route stressful or ineffective. We hypothesized that intravenous administration of diazepam during a rapid infusion of 30 mL.kg(-1) of cold (4 degrees C) 0.9% saline to healthy subjects would be more comfortable and reduce core body temperature more than the administration of cold saline alone. Fifteen subjects received rapidly infused cold (4 degrees C) 0.9% saline. Subjects were randomly assigned to receive, intravenously, 20 mg diazepam (HIGH), 10 mg diazepam (LOW), or placebo (CON). Main outcomes were core temperature, skin temperature, and oxygen consumption. Data for the main outcomes were analyzed with generalized estimating equations to identify differences in group, time, or a group x time interaction. Core temperature decreased in all groups (CON, 1.0 +/- 0.2 degrees C; LOW, 1.4 +/- 0.2 degrees C; HIGH, 1.5 +/- 0.2 degrees C), while skin temperature was unchanged. Mean (95% CI) oxygen consumption was 315.3 (253.8, 376.9) mL.kg(-1).min(-1) in the CON group, 317.9 (275.5, 360.3) in the LOW group, and 226.1 (216.4, 235.9) in the HIGH group. Significant time and group x time interaction was observed for core temperature and oxygen consumption (p < 0.001). Administration of high-dose diazepam resulted in decreased oxygen consumption during cold saline infusion, suggesting that 20 mg of intravenous diazepam may reduce the shivering threshold without compromising respiratory or cardiovascular function.	[Hostler, David; Northington, William E.; Callaway, Clifton W.] Univ Pittsburgh, Dept Emergency Med, Emergency Responder Human Performance Lab, Pittsburgh, PA 15213 USA		Hostler, D (corresponding author), Univ Pittsburgh, Dept Emergency Med, Emergency Responder Human Performance Lab, Pittsburgh, PA 15213 USA.	hostlerdp@upmc.edu		Hostler, David/0000-0002-7711-4001; Callaway, Clifton/0000-0002-3309-1573	University of Pittsburgh General Clinical Research CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); NIH/NCRR/GCRCUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR000056]; Clinical and Translation Research Center; NIH/NCRR/CTSAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR) [UL1 RR024153]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000056, UL1RR024153] Funding Source: NIH RePORTER	This study was funded by a grant from the University of Pittsburgh General Clinical Research Center (NIH/NCRR/GCRC Grant M01 RR000056) and the Clinical and Translation Research Center (NIH/NCRR/CTSA Grant UL1 RR024153). The authors thank the staff of the Clinical and Translation Research Center and George Grove from the University of Pittsburgh Obesity Nutrition Research Center for their support during this project.	Armstrong LE, 1996, AM J EMERG MED, V14, P355, DOI 10.1016/S0735-6757(96)90048-0; Aronowski J, 2003, STROKE, V34, P1246, DOI 10.1161/01.STR.0000068170.80517.B3; Ayling J H, 1986, Br J Sports Med, V20, P35; BELLER GA, 1975, MIL MED, V140, P464; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bouchama A, 2007, CRIT CARE, V11, DOI 10.1186/cc5910; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; COSTRINI AM, 1979, AM J MED, V66, P296, DOI 10.1016/0002-9343(79)90548-5; DAHMASH NS, 1993, CHEST, V103, P1210, DOI 10.1378/chest.103.4.1210; De Georgia MA, 2004, NEUROLOGY, V63, P312, DOI 10.1212/01.WNL.0000129840.66938.75; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Frank SM, 1997, AM J PHYSIOL-REG I, V272, pR557, DOI 10.1152/ajpregu.1997.272.2.R557; GAGGE AP, 1969, ENVIRON RES, V2, P209, DOI 10.1016/0013-9351(69)90037-1; HART GR, 1982, MEDICINE, V61, P189, DOI 10.1097/00005792-198205000-00005; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hsiao SH, 2007, RESUSCITATION, V73, P437, DOI 10.1016/j.resuscitation.2006.11.003; Lyden Patrick D, 2005, J Stroke Cerebrovasc Dis, V14, P107, DOI 10.1016/j.jstrokecerebrovasdis.2005.01.001; Moore TM, 2008, ANN EMERG MED, V51, P153, DOI 10.1016/j.annemergmed.2007.07.012; O'Brien C, 1998, MED SCI SPORT EXER, V30, P468, DOI 10.1097/00005768-199803000-00020; ODONNELL TF, 1972, NEW ENGL J MED, V287, P734, DOI 10.1056/NEJM197210122871502; Rajek A, 2000, ANESTHESIOLOGY, V93, P629, DOI 10.1097/00000542-200009000-00010; SPRUNG CL, 1979, CHEST, V75, P362, DOI 10.1378/chest.75.3.362; Wilkinson DM, 2008, MED SCI SPORT EXER, V40, P523, DOI [10.1249/mss.0b013e31815cc43e, 10.1249/MSS.0b013e31815cc43e]; ZWISCHENBERGER JB, 1987, ANN THORAC SURG, V43, P428, DOI 10.1016/S0003-4975(10)62823-8	24	22	23	0	3	NATL RESEARCH COUNCIL CANADA-N R C RESEARCH PRESS	OTTAWA	BUILDING M 55, OTTAWA, ON K1A 0R6, CANADA	1715-5312			APPL PHYSIOL NUTR ME	Appl. Physiol. Nutr. Metab.	AUG	2009	34	4					582	586		10.1139/H09-011			5	Nutrition & Dietetics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics; Physiology; Sport Sciences	496KP	WOS:000269972200003	19767791				2022-02-06	
J	Walker, PA; Harting, MT; Baumgartner, JE; Fletcher, S; Strobel, N; Cox, CS				Walker, Peter A.; Harting, Matthew T.; Baumgartner, James E.; Fletcher, Stephen; Strobel, Nathan; Cox, Charles S., Jr.			Modern Approaches to Pediatric Brain Injury Therapy	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	National Summit on Pediatric Disaster and Emergency Services	SEP 11-12, 2008	Los Angeles, CA	Eastern Assoc Surg Trauma, Trauma Assoc Canada, Western Trauma Assoc		Traumatic brain injury; Treatment; Therapy; Stem cells; Progenitor cells; Hypothermia; Hypertonic saline; Review	MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; HYPERTONIC SALINE; CEREBROSPINAL-FLUID; HEAD-INJURY; HEMORRHAGIC-SHOCK; OXIDATIVE DAMAGE; LACTATED RINGERS; MOUSE MODEL; TIME-COURSE	Each year, pediatric traumatic brain injury (TBI) accounts for 435,000 emergency department visits, 37,000 hospital admissions, and approximately 2,500 deaths in the United States. TBI results in immediate injury from direct mechanical force and shear. Secondary injury results from the release of biochemical or inflammatory factors that alter the loco-regional milieu in the acute, subacute, and delayed intervals after a mechanical insult. Preliminary preclinical and clinical research is underway to evaluate the benefit from progenitor cell therapeutics, hypertonic saline infusion, and controlled hypothermia. However, all phase III clinical trials investigating pharmacologic monotherapy for TBI have shown no benefit. A recent National Institutes of Health consensus statement recommends research into multimodality treatments for TBI. This article will review the complex pathophysiology of TBI as well as the possible therapeutic mechanisms of progenitor cell transplantation, hypertonic saline infusion, and controlled hypothermia for possible utilization in multimodality clinical trials.	[Walker, Peter A.; Harting, Matthew T.; Baumgartner, James E.; Fletcher, Stephen; Cox, Charles S., Jr.] Univ Texas Houston, Sch Med, Dept Pediat Surg, Houston, TX 77030 USA; [Strobel, Nathan] Childrens Mem Hermann Hosp, Dept Pediat, Houston, TX USA		Cox, CS (corresponding author), Univ Texas Houston, Sch Med, Dept Pediat Surg, 6431 Fannin St,MSB 5-234, Houston, TX 77030 USA.	charles.s.cox@uth.tmc.edu		Harting, Matthew/0000-0002-8929-8311	NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024148, M01RR002558] Funding Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR002558, M01 RR02558, UL1 RR024148-03] Funding Source: Medline; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [N01 HB037163, P018/N01 HB 37163] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM 08 79201, T32 GM008792] Funding Source: Medline		Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Aguilar S, 2007, STEM CELLS, V25, P1586, DOI 10.1634/stemcells.2006-0762; Baker KS, 2003, J CLIN ONCOL, V21, P1352, DOI 10.1200/JCO.2003.05.108; BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bing Mei, 2007, Chin J Traumatol, V10, P263; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Froehler MT, 2007, J NEUROL SCI, V261, P118, DOI 10.1016/j.jns.2007.04.042; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Harada K, 2002, J NEUROSCI RES, V67, P664, DOI 10.1002/jnr.10159; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hawley CA, 2004, J NEUROL NEUROSUR PS, V75, P737, DOI 10.1136/jnnp.2003.020651; *HLTH NIO, 2008, COMB THER TRAUM BRAI; Holzer M, 2002, NEW ENGL J MED, V346, P549; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Inamasu J, 2001, NEUROL RES, V23, P105, DOI 10.1179/016164101101198217; Infanti JL, 2008, J NEUROSCI NURS, V40, P362, DOI 10.1097/01376517-200812000-00009; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Lampl C, 2002, EUR NEUROL, V47, P3, DOI 10.1159/000047939; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lansman SL, 1999, ANN THORAC SURG, V67, P1975, DOI 10.1016/S0003-4975(99)00419-1; LAPTOOK AR, 1995, STROKE, V26, P1240, DOI 10.1161/01.STR.26.7.1240; LAPTOOK AR, 1995, PEDIATR RES, V38, P919, DOI 10.1203/00006450-199512000-00015; Lei BP, 1997, NEUROSCI LETT, V222, P91, DOI 10.1016/S0304-3940(97)13349-3; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Maeda H, 2007, THER APHER DIAL, V11, P309, DOI 10.1111/j.1744-9987.2007.00469.x; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; McCarthy ML, 2002, ACAD EMERG MED, V9, P684; McCullough JN, 1999, ANN THORAC SURG, V67, P1895, DOI 10.1016/S0003-4975(99)00441-5; Mirski MA, 2000, J NEUROSURG ANESTH, V12, P334, DOI 10.1097/00008506-200010000-00006; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; MOSS GS, 1988, AM J SURG, V155, P425, DOI 10.1016/S0002-9610(88)80106-5; Nonaka M, 1998, J NEUROL SCI, V157, P25, DOI 10.1016/S0022-510X(98)00062-8; Noppens R, 2004, EXP TOXICOL PATHOL, V56, P113, DOI 10.1016/j.etp.2004.04.005; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; Qureshi AI, 1998, J NEUROSURG ANESTH, V10, P188, DOI 10.1097/00008506-199807000-00010; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Soustiel JF, 2006, BRAIN RES, V1101, P136, DOI 10.1016/j.brainres.2006.05.045; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vendrame M, 2006, EXP NEUROL, V199, P191, DOI 10.1016/j.expneurol.2006.03.017; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wallace GQ, 2008, AM J PATHOL, V173, P792, DOI 10.2353/ajpath.2008.080259; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; Weiner Leslie P., 2008, V438, P3, DOI 10.1007/978-1-59745-133-8_1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	87	22	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2009	67	2		S			S120	S127		10.1097/TA.0b013e3181ad323a			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	482OM	WOS:000268898600015	19667844	Green Accepted			2022-02-06	
J	Yao, CP; Williams, AJ; Ottens, AK; Lu, XCM; Liu, MC; Hayes, RL; Wang, KK; Tortella, FC; Dave, JR				Yao, Changping; Williams, Anthony J.; Ottens, Andrew K.; Lu, X. -C. May; Liu, Ming Cheng; Hayes, Ronald L.; Wang, Kevin K.; Tortella, Frank C.; Dave, Jitendra R.			P43/pro-EMAPII: A Potential Biomarker for Discriminating Traumatic Versus Ischemic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury biomarkers; diagnostic biomarker; middle cerebral artery occlusion; penetrating ballistic-like brain injury; protein expression	TRANSFER-RNA SYNTHETASE; POLYPEPTIDE-II; EMAP-II; PROINFLAMMATORY CYTOKINE; LESIONAL EXPRESSION; P43; RAT; CELLS; ACCUMULATION; MONOCYTES	To gain additional insights into the pathogenic cellular and molecular mechanisms underlying different types of brain injury (e. g., trauma versus ischemia), recently attention has focused on the discovery and study of protein biomarkers. In previous studies, using a high-throughput immunoblotting (HTPI) technique, we reported changes in 29 out of 998 proteins following acute injuries to the rat brain (penetrating traumatic versus focal ischemic). Importantly, we discovered that one protein, endothelial monocyte-activating polypeptide II precursor (p43/pro-EMAPII), was differentially expressed between these two types of brain injury. Among other functions, p43/pro-EMAPII is a known pro-inflammatory cytokine involved in the progression of apoptotic cell death. Our current objective was to verify the changes in p43/pro-EMAPII expression, and to evaluate the potentially important implications that the differential regulation of this protein has on injury development. At multiple time points following either a penetrating ballistic-like brain injury (PBBI), or a transient middle cerebral artery occlusion (MCAo) brain injury, tissue samples (6-72 h), CSF samples (24 h), and blood samples (24 h) were collected from rats for analysis. Changes in protein expression were assessed by Western blot analysis and immunohistochemistry. Our results indicated that p43/pro-EMAPII was significantly increased in brain tissues, CSF, and plasma following PBBI, but decreased after MCAo injury compared to their respective sham control samples. This differential expression of p43/pro-EMAPII may be a useful injury-specific biomarker associated with the underlying pathologies of traumatic versus ischemic brain injury, and provide valuable information for directing injury-specific therapeutics.	[Dave, Jitendra R.] Walter Reed Army Inst Res, Div Psychiat & Neurosci, Dept Appl Neurobiol, Silver Spring, MD 20910 USA; [Ottens, Andrew K.] Virginia Commonwealth Univ, Richmond, VA USA; [Hayes, Ronald L.] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Wang, Kevin K.] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Liu, Ming Cheng; Hayes, Ronald L.; Wang, Kevin K.] Banyan Biomarkers Inc, Ctr Innovat Res, Alachua, FL USA		Dave, JR (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, Dept Appl Neurobiol, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	jit.dave@amedd.army.mil	Dave, Jitendra R/A-8940-2011; Ottens, Andrew/K-3352-2012	Wang, Kevin/0000-0002-9343-6473; Ottens, Andrew/0000-0002-2118-3796	Department of DefenseUnited States Department of Defense [DAMD-03-1-0066]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS04917501-A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049175] Funding Source: NIH RePORTER	The authors thank Mrs. Christine Murphy for her critical comments and suggestions for improving the manuscript. The authors thank Mr. Zhilin Liao, Ms. Xiaofang Yang, S. P. C. Monika Torres, and SPC Franco Antinia for their excellent technical assistance in these studies. The authors would also like to acknowledge the support of Department of Defense grant DAMD-03-1-0066, and NIH grant R01NS04917501-A1.	Bate C, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-5; Brabeck C, 2002, EXP NEUROL, V177, P341, DOI 10.1006/exnr.2002.7985; Chen RW, 2003, J NEUROCHEM, V84, P566, DOI 10.1046/j.1471-4159.2003.01548.x; HORSSEN RV, 2006, CYTOKINE GROWTH F R, V17, P339; Knies UE, 1998, P NATL ACAD SCI USA, V95, P12322, DOI 10.1073/pnas.95.21.12322; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Liu J, 2006, EXP CELL RES, V312, P2231, DOI 10.1016/j.yexcr.2006.03.024; Matschurat S, 2003, AM J PATHOL, V162, P93, DOI 10.1016/S0002-9440(10)63801-1; Mueller CA, 2003, J NEUROTRAUM, V20, P1007, DOI 10.1089/089771503770195858; Mueller CA, 2003, NEUROSCI LETT, V339, P215, DOI 10.1016/S0304-3940(03)00024-7; Mueller CA, 2003, J NEUROIMMUNOL, V135, P1, DOI 10.1016/S0165-5728(02)00427-7; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Murray JC, 2004, J IMMUNOL, V172, P274, DOI 10.4049/jimmunol.172.1.274; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Park SG, 2002, J BIOL CHEM, V277, P45243, DOI 10.1074/jbc.M207934200; Quevillon S, 1997, J BIOL CHEM, V272, P32573, DOI 10.1074/jbc.272.51.32573; Schluesener HJ, 1997, GLIA, V20, P365, DOI 10.1002/(SICI)1098-1136(199708)20:4<365::AID-GLIA8>3.0.CO;2-4; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; Urbich C, 2005, NAT MED, V11, P206, DOI 10.1038/nm1182; WEI G, 2008, 38 ANN M SOC NEUR; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Yao C, 2005, LIFE SCI, V77, P1116, DOI 10.1016/j.lfs.2005.02.008; Yao CP, 2008, BRAIN INJURY, V22, P723, DOI 10.1080/02699050802304706; Zhang ZY, 2007, J CELL MOL MED, V11, P307, DOI 10.1111/j.1582-4934.2007.00019.x	28	22	24	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1295	1305		10.1089/neu.2008.0811			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900012	19317603	Green Published			2022-02-06	
J	Atighechi, S; Salari, H; Baradarantar, MH; Jafari, R; Karimi, G; Mirjali, M				Atighechi, Saeid; Salari, Hadi; Baradarantar, Mohammad Hossein; Jafari, Rozita; Karimi, Ghasem; Mirjali, Mehdi			A comparative study of brain perfusion single-photon emission computed tomography and magnetic resonance imaging in patients with post-traumatic anosmia	AMERICAN JOURNAL OF RHINOLOGY & ALLERGY			English	Article						Anosmia; frontal lobe; head injury; MRI; 99mtc-ethyl-cysteinate-dimer; olfactory bulb; SPECT	CLOSED HEAD-INJURY; OLFACTORY FUNCTION; COMPARING SPECT; SMELL; DYSFUNCTION; TASTE; MRI	Background: Loss of smell is a problem that can occur in up to 30% of patients with head trauna. The olfactory function investigation methods so far in use have mostly relied on subjective responses given by patients. Recently, some studies have used magnetic resonance imaging (MRI) and single-photon emission computed tomography (SPECT) to evaluate patients with post-traumatic anosmia. The present study seeks to detect post-traumatic anosmia and the areas in the brain that are related to olfactory impairment by using SPECT and MRI as imaging techniques. Methods: The study was conducted on 21 patients suffering from head injury and consequently anosmia as defined by an olfactory identification test. Two control groups (traumatic normosmic and nontraumatic healthy individuals) were selected. Brain MRI, qualitative and semiquantitative SPECT with 99mtc-ethyl-cysteinate-dimer were taken from all the patients. Then the brain SPECT and MRI were compared with each other. Results: Semi-quantitative assessment of the brain perfusion SPECT revealed frontal, left parietal, and left temporal hypoperfusion as compared with the two control groups. Eighty-five percent of the anosmic patients had abnormal brain MRI. Regarding the MRI, the main abnormality proved to be in the anterior inferior region of the frontal lobes and olfactory bulbs. Conclusions: The findings of this study suggest that damage to the frontal lobes and olfactory bulbs as shown in the brain MRI and hypoperfusion in the frontal, left parietal, and left temporal lobes in the semiquantitative SPECT corresponds to post-traumatic anosmia. Further neurophysiological and imaging studies are definitely needed to set the idea completely. (Am J Rhinol Allergy 23, 409-412, 2009; doi: 10.2500/ajra.2009.23.3345)	[Atighechi, Saeid; Baradarantar, Mohammad Hossein; Jafari, Rozita; Karimi, Ghasem] Yazd Univ Med Sci, Shahid Sadughi Hosp, Dept Otolaryngol, Shahid Ghandi 8915887857, Yazd, Iran; [Mirjali, Mehdi] Forens Med Org Yazd, Yazd, Iran		Atighechi, S (corresponding author), Yazd Univ Med Sci, Shahid Sadughi Hosp, Dept Otolaryngol, Shahid Ghandi 8915887857, Yazd, Iran.	atighechi@ssu.ac.ir	atighechi, saeid/F-6352-2017; karimi, ghasem/Q-3127-2018	atighechi, saeid/0000-0002-9330-5342; karimi, ghasem/0000-0001-9400-3488			CAIN WS, 1988, LARYNGOSCOPE, V98, P83; CAIN WS, 1983, AM J OTOLARYNG, V4, P252, DOI 10.1016/S0196-0709(83)80068-4; Di Nardo W, 2000, AM J RHINOL, V14, P57, DOI 10.2500/105065800781602984; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Eftekhari M, 2006, AM J RHINOL, V20, P577, DOI 10.2500/ajr.2006.20.2906; Eibenstein A, 2005, NEUROL SCI, V26, P147, DOI 10.1007/s10072-005-0452-3; HENDRIKS A P J, 1988, Rhinology (Utrecht), V26, P229; HENKIN RI, 1976, AM J MED SCI, V272, P285, DOI 10.1097/00000441-197611000-00006; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P467; Liu Jian-Feng, 2008, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V43, P198; Mann NM, 2004, OTOLARYNG CLIN N AM, V37, P289, DOI 10.1016/S0030-6665(03)00157-9; Mann NM, 2006, CLIN NUCL MED, V31, P458, DOI 10.1097/01.rlu.0000227010.72925.6d; MOTT AE, 1991, MED CLIN N AM, V75, P1321, DOI 10.1016/S0025-7125(16)30391-1; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Nik H, 2007, BRIT J HOSP MED, V68, P237, DOI 10.12968/hmed.2007.68.5.23328; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; Scott A E, 1989, Ear Nose Throat J, V68, P297; Summer D, 1976, HDB CLIN NEUROLOGY, P235; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63; Yousem DM, 2001, SEMIN ULTRASOUND CT, V22, P456, DOI 10.1016/S0887-2171(01)90001-0	21	22	23	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1945-8924	1945-8932		AM J RHINOL ALLERGY	Am. J. Rhinol. Allergy	JUL-AUG	2009	23	4					409	412		10.2500/ajra.2009.23.3345			4	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	481HC	WOS:000268797300009	19671257				2022-02-06	
J	Kayani, NA; Homan, S; Yun, SM; Zhu, BP				Kayani, Noaman A.; Homan, Sherri; Yun, Shumei; Zhu, Bao Ping			Health and Economic Burden of Traumatic Brain Injury: Missouri, 2001-2005	PUBLIC HEALTH REPORTS			English	Article							OUTCOMES; COSTS	Objective. We examined the financial and social costs resulting from traumatic brain injury (TBI) in Missouri. Methods. We computed mortality rates from death certificates, the direct cost of TBI from hospital and emergency department (ED) visit charges, the social cost in terms of years of potential life lost (YPLL) using an abridged Missouri life table, and the indirect financial cost in terms of lost productivity due to premature death for all TBI and four major causes of TBI in Missouri. Results. During 2001-2005, a mean of 1,358 lives were lost due to TBI in Missouri. Four major causes-unintentional falls, motor vehicle traffic crashes, motorcycle crashes, and firearms-accounted for 88% of all TBI deaths. We estimated the annual direct medical cost of TBI at $95 million, or about $1.67 million per 100,000 Missourians. This cost increased by about 60% between 2001 and 2005. The four major causes of TBI accounted for 68% of all direct medical costs of TBI. We estimated the cost per hospitalization and ED visit at $6,948 and the indirect social cost at 48,501 YPLL. During this period, the mean age of TBI fatality was 44 years. We determined the lost productivity due to TBI mortality-$1.1 billion, or about $18.8 million per 100,000 Missourians-to be three times as high for males as for females. Conclusions. The types of costs covered in this study underestimated the total cost of TBI in Missouri, as we did not include outpatient care, rehabilitation, and drug costs. Nevertheless, we found the health and economic burden from medical care and mortality related to TBI to be substantial in Missouri.	[Kayani, Noaman A.; Homan, Sherri; Yun, Shumei; Zhu, Bao Ping] Missouri Dept Hlth & Senior Serv, Div Community & Publ Hlth, Jefferson City, MO 65102 USA		Kayani, NA (corresponding author), Missouri Dept Hlth & Senior Serv, Div Community & Publ Hlth, POB 570,920 Wildwood Dr, Jefferson City, MO 65102 USA.	noaman.kayani@dhss.mo.gov		Zhu, Baoping/0000-0003-0065-0153	Division of Community and Public Health, Missouri Department of Health and Senior Services	This research was supported by the Division of Community and Public Health, Missouri Department of Health and Senior Services, as well as state general revenue.	Borg J, 2004, J REHABIL MED, V36, P76, DOI 10.1080/16501960410023840; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Christensen MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6797; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; Haddix AC, 2002, PREVENTION EFFECTIVE; HOMAN SG, 2006, PUBLIC HLTH BURDEN T; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Max W, 2004, VALUING HUMAN LIFE E; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; *MISS DEP HLTH SEN, 2003, MISS VIT STAT ABR LI; *MISS DEP HLTH SEN, 1999, PAT ABSTR SYST; *MISS DEP HLTH SEN, MISS INF COMM ASS DE; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; U.S. Bureau of Labor Statistics, CONS PRIC IND MED CA; *US NATL CTR HLTH, CLASS DIS FUNCT DIS; 2001, FED REG, V66, P22727	19	22	24	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0033-3549	1468-2877		PUBLIC HEALTH REP	Public Health Rep.	JUL-AUG	2009	124	4					551	560		10.1177/003335490912400412			10	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	455VO	WOS:000266795700011	19618792	Green Published			2022-02-06	
J	Salvarani, CP; Colli, BO; Carlotti, CG				Salvarani, Carmine Porcelli; Colli, Benedicto Oscar; Carlotti Junior, Carlos Gilberto			Impact of a program for the prevention of traffic accidents in a Southern Brazilian city: a model for implementation in a developing country	SURGICAL NEUROLOGY			English	Article						Accidents; Traffic; Prevention; Trauma; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; MOTORCYCLE HELMET USE; HEAD-INJURY; MORTALITY; EPIDEMIOLOGY; CALIFORNIA; RIDERS; LAW	Background: Traffic accidents constitute the main cause of death in the first decades of life. Traumatic brain injury is the event most responsible for the severity of these accidents. The SBN started an educational program for the prevention of traffic accidents, adapted from the American model "Think First" to the Brazilian environment, since 1995, with special effort devoted to the prevention of TBI by using seat belts and motorcycle helmets. The objective of the present study was to set up a traffic accident prevention program based on the adapted Think First and to evaluate its impact by comparing epidemiological variables before and after the beginning of the program. Methods: The program was executed in Maringa city, from September 2004 to August 2005, with educational actions targeting the entire population, especially teenagers and young adults. The program was implemented by building a network of information facilitators and multipliers inside the organized civil society, with widespread population dissemination. To measure the impact of the program, a specific software was developed for the storage and processing of the epidemiological variables. Results: The results showed a reduction of trauma severity due to traffic accidents after the execution of the program, mainly TBI. Conclusions: The adapted Think First was systematically implemented and its impact measured for the first time in Brazil, revealing the usefulness of the program for reducing trauma and TBI severity in traffic accidents through public education and representing a standardized model of implementation in a developing country. (C) 2009 Elsevier Inc. All rights reserved.	[Salvarani, Carmine Porcelli] State Univ Maringa Parana, Maringa Med Sch, Div Neurosurg, Maringa, Parana, Brazil; [Colli, Benedicto Oscar; Carlotti Junior, Carlos Gilberto] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Div Neurosurg, BR-05508 Sao Paulo, Brazil		Salvarani, CP (corresponding author), State Univ Maringa Parana, Maringa Med Sch, Div Neurosurg, Maringa, Parana, Brazil.	cinnmaringa@wnet.com.br	Colli, Benedicto/A-2833-2016; Carlotti, Carlos G/C-1608-2012	Colli, Benedicto/0000-0002-0222-6770; Carlotti, Carlos G/0000-0002-7055-0564			Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; *AM COLL SURG, 2004, INF ATLS PROGR COURS; Amatuzzi M M, 1998, Rev Hosp Clin Fac Med Sao Paulo, V53, P299; Auman KM, 2002, AM J PUBLIC HEALTH, V92, P1352, DOI 10.2105/AJPH.92.8.1352; Bastos Yara Gerber Lima, 2005, Cad. Saúde Pública, V21, P815, DOI 10.1590/S0102-311X2005000300015; Brandt MM, 2002, J TRAUMA, V53, P469, DOI 10.1097/00005373-200209000-00012; *BRAZ ASS TRAFF ME, 2004, MORT BRAS IMP AC TRA; *BRAZ I GEOGR STAT, 2005, EST POP RES MUN 2005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Coben JH, 2007, ACCIDENT ANAL PREV, V39, P190, DOI 10.1016/j.aap.2006.06.018; Colli BO, 1997, ARQ NEURO-PSIQUIAT, V55, P91, DOI 10.1590/S0004-282X1997000100015; Oliveira Nelson Luiz Batista de, 2003, Rev. Latino-Am. Enfermagem, V11, P749, DOI 10.1590/S0104-11692003000600008; Engberg A, 1998, EUR J EPIDEMIOL, V14, P165, DOI 10.1023/A:1007492025190; Gericke CA, 2004, J PUBLIC HEALTH-UK, V26, P230, DOI 10.1093/pubmed/fdh149; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Hijar M, 2000, INT J EPIDEMIOL, V29, P715, DOI 10.1093/ije/29.4.715; HONSSON B, 2007, TRAFFIC INJ PREV, V8, P87; Hundley JC, 2004, J TRAUMA, V57, P944, DOI 10.1097/01.TA.0000149497.20065.F4; *I APPL EC RES IPE, 2002, CAR TEND RED URB BRA; *I APPL EC RES IPE, 2003, IMP SOC EC AC TRANS; Jorge Maria Helena Prado de Mello, 2004, Rev. bras. epidemiol., V7, P228; Jorge Maria Helena Prado de Mello, 2002, Rev. bras. epidemiol., V5, P212, DOI 10.1590/S1415-790X2002000200008; KRAUS JF, 1995, J NEUROTRAUM, V12, P873, DOI 10.1089/neu.1995.12.873; Leitao FBP, 1997, REV SAUDE PUBL, V31, P47, DOI 10.1590/S0034-89101997000500005; Liberatti C L, 2001, Inj Prev, V7, P190, DOI 10.1136/ip.7.3.190; LIMA RAC, 2001, TRAUMA DOENCA SECULO, P2849; Lindqvist K, 2001, ACCIDENT ANAL PREV, V33, P599, DOI 10.1016/S0001-4575(00)00071-3; Minayo MCS, 1994, CAD SAUDE PUBLICA, V10, P7, DOI [10. 1590/ S0102- 311X1994000500002, DOI 10.1590/S0102-311X1994000500002]; Minayo MCS, 1997, HIST CIENC SAUDE-MAN, V4, P513; Montazeri A, 2004, PUBLIC HEALTH, V118, P110, DOI 10.1016/S0033-3506(03)00173-2; Murray CJL., 1996, GLOBAL BURDEN DIS CO; Nakamura N, 2002, NEUROL RES, V24, P45, DOI 10.1179/016164102101199530; *NAT DEP TRAFF ROA, IMP USO EST AC TRANS; Pikoulis E, 2006, Int J Inj Contr Saf Promot, V13, P190, DOI 10.1080/17457300500294547; Posada J, 2000, Rev Panam Salud Publica, V7, P88, DOI 10.1590/S1020-49892000000200003; Regidor Poyatos E, 1992, Gac Sanit, V6, P245; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Scalassara MB, 1998, REV SAUDE PUBL, V32, P125, DOI 10.1590/S0034-89101998000200004; SELECKI BR, 1982, AUST NZ J SURG, V52, P93, DOI 10.1111/j.1445-2197.1982.tb05297.x; Senserrick TM, 2006, INJURY PREV, V12, P56, DOI 10.1136/ip.2006.012773; Servadei F, 2003, INJURY PREV, V9, P257, DOI 10.1136/ip.9.3.257; Silveira Renata, 2002, Rev. Latino-Am. Enfermagem, V10, P765; SILVERBERG D, 1992, EUR J EPIDEMIOL, V8, P826, DOI 10.1007/BF00145327; Soares Dorotéia Fátima Pelissari de Paula, 2006, Rev. bras. epidemiol., V9, P193, DOI 10.1590/S1415-790X2006000200006; Solagberu BA, 2006, INJURY PREV, V12, P266, DOI 10.1136/ip.2005.011221; TEASDALE G, 1974, LANCET, V2, P81; *THINK 1 FDN, MISS HIST; *THINK 1 FDN, THINK 1 VAL; *THINK WELL MAR, 2004, EST TRANS URB MAR; *THINK WELL MAR, 2003, EST TRANS URB MAR; *THINK WELL MAR, 2005, EST TRANS URB MAR; *THINK WELL PROGR, 2003, BAS PROGR PENS BEM; *TRAFF ROAD DEP PA, 2005, FROT VEIC MAR; *TRAFF ROAD DEP PA, 2003, FROT VEIC MAR; *TRAFF ROAD DEP PA, 2004, FROT VEIC MAR; WHO, 2004, WORLD REP ROAD TRAFF; WYATT G B, 1980, Papua New Guinea Medical Journal, V23, P60; Yan-Hong Li, 2006, Int J Inj Contr Saf Promot, V13, P217, DOI 10.1080/17457300600580779	60	22	22	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUL	2009	72	1					6	14		10.1016/j.surneu.2007.10.008			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	467XG	WOS:000267775800002	18328548				2022-02-06	
J	Solmaz, I; Kural, C; Temiz, C; Secer, HI; Duz, B; Gonul, E; Izci, Y				Solmaz, Iiker; Kural, Cahit; Temiz, Caglar; Secer, Halil Ibrahim; Duz, Buelent; Gonul, Engin; Izci, Yusuf			Traumatic Brain Injury Due To Gunshot Wounds: A Single Institution's Experience With 442 Consecutive Patients	TURKISH NEUROSURGERY			English	Article						Traumatik brain injury; Gunshot wounds; Surgery; Prognosis; Brain injury	PENETRATING CRANIOCEREBRAL INJURIES; HEAD-INJURY; POSTTRAUMATIC EPILEPSY; RETROSPECTIVE ANALYSIS; MISSILE INJURIES; VIETNAM; IRAQ; WAR; INFECTIONS; MANAGEMENT	AIM: Traumatic brain injury (TBI) caused by a gunshot wound is a complex injury with a broad spectrum of symptoms and high rates of mortality and morbidity. This study presents an evaluation of TBI caused by gunshot Wounds presenting at a single institution and discusses possible predictive factors for the outcome of surgical intervention. MATERIAL and METHODS: The study sample consisted of 442 patients who underwent surgery for TBI over a 16-year period. All injuries were caused by gunshot wounds, Such as bullets and shrapnel. All patients underwent Surgical intervention. RESULTS: Almost all patients (99.3%) were male, and the mean patient age was 22.3 years. Wounds were caused by shrapnel in 68 percent of patients. The Glasgow Coma Scale (GCS) score at admission was below 8 in 116 patients (26.2%,=) and above 8 in 326 patients (73.8%). In total, 47 patients (10.6%) died despite surgical management, with diffuse brain injury the most common cause of death. CONCLUSION: Low GCS scores, ventricular injuries and bihemispheric injuries are correlated with poor Prognosis. Early and less invasive surgery in conjunction with short transportation time to the hospital could decrease mortality rates.	[Solmaz, Iiker; Kural, Cahit; Temiz, Caglar; Secer, Halil Ibrahim; Duz, Buelent; Gonul, Engin; Izci, Yusuf] Gulhane Mil Med Acad, Dept Neurosurg, Ankara, Turkey		Izci, Y (corresponding author), Gulhane Mil Med Acad, Dept Neurosurg, Ankara, Turkey.	yusufizci@yahoo.com	DUZ, Bulent/F-6772-2011				AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; Aarabi B, 2003, NEUROSURG QUART, V13, P87, DOI 10.1097/00013414-200306000-00004; Aarabi Bizhan, 2001, Journal of Trauma Injury Infection and Critical Care, V51, pS1; ADAMS G, TRAUMATIC BRAIN INJU; Allen MB, 1995, ESSENTIALS NEUROSURG; [Anonymous], TRAUMATIC BRAIN INJU; Bakir A, 2005, NEUROL MED-CHIR, V45, P281, DOI 10.2176/nmc.45.281; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAREY ME, 1972, SURG GYNECOL OBSTETR, V135, P386; CAVENESS WF, 1962, J NEUROSURG, V19, P122, DOI 10.3171/jns.1962.19.2.0122; COOPER PR, 1979, NEUROSURGERY, V4, P373, DOI 10.1227/00006123-197905000-00001; Erdogan E, 2004, MIL MED, V169, P691, DOI 10.7205/MILMED.169.9.691; Erdogan E, 2002, NEUROSURG QUART, V12, P1, DOI 10.1097/00013414-200203000-00001; Gonul E, 1997, NEUROSURG REV, V20, P177, DOI 10.1007/BF01105561; Gonul E, 1999, MINIM INVAS NEUROSUR, V42, P207, DOI 10.1055/s-2008-1053401; Gonul E, 1999, TURK NEUROSURG, V9, P1; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Izci Y, 2005, EMERG MED J, V22, P409, DOI 10.1136/emj.2004.014704; Izci Y, 2003, TOHOKU J EXP MED, V201, P39, DOI 10.1620/tjem.201.39; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KENNEDY K, 2007, TRAUMATIC BRAIN INJU; KIM PE, 1995, NEUROSURG CLIN N AM, V6, P669; LEVY ML, 1993, NEUROSURGERY, V33, P1018; Liebenberg WA, 2005, NEUROSURGERY, V57, P293, DOI 10.1227/01.NEU.0000166662.77797.EC; MATSON DD, 1981, J NEUROSURG, V54, P44; Meirowsky A., 1965, NEUROLOGICAL SURGERY, P103; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; PITLYK PJ, 1970, J NEUROSURG, V33, P19, DOI 10.3171/jns.1970.33.1.0019; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Secer HI, 2007, ACTA NEUROCHIR, V149, P777, DOI 10.1007/s00701-007-1236-8; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; STRICH SJ, 1961, LANCET, V2, P443; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; TSAI FY, 1978, J COMPUT ASSIST TOMO, V2, P323, DOI 10.1097/00004728-197807000-00018; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; Xiong Y, 2001, HEAD TRAUMA, P257; Xydakis MS, 2005, OTOLARYNG HEAD NECK, V133, P497, DOI 10.1016/j.otohns.2005.07.003; ZIMMERMAN RA, 1978, RADIOLOGY, V174, P393	42	22	24	0	1	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	JUL	2009	19	3					216	223					8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	476PQ	WOS:000268455100002	19621284				2022-02-06	
J	Bianchin, A; Pellizzato, N; Martano, L; Castioni, CA				Bianchin, A.; Pellizzato, N.; Martano, L.; Castioni, C. A.			Therapeutic Hypothermia in Italian Intensive Care Units: a national survey	MINERVA ANESTESIOLOGICA			English	Article; Proceedings Paper	8th Annual Neuromeeting	MAY 06-10, 2008	Siena, ITALY			Hypothermia; Resuscitation; Cardiopulmonary resuscitation; Education; Treatment, outcome	HOSPITAL CARDIAC-ARREST; INTERNATIONAL-LIAISON-COMMITTEE; SEVERE SEPSIS; GUIDELINES; RESUSCITATION; MECHANISMS; PROTECTION; EXPERIENCE; MANAGEMENT; COUNCIL	Background. The aim of this study was to investigate the use of therapeutic hypothermia (TH) in Italian Intensive Care Units (ICUs). Methods. Design and settings: After being contacted by phone, a structured questionnaire to evaluate the use of TH was sent to all Italian ICUs. The questionnaire was aimed at determining the extent of TH use (indications, methods employed, target temperature, side effects) as well as the reasons why sonic ICUs did not make Use of TH for the treatment of cardiac arrest patients. Results. Out of the 448 ICUs contacted, 90% (n=404) returned the questionnaire completely filled in. Sixty-six responders (16%) made Use of TH for post-resuscitation care, and 4% Used TH for other clinical scenarios (10 ICUs For traumatic brain injury; 5 ICUs for other reasons). More than half used TH not only for cardiac arrest subsequent to ventricular fibrillation (VF), but also for non-VF cardiac arrest with the duration of TH treatment being within the time suggested by advanced cardiac life support guidelines. On the other hand, 80% of questionnaire responders did not use TH, mainly because they felt they did not have enough data/experience (45%), or simply because they had never thought about it (18%). Conclusion. Despite authoritative data supporting its effectiveness and safety, use of TH as part of the therapy in a post-resuscitation period in Italian ICUs remains low. The reasons for not using it are not completely justified and suggest that an educational program is advisable in order to boost the utilization of TH in Italy	[Bianchin, A.; Pellizzato, N.; Martano, L.] Hosp Montebelluna, Azienda ULSS 8, Anesthesia & Intens Care Unit, Treviso, Italy; [Castioni, C. A.] S Giovanni Bosco Hosp, ASL TO 4, Intens Care Unit, Turin, Italy		Bianchin, A (corresponding author), Osped Civile, Azienda Sanit ULSS 8, Via Monte Grappa 34, I-31044 Montebelluna, TV, Italy.	andbia@libero.it	Castioni, Carlo Alberto/AAC-3167-2021	Castioni, Carlo Alberto/0000-0002-8895-425X			Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Alzaga AG, 2006, RESUSCITATION, V70, P369, DOI 10.1016/j.resuscitation.2006.01.017; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Band RA, 2008, CRIT CARE, V12, DOI 10.1186/cc6845; BENSON D W, 1959, Anesth Analg, V38, P423; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Dellinger R Phillip, 2008, Crit Care Med, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Greer DM, 2006, SEMIN NEUROL, V26, P373, DOI 10.1055/s-2006-948317; *GRUPP IT VAL INT, RAPP GEN 2007 TI POL; Haque IU, 2006, PEDIATR CRIT CARE ME, V7, P7, DOI 10.1097/01.PCC.0000192322.45123.80; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Holzer M, 2005, CRIT CARE MED, V33, P414, DOI 10.1097/01.CCM.0000153410.87750.53; Holzer M, 2002, NEW ENGL J MED, V346, P549; Howes Daniel, 2006, CJEM, V8, P109; Jiang JY, 2007, CURR OPIN CRIT CARE, V13, P153, DOI 10.1097/MCC.0b013e32807f2a80; Kette F, 1998, RESUSCITATION, V36, P153, DOI 10.1016/S0300-9572(98)00022-7; L'Her E, 2006, CRIT CARE MED, V34, P2621, DOI 10.1097/01.CCM.0000240231.76837.DC; Laver SR, 2006, ANAESTHESIA, V61, P873, DOI 10.1111/j.1365-2044.2006.04552.x; Merchant RM, 2006, CRIT CARE MED, V34, P1935, DOI 10.1097/01.CCM.0000220494.90290.92; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Peter JV, 2002, CRIT CARE MED, V30, P555, DOI 10.1097/00003246-200203000-00010; Ramani R, 2006, CURR OPIN ANESTHESIO, V19, P487, DOI 10.1097/01.aco.0000245272.84539.97; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sander M, 2006, CRIT CARE, V10, DOI 10.1186/cc4882; Scott BD, 2006, CLIN CARDIOL, V29, P525, DOI 10.1002/clc.23; Soar J, 2007, BRIT MED J, V335, P459, DOI 10.1136/bmj.39315.519201.BE; Wolfrum S, 2008, CRIT CARE MED, V36, P1780, DOI 10.1097/CCM.0b013e31817437ca; Wolfrum S, 2007, RESUSCITATION, V72, P207, DOI 10.1016/j.resuscitation.2006.06.033	31	22	25	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	JUN	2009	75	6					357	362					6	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology; General & Internal Medicine	451PM	WOS:000266482100003	19088699				2022-02-06	
J	Thompson, HJ				Thompson, Hilaire J.			A Critical Analysis of Measures of Caregiver and Family Functioning Following Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article							SOCIAL SUPPORT; PSYCHOLOGICAL DISTRESS; BURDEN; PREDICTORS; CARERS; NEEDS; TBI; SATISFACTION; INDIVIDUALS; APPRAISAL	More than 5.3 million Americans are living with long-term disability following traumatic brain injury (TBI), and approximately 40% of TBI survivors report at least one unmet need at 1 year postinjury. The totality of the problem of TBI may therefore put increased responsibilities on the significant other and the family. The purpose of this work was to conduct an integrative review of the literature to identify available instruments that might be useful to researchers and clinicians interested in the effects of TBI on family functioning. A review of the literature was undertaken using CINAHL Plus, Family Systems Abstracts, and PubMed from 1998 to 2008. Thirty-five articles were identified in the initial search, and 8 were excluded, leaving 27 articles for full review and analysis. Conceptual and methodological issues identified across the studies resulted in an inability to recommend any of the instruments used in the present studies for use without further study. The issues identified included a lack of conceptual framework for construct validity, variability in injury characteristics, issues with sampling methodology, a lack of longitudinal designs, comparison group issues, and an inability to compare instruments across studies.	Univ Washington, Seattle, WA 98195 USA		Thompson, HJ (corresponding author), Univ Washington, Seattle, WA 98195 USA.	hilairet@u.washington.edu			Building Geriatric Academic Nursing Capacity Program; John A. Hartford Foundation; National Institutes of Health Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [KL2RR025015-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000423] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR025015] Funding Source: NIH RePORTER	This work was funded in part by the Building Geriatric Academic Nursing Capacity Program, John A. Hartford Foundation, and the National Institutes of Health Roadmap for Medical Research (Grant KL2RR025015-01). The author thanks Dr. Karen Schepp for thoughtful discussions regarding this work.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Brown R, 1999, J HEAD TRAUMA REHAB, V14, P257, DOI 10.1097/00001199-199906000-00006; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; *DEP HLTH HUM SERV, 2000, HLTH PEOPL 2010, V2; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Folkman S., 1984, STRESS; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Godfrey HPD, 2003, BRAIN INJURY, V17, P427, DOI 10.1080/0269905031000066201; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hopkins R., 2007, KINGSTON CAREGIVER S; Hutchison C, 1999, J ADV NURS, V29, P1520, DOI 10.1046/j.1365-2648.1999.01041.x; Katz S, 2005, BRAIN INJURY, V19, P59, DOI 10.1080/02699050410001719970; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lawton M. P., 1989, J GERONTOL, V44, P61, DOI 10.1093/geronj/44.3.P61; Layman DE, 2005, BRAIN INJURY, V19, P909, DOI 10.1080/02699050500109928; Man DWK, 2002, BRAIN INJURY, V16, P1025, DOI 10.1080/0269905021000010087; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Marwit SJ, 2006, BRAIN INJURY, V20, P1419, DOI 10.1080/02699050601082214; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; *NAT CTR INJ PREV, 2002, INJ FACT BOOK; OREILLY P, 1988, SOC SCI MED, V26, P863, DOI 10.1016/0277-9536(88)90179-7; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Rapport LJ, 2006, J HEAD TRAUMA REHAB, V21, P432, DOI 10.1097/00001199-200609000-00055; Sander AM, 2007, NEUROREHABILITATION, V22, P9; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Thornton M, 2003, J GERONTOL B-PSYCHOL, V58, pS127, DOI 10.1093/geronb/58.2.S127; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	40	22	22	0	12	AMER ASSOC NEUROSCIENCE NURSES	GLENVIEW	4700 W LAKE AVENUE, GLENVIEW, IL 60025 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2009	41	3					148	158		10.1097/JNN.0b013e3181a23eda			11	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	516XK	WOS:000271576500005	19517765	Green Accepted			2022-02-06	
J	Ornstein, TJ; Levin, HS; Chen, S; Hanten, G; Ewing-Cobbs, L; Dennis, M; Barnes, M; Max, JE; Logan, GD; Schachar, R				Ornstein, Tisha J.; Levin, Harvey S.; Chen, Shirley; Hanten, Gerri; Ewing-Cobbs, Linda; Dennis, Maureen; Barnes, Marcia; Max, Jeffrey E.; Logan, Gordon D.; Schachar, Russell			Performance monitoring in children following traumatic brain injury	JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY			English	Article						Performance monitoring; traumatic brain injury; children; head injury; neuropsychology; pediatrics	MEDIAL FRONTAL-CORTEX; CLOSED-HEAD INJURY; ANTERIOR CINGULATE; STOP-SIGNAL; RESPONSE-INHIBITION; SOCIAL OUTCOMES; MOTOR CONTROL; CONFLICT; COGNITION; RECOVERY	Executive control deficits are common sequelae of childhood traumatic brain injury (TBI). The goal of the current study was to assess a specific executive control function, performance monitoring, in children following TBI. Thirty-one children with mild-moderate TBI, 18 with severe TBI, and 37 control children without TBI, of comparable age and sex, performed the stop signal task, a speeded choice reaction time task. On occasion, they were presented with a signal to stop their responses. Performance monitoring was defined as the extent of slowing in go-task reaction time following failure to stop responses. The TBI group as a whole demonstrated less post-error slowing than did controls. This finding suggested impaired error monitoring performance. In addition, time since injury and socioeconomic status predicted less slowing after stopped responses. We suggest that alterations in performance monitoring expressed as the inability to notice, regulate and adjust behavior to changing situations are an effect of TBI in children.	[Chen, Shirley; Schachar, Russell] Hosp Sick Children, Dept Psychiat, Toronto, ON M5N 2L1, Canada; [Ornstein, Tisha J.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Levin, Harvey S.; Hanten, Gerri] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Ctr, Houston, TX USA; [Dennis, Maureen] Hosp Sick Children, Dept Psychol, Toronto, ON M5N 2L1, Canada; [Barnes, Marcia] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Max, Jeffrey E.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Max, Jeffrey E.] Childrens Hosp & Hlth Ctr, San Diego, CA USA; [Logan, Gordon D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA		Schachar, R (corresponding author), Hosp Sick Children, Dept Psychiat, 555 Univ Ave, Toronto, ON M5N 2L1, Canada.	russell.schachar@sickkids.ca		Schachar, Russell/0000-0002-2015-4395; Logan, Gordon/0000-0002-8301-7726	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [M0P44070, NET 54016]; National Institute of Neurological Diseases and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; Mental Health Research Fellowship, Department of Psychiatry, University of TorontoUniversity of Toronto; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This research was supported by grants from the Canadian Institutes of Health Research (M0P44070; NET 54016) and the National Institute of Neurological Diseases and Stroke (NS-21889). TO was supported by a Mental Health Research Fellowship, Department of Psychiatry, University of Toronto.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bakker K, 1999, Pediatr Rehabil, V3, P149; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Chevrier AD, 2007, HUM BRAIN MAPP, V28, P1347, DOI 10.1002/hbm.20355; Christ SE, 2003, NEUROPSYCHOLOGY, V17, P171, DOI 10.1037/0894-4105.17.1.171; Coles MGH, 2001, BIOL PSYCHOL, V56, P173, DOI 10.1016/S0301-0511(01)00076-X; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Kelly T P, 1999, Pediatr Rehabil, V3, P187; Kramer UM, 2007, J NEUROSCI, V27, P14190, DOI 10.1523/JNEUROSCI.4229-07.2007; Krusch DA, 1996, J ABNORM CHILD PSYCH, V24, P633, DOI 10.1007/BF01670104; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LOGAN GD, 1985, J EXP PSYCHOL LEARN, V11, P675, DOI 10.1037/0278-7393.11.1-4.675; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Logan Gordon D., 1994, P189; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; MENDELSOHN D, 1992, CHILD NERV SYST, V8, P445, DOI 10.1007/BF00274405; Middleton JA, 2001, J CHILD PSYCHOL PSYC, V42, P165, DOI 10.1111/1469-7610.00708; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; RABBITT P, 1977, Q J EXP PSYCHOL, V29, P727, DOI 10.1080/14640747708400645; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; RYLANDER G, 1947, RES PUBLICATIONS ASS, P691; Schachar RJ, 2004, J ABNORM CHILD PSYCH, V32, P285, DOI 10.1023/B:JACP.0000026142.11217.f2; Scheffers MK, 2000, J EXP PSYCHOL HUMAN, V26, P141, DOI 10.1037/0096-1523.26.1.141; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Tarazi RA, 2007, REHABIL PSYCHOL, V52, P196, DOI 10.1037/0090-5550.52.2.196; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; TOW PM, 1953, J NEUROL NEUROSUR PS, V16, P186, DOI 10.1136/jnnp.16.3.186; Ullsperger M, 2006, INT J PSYCHOPHYSIOL, V59, P59, DOI 10.1016/j.ijpsycho.2005.06.010; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Wiersema JR, 2007, NEUROPSYCHOLOGIA, V45, P1649, DOI 10.1016/j.neuropsychologia.2007.01.004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; [No title captured]	61	22	22	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9630	1469-7610		J CHILD PSYCHOL PSYC	J. Child Psychol. Psychiatry	APR	2009	50	4					506	513		10.1111/j.1469-7610.2008.01997.x			8	Psychology, Developmental; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	424KB	WOS:000264564500016	19207625				2022-02-06	
J	Berger, R; Richichi, R				Berger, Rachel; Richichi, Rudolph			Derivation and validation of an equation for adjustment of neuron-specific enolase concentrations in hemolyzed serum	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						neuron-specific enolase; hemolysis; brain injury; children; derivation and validation	TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; MARKERS; PROTEINS; DAMAGE; NSE	Objective: To derive and validate a formula to allow for adjustment of serum neuron-specific enolase (NSE) concentrations based on the amount of hemolysis in the sample. To compare the accuracy of qualitative and quantitative assessment of hemolysis. Design: Derivation and validation of a formula. Subjects: Eighty-three children <11 years of age were used for the derivation. Twenty-three children <11 years without brain injury and 30 with brain injury were used for the validation. Interventions: We evaluated the amount of hemolysis quantitatively using a hemocue and qualitatively by visualization. We measured NSE concentrations by enzyme-linked immunosorbent assay. Using a subset of subjects, we used linear regression analysis to derive an equation to adjust serum NSE concentrations based on the degree of hemolysis. We prospectively validated the formula in a different group. NSE <= 11.5 ng/mL was considered normal. Results: The formula derived was as follow: Adjusted NSE = Unadjusted NSE - (1.659) (square root of the hemocue). In the validation, 96% of children without brain injury had a normal adjusted NSE; 93% of children with brain injury had an abnormal adjusted NSE. Qualitative analysis of hemolysis was inconsistent and both overassessed and under-assessed hemolysis as quantified by hemocue. Conclusions: We retrospectively derived and prospectively validated an equation for adjusting serum NSE concentrations based on the amount of hemolysis in the sample. Use of this formula will allow for accurate measurement of NSE even in hemolyzed sample and may improve its usefulness as a marker of brain injury in children. Qualitative assessment of the degree of hemolysis is not accurate and should not be used. (Pediatr Crit Care Med 2009; 10:260-263)	[Berger, Rachel] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Richichi, Rudolph] Stat Anal & Measurement Consultants, Lanexa, VA USA		Berger, R (corresponding author), Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA.	rberger@pitt.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K23HD43843-01]; Children's Hospital of Pittsburgh General Clinical Research CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR00084]; University of Pittsburgh Center for Injury Research and Control (CIRCL)University of Pittsburgh; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD043843] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000084] Funding Source: NIH RePORTER	Supported by grant 1K23HD43843-01 from the National Institutes of Health, by grant M01 RR00084 from the Children's Hospital of Pittsburgh General Clinical Research Center, and the University of Pittsburgh Center for Injury Research and Control (CIRCL) (RB).	Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; Amer-Wahlin I, 2001, CLIN CHIM ACTA, V304, P57, DOI 10.1016/S0009-8981(00)00408-3; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Burns ER, 2002, LAB MED, V33, P378, DOI 10.1309/PGM4-4F8L-2P1M-LKPB; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Lemery L, 1998, ADV MED LAB PROFESSI, P24; *NAT COMM CLIN LAB, 2007, PROC COLL DIAGN BLOO; NOTOMI T, 1985, TUMOUR BIOL, V6, P57; Nygaard O, 1998, SCAND J CLIN LAB INV, V58, P183; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Sharp MK, 1998, ANN BIOMED ENG, V26, P788, DOI 10.1114/1.65; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC	16	22	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAR	2009	10	2					260	263		10.1097/PCC.0b013e31819a376d			4	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	419VK	WOS:000264247600020	19188872				2022-02-06	
J	Ruchelsman, DE; Tejwani, NC; Kwon, YW; Egol, KA				Ruchelsman, David E.; Tejwani, Nirmal C.; Kwon, Young W.; Egol, Kenneth A.			Open Reduction and Internal Fixation of Capitellar Fractures with Headless Screws	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article							CORONAL SHEAR FRACTURES; HUMERAL CAPITELLUM; CAPITULUM HUMERI; DISTAL END	BACKGROUND: The outcome of operatively treated capitellar fractures has not been reported frequently. The purpose of the present study was to evaluate the clinical, radiographic, and functional outcomes following open reduction and internal fixation of capitellar fractures that were treated with a uniform surgical approach in order to further define the impact on the outcome of fracture type and concomitant lateral column osseous and/or ligamentous injuries. METHODS: A retrospective evaluation of the upper extremity database at our institution identified sixteen skeletally mature patients (mean age, 40 17 years) with a closed capitellar fracture. In all cases, an extensile lateral exposure and articular fixation with buried cannulated variable-pitch headless compression screws was performed at a mean of ten days after the injury. Clinical, radiographic, and elbow-specific outcomes, including the Mayo Elbow Performance Index, were evaluated at a mean of 27 19 months postoperatively. RESULTS: Six Typed, two Type-III, and eight Type-IV fractures were identified with use of the Bryan and Morrey classification system. Four of five ipsilateral radial head fractures occurred in association with a Type-IV fracture. The lateral collateral ligament was intact in fifteen of the sixteen elbows. Metaphyseal comminution was observed in association with five fractures (including four Type-IV fractures and one Type-III fracture). Supplemental mini-fragment screws were used for four of eight Type-IV fractures and one of two Type-III fractures. All fractures healed, and no elbow had instability or weakness. Overall, the mean ulnohumeral motion was 123 degrees (range, 70 degrees to 150 degrees). Fourteen of the sixteen patients achieved a functional arc of elbow motion, and all patients had full forearm rotation. The mean Mayo Elbow Performance Index score was 92 10 points, with nine excellent results, six good results, and one fair result. Patients with a Type-IV fracture had a greater magnitude of flexion contracture (p = 0.04), reduced terminal flexion (p = 0.02), and a reduced net ulnohumeral arc (p = 0.01). An ipsilateral radial head fracture did not appear to affect ulnohumeral motion or the functional outcome. CONCLUSIONS: Despite the presence of greater flexion contractures at the time of follow-up in elbows with Type-IV fractures or fractures with an ipsilateral radial head fracture, good to excellent outcomes with functional ulnohumeral motion can be achieved following internal fixation of these complex fractures. Type-IV injuries may be more common than previously thought; such fractures often are associated with metaphyseal comminution or a radial head fracture and may require supplemental fixation. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions to Authors for a complete description of levels of evidence.	[Ruchelsman, David E.; Tejwani, Nirmal C.; Kwon, Young W.; Egol, Kenneth A.] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY 10003 USA		Ruchelsman, DE (corresponding author), NYU, Hosp Joint Dis, Dept Orthopaed Surg, 301 E 17th St,14th Floor, New York, NY 10003 USA.	man@nyumc.org; Nirmal.Tejwani@nyumc.org; Young.Kwon@nyumc.org; Kenneth.Egol@nyumc.org		Kwon, Young/0000-0003-2465-9945; Tejwani, Nirmal/0000-0001-8578-6556			ALVAREZ E, 1975, J BONE JOINT SURG AM, V57, P1093, DOI 10.2106/00004623-197557080-00010; Bryan R., 1985, ELBOW ITS DISORDERS, P325; Dubberley JH, 2006, J BONE JOINT SURG AM, V88A, P46, DOI 10.2106/JBJS.D.02954; DUSHUTTLE RP, 1985, J TRAUMA, V25, P317, DOI 10.1097/00005373-198504000-00006; FOWLES JV, 1974, J BONE JOINT SURG AM, VA 56, P794, DOI 10.2106/00004623-197456040-00013; Goodman HJ, 2005, BULL HOSP JT DIS, V62, P85; GRANTHAM SA, 1981, CLIN ORTHOP RELAT R, P262; Imatani J, 2001, J SHOULDER ELB SURG, V10, P554, DOI 10.1067/mse.2001.118005; MA YZ, 1984, CLIN ORTHOP RELAT R, P17; Mahirogullari M, 2006, J HAND SURG-BRIT EUR, V31B, P320, DOI 10.1016/j.jhsb.2006.02.002; McKee MD, 1996, J BONE JOINT SURG AM, V78A, P49, DOI 10.2106/00004623-199601000-00007; Mighell MA, 2006, J ORTHOP TRAUMA, V20, P699, DOI 10.1097/01.bot.0000246411.33047.80; Ochner RS, 1996, J TRAUMA, V40, P199, DOI 10.1097/00005373-199602000-00005; Ring D, 2003, J BONE JOINT SURG AM, V85A, P232, DOI 10.2106/00004623-200302000-00008; Ruchelsman DE, 2008, J BONE JOINT SURG AM, V90A, P1321, DOI 10.2106/JBJS.G.00940; Sano S, 2005, J SHOULDER ELB SURG, V14, P307, DOI 10.1016/j.jse.2004.09.005; Stamatis E, 2003, J ORTHOP TRAUMA, V17, P279, DOI 10.1097/00005131-200304000-00006	17	22	24	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0021-9355	1535-1386		J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. Vol.	MAR	2009	91A		1	2			38	49		10.2106/JBJS.H.01195			12	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	419GZ	WOS:000264208900005	19255199				2022-02-06	
J	Jin, W; Wang, HD; Ji, Y; Zhu, L; Yan, W; Qiao, L; Yin, HX				Jin, Wei; Wang, Handong; Ji, Yan; Zhu, Lin; Yan, Wei; Qiao, Liang; Yin, Hongxia			Genetic Ablation of Nrf2 Enhances Susceptibility to Acute Lung Injury After Traumatic Brain Injury in Mice	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						nuclear factor E2-related factor 2; traumatic brain injury; acute lung injury; apoptosis; inflammation; oxidative stress	INTRACEREBRAL HEMORRHAGE; NRF2-DEFICIENT MICE; PULMONARY-EDEMA; HEAD-INJURY; PROTECTION; INFLAMMATION; REDUCTASE; SEPSIS; CHEMOPREVENTION; PERMEABILITY	Previous studies have shown that nuclear factor erythrold 2-related factor 2 (Nrf2) plays a unique role in many physiological stress processes. The present study Investigated the role of Nrf2 in the regulation of traumatic brain Injury (TBI)-induced acute lung Injury (ALI). Wild-type Nrf2 (+/+) and Nrf2 (-/-)-deficient mice were subjected to a moderately severe weight-drop Impact head injury. Pulmonary capillary permeability (PCP), wet/dry weight ratio, apoptosis, inflammatory cytokines and antioxidant/detoxifying enzymes were measured at 24 h after TBI. Mice lacking Nrf2 were found to be more susceptible to TBI-Induced ALI, as characterized by the higher Increase in PCP, wet/dry weight ratio and alveolar cells apoptosis after TBI. This exacerbation of lung Injury in Nrf2-deficient mice was associated with increased pulmonary mRNA and protein expression of Inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6); and with decreased pulmonary mRNA expression and enzymatic activities of antioxidant and detoxifying enzymes Including NAD(P)H:quinone oxidoreductase 1 (NQO1) and glutathione S-transferese oil (GST-alpha 1)-as compared with their wild-type Nrf2 (+/+) counterparts after TBI. The results of the present study suggest that Nrf2 reduces TBI-Induced acute lung Injury, possibly by decreasing pulmonary Inflammation and inducing antioxidant and detoxifying enzymes. Exp Biol Med 234:181-189, 2009	[Jin, Wei; Wang, Handong; Zhu, Lin; Qiao, Liang; Yin, Hongxia] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China; [Ji, Yan] Nanjing Univ, Affiliated Stomatol Hosp, Sch Med, Dept Prevent Dent, Nanjing 210008, Jiangsu Prov, Peoples R China; [Yan, Wei] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China		Wang, HD (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	hdwang_jw@yahoo.com.cn	Yin, Hong/AAC-5784-2020	Yan, Wei/0000-0002-1123-0835	Jinling Hospital of China	This work wits supported by grants from Jinling Hospital of China.	BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Cho HY, 2004, FASEB J, V18, P1258, DOI 10.1096/fj.03-1127fje; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Das A, 2006, FREE RADICAL BIO MED, V40, P1843, DOI 10.1016/j.freeradbiomed.2006.01.025; DETTBARN CL, 1989, HEART LUNG, V18, P583; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HECHT SS, 1995, J CELL BIOCHEM, P195; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; Kamada F, 2007, INT ARCH ALLERGY IMM, V144, P275, DOI 10.1159/000106316; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kelly VP, 2000, CANCER RES, V60, P957; Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee JM, 2004, J BIOCHEM MOL BIOL, V37, P139; Lv R, 2005, ANN CLIN LAB SCI, V35, P174; Mikrogianakis A, 2007, J NEUROTRAUM, V24, P338, DOI 10.1089/neu.2006.003615; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Osburn WO, 2006, ARCH BIOCHEM BIOPHYS, V454, P7, DOI 10.1016/j.abb.2006.08.005; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Rangasamy T, 2005, J EXP MED, V202, P47, DOI 10.1084/jem.20050538; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; ROSS D, 1993, CANCER METAST REV, V12, P83, DOI 10.1007/BF00689803; Saldivar SJ, 2005, MUTAT RES-GEN TOX EN, V582, P71, DOI 10.1016/j.mrgentox.2004.12.010; Saydam N, 1997, CANCER LETT, V119, P13, DOI 10.1016/S0304-3835(97)00245-0; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Sreeja Leelakumari, 2008, J Exp Ther Oncol, V7, P73; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Ware LB, 2005, EUR RESPIR J, V26, P101, DOI 10.1183/09031936.05.00106604; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wu S, 2006, EXP NEUROL, V200, P245, DOI 10.1016/j.expneurol.2006.01.027	41	22	25	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1535-3702	1535-3699		EXP BIOL MED	Exp. Biol. Med.	FEB	2009	234	2					181	189		10.3181/0807-RM-232			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	403MX	WOS:000263087800008	19176347				2022-02-06	
J	Chan, J; Parmenter, T; Stancliffe, R				Chan, Jeffrey; Parmenter, Trevor; Stancliffe, Roger			The impact of traumatic brain injury on the mental health outcomes of individuals and their family carers	ADVANCES IN MENTAL HEALTH			English	Article						traumatic brain injury; mental illness; suicide; disability; quality of life; rehabilitation; carers		Traumatic brain injury (TBI) is one of the leading causes of death and life- long disability. The impact of TBI on the person and family carers is significant and long- term, such that persons with TBI require continuing support and care in various aspects of their lives many years after the injury. Family carers also require ongoing support. Mental ill health is one aspect that greatly impacts on the lives of these people. People with TBI may experience a range of psychiatric symptoms, such as depression, anxiety disorders, mood disorders or panic disorder. They are also at risk of suicidality and offending behaviours. Family carers of people with TBI also experienced a range of psychological distress. TBI also impacts negatively on the quality of life of the individuals and their family carers. There is a definite role for mental health services and practitioners to provide support to people with TBI and their family carers. This review paper argues for an appropriate level of mental health support for people with TBI and their family carers because the concerns are not only health- related but are a social concern for the community and government.	[Chan, Jeffrey] Dept Human Serv, 50 Lonsdale St, Melbourne, Vic 3141, Australia; [Parmenter, Trevor] Univ Sydney, Ctr Disabil Studies & Fac Med, Sydney, NSW, Australia; [Stancliffe, Roger] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia		Chan, J (corresponding author), Dept Human Serv, 50 Lonsdale St, Melbourne, Vic 3141, Australia.	jeffrey.chan@dhs.vic.gov.au	Stancliffe, Roger/C-3430-2008	Stancliffe, Roger/0000-0003-4265-7433; Parmenter, Trevor/0000-0002-8297-8488			Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN; Australian Institute of Health and Welfare, 2003, DIA PREV TRENDS; Barker-Collo S., 2007, BRAIN IMPAIR, V8, DOI [DOI 10.1375/BRIM.8.1.22, https://doi.org/10.1375/brim.8.1.22]; Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Chan J., 2004, AUSTR E J ADV MENTAL, V3; Chan J, 2008, INT J REHABIL RES, V31, P3, DOI 10.1097/MRR.0b013e3282f45215; Chan J, 2007, INT J REHABIL RES, V30, P137, DOI 10.1097/MRR.0b013e32813a2f11; Colantonio A, 2007, BRAIN INJURY, V21, P1353, DOI 10.1080/02699050701785054; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Deb S, 1999, AM J PSYCHIAT, V156, P374; Department of Human Services, 2004, ACQ BRAIN INJ MENT I; Department of Human Services Victoria, 2001, ACQ BRAIN INJ STRAT; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kishi Y, 2001, J NERV MENT DIS, V189, P623, DOI 10.1097/00005053-200109000-00009; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Man DWK, 2004, BRAIN INJURY, V18, P577, DOI 10.1080/02699050310001646143; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Onsworth T., 2004, BRAIN IMPAIR, V5, P53; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson G, 2001, J HEAD TRAUMA REHAB, V16, P556, DOI 10.1097/00001199-200112000-00004; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Simpson G. K., 2004, THESIS; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tate R., 2007, LONG TERM OUTCOMES T; Tate R., 2003, FINAL REPORT MOTOR A; Tate RL, 2004, BRAIN INJURY OUTCOME; Teasell R, 2007, BRAIN INJURY, V21, P107, DOI 10.1080/02699050701201524; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Torsney K, 2004, PSYCHIATR REHABIL J, V28, P75, DOI 10.2975/28.2004.75.77; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Viguier D, 2001, BRAIN INJURY, V15, P263; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Xu XY, 2007, BRAIN INJURY, V21, P575, DOI 10.1080/02699050701426881; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	73	22	22	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1838-7357	1837-4905		ADV MENT HEALTH	Adv. Ment. Health		2009	8	2					155	164		10.5172/jamh.8.2.155			10	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	V75EV	WOS:000211828800006					2022-02-06	
J	Cullen, N; Perera, J				Cullen, Nora; Perera, Jerome			Heterotopic Ossification: Pharmacologic Options	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; BONE; HIP		[Cullen, Nora] Univ Toronto, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Cullen, Nora] Univ Toronto, Div Physiatry, Toronto, ON M5G 2A2, Canada; [Perera, Jerome] Univ Toronto, Fac Med, Toronto, ON M5G 2A2, Canada		Cullen, N (corresponding author), Univ Toronto, Toronto Rehabil Inst, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	cullen.nora@torontohab.on.ca		Cullen, Nora/0000-0001-6359-9418			Banovac K, 2001, SPINAL CORD, V39, P370, DOI 10.1038/sj.sc.3101166; BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; Estrores IM, 2004, J SPINAL CORD MED, V27, P434, DOI 10.1080/10790268.2004.11752233; HARAN M, 2008, COCHRANE DB SYST REV, P4; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; HU HP, 1991, CLIN ORTHOP RELAT R, P259; Macfarlane RJ, 2008, EXPERT OPIN PHARMACO, V9, P767, DOI 10.1517/14656566.9.5.767; Mahay PR, 1988, CLIN ORTHOP RELAT R, V237, P236; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; STOVER SL, 1975, ARCH PHYS MED REHAB, V56, P199; Sugita A, 2005, J BONE MINER METAB, V23, P329, DOI 10.1007/s00774-005-0608-5; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; Vuolteenaho K, 2008, BASIC CLIN PHARMACOL, V102, P10, DOI 10.1111/j.1742-7843.2007.00149.x	15	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2009	24	1					69	71		10.1097/HTR.0b013e31819a8fcc			3	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	427GT	WOS:000264768500011	19158599				2022-02-06	
J	Hessen, E; Nestvold, K				Hessen, Erik; Nestvold, Knut			Indicators of complicated mild TBI predict MMPI-2 scores after 23 years	BRAIN INJURY			English	Article						Long term TBI outcome; mild brain injury; mTBI; MMPI-2; post-concussive syndrome	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL FUNCTION; POSTCONCUSSIVE SYMPTOMS; CHILDREN; CLASSIFICATION; ADOLESCENTS; TOMOGRAPHY; PROFILES; SCALE	Primary objective: Research suggests that post-concussive syndrome may become persistent after mild traumatic brain injury (mTBI). The aim of this study was to investigate determinants of subjective complaints, characteristic for post-concussive syndrome, 23 years after mTBI. Research design: The study was a follow-up after a prospective head injury study at a general hospital in Norway. Methods and procedures: Ninety-seven patients were assessed with the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) 23 years after sustaining primarily mTBI. Main outcomes and results: A good overall outcome was found with scores close to the normative mean, average length of education and normal employment rate. However, the patients that sustained complicated mTBI showed somewhat more pathological scores, well-matched with mild post-concussive syndrome. The most important predictors of poor outcome were a combination of post-traumatic amnesia 30 minutes and EEG pathology within 24 hours after TBI. No influence of pre- and post-injury risk factors on current MMPI-2 profiles was found. Conclusions: The results are in line with previous research findings and support the notion of potentially differential impact of uncomplicated vs. complicated mTBI. The findings suggest that complicated mTBI may cause subtle chronic symptoms typical of post-concussive syndrome.	[Hessen, Erik; Nestvold, Knut] Akershus Univ Hosp, Dept Neurol, Oslo, Norway		Hessen, E (corresponding author), Akershus Univ Hosp, Dept Neurol, N-1478 Lorenskog, Norway.	erik.hessen@nevropsykologi.no					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; BUTCHER JN, 2004, MMPI 2 NORWEGIAN; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; Dearth CS, 2005, ARCH CLIN NEUROPSYCH, V20, P95, DOI 10.1016/j.acn.2004.03.004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; DIKMEN SS, 1989, MILD HEAD INJURY, P229; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Greene RL, 2000, MMPI 2 INTERPRETIVE; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Hartlage LC, 2001, ARCH CLIN NEUROPSYCH, V16, P561, DOI 10.1016/S0887-6177(00)00067-6; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Hessen E, 2008, BRAIN INJURY, V22, P39, DOI 10.1080/02699050701846179; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; JENNETT B, 1975, LANCET, V1, P480; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MACK JL, 1979, MMPI CLIN RES TRENDS, P53; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; Miller L, 1996, J COGNITIVE REHABILI, V14, P8; Mittenberg W., 1997, CLIN NEUROPSYCHOL, V11, P305; Nell V, 2000, ARCH PHYS MED REHAB, V81, P614, DOI 10.1053/mr.2000.3877; NESTVOLD K, 1988, NEUROEPIDEMIOLOGY, V7, P134, DOI 10.1159/000110147; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Tellier A, 1999, BRAIN INJURY, V13, P463; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003; ZAKZANIS KK, 1999, MILD TRAUMATIC BRAIN, P163	47	22	22	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2009	23	3					234	242	PII 908613873	10.1080/02699050902748349			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	406AJ	WOS:000263267100007	19205960				2022-02-06	
J	Jang, SH; Kim, SH; Kim, OL; Byun, WM; Ahna, SH				Jang, Sung Ho; Kim, Seong Ho; Kim, Oh Lyong; Byun, Woo Mok; Ahna, Sang Ho			Corticospinal tract injury in patients with diffuse axonal injury: A diffusion tensor imaging study	NEUROREHABILITATION			English	Article						Diffusion tensor imaging; corticospinal tract; diffuse axonal injury	TRAUMATIC BRAIN-INJURY; FIBER TRACKING; FOCAL LESIONS; HEAD TRAUMA; MR; RECOVERY; ABNORMALITIES; FEATURES	Diffusion tensor imaging (DTI) can be useful in detecting corticospinal tract (CST) injury at the subcortical white matter level. In the current study, we attempted to investigate the incidence and distribution of CST injury in patients with diffuse axonal injury (DAI), using DTI. Fourteen patients who showed motor weakness without any specific lesion along the CST pathway on conventional brain MRI, and twelve age-matched, normal healthy control subjects were recruited. DTI was performed using 1.5 T with a synergy-L Sensitivity Encoding (SENSE) head coil. Fractional anisotropy was measured using the region of interest method. A CST injury was defined as the FA value of a certain area being decreased two standard deviations below that of normal controls. All 14 patients had more than one lesion at the CST injury, and the mean number of CST injuries was 3.6 (range: 2-7). The CSTs were involved at the following locations: the pons (61%), the cerebral peduncle (39%), the corona radiata (21%), the medulla (14%), and the posterior limb (11%). The pons was the most prevalent area of CST injury in patients with weakness caused by DAI at the subcortical level. We found that DTI is a useful technique for detecting a DAI of the CST at the subcortical level.	[Jang, Sung Ho; Ahna, Sang Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea; [Kim, Seong Ho; Kim, Oh Lyong] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea; [Byun, Woo Mok] Yeungnam Univ, Coll Med, Dept Diagnost Radiol, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1,Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Ducreux D, 2005, NEURORADIOLOGY, V47, P604, DOI 10.1007/s00234-005-1389-1; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Han BS, 2007, NEUROREHABILITATION, V22, P151; Holodny AI, 2005, ANN NY ACAD SCI, V1064, P88, DOI 10.1196/annals.1340.016; Katz DI, 1998, ARCH PHYS MED REHAB, V79, P488, DOI 10.1016/S0003-9993(98)90060-0; Kwon YH, 2007, NEUROSCI LETT, V417, P138, DOI 10.1016/j.neulet.2007.01.084; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Lee JW, 2006, J HEAD TRAUMA REHAB, V21, P272, DOI 10.1097/00001199-200605000-00007; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shelton FDAP, 2001, STROKE, V32, P107, DOI 10.1161/01.STR.32.1.107; Skoglund TS, 2008, ACTA RADIOL, V49, P98, DOI 10.1080/02841850701561372; Son SM, 2007, NEUROSCI LETT, V420, P34, DOI 10.1016/j.neulet.2007.04.054; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yamada K, 2007, J MAGN RESON IMAGING, V26, P519, DOI 10.1002/jmri.21006; Yasokawa YT, 2007, J NEUROTRAUM, V24, P163, DOI 10.1089/neu.2006.0073	26	22	25	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2009	25	4					229	233		10.3233/NRE-2009-0519			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	540LC	WOS:000273332100001	20037214				2022-02-06	
S	Kawase, M; Sakagami, H; Motohashi, N		Motohashi, N		Kawase, Masami; Sakagami, Hiroshi; Motohashi, Noboru			The Chemistry of Bioactive Mesoionic Heterocycles	BIOACTIVE HETEROCYCLES VII: FLAVONOIDS AND ANTHOCYANINS IN PLANTS, AND LATEST BIOACTIVE HETEROCYCLES II	Topics in Heterocyclic Chemistry		English	Article; Book Chapter						Mesoionic; Sydnones; Sydnonimines; 1,2,3,4-Oxatriazolium-5-aminates; 1,3,4-Thiadiazolium-2-aminides	NITRIC-OXIDE DONORS; SUBSTITUTED OXATRIAZOLE-5-IMINE DERIVATIVES; HUMAN LYMPHOCYTE-PROLIFERATION; ENERGY-LINKED FUNCTIONS; TRAUMATIC BRAIN-INJURY; RAT-LIVER MITOCHONDRIA; INDUCED CELL-DEATH; COMPOUND MI-D; BIOLOGICAL EVALUATION; ANTIOXIDANT ACTIVITY	This review focuses on the latest developments in biologically interesting mesoionic compounds, such as sydnones, sydnonimines, 1,2,3,4-oxatriazolium-5-aminates, and 1,3,4-thiadiazolium-2-aminides, mainly since 2000.	[Kawase, Masami] Matsuyama Univ, Fac Pharmaceut Sci, Matsuyama, Ehime 7908578, Japan; [Sakagami, Hiroshi] Meikai Univ, Sch Dent, Saitama 3500238, Japan; [Motohashi, Noboru] Meiji Pharmaceut Univ, Tokyo 2048588, Japan		Kawase, M (corresponding author), Matsuyama Univ, Fac Pharmaceut Sci, 4-2 Bunkyo Cho, Matsuyama, Ehime 7908578, Japan.	kawase@cc.matsuyama-u.ac.jp					Anderzhanova EA, 2000, ANN NY ACAD SCI, V914, P137, DOI 10.1111/j.1749-6632.2000.tb05191.x; Azarifar D, 2006, SYNTHESIS-STUTTGART, P1123, DOI 10.1055/s-2006-926380; Besthorn, 1882, LIEBIGS ANN CHEM, V212, P316, DOI DOI 10.1002/JLAC.18822120303; BIEBER TI, 1955, CHEM IND-LONDON, P910; BROOKES P, 1957, J CHEM SOC, P4409, DOI 10.1039/jr9570004409; Bryan-Lluka LJ, 2004, BRIT J PHARMACOL, V143, P63, DOI 10.1038/sj.bjp.0705904; Cadena SMSC, 2002, CELL BIOCHEM FUNCT, V20, P31, DOI 10.1002/cbf.932; Cadena SMSC, 1998, FEBS LETT, V440, P46, DOI 10.1016/S0014-5793(98)01427-6; Cai TB, 2005, J ORG CHEM, V70, P3518, DOI 10.1021/jo050010o; Cardoso JC, 2004, DRUG DEVELOP RES, V61, P207, DOI 10.1002/ddr.10354; Choi KM, 2007, NEUROGASTROENT MOTIL, V19, P585, DOI 10.1111/j.1365-2982.2007.00936.x; Corell Tim, 1994, Polish Journal of Pharmacology, V46, P553; da Silva EF, 2002, EUR J MED CHEM, V37, P979, DOI 10.1016/S0223-5234(02)01401-0; Dunkley CS, 2003, BIOORG MED CHEM LETT, V13, P2899, DOI 10.1016/S0960-894X(03)00487-6; Ferry-Dumazet H, 2002, LEUKEMIA, V16, P708, DOI 10.1038/sj.leu.2402404; FINNEGAN WG, 1965, J ORG CHEM, V30, P567, DOI 10.1021/jo01013a066; Gasco A, 2005, NITRIC OXIDE DONORS: FOR PHARMACEUTICAL AND BIOLOGICAL APPLICATIONS, P131, DOI 10.1002/3527603751.ch6; Gryglewski RJ, 2002, CURR PHARM DESIGN, V8, P167, DOI 10.2174/1381612023396311; GRYNBERG N, 1992, ANTICANCER RES, V12, P1025; Grynberg N, 1997, ANTI-CANCER DRUG, V8, P88, DOI 10.1097/00001813-199701000-00012; Halila GC, 2007, CHEM-BIOL INTERACT, V169, P160, DOI 10.1016/j.cbi.2007.06.003; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Herman AG, 2005, EUR HEART J, V26, P1945, DOI 10.1093/eurheartj/ehi333; Holm P, 1998, EUR J PHARMACOL, V346, P97, DOI 10.1016/S0014-2999(98)00009-0; Hsu MF, 2006, EUR J PHARMACOL, V535, P43, DOI 10.1016/j.ejphar.2006.02.013; Kankaanranta H, 1997, MOL PHARMACOL, V51, P882, DOI 10.1124/mol.51.5.882; Kankaanranta H, 1996, BRIT J PHARMACOL, V117, P401, DOI 10.1111/j.1476-5381.1996.tb15204.x; Kato H., 1957, NIPPON KAGAKU ZASSHI, V78, P707; KIER LB, 1967, J PHARM SCI, V56, P149, DOI 10.1002/jps.2600560202; Kojima S, 2006, EUR J PHARMACOL, V550, P162, DOI 10.1016/j.ejphar.2006.08.047; Kosonen O, 1997, EUR J PHARMACOL, V337, P55, DOI 10.1016/S0014-2999(97)01266-1; Kosonen O, 1998, BRIT J PHARMACOL, V125, P247, DOI 10.1038/sj.bjp.0702042; Kosonen O, 1998, J PHARMACOL EXP THER, V286, P215; Lahteenmaki T, 1998, BRIT J PHARMACOL, V125, P402, DOI 10.1038/sj.bjp.0702076; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; Laursen BE, 2006, CARDIOVASC DRUG REV, V24, P247, DOI 10.1111/j.1527-3466.2006.00247.x; Lee CS, 2007, LIFE SCI, V80, P1759, DOI 10.1016/j.lfs.2007.02.003; Lee CS, 2005, BRAIN RES, V1036, P18, DOI 10.1016/j.brainres.2004.12.036; Luchowski P, 2007, EUR J PHARMACOL, V563, P130, DOI 10.1016/j.ejphar.2007.02.044; Marcos E, 2003, AM J RESP CRIT CARE, V168, P487, DOI 10.1164/rccm.200210-1212OC; Martinet W, 2007, BRIT J PHARMACOL, V152, P493, DOI 10.1038/sj.bjp.0707426; MASUDA K, 1971, CHEM PHARM BULL, V19, P559; McGrowder D., 2006, INT J PHARMACEUT, V2, P366, DOI DOI 10.3923/IJP.2006.366.373; Meij JTA, 2004, MOL PHARMACOL, V66, P1043, DOI 10.1124/mol.104.001354; Miller MR, 2007, BRIT J PHARMACOL, V151, P305, DOI 10.1038/sj.bjp.0707224; MONCADA S, 1995, FASEB J, V9, P1319, DOI 10.1096/fasebj.9.13.7557022; Moustafa MA, 2004, ARCH PHARM, V337, P427, DOI 10.1002/ardp.200300847; Moustafa MA, 2004, ARCH PHARM, V337, P164, DOI 10.1002/ardp.200300814; NEWTON CG, 1982, TETRAHEDRON, V38, P2965, DOI 10.1016/0040-4020(82)80186-5; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Patel KP, 2001, EXP BIOL MED, V226, P814, DOI 10.1177/153537020122600902; Pitsikas N, 2005, NEUROBIOL AGING, V26, P259, DOI 10.1016/j.neurobiolaging.2004.04.003; Pitsikas N, 2007, EUR J PHARMACOL, V571, P174, DOI 10.1016/j.ejphar.2007.06.019; Rabkin SW, 2007, AUTOPHAGY, V3, P347, DOI 10.4161/auto.4054; Rabkin SW, 2007, NITRIC OXIDE-BIOL CH, V16, P339, DOI 10.1016/j.niox.2006.10.007; Ramsden, 1976, ADV HETEROCYCL CHEM, V19, P1, DOI [10.1016/S0065-2725(08)60230-5, DOI 10.1016/S0065-2725(08)60230-5]; Rodrigues RF, 2007, EUR J MED CHEM, V42, P1039, DOI 10.1016/j.ejmech.2006.12.026; Schrammel A, 1998, MOL PHARMACOL, V54, P207, DOI 10.1124/mol.54.1.207; Schwenke DO, 2007, CLIN EXP PHARMACOL P, V34, P88, DOI 10.1111/j.1440-1681.2007.04544.x; Schwenke DO, 2005, CLIN EXP PHARMACOL P, V32, P952, DOI 10.1111/j.1440-1681.2005.4290.x; Senff-Ribeiro A, 2004, BRIT J CANCER, V91, P297, DOI 10.1038/sj.bjc.6601946; Senff-Ribeiro A, 2004, ANTI-CANCER DRUG, V15, P269, DOI 10.1097/00001813-200403000-00012; Senff-Ribeiro A, 2003, MELANOMA RES, V13, P465, DOI 10.1097/00008390-200310000-00005; Shih MH, 2007, TETRAHEDRON, V63, P2990, DOI 10.1016/j.tet.2007.01.066; Shih MH, 2007, CHEM PHARM BULL, V55, P1126, DOI 10.1248/cpb.55.1126; Shih MH, 2005, TETRAHEDRON, V61, P10917, DOI 10.1016/j.tet.2005.08.107; Shih MH, 2004, BIOORGAN MED CHEM, V12, P4633, DOI 10.1016/j.bmc.2004.06.033; Shih MH, 2003, TETRAHEDRON, V59, P4103, DOI 10.1016/S0040-4020(03)00574-X; Shpak AV, 2005, J CHROMATOGR SCI, V43, P11, DOI 10.1093/chromsci/43.1.11; Siegemund M, 2007, ACTA ANAESTH SCAND, V51, P693, DOI 10.1111/j.1399-6576.2007.01334.x; Sitmo M, 2007, AM J PHYSIOL-GASTR L, V293, pG886, DOI 10.1152/ajpgi.00124.2007; Taylor EL, 2004, BRIT J PHARMACOL, V143, P179, DOI 10.1038/sj.bjp.0705909; Taylor EL, 2007, BIOCHEM PHARMACOL, V74, P1039, DOI 10.1016/j.bcp.2007.06.028; Vilpo JA, 1997, ANTI-CANCER DRUG DES, V12, P75; Vinatier V, 2006, NITRIC OXIDE-BIOL CH, V15, P363, DOI 10.1016/j.niox.2006.03.006; Wang JP, 2003, EUR J PHARMACOL, V458, P243, DOI 10.1016/S0014-2999(02)02790-5; Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l; Wiley JW, 2007, NEUROGASTROENT MOTIL, V19, P541, DOI 10.1111/j.1365-2982.2007.00958.x	78	22	22	0	3	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES	1861-9282		978-3-642-00335-6	TOP HETEROCYCL CHEM			2009	16						135	152		10.1007/7081_2007_096	10.1007/978-3-642-00336-3		18	Biochemistry & Molecular Biology; Chemistry, Organic; Food Science & Technology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Chemistry; Food Science & Technology	BKC41	WOS:000267752400004					2022-02-06	
J	Larrabee, GJ				Larrabee, Glenn J.			MALINGERING SCALES FOR THE CONTINUOUS RECOGNITION MEMORY TEST AND THE CONTINUOUS VISUAL MEMORY TEST	CLINICAL NEUROPSYCHOLOGIST			English	Article						Continuous Recognition Memory Test; Continuous Visual Memory Test; Malingering	VERBAL-LEARNING TEST; FAKE-BAD SCALE; CONSTRUCT-VALIDITY; INCOMPLETE EFFORT; SUSPECT EFFORT; HEAD-INJURY; MMPI-2	Continuous Visual Memory Test (CVMT) and Continuous Recognition Memory Test (CRM) scores of 24 litigants with definite malingered neurocognitive dysfunction (definite MND) were contrasted with those of 27 patients with moderate (n=12) and severe (n=15) traumatic brain injury (TBI). Analysis with chi-square identified 20 CVMT and 33 CRM items that discriminated the definite MND from TBI cases. Receiver operating characteristic (ROC) area under curve (AUC) was 0.918 for the CVMT scale, and 0.962 for the CRM scale, p=0.184. Cutting scores were derived yielding sensitivity and specificity of 0.83 and 0.889 for the 20-item CVMT scale, and 0.875 and 0.93 for the 33-item CRM scale. On cross-validation contrasting performance of 17 litigants with evidence of probable MND and non-litigating psychiatric (n=14) and neurologic (n=13) patients, ROC AUC was 0.779 for the CVMT scale, and 0.847 for the CRM scale, p=0.447. Sensitivity and specificity were 0.35 and 0.93 for the CVMT, and 0.529 and 0.96 for the CRM, using the cutting scores from the derivation sample. ROC AUC differences contrasting values for the definite MND/TBI comparison to the probable MND/neurologic and psychiatric comparison approached significance for the CRM SVT scale (p=0.059), and for the CVMT SVT scale (p=0.082). These data suggest that the malingering scales for the CVMT and CRM are more sensitive to definite rather than probable MND, and these scales are better at ruling in than ruling out malingered visual memory deficits.			Larrabee, GJ (corresponding author), 2650 Bahia Vista St,Suite 308, Sarasota, FL 34239 USA.	GLarrabee@aol.com					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Benton A., 1994, CONTRIBUTIONS NEUROP; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; DRAKE AI, 1992, J CLIN EXP NEUROPSYC, V14, P539, DOI 10.1080/01688639208402843; Fuchs KL, 1999, CLIN NEUROPSYCHOL, V13, P54, DOI 10.1076/clin.13.1.54.1977; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GREVE KW, CLIN NEUROP IN PRESS; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; HANNAY HJ, 1989, J CLIN EXP NEUROPSYC, V11, P444, DOI 10.1080/01688638908400905; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; LARRABEE GJ, 1992, ARCH CLIN NEUROPSYCH, V7, P395, DOI 10.1016/0887-6177(92)90152-D; LARRABEE GJ, CLIN NEUROP IN PRESS; Larrabee GJ, 1988, NEUROPSYCHOLOGY, V2, P173, DOI 10.1037//0894-4105.2.3-4.173; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lemeshow S, 2000, APPL LOGISTIC REGRES; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; McNichol D, 1972, PRIMER SIGNAL DETECT; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; STRAUS SE, 2005, EVIDENCE BASED MED R; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRAHAN DE, 1986, EXP AGING RES, V12, P147; TRAHAN DE, 1990, J CLIN EXP NEUROPSYC, V12, P857, DOI 10.1080/01688639008401027; Trahan DE, 1988, CONTINUOUS VISUAL ME; TRAHAN DE, 1989, CLIN NEUROPSYCHOL, V3, P169, DOI DOI 10.1080/13854048908403290; Trahan DE, 1988, NEUROPSYCHOLOGY, V2, P29, DOI 10.1037//0894-4105.2.1.29; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Wolfson, 1993, HALSTEAD REITAN NEUR	41	22	22	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	1					167	180		10.1080/13854040801968443			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	399LR	WOS:000262801900010	18609339				2022-02-06	
J	Lo, TYM; Jones, PA; Chambers, IR; Beattie, TF; Forsyth, R; Mendelow, AD; Minns, RA				Lo, T. Y. M.; Jones, P. A.; Chambers, I. R.; Beattie, T. F.; Forsyth, R.; Mendelow, A. D.; Minns, R. A.			Modulating effect of apolipoprotein E polymorphisms on secondary brain insult and outcome after childhood brain trauma	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Apolipoprotein E genetic polymorphisms; Cerebral perfusion pressure; Outcome; GCS; Paediatrics	CEREBRAL-BLOOD-FLOW; E EPSILON-4 ALLELE; SEVERE HEAD-INJURY; APOE GENOTYPE; E PHENOTYPE; INTRACRANIAL-PRESSURE; ASSOCIATION; DISEASE; CHILDREN; SYSTEM	The aim of this study was to determine the relationship between apolipoprotein E (APO E) alleles, the amount of cerebral perfusion pressure (CPP) insult and outcome in children after brain trauma. In a prospective two-centre case-control study, the APO E genotypes of 65 critically ill children admitted after brain trauma were correlated with age-related CPP insult quantification, conscious state at the time of discharge from intensive care and global outcome at 6 months post-injury. One hundred sixty healthy age- and sex-matched children were genotyped as controls. The CPP insult level among the e4 carriers with poor outcome was significantly less than the non-e4 carriers (p = 0.03). Homozygotic e3 patients with good recovery did so despite having suffered nearly 26 times more CPP insult than those who were not e3 homzygous (p = 0.02). Different APO E alleles may potentially affect cerebral ischaemic tolerance differently in children after brain trauma.	[Lo, T. Y. M.; Jones, P. A.; Minns, R. A.] Univ Edinburgh, Sect Child Life & Hlth, Edinburgh EH9 1LF, Midlothian, Scotland; [Lo, T. Y. M.; Beattie, T. F.; Minns, R. A.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Chambers, I. R.; Forsyth, R.; Mendelow, A. D.] Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England		Lo, TYM (corresponding author), Univ Edinburgh, Sect Child Life & Hlth, 20 Sylvan Pl, Edinburgh EH9 1LF, Midlothian, Scotland.	mils.lo@doctors.org.uk	Forsyth, Rob/H-9193-2019; Forsyth, Rob J/I-9226-2012; Mendelow, Alexander/AAW-2878-2021	Forsyth, Rob/0000-0002-5657-4180; Forsyth, Rob J/0000-0002-5657-4180; 	Newcastle General Hospital	We are grateful to our medical and nursing colleagues in the Intensive Care Units at RHSC, Edinburgh, and Newcastle General Hospital for their support with this project. We thank J. Croft and G. Wilson who facilitated demographic data and buccal smear collection for patients recruited in Tyneside.	Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Aono M, 2002, NEUROBIOL DIS, V11, P214, DOI 10.1006/nbdi.2002.0541; Becher JC, 2005, BIOL NEONATE, V88, P164, DOI 10.1159/000086205; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiang MF, 2003, ACTA NEUROCHIR, V145, P649, DOI 10.1007/s00701-003-0069-3; Colton CA, 2004, J NEUROIMMUNOL, V147, P62, DOI 10.1016/j.jneuroim.2003.10.015; COUDERC R, 1993, STROKE, V24, P661, DOI 10.1161/01.STR.24.5.661; CUMMING AM, 1984, CLIN GENET, V25, P310; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DEKNIJFF P, 1994, LANCET, V343, P1234, DOI 10.1016/S0140-6736(94)92451-1; ETO M, 1989, CLIN GENET, V36, P183; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Guo L, 2004, J MOL NEUROSCI, V23, P205, DOI 10.1385/JMN:23:3:205; HIXSON JE, 1990, J LIPID RES, V31, P545; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Mazur-Kolecka B, 2006, NEUROBIOL AGING, V27, P804, DOI 10.1016/j.neurobiolaging.2005.04.012; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Quinn TJ, 2004, NEUROPATH APPL NEURO, V30, P569, DOI 10.1111/j.1365-2990.2004.00581.x; Rantala M, 1997, AM J CLIN NUTR, V65, P543, DOI 10.1093/ajcn/65.2.543; Sabo T, 2000, NEUROSCIENCE, V101, P879, DOI 10.1016/S0306-4522(00)00438-3; Scarmeas N, 2003, JAMA-J AM MED ASSOC, V290, P1581, DOI 10.1001/jama.290.12.1581; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Smith C, 2006, J NEUROL NEUROSUR PS, V77, P363, DOI 10.1136/jnnp.2005.074617; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Tziakas DN, 2006, J AM COLL CARDIOL, V48, P2471, DOI 10.1016/j.jacc.2006.08.032; UTERMANN G, 1980, AM J HUM GENET, V32, P339; UUSITUPA M, 1994, LANCET, V343, P57, DOI 10.1016/S0140-6736(94)90912-1; Uusitupa MIJ, 1996, AM J CLIN NUTR, V64, P131, DOI 10.1093/ajcn/64.2.131; van Dyck CH, 1998, ARCH NEUROL-CHICAGO, V55, P1460, DOI 10.1001/archneur.55.11.1460	37	22	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JAN	2009	25	1					47	54		10.1007/s00381-008-0723-4			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	379CW	WOS:000261374800008	18839184				2022-02-06	
J	O'Hara, R; Luzon, A; Hubbard, J; Zeitzer, JM				O'Hara, Ruth; Luzon, Avinoam; Hubbard, Jeffrey; Zeitzer, Jamie M.			Sleep apnea, apolipoprotein epsilon 4 allele, and TBI: Mechanism for cognitive dysfunction and development of dementia	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						Alzheimer disease; apolipoprotein epsilon 4; cognition; daytime sleepiness; dementia; mild cognitive impairment; obstructive sleep apnea; sleep apnea; sleep disordered breathing; traumatic brain injury	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTOR; APOE EPSILON-4; OLDER-ADULTS; MOUSE MODEL; ASSOCIATION; PERFORMANCE; IMPAIRMENT	Sleep apnea is prevalent among patients with traumatic brain injuries (TBIs), and initial studies suggest it is associated with cognitive impairments in these patients. Recent studies found that the apolipoprotein epsilon 4 (APOE epsilon 4) allele increases the risk for sleep disordered breathing, particularly sleep apnea. The APOE epsilon 4 allele is associated with cognitive decline and the development of dementia in the general population as well as in patients with TBI. These findings raise the question of whether patients with TBI who are APOE epsilon 4 allele carriers are more vulnerable to the negative effects of sleep apnea on their cognitive functioning. While few treatments are available for cognitive impairment, highly effective treatments are available for sleep apnea. Here we review these different lines of evidence, making a case that the interactive effects of sleep apnea and the APOE epsilon 4 allele represent an important mechanism by which patients with TBI may develop a range of cognitive and neurobehavioral impairments. Increased understanding of the relationships among sleep apnea, the APOE epsilon 4 allele, and cognition could improve our ability to ameliorate one significant source of cognitive impairment and risk for dementia associated with TBI.	[O'Hara, Ruth; Hubbard, Jeffrey; Zeitzer, Jamie M.] Sierra Pacific Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [O'Hara, Ruth; Luzon, Avinoam; Hubbard, Jeffrey; Zeitzer, Jamie M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA		O'Hara, R (corresponding author), Sierra Pacific Mental Illness Res Educ & Clin Ctr, Dept Vet Affairs Palo Alto Hlth Care Syst, 151-Y,3801 Miranda Ave, Palo Alto, CA 94304 USA.	roh@stanford.edu	Zeitzer, Jamie M/A-1168-2007; Longo, Kenneth A/A-5631-2010; Hubbard, Jeffrey/Y-4777-2019; Zeitzer, Jamie/AAO-2103-2020	Zeitzer, Jamie M/0000-0001-6174-5282; Hubbard, Jeffrey/0000-0002-0405-9398; Zeitzer, Jamie/0000-0001-6174-5282	VA Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC); Stanford/VA Alzheimer's Research Center; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH 070886, AG 18784, AG 17824]; State of California Department of Health Services [06-55310]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH070886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG018784, P30AG017824] Funding Source: NIH RePORTER	This work was supported in part by the VA Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC); the Stanford/VA Alzheimer's Research Center; the National Institutes of Health (grants MH 070886, AG 18784, and AG 17824); and the State of California Department of Health Services (grant 06-55310).	Aloia MS, 2003, J PSYCHOSOM RES, V54, P71, DOI 10.1016/S0022-3999(02)00548-2; AMADUCCI LA, 1986, NEUROLOGY, V36, P1497, DOI 10.1212/WNL.36.11.1497; Ancoli-Israel S, 1989, Clin Geriatr Med, V5, P347; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; ANCOLIISRAEL S, 1991, BIOFEEDBACK SELF-REG, V16, P349, DOI 10.1007/BF00999989; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; BLIWISE DL, 1995, J BEHAV THER EXP PSY, V26, P17, DOI 10.1016/0005-7916(94)00073-U; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; CARSKADON MA, 1981, J GERONTOL, V36, P420, DOI 10.1093/geronj/36.4.420; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; CHANDRA V, 1989, NEUROLOGY, V39, P1576, DOI 10.1212/WNL.39.12.1576; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chestnut R M, 1998, Evid Rep Technol Assess (Summ), P1; Cohen-Zion M, 2001, J AM GERIATR SOC, V49, P1622, DOI 10.1111/j.1532-5415.2001.49270.x; Cosentino FII, 2008, SLEEP MED, V9, P831, DOI 10.1016/j.sleep.2007.10.015; Decary A, 2000, SLEEP, V23, P369; Dunham CM, 2004, J TRAUMA, V56, P482, DOI 10.1097/01.TA.0000114537.52540.95; DURON B, 1966, REV NEUROL-FRANCE, V115, P562; Ellen RLB, 2006, J CLIN SLEEP MED, V2, P193; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Gottlieb DJ, 2004, NEUROLOGY, V63, P664, DOI 10.1212/01.WNL.0000134671.99649.32; Gottlieb S, 2000, BRIT MED J, V321, P1100; Gozal D, 2007, NEUROLOGY, V69, P243, DOI 10.1212/01.wnl.0000265818.88703.83; Gozal E, 2001, NEUROSCI LETT, V305, P197, DOI 10.1016/S0304-3940(01)01853-5; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; GUILLEMINAULT C, 1976, ANNU REV MED, V27, P465, DOI 10.1146/annurev.me.27.020176.002341; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hauri P, 1991, SLEEP HYGIENE RELAXA, P65; Horstmann S, 2000, SLEEP, V23, P383; Ikonomovic MD, 2007, ARCH NEUROL-CHICAGO, V64, P1312, DOI 10.1001/archneur.64.9.1312; Isoniemi H, 2006, J NEUROTRAUM, V23, P1600, DOI 10.1089/neu.2006.23.1600; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; Jellinger KA, 2004, J NEUROL NEUROSUR PS, V75, P511; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kadotani H, 2001, JAMA-J AM MED ASSOC, V285, P2888, DOI 10.1001/jama.285.22.2888; Kalra M, 2008, SLEEP MED, V9, P260, DOI 10.1016/j.sleep.2007.05.001; Kemp AM, 2003, ARCH DIS CHILD, V88, P472, DOI 10.1136/adc.88.6.472; Khaime Ts B, 1976, Zh Nevropatol Psikhiatr Im S S Korsakova, V76, P1028; KREIS P, 1983, WESTERN J MED, V139, P171; KRIEGER J, 1980, Revue d'Electroencephalographie et de Neurophysiologie Clinique, V10, P177, DOI 10.1016/S0370-4475(80)80051-7; Lee HCB, 2003, INT REV PSYCHIATR, V15, P359, DOI 10.1080/09540260310001606746; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; Mauri M, 2006, FUNCT NEUROL, V21, P223; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Moffat SD, 2000, ARCH INTERN MED, V160, P2193, DOI 10.1001/archinte.160.14.2193; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mustafa Masroor, 2005, Sleep Breath, V9, P57, DOI 10.1007/s11325-005-0016-z; Naegele B, 1998, SLEEP, V21, P392, DOI 10.1093/sleep/21.4.392; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; O'Hara R, 2005, NEUROLOGY, V65, P642, DOI 10.1212/01.wnl.0000173055.75950.bf; O'Hara R, 2001, Dialogues Clin Neurosci, V3, P191; O'Hara R, 1998, J AM GERIATR SOC, V46, P1493, DOI 10.1111/j.1532-5415.1998.tb01532.x; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rami A, 2003, NEUROSCI RES, V47, P373, DOI 10.1016/j.neures.2003.07.002; Redline S, 1997, SLEEP, V20, P160, DOI 10.1093/sleep/20.2.160; Robbins J, 2005, J CLIN SLEEP MED, V1, P159; ROSNER G, 2003, JEMS, V28, P118; Rosner Gregg, 2003, JEMS, V28, P100; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Schwartz DJ, 2007, J CLIN SLEEP MED, V3, P631; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Shea TB, 2004, J ALZHEIMERS DIS, V6, P269; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SOININEN H, 1995, NEUROLOGY, V45, P391, DOI 10.1212/WNL.45.2.391; Stepanski EJ, 2003, SLEEP MED REV, V7, P215, DOI 10.1053/smrv.2001.0246; SULLIVAN CE, 1981, LANCET, V1, P862; Sundstrom A, 2007, BRAIN INJURY, V21, P1049, DOI 10.1080/02699050701630367; Szczygielski J, 2005, J NEURAL TRANSM, V112, P1547, DOI 10.1007/s00702-005-0326-0; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; VERDI FJ, 1991, CLEFT PALATE-CRAN J, V28, P301, DOI 10.1597/1545-1569_1991_028_0301_cotspf_2.3.co_2; Victor LD, 1999, AM FAM PHYSICIAN, V60, P2279; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wilde MC, 2007, ARCH PHYS MED REHAB, V88, P1284, DOI 10.1016/j.apmr.2007.07.012; Yaffe K, 1998, J AM GERIATR SOC, V46, P816, DOI 10.1111/j.1532-5415.1998.tb02713.x; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608	90	22	22	1	15	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2009	46	6					837	850		10.1682/JRRD.2008.10.0140			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	531BQ	WOS:000272638100015	20104407	Bronze			2022-02-06	
J	Penn, PR; Rose, FD; Johnson, DA				Penn, P. R.; Rose, F. D.; Johnson, D. A.			Virtual enriched environments in paediatric neuropsychological rehabilitation following traumatic brain injury: Feasibility, benefits and challenges	DEVELOPMENTAL NEUROREHABILITATION			English	Article						Environmental enrichment; virtual reality; paediatric neuropsychological rehabilitation	SEROTONIN RECEPTOR EXPRESSION; FUNCTIONAL RECOVERY; COGNITIVE PERFORMANCE; NEUROTROPHIN LEVELS; NEURAL PLASTICITY; STROKE PATIENTS; CORTICAL DEPTH; MOTOR FUNCTION; MOUSE MODEL; REALITY	A frequent consequence of traumatic brain injury (TBI) is a significant reduction in patients' cerebral activation/arousal, which clinicians agree is not conducive to optimal rehabilitation outcomes. In the context of paediatric rehabilitation, sustained periods of inactivity are particularly undesirable, as contemporary research has increasingly called into question the Kennard principle that youth inherently promotes greater neural plasticity and functional recovery following TBI. Therefore, the onus to create rehabilitation conditions most conducive to harnessing plasticity falls squarely on the shoulders of clinicians. Having noted the efficacy of environmental enrichment in promoting neural plasticity and positive functional outcomes in the animal literature, some researchers have suggested that the emerging technology of Virtual Reality (VR) could provide the means to increase patients' cerebral activation levels via the use of enriched Virtual Environments (VEs). However, 10 years on, this intuitively appealing concept has received almost no attention from researchers and clinicians alike. This paper overviews recent research on the benefits of enriched environments in the injured brain and identifies the potential and challenges associated with implementing VR-based enrichment in paediatric neuropsychological rehabilitation.	[Penn, P. R.; Rose, F. D.] Univ E London, Sch Psychol, London E15 4LZ, England; [Johnson, D. A.] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland		Penn, PR (corresponding author), Univ E London, Sch Psychol, Romford Rd, London E15 4LZ, England.	p.r.penn@uel.ac.uk					Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Allred RP, 2005, RESTOR NEUROL NEUROS, V23, P297; Amaral OB, 2008, PHYSIOL BEHAV, V93, P388, DOI 10.1016/j.physbeh.2007.09.009; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Andin J, 2007, BRAIN RES, V1174, P18, DOI 10.1016/j.brainres.2007.06.101; Aram DM, 1986, DEV NEUROPSYCHOL, V2, P155, DOI 10.1080/87565648609540339; Behr KM, 2005, PRESENCE-TELEOP VIRT, V14, P668, DOI 10.1162/105474605775196535; Bennett JC, 2006, NEUROBIOL LEARN MEM, V85, P139, DOI 10.1016/j.nlm.2005.09.003; Biernaskie J, 2004, J NEUROSCI, V24, P1245, DOI 10.1523/JNEUROSCI.3834-03.2004; Broeren J, 2007, ACTA NEUROL SCAND, V116, P157, DOI 10.1111/j.1600-0404.2007.00821.x; Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; BROOKS BM, 2002, DISABILITY REHABILIT, V24, P11; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Bryanton C, 2006, CYBERPSYCHOL BEHAV, V9, P123, DOI 10.1089/cpb.2006.9.123; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Celnik PA, 2004, RESTOR NEUROL NEUROS, V22, P261; CHUGANI HT, 1993, EPILEPSIA, V34, P764, DOI 10.1111/j.1528-1157.1993.tb00459.x; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Dahlqvist P, 2003, NEUROSCIENCE, V119, P643, DOI 10.1016/S0306-4522(03)00195-7; de Azevedo CS, 2007, APPL ANIM BEHAV SCI, V102, P329, DOI 10.1016/j.applanim.2006.05.034; De Weerdt W, 2000, DISABIL REHABIL, V22, P181, DOI 10.1080/096382800296872; DeBow SB, 2004, CAN J PHYSIOL PHARM, V82, P231, DOI 10.1139/Y04-013; Deutsch JE, 2006, 2006 INTERNATIONAL WORKSHOP ON VIRTUAL REHABILITATION, P140, DOI 10.1109/IWVR.2006.1707542; DEWIT L, 2005, J AM HEART ASS; DIAMOND MC, 1967, J COMP NEUROL, V131, P357, DOI 10.1002/cne.901310305; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301; Elliott BM, 2005, BEHAV BRAIN RES, V165, P187, DOI 10.1016/j.bbr.2005.06.025; Faherty CJ, 2005, MOL BRAIN RES, V134, P170, DOI 10.1016/j.molbrainres.2004.08.008; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Garner JP, 2005, ILAR J, V46, P106, DOI 10.1093/ilar.46.2.106; Gil AM, 2003, J SCHOOL PSYCHOL, V41, P337, DOI 10.1016/S0022-4405(03)00085-2; Glass M, 2004, NEUROSCIENCE, V123, P207, DOI 10.1016/S0306-4522(03)00595-5; Glover S, 2006, J COGNITIVE NEUROSCI, V18, P833, DOI 10.1162/jocn.2006.18.5.833; Gobbo OL, 2004, BEHAV BRAIN RES, V152, P231, DOI 10.1016/j.bbr.2003.10.017; Gold JI, 2006, CYBERPSYCHOL BEHAV, V9, P207, DOI 10.1089/cpb.2006.9.207; Gramann K, 2005, J EXP PSYCHOL HUMAN, V31, P1199, DOI 10.1037/0096-1523.31.6.1199; GREALY MA, 2001, DEV NEUROREHABIL, V4, P41; Hannigan JH, 2007, NEUROSCI BIOBEHAV R, V31, P202, DOI 10.1016/j.neubiorev.2006.06.019; HART K, 1988, J CLIN PSYCHOL, V44, P780, DOI 10.1002/1097-4679(198809)44:5<780::AID-JCLP2270440519>3.0.CO;2-1; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hebb, 1947, AM PSYCHOL, V2, P306, DOI DOI 10.1037/H0028720; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; Herrera G, 2008, AUTISM, V12, P143, DOI 10.1177/1362361307086657; Hoffman HG, 2006, CNS SPECTRUMS, V11, P45, DOI 10.1017/S1092852900024202; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Hovorka R., 2006, INT J DISABIL HUM DE, V5, P351, DOI DOI 10.1515/IJDHD.2006.5.4.351; Humm JL, 1999, EXP NEUROL, V157, P349, DOI 10.1006/exnr.1999.7061; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jadavji NM, 2006, NEUROSCIENCE, V140, P1127, DOI 10.1016/j.neuroscience.2006.03.027; Johansson BB, 2004, RESTOR NEUROL NEUROS, V22, P163; JOHNSON DA, 2003, J HEAD TRAUMA REHAB, V18, P342; Jung KE, 2006, ANN REV CYBERTHERAPY, V4, P45; Jung SH, 2005, ARCH PHYS MED REHAB, V86, P2218, DOI 10.1016/j.apmr.2005.04.015; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; KLINE S, 2006, ARCH PHYS MED REHAB, V87, P2; Koh S, 2007, EPILEPSY BEHAV, V10, P26, DOI 10.1016/j.yebeh.2006.11.008; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Laatsch L, 2006, BRAIN INJURY, V20, P1367, DOI 10.1080/02699050600983743; Lankhorst AJ, 2001, J NEUROTRAUM, V18, P203, DOI 10.1089/08977150150502622; Lazic SE, 2006, EUR J NEUROSCI, V23, P1829, DOI 10.1111/j.1460-9568.2006.04715.x; Lee JH, 2005, APPL PSYCHOPHYS BIOF, V30, P195, DOI 10.1007/s10484-005-6377-z; Lee JH, 2003, CYBERPSYCHOL BEHAV, V6, P383, DOI 10.1089/109493103322278763; Leggio MG, 2005, BEHAV BRAIN RES, V163, P78, DOI 10.1016/j.bbr.2005.04.009; LINCOLN NB, 1997, STROKE, V28, P543; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; Lo Priore C, 2003, CYBERPSYCHOL BEHAV, V6, P281, DOI 10.1089/109493103322011579; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Meinzer M, 2007, NEUROPSYCHOLOGIA, V45, P1247, DOI 10.1016/j.neuropsychologia.2006.10.003; Monfils MH, 2004, NEUROSCIENCE, V125, P329, DOI 10.1016/j.neuroscience.2004.01.048; Morganti F, 2004, ST HEAL T, V99, P55; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Naka F, 2005, BRAIN DEV-JPN, V27, P275, DOI 10.1016/j.braindev.2004.07.006; Newall JT, 1997, CLIN REHABIL, V11, P146, DOI 10.1177/026921559701100208; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Padgett LS, 2006, J PEDIATR PSYCHOL, V31, P65, DOI 10.1093/jpepsy/jsj030; Parslow DM, 2004, NEUROPSYCHOLOGY, V18, P450, DOI 10.1037/0894-4105.18.3.450; Parsons TD, 2007, CHILD NEUROPSYCHOL, V13, P363, DOI 10.1080/13825580600943473; Penn PR, 2005, ANN REV CYBERTHERAPY, V3, P31; PENN PR, 2008, BRAIN INJURY EXECUTI, P255; PUGNETTI L, 1995, COMPUT BIOL MED, V25, P213, DOI 10.1016/0010-4825(94)00040-W; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Rizzo AA, 2004, COMPUTER, V37, P87, DOI 10.1109/MC.2004.23; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; ROBBINS JA, 2007, J SPEECH LANG HEAR R, V50, P276; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Rose FD, 2000, ERGONOMICS, V43, P494, DOI 10.1080/001401300184378; ROSE FD, 1998, VIRTUAL ENV CLIN PSY, P233; ROSENZWEIG MR, 1961, B BRIT PSYCHOL SOC, pA6; Saucier DM, 2007, BRAIN RES, V1170, P31, DOI 10.1016/j.brainres.2007.07.020; SchmitterEdgecombe M, 1996, J HEAD TRAUMA REHAB, V11, P17, DOI 10.1097/00001199-199604000-00003; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Shieh E. Y., 2000, Journal of Neurotrauma, V17, P986; Shipman SL, 2008, BEHAV BRAIN RES, V187, P433, DOI 10.1016/j.bbr.2007.10.014; SHOPLAND N, 2004, P 5 INT C DIS VIRT R, P69; Slobounov S, 2006, BIOL PSYCHOL, V72, P188, DOI 10.1016/j.biopsycho.2005.10.005; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tarou LR, 2007, APPL ANIM BEHAV SCI, V102, P189, DOI 10.1016/j.applanim.2006.05.026; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; Titov N, 2005, BRAIN INJURY, V19, P315, DOI 10.1080/02699050400013725; Turkstra LS, 2003, ARCH PHYS MED REHAB, V84, P604, DOI 10.1053/apmr.2003.50146; VONSTEINBUCHEL N, 1993, BEHAV BRAIN RES, V56, P1, DOI 10.1016/0166-4328(93)90017-K; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5; Wurbel H, 2007, REFINEMENT RODENT RE; Yager JY, 2006, BEHAV BRAIN RES, V173, P171, DOI 10.1016/j.bbr.2006.06.019; Yen HL, 2007, ANN ACAD MED SINGAP, V36, P62; You SH, 2005, DEV MED CHILD NEUROL, V47, P628, DOI 10.1017/S0012162205001234; Zhu SW, 2006, BEHAV BRAIN RES, V169, P10, DOI 10.1016/j.bbr.2005.11.024; Zimmermann A, 2001, BEHAV BRAIN RES, V121, P11, DOI 10.1016/S0166-4328(00)00377-6	123	22	22	0	21	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1751-8423	1751-8431		DEV NEUROREHABIL	Dev. Neurorehabil.		2009	12	1					32	43		10.1080/17518420902739365			12	Clinical Neurology; Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Rehabilitation	V15FJ	WOS:000207787600005	19283532				2022-02-06	
J	Waldron-Perrine, B; Rapport, LJ; Ryan, KA; Harper, KT				Waldron-Perrine, Brigid; Rapport, Lisa J.; Ryan, Kelly A.; Harper, Kaja Telmet			Predictors of life satisfaction among caregivers of individuals with multiple sclerosis	CLINICAL NEUROPSYCHOLOGIST			English	Article						Multiple sclerosis; Caregiver; Social support; Awareness of deficit; Illness uncertainty	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; IMPAIRED AWARENESS; EXECUTIVE FUNCTION; DISTRESS; UNCERTAINTY; ILLNESS; CARERS; BURDEN; MS	Research on life satisfaction among caregivers of persons with multiple sclerosis (MS) is sparse. This study examined the extent to which MS-specific disease and psychosocial characteristics predict caregiver life satisfaction. Participants were 64 caregivers of patients with MS and the patients for whom they care. Multiple regression analysis indicated that caregiver perception of illness uncertainty and patients' unawareness of deficits have unique value in predicting caregiver life satisfaction, even after accounting for general financial status. Gender and level of social support were also important contributing factors to caregiver life satisfaction. The findings suggest that duration and severity of the patients' illness take a greater toll on life satisfaction of caregivers with low versus high social support, particularly among women caregivers.	[Rapport, Lisa J.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 5057 Woodward Ave, Detroit, MI 48202 USA.	rapport@sun.science.wayne.edu		Rapport, Lisa/0000-0001-8014-9523	Blue Cross Blue Shield of Michigan; Wayne State University Thesis Research Grant	This research was supported in part by a grant from Blue Cross Blue Shield of Michigan and a Wayne State University Thesis Research Grant. The authors thank Drs. Robert Lisak and Omar Khan and their staff at the MS Clinic of University Health Center, Detroit Medical Center, Detroit, MI for their assistance in the data collection process. Kelly Ryan is now at the University of Michigan.	Aronson KJ, 1997, NEUROLOGY, V48, P74, DOI 10.1212/WNL.48.1.74; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; BENTON A, 1994, BENTON VISUAL NAMING; BOYLE EA, 1991, ARCH NEUROL-CHICAGO, V48, P1150, DOI 10.1001/archneur.1991.00530230058022; Brassington JC, 1998, NEUROPSYCHOL REV, V8, P43, DOI 10.1023/A:1025621700003; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Chipchase SY, 2001, DISABIL REHABIL, V23, P768; Cottrell SS, 1926, J NEUROL PSYCHOPATHO, V7, P1; CUTRONA C, 1987, ADV PERSONAL RELATIO, P37; DEROSIER MB, 1992, REHABIL NURS, V17, P87; Diener E., 2002, HDB POSITIVE PSYCHOL, V2, P63; Dijkers M, 1999, AM J PHYS MED REHAB, V78, P286, DOI 10.1097/00002060-199905000-00022; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Good D M, 1995, J Neurosci Nurs, V27, P305; Goode KT, 1998, HEALTH PSYCHOL, V17, P190, DOI 10.1037/0278-6133.17.2.190; Gulick EE, 1998, NURS RES, V47, P137, DOI 10.1097/00006199-199805000-00004; Kenealy PM, 2000, J CLIN EXP NEUROPSYC, V22, P125, DOI 10.1076/1380-3395(200002)22:1;1-8;FT125; Knight RG, 1997, J CLIN EXP NEUROPSYC, V19, P7, DOI 10.1080/01688639708403832; Kooptiwoot S, 2006, SOFT COMPUT, V10, P369, DOI 10.1007/s00500-005-0496-6; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Long KA., 1993, FAM COMMUNITY HEALTH, V16, P46, DOI 10.1097/00003727-199304000-00009; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Lucas RE, 1996, J PERS SOC PSYCHOL, V71, P616, DOI 10.1037/0022-3514.71.3.616; Maor Y, 2001, MULT SCLER, V7, P131, DOI 10.1191/135245801678227658; McKeown LP, 2003, CLIN REHABIL, V17, P234, DOI 10.1191/0269215503cr618oa; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Mishel M H, 1987, West J Nurs Res, V9, P43, DOI 10.1177/019394598700900106; MISHEL MH, 1984, RES NURS HEALTH, V7, P163, DOI 10.1002/nur.4770070304; MISHEL MH, 1981, NURS RES, V30, P258; Mullins LL, 2001, REHABIL PSYCHOL, V46, P139, DOI 10.1037/0090-5550.46.2.139; O'Brien M T, 1993, J Community Health Nurs, V10, P123, DOI 10.1207/s15327655jchn1003_1; OBRIEN MT, 1995, SCHOLARLY INQUIRY NU, V9, P323; Padilla G V, 1992, Qual Life Res, V1, P155, DOI 10.1007/BF00635615; Pakenham KI, 2005, DISABIL REHABIL, V27, P985, DOI 10.1080/09638280500052583; Pakenham KI, 2005, J CLIN PSYCHOL MED S, V12, P25, DOI 10.1007/s10880-005-0910-3; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Pozzilli C, 2004, MULT SCLER, V10, P442, DOI 10.1191/1352458504ms1046oa; Provinciali L, 1999, ACTA NEUROL SCAND, V100, P156; Rao S., 1990, MANUAL BRIEF REPEATA; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Regard M., 1981, THESIS U VICTORIA; Reitan RM, 1985, HALSTEADREITAN NEURO; Ryan KA, 2007, CLIN NEUROPSYCHOL, V21, P239, DOI 10.1080/13854040600582460; Rymer S, 2002, ALZ DIS ASSOC DIS, V16, P248, DOI 10.1097/00002093-200210000-00006; Seltzer B, 1997, GERONTOLOGIST, V37, P20, DOI 10.1093/geront/37.1.20; Sherer M, 2005, J HEAD TRAUMA REHAB, V20, P287, DOI 10.1097/00001199-200507000-00002; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sherman TE, 2007, MULT SCLER, V13, P238, DOI 10.1177/1352458506070754; Smith, 1973, SYMBOL DIGIT MODALIT; Spreen O, 1991, COMPENDIUM NEUROPSYC; SURRIDGE D, 1969, BRIT J PSYCHIAT, V115, P749, DOI 10.1192/bjp.115.524.749; VITALIANO PP, 1991, GERONTOLOGIST, V31, P76, DOI 10.1093/geront/31.1.76; Wollin J., 1999, INT J MS CARE, V1, P6, DOI [10.7224/1537-2073-1.2.41, DOI 10.7224/1537-2073-1.2.41]	59	22	22	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	3					462	478	PII 901634984	10.1080/13854040802279683			17	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	423QH	WOS:000264510300006	18720271				2022-02-06	
J	Yang, XF; Wen, L; Li, G; Zhan, RY; Ma, L; Liu, WG				Yang, X. F.; Wen, L.; Li, G.; Zhan, R. Y.; Ma, L.; Liu, W. G.			Contralateral Subdural Effusion Secondary to Decompressive Craniectomy Performed in Patients with Severe Traumatic Brain Injury: Incidence, Clinical Presentations, Treatment and Outcome	MEDICAL PRINCIPLES AND PRACTICE			English	Article						Traumatic brain injury; Decompressive craniectomy; Subdural effusion, complication, incidence rate	SURGICAL DECOMPRESSION; FLUID COLLECTION; DURAPLASTY	Objective: This study was performed to better understand postoperative contralateral subdural effusion, an uncommon but serious complication secondary to decompressive craniectomy in patients with head trauma. Subjects and Methods: Data from medical records of 169 patients who underwent decompressive craniectomy after head trauma between 2003 and 2006 were collected. The data included demographics, clinical presentations, treatment and outcome. Results: Of the 169 patients, 11 (6.5%) had contralateral subdural effusion. On the average, this complication was found 14 days after decompressive craniectomy. Of the 11 patients, conservative treatment was effective in 7 with a gradual resolution which lasted 52.7 days on average. The effusion in the remaining 4 patients led to progressive deterioration of clinical presentation, and surgical intervention was necessary: subduroperitoneal shunting in 3 cases and burr hole drainage in the remaining 1 case. Conclusions: Our findings confirmed that postoperative contralateral subdural effusion was not an uncommon complication secondary to decompressive craniectomy. Most contralateral subdural effusions resolved spontaneously after conservative management, but surgical management may be necessary if the patients develop deteriorating clinical manifestations or the subdural effusion has an apparent mass effect. Copyright (C) 2008 S. Karger AG, Basel	[Yang, X. F.; Wen, L.; Li, G.; Zhan, R. Y.] Zhejiang Univ, Affiliated Hosp 1, Dept Neurosurg, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, L.; Liu, W. G.] Zhejiang Univ, Affiliated Hosp 2, Dept Neurosurg, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, X. F.; Wen, L.; Li, G.; Zhan, R. Y.; Ma, L.; Liu, W. G.] Zhejiang Univ, Inst Brain Med, Hangzhou 310003, Zhejiang, Peoples R China		Wen, L (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Neurosurg, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	wenlneuron@126.com					Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Andre C, 2003, ARQ NEURO-PSIQUIAT, V61, P682, DOI 10.1590/S0004-282X2003000400030; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Coplin WM, 2001, NEUROL RES, V23, P277, DOI 10.1179/016164101101198433; FRENCH BN, 1978, SURG NEUROL, V9, P145; Hutchinson PJ, 2005, ACTA NEUROCHIR, V147, P1, DOI 10.1007/s00701-004-0400-7; Kilincer C, 2005, CLIN NEUROL NEUROSUR, V107, P412, DOI 10.1016/j.clineuro.2004.09.018; LEE KS, 1994, BRIT J NEUROSURG, V8, P551, DOI 10.3109/02688699409002947; Miyake H, 2002, CHILD NERV SYST, V18, P500, DOI 10.1007/s00381-002-0596-x; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; SHULMAN K, 1963, J NEUROSURG, V20, P1040, DOI 10.3171/jns.1963.20.12.1040; STONE JL, 1981, NEUROSURGERY, V8, P542, DOI 10.1227/00006123-198105000-00005; TABADDOR K, 1976, J NEUROSURG, V44, P506, DOI 10.3171/jns.1976.44.4.0506; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Vinchon M, 2006, J NEUROSURG, V104, P383, DOI 10.3171/ped.2006.104.6.383; Wagner S, 2001, J NEUROSURG, V94, P693, DOI 10.3171/jns.2001.94.5.0693; YAMADA H, 1980, SURG NEUROL, V13, P441; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	19	22	30	0	5	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1011-7571	1423-0151		MED PRIN PRACT	Med. Princ. Pract.		2009	18	1					16	20		10.1159/000163040			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	379GX	WOS:000261385800003	19060485	Bronze			2022-02-06	
J	Berntsen, D; Rubin, DC; Bohni, MK				Berntsen, Dorthe; Rubin, David C.; Bohni, Malene Klindt			Contrasting Models of Posttraumatic Stress Disorder: Reply to Monroe and Mineka (2008)	PSYCHOLOGICAL REVIEW			English	Article						posttraumatic stress disorder; autobiographical memory; involuntary remembering	TRAUMATIC BRAIN-INJURY; MEMORIES; INVOLUNTARY; DISSOCIATION; ORGANIZATION; NARRATIVES; DIAGNOSIS; ATTENTION; IDENTITY; IMAGES	The authors address the 4 main points in S. M. Monroe and S. Mineka's (2008) comment. First, the authors show that the Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.; American Psychiatric Association, 2000) posttraumatic stress disorder (PTSD) diagnosis includes an etiology and that it is based on a theoretical model with a distinguished history in psychology and psychiatry. Two tenets of this theoretical model are that voluntary (strategic) recollections of the trauma are fragmented and incomplete while involuntary (spontaneous) recollections are vivid and persistent and yield privileged access to traumatic material. Second, the authors describe differences between their model and other cognitive models of PTSD. They argue that these other models share the same 2 tenets as the diagnosis and show that these 2 tenets are largely unsupported by empirical evidence. Third, the authors counter arguments about the strength of the evidence favoring the mnemonic model. Fourth, they show that concerns about the causal role of memory in PTSD are based on views of causality that are generally inappropriate for the explanation of PTSD in the social and biological sciences.	[Rubin, David C.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Berntsen, Dorthe; Bohni, Malene Klindt] Univ Aarhus, Dept Psychol, Aarhus, Denmark		Rubin, DC (corresponding author), Duke Univ, Dept Psychol & Neurosci, Box 27708-0086, Durham, NC 27708 USA.	david.rubin@duke.edu	Rubin, David C/B-4741-2009		Danish Research Council for the Humanities and National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01 MH066079]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH066079] Funding Source: NIH RePORTER	We wish to thank Barbara Herrnstein Smith and Jen Talarico for suggestions and the Danish Research Council for the Humanities and National Institute of Mental Health Grant R01 MH066079 for funding.	American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Amir N, 1998, J TRAUMA STRESS, V11, P385, DOI 10.1023/A:1024415523495; Berntsen D, 2006, PSYCHOL AGING, V21, P127, DOI 10.1037/0882-7974.21.1.127; Berntsen D, 2006, BEHAV RES THER, V44, P219, DOI 10.1016/j.brat.2005.01.009; Berntsen D, 2004, MEM COGNITION, V32, P789, DOI 10.3758/BF03195869; BERNTSEN D, INVOLUNTARY IN PRESS; Berntsen D, 2007, APPL COGNITIVE PSYCH, V21, P417, DOI 10.1002/acp.1290; Berntsen D, 2008, MEM COGNITION, V36, P449, DOI 10.3758/MC.36.2.449; BREUER J, 1955, STANDARD EDITION COM, V2, P3; Brewin CR, 2001, BRIT J MED PSYCHOL, V74, P467, DOI 10.1348/000711201161118; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; deRivera J, 1997, PSYCHOL INQ, V8, P271, DOI 10.1207/s15327965pli0804_1; FOA EB, 1995, J TRAUMA STRESS, V8, P675, DOI 10.1007/BF02102894; FRANKE S, 1994, ASA NEWSLETTER, V42, P1; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Hall NM, 2008, MEMORY, V16, P48, DOI 10.1080/09658210701333271; Halligan SL, 2003, J CONSULT CLIN PSYCH, V71, P419, DOI 10.1037/0022-006X.71.3.419; Halligan SL, 2002, J BEHAV THER EXP PSY, V33, P73, DOI 10.1016/S0005-7916(02)00014-9; Harvey AG, 1999, BRIT J CLIN PSYCHOL, V38, P401, DOI 10.1348/014466599162999; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Holmes EA, 2004, J EXP PSYCHOL GEN, V133, P3, DOI 10.1037/0096-3445.133.1.3; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; Horowitz M. J., 1976, STRESS RESPONSE SYND; HOROWITZ MJ, 1969, AM J PSYCHIAT, V126, P565, DOI 10.1176/ajp.126.4.565; HOROWITZ MJ, 1969, ARCH GEN PSYCHIAT, V20, P552; HOROWITZ MJ, 1975, ARCH GEN PSYCHIAT, V32, P1457; HOROWITZ MJ, 1999, ESSENTIAL PAPERS POS, P1; *I MED, 2006, POSTTR STRESS DIS DI; Jones C, 2007, BEHAV RES THER, V45, P151, DOI 10.1016/j.brat.2006.02.004; Jones E, 2007, J ANXIETY DISORD, V21, P164, DOI 10.1016/j.janxdis.2006.09.009; Klein KJ, 2004, J APPL PSYCHOL, V89, P931, DOI 10.1037/0021-9010.89.6.931; Koenigs M, 2008, NAT NEUROSCI, V11, P232, DOI 10.1038/nn2032; McGaugh, 2003, MEMORY EMOTION MAKIN; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; McNally RJ, 2006, J CONSULT CLIN PSYCH, V74, P237, DOI 10.1037/0022-006X.74.2.237; McNally RJ, 2003, ANNU REV PSYCHOL, V54, P229, DOI 10.1146/annurev.psych.54.101601.145112; Monroe SM, 2008, PSYCHOL REV, V115, P1084, DOI 10.1037/a0013723; Mulligan NW, 1998, J EXP PSYCHOL LEARN, V24, P27, DOI 10.1037/0278-7393.24.1.27; Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363; Oyama S, 2000, ONTOGENY INFORM DEV; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Porter S, 2001, APPL COGNITIVE PSYCH, V15, pS101, DOI 10.1002/acp.766; Rosen GM, 2008, CLIN PSYCHOL REV, V28, P837, DOI 10.1016/j.cpr.2007.12.002; Rosen GM, 2008, BRIT J PSYCHIAT, V192, P3, DOI 10.1192/bjp.bp.107.043083; Rubin DC, 2006, PERSPECT PSYCHOL SCI, V1, P277, DOI 10.1111/j.1745-6916.2006.00017.x; RUBIN DC, J EXPT PSYC IN PRESS; SCOTT WJ, 1990, SOC PROBL, V37, P294, DOI 10.1525/sp.1990.37.3.03a00020; Shobe KK, 1997, CURR DIR PSYCHOL SCI, V6, P70, DOI 10.1111/1467-8721.ep11512658; Spitzer RL, 2008, COMPR PSYCHIAT, V49, P319, DOI 10.1016/j.comppsych.2008.01.006; WHETTEN DA, 1989, ACAD MANAGE REV, V14, P490, DOI 10.2307/258554; Woodward J., 2003, MAKING THINGS HAPPEN; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705; Young Allan, 1995, HARMONY ILLUSIONS IN	55	22	23	1	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0033-295X	1939-1471		PSYCHOL REV	Psychol. Rev.	OCT	2008	115	4					1099	1106		10.1037/a0013730			8	Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	362PU	WOS:000260210400014	20808720	Green Accepted			2022-02-06	
J	Hartings, JA; Gugliotta, M; Gilman, C; Strong, AJ; Tortella, FC; Bullock, MR				Hartings, Jed A.; Gugliotta, Marinella; Gilman, Charlotte; Strong, Anthony J.; Tortella, Frank C.; Bullock, M. Ross			Repetitive cortical spreading depolarizations in a case of severe brain trauma	NEUROLOGICAL RESEARCH			English	Article						Spreading cortical depression; seizure; traumatic brain injury; microdialysis; electroencephalography; critical care	FOCAL CEREBRAL-ISCHEMIA; PERIINFARCT DEPOLARIZATIONS; ARTERY OCCLUSION; BLOOD-FLOW; REGIONAL CHANGES; DEPRESSION; INJURY; GLUCOSE; HYPOTHERMIA; MICRODIALYSIS	Objective and importance: Cortical spreading depolarizations (CSD) are waves of mass tissue depolarization that mediate progressive development of cortical infarction in animal models and occur in similar to 50% of patients with acute brain injury. Here we performed multi-modal cerebral monitoring to investigate pathologies associated with CSD occurrence in a case of severe traumatic brain injury. Clinical presentation: A 20 years old male suffering severe traumatic brain injury from a fall had extensive frontal subdural and intraparenchymal hemorrhage with mass effect. Craniectomy was performed for hematoma evacuation and decompression. Intervention: During surgery, a subdural electrocorticography (ECoG) electrode strip, along with microdialysis and PtiO2 probes, was placed beside injured cortex for CSD monitoring. Within 13-81 hours post-injury, 34 CSD occurred. CSD incidence increased during spontaneous hyperthermia and decreased during induced normothermia. Periods of CSD activity were also associated with low brain glucose (<0.10 mmol/l), elevated glutamate (>40 mmol/l) and lactate/pyruvate (>40), and PtiO2<10 mmHg. CSD caused progressive deterioration of ECoG activity only in regions with infarction at follow-up on day 27. Conclusion: Repetitive mass tissue depolarizations accompanied a negative course of hemorrhagic lesion progression in the presence of ischemic conditions after traumatic brain injury. Whether as cause or effect, CSD may represent an inherent component of progressive metabolic failure leading to tissue death, and temperature appears to be an important factor influencing their occurrence. Continuous ECoG is a valuable tool for monitoring subclinical events such as CSD and seizures and for translational research in acute brain injury mechanisms and therapeutics. [Neurol Res 2008; 30: 876-882]	[Hartings, Jed A.; Tortella, Frank C.] Walter Reed Army Inst Res, Div Psychiat & Neurosci, Silver Spring, MD 20910 USA; [Gugliotta, Marinella; Gilman, Charlotte; Bullock, M. Ross] Virginia Commonwealth Univ, Div Neurosurg, Richmond, VA USA; [Strong, Anthony J.] Kings Coll Hosp London, Dept Neurosurg, London, England		Hartings, JA (corresponding author), Walter Reed Army Inst Res, Div Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	jed.hartings@na.amedd.army.mil		Hartings, Jed/0000-0001-8583-3471	US Department of DefenseUnited States Department of Defense	This work was supported by US Department of Defense funding. The views of the authors do not purport or reflect the position of the Department of the Army or the Department of Defense (para 4-3, AR 360-5).	Alkan T, 2001, NEUROSURG QUART, V11, P96, DOI 10.1097/00013414-200106000-00003; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; Bhatia R, 2006, NEUROSURGERY, V58, P313, DOI 10.1227/01.NEU.0000208963.42378.83; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; CHEN Q, 1993, J CEREBR BLOOD F MET, V13, P389, DOI 10.1038/jcbfm.1993.52; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CSIBA L, 1985, BRAIN RES, V336, P167, DOI 10.1016/0006-8993(85)90430-5; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Gyngell ML, 1995, NMR BIOMED, V8, P206, DOI 10.1002/nbm.1940080505; Hartings JA, 2005, J NEUROTRAUM, V22, P1201; Hartings JA, 2006, J CEREBR BLOOD F MET, V26, P696, DOI 10.1038/sj.jcbfm.9600223; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; Menna G, 2000, J NEUROPHYSIOL, V83, P1338, DOI 10.1152/jn.2000.83.3.1338; MIES G, 1984, EXP NEUROL, V84, P249, DOI 10.1016/0014-4886(84)90222-X; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; Otori T, 2003, J CEREBR BLOOD F MET, V23, P43, DOI 10.1097/01.WCB.0000035180.38851.38; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Soukup J, 2002, NEUROL RES, V24, P161, DOI 10.1179/016164102101199710; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Strong AJ, 2000, STROKE, V31, P214, DOI 10.1161/01.STR.31.1.214; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Trabold R, 2006, J NEUROTRAUM, V23, P760; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906	42	22	22	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	OCT	2008	30	8					876	882		10.1179/174313208X309739			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	358FG	WOS:000259901900015	18534057				2022-02-06	
J	Hosalkar, H; Goebel, J; Reddy, S; Pandya, NK; Keenan, MA				Hosalkar, Harish; Goebel, Jennifer; Reddy, Sudheer; Pandya, Nirav K.; Keenan, Mary Ann			Fixation techniques for split anterior tibialis transfer in spastic equinovarus feet	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							EQUINUS DEFORMITY; TOE FLEXORS; ADULT; FOOT; MANAGEMENT; GAIT	Equinovarus of the foot is the most common lower extremity deformity following traumatic brain injury. We evaluated outcomes of the split anterior tibialis tendon transfer (SPLATT) for correction of equinovarus in 47 patients with hemiplegic traumatic brain injury and specifically studied differences in outcomes with two tendon fixation techniques. Seventeen patients constituting Group I underwent fixation with one technique and 30 constituting Group II had another technique. Patients in both groups had appropriate procedures based on dynamic electromyography and gait analyses. Both groups were demographically comparable. All 47 feet were corrected to plantigrade position. Thirty-six of 47 patients became brace-free at final followup. There was a notable decrease in the use of ambulatory aids and ambulatory status improved in both groups. There were three fixation-related complications in Group I and none in Group II. Surgical correction of the spastic equinovarus with SPLATT, in the appropriate patient, with or without associated tendon procedures helps to achieve and maintain correction, improves the ambulatory status of the patient, and eliminates the need for bracing in as much as 77% of patients. We recommend the Group II construct owing to the considerably lower complication rate.	[Hosalkar, Harish; Goebel, Jennifer; Reddy, Sudheer; Pandya, Nirav K.; Keenan, Mary Ann] Hosp Univ Penn, Dept Orthopaed Surg, Philadelphia, PA 19104 USA		Keenan, MA (corresponding author), Hosp Univ Penn, Dept Orthopaed Surg, 3400 Spruce St,2 Silverstein, Philadelphia, PA 19104 USA.	maryann.keenan@uphs.upenn.edu	Keenan, Mary Ann/ABB-1551-2020				Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; BANKS HH, 1977, CLIN ORTHOP RELAT R, P70; EDWARDS P, 1993, FOOT ANKLE, V14, P335, DOI 10.1177/107110079301400605; Fuller DA, 2004, ORTHOPEDICS, V27, P372; HOFFER MM, 1974, ORTHOP CLIN N AM, V5, P31; Hosalkar HS, 2007, J BONE JOINT SURG AM, V89A, P2316, DOI 10.2106/JBJS.G.00285; KEENAN MA, 1984, CLIN ORTHOP RELAT R, P165; KEENAN MA, 1984, FOOT ANKLE, V5, P35, DOI 10.1177/107110078400500105; Keenan MAE, 1999, J HEAD TRAUMA REHAB, V14, P163, DOI 10.1097/00001199-199904000-00006; LAWRENCE SJ, 1994, FOOT ANKLE INT, V15, P340, DOI 10.1177/107110079401500610; LEMPERG R, 1969, ACTA ORTHOP SCAND, V40, P507, DOI 10.3109/17453676909046536; ONO K, 1980, INT ORTHOP, V4, P225, DOI 10.1007/BF00268160; Perry J., 1992, GAIT ANAL NORMAL PAT, P381; PINZUR MS, 1986, J BONE JOINT SURG AM, V68A, P1249, DOI 10.2106/00004623-198668080-00016; ROPER BA, 1978, J BONE JOINT SURG BR, V60, P533, DOI 10.1302/0301-620X.60B4.711804; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Viosca E, 2005, ARCH PHYS MED REHAB, V86, P1234, DOI 10.1016/j.apmr.2004.11.016; WATERS RL, 1982, J BONE JOINT SURG AM, V64, P284, DOI 10.2106/00004623-198264020-00022	18	22	22	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	OCT	2008	466	10					2500	2506		10.1007/s11999-008-0395-0			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	347KX	WOS:000259141600027	18648897	Green Published			2022-02-06	
J	Llompart-Pou, JA; Raurich, JM; Perez-Barcena, J; Barcelo, A; Ibanez, J; Ayestaran, JI				Llompart-Pou, Juan A.; Raurich, Joan M.; Perez-Barcena, Jon; Barcelo, Antonia; Ibanez, Jordi; Ayestaran, Jose I.			Acute hypothalamic-pituitary-adrenal response in traumatic brain injury with and without extracerebral trauma	NEUROCRITICAL CARE			English	Article						traumatic brain injury; extracerebral trauma; adrenal insufficiency; cortisol; HPA axis; adrenocorticotrophin hormone; risk factors; outcome	HEAD-INJURY; INSUFFICIENCY; HYPOPITUITARISM; SEVERITY; ADRENOCORTICOTROPIN; CLASSIFICATION; ABNORMALITIES; CORTISOL; HORMONE	Objective Endocrine disturbances are common after traumatic brain injury (TBI). Hypothalamic-pituitary-adrenal (HPA) axis response in TBI patients may be related with hemodynamic status. However, its relationship with outcome is unclear. Our objective was to evaluate HPA axis response in the acute phase after TBI in patients with or without extracerebral trauma (ECT), and to investigate the impact of systemic injury and the mechanisms underlying HPA response. Methods We prospectively studied 165 patients with moderate to severe TBI. Between 24 and 48 h after TBI, blood samples were taken for plasma adrenocorticotrophin hormone (ACTH) and baseline cortisol measurements. Afterwards, a short corticotrophin hormone test (250 mu g Synacthen) was performed and samples were obtained at 30 and 60 min. We compared HPA response in TBI patients presenting with and without ECT and investigate potential mechanisms underlying this response. Results One hundred and eight patients presented with isolated TBI, whereas 57 patients presented associated ECT. Both groups were comparable. Overall, 23.6% of patients fulfilled adrenal insufficiency (AI) criteria. Patients with plasma ACTH < 9 pg/ml and patients presenting with hemorrhagic shock were more likely to present adrenal impairment. Variables associated with mortality were Injury Severity Score, Glasgow Coma Scale, Traumatic Coma Data Bank classification different than type II, need of second level measures to control intracranial pressure and plasma ACTH > 9 pg/ml. Conclusion Patients with TBI presenting with or without associated ECT present similar acute HPA response. AI is present in 23.6% of patients. Risk is increased in patients with low plasma ACTH levels and in patients with hemorrhagic shock. Both primary and secondary mechanisms of HPA failure were found. However, AI did not affect outcome.	[Llompart-Pou, Juan A.; Raurich, Joan M.; Perez-Barcena, Jon; Ibanez, Jordi; Ayestaran, Jose I.] Hosp Univ Son Dureta, Serv Med Intens, Palma de Mallorca 07014, Illes Balears, Spain; [Barcelo, Antonia] Hosp Univ Son Dureta, Illes Balears, Spain		Llompart-Pou, JA (corresponding author), Hosp Univ Son Dureta, Serv Med Intens, C Andrea Doria 55, Palma de Mallorca 07014, Illes Balears, Spain.	jallompart@hsd.es		Barcelo Bennasar, Antonia/0000-0002-3170-5439			Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARTON RN, 1987, J TRAUMA, V27, P384, DOI 10.1097/00005373-198704000-00007; Bernard F, 2006, BRIT J ANAESTH, V96, P72, DOI 10.1093/bja/aei277; Bernard F, 2006, NEUROCRIT CARE, V5, P176, DOI 10.1385/NCC:5:3:176; BTF Guidelines, 2000, J NEUROTRAUM, V17, P591; CHIOLERO R, 1988, J TRAUMA, V28, P1368, DOI 10.1097/00005373-198809000-00011; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Dimopoulou I, 2005, INTENS CARE MED, V31, P1020, DOI 10.1007/s00134-005-2689-y; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Dimopoulou L, 2004, CRIT CARE MED, V32, P404, DOI 10.1097/01.CCM.0000108885.37811.CA; Edwards P, 2005, LANCET, V365, P1957; Gannon TA, 2006, AM SURGEON, V72, P373; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koiv L, 1997, ACTA NEUROL SCAND, V96, P52; Llompart-Pou JA, 2007, J ENDOCRINOL INVEST, V30, P393, DOI 10.1007/BF03346316; Llompart-Pou JA, 2007, J TRAUMA, V62, P1457, DOI 10.1097/01.ta.0000219143.69483.71; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Powner DJ, 2006, NEUROCRIT CARE, V5, P61, DOI 10.1385/NCC:5:1:61; Rushing GD, 2006, AM SURGEON, V72, P552; Rushing GD, 2006, ANN SURG, V243, P652, DOI 10.1097/01.sla.0000216759.36819.1b; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; TEASDALE G, 1974, LANCET, V2, P81; Urban RJ, 2006, GROWTH HORM IGF RES, V16, pS25, DOI 10.1016/j.ghir.2006.03.017	28	22	26	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2008	9	2					230	236		10.1007/s12028-008-9115-6			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	351RC	WOS:000259441300010	18551387				2022-02-06	
J	Zhou, ZW; Sun, D; Levasseur, JE; Merenda, A; Hamm, RJ; Zhu, JP; Spiess, BD; Bullock, MR				Zhou, Zhengwen; Sun, Dong; Levasseur, Joseph E.; Merenda, Amedeo; Hamm, Robert J.; Zhu, Jiepei; Spiess, Bruce D.; Bullock, M. Ross			PERFLUOROCARBON EMULSIONS IMPROVE COGNITIVE RECOVERY AFTER LATERAL FLUID PERCUSSION BRAIN INJURY IN RATS	NEUROSURGERY			English	Article						Cognitive deficits; Hippocampus; Perfluorocarbon emulsion; Traumatic brain injury	INTRAVENOUS PERFLUBRON EMULSION; CEREBRAL BLOOD-FLOW; FLUOSOL DA 20-PERCENT; ISOVOLEMIC HEMODILUTION; RETROGRADE-AMNESIA; OXYGEN-CONSUMPTION; HEALTHY-VOLUNTEERS; RANDOMIZED SAFETY; CELL LOSS; ISCHEMIA	OBJECTIVE: Perfluorocarbon emulsions have been shown to improve outcomes in stroke models. This study examined the effect of Oxycyte, a third-generation perfluorocarbon emulsion (04RD33; Synthetic Blood International, Inc., Costa Mesa, CA) treatment on cognitive recovery and mitochondrial oxygen consumption after a moderate lateral fluid percussion injury (LFPI). METHODS: Adult male Sprague-Dawley rats (Harlan Bioproducts for Science, Indianapolis, IN) were allocated to 4 groups: 1) LFPI treated with a lower dose of Oxycyte (4.5 mL/kg); 2) LFPI with a higher dose of Oxycyte (9.0 mL/kg); 3) LFPI with saline infusion; and 4) sham animals treated with saline. Fifteen minutes after receiving moderate LFPI or sham surgery, animals were infused intravenously with Oxycyte or saline within 30 minutes while breathing 100% O-2. Animals breathed 100% O-2 continuously for a total of 4 hours after injury. At 11 to 15 days after LFPI, animals were assessed for cognitive deficits using the Morris water maze test. They were sacrificed at Day 15 after injury for histology to assess hippocampal neuronal cell loss. In a parallel study, mitochondrial oxygen consumption values were measured by the Cartesian diver microrespirometer method. RESULTS: We found that injured animals treated with a lower or higher dose of Oxycyte had significant improvement in cognitive function when compared with injured saline-control animals (P < 0.05). Moreover, injured animals that received either dose of Oxycyte had significantly less neuronal cell loss in the hippocampal CA3 region compared with saline-treated animals (P < 0.05). Furthermore, a lower dose of Oxycyte significantly improved mitochondrial oxygen consumption levels (P < 0.05). CONCLUSION: The current study demonstrates that Oxycyte can improve cognitive recovery and reduce CA3 neuronal cell loss after traumatic brain injury in rats.	[Zhou, Zhengwen; Sun, Dong; Levasseur, Joseph E.; Merenda, Amedeo; Bullock, M. Ross] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Hamm, Robert J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Zhu, Jiepei; Spiess, Bruce D.] Virginia Commonwealth Univ, Dept Anesthesiol, Richmond, VA USA		Bullock, MR (corresponding author), Univ Miami, Miller Sch Med, Dept Neurosurg, Lois Pope LIFE Ctr, Room 3-20,1095 NW 14th Terrace, Miami, FL 33136 USA.	rbullock@med.miami.edu		MERENDA, AMEDEO/0000-0002-9270-7470	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS12587]; Reynolds Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER	This study was funded by the National Institutes of Health Grant No. NS12587 and by the Reynolds Foundation (MRB).	AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bell RD, 2002, CRIT CARE MED, V30, P2684, DOI 10.1097/00003246-200212000-00012; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CLEMAN M, 1986, CIRCULATION, V74, P555, DOI 10.1161/01.CIR.74.3.555; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Conti AC, 1998, J NEUROSCI, V18, P5663; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Daugherty WP, 2004, NEUROSURGERY, V54, P1223, DOI 10.1227/01.NEU.0000119238.68938.5D; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ECKSTEIN EC, 1989, T AM SOC ART INT ORG, V35, P188; FAITHFULL NS, 1992, BIOMAT ARTIF CELL IM, V20, P797, DOI 10.3109/10731199209119721; FAITHFULL NS, 1994, ARTIF CELL BLOOD SUB, V22, P181, DOI 10.3109/10731199409117413; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Franke Ralf-Peter, 2004, J Invasive Cardiol, V16, P110; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GUO J, 1995, NEUROSURGERY, V36, P350, DOI 10.1227/00006123-199502000-00015; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; JOHNSON EC, 1995, J APPL PHYSIOL, V79, P1777, DOI 10.1152/jappl.1995.79.5.1777; KLINE RA, 1992, BIOMAT ARTIF CELL IM, V20, P979; KLINE RA, 1991, AM J SURG, V162, P103, DOI 10.1016/0002-9610(91)90168-D; KOLLURI S, 1986, SURG NEUROL, V26, P3, DOI 10.1016/0090-3019(86)90055-8; Kwon TH, 2005, J NEUROSURG, V103, P724, DOI 10.3171/jns.2005.103.4.0724; LEE PA, 1988, AM J PHYSIOL, V254, pH719, DOI 10.1152/ajpheart.1988.254.4.H719; Leese PT, 2000, ANESTH ANALG, V91, P804, DOI 10.1097/00000539-200010000-00008; Levasseur JE, 2000, J NEUROTRAUM, V17, P101, DOI 10.1089/neu.2000.17.101; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; McIntosh TK, 1996, LAB INVEST, V74, P315; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MITSUNO T, 1984, ARTIF ORGANS, V8, P25, DOI 10.1111/j.1525-1594.1984.tb04240.x; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Noveck RJ, 2000, ANESTH ANALG, V91, P812, DOI 10.1097/00000539-200010000-00009; OBRIEN RN, 1982, SCIENCE, V217, P153, DOI 10.1126/science.6806902; OSTERHOLM JL, 1983, NEUROSURGERY, V13, P381, DOI 10.1227/00006123-198310000-00006; Padnick LB, 1999, J APPL PHYSIOL, V86, P1497, DOI 10.1152/jappl.1999.86.5.1497; PEERLESS SJ, 1981, STROKE, V12, P558, DOI 10.1161/01.STR.12.5.558; PEREIRA BM, 1988, NEUROSURGERY, V23, P139, DOI 10.1227/00006123-198808000-00001; Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824; RIESS JG, 1984, ARTIF ORGANS, V8, P44, DOI 10.1111/j.1525-1594.1984.tb04243.x; SAKAS DE, 1994, STROKE, V25, P197, DOI 10.1161/01.STR.25.1.197; SATTERFIELD R, 1993, INVEST RADIOL, V28, P325, DOI 10.1097/00004424-199304000-00013; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; SLOVITER HA, 1967, NATURE, V216, P458, DOI 10.1038/216458a0; Spahn DR, 2002, ANESTHESIOLOGY, V97, P1338, DOI 10.1097/00000542-200212000-00004; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; SUZUKI J, 1984, STROKE, V15, P672, DOI 10.1161/01.STR.15.4.672; Vaz R, 1997, ACTA NEUROCHIR, V139, P215, DOI 10.1007/BF01844754; WINOCUR G, 1990, BEHAV BRAIN RES, V38, P145, DOI 10.1016/0166-4328(90)90012-4; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	54	22	27	0	5	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	OCT	2008	63	4					799	806		10.1227/01.NEU.0000325493.51900.53			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	367UR	WOS:000260578600052	18981892				2022-02-06	
J	Baranova, AI; Wei, EP; Ueda, Y; Sholley, MM; Kontos, HA; Povlishock, JT				Baranova, Anna I.; Wei, Enoch P.; Ueda, Yuji; Sholley, Milton M.; Kontos, Hermes A.; Povlishock, John T.			Cerebral vascular responsiveness after experimental traumatic brain injury: the beneficial effects of delayed hypothermia combined with superoxide dismutase administration - Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						brain injury; hypothermia; pial vasculature; rat; vasoreactivity	POSTISCHEMIC HYPOTHERMIA; BLOOD-FLOW; POSTTRAUMATIC HYPOTHERMIA; HEAD-INJURY; AUTOREGULATION; RESPONSES; CATS; RATS; MICROCIRCULATION; ABNORMALITIES	Object. Traumatic brain injury (TBI) induces cerebral vascular dysfunction reflected in altered responses to vasodilators such as acetylcholine and hypercapnia. It has been demonstrated that the use of either posttraumatic hypothermia or free radical scavengers offered vascular protection when those treatments were delivered early after the injury, losing efficacy when the initiation of either treatment was delayed. Because immediate posttraumatic treatment is not realistic in the clinical setting, the authors undertook this study to investigate whether the combination of delayed hypothermia and the delayed administration of the free radical scavenger superoxide dismutase (SOD) could result in improved vascular protection. Methods. Male Sprague-Dawley rats were anesthetized and subjected to either an impact-acceleration or sham injury. Animals were treated either with hypothermia (32 degrees C) initiated 60 minutes after TBI, delayed SOD (60 U/ml) applied 90 minutes after TBI, or a combination of delayed hypothermia (32 degrees C) and delayed SOD (60 U/ml) applied 15 minutes prior to the cessation of hypothermia. In this investigation, the diameter of cerebral pial arterioles was measured at rest and then challenged with vasodilator acetylcholine and hypercapnia. Four vessels were assessed per animal prior to injury and then again tip to 6 hours after injury. Results. Delayed SOD treatment did not enhance vascular function, while delayed hypothermia treatment only partially preserved pial vascular function. However, the combination of delayed hypothermia and delayed SOD significantly preserved vascular function after the injury. Conclusions. The results of these studies demonstrate that delayed hypothermia partially preserves vascular function after TBI, while expanding the therapeutic window over which agents such as SOD can now provide enhanced protection.	[Baranova, Anna I.; Wei, Enoch P.; Sholley, Milton M.; Kontos, Hermes A.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Wei, Enoch P.; Kontos, Hermes A.] Virginia Commonwealth Univ, Med Ctr, Dept Med, Richmond, VA 23298 USA; [Ueda, Yuji] Yamaguchi Univ, Sch Med, Dept Neurosurg, Yamaguchi, Japan		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	jtpoviis@vcu.edu			 [HD055813];  [NS057175]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD055813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS057175] Funding Source: NIH RePORTER	This study was supported by grants HD055813 and NS057175.	BERING EA, 1961, AM J PHYSIOL, V200, P417; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; COLBOURNE F, 1995, J NEUROSCI, V15, P7250; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; Erecinska M, 2003, J CEREBR BLOOD F MET, V23, P513, DOI 10.1097/01.WCB.0000066287.21705.21; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1981, FED PROC, V40, P2326; LEVASSEUR JE, 1975, STROKE, V6, P308, DOI 10.1161/01.STR.6.3.308; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; Zhao H, 2004, STROKE, V35, P572, DOI 10.1161/01.STR.0000110787.42083.58	25	22	22	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2008	109	3					502	509		10.3171/JNS/2008/109/9/0502			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	344CX	WOS:000258904400023	18759584				2022-02-06	
J	Castellani, C; Stojakovic, T; Cichocki, M; Scharnagl, H; Erwa, W; Gutmann, A; Weinberg, AM				Castellani, Christoph; Stojakovic, Tatjana; Cichocki, Martin; Scharnagl, Hubert; Erwa, Wolfgang; Gutmann, Anton; Weinberg, Annelie-Martina			Reference ranges for neuroprotein S-100B: from infants to adolescents	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						children; neuroprotein; reference range; S-100B; traumatic brain injury	TRAUMATIC BRAIN-INJURY; MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; CEREBROSPINAL-FLUID; PROTEIN CONCENTRATIONS; S100B CONCENTRATIONS; REFERENCE INTERVALS; SERUM S100B; CHILDREN; AGE	Background: Diagnosis and treatment of mild traumatic brain injuries in children are especially problematic. At present, computed tomography (CT) is the standard method to identify if patients with intracranial lesions require inpatient monitoring. CT, however, involves exposure to high doses of X-rays, which should be avoided if possible. In adults, the serum level of neuroprotein S-100B has already been proven to be effective for the selection of patients requiring CT. The aim of the present study was to determine reference ranges for serum S-100B in a large number of healthy children. Methods: All patients younger than 18 years with no recent history of head injuries presenting for routine operations were included in the study. Results: A total of 394 patients were evaluated. In children from 3 to 18 years an upper reference level of 0.16 mu g/ L was determined. There was a strong inverse relation between age and S-100B in patients younger than 3 years. As the values in this age group were scattered and the number of cases limited (n = 65), no reference range could be calculated. Conclusions: This study provides S-100B reference ranges for pediatric patients based on the largest group of healthy pediatric patients yet analyzed. Clin Chem Lab Med 2008; 46: 1296-9.	[Castellani, Christoph; Cichocki, Martin; Weinberg, Annelie-Martina] Graz Med Univ, Dept Pediat Surg, A-8036 Graz, Austria; [Stojakovic, Tatjana; Scharnagl, Hubert; Erwa, Wolfgang] Graz Med Univ, Inst Clin Med, A-8036 Graz, Austria; [Stojakovic, Tatjana; Scharnagl, Hubert; Erwa, Wolfgang] Graz Med Univ, Chem Lab Diagnost, A-8036 Graz, Austria; [Gutmann, Anton] Graz Med Univ, Dept Anesthesiol, Graz, Austria		Weinberg, AM (corresponding author), Graz Med Univ, Dept Pediat Surg, Auenbruggerpl 34, A-8036 Graz, Austria.	annelie.weinberg@t-online.de		Weinberg, Annelie/0000-0003-0385-4346	Roche Diagnostics	The study was supported by a research grant from Roche Diagnostics.	Alber B, 2005, CLIN CHEM LAB MED, V43, P557, DOI 10.1515/CCLM.2005.097; Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; CHEN C, 2007, P 30 ANN SAS US GROU; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Korfias S, 2006, CURR MED CHEM, V13, P3719, DOI 10.2174/092986706779026129; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Nygaard O, 1997, CLIN CHEM, V43, P541; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Rice HE, 2007, J PEDIATR SURG, V42, P603, DOI 10.1016/j.jpedsurg.2006.12.009; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Wright EM, 1997, STAT MED, V16, P2785, DOI 10.1002/(SICI)1097-0258(19971230)16:24<2785::AID-SIM797>3.0.CO;2-Z; Zurakowski D, 1999, CLIN CHEM, V45, P1087	22	22	23	0	6	WALTER DE GRUYTER & CO	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621			CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	SEP	2008	46	9					1296	1299		10.1515/CCLM.2008.262			4	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	358PF	WOS:000259929300016	18785867				2022-02-06	
J	Evans, CC; Sherer, M; Nakase-Richardson, R; Mani, T; Irby, JW				Evans, Clea C.; Sherer, Mark; Nakase-Richardson, Risa; Mani, Tanja; Irby, James W., Jr.			Evaluation of an interdisciplinary team intervention to improve therapeutic alliance in post-acute brain injury rehabilitation	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; rehabilitation; therapeutic alliance; treatment outcomes	FAMILY ASSESSMENT DEVICE; WORKING ALLIANCE; AWARENESS	Objective: Evaluate an intervention to improve an alliance between an interdisciplinary team and clients with traumatic brain injury attending post-acute brain injury rehabilitation. Design: Prospective design, 2 consecutive samples-historical control (CNT) and treatment (TX). Methods: Sample of 104 clients (69 CNT, 35 TX) admitted to post-acute brain injury rehabilitation completed admit/discharge questionnaires. Results: The TX group had higher functional status at discharge than the CNT group. Stronger team alliance was associated with program completion, return to productivity, stronger client alliance, less family discord, and fewer depressive symptoms. Conclusions: Findings provide direction for a larger study examining the effectiveness of this intervention to improve outcome after traumatic brain injury.	[Evans, Clea C.; Sherer, Mark; Nakase-Richardson, Risa; Mani, Tanja; Irby, James W., Jr.] Methodist Rehabil Ctr, Jackson, MS USA; [Evans, Clea C.; Nakase-Richardson, Risa] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Sherer, Mark] Baylor Coll Med, Houston, TX 77030 USA; [Nakase-Richardson, Risa] Tampa VA Med Ctr, Tampa, FL USA		Evans, CC (corresponding author), 1350 E Woodrow Wilson D, Jackson, MS 39047 USA.	cevans@mmrcrebab.org					Bordin ES, 1979, PSYCHOTHER THEORY RE, V16, P252, DOI DOI 10.1037/H0085885; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Gaston L., 1994, CALIFORNIA PSYCHOTHE, P85; HORVATH AO, 1994, WORKING ALLIANCE THE; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Lambert MJ, 2001, PSYCHOTHERAPY, V38, P357, DOI 10.1037/0033-3204.38.4.357; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Safran J. D., 1991, PSYCHOL ASSESSMENT J, V3, P188, DOI DOI 10.1037/1040-3590.3.2.188; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2007, BRAIN INJURY, V21, P663, DOI 10.1080/02699050701481589; Summers RE, 2003, ACAD PSYCHIATR, V27, P160, DOI 10.1176/appi.ap.27.3.160	21	22	22	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2008	23	5					329	338		10.1097/01.HTR.0000336845.06704.bc			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	357GN	WOS:000259834400007	18815509				2022-02-06	
J	Fink, EL; Lai, YC; Zhang, XP; Janesko-Feldman, K; Adelson, PD; Szabo, C; Berger, RP; Sarnaik, AA; Kochanek, PM; Clark, RSB				Fink, Ericka L.; Lai, Yichen; Zhang, Xiaopeng; Janesko-Feldman, Keri; Adelson, P. David; Szabo, Csaba; Berger, Rachel P.; Sarnaik, Ajit A.; Kochanek, Patrick M.; Clark, Robert S. B.			Quantification of poly(ADP-ribose)-modified proteins in cerebrospinal fluid from infants and children after traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						ADP-ribosyltransferase; biomarker; enzyme-linked immunosorbent assay; head injury; poly(ADP-ribose) polymerase; poly(ADP-ribose) synthetase	APOPTOSIS-INDUCING FACTOR; PROGRAMMED CELL-DEATH; POLYMERASE INHIBITORS; NAD(+) DEPLETION; ADP-RIBOSYLATION; GENE DISRUPTION; MICE; ISCHEMIA; ACTIVATION; EXPRESSION	Poly-ADP-ribosylation (PAR) of proteins by poly(ADP-ribose) polymerases (PARP) occurs after experimental traumatic brain injury (TBI) and modulates neurologic outcome. Several promising pharmacological PARP inhibitors have been developed for use in humans, but there is currently no clinically relevant means of monitoring treatment effects. We therefore used an enzyme-linked immunosorbent assay to measure PAR-modified proteins in cerebrospinal fluid (CSF). Cerebrospinal fluid samples from 17 pediatric TBI patients and 15 controls were plated overnight and then incubated with polyclonal antibody against PAR. Histone-1, a PARP substrate, was incubated with active PARP, NAD, and nicked DNA, and served as the standard. Both peak and mean CSF PAR-modified proteins were increased in TBI patients versus controls. Peak CSF PAR-modified protein levels occurred on day 1 and levels remained increased on day 2 after TBI. Increases in peak CSF PAR-modified protein concentrations were independently associated with age and male sex, but not initial Glasgow Coma Scale score, Glasgow outcome score, or mechanism of injury. The increase in PAR-modified proteins in CSF after TBI may be because of increased PARP activation, decreased PAR degradation, or both. As PAR-modified protein concentration correlated with age and male sex, developmental and sex-dependent roles for PARP after TBI are implicated.	[Fink, Ericka L.; Lai, Yichen; Zhang, Xiaopeng; Janesko-Feldman, Keri; Sarnaik, Ajit A.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Fink, Ericka L.; Lai, Yichen; Zhang, Xiaopeng; Janesko-Feldman, Keri; Sarnaik, Ajit A.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Fink, Ericka L.; Berger, Rachel P.; Kochanek, Patrick M.; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; [Adelson, P. David] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Szabo, Csaba] Univ Med & Dent New Jersey, Dept Surg, Newark, NJ 07103 USA		Clark, RSB (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	clarkrs@ccm.upmc.edu	Fink, Ericka/AAU-9792-2021; Szabo, Csaba/D-1882-2013; Szabo, Csaba/ABG-2644-2021; Kochanek, Patrick M/D-2371-2015; Adelson, David/W-2083-2019	Kochanek, Patrick M/0000-0002-2627-913X; Fink, Ericka/0000-0002-3683-4571; Lai, Yi-Chen/0000-0002-9450-5506	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO1 NS38620, P50 NS30318]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD4068, K12 HD04734, RO1 HD04596896, RO1 GM060915]; Children's Hospital of Pittsburgh; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD047349, T32HD040686] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD045968] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM060915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038620, P01NS030318, P50NS030318] Funding Source: NIH RePORTER	Supported by NINDS RO1 NS38620 and P50 NS30318, NICHD T32 HD40686, K12 HD047349 and RO1 HD045968, RO1 GM060915, and the Children's Hospital of Pittsburgh.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; de la Lastra CA, 2007, CURR PHARM DESIGN, V13, P933; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Chevanne M, 2007, REJUV RES, V10, P191, DOI 10.1089/rej.2006.0514; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Cosi C, 1996, BRAIN RES, V729, P264, DOI 10.1016/0006-8993(96)00571-9; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; Halmosi R, 2001, MOL PHARMACOL, V59, P1497, DOI 10.1124/mol.59.6.1497; Klaidman LK, 1996, NEUROSCI LETT, V206, P5, DOI 10.1016/0304-3940(96)12446-0; Lai Y, 2008, J NEUROCHEM, V104, P1700, DOI 10.1111/j.1471-4159.2007.05114.x; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; LAPLACA MC, 1998, J NEUROTRAUM, V15, P878; Love S, 1999, BRAIN, V122, P247, DOI 10.1093/brain/122.2.247; Mabley JG, 2005, J PHARMACOL EXP THER, V315, P812, DOI 10.1124/jpet.105.090480; Martin SS, 2005, INT J DEV NEUROSCI, V23, P673, DOI 10.1016/j.ijdevneu.2005.08.002; MESSRIPOUR M, 1994, J NEUROCHEM, V62, P502; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Satchell MA, 2005, J CEREBR BLOOD F MET, V25, P919, DOI 10.1038/sj.jcbfm.9600088; SHAMBAUGH GE, 1988, NEUROCHEM RES, V13, P973, DOI 10.1007/BF00970771; UEDA K, 1985, ANNU REV BIOCHEM, V54, P73, DOI 10.1146/annurev.biochem.54.1.73; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang XP, 2002, J NEUROCHEM, V82, P181, DOI 10.1046/j.1471-4159.2002.00975.x	31	22	22	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	SEP	2008	28	9					1523	1529		10.1038/jcbfm.2008.52			7	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	341LQ	WOS:000258716400001	18506195	Green Accepted, Bronze			2022-02-06	
J	Soustiel, JF; Palzur, E; Vlodavsky, E; Veenman, L; Gavish, M				Soustiel, J. F.; Palzur, E.; Vlodavsky, E.; Veenman, L.; Gavish, M.			The effect of oxygenation level on cerebral post-traumatic apoptotsis is modulated by the 18-kDa translocator protein (also known as peripheral-type benzodiazepine receptor) in a rat model of cortical contusion	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						apoptosis; brain injury; hyperbaric oxygen; mitochondria; peripheral-type benzodiazepine receptor	TRAUMATIC BRAIN-INJURY; COLORECTAL-CANCER CELLS; IN-VITRO; APOPTOSIS; LIGANDS; PROLIFERATION; MITOCHONDRIA; EXPRESSION; INDUCTION; THERAPY	Aims: Hyperbaric hyperoxia has been shown to reduce apoptosis in brain injury. As the 18-kDa translocator protein (TSPO), also known as peripheral-type benzodiazepine receptor, is closely associated with the mitochondrial transition pore and because of its role in mitochondrial respiration and apoptosis, we hypothesized that reduction of apoptosis by hyperoxia may involve the TSPO. Methods: TSPO and transferase-mediated dUTP nick end labelling (TUNEL) immunopositivity was first assessed in cortical contusion, created by dynamic cortical deformation, by immunohistochemistry in rats exposed to normoxia [(dynamic cortical deformation (DCD)], normobaric hyperoxia or hyperbaric hyperoxia [hyperbaric oxygen therapy (HBO)]. In a second step, transmembrane mitochondrial potential (Delta psi(M)) and caspase 9 activity were assessed in the injured area in comparison with the noninjured hemisphere. Measurements were performed in DCD and HBO groups. A third group receiving both HBO and the TSPO ligand PK11195 was investigated as well. Results: TSPO correlated quantitatively and regionally with TUNEL immunopositivity in the perilesional area. Hyperoxia reduced both the number of TSPO expressing and TUNEL positive cells in the perilesional area, and this effect proved to be pressure dependent. After contusion, we demonstrated a dissipation of Delta psi(M) in isolated mitochondria and an elevation of caspase 9 activity in tissue homogenates from the contused area, both of which could be substantially reversed by hyperbaric hyperoxia. This protective effect of hyperoxia was reversed by PK11195. Conclusions: The present findings suggest that the protective effect of hyperoxia may be due to a negative regulation of the proapoptotic function of mitochondrial TSPO, including conservation of the mitochondrial membrane potential.	[Veenman, L.; Gavish, M.] Technion Israel Inst Technol, Rappaport Family Inst Res, Dept Pharmacol, Fac Med, IL-31096 Haifa, Israel; [Soustiel, J. F.; Palzur, E.] Technion Israel Inst Technol, Acute Brain Injury Res Lab, IL-31096 Haifa, Israel; [Vlodavsky, E.] Rambam Med Ctr, Inst Pathol, Haifa, Israel		Gavish, M (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res, Dept Pharmacol, Fac Med, Ephron St,POB 9649, IL-31096 Haifa, Israel.	j_soustiel@rambam.health.gov.il; mgavish@tx.technion.ac.il		Palzur, Eilam/0000-0003-2032-2974			Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Bono F, 1999, BIOCHEM BIOPH RES CO, V265, P457, DOI 10.1006/bbrc.1999.1683; Carmel I, 1999, BIOCHEM PHARMACOL, V58, P273, DOI 10.1016/S0006-2952(99)00093-3; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; Decaudin D, 2002, CANCER RES, V62, P1388; GARNIER M, 1994, MOL PHARMACOL, V45, P201; GAVISH M, 1992, J NEUROCHEM, V58, P1589, DOI 10.1111/j.1471-4159.1992.tb10030.x; Golani I, 2001, BIOCHEMISTRY-US, V40, P10213, DOI 10.1021/bi010431+; Gonzalez-Polo RA, 2005, ONCOGENE, V24, P7503, DOI 10.1038/sj.onc.1208907; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; HIRSCH JD, 1989, MOL PHARMACOL, V35, P157; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kuhlmann AC, 2000, J NEUROCHEM, V74, P1694, DOI 10.1046/j.1471-4159.2000.0741694.x; Levin E, 2005, BIOCHEMISTRY-US, V44, P9924, DOI 10.1021/bi050150s; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Maaser K, 2005, BIOCHEM BIOPH RES CO, V332, P646, DOI 10.1016/j.bbrc.2005.05.005; Maaser K, 2001, BRIT J CANCER, V85, P1771, DOI 10.1054/bjoc.2001.2181; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; MORENOSANCHEZ R, 1991, BIOCHEM PHARMACOL, V41, P1479, DOI 10.1016/0006-2952(91)90564-L; O'Hara MF, 2003, REPROD TOXICOL, V17, P365, DOI 10.1016/S0890-6238(03)00035-2; Palzur E, 2004, J NEUROTRAUM, V21, P41, DOI 10.1089/089771504772695931; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; RAGHAVENDRA RV, 2000, EXP NEUROL, V0161, P00102, DOI DOI 10.1006/exnr.1999.7269; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; STAROSTARUBINSTEIN S, 1987, P NATL ACAD SCI USA, V84, P891, DOI 10.1073/pnas.84.3.891; TOULMOND S, 1993, BRAIN RES, V620, P24, DOI 10.1016/0006-8993(93)90266-P; Veenman L, 2002, J NEUROCHEM, V80, P917, DOI 10.1046/j.0022-3042.2002.00769.x; Veenman L, 2007, CURR PHARM DESIGN, V13, P2385; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Vlodavsky E, 2005, ACTA NEUROPATHOL, V110, P120, DOI 10.1007/s00401-004-0946-8; Vlodavsky E, 2007, J NEURO-ONCOL, V81, P1, DOI 10.1007/s11060-006-9199-9; Wada K, 2000, ACT NEUR S, V76, P285; WANG JKT, 1984, P NATL ACAD SCI-BIOL, V81, P753, DOI 10.1073/pnas.81.3.753; Yeliseev AA, 1997, P NATL ACAD SCI USA, V94, P5101, DOI 10.1073/pnas.94.10.5101; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	42	22	25	1	8	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0305-1846			NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	AUG	2008	34	4					412	423		10.1111/j.1365-2990.2007.00906.x			12	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	327CB	WOS:000257706100004	17973904				2022-02-06	
J	Degeneffe, CE; Olney, MF				Degeneffe, Charles Edmund; Olney, Marjorie F.			Future Concerns of Adult Siblings of Persons With Traumatic Brain Injury	REHABILITATION COUNSELING BULLETIN			English	Article						family adaptations; traumatic brain injury; stress and coping; adjustment; sibling caregiving	MENTAL-RETARDATION; DISABILITIES; CHILDREN	This study examined future concerns conveyed by adult siblings who provided regular caregiving support to their brothers and sisters with traumatic brain injury (TBI). The authors surveyed a national sample of 280 adult siblings of persons with TBI. Using a constant comparative approach to text analysis, the authors analyzed responses to the question "What are your concerns regarding the future for your sibling with TBI?" Common themes of such concerns were related to the caregiving siblings' roles as future caregivers and their perceptions of the quality of professional care provided to their injured family members. Also, participants endorsed concerns for their injured siblings' independence, recovery, and relationships with family and friends. Clinical, advocacy, and research implications of these findings are discussed.	[Degeneffe, Charles Edmund; Olney, Marjorie F.] San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, San Diego, CA 92182 USA		Degeneffe, CE (corresponding author), San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, San Diego, CA 92182 USA.						Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Bogdan R.C., 1998, QUALITATIVE RES ED I, V3rd; *BRAIN INJ ASS AM, 2007, COSTS CAUS TRAUM BRA; Carson P, 1993, J Neurosci Nurs, V25, P165; Corbin, 1988, BASICS QUALITATIVE R; Cunningham J. M., 2005, CASE MANAGEMENT REHA, P91; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Denzin N.K., 1994, HDB QUALITATIVE RES; DEPUIS PR, 1994, HYPERRESEARCH; Gephart R, 1997, J ORGAN BEHAV, V18, P583, DOI 10.1002/(SICI)1099-1379(199711)18:1+<583::AID-JOB908>3.0.CO;2-T; Gilbride D, 2003, REHABIL COUNS BULL, V46, P130, DOI 10.1177/00343552030460030101; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; Glaser B., 1967, DISCOVERY GROUNDED T; GRIFFITHS DL, 1994, FAM RELAT, V43, P221, DOI 10.2307/585326; HAGNER DC, 1994, REHABIL COUNS BULL, V37, P290; HARDGROVE H, 1991, HEAD INJURY FAMILY M, P25; Hodder I, 1994, HDB QUALITATIVE RES, P393; HORWITZ AV, 1993, J MARRIAGE FAM, V55, P623, DOI 10.2307/353343; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Krauss MW, 1996, MENT RETARD, V34, P83; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; KUO C, 2005, THESIS OHIO STATE U; LOBATO D, 1983, J AUTISM DEV DISORD, V13, P347, DOI 10.1007/BF01531585; McMahon MA, 2001, J HEAD TRAUMA REHAB, V16, P587, DOI 10.1097/00001199-200112000-00006; *NAT I HLTH, 1999, REPORT NIH CONSENSUS; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; Pruchno RA, 1996, FAM RELAT, V45, P318, DOI 10.2307/585504; REDMOND G, 1989, THESIS BOSTON COLL; Rosenthal M., 1989, TRAUMATIC BRAIN INJU, P191; SACHS PR, 1991, TREATING FAMILIES BR; SELTZER GB, 1991, FAM RELAT, V40, P310, DOI 10.2307/585017; Seltzer MM, 1997, FAM RELAT, V46, P395, DOI 10.2307/585099; Spearman RC, 2001, J HEAD TRAUMA REHAB, V16, P47, DOI 10.1097/00001199-200102000-00007; SPRIGGS VT, 1998, PROMOTING CULTURAL C, P149; Tian Y, 2006, CORP COMMUN, V11, P13, DOI 10.1108/13563280610643516; ZETLIN AG, 1986, AM J MENT DEF, V91, P217; [No title captured]	38	22	22	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552			REHABIL COUNS BULL	Rehabil. Couns. Bull.	JUL	2008	51	4					240	250		10.1177/0034355207311319			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	390MB	WOS:000262167300005					2022-02-06	
J	Grathwohl, KW; Black, IH; Spinella, PC; Sweeney, J; Robalino, J; Helminiak, J; Grimes, J; Gullick, R; Wade, CE				Grathwohl, Kurt W.; Black, Ian H.; Spinella, Phillip C.; Sweeney, Jason; Robalino, Joffre; Helminiak, Joseph; Grimes, Jamie; Gullick, Richard; Wade, Charles E.			Total intravenous anesthesia including ketamine versus volatile gas anesthesia for combat-related operative traumatic brain injury	ANESTHESIOLOGY			English	Article							CEREBRAL-BLOOD-FLOW; WARTIME NEUROSURGICAL EXPERIENCE; GLASGOW OUTCOME SCALE; INTRACRANIAL-PRESSURE; CRANIOCEREBRAL INJURIES; SEVOFLURANE ANESTHESIA; PROPOFOL ANESTHESIA; PERFUSION-PRESSURE; OXYGEN-CONSUMPTION; HEMORRHAGIC-SHOCK	Background: Traumatic brain injury is a leading cause of death and severe neurologic disability. The effect of anesthesia techniques on neurologic outcomes in traumatic brain injury and potential benefits of total intravenous anesthesia (TIVA) compared with volatile gas anesthesia (VGA), although proposed, has not been well evaluated. The purpose of this study was to compare TIVA versus VGA in patients with combat-related traumatic brain injury. Methods: The authors retrospectively reviewed 252 patients who had traumatic brain injury and underwent operative neurosurgical intervention. Statistical analyses, including propensity score and matched analyses, were performed to assess differences between treatment groups (TWA vs. VGA) and good neurologic outcome. Results: Two hundred fourteen patients met inclusion criteria and were analyzed; 120 received VGA and 94 received TIVA. Good neurologic outcome (Glasgow Outcome Score 4-5) and decreased mortality were associated with TIVA compared with VGA (75% vs. 54%; P = 0.002 and 5% vs. 16%; P = 0.02, respectively). Multivariate logistic regression found admission Glasgow Coma Scale score of 8 or greater (odds ratio, 13.3; P < 0.001) and TIVA use (odds ratio, 2.3; P = 0.05) to be associated with good neurologic outcomes. After controlling for confounding factors using propensity analysis and repeated one-to-one matching of patients receiving TIVA with those receiving VGA with regard to Injury Severity Score, Glasgow Coma Scale score, base deficit, Head Abbreviated injury Score, and craniectomy or craniotomy, the authors could not find an association between treatment and neurologic outcome. Conclusion: Total intravenous anesthesia often including ketamine was not associated with improved neurologic outcome compared with VGA. Multiple confounders limit conclusions that can be drawn from this retrospective study.	[Grathwohl, Kurt W.] Brooke Army Med Ctr, Div Anesthesiol Crit Care Med, San Antonio Uniformed Serv Hlth Educ Consortium, San Antonio, TX 78234 USA; [Grathwohl, Kurt W.] Univ Texas Hlth Sci Ctr San Antonio, Trauma Div, San Antonio, TX USA; [Black, Ian H.] Uniformed Serv Univ Hlth Sci, Brooke Army Med Ctr, TARGIT, Bethesda, MD 20814 USA; [Spinella, Phillip C.] Connecticut Childrens Med Ctr, Hartford, CT USA; [Sweeney, Jason] Elmendorf AF Base, Anchorage, AK USA; [Robalino, Joffre] Walter Reed Army Med Ctr, Washington, DC 20307 USA; [Helminiak, Joseph] William Beaumont Army Med Ctr, El Paso, TX 79920 USA; [Grimes, Jamie] Brooke Army Med Ctr, San Antonio Uniformed Serv Hlth Educ Consortium, Program Director Transit Year, San Antonio, TX USA; [Wade, Charles E.] USA, Inst Surg Res, San Antonio, TX USA; Brooke Army Med Ctr, TARGIT, Div Anesthesiol Crit Care Med, Dept Anesthesia & Operat Services, San Antonio, TX USA		Grathwohl, KW (corresponding author), Brooke Army Med Ctr, Div Anesthesiol Crit Care Med, San Antonio Uniformed Serv Hlth Educ Consortium, Bldg 3600,3851 Roger Brooke Dr, San Antonio, TX 78234 USA.	kurt.grathwohl@amedd.army.mil					Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Basagan-Mogol E, 2005, J NEUROSURG ANESTH, V17, P20; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Bayona NA, 2004, ANESTHESIOLOGY, V100, P1151, DOI 10.1097/00000542-200405000-00017; Bedell Eric, 2002, Anesthesiol Clin North Am, V20, P417, DOI 10.1016/S0889-8537(01)00010-4; Breslow N., 1980, STAT METHODS CANC RE, V1; BROWN WR, 2006, TRAUMATIC BRAIN INJU; Engelhard K, 2004, ANESTHESIOLOGY, V101, P912, DOI 10.1097/00000542-200410000-00016; FINKELSTEIN EA, 2006, INCIDENCE EC BURDEN, P55; Fraga M, 2003, ANESTHESIOLOGY, V98, P1085, DOI 10.1097/00000542-200305000-00010; Frizelle HP, 1997, ANESTH ANALG, V84, P1318, DOI 10.1097/00000539-199706000-00026; FUJIKAWA DG, 1995, EPILEPSIA, V36, P186, DOI 10.1111/j.1528-1157.1995.tb00979.x; Furuya A, 2001, EUR J ANAESTH, V18, P88; Gelb AW, 2002, ANESTHESIOLOGY, V96, P1183, DOI 10.1097/00000542-200205000-00023; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hans P, 2006, CURR OPIN ANESTHESIO, V19, P498, DOI 10.1097/01.aco.0000245274.69292.ad; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hollrigel GS, 1996, J NEUROPHYSIOL, V76, P2412, DOI 10.1152/jn.1996.76.4.2412; JENNETT B, 1975, LANCET, V1, P480; Johnson KB, 2004, ANESTHESIOLOGY, V101, P647, DOI 10.1097/00000542-200409000-00013; Kahveci FS, 2001, SURG NEUROL, V56, P206, DOI 10.1016/S0090-3019(01)00555-9; Kaisti KK, 2002, ANESTHESIOLOGY, V96, P1358, DOI 10.1097/00000542-200206000-00015; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kawasaki T, 1999, ANESTH ANALG, V89, P665; Langsjo JW, 2003, ANESTHESIOLOGY, V99, P614, DOI 10.1097/00000542-200309000-00016; LEVI L, 1990, ISRAEL J MED SCI, V26, P548; LEVI L, 1990, ISRAEL J MED SCI, V26, P555; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Marval PD, 2005, ANESTH ANALG, V100, P835, DOI 10.1213/01.ANE.0000146522.84181.D3; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; PAGEL PS, 2005, CARDIOVASCULAR PHARM, P191; Petersen KD, 2003, ANESTHESIOLOGY, V98, P329, DOI 10.1097/00000542-200302000-00010; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; PFENNINGER E, 1985, ACTA NEUROCHIR, V78, P113, DOI 10.1007/BF01808689; Sagara Y, 1999, J NEUROCHEM, V73, P2524, DOI 10.1046/j.1471-4159.1999.0732524.x; Schulte am Esch J, 1978, ACTA NEUROCHIR, V45, P15; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; Summors AC, 1999, ANESTH ANALG, V88, P341, DOI 10.1097/00000539-199902000-00022; Taniguchi T, 2001, ANESTHESIOLOGY, V95, P928, DOI 10.1097/00000542-200110000-00022; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Todd MM, 1996, J NEUROSURG ANESTH, V8, P296, DOI 10.1097/00008506-199610000-00007; *USA I SURG RES, 1970, WOUND DAT MUN EFF TE; *USA I SURG RES, 2006, JOINT THEAT TRAUM RE; VELISEK L, 1993, PHARMACOL BIOCHEM BE, V45, P889, DOI 10.1016/0091-3057(93)90136-H; WONG DHW, 1975, CAN ANAESTH SOC J, V22, P339, DOI 10.1007/BF03004843; WYTE SR, 1972, ANESTHESIOLOGY, V36, P174, DOI 10.1097/00000542-197202000-00021; Zhao P, 2004, ANESTHESIOLOGY, V101, P695, DOI 10.1097/00000542-200409000-00018	54	22	25	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	JUL	2008	109	1					44	53		10.1097/ALN.0b013e31817c02e3			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	319AX	WOS:000257135300008	18580171	Bronze			2022-02-06	
J	Mitra, B; Cameron, PA; Gabbe, BJ; Rosenfeld, JV; Kavar, B				Mitra, Biswadev; Cameron, Peter A.; Gabbe, Belinda J.; Rosenfeld, Jeffrey V.; Kavar, Bhadrakant			Management and hospital outcome of the severely head injured elderly patient	ANZ JOURNAL OF SURGERY			English	Article						craniocerebral trauma; elderly; emergency; neurosurgery	TRAUMATIC BRAIN-INJURY; PROGNOSTIC-FACTORS; INTRACRANIAL HEMATOMAS; MORTALITY; AGE; COMA; ANTICOAGULATION; CLASSIFICATION; TOMOGRAPHY; SEVERITY	Introduction: Severe traumatic head injury in the elderly has been associated with poor outcomes. However, there is currently no consensus to direct management in these patients. This study outlines the demographics, injury characteristics, management and outcome of the elderly trauma patients with severe head injury across a defined population. Materials and Methods: A retrospective review of all elderly patients (age > 64 years) with a Glasgow Coma Scale (GCS) score of 8 or less, and confirmed intracranial pathology or fractured skull, was undertaken over a period of 40 months from July 2001 to September 2005. Data on patient demographics, injury cause, presenting clinical features and interventions were collected. In-hospital mortality was used as the primary outcome. Results: There were 96 patients who met the inclusion criteria. One-third of the patients were managed palliatively, one-third supportively without surgery and another third underwent surgery. Overall mortality was 70.8% (n = 68). Older age and brainstem injuries were identified as independent predictors of mortality. Mortality was reported in all patients aged 85 years or older. Conclusions: Although overall outcomes were poor, careful consideration should be given to active treatment as favourable outcomes were possible even in the presence of extremely low GCS scores. Prediction of outcome on the basis of age and anatomical diagnoses may help in this decision-making.	[Mitra, Biswadev; Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic 3004, Australia; [Cameron, Peter A.; Rosenfeld, Jeffrey V.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Mitra, Biswadev; Cameron, Peter A.; Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg & Surg, Melbourne, Vic, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Neurosurg & Surg, Melbourne, Vic 3004, Australia; [Kavar, Bhadrakant] Royal Melbourne Hosp, Dept Neurosurg, Melbourne, Vic, Australia		Mitra, B (corresponding author), Alfred Hosp, Emergency & Trauma Ctr, Commercial Rd, Melbourne, Vic 3004, Australia.	b.mitra@alfred.org.au	Rosenfeld, Jeffrey V/B-7249-2011; Mitra, Biswadev/AAC-3724-2019	Mitra, Biswadev/0000-0002-0508-2450; Cameron, Peter/0000-0002-1443-557X; Gabbe, Belinda/0000-0001-7096-7688			*AUSTR BUR STAT, 2004, CAUS DEATH; *AUSTR BUR STAT, 2005, POP AG SEX AUSTR EL; *AUSTR BUR STAT, 2005, ABBR INJ SCAL AIS 20; Australian Bureau of Statistics, 2006, YB AUSTR 2006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Baltas I, 1998, J Neurosurg Sci, V42, P85; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; JAMJOOM A, 1992, BRIT J NEUROSURG, V6, P27, DOI 10.3109/02688699209002898; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Rosenfeld JV, 2005, LANCET, V366, P1509, DOI 10.1016/S0140-6736(05)67609-X; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tornetta P, 1999, J TRAUMA, V46, P702, DOI 10.1097/00005373-199904000-00024; Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763; Vos PE, 2001, J NEUROTRAUM, V18, P649, DOI 10.1089/089771501750357591	34	22	24	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1445-1433			ANZ J SURG	ANZ J. Surg.	JUL	2008	78	7					588	592		10.1111/j.1445-2197.2008.04579.x			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	314WV	WOS:000256840800018	18593416				2022-02-06	
J	Muroi, C; Frei, K; El Beltagy, M; Cesnulis, E; Yonekawa, Y; Keller, E				Muroi, Carl; Frei, Karl; El Beltagy, Mohamed; Cesnulis, Evaldas; Yonekawa, Yasuhiro; Keller, Emanuela			Combined therapeutic hypothermia and barbiturate coma reduces interleukin-6 in the cerebrospinal fluid after aneurysmal subarachnoid hemorrhage	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						subarachnoid hemorrhage; inflammation; hypothermia; cytokine; IL-6	TUMOR-NECROSIS-FACTOR; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MODERATE HYPOTHERMIA; EXPERIMENTAL STROKE; BASILAR ARTERY; CARDIAC-ARREST; FACTOR-ALPHA; INFLAMMATION; EXPRESSION	Inflammatory response with cytokine release is reported to correlate with clinical outcome after aneurysmal subarachnoid hemorrhage (SAH). In selected cases, hypothermia and barbiturate coma are applied as means for neuroprotection after severe SAH. Hypothermia and high-dose barbiturate are reported to attenuate the inflammatory response. In this pilot study, we assessed the effect of the combined therapy on the inflammatory response. In 15 patients with SAH, daily cerebrospinal fluid (CSF) and plasma samples were collected. Interleukin (IL)-6, tumor necrosis factor alpha (TNF-alpha), IL-1 beta, systemic leukocyte, and leukocyte Counts in the CSF were quantified. Group 1 represented 7 cases treated with combined therapeutic hypothermia (33 degrees C) and barbiturate coma. Group 2 represented 8 cases without combined therapy. Compared with the systemic levels, all cases showed higher cytokine levels in the CSF. Mean IL-6 level in the CSF was significantly lower in group 1 (P < 0.001). The ratio between IL-6 levels in the CSF and plasma, as a parameter for intrathecal synthesis, was significantly lower in group 1 (P = 0.014). Mean CSF and systemic levels of TNF-alpha of group I were significantly higher compared with group 2 (P = 0.009 and P < 0.001). The mean systemic IL-1 beta level was significantly lower in group 1 (P < 0.001), as well as the leukocyte counts, both, systemic and in the CSF (P < 0.001 and P = 0.032). The present data show a most pronounced decrease of IL-6 levels in the CSF, beside decrease in systemic IL-1 beta levels, systemic leukocyte counts, and CSF leukocyte counts in group 1, which would be expected to reflect an attenuation of inflammatory response. The impact and role of TNF-alpha remains unclear.	[Muroi, Carl; Frei, Karl; El Beltagy, Mohamed; Cesnulis, Evaldas; Yonekawa, Yasuhiro; Keller, Emanuela] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland		Muroi, C (corresponding author), Univ Zurich Hosp, Dept Neurosurg, Frauenklin Str 10, CH-8091 Zurich, Switzerland.	carl.muroi@usz.ch	Keller, Emanuela/M-2917-2015; Keller, Emanuela/G-4040-2013	Keller, Emanuela/0000-0001-7892-8261; El beltagy, Mohamed/0000-0003-3856-4015; /0000-0001-9999-3345; Muroi, Carl/0000-0003-2529-2022; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574			Abe R, 2004, HYPOTHERMIA FOR ACUTE BRAIN DAMAGE: PATHOMECHANISM AND PRACTICAL ASPECTS, P315; Aibiki M, 1999, J NEUROTRAUM, V16, P225, DOI 10.1089/neu.1999.16.225; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS21; Castillo J, 2003, ANN NEUROL, V54, P811, DOI 10.1002/ana.10765; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Emsley HCA, 2002, J CEREBR BLOOD F MET, V22, P1399, DOI 10.1097/01.WCB.0000037880.62590.28; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Gaetani P, 1998, NEUROL RES, V20, P337, DOI 10.1080/01616412.1998.11740528; Gasser S, 2003, J NEUROSURG ANESTH, V15, P240, DOI 10.1097/00008506-200307000-00012; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; HANDA Y, 1995, ACTA NEUROCHIR, V132, P92, DOI 10.1007/BF01404854; Holzer M, 2002, NEW ENGL J MED, V346, P549; Huang J, 2006, SURG NEUROL, V66, P232, DOI 10.1016/j.surneu.2005.12.028; Keller E, 2005, ACT NEUR S, V94, P65; KIKUCHI T, 1995, NEUROL RES, V17, P106, DOI 10.1080/01616412.1995.11740296; Kwon KY, 2001, J KOREAN MED SCI, V16, P774, DOI 10.3346/jkms.2001.16.6.774; Lerch C, 2006, NEUROCRIT CARE, V5, P85, DOI 10.1385/NCC:5:2:85; Loop T, 2002, ANESTHESIOLOGY, V96, P1202, DOI 10.1097/00000542-200205000-00025; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; Naidech AM, 2006, J NEUROL NEUROSUR PS, V77, P1340, DOI 10.1136/jnnp.2006.089748; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; NEILDWYER G, 1974, BRAIN, V97, P79, DOI 10.1093/brain/97.1.79; Osuka K, 2006, BRAIN RES, V1072, P1, DOI 10.1016/j.brainres.2005.12.003; PARKINSON D, 1984, SURG NEUROL, V21, P132, DOI 10.1016/0090-3019(84)90330-6; Polin RS, 1998, J NEUROSURG, V89, P559, DOI 10.3171/jns.1998.89.4.0559; Provencio JJ, 2005, SEMIN NEUROL, V25, P435, DOI 10.1055/s-2005-923537; Sasaki T, 2004, STROKE, V35, P1466, DOI 10.1161/01.STR.0000127425.47266.20; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sutcliffe IT, 2001, J CEREBR BLOOD F MET, V21, P1310, DOI 10.1097/00004647-200111000-00007; Takizawa T, 2001, NEUROL RES, V23, P724, DOI 10.1179/016164101101199243; Thome C, 2005, NEUROL RES, V27, P229, DOI 10.1179/016164105X25252; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Yanagawa Y, 2002, RESUSCITATION, V53, P93, DOI 10.1016/S0300-9572(01)00499-3; Yatsushige H, 2005, STROKE, V36, P1538, DOI 10.1161/01.STR.0000170713.22011.c8; Zhou ML, 2007, BRAIN RES, V1173, P110, DOI 10.1016/j.brainres.2007.07.059	40	22	23	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2008	20	3					193	198		10.1097/ANA.0b013e31817996bf			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	321IF	WOS:000257297300006	18580350				2022-02-06	
J	Skandsen, T; Lund, TI; Fredriksli, O; Vik, A				Skandsen, Toril; Lund, Tom Ivar; Fredriksli, Oddrun; Vik, Anne			Global outcome, productivity and epilepsy 3-8 years after severe head injury. The impact of injury severity	CLINICAL REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; LATE POSTTRAUMATIC SEIZURES; FOLLOW-UP; STRUCTURED INTERVIEWS; PROSPECTIVE COHORT; YOUNG-PEOPLE; SCALE; DISABILITY; RECOVERY; MODERATE	Objective: To assess long-term outcome in survivors after severe head injury and relate outcome to injury severity. Design: Follow-up 3-8 years post injury in a retrospectively collected sample. Setting: A neurosurgical department in a regional trauma centre. Subjects: Of 146 individuals admitted, 135 were actively treated. Twenty-four per cent of these died within six months. Ninety-three of the 94 (aged 1-88 years) who survived more than three years were included in the follow-up. They were separated into groups based on their level of consciousness at four weeks post injury: oriented (n=39), confused (n=22) or in a minimally conscious/vegetative state (MCS/VS) (n=26) and not possible to assess (n=6). Outcome measures: Glasgow Outcome Scale Extended (GOSE), participation in work/education (productivity) and posttraumatic epilepsy. Results: GOSE scores were: vegetative state: 3%, severe disability: 28% (22% lower level, 6% upper level), moderate disability: 39% (22% lower level, 17% upper level) and good recovery: 27% (10% lower level, 17% upper level). Productivity was 34% (aged 7-64 years). The three severity groups had different GOSE scores (P < 0.001) and different proportion of productive individuals (P < 0.001). Twenty-three per cent experienced posttraumatic epilepsy and this was significantly associated with the highest injury severity (P < 0.001) and intracranial surgery (P=0.01). Conclusions: Being independent in daily life but unable to work was the typical long-term outcome. Stratifying the patients based on consciousness at four weeks we found different outcomes. Among oriented patients, almost all regained independency, whereas in the most severe group, poor outcomes and posttraumatic epilepsy was common.	[Skandsen, Toril] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, N-7006 Trondheim, Norway; [Skandsen, Toril] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Lund, Tom Ivar] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Fredriksli, Oddrun] Univ Trondheim Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway		Skandsen, T (corresponding author), Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, N-7006 Trondheim, Norway.	toril.skandsen@ntnu.no	Skandsen, Toril/P-6767-2014	Skandsen, Toril/0000-0001-5495-9338			Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CHOI SC, 1994, J NEUROSURG, V81, P169, DOI 10.3171/jns.1994.81.2.0169; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; CRERNER OL, 2007, J TRAUMA, V61, P1484; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; HAGEN C, 1972, LERELS EMOTIONAL COG; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Malec JF, 2005, REHABILITATION TRAUM, P176; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; MOEN KG, 2005, EUR J EMERG IN PRESS; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	42	22	23	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155			CLIN REHABIL	Clin. Rehabil.	JUL	2008	22	7					653	662		10.1177/0269215508089067			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	329YZ	WOS:000257907800009	18586817				2022-02-06	
J	Sawauchi, S; Abe, T				Sawauchi, S.; Abe, T.			The effect of haematoma, brain injury, and secondary insult on brain swelling in traumatic acute subdural haemorrhage	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; acute subdural haematoma; brain swelling; secondary insult; outcome	SEVERE HEAD-INJURY; EDEMA; HYPOXEMIA; MORTALITY; VOLUME; RAT	Objective. The high mortality of acute subdural haematoma (ASDH) is largely explained by its frequent association with primary brain damage consisting of contusion and brain swelling. However, the nature and causes of brain swelling after traumatic brain injury are multifactorial and poorly understood. The purpose of this study was to investigate the pathophysiology of brain swelling associated with ASDH in traumatic brain injury. Methods. We examined whether the thickness of the haematoma, parenchymal injury, or presence of a secondary insult had an effect on traumatic brain swelling. The variables that might affect the pathophysiology of ASDH were examined, including: (1) age and mechanism of injury, (2) neurological findings, (3) secondary insult and extracranial injuries, (4) pre-operative computed tomography (CT) scan results, and (5) outcome. Results. A total of 212 patients were included in this study. On CT scan, 159 patients (75.0%) did not have brain swelling, 29 (13.7%) had hemispheric brain swelling, and 24 (11.3%) had diffuse brain swelling. Brain swelling associated with ASDH is caused by secondary insult in addition to parenchymal injury. In the present study, the outcome of ASDH associated with brain swelling was poor, even when treated with early surgical evacuation; the mortality rate of such patients was over 75%. Conclusions. Given our findings, it is possible that the poor outcome of ASDH patients depends not only on the characteristics of the haematoma itself, but also on the presence of additional cerebral parenchymal injury and secondary insult.	[Sawauchi, S.] Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, Tokyo 1058461, Japan		Sawauchi, S (corresponding author), Jikei Univ, Sch Med, Dept Neurosurg, Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	ssawauchi@jcom.home.ne.jp	Sahuquillo, Juan/B-3577-2008	Sahuquillo, Juan/0000-0003-0713-5875			CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Field AS, 2003, AM J NEURORADIOL, V24, P1461; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JAMIESON KG, 1972, J NEUROSURG, V37, P137, DOI 10.3171/jns.1972.37.2.0137; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A, 2003, ACT NEUR S, V86, P7; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Sawauchi S, 2004, J NEUROTRAUM, V21, P563, DOI 10.1089/089771504774129892; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	16	22	23	1	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUN	2008	150	6					531	536		10.1007/s00701-007-1497-2			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	309AJ	WOS:000256431800002	18493704				2022-02-06	
J	Jain, S; Dharap, SB; Gore, MA				Jain, Sandeep; Dharap, Satish B.; Gore, Madhuri A.			Early prediction of outcome in very severe closed head injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						prognosis; outcome; prediction; severe head injury; GCS	TRAUMATIC BRAIN-INJURY; COMA SCALE SCORE; PROGNOSTIC-FACTORS; VARIABLES; MORTALITY; ADMISSION; SURVIVAL; AGE	Background: People with severe head injury and admission Glasgow Coma Scale (GCS) score <= 5 have a poor outcome and greatly strain limited resources. Aim: To identify patients with the best chances of survival, using routine clinical measures. Methods: People attending the trauma intensive care unit, who had isolated blunt head injury and GCS <= 5 and who had survived >= 4 h, were included in the study, resuscitated and clinically assessed. The GCS score was followed serially after admission. Bivariate analysis of various parameters with outcome was performed using the chi-square test. Serial GCS scores were compared with admission GCS by paired t-testing. Results: Of the 102 patients who were studied prospectively, 78 (76.5%) died and 24 (23.5%) survived. Age, gender, pre-hospital delay and admission GCS scores were comparable between the two groups. Adequate spontaneous respiration, brisk pupillary light reactivity on admission and increase in GCS by at least 2 at 24 h after admission significantly affected the outcome (p < 0.05). In the presence of all these factors, the survival rate increased from 6.1% to 57.1% (p < 0.001). Conclusions: People with GCS score <= 5 still have a reasonable chance of survival, so all patients should be aggressively managed initially. Better survival was observed among those with adequate spontaneous respiration, good pupillary reaction and improvement in GCS of at least 2 at 24 h. These clinical parameters can help to predict survival and thus make best use of limited resources. (C) 2007 Elsevier Ltd. All rights reserved.	[Jain, Sandeep; Dharap, Satish B.; Gore, Madhuri A.] LTM Med Coll, Bombay 400022, Maharashtra, India		Jain, S (corresponding author), LTM Med Coll, Bombay 400022, Maharashtra, India.	sjain7172@yahoo.com	Dharap, Satish/AAE-8565-2020	Dharap, Satish/0000-0002-9304-9617			BOFFARD KB, JOHANNESBURG HOSP TR, P5; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Dimopoulou I, 2003, NEUROLOGY, V60, P947, DOI 10.1212/01.WNL.0000049931.77887.7F; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; GENNRELLI TA, 1989, J TRAUMA, V29, P1195; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; Li Ning, 2004, Chin J Traumatol, V7, P156; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; Pillai SV, 2003, NEUROL INDIA, V51, P345; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Ratanalert S, 2002, BRIT J NEUROSURG, V16, P487, DOI 10.1080/0268869021000030311; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; SELLADURAI BM, 1992, BRIT J NEUROSURG, V6, P549, DOI 10.3109/02688699209002372; SHIGEMORI M, 1989, NEUROSURG REV, V12, P1436; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Wilson WJ, 2002, J NEUROSURG, V97, P1062, DOI 10.3171/jns.2002.97.5.1062	26	22	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	MAY	2008	39	5					598	603		10.1016/j.injury.2007.06.003			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	298OZ	WOS:000255698300015	17884053				2022-02-06	
J	Spaeth, DM; Mahajan, H; Karmarkar, A; Collins, D; Cooper, RA; Boninger, ML				Spaeth, Donald M.; Mahajan, Harshal; Karmarkar, Amol; Collins, Diane; Cooper, Rory A.; Boninger, Michael L.			Development of a wheelchair virtual driving environment: Trials with subjects with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; rehabilitation; wheelchairs	ELECTRIC-POWERED WHEELCHAIRS; ISOMETRIC JOYSTICKS; AMNESIA; TECHNOLOGY; POSITION; STATES	Objective: To develop and test a wheelchair virtual driving environment that can provide quantifiable measures of driving ability, offer driver training, and measure the performance of alternative controls. Design: A virtual driving environment was developed. The wheelchair icon is displayed in a 2-dimensional, bird's eye view and has realistic steering and inertial properties. Eight subjects were recruited to test the virtual driving environment. They were clinically evaluated for range of motion, muscle strength, and visual field function. Driving capacity was assessed by a brief trial with an actual wheelchair. During virtual trials, subjects were seated in a stationary wheelchair: a standard motion sensing joystick (MSJ) was compared with an experimental isometric joystick by using a repeated-measures design. Setting: Subjects made 2 laboratory visits. The first visit included clinical evaluation, tuning the isometric joystick. familiarization with virtual driving environment, and 4 driving tasks. The second visit included 40 trials with each joystick. Participants: Subjects (n=8; 7 men, I woman) with a mean age of 22.65 +/- 2y and traumatic brain injury, both ambulatory and nonambulatory, were recruited. Interventions: The MSJ used factory settings. A tuning program customized the isometric joystick transfer functions during visit 1. During the second visit, subjects performed 40 trials with each joystick. Main Outcome Measure: The root mean square error (RMSE) was defined as the average deviation from track centerline (in meters) and speed (in m/s). Results: Data analysis from the first 8 subjects showed no statistically significant differences between joysticks. RMSE averaged.12 to .21m; speed averaged.75 m/s. For all tasks and joysticks, driving in reverse resulted in a higher RMSE and more virtual collisions than forward driving. RMSE rates were greater in left and right turns than straight and docking tasks. Conclusions: Testing with instrumented real wheelchairs can validate the virtual driving environment and assess whether virtual driving skills transfer to actual driving.	[Spaeth, Donald M.] VA Pittsburgh HealthCare Syst, Human Engn Res Labs, Ctr Excellence Wheelchairs & Related Technol, Pittsburgh, PA 15206 USA; [Spaeth, Donald M.; Mahajan, Harshal; Karmarkar, Amol; Collins, Diane; Cooper, Rory A.; Boninger, Michael L.] Univ Pittsburgh, Human Engn Res Labs, Pittsburgh, PA USA; [Boninger, Michael L.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Spaeth, Donald M.; Mahajan, Harshal; Karmarkar, Amol; Collins, Diane; Cooper, Rory A.; Boninger, Michael L.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Cooper, Rory A.; Boninger, Michael L.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA		Spaeth, DM (corresponding author), VA Pittsburgh HealthCare Syst, Human Engn Res Labs, Ctr Excellence Wheelchairs & Related Technol, 7180 Highland Dr,Bldg 4,2nd F1 E,151R1-H, Pittsburgh, PA 15206 USA.	spaethd@herlpitt.org	Karmarkar, Amol/E-6030-2011	Karmarkar, Amol/0000-0001-8355-1585; Collins, Diane/0000-0003-0646-0457; Boninger, Michael/0000-0001-6966-919X	National Institute on Disability and Rehabilitation Research; U.S. Department of EducationUS Department of Education [H133A020502]; Human Engineering Research Laboratories	Supported by the National Institute on Disability and Rehabilitation Research. U.S. Department of Education (grant no. H133A020502) and supported with resources and facilities by the Human Engineering Research Laboratories. VA Pittsburgh Healthcare System.	BEVLY A, P 28 ANN RESNA C 200; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; COOPER R, 2005, Patent No. 20050195166; Cooper RA, 2000, IEEE T CONTR SYST T, V8, P112, DOI 10.1109/87.817696; Cooper RA, 2000, IEEE T BIO-MED ENG, V47, P902, DOI 10.1109/10.846684; Cooper RA, 2002, MED ENG PHYS, V24, P703, DOI 10.1016/S1350-4533(02)00111-X; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Dicianno BE, 2007, IEEE T NEUR SYS REH, V15, P144, DOI 10.1109/TNSRE.2007.891394; Dicianno BE, 2006, AM J PHYS MED REHAB, V85, P631, DOI 10.1097/01.phm.0000228519.54763.b4; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Fehr L, 2000, J REHABIL RES DEV, V37, P353; GLISKY EL, 1989, NEUROPSYCHOLOGIA, V27, P107, DOI 10.1016/0028-3932(89)90093-6; Harrison A, 2002, DISABIL REHABIL, V24, P599, DOI 10.1080/09638280110111360; Kanyer B., 1992, J HEAD TRAUMA REHAB, V7, P81; Kaye HS, 2000, DISABILITY STAT REPO; MAUGUS P, 2006, FACETS MAGAZINE  FAL, P26; NINISS H, 2000, P 3 INT C DIS VIRT R, P9; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Spaeth D, 2002, THESIS U PITTSBURGH; SPAETH DM, P 29 ANN RESNA C 200; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VICTORIEN C, 2007, INT J REHABIL RES, V30, P91; Webster JS, 2001, ARCH PHYS MED REHAB, V82, P769, DOI 10.1053/apmr.2001.23201; WU HS, 2006, Patent No. 7004885; ZHAI S, P IEEE VIRT REAL C 2	25	22	24	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2008	89	5					996	1003		10.1016/j.apmr.2007.11.030			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	341ST	WOS:000258735900028	18452751				2022-02-06	
J	Elliott, MB; Jallo, JJ; Tuma, RF				Elliott, Melanie B.; Jallo, Jack J.; Tuma, Ronald F.			An investigation of cerebral edema and injury volume assessments for controlled cortical impact injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						controlled cortical impact; CCI injury; traumatic brain injury; cerebral edema; injury volume; triphenyltetrazolium chloride	TRAUMATIC BRAIN-INJURY; RATS; CONTUSION; ISCHEMIA; MODEL	Using the controlled cortical impact (CCI) model, our laboratory compared edema in contralateral and ipsilateral regions to help clarify conflicting reports of contralateral edema and for enhanced assessment and interpretation of CCI injury pathophysiology. This investigation examined regional edema in response to graded injury severities over time with regards to tissue damage. Prior to injury rats were anesthetized with ketamine and xylazine (1:1). CCI injury parameters were set at 4.0 m/s and 120 to 130 ms. Rats were randomized to receive moderate or severe injuries set at 2.0 and 3.0 mm depths, respectively. Cerebral edema and injury volume were examined separately following euthanasia with pentobarbital. Cerebral edema was measured using the wet-dry weight technique at 24 or 48 It after injury. Sham animals underwent all surgical procedures except the impact injury. Injury volume was quantified using 2,3,5-triphenyltetrazolium chloride staining at 24 h or 7 days after injury. The results of this investigation confirm that cerebral edema is absent in the uninjured, contralateral hemisphere after moderate and severe CCI injury. There were regional differences in cerebral edema formation in the hemisphere ipsilateral to injury that were dependent on injury severity and the length of time after injury. Tissue damage was reduced over 7 days following moderate CCI injury. Conclusions: (1) the absence of edema in the contralateral hemisphere allows it to serve as a valid control for edema formation, (2) misrepresenting injury volume because of edema continues to be a problem for evaluating CCI injury and treatment efficacy, and (3) reduced injury volume over 7 days following CCI injury suggests tissue recovery after initial dysfunction. (c) 2007 Elsevier B.V. All rights reserved.	[Elliott, Melanie B.] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19140 USA; [Jallo, Jack J.] Temple Univ, Sch Med, Dept Neurosurg, Philadelphia, PA 19140 USA; [Tuma, Ronald F.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA		Elliott, MB (corresponding author), Temple Univ, Dept Phys Therapy, 3307 N Broad St, Philadelphia, PA 19140 USA.	mdion@temple.edu; jack.jallo@teinple.edu; ronald.tuma@teniple.edu		Jallo, Jack/0000-0002-5512-1729			BARONE FC, 1991, BRAIN RES BULL, V26, P285, DOI 10.1016/0361-9230(91)90240-K; Baskaya MFK, 1996, NEUROSURGERY, V38, P140; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; Elliott MB, 2007, J NEUROTRAUM, V24, P195, DOI 10.1089/neu.2006.0094; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Okuno S, 2001, NEUROL RES, V23, P657, DOI 10.1179/016164101101198983; Onal MZ, 1997, STROKE, V28, P1060, DOI 10.1161/01.STR.28.5.1060; Stroop R, 1998, ACT NEUR S, V71, P303; SUTTON RL, 1994, ACTA NEUROCHIR, P446; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Unterberg AW, 1997, ACT NEUR S, V70, P106; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	20	22	24	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAR 15	2008	168	2					320	324		10.1016/j.jneumeth.2007.10.019			5	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	271YK	WOS:000253824400005	18076998				2022-02-06	
J	Kay, LG; Bundy, AC; Clemson, LM				Kay, Lynnette G.; Bundy, Anita C.; Clemson, Lindy M.			Predicting fitness to drive using the Visual Recognition Slide Test (USyd)	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article; Proceedings Paper	Conference of the Australian-Consortium-for-Social-and-Political-Research-Incorporated	DEC, 2006	Sydney, AUSTRALIA	Australian Consortium Social & Polit Res Inc		driving; fitness to drive; rehabilitation	TRAUMATIC BRAIN-INJURY; OLDER DRIVERS; SCREENING ASSESSMENT; ALZHEIMER-DISEASE; IMPAIRMENT; STROKE; PERFORMANCE; ADULTS; SELF; COMPETENCE	OBJECTIVE. The authors examined the construct and predictive validity and internal reliability of the Visual Recognition Slide Test developed at the University of Sydney (VRST-USyd). METHOD. A historical cohort study using retrospective descriptive analysis of VRST-USyd scores and on-road driving performance for 838 drivers with impairments was conducted. RESULTS. Rasch analysis provided evidence for the construct validity and internal reliability of the VRST-USyd. Goodness-of-fit statistics for all items were acceptable. The test had high participant and item reliability indexes and separated the participants into four groups with varying levels of skill. Using a cutoff score of 95/164, the sensitivity of the test was 81%, and the specificity was 90%. However, when coupled with clinicians' judgment of participants' awareness of their driving performance during the on-road assessment, this score improved. CONCLUSION. There is evidence for reliability and construct and predictive validity of the VRST-USyd. The measurement of awareness requires further research.	[Kay, Lynnette G.] Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, Lidcombe, NSW 1825, Australia; [Bundy, Anita C.; Clemson, Lindy M.] Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, Sydney, NSW 2006, Australia		Kay, LG (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, POB 170, Lidcombe, NSW 1825, Australia.	L.Kay@usyd.edu.au		Bundy, Anita/0000-0003-4743-9144			Anastasi A., 1988, PSYCHOL TESTING; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Austroads, 2004, APR25904 AUSTR; BADIA X, 2002, DIFF IT TEST FUNCT; Ball K, 1998, ACCIDENT ANAL PREV, V30, P313, DOI 10.1016/S0001-4575(97)00102-4; Ball KK, 2006, J AM GERIATR SOC, V54, P77, DOI 10.1111/j.1532-5415.2005.00568.x; Bond T. G., 2001, APPL RASCH MODEL; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; Brooks N, 2005, BRAIN INJURY, V19, P165, DOI 10.1080/02699050410001720004; COLEMAN B, 2006, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Cotrell V, 1999, ALZ DIS ASSOC DIS, V13, P151, DOI 10.1097/00002093-199907000-00007; De Raedt R, 2000, J AM GERIATR SOC, V48, P1664, DOI 10.1111/j.1532-5415.2000.tb03880.x; Engum E. S., 1988, COGNITIVE REHABILITA, V6, P34; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; Garratt AM, 2003, SPINE, V28, P79, DOI 10.1097/00007632-200301010-00019; Grace J, 2005, J INT NEUROPSYCH SOC, V11, P766, DOI 10.1017/S135561770505848; Hoffman L, 2005, PSYCHOL AGING, V20, P610, DOI 10.1037/0882-7974.20.4.610; Howorth P, 2003, AGING MENT HEALTH, V7, P113, DOI 10.1080/1360786031000072286; Huchler S., 2001, EURA MEDICOPHYS, V37, P283; Kantor B, 2004, J AM GERIATR SOC, V52, P1326, DOI 10.1111/j.1532-5415.2004.52363.x; KATZ RT, 1990, ARCH PHYS MED REHAB, V71, P133; Klavora P, 2000, ARCH PHYS MED REHAB, V81, P701, DOI 10.1016/S0003-9993(00)90096-0; Korner-Bitensky N, 2000, AM J PHYS MED REHAB, V79, P253, DOI 10.1097/00002060-200005000-00007; Linacre JM., 2005, USERS GUIDE WINSTEPS; Lincoln N., 1992, CLIN REHABIL, V6, P275, DOI DOI 10.1177/026921559200600402; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Marottoli RA, 1998, ACCIDENT ANAL PREV, V30, P331, DOI 10.1016/S0001-4575(97)00100-0; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Mazer BL, 2004, CRITICAL REV ARCH PH, V16, P291, DOI DOI 10.1615/CRITREVPHYSREHABILMED.V16.I4.40; McKenna P, 2004, BRIT J CLIN PSYCHOL, V43, P325, DOI 10.1348/0144665031752952; Michon J. A., 1985, HUMAN BEHAV TRAFFIC, P485, DOI [DOI 10.1007/978-1-4613-2173-6_19, 10.1007/978-1-4613-2173-6_19]; Myers RS, 2000, PERCEPT MOTOR SKILL, V91, P279, DOI 10.2466/PMS.91.5.279-290; Norman, 1995, HLTH MEASUREMENT SCA; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Radford KA, 2004, ARCH PHYS MED REHAB, V85, P324, DOI 10.1016/S0003-9993(03)00765-2; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; SMITH RM, 1996, POLYTOMOUS MEAN SQUA; Snellgrove CA., 2005, COGNITIVE SCREENING; Stutts JC, 2003, J SAFETY RES, V34, P431, DOI 10.1016/j.jsr.2003.09.014; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002; Wild K, 2003, ALZ DIS ASSOC DIS, V17, P27, DOI 10.1097/00002093-200301000-00004; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065	46	22	22	0	5	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	MAR-APR	2008	62	2					187	197		10.5014/ajot.62.2.187			11	Rehabilitation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Rehabilitation	272AK	WOS:000253829600008	18390012				2022-02-06	
J	Lu, DC; Binder, DK; Chien, B; Maisel, A; Manley, GT				Lu, Daniel C.; Binder, Devin K.; Chien, Bonnie; Maisel, Alan; Manley, Geoffrey T.			Cerebral salt wasting and elevated brain natriuretic peptide levels after traumatic brain injury: 2 case reports	SURGICAL NEUROLOGY			English	Article						brain natriuretic peptide; traumatic brain injury; cerebral salt-wasting syndrome	CENTRAL-NERVOUS-SYSTEM; SUBARACHNOID HEMORRHAGE; HYPONATREMIA; RECEPTORS; SECRETION; HEART	Background: Historically, hyponatremia in patients with varying brain diseases was termed cerebral salt wasting. Hyponatremia secondary to CSW was reported to be a distinct entity from SIADH, with the distinguishing feature of decreased extracellular fluid volume. Brain natriuretic peptide, a peptide with natriuretic, vasorelaxant, and aldosterone-inhibiting properties, was recently implicated in aneurysmal SAH patients with CSW. Here, we describe 2 cases of CSW in TBI patients with elevated BNP levels. This phenomenon has not been previously described. Case Description: Two patients with TBI and hyponatremia were subject to analysis. Central lines were placed to assess volume status. Levels of BNP were measured at the onset of hypertonic saline infusion. Electrocardiogram and cardiac enzyme studies were performed to assess cardiac function. Serial imaging was performed to assess the extent of brain injury. Conclusions: These patients with TBI had findings consistent with CSW with elevated BNP levels in the setting of normal cardiac function. In both cases, a high BNP level was observed after declining plasma Na levels despite aggressive hypertonic saline infusion. High BNP levels may be associated with CSW. Further studies are necessary to establish a causative role for BNP in TBI-induced CSW. (c) 2008 Elsevier Inc. All rights reserved.	[Lu, Daniel C.; Binder, Devin K.; Chien, Bonnie; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Maisel, Alan] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA		Lu, DC (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, POB 0112, San Francisco, CA 94143 USA.	ludan@neurosurg.ucsf.edu					Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; COOPER WC, 1965, ARCH INTERN MED, V116, P113, DOI 10.1001/archinte.1965.03870010115014; CORT JH, 1954, LANCET, V1, P752; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; GOLDBERG M, 1960, NEW ENGL J MED, V263, P1037, DOI 10.1056/NEJM196011242632101; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; HOSODA K, 1991, HYPERTENSION, V17, P1152, DOI 10.1161/01.HYP.17.6.1152; MAACK T, 1992, ANNU REV PHYSIOL, V54, P11, DOI 10.1146/annurev.physiol.54.1.11; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; McGirt MJ, 2004, NEUROSURGERY, V54, P1369, DOI 10.1227/01.NEU.0000125016.37332.50; Moser AM, 1994, HARRISONS PRINCIPLES, P1921; Munagala VK, 2004, CURR PROB CARDIOLOGY, V29, P707, DOI 10.1016/j.cpcardiol.2004.07.002; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57; Scotland RS, 2005, PHARMACOL THERAPEUT, V105, P85, DOI 10.1016/j.pharmthera.2004.08.011; STINGO AJ, 1992, AM J PHYSIOL, V263, pH1318, DOI 10.1152/ajpheart.1992.263.4.H1318; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; WELT LG, 1952, ARCH INTERN MED, V90, P355, DOI 10.1001/archinte.1952.00240090076007	19	22	24	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	MAR	2008	69	3					226	229		10.1016/j.surneu.2007.02.051			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	275SJ	WOS:000254091600005	18325424				2022-02-06	
J	Skoglund, TS; Nilsson, D; Ljungberg, M; Jonsson, L; Rydenhag, B				Skoglund, T. S.; Nilsson, D.; Ljungberg, M.; Jonsson, L.; Rydenhag, B.			Long-term follow-up of a patient with traumatic brain injury using diffusion tensor imaging	ACTA RADIOLOGICA			English	Article						brain/brain stem; CNS; MR diffusion/perfusion; trauma	FIBER TRACKING; AXONAL INJURY	This case report describes a patient who sustained severe head trauma with diffuse axonal injury (DAI). Examination with magnetic resonance diffusion tensor imaging (MR-DTI), 6 days post-injury, showed a severe reduction in fractional anisotropy (FA) in the rostral pons containing the corticospinal tract, which correlated to the patient's severe hemiparesis. By 18 months post-accident, the patient had recovered completely and conventional MRI showed no pathology. However, although her FA values in the rostral pons had increased, they were still not normalized. It seems that a complete normalization of the FA values is not required to achieve clinical recovery, and that MR-DTI seems to be more sensitive to DAI compared to conventional MRI.	Sahlgrens Univ Hosp, Dept Neurosurg, SE-41345 Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Biomed Engn & Med Phys, Gothenburg, Sweden; Sahlgrens Univ Hosp, Dept Radiol, Gothenburg, Sweden; Univ Gothenburg, Dept Radiat Phys, Gothenburg, Sweden		Skoglund, TS (corresponding author), Sahlgrens Univ Hosp, Dept Neurosurg, Bldg Straket 7, SE-41345 Gothenburg, Sweden.	thomas.skoglund@vgregion.se	Nilsson, Daniel/AAF-3868-2020				Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861	12	22	25	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0284-1851	1600-0455		ACTA RADIOL	Acta Radiol.	FEB	2008	49	1					98	100		10.1080/02841850701561372			3	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	264UM	WOS:000253315900019	17963089				2022-02-06	
J	Thorat, JD; Wang, EC; Lee, KK; Seow, WT; Ng, I				Thorat, J. D.; Wang, E. C.; Lee, K. K.; Seow, W. T.; Ng, I.			Barbiturate therapy for patients with refractory intracranial hypertension following severe traumatic brain injury: Its effects on tissue oxygenation, brain temperature and autoregulation	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						barbiturate coma; brain oxygenation; head injury; cerebral autoregulation; brain temperature	CEREBROVASCULAR PRESSURE REACTIVITY; HEAD-INJURY; CEREBRAL AUTOREGULATION; MANAGEMENT	The aim of this study was to explore the effects of barbiturate coma on cerebral tissue oxygen tension and cerebrovascular pressure reactivity (PRx), as an index of cerebral autoregulation in severe head injury patients. This was a prospective observational clinical study of 12 patients with severe traumatic brain injury, carried out at a tertiary-level neurosurgical intensive care unit between April 2002 and May 2005. All patients received standard neurosurgical intensive care and monitoring. Probes for intracranial pressure (ICP), brain temperature (BT) and brain tissue oxygenation (PTiO2) were inserted into (noncontused) normal-looking white matter. Cerebrovascular PRx was measured as a moving correlation between ICP and arterial blood pressure. Barbiturate coma was instituted when ICP became refractory (ICP > 20 mmHg). All data from the multimodal monitoring were digitally extracted and statistically analysed. The mean ICP decreased with barbiturate coma in eight of the 12 patients (75% of the patients), but only four achieved a value below 20 mmHg. Of eight patients with prebarbiturate PTiO2 levels above 10 mmHg, six had a further improvement in oxygenation. Thus, concordant favourable changes in ICP, PRx and PTiO2 with barbiturate coma were seen in those who survived. Effective response to barbiturates can be detected by improved PTiO2 and autoregulation (PRx) in severe head injury patients. (c) 2007 Elsevier Ltd. All rights reserved.	[Thorat, J. D.; Wang, E. C.; Lee, K. K.; Seow, W. T.; Ng, I.] Tan Tock Seng Hosp, Natl Inst Neurosci, Dept Neurosurg, Acute Brain Injury Res Lab, Singapore 308433, Singapore		Thorat, JD (corresponding author), Tan Tock Seng Hosp, Natl Inst Neurosci, Dept Neurosurg, Acute Brain Injury Res Lab, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.	jthorat@hotmail.com					*BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P597; BULLOCK HR, 1998, J NEUROTRAUM, V13, P344; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gupta AK, 2002, J NEUROSURG, V96, P263, DOI 10.3171/jns.2002.96.2.0263; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; McKinley BA, 1988, ACTA NEUROCHIR WIE S, V71, P177; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Menzel M, 2003, J NEUROSURG ANESTH, V15, P33, DOI 10.1097/00008506-200301000-00006; Miller JD, 1992, NEUROSURG QUART, V2, P28; NILSSON L, 1975, ACTA ANAESTH SCAND, P18; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; REA GL, 1983, NEUROSURGERY, V12, P401, DOI 10.1227/00006123-198304000-00005; REILLY P, 1997, HEAD INJURY, P385; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; Soukup J, 2002, J NEUROTRAUM, V19, P559, DOI 10.1089/089771502753754046; Steiner LA, 2003, J NEUROL NEUROSUR PS, V74, P765, DOI 10.1136/jnnp.74.6.765; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; van den Brink WA, 1998, ACT NEUR S, V71, P190	30	22	23	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2008	15	2					143	148		10.1016/j.jocn.2006.08.014			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	256SH	WOS:000252749600009	17997313				2022-02-06	
J	Greiffenstein, MF; Baker, WJ				Greiffenstein, Manfred F.; Baker, W. John			Validity testing in dually diagnosed post-traumatic stress disorder and mild closed head injury	CLINICAL NEUROPSYCHOLOGIST			English	Article; Proceedings Paper	110th Annual Convention of the American-Psychological-Association	AUG 22-25, 2002	CHICAGO, IL	Amer Psychol Assoc		dual diagnosis; late post-concussion syndrome; malingering; mild traumatic brain injury; noncredible scores; post-traumatic stress disorder; validity testing	TRAUMATIC BRAIN-INJURY; MALINGERED NEUROCOGNITIVE DYSFUNCTION; MOTOR-VEHICLE ACCIDENTS; RELIABLE DIGIT SPAN; FAKE BAD SCALE; NEUROPSYCHOLOGICAL TESTS; BASE RATES; CONCUSSION; MEMORY; MMPI-2	Prospects for the coexistence of post-traumatic stress syndrome (PTSS) and mild traumatic brain injury (mTBI) rely exclusively on subjective evidence, increasing the risk of response bias in a compensatable social context. Using a priori specificities derived from genuine brain disorder groups, we examined validity failure rates in three domains (symptom, cognitive, motor) in 799 persons reporting persistent subjective disability long after mild neurological injury. Validity tests included the Test of Memory Malingering, MMPI-2 Fake Bad Scale, and Infrequency (F) scales, reliable digit span, and Halstead-Reitan finger tapping. Analyses showed invalidity signs in large excess of actuarial expectations, with rising invalidity risk conditional on post-traumatic complexity; the highest failure rates were produced by the 95 persons reporting both neurogenic amnesia and re-experiencing symptoms. We propose an "over-endorsement continuum" hypothesis: The more complex the post-traumatic presentation after mild neurological injury, the stronger the association with response bias. Late-appearing dual diagnosis is a litigation phenomenon so intertwined with secondary gain as to be a byproduct of it.	[Greiffenstein, Manfred F.; Baker, W. John] Psychol Syst Inc, Royal Oak, MI USA		Greiffenstein, MF (corresponding author), 32121 Woodward,Suite 201, Royal Oak, MI 48073 USA.	mfgreiff@comcast.net					Alexander, 1997, Semin Clin Neuropsychiatry, V2, P177; Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arbisi P.A, 2004, PSYCHOL SERV, V1, P56, DOI DOI 10.1037/1541-1559.1.1.56; Arbisi PA, 1997, PSYCHOL ASSESSMENT, V9, P102, DOI 10.1037/1040-3590.9.2.102; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BENPORATH YS, 2006, MMPI 2 FAKE BAD SCAL; Berthier M L, 1998, Depress Anxiety, V8, P43, DOI 10.1002/(SICI)1520-6394(1998)8:1<43::AID-DA9>3.0.CO;2-6; Binder LM, 2004, J CLIN EXP NEUROPSYC, V26, P369, DOI 10.1080/13803390490510095; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Blanchard EB, 1998, J TRAUMA STRESS, V11, P337, DOI 10.1023/A:1024407321677; Blanchard EB, 1998, J ANXIETY DISORD, V12, P21, DOI 10.1016/S0887-6185(97)00047-9; Boake C, 1996, J HEAD TRAUMA REHAB, V11, P98; BONTKE CF, 1996, J HEAD TRAUMA REHAB, V11, P98; Breslau N, 1998, ARCH GEN PSYCHIAT, V55, P626, DOI 10.1001/archpsyc.55.7.626; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Buckley TC, 2003, J TRAUMA STRESS, V16, P59, DOI 10.1023/A:1022063412056; Burges C, 2001, BRIT J CLIN PSYCHOL, V40, P209, DOI 10.1348/014466501163544; Butters MA, 1998, ARCH CLIN NEUROPSYCH, V13, P721, DOI 10.1016/S0887-6177(98)00010-9; Cohen J., 2013, STAT POWER ANAL BEHA; DAHLSTROM WG, 1975, MMPI HDB, V1; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Duncan SA, 2002, ASSESSMENT, V9, P56, DOI 10.1177/1073191102009001007; Eisenman DP, 2003, JAMA-J AM MED ASSOC, V290, P627, DOI 10.1001/jama.290.5.627; Etherton J, 2005, ASSESSMENT, V12, P130, DOI 10.1177/1073191105274859; Etherton JL, 2005, ARCH CLIN NEUROPSYCH, V20, P375, DOI 10.1016/j.acn.2004.09.007; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Greiffenstein MF, 2004, CLIN NEUROPSYCHOL, V18, P573, DOI 10.1080/13854040490888512; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, CLIN NEUROPSYCHOL, V20, P491, DOI 10.1080/13854040590967144; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Hickling EJ, 1997, BEHAV RES THER, V35, P191, DOI 10.1016/S0005-7967(96)00090-3; HICKLING EJ, 2002, J FORENSIC PSYCHOL P, V0002, P00033, DOI [DOI 10.1300/J158v02n01_02, DOI 10.1300/J158V02N01_]; Kaemmer, 1989, MMPI 2 MANUAL ADM SC; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; KOCH WJ, 2006, PSYCHOL INJURIES; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lipsey M.W., 2001, PRACTICAL META ANAL; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Martin RC, 1996, J CLIN EXP NEUROPSYC, V18, P265, DOI 10.1080/01688639608408281; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; MCGUIRE BE, 1999, PSYCHIAT PSYCHOL LAW, V6, P163; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; McNally RJ, 2004, PSYCHOL SCI, V15, P493, DOI 10.1111/j.0956-7976.2004.00707.x; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; MILLER H, 1972, LANCET, V1, P580; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; North C S, 2001, Mil Med, V166, P51; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; OTHMER E, 1992, PSYCHIAT DIAGNOSTIC; OTHMER E, 1988, PSYCHIAT DIAGNOSTIC; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; Peterson DI, 1998, NEUROLOGIST, V4, P131, DOI 10.1097/00127893-199805000-00004; Prigatano GP, 1997, ARCH CLIN NEUROPSYCH, V12, P609, DOI 10.1016/S0887-6177(97)00020-6; Rattok J, 1996, J HEAD TRAUMA REHAB, V11, P95, DOI 10.1097/00001199-199602000-00011; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reitan R. M., 1993, HALSTED REITAN NEURO; Rogers R, 1990, Bull Am Acad Psychiatry Law, V18, P323; Rogers R., 1997, CLIN ASSESSMENT MALI; Rosen, 2004, SCI REV MENTAL HLTH, V3, P39; Rosen GM, 2004, PERS INDIV DIFFER, V36, P1291, DOI 10.1016/S0191-8869(03)00216-2; Rosen GM, 1996, B AM ACAD PSYCH LAW, V24, P267; ROSEN GM, 1995, PROF PSYCHOL-RES PR, V26, P82, DOI 10.1037/0735-7028.26.1.82; Ruiz MA, 2002, PROF PSYCHOL-RES PR, V33, P294, DOI 10.1037//0735-7028.33.3.294; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Steiner H, 1997, J AM ACAD CHILD PSY, V36, P357, DOI 10.1097/00004583-199703000-00014; Straus SE., 2005, EVIDENCE BASED MED P, V3rd; TEASDALE G, 1974, LANCET, V2, P81; TOMBAUGH T, 1995, TESTS MEMORY MALINGE; van Hout MSE, 2003, NEUROTOXICOLOGY, V24, P547, DOI 10.1016/S0161-813X(03)00054-8; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P241, DOI 10.1023/A:1007754611030; Vasterling JJ, 1998, NEUROPSYCHOLOGY, V12, P125, DOI 10.1037/0894-4105.12.1.125; Verma S, 2001, INT J GERIATR PSYCH, V16, P356, DOI 10.1002/gps.333; World Health Organization, 1992, ICD 10 CLASSIFICATIO; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177; [No title captured]	94	22	22	0	10	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2008	22	3					565	582		10.1080/13854040701377810			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Psychology; Neurosciences & Neurology	298LU	WOS:000255690000194	17853127				2022-02-06	
J	Wright, DW; Hoffman, SW; Virmani, S; Stein, DG				Wright, David W.; Hoffman, Stuart W.; Virmani, Sharad; Stein, Donald G.			Effects of medroxyprogesterone acetate on cerebral oedema and spatial learning performance after traumatic brain injury in rats	BRAIN INJURY			English	Article						traumatic brain injury; psychopharmacology; trauma; intervention	REPLACEMENT THERAPY; NERVOUS-SYSTEM; PROGESTERONE; ESTROGEN; PROGESTINS; NEUROPROTECTION; NEUROSTEROIDS; BENEFITS; RISKS	Background: Given after brain injury (TBI), progesterone reduces cerebral oedema and facilitates functional recovery. Progesterone analogues have been synthesized for use in many medical conditions and exhibit different chemical and biological properties. Medroxyprogesterone acetate (MPA) is widely used in clinical practice, but oestrogen/MPA combinations may increase the risk of stroke and cardiovascular disease rather than preventing them. In some conditions, MPA can exhibit pharmacological actions that are different from those of natural progesterone. Primary objective and hypothesis: Using laboratory rats, this study assessed the efficacy of MPA to determine whether this progestin and natural progesterone exert similar effects as a treatment after bilateral injury to the frontal cortex. Main outcomes and results: MPA produced a dose-related reduction of cerebral oedema at 48 hours post-TBI but neither 4 nor 16 mg/kg doses of MPA enhanced behavioural recovery. Conclusion: These findings help to clarify the divergent results from prior positive progesterone studies and the negative MPA clinical trials for hormone replacement therapy. The results can be taken to suggest that the control of cerebral oedema, while clearly desirable, is not the only contributor to progesterone-induced behavioural recovery.	[Wright, David W.; Hoffman, Stuart W.; Virmani, Sharad; Stein, Donald G.] Emory Univ, Dept Emergency Med, Sch Med, Atlanta, GA 30322 USA		Stein, DG (corresponding author), Emory Univ, Dept Emergency Med, Sch Med, 1365 B Clifton Rd NE,Suite 5100, Atlanta, GA 30322 USA.	dstei04@emory.edu	Wright, David/F-1209-2013; Stein, Donald/AAJ-5139-2020	Wright, David/0000-0002-7145-9105; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD044857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040825] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5R21 HD44857] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS40825] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [5R01NSO48451] Funding Source: Medline		Bamberger CM, 1999, J CLIN ENDOCR METAB, V84, P4055, DOI 10.1210/jc.84.11.4055; Bernardi F, 2006, NEUROENDOCRINOLOGY, V83, P348, DOI 10.1159/000095400; Cagnacci A, 2004, MATURITAS, V48, P456, DOI 10.1016/j.maturitas.2003.10.003; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Garcia-Becerra R, 2004, J STEROID BIOCHEM, V91, P21, DOI 10.1016/j.jsbmb.2004.02.003; GUENNOUN R, 2007, IN PRESS BRAIN RES R; Hapgood JP, 2004, TRENDS PHARMACOL SCI, V25, P554, DOI 10.1016/j.tips.2004.09.005; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Kuhl H, 2006, GYNECOL ENDOCRINOL, V22, P303, DOI 10.1080/09513590600717368; Meffre D, 2007, ENDOCRINOLOGY, V148, P2505, DOI 10.1210/en.2006-1678; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Meffre D, 2007, J STEROID BIOCHEM, V104, P293, DOI 10.1016/j.jsbmb.2007.03.003; Nilsen J, 2006, GYNECOL ENDOCRINOL, V22, P355, DOI 10.1080/09513590600863337; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salkind, 2007, ENCY MEASUREMENT STA, P1055; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Schumacher M, 2003, PROG NEUROBIOL, V71, P3, DOI 10.1016/j.pneurobio.2003.09.004; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Schumacher M, 2007, ENDOCR REV, V28, P387, DOI 10.1210/er.2006-0050; Shadoan MK, 2007, METABOLISM, V56, P830, DOI 10.1016/j.metabol.2007.01.014; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Singh M, 2007, Minerva Endocrinol, V32, P95; Singh M, 2006, ENDOCRINE, V29, P271, DOI 10.1385/ENDO:29:2:271; STEIN DG, 2007, IN PRESS ANN EMERGEN; STEIN DG, 2007, IN PRESS BRAIN RES; Stein DG, 2006, FUTUR NEUROL, V1, P429, DOI 10.2217/14796708.1.4.429; Thomas T, 2003, CLIMACTERIC, V6, P293, DOI 10.1080/713605430; VANLANDINGHAM JW, 2007, IN PRESS NEUROSCIENC; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534	32	22	24	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	2					107	113		10.1080/02699050701867399			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	258DW	WOS:000252849600001	18240039	Green Submitted			2022-02-06	
J	Gobbel, GT; Bonfield, C; Carson-Walter, EB; Adelson, PD				Gobbel, G. T.; Bonfield, C.; Carson-Walter, E. B.; Adelson, P. D.			Diffuse alterations in synaptic protein expression following focal traumatic brain injury in the immature rat	CHILDS NERVOUS SYSTEM			English	Article						pediatric; rat; NeuN; synaptophysin; traumatic brain injury	HEAD-INJURY; SYNAPTOPHYSIN IMMUNOREACTIVITY; NERVOUS-SYSTEM; SYNAPTOGENESIS; NEUN; QUANTIFICATION; IDENTIFICATION; LOCALIZATION; GLYCOPROTEIN; HIPPOCAMPUS	Introduction The mechanisms responsible for cognitive decline after traumatic brain injury (TBI) in pediatric patients are poorly understood. The present study examined the potential role of synaptic alterations in this process by using an animal model of immature head injury to define the impact of TBI on expression of the synaptic protein, synaptophysin. Materials and methods After craniotomy, TBI was induced in postnatal day 17 (PND17) rats using controlled cortical impact delivered to the left hemisphere. NeuN, a neuronal marker, and synaptophysin expression were examined 1 day, 1 week, and 1 month after injury by immunohistochemistry and immunoblotting. Results There were significant decreases in both NeuN and synaptophysin after 1 day and 1 week but not 1 month after injury within the hippocampus and neocortex adjacent to the impact site compared to sham-injured controls. The decrease in synaptophysin and NeuN was also noted in the contralateral hippocampus by 1 day after injury and in the contralateral neocortex by 1 week, indicating that changes in protein expression were not solely localized to the injury site but occurred in more distant regions as well. Discussion In conclusion, the decrease and recovery in synaptophysin parallel the cognitive changes that occur after experimental TBI in the PND17 rat, which suggests that changes in this protein may contribute to cognitive declines after injury. The results also suggest that, in spite of the focal nature of the impact, diffuse alterations in protein expression can occur after immature TBI and may contribute to the subsequent cognitive dysfunction.	Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, Pittsburgh, PA 15213 USA		Adelson, PD (corresponding author), Univ Pittsburgh, Dept Neurol Surg, UPMC Presbyterian, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	gobbleg@upmc.edu; bonfield.christopher@medstudent.pitt.edu; David.Adelson@chp.edu	Adelson, David/W-2083-2019		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042298] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS42298-01] Funding Source: Medline		Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; BAYER SA, 1993, NEUROTOXICOLOGY, V14, P83; BAYER SA, 1980, J COMP NEUROL, V190, P115, DOI 10.1002/cne.901900108; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Calhoun ME, 1998, NEUROBIOL AGING, V19, P599, DOI 10.1016/S0197-4580(98)00098-0; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; CHEN KS, 1995, NEUROSCIENCE, V68, P19, DOI 10.1016/0306-4522(95)00099-5; Deweer B, 2001, BEHAV BRAIN RES, V127, P209, DOI 10.1016/S0166-4328(01)00366-7; FLETCHER EJ, 1995, RECEPTOR CHANNEL, V3, P21; Hagberg H, 1997, ACTA PAEDIATR, V86, P85; Hunter SF, 1997, BRAIN, V120, P2071, DOI 10.1093/brain/120.11.2071; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Iwasaki N, 1997, NEURORADIOLOGY, V39, P841, DOI 10.1007/s002340050517; JACOBSONM, 1991, DEV NEUROBIOL, P223; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; KRAUS JF, 1987, PEDIATRICS, V79, P501; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; Lind D, 2005, J NEUROSCI RES, V79, P295, DOI 10.1002/jnr.20354; Liu HX, 2005, MOL BRAIN RES, V139, P169, DOI 10.1016/j.molbrainres.2005.05.014; LOHMANN SM, 1978, P NATL ACAD SCI USA, V75, P4037, DOI 10.1073/pnas.75.8.4037; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MASLIAH E, 1991, EXP NEUROL, V113, P131, DOI 10.1016/0014-4886(91)90169-D; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Shojo H, 2006, BRAIN RES, V1078, P198, DOI 10.1016/j.brainres.2006.01.063; Smith M.L., 1989, HDB NEUROPSYCHOLOGY, P91; Smith TD, 2000, J NEUROSCI, V20, P6587, DOI 10.1523/JNEUROSCI.20-17-06587.2000; Stevenson K. L., 2000, Journal of Neurotrauma, V17, P944; TRAN MP, 2001, J NEUROTRAUM, V18, P1141; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31, DOI DOI 10.1007/s00429-005-0042-4; VOIGT T, 1993, J COMP NEUROL, V330, P48, DOI 10.1002/cne.903300105; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9	41	22	22	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2007	23	10					1171	1179		10.1007/s00381-007-0345-2			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	208CO	WOS:000249297600013	17457592				2022-02-06	
J	Kuo, JR; Lin, KC; Lu, CL; Lin, HJ; Wang, CC; Chang, CH				Kuo, J.-R.; Lin, K.-C.; Lu, C.-L.; Lin, H.-J.; Wang, C.-C.; Chang, C. H.			Correlation of a high D-dimer level with poor outcome in traumatic intracranial hemorrhage	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						D-dimer level; outcome; traumatic and non-traumatic ICH	BRAIN-INJURY; HEAD-INJURY; COMA; COAGULOPATHY; FIBRIN; SCALE	The correlations between D-dimer and Glasgow Coma Scale (GCS), pupillary light reflex, distance of midline shift on brain computed tomography (CT), and Glasgow Outcome Score (GOS) in patients with trauma/non-trauma intracranial hemorrhage (ICH) are not consistent in studies. Ninety-eight traumatic and 59 non-traumatic ICH patients were studied. Pre-existing venous thrombosis, recent surgery, drug use (aspirin or coumadin), or malignancy, were excluded. D-dimer level was estimated within hours after acute insult, and statistical analyses were used for comparisons between groups. Traumatic ICH patients had higher D-dimer levels than controls (2984 vs. 256 mu g/l; P = 0.001). The GCS, midline shift on brain CT, pupillary reflex, and GOS at 3 months were significantly correlated with high D-dimer value in traumatic patients (individual P < 0.001), but not in the non-traumatic group. Using receiver-operating characteristic curve (ROC), the cutoff point was 1496 mu g/l, with sensitivity and specificity of 100% and 83%, respectively. D-dimer >= 1496 mu g/l predicted a poor outcome [adjusted odds ratio (OR) 14.44, 95% CI 1.16-179.27; P = 0.038]. A high D-dimer level is associated with a poor outcome in patients with traumatic ICH. It can be used in addition to neurological assessment to predict the outcome.	Chi Mei Med Ctr, Dept Neurol, Yung Kung City 710, Tainan, Taiwan; Chi Mei Med Ctr, Dept Neurosurg, Yung Kung City 710, Tainan, Taiwan; Chi Mei Med Ctr, Clin Res Inst, Yung Kung City 710, Tainan, Taiwan; Chi Mei Med Ctr, Dept Emergency Med, Yung Kung City 710, Tainan, Taiwan		Lin, KC (corresponding author), Chi Mei Med Ctr, Dept Neurol, 901 Chung Hwa Rd, Yung Kung City 710, Tainan, Taiwan.	gaujang@mail2000.com.tw		Lu, Chin-Li/0000-0002-0818-4823			Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; BREDBACKA S, 1994, J NEUROSURG ANESTH, V6, P75; Cenic A, 2005, CAN J NEUROL SCI, V32, P501, DOI 10.1017/S0317167100004510; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; CRONE KR, 1987, NEUROSURGERY, V21, P532, DOI 10.1227/00006123-198710000-00015; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fujii Y, 2001, STROKE, V32, P883, DOI 10.1161/01.STR.32.4.883; Hudak AM, 2005, J NEUROTRAUM, V22, P1319, DOI 10.1089/neu.2005.22.1319; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; JENNETT B, 1975, LANCET, V1, P480; Juvela S, 2006, STROKE, V37, P1451, DOI 10.1161/01.STR.0000221710.55467.33; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Pathak A, 2005, Neurol India, V53, P178; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Takahashi H, 1997, J NEUROSURG, V86, P768, DOI 10.3171/jns.1997.86.5.0768; Ungerstedt JS, 2003, J NEUROSURG ANESTH, V15, P13, DOI 10.1097/00008506-200301000-00003; ZWEIG MH, 1993, CLIN CHEM, V39, P561	22	22	28	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1351-5101	1468-1331		EUR J NEUROL	Eur. J. Neurol.	OCT	2007	14	10					1073	1078		10.1111/j.1468-1331.2007.01908.x			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	213IU	WOS:000249660900007	17880559				2022-02-06	
J	Chio, CC; Kuo, JR; Hsiao, SH; Chang, CP; Lin, MT				Chio, Chung-Ching; Kuo, Jinn-Rung; Hsiao, Sheng-Huang; Chang, Ching-Ping; Lin, Mao-Tsun			Effect of brain cooling on brain ischemia and damage markers after fluid percussion brain injury in rats	SHOCK			English	Article						lactate; pyruvate; glutamate; glycerol; microdialysate; mild hypothermia; traumatic brain injury	EXCITATORY AMINO-ACIDS; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; STROKE; HEATSTROKE; MICRODIALYSIS; ACCUMULATION; GLUTAMATE; DEFICITS; FAILURE	Although systemic cooling had recently been reported as effective in improving the neurological outcome after traumatic brain injury, several problems are associated with whole-body cooling. The present study was conducted to test the effectiveness of brain cooling without interference with the core temperature in rats after fluid percussion traumatic brain injury (TBI). Brain dialysates ischemia (e.g., glutamate and lactate-to-pyruvate ratio) and injury (e.g., glycerol) markers before and after TBI were measured in rats with mild brain cooling (33 degrees C) and in the sham control group. Brain cooling was accomplished by infusion of 5 mL cold saline via the external jugular vein under general anesthesia. The weight loss was determined by the difference between the first and third day of body weight after TBI. The maximum grip angle in an inclined plane was measured to determine motor performance, whereas the percentage of maximal possible effect was used to measure blockade of proprioception. The triphenyltetrazolium chloride staining procedures were used for cerebral infarction assay. As compared with those of the sham-operated controls, the animals with TBI had higher values of extracellular levels of glutamate, lactate-to-pyruvate ratio, and glycerol in brain and intracranial pressure, but lower values of cerebral perfusion pressure. Brain cooling adopted immediately, after TBI significantly attenuated the TBI-induced increased cerebral ischernia and injury markers, intracranial hypertension, and cerebral hypoperfusion. In addition, the TBI-induced cerebral infarction, motor and proprioception deficits, and body weight loss evaluated 3 days after TBI were significantly attenuated by brain cooling. We successfully demonstrate that brain cooling causes attenuation of TBI in rats by reducing cerebral ischernia and injury resulting from intracranial hypertension and cerebral hypoperfusion. Because jugular venipuncture is an easy procedure frequently used in the emergency department, for preservation of brain function, jugular infusion of cold saline may be useful in resuscitation for trauma patients.	Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan; Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; Ren Ai City Hosp, Dept Surg, Taipei, Taiwan; So Taiwan Univ Technol, Dept Biotechnol, Tainan, Taiwan		Lin, MT (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan.	891201@mail.chimei.org.tw		Chang, Ching-Ping/0000-0003-0890-9414			Allers M, 2006, CARDIOVASC INTER RAD, V29, P260, DOI 10.1007/s00270-004-0271-6; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; CDC, 1999, TRAUM BRAIN INJ US R; Chen T, 2000, J NEUROTRAUM, V17, P135, DOI 10.1089/neu.2000.17.135; Chou YT, 2003, SHOCK, V19, P388, DOI 10.1097/00024382-200304000-00016; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Gerner P, 2003, ANESTHESIOLOGY, V98, P1484, DOI 10.1097/00000542-200306000-00028; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hayashi N, 2000, BRAIN HYPOTHERMIA: PATHOLOGY, PHARMACOLOGY, AND TREATMENT OF SEVERE BRAIN INJURY, P121; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hillered L, 1999, SCAND J CLIN LAB INV, V59, P9, DOI 10.1080/00365519950185904; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hsu SF, 2006, SHOCK, V26, P210, DOI 10.1097/01.shk.0000223124.49265.10; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2004, NEUROSURGERY, V54, P713, DOI 10.1227/01.NEU.0000109535.58429.49; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; LASSEN NA, 1974, CIRC RES, V34, P749, DOI 10.1161/01.RES.34.6.749; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Marion DW, 1996, CRIT CARE MED, V24, pS81; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Nilsson OG, 1996, ACT NEUR S, V67, P45; Paxinos G, 1982, RAT BRAIN STEREOTOXI; REIS DJ, 1974, PROG CARDIOVASC DIS, V17, P51, DOI 10.1016/0033-0620(74)90038-3; SHIH CJ, 1984, J NEUROSURG, V60, P1246, DOI 10.3171/jns.1984.60.6.1246; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sudoh Y, 2003, PAIN, V103, P49, DOI 10.1016/S0304-3959(02)00375-5; THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026; Thurman DJ, 2001, HEAD TRAUMA THERAPEU; Wang Y, 1997, J NEUROSCI, V17, P4341; Wen YS, 2005, J TRAUMA, V58, P577, DOI 10.1097/01.TA.0000152635.99243.30; Wen YS, 2003, CRIT CARE MED, V31, P2641, DOI 10.1097/01.CCM.0000094229.39473.C1	42	22	24	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2007	28	3					284	290		10.1097/SHK.0b013e3180311e60			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	204KC	WOS:000249041500006	17529907				2022-02-06	
J	Hofgren, C; Esbjornsson, E; Aniansson, H; Sunnerhagen, KS				Hofgren, Caisa; Esbjornsson, Eva; Aniansson, Hans; Sunnerhagen, Katharina Stibrant			Application and validation of the barrow neurological institute screen for higher cerebral functions in a control population and in patient groups commonly seen in neurorehabilitation	JOURNAL OF REHABILITATION MEDICINE			English	Article						BNIS; cognition; stroke; traumatic brain injury; anoxia; Parkinson's disease; neuro-rehabilitation	MINI-MENTAL-STATE; COGNITIVE STATUS EXAMINATION; TRAUMATIC BRAIN-INJURY; BNI SCREEN; PERFORMANCE; COGNISTAT; SEQUELAE	Objective: To determine whether the Barrow Neurological Institute Screen for Higher Cerebral Functions (BNIS) can differentiate brain-dysfunctional patients from controls. Design: A case-control study. Subjects: A total of 92 controls and 120 patients from a neuro-rehabilitation clinic with a diagnosis of: right and left hemisphere stroke, traumatic brain injury, Parkinson's disease or anoxic brain damage. Methods: The BNIS has a maximum total score of 50 points, < 47 indicates cognitive dysfunction. Group comparisons and exploration of variables influencing the BNIS total score were made. Results: A significant difference was found between the control group and the total patient group for the BNIS total score and for the subscales (p < 0.0005). Sensitivity was 88% and specificity 78%. Presence of disease and educational level had the greatest influence on the results of the BNIS. Patients with Parkinson's disease were shown to be the least cognitively affected and those with anoxic brain damage the most affected. Conclusion: The BNIS has potential value as a screening instrument for cognitive functions and is sufficiently sensitive to differentiate brain-dysfunctional patients from a control population. It appears to be applicable in a neurological rehabilitation setting, and can be used early in the process, giving a baseline cognitive functional level.	Inst Neurosci & Physiol Rehabil Med, SE-41345 Gothenburg, Sweden; Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil Med, Gothenburg, Sweden		Hofgren, C (corresponding author), Inst Neurosci & Physiol Rehabil Med, Guldhedsgatan 19, SE-41345 Gothenburg, Sweden.	caisa.hofgren@rehab.gu.se	Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400			Borgaro SR, 2003, J HEAD TRAUMA REHAB, V18, P284, DOI 10.1097/00001199-200305000-00006; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; Denvall V, 2002, J REHABIL MED, V34, P153, DOI 10.1080/16501970213231; Drane DL, 2003, J CLIN EXP NEUROPSYC, V25, P133, DOI 10.1076/jcen.25.1.133.13628; Drane DL, 1997, ARCH CLIN NEUROPSYCH, V12, P139, DOI 10.1016/S0887-6177(96)00057-1; FEHER EP, 1992, ARCH NEUROL-CHICAGO, V49, P87, DOI 10.1001/archneur.1992.00530250091022; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Lai F.D.M., 2004, BARROW Q, V20, P16; LEZAK M, 2004, NEUROPSYCHOLOGICAL A; Macaulay C, 2003, ARCH CLIN NEUROPSYCH, V18, P463, DOI 10.1016/S0887-6177(02)00141-5; MOMTAZI R, 2004, BARROW Q, V20, P13; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Prigatano G., 1991, BNI Q, V7, P2; Prigatano G. P., 2004, BARROW Q, V20, P4; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Prigatano GP, 1993, BNI Q, V9, P2; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; Rosenstein LD, 1997, NEUROPSY NEUROPSY BE, V10, P113; Rosenstein LD., 1995, ADM SCORING MANUAL B; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Strickland TL, 2005, CLIN NEUROPSYCHOL, V19, P87, DOI 10.1080/13854040490887243; Strub R, 1985, MENTAL STATUS EXAMIN; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Truelle JL., 2004, BARROW Q, V20, P19	24	22	22	0	4	TAYLOR & FRANCIS AS	OSLO	PO BOX 12 POSTHUSET, NO-0051 OSLO, NORWAY	1650-1977			J REHABIL MED	J. Rehabil. Med.	SEP	2007	39	7					547	553		10.2340/16501977-0085			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	213IS	WOS:000249660700007	17724554	gold, Green Submitted			2022-02-06	
J	Soo, C; Tate, R; Hopman, K; Forman, M; Secheny, T; Aird, V; Browne, S; Coulston, C				Soo, Cheryl; Tate, Robyn; Hopman, Kate; Forman, Marcella; Secheny, Tanya; Aird, Vanessa; Browne, Stuart; Coulston, Carissa			Reliability of the care and needs scale for assessing support needs after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						assessment tool; psychometric properties; reliability; support needs; traumatic brain injury	MEASURING PSYCHOSOCIAL RECOVERY; HEAD-INJURY; FOLLOW-UP; RELATIVES	Objective: To investigate the reliability of the Care and Needs Scale (CANS) for measuring the level and types of support needs of people with traumatic brain injury (TBI). Method: Interrater reliability was examined in a cohort of 30 community clients with TBI by comparing CANS ratings completed by 2 occupational therapists (OTs) and a case manager. CANS ratings on the same clients were also completed 1 week later to examine test-retest reliability. Reliability of proxy ratings was investigated in a cohort of 40 community clients with TBI by comparing CANS ratings completed by a clinical researcher, multidisciplinary team, relative, and client. Results: Level of support need as measured by the CANS showed excellent interrater reliability both within and across disciplines: ICC = 0.95 between 2 OTs and ICC = 0.93 and 0.96 between OTs and case manager. Test-retest reliability of the CANS over a 1-week period was also excellent (ICC = 0.98). Although the agreement between the clinical researcher and multidisciplinary team was excellent (ICC = 0.92), ICCs with relative and client ratings were variable, ranging from 0.37 to 0.72. Conclusions: The excellent inter-rater and test-retest reliability findings from this present study, together with the evidence for validity reported previously, indicate that the CANS is a reliable and valid instrument for application in clinical practice.	Univ Sydney, Rehabil Studies Unit, Fac Med, No Clin Sch,Royal Rehabil Ctr Sydney, RYDE, NSW 1680, Australia; Royal Rehabil Ctr Sydney, Brain Injury Rehabil Unit, Sydney, NSW, Australia		Tate, R (corresponding author), Univ Sydney, Rehabil Studies Unit, Fac Med, No Clin Sch,Royal Rehabil Ctr Sydney, POB 6, RYDE, NSW 1680, Australia.	rtate@med.usyd.edu.au	Coulston, Carissa/ABB-8090-2020				Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Brooks CA, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90152-0; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Johnson J, 2001, INT J PSYCHIAT CLIN, V5, P141, DOI 10.1080/136515001300374894; Malec JF, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199706000-00002; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P353, DOI 10.1016/S0003-9993(97)90225-2; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate R.L., 2006, BRAIN IMPAIR, V7, P1, DOI DOI 10.1375/brim.7.1.1; Tate RL, 2004, ARCH PHYS MED REHAB, V85, P538, DOI 10.1016/j.apmr.2003.08.078; Tate RL, 2004, BRAIN INJURY, V18, P445, DOI 10.1080/02699050310001641183; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; [No title captured]	26	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2007	22	5					288	295		10.1097/01.HTR.0000290973.01872.4c			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	216RA	WOS:000249895500004	17878770				2022-02-06	
J	Corrigan, JD; Selassie, AW; Lineberry, LA; Millis, SR; Wood, KD; Pickelsimer, EE; Rosenthal, M				Corrigan, John D.; Selassie, Anbesaw W.; Lineberry, Lee A.; Millis, Scott R.; Wood, Kenneth D.; Pickelsimer, E. Elisabeth; Rosenthal, Mitchell			Comparison of the Traumatic Brain Injury (TBI) Model Systems national dataset to a population-based cohort of TBI hospitalizations	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; injury severity score; population; rehabilitation	EMERGENCY-DEPARTMENT; INSURANCE STATUS; GENDER; RACE	Objective: To determine whether severity alone accounts for differences observed between a population-based cohort of acute care hospitalizations for traumatic brain injury (TBI) and the Traumatic Brain Injury Model Systems (TBIMS) national dataset. Design: Prospective cohort. Setting: Acute care hospitals in South Carolina and TBIMS rehabilitation centers. Participants: Subjects enrolled in the TRIMS national dataset and the South Carolina TBI Follow-up Registry (SCTBIFR). Interventions: Not applicable. Main Outcome Measures: Comparable variables in the 2 datasets included demographic characteristics, etiology of injury, initial Glasgow Coma Scale score, Abbreviated Injury Scale score for the head region derived from International Classification of Diseases codes, presence of computed tomography (CT) abnormalities, acute hospital length of stay, and payer source. Results: As hypothesized, TBIMS participants showed greater initial injury severity, frequency of abnormal CT scans, and longer lengths of acute care hospitalization, explaining over 75% of cohort membership. Counter to a priori hypotheses, when all other factors were held constant, there were also differences in racial and ethnic background and insurance payer source. Conclusions: Differences between the TBIMS cohort and patients acutely hospitalized with TBI are primarily due to injury severity; however, an additional difference in payer source may need to be taken into account when generalizing findings. Results showed that TBIMS and SCTBIFR datasets are complementary, each having different strengths for understanding factors that impact long-term recovery after TBI. Recommendations are made for methodologic improvements in both data collection for the TBIMS and future outcome surveillance.	Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Med Univ S Carolina, Dept Biostat Bioinformat & Epidemiol, Charleston, SC 29425 USA; Wayne State Univ, Detroit, MI USA; Kessler Med Rehabil Res & Educ Corp, Traumat Brain Injury Natl Data Ctr, W Orange, NJ USA		Corrigan, JD (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 W 9th Ave, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Corrigan, John D./E-2921-2011		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [U17/CCU421926] Funding Source: Medline		Allison PD, 2001, LOGISTIC REGRESSION; Baker SP, 1992, THE INJURY FACT BOOK, VSecond; *CDCP, 1998, ANN DAT SUBM STAND I; CHARLSON ME, 1997, J CHRON DIS, V40, P273; Committee on Injury Scaling, 1990, ABBR INJ SCAL 1990 R; CORRIGAN J, 1999, TRAUM BRAIN INJ 21 C; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Friedman Bernard, 2004, Int J Health Care Finance Econ, V4, P231, DOI 10.1023/B:IHFE.0000036048.26098.9d; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; *J HOPK U TRIAN IN, 1997, ICDMAP90 SOFTW US GU; JOHNSON D E, 1975, Environmental Health Perspectives, V12, P27, DOI 10.2307/3428206; Langlois JA., 2004, TRAUMATIC BRAIN INJU; *OFF INSP GEN DEP, 2006, 0501818165 DEP VET A; PETRUCELLI E, 1981, ACCIDENT ANAL PREV, V13, P29, DOI 10.1016/0001-4575(81)90040-3; SELASSIE A, 2004, S CAROLINA TRAUMATIC, P118; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Selassie AW, 2003, ACAD EMERG MED, V10, P1260, DOI 10.1197/S1069-6563(03)00497-4; Sox CM, 1998, AM J MED, V105, P506, DOI 10.1016/S0002-9343(98)00324-6; Thurman DJ., 1995, GUIDELINES SURVEILLA; *US CENS BUR, 2005 AM COMM SURV DA; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P456, DOI 10.1097/00002060-199611000-00011; [No title captured]; 1998, NIH CONSEN STATEMENT, V16, P1	31	22	22	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2007	88	4					418	426		10.1016/j.apmr.2007.01.010			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	160CC	WOS:000245913400005	17398241				2022-02-06	
J	Schwartz, I; Tsenter, J; Shochina, M; Shiri, S; Kedary, M; Katz-Leurer, M; Meiner, Z				Schwartz, Isabella; Tsenter, Jeanna; Shochina, Mara; Shiri, Shimon; Kedary, Michal; Katz-Leurer, Michal; Meiner, Zeev			Rehabilitation outcomes of terror victims with multiple traumas	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; multiple trauma; rehabilitation; spinal cord injuries; stress disorders; post-traumatic; terrorism; treatment outcome	SPINAL-CORD INJURY; BRAIN-INJURY; PHYSICAL MEDICINE; HEAD-INJURY; ATTACKS; ISRAEL; SEPTEMBER-11; EXPERIENCE; CASUALTIES; DISORDERS	Objectives: To describe the rehabilitation outcomes of terror victims with multiple traumas, and to compare those outcomes with those of patients with nonterror-related multiple traumas treated in the same rehabilitation facility over the same time period. Design: Retrospective chart reviews. Setting: Rehabilitation department in a university hospital in Jerusalem, Israel. Participants: Between September 2000 and September 2004, we treated 72 victims of terrorist attacks who had multiple traumas. Among them, 47 (65%) had multiple traumas without central nervous system involvement (MT subgroup), 19 (26%) had multiple traumas with traumatic brain injury (TBI subgroup), and 6 (8%) had multiple traumas with spinal cord injury (SCI subgroup). We matched, according to their types of injury and demographic data, each terror victim with a control patient treated in the same period in our rehabilitation department. Intervention: Interdisciplinary inpatient and outpatient rehabilitation. Main Outcome Measures: Hospital length of stay (LOS) in acute care departments, inpatient and outpatient rehabilitation departments, functional outcome (FIM instrument score), occupational outcome (returning to previous occupation), and psychologic outcome (Solomon PTSD [post-traumatic stress disorder] Inventory). Results: The mean LOS of terror victims was 218 +/- 131 days; for the nonterror group it was 152 +/- 114 days (P <.01). In comparison with the control subgroups, the MT subgroup of terrorist victims had significantly longer LOS in the acute care and outpatient rehabilitation departments (P=.06) and the terror TBI subgroup had a longer LOS in outpatient department only (P <.05). The LOS of the SCI patients, both terror victims and control patients, was significantly longer than that of the other 2 subgroups. The difference between FIM value at entry and discharge (Delta FIM) was significantly higher for terror victims than for the controls (41.1 +/- 21.6 vs 30.8 +/- 21.8, P=.002). This difference was mainly the result of the significantly higher Delta FIM achieved by the terror MT subgroup than by the MT controls. The rate of PTSD was higher among terror victims than among controls (40.9% vs 24.2%, P=.04). The rate of return to previous occupations was similar between terror victims and nonterror patients (53% vs 46.9%, respectively). Conclusions: Victims of terror spent longer periods in rehabilitation than the nonterror group; however, they regained most activity of daily living functions similar to the nonterror group. Despite the higher rate of PTSD, terror victims succeeded in returning to their previous occupations at a similar rate to that of the nonterror group.	Hadassah Univ Hosp, Dept Phys Med & Rehabil, IL-91420 Jerusalem, Israel; Tel Aviv Univ, Sch Hlth Profess, Dept Phys Therapy, Ramat Aviv, Israel		Meiner, Z (corresponding author), Hadassah Univ Hosp, Dept Phys Med & Rehabil, POB 24035,Mt Scopus, IL-91420 Jerusalem, Israel.	meiner@hadassah.org.il					Aharonson-Daniel L, 2005, SCAND J SURG, V94, P185, DOI 10.1177/145749690509400302; Aharonson-Daniel L, 2003, PEDIATRICS, V112, pE280, DOI 10.1542/peds.112.4.e280; Almogy G, 2004, ANN SURG, V239, P295, DOI 10.1097/01.sla.0000114014.63423.55; American Spinal Injury Association, 2002, INT STAND NEUR CLASS; Arnold JL, 2004, ANN EMERG MED, V43, P263, DOI 10.1016/S0196-0644(03)00723-6; BELLAMY RF, 1984, MIL MED, V149, P55; Bleich A, 2003, JAMA-J AM MED ASSOC, V290, P612, DOI 10.1001/jama.290.5.612; BLEICH A, 2006, BMC MED, V27, P4; Bode RK, 2002, ARCH PHYS MED REHAB, V83, P100, DOI 10.1053/apmr.2002.26073; Derogatis L. R., 1982, ADM PROCEDURES BSI M; DILLINGHAM TR, 1993, AM J PHYS MED REHAB, V72, P214, DOI 10.1097/00002060-199308000-00008; DILLINGHAM TR, 1998, TXB MILITARY MED REH, V1; Einav S, 2006, ANN SURG, V243, P533, DOI 10.1097/01.sla.0000206417.58432.48; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P483, DOI 10.1053/apmr.2002.31203; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Gidron Y, 2004, ISRAEL MED ASSOC J, V6, P387; GRANGER CV, 1986, GUIDE USE UNIFORM DA; Hanoch J, 1996, JAMA-J AM MED ASSOC, V276, P388, DOI 10.1001/jama.276.5.388; HARDAWAY RM, 1978, J TRAUMA, V18, P635, DOI 10.1097/00005373-197809000-00004; HERTZMAN CA, 1968, AMER J PHYSICAL MED, V47, P113; *INT TERR INF CTR, JER PREF TARG PAL TE; *ISR DEF FORC, GEN INF STAT; Jehel L, 2001, ENCEPHALE, V27, P393; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kluger Y, 2004, J AM COLL SURGEONS, V199, P875, DOI 10.1016/j.jamcollsurg.2004.09.003; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Marin R, 2001, MIL MED, V166, P335, DOI 10.1093/milmed/166.4.335; McKinley WO, 2001, AM J PHYS MED REHAB, V80, P693, DOI 10.1097/00002060-200109000-00010; Mintz Y, 2002, ISRAEL MED ASSOC J, V4, P554; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; *ON FAM FUND, TERR STAT; Peleg K, 2006, J AM COLL SURGEONS, V202, P643, DOI 10.1016/j.jamcollsurg.2005.12.019; Peleg K, 2003, AM J EMERG MED, V21, P258, DOI 10.1016/S0735-6757(03)00043-3; Peleg K, 2004, ANN SURG, V239, P311, DOI 10.1097/01.sla.0000114012.84732.be; Ronen J, 2004, SPINAL CORD, V42, P353, DOI 10.1038/sj.sc.3101590; Rusk H A, 1969, Arch Phys Med Rehabil, V50, P463; Schlenger WE, 2002, JAMA-J AM MED ASSOC, V288, P581, DOI 10.1001/jama.288.5.581; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Shalev AY, 2005, AM J PSYCHIAT, V162, P1188, DOI 10.1176/appi.ajp.162.6.1188; Silver RC, 2002, JAMA-J AM MED ASSOC, V288, P1235, DOI 10.1001/jama.288.10.1235; Singer Pierre, 2005, Crit Care Med, V33, pS61, DOI 10.1097/01.CCM.0000151068.33935.3E; SOLOMON Z, 1993, ISRAEL J PSYCHIAT, V30, P110; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Yasuda S, 2002, NEUROREHABILITATION, V17, P177	46	22	22	2	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2007	88	4					440	448		10.1016/j.apmr.2007.01.001			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	160CC	WOS:000245913400008	17398244				2022-02-06	
J	Briassoulis, G; Papassotiriou, I; Mavrikiou, M; Lazaropoulou, C; Margeli, A				Briassoulis, George; Papassotiriou, Ioannis; Mavrikiou, Maria; Lazaropoulou, Christina; Margeli, Alexandra			Longitudinal course and clinical significance of TGF-beta 1, sL- and sE-Selectins and sICAM-1 levels during severe acute stress in children	CLINICAL BIOCHEMISTRY			English	Article						TGF-beta 1; sclectins; sICAM-1; sepsis; traumatic brain injury; ARDS	RESPIRATORY-DISTRESS-SYNDROME; INTERCELLULAR-ADHESION MOLECULE-1; GROWTH-FACTOR-BETA; SYSTEMIC INFLAMMATORY RESPONSE; TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; SOLUBLE L-SELECTIN; TRANSFORMING GROWTH-FACTOR-BETA-1; CONSENSUS CONFERENCE; MAJOR TRAUMA	Objectives: To elucidate the potential role of circulating levels of transforming growth factor-beta1 (TGF-beta 1), soluble intercellular adhesion molecule-1 (sICAM-1), soluble L- and sE-Selectins (sL- and sE-Selectins) in children with sepsis, traumatic brain injury (TB1) or acute respiratory distress syndrome (ARDS). Design and methods: Levels of TGF-beta 1, sICAM-1, L- and sE-Selectins were determined using solid-phase sandwich enzyme-linked immunosorbent assay in plasma of 10 patients with sepsis, 10 patients with TBI, 10 patients with ARDS, compared to 10 ventilated controls with chronic illness but not in acute stress, on days 1, 3, 5, 7 and 10. Results: The highest values of sICAM-1 were observed in patients with TBI (p < 0.001) and those of sE-Selectin in patients with sepsis (p=0.0001). Patients in the control group did not show an elevation of sE-Selectin and sICAM-1 levels longitudinally. Increased levels of measured molecules (TGF-beta 1, p < 0.02, sE-Selectin, p < 0.02, sL-Selectin, p=0.06, sICAM-1, p < 0.03) were demonstrated among survivors in the sepsis and ARDS groups of patients and were positively correlated with length of stay (p < 0.04) and mechanical ventilation (p < 0.001). Conclusions: A sustained increase of adhesion molecules occurs during acute stress in children which may contribute to morbidity in patients with sepsis (sE-Selectin) or traumatic brain injury (sICAM-1). Suppression of the expected response of sE-Selectins, s-ICAM-1 and TGF-beta 1 is associated with poor outcome. (c) 2007 Published by The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	Aghia Sophia Childrens Hosp, Dept Clin Biochem, Athens 11527, Greece; Aghia Sophia Childrens Hosp, Paediat Intens Care Med, Athens, Greece; Univ Hosp Heraklion, Paediat Intens Care Unit, Iraklion, Greece		Papassotiriou, I (corresponding author), Aghia Sophia Childrens Hosp, Dept Clin Biochem, Athens 11527, Greece.	biochem@paidon-agiasofia.gr					Agouridakis P, 2002, RESPIR RES, V3, DOI 10.1186/rr193; Armstrong L, 2000, AM J RESP CELL MOL, V22, P68, DOI 10.1165/ajrcmb.22.1.3728; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Beck-Schimmer B, 2002, EUR RESPIR J, V19, P1142, DOI 10.1183/09031936.02.00236602; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Dhainaut JF, 2003, CRIT CARE MED, V31, pS258, DOI 10.1097/01.CCM.0000057901.92381.75; DONNELLY SC, 1994, LANCET, V344, P215, DOI 10.1016/S0140-6736(94)92995-5; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Kourtis AP, 2003, CLIN IMMUNOL, V109, P224, DOI 10.1016/S1521-6616(03)00209-2; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Laudes IJ, 2004, AM J PATHOL, V164, P1435, DOI 10.1016/S0002-9440(10)63230-0; Laun RA, 2003, SHOCK, V19, P16, DOI 10.1097/00024382-200301000-00004; MEDURI GU, 1995, CHEST, V107, P1062, DOI 10.1378/chest.107.4.1062; Megarbane B, 2004, INTENS CARE MED, V30, P867, DOI 10.1007/s00134-004-2253-1; Miura M, 2004, PEDIATR INFECT DIS J, V23, P931, DOI 10.1097/01.inf.0000142171.91235.fc; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Moss M, 1996, CRIT CARE MED, V24, P1782, DOI 10.1097/00003246-199611000-00004; Muller JC, 1998, J TRAUMA, V45, P705, DOI 10.1097/00005373-199810000-00013; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; PUGIN J, 1996, AM J RESP CRIT CARE, V153, P1820; Puthothu B, 2006, GENES IMMUN, V7, P322, DOI 10.1038/sj.gene.6364302; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.3.CO;2-G; RINALDO JE, 1990, CLIN CHEST MED, V11, P621; Seidelin JB, 2002, INTENS CARE MED, V28, P1613, DOI 10.1007/s00134-002-1501-5; SHANLEY TP, 1995, MOL MED TODAY, V1, P40, DOI 10.1016/1357-4310(95)80019-0; Stengel D, 2001, J SURG RES, V99, P321, DOI 10.1006/jsre.2001.6173; SternerKock A, 1996, IMMUNOLOGY, V87, P454; Stoll G, 2004, BRAIN PATHOL, V14, P51, DOI 10.1111/j.1750-3639.2004.tb00497.x; Torii K, 1997, AM J RESP CRIT CARE, V155, P43, DOI 10.1164/ajrccm.155.1.9001287; Torre D, 2000, MEDIAT INFLAMM, V9, P193, DOI 10.1080/09629350020002912; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; Yeh FL, 2002, BURNS, V28, P631, DOI 10.1016/S0305-4179(02)00113-4	36	22	27	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	MAR	2007	40	5-6					299	304		10.1016/j.clinbiochem.2006.11.015			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	147IU	WOS:000244997400003	17291476				2022-02-06	
J	Eilander, HJ; Timmerman, RBW; Scheirs, JGM; Van Heugten, CM; De Kort, PLM; Prevo, AJH				Eilander, H. J.; Timmerman, R. B. W.; Scheirs, J. G. M.; Van Heugten, C. M.; De Kort, P. L. M.; Prevo, A. J. H.			Children and young adults in a prolonged unconscious state after severe brain injury: Long-term functional outcome as measured by the DRS and the GOSE after early intensive neurorehabilitation	BRAIN INJURY			English	Article						consciousness; brain-injured children; functional recovery; long-term functioning; minimally conscious state; neurorehabilitation; severe brain injury; vegetative state; youngsters	DISABILITY RATING-SCALE; PERSISTENT VEGETATIVE STATE; SEVERE HEAD-INJURY; POSTTRAUMATIC UNAWARENESS; LIFE SATISFACTION; PRACTICAL SCALE; MEDICAL ASPECTS; RECOVERY; CONSCIOUSNESS; GUIDELINES	Objective: To investigate the long-term (2-15 years) functional outcome of children and young adults who received an early intensive neurorehabilitation programme (EINP) after a prolonged period of unconsciousness due to severe brain injury; to differentiate between traumatic brain injury (TBI) and non-traumatic brain injury (nTBI); and to compare the results on two different outcome scales: the Disability Rating Scale (DRS) and the Glasgow Outcome Scale Extended (GOSE). Subjects: One hundred and forty-five patients, who were admitted to EINP between December 1987 and January 2001. Outcome measures: The Post-Acute Level of Consciousness scale (PALOC-s), the DRS, including categorized scores (DRScat), and the GOSE. Results: The long-term functional level of 90 patients could be determined, of whom 25 were deceased. The mean DRSscore of the surviving patients was 6.8 (SD = 6.6) - the mean score on the GOSE was 4.5 (SD = 1.7). There was a significant difference in the outcome amongst traumatic and non-traumatic patients (t((88)) = 4.21; 3 p < 0.01). The correlation between the DRS and the GOSE was high (Spearman rho = 0.85; p < 0.01), as well as the correlation between the categorized scores of the DRS and the GOSE (Spearman rho = 0.81; p < 0.01). The distribution of outcome scores on the DRScat is more diverse than on the GOSH. Especially item 7 of the DRS, measuring functional independence, showed considerable variance in discriminating between different outcome levels. Conclusions: More patients with TBI than expected reached a (semi-) independent level of functioning, indicating a possible effect of EINP. Patients suffering from nTBI did not demonstrate these outcome levels. Only a few patients stayed in a vegetative state for more than a couple of years. In this cohort of severe brain-injured young people, the DRS offered the best investigative possibilities for long-term level of functioning.	Rehabil Ctr, Div Res, Project VLBNAH, NL-5004 EA Tilburg, Netherlands; Tilburg Univ, Fac Social Sci, Dept Psychol & Hlth, NL-5000 LE Tilburg, Netherlands; Inst Rehabil Res, iRv, Hoensbroek, Netherlands; Maastricht Univ, Maastricht, Netherlands; St Elizabeth Hosp, Div Neurol, Tilburg, Netherlands; UMC Utrecht, Rudolf Magnus Inst Neurosci, Rehabil Ctr De Hoogstr, Utrecht, Netherlands		Eilander, HJ (corresponding author), Rehabil Ctr, Div Res, Project VLBNAH, Leijpk POB 5022, NL-5004 EA Tilburg, Netherlands.	H.J.Eilander@hccnet.nl	Eilander, Henk/D-9643-2016				ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; BULLOCK RM, 2002, NEUROSURGICAL FOCUS, V13, P1; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; *CTR OUTC MEAS BRA, 2000, GLASG OUTC SCAL; *CTR OUTC MEAS BRA, 2002, EXT GLASG OUTC SCAL; *CTR OUTC MEAS BRA, 2000, DIS RAT SCAL DRS; DOMAN RJ, 1960, JAMA-J AM MED ASSOC, V174, P257, DOI 10.1001/jama.1960.03030030037007; Eilander HJ, 2005, BRAIN INJURY, V19, P425, DOI 10.1080/02699050400025299; EILANDER HJ, UNPUB RELIABILITY VA; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199708000-00008; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gray DB, 2000, ARCH PHYS MED REHAB, V81, pS10, DOI 10.1053/apmr.2000.20616; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KRIEL RL, 1993, PEDIATR NEUROL, V9, P362, DOI 10.1016/0887-8994(93)90104-K; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Lollar DJ, 2000, ARCH PHYS MED REHAB, V81, pS46, DOI 10.1053/apmr.2000.20624; LOMBARDI F, 2003, COCHRANE LIB, P1; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; McKevitt C, 2001, STROKE, V32, P681, DOI 10.1161/01.STR.32.3.681; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; Stewart DG, 1998, NEUROREHABILITATION, V10, P13, DOI 10.3233/NRE-1998-10103; Stucki G, 2005, DISABIL REHABIL, V27, P353, DOI 10.1080/09638280400014105; TEASDALE G, 1974, LANCET, V2, P81; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Whyte J, 2006, J HEAD TRAUMA REHAB, V21, P99, DOI 10.1097/00001199-200603000-00003; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	38	22	25	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2007	21	1					53	61		10.1080/02699050601151795			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	141FQ	WOS:000244564600007	17364520				2022-02-06	
J	Elliott, MB; Jallo, JJ; Gaughan, JP; Tuma, RF				Elliott, Melanie B.; Jallo, Jack J.; Gaughan, John P.; Tuma, Ronald F.			Effects of crystalloid-colloid solutions on traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						albumin; cerebral edema; colloid; crystalloid; hypertonic saline; tissue damage; traumatic brain injury	CONTROLLED CORTICAL IMPACT; HYPERTONIC SALINE RESUSCITATION; FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; HYDRAULIC PERMEABILITY; EXPERIMENTAL STROKE; HEMORRHAGIC-SHOCK; HUMAN-ALBUMIN; RATS; EDEMA	The purpose of this study was to compare the effects of crystalloid and crystalloid-colloid solutions administered at different times after isolated traumatic brain injury. Male Sprague-Dawley rats were randomized to receive one of three intravenous treatments (4 mL/kg body weight) at 10 min or 6 h after moderate traumatic brain injury. Treatments included hypertonic saline, hypertonic albumin, and normal albumin. Moderate injuries were produced using the controlled cortical impact injury model set at 2.0 mm, 4.0 m/sec, and 130 msec. Tissue damage and cerebral edema were measured to evaluate the effect of treatments for traumatic brain injury. Blood brain barrier permeability was assessed at different time points after injury to identify a mechanism for treatment effectiveness. Injury volume was the smallest for animals treated with hypertonic albumin at 6 h after injury compared to all other treatments and administration times. Ipsilateral brain water content was significantly attenuated with immediate normal saline-albumin treatment. The presence of colloid in the infusion solutions was associated with an improvement in tissue damage and edema following isolated head injury while hypertonic saline alone, when given immediately after injury, worsened tissue damage and edema. When hypertonic saline was administered at 6 h after injury, tissue damage and edema were not worsened. In conclusion, the presence of colloid in solutions used to treat traumatic brain injury and the timing of treatment have a significant impact on tissue damage and edema.	Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Dept Neurosurg, Philadelphia, PA 19122 USA; Temple Univ, Sch Med, Dept Biostat, Philadelphia, PA 19122 USA		Elliott, MB (corresponding author), 15 Ascot Dr, Cinnaminson, NJ 08077 USA.	melaniedion@comcast.net		Jallo, Jack/0000-0002-5512-1729			Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; Angle N, 1998, J TRAUMA, V45, P7, DOI 10.1097/00005373-199807000-00002; BALDWIN RL, 1996, FOLD DES, V1, P1; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Chang Y, 2006, J APPL PHYSIOL, V100, P1445, DOI 10.1152/japplphysiol.00763.2005; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gourin CG, 1996, J TRAUMA, V41, P129, DOI 10.1097/00005373-199607000-00021; Hartl R, 1997, J TRAUMA, V42, pS41, DOI 10.1097/00005373-199705001-00008; Junger WG, 1998, J CLIN INVEST, V101, P2768, DOI 10.1172/JCI1354; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu YT, 2001, EUR J PHARMACOL, V428, P193, DOI 10.1016/S0014-2999(01)01255-9; McIntosh TK, 1996, LAB INVEST, V74, P315; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Okuno S, 2001, NEUROL RES, V23, P657, DOI 10.1179/016164101101198983; Pascual JL, 2002, ANN SURG, V236, P634, DOI 10.1097/00000658-200211000-00014; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Remmers M, 1999, BRAIN RES, V827, P237, DOI 10.1016/S0006-8993(99)01304-9; Roth P, 2000, Crit Care Nurs Q, V23, P14; Rotstein OD, 2000, J TRAUMA, V49, P580, DOI 10.1097/00005373-200010000-00002; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; Spera PA, 1998, SPINE, V23, P2444, DOI 10.1097/00007632-199811150-00018; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Toung TJK, 2005, CRIT CARE MED, V33, P203, DOI 10.1097/01.CCM.0000150659.15558.23; Tuma RF, 1997, J TRAUMA, V42, pS54, DOI 10.1097/00005373-199705001-00010; Victorino GP, 2004, J SURG RES, V122, P167, DOI 10.1016/j.jss.2004.07.019; Victorino GP, 2003, SHOCK, V20, P171, DOI 10.1097/01.shk.0000079424.52617.92; Warner DS, 2004, ANESTH ANALG, V99, P1208, DOI 10.1213/01.ANE.0000139930.04010.0D; Weaver KD, 2000, J TRAUMA, V48, P1081, DOI 10.1097/00005373-200006000-00014; Whalen MJ, 1999, J NEUROTRAUM, V16, P583, DOI 10.1089/neu.1999.16.583; Zausinger S, 2004, NEUROSURGERY, V55, P679, DOI 10.1227/01.NEU.0000134558.28977.EE; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	36	22	25	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2007	24	1					195	202		10.1089/neu.2006.0094			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	131GX	WOS:000243858100019	17263683				2022-02-06	
J	Hanten, G; Li, XQ; Chapman, SB; Swank, P; Gamino, J; Roberson, G; Levin, HS				Hanten, Gerri; Li, Xiaoqi; Chapman, Sandra B.; Swank, Paul; Gamino, Jacque; Roberson, Garland; Levin, Harvey S.			Development of verbal selective learning	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; RECALL; MEMORY; REHEARSAL; CHILDREN; ADOLESCENCE; INHIBITION; INCENTIVES; STRATEGY	Using incentive-based auditory word recall we studied the efficiency of selective learning in children ages 6-18 years. We found effects of age or both selective learning efficiency and for total words recalled, which differed in developmental trajectory. The number of words recalled showed a nonlinear component, reflecting a negatively accelerated increase with age. In contrast, the measure of selective learning was linear with age. Overall, selective learning efficiency was not related to the total number of words recalled. The findings provide a framework for interpretation of studies of selective learning in clinical populations.	Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, Houston, TX 77030 USA; Univ Texas, Ctr BrainHlth, Dallas, TX 75230 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, Houston, TX 77225 USA		Hanten, G (corresponding author), Baylor Coll Med, Dept Phys Med & Rehabil, Cognit Neurosci Lab, 1709 Dryden Rd,Suite 725, Houston, TX 77030 USA.	ghanten@bcm.tmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		APPEL LF, 1972, CHILD DEV, V43, P1365, DOI 10.2307/1127522; BAUER R, 1991, J GEN PSYCHOL, V117, P447; Bjork R.A., 1989, VARIETIES MEMORY CON, P309; Bjorklund DF, 2004, DEV REV, V24, P343, DOI 10.1016/j.dr.2004.08.002; BJORKLUND DF, 1989, J EXP CHILD PSYCHOL, V48, P451, DOI 10.1016/0022-0965(89)90052-0; BRAY NW, 1985, DEV PSYCHOL, V21, P290, DOI 10.1037/0012-1649.21.2.290; BRAY NW, 1978, INTELLIGENCE, V2, P153; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Castel AD, 2002, MEM COGNITION, V30, P1078, DOI 10.3758/BF03194325; DEMPSTER FN, 1981, PSYCHOL BULL, V89, P63, DOI 10.1037/0033-2909.89.1.63; Diamond A., 2002, PRINCIPLES FRONTAL L, P466, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0029; DUSEK JB, 1978, DEV PSYCHOL, V14, P115, DOI 10.1037/0012-1649.14.1.115; ENGLE RW, 1995, PSYCHOL SCI, V6, P122, DOI 10.1111/j.1467-9280.1995.tb00318.x; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; GUTTENTAG RE, 1984, J EXP CHILD PSYCHOL, V37, P92, DOI 10.1016/0022-0965(84)90060-2; Hanten G, 2004, ANN NEUROL, V56, P847, DOI 10.1002/ana.20298; Hanten G, 2002, CHILD NEUROPSYCHOL, V8, P107, DOI 10.1076/chin.8.2.107.8729; HANTEN G, 2001, SELECTIVE LEARNING D; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; KEENEY TJ, 1967, CHILD DEV, V38, P953, DOI 10.1111/j.1467-8624.1967.tb04373.x; KUNZINGER EL, 1984, J GENET PSYCHOL, V144, P19; MILLER PH, 1991, J EXP CHILD PSYCHOL, V52, P149, DOI 10.1016/0022-0965(91)90057-Y; MOELY BE, 1969, DEV PSYCHOL, V1, P26, DOI 10.1037/h0026804; OSULLIVAN JT, 1993, J EXP CHILD PSYCHOL, V55, P396, DOI 10.1006/jecp.1993.1022; Posthuma D, 2003, TWIN RES, V6, P131, DOI 10.1375/136905203321536254; VACHHA B, 2005, CEREBROSPINAL FLUID, V17, P2; WATKINS MJ, 1999, UNPUB SELECTIVITY ME	27	22	23	0	10	LAWRENCE ERLBAUM ASSOC INC-TAYLOR & FRANCIS	PHILADELPHIA	325 CHESTNUT STREET, STE 800, PHILADELPHIA, PA 19106 USA	8756-5641			DEV NEUROPSYCHOL	Dev. Neuropsychol.		2007	32	1					585	596		10.1080/87565640701361112			12	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	197QF	WOS:000248570000005	17650995				2022-02-06	
J	Lippert-Gruener, M; Lefering, R; Svestkova, O				Lippert-Gruener, M.; Lefering, R.; Svestkova, O.			Functional outcome at 1 vs. 2 years after severe traumatic brain injury	BRAIN INJURY			English	Article						outcome; rehabilitation; traumatic brain injury; professional reintegration; activities of daily living; need of care	SEVERE HEAD-INJURY; REHABILITATION; THERAPY; MODERATE	Purpose: The aim of the study was to evaluate the outcome of patients with severe traumatic brain injury (STBI) after 12 and 24 months (Glasgow Coma Scale GCS <= 8 points for at least 24 hours). Methods: A total of 51 patients underwent a multidisciplinary early rehabilitation treatment until they were discharged from hospital and local ambulatory care was deemed sufficient. The follow-up examination took place 12 and 24 months after the STBI. Results: Data revealed a high level of independence in activities of daily living (mean Barthel Index after 1 year 92.7 points, after 2 years 93.7 points). After 1 and 2 years, 74.5% and 80.4% of the patients, respectively, were completely independent of need for care. Nevertheless, more than half of the patients had sensorimotor, behavioural, speech, visual and/or auditory disturbances. Return to work rates improved between 1 - 2 years after trauma, as evidenced by the rate of patients being back to full time work at 1 year ( n = 14, 28%) and 2 years ( n = 20, 40%) post- STBI; although none of these changes reached statistical significance. Conclusion: In summary, there are still changes in both impairment and disability related areas between 1 - 2 years post STBI, but the degree of improvement is variable depending on the area being considered. Clinicians should remain aware of the fact that modulation of impairment and disability appear to continue well beyond 1 year post- STBI, which may impact on decisions regarding the provision and intensity of further rehabilitation efforts.	Univ Hosp Cologne, Dept Neurosurg, D-50931 Cologne, Germany; Univ Witten Herdecke, Fac Med, IFOM, Cologne, Germany; Gen Teaching Hosp Prague, Dept Rehabil Med, Prague, Czech Republic		Lippert-Gruener, M (corresponding author), Univ Hosp Cologne, Dept Neurosurg, Joseph Stelzmann Str 9, D-50931 Cologne, Germany.	lippert.gruener@medizin.uni-koeln.de	Svetkova, Olga/O-1062-2017	Svetkova, Olga/0000-0002-4271-4795			Anderson SI, 1996, BRAIN INJURY, V10, P115, DOI 10.1080/026990596124601; BAEHR M, 1997, KLIN NEUROBIOLOGIE M; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; BROOCKS N, 1986, J NEUROL NEUROSUR PS, V46, P336; Chua KSG, 1999, INT J REHABIL RES, V22, P189, DOI 10.1097/00004356-199909000-00005; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; Hoffmann B, 2002, ACT NEUR S, V79, P33; Hoofien D, 2001, BRAIN INJURY, V15, P189; KIRCHBERGER S, 1993, SPEKTRUM NEUROREHABI, P91; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; LIPPERTGRUNER M, 2003, ORTHOPADISCHE PRAXIS, V39, P334; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MAYER K, 1994, TAGUNGSBERICHT KURAT, P8; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Naredi S, 1998, INTENS CARE MED, V24, P446, DOI 10.1007/s001340050594; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; RUSK HA, 1968, MED CLIN N AM, V53, P677; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; UNTERBERG A, 1999, GRUNDLAGEN NEUROCHIR, P201; [No title captured]	30	22	22	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	10					1001	1005		10.1080/02699050701468933			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222WU	WOS:000250329600001	17891561				2022-02-06	
J	Shotton, L; Simpson, J; Smith, M				Shotton, Laura; Simpson, Jane; Smith, Mike			The experience of appraisal, coping and adaptive psychosocial adjustment following traumatic brain injury: A qualitative investigation	BRAIN INJURY			English	Article						traumatic brain injury; qualitative; appraisal; coping; adjustment	CHRONIC ILLNESS; STRATEGIES; SEQUELAE; INDIVIDUALS; TBI	Purpose: The experience of appraisal and coping in relation to psychosocial adjustment was explored with individuals who had sustained a traumatic brain injury. Methods: Nine participants were interviewed using a semi-structured schedule. Interpretative phenomenological analysis was used to analyse the data and highlighted four over-riding themes. Results: The emergent themes included: (1) 'waking up': understanding TBI; (2) 'I keep going': coping with TBI; (3) I knew I'd get better': beliefs about TBI; and (4) 'the benefits have far outweighed the consequences': searching for positives. These themes highlighted the adaptive and fluid way in which participants coped over time. In addition, the balance between perceptions of luck vs controllability and optimism vs realism were evident for many participants. All but one participant showed adaptive adjustment; therefore the non-adaptive case was used to critique the emergent themes. Conclusions: The case of non-adaptive adjustment illustrated less fluidity in terms of the coping strategies utilised, little perceived controllability and a greater degree of externalizing blame. The findings give some direction to neuropsychological rehabilitation with regard to the pliable nature of appraisals and coping and their potential to facilitate adaptive adjustment.	Northgate Hosp, Northumberland Head Injury Serv, Tyne & Wear NHS Trust, Morpeth NE61 3BP, Northd, England; Univ Lancaster, Lancaster, England; Lancaster Teaching Hosp NHS Trust, Lancaster, England		Shotton, L (corresponding author), Northgate Hosp, Northumberland Head Injury Serv, Tyne & Wear NHS Trust, Morpeth NE61 3BP, Northd, England.	laura.hotton@ntw.nhs.uk		Simpson, Jane/0000-0001-5071-4077			ALDERMAN N, 1996, BEHAV ASSESSMENT DYS; BOMBARDIER CH, 1990, BEHAV RES THER, V28, P297, DOI 10.1016/0005-7967(90)90081-S; Bowman ML, 1996, CLIN NEUROPSYCHOL, V10, P382, DOI 10.1080/13854049608406699; Charlton GS, 2002, HEALTH SOC CARE COMM, V10, P472, DOI 10.1046/j.1365-2524.2002.00385.x; CONRAD P, 1987, RES SOCIOLOGY HLTH C, V6, P1; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Elliott R, 1999, BRIT J CLIN PSYCHOL, V38, P215, DOI 10.1348/014466599162782; FELTON BJ, 1984, J CONSULT CLIN PSYCH, V52, P343, DOI 10.1037/0022-006X.52.3.343; Finset A, 2000, BRAIN INJURY, V14, P887; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Folkman S., 1984, STRESS; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; HAGEN C, 1972, RANCHO AMIGOS COGNIT; HOLOROYD KA, 1982, STRESS COPING SOMATI; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Klonoff P. S., 1991, J HEAD TRAUMA REHAB, V6, P11, DOI [10.1097/00001199-199112000-00005, DOI 10.1097/00001199-199112000-00005]; LAZARUS RS, 1993, PSYCHOSOM MED, V55, P234, DOI 10.1097/00006842-199305000-00002; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; MCNETT S, 1997, NURS RES, V36, P98; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; Nochi M, 2000, SOC SCI MED, V51, P1795, DOI 10.1016/S0277-9536(00)00111-8; PATERSON RJ, 1987, PSYCHOL BULL, V101, P404, DOI 10.1037/0033-2909.101.3.404; Poggi G, 2003, BRAIN INJURY, V17, P835, DOI 10.1080/0269905031000088612; Scioli A, 2000, INT J AGING HUM DEV, V51, P115, DOI 10.2190/0BAJ-HPJ8-V0QL-DFMQ; SMITH J, 2003, QUALITATIVE PSYCHOL, pCH4; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256; SMITH JA, 1999, QUALITATIVE HLTH PSY; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; Tate RL, 1999, PSYCHOL MED, V29, P713, DOI 10.1017/S0033291799008466; Turpin G., 1997, CLIN PSYCHOL FORUM, V108, P3; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Wills L., 1991, SOCIAL COMP CONT THE, P51; [No title captured], DOI DOI 10.1080/09602019108520164	40	22	23	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	8					857	869		10.1080/02699050701481621			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	202YZ	WOS:000248942400007	17676443				2022-02-06	
J	Trudel, TM; Nidiffer, FD; Barth, JT				Trudel, Tina M.; Nidiffer, F. Don; Barth, Jeffrey T.			Community-integrated brain injury rehabilitation: Treatment models and challenges for civilian, military, and veteran populations	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						brain injury; cognitive rehabilitation; community-integrated rehabilitation; community integration; community reentry; Defense and Veterans Brain Injury Center; functional rehabilitation; home-based rehabilitation; neurobehavioral rehabilitation; treatment manuals	RANDOMIZED CONTROLLED-TRIAL; COMPREHENSIVE DAY TREATMENT; COGNITIVE-BEHAVIOR THERAPY; POSTACUTE REHABILITATION; NEUROREHABILITATION PROGRAM; COST-EFFECTIVENESS; TREATMENT MANUALS; RATING-SCALE; HEAD-INJURY; DISABILITY	Traumatic brain injury (TBI) is a major health problem in civilian, military, and veteran populations. Individuals experiencing moderate to severe TBI require a continuum of care involving acute hospitalization and postacute rehabilitation, including community reintegration and, one would hope, a return borne to function as a productive member of the community. In the military, the goal is to help individuals with TBI return to active duty or make an optimal return to civilian life if the extent of their injuries necessitates a "medical board" discharge. Whether civilian, military, or veteran with TBI, individuals who move beyond the need to live in a facility must be reintegrated back into the community. This article discusses four treatment models for community reintegration, reviews treatment standardization and outcome issues, and describes a manualized rehabilitation pilot program designed to provide community reintegration and return to duty/work for civilians, veterans, and military personnel with TBI.	[Trudel, Tina M.; Nidiffer, F. Don; Barth, Jeffrey T.] Univ Virginia, Sch Med, Lakeview Healthcare Syst, Def & Vet Brain Injury Ctr Virgina Neurocare, Charlottesville, VA 22902 USA		Trudel, TM (corresponding author), Univ Virginia, Sch Med, Lakeview Healthcare Syst, Def & Vet Brain Injury Ctr Virgina Neurocare, 1101-B E High St, Charlottesville, VA 22902 USA.	ttrudel@lakeview.ws					Bach AK, 2004, BEHAV THER, V35, P55, DOI 10.1016/S0005-7894(04)80004-2; Bach-y-Rita P, 2003, ARCH PHYS MED REHAB, V84, P1100, DOI 10.1016/S0003-9993(03)00312-5; Ball Jillian, 2004, Eat Disord, V12, P303, DOI 10.1080/10640260490521389; Bazelmans Ellen, 2004, Cognitive Behaviour Therapy, V33, P143, DOI 10.1080/16506070410025823; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Blanchard EB, 2001, IRRITABLE BOWEL SYND; Bowen A, 1999, NEUROREHABILITATION, V13, P147; Carnevale GJ, 2002, J HEAD TRAUMA REHAB, V17, P83, DOI 10.1097/00001199-200204000-00002; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1073, DOI 10.1016/j.apmr.2005.01.003; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Coetzer R, 2005, INT J REHABIL RES, V28, P361, DOI 10.1097/00004356-200512000-00010; Cooper Z, 2003, COGNITIVE BEHAV TREA; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Davis LW, 2005, J REHABIL RES DEV, V42, P35, DOI 10.1682/JRRD.2003.05.0083; DELOCHE G, 2000, INT HDB NEUROPSYCHOL, P83; Duncan EAS, 2004, BEHAV COGN PSYCHOTH, V32, P199, DOI 10.1017/S135246580400116X; Glenn MB, 2005, J HEAD TRAUMA REHAB, V20, P393, DOI 10.1097/00001199-200509000-00001; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Hashimoto K, 2006, J REHABIL MED, V38, P20, DOI 10.1080/16501970510038473; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; *HM JACKSON FDN AD, 2007, DEFENSE VETERANS BRA; Hunsley J, 1999, J CLIN PSYCHOL, V55, P1507, DOI 10.1002/(SICI)1097-4679(199912)55:12<1507::AID-JCLP8>3.0.CO;2-A; IPSEN SM, 1986, EDUC TRAIN MENT RET, V21, P153; JEFFREY DB, 1973, J AM COLL HEALTH ASS, V21, P455; Klinger E, 2005, CYBERPSYCHOL BEHAV, V8, P76, DOI 10.1089/cpb.2005.8.76; KREUTZER JS, 2001, JUDGMENT SAFETY SCRE, P56; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Linden M, 2005, PSYCHOTHER PSYCHOSOM, V74, P36, DOI 10.1159/000082025; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malinowski A., 2003, J SUBST USE, V8, P223, DOI DOI 10.1080/14659890310001636107; Minnes P, 2003, BRAIN INJURY, V17, P149, DOI 10.1080/02699050301828; Miranda J, 2003, JAMA-J AM MED ASSOC, V290, P57, DOI 10.1001/jama.290.1.57; Morley Stephen, 2004, Cognitive Behaviour Therapy, V33, P1, DOI 10.1080/16506070310001794; Munoz RF, 2005, J CONSULT CLIN PSYCH, V73, P790, DOI 10.1037/0022-006X.73.5.790; O'Connor K.P., 2005, COGNITIVE BEHAV MANA; Pace GM, 1999, BRAIN INJURY, V13, P535; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Salazar AM, 2000, J HEAD TRAUMA REHAB, V15, P1081, DOI 10.1097/00001199-200010000-00002; Sander AM, 2001, J HEAD TRAUMA REHAB, V16, P356, DOI 10.1097/00001199-200108000-00006; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Sholomskas DE, 2005, J CONSULT CLIN PSYCH, V73, P106, DOI 10.1037/0022-006X.73.1.106; Stith SA, 2002, J MARITAL FAM THER, V28, P21, DOI 10.1111/j.1752-0606.2002.tb01168.x; Taylor J., 2005, ANGER TREATMENT PEOP; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ, 2001, HEAD TRAUMA THERAPEU; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Turner-Stokes L, 2004, CLIN MED, V4, P10, DOI 10.7861/clinmedicine.4-1-10; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Vander Laan R, 2001, NEUROREHABILITATION, V16, P17; Vanderploeg RD, 2006, J HEAD TRAUMA REHAB, V21, P179, DOI 10.1097/00001199-200603000-00010; Warden DL, 2000, J HEAD TRAUMA REHAB, V15, P1092, DOI 10.1097/00001199-200010000-00003; Whyte J, 2002, ARCH PHYS MED REHAB, V83, P1320, DOI 10.1053/apmr.2002.34807; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Wood RL, 1999, NEUROPSYCHOL REHABIL, V9, P505, DOI 10.1080/096020199389554; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746	61	22	23	0	19	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2007	44	7					1007	1016		10.1682/JRRD.2006.12.0167			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	253NL	WOS:000252524800013	18075957	Bronze			2022-02-06	
J	Xiang, HY; Sinclair, SA; Yu, SL; Smith, GA; Kelleher, K				Xiang, Huiyun; Sinclair, Sara A.; Yu, Songlin; Smith, Gary A.; Kelleher, Kelly			Case ascertainment in pediatric traumatic brain injury: Challenges in using the NEISS	BRAIN INJURY			English	Article						traumatic brain injury; US National Electronic Injury Surveillance System; international classification of diseases	US EMERGENCY-DEPARTMENTS; SURVEILLANCE SYSTEM; UNITED-STATES; ACCURACY; DATABASE; CHILDREN	Primary objective: To evaluate mild traumatic brain injury ( TBI) case ascertainment in the US National Electronic Injury Surveillance System ( NEISS). Research design: A sample of NEISS injury cases was analyzed. Two trained researchers independently reviewed diagnostic codes based on the International Classification of Diseases, 9th Revision, Clinical Modification ( ICD- 9- CM). The sensitivity and specificity of two NEISS TBI definitions were evaluated, and Kappa coefficients were calculated to evaluate the agreement between NEISS TBI definitions and the standard TBI definition based on the ICD- 9- CM. Results: Our sampling procedures provided a total of 1,018 NEISS cases, of which 880 were injury cases and 138 were non- injury cases. Out of the injury cases, 54 cases were defined as mild TBI cases based on the ICD- 9- CM diagnosis codes. Compared with non- TBI injury cases, a significantly higher percentage of TBI cases ( 33.3% versus 15.4%) were infants less than 1 year old and TBI cases were more likely to be admitted for hospitalization. If TBI was identified using NEISS definition 1 ( diagnosis code 52 for 'concussion'), the sensitivity was only 38.9% ( 95% confidence intervals ( CI) 25.9 - 51.9%). However, if TBI was identified using NEISS definition 2 ( diagnosis code 52 for ` concussion' or 62 for ` internal organ injury' and ` head' was the affected body part), the sensitivity increased dramatically to 79.6% ( 95% CI 68.9 - 90.4%). The Kappa coefficient for overall agreement between the NEISS and ICD- 9- CM system was 0.528 ( 95% CI 0.393 - 0.664) for NEISS definition 1 and 0.807 ( 95% CI 0.723 - 0.892) for NEISS definition 2. Conclusions: The current approach of pediatric TBI case ascertainment in the NEISS faces some challenges in identifying mild TBI. Future research efforts are needed to refine TBI case ascertainment in the NEISS.	Ohio State Univ, Childrens Hosp Columbus, Coll Med, Columbus Childrens Res Inst,Ctr Injury Res & Poli, Columbus, OH 43210 USA		Xiang, HY (corresponding author), Ohio State Univ, Childrens Hosp Columbus, Coll Med, Columbus Childrens Res Inst,Ctr Injury Res & Poli, 700 Childrens Dr, Columbus, OH 43210 USA.	xiangh@pediatrics.ohio-state.edu	Kelleher, Kelly/E-3361-2011; Xiang, Huiyun/E-4335-2011		NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE000241] Funding Source: NIH RePORTER; NCIPC CDC HHS [1R49CE000241-01] Funding Source: Medline		Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Fingerhut LA, 2002, INJ PREV, V8, P259, DOI 10.1136/ip.8.3.259; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hostetler SG, 2005, AM J SPORT MED, V33, P1065, DOI 10.1177/0363546504271748; Hostetler SG, 2004, PEDIATRICS, V114, pE661, DOI 10.1542/peds.2004-1565; Hunt JP, 2000, J TRAUMA, V49, P679, DOI 10.1097/00005373-200010000-00016; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Kostylova A, 2005, INJURY PREV, V11, P186, DOI 10.1136/ip.2004.006585; KRAMER CF, 1995, J TRAUMA, V39, P935, DOI 10.1097/00005373-199511000-00019; LANGLOISE J, 2006, TRAUMATIC BRAIN INJU; Linakis JG, 2006, ACAD EMERG MED, V13, P567, DOI [10.1111/j.1553-2712.2006.tb01009.x, 10.1197/j.aem.2005.11.073]; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Quinlan KP, 1999, ANN EMERG MED, V34, P637, DOI 10.1016/S0196-0644(99)70166-6; Shields BJ, 2006, PEDIATRICS, V117, pE452, DOI 10.1542/peds.2005-1916; Thurman DJ., 1995, STANDARDS SURVEILLAN; Weiss H B, 1996, Inj Prev, V2, P166, DOI 10.1136/ip.2.2.166; Weiss H B, 1996, Inj Prev, V2, P61, DOI 10.1136/ip.2.1.61; Xiang HY, 2005, J TRAUMA, V58, P112, DOI 10.1097/01.TA.0000151270.26634.DD; Yeates KO, 2005, NEUROPSYCHOLOGY, V19, P618, DOI 10.1037/0894-4105.19.5.618	25	22	22	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	3					293	299		10.1080/02699050701311034			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	168IW	WOS:000246518400004	17453757				2022-02-06	
J	Kennedy, MRT; Turkstra, L				Kennedy, Mary R. T.; Turkstra, Lyn			Group intervention studies in the cognitive rehabilitation of individuals with traumatic brain injury: Challenges faced by researchers	NEUROPSYCHOLOGY REVIEW			English	Article						cognitive rehabilitation; traumatic brain injury; randomized control trials	PRACTICE GUIDELINES; MANAGEMENT; DEFICITS	There are many factors to consider in designing and interpreting group studies. These include both analytic considerations, such as the selection of valid and reliable outcome measures, and subjective considerations, such as the selection of outcomes that are perceived to be important to participants and researchers. In this paper, we review key issues to consider in the design of group studies in neurorehabilitation, using problem-solving studies in traumatic brain injury as an example.	Univ Minnesota, Minneapolis, MN USA; Univ Wisconsin, Madison, WI USA		Kennedy, MRT (corresponding author), Univ Minnesota, 164 Pillsbury Dr SE,115 Shevlin Hall, Minneapolis, MN USA.	kenne047@umn.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921			*AM AC NEUR, 2004, CLIN PRACT GUID PROC; American Psychological Association, 2010, PUBL MAN AM PSYCH AS, V6; Bedell GM, 2005, AM J OCCUP THER, V59, P273, DOI 10.5014/ajot.59.3.273; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Cohen J., 2013, STAT POWER ANAL BEHA; COOPER H, 1994, HDB RES SYNTHESIS, P215; ELLENBERG JH, 1996, DRUG INF J, V30, P535, DOI DOI 10.1177/009286159603000229; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; FOXX RM, 1989, BEHAV THER, V20, P61, DOI 10.1016/S0005-7894(89)80118-2; Frattali C, 2003, J MED SPEECH-LANG PA, V11, pIX; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Hashimoto K, 2006, J REHABIL MED, V38, P20, DOI 10.1080/16501970510038473; *INJ VIOL PREV UN, 2005, EM DEP TREAT TRAUM B; Kelemen WL, 2000, MEM COGNITION, V28, P92, DOI 10.3758/BF03211579; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Marshall RC, 2004, APHASIOLOGY, V18, P659, DOI 10.1080/02687030444000237; Montori VM, 2003, BMC MED, V1, DOI 10.1186/1741-7015-1-2; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; RAYMER S, 2006, IN PRESS J SPEECH LA; Riley GA, 2003, BRIT J CLIN PSYCHOL, V42, P319, DOI 10.1348/01446650360703410; SCHIAVETTI N, 2005, EVALUATING RES COMMU; SOHLBERG M, IN PRESS J MED SPEEC; Sohlberg MM, 2003, J MED SPEECH-LANG PA, V11, pXIX; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; TATE R, 2004, PSYCBITE PSYCHOL DAT; Thompson B, 2002, ED RES, V31, P25, DOI DOI 10.3102/0013189X031003025; TURKSTRA L, 2005, J MED SPEECH LANGUAG, V13; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103	36	22	22	0	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1040-7308	1573-6660		NEUROPSYCHOL REV	Neuropsychol. Rev.	DEC	2006	16	4					151	159		10.1007/s11065-006-9012-8			9	Psychology, Clinical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	121RZ	WOS:000243176000002	17160698				2022-02-06	
J	Kunik, CL; Flowers, L; Kazanjian, T				Kunik, Cherie L.; Flowers, Laura; Kazanjian, Terri			Time to rehabilitation admission and associated outcomes for patients with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; length of stay; outcome assessment (health care); rehabilitation	LENGTH-OF-STAY; MULTICENTER ANALYSIS; OLDER-ADULTS; THERAPY; CHARGES	Objective: To examine the association between time from injury to rehabilitation admission and outcomes for patients with traumatic brain injuries (TBIs). Design: Retrospective chart review. Setting: One hundred-bed inpatient rehabilitation facility with a 20-bed brain injury unit. Participants: Patients with TBIs discharged from initial inpatient rehabilitation between 2003 and 2004 (N= 158). Interventions: Not applicable. Main Outcome Measures: Outcomes examined were functional independence at discharge (motor, cognitive, total FIM scores), rehabilitation length of stay (LOS), and rehabilitation cost. Results: Significant linear trends were observed for time to admission and motor FIM scores, total FIM scores, rehabilitation LOS, and cost. All linear regression models contained time to admission as a significant predictor of rehabilitation outcomes. Over half of the variability in outcomes was explained by predictors including time to admission and case-mix group or individual FIM scores with the exception of discharge motor FIM score, for which only 45% of the variability was explained. Conclusions: Patients who progress to rehabilitation earlier do better functionally and have lower costs and shorter LOSS. Furthermore, the time to rehabilitation admission is easily calculated and could be used by rehabilitation providers in adjunct with admission FIM scores to estimate resource utilization.	Shepherd Ctr, Crawford Res Inst, Atlanta, GA 30309 USA		Flowers, L (corresponding author), Shepherd Ctr, Crawford Res Inst, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.	Laura_Flowers@shepherd.org					Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; HAGEN C, 1972, LOS AMIGOS SCALE FUN; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; Ryser DK, 2005, ARCH PHYS MED REHAB, V86, P1108, DOI 10.1016/j.apmr.2004.11.041; Stineman MG, 1998, ARCH PHYS MED REHAB, V79, P241, DOI 10.1016/S0003-9993(98)90001-6; *TRAUM BRAIN INJ M, 2006, TRAUM BRAIN INJ FACT, V12; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; 2000, FED REG, V65, P66410	16	22	22	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2006	87	12					1590	1596		10.1016/j.apmr.2006.09.001			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	114OH	WOS:000242675000006	17141638				2022-02-06	
J	Eisele, JA; Kegler, SR; Trent, RB; Coronado, VG				Eisele, Julie A.; Kegler, Scott R.; Trent, Roger B.; Coronado, Victor G.			Nonfatal traumatic brain injury-related hospitalization in very young children - 15 states, 1999	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						injury surveillance; pediatric injury; traumatic brain injury		Objective: To document age-related patterns of nonfatal hospitalization associated with traumatic brain injury (TBI) among children younger than 2 years of age, by intent/cause and diagnosis. Methods: Data describing 2536 nonfatal TBI-related hospitalizations in 15 states for the year 1999 were obtained from the Centers for Disease Control and Prevention Central Nervous System Injury surveillance system for children younger than 2 years of age (0-23 months) at the time of injury. Main Outcome Measures: Incidence rates (overall, by intent/cause, and by diagnosis) were calculated by combining TBI surveillance data with population data from the US Census Bureau and the National Center for Health Statistics. Results: Overall rates of nonfatal TBI-related hospitalization peaked at I month of age (178.0 cases per 100,000 person-years) followed by a secondary peak at 8 months of age (127.9 cases per 100,000 person-years). Rates for fall-related (unintentional) cases and assault-related cases were significantly higher for infants (0-11 months) than for 1-year-olds (12-23 months), with rates for both types of cases peaking in the earliest months of life. Rates for cases with diagnoses of skull fracture and/or intracranial injury were also significantly higher for the younger group. Assault-related cases frequently coincided with a diagnosis of intracranial injury regardless of age. Conclusions: Prevention efforts should focus on falls and assaults, which account for the majority of TBI-related hospitalizations in early childhood. Such efforts may also need to emphasize the unusually high risk during the first few months of life.	Ctr Dis Control & Prevent, Off Stat & Programming, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; Calif Dept Hlth Serv, Epidemiol & Prevent Injury Control Branch, Sacramento, CA USA; Ctr Dis Control & Prevent, Div Injury Response, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Kegler, SR (corresponding author), Ctr Dis Control & Prevent, Off Stat & Programming, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy NE,Mailstop K-59, Atlanta, GA 30341 USA.	skegler@cdc.gov					Agran PF, 2003, PEDIATRICS, V111, pE683, DOI 10.1542/peds.111.6.e683; *AM MED ASS, 1997, INT CLASS DIS 9 REV; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; BRILLINGER DR, 1986, BIOMETRICS, V42, P693, DOI 10.2307/2530689; *CDCP, REC FRAM E COD GROUP; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; *NAT CTR HLTH STAT, 1999, NAT VIT STAT REP, V49; *NAT CTR HLTH STAT, 1999, NAT VIT STAT REP, V50; *NAT CTR HLTH STAT, 2001, LIV BIRTHS STAT RES; *NAT CTR HLTH STAT, 1999, INF GEN FIL GMWK264B; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; SAS Institute Inc, 1999, SAS PROC GUID VERS 8; Thurman DJ., 1995, GUIDELINES SURVEILLA; *US CENS BUR, 1999, POP EST US STAT SING; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005	18	22	24	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2006	21	6					537	543		10.1097/00001199-200611000-00008			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	109UC	WOS:000242333400008	17122684				2022-02-06	
J	Heiduschka, P; Thanos, S				Heiduschka, Peter; Thanos, Solon			Cortisol promotes survival and regeneration of axotomised retinal ganglion cells and enhances effects of aurintricarboxylic acid	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						retinal ganglion cells; neuroprotection; aurintricarboxylic acid; optic nerve injury; cortisol; axonal regeneration	SPINAL-CORD-INJURY; HIGH-DOSE METHYLPREDNISOLONE; GLUCOCORTICOID-RECEPTOR; PERIPHERAL-NERVES; MICROGLIAL CELLS; BRAIN; INHIBITION; NEUROPROTECTION; ACTIVATION; PROTEIN	Neuroprotection is essential for repair processes after a traumatic insult in the central nervous system. We have demonstrated previously significant neuroprotective properties of the anti-apoptotic drug aurintricarboxylic acid in the model of axotomised retinal ganglion cells. Glucocorticoids are widely used to treat injuries of the nervous system. Due to the anti-inflammatory and microglia-inhibiting properties of glucocorticoids, we studied the neuroprotective effects of intravitreally administered cortisol after an optic nerve cut. Ninety-eight adult Sprague-Dawley rats were used in this study. The optic nerve was cut intra-orbitally. Either vehicle or compound solution was injected intravitreally. Fluorescent dye was put onto the optic nerve stump to label retinal ganglion cells retrogradely. Retinal whole mounts were prepared 2 weeks after axotomy, and surviving retinal ganglion cells were counted. Two weeks after axotomy, up to 50 +/- 7% of all retinal ganglion cells survived if cortisol was injected into the eye compared with 17 +/- 5% survival if only vehicle solution was injected. The neuroprotective effects of aurintricarboxylic acid (43 +/- 5% survival) could be further enhanced if combined with cortisol (up to 61 +/- 5% survival). Regeneration of cut retinal ganglion cell axons into a peripheral nerve graft could also be enhanced by an intravitreal injection of cortisol (169 +/- 42 regenerating retinal ganglion cells per mm(2) vs. 73 +/- 12 cells per mm(2) after vehicle injection). The increase was not as high as with aurintricarboxylic acid (192 +/- 40 cells per mm(2)), although more retinal ganglion cells survived with cortisol. This indicates that neuronal survival alone is not sufficient for subsequent axonal regeneration. Nevertheless, regeneration could be markedly increased if aurintricarboxylic acid and cortisol were combined (308 +/- 72 cells per mm(2)). Whereas aurintricarboxylic acid seems to act directly on lesioned retinal ganglion cells, cortisol seems to act on the glial environment, as indicated by microglial cell morphology and enhanced glial fibrillary acidic protein expression. The results show that both neuroprotection and regeneration can be enhanced by the combination of two simple compounds acting on different sites.	Univ Tubingen, Hosp Eye, D-72076 Tubingen, Germany; Univ Munster, Hosp Eye, Dept Expt Ophthalmol, D-48149 Munster, Germany		Heiduschka, P (corresponding author), Univ Tubingen, Hosp Eye, Schleichstr 12-1, D-72076 Tubingen, Germany.	peter.heiduschka@med.uni-tuebingen.de	Heiduschka, Peter/AAX-3882-2021				Almeida OFX, 2000, FASEB J, V14, P779, DOI 10.1096/fasebj.14.5.779; AMIN AR, 1995, P NATL ACAD SCI USA, V92, P7926, DOI 10.1073/pnas.92.17.7926; ARMALY MANSOUR F., 1965, INVEST OPHTHALMOL, V4, P187; Barkana Y, 2004, BRAIN RES BULL, V62, P447, DOI 10.1016/S0361-9230(03)00071-6; Barr CS, 1999, BRAIN RES, V847, P9, DOI 10.1016/S0006-8993(99)01988-5; BECKER KW, 1987, NEUROCHIRURGIA, V30, P161; Bianchi M, 2000, P NATL ACAD SCI USA, V97, P9573, DOI 10.1073/pnas.160099797; Biola A, 2000, FEBS LETT, V487, P229, DOI 10.1016/S0014-5793(00)02297-3; BOLDREY E, 1951, SURG FORUM, V2, P386; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; BRAUGHLER JM, 1985, J NEUROSURG, V62, P806, DOI 10.3171/jns.1985.62.6.0806; Carnahan M C, 2000, Curr Opin Ophthalmol, V11, P478, DOI 10.1097/00055735-200012000-00016; Castano A, 1996, EUR J NEUROSCI, V8, P581, DOI 10.1111/j.1460-9568.1996.tb01243.x; Chan T. K., 1996, Singapore Medical Journal, V37, P216; CHAO TC, 1994, AM J REPROD IMMUNOL, V32, P43, DOI 10.1111/j.1600-0897.1994.tb00877.x; Chaum E, 2003, J CELL BIOCHEM, V88, P57, DOI 10.1002/jcb.10354; Chen CW, 2002, BRIT J PHARMACOL, V137, P1011, DOI 10.1038/sj.bjp.0704955; Coleman WP, 2000, J SPINAL DISORD, V13, P185, DOI 10.1097/00002517-200006000-00001; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Nicola AF, 1998, J STEROID BIOCHEM, V65, P253, DOI 10.1016/S0960-0760(97)00190-8; DEROUICHE A, 1995, J NEUROSCI RES, V42, P131, DOI 10.1002/jnr.490420115; Diem R, 2003, J NEUROSCI, V23, P6993, DOI 10.1523/JNEUROSCI.23-18-06993.2003; Drew PD, 2000, BRAIN RES BULL, V52, P391, DOI 10.1016/S0361-9230(00)00275-6; Farkas RH, 2001, INT OPHTHALMOL CLIN, V41, P111, DOI 10.1097/00004397-200101000-00011; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; GARCIAZAMBRANO W, 1982, ARCH INVEST MED, V13, P157; Garrido C, 1999, FASEB J, V13, P2061, DOI 10.1096/fasebj.13.14.2061; Gorovits R, 1997, P NATL ACAD SCI USA, V94, P7024, DOI 10.1073/pnas.94.13.7024; Graham W P 3rd, 1973, Surg Forum, V24, P457; Heiduschka P, 2000, NEUROPHARMACOLOGY, V39, P889, DOI 10.1016/S0028-3908(99)00245-2; Heiduschka P, 2004, KLIN MONATSBL AUGENH, V221, P684, DOI 10.1055/s-2004-813054; Heiduschka P, 2000, PROG RETIN EYE RES, V19, P577, DOI 10.1016/S1350-9462(00)00011-2; HUANG ZB, 1993, CHEST, V104, P751, DOI 10.1378/chest.104.3.751; KAUR C, 1994, ARCH HISTOL CYTOL, V57, P449, DOI 10.1679/aohc.57.449; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; LAPING NJ, 1994, BRAIN PATHOL, V4, P259, DOI 10.1111/j.1750-3639.1994.tb00841.x; Lechner J, 1997, IMMUNOBIOLOGY, V198, P112, DOI 10.1016/S0171-2985(97)80032-0; Maurel D, 2000, GLIA, V29, P212, DOI 10.1002/(SICI)1098-1136(20000201)29:3<212::AID-GLIA3>3.0.CO;2-6; MORRISON RS, 1985, J NEUROSCI RES, V14, P167, DOI 10.1002/jnr.490140202; NICHOLS NR, 1990, MOL BRAIN RES, V7, P1, DOI 10.1016/0169-328X(90)90066-M; OCALLAGHAN JP, 1991, J NEUROCHEM, V57, P860, DOI 10.1111/j.1471-4159.1991.tb08230.x; Osborne NN, 2001, CURR EYE RES, V22, P321, DOI 10.1076/ceyr.22.5.321.5496; PACKAN DR, 1990, NEUROENDOCRINOLOGY, V51, P613, DOI 10.1159/000125400; Qian T, 2000, MED HYPOTHESES, V55, P452, DOI 10.1054/mehy.2000.1165; Rauen T, 2000, NEUROCHEM INT, V37, P179, DOI 10.1016/S0197-0186(00)00021-8; Sheng Yanjuan, 2004, Yan Ke Xue Bao, V20, P181; Sherif Z, 2002, OPHTHALMOLOGICA, V216, P305, DOI 10.1159/000066189; Short DJ, 2000, SPINAL CORD, V38, P273, DOI 10.1038/sj.sc.3100986; So EY, 2002, FEBS LETT, V518, P53, DOI 10.1016/S0014-5793(02)02635-2; SPOOR TC, 1990, AM J OPHTHALMOL, V110, P665, DOI 10.1016/S0002-9394(14)77065-5; STARKMAN MN, 1992, BIOL PSYCHIAT, V32, P756, DOI 10.1016/0006-3223(92)90079-F; Steinsapir KD, 2000, RESTOR NEUROL NEUROS, V17, P157; Tanaka J, 1997, GLIA, V20, P23, DOI 10.1002/(SICI)1098-1136(199705)20:1<23::AID-GLIA3>3.3.CO;2-U; THANOS S, 1993, J NEUROSCI, V13, P455; THANOS S, 1994, TRENDS NEUROSCI, V17, P177, DOI 10.1016/0166-2236(94)90098-1; URBAN RC, 1986, SURV OPHTHALMOL, V31, P102, DOI 10.1016/0039-6257(86)90077-9; van der Goes A, 2000, J LEUKOCYTE BIOL, V67, P801, DOI 10.1002/jlb.67.6.801; Vardimon L, 1999, J NEUROBIOL, V40, P513, DOI 10.1002/(SICI)1097-4695(19990915)40:4<513::AID-NEU8>3.0.CO;2-D; VIJAYAN VK, 1987, EXP NEUROL, V96, P307, DOI 10.1016/0014-4886(87)90049-5; Zhao ZQ, 2003, CARDIOVASC RES, V59, P132, DOI 10.1016/S0008-6363(03)00344-4	60	22	22	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	NOV	2006	244	11					1512	1521		10.1007/s00417-005-0164-7			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	103PL	WOS:000241899100019	16568288				2022-02-06	
J	Monroe, RK; Halvorsen, SW				Monroe, Richard K.; Halvorsen, Stanley W.			Mercury abolishes neurotrophic factor-stimulated Jak-STAT signaling in nerve cells by oxidative stress	TOXICOLOGICAL SCIENCES			English	Article						ciliary neurotrophic factor; gp130; tyrosine kinase; cytokine; interferon-gamma; transition metals; signal transduction; neurotoxicity	NEUROBLASTOMA-CELLS; MOTOR-NEURONS; CILIARY; ACTIVATION; CHLORIDE; SURVIVAL; BRAIN; RAT; PROTEINS; RECEPTOR	Mercury is a potent neurotoxin that can delay neurological development in neonates, and has been proposed to be an environmental risk factor for several neurodegenerative conditions. The mechanisms by which environmental factors may influence the propagation of neurodegenerative diseases are not yet well delineated. However, it is known that neurons require trophic factor support for maintenance and survival following traumatic physical and toxic insults. We found that divalent mercury (HgCl2) inhibited ciliary neurotrophic factor and interferon-gamma receptor-mediated Janus tyrosine kinase (Jak)/signal transducers and activators of transcription (STAT) pathway activation in SK-N-BE(2)-C neuroblastoma cell cultures, but did not inhibit the fibroblast growth factor receptor tyrosine kinase. Results of dichlorofluorescein experiments showed increased levels of oxidative stress in HgCl2-treated cells that was similar in magnitude to that caused by treatment with H2O2. The antioxidant agents glutathione, N-acetylcysteine, and sodium ascorbate each protected neurons against HgCl2-induced inhibition of STAT activation. HgCl2 also inhibited Jak-STAT signaling in cultures of chick retina neurons, but did not affect signaling in nonneuronal HepG2 cells and chick skeletal myotubes. The specific inhibition of growth factor-mediated Jak-STAT signaling pathways in neurons by HgCl2-induced oxidative stress offers a new mechanism by which mercury may produce neurotoxic symptoms in the developing nervous system, promote neurodegeneration in mature neurons, and inhibit recovery following neurotrauma.	SUNY Buffalo, Program Neurosci, Buffalo, NY 14214 USA; SUNY Buffalo, Dept Pharmacol & Toxicol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA		Halvorsen, SW (corresponding author), SUNY Buffalo, Program Neurosci, Buffalo, NY 14214 USA.	stanh@buffalo.edu		Halvorsen, Stanley/0000-0002-2430-4610			Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; Arciello M, 2005, BIOCHEM BIOPH RES CO, V327, P454, DOI 10.1016/j.bbrc.2004.12.022; BARTOLOME J, 1984, TOXICOL LETT, V22, P101, DOI 10.1016/0378-4274(84)90052-3; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; BIEDLER JL, 1978, CANCER RES, V38, P3751; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Brawer JR, 1998, NEUROTOXICOLOGY, V19, P767; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Chen F, 2002, CRIT REV ONCOL HEMAT, V42, P105, DOI 10.1016/S1040-8428(01)00211-6; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Crump KS, 1998, RISK ANAL, V18, P701, DOI 10.1023/B:RIAN.0000005917.52151.e6; Daniels WMU, 2004, METAB BRAIN DIS, V19, P79, DOI 10.1023/B:MEBR.0000027419.79032.bd; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duhe RJ, 1998, P NATL ACAD SCI USA, V95, P126, DOI 10.1073/pnas.95.1.126; El-Demerdash FM, 2001, J ENVIRON SCI HEAL B, V36, P489, DOI 10.1081/PFC-100104191; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Finn TP, 1998, J NEUROBIOL, V34, P283, DOI 10.1002/(SICI)1097-4695(19980215)34:3<283::AID-NEU7>3.0.CO;2-Z; Grandjean P, 2003, AMBUL PEDIATR, V3, P18, DOI 10.1367/1539-4409(2003)003<0018:NRCBSA>2.0.CO;2; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hussain S, 1997, J ENVIRON SCI HEAL B, V32, P395, DOI 10.1080/03601239709373094; IP NY, 1991, J NEUROSCI, V11, P3124; Jiao JW, 2003, MOL BRAIN RES, V116, P135, DOI 10.1016/S0169-328X(03)00286-9; Kaur N, 2005, J NEUROCHEM, V92, P1521, DOI 10.1111/j.1471-4159.2004.02990.x; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Konigsberg M, 2001, J APPL TOXICOL, V21, P323; Koshlukova S, 1996, NEUROSCIENCE, V72, P821, DOI 10.1016/0306-4522(95)00560-9; Krantz A, 2004, DM-DIS MON, V50, P220, DOI 10.1016/j.disamonth.2004.04.001; Krejsa CM, 1998, ENVIRON HEALTH PERSP, V106, P1179, DOI 10.2307/3433983; Kumagai Y, 1997, BRAIN RES, V769, P178, DOI 10.1016/S0006-8993(97)00846-9; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Leonard SS, 2004, FREE RADICAL BIO MED, V37, P1921, DOI 10.1016/j.freeradbiomed.2004.09.010; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lotz B, 1996, NEUROLOGY, V46, P1244; Maher P, 2000, CELL MOL LIFE SCI, V57, P1287, DOI 10.1007/PL00000766; Malek RL, 1997, J NEUROBIOL, V32, P81, DOI 10.1002/(SICI)1097-4695(199701)32:1<81::AID-NEU8>3.3.CO;2-U; MANTHORPE M, 1985, FED PROC, V44, P2753; Monroe RK, 2006, FREE RADICAL BIO MED, V41, P493, DOI 10.1016/j.freeradbiomed.2006.04.023; Ninomiya T, 1995, ENVIRON RES, V70, P47, DOI 10.1006/enrs.1995.1045; OYAMA Y, 1994, BRAIN RES, V635, P113, DOI 10.1016/0006-8993(94)91429-X; Pamphlett R, 1998, J NEUROL SCI, V159, P121, DOI 10.1016/S0022-510X(98)00161-0; Patrick Lyn, 2002, Altern Med Rev, V7, P456; PHILBERT MA, 1991, TOXICOL APPL PHARM, V107, P215, DOI 10.1016/0041-008X(91)90204-R; Pourahmad J, 2001, FREE RADICAL BIO MED, V30, P89, DOI 10.1016/S0891-5849(00)00450-0; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; ROSS RA, 1995, CELL GROWTH DIFFER, V6, P449; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Wang X, 1998, NEUROSCI LETT, V240, P9, DOI 10.1016/S0304-3940(97)00927-0; Wishingrad MA, 1997, J BIOL CHEM, V272, P19752, DOI 10.1074/jbc.272.32.19752; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253	57	22	24	0	4	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	NOV	2006	94	1					129	138		10.1093/toxsci/kfl073			10	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	092KL	WOS:000241095300013	16896058	Bronze			2022-02-06	
J	Moore, M; Taylor, HG; Klein, N; Minich, N; Hack, M				Moore, Melisa; Taylor, H. Gerry; Klein, Nancy; Minich, Nori; Hack, Maureen			Longitudinal changes in family outcomes of very low birth weight	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						family outcomes; low birth weight; longitudinal change	TRAUMATIC BRAIN INJURY; SCHOOL-AGE OUTCOMES; PSYCHOLOGICAL ADJUSTMENT; CHILDREN; IMPACT; PARENT; ADOLESCENCE; ACHIEVEMENT; CONFLICT; INFANTS	Objectives. Although children with very low birth weight (VLBW, < 1500 g) are at high risk for developmental impairments, we know little about the long-term effects of VLBW on families. This study examined long-term family outcomes and their stability over time. Methods. Participants were the families of 64 children with < 750 g birth weight, 54 with 750 - 1499 g birth weight, and 66 term-born controls. Family burden and parental distress were assessed annually as part of longitudinal follow-up of the children from mean ages 11 - 14 years. Results. Family burden and parental distress were higher in the < 750 g group than in the term-born group, but differences varied with the child's age and family environment. Conclusions. The findings document long-term effects of VLBW on families that are moderated by the degree of low birth weight, child's age, and family environment.	Univ Hosp Cleveland, Dept Pediat, Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Psychol, Cleveland, OH 44106 USA; Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; Cleveland State Univ, Dept Educ, Cleveland, OH 44115 USA		Taylor, HG (corresponding author), Univ Hosp Cleveland, Dept Pediat, Rainbow Babies & Childrens Hosp, 11100 Euclid Ave, Cleveland, OH 44106 USA.	hudson.taylor@case.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD026554] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 26554] Funding Source: Medline		BENDERSKY M, 1994, DEV PSYCHOL, V30, P484, DOI 10.1037/0012-1649.30.4.484; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; Breslau N, 1996, BIOL PSYCHIAT, V40, P389, DOI 10.1016/0006-3223(95)00399-1; Burchinal M. R., 1999, EARLY EDUC DEV, V10, P83, DOI 10.1207/s15566935eed1001_6; Cohen J., 2013, STAT POWER ANAL BEHA; CRONIN CMG, 1995, ARCH PEDIAT ADOL MED, V149, P151, DOI 10.1001/archpedi.1995.02170140033005; Derogatis LR., 1982, BRIEF SYMPTOM INVENT; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Drotar D, 1997, J PEDIATR PSYCHOL, V22, P149; Fanaroff AA, 2003, SEMIN PERINATOL, V27, P281, DOI 10.1016/S0146-0005(03)00055-7; FRISK V, 1994, DEV NEUROPSYCHOL, V10, P313, DOI 10.1080/87565649409540586; HACK M, 1995, FUTURE CHILD, V5, P176, DOI 10.2307/1602514; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Horwood LJ, 1998, ARCH DIS CHILD-FETAL, V79, pF12, DOI 10.1136/fn.79.1.F12; Keogh BK, 2000, AM J MENT RETARD, V105, P32, DOI 10.1352/0895-8017(2000)105<0032:MOCIFC>2.0.CO;2; KLEBANOV PK, 1994, J DEV BEHAV PEDIATR, V15, P248, DOI 10.1097/00004703-199408000-00005; KLEIN NK, 1989, J DEV BEHAV PEDIATR, V10, P32; LANDRY SH, 1988, J PEDIATR PSYCHOL, V13, P317, DOI 10.1093/jpepsy/13.3.317; Laursen B, 1998, CHILD DEV, V69, P817, DOI 10.1111/j.1467-8624.1998.00817.x; McCain G C, 1990, J Pediatr Nurs, V5, P97; MCCORMICK MC, 1986, J DEV BEHAV PEDIATR, V7, P217, DOI 10.1097/00004703-198608000-00001; MONTEMAYOR R, 1986, J ADOLES RES, V0001, P00015, DOI DOI 10.1177/074355488611003; MOOS R, 1994, LIFE STRESSES SOCIAL; Saigal S, 2000, J PEDIATR-US, V137, P701, DOI 10.1067/mpd.2000.109001; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Schafer JL, 1997, ANAL INCOMPLETE MULT; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799; Smetana J, 1999, CHILD DEV, V70, P1447, DOI 10.1111/1467-8624.00105; Stein R, 1985, PACTS PAPERS AECOM T; SZATMARI P, 1993, DEV PSYCHOPATHOL, V5, P345, DOI 10.1017/S0954579400004454; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Taylor HG, 1998, J DEV BEHAV PEDIATR, V19, P235; Taylor HG, 2004, J INT NEUROPSYCH SOC, V10, P149, DOI 10.1017/S1355617704102038; Taylor HG, 2002, CHILD NEUROPSYCHOL, V8, P163, DOI 10.1076/chin.8.3.163.13500; TAYLOR HG, 1995, J PEDIATR PSYCHOL, V20, P703, DOI 10.1093/jpepsy/20.6.703; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Taylor HG, 2001, ARCH PEDIAT ADOL MED, V155, P155, DOI 10.1001/archpedi.155.2.155; THOMPSON RJ, 1993, INFANT BEHAV DEV, V16, P471, DOI 10.1016/0163-6383(93)80005-S; WADE S, 1995, J PEDIATR PSYCHOL, V20, P737, DOI 10.1093/jpepsy/20.6.737; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wade SL, 2002, J HEAD TRAUMA REHAB, V17, P96, DOI 10.1097/00001199-200204000-00003; Wade SL, 1996, J LEARN DISABIL, V29, P652, DOI 10.1177/002221949602900609; WALLANDER JL, 1988, J PEDIATR PSYCHOL, V13, P197, DOI 10.1093/jpepsy/13.2.197	45	22	22	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	NOV-DEC	2006	31	10					1024	1035		10.1093/jpepsy/jsj075			12	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	104JU	WOS:000241955500003	16150877	Bronze, Green Published			2022-02-06	
J	Alessandri, B; Nishioka, T; Heimann, A; Bullock, RM; Kempski, O				Alessandri, B.; Nishioka, T.; Heimann, A.; Bullock, R. M.; Kempski, O.			Caspase-dependent cell death involved in brain damage after acute subdural hematoma in rats	BRAIN RESEARCH			English	Article						subdural hemorrhage; caspase inhibitor; apoptotic cell death; neuroprotection; brain	CEREBRAL-BLOOD-FLOW; FREE-RADICAL PRODUCTION; INTRACEREBRAL HEMORRHAGE; INDUCED APOPTOSIS; TEMPORAL PROFILE; ARTERY OCCLUSION; NEURONAL DEATH; HEAD-INJURY; ISCHEMIA; INFLAMMATION	Traumatic brain injury is associated with acute subdural hematoma (ASDH) that worsens outcome. Although early removal of blood can reduce mortality, patients still die or remain disabled after surgery and additional treatments are needed. The blood mass and extravasated blood induce pathomechanisms such as high intracranial pressure (ICP), ischemia, apoptosis and inflammation which lead to acute as well as delayed cell death. Only little is known about the basis of delayed cell death in this type of injury. Thus, the purpose of the study was to investigate to which extent caspase-dependent intracellular processes are involved in the lesion development after ASDH in rats. A volume of 300 mu L blood was infused into the subdural space under monitoring of ICP and tissue oxygen concentration. To asses delayed cell death mechanisms, DNA fragmentation was measured 1, 2, 4 and 7 days after ASDH by TUNEL staining, and the effect of the pan-caspase inhibitor zVADfmk on lesion volume was assessed 7 days post-ASDH. A peak of TUNEL-positive cells was found in the injured cortex at day 2 after blood infusion (53.4 +/- 11.6 cells/mm(2)). zVADfmk (160ng), applied by intracerebroventricular injection before ASDH, reduced lesion volume significantly by more than 50% (vehicle: 23.79 +/- 7.62mm(3); zVADfmk: 9.06 +/- 4.08). The data show for the first time that apoptotic processes are evident following ASDH and that caspase-dependent mechanisms play a crucial role in the lesion development caused by the blood effect on brain tissue. (c) 2006 Elsevier B.V. All rights reserved.	Univ Mainz, Inst Neurosurg Pathophysiol, D-55131 Mainz, Germany; Nara Med Univ, Dept Neurosurg, Kashihara, Nara 6348521, Japan; Virginia Commonwealth Univ, Coll Med, Dept Neurosurg, Richmond, VA USA		Alessandri, B (corresponding author), Univ Mainz, Inst Neurosurg Pathophysiol, Langenbeckstr 1, D-55131 Mainz, Germany.	beat.alessandri@uni-mainz.de		Heimann, Axel/0000-0003-2510-3228			Alessandri B, 1999, ACT NEUR S, V75, P21; Alessandri B, 1999, BRAIN RES, V845, P232, DOI 10.1016/S0006-8993(99)01948-4; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Cao GD, 2003, J CEREBR BLOOD F MET, V23, P1137, DOI 10.1097/01.WCB.0000087090.01171.E7; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; Chen J, 1998, J NEUROSCI, V18, P4914; Chiari P, 2000, J HEART LUNG TRANSPL, V19, P675, DOI 10.1016/S1053-2498(00)00127-3; Conti AC, 1998, J NEUROSCI, V18, P5663; Didenko VV, 2002, MOL MED, V8, P347, DOI 10.1007/BF03402015; Eijkenboom M, 1999, NEUROSCIENCE, V94, P373, DOI 10.1016/S0306-4522(99)00332-2; Eijkenboom M, 2000, NEUROPHARMACOLOGY, V39, P817, DOI 10.1016/S0028-3908(00)00002-2; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Gong C, 2000, BRAIN RES, V871, P57, DOI 10.1016/S0006-8993(00)02427-6; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Hengartner MO, 2001, NATURE, V412, P27, DOI 10.1038/35083663; INGLIS FM, 1990, ACT NEUR S, V51, P277; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; KURODA Y, 1992, NEUROSURGERY, V30, P687; Kwon TH, 2003, J NEUROTRAUM, V20, P337, DOI 10.1089/089771503765172291; LINNIK MD, 1995, MOL BRAIN RES, V32, P116, DOI 10.1016/0169-328X(95)00069-5; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Mauler F, 2004, EUR J NEUROSCI, V20, P1761, DOI 10.1111/j.1460-9568.2004.03615.x; Mayne M, 2001, STROKE, V32, P240, DOI 10.1161/01.STR.32.1.240; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Namura S, 1998, J NEUROSCI, V18, P3659; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Patel TR, 1999, J NEUROTRAUM, V16, P1049, DOI 10.1089/neu.1999.16.1049; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; Peeling J, 2001, EXP NEUROL, V167, P341, DOI 10.1006/exnr.2000.7564; Qureshi AI, 2001, CRIT CARE MED, V29, P152, DOI 10.1097/00003246-200101000-00030; RINK A, 1995, AM J PATHOL, V147, P1575; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Sasaki C, 2000, NEUROL RES, V22, P223, DOI 10.1080/01616412.2000.11741065; Sawauchi S, 2003, J NEUROTRAUM, V20, P613, DOI 10.1089/089771503322144536; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Soehle M, 2001, J NEUROSCI METH, V110, P91, DOI 10.1016/S0165-0270(01)00422-8; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Tenneti L, 2000, J NEUROCHEM, V74, P134, DOI 10.1046/j.1471-4159.2000.0740134.x; Tsuchida E, 1999, J NEUROTRAUM, V16, P595, DOI 10.1089/neu.1999.16.595; Xue MZ, 2000, STROKE, V31, P1721, DOI 10.1161/01.STR.31.7.1721; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	48	22	26	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	SEP 21	2006	1111						196	202		10.1016/j.brainres.2006.06.105			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	089TY	WOS:000240905200024	16890922				2022-02-06	
J	Sandford, AA; Davidson, TM; Herrera, N; Gilbert, P; Magit, AE; Haug, K; Gutglass, D; Murphy, C				Sandford, Amanda A.; Davidson, Terence M.; Herrera, Norma; Gilbert, Paul; Magit, Anthony E.; Haug, Kevin; Gutglass, David; Murphy, Claire			Olfactory dysfunction: A sequela of pediatric blunt head trauma	INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY			English	Article						head injuries; closed; olfactory nerve diseases; smell disorder; smell; olfaction; evoked potentials	EVENT-RELATED POTENTIALS; OF-PENNSYLVANIA SMELL; BRAIN-INJURY; TASTE; IMPAIRMENT; ANOSMIA; ODOR; FMRI	Objective: To evaluate olfactory function in children with blunt head trauma. Methods: Eligible subjects were consecutive children presenting at San Diego Children's Hospital Emergency Department or Trauma Service with blunt head trauma. Thirty-seven head injured children mean age 10.11 +/- 2.74 were evaluated; 36 healthy age and gender matched community children, mean age 10.08 +/- 2.99, served as controls. The medical record was reviewed for clinical measures related to head injury (HI). All children underwent olfactory assessment with the San Diego Children's Odor Identification Test (SDOIT). Olfactory event-related potentials were recorded on a subset of head injured and control children. Results: Three of 37 head injured children had olfactory dysfunction. The head injured hyposmics had signs of more severe head injury represented by lower Glasgow Coma Scores (GCS), 10.33 +/- 5.51, when compared to their normosmic counterparts with mean GCS of 14.06 +/- 2.82. When stratifying the head injured children by clinical measures, lower Glasgow Coma Score, and abnormalities on head CT scan were associated with poorer olfactory performance. Conclusion: Children with blunt head injury may suffer post-traumatic olfactory impairment. More severe head injuries are more likely to produce olfactory deficits. In cases of significant head injury, cranial nerve I evaluation is imperative. (C) 2005 Elsevier Ireland Ltd. All rights reserved.	San Diego State Univ, Ctr Lifespan Human Senses, Dept Psychol, San Diego, CA 92120 USA		Murphy, C (corresponding author), San Diego State Univ, Ctr Lifespan Human Senses, Dept Psychol, 6363 ALvarado Court,Ste 101, San Diego, CA 92120 USA.	cmurphy@sciences.sdsu.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG004085, AG04085] Funding Source: Medline; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC02064] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG004085, R01AG004085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC002064] Funding Source: NIH RePORTER		Blomqvist EH, 2004, RHINOLOGY, V42, P189; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; COMETTOMUNIZ JE, 1991, PHARMACOL BIOCHEM BE, V39, P983, DOI 10.1016/0091-3057(91)90063-8; COSTANZO RM, 1987, ANN NY ACAD SCI, V510, P242; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; DAVIDSON TM, 1993, WESTERN J MED, V159, P71; DAVIDSON TM, 1987, WESTERN J MED, V146, P434; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; DINARDO LJ, 1997, TASTE SMELL DISORDER, P79; Doty R., 2003, HDB OLFACTION GUSTAT, P229; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; EKMAN G, 1967, SCAND J PSYCHOL, V8, P177, DOI 10.1111/j.1467-9450.1967.tb01392.x; Ferdon S, 2003, NEUROIMAGE, V20, P12, DOI 10.1016/S1053-8119(03)00276-3; Geisler MW, 1999, J CLIN NEUROPHYSIOL, V16, P77, DOI 10.1097/00004691-199901000-00008; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; HARRIS R, IN PRESS CLIN EVALUA; Jackson JH, 1864, LOND HOSP REP, V1, P470; JACOBI G, 1986, Acta Paediatrica Hungarica, V27, P173; Kalavrezos ND, 2000, J ROY COLL SURG EDIN, V45, P359; Leigh AD, 1943, LANCET, V1, P38; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; Mann NM, 2002, CLEV CLIN J MED, V69, P329, DOI 10.3949/ccjm.69.4.329; MENDELSOHN B, UNPUB OERP YOUNG CHI; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Morgan CD, 1997, EVOKED POTENTIAL, V104, P351, DOI 10.1016/S0168-5597(97)00020-8; Murphy C, 2000, INT J PSYCHOPHYSIOL, V36, P133, DOI 10.1016/S0167-8760(99)00107-5; MURPHY C, 1994, CHEM SENSES, V19, P47, DOI 10.1093/chemse/19.1.47; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; MURPHY C, OLFACTION TASTE, V11, P609; National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention, 2000, TRAUM BRAIN INJ US A; Ogawa T, 1999, ACTA OTO-LARYNGOL, P50; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Renzi G, 2002, ANN PLAS SURG, V48, P355, DOI 10.1097/00000637-200204000-00003; Roberts M A, 1996, Appl Neuropsychol, V3, P86, DOI 10.1207/s15324826an0302_7; RUTHERFORD WH, 1977, LANCET, V1, P1; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Seiden AM, 2001, LARYNGOSCOPE, V111, P9, DOI 10.1097/00005537-200101000-00002; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; TEASDALE G, 1974, LANCET, V2, P81; TEMMEL A, 2002, ARCH OTOLARNGOL HEAD, V128; THESEN T, 2000, INT J PSYCHOPHYSIOL, P2; TORNER JC, 1999, TRAUMATIC BRAIN INJU, P9; Vigouroux M, 2005, J NEUROSCI METH, V142, P35, DOI 10.1016/j.jneumeth.2004.07.010; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	50	22	23	0	8	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-5876	1872-8464		INT J PEDIATR OTORHI	Int. J. Pediatr. Otorhinolaryngol.	JUN	2006	70	6					1015	1025		10.1016/j.ijporl.2005.10.013			11	Otorhinolaryngology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Pediatrics	047FB	WOS:000237864100009	16360887				2022-02-06	
J	O'Jile, JR; Ryan, LM; Betz, B; Parks-Levy, J; Hilsabeck, RC; Rhudy, JL; Gouvier, WD				O'Jile, Judith R.; Ryan, Laurie M.; Betz, Brian; Parks-Levy, Judith; Hilsabeck, Robin C.; Rhudy, Jamie L.; Gouvier, Wm. Drew			Information processing following mild head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						MTBI; PASAT; brain	SERIAL ADDITION TEST; MULTIPLE-SCLEROSIS; POSTCONCUSSION SYMPTOMS; WORKING-MEMORY; DEFICITS; CONCUSSION; RECOVERY	Research has shown that individuals who have sustained mild head injury demonstrate a slowed speed of processing that is exacerbated by fatigue/stress. We administered the Paced Auditory Serial Addition Test (PASAT) at the beginning and at the end of a 4-h experimental protocol to determine whether fatigue or a stressor would result in poorer scores for individuals who had previously sustained mild head injury. A significant improvement was found between the first and second administration for both head-injured and control subjects, but difference scores revealed a significant between-groups difference for the first of the four trials, with the head-injured participants performing worse than controls. Apparently, head-injured participants were slower to develop, as well as slower to regain, a means of efficiently processing rapidly presented information. (c) 2006 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA; Def & Vet Brain Injury Ctr, Dept Neurol, Washington, DC USA; USC, Rancho Los Amigos Natl Rehabil Ctr, Geriatr Neurobehav & Alzheimer Ctr, Downey, CA USA; Matrix Inc, Baton Rouge, LA USA; Texas Tech Univ, Hlth Sci Ctr, Dept Neuropsychiat & Behav Sci, Lubbock, TX 79409 USA; Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA; Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA		O'Jile, JR (corresponding author), Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, 2500 N State St, Jackson, MS 39216 USA.	jojile@psychiatry.umsmed.edu	Hilsabeck, Robin/ABC-5093-2020				Aupperle RL, 2002, MULT SCLER J, V8, P382, DOI 10.1191/1352458502ms832oa; BOHNEN NI, 1995, BRAIN INJURY, V9, P27, DOI 10.3109/02699059509004568; Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050150209156; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; Fisk JD, 2001, J INT NEUROPSYCH SOC, V7, P363, DOI 10.1017/S1355617701733103; Fos L A, 2000, Appl Neuropsychol, V7, P140, DOI 10.1207/S15324826AN0703_4; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; Shawaryn MA, 2002, MULT SCLER J, V8, P310, DOI 10.1191/1352458502ms808oa; Shucard JL, 2004, J INT NEUROPSYCH SOC, V10, P35, DOI 10.1017/S1355617704101057; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SZYMANSKI HV, 1992, INT J PSYCHIAT MED, V22, P357, DOI 10.2190/XARA-B1EF-J2HC-VAE0; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; WOOD F, 1984, INT J PSYCHIAT MED, V14, P277	17	22	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2006	21	4					293	296		10.1016/j.acn.2006.03.003			4	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	067GI	WOS:000239289500005	16765017	Bronze			2022-02-06	
J	Dyson, R; Buchanan, M; Hale, T				Dyson, R; Buchanan, M; Hale, T			Incidence of sports injuries in elite competitive and recreational windsurfers	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article								Objective: To investigate the incidence of injury in windsurfing and to consider methods of prevention. Methods: A total of 107 raceboard (RB) and wave/slalom (WS) national/international competitors and recreational (REC) windsurfers completed a questionnaire on injury incidence over two years. Recurrent injury, ability level, and any preventive measures taken were noted. Results: Overall the injury incidence was 1.5/person/year. The WS group suffered more injuries (2.0/person/ year) than the RB (1.0) or REC (1.2) group. The most common injury was muscle strain at 35% of new injuries, much higher than in earlier studies. Overall 45% of new injuries were muscle/tendon strains (RB 55%, WS 42%, and REC 43%) and 8% were ligament sprains. In the WS group cuts and abrasions were common. The WS and REC groups reported five and one case of concussion respectively. Nearly a quarter (22%) of new lower body injuries were lower back muscular strain, with 34% of recurrent injuries. Approximately 60% of the remaining lower body soft tissue injuries involved the knee or lower leg, with the ankle/foot most often involved. The shoulder, upper arm, and elbow were the sites of 41% of new upper body soft tissue injuries. The WS group reported 250% more recurrent muscular strains than the RB group. Recurrent ligament injuries (particularly knee) were most common in the WS group. The RB group reported recurrent serious bruising to the lower leg. Conclusion: The injury incidence was 1.5/person/year with a high incidence of new and recurrent muscular strain. Lower back muscular strain was prevalent, indicating the need for preventive measures. Wave/slalom was associated with more new and recurrent injuries and the need for head protection.	Univ Chichester, Chichester PO19 6PE, W Sussex, England		Dyson, R (corresponding author), Univ Chichester, Coll Lane, Chichester PO19 6PE, W Sussex, England.	r.dyson@ucc.ac.uk					ALLEN GD, 1989, AUST J SCI MED SPORT, V21, P12; DUBRANA F, 1993, J TRAUMATOLOGIE SPOR, V10, P14; Dyson RJ, 1996, J SPORT SCI, V14, P125, DOI 10.1080/02640419608727694; Gosheger G, 2001, SPORTVERLETZ SPORTSC, V15, P50, DOI 10.1055/s-2001-14815; Jablecki CK, 2000, SEMIN NEUROL, V20, P219, DOI 10.1055/s-2000-9831; Kalogeromitros A, 2002, Eur J Emerg Med, V9, P149, DOI 10.1097/00063110-200206000-00009; LABADIE JC, 1981, CINESIOLOGIE, V80, P251; LOCKE S, 1992, MED SCI SPORT EXER, V24, P964; McCormick D P, 1988, Br J Sports Med, V22, P95; Nathanson AT, 1999, WILD ENVIRON MED, V10, P218, DOI 10.1580/1080-6032(1999)010[0218:WIROAP]2.3.CO;2; Petersen W, 2003, SPORTVERLETZ SPORTSC, V17, P118; Prymka M, 1999, SPORTVERLETZ SPORTSC, V13, P107, DOI 10.1055/s-2007-993325; Rosenbaum DA, 2002, PHYSICIAN SPORTSMED, V30, P15, DOI 10.3810/psm.2002.05.280; Salvi M, 1997, J SPORT TRAUMATOL, V19, P30; ULLIS KC, 1984, PHYSICIAN SPORTSMED, V12, P86; Witt J., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P311	16	22	24	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	APR	2006	40	4					346	350		10.1136/bjsm.2005.023077			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	024VI	WOS:000236224000014	16556791	Green Published			2022-02-06	
J	Jensen, AR; Hughes, WB; Grewal, H				Jensen, AR; Hughes, WB; Grewal, H			Secondary abdominal compartment syndrome in children with burns and trauma: A potentially lethal complication	JOURNAL OF BURN CARE & RESEARCH			English	Article; Proceedings Paper	55th Meeting of the American-Academy-of-Pediatrics	OCT 31-NOV 05, 2003	New Orleans, LA	Amer Acad Pediat			INTRAABDOMINAL PRESSURE; BLOOD-FLOW; HYPERTENSION; PULMONARY; FAILURE; INJURY; SHOCK	Acute, rapid, and unimpeded increases in intra-abdominal pressure can lead to multiple organ dysfunction defined as the abdominal compartment syndrome (ACS). If this develops in the absence of obvious intra-abdominal injury, it has been termed secondary ACS (2 degrees ACS). Massive fluid resuscitation in the presence of large burns or shock can lead to 2 degrees ACS. The importance of early recognition and the need for urgent abdominal decompression have been recognized in adults; however, this has not been appreciated in the pediatric population. Medical records of four children diagnosed with 2 degrees ACS were reviewed. Secondary ACS occurred in three children with burns and in one child with a traumatic brain injury. Three children underwent decompressive laparotomy, and one underwent successful percutaneous drainage. There were two survivors. Secondary ACS may be observed in burnt or traumatized children needing large volume resuscitation. Early recognition of 2 degrees ACS by routine bladder pressure monitoring in this high-risk group of children may result in earlier decompression and a possible decrease in morbidity and mortality.	Temple Univ, Childrens Med Ctr, Sect Pediat Surg, Sch Med, Philadelphia, PA 19140 USA		Grewal, H (corresponding author), Temple Univ, Childrens Med Ctr, Sect Pediat Surg, Sch Med, 3509 N Broad St,5 E, Philadelphia, PA 19140 USA.						Balogh Z, 2003, J TRAUMA, V54, P848, DOI 10.1097/01.TA.0000070166.29649.F3; Balogh Z, 2002, AM J SURG, V184, P538, DOI 10.1016/S0002-9610(02)01050-4; Beck R, 2001, Pediatr Crit Care Med, V2, P51, DOI 10.1097/00130478-200101000-00011; Biffl WL, 2001, AM J SURG, V182, P645, DOI 10.1016/S0002-9610(01)00814-5; Burch JM, 1996, SURG CLIN N AM, V76, P833, DOI 10.1016/S0039-6109(05)70483-7; Corcos AC, 2001, J TRAUMA, V51, P1062, DOI 10.1097/00005373-200112000-00006; CULLEN DJ, 1989, CRIT CARE MED, V17, P118, DOI 10.1097/00003246-198902000-00002; DeCou JM, 2000, J PEDIATR SURG, V35, P840, DOI 10.1053/jpsu.2000.6857; DIEBEL L, 1992, AM SURGEON, V58, P573; DIEBEL LN, 1992, J TRAUMA, V33, P45, DOI 10.1097/00005373-199207000-00010; Engum SA, 2002, J PEDIATR SURG, V37, P214, DOI 10.1053/jpsu.2002.30257; GREENHALGH DG, 1994, J TRAUMA, V36, P685, DOI 10.1097/00005373-199405000-00015; Hobson KG, 2002, J TRAUMA, V53, P1129, DOI 10.1097/00005373-200212000-00016; IBERTI TJ, 1987, CRIT CARE MED, V15, P1140, DOI 10.1097/00003246-198712000-00014; Ivatury RR, 1997, SURG CLIN N AM, V77, P783, DOI 10.1016/S0039-6109(05)70584-3; Ivatury RR, 1998, J TRAUMA, V44, P1016, DOI 10.1097/00005373-199806000-00014; Ivy ME, 2000, J TRAUMA, V49, P387, DOI 10.1097/00005373-200009000-00001; Ivy ME, 1999, J BURN CARE REHABIL, V20, P351, DOI 10.1097/00004630-199909000-00003; Kawar B, 2003, EUR J PEDIATR SURG, V13, P330; Kopelman T, 2000, J TRAUMA, V49, P744, DOI 10.1097/00005373-200010000-00025; KRON IL, 1984, ANN SURG, V199, P28, DOI 10.1097/00000658-198401000-00005; Latenser BA, 2002, J BURN CARE REHABIL, V23, P190, DOI 10.1097/00004630-200205000-00008; Maxwell RA, 1999, J TRAUMA, V47, P995, DOI 10.1097/00005373-199912000-00001; Reeves ST, 1997, CAN J ANAESTH, V44, P308, DOI 10.1007/BF03015370; RICHARDS WO, 1983, ANN SURG, V197, P183, DOI 10.1097/00000658-198302000-00010; RICHARDSON JD, 1976, J SURG RES, V20, P401, DOI 10.1016/0022-4804(76)90112-8; Saggi B, 1998, J TRAUMA, V45, P597, DOI 10.1097/00005373-199809000-00033; Simon RJ, 1997, J TRAUMA, V42, P398, DOI 10.1097/00005373-199703000-00006	28	22	24	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1559-047X			J BURN CARE RES	J. Burn Care Res.	MAR-APR	2006	27	2					242	246		10.1097/01.BCR.0000202643.16576.75			5	Critical Care Medicine; Dermatology; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	044UL	WOS:000237697800023	16566576				2022-02-06	
J	Liu, J; Chau, CH; Liu, HY; Jang, BR; Li, XG; Chan, YS; Shum, DKY				Liu, J; Chau, CH; Liu, HY; Jang, BR; Li, XG; Chan, YS; Shum, DKY			Upregulation of chondroitin 6-sulphotransferase-1 facilitates Schwann cell migration during axonal growth	JOURNAL OF CELL SCIENCE			English	Article						chondroitin sulphate proteoglycans; development; dorsal root ganglion; sciatic nerve crush; nerve regeneration	MOLECULAR-CLONING; SCIATIC-NERVES; SULFATE PROTEOGLYCANS; NG2 PROTEOGLYCAN; REGENERATION; EXPRESSION; INJURY; BRAIN; CNS; GLYCOSAMINOGLYCANS	Cell migration is central to development and post-traumatic regeneration. The differential increase in 6-sulphated chondroitins during axonal growth in both crushed sciatic nerves and brain development suggests that chondroitin 6-sulphotransferase-1 (C6ST-1) is a key enzyme that mediates cell migration in the process. We have cloned the cDNA of the C6ST-1 gene (C6st1) (GenBank accession number AF178689) from crushed sciatic nerves of adult rats and produced ribonucleotide probes accordingly to track signs of 6-sulphated chondroitins at the site of injury. We found C6st1 mRNA expression in Schwann cells emigrating from explants of both sciatic nerve segments and embryonic dorsal root ganglia. Immunocytochemistry indicated pericellular 6-sulphated chondroitin products around C6ST-1-expressing frontier cells. Motility analysis of frontier cells in cultures subjected to staged treatment with chondroitinase ABC indicated that freshly produced 6-sulphated chondroitin moieties facilitated Schwann cell motility, unlike restrictions resulting from proteoglycan interaction with matrix components. Sciatic nerve crush provided further evidence of in vivo upregulation of the C6ST-1 gene in mobile Schwann cells that guided axonal regrowth 1-14 days post crush; downregulation then accompanied declining mobility of Schwarm cells as they engaged in the myelination of re-growing axons. These findings are the first to identify upregulated C6st1 gene expression correlating with the motility of Schwann cells that guide growing axons through both developmental and injured environments.	Univ Hong Kong, Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Fac Med, Dept Physiol, Hong Kong, Hong Kong, Peoples R China; Peking Union Coll Hosp, Dept Neurol, Beijing, Peoples R China		Shum, DKY (corresponding author), Univ Hong Kong, Fac Med, Dept Biochem, 21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	shumdkhk@hkucc.hku.hk		Chan, Ying Shing/0000-0002-6228-1595			BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P792, DOI 10.1111/j.1460-9568.1995.tb00682.x; Bunge MB, 2001, NEUROSCIENTIST, V7, P325, DOI 10.1177/107385840100700409; CATERSON B, 1985, FED PROC, V44, P386; Chandramouli V, 1997, ANALOG INTEGR CIRC S, V14, P9, DOI 10.1023/A:1008274123958; Chau CH, 2004, FASEB J, V18, P194, DOI 10.1096/fj.03-0196fje; Chau CH, 1999, EUR J NEUROSCI, V11, P1914, DOI 10.1046/j.1460-9568.1999.00615.x; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; FernaudEspinosa I, 1996, J NEUROBIOL, V30, P410, DOI 10.1002/(SICI)1097-4695(199607)30:3<410::AID-NEU9>3.0.CO;2-7; Fukaya K, 2003, J NEUROPATH EXP NEUR, V62, P162, DOI 10.1093/jnen/62.2.162; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1074/jbc.R100049200; FUKUTA M, 1995, J BIOL CHEM, V270, P18575, DOI 10.1074/jbc.270.31.18575; Fukuta M, 1998, BBA-GENE STRUCT EXPR, V1399, P57, DOI 10.1016/S0167-4781(98)00089-X; Habuchi O, 2000, BBA-GEN SUBJECTS, V1474, P115, DOI 10.1016/S0304-4165(00)00016-7; Henke CA, 1996, J CLIN INVEST, V97, P2541, DOI 10.1172/JCI118702; Hirata K, 2000, EUR J NEUROSCI, V12, P4147, DOI 10.1046/j.1460-9568.2000.00307.x; Horie H, 2004, J NEUROSCI, V24, P1873, DOI 10.1523/JNEUROSCI.4483-03.2004; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; Kitagawa H, 1997, J BIOL CHEM, V272, P31377, DOI 10.1074/jbc.272.50.31377; Levy D, 2000, EUR J NEUROSCI, V12, P2323, DOI 10.1046/j.1460-9568.2000.00129.x; LIU J, 2001, SOC NEUR ABSTR; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Martin S, 2001, J NEUROSCI, V21, P8119, DOI 10.1523/JNEUROSCI.21-20-08119.2001; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Mueller M, 2001, AM J PATHOL, V159, P2187, DOI 10.1016/S0002-9440(10)63070-2; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Prydz K, 2000, J CELL SCI, V113, P193; Rezajooi K, 2004, MOL CELL NEUROSCI, V25, P572, DOI 10.1016/j.mcn.2003.10.009; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Schneider S, 2001, J NEUROSCI, V21, P920, DOI 10.1523/JNEUROSCI.21-03-00920.2001; Scott JE, 2003, J PHYSIOL-LONDON, V553, P335, DOI 10.1113/jphysiol.2003.050179; SCOTT JE, 1992, EUR J BIOCHEM, V209, P675, DOI 10.1111/j.1432-1033.1992.tb17335.x; Shum DKY, 1999, J AM SOC NEPHROL, V10, pS397; Shum DKY, 1996, J NEUROSCI RES, V46, P465, DOI 10.1002/(SICI)1097-4547(19961115)46:4<465::AID-JNR8>3.0.CO;2-E; Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Snow DM, 2003, EXP NEUROL, V182, P310, DOI 10.1016/S0014-4886(03)00034-7; Torigoe K, 1996, EXP NEUROL, V137, P301, DOI 10.1006/exnr.1996.0030; Tseng CY, 2003, J RECONSTR MICROSURG, V19, P331; TURLEY EA, 1980, NATURE, V283, P268, DOI 10.1038/283268a0; Uchimura K, 1998, GLYCOBIOLOGY, V8, P489, DOI 10.1093/glycob/8.5.489; Uchimura K, 2002, J BIOL CHEM, V277, P1443, DOI 10.1074/jbc.M104719200; Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.3.CO;2-4	49	22	22	0	2	COMPANY BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND	0021-9533	1477-9137		J CELL SCI	J. Cell Sci.	MAR 1	2006	119	5					933	942		10.1242/jcs.02796			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	027AO	WOS:000236385300015	16495484	Green Submitted, Bronze			2022-02-06	
J	Bradley, LJ; Kirker, SGB; Corteen, E; Seeley, HM; Pickard, JD; Hutchinson, PJ				Bradley, LJ; Kirker, SGB; Corteen, E; Seeley, HM; Pickard, JD; Hutchinson, PJ			Inappropriate acute neurosurgical bed occupancy and short falls in rehabilitation: implications for the National Service Framework	BRITISH JOURNAL OF NEUROSURGERY			English	Article						head injury; rehabilitation; subarachnoid haemorrhage	SEVERE HEAD-INJURY; CARE	Patients undergoing neurosurgical intervention may require different types of organized rehabilitation. A prospective study was performed of the care needs of neurosurgical inpatients between the ages of 16 and 70 years who were in acute wards for more than 2 weeks. Only 58% of bed occupancy days were devoted to essential acute neurosurgical ward management. This figure was even lower for patients admitted with subarachnoid haemorrhage (36%) or traumatic brain injury (38%). Overall, 21% of bed days would have more appropriately spent in 'rapid access'/ acute rehabilitation beds, 13% in 'active participation' rehabilitation beds and 5% in cognitive/behavioural rehabilitation units. Addressing this unmet need would increase the availability of acute neurosurgery beds, without needing to build and staff more neurosurgery wards.	Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Dept Rehabil Med, Cambridge CB2 2QQ, England		Hutchinson, PJ (corresponding author), Addenbrookes Hosp, Dept Acad Neurosurg, Hills Rd, Cambridge CB2 2QQ, England.	pjah2@cam.ac.uk		Corteen, Elizabeth/0000-0002-3069-9655	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0001237] Funding Source: Medline		DoH, 2005, NAT SERV FRAM LONG T; Evans A, 2001, LANCET, V358, P1586, DOI 10.1016/S0140-6736(01)06652-1; Greenwood R, 2004, BRIT J NEUROSURG, V18, P573, DOI 10.1080/02688690400022888; Greenwood RJ, 2004, BRIT J NEUROSURG, V18, P462, DOI 10.1080/02688690400012327; Kalra L, 2000, LANCET, V356, P894, DOI 10.1016/S0140-6736(00)02679-9; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Pickard JD, 2004, J ROY SOC MED, V97, P384, DOI 10.1258/jrsm.97.8.384; *RCS, 1999, REP WORK PART MAN PA; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Sirois MJ, 2004, ARCH PHYS MED REHAB, V85, P184, DOI 10.1016/j.apmr.2003.06.009	10	22	22	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2006	20	1					36	39		10.1080/02688690600600855			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	037RC	WOS:000237163600006	16698607				2022-02-06	
J	Mussack, T; Hauser, C; Klauss, V; Tato, F; Rieger, J; Ruppert, V; Jochum, M; Hoffmann, U				Mussack, T; Hauser, C; Klauss, V; Tato, F; Rieger, J; Ruppert, V; Jochum, M; Hoffmann, U			Serum S-100B protein levels during and after successful carotid artery stenting or carotid endarterectomy	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						carotid artery stenosis; angioplasty; stent; carotid endarterectomy; transient ischemic attack; stroke; neuroprotein S-100B	NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; S-100-BETA PROTEIN; DAMAGE; S100B; RELEASE; SURGERY; BLOOD; STROKE; MARKER	Purpose: To characterize the course of S-100B serum levels, a reliable marker for cellular brain damage, in patients undergoing carotid artery stenting (CAS) or endarterectomy (CEA) for carotid artery stenosis compared to control groups undergoing hemithyroidectomy (HT) or coronary angiography (CA). Methods: Forty-six consecutive patients scheduled for revascularization of internal carotid artery (ICA) stenosis were included in the study. Fourteen patients (11 men; median age 70 years, interquartile range [IQR] 63-74) were selected for treatment with CAS, while CEA was performed in 31 patients (24 men; median age 68 years, IQR 54-78) during the same time period. Fourteen consecutive patients (8 men; median age 60 years, IQR 48-70) undergoing CA for suspected coronary heart disease and 14 patients (10 women; median age 36 years, IQR 26-54) undergoing HT for a single thyroid nodule served as controls. Results: All procedures were completed successfully. During ICA clamping in CEA patients without postoperative neurological deficits, median S-100B serum levels transiently increased from 0.04 to 0.26 ng/mL (p < 0.01) and returned to baseline levels after declamping. Median S-100B serum levels of CAS patients without neurological impairment remained at baseline values. No increase in S-100B levels occurred in either control group. Three CEA patients who suffered from neurological deficits 0 transient ischemic attack and I major stroke) showed sustained elevation of S-100B serum levels 6 hours after extubation. Conclusion: In patients without neurological complications, CEA but not CAS was associated with a transient increase in the S-100B serum levels. Results indicate that the increase in S-100B does not originate from extracerebral sources, but rather appears to represent an impairment of the blood-brain barrier integrity or subtle brain cell damage probably due to hypoperfusion during clamping. Sustained elevation of S-100B serum levels corresponded to the development of postoperative neurological deficits.	Klinikum Univ Munich, Dept Gen & Vasc Surg, D-80336 Munich, Germany; Klinikum Univ Munich, Dept Internal Med Cardiol, D-80336 Munich, Germany; Klinikum Univ Munich, Dept Vasc Med, D-80336 Munich, Germany; Klinikum Univ Munich, Inst Clin Radiol, D-80336 Munich, Germany; Klinikum Univ Munich, Dept Clin Chem & Clin Biochem Innenstadt, D-80336 Munich, Germany		Mussack, T (corresponding author), Klinikum Univ Munich, Dept Gen & Vasc Surg Innenstadt, Nussbaumstr 20, D-80336 Munich, Germany.	Thomas.Mussack@med.uni-muenchen.de					Anderson RE, 2001, ANN THORAC SURG, V71, P1512, DOI 10.1016/S0003-4975(01)02399-2; Connolly ES, 2001, NEUROSURGERY, V49, P1076, DOI 10.1097/00006123-200111000-00010; Di Legge S, 2003, NEUROL SCI, V24, P351, DOI 10.1007/s10072-003-0188-x; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Gao F, 2000, ANAESTHESIA, V55, P764, DOI 10.1046/j.1365-2044.2000.01466.x; Godet G, 2001, J CARDIOTHOR VASC AN, V15, P25, DOI 10.1053/jcan.2001.20213; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Jaranyi Z, 2003, CLIN CHEM LAB MED, V41, P1320, DOI 10.1515/CCLM.2003.201; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Jonsson H, 1999, ANN THORAC SURG, V68, P2202, DOI 10.1016/S0003-4975(99)00851-6; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Mayo SW, 1998, J VASC SURG, V27, P1017, DOI 10.1016/S0741-5214(98)70004-7; Muller M, 2000, AM J NEURORADIOL, V21, P47; Mussack T, 2002, WORLD J SURG, V26, P1251, DOI 10.1007/s00268-002-6547-6; Mussack T, 2002, SHOCK, V18, P395, DOI 10.1097/00024382-200211000-00002; Pelinka LE, 2003, SHOCK, V19, P195, DOI 10.1097/00024382-200303000-00001; Poppert H, 2004, J NEUROL, V251, P1198, DOI 10.1007/s00415-004-0502-4; Powell RJ, 2004, J VASC SURG, V39, P1193, DOI 10.1016/j.jvs.2003.12.038; Primozich JF, 2002, DUPLEX SCANNING VASC, V3, P191; Rasmussen LS, 2000, J CARDIOTHOR VASC AN, V14, P166, DOI 10.1016/S1053-0770(00)90012-0; Romner B, 2001, NEUROSURGERY, V49, P1490, DOI 10.1097/00006123-200112000-00053; Sahlein DH, 2003, NEUROSURGERY, V53, P1243, DOI 10.1227/01.NEU.0000093493.16850.11; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445	24	22	23	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	FEB	2006	13	1					39	46		10.1583/05-1656.1			8	Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Cardiovascular System & Cardiology	014DP	WOS:000235459300005	16445322				2022-02-06	
J	Bazarian, JJ; Beck, C; Blyth, B; von Ahsen, N; Hasselblatt, M				Bazarian, Jeffrey J.; Beck, Christopher; Blyth, Brian; von Ahsen, Nicolas; Hasselblatt, Martin			Impact of creatine kinase correction on the predictive value of S-100B after mild traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 22-25, 2005	New York, NY	Soc Acad Emergency Med		mild traumatic brain injury; cerebral concussion; serum markers; post concussive syndrome	MINOR HEAD-INJURY; POST-CONCUSSION SYMPTOMS; PROTEIN MEASUREMENTS; FOLLOW-UP; SERUM S100-BETA; S100B LEVELS; DAMAGE; MARKER; QUESTIONNAIRE; S-100-BETA	Purpose: To validate a correction factor for the extracranial release of the astroglial protein, S-100B, based on concomitant creatine kinase (CK) levels. Methods: The CK-S-100B relationship in non-head injured marathon runners was used to derive a correction factor for the extracranial release of S-100B. This factor was then applied to a separate cohort of 96 mild traumatic brain injury (TBI) patients in whom both CK and S-100B levels were measured. Corrected S-100B was compared to uncorrected S-100B for the prediction of initial head CT, three-month headache and three-month post concussive syndrome (PCS). Results: Corrected S-100B resulted in a statistically significant improvement in the prediction of 3-month headache (area under curve [AUC] 0.46 vs 0.52, p = 0.02), but not PCS or initial head CT. Using a cutoff that maximizes sensitivity (>= 90%), corrected S-100B improved the prediction of initial head CT scan (negative predictive value from 75% [95% CI, 2.6%, 67.0%] to 96% [95% CI: 83.5%, 99.8%]). Conclusions: Although S-100B is overall poorly predictive of outcome, a correction factor using CK is a valid means of accounting for extracranial release. By increasing the proportion of mild TBI patients correctly categorized as low risk for abnormal head CT CK-corrected S 100-B can further reduce the number of unnecessary brain CT scans performed after this injury.	Univ Rochester, Med Ctr, Sch Med, Dept Emergency Med, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Dept Biostat, Rochester, NY 14642 USA; Univ Hosp Gottingen, Dept Clin Chem, Gottingen, Germany; Munster Univ Hosp, Inst Neuropathol, Munster, Germany		Bazarian, JJ (corresponding author), Univ Rochester, Med Ctr, Sch Med, Dept Emergency Med, 601 Elmwood Ave,Box 655, Rochester, NY 14642 USA.	jeff_bazarian@urmc.rochester.edu		Hasselblatt, Martin/0000-0003-2707-8484	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1K23NS41952-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS041952] Funding Source: NIH RePORTER		Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; AUDENAERT K, 2003, MED SCI MONITOR, V9, pT112; BAZARIAN J, 2004, ACAD EMERG MED, V11, P516; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Berger Rachel, 2003, Pediatr Crit Care Med, V4, P391, DOI 10.1097/01.PCC.0000075324.45784.8A; Biberthaler P, 2004, UNFALLCHIRURG, V107, P197, DOI 10.1007/s00113-004-0730-1; Biberthaler P, 2001, WORLD J SURG, V25, P93, DOI 10.1007/s002680020370; BLACK HR, 1986, AM J MED, V81, P479, DOI 10.1016/0002-9343(86)90303-7; Chambers J, 1996, J TRAUMA, V41, P976, DOI 10.1097/00005373-199612000-00006; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; COOK JC, 1990, J NATL MED ASSOC, V82, P249; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Ergun R, 1998, NEUROL RES, V20, P418; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; HENDERSON AR, 1993, ANN CLIN BIOCHEM, V30, P521, DOI 10.1177/000456329303000601; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Ingebrigtsen T, 2000, BRAIN INJURY, V14, P1047; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; METZ C, CLABROC PROGRAM; METZ C, LABROC4 PROGRAM; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Wiesmann M, 1999, BIOL PSYCHIAT, V45, P1508, DOI 10.1016/S0006-3223(98)00217-0; WONG ET, 1983, AM J CLIN PATHOL, V79, P582, DOI 10.1093/ajcp/79.5.582; BLOOD TEST RESULTS N	50	22	24	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2006	24	3					163	172					10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology	073AE	WOS:000239713700003	16873971				2022-02-06	
J	Suz, P; Vavilala, MS; Souter, M; Muangman, S; Lam, AM				Suz, P; Vavilala, MS; Souter, M; Muangman, S; Lam, AM			Clinical features of fever associated with poor outcome in severe pediatric traumatic brain injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						pyrexia; children; temperature; head trauma; fever	INTENSIVE-CARE; EARLY HYPERTHERMIA; TEMPERATURE; CHILDREN; RISK; MECHANISMS; STATE; RATS	We describe the incidence and etiology of fever and the relationship between fever characteristics and outcome in children with severe traumatic brain injury (TBI). We conducted a retrospective study of children <14 years and with Glasgow Coma Scale (GCS) score of <9 admitted to a level I pediatric trauma center intensive care unit (PICU) between 1998 and 2003. We examined whether fever characteristics were associated with poor outcome (hospital discharge GCS score <13 and discharge disposition of either death or discharge to a skilled nursing facility). PICU length of stay (LOS) and hospital LOS were also examined. Data are presented as means and medians (SD), and P < 0.05 reflects significance. Ninety-three records were reviewed. Patients were 5.7 (SD 4.1) years old, 70% were male, and the average admission GCS score was 5. Mortality rate was 14%. Forty-eight (52%) patients had fever, and 23 (48%) of those patients had infectious fever. Each additional febrile episode was associated with a twofold higher risk of patients having a hospital discharge GCS score of < 13 (odds ratio 2.4, 95% confidence interval 1.2-5.0) and having a 0.4-day longer PICU LOS (P < 0.001). Patients with infections fever had a 0.9-day longer PICU LOS (P < 0.001). Patients with any fever in the PICU had an increased HLOS (0.9 days; P < 0.001). Our data suggest that in severe pediatric TBI, both fever and infection were common, and both were associated with longer LOS. Patients with higher fever burden had poor hospital discharge GCS score.	Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Seattle, WA 98104 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol, Box 359724,325 9th Ave, Seattle, WA 98104 USA.	vavilala@u.washington.edu	Souter, Michael/ABE-1890-2020		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD044632] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD044632] Funding Source: Medline		Albrecht RF, 1998, MAYO CLIN PROC, V73, P629; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Chatzipanteli K, 2000, J CEREBR BLOOD F MET, V20, P531, DOI 10.1097/00004647-200003000-00012; CHILDERS MK, 1994, BRAIN INJURY, V8, P335, DOI 10.3109/02699059409150984; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1990, STROKE, V21, P1318, DOI 10.1161/01.STR.21.9.1318; Geffroy A, 2004, INTENS CARE MED, V30, P785, DOI 10.1007/s00134-004-2280-y; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; Natale JE, 2000, CRIT CARE MED, V28, P2608, DOI 10.1097/00003246-200007000-00071; Rossi S, 2001, J NEUROL NEUROSUR PS, V71, P448, DOI 10.1136/jnnp.71.4.448; Sarginson RE, 2004, CRIT CARE MED, V32, P839, DOI 10.1097/01.CCM.0000117319.17600.E8; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1	17	22	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2006	18	1					5	10		10.1097/01.ana.0000189079.26212.37			6	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	000YF	WOS:000234497700002	16369134				2022-02-06	
J	Tanriverdi, T; Uzan, M; Sanus, GZ; Baykara, O; Is, M; Ozkara, C; Buyra, N				Tanriverdi, T; Uzan, M; Sanus, GZ; Baykara, O; Is, M; Ozkara, C; Buyra, N			Lack of association between the IL1A gene (-889) polymorphism and outcome after head injury	SURGICAL NEUROLOGY			English	Article						cytokine; head injury; interleukin 1 alpha; outcome	INTERLEUKIN-1-ALPHA GENE POLYMORPHISM; ALZHEIMERS-DISEASE; IL-1-ALPHA; BRAIN; RISK; MECHANISMS; EXPRESSION; IL-1-BETA	Background: Interleukin (IL) I is a proinflammatory cytokine that has been identified as an important mediator of neurodegeneration induced by ischemia or traumatic brain injury. Accumulating evidence to date has suggested that the major cytokine contributing to neurodegeneration after head injury is IL-1 beta rather than IL-1 alpha; however, there is no sufficient data regarding IL-1 alpha in literature, and there may be an association between IL1A gene polymorphism and outcome after head injury. Methods: We performed a prospective clinical study and included a recruited series of 71 patients who had head injury and were admitted to our neurosurgical unit. Severity of initial injury was assessed by the Glasgow Coma Scale. Outcome at 6 months after injury was assessed by means of the Glasgow Outcome Score. Interleukin la genotypes were determined from blood samples by standard methods. Results: Of 40 patients with ILIA*2, 18 (45%) had an unfavorable outcome (dead, vegetative state, or severe disability) compared with 7 (22.5%) of 31 without ILIA*2 (P =.08). Conclusion: Our findings show that there is no genetic association between ILIA gene polymorphism and outcome after head injury. Further clinical studies should be designed to confirm and further evaluate these findings. (c) 2006 Elsevier Inc. All rights reserved.	Istanbul Univ, Cerrahpasa Med Fac, Dept Neurosurg, Istanbul, Turkey; Istanbul Univ, Cerrahpasa Med Fac, Dept Med Biol, Istanbul, Turkey; Istanbul Univ, Cerrahpasa Med Fac, Dept Neurol, Istanbul, Turkey; Duzce Izzet Baysal Univ, Med Fac, Dept Neurosurg, Duzce, Turkey		Uzan, M (corresponding author), POB 5, TR-34301 Istanbul, Turkey.	uzan@istanbul.edu.tr	Baykara, Onur/V-5990-2018; Tanriverdi, Taner/C-9003-2019; Uzan, Mustafa/D-6571-2019; Buyru, Nur/D-1810-2019; Sanus, Galip Zihni/D-6715-2019; Ozkara, Cigdem/AAA-2562-2020	Baykara, Onur/0000-0002-9754-8456; Buyru, Nur/0000-0002-6920-1455; Ozkara, Cigdem/0000-0003-0548-1838; Sanus, Galip Zihni/0000-0001-6539-7254; Uzan, Mustafa/0000-0001-7214-380X			Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Green EK, 2002, NEUROLOGY, V58, P1566, DOI 10.1212/WNL.58.10.1566; GRIFFIN WST, 1994, NEUROSCI LETT, V176, P133, DOI 10.1016/0304-3940(94)90066-3; Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N; Hedley R, 2002, ANN NEUROL, V51, P795, DOI 10.1002/ana.10196; Kanemoto K, 2000, ANN NEUROL, V47, P571, DOI 10.1002/1531-8249(200005)47:5<571::AID-ANA3>3.0.CO;2-A; Ki CS, 2001, ANN NEUROL, V49, P817, DOI 10.1002/ana.1067; Kornman K S, 1998, Ann Periodontol, V3, P327, DOI 10.1902/annals.1998.3.1.327; MCDOWELL TL, 1995, ARTHRITIS RHEUM, V38, P221, DOI 10.1002/art.1780380210; Minster RL, 2000, ANN NEUROL, V48, P817, DOI 10.1002/1531-8249(200011)48:5<817::AID-ANA22>3.3.CO;2-J; Moller JC, 2004, NEUROSCI LETT, V359, P195, DOI 10.1016/j.neulet.2004.01.058; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; MURZIN AG, 1992, J MOL BIOL, V223, P531, DOI 10.1016/0022-2836(92)90668-A; Nicoll JAR, 2000, ANN NEUROL, V47, P365, DOI 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.3.CO;2-7; Nishimura M, 2004, NEUROSCI LETT, V368, P140, DOI 10.1016/j.neulet.2004.06.076; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Pirskanen M, 2002, DEMENT GERIATR COGN, V14, P123, DOI 10.1159/000063603; Rebeck GW, 2000, NEUROSCI LETT, V293, P75, DOI 10.1016/S0304-3940(00)01487-7; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Schulte T, 2002, NEUROSCI LETT, V326, P70, DOI 10.1016/S0304-3940(02)00301-4; SHENG JG, 1994, J NEUROCHEM, V63, P1872; STEINKASSERER A, 1992, GENOMICS, V13, P654, DOI 10.1016/0888-7543(92)90137-H; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Touzani O, 2002, J NEUROSCI, V22, P38, DOI 10.1523/JNEUROSCI.22-01-00038.2002; Touzani O, 1999, J NEUROIMMUNOL, V100, P203, DOI 10.1016/S0165-5728(99)00202-7; Tsai SJ, 2003, NEUROSCI LETT, V343, P93, DOI 10.1016/S0304-3940(03)00333-1; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z	30	22	27	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JAN	2006	65	1					7	10		10.1016/j.surneu.2005.05.024			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	004SX	WOS:000234773600003	16378839				2022-02-06	
J	De Tanti, A; Gasperini, G; Rossini, M				De Tanti, A; Gasperini, G; Rossini, M			Paroxysmal episodic hypothalamic instability with hypothermia after traumatic brain injury	BRAIN INJURY			English	Article						autonomic dysfunction syndrome; hypothalamic instability; spontaneous periodic hypothermia; traumatic brain injury	HYPERHIDROSIS; DYSAUTONOMIA; HYPERTHERMIA; HYPERTENSION; AGENESIS	This case report describes a patient in vegetative state after severe traumatic brain injury (TBI) with hypothalamic damage and clinical manifestations of autonomic dysfunction. He also presented late onset paroxysmal hypothermia associated with mild bradycardia and hypotension. Hypothermia due to traumatic lesions of the hypothalamus is an uncommon clinical problem and few cases have been reported; no cases could be found in the literature which evidenced periodic hypothermia associated with clinical features of autonomic dysfunction after TBI. In the article, the main causes and the primary pathophysiology of hypothermia after TBI are discussed. The manifestations in this patient have been interpreted as possible consequences of autonomic dysfunction and considered atypical and rare clinical expression of acute post-traumatic hypothalamic instability.	Osped Valduce, Dept Rehabil Med, Costamasnaga, Lecco, Italy		De Tanti, A (corresponding author), Ctr Cardinal Ferrari, Via 4 Novembre 21, I-43012 Fontanellato, Pr, Italy.	a.detanti@gsante.it		Rossini, Mauro/0000-0002-7670-5758			ARROYO HA, 1990, NEUROLOGY, V40, P556, DOI 10.1212/WNL.40.3_Part_1.556-a; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Baguley IJ, 2004, BRAIN INJURY, V18, P409, DOI 10.1080/02699050310001645775; Bernardo L M, 1999, Int J Trauma Nurs, V5, P101, DOI 10.1016/S1075-4210(99)90057-3; Blackman JA, 2004, ARCH NEUROL-CHICAGO, V61, P321, DOI 10.1001/archneur.61.3.321; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; DeRoche ME, 2002, OBSTET GYNECOL, V99, P880, DOI 10.1016/S0029-7844(01)01604-0; ELGAMAL N, 1995, ANESTH ANALG, V80, P1245, DOI 10.1097/00000539-199506000-00032; FOX RH, 1973, BRIT MED J, V2, P693, DOI 10.1136/bmj.2.5868.693; Fritsch D E, 1995, AACN Clin Issues, V6, P196, DOI 10.1097/00044067-199505000-00004; GRIFFITH ER, 1990, REHABILITATION ADULT; Hagen C, 1979, REHABILITATION HEAD; JENNETT B, 1975, LANCET, V1, P480; Klein CJ, 2001, NEUROLOGY, V56, P254, DOI 10.1212/WNL.56.2.254; KLOOS RT, 1995, MEDICINE, V74, P268, DOI 10.1097/00005792-199509000-00004; Kubota M, 1991, No To Shinkei, V43, P81; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; LEWITT PA, 1983, NEUROLOGY, V33, P1122, DOI 10.1212/WNL.33.9.1122; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Magnifico F, 2002, NEUROLOGY, V58, P1300, DOI 10.1212/WNL.58.8.1300; MENARD MR, 1991, ARCH PHYS MED REHAB, V72, P421; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; Moulignier A, 2003, NEUROLOGY, V61, P418, DOI 10.1212/01.WNL.0000073539.21469.b7; Mouton P, 1996, ANN MED INTERNE, V147, P107; Ogawa T, 1997, CLIN AUTONOMIC DISOR, P83; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; PFEIFFER RF, 1990, NEUROLOGY, V40, P383; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RATCLIFFE PJ, 1983, J NEUROL NEUROSUR PS, V46, P72, DOI 10.1136/jnnp.46.1.72; REULER JB, 1978, ANN INTERN MED, V89, P519, DOI 10.7326/0003-4819-89-4-519; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; Ruiz C, 2003, PEDIATR NEUROL, V28, P304, DOI 10.1016/S0887-8994(02)00631-8; SANDEL ME, 1986, ARCH PHYS MED REHAB, V67, P469; SHAPIRO WR, 1969, BRAIN, V92, P423, DOI 10.1093/brain/92.2.423; SHETH RD, 1994, PEDIATR NEUROL, V10, P58, DOI 10.1016/0887-8994(94)90069-8; THOMAS DJ, 1973, BRIT MED J, V2, P696, DOI 10.1136/bmj.2.5868.696; Thompson HJ, 2003, NEUROBIOL DIS, V12, P163, DOI 10.1016/S0969-9961(02)00030-X; Thorley RR, 2001, ARCH PHYS MED REHAB, V82, P246, DOI 10.1053/apmr.2001.18698; Tuettenberg J, 2003, J NEUROSURG, V99, P610, DOI 10.3171/jns.2003.99.3.0610; WHYTE J, 1993, AM J PHYS MED REHAB, V72, P281, DOI 10.1097/00002060-199310000-00006; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	43	22	22	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	14					1277	1283		10.1080/02699050500309270			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	983ZF	WOS:000233270200012	16286344				2022-02-06	
J	Huang, WD; Fei, Z; Zhang, X				Huang, WD; Fei, Z; Zhang, X			Traumatic injury induced homer-1a gene expression in cultured cortical neurons of rat	NEUROSCIENCE LETTERS			English	Article						receptor; glutamate; trauma; neurons; homers	METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; PROLINE-RICH MOTIF; MESSENGER-RNA; BRAIN-INJURY; PROTEINS; FAMILY; BINDS	The Homer proteins belong to one of the newly found postsynaptic density protein families. As an immediately early gene, the homer-1a is dynamically expressed and is upregulated by synaptic activity. The homer-1b/c is constitutively expressed and there is no change of gene expression with neuronal activity. In this study, we investigated whether a traumatic injury might regulate the homer-1a expression in cultured cortical neurons of rat. After 7 days in vitro cultivation, the rat fetus cortical neurons were divided into control and injured groups. Then, a traumatic injury was performed on a cortical neuronal culture using a punch device that consisted of 28 stainless steel blades joined together, these produced parallel cuts of 1.2 mm that were uniformly distributed through the cell layer. The lactate dehydrogenase level of the neuronal cultures medium was evaluated and the expression patterns of homer-1a, homer-1b/c were analyzed with the method of RT-PCR and Western blot at different times after the injury (10, 30 min, 1, 3, 6, 12, 24, 72 h). It was shown that there was no expression of homer-1a in the control group, but homer-1a was upregulated in the period of 10 min to 72 It after the traumatic injury. The homer-1b/c was clearly observed in the control group, but there was no change in its expression after traumatic stimulation. It was concluded that traumatic stimulation could induce the homer-1a gene expression, dynamically expressed homer-1a and constitutively expressed homer-1b/c might modulate the distribution and function of group I metabotropic glutamate receptors. (C) 2005 Elsevier Ireland Ltd. All rights reserved.	Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, Xian 710032, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Dept Neurosurg, Xijing Hosp, 15 W Changle Rd, Xian 710032, Peoples R China.	feizhou@fmmu.edu.cn					Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Fei Z, 2005, NEUROSCI LETT, V380, P280, DOI 10.1016/j.neulet.2005.01.063; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hiroaki Y, 2002, BIOCHEM BIOPH RES CO, V295, P756, DOI 10.1016/S0006-291X(02)00738-6; Irie K, 2002, J MOL BIOL, V318, P1117, DOI 10.1016/S0022-2836(02)00170-5; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Morioka R, 2001, NEUROSCI LETT, V313, P99, DOI 10.1016/S0304-3940(01)02224-8; Nielsen HS, 2002, MOL BRAIN RES, V105, P79, DOI 10.1016/S0169-328X(02)00395-9; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Soloviev MM, 2000, J MOL BIOL, V295, P1185; Tadokoro S, 1999, P NATL ACAD SCI USA, V96, P13801, DOI 10.1073/pnas.96.24.13801; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7	18	22	27	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 25	2005	389	1					46	50		10.1016/j.neulet.2005.07.014			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	964PX	WOS:000231894100010	16087291				2022-02-06	
J	Kim, JH; Do, SH; Kim, YL; Zuo, ZY				Kim, JH; Do, SH; Kim, YL; Zuo, ZY			Effects of chronic exposure to ethanol on glutamate transporter EAAT3 expressed in Xenopus oocytes: Evidence for protein kinase C involvement	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						chronic ethanol; glutamate transporter; EAAT3; protein kinase C; voltage clamp	TRAUMATIC BRAIN INJURY; PHORBOL ESTER BINDING; RAT-BRAIN; PHOSPHATIDYLINOSITOL 3-KINASE; GABA SYNTHESIS; ASTROCYTES; WITHDRAWAL; TYPE-3; MICE; CONTRIBUTES	Background: Glutamate transporters (excitatory amino acid transporters, EAAT) regulate extracellular concentrations of glutamate, a major excitatory neurotransmitter. We reported that acute ethanol exposure increases the activity of a major neuronal EAAT, EAAT3. This effect is consistent with the general inhibitory effect of acute alcohol toxicity in the central nervous system (CNS). However, chronic ethanol exposure has CNS presentations different from acute alcohol toxicity. We hypothesize that chronic ethanol exposure will affect the EAAT3 activity differently from acute ethanol exposure. Methods: EAAT3 was expressed in Xenopus oocytes by injection of EAAT3 mRNA. Oocytes were incubated with diluted ethanol for 24-96 hr. Using two-electrode voltage clamp, membrane currents were recorded after the application of L-glutamate. Responses were quantified by integration of the current trace and reported as microCoulombs (mu C). Results: Ethanol (10-100 mM) reduced EAAT3 activity in a time-dependent and reversible manner. After a 96 hr-incubation, the activity was significantly decreased compared to the control values at any concentrations tested in this study. Kinetic study demonstrated that a 96 hr-exposure to 50 mM ethanol significantly decreased Vmax (3.6 +/- 0.3 for control versus 2.6 +/- 0.3 mu C for ethanol, n = 20, p < 0.05) but had no effect on Km (57.6 +/- 12.8 for control versus 51.8 +/- 16.3 mu M for ethanol, n = 20, p > 0.05) of EAAT3 for glutamate. When ethanol (50 mM for 96 hr)-treated oocytes were incubated with phorbol-12-myrisate13-acetate (50 or 100 nM for 10 min), ethanol-induced decrease in EAAT3 activity was abolished. Preincubation of the oocytes with 100 mu M chelerythrine significantly decreased EAAT3 activity (1.00 +/- 0.08 for control versus 0.51 +/- 0.09 mu C for chelerythrine group, n = 18-20, p < 0.05). However, there was no statistical difference among the chelerythrine, ethanol, or chelerythrine plus ethanol groups. Likewise, staurosporine (2 mu M for 1 hr) significantly decreased EAAT3 activity and there was no statistical difference among the staurosporine, ethanol, or staurosporine plus ethanol groups. Conclusions: Our results show that chronic ethanol exposure decreases EAAT3 activity at clinically relevant concentrations and that this effect may be protein kinase C-dependent. Such an effect could be a neuroadaptive mechanism to overcome the inhibitory effect of ethanol on the excitatory neurotransmission.	Seoul Natl Univ Hosp, Dept Anesthesiol, Seoul 110744, South Korea; Seoul Natl Univ, Coll Med, Dept Anesthesiol, Seoul 110744, South Korea; Univ Virginia, Hlth Sci Ctr, Dept Anesthesiol, Hlth Syst, Charlottesville, VA 22908 USA		Do, SH (corresponding author), Seoul Natl Univ Hosp, Dept Anesthesiol, 28 Yongon Dong, Seoul 110744, South Korea.	shdo@snu.ac.kr	Zuo, Zhiyi/F-3950-2010; Kim, Jin Hee/J-5443-2012; Do, Sang Hwan/J-5461-2012	Zuo, Zhiyi/0000-0002-3542-5047; 			BATTAINI F, 1989, ALCOHOL, V6, P169, DOI 10.1016/0741-8329(89)90043-8; Buckman JF, 1999, PSYCHOPHARMACOLOGY, V143, P174, DOI 10.1007/s002130050933; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; Do SH, 2003, NEUROSCI LETT, V343, P113, DOI 10.1016/S0304-3940(03)00358-6; Do SH, 2002, ANESTH ANALG, V95, P1263, DOI 10.1097/00000539-200211000-00030; Do SH, 2002, ANESTHESIOLOGY, V96, P1492, DOI 10.1097/00000542-200206000-00032; FOLLESA P, 1995, MOL BRAIN RES, V29, P99, DOI 10.1016/0169-328X(94)00235-7; Gorter JA, 2002, J COMP NEUROL, V442, P365, DOI 10.1002/cne.10101; Greene JG, 1996, J NEUROCHEM, V66, P637; HOFFMAN PL, 1992, ANN NY ACAD SCI, V654, P52, DOI 10.1111/j.1749-6632.1992.tb25955.x; HUANG Y, 2005, MOL PHARM; Hudspith MJ, 1997, BRIT J ANAESTH, V78, P731, DOI 10.1093/bja/78.6.731; JOHNSTONE RE, 1975, ANESTH ANALG, V54, P277; Kim JH, 2003, ALCOHOL CLIN EXP RES, V27, P1548, DOI 10.1097/01.ALC.0000092061.92393.79; LALLEMENT G, 1991, BRAIN RES, V563, P234, DOI 10.1016/0006-8993(91)91539-D; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Mathews GC, 2003, J NEUROSCI, V23, P2040; Nilsson P, 1996, J CEREBR BLOOD F MET, V16, P262, DOI 10.1097/00004647-199603000-00011; Othman T, 2002, NEUROCHEM RES, V27, P289, DOI 10.1023/A:1014955111742; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PANDEY SC, 1993, ALCOHOL, V10, P259, DOI 10.1016/0741-8329(93)90002-6; Rajgopal Y, 2003, EUR J PHARMACOL, V470, P117, DOI 10.1016/S0014-2999(03)01795-3; ROSSETTI ZL, 1995, EUR J PHARMACOL, V283, P177, DOI 10.1016/0014-2999(95)00344-K; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Schreiber R, 2000, Med Sci Monit, V6, P649; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Smith TL, 1999, NEUROSCI LETT, V269, P145, DOI 10.1016/S0304-3940(99)00438-3; Smith TL, 1996, NEUROSCI LETT, V218, P142, DOI 10.1016/S0304-3940(96)13123-2; Smith TL, 1997, LIFE SCI, V61, P2499, DOI 10.1016/S0024-3205(97)00985-5; SNELL LD, 1993, BRAIN RES, V602, P91, DOI 10.1016/0006-8993(93)90246-J; Sultana R, 2003, NEUROSCI LETT, V349, P45, DOI 10.1016/S0304-3940(03)00755-9; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TREVISAN L, 1994, J NEUROCHEM, V62, P1635; Tsai GCE, 1998, AM J PSYCHIAT, V155, P726	38	22	24	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	NOV	2005	29	11					2046	2052		10.1097/01.alc.0000187594.92476.07			7	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse	994EX	WOS:000234014700018	16340463				2022-02-06	
J	Bader, MK; Arbour, R; Palmer, S				Bader, Mary Kay; Arbour, Richard; Palmer, Sylvain			Refractory Increased Intracranial Pressure in Severe Traumatic Brain Injury Barbiturate Coma and Bispectral Index Monitoring	AACN ADVANCED CRITICAL CARE			English	Article						barbiturate coma; Bispectral Index monitoring; increased intracranial pressure; severe traumatic brain injury		Patients with severe traumatic brain injury resulting in increased intracranial pressure refractory to first-tier interventions challenge the critical care team. After exhausting these initial interventions, critical care practitioners may utilize barbiturate-induced coma in an attempt to reduce the intracranial pressure. Titrating appropriate levels of barbiturate is imperative. Underdosing the drug may fail to control the intracranial pressure, whereas overdosing may lead to untoward effects such as hypotension and cardiac compromise. Monitoring for a therapeutic level of barbiturate coma includes targeting drug levels and using continuous electroencephalogram monitoring, considered the gold standard. New technology, the Bispectral Index monitor, utilizes electroencephalogram principles to monitor the level of sedation and hypnosis in the critical care environment. This technology is now being considered for targeting appropriate levels of barbiturate coma.	[Bader, Mary Kay; Palmer, Sylvain] Mission Hosp, Mission Viejo, CA USA; [Arbour, Richard] Albert Einstein Healthcare Network, Philadelphia, PA USA		Bader, MK (corresponding author), 15 Las Alforjas, Rancho Santa Margarita, CA 92688 USA.	Badermk@aol.com					Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; Allen CH, 1998, CRIT CARE CLIN, V14, P485, DOI 10.1016/S0749-0704(05)70012-9; [Anonymous], 2001, INJ FACT BOOK; Arbour R, 2004, AM J CRIT CARE, V13, P66, DOI 10.4037/ajcc2004.13.1.66; Arbour R B, 2000, Am J Crit Care, V9, P383; Arbour Richard, 2003, AACN Clin Issues, V14, P185, DOI 10.1097/00044067-200305000-00009; Azim N, 2004, ANAESTHESIA, V59, P610, DOI 10.1111/j.1365-2044.2004.03736.x; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; BULLOCK R, 2000, MANAGEMENT PROGNOSIS; Bullock R, 2003, UPDATE NOTICE CEREBR; Center for Disease Control and Prevention (CDC), 2004, TRAUM BRAIN INJ FACT; Chesnut RM, 2004, CRIT CARE CLIN, V20, P25, DOI 10.1016/S0749-0704(03)00090-3; Claassen Jan, 2002, Curr Neurol Neurosci Rep, V2, P534, DOI 10.1007/s11910-002-0042-1; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Courtman SP, 2003, INTENS CARE MED, V29, P2239, DOI 10.1007/s00134-003-1997-3; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; Deogaonkar A, 2004, CRIT CARE MED, V32, P2403, DOI 10.1097/01.CCM.0000147442.14921.A5; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Fabregas N, 2004, ANESTHESIOLOGY, V101, P43, DOI 10.1097/00000542-200407000-00009; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Grindstaff Ryan J, 2004, J Intensive Care Med, V19, P111, DOI 10.1177/0885066603262066; Grissom TE, 2000, ANESTHESIOL ONLINE 2; Guerit JM, 1999, NEUROPHYSIOL CLIN, V29, P301, DOI 10.1016/S0987-7053(99)90044-8; Huszar L., E MED 2001; Jaggi P, 2003, PEDIATR NEUROL, V28, P219, DOI 10.1016/S0887-8994(02)00633-1; Kelly DF, 1996, NEUROTRAUMA, P71; Langlois JA., 2004, TRAUMATIC BRAIN INJU; LEE MW, 1994, J NEUROTRAUM, V11, P325, DOI 10.1089/neu.1994.11.325; March K., 2004, AANN CORE CURRICULUM, P87; Marr AL, 2004, CENTRAL NERVOUS SYST, P20; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; McCall M, 2003, JPEN-PARENTER ENTER, V27, P27, DOI 10.1177/014860710302700127; McGaffigan Patricia A, 2002, Crit Care Nurse, VSuppl, P29; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P58; Miller JD, 1996, NEUROTRAUMA, P61; Mondello Epifanio, 2002, J Clin Monit Comput, V17, P271, DOI 10.1023/A:1021250320103; Mourisse J, 2003, J CARDIOTHOR VASC AN, V17, P76, DOI 10.1053/jcan.2003.14; Mulvey JM, 2004, NEUROCRIT CARE, V1, P391, DOI 10.1385/NCC:1:3:391; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Rhoney DH, 2001, NEUROL RES, V23, P237, DOI 10.1179/016164101101198398; Riker RR, 2003, PHARMACOTHERAPY, V23, P1087, DOI 10.1592/phco.23.10.1087.32766; Roberts IG, 2003, COCHRANE DB SYST REV, V2; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Schneider GH, 1998, ACT NEUR S, V71, P62; Schneider GH, 2002, ACT NEUR S, V81, P77; Schrot RJ, 2002, LANCET, V359, P1633, DOI 10.1016/S0140-6736(02)08545-8; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SHAPIRO HM, 1985, BRIT J ANAESTH, V57, P82, DOI 10.1093/bja/57.1.82; SHAPIRO HM, 1974, J NEUROSURG, V40, P90, DOI 10.3171/jns.1974.40.1.0090; Stecker MM, 2001, ANN THORAC SURG, V71, P14, DOI 10.1016/S0003-4975(00)01592-7; Stover JF, 1998, EUR NEUROL, V39, P223, DOI 10.1159/000007938; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; van den Brink WA, 1998, ACT NEUR S, V71, P190; Vespa P, 2003, NEUROSURG FOCUS, V15, P1, DOI DOI 10.3171/foc.2003.15.6.4; Vivien B, 2003, ANESTHESIOLOGY, V99, P9, DOI 10.1097/00000542-200307000-00006; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Young CC, 2001, CRIT CARE CLIN, V17, P843, DOI 10.1016/S0749-0704(05)70183-4	69	22	23	0	0	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	OCT-DEC	2005	16	4					526	541		10.1097/00044067-200510000-00009			16	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF0BG	WOS:000441621700009	16269897				2022-02-06	
J	Chiarugi, A				Chiarugi, A			Intrinsic mechanisms of poly(ADP-ribose) neurotoxicity: Three hypotheses	NEUROTOXICOLOGY			English	Article; Proceedings Paper	1st international Porto Pirgos Conference on Advances in Neuroscience	SEP 22-25, 2004	Calabria, ITALY			neurodegeneration; PARP; PARG; poly(ADP-ribose); gene expression; brain ischemia	NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; POLY-ADP-RIBOSYLATION; NITRIC-OXIDE SYNTHASE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS-INDUCING FACTOR; ISCHEMIC CELL-DEATH; GENE-EXPRESSION; NEURODEGENERATIVE DISORDERS; TRANSCRIPTIONAL ACTIVATION	Poly(ADP-ribose) (PAR) is a branched and negatively charged polymeric macromolecule formed by poly(ADP-ribose) polymerases. Targeting of PAR onto acceptor proteins affects their functioning and regulates cellular homeostasis. A large body of evidence demonstrates that increased neo-formation of PAR has a crucial role in neurodegeneration. Consistently, strategies aimed at reducing PAR synthesis are of therapeutic relevance to treatment of several experimental neurodegenerative diseases. However, how PAR causes neuronal death is still elusive. This review provides all appraisal of the possible molecular mechanisms underlying PAR neurotoxicity, highlighting the pleiotypic effects of the polymer on neural cells exposed to different stressful conditions. (c) 2005 Elsevier Inc. All rights reserved.	Univ Florence, Dept Pharmacol, I-50139 Florence, Italy		Chiarugi, A (corresponding author), Univ Florence, Dept Pharmacol, I-50139 Florence, Italy.	alberto.chiarugi@unifi.it					Akiyama T, 2001, P NATL ACAD SCI USA, V98, P48, DOI 10.1073/pnas.240458597; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; ALTHAUS FR, 1995, BIOCHIMIE, V77, P423, DOI 10.1016/0300-9084(96)88155-7; ALTHAUS FR, 1990, ACTA BIOL HUNG, V41, P9; ALTHAUS FR, 1994, MOL CELL BIOCHEM, V138, P53, DOI 10.1007/BF00928443; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Carty SM, 2002, MOL CELL PROTEOMICS, V1, P598, DOI 10.1074/mcp.M200029-MCP200; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Chiarugi A, 2002, BRIT J PHARMACOL, V137, P761, DOI 10.1038/sj.bjp.0704934; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Chiarugi A, 2002, SCIENCE, V297, P200, DOI 10.1126/science.1074592; Cohen-Armon M, 2004, SCIENCE, V304, P1820, DOI 10.1126/science.1096775; Cosi C, 1998, BRAIN RES, V809, P58, DOI 10.1016/S0006-8993(98)00829-4; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; DEMURCIA G, 1986, J BIOL CHEM, V261, P7011; DEMURCIA G, 1988, BIOCHEM CELL BIOL, V66, P626, DOI 10.1139/o88-072; DU L, 2003, J BIOL CHEM; Ducrocq S, 2000, J NEUROCHEM, V74, P2504, DOI 10.1046/j.1471-4159.2000.0742504.x; Dumitriu IE, 2004, CELL DEATH DIFFER, V11, P314, DOI 10.1038/sj.cdd.4401348; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; GAAL JC, 1987, TRENDS BIOCHEM SCI, V12, P129, DOI 10.1016/0968-0004(87)90061-2; Gagne JP, 2003, BIOCHEM J, V371, P331, DOI 10.1042/BJ20021675; GENOVESE T, 2004, J PHARM EXP THER; Goto S, 2002, STROKE, V33, P1101, DOI 10.1161/01.STR.0000014203.65693.1E; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Ha HC, 2002, P NATL ACAD SCI USA, V99, P3270, DOI 10.1073/pnas.052712399; Hanai S, 2004, P NATL ACAD SCI USA, V101, P82, DOI 10.1073/pnas.2237114100; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; HERCEG Z, 2001, BIOCHEM J, V477, P97; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Hortobagyi T, 2003, NEUROSCIENCE, V121, P983, DOI 10.1016/S0306-4522(03)00482-2; Iwashita A, 2004, J PHARMACOL EXP THER, V310, P425, DOI 10.1124/jpet.104.066944; Iwashita A, 2004, J PHARMACOL EXP THER, V309, P1067, DOI 10.1124/jpet.103.064642; Koedel U, 1999, BRAIN PATHOL, V9, P57; Koh SH, 2004, EUR J NEUROSCI, V20, P1461, DOI 10.1111/j.1460-9568.2004.03632.x; Komjati K, 2004, INT J MOL MED, V13, P373; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kun E, 2002, J BIOL CHEM, V277, P39066, DOI 10.1074/jbc.C200410200; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Le Page C, 1998, BIOCHEM BIOPH RES CO, V243, P451; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Malanga M, 2004, J BIOL CHEM, V279, P5244, DOI 10.1074/jbc.C300437200; Malanga M, 2000, BIOL CHEM, V381, P1047, DOI 10.1515/BC.2000.129; Mandir AS, 2000, J NEUROSCI, V20, P8005; Mandir AS, 1999, P NATL ACAD SCI USA, V96, P5774, DOI 10.1073/pnas.96.10.5774; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mishra OP, 2003, NEUROSCIENCE, V119, P1023, DOI 10.1016/S0306-4522(03)00166-0; Nagayama T, 2000, J NEUROCHEM, V74, P1636, DOI 10.1046/j.1471-4159.2000.0741636.x; Nakajima H, 2004, J BIOL CHEM, V279, P42774, DOI 10.1074/jbc.M407923200; Nirodi C, 2001, J BIOL CHEM, V276, P9366, DOI 10.1074/jbc.M009897200; Nucci C, 2000, BIOCHEM BIOPH RES CO, V278, P360, DOI 10.1006/bbrc.2000.3811; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Oliver FJ, 1999, EMBO J, V18, P4446, DOI 10.1093/emboj/18.16.4446; Park EM, 2004, STROKE, V35, P2896, DOI 10.1161/01.STR.0000147042.53659.6c; Paschen W, 2000, J NEUROCHEM, V75, P1675, DOI 10.1046/j.1471-4159.2000.0751675.x; Plaschke K, 2000, NEUROSCI LETT, V284, P109, DOI 10.1016/S0304-3940(00)00988-5; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Satchell MA, 2003, J NEUROCHEM, V85, P697, DOI 10.1046/j.1471-4159.2003.01707.x; Satoh M, 2001, STROKE, V32, P225, DOI 10.1161/01.STR.32.1.225; Scott GS, 2004, J PHARMACOL EXP THER, V310, P1053, DOI 10.1124/jpet.103.063214; Scott GS, 2001, J NEUROIMMUNOL, V117, P78, DOI 10.1016/S0165-5728(01)00329-0; Scovassi AI, 2004, FASEB J, V18, P1487, DOI 10.1096/fj.04-1841rev; Skaper SD, 2003, CNS NEUROL DISORD-DR, V2, P279, DOI 10.2174/1568007033482733; Skaper SD, 2003, ANN NY ACAD SCI, V993, P217, DOI 10.1111/j.1749-6632.2003.tb07532.x; SLATTERY E, 1983, J BIOL CHEM, V258, P5955; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; SUGN YJ, 2004, BIOESSAYS, V26, P1268; Szabo C, 1998, TRENDS PHARMACOL SCI, V19, P287, DOI 10.1016/S0165-6147(98)01193-6; TASKER RC, 1998, J CEREB BLOOD FLOW M, V18, P13; Tong WM, 2001, BBA-REV CANCER, V1552, P27, DOI 10.1016/S0304-419X(01)00035-X; Ullrich O, 2001, FASEB J, V15, P1460, DOI 10.1096/fj.00-0540fje; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; WANG H, 2003, SOC NEUROSCI, V34, P1232; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yang J, 2004, PHARMACOL BIOCHEM BE, V78, P179, DOI 10.1016/j.pbb.2004.03.007; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Ying WH, 2002, J CEREBR BLOOD F MET, V22, P774, DOI 10.1097/00004647-200207000-00002; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	94	22	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0161-813X			NEUROTOXICOLOGY	Neurotoxicology	OCT	2005	26	5			SI		847	855		10.1016/j.neuro.2005.01.012			9	Neurosciences; Pharmacology & Pharmacy; Toxicology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Toxicology	979BH	WOS:000232916600014	15923038				2022-02-06	
J	Ojha, BK; Jha, DK; Kale, SS; Mehta, VS				Ojha, BK; Jha, DK; Kale, SS; Mehta, VS			Trans-cranial Doppler in severe head injury: Evaluation of pattern of changes in cerebral blood flow velocity and its impact on outcome	SURGICAL NEUROLOGY			English	Article						TCD; severe head injury; hyperemia; oligemia; vasospasm; outcome	INTRACRANIAL HYPERTENSION; ANGIOGRAPHIC FINDINGS; ARTERIAL SPASM; BRAIN INJURY; ULTRASOUND; HYPEREMIA; METABOLISM; VASOSPASM; ISCHEMIA; TRAUMA	Background: Trans-cranial Doppler (TCD) studies after head injury have been done in the first 24 hours after injury and do not specify the exact interval between injury and time of recordings. We have studied cerebral blood flow changes in patients with severe head injury using serial TCD starting within 6 hours after trauma, and present our findings and its correlation with clinical outcome. Methods: Thirty-two patients with closed severe brain injuries formed the study group. Six-hourly serial TCD studies were done starting within 6 hours after trauma until 48 hours after trauma or death of the patient, whichever was earlier. Flow velocities of the extracranial internal carotid (VEC-ICA) and middle cerebral artery (V-MCA) were recorded to identify vasospasm, hyperemia, or oligemia. Serial changes in flow velocities were correlated with the clinical outcome of the patients at 12 months' follow-up after injury. Result: Oligemia (n = 30) and vasospasm (n = 2) were the earliest changes observed within 6 hours of trauma. In the oligemia group, persistent oligemia (n = 14), hyperemia (n = 6), normal flow velocity (n = 5), and vasospasm developing within 24 hours (n = 5) were observed. Eight patients developed vasospasm after 24 hours. All patients with persistent oligemia and vasospasm developing within 24 hours had poor outcome. Conclusion: Oligemia is the most common change within 6 hours of head injury. Persistence of oligemia beyond 24 hours is associated with poor outcome. Early (within 24 hours posttrauma) onset of vasospasm is associated with poor outcome; however, delayed (> 24 hours after trauma) vasospasm is not associated with poor outcome. (c) 2005 Published by Elsevier Inc.	King Georges Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India; All India Inst Med Sci, Dept Neurosurg, New Delhi 110027, India		Ojha, BK (corresponding author), King Georges Med Univ, Dept Neurosurg, Lucknow 226003, Uttar Pradesh, India.	bkojha@rediffmail.com					AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; BARIE PS, 1993, J TRAUMA, V35, P88, DOI 10.1097/00005373-199307000-00015; BARZO P, 1991, NEUROSURGERY, V28, P821, DOI 10.1227/00006123-199106000-00006; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; CHAN KH, 1992, NEUROSURGERY, V30, P697; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; CHOKSEY MS, 1991, J NEUROL NEUROSUR PS, V54, P6, DOI 10.1136/jnnp.54.1.6; DICKMAN CA, 1991, NEUROSURGERY, V28, P467, DOI 10.1227/00006123-199103000-00026; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; KIRKPATRICK PJ, 1995, J NEUROSURG, V83, P963, DOI 10.3171/jns.1995.83.6.0963; KOSHU K, 1987, NEUROSURGERY, V21, P693, DOI 10.1227/00006123-198711000-00016; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; LINDEGAARD KF, 1987, STROKE, V18, P1025, DOI 10.1161/01.STR.18.6.1025; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; McQuire JC, 1998, J NEUROSURG, V89, P526, DOI 10.3171/jns.1998.89.4.0526; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUTTAQIN Z, 1993, ACTA NEUROCHIR, V123, P76, DOI 10.1007/BF01476289; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; TEASDALE G, 1974, LANCET, V2, P81; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P41, DOI 10.1016/0022-510X(95)00178-X	39	22	26	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	AUG	2005	64	2					174	179		10.1016/j.surneu.2004.11.030			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	952UN	WOS:000231031100015	16051018				2022-02-06	
J	Mossberg, KA; Greene, BP				Mossberg, KA; Greene, BP			Reliability of graded exercise testing after traumatic brain injury: Submaximal and peak responses	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article; Proceedings Paper	Annual Meeting of the American-Physical-Therapy-Association	JUL   01, 2004	Chicago, IL	Amer Phys Therapy Assoc		head injury; treadmill testing; consistency; minimal detectable change; rehabilitation	AEROBIC CAPACITY; TREADMILL TEST; ADOLESCENTS; REPRODUCIBILITY; PROTOCOLS; PERFORMANCE; VALIDITY; CHILDREN; WOMEN	Objective: To assess the reliability of the submaximal and peak responses to a treadmill graded exercise test in individuals recovering from traumatic brain injury. Design: A total of 15 individuals (11 men, 4 women; 28.5 +/- 9.2 yrs) with moderate to severe traumatic brain injury admitted into a postacute residential treatment center 10 +/- 7 mos after injury performed two treadmill graded exercise tests separated by 4-8 days. Heart rate, oxygen consumption (in milliliters per minute per kilogram), minute ventilation (in liters per minute), and respiratory exchange ratio (carbon dioxide output/oxygen consumption) were continuously monitored at 1-min intervals. Submaximal and peak values were analyzed for absolute level of agreement using the intraclass correlation coefficient. Results: The submaximal intraclass correlation coefficient values for all variables between minutes 3 and 7 ranged from 0.80 to 0.93. Submaximal intraclass correlation coefficients before and in the subsequent minutes were less than optimal for heart rate and minute ventilation. Lower intensity workloads elicited slightly better agreement than higher intensity workloads. The peak response intraclass correlation coefficients ranged from 0.77 (heart rate) to 0.92 (oxygen consumption). Conclusion: Despite the presence of other co-morbidities, subjects recovering from traumatic brain injury provided consistent individual responses, allowing for reliable assessments of Gardiorespiratory conditioning programs. Assessments of ambulatory efficiency, endurance, and aerobic fitness adaptations as a result of treatment for persons with traumatic brain injury should include analyses of submaximal responses to graded exercise.	Univ Texas, Med Branch, Dept Phys Therapy, Galveston, TX 77555 USA		Mossberg, KA (corresponding author), Univ Texas, Med Branch, Dept Phys Therapy, 301 Univ Blvd, Galveston, TX 77555 USA.						[Anonymous], 2000, ACSMS GUIDELINES EXE; BALKE B, 1959, U S Armed Forces Med J, V10, P675; Bhambhani Y, 2003, ARCH PHYS MED REHAB, V84, P1629, DOI 10.1053/S0003-9993(03)00343-5; *CDCP, 2001, INJ FB 2001 2002; DEAN E, 1989, ARCH PHYS MED REHAB, V70, P599; Dobrovolny CL, 2003, ARCH PHYS MED REHAB, V84, P1308, DOI 10.1016/S0003-9993(03)00150-3; FERNHALL B, 1990, ARCH PHYS MED REHAB, V71, P1065; Fielding RA, 1997, MED SCI SPORT EXER, V29, P1109, DOI 10.1097/00005768-199708000-00018; FOSTER VL, 1986, MED SCI SPORT EXER, V18, P425; FROELICHER VF, 1974, CHEST, V65, P512, DOI 10.1378/chest.65.5.512; Gaskill SE, 2001, MED SCI SPORT EXER, V33, P1841, DOI 10.1097/00005768-200111000-00007; HO BL, 1982, AVIAT SPACE ENVIR MD, V53, P112; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Larsen GE, 2002, RES Q EXERCISE SPORT, V73, P66, DOI 10.1080/02701367.2002.10608993; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2002, BRAIN INJURY, V16, P789, DOI 10.1080/02699050210131894; Noonan V, 2000, PHYS THER REHABIL J, V80, P782, DOI 10.1093/ptj/80.8.782; OTTENBACHER KJ, 1993, AM J PHYS MED REHAB, V72, P266, DOI 10.1097/00002060-199310000-00003; Pitetti KH, 1999, ADAPT PHYS ACT Q, V16, P362, DOI 10.1123/apaq.16.4.362; Pitetti KH, 2000, ADAPT PHYS ACT Q, V17, P322, DOI 10.1123/apaq.17.3.322; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; SHEPHARD RJ, 1984, SPORTS MED, V1, P99, DOI 10.2165/00007256-198401020-00002; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; TENINE R, 1988, J GERONTOL, V43, pM101; THOMAS SG, 1987, CAN J SPORT SCI, V12, P144; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Zeimetz G, 1985, J CARDIOPULM REHABIL, V5, P525	28	22	22	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL	2005	84	7					492	500		10.1097/01.phm.0000166883.97562.cd			9	Rehabilitation; Sport Sciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	938XN	WOS:000230036800002	15973085				2022-02-06	
J	Kurz, JE; Hamm, RJ; Singleton, RH; Povlishock, JT; Churn, SB				Kurz, JE; Hamm, RJ; Singleton, RH; Povlishock, JT; Churn, SB			A persistent change in subcellular distribution of calcineurin following fluid percussion injury in the rat	BRAIN RESEARCH			English	Article						translocation; phosphatase; synaptoplasmic membrane; hippocampus; immunohistochemistry; western analysis	TRAUMATIC BRAIN-INJURY; LONG-TERM DEPRESSION; GABA(A) RECEPTOR; CEREBRAL-CORTEX; CYCLOSPORINE-A; AXONAL INJURY; CA1 NEURONS; CELL-DEATH; PHOSPHATASE; HIPPOCAMPUS	Calcineurin, a neuronally enriched, calcium-stimulated phosphatase, is an important modulator of many neuronal processes, including several that are physiologically related to the pathology of traumatic brain injury. The effect of moderate, central fluid percussion injury on the subcellular distribution of this important neuronal enzyme was examined. Animals were sacrificed at several time points post-injury and calcineurin distribution in subcellular fractions was assayed by Western blot analysis and immunohistochemistry. A persistent increase in calcineurin concentration was observed in crude synaptoplasmic membrane-containing fractions. In cortical fractions, calcineurin immunoreactivity remained persistently increased for 2 weeks post-injury. In hippocampal homogenates, calcineurin immunoreactivity remained increased for up to 4 weeks. Finally, immunohistochemical analysis of hippocampal slices revealed increased staining in the apical dendrites of CA1 neurons. The increased staining was greatest in magnitude 24 h post-injury; however, staining was still more intense than control 4 weeks post-injury. The data support the conclusion that fluid percussion injury results in redistribution of the enzyme in the rat forebrain. These changes have broad physiological implications, possibly resulting in altered cellular excitability or a greater likelihood of neuronal cell death. (c) 2005 Elsevier B.V. All rights reserved.	Virginia Commonwealth Univ, Dept Neurol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Physiol, Richmond, VA 23298 USA		Churn, SB (corresponding author), Virginia Commonwealth Univ, Dept Neurol, Box 980599, Richmond, VA 23298 USA.	sbchurn@vcu.edu		Kurz, Jonathan/0000-0002-2259-4263	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS025630] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NSO7288, P01-NS25630, R01-NS399700] Funding Source: Medline		Akasu T, 2002, NEUROSCI LETT, V329, P305, DOI 10.1016/S0304-3940(02)00707-3; Amico C, 1998, NEUROSCIENCE, V84, P529, DOI 10.1016/S0306-4522(97)00555-1; Ankarcrona M, 1996, FEBS LETT, V394, P321, DOI 10.1016/0014-5793(96)00959-3; ANTHONY FA, 1988, J NEUROSCI, V8, P1245; CHURN SB, 1992, J CEREBR BLOOD F MET, V12, P784, DOI 10.1038/jcbfm.1992.109; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EDELMAN AM, 1985, J NEUROSCI, V5, P2609; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Herring D, 2003, J BIOL CHEM, V278, P24046, DOI 10.1074/jbc.M301420200; Hodgkiss JP, 1995, BRAIN RES, V705, P241, DOI 10.1016/0006-8993(95)01168-4; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jouvenceau A, 2003, EUR J NEUROSCI, V18, P1279, DOI 10.1046/j.1460-9568.2003.02831.x; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Kurz JE, 2003, NEUROBIOL DIS, V14, P483, DOI 10.1016/j.nbd.2003.08.018; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Price M, 2003, MOL BRAIN RES, V117, P58, DOI 10.1016/S0169-328X(03)00285-7; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; SCHWARZBACH EP, 2004, ABSTR SOC NEUR; SHIBASAKI F, 1995, J CELL BIOL, V131, P735, DOI 10.1083/jcb.131.3.735; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; SOMBATI S, 2001, J NEUROTRAUM, V17, pJ15; Suehiro E, 2001, EXP NEUROL, V172, P199, DOI 10.1006/exnr.2001.7765; SUN DA, 2001, J NEUROTRAUM, V17, pJ5; TYMANSKI M, 1996, NEUROSURGERY, V38, P1176; Wang J, 2003, J NEUROSCI, V23, P826; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5	39	22	23	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 28	2005	1048	1-2					153	160		10.1016/j.brainres.2005.04.062			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	942CD	WOS:000230259600018	15919062				2022-02-06	
J	Sanchez-Olmedo, JI; Flores-Cordero, JM; Rincon-Ferrari, MD; Perez-Ale, M; Munoz-Sanchez, MA; Dominguez-Roldan, JM; Murillo-Cabezas, F				Sanchez-Olmedo, JI; Flores-Cordero, JM; Rincon-Ferrari, MD; Perez-Ale, M; Munoz-Sanchez, MA; Dominguez-Roldan, JM; Murillo-Cabezas, F			Brain death after severe traumatic brain injury: The role of systemic secondary brain insults	TRANSPLANTATION PROCEEDINGS			English	Article							HEAD-INJURY; ORGAN DONORS	Secondary brain insults predominantly due to hypotension are frequent among patients with fatal traumatic brain injury. We assessed the correlation between different systemic secondary brain insults and brain death in 404 patients admitted to our intensive care unit (ICU) after severe traumatic brain injury. We collated data on hypoxemia and hypotension prior to as well as the occurrence of hypoxemia, hypotension, shock, anemia, hyperglycemia, and hyperthermia within the first 24 hours after ICU admission. We also considered both the presence of extracranial injuries and the category of traumatic brain injury using computerized tomography. The 59 patients (14.6%) who developed brain death, were significantly older than patients without a fatal neurological outcome (46.1 +/- 22 vs 29.5 +/- 14.9 years; P < .0001). Intracranial mass lesions, whether surgically evacuated were more frequent among brain-dead patients. The systemic secondary brain insults significantly associated with brain death were hypoxemia, hypotension, shock, anemia, and hyperglycemia within the first 24 hours after ICU admission. After multivariate analysis, the factors that independently predicted brain death were the occurrence of shock (odds ratio [OR], 6.74; 95% confidence interval [CI], 2.85-15.84; P =.001) and older age (OR, 1.05; 95% CI, 1.03-1.07; P =.003). In conclusion, early shock seems to be the major systemic secondary brain insult associated with brain death in patients with severe traumatic brain injury. Prevention of or correction of shock might help to either decrease the occurrence of a fatal neurological outcome or in brain-dead patients to preserve organs in better condition for procurement.	Hosp Traumatol Virgen Rocio, Intens Care Unit, Dept Emergency & Crit Care, Seville 4103, Spain		Flores-Cordero, JM (corresponding author), Hosp Traumatol Virgen Rocio, Intens Care Unit, Dept Emergency & Crit Care, Avda Manuel Siurot S-N, Seville 4103, Spain.	juanflores@inicla.es	Murillo-Cabezas, Francisco/AAO-3348-2021; IBIS, NEUROCRITICOS/C-1805-2016; Dominguez-Roldan, Jose-Maria/M-1728-2016	Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478			ANGSTWURM H, 1984, TRANSPLANT P, V16, P95; Bullock MR, 1996, J NEUROTRAUM, V13, P719; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cuende N, 2002, TRANSPLANTATION, V73, P1360, DOI 10.1097/00007890-200204270-00033; Dominguez-Roldan JM, 1999, TRANSPL P, V31, P2595, DOI 10.1016/S0041-1345(99)00516-3; Hauptman PJ, 1997, NEW ENGL J MED, V336, P422, DOI 10.1056/NEJM199702063360607; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; WERKMAN HA, 1991, TRANSPLANT P, V23, P2553	11	22	23	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	JUN	2005	37	5					1990	1992		10.1016/j.transproceed.2005.03.048			3	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	938TB	WOS:000230024800003	15964320				2022-02-06	
J	Colwell, CB; McVaney, KE; Haukoos, JS; Wiebe, DP; Gravitz, CS; Dunn, WW; Bryan, T				Colwell, CB; McVaney, KE; Haukoos, JS; Wiebe, DP; Gravitz, CS; Dunn, WW; Bryan, T			An evaluation of out-of-hospital advanced airway management in an urban setting	ACADEMIC EMERGENCY MEDICINE			English	Article						endotracheal intubation; urban; complications; prehospital care	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; FIELD; PARAMEDICS; COMPLICATIONS; PERSONNEL; SURVIVAL; TRIAL; RATES	Objectives: To determine the success and complication rates associated with endotracheal intubation in an urban emergency medical services (EMS) system. Methods: This study evaluated consecutive airway interventions between March 2001 and May 2001 performed by paramedics from the Denver Health Paramedic Division in Denver, Colorado. Patients were identified and enrolled prospectively with the identification of all patients for whom intubation was attempted. A retrospective chart review of the emergency department (ED), intensive care unit, other hospital records, and the coroner's records was then conducted with the intent of identifying all complications related to attempted intubation, including the placement of each endotracheal tube. Results: A total of 278 patients were included in this study. Of these, 154 (55%) had an initial nasal intubation attempt, and 124 (45%) had an initial oral intubation attempt. Of the 278 patients for whom an intubation was attempted, 234 (84%, 95% CI = 77% to 88%) were reported by paramedics to be successfully intubated. Of 114 nasal intubations reported as successful by paramedics, two (2%; 95% CI = 0.2% to 6%) were found to be misplaced. Of the 120 oral intubations reported as successful by paramedics, one (10%; 95% CI = 0.02%, to 5%) was found to be misplaced. Of the 278 patients, 22 (8%; 95% CI = 5% to 12%) had complications; three (1%; 95% CI = 0.2% to 3%) endotracheal tubes were incorrectly positioned, two (0.7%; 95% CI = 0.08% to 3%) of which were undetected esophageal intubations and one (0.4%; 95% CI = 0 to 2%) of which was in the posterior pharynx. Conclusions: Reasonable success and complication rates of endotracheal intubation in the out-of-hospital setting can be achieved in a busy, urban EMS system without the assistance of medications.	Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA; Denver Hlth Med Ctr, Paramed Div, Denver, CO 80204 USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA		Colwell, CB (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, 777 Bannock St,Mail Code 0108, Denver, CO 80204 USA.	christophencolweil@dhha.org					Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; CUMMINGS RO, 2003, ACLS PRINCIPLES PRAC; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Garner A, 1999, AUST NZ J SURG, V69, P697, DOI 10.1046/j.1440-1622.1999.01688.x; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GRAY AJ, 1992, ARCH EMERG MED, V9, P347; Jones JH, 2004, ACAD EMERG MED, V11, P707, DOI 10.1197/j.aem.2003.12.026; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Li J, 1999, AM J EMERG MED, V17, P141, DOI 10.1016/S0735-6757(99)90046-3; OBRIEN DJ, 1989, ANN EMERG MED, V18, P612, DOI 10.1016/S0196-0644(89)80512-8; POINTER J E, 1988, Journal of Emergency Medicine, V6, P505, DOI 10.1016/0736-4679(88)90409-X; Sayre MR, 1998, ANN EMERG MED, V31, P228, DOI 10.1016/S0196-0644(98)70312-9; STEWART RD, 1984, CHEST, V85, P341, DOI 10.1378/chest.85.3.341; Wang HE, 2003, RESUSCITATION, V58, P49, DOI 10.1016/S0300-9572(03)00058-3; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	16	22	22	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2005	12	5					417	422		10.1197/j.aem.2004.11.024			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	922DT	WOS:000228817100006	15860695	Bronze			2022-02-06	
J	Douglas, CL; Bowman, GN; Baghdoyan, HA; Lydic, R				Douglas, CL; Bowman, GN; Baghdoyan, HA; Lydic, R			C57BL/6J and B6.V-LEPOB mice differ in the cholinergic modulation of sleep and breathing	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						acetylcholine; pontine reticular formation; respiratory control; obesity	PONTINE RETICULAR-FORMATION; EYE-MOVEMENT SLEEP; VESICULAR ACETYLCHOLINE TRANSPORTER; MUSCARINIC RECEPTOR SUBTYPES; TRAUMATIC BRAIN-INJURY; REM-SLEEP; VENTILATORY BEHAVIOR; FUNCTIONAL GENOMICS; PREFRONTAL CORTEX; GENE-EXPRESSION	Respiratory and arousal state control are heritable traits in mice. B6. V-Lep(ob) (ob) mice are leptin deficient and differ from C57BL/6J ( B6) mice by a variation in the gene coding for leptin. The ob mouse has morbid obesity and disordered breathing that is homologous to breathing of obese humans. This study tested the hypothesis that microinjecting neostigmine into the pontine reticular nucleus, oral part (PnO), of B6 and ob mice alters sleep and breathing. In B6 and ob mice, neostigmine caused a concentration-dependent increase ( P < 0.0001) in percentage of time spent in a rapid eye movement (REM) sleeplike state (REM-Neo). Relative to saline ( control), higher concentrations of neostigmine increased REM-Neo duration and the number of REM-Neo episodes in B6 and ob mice and decreased percent wake, percent non-REM, and latency to onset of REM-Neo ( P < 0.001). In B6 and ob mice, REM sleep enhancement by neostigmine was blocked by atropine. Differences in control amounts of sleep and wakefulness between B6 and the congenic ob mice also were identified. After PnO injection of saline, ob mice spent significantly ( P < 0.05) more time awake and less time in non-REM sleep. B6 mice displayed more ( P < 0.01) baseline locomotor activity than ob mice, and PnO neostigmine decreased locomotion ( P < 0.0001) in B6 and ob mice. Whole body plethysmography showed that PnO neostigmine depressed breathing ( P < 0.001) in B6 and ob mice and caused greater respiratory depression in B6 than ob mice ( P < 0.05). Western blot analysis identified greater ( P < 0.05) expression of M2 muscarinic receptor protein in ob than B6 mice for cortex, midbrain, cerebellum, and pons, but not medulla. Considered together, these data provide the first evidence that pontine cholinergic control of sleep and breathing varies between mice known to differ by a spontaneous mutation in the gene coding for leptin.	Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48109 USA		Lydic, R (corresponding author), Univ Michigan, Dept Anesthesiol, 7433 Med Sci 1,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rlydic@umich.edu	Lydic, Ralph/O-9396-2014	Lydic, Ralph/0000-0002-2686-251X; Baghdoyan, Helen A./0000-0003-0627-2448	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL057120, R01HL040881, R01HL065272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R37MH045361, R01MH045361, R29MH045361] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-57120, HL-65272, HL-40881] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH-45361] Funding Source: Medline		Baghdoyan HA, 2002, SLEEP AND EPILEPSY: THE CLINICAL SPECTRUM, P17; BAGHDOYAN HA, 1989, NEUROPSYCHOPHARMACOL, V2, P67, DOI 10.1016/0893-133X(89)90009-2; Baghdoyan HA, 1997, AM J PHYSIOL-REG I, V273, pR896, DOI 10.1152/ajpregu.1997.273.3.R896; BAGHDOYAN HA, 1984, J PHARMACOL EXP THER, V231, P173; BAGHDOYAN HA, 1987, BRAIN RES, V414, P245, DOI 10.1016/0006-8993(87)90005-9; Baghdoyan HA, 1999, SLEEP, V22, P835, DOI 10.1093/sleep/22.7.835; Blake JA, 2003, NUCLEIC ACIDS RES, V31, P193, DOI 10.1093/nar/gkg047; Bogue CW, 2003, J APPL PHYSIOL, V94, P2502, DOI 10.1152/japplphysiol.00209.2003; BOURGIN P, 1995, NEUROREPORT, V6, P532, DOI 10.1097/00001756-199502000-00031; Boutin P, 2001, BEST PRACT RES CL EN, V15, P391, DOI 10.1053/beem.2001.0153; Bowman GN, 2003, SLEEP, V26, pA1; Brockmann GA, 2000, GENOME RES, V10, P1941, DOI 10.1101/gr.GR1499R; Capece ML, 1997, AM J PHYSIOL-REG I, V273, pR1430, DOI 10.1152/ajpregu.1997.273.4.R1430; Capece ML, 1997, NEUROREPORT, V8, P481, DOI 10.1097/00001756-199701200-00021; Chen LC, 2003, BRAIN RES, V973, P214, DOI 10.1016/S0006-8993(03)02484-3; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; Coleman CG, 2004, NEUROSCIENCE, V126, P821, DOI 10.1016/j.neuroscience.2004.04.029; Coleman CG, 2004, NEUROSCIENCE, V126, P831, DOI 10.1016/j.neuroscience.2004.04.045; Conway B, 2004, Obes Rev, V5, P145, DOI 10.1111/j.1467-789X.2004.00144.x; Demarco GJ, 2004, NEUROSCIENCE, V123, P17, DOI 10.1016/j.neuroscience.2003.08.045; Demarco GJ, 2003, J COMP NEUROL, V457, P175, DOI 10.1002/cne.10548; Di Marco A, 2000, EUR J BIOCHEM, V267, P2939, DOI 10.1046/j.1432-1033.2000.01308.x; Diament A L, 2003, Obes Rev, V4, P249, DOI 10.1046/j.1467-789X.2003.00113.x; Douglas CL, 2002, J NEUROPHYSIOL, V87, P2817, DOI 10.1152/jn.2002.87.6.2817; Douglas CL, 2002, J NEUROPHYSIOL, V88, P3003, DOI 10.1152/jn.00318.2002; Douglas CL, 2001, J PHARMACOL EXP THER, V299, P960; DOUGLAS CL, 2004, SOC NEUR ABSTR, V30; ELMANSARI M, 1989, EXP BRAIN RES, V76, P519, DOI 10.1007/BF00248908; Eppig JT, 2002, GENESIS, V32, P63, DOI 10.1002/gene.10055; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127, DOI 10.1152/ajpregu.1998.275.4.R1127; Friedman JM, 1998, NUTR REV, V56, pS38; Friedman L, 2004, J APPL PHYSIOL, V97, P1787, DOI 10.1152/japplphysiol.01394.2003; Gilman S, 2003, NEUROLOGY, V61, P35, DOI 10.1212/01.WNL.0000073624.13436.32; GNADT JW, 1986, BRAIN RES, V384, P29, DOI 10.1016/0006-8993(86)91216-3; Han F, 2000, RESP PHYSIOL, V121, P247, DOI 10.1016/S0034-5687(00)00132-8; Haxhiu MA, 2003, FRONT BIOSCI-LANDMRK, V8, pD946, DOI 10.2741/1099; Haxhiu MA, 2001, RESP PHYSIOL, V129, P191, DOI 10.1016/S0034-5687(01)00290-0; Hedner J, 2003, AM J RESP CRIT CARE, V168, P1246, DOI 10.1164/rccm.200211-1344OC; HOBSON JA, 1983, BRAIN RES, V275, P127, DOI 10.1016/0006-8993(83)90424-9; Homma Y, 2002, J NEUROPHYSIOL, V87, P3033, DOI 10.1152/jn.2002.87.6.3033; Horner RL, 1999, NEUROSCIENCE, V93, P215, DOI 10.1016/S0306-4522(99)00126-8; Huber R, 2000, BRAIN RES, V857, P8, DOI 10.1016/S0006-8993(99)02248-9; IMERI L, 1994, BRAIN RES, V636, P68, DOI 10.1016/0006-8993(94)90176-7; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Ip MSM, 2000, CHEST, V118, P580, DOI 10.1378/chest.118.3.580; Joseph V, 2002, RESP PHYSIOL NEUROBI, V130, P253, DOI 10.1016/S0034-5687(02)00012-9; Kobayashi T, 2004, J APPL PHYSIOL, V96, P735, DOI 10.1152/japplphysiol.00908.2003; Kohyama J, 2000, BRAIN DEV-JPN, V22, pS136; Kubin L, 2001, ARCH ITAL BIOL, V139, P147; Lai YY, 1999, RAPID EYE MOVEMENT SLEEP, P69; LEE LH, 1995, AM J PHYSIOL-LUNG C, V268, pL251, DOI 10.1152/ajplung.1995.268.2.L251; Lydic R, 2002, SLEEP, V25, P835, DOI 10.1093/sleep/25.8.835; LYDIC R, 1989, NEUROSCI LETT, V102, P211, DOI 10.1016/0304-3940(89)90080-3; LYDIC R, 1993, AM J PHYSIOL, V264, pR544, DOI 10.1152/ajpregu.1993.264.3.R544; Lydic R, 2003, SLEEP RELATED BREATH, P57; Mackiewicz M, 2003, RESP PHYSIOL NEUROBI, V135, P207, DOI 10.1016/S1569-9048(03)00045-4; Marks GA, 1998, NEUROSCIENCE, V86, P29, DOI 10.1016/S0306-4522(98)00005-0; MITANI A, 1988, BRAIN RES, V451, P397, DOI 10.1016/0006-8993(88)90792-5; MORALES F, 1981, BRAIN RES, V225, P279, DOI 10.1016/0006-8993(81)90836-2; MORALES FR, 1987, J NEUROPHYSIOL, V57, P1118, DOI 10.1152/jn.1987.57.4.1118; Naciff JM, 1997, NEUROREPORT, V8, P3467, DOI 10.1097/00001756-199711100-00011; O'Donnell CP, 2000, RESP PHYSIOL, V119, P163, DOI 10.1016/S0034-5687(99)00111-5; O'Donnell CP, 1999, AM J RESP CRIT CARE, V159, P1477, DOI 10.1164/ajrccm.159.5.9809025; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Polotsky VY, 2004, J APPL PHYSIOL, V96, P991, DOI 10.1152/japplphysiol.00926.2003; Punjabi NM, 2002, SLEEP, V25, P307; Puscau C, 2003, FASEB J, V17, pA73; Reinoso-Suarez F, 2001, SLEEP MED REV, V5, P63, DOI 10.1053/smrv.2000.0136; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schaub CD, 1998, J APPL PHYSIOL, V85, P366, DOI 10.1152/jappl.1998.85.1.366; Schneider H, 2003, J APPL PHYSIOL, V95, P11, DOI 10.1152/japplphysiol.01144.2002; Shao LF, 1999, J NEUROTRAUM, V16, P555, DOI 10.1089/neu.1999.16.555; SHIROMANI PJ, 1986, PHARMACOL BIOCHEM BE, V25, P1253, DOI 10.1016/0091-3057(86)90120-6; SHIROMANI PJ, 1988, NEUROSCI LETT, V95, P19, DOI 10.1016/0304-3940(88)90625-8; Strohl KP, 2003, RESP PHYSIOL NEUROBI, V135, P179, DOI 10.1016/S1569-9048(03)00036-3; STROHL KP, 1998, HDB OBESITY, P725; Tafti M, 2002, J APPL PHYSIOL, V92, P1339, DOI 10.1152/japplphysiol.00834.2001; Tagaito Y, 2001, J APPL PHYSIOL, V91, P2758, DOI 10.1152/jappl.2001.91.6.2758; Tang XD, 2002, SLEEP, V25, P691; Tankersley C, 1996, J APPL PHYSIOL, V81, P716, DOI 10.1152/jappl.1996.81.2.716; Tankersley C G, 1999, Curr Opin Pulm Med, V5, P344, DOI 10.1097/00063198-199911000-00004; Tankersley CG, 1998, J APPL PHYSIOL, V85, P2261, DOI 10.1152/jappl.1998.85.6.2261; TANKERSLEY CG, 1994, AM J PHYSIOL-REG I, V267, pR1371, DOI 10.1152/ajpregu.1994.267.5.R1371; Tankersley CG, 2002, J APPL PHYSIOL, V92, P1277, DOI 10.1152/japplphysiol.00609.2001; Thurnheer R, 2001, J APPL PHYSIOL, V90, P981, DOI 10.1152/jappl.2001.90.3.981; Tobler I, 1997, J NEUROSCI, V17, P1869; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Toth LA, 2001, BEHAV GENET, V31, P39, DOI 10.1023/A:1010205824874; Ulloor J, 2004, J NEUROPHYSIOL, V91, P1822, DOI 10.1152/jn.01104.2003; VANNIMERCIER G, 1989, ARCH ITAL BIOL, V127, P133; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Veasey SC, 2000, SLEEP, V23, P1025; Wang GJ, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e81; YAKSH TL, 1978, PAIN, V4, P299, DOI 10.1016/0304-3959(77)90145-2; YAMASHITA T, 1993, POLYM DEGRAD STABIL, V39, P279, DOI 10.1016/0141-3910(93)90002-Z; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	98	22	22	0	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	MAR	2005	98	3					918	929		10.1152/japplphysiol.00900.2004			12	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	895LG	WOS:000226863100022	15475596				2022-02-06	
J	LaBotz, M; Martin, MR; Kimura, IE; Hetzler, RK; Nichols, AW				LaBotz, M; Martin, MR; Kimura, IE; Hetzler, RK; Nichols, AW			A comparison of a preparticipation evaluation history form and a symptom-based concussion survey in the identification of previous head injury in collegiate athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; head injury; mild traumatic brain injury; sports injury; preparticipation physical examination	SPORT-RELATED CONCUSSION; FOOTBALL PLAYERS; SCHOOL	Objective: The purpose of this study was to compare the incidence of prior head injury reported on preparticipation physical evaluation (PPE) history forms with a retrospective symptom-based survey. Design: A comparison of 2 retrospective survey instruments. Setting: NCAA Division I varsity athletic program. Participants: A total of 93 male and 79 female athletes participating in intercollegiate contact/collision sports. Main Outcome Measures: Athletes were administered a concussion symptom survey (CSS) with questions about symptom incidence after head injury. These responses were compared with answers given about previous concussion/head injury on the university's PPE history form. The numbers of positive responses were analyzed using descriptive statistics, and differences between the PPE medical history form and the concussion symptom survey were assessed using chi(2) analysis. Factor analysis was performed to assess for possible variance structure between reported symptoms. Results: Seventy-one percent of athletes reporting symptoms consistent with concussion were not identified as having a history of head injury on the PPE medical history form. The most common symptom on the CSS was headache, which accounted for 46 (56.1%) positive responses. Conclusions: The CSS revealed greater numbers of athletes experiencing symptomatic head injuries than the screening questions on the PPE history form. Screening for signs and symptoms of concussion may enhance the sensitivity of the PPE in detecting a prior history of concussion.	Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI 96822 USA		LaBotz, M (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Honolulu, HI 96822 USA.	labotz@hawaii.edu					Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HOLMES CF, 2000, PRIM CARE REP, V6, P189; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P581; Koester MC, 2003, PHYSICIAN SPORTSMED, V31, P35, DOI 10.3810/psm.2003.08.460; KOVAN JR, 1998, MANUAL SPORTS MED, P10; MADDEN CC, 2003, DELEE DREZS ORTHOPAE, P737; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McKeag DB, 2003, JAMA-J AM MED ASSOC, V290, P2604, DOI 10.1001/jama.290.19.2604; Pfister GC, 2000, JAMA-J AM MED ASSOC, V283, P1597, DOI 10.1001/jama.283.12.1597; Piland SG, 2003, J ATHL TRAINING, V38, P104; *PREP PHYS EV WORK, 2005, PHYS SPORTSM; PRIGGE R, 2000, SPORTS MED PRIMARY C, P31; Sallis RE, 2000, MED SCI SPORT EXER, V32, P1820, DOI 10.1097/00005768-200011000-00002; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; 1997, PHYS SPORTSMEDICINE	27	22	22	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2005	15	2					73	78		10.1097/01.jsm.0000157649.99867.fc			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	943CF	WOS:000230328800006	15782050				2022-02-06	
J	Vangel, SJ; Rapport, LJ; Hanks, RA; Black, KL				Vangel, SJ; Rapport, LJ; Hanks, RA; Black, KL			Long-term medical care utilization and costs among traumatic brain injury survivors	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						brain injuries; costs; cost analysis; cost control; utilization	DISABILITIES; ADHERENCE	Objective: To examine billing patterns and predictors of healthcare utilization and costs associated with traumatic brain injury. Design: Retrospective cohort study of healthcare billings for 63 survivors of traumatic brain injury, over a 19-mo period, using a state-sponsored Medicaid program. The relationship of indicators of injury severity and disability to billings and payments was investigated. Mean age at time of injury was 33 yrs. Mean highest Glasgow Coma Scale rating immediately after brain injury was 8. Results: A total of $795,635 was billed to Medicaid for 3,950 services and medications used. A total of $281,897 was paid for these billings out of the Medicaid account studied. Billings were used for statistical analyses, as they were considered the most stable indicator of cost. Motor deficits at discharge from inpatient rehabilitation (FIM(TM) motor score) showed inverse relationships to total billings (rho = -0.42, P < 0.001), subcategories of billings reflecting equipment and supplies (rho = -.26, P = 0.020), and outpatient billings (rho = -0.27, P = 0.015). Change in FIM motor scores during inpatient rehabilitation was inversely associated with billings (rho = -0.40). Change in FIM motor scores provided unique information in predicting utilization after accounting for demographic characteristics and severity of injury. Conclusions: Motor disability and improvement during inpatient rehabilitation were significant predictors of billings after traumatic brain injury. Initial severity of brain injury was not a significant factor in utilization.	Wayne State Univ, Rehabil Inst Michigan, Detroit, MI 48201 USA; Wayne State Univ, Dept Phys Med & Rehabil, Sch Med, Detroit, MI 48201 USA; Wayne State Univ, Dept Psychol, Sch Sci, Detroit, MI 48201 USA		Vangel, SJ (corresponding author), Wayne State Univ, Rehabil Inst Michigan, 261 Mack Blvd,Room 555, Detroit, MI 48201 USA.			Rapport, Lisa/0000-0001-8014-9523			Andriacchi R, 1997, AM J PHYS MED REHAB, V76, pS17; BURNS TJ, 1990, ARCH PHYS MED REHAB, V71, P138; Chan L, 2002, ARCH PHYS MED REHAB, V83, P1196, DOI 10.1053/apmr.2002.34811; Gans BM, 1997, AM J PHYS MED REHAB, V76, pS9; Hinkin CH, 2002, NEUROLOGY, V59, P1944, DOI 10.1212/01.WNL.0000038347.48137.67; Hoffman JM, 2003, ARCH PHYS MED REHAB, V84, P1165, DOI 10.1016/S0003-9993(03)00232-6; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; ROBINSON DG, 1994, AM J PHYS MED REHAB, V73, P58; Rosen MI, 2003, J BEHAV MED, V26, P349, DOI 10.1023/A:1024257027839; TEASDALE G, 1974, LANCET, V2, P81; Thomas DC, 1999, MT SINAI J MED, V66, P188; 1993, UNIFORM DATA SYSTEM	13	22	24	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAR	2005	84	3					153	160		10.1097/01.PHM.0000154896.55045.E7			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	898TE	WOS:000227098300002	15725788				2022-02-06	
J	Winkler, D; Unsworth, C; Sloan, S				Winkler, Dianne; Unsworth, Carolyn; Sloan, Sue			Time Use Following a Sever Traumatic Brain Injury	JOURNAL OF OCCUPATIONAL SCIENCE			English	Article						Time use; Traumatic brain injury; Occupation; Social isolation		Recent outcome studies have found that a significant number of people have limited opportunity for meaningful occupation following severe traumatic brain injury (TBI). The aim of this study was to compare the time use of 37 people more than three years post injury with time use in the general Australian population. This time use study was part of a broader research project, which examined community integration and factors that lead to successful community integration. The results of this study were that the TBI sample spent less time in employment related activities and more time on personal care than the general population. They also spent more time alone and less time with family. The TBI sample spent as much time in the community as their peers, however they were less involved in shared occupation. Although this group of people had received comprehensive rehabilitation services following their injury, they experienced decreased opportunities for meaningful occupation and changes in social contact several years post injury. Comparisons of the sample with people who are not employed suggest that unemployment is only one of the factors that contribute to the under-occupation of people with TBI. The time use data collected provides a window on lifestyle changes and indicates that severe TBI has a significant negative impact on people's level of participation and well-being.	[Winkler, Dianne] La Trobe Univ, Bundoora, Vic, Australia; [Unsworth, Carolyn] La Trobe Univ, Occupat Therapy, Bundoora, Vic, Australia; [Sloan, Sue] Bethesda Hosp, Head Injury team, Melbourne, Vic, Australia		Winkler, D (corresponding author), POB 486 Brentford Sq, Forest Hill, Vic 3131, Australia.	winklers@mac.com		Winkler, Di/0000-0003-3899-6248; Unsworth, Carolyn/0000-0001-6430-2823	OT Australia Victoria; Occupational Therapy Trust Fund	This study was conducted with small grants from OT Australia Victoria and the Occupational Therapy Trust Fund for which we are grateful. We also offer sincere thanks to all the people who participated in the study and thereby offered insights to time use of individuals following severe traumatic brain injury.	Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Australian Bureau of Statistics, 2002, 6202 0 LAB FORC AUST; Australian Bureau of Statistics, 2002, AUSTR SOC TRENDS 200; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bogdan R., 1991, BUILDING STRONGER CO; Brain Injury Association, 2001, COSTS CAUS TRAUM BRA; Brzuzy S, 1996, J HEAD TRAUMA REHAB, V11, P74, DOI 10.1097/00001199-199606000-00011; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Burleigh SA, 1998, AM J OCCUP THER, V52, P45, DOI 10.5014/ajot.52.1.45; *CAN ASS OCC THER, 1997, EN OCC OCC THER PERS; CHARLTON JRH, 1983, J EPIDEMIOL COMMUN H, V37, P296, DOI 10.1136/jech.37.4.296; Christiansen C.H., 1996, OCCUPATIONAL SCI EVO, P431; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Csikszentmihalyi M., 1988, OPTIMAL EXPERIENCE P; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; ELLIOTT MS, 1987, OCCUP THER J RES, V7, P215, DOI 10.1177/153944928700700403; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Fleming J, 1999, BRAIN INJURY, V13, P417; FORTUNE N, 1999, DEFINITION INCIDENCE; Frederick JA, 1995, TIME GOES TIME USE C; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; Granger CV, 1987, UNIFORM DATA SET MED; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HALLETT JD, 1994, AM J OCCUP THER, V48, P241, DOI 10.5014/ajot.48.3.241; Harvey A., 1991, WHERE DOES TIME GO; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199508000-00007; Hillier SL, 1997, BRAIN INJURY, V11, P661; Jennett B, 1981, MANAGEMENT HEAD INJU; Juster F.T., 1985, TIME GOODS WELL BEIN; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; LARSON KB, 1990, AM J OCCUP THER, V44, P902, DOI 10.5014/ajot.44.10.902; Law M, 2002, AM J OCCUP THER, V56, P640, DOI 10.5014/ajot.56.6.640; MAHONEY F I, 1965, Md State Med J, V14, P61; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McLennan W., 1998, TIME USE SURVEY AUST; McLennan W., 1998, AUSTR USE THEIR TIME; O'Connor P., 1999, NEEDS OPPORTUNITIES; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pentland W, 1999, SPINAL CORD, V37, P786, DOI 10.1038/sj.sc.3100908; Pentland W, 1998, J OCCUPATIONAL SCI, V5, P14, DOI DOI 10.1080/14427591.1998.9686431; Pentland WE, 1999, TIME USE RESEARCH IN THE SOCIAL SCIENCES, P169; PONSFORD J, 2003, 26 ANN BRAIN IMP C S; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Robinson J. P, 1977, AM USE TIME SOCIAL P; Robinson J. P., 1985, TIME GOODS WELL BEIN; ROBINSON JP, 1976, CHANGES AM USE TIME; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Shimitras L, 2003, BR J OCCUP THER, V66, P46, DOI [DOI 10.1177/, DOI 10.1177/030802260306600202]; Soderback I, 1992, Disabil Rehabil, V14, P30; Szalai A., 1972, USE TIME DAILY ACTIV USE TIME DAILY ACTIV; TATE RL, 2003, 26 ANN BRAIN IMP C S; Transport Accident Commission, 2000, ANN REPORT; Ver Ploeg M., 2000, TIM US MEAS RES WROK; Victorian WorkCover Authority, 1999, ANN REPORT; Whiteford G., 2000, BRIT J OCCUP THER, V63, P200, DOI [10.1177/030802260006300503, DOI 10.1177/030802260006300503]; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P11; Winkler D., 2002, THESIS; YERXA EJ, 1990, AM J OCCUP THER, V44, P318, DOI 10.5014/ajot.44.4.318	66	22	22	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1442-7591			J OCCUP SCI	J. Occup. Sci.		2005	12	2					69	81		10.1080/14427591.2005.9686550			13	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	V75QD	WOS:000211858200002					2022-02-06	
J	Arciniegas, DB; Frey, KL; Anderson, CA; Brousseau, KM; Harris, SN				Arciniegas, DB; Frey, KL; Anderson, CA; Brousseau, KM; Harris, SN			Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy	BRAIN INJURY			English	Article							TRAUMATIC BRAIN-INJURY; CARBON-MONOXIDE ASPHYXIA; POSTANOXIC ENCEPHALOPATHY; DEMYELINATION; ARYLSULFATASE; LEUKOENCEPHALOPATHY; PSEUDODEFICIENCY; SEQUELAE	Delayed post-hypoxic encephalopathy is an uncommon but potentially debilitating consequence of hypoxic-ischemic brain injury. This condition is characterized by delayed neurological deterioration days-to-weeks after an initial partial or complete recovery from hypoxic-ischemic brain injury. The course of recovery from this condition is highly variable, ranging from rapid and fatal progression over several weeks to delayed but occasionally complete recovery. There are no reports describing neuro-rehabilitative, including neuropharmacologic, interventions for persons with persistent neurological and/or neurobehavioural deficits following delayed post-hypoxic encephalopathy. This study describes the case of a 24-year old male who developed delayed post-hypoxic encephalopathy following an unintentional methadone and diazepam overdose and who demonstrated cognitive and neurobehavioural improvements during treatment with amantadine HCl hydrochloride in a single-case, open-label design. A brief review of the literature regarding this condition, its treatment and suggestions for further study are presented.	Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Psychiat,Neuropsychiat Serv, Denver, CO 80262 USA; Spalding Rehabil Hosp, Brain Injury Rehabil Unit, Aurora, CO USA; Univ Colorado, Sch Med, Dept Neurol, Behav Neurol Sect, Denver, CO USA		Arciniegas, DB (corresponding author), Univ Colorado, Hlth Sci Ctr, Sch Med, Dept Psychiat,Neuropsychiat Serv, Campus Box C268-68,4200 E 9th Ave, Denver, CO 80262 USA.	david.arciniegas@uchsu.edu	Arciniegas, David/A-3792-2009				Barker RA, 1999, J NEUROL, V246, P1103, DOI 10.1007/s004150050523; CHOI IS, 1983, ARCH NEUROL-CHICAGO, V40, P433, DOI 10.1001/archneur.1983.04050070063016; COURVILLE C B, 1955, Bull Los Angel Neuro Soc, V20, P9; COURVILLE CB, 1957, J NERV MENT DIS, V125, P534, DOI 10.1097/00005053-195710000-00007; COURVILLE CB, 1953, CONTRIUTIONS STUDY C; DEUTSCH H, 1917, JB PSYCHIAT, V37, P237; DOOLING EC, 1976, ARCH NEUROL-CHICAGO, V33, P196, DOI 10.1001/archneur.1976.00500030052011; GAMPER E, 1937, ARCH PSYCHIAT NERVEN, V106, P774; Ginsberg M D, 1979, Adv Neurol, V26, P21; GINSBERG MD, 1976, ARCH NEUROL-CHICAGO, V33, P5, DOI 10.1001/archneur.1976.00500010007002; GINSBERG MD, 1974, ARCH NEUROL-CHICAGO, V30, P202, DOI 10.1001/archneur.1974.00490330010002; Gottfried JA, 1997, NEUROLOGY, V49, P1400, DOI 10.1212/WNL.49.5.1400; Grinker RR, 1926, J NERV MENT DIS, V64, P18, DOI 10.1097/00005053-192607000-00003; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; Karli DC, 1999, BRAIN INJURY, V13, P63, DOI 10.1080/026990599121908; LEE MH, 1978, J KOREAN NEUROPSYCHI, V15, P374; MARIN RS, 1995, J NEUROPSYCH CLIN N, V7, P23; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; MEIGS JW, 1939, ARCH IND HYGIENE, V6, P344; MERIWETHER LS, 1955, ARCH NEURO PSYCHIATR, V73, P286, DOI 10.1001/archneurpsyc.1955.02330090032003; MEYER J E, 1961, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V202, P113, DOI 10.1007/BF00356094; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; PLUM F, 1962, ARCH INTERN MED, V110, P56; PROTASS LM, 1971, ANN INTERN MED, V74, P738, DOI 10.7326/0003-4819-74-5-738; RICHARDSON JC, 1959, ARCH NEUROL-CHICAGO, V1, P178, DOI 10.1001/archneur.1959.03840020052007; SCHWEDENBERG TH, 1959, J NEUROPATH EXP NEUR, V18, P597, DOI 10.1097/00005072-195910000-00012; Shillito FH, 1936, J AMER MED ASSOC, V106, P669; Sohlberg M.M., 1986, ATTENTION PROCESS TR; ULE G, 1958, Arztl Wochensch, V13, P1038; WEINBERGER LM, 1994, NEUROLOGY, V44, P152, DOI 10.1212/WNL.44.1.152; WILSON B, 1989, REVERMEAD BEHAV MEMO	31	22	23	0	1	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2004	18	12					1309	1318		10.1080/02699050410001720130			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	871BW	WOS:000225105300011	15666573				2022-02-06	
J	Pastorek, NJ; Hannay, HJ; Contant, CS				Pastorek, NJ; Hannay, HJ; Contant, CS			Prediction of global outcome with acute neuropsychological testing following closed-head injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article; Proceedings Paper	29th Annual INS Meeting	FEB, 2001	Chicago, IL	INS		closed-head injury; assessment; outcome	TRAUMATIC BRAIN-INJURY; DISABILITY RATING-SCALE; POSTTRAUMATIC AMNESIA; VERBAL IMPAIRMENT; PRACTICAL SCALE; RECOVERY; MEMORY; COMA; REHABILITATION; HYPOTHERMIA	Delaying assessment until emergence from post-traumatic amnesia increases completion rates, but this practice causes variable time delays front the date of injury to testing, which can complicate the interpretation of research findings. In the current study, the performance of 105 head injury Survivors Oil simple tests of language comprehension and attention was used to predict global outcome. It was hypothesized that 1 month performance on these measures would aid in the prediction of Disability Rating Scale (DRS) and Glasgow Outcome Scale (GOS) scores collected at 6 months post injury. Only raw scores on the modified Test of Complex Ideational Material accounted for a significant amount of the variance in DRS scores (4.4%) above that accounted for by age, education. Glasgow Coma Scale score, and pupil response. However, testability at 1 month post injury oil all four tests consistently accounted for a larger portion of the variance in DRS scores (10.1-13.2%) and significantly improved prediction of GOS scores. Galveston Orientation and Amnesia Test scores collected at 1 month post injury accounted for Substantially less variance in DRS scores (7.7-8.4%). Neuropsychological data, including the testability of patients, collected uniformly at 1 month following injury can contribute to the prediction of global Outcome.	Univ Houston, Dept Psychol, Houston, TX 77204 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Hannay, HJ (corresponding author), Univ Houston, Dept Psychol, 4800 Calhoun, Houston, TX 77204 USA.	jhannay@uh.edu		Pastorek, Nicholas/0000-0002-9290-380X; Hannay, H. Julia/0000-0001-7023-912X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616, P01NS038660] Funding Source: NIH RePORTER		Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; BORENSTEIN M, 1988, STAT POWER ANAL COMP; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FODOR IE, 1972, J NEUROL NEUROSUR PS, V35, P818, DOI 10.1136/jnnp.35.6.818; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Goodglass H., 1983, ASSESSMENT APHASIA O; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; JENNETT B, 1975, LANCET, V1, P480; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; MAXWELL SE, 2000, DESIGNING EXPT ANAL; McCauley SR, 2001, J INT NEUROPSYCH SOC, V7, P457, DOI 10.1017/S1355617701744025; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Ruesch J, 1943, ARCH NEURO PSYCHIATR, V50, P165, DOI 10.1001/archneurpsyc.1943.02290200065005; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Scheibel RS, 1998, J NEUROTRAUM, V15, P685, DOI 10.1089/neu.1998.15.685; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stuss D. T., 1992, J HEAD TRAUMA REHAB, V7, P40; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tabachnick B.G., 2001, USING MULTIVARIATE S; TEASDALE G, 1974, LANCET, V2, P81; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	49	22	23	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	OCT	2004	10	6					807	817		10.1017/S1355617704106012			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Psychiatry; Psychology	862PB	WOS:000224502000001	15637771				2022-02-06	
J	Berger, RP; Heyes, MP; Wisniewski, SR; Adelson, PD; Thomas, N; Kochanek, PM				Berger, RP; Heyes, MP; Wisniewski, SR; Adelson, PD; Thomas, N; Kochanek, PM			Assessment of the macrophage marker quinolinic acid in cerebrospinal fluid after pediatric traumatic brain injury: Insight into the timing and severity of injury in child abuse	JOURNAL OF NEUROTRAUMA			English	Article						head injury; inflammation; inflicted childhood neurotrauma; macrophage; shaken baby syndrome	HEAD-INJURY; KYNURENINE PATHWAY; INFANTS; CSF	This study measured quinolinic acid (QUIN), a macrophage-microglia derived neurotoxin, in the cerebrospinal fluid (CSF) of children after non-inflicted and inflicted traumatic brain injury (nTBI, iTBI), and correlated QUIN concentrations with age, mechanism of injury (nTBi vs. iTBI), Glasgow Coma Scale (GCS) score and 6-month Glasgow Outcome Score. One hundred fifty-two CSF samples were collected from 51 children with severe TBI (GCS less than or equal to5 8). CSF was collected at the time an intraventricular catheter was placed and daily thereafter. QUIN concentration was measured by gas chromatography-mass spectroscopy. Patients ranged in age from 2 months to 16 years. Eleven children (22%) had iTBI. Initial and peak CSF QUIN concentrations were higher in patients with iTBI versus nTBI after adjusting for time after injury and GCS. Despite the lack of a history of trauma in 82% of children with iTBI, 100% had a peak QUIN concentration of >100 nM. There was a significant increase in the CSF concentrations of QUIN following severe nTBI and iTBI in children. Higher initial and peak QUIN concentrations after iTBI may be due to severity of injury, young age, and/or delay in seeking medical care, which allows for increased secondary injury.	Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA; Psychogen Inc, Hawthorne, NY USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15213 USA; Penn State Univ, Coll Med, Penn State Childrens Hosp, Div Pediat Crit Care Med, Hershey, PA USA; Univ Pittsburgh, Safar Ctr Resusciat Res, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA		Berger, RP (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.	rberger@pitt.edu	Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860; Thomas, Neal/0000-0002-7991-7510	NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR 00084] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD 43843-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD043843] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000084] Funding Source: NIH RePORTER		Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; BATSHAW ML, 1993, ANN NEUROL, V34, P676, DOI 10.1002/ana.410340509; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Berger R, 2003, J NEUROTRAUM, V20, P1114; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BLIGHT AR, 1995, BRAIN, V118, P735, DOI 10.1093/brain/118.3.735; BROUWERS P, 1993, J INFECT DIS, V168, P1380, DOI 10.1093/infdis/168.6.1380; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; DUHAIME AC, 1992, PEDIATRICS, V90, P179; ETTARO L, 2004, IN PRESS CHILD ABUSE; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; GIULIAN D, 1993, J NEUROSCI, V13, P29; Guillemin GJ, 2003, GLIA, V41, P371, DOI 10.1002/glia.10175; Guillemin GJ, 2002, REDOX REP, V7, P199, DOI 10.1179/135100002125000550; Han Yong Y, 2003, Pediatr Crit Care Med, V4, P21, DOI 10.1097/00130478-200301000-00004; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; HEYES MP, 1995, J NEUROL SCI, V133, P112, DOI 10.1016/0022-510X(95)00164-W; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; HEYES MP, 1988, ANAL BIOCHEM, V174, P349, DOI 10.1016/0003-2697(88)90556-8; Heyes MP, 1998, FASEB J, V12, P881, DOI 10.1096/fasebj.12.10.881; Janesko K. L., 2000, Journal of Neurotrauma, V17, P956; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; LASKEY A, 1998, 1998 NAT SHAK BAB C; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MILSTIEN S, 1994, J NEUROCHEM, V63, P1178; Nottet HSLM, 1996, J NEUROVIROL, V2, P111, DOI 10.3109/13550289609146544; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; WHETSELL WO, 1989, NEUROSCI LETT, V97, P271, DOI 10.1016/0304-3940(89)90609-5	34	22	22	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2004	21	9					1123	1130					8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	855HC	WOS:000223962900002	15453983				2022-02-06	
J	Kirsch, NL; Shenton, M; Rowan, J				Kirsch, NL; Shenton, M; Rowan, J			A generic, 'in-house', alphanumeric paging system for prospective activity impairments after traumatic brain injury	BRAIN INJURY			English	Article							MEMORY AID; REHABILITATION	Objective : For settings having suitable infrastructure, generic, 'in-house' alphanumeric paging systems can be constructed that are fully under clinician control. Development of such a system for therapeutic application is described and a single-case study presented that assessed whether the system could improve repetitive, prospective use of a daily planner. Design : ABA' single case. Methods : The participant was male, in his mid-30s, having cognitive impairments subsequent to recent TBI superimposed on remote neurological changes. The pager reminded him to record therapeutic information in a daily planner, for discussion with a family member each evening. Results : During intervention (B) trials, reliable memory log usage was noted. By trial five of return-to-baseline (A') trials, there was decreased memory log use. Conclusions : Alphanumeric paging facilitated reliable use of a memory log compensation technique. The 'in-house' paging system proved particularly suitable for intervention development. Limits of the study are discussed and other therapeutically useful wireless technologies are noted.	Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA		Kirsch, NL (corresponding author), Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, 355 Briarwood Circle, Ann Arbor, MI 48108 USA.	nlkirsch@umich.edu	Shenton, Martha/V-8780-2019				Bergman M M, 2000, Appl Neuropsychol, V7, P76, DOI 10.1207/S15324826AN0702_2; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; CHESTNUT RM, 1999, REHABILITATION TRAUM; Chute DL, 1988, NEUROPSYCHOLOGY, V2, P41, DOI 10.1037//0894-4105.2.1.41; Cole E, 1999, NEUROREHABILITATION, V12, P39; Cole E, 1994, NeuroRehabilitation, V4, P174, DOI 10.3233/NRE-1994-4308; DAVISON AG, 2002, POSTIE PERSONAL EDIT; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Flannery M A, 1997, Pediatr Rehabil, V1, P239; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Hersh N A, 1994, NeuroRehabilitation, V4, P187, DOI 10.3233/NRE-1994-4309; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kim HJ, 2000, BRAIN INJURY, V14, P187, DOI 10.1080/026990500120844; Kime SK, 1996, BRAIN INJURY, V10, P17; KIRSCH NL, IN PRESS REHABILITAT; KIRSCH NL, 1987, J HEAD TRAUMA REHAB, V2, P77; KIRSCH NL, 1992, J HEAD TRAUMA REHAB, V7, P13, DOI DOI 10.1097/00001199-199209000-00004; LEVINE SP, 1992, J HEAD TRAUMA REHAB, V7, P46, DOI DOI 10.1097/00001199-199209000-00007; LOPRESTI EF, IN PRESS NEUROPSYCHO; ROTHI LJ, 1983, J CLIN NEUROPSYCHOL, V5, P73, DOI 10.1080/01688638308401152; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; van den Broek MD, 2000, BRAIN INJURY, V14, P455; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 1999, REHABIL PSYCHOL, V44, P284, DOI 10.1037/0090-5550.44.3.284; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477	26	22	22	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2004	18	7					725	734		10.1080/02699050310001646161			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	821HJ	WOS:000221450700008	15204332				2022-02-06	
J	Sengoku, T; Bondada, V; Hassane, D; Dubal, S; Geddes, JW				Sengoku, T; Bondada, V; Hassane, D; Dubal, S; Geddes, JW			Tat-calpastatin fusion proteins transduce primary rat cortical neurons but do not inhibit cellular calpain activity	EXPERIMENTAL NEUROLOGY			English	Article						cysteine proteases; endosomes; protein transduction; spectrin	FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; MAMMALIAN-CELLS; BRAIN INJURY; PENETRATING PEPTIDES; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; PROTEASE CALPAIN; ESCHERICHIA-COLI; ALPHA-SYNUCLEIN	Excessive activation of calpains (calcium-activated neutral proteases) is observed following spinal cord contusion injury, traumatic brain injury, stroke, and in neurodegenerative disorders including Alzheimer's disease. Calpain inhibition represents an attractive therapeutic target, but current calpain inhibitors possess relatively weak potency, poor specificity, and in many cases, limited cellular and blood-brain barrier permeability. We developed novel calpain inhibitors consisting of the endogenous inhibitor, calpastatin or its inhibitory domain I, fused to the protein transduction domain of the HIV trans-activator (Tat) protein (Tat(47-57)). The Tat-calpastatin fusion proteins were potent calpain inhibitors in a cell-free activity assay, but did not inhibit cellular calpain activity in primary rat cortical neurons when applied exogenously at concentrations up to 5 muM. The fusion proteins were able to transduce neurons, but were localized within endosome-like structures. A similar endosomal uptake was observed for Tat-GFP. Together, the results suggest that endosomal uptake of the Tat-calpastatin prevents its interaction with calpain in other cellular compartments. Endosomal uptake of proteins fused to the Tat protein transduction domain severely limits the applications of this methodology. (C) 2004 Elsevier Inc. All rights reserved.	Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Geddes, JW (corresponding author), Univ Kentucky, Dept Anat & Neurobiol, Sander Brown Bldg,Room 226,800 S Limestone St, Lexington, KY 40536 USA.	jgeddes@uky.edu	Hassane, Duane/AAA-3456-2021	Hassane, Duane/0000-0002-0719-9572	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045726] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS45726-01A1] Funding Source: Medline		Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Adamec E, 2002, ACTA NEUROPATHOL, V104, P92, DOI 10.1007/s00401-002-0528-6; ANDERSON GJ, 1994, GASTROENTEROLOGY, V106, P414, DOI 10.1016/0016-5085(94)90600-9; ARIYOSHI H, 1993, BIOCHEM MOL BIOL INT, V30, P63; Asoh S, 2002, P NATL ACAD SCI USA, V99, P17107, DOI 10.1073/pnas.262460299; BARTUS RT, 1994, J CEREBR BLOOD F MET, V14, P537, DOI 10.1038/jcbfm.1994.67; BAUDRY M, 1987, SYNAPSE, V1, P506, DOI 10.1002/syn.890010603; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao GD, 2002, J NEUROSCI, V22, P5423; Chakrabarti AK, 1997, J NEUROSCI RES, V47, P609, DOI 10.1002/(SICI)1097-4547(19970315)47:6<609::AID-JNR6>3.0.CO;2-H; CHAKRABARTI AK, 1989, NEUROCHEM RES, V14, P259, DOI 10.1007/BF00971321; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; De Tullio R, 1999, BIOCHEM J, V343, P467; Di Rosa G, 2002, J MOL NEUROSCI, V19, P135, DOI 10.1007/s12031-002-0024-4; Dietz GPH, 2002, MOL CELL NEUROSCI, V21, P29, DOI 10.1006/mcne.2002.1165; Donkor IO, 2000, CURR MED CHEM, V7, P1171, DOI 10.2174/0929867003374129; Egleton RD, 1997, PEPTIDES, V18, P1431, DOI 10.1016/S0196-9781(97)00242-8; EMORI Y, 1988, J BIOL CHEM, V263, P2364; Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200; Ford KG, 2001, GENE THER, V8, P1, DOI 10.1038/sj.gt.3301383; Futaki S, 2003, CURR PROTEIN PEPT SC, V4, P87, DOI 10.2174/1389203033487261; Gafni J, 2002, J NEUROSCI, V22, P4842, DOI 10.1523/JNEUROSCI.22-12-04842.2002; Gil-Parrado S, 2003, BIOL CHEM, V384, P395, DOI 10.1515/BC.2003.045; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hitomi K, 1998, BIOSCI BIOTECH BIOCH, V62, P136, DOI 10.1271/bbb.62.136; Hood JL, 2003, BIOCHEM BIOPH RES CO, V310, P1200, DOI 10.1016/j.bbrc.2003.09.142; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Kim SJ, 2003, J BIOL CHEM, V278, P41890, DOI 10.1074/jbc.M306017200; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Kwon HY, 2000, FEBS LETT, V485, P163, DOI 10.1016/S0014-5793(00)02215-8; Lundberg M, 2001, NAT BIOTECHNOL, V19, P713, DOI 10.1038/90741; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; MAKI M, 1989, J BIOL CHEM, V264, P18866; MAKI M, 1991, BIOMED BIOCHIM ACTA, V50, P509; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Mellgren RL, 1997, J BIOL CHEM, V272, P29899, DOI 10.1074/jbc.272.47.29899; Melloni E, 1998, FEBS LETT, V431, P55, DOI 10.1016/S0014-5793(98)00724-8; Minger SL, 1998, BRAIN RES, V810, P181, DOI 10.1016/S0006-8993(98)00921-4; Mishizen-Eberz AJ, 2003, J NEUROCHEM, V86, P836, DOI 10.1046/j.1471-4159.2003.01878.x; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Namiki S, 2003, BIOCHEM BIOPH RES CO, V305, P592, DOI 10.1016/S0006-291X(03)00807-6; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; Ono Y, 1999, CALPAIN PHARM TOXICO, P1; PERLMUTTER LS, 1988, SYNAPSE, V2, P79, DOI 10.1002/syn.890020111; Potocky TB, 2003, J BIOL CHEM, V278, P50188, DOI 10.1074/jbc.M308719200; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; SAIDO TC, 1993, J BIOL CHEM, V268, P25239; SATO K, 1995, EUR J BIOCHEM, V230, P25, DOI 10.1111/j.1432-1033.1995.0025i.x; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; TAKANO E, 1989, BIOCHEM INT, V19, P633; TAKANO E, 1991, BIOMED BIOCHIM ACTA, V50, P517; Takano J, 2000, J BIOCHEM, V128, P83, DOI 10.1093/oxfordjournals.jbchem.a022733; TAKEUCHI KH, 1992, J NEUROCHEM, V58, P1526, DOI 10.1111/j.1471-4159.1992.tb11374.x; TAYLOR RG, 1991, BIOMED BIOCHIM ACTA, V50, P491; Thompson VF, 2000, ANAL BIOCHEM, V279, P170, DOI 10.1006/abio.1999.4475; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; Vazquez J, 2003, HYPERTENSION, V41, P751, DOI 10.1161/01.HYP.0000047878.13793.41; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Volbracht C, 2001, NEUROREPORT, V12, P3645, DOI 10.1097/00001756-200112040-00008; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; WANG KKW, 1999, CALPAIN PHARM TOXICO, P77; Wu HY, 2003, NEUROSCI RES, V47, P131, DOI 10.1016/S0168-0102(03)00195-0; Xia HB, 2001, NAT BIOTECHNOL, V19, P640, DOI 10.1038/90242; Zhang SX, 2003, J NEUROTRAUM, V20, P59, DOI 10.1089/08977150360517182	81	22	22	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2004	188	1					161	170		10.1016/j.expneurol.2004.03.018			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	831DY	WOS:000222174700016	15191812				2022-02-06	
J	Wang, T; Wang, J; Cottrell, JE; Kass, IS				Wang, T; Wang, J; Cottrell, JE; Kass, IS			Small physiologic changes in calcium and magnesium alter excitability and burst firing of CA1 pyramidal cells in rat hippocampal slices	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						Ca; Mg; excitability; epilepsy; cerebrospinal fluid; hippocampal neurons	CLOSED-HEAD INJURY; EXTRACELLULAR POTASSIUM; CEREBRAL-ISCHEMIA; ANOXIC DAMAGE; BRAIN; SULFATE; NEURONS; INVITRO; POTENTIALS; EFFICACY	The effects of small physiologic changes in Ca and Mg concentrations on neuronal burst firing were examined. Intracellular electrophysiologic recordings were made from CA1 pyramidal neutrons in rat hippocampal slices. There was no difference in the resting potential or the input resistance of neurons bathed in the lower Ca-Mg artificial Cerebrospinal fluid (aCSF) (1.4 mM Ca; 1.3 mM Mg) compared with the higher Ca-Mg aCSF (2 mM Ca; 2 mM Mg). However, neurons in the lower Ca-Mg aCSF, but not the higher Ca-Mg aCSF, demonstrated depolarizing waves and bursts of action potentials; no single component of the aCSF accounted for this difference. Reducing the Ca from 2 to 1 mM in the higher Ca-Mg aCSF increased the mean frequency of action potentials from 28 to 171 Hz; the addition of 6-cyano-7-nitroquinoxaline-2,3-dione did not reduce the frequency. The threshold of potassium for inducing bursts was 5.25 with 1 mM Ca, 7.25 with 2 mM Ca, and 11.25 with 3 mM Ca. When Mg was reduced from 2 to 1 mM, the number of potassium-induced bursts increased to 190%; increasing Mg from 2 to 3 mM reduced the bursts to 58% (frequency with 2 mM Mg set to 100%). Small decreases in extracellular Ca and/or Mg led to increased excitability and burst firing, which may alter physiologic and pathophysiologic processes such as enhancing long-term potentiation, pain transmission, epileptogenesis, and neuronal damage and decreasing anesthetic potency. Increases in extracellular Ca and/or Mg Would have the opposite effect on these processes. These effects of extracellular divalent ions on burst firing may explain some of the pathophysiologic effects of hypocalcemia and hypomagnesemia.	SUNY, Dept Anesthesiol, Downstate Med Ctr, Brooklyn, NY 11203 USA; SUNY, Dept Physiol, Downstate Med Ctr, Brooklyn, NY 11203 USA; SUNY, Dept Pharmacol, Downstate Med Ctr, Brooklyn, NY 11203 USA; Xuzhou Med Coll, Dept Anesthesiol, Xuzhou, Jiangsu, Peoples R China		Kass, IS (corresponding author), SUNY, Dept Anesthesiol, Downstate Med Ctr, Box 6, Brooklyn, NY 11203 USA.	ikass@downstate.edu			NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM38866] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM038866, R29GM038866] Funding Source: NIH RePORTER		ASTRUP J, 1981, ANESTHESIOLOGY, V55, P256, DOI 10.1097/00000542-198109000-00012; Banerjee S, 2003, MAGNESIUM RES, V16, P127; BENNINGER C, 1980, BRAIN RES, V187, P165, DOI 10.1016/0006-8993(80)90502-8; Brill S, 2002, BRIT J ANAESTH, V89, P711, DOI 10.1093/bja/aef266; Carrazza F R, 2000, J Pediatr (Rio J), V76, P310; CHURCH J, 1989, J PHYSIOL-LONDON, V415, P85, DOI 10.1113/jphysiol.1989.sp017713; Clark S, 1999, Adv Neurol, V79, P607; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; HALLAK M, 1992, AM J OBSTET GYNECOL, V167, P1605, DOI 10.1016/0002-9378(92)91749-Z; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; HILLE B, 1992, IONIC CHANNELS EXCIT, P445; Ip Patrick, 2003, Archives of Gynecology and Obstetrics, V268, P227, DOI 10.1007/s00404-002-0316-5; JENSEN MS, 1994, J NEUROPHYSIOL, V71, P831, DOI 10.1152/jn.1994.71.3.831; Johnston D., 1984, ELECTROPHYSIOLOGY EP, P277; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; KASS IS, 1988, ANESTHESIOLOGY, V69, P710, DOI 10.1097/00000542-198811000-00012; KASS IS, 1982, J PHYSIOL-LONDON, V332, P459, DOI 10.1113/jphysiol.1982.sp014424; KONNERTH A, 1986, J NEUROPHYSIOL, V56, P409, DOI 10.1152/jn.1986.56.2.409; Lee MS, 2002, CLIN CHIM ACTA, V318, P121, DOI 10.1016/S0009-8981(01)00807-5; Marinov MB, 1996, J NEUROSURG, V85, P117, DOI 10.3171/jns.1996.85.1.0117; Mathern G.W., 1997, EPILEPSY COMPREHENSI, P133; Miles AN, 2001, NEUROSURGERY, V49, P1443, DOI 10.1097/00006123-200112000-00025; MORRIS ME, 1991, J NEUROPHYSIOL, V65, P157, DOI 10.1152/jn.1991.65.2.157; Muir KW, 1998, MAGNESIUM RES, V11, P43; POCKETT S, 1995, ANESTH ANALG, V80, P173, DOI 10.1097/00000539-199501000-00026; REINERT M, 2000, J NEUROSURG, V94, P1025; ROPER SN, 1992, ANN NEUROL, V31, P81, DOI 10.1002/ana.410310115; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; Santos AC, 2001, CLIN ANESTH, P1141; Sasaki R, 2002, ANESTHESIOLOGY, V96, P681, DOI 10.1097/00000542-200203000-00026; Singhi SC, 2003, J TROP PEDIATRICS, V49, P298, DOI 10.1093/tropej/49.5.298; SOMJEN GG, 1984, ELECTROPHYSIOLOGY EP, P304; Sood Arvind, 2003, Indian Journal of Pediatrics, V70, P221, DOI 10.1007/BF02725588; Suzuki M, 1997, GEN PHARMACOL, V28, P119, DOI 10.1016/S0306-3623(96)00148-6; TANCREDI V, 1988, NEUROSCI LETT, V89, P293, DOI 10.1016/0304-3940(88)90542-3; Tramer MR, 1996, ANESTHESIOLOGY, V84, P340, DOI 10.1097/00000542-199602000-00011; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Wang T, 1997, Methods Mol Biol, V72, P1; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121	40	22	23	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2004	16	3					201	209		10.1097/00008506-200407000-00004			9	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	836BT	WOS:000222530800004	15211157				2022-02-06	
J	Griffin, JL; Anthony, DC; Campbell, SJ; Gauldie, J; Pitossi, F; Styles, P; Sibson, NR				Griffin, JL; Anthony, DC; Campbell, SJ; Gauldie, J; Pitossi, F; Styles, P; Sibson, NR			Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine	FEBS LETTERS			English	Article						multiple sclerosis; metabolomics; metabonomics; pattern recognition	BRAIN-BARRIER PERMEABILITY; CEREBRAL BLOOD-VOLUME; MULTIPLE-SCLEROSIS; PATTERN-RECOGNITION; MAGNETIC-RESONANCE; METABONOMICS; DISEASE; INJURY; ALPHA; PROGRESSION	Multiple sclerosis is a major cause of non-traumatic neurological disability. The identification of markers that differentiate disease progression is critical to effective therapy. A combination of NMR spectroscopic metabolic profiling of urine and statistical pattern recognition was used to detect focal inflammatory central nervous system (CNS) lesions induced by microinjection of a replication-deficient recombinant adenovirus expressing TNF-alpha or IL1-beta cDNA into the brains of Wistar rats. These animals were compared with a group of naive rats :and a group of animals injected with an equivalent null adenovirus. Urine samples were collected 7 days after adenovirus injection, when the inflammatory lesion is maximally active. Principal components analysis and Partial Least Squares-Discriminate analysis of the urine H-1 NMR spectra revealed significant differences between each of the cytokine adenovirus groups and the control groups; for the TNF-alpha group the main differences lay in citrate and succinate, while for the IL-1beta group the predominant changes occurred in leucine, isoleucine, valine and myoinositol. Thus, we can identify urinary metabolic vectors that not only separate rats with inflammatory lesions in the brain from control animals, but also distinguish between different types of CNS inflammatory lesions. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Univ Southampton, Mol Neuropathol Lab, Southampton, Hants, England; McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; McMaster Univ, Ctr Gene Therapeut, Hamilton, ON, Canada; Fdn Leloir Inst, Buenos Aires, DF, Argentina; Univ Oxford, Dept Biochem, Oxford, England		Griffin, JL (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	jlg40@mole.bio.cam.ac.uk	Anthony, Daniel C/F-7765-2010	Anthony, Daniel C/0000-0003-1380-6655; Pitossi, Fernando/0000-0001-5104-9726			Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Anthony DC, 1998, J NEUROIMMUNOL, V87, P62, DOI 10.1016/S0165-5728(98)00046-0; Azmi J, 2002, ANALYST, V127, P271, DOI 10.1039/b109430k; Beckwith-Hall BM, 1998, CHEM RES TOXICOL, V11, P260, DOI 10.1021/tx9700679; Blamire AM, 2000, J NEUROSCI, V20, P8153; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Brindle JT, 2003, ANALYST, V128, P32, DOI 10.1039/b209155k; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Eriksson L., 1999, INTRO MULTI MEGAVARI; Fan WMT, 1996, PROG NUCL MAG RES SP, V28, P161, DOI 10.1016/0079-6565(95)01017-3; Fiehn O, 2001, COMP FUNCT GENOM, V2, P155, DOI 10.1002/cfg.82; Griffin JL, 2002, ANALYST, V127, P582, DOI 10.1039/b201207c; Griffin JL, 2001, CHEM RES TOXICOL, V14, P1428, DOI 10.1021/tx015521u; Holmes E, 1998, CHEMOMETR INTELL LAB, V44, P245, DOI 10.1016/S0169-7439(98)00110-5; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Ledeen RW, 1998, NEUROCHEM RES, V23, P277, DOI 10.1023/A:1022493013904; Lindon JC, 2001, PROG NUCL MAG RES SP, V39, P1, DOI 10.1016/S0079-6565(00)00036-4; Lindon JC, 2003, TOXICOL APPL PHARM, V187, P137, DOI 10.1016/S0041-008X(02)00079-0; Mehta PD, 1998, MULT SCLER, V4, P254, DOI 10.1177/135245859800400331; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; OLSSON T, 1995, NEUROLOGY, V45, pS11, DOI 10.1212/WNL.45.6_Suppl_6.S11; Rieckmann P, 2001, TRENDS NEUROSCI, V24, P548, DOI 10.1016/S0166-2236(00)01860-9; Schnell L, 1999, J NEUROPATH EXP NEUR, V58, P245, DOI 10.1097/00005072-199903000-00004; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Sibson NR, 2002, BRAIN, V125, P2446, DOI 10.1093/brain/awf256; Sorensen PS, 1999, MULT SCLER, V5, P287, DOI 10.1191/135245899678846230; 't Hart BA, 2003, J NEUROL SCI, V212, P21, DOI 10.1016/S0022-510X(03)00080-7; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Waters NJ, 2001, CHEM RES TOXICOL, V14, P1401, DOI 10.1021/tx010067f; Wilcockson DC, 2002, J CEREBR BLOOD F MET, V22, P318, DOI 10.1097/00004647-200203000-00009	32	22	22	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1873-3468			FEBS LETT	FEBS Lett.	JUN 18	2004	568	1-3					49	54		10.1016/j.febslet.2004.04.096			6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	831OX	WOS:000222205200011	15196919	Bronze			2022-02-06	
J	Ozisik, K; Yildirim, E; Kaplan, S; Solaroglu, I; Sargon, MF; Kilinc, K				Ozisik, K; Yildirim, E; Kaplan, S; Solaroglu, I; Sargon, MF; Kilinc, K			Ultrastructural changes of rat cardiac myocytes in a time-dependent manner after traumatic brain injury	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						heart; histology; rat; reactive oxygen species	LIPID-PEROXIDATION; PULMONARY-EDEMA; DEATH; TISSUES	We suggest an ultrastructural scoring system to evaluate the degree of damage in a time-dependent manner in cardiac myocytes after traumatic brain injury (TBI). Forty Wistar-Albino female rats weighing 170-200 g were randomly allocated into five groups. Group 1 was the control and Group 2 was the sham-operated group. Group 3, Group 4 and Group 5 were trauma groups. Weight-drop technique was used for achieving TBI. Lipid peroxidation was estimated by thiobarbituric acid test. An electron microscopic scoring model was used to grade the subcellular changes. Results of heart injury score (HIS) showed that the 24-h trauma group had statistically significant levels in nuclear damage compared with the other groups (p<0.05). Sarcoplasmic reticulum and mitochondria scores of all trauma groups were significantly different from the control and sham groups (p<0.05). The results showed that lipid per oxidation levels were statistically significant different between the control and all trauma groups (p<0.05). The electron microscopic scoring model worked well in depicting the traumatic changes, which were supported by lipid peroxidation levels. Traumatic brain injury produced obvious gradual damage on the ultrastructure of the cardiac myocytes and this damage was more significant in the 24-h trauma group.	Ankara Numune Educ & Res Hosp, Dept Thorac & Cardiovasc Surg, Ankara, Turkey; TYIH, Dept Cardiovasc Surg, Ankara, Turkey; Ankara Numune Educ & Res Hosp, Dept Neurosurg, Ankara, Turkey; Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey		Ozisik, K (corresponding author), Ankara Numune Educ & Res Hosp, Dept Thorac & Cardiovasc Surg, Ankara, Turkey.	sozisik2002@yahoo.com	Sargon, Mustafa F./AAZ-5470-2021; Solaroglu, Ihsan/ABE-8816-2020; Solaroglu, Ihsan/ABF-7606-2020	Sargon, Mustafa F./0000-0001-6360-6008; Solaroglu, Ihsan/0000-0002-9472-1735; 			Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Bruinsma GJBB, 1997, J SURG RES, V68, P7, DOI 10.1006/jsre.1997.5002; Ercan M, 2001, NEUROSURG REV, V24, P127, DOI 10.1007/PL00012396; GALINANES M, 1992, CIRC RES, V71, P1213, DOI 10.1161/01.RES.71.5.1213; GILBERT EM, 1988, J THORAC CARDIOV SUR, V95, P1003; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; GREENHOO.JH, 1969, J NEUROSURG, V30, P521, DOI 10.3171/jns.1969.30.5.0521; Hall SRR, 2002, ANESTH ANALG, V94, P948; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; NOVITZKY D, 1986, TRANSPLANT P, V18, P609; Palac Robert T, 2003, Prog Transplant, V13, P42; Pyeron A M, 2001, J Neurosci Nurs, V33, P203; Rathore N, 1998, PHARMACOL RES, V38, P297, DOI 10.1006/phrs.1998.0365; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; YILDIRIM E, 2004, J HEART LUNG TRANSPL	16	22	24	0	1	BLACKWELL MUNKSGAARD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	1600-6135			AM J TRANSPLANT	Am. J. Transplant.	JUN	2004	4	6					900	904		10.1111/j.1600-6143.2004.00448.x			5	Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Transplantation	820VM	WOS:000221417600010	15147423	Bronze			2022-02-06	
J	Siu, TLT; Chandran, KN; Newcombe, RL; Fuller, JW; Pik, JHT				Siu, TLT; Chandran, KN; Newcombe, RL; Fuller, JW; Pik, JHT			Snow sports related head and spinal injuries: an eight-year survey from the neurotrauma centre for the Snowy Mountains, Australia	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						head injury; spinal injury; ski; snowboard; biomechanics	SKIING INJURIES; SNOWBOARDERS; SKIERS; CHILDREN; TRENDS; RISK	Neurotrauma from snow-sports related injuries is infrequently documented in the literature. In Australia no collective data has ever been published. The aim of this study is to document the injury pattern of snow sports related neurotrauma admissions to The Canberra Hospital, the regional trauma centre for the Snowy Mountains. A computerised hospital record search conducted between January 1994 and July 2002 revealed 25 head and 66 spinal injury admissions. The incidence of severe injuries requiring referral to tertiary trauma hospital was estimated to be 7.4 per 100,000 skier-days and for head and spinal injury 1.8 per 1,000,000 skier-days and 5.6 per 1,000,000 skier-days, respectively. Collision with a stationary object was disproportionately associated with head injury (p < 0.01) and falling forward with spinal injury (p < 0.005). Snowboarders; tended to sustain cervical fractures more often than skiers (p = 0.009). The importance of helmet usage in buffering the impact of head-on collision and the proposition of having both feet fastened to a snowboard in leading to cervical injury were highlighted. (C) 2003 Elsevier Ltd. All rights reserved.	Canberra Hosp, Dept Neurosurg, Garran, ACT 2605, Australia		Siu, TLT (corresponding author), Canberra Hosp, Dept Neurosurg, Yamba Dr, Garran, ACT 2605, Australia.	siloti@tpg.com.au		Siu, Timothy/0000-0001-8050-891X; Fuller, John/0000-0002-9825-9103			ABULABAN RB, 1991, CAN MED ASSOC J, V145, P1097; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BLADIN C, 1993, AM J SPORT MED, V21, P701, DOI 10.1177/036354659302100511; BREATHOUR, COMMUNICATION; Chissell HR, 1996, SPORTS MED, V22, P141, DOI 10.2165/00007256-199622030-00001; *CO TRAUM I, 1995, COLORADO TRAUMA B, V1, P1; Deibert MC, 1998, J BONE JOINT SURG AM, V80A, P25, DOI 10.2106/00004623-199801000-00006; Floyd T, 2001, ARCH ORTHOP TRAUM SU, V121, P433, DOI 10.1007/s004020100267; FRIERMOOD TG, 1994, J ORTHOP TRAUMA, V8, P116, DOI 10.1097/00005131-199404000-00007; Fukuda O, 2001, AM J SPORT MED, V29, P437, DOI 10.1177/03635465010290040901; Holmes JF, 2001, ACAD EMERG MED, V8, P866, DOI 10.1111/j.1553-2712.2001.tb01146.x; HUTCHINGS J, 1969, MED J AUSTRALIA, V2, P174, DOI 10.5694/j.1326-5377.1969.tb105690.x; KELLY P, 1991, ANN EMERG MED, V20, P852, DOI 10.1016/S0196-0644(05)81426-X; Koo D W, 1999, J Spinal Cord Med, V22, P246; Levy AS, 2000, SEMIN NEUROL, V20, P233, DOI 10.1055/s-2000-9833; MCLENNAN JC, 1991, J MUSCULOSKELETAL ME, V8, P75; MYLES ST, 1992, CAN J SURG, V35, P643; Nakaguchi H, 1999, J TRAUMA, V46, P1066, DOI 10.1097/00005373-199906000-00017; O'Neill DF, 1999, AM J SPORT MED, V27, P94; OH S, 1984, INT J SPORTS MED, V5, P268, DOI 10.1055/s-2008-1025918; *PER RANG RES, 2002, PER BLUE SKI RES SKI; Prall JA, 1995, J TRAUMA, V39, P1115, DOI 10.1097/00005373-199512000-00018; Sacco DE, 1998, J TRAUMA, V44, P654, DOI 10.1097/00005373-199804000-00016; SHERRY E, 1991, MED J AUSTRALIA, V155, P513, DOI 10.5694/j.1326-5377.1991.tb93885.x; SHERRY E, 1984, MED J AUSTRALIA, V140, P530, DOI 10.5694/j.1326-5377.1984.tb108226.x; SHERRY E, 1988, MED J AUSTRALIA, V149, P615, DOI 10.5694/j.1326-5377.1988.tb120803.x; Shorter NA, 1996, J TRAUMA, V40, P997, DOI 10.1097/00005373-199606000-00024; Tarazi F, 1999, AM J SPORT MED, V27, P177, DOI 10.1177/03635465990270021101; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Yamakawa H, 2001, J TRAUMA, V50, P1101, DOI 10.1097/00005373-200106000-00020; ZELCER J, 1976, ORTHOP CLIN N AM, V7, P37	32	22	22	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	APR	2004	11	3					236	242		10.1016/j.jocn.2003.08.003			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	804RQ	WOS:000220316200002	14975409				2022-02-06	
J	Zafonte, R; Elovic, EP; Lombard, L				Zafonte, R; Elovic, EP; Lombard, L			Acute care management of post-TBI spasticity	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute care; intensive care; spasticity; TBI	UPPER-LIMB SPASTICITY; TRAUMATIC BRAIN-INJURY; BOTULINUM TOXIN; LONG-TERM; INTRATHECAL BACLOFEN; DOUBLE-BLIND; ELECTRICAL-STIMULATION; FUNCTIONAL RECOVERY; DANTROLENE SODIUM; FLEXOR SPASTICITY	The management of persons with traumatic brain injury (TBI) who have acute spasticity remains a challenge. A correct stratification is essential to clinical care and determination of efficacy from proposed interventions. The secondary severe sequlae of spasticity after TBI can result in profound functional impairment. These concerns are often best addressed early in the patient's course. Limited research in the area of the acute care treatment of severe spasticity is available. The authors employ a review of the available data as well as recount their own clinical experience in the acute care management of severe spasticity to assist in developing an order for the plethora of potential treatments available to clinicians and researchers. We propose to use a case example to emphasize key clinic points in the management of spasticity in the acute care setting.	Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Univ Med & Dent New Jersey, Newark, NJ 07103 USA		Zafonte, R (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 201,Kuafman Bldg, Pittsburgh, PA 15213 USA.	zafonterd@upmc.edu					Albert TA, 2002, ARCH PHYS MED REHAB, V83, P692, DOI 10.1053/apmr.2002.32307; Albright AL, 2003, J NEUROSURG, V98, P291, DOI 10.3171/jns.2003.98.2.0291; BAJD T, 1985, ARCH PHYS MED REHAB, V66, P515; BARNARD P, 1984, PHYS THER, V64, P1540, DOI 10.1093/ptj/64.10.1540; Barnes M, 2003, J REHABIL MED, V35, P56, DOI 10.1080/16501960310010151; Brashear A, 2003, ARCH PHYS MED REHAB, V84, P103, DOI 10.1053/apmr.2003.50070; BRASHEAR A, 2002, NEJM; CASTELLANO C, 1989, BEHAV NEURAL BIOL, V52, P170, DOI 10.1016/S0163-1047(89)90285-9; CHAN CH, 1990, NEUROLOGY, V40, P1427, DOI 10.1212/WNL.40.9.1427; Childers MK, 1999, ARCH PHYS MED REHAB, V80, P714, DOI 10.1016/S0003-9993(99)90178-8; Childers MK, 1997, BRAIN INJURY, V11, P537, DOI 10.1080/713802187; Cho S, 2003, ANESTH ANALG, V96, P1369, DOI 10.1213/01.ANE.0000055805.27590.FB; Chou TC, 1999, THROMB RES, V96, P299, DOI 10.1016/S0049-3848(99)00114-0; Coffey RJ, 2002, ARCH PHYS MED REHAB, V83, P735, DOI 10.1053/apmr.2002.32820; Corbett M, 1972, Paraplegia, V10, P19; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Cutter NC, 2000, ARCH PHYS MED REHAB, V81, P164, DOI 10.1016/S0003-9993(00)90135-7; DAHM LS, 1989, STEREOT FUNCT NEUROS, V53, P85, DOI 10.1159/000099523; DAHM LS, 2000, EUR J NEUROL, V7, P741; Dall JT, 1996, BRAIN INJURY, V10, P453; Dalyan M, 1998, SPINAL CORD, V36, P405, DOI 10.1038/sj.sc.3100620; Dewald J P, 1996, IEEE Trans Rehabil Eng, V4, P231, DOI 10.1109/86.547923; DONOVAN WH, 1988, ARCH PHYS MED REHAB, V69, P193; Dunevsky A, 1998, AM J PHYS MED REHAB, V77, P451, DOI 10.1097/00002060-199809000-00020; DURHAM JA, 1984, DRUG CHEM TOXICOL, V7, P23, DOI 10.3109/01480548409014171; Elovic E, 2001, Phys Med Rehabil Clin N Am, V12, P793; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Francisco GE, 2002, AM J PHYS MED REHAB, V81, P355, DOI 10.1097/00002060-200205000-00007; GERTZEN P, 1997, PEDIATR NEUROSURG, V27, P40; Gilman TM, 1996, J CLIN PHARMACOL, V36, P64, DOI 10.1002/j.1552-4604.1996.tb04153.x; Glenn MB, 1997, J HEAD TRAUMA REHAB, V12, P40, DOI 10.1097/00001199-199712000-00005; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P865, DOI 10.1212/WNL.45.5.865; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; Gracies JM, 1997, ARCH PHYS MED REHAB, V78, P1066, DOI 10.1016/S0003-9993(97)90129-5; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; Groves L, 1998, ADV THER, V15, P241; Gruenthal M, 1997, SPINAL CORD, V35, P686, DOI 10.1038/sj.sc.3100481; Hinderer S R, 2001, Phys Med Rehabil Clin N Am, V12, P733; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; KING TI, 1982, AM J OCCUP THER, V36, P671, DOI 10.5014/ajot.36.10.671; KNUTSSON E, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P159; Langeron O, 1999, ANESTH ANALG, V89, P466; Lannin NA, 2003, ARCH PHYS MED REHAB, V84, P297, DOI 10.1053/apmr.2003.50031; MAYNARD FM, 1986, PARAPLEGIA, V24, P175, DOI 10.1038/sc.1986.24; McGuire J R, 2001, Top Stroke Rehabil, V8, P47; MEDICI M, 1989, CURR MED RES OPIN, V11, P398, DOI 10.1185/03007998909110141; Megna JL, 2002, ANN PHARMACOTHER, V36, P12; MEYLER WJ, 1979, EUR J CLIN PHARMACOL, V16, P203, DOI 10.1007/BF00562062; Meythaler JA, 2001, ARCH PHYS MED REHAB, V82, P1155, DOI 10.1053/apmr.2001.25141; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; MIGLIETTA O, 1973, AM J PHYS MED REHAB, V52, P198; Miller LJ, 2001, ANN PHARMACOTHER, V35, P427; MILLS VM, 1984, PHYS THER, V64, P190, DOI 10.1093/ptj/64.2.190; MIZUNO J, 2002, MASUI, V15, P781; Mueller ME, 1997, ARCH PHYS MED REHAB, V78, P521, DOI 10.1016/S0003-9993(97)90168-4; Nakayama R, 2002, ANESTHESIOLOGY, V96, P705, DOI 10.1097/00000542-200203000-00029; Nance P W, 1994, J Am Paraplegia Soc, V17, P150; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; OTIS JC, 1985, J PEDIATR ORTHOPED, V5, P682, DOI 10.1097/01241398-198511000-00010; Pohl M, 2003, CLIN REHABIL, V17, P373, DOI 10.1191/0269215503cr636oa; Pohl M, 2002, ARCH PHYS MED REHAB, V83, P784, DOI 10.1053/apmr.2002.32821; Popescu BO, 2002, J CELL MOL MED, V6, P555, DOI 10.1111/j.1582-4934.2002.tb00454.x; Priebe MM, 1997, SPINAL CORD, V35, P171, DOI 10.1038/sj.sc.3100366; Richardson D, 2000, J NEUROL NEUROSUR PS, V69, P499, DOI 10.1136/jnnp.69.4.499; Rossier P, 2000, EUR J NEUROL, V7, P741, DOI 10.1046/j.1468-1331.2000.00142.x; SANDYK R, 1985, CLIN NEUROPHARMACOL, V8, P294, DOI 10.1097/00002826-198509000-00011; Scheker LR, 1999, J HAND SURG-BRIT EUR, V24B, P226, DOI 10.1054/jhsb.1998.0002; SEIB TP, 1994, ARCH PHYS MED REHAB, V75, P746; SEINBERG F, 1975, J AM GERIATR SOC, V23, P70; Singer BJ, 2003, BRAIN INJURY, V17, P309, DOI 10.1080/0269905021000013237; Singer BJ, 2003, ARCH PHYS MED REHAB, V84, P483, DOI 10.1053/apmr.2003.50041; Smith SJ, 2000, CLIN REHABIL, V14, P5, DOI 10.1191/026921500666642221; Soni BM, 2003, SPINAL CORD, V41, P586, DOI 10.1038/sj.sc.3101471; STARRING DT, 1988, PHYS THER, V68, P314, DOI 10.1093/ptj/68.3.314; Taricco M., 2000, COCHRANE DB SYST REV, P1131, DOI [10.1002/14651858.CD001131, DOI 10.1002/14651858.CD001131]; TERRENCE CF, 1983, ARCH NEUROL-CHICAGO, V40, P28, DOI 10.1001/archneur.1983.04050010048011; TREMBLAY F, 1990, SCAND J REHABIL MED, V22, P171; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Wallace AE, 1999, RESTOR NEUROL NEUROS, V14, P35; Ward AB, 2003, J REHABIL MED, V35, P98, DOI 10.1080/16501970306112; WEINGARDEN SI, 1992, ARCH PHYS MED REHAB, V73, P876; WUIS EW, 1990, INT J CLIN PHARM RES, V10, P203; YABLON SA, 1993, AM J PHYS MED REHAB, V72, P154, DOI 10.1097/00002060-199306000-00009; Zafonte R D, 2001, Phys Med Rehabil Clin N Am, V12, P817	84	22	22	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2004	19	2					89	100		10.1097/00001199-200403000-00002			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	809NR	WOS:000220643900002	15247820				2022-02-06	
J	Strens, LHA; Mazibrada, G; Duncan, JS; Greenwood, R				Strens, LHA; Mazibrada, G; Duncan, JS; Greenwood, R			Misdiagnosing the vegetative state after severe brain injury: the influence of medication	BRAIN INJURY			English	Article							INTRATHECAL BACLOFEN INFUSION; SEVERE HEAD-INJURY; SPASTICITY; DIAGNOSIS; LIFE	Patients who suffer severe brain damage may be left unaware of self and of the environment and in a permanent vegetative state (PVS). The difficulties in correctly ascertaining unawareness after brain injury have been emphasized by a number of authors. It is well recognized that toxic-metabolic and drug-induced cerebral depression occurs acutely after brain injury. However, less attention has been drawn to the effects of medication months after brain injury and the way in which medication may confound assessment of awareness and, thus, the reliable assessment of long-term prognosis. This paper describes two patients who sustained a severe and well-documented structural brain injury, one hypoxic and one traumatic. Both were unaware when first seen at 3 months post-injury, but both have made useful functional recovery. The paper discusses their progress and how the early prescription of large doses of anti-epileptic drugs, sedatives and anti-spastic agents in these circumstances may result in an initial misdiagnosis of the vegetative state.	Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; Inst Neurol, Dept Clin & Expt Epilepsy, London WC1N 3BG, England; UCL Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England		Strens, LHA (corresponding author), Inst Neurol, Sobell Dept Motor Neurosci, 2nd Floor 8-11 Queen Sq, London WC1N 3BG, England.	l.strens@ion.ucl.ac.uk		Duncan, John S/0000-0002-1373-0681	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9805989] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9805989] Funding Source: UKRI		Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; AUER RN, 2002, GREENFIELDS NEUROPAT, V2, P823; Bates David, 2001, Journal of Neurology Neurosurgery and Psychiatry, V71, pi20; Becker R, 1997, J NEUROL, V244, P160, DOI 10.1007/s004150050067; Bernat JL, 2002, NEUROLOGY, V58, P337, DOI 10.1212/WNL.58.3.337; Black D, 1996, J ROY COLL PHYS LOND, V30, P119; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; Dario A, 2002, ACTA NEUROL SCAND, V105, P83, DOI 10.1034/j.1600-0404.2002.1o042.x; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GRAHAM DI, 2002, GREENFIELDS NEUROPAT, V2, P233; Heindl UT, 1996, NEUROPEDIATRICS, V27, P94, DOI 10.1055/s-2007-973756; Korenkov AI, 2002, NEUROSURG REV, V25, P228, DOI 10.1007/s10143-002-0221-1; Lazorthes Y, 1998, NEUROCHIRURGIE, V44, P201; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; McMillan TM, 1997, BRAIN INJURY, V11, P483, DOI 10.1080/713802184; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Shiel A, 1998, BRAIN INJURY, V12, P809, DOI 10.1080/026990598122043; VanCott AC, 1996, EPILEPSIA, V37, P868; Wade DT, 1999, BMJ-BRIT MED J, V319, P841, DOI 10.1136/bmj.319.7213.841	23	22	22	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	2004	18	2					213	218		10.1080/0269905031000149533			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	751DR	WOS:000187038000009	14660232				2022-02-06	
J	Borgaro, SR; Prigatano, GP; Kwasnica, C; Alcott, S; Cutter, N				Borgaro, SR; Prigatano, GP; Kwasnica, C; Alcott, S; Cutter, N			Disturbances in affective communication following brain injury	BRAIN INJURY			English	Article							HIGHER CEREBRAL FUNCTIONS; BLUNT HEAD-INJURY; RELATIVES VIEW; BNI SCREEN	Primary objective: Disturbances in affect expression and perception are often clinically observed in brain injured patients during the acute stages of recovery. This study examined whether such disturbances are related to the acute nature of the injury or specific type of injury in patients with stroke (CVA) versus traumatic brain injury (TBI). Research design : Retrospective cohort of patients seen for inpatient rehabilitation following brain injury. Procedures : Participants were 27 CVA and 27 TBI patients. Their performance was compared to 27 normal controls on the BNI Screen for Higher Cerebral Functions. Outcomes and results : While both patient groups performed significantly worse than the control group on affect expression, perception and spontaneity ( p <0.01), the CVA group performed significantly worse than the TBI group ( p <0.01) on affect perception. Results of this study document disturbances in affect in brain injured patients and highlight the importance of assessing affect during early recovery.	St Joseph Hosp & Med Ctr, Barrow Neurol Inst, Dept Clin Neuropsychol, Div Neurol,Sect Neuropsychol, Phoenix, AZ 85013 USA		Borgaro, SR (corresponding author), St Joseph Hosp & Med Ctr, Barrow Neurol Inst, Dept Clin Neuropsychol, Div Neurol,Sect Neuropsychol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.						BORGARO S, 2002, BNI Q, V17, P14; Borgaro SR, 2002, J HEAD TRAUMA REHAB, V17, P526, DOI 10.1097/00001199-200212000-00004; BOROD J, 1987, J NEUROL NEUROSUR PS, V51, P826; BOROD JC, 1992, J CONSULT CLIN PSYCH, V60, P339, DOI 10.1037/0022-006X.60.3.339; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; JENNETT B, 1974, MANAGEMENT HEAD INJU; PRIGATANO G, 1996, NEUROPSYCHOLOGICAL R; Prigatano G. P., 1995, BNI Q, V9, P2; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Rosenstein LD, 1997, NEUROPSY NEUROPSY BE, V10, P113; TOMPKINS C, 1995, RIGHT HEMIPSHERE COM; ZIGLER L, 1996, BNI Q, V16, P32	15	22	22	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2004	18	1					33	39		10.1080/0269905031000110562			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	749PB	WOS:000186928200002	14660234				2022-02-06	
J	Quemada, JI; Cespedes, JMM; Ezkerra, J; Ballesteros, JM; Ibarra, N; Urruticoechbea, I				Quemada, JI; Cespedes, JMM; Ezkerra, J; Ballesteros, JM; Ibarra, N; Urruticoechbea, I			Outcome of memory rehabilitation in traumatic brain injury assessed by neuropsychological tests and questionnaires	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activities of daily living; ecological validity; memory rehabilitation; neuropsychological assessment; tests; traumatic brain injury	EVERYDAY MEMORY; HEAD-INJURY; COGNITIVE REHABILITATION; INDIVIDUALS; PERFORMANCE; COMMUNITY; DEFICITS; LIFE; AID	Objectives: To evaluate the effectiveness of a memory rehabilitation program. To compare different outcome measures. Participants: Twelve patients with severe traumatic brain injury. Setting: Outpatient rehabilitation service. Main outcome measures: Rey-Osterrieth Complex Figure Test (REY), California Verbal Learning Test (CVLT), Rivermead Behavioural Memory Test (RBMT), and the Memory Failures in Everyday Memory Questionnaire (MFE). Statistical analysis: Exact nonparametric procedures. Results: All patients achieved meaningful functional gains. Modest improvements were found in some of the scales of the CVLT but not in the REY, RBMT, or MFE. Conclusion: Functional gains did not correlate with improvement in memory processes. Measurement of changes in independence in activities of daily living mediated by compensatory aids and educational intervention plans with relatives are proposed.	Hosp Aita Menni, Serv Dano Cerebral, Bilbao, Spain; Univ Complutense, Hosp Beata Maria Ana, Fac Psicol, Unidad Dano Cerebral, E-28040 Madrid, Spain; Inst Invest Psiquiatr, Bilbao, Spain		Quemada, JI (corresponding author), Serv Dano Cerebral, C-Egana 10, Bilbao 48010, Spain.		Ballesteros, Javier/O-8267-2015	Ballesteros, Javier/0000-0002-6713-1916			ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; BADDELEY A, 1987, NEUROBEHAVIORAL RECO; Benedet M.J., 1998, TAVEC TEST APRENDIZA; BERG IJ, 1991, NEUROPSYCHOL REHABIL, V1, P87; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; BROWN FH, 1991, J CLIN PSYCHOL, V47, P772, DOI 10.1002/1097-4679(199111)47:6<772::AID-JCLP2270470607>3.0.CO;2-P; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CESPEDES JMM, 1999, ANSIEDAD ESTRES, V5, P313; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cohen J., 1997, STAT POWER ANAL BEHA; DELIS D, 1987, CALIFORNIA VERBAL LE; DIXON RA, 1999, COGNITIVE NEUROREHAB; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; FRANZEN M D, 1991, Neuropsychology Review, V2, P29, DOI 10.1007/BF01108846; Garcia Mart?nez J., 1994, B PSICOLOGIA, V43, P89; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; HERRMANN DJ, 1982, PSYCHOL BULL, V92, P434, DOI 10.1037/0033-2909.92.2.434; Kim HJ, 1999, BRAIN INJURY, V13, P147, DOI 10.1080/026990599121818; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; KNIGHT RG, 1995, HDB MEMORY DISORDERS; Lanham RA, 2000, J HEAD TRAUMA REHAB, V15, P1123, DOI 10.1097/00001199-200010000-00006; LARRABEE GJ, 1996, ECOLOGICAL VALIDITY, P225; LEVIN HS, 1997, BEHAV NEUROLOGY NEUR; LIBERMAN J, 1994, J CLIN PSYCHOL, V50, P615, DOI 10.1002/1097-4679(199407)50:4<615::AID-JCLP2270500419>3.0.CO;2-R; LYNCH WJ, 1995, J HEAD TRAUMA REHAB, V10, P94, DOI 10.1097/00001199-199502000-00011; Makatura TJ, 1999, BRAIN INJURY, V13, P355; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; Pelegrin C., 1997, NEUROPSIQUIATRIA DAN; Raskin SA, 1996, J HEAD TRAUMA REHAB, V11, P32, DOI 10.1097/00001199-199606000-00007; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SCHWARTZ AF, 1989, CORTEX, V25, P665, DOI 10.1016/S0010-9452(89)80026-7; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); SUNDERLAND A, 1984, EVERYDAY MEMORY ACTI; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wallace CA, 1998, BRAIN INJURY, V12, P483, DOI 10.1080/02699052.1998.11910751; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wills P, 2000, BRAIN INJURY, V14, P693; Wilson, 1993, APPL PREV PSYCHOL, V2, P209, DOI DOI 10.1016/S0962-1849(05)80091-5; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; WILSON BA, 1984, EVERYDAY MEMORY ACTI; WILSON BA, 1999, COGNITIVE NEUROREHAB; WILSON BA, 1996, MEMORY, V4, P456; Wood RL, 1999, NEUROPSYCHOL REHABIL, V9, P505, DOI 10.1080/096020199389554; ZABALA A, IN PRESS REHABILITAC; ZELINSKI EM, 1990, PSYCHOL AGING, V5, P388, DOI 10.1037/0882-7974.5.3.388; ZENCIUS A, 1990, Brain Injury, V4, P33, DOI 10.3109/02699059009026146	54	22	22	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					532	540		10.1097/00001199-200311000-00007			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200007	14707883				2022-02-06	
J	Warschausky, S; Argento, AG; Hurvitz, E; Berg, M				Warschausky, S; Argento, AG; Hurvitz, E; Berg, M			Neuropsychological status and social problem solving in children with congenital or acquired brain dysfunction	REHABILITATION PSYCHOLOGY			English	Article							SEVERE HEAD-INJURY; SPINA-BIFIDA; HYDROCEPHALIC CHILDREN; COMPETENCE; ADOLESCENTS; PREVENTION; ADJUSTMENT; PEOPLE	Objective: To describe the associations between neuropsychological variables and social problem-solving skills in children with congenital versus acquired brain dysfunction. Participants: Twenty-two children and adolescents with cerebral palsy or myelomeningocele (developmental condition, or DC) and 22 with history of traumatic brain injury (TBI), ages 7-12 years, IQ > 70. Measures: Social Problem-Solving Measure (SPSM), Video Cues and Consequences (VCC), and brief motor-free neuropsychological assessment. Results: The DC group generated significantly fewer solutions to hypothetical problematic social scenarios than the TBI group, but differences in the relative frequencies of solution types were minimal. The pattern of associations between neuropsychological and social problem-solving variables differed between groups. Conclusions: Neuropsychological status may contribute to development and expression of aspects of social skills, but there may be subtle differences in the nature of that contribution in children with congenital versus acquired brain lesions.	Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Warschausky, S (corresponding author), Univ Michigan Hosp, Dept Phys Med & Rehabil, Box 0718,1500 E Med Ctr, Ann Arbor, MI 48109 USA.			Macy, Michelle/0000-0003-4401-7384			BADELLRIBERA A, 1966, PEDIATRICS, V37, P787; BELLACK AS, 1994, J ABNORM PSYCHOL, V103, P371, DOI 10.1037/0021-843X.103.2.371; BERNINGER VW, 1988, ARCH PHYS MED REHAB, V69, P250; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; BROWN J, 1988, UNPUB SCORING MANUAL; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; CROFOOT MJ, 1980, PSYCHOL SCHOOLS, V17, P474, DOI 10.1002/1520-6807(198010)17:4<474::AID-PITS2310170410>3.0.CO;2-O; DALLAS E, 1993, J CHILD PSYCHOL PSYC, V34, P649, DOI 10.1111/j.1469-7610.1993.tb01063.x; DENNIS M, 1981, ARCH NEUROL-CHICAGO, V38, P607, DOI 10.1001/archneur.1981.00510100035004; DODGE KA, 1986, MONOGR SOC RES CHILD, V51, P1; DORNER S, 1976, ARCH DIS CHILD, V51, P439, DOI 10.1136/adc.51.6.439; Dunn L. M., 1981, EXAMINERS MANUAL PEA; DZURILLA TJ, 1990, COGNITIVE THERAPY RE, V4, P67; ESLINGER PJ, 1993, NEUROPSYCHOLOGIA, V31, P17, DOI 10.1016/0028-3932(93)90077-D; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; FLETCHER JM, 1992, ARCH NEUROL-CHICAGO, V49, P818, DOI 10.1001/archneur.1992.00530320042010; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; HEALEY KN, 1992, AM J MENT RETARD, V96, P367; Heaton R.K., 1981, WISCONSIN CARD SORTI; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Kendall E, 1997, J HEAD TRAUMA REHAB, V12, P68, DOI 10.1097/00001199-199706000-00007; KOKKONEN J, 1991, DEV MED CHILD NEUROL, V33, P1095; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; MCANDREW I, 1979, DEV MED CHILD NEUROL, V21, P619; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; McDermott S, 1996, J PEDIATR PSYCHOL, V21, P447, DOI 10.1093/jpepsy/21.3.447; PETTIT GS, 1988, CHILD DEV, V59, P107, DOI 10.2307/1130393; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Sheslow D., 1990, WIDE RANGE ASSESSMEN; SHURE MB, 1979, J CLIN CHILD PSYCHOL, V8, P89, DOI 10.1080/15374417909532894; SHURE MB, 1982, AM J COMMUN PSYCHOL, V10, P341, DOI 10.1007/BF00896500; Van Horn K R, 1992, Brain Inj, V6, P15, DOI 10.3109/02699059209008118; WALLANDER JL, 1987, CLIN PSYCHOL REV, V7, P203; Warschausky S, 1996, ARCH CLIN NEUROPSYCH, V11, P147, DOI 10.1016/0887-6177(95)00004-6; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Warschausky S, 2003, HDB PEDIAT PSYCHOL, P375; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Yude C, 1999, DEV MED CHILD NEUROL, V41, P4, DOI 10.1017/S001216229900002X	39	22	22	0	9	EDUCATIONAL PUBLISHING FOUNDATION	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2003	48	4					250	254		10.1037/0090-5550.48.4.250			5	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	741ER	WOS:000186446200004					2022-02-06	
J	Mauritz, W; Pelinka, LE; Kaff, A; Segall, B; Fridrich, P				Mauritz, W; Pelinka, LE; Kaff, A; Segall, B; Fridrich, P			First aid measures provided by bystanders at the accident site. A prospective epidemiological study in the area of Vienna	WIENER KLINISCHE WOCHENSCHRIFT			German	Article						bystander; lay persons; prehospital care; emergency measures; first aid training	HOSPITAL CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; SURVIVAL; QUALITY; EFFICIENCY; COSTS; SCALE; CPR	The object of this prospective, epidemiological study was to determine whether bystanders provided necessary first aid measures in the prehospital trauma setting, whether they performed these measures correctly, and whether the level of first aid training affected the quality of first aid measures performed. Data were collected by means of a questionnaire, which was filled out between March and July 2000 for all cases attended to by the Vienna Ambulance Service. A total of 2812 cases were documented. The most frequent causes of trauma were falls from heights less than 1 meter (50%) and traffic accidents (17%). The most frequent injuries were injuries to the extremities (59%) and head and traumatic brain injuries (42%). Most patients were "moderately" or "severely" injured (69% and 29%, respectively), but life-threatening injuries were rare (2%). Bystanders were present in 57% of the cases. The most frequently required first aid measures were "application of a dressing" and "positioning" of the patient. "Control of haemorrhage", "ensuring accident site safety " and "extrication" of the patient were less frequently required. "Clearing of the airway", "precautions against hypothermia" and cardio-pulmonary resuscitation were very rarely required. Bystanders were most frequently policemen, relatives or friends of the patient, and strangers. The vast majority of bystanders had no training in first aid or had only attended the first aid course required to attain a driving licence. We found a clear relationship between the level of first aid training and the quality of first aid measures provided. It would be advisable to offer an increased amount of refresher courses in first aid to improve bystander trauma care.	AUVA, Unfallkrakenhaus Lorenz Bohler, Inst Anasthesiol & Intensivmed, A-1200 Vienna, Austria; Rettungs & Krankenbeforderungsdienst Stadt Wien, Vienna, Austria		Mauritz, W (corresponding author), AUVA, Unfallkrakenhaus Lorenz Bohler, Inst Anasthesiol & Intensivmed, Donaueschingenstr 13, A-1200 Vienna, Austria.			Mauritz, Walter/0000-0001-9043-3712			BARTSCH A, 1989, NOTARZT, V5, P77; Bur A, 2001, INTENS CARE MED, V27, P1474, DOI 10.1007/s001340101045; Donner-Banzhoff N, 1999, ANASTH INTENSIV NOTF, V34, P140; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; Gaul GB, 1996, RESUSCITATION, V32, P169, DOI 10.1016/0300-9572(96)00956-2; Holmberg M, 2000, RESUSCITATION, V47, P59, DOI 10.1016/S0300-9572(00)00199-4; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Jackson RE, 1997, ACAD EMERG MED, V4, P540, DOI 10.1111/j.1553-2712.1997.tb03574.x; Koeck CM, 2001, WIEN KLIN WOCHENSCHR, V113, P371; KROESEN G, 1994, WIEN KLIN WOCHENSCHR, V106, P634; MAURITZ W, 2000, NOTFALLMEDIZIN, pS46; Peterson T D, 1999, Prehosp Emerg Care, V3, P225, DOI 10.1080/10903129908958941; ROGGLA G, 1991, ACTA MED AUST, V18, P78; SWOR RA, 1995, ANN EMERG MED, V25, P780, DOI 10.1016/S0196-0644(95)70207-5; TEASDALE G, 1974, LANCET, V2, P81; VANHOEYWEGHEN RJ, 1993, RESUSCITATION, V26, P47, DOI 10.1016/0300-9572(93)90162-J; Weiss M, 2001, ANAESTHESIST, V50, P150, DOI 10.1007/s001010170030; WIK L, 1994, RESUSCITATION, V28, P195, DOI 10.1016/0300-9572(94)90064-7	18	22	22	0	5	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0043-5325			WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	OCT 31	2003	115	19-20					698	704		10.1007/BF03040885			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745NE	WOS:000186694100005	14650944				2022-02-06	
J	Kumar, R; Gupta, RK; Rao, SB; Chawla, S; Husain, M; Rathore, RKS				Kumar, R; Gupta, RK; Rao, SB; Chawla, S; Husain, M; Rathore, RKS			Magnetization transfer and T2 quantitation in normal appearing cortical gray matter and white matter adjacent to focal abnormality in patients with traumatic brain injury	MAGNETIC RESONANCE IMAGING			English	Article						traumatic brain injury; T2 relaxometry; MT ratio quantitation; gray matter; white matter	DIFFUSE AXONAL INJURY; CLOSED HEAD-INJURY; MULTIPLE-SCLEROSIS; TRANSFER RATIO; HISTOPATHOLOGIC CORRELATION; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; RELAXATION-TIME; LESIONS; ATROPHY	Traumatic brain injury (TBI) is one of the commonest causes of morbidity and mortality in the developed countries with posttraumatic epilepsy and functional disability being its major sequelae. The purpose of this study was to test the hypothesis whether the normal appearing adjacent gray and white matter regions on T2 and T1 weighted magnetization transfer (MT) weighted images show any abnormality on quantitative imaging in patients with TBI. A total of 51 patients with TBI and 10 normal subjects were included in this study. There were significant differences in T2 and MT ratio values of T2 weighted and T1 weighted MT normal appearing gray matter regions adjacent to focal image abnormality compared to normal gray matter regions in the normal individuals as corresponding contralateral regions of the TBI patient's group (p < 0.05). However the adjoining normal appearing white matter quantitative values did not show any significant change compared to the corresponding contralateral normal white matter values. We conclude that quantitative T2 and MT ratio values provide additional abnormality in patients with TBI that is not discernable on conventional T2 weighted and T1 weighted MT imaging especially in gray matter. This additional information may be of value in overall management of these patients with TBI. (C) 2003 Elsevier Inc. All rights reserved.	Sanjay Gandhi Postgrad Inst Med Sci, Dept Radiodiag, Lucknow, Uttar Pradesh, India; King Georges Med Coll, Dept Neurosurg, Lucknow, Uttar Pradesh, India; Indian Inst Technol, Dept Math, Kanpur, Uttar Pradesh, India		Gupta, RK (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Radiodiag, Lucknow, Uttar Pradesh, India.	rgupta@sgpgi.ac.in					ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; BALABAN R S, 1992, Magnetic Resonance Quarterly, V8, P116; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Blinkenberg M, 1999, NEUROLOGY, V53, P149, DOI 10.1212/WNL.53.1.149; BOORSTEIN JM, 1994, RADIOLOGY, V191, P799, DOI 10.1148/radiology.191.3.8184068; Bozzali M, 2001, NEUROLOGY, V57, P1135, DOI 10.1212/WNL.57.6.1135; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; COMI G, 1995, J NEUROL SCI, V132, P222, DOI 10.1016/0022-510X(95)00168-2; Convit A, 2000, NEUROBIOL AGING, V21, P19, DOI 10.1016/S0197-4580(99)00107-4; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; Duncan JS, 1996, AM J NEURORADIOL, V17, P1805; ELIAS RM, 1998, RADIOLOGY, V209, P551; FILIPPI M, 1995, NEUROLOGY, V45, P478, DOI 10.1212/WNL.45.3.478; Ge YL, 2002, J COMPUT ASSIST TOMO, V26, P62, DOI 10.1097/00004728-200201000-00009; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GOMORI JM, 1993, AM J NEURORADIOL, V14, P871; Gupta RK, 2001, J COMPUT ASSIST TOMO, V25, P698, DOI 10.1097/00004728-200109000-00006; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; Kabani NJ, 2002, NEUROIMAGE, V15, P604, DOI 10.1006/nimg.2001.0992; Kasner SE, 1997, NEUROLOGY, V48, P534, DOI 10.1212/WNL.48.2.534; Kathuria MK, 1998, J MAGN RESON IMAGING, V8, P473, DOI 10.1002/jmri.1880080231; Kato Y, 1997, AM J NEURORADIOL, V18, P1541; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; Kumar R, 2002, NEUROIMAGE, V15, P1015, DOI 10.1006/nimg.2001.1036; KURTZKE JF, 1987, CLIN NEUROLOGY, P1; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEXA FJ, 1994, AM J NEURORADIOL, V15, P201; LOEVNER LA, 1995, RADIOLOGY, V196, P511, DOI 10.1148/radiology.196.2.7617869; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.0.CO;2-6; Namer IJ, 1999, EPILEPSIA, V40, P1424, DOI 10.1111/j.1528-1157.1999.tb02015.x; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; RAINE CS, 1989, LAB INVEST, V60, P714; Swann A, 1997, INT J GERIATR PSYCH, V12, P1182, DOI 10.1002/(SICI)1099-1166(199712)12:12<1182::AID-GPS714>3.0.CO;2-M; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vavasour IM, 1998, MAGNET RESON MED, V40, P763, DOI 10.1002/mrm.1910400518; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113	46	22	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	OCT	2003	21	8					893	899		10.1016/S0730-725X(03)00189-9			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	740QA	WOS:000186412000009	14599540				2022-02-06	
J	Al Moutaery, K; Al Deeb, S; Khan, HA; Tariq, M				Al Moutaery, K; Al Deeb, S; Khan, HA; Tariq, M			Caffeine impairs short-term neurological outcome after concussive head injury in rats	NEUROSURGERY			English	Article						adenosine; caffeine; free radicals; head injury; neurotrauma; secondary injury	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; EXCITATORY AMINO-ACIDS; CEREBRAL-ISCHEMIA; NONCOMPETITIVE BLOCKADE; QUANTITATIVE-EVALUATION; ADENINE-NUCLEOTIDES; ANALGESIC ADJUVANT; LIPID-PEROXIDATION; TRANSIENT ISCHEMIA	OBJECTIVE: Adenosine is an endogenous neuroprotective agent that is released during ischemia, hypoxia, epilepsy, and ischemic brain injury. Caffeine is a receptor antagonist for adenosine that might interfere with the neuroprotective effect of adenosine in ischemic-hypoxic conditions. An investigation was undertaken to study the effect of caffeine on neurological function, edema formation, and blood-brain barrier permeability after experimental head injury in rats. METHODS: Adult female Wistar rats classified into different groups received caffeine intraperitoneally at doses of 0, 50, 100, and, 150 mg/kg body weight. Thirty minutes after the caffeine treatment, the animals were subjected to concussive head injury (CHI) administered by a controlled cortical impact device. Neurological severity score was recorded in each rat at 2 hours after CHI. Specific gravity, water content (as an indicator of edema), and blood-brain barrier impairment were analyzed in the cortical tissue surrounding the injury site. The levels of myeloperoxidase and malondialdehyde in the cortical region were measured as indicators of of neutrophil infiltration and lipid peroxidation, respectively. RESULTS: A significant increase in righting latency and neurological deficiency after CHI was observed in caffeine-treated rats as compared with untreated animals. Although no deaths occurred in the rats exposed to CHI after pretreatment with saline, pretreatment with caffeine caused significant mortality of animals after trauma in a dose-dependent manner. Caffeine also exacerbated neutrophil infiltration, edema, and disruption of blood-brain barrier in the traumatic cortex. Light microscopy of brain revealed more severe hemorrhage and, neuronal degeneration in the injured hemisphere of caffeine-treated rats as compared with rats in the injury-alone group. A significant increase in malondialdehyde in the brain of injured rats treated with caffeine before CHI clearly indicated the role of oxidative stress. CONCLUSION: Caffeine adversely affects outcome after CHI, possibly as a result of blockade of adenosine receptors. The findings also point toward the involvement of free radical-mediated neuronal damage in caffeine-induced exacerbation of neurotrauma.	Armed Forces Hosp, Neurosci Res Grp, Riyadh 11159, Saudi Arabia		Tariq, M (corresponding author), Armed Forces Hosp, Neurosci Res Grp, POB 7897 W-912, Riyadh 11159, Saudi Arabia.		Khan, Haseeb A./E-3872-2014	Khan, Haseeb A./0000-0001-6084-8589			Ahmed S, 2000, AM J CLIN ONCOL-CANC, V23, P420, DOI 10.1097/00000421-200008000-00022; AKTAN S, 1991, PROSTAG LEUKOTR ESS, V42, P67, DOI 10.1016/0952-3278(91)90069-H; Al Deeb S, 2002, NEUROSCI LETT, V325, P216, DOI 10.1016/S0304-3940(02)00042-3; Al Moutaery K, 2000, J NEUROSURG, V93, P276; ANDINE P, 1990, BRIT J PHARMACOL, V100, P814, DOI 10.1111/j.1476-5381.1990.tb14097.x; Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309; BECKER AB, 1984, NEW ENGL J MED, V310, P743, DOI 10.1056/NEJM198403223101202; BERNE RM, 1974, CIRC RES, V35, P262, DOI 10.1161/01.RES.35.2.262; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Buck LT, 1998, J EXP BIOL, V201, P289; Burg A. W., 1975, Tea and Coffee Trade Journal, V147, P40; COLLINS WF, 1983, PARAPLEGIA, V21, P204, DOI 10.1038/sc.1983.34; CRONSTEIN BN, 1994, J APPL PHYSIOL, V76, P5, DOI 10.1152/jappl.1994.76.1.5; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; DALY, 1993, CAFFEINE COFFEE HLTH, P97; Darakchiev BJ, 1997, ACT NEUR S, V70, P98; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; DERLET RW, 1992, AM J EMERG MED, V10, P211, DOI 10.1016/0735-6757(92)90211-F; DOLPHIN AC, 1983, NEUROSCI LETT, V43, P49, DOI 10.1016/0304-3940(83)90127-1; DUNWIDDIE TV, 1980, BRIT J PHARMACOL, V69, P59, DOI 10.1111/j.1476-5381.1980.tb10883.x; Erenberg A, 2000, PHARMACOTHERAPY, V20, P644, DOI 10.1592/phco.20.7.644.35167; Eun BL, 2000, PEDIATR RES, V47, P73, DOI 10.1203/00006450-200001000-00014; EVANS MC, 1987, NEUROSCI LETT, V83, P287, DOI 10.1016/0304-3940(87)90101-7; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; Fredholm BB, 1997, INT REV NEUROBIOL, V40, P259; GARTHWAITE G, 1986, NEUROSCIENCE, V18, P437, DOI 10.1016/0306-4522(86)90164-8; GOLDING EM, 1995, MOL CHEM NEUROPATHOL, V24, P137, DOI 10.1007/BF02962139; Griffiths RR, 2000, ARCH FAM MED, V9, P727, DOI 10.1001/archfami.9.8.727; HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169; HALL ED, 1994, ANN NY ACAD SCI, V738, P15; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HERON A, 1993, BRAIN RES, V608, P27, DOI 10.1016/0006-8993(93)90769-J; HSU CY, 1985, NEUROLOGY, V35, P1003, DOI 10.1212/WNL.35.7.1003; Hudome S, 1997, PEDIATR RES, V41, P607, DOI 10.1203/00006450-199705000-00002; IKEDA Y, 1990, ACT NEUR S, V51, P74; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Kamimori GH, 2000, EUR J CLIN PHARMACOL, V56, P537, DOI 10.1007/s002280000186; Karas Maria, 2001, Journal of Environmental Pathology Toxicology and Oncology, V20, P141; Karhapaa L, 1997, J CELL PHYSIOL, V171, P52; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KULKARNI C, 1989, INDIAN J EXP BIOL, V27, P1048; LASKA EM, 1984, JAMA-J AM MED ASSOC, V251, P1711, DOI 10.1001/jama.251.13.1711; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; LIEBERMAN HR, 1987, PSYCHOPHARMACOLOGY, V92, P308, DOI 10.1007/BF00210835; Liguori A, 2001, DRUG ALCOHOL DEPEN, V63, P123, DOI 10.1016/S0376-8716(00)00196-4; MAGGIRWAR SB, 1994, BIOCHEM BIOPH RES CO, V201, P508, DOI 10.1006/bbrc.1994.1731; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; Molnar D, 2000, INT J OBESITY, V24, P1573, DOI 10.1038/sj.ijo.0801433; MORII S, 1983, J CEREB BLOOD FLO S1, V3, pS480; Nakamichi T, 1998, Jpn J Thorac Cardiovasc Surg, V46, P354; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; NILSSON B, 1977, J NEUROSURG, V47, P252, DOI 10.3171/jns.1977.47.2.0252; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; OSTERHOLM JL, 1972, J NEUROSURG, V36, P386, DOI 10.3171/jns.1972.36.4.0386; PETKOV VV, 1984, METHOD FIND EXP CLIN, V6, P433; PUIROUD S, 1988, BRAIN RES, V453, P287, DOI 10.1016/0006-8993(88)90169-2; RUDOLPHI KA, 1990, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1990, P439; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; Ruijter J, 2000, PHARMACOL BIOCHEM BE, V66, P29, DOI 10.1016/S0091-3057(00)00229-X; SALZMAN SK, 1987, J NEUROSURG, V66, P431, DOI 10.3171/jns.1987.66.3.0431; SANDLER AN, 1976, J NEUROSURG, V45, P638, DOI 10.3171/jns.1976.45.6.0638; SAWYNOK J, 1993, PHARMACOL REV, V45, P43; Schubert P, 1997, ANN NY ACAD SCI, V825, P1, DOI 10.1111/j.1749-6632.1997.tb48409.x; SCHUBERT P, 1986, BRAIN RES, V376, P382, DOI 10.1016/0006-8993(86)90204-0; SCHUBERT P, 1979, BRAIN RES, V172, P186, DOI 10.1016/0006-8993(79)90910-7; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1992, ANESTHESIOLOGY, V77, P79, DOI 10.1097/00000542-199207000-00012; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRO P, 1982, LANCET, V1, P793; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; SULLIVAN GW, 1995, IMMUNOPHARMACOLOGY, V31, P19, DOI 10.1016/0162-3109(95)00030-0; SUTHERLAND GR, 1991, NEUROSCIENCE, V42, P171, DOI 10.1016/0306-4522(91)90157-J; Taoka Y, 1997, J NEUROSURG, V86, P1007, DOI 10.3171/jns.1997.86.6.1007; Taoka Y, 1997, CRIT CARE MED, V25, P874, DOI 10.1097/00003246-199705000-00026; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Turcani P, 2001, J NEUROL SCI, V183, P57, DOI 10.1016/S0022-510X(00)00477-9; Ustun ME, 2001, INTENS CARE MED, V27, P264, DOI 10.1007/s001340000780; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; WATANABE H, 1981, J PHARMACOBIO-DYNAM, V4, P301, DOI 10.1248/bpb1978.4.301; WEI EP, 1981, J CEREB BLOOD FLO S1, V1, pS395; WILSON JT, 1995, J TRAUMA, V39, P473; WINN HR, 1979, CIRC RES, V45, P486, DOI 10.1161/01.RES.45.4.486; WINN HR, 1980, AM J PHYSIOL, V239, pH636, DOI 10.1152/ajpheart.1980.239.5.H636; Zubkov AY, 2000, ACT NEUR S, V76, P223	91	22	24	0	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2003	53	3					704	711		10.1227/01.NEU.0000079487.66013.6F			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	718AL	WOS:000185122900035	12943586				2022-02-06	
J	Kahraman, S; Ozgurtas, T; Kayali, H; Atabey, C; Kutluay, T; Timurkaynak, E				Kahraman, S; Ozgurtas, T; Kayali, H; Atabey, C; Kutluay, T; Timurkaynak, E			Monitoring of serum ionized magnesium in neurosurgical intensive care unit: preliminary results	CLINICA CHIMICA ACTA			English	Article						head injury; intensive care; ionized magnesium; neurotrauma	TRAUMATIC BRAIN-INJURY; CALCIUM; DECLINE	Background: Our purpose was to determine the values for serum ionized magnesium (Mg) concentrations in traumatic brain injury and its effect on the prognostic scores of patients. Methods: We prospectively measured serum ionized magnesium concentrations in 30 patients that were classified into three groups (severe, moderate, mild) by Glasgow Coma Scale Score. Serum ionized magnesium concentrations were measured during posttraumatic 5 days. Thirty patients with head trauma were followed in a neurosurgical intensive care unit with monitoring serum ionized magnesium concentrations. All patients were treated conservatively. Results: We found significant difference of serum ionized magnesium concentrations when we compared all groups with each other (p<0.001). Conclusions: Based on this clinical preliminary study, traumatic brain injury is associated with graded deficit in serum ionized magnesium concentrations. Thus, measurement of serum ionized magnesium concentrations can be used as a clinical marker in traumatic brain injury. (C) 2003 Elsevier B.V. All rights reserved.	Gulhane Mil Med Acad, Dept Neurosurg, TR-06018 Etlik, Turkey; Gulhane Mil Med Acad, Dept Biochem, TR-06018 Etlik, Turkey		Kahraman, S (corresponding author), Gulhane Mil Med Acad, Dept Neurosurg, TR-06018 Etlik, Turkey.	skahraman@gata.edu.tr	OZGURTAS, TANER/X-4768-2019; Kahraman, Serdar/K-4658-2019; Atabey, Cem/A-1391-2018	Kahraman, Serdar/0000-0003-2489-3854; Atabey, Cem/0000-0002-9047-196X			Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cormio M, 1997, J CLIN NEUROSCI, V4, P132, DOI 10.1016/S0967-5868(97)90062-X; Heath DL, 1998, SCAND J CLIN LAB INV, V58, P161, DOI 10.1080/00365519850186751; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; HRISTOVA EN, 1995, CLIN CHEM, V41, P1649; Huijgen HJ, 1999, CLIN CHEM LAB MED, V37, P465, DOI 10.1515/CCLM.1999.075; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Quamme GA, 1997, KIDNEY INT, V52, P1180, DOI 10.1038/ki.1997.443; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; SIESJO BK, 1986, EUR NEUROL, V25, P45, DOI 10.1159/000116060; SIESJO BK, 1989, J CEREBR BLOOD F MET, V9, P127, DOI 10.1038/jcbfm.1989.20; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; VANINGEN HE, 1994, CLIN CHEM, V40, P52; Vink R, 2000, FRONT BIOSCI, V5, pD656, DOI 10.2741/Vink; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1991, MAGNES TRACE ELEM, V92, P1	25	22	25	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	AUG	2003	334	1-2					211	215		10.1016/S0009-8981(03)00235-3			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	706XZ	WOS:000184481500023	12867294				2022-02-06	
J	Saljo, A; Huang, YL; Hansson, HA				Saljo, A; Huang, YL; Hansson, HA			Impulse noise transiently increased the permeability of nerve and glial cell membranes, an effect accentuated by a recent brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebrospinal fluid; closed head injury; diffuse brain damage; impulse noise; neuron specific enolase; S-100; shock wave	NEURON-SPECIFIC ENOLASE; ADULT-RAT BRAIN; COMBINED FLUID PERCUSSION; INDUCED AXONAL INJURY; CEREBROSPINAL-FLUID; S-100 PROTEIN; BLAST INJURY; CYTOCHEMICAL EVIDENCE; COGNITIVE IMPAIRMENT; STRETCH INJURY	A single exposure to intense impulse noise may cause diffuse brain injury, revealed by increased expression of immediate early gene products, transiently altered distribution of neurofilaments, accumulation of beta-amyloid precursor protein, apoptosis, and gliosis. Neither hemorrage nor any gross structural damage are seen. The present study focused on whether impulse noise exposure increased the permeability of nerve and glial cell membranes to proteins. Also, we investigated whether a preceding,,minor focal surgical brain lesion accentuated the leakage of cytosolic proteins. Anaesthetized rats were exposed to a single impulse noise at either 199 or 202 dB for 2 milliseconds. Transiently elevated levels of the cellular protein neuron specific enolase (NSE) and the glial cytoplasmic protein S-100 were recorded in the cerebrospinal fluid (CSF) during the first hours after the exposure to 202 dB. A surgical brain injury, induced the day before the exposure to the impulse noise, was associated with significantly increased concentrations of both markers in the CSF. It is concluded that intense impulse noise damages both nerve and glial cells, an effect aggravated by a preexisting surgical lesion. The impulse of the shock wave, i.e. the pressure integrated over time, is likely to be the injurious mechanism. The abnormal membrane permeability and the associated cytoskeletal changes may initiate events, which eventually result in a progressive diffuse brain injury.	Univ Gothenburg, Inst Anat & Cell Biol, SE-40530 Gothenburg, Sweden		Hansson, HA (corresponding author), Univ Gothenburg, Inst Anat & Cell Biol, POB 420, SE-40530 Gothenburg, Sweden.	hansarne.hansson@anatcell.gu.se					Argyros GJ, 1997, TOXICOLOGY, V121, P105, DOI 10.1016/S0300-483X(97)03659-7; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 1999, BRAIN INJURY, V13, P1005; CERNAK I, 1997, INT REV ARMED FORCES, V70, P114; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Dancer A, 1998, SCAND AUDIOL, V27, P123; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Elsayed NM, 1997, TOXICOLOGY, V121, P1, DOI 10.1016/S0300-483X(97)03651-2; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fitzpatrick MO, 1998, J NEUROL NEUROSUR PS, V64, P285, DOI 10.1136/jnnp.64.3.285; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; GRASSO A, 1977, BRAIN RES, V122, P582, DOI 10.1016/0006-8993(77)90472-3; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; HATFIELD RH, 1992, BRAIN RES, V577, P249, DOI 10.1016/0006-8993(92)90280-M; Huang YL, 1995, J NEUROSCI METH, V63, P13, DOI 10.1016/0165-0270(95)00080-1; Huang YL, 1996, BRAIN RES BULL, V41, P273, DOI 10.1016/S0361-9230(96)00176-1; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; KRUSE A, 1991, ACTA NEUROCHIR, V110, P106, DOI 10.1007/BF01400675; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Maxwell WL, 1999, J NEUROTRAUM, V16, P273, DOI 10.1089/neu.1999.16.273; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Moore B W, 1972, Int Rev Neurobiol, V15, P215; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Ortengren T, 1996, J NEUROTRAUM, V13, P171, DOI 10.1089/neu.1996.13.171; PERSSON L, 1987, STROKE, V18, P911, DOI 10.1161/01.STR.18.5.911; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Phillips LL, 1997, J NEUROSCI RES, V49, P197; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; Povlishock JT, 1999, ACT NEUR S, V73, P15; Price GR, 1999, J ACOUST SOC AM, V106, P2629, DOI 10.1121/1.428092; PRICE GR, 1989, SCAND AUDIOL S, V34, P21; Reeves TM, 1997, NEUROSCIENCE, V77, P431, DOI 10.1016/S0306-4522(96)00486-1; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2002, J NEUROTRAUM, V19, P379, DOI 10.1089/089771502753594945; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Siegel GJ, 1999, BASIC NEUROCHEMISTRY; SINDIC CJM, 1982, J NEUROL NEUROSUR PS, V45, P1130, DOI 10.1136/jnnp.45.12.1130; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Stuhmiller JH, 1997, TOXICOLOGY, V121, P91, DOI 10.1016/S0300-483X(97)03658-5; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; SUNESON A, 1990, J TRAUMA, V30, P10; SVENSSON MY, 1990, P INT IRCOBI, V13, P189; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; VALLFORS B, 1976, BRAIN INJURY CAUSED; WESTERGREN I, 1991, BRAIN RES BULL, V27, P283, DOI 10.1016/0361-9230(91)90083-V; Yaremchuk K, 2001, OTOLARYNG HEAD NECK, V125, P130, DOI 10.1067/mhn.2001.117872	54	22	24	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2003	20	8					787	794		10.1089/089771503767870014			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	712BU	WOS:000184777000009	12965057				2022-02-06	
J	Abe, M; Udono, H; Tabuchi, K; Uchino, A; Yoshikai, T; Taki, K				Abe, M; Udono, H; Tabuchi, K; Uchino, A; Yoshikai, T; Taki, K			Analysis of ischemic brain damage in cases of acute subdural hematomas	SURGICAL NEUROLOGY			English	Article						head injury; cerebral blood flow; subdural hematoma; cerebral herniation	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; PRACTICAL SCALE; CONSCIOUSNESS; HERNIATION; METABOLISM; MORTALITY; ARTERIES; REMOVAL	BACKGROUND Ischemic damage of the brain is one of the most important factors for the sequelae of acute subdural hematomas (ASDHs). However, ischemic damage is infrequently addressed in a systematic manner in the clinical setting. METHODS The analysis of ischemic brain damage was performed based on serial computed tomography (CT) scans in 80 patients with traumatic ASDHs. Single photon emission computed tomography (SPECT) for regional blood flow and/or magnetic resonance imaging (MRI) were also performed. RESULTS Follow-up CT scans showed ischemic brain damage in 19 patients and no significant damage in 35 patients. The remaining 26 patients progressively deteriorated to the point of brain death. The ischemic brain damage was seen most frequently in the territory of the anterior cerebral artery (13 cases), followed by the territory of the posterior cerebral artery (12 cases). The ischemic damages in the pallidum, the hypothalamus and the thalamus were demonstrated in 4, 8, and 4 cases, respectively. The ischemic damage in the underlying brain that was probably because of the direct compression of the hematoma was seen in only two cases. CONCLUSION Most of the ischemic brain damage noted in this study was because of arterial compression secondary to the brain shift and brain herniation, rather than the direct effect of the hematoma upon the underlying brain. Ischemic brain damage adversely affects outcome morbidity, and the difficulty in preventing ischemic damage in cases with marked brain shift leads to poor outcome in patients with ASDHs. (C) 2003 Elsevier Inc. All rights reserved.	Saga Med Sch, Dept Neurosurg, Saga 8498501, Japan; Saga Med Sch, Dept Radiol, Saga 8498501, Japan; Saga Med Sch, Dept Emergency Med, Saga 8498501, Japan		Abe, M (corresponding author), Saga Med Sch, Dept Neurosurg, Nabeshima 5-1-1, Saga 8498501, Japan.						BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; FUJISAWA H, 1994, ACT NEUR S, V60, P193; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HAYMAN LA, 1981, AM J ROENTGENOL, V137, P13, DOI 10.2214/ajr.137.1.13; JENNETT B, 1975, LANCET, V1, P480; KURODA Y, 1992, NEUROSURGERY, V30, P687; LANGFITT TW, 1982, J NEUROSURG, V56, P19, DOI 10.3171/jns.1982.56.1.0019; LINDENBERG R, 1955, J NEUROPATH EXP NEUR, V14, P223, DOI 10.1097/00005072-195507000-00001; LOBATO RD, 1988, J NEUROSURG, V68, P417, DOI 10.3171/jns.1988.68.3.0417; Lubillo S, 1999, J NEUROSURG, V91, P581, DOI 10.3171/jns.1999.91.4.0581; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MORETTI JL, 1990, EUR J NUCL MED, V16, P17, DOI 10.1007/BF01566007; Niikawa S, 1988, No To Shinkei, V40, P1151; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; ROSENORN J, 1978, J NEUROSURG, V48, P345, DOI 10.3171/jns.1978.48.3.0345; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; ROTHFUS WE, 1987, AM J NEURORADIOL, V8, P1073; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SATO M, 1986, NEUROSURGERY, V18, P300, DOI 10.1227/00006123-198603000-00007; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; TEASDALE G, 1974, LANCET, V2, P81; WERNICK S, 1989, J COMPUT ASSIST TOMO, V13, P323, DOI 10.1097/00004728-198903000-00027; WESTBERG G, 1966, ACTA RADIOL DIAGN, V5, P581, DOI 10.1177/02841851660050P163; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Yoshikai T, 1997, Radiat Med, V15, P419; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	33	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUN	2003	59	6					464	472		10.1016/S0090-3019(03)00078-8			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	695QN	WOS:000183841900012	12826344				2022-02-06	
J	Buck, CR; Jurynec, MJ; Gupta, DK; Law, AKT; Bilger, J; Wallace, DC; McKeon, RJ				Buck, CR; Jurynec, MJ; Gupta, DK; Law, AKT; Bilger, J; Wallace, DC; McKeon, RJ			Increased adenine nucleotide translocator 1 in reactive astrocytes facilitates glutamate transport	EXPERIMENTAL NEUROLOGY			English	Article						glial scar; neuroprotection; mitochondria; transforming growth factor-beta 1 (TGF-beta 1); CNS injury; differential display PCR	FIBRILLARY ACIDIC PROTEIN; TRANSFORMING GROWTH FACTOR-BETA-1; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD INJURY; RAT-BRAIN; MICE LACKING; EXTRACELLULAR-MATRIX; CULTURED ASTROCYTES; NEURITE OUTGROWTH; TRAUMATIC INJURY	A hallmark of central nervous system (CNS) pathology is reactive astrocyte production of the chronic glial scar that is inhibitory to neuronal regeneration. The reactive astrocyte response is complex; these cells also produce neurotrophic factors and are responsible for removal of extracellular glutamate, the excitatory neurotransmitter that rises to neurotoxic levels in injury and disease. To identify genes expressed by reactive astrocytes, we employed an in vivo model of the glial scar and differential display PCR and found an increase in the level of Aral, a mitochondrial ATP/ADP exchanger that facilitates the flux of ATP out of the mitochondria. Ant1 expression in reactive astrocytes is regulated by transforming growth factor-beta1, a pluripotent CNS injury-induced cytokine. The significance of increased Ant1 is evident from the observation that glutamate uptake is significantly decreased in astrocytes from Ant1 null mutant mice while a specific Ant inhibitor reduces glutamate uptake in wild-type astrocytes. Thus, the astrocytic response to CNS injury includes an apparent increase in energy mobilization capacity by Ant1 that contributes to neuroprotective, energy-dependent glutamate uptake. (C) 2003 Elsevier Science (USA). All rights reserved.	Oridis Biomed, A-8010 Graz, Austria; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Emory Univ, Dept Physiol, Atlanta, GA 30322 USA; Emory Univ, Ctr Mol Med, Atlanta, GA 30322 USA; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA		Buck, CR (corresponding author), Oridis Biomed, Elisabethstr 84, A-8010 Graz, Austria.		Jurynec, Michael/AAH-8765-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS035986, R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG013154] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL64017] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG13154, R01 AG013154] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21328, NS35986, R01 NS021328] Funding Source: Medline		Asher RA, 2000, J NEUROSCI, V20, P2427; BAGHDASSARIAN D, 1993, GLIA, V7, P193, DOI 10.1002/glia.440070302; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; Blanc EM, 1998, GLIA, V22, P149, DOI 10.1002/(SICI)1098-1136(199802)22:2<149::AID-GLIA6>3.0.CO;2-2; Bovolenta P, 1997, EUR J NEUROSCI, V9, P977, DOI 10.1111/j.1460-9568.1997.tb01448.x; Buisson A, 1998, FASEB J, V12, P1683, DOI 10.1096/fasebj.12.15.1683; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Dorner A, 1999, BBA-BIOMEMBRANES, V1417, P16, DOI 10.1016/S0005-2736(98)00245-4; Eng DL, 1997, BRAIN RES, V778, P215, DOI 10.1016/S0006-8993(97)01093-7; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Greene JG, 1996, PROG NEUROBIOL, V48, P613, DOI 10.1016/0301-0082(96)00006-8; KLINGENBERG M, 1985, ENZYMES BIOL MEMBR, V4, P511; Krohn K, 1999, J NEUROCHEM, V72, P1353, DOI 10.1046/j.1471-4159.1999.721353.x; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Levy SE, 2000, GENE, V254, P57, DOI 10.1016/S0378-1119(00)00252-3; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; Logan A, 1999, EUR J NEUROSCI, V11, P2367, DOI 10.1046/j.1460-9568.1999.00654.x; LOGAN A, 1992, BRAIN RES, V587, P216, DOI 10.1016/0006-8993(92)91000-5; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Mocchetti I, 1996, EXP NEUROL, V141, P154, DOI 10.1006/exnr.1996.0149; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Peuchen S, 1997, PROG NEUROBIOL, V52, P261, DOI 10.1016/S0301-0082(97)00010-5; Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; RUDGE JS, 1989, EXP NEUROL, V103, P1, DOI 10.1016/0014-4886(89)90180-5; RUDGE JS, 1992, EUR J NEUROSCI, V4, P459, DOI 10.1111/j.1460-9568.1992.tb00896.x; Silver IA, 1997, NEUROSCIENCE, V78, P589, DOI 10.1016/S0306-4522(96)00600-8; Silver IA, 1997, GLIA, V21, P35, DOI 10.1002/(SICI)1098-1136(199709)21:1<35::AID-GLIA4>3.0.CO;2-0; Smith GM, 1997, J NEUROSCI, V17, P9624; Sonnewald U, 1997, GLIA, V21, P56, DOI 10.1002/(SICI)1098-1136(199709)21:1<56::AID-GLIA6>3.0.CO;2-#; STREICHERSCOTT J, 1993, ANAL BIOCHEM, V210, P69, DOI 10.1006/abio.1993.1152; Swanson RA, 1996, DEV NEUROSCI-BASEL, V18, P515, DOI 10.1159/000111448; Takahashi M, 1997, J EXP BIOL, V200, P401; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wang X, 1997, EXP NEUROL, V148, P568, DOI 10.1006/exnr.1997.6702; Ye ZC, 1998, GLIA, V22, P237, DOI 10.1002/(SICI)1098-1136(199803)22:3<237::AID-GLIA3>3.0.CO;2-2; YU ACH, 1993, J NEUROSCI RES, V34, P295, DOI 10.1002/jnr.490340306; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	46	22	22	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	JUN	2003	181	2					149	158		10.1016/S0014-4886(03)00043-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	687RR	WOS:000183391000003	12781988	Green Accepted			2022-02-06	
J	Gabbe, B; Finch, CF; Wajswelner, H; Bennell, K				Gabbe, B; Finch, CF; Wajswelner, H; Bennell, K			Does community-level Australian football support injury prevention research?	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article							PROFILE	The progress of injury prevention research in Australian football to date has been slow despite its recognition as a public health goal. In particular, field-based studies to identify injury risk factors and evaluate the effectiveness of injury prevention strategies need to be undertaken to ensure safety gains in this sport. For these types of studies to be successful and complied with, considerable support is required from clubs, coaches and players. To date, the actual level of support for injury prevention research at the community-level of football has not been established. A survey of 82 club administrators and coaches from the Victorian Amateur Football Association was undertaken to determine the level of support for injury prevention research, along with incentives for, and barriers towards, participation in such research. The highest priorities for injury prevention research were given as the prevention of knee, hamstring and concussion injuries and investigation into the content of training programs. The most common incentives reported as being necessary for participation in injury prevention research were financial assistance (59.5%), more club staff (57.0%) and further education (36.7%). The most commonly reported barriers to research were the expertise (50.0%) and number of (48.8%) of club medical staff members. Overall community-level football club administrators and coaches rank the importance of injury prevention research highly. The findings of this study are positive for injury prevention researchers and suggest that clubs are keen to participate in such research.	Univ Melbourne, Sch Physiotherapy, Ctr Sports Med Res & Educ, Melbourne, Vic, Australia; Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic 3168, Australia		Gabbe, B (corresponding author), Univ Melbourne, Sch Physiotherapy, Ctr Sports Med Res & Educ, Melbourne, Vic, Australia.		Bennell, Kim/C-7022-2014	Bennell, Kim/0000-0003-4982-5639; Wajswelner, Henry/0000-0003-2082-3816; Gabbe, Belinda/0000-0001-7096-7688			BANGDIWALA S, 2001, INJ CONTROL SAF PROM, V8, P91; Finch C, 1995, FEASIBILITY IMPROVED; Gabbe B, 2001, J SCI MED SPORT, V4, P386, DOI 10.1016/S1440-2440(01)80048-7; Gabbe B, 2002, J SCI MED SPORT, V5, P149, DOI 10.1016/S1440-2440(02)80036-6; GABBE B, 1998, TACKLING AUSTR FOOTB; Jekel JF, 1999, EPIDEMIOLOGY BIOSTAT; MCMAHON KA, 1993, MED J AUSTRALIA, V159, P301, DOI 10.5694/j.1326-5377.1993.tb137864.x; MOLLER J, 1999, PARADIGM SHIFT INJUR; Newton D. P., 2001, RES EDUC, V66, P54, DOI DOI 10.7227/RIE.66.5; Orchard J, 1999, MED J AUSTRALIA, V170, P304, DOI 10.5694/j.1326-5377.1999.tb127782.x; Orchard J, 1998, J SCI MED SPORT, V1, P82; SEWARD H, 1993, MED J AUSTRALIA, V159, P298, DOI 10.5694/j.1326-5377.1993.tb137863.x; Seward H. G., 1992, AUST J SCI MED SPORT, V24, P51; Shawdon A, 1994, Aust J Sci Med Sport, V26, P59; Stevenson MR, 2000, BRIT J SPORT MED, V34, P188, DOI 10.1136/bjsm.34.3.188; vanMechelen W, 1997, SPORTS MED, V24, P164, DOI 10.2165/00007256-199724030-00003; ZAZRYN T, 2002, UNPUB BRIT J SPORTS	17	22	22	1	7	SPORTS MEDICINE AUSTRALIA	DICKSON	PO BOX 237, DICKSON, ACT 2602, AUSTRALIA	1440-2440			J SCI MED SPORT	J. Sci. Med. Sport	JUN	2003	6	2					231	236		10.1016/S1440-2440(03)80259-1			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	710QP	WOS:000184691200012	12945630				2022-02-06	
J	van der Heijden, P; Donders, J				van der Heijden, P; Donders, J			WAIS-III factor index score patterns after traumatic brain injury	ASSESSMENT			English	Article						WAIS-III; cluster analysis; profile subtypes; traumatic brain injury	WISC-III; INTELLIGENCE; PERFORMANCE	Profile subtypes, based on the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) factor index scores, were examined in a sample of 166 patients with traumatic brain injury (TBI) by means of a two-stage clustering procedure. Three reliable subtypes were found that were differentiated primarily by level of performance across all factor index scores, although each of them demonstrated a relative weakness on the Processing Speed index. These subtypes were then validated on the basis of demographic variables, injury parameters, and additional psychometric measures that had not been included in the clustering procedures. The results indicated that performance on the WAIS-III after TBI was affected by both injury severity and level of education. It is concluded that there is no unique "signature" profile on the WAIS-III after TBI, except that a relative strength on the Processing Speed index is uncommon with this condition.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI USA; Univ Nijmegen, Nijmegen, Netherlands		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI USA.	jdonders@mfbrc.com					*AM ED RES ASS AM, 1999, STAND ED PSYCH TEST; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 2001, ASSESSMENT, V8, P193, DOI 10.1177/107319110100800207; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Fuerst DR, 1995, CHILD NEUROPSYCHOL, V1, P38, DOI 10.1080/09297049508401341; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton RK, 1991, COMPREHENSIVE NORMS; Kaufman AS, 2001, ASSESSMENT, V8, P267, DOI 10.1177/107319110100800303; KAUFMAN AS, 1999, ESSENTIALS WAIS 3 AS; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Martin J, 2001, J TURBUL, V2, P1; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MCDERMOTT PA, 1990, J PSYCHOEDUC ASSESS, V8, P290, DOI 10.1177/073428299000800307; MCDERMOTT PA, 1989, PSYCHOL ASSESSMENT J, V1, P118; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; *PSYCH CORP, 2001, WAIS 3 WMS 3 WIAT 2; Reitan R.M., 1993, HALSTEADREITAN NEURO; Saklofske DH, 2000, PSYCHOL ASSESSMENT, V12, P436, DOI 10.1037/1040-3590.12.4.436; *SAS I, 1990, SAS STAT US GUID, V1; SATTLER JM, 1999, ASSESSMENT CHILDREN; Schinka JA, 1998, PSYCHOL ASSESSMENT, V10, P171, DOI 10.1037/1040-3590.10.2.171; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tulsky DS, 2000, CLIN NEUROPSYCHOL, V14, P451, DOI 10.1076/clin.14.4.451.7202; VANDERHEIJDEN P, IN PRESS J CLIN EXPT; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1997, WAIS 3 WMS 3 TECHNIC; WechslerD, 2001, WECHSLER TEST ADULT; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925	36	22	22	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	JUN	2003	10	2					115	122		10.1177/1073191103010002001			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	683WA	WOS:000183173000001	12801182				2022-02-06	
J	Booher, MA; Wisniewski, T; Smith, BW; Sigurdsson, A				Booher, MA; Wisniewski, T; Smith, BW; Sigurdsson, A			Comparison of reporting systems to determine concussion incidence in NCAA Division I collegiate football	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; Internet; college football; NCAA	SPORTS; MANAGEMENT; PLAYERS	Objective: To determine the incidence of concussion during the 2001 Division I-A college football season through utilization of the Internet. Design: Prospective Internet survey. Setting: Internet Web site. Participants: Head athletic trainers from Division I-A collegiate football programs. Main Outcome Measures: During the 2001-2002 football season, head athletic trainers from 87 Division I-A football programs agreed to use an Internet Web site to submit weekly data on the number of athlete exposures and concussions. Results: A total of 373 concussions were reported over the course of a season in both practices and games combined. Of these concussions, 256 (68.6%) occurred during games, and 117 (31.4%) occurred during practice. The injury rate per 1,000 athletic exposures was 5.56 in games and 0.25 in practices. There were 230 grade 1 (61.7%), 134 grade 2 (35.9%), and 9 grade 3 (2.4%) concussions reported. There was a significant (p < 0.01) difference found between the total concussion injury rate and game concussion injury rate when comparing the Internet and the NCAA injury data collection methods. Conclusions: The results of this study suggest an underreporting of concussions using the NCAA Injury Surveillance System and demonstrate that the Internet is a simple and effective tool for data collection.	Univ N Carolina, James A Taylor Student Hlth Serv, Div Sports Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Endodont, Div Sports Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Pediat & Orthoped, Div Sports Med, Chapel Hill, NC 27599 USA		Booher, MA (corresponding author), Univ N Carolina, James A Taylor Student Hlth Serv, Div Sports Med, CB 7470, Chapel Hill, NC 27599 USA.	booher@email.unc.edu	Wisniewski, Thomas/Q-6525-2019; Sigurdsson, Asgeir/ABA-8829-2021	Wisniewski, Thomas/0000-0002-3379-8966; 			CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; DICK RW, 2002, FOOTBALL INJURY REPO; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; SIGURDSSON A, IN PRESS DENT TRAUMA	9	22	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2003	13	2					93	95		10.1097/00042752-200303000-00005			3	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	658ZH	WOS:000181750900005	12629426				2022-02-06	
J	Setkowicz, Z; Janeczko, K				Setkowicz, Z; Janeczko, K			Long-term changes in susceptibility to pilocarpine-induced status epilepticus following neocortical injuries in the rat at different developmental stages	EPILEPSY RESEARCH			English	Article						developing brain; mechanical injury; seizure susceptibility; pilocarpine model of epilepsy	TRAUMATIC BRAIN INJURY; TEMPORAL-LOBE EPILEPSY; AGE-DEPENDENT CHANGES; SEIZURE SUSCEPTIBILITY; IMMATURE RAT; PROLIFERATIVE RESPONSE; CEREBRAL HEMISPHERE; NERVOUS-SYSTEM; GAP-JUNCTIONS; NEONATAL RAT	In the brain, injury-induced gliosis and axonal sprouting have been regarded as age-dependent repairing processes with, unfortunately, epileptogenic effects. The present study examines whether brains injured at different developmental stages become more or less susceptible to experimentally-induced status epilepticus. In 6- and 30-day-old Wistar rats (P6s and P30s, respectively), a mechanical injury was performed in the cortex of the left cerebral hemisphere. On postnatal day 60, all the animals and naive controls received single intraperitoneally pilocarpine injections to evoke status epilepticus. During a 6-h period following the injection, the animals were observed continuously and motor manifestations of seizure activity were recorded and rated. Seven days after pilocarpine injection, the animals were perfused and their body and brain weights recorded. When compared to controls, P6s showed neither significant variations in their epileptic behavior nor in brain and body weights. In relation to controls and to P6s, P30s presented an extremely high mortality, a significant loss of body weight and much longer-lasting seizures of much higher intensity. The data provide evidence that the long-term variations in susceptibility to experimentally-induced status epilepticus are determined by differences in the brain response to injury at different stages of postnatal development. (C) 2003 Elsevier Science B.V. All rights reserved.	Jagiellonian Univ, Dept Neuroanat, Inst Zool, PL-30060 Krakow, Poland		Janeczko, K (corresponding author), Jagiellonian Univ, Dept Neuroanat, Inst Zool, Ingardena 6, PL-30060 Krakow, Poland.			Janeczko, Krzysztof/0000-0002-9544-918X; Setkowicz, Zuzanna/0000-0002-7213-8194			Acarin L, 2001, Prog Brain Res, V132, P375; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31; Carlen PL, 2000, BRAIN RES REV, V32, P235, DOI 10.1016/S0165-0173(99)00084-3; CASSEL JC, 1987, EXP NEUROL, V97, P564, DOI 10.1016/0014-4886(87)90114-2; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; DORETTO MC, 1995, PHYSIOL BEHAV, V58, P273, DOI 10.1016/0031-9384(95)00050-S; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; Fernandes MJD, 1999, J CEREBR BLOOD F MET, V19, P195; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jacobs KM, 2000, EPILEPSIA, V41, pS153, DOI 10.1111/j.1528-1157.2000.tb01574.x; JANECZKO K, 1994, INT J DEV NEUROSCI, V12, P431, DOI 10.1016/0736-5748(94)90027-2; JANECZKO K, 1988, BRAIN RES, V456, P280, DOI 10.1016/0006-8993(88)90229-6; JANECZKO K, 1989, BRAIN RES, V485, P236, DOI 10.1016/0006-8993(89)90566-0; JENSEN FE, 1992, EPILEPSIA, V33, P971, DOI 10.1111/j.1528-1157.1992.tb01746.x; Koh S, 1999, NEUROLOGY, V53, P915, DOI 10.1212/WNL.53.5.915; KOLASA K, 1992, PHARMACOL BIOCHEM BE, V41, P99, DOI 10.1016/0091-3057(92)90066-O; Kolb B, 1998, BEHAV BRAIN RES, V91, P127, DOI 10.1016/S0166-4328(97)00112-5; LOSCHER W, 1995, BRAIN RES, V697, P197, DOI 10.1016/0006-8993(95)00843-F; MAROSI M, 1994, EPILEPSY RES, V19, P63, DOI 10.1016/0920-1211(94)90089-2; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P501, DOI 10.1098/rstb.1990.0122; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MITTMANN T, 1994, NEUROSCIENCE, V60, P891, DOI 10.1016/0306-4522(94)90270-4; MOSHE SL, 1985, BRAIN RES, V337, P368, DOI 10.1016/0006-8993(85)90077-0; Nehlig A, 2002, EPILEPSY RES, V51, P189, DOI 10.1016/S0920-1211(02)00125-0; OKADA R, 1984, DEV BRAIN RES, V15, P177, DOI 10.1016/0165-3806(84)90095-6; Priel MR, 1996, EPILEPSY RES, V26, P115, DOI 10.1016/S0920-1211(96)00047-2; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1219; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Rice DC, 2000, ENVIRON HEALTH PERSP, V108, P405, DOI 10.2307/3454528; ROMIJN HJ, 1994, EPILEPSY RES, V17, P31, DOI 10.1016/0920-1211(94)90077-9; Rozental R, 2000, BRAIN RES REV, V32, P11, DOI 10.1016/S0165-0173(99)00095-8; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salin P, 1995, J NEUROSCI, V15, P8234; Sankar R, 1998, J NEUROSCI, V18, P8382; Schmid R, 1999, NEUROLOGY, V53, P1754, DOI 10.1212/WNL.53.8.1754; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Siesjo BK, 1996, EUR J ANAESTH, V13, P247, DOI 10.1046/j.1365-2346.1996.00976.x; Towfighi J, 1997, DEV BRAIN RES, V100, P149, DOI 10.1016/S0165-3806(97)00036-9; TURSKI L, 1989, SYNAPSE, V3, P154, DOI 10.1002/syn.890030207; Wong M, 2001, DEV BRAIN RES, V128, P113, DOI 10.1016/S0165-3806(01)00149-3; XIA Y, 1995, BRAIN RES, V675, P224, DOI 10.1016/0006-8993(95)00079-6	45	22	25	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	MAR	2003	53	3					216	224		10.1016/S0920-1211(03)00029-9			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	674KH	WOS:000182635600006	12694930				2022-02-06	
J	Foxx-Orenstein, A; Kolakowsky-Hayner, S; Marwitz, JH; Cifu, DX; Dunbar, A; Englander, J; Francisco, G				Foxx-Orenstein, A; Kolakowsky-Hayner, S; Marwitz, JH; Cifu, DX; Dunbar, A; Englander, J; Francisco, G			Incidence, risk factors, and outcomes of fecal incontinence after acute brain injury: Findings form the traumatic brain injury model systems national database	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; fecal incontinence; incidence; rehabilitation; risk factors; treatment outcome	STROKE REHABILITATION	Objective: To investigate the incidence, risk factors, and outcome in patients with fecal incontinence after acute brain injury. Design: A retrospective study of the incidence of and risk factors contributing to fecal incontinence, and outcomes at admission to and discharge from inpatient rehabilitation and at 1-year follow-up. Setting: Medical centers in the federally sponsored Traumatic Brain Injury Model Systems (TBIMS). Participants: A total of 1013 consecutively enrolled rehabilitation inpatients from 17 TBIMS centers who were admitted to acute care within 24 hours of traumatic brain injury and seen at 1-year postinjury between 1990 and 2000. Interventions: Not applicable. Main Outcome Measures: Incidence of fecal incontinence, length of coma, length of posttraumatic amnesia (PTA), admission Glasgow Coma Scale (GCS) score, length of stay (LOS), FIM(TM) instrument scores, disposition at discharge and follow-up, and incidences of pelvic fracture, frontal contusion, and urinary tract infection (UTI). Results: The incidence of fecal incontinence was 68% at admission to inpatient rehabilitation, 12.4% at rehabilitation discharge, and 5.2% at 1-year follow-up. Analysis of variance and chi-square analyses revealed statistically significant associations between the incidence of fecal incontinence at rehabilitation admission and admission GCS score, length of coma and PTA, LOS, and incidence of UTI and frontal contusion. Fecal incontinence at rehabilitation discharge was significantly associated with several variables, including age, discharge disposition, admission GCS score, length of coma, PTA, LOS, FIM scores, and incidence of pelvic fracture and frontal contusion. Significant associations were also found between fecal incontinence at 1-year follow-up and age, discharge and current 1-year disposition, admission GCS score, length of coma, LOS, FIM scores, and incidence of UTI (P<.05). Although logistic regression analyses were significant (P<.001), and predicted continence with 100% accuracy, demographics, injury characteristics, medical complications, and functional outcomes did not predict incontinence at discharge and at 1-year follow-up. Conclusions: Fecal incontinence is a significant problem after brain injury. Certain factors may increase its likelihood. Further studies evaluating mechanisms of fecal incontinence and treatment or control interventions would be useful.	Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Santa Clara Valley Med Ctr, San Jose, CA 95128 USA; TIRR, Houston, TX USA		Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Box 980542, Richmond, VA 23298 USA.		Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Cifu, David/0000-0003-1600-9387			CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; CIFU DX, 1994, ARCH PHYS MED REHAB, V75, pS56; Faltin DL, 2001, INT UROGYNECOL J, V12, P117, DOI 10.1007/PL00004031; FORER S, 1982, J ORGAN REHABIL EVAL, V2, P29; Francombe J, 2001, HOSP MED, V62, P529, DOI 10.12968/hosp.2001.62.9.1641; Gibson E, 1990, Prof Nurse, V6, P38; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; GRANGER CV, 1989, ARCH PHYS MED REHAB, V70, P100; HAGEN C, 1982, COGNITIVE REHABILITA, P131; HALL KM, 1994, ARCH PHYS MED REHAB, V75, pSC10; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Haugen V, 1995, J Wound Ostomy Continence Nurs, V22, P291; Jacquot JM, 1999, REV RHUM, V66, P109; MALKMUS D, 1979, REHABILITATION HEAD; Toglia MR, 1998, OBSTET GYN CLIN N AM, V25, P771, DOI 10.1016/S0889-8545(05)70042-5; 1996, GUIDE UNIFORM DATA S	17	22	22	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2003	84	2					231	237		10.1053/apmr.2003.50095			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	643QV	WOS:000180872700012	12601654				2022-02-06	
J	Bittigau, P; Sifringer, M; Felderhoff-Mueser, U; Hansen, HH; Ikonomidou, C				Bittigau, P; Sifringer, M; Felderhoff-Mueser, U; Hansen, HH; Ikonomidou, C			Neuropathological and biochemical features of traumatic injury in the developing brain	NEUROTOXICITY RESEARCH			English	Article						apoptosis; excitotoxicity; neuroprotection	DEVELOPING RAT-BRAIN; NONACCIDENTAL HEAD-INJURY; SHAKEN-BABY SYNDROME; METHYL-D-ASPARTATE; NEURODEGENERATION FOLLOWING TRAUMA; HYPOXIC-ISCHEMIC INJURY; APOPTOTIC CELL-DEATH; CEREBROSPINAL-FLUID; IN-VIVO; CASPASE INHIBITOR	Trauma to the developing brain constitutes a poorly explored field. Some recent studies attempting to model and study pediatric head trauma, the leading cause of death and disability in the pediatric population, revealed interesting aspects and potential targets for future research. Trauma triggers both excitotoxic and apoptotic neurodegeneration in the developing rat brain. Excitotoxic neurodegeneration develops and subsides rapidly (within hours) whereas apoptotic cell death occurs in a delayed fashion over several days following the initial traumatic insult. Apoptotic neurodegeneration contributes in an age-dependent fashion to neuronal injury following head trauma, with the immature brain being exceedingly sensitive. In the most vulnerable ages the apoptosis contribution to the extent of traumatic brain damage far outweighs that of the excitotoxic component. Molecular and biochemical studies indicate that both extrinsic and intrinsic mechanisms are involved in pathogenesis of apoptotic cell death following trauma. Interestingly, in infant rats a pan-caspase inhibitor ameliorated apoptotic neurodegeneration with a therapeutic time window of up to 8 h after trauma. These results help explain unfavorable outcomes of very young pediatric head trauma patients and imply that regimen which target slow active forms of cell death may comprise a successful neuroprotective approach.	Humboldt Univ, Dept Pediat Neurol, D-13353 Berlin, Germany; Humboldt Univ, Charite Childrens Hosp, Dept Neonatol, D-13353 Berlin, Germany; Danish Univ Pharmaceut Sci, Dept Pharmacol, DK-2100 Copenhagen, Denmark		Ikonomidou, C (corresponding author), Humboldt Univ, Dept Pediat Neurol, Augustenburger Pl 1, D-13353 Berlin, Germany.	hrissanthi.ikonomidou@charite.de	Felderhoff-Muser, Ursula/AAU-9682-2020				Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; ALMOG N, 1997, BIOCHIM BIOPHYS ACTA, V1333, P1; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Bonnier C, 2002, BRAIN PATHOL, V12, P320; Borovitskaya AE, 1996, MOL BRAIN RES, V35, P19, DOI 10.1016/0169-328X(95)00177-T; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; BROWN JK, 1993, DEV MED CHILD NEUROL, V35, P849; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; David TJ, 1999, J ROY SOC MED, V92, P556, DOI 10.1177/014107689909201105; DEOLMOS JS, 1971, BRAIN RES, V33, P523, DOI 10.1016/0006-8993(71)90130-2; Diamond PT, 1996, BRAIN INJURY, V10, P413, DOI 10.1080/026990596124278; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Downer E, 2001, NEUROREPORT, V12, P3973, DOI 10.1097/00001756-200112210-00024; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Endres H, 1998, J CEREBR BLOOD F MET, V18, P238, DOI 10.1097/00004647-199803000-00002; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Felderhoff-Mueser U, 2000, BRAIN PATHOL, V10, P17; Ferrer I, 1996, EUR J NEUROSCI, V8, P1286, DOI 10.1111/j.1460-9568.1996.tb01297.x; Fink K, 1998, J CEREBR BLOOD F MET, V18, P1071, DOI 10.1097/00004647-199810000-00003; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gillardon F, 1999, NEUROSCIENCE, V93, P1219, DOI 10.1016/S0306-4522(99)00292-4; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Guzman M, 2001, J MOL MED-JMM, V78, P613, DOI 10.1007/s001090000177; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hansen HH, 2001, J NEUROCHEM, V78, P1415, DOI 10.1046/j.1471-4159.2001.00542.x; Hansen HH, 2002, J NEUROCHEM, V82, P154, DOI 10.1046/j.1471-4159.2002.00961.x; Hansen HH, 2001, J NEUROCHEM, V76, P39, DOI 10.1046/j.1471-4159.2001.00006.x; Hansen HS, 2000, CHEM PHYS LIPIDS, V108, P135, DOI 10.1016/S0009-3084(00)00192-4; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Himi T, 1998, EUR J NEUROSCI, V10, P777, DOI 10.1046/j.1460-9568.1998.00073.x; IKONOMIDOU C, 1989, J NEUROSCI, V9, P2809; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Ishimaru MJ, 1999, J COMP NEUROL, V408, P461; James HE, 1999, ACT NEUR S, V73, P85; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; KRAUS JF, 1987, PEDIATRICS, V79, P501; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Liou JC, 1997, J NEUROSCI, V17, P2459; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Morita-Fujimura Y, 1999, NEUROSCI LETT, V267, P201, DOI 10.1016/S0304-3940(99)00327-4; MUNGER CE, 1993, AM J FOREN MED PATH, V14, P193, DOI 10.1097/00000433-199309000-00004; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Nakashima K, 1999, J NEUROTRAUM, V16, P143, DOI 10.1089/neu.1999.16.143; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Norimura T, 1996, NAT MED, V2, P577, DOI 10.1038/nm0596-577; OLIVER JE, 1975, BRIT MED J, V2, P262, DOI 10.1136/bmj.2.5965.262; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Robertson CL, 2001, CRIT CARE MED, V29, P2287, DOI 10.1097/00003246-200112000-00009; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687	100	22	23	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.		2003	5	7					475	490		10.1007/BF03033158			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	764YB	WOS:000188233300002	14715432				2022-02-06	
J	King, JH; Sweet, JJ; Sherer, M; Curtiss, G; Vanderploeg, RD				King, JH; Sweet, JJ; Sherer, M; Curtiss, G; Vanderploeg, RD			Validity indicators within the Wisconsin Card Sorting Test: Application of new and previously researched multivariate procedures in multiple traumatic brain injury samples	CLINICAL NEUROPSYCHOLOGIST			English	Article							FORCED-CHOICE METHOD; VERBAL-LEARNING TEST; HEAD-INJURY; PERFORMANCE; IMPAIRMENT	The Wisconsin Card Sorting Test (WCST) is a popular neuropsychological measure of executive dysfunction that has been researched with regard to invalid performances, a subset of which in a forensic context could be associated with malingering. In the first of three studies, WCST multivariate approaches identified in prior research (Bernard, McGrath, Houston, 1996; Suhr & Boyer, 1999), as well as newly created variables, were used to differentiate 33 chronic traumatic brain injury (TBI) patients with good effort and 27 patients with probable insufficient effort (IE). Newly created variables that were derived logically based upon hypotheses regarding strategies that might be employed by malingerers were not effective in differentiating TBI and IE groups. Application of previously researched validity indicators based upon commonly used WCST variables, individually, and within new logistic regression findings were reasonably effective in differentiating TBI and IE groups. In order to determine whether results would vary in different TBI samples, these validity indicators were examined in Study 2 with 75 moderate and severe, acute TBI rehabilitation patients whose posttraumatic amnesia had just resolved. Statistically significant differences were present between the IE group of Study I and the rehabilitation patient group of Study 2 on failures to maintain set, number of trials to achieve first correct category, and number of categories completed. All these measures were performed more poorly by the IE group. However, previously used multivariate approaches and the logistic regression analysis developed in Study 1 ranged widely in the degree to which Study 2's more acute rehabilitation patients were correctly classified. Specifically, the discriminant function of Bernard and colleagues correctly classified 73% and the Suhr and Boyer logistic regression correctly classified 75% of the Study 2 participants. The Study I1 logistic regression classified 97% of the Study 2 participants correctly. In Study 3, 130 mild to severe TBI patients in the VA system were studied. The Study 1 IE group performed significantly worse than the more acute and more severe VATBI group on all 10 common WCST variables of interest. Application of the three multivariate procedures resulted in good to excellent classification rates: Suhr and Boyer logistic regression 85%, Bernard et al. discriminant function 85%, and Study I logistic regression 99%. The aggregate discussion of the three studies focuses on apparent differences in samples associated with varying degrees of success in identifying TBI patients. Application of these validity indicators in forensic situations should consider that some of these multivariate approaches possess possible classification limitations associated with chronicity and severity of the reported TBI. Only the Study I logistic regression demonstrated improved classification rates with the more acute and severe patients of Study 2 and Study 3. As with all validity indicators, use of any WCST IE criteria in isolation would not be appropriate.	Evanston NW Healthcare, Evanston, IL USA; Univ Mississippi, Med Ctr, Methodist Rehabil Ctr, Jackson, MS 39216 USA; James A Haley Vet Adm Med Ctr, Tampa, FL 33612 USA		Sweet, JJ (corresponding author), ENH Med Grp, 909 Davis St,Suite 160, Evanston, IL 60201 USA.	j-sweet@northwestern.edu	Curtiss, Glenn/ABB-5566-2020				American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; Bolter J. F., 1985, ANN M NAT AC NEUR PH; BOLTER JF, 1990, MULTIDIGIT MEMORY TE; CONDER R, 1992, COMPUTERIZED ASSESSM; Delis DC, 1987, CALIFORNIA VERBAL LE; DEMAKIS G, IN PRESS NEUROPSYCHO; Demakis GJ, 2001, PSYCHOL ASSESSMENT, V13, P240, DOI 10.1037//1040-3590.13.2.240; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; DONDERS JD, 1999, J FORENSIC NEUROPSYC, V1, P34; Ferland MB, 1998, J CLIN EXP NEUROPSYC, V20, P473, DOI 10.1076/jcen.20.4.473.1475; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Greve KW, 2002, J CLIN EXP NEUROPSYC, V24, P48, DOI 10.1076/jcen.24.1.48.968; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Heaton R.K., 1981, WISCONSIN CARD SORTI; HEATON RK, 1993, WCST COMPUTER VERSIO; HEATON RK, 1999, WCST COMPUTER VERSIO; Hellman S. G., 1992, INT J METH PSYCH RES, V2, P151; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Iverson GL, 1998, BRAIN INJURY, V12, P275, DOI 10.1080/026990598122575; Iverson GL, 2000, J CLIN EXP NEUROPSYC, V22, P191, DOI 10.1076/1380-3395(200004)22:2;1-1;FT191; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; IVERSON GL, 2001, AM J FORENSIC PSYCH, V19, P5; King JH, 1998, J CLIN EXP NEUROPSYC, V20, P603, DOI 10.1076/jcen.20.5.603.1124; Miller A., 2000, CLIN NEUROPSYCHOLOGI, V2, P141; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; ROGERS R, 1990, PROFESSIONAL PSYCHOL, V32, P182; Salazar AM, 2000, J HEAD TRAUMA REHAB, V15, P1081, DOI 10.1097/00001199-200010000-00002; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 1999, STUD NEUROPSYCHOL DE, P255; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; [No title captured]	48	22	22	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	2002	16	4					506	523		10.1076/clin.16.4.506.13912			18	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	681AY	WOS:000183015300009	12822059				2022-02-06	
J	Dai, YT; Wu, SC; Weng, R				Dai, YT; Wu, SC; Weng, R			Unplanned hospital readmission and its predictors in patients with chronic conditions	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						unplanned readmission; predictors	ELDERLY-PATIENTS; CARE; INDEX	Background and Purpose: Unplanned hospital readmission is a devastating experience for patients and is costly for society. This study determined the 60-day unplanned readmission rate and its predicting factors in patients with chronic conditions. Methods: A total of 334 patients discharged from five hospitals were followed for 2 months after discharge. Patients enrolled in the study were disabled and had a diagnosis of progressive chronic disease (congestive heart failure, chronic pulmonary disease, cancer) or chronic impairment following an acute episode (stroke, traumatic brain injury, hip fracture). Patients were assessed before discharge to collect in-hospital variables. Telephone interviews with patients and families were used to collect data on hospital readmission. Results: Of the 334 patients followed, 76 had unplanned readmission (24.4%). Patients with progressive chronic disease had a higher readmission rate (40.9%) than those with chronic impairment following an acute episode (15.1%). Frailty and abnormal respiratory pattern were significant predictors of readmission for patients with progressive chronic disease. The predictors of readmission for patients with chronic impairment following an acute episode included frailty, clinical instability and discharge from a regional hospital. The major reasons for hospital readmission were exacerbation of the initial major disease (33/76, 43.4%) and infection (21/76, 27.7%). Conclusions: Exacerbation of chronic diseases and infection are the two major reasons for unplanned readmission. Patients with a progressive chronic disease are more likely to be readmitted.	Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 100, Taiwan; Natl Taiwan Univ Hosp, Dept Nursing, Taipei, Taiwan; Natl Taiwan Univ, Grad Inst Hlth Policy & Management, Coll Publ Hlth, Taipei 100, Taiwan; Dept Hlth, Bur Hlth Promot, Taipei, Taiwan		Dai, YT (corresponding author), Natl Taiwan Univ, Coll Med, Dept Nursing, 1 Jen Ai Rd,Sect 1, Taipei 100, Taiwan.			DAI, YU-TZU/0000-0002-3803-3516			ANDERSON GF, 1984, NEW ENGL J MED, V311, P1349, DOI 10.1056/NEJM198411223112105; ANDERSON GF, 1985, INQUIRY-J HEALTH CAR, V22, P251; Anderson M A, 1996, J Community Health Nurs, V13, P1, DOI 10.1207/s15327655jchn1301_1; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; CHIEN LN, 2002, THESIS NATL Y MING U; D'Agostino RS, 1999, J THORAC CARDIOV SUR, V118, P823, DOI 10.1016/S0022-5223(99)70051-6; DAI YT, 2002, IN PRESS RES NURS HL; Experton B, 1999, AM J PREV MED, V16, P163, DOI 10.1016/S0749-3797(98)00098-1; Friedmann JM, 1997, AM J CLIN NUTR, V65, P1714, DOI 10.1093/ajcn/65.6.1714; GOODING J, 1985, J AM GERIATR SOC, V33, P595, DOI 10.1111/j.1532-5415.1985.tb06315.x; GRAHAM H, 1983, LANCET, V1, P404; Hsueh IP, 2001, J FORMOS MED ASSOC, V100, P526; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Lahey SJ, 1998, CIRCULATION, V98, pII35; MacLeod R D, 1970, Gerontol Clin (Basel), V12, P31; MAHONEY F I, 1965, Md State Med J, V14, P61; Miles T A, 1999, J Qual Clin Pract, V19, P211, DOI 10.1046/j.1440-1762.1999.00334.x; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Sabourin CB, 1999, HEART LUNG, V28, P243, DOI 10.1016/S0147-9563(99)70070-1; Schwarz K A, 2000, J Gerontol Nurs, V26, P29; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SMITH DM, 1988, MED CARE, V26, P699, DOI 10.1097/00005650-198807000-00005; Stewart RD, 2000, ANN THORAC SURG, V70, P169, DOI 10.1016/S0003-4975(00)01386-2; SULLIVAN DH, 1992, J AM GERIATR SOC, V40, P792, DOI 10.1111/j.1532-5415.1992.tb01851.x; TIERNEY AJ, 1995, AGE AGEING, V24, P163, DOI 10.1093/ageing/24.2.163; VINSON JM, 1990, J AM GERIATR SOC, V38, P1290, DOI 10.1111/j.1532-5415.1990.tb03450.x; WU SC, 2002, HEALTHCARE QUALITY, V2, P1; YEH SY, 2002, PRELIMINARY ANAL RES	29	22	22	0	10	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	0929-6646	1876-0821		J FORMOS MED ASSOC	J. Formos. Med. Assoc.	NOV	2002	101	11					779	785					7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RR	WOS:000180010800007	12517058				2022-02-06	
J	Goda, M; Isono, M; Fujiki, M; Kobayashi, H				Goda, M; Isono, M; Fujiki, M; Kobayashi, H			Both MK801 and NBQX reduce the neuronal damage after impact-acceleration brain injury	JOURNAL OF NEUROTRAUMA			English	Article						impact-acceleration injury; traumatic brain injury; neuronal degeneration; Fluoro-Jade; amyloid precursor protein; MK-801; NBQX	D-ASPARTATE RECEPTOR; ANTICONVULSANT MK-801; GLUTAMATE RECEPTORS; AXONAL INJURY; AMINO-ACIDS; RAT-BRAIN; ANTAGONIST; TRAUMA; MODEL; NMDA	To understand the pathogenesis of diffuse axonal injury, we investigated the temporal and spatial profiles of neuronal degeneration in impact-acceleration injury in rats using Fluoro-Jade (FJ) staining. Impact-acceleration injury was produced in Wistar rats by the method described by Marmarou et al. with some modifications. Animals were sacrificed 1, 2, 7, 14, or 28 days after injury. Paraffin-embedded coronal sections were stained with HE or FJ, or analyzed immunohistochemically for GFAP or amyloid precursor protein (APP). FJ-positive degenerative neurons were found primarily in the dorsal brainstem and thalamus from 1 to 2 days following injury and these were associated with GFAP expression. However, FJ-positive cells were rarely found after 7 days. In all rats, significant expression of APP was observed primarily in the cingulum, cerebral peduncle and pontomedullary junction. FJ also stained these injured axons. Intrathecal administration of both NMDA and AMPA/kinate glutamate receptor antagonists MK-801 and NBQX, respectively, reduced the neuronal injury. NBQX showed more significant effects on axonal injury than MK-801. These observations indicate that not only axonal damage, but also primary neuronal damage occurs in this impact-acceleration injury model. It is also suggested that NBQX can act both directly on neuronal cells and white matter and that NMDA could have a significant protective effect against not only neuronal, but also axonal injury.	Oita Med Univ, Dept Neurosurg, Oita 8795593, Japan		Goda, M (corresponding author), Oita Med Univ, Dept Neurosurg, 1-1 Idaigaoka, Oita 8795593, Japan.		Goda, Makoto/R-3164-2019				Agrawal SK, 1997, J NEUROSCI, V17, P1055; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P227; Bullock Ross, 1993, Journal of Emergency Medicine, V11, P23; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FOSTER AC, 1987, BRIT J PHARMACOL, V91, P403, DOI 10.1111/j.1476-5381.1987.tb10295.x; Garcia-Barcina JM, 1998, MOL BRAIN RES, V53, P270, DOI 10.1016/S0169-328X(97)00318-5; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; LUEL MS, 1996, PHARMACOTHERAPY, V16, P830; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAYER ML, 1987, J NEUROSCI, V7, P3230; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; Okiyama K, 1998, BRAIN RES, V792, P291, DOI 10.1016/S0006-8993(98)00158-9; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Rosen CJ, 1999, J CLIN DENSITOM, V2, P3, DOI 10.1385/JCD:2:1:3; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SIVERMAN JD, 1985, BRAIN RES, V361, P383; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; Williams J. M. G., 1993, J MENTAL HLTH, V2, P3; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; YOSHIDA A, 1991, J COMP NEUROL, V307, P609, DOI 10.1002/cne.903070408	32	22	22	0	7	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2002	19	11					1445	1456		10.1089/089771502320914679			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	620JD	WOS:000179529500005	12490009				2022-02-06	
J	Mollica, RF; Henderson, DC; Tor, S				Mollica, RF; Henderson, DC; Tor, S			Psychiatric effects of traumatic brain injury events in Cambodian survivors of mass violence	BRITISH JOURNAL OF PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COMBAT VETERANS; POW SURVIVORS; HEAD-INJURY; KOREAN CONFLICT; COGNITIVE DEFICITS; FORMER PRISONERS; MEMORY; TORTURE; WAR	Background The prevalence of brain injury and its effects in populations exposed to war violence has not been studied in recent years. Aims To examine the association between traumatic brain injury events and psychiatric symptoms of major depression and post-traumatic stress disorder (PTSD) in Cambodian survivors of mass violence. Method The population comprised a multi-stage random sample of Cambodian refugees living in a Thai refugee camp. The main results analysed the relationship between six categories of trauma events and psychiatric symptoms of depression and PTSD during two time periods. Results Almost 15 000 trauma events were reported (n=13481, Pol Pot period; n=1249, past year). Traumatic brain injury was most common in the highly educated and in individuals with the highest levels of cumulative trauma. Of all trauma categories, traumatic brain injury revealed the strongest association with symptoms of depression, and a weaker association with PTSD. Brain injury represented 4% of the total number of traumatic events for both time periods, contributing 20% of the total symptom score for depression and 8% of that for PTSD. Conclusions Clinical identification and treatment of traumatic brain injuries in highly traumatised populations must be maintained in order to develop a new public health model for their treatment. Declaration of interest None. Funding detailed in Acknowledgements.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Program Refugee Trauma, Cambridge, MA 02138 USA		Henderson, DC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Program Refugee Trauma, 22 Putnam St, Cambridge, MA 02138 USA.	dchenderson@partners.org					*AM PSYCH ASS, 1984, DIAGN STAT MAN MENT; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barrett DH, 1996, AM J PSYCHIAT, V153, P1492; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; CASPIYAVIN Y, 1995, PSYCHIAT FUNCTIONAL; COURVILLE CB, 1937, PATHOLOGY CENTRAL 4; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN S, 1996, NEUROPSYCHOLOGICAL A, P552; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Fawzi MCS, 1997, ACTA PSYCHIAT SCAND, V95, P87, DOI 10.1111/j.1600-0447.1997.tb00379.x; First MB, 2001, STRUCTURAL CLIN INTE; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; GOLDFELD AE, 1988, JAMA-J AM MED ASSOC, V259, P2725, DOI 10.1001/jama.259.18.2725; GURVITS TV, 1993, J NEUROPSYCH CLIN N, V5, P183; JENNETT B, 1981, CONT NEUROLOGY SERIE, V20; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LYNCH J, 1989, BORDER KHMER DEMOGRA, V2; MANUELDUPONT A, 1992, HDB NEUROPSYCHOLOGIC, P193; MESULAM MM, 1986, ANN NEUROL, V19, P320, DOI 10.1002/ana.410190403; MOLLICA R, 1991, PSYCHOL ASSESSMENT, V3, P1; MOLLICA RF, 1992, J NERV MENT DIS, V180, P111, DOI 10.1097/00005053-199202000-00008; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Mollica RF, 2002, J NERV MENT DIS, V190, P158, DOI 10.1097/00005053-200203000-00004; Mollica RF, 1998, ADVERSITY, STRESS AND PSYCHOPATHOLOGY, P34; Mollica RF, 1998, BRIT J PSYCHIAT, V173, P482, DOI 10.1192/bjp.173.6.482; MOLLICA RF, 1993, JAMA-J AM MED ASSOC, V270, P581, DOI 10.1001/jama.270.5.581; MOLLICA RF, 1989, COMMUNITY CONFINEMEN; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RASMUSSEN OV, 1990, DAN MED BULL, V37, P1; REYNELL J, 1989, POLITICAL PAWNS REGU; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; Sulway MR, 1996, NEUROLOGY, V46, P650, DOI 10.1212/WNL.46.3.650; SUTKER PB, 1995, NEUROPSYCHOLOGY, V9, P118, DOI 10.1037/0894-4105.9.1.118; SUTKER PB, 1991, AM J PSYCHIAT, V148, P67; SUTKER PB, 1990, J PERS ASSESS, V54, P170, DOI 10.1207/s15327752jpa5401&2_17; Sutker PB, 1996, PSYCHOL ASSESSMENT, V8, P18, DOI 10.1037/1040-3590.8.1.18; SUTKER PB, 1990, J CONSULT CLIN PSYCH, V58, P323, DOI 10.1037/0022-006X.58.3.323; SUTKER PB, 1992, ARCH CLIN NEUROPSYCH, V7, P431, DOI 10.1016/0887-6177(92)90156-H; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vasterling JJ, 2000, J TRAUMA STRESS, V13, P441, DOI 10.1023/A:1007781107513; Weinstein CS, 2001, NEUROPSYCHOL REV, V11, P131, DOI 10.1023/A:1016650623996; WESTERMEYER J, 1985, AM J PSYCHIAT, V142, P798; Willis GB, 1998, J NERV MENT DIS, V186, P283, DOI 10.1097/00005053-199805000-00004; World Health Organization, 1978, MENT DIS GLOSS GUID; World Health Organization (WHO), 1992, 10 REV INT CLASS DIS; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137	48	22	22	1	9	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0007-1250	1472-1465		BRIT J PSYCHIAT	Br. J. Psychiatry	OCT	2002	181						339	347		10.1192/bjp.181.4.339			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	603EE	WOS:000178545200013	12356662	Bronze			2022-02-06	
J	Wu, XR; Stezoski, J; Safar, P; Behringer, W; Kentner, R; Kochanek, PM; Tisherman, SA				Wu, XR; Stezoski, J; Safar, P; Behringer, W; Kentner, R; Kochanek, PM; Tisherman, SA			Systemic hypothermia, but not regional gut hypothermia, improves survival from prolonged hemorrhagic shock in rats	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						hypothermia; hemorrhagic shock; ischemia; rat; intestine; survival; tissue injury	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; BODY-TEMPERATURE; CARDIAC-ARREST; PERMEABILITY; INCREASE; DAMAGE; PROTECTS	Background. Extracorporeal blood perfusion of the gut or enterectomy can improve survival during hemorrhagic shock (HS), suggesting that the gut may be of primary importance in resuscitation. We hypothesized that cooling the gut alone could improve survival in a rat HS model and avoid potential deleterious effects of systemic hypothermia. Methods: Thirty-two Sprague-Dawley rats were anesthetized with halothane. The gut (small intestine, cecum, and colon) was exteriorized. The right atrial (T-RA), rectal, and gut (T-GUT) intraluminal temperatures were monitored. HS was induced by withdrawal of 2 mL of blood per 100 g body weight over 10 minutes. Mean arterial pressure was then maintained at 35 to 40 mm Hg to HS 90 min. From HS 20 min to resuscitation time 1 h, rats were randomized into four groups (n = 8 each): normothermia (T-RA and T-Gut similar to38.0degreesC), gut-25degreesC (T-RA similar to38degreesC, T-Gut similar to25degreesC, induced by rinsing the gut with cooled saline), gut-33degreesC (T-RA similar to38degreesC, T-GUT similar to33degreesC), and systemic hypothermia (T-RA similar to33degreesC, T-GUT similar to25degreesC). At HS 90 min, shed blood and Ringer's solution were infused to restore normotension. Survival, metabolism, and tissue damage were observed to 72 hours. Results: Blood pressure was not different between groups. Compared with the normothermia group, the systemic hypothermia group had lower base deficit and lactate, and needed less fluid during resuscitation for normotension (p < 0.05), but these values were not different in the gut hypothermia groups. In addition, there were no significant improvements in tissue protection induced by regional gut hypothermia, whereas the systemic hypothermia group had lower plasma potassium, lower ornithine carbamoyltransferase (marker of liver injury), and higher glucose levels after HS (all p < 0.05). All rats in the systemic hypothermia group survived to 72 hours, whereas there was only one survivor in the normothermia group, two in the gut-33degreesC group, and none in the gut-25degreesC group (all p < 0.05 vs. systemic hypothermia). Conclusion. Cooling the gut alone does not improve acute survival from HS, suggesting that early deaths are not secondary to gut ischemia. Mild systemic hypothermia allowed 100% survival from prolonged HS.	Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Anesthesiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA		Tisherman, SA (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	tishermansa@msx.upmc.edu	Tisherman, Samuel A./AAK-9377-2020; Kochanek, Patrick M/D-2371-2015	Tisherman, Samuel A./0000-0003-3810-3729; Kochanek, Patrick M/0000-0002-2627-913X; Behringer, Wilhelm/0000-0003-2261-3193			Barr J, 2000, CRIT CARE MED, V28, P3896, DOI 10.1097/00003246-200012000-00027; BIGELOW WG, 1950, ANN SURG, V132, P849, DOI 10.1097/00000658-195011000-00001; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Carattino MD, 1999, IMMUNOPHARMACOLOGY, V43, P241, DOI 10.1016/S0162-3109(99)00095-8; Chang TW, 1997, J TRAUMA, V42, P223, DOI 10.1097/00005373-199702000-00007; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; DEITCH EA, 1994, SHOCK, V1, P141, DOI 10.1097/00024382-199402000-00010; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1250; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; GUBLER KD, 1994, J TRAUMA, V36, P847, DOI 10.1097/00005373-199406000-00015; HAGBERG S, 1970, Acta Chirurgica Scandinavica, V136, P23; HAGLUND U, 1993, CRIT CARE MED, V21, pS15, DOI 10.1097/00003246-199302001-00004; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; JURKOVICH GJ, 1988, J SURG RES, V44, P514, DOI 10.1016/0022-4804(88)90156-4; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; KARIBE H, 1994, J CEREBR BLOOD F MET, V14, P620, DOI 10.1038/jcbfm.1994.77; Kim SH, 1998, J TRAUMA, V44, P485, DOI 10.1097/00005373-199803000-00010; KOBELT F, 1994, SHOCK, V2, P281, DOI 10.1097/00024382-199410000-00009; Krieger DW, 2001, STROKE, V32, P1847, DOI 10.1161/01.STR.32.8.1847; Laffon M, 1999, AM J PHYSIOL-LUNG C, V277, pL760, DOI 10.1152/ajplung.1999.277.4.L760; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; LILLEHEI RC, 1957, SURGERY, V42, P1043; LITTLE RA, 1981, BRIT J SURG, V68, P221, DOI 10.1002/bjs.1800680402; LUNA GK, 1987, J TRAUMA, V27, P1014, DOI 10.1097/00005373-198709000-00010; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MEYER D M, 1988, Current Surgery, V45, P295; Mizushima Y, 2000, ARCH SURG-CHICAGO, V135, P175, DOI 10.1001/archsurg.135.2.175; OHSHITA M, 1976, CLIN CHIM ACTA, V67, P145; Patel S, 2000, J AM COLL SURGEONS, V191, P650, DOI 10.1016/S1072-7515(00)00736-5; PATT A, 1988, SURG CLIN N AM, V68, P775; Phanithi PB, 2000, NEUROPATHOLOGY, V20, P273, DOI 10.1046/j.1440-1789.2000.00346.x; Prueckner S, 2001, J TRAUMA, V50, P253, DOI 10.1097/00005373-200102000-00010; Qu XW, 1999, CRIT CARE MED, V27, P356, DOI 10.1097/00003246-199902000-00043; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Rollwagen FM, 1996, CYTOKINE, V8, P121, DOI 10.1006/cyto.1996.0017; ROOT HD, 1965, SURGERY, V57, P633; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; SAYEED MM, 2001, CIRCULATORY SHOCK PA, P112; Shahani R, 2000, AM J PHYSIOL-HEART C, V278, pH942, DOI 10.1152/ajpheart.2000.278.3.H942; Sick TJ, 1999, STROKE, V30, P2416, DOI 10.1161/01.STR.30.11.2416; Smail N, 1998, ARCH SURG-CHICAGO, V133, P399, DOI 10.1001/archsurg.133.4.399; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Takasu A, 1999, CRIT CARE MED, V27, P1557, DOI 10.1097/00003246-199908000-00025; Takasu A, 2000, CRIT CARE MED, V28, P2465, DOI 10.1097/00003246-200007000-00047; Toyoda T, 1996, NEUROSURGERY, V39, P1200, DOI 10.1097/00006123-199612000-00024; Udassin R, 1997, ARCH SURG-CHICAGO, V132, P406; Wladis A, 2001, SHOCK, V15, P60, DOI 10.1097/00024382-200115010-00010; WRIGHT JG, 1988, J TRAUMA, V28, P1026, DOI 10.1097/00005373-198807000-00019; WU X, 2001, SHOCK, V15, P49; Wu XR, 2001, SHOCK, V16, P449, DOI 10.1097/00024382-200116060-00008; Wu XR, 2001, CRIT CARE MED, V29, P1767, DOI 10.1097/00003246-200109000-00019; XIAO F, 1995, RESUSCITATION, V30, P51, DOI 10.1016/0300-9572(94)00858-D; ZEINER A, 2002, NEW ENGL J MED, V346, P549; ZHANG JX, 1994, CRYOBIOLOGY, V31, P94, DOI 10.1006/cryo.1994.1012	58	22	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	OCT	2002	53	4					654	662		10.1097/00005373-200210000-00006			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	604JZ	WOS:000178618400009	12394862				2022-02-06	
J	Cairns, CJS; Thomas, B; Fletcher, S; Parr, MJA; Finfer, SR				Cairns, CJS; Thomas, B; Fletcher, S; Parr, MJA; Finfer, SR			Life-threatening hyperkalaemia following therapeutic barbiturate coma	INTENSIVE CARE MEDICINE			English	Article						thiopentone; barbiturate; hypokalaemia; hyperkalaemia; acute brain injury; subarachnoid haemorrhage	HEAD-INJURY; HYPERKALEMIA	Objective: To report the occurrence of life-threatening hyperkalaemia following treatment with therapeutic thiopentone coma. Setting: The neurosurgical intensive care units of Royal North Shore Hospital and Liverpool Hospital, Sydney, Australia. Patients: Three patients treated with therapeutic thiopentone coma. One patient with raised intracranial pressure secondary to a severe traumatic brain injury and two patients with refractory vasospasm secondary to subarachnoid haemorrhage. Two of the three patients developed hypokalaemia on starting thiopentone, which was resistant to potassium supplementation. All three patients developed severe hyperkalaemia during the recovery phase of coma. This was life-threatening in all three patients and fatal in one. Conclusions: Severe hypokalaemia refractory to potassium therapy may occur during therapeutic thiopentone coma. Severe rebound hyperkalaemia may occur after cessation of thiopentone infusion. Protocols for the management of patients with therapeutic barbiturate coma should recognise this potentially serious complication.	Royal N Shore Hosp, Intens Care Unit, St Leonards, NSW 2065, Australia; Liverpool Hosp, Intens Care Unit, Sydney, NSW, Australia		Finfer, SR (corresponding author), Royal N Shore Hosp, Intens Care Unit, St Leonards, NSW 2065, Australia.			Parr, Michael/0000-0003-3507-474X			BALI IM, 1973, BRIT J ANAESTH, V45, P1238, DOI 10.1093/bja/45.12.1238; CARLSSON C, 1975, Acta Anaesthesiologica Scandinavica Supplementum, V57, P7; Cloetta M, 1934, N-S ARCH EX PATH PH, V174, P589, DOI 10.1007/BF01878396; Finfer SR, 1999, INTENS CARE MED, V25, P406, DOI 10.1007/s001340050866; Friederich P, 1999, ANESTHESIOLOGY, V91, P1853, DOI 10.1097/00000542-199912000-00040; NORDBY HK, 1984, ACTA NEUROCHIR WIEN, V72, P158; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; SCHAEFER M, 1995, INTENS CARE MED, V21, P235, DOI 10.1007/BF01701479; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; STEVENSON DE, 1960, BRIT J ANAESTH, V32, P353, DOI 10.1093/bja/32.8.353; Stover JF, 1998, EUR NEUROL, V39, P223, DOI 10.1159/000007938; STOVNER J, 1972, ACTA ANAESTH SCAND, V16, P46, DOI 10.1111/j.1399-6576.1972.tb00568.x; TOUWBORST A, 1984, INJURY, V15, P293	14	22	22	0	1	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	SEP	2002	28	9					1357	1360		10.1007/s00134-002-1399-y			4	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598NK	WOS:000178282400029	12209290				2022-02-06	
J	Hoskote, A; Richards, P; Anslow, P; McShane, T				Hoskote, A; Richards, P; Anslow, P; McShane, T			Subdural haematoma and non-accidental head injury in children	CHILDS NERVOUS SYSTEM			English	Article						child abuse; head trauma; intracranial haemorrhage; traumatic brain injury; neuro-imaging; shaking injury	INTRACRANIAL HEMORRHAGE; COMPUTED-TOMOGRAPHY; INFANTS; DISORDERS	Patients and methods: In this retrospective study, 36 children referred to paediatric neurology and neurosurgery during April 1995-June 1998 with a diagnosis of subdural haematoma (SDH) were studied. Nine were accidental secondary to witnessed trauma and 4 were iatrogenic. Non-accidental head injury (NAHI) was suspected in the remaining 23 children. Results: After a full clinical, radiological and social assessment, NAHI was diagnosed in 14, lateral sinus thrombosis in 1, 2 were accepted as accidental and 6 remained unexplained. In the NAHI group (n=14), 12 were between 4 and 16 weeks of age, 12 (85%) had retinal haemorrhages and skeletal surveys showed evidence of additional injury in 8. Computerised tomography (CT) brain scans showed bilateral SDH in 11, and 6 had interhemispheric bleeding along with loss of grey-white differentiation. Eleven had magnetic resonance imaging (MRI), which yielded additional information in 7. Seven required intensive care, and 2 died. Twelve had surgical aspiration. In the group with no satisfactory explanation for SDH (n=6); 5 had neonatal problems, all except I were older than 5 months of age and not as ill with bilateral, old SDH. All but I had skeletal surveys, which were normal, and eye examination showed no retinal haemorrhages. A social services enquiry was non-contributory. Conclusions: SDH is frequently traumatic whether accidental or non-accidental. SDH due to NAHI tends to present before 4 months of age with an inconsistent history; the patients are more seriously ill and have other findings, such as fractures and retinal haemorrhages. A small subgroup of patients was identified who had isolated, old SDH and in whom full investigation remained inconclusive. A consistent, comprehensive approach needs to be maintained in all cases with the essential backup of detailed neuro-imaging including MRI.	John Radcliffe Hosp, Dept Paediat Neurol, Oxford OX3 9DU, England; Radcliffe Infirm, Dept Paediat Neurosurg & Neuroradiol, Oxford OX2 6HE, England		McShane, T (corresponding author), John Radcliffe Hosp, Dept Paediat Neurol, Headley Way, Oxford OX3 9DU, England.	Tony.McShane@orh.anglox.nhs.uk		Hoskote, Aparna/0000-0003-4760-1199			Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; BROWN JK, 1993, DEV MED CHILD NEUROL, V35, P849; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Carter J E, 1983, Child Abuse Negl, V7, P279, DOI 10.1016/0145-2134(83)90005-4; Dashti SR, 1999, PEDIATR NEUROSURG, V31, P302, DOI 10.1159/000028880; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Morris MW, 2000, PEDIATRICS, V105, P549, DOI 10.1542/peds.105.3.549; NEWTON RW, 1989, ARCH DIS CHILD, V64, P188, DOI 10.1136/adc.64.2.188; OHARE AE, 1984, ARCH DIS CHILD, V59, P860, DOI 10.1136/adc.59.9.860; Perrin RG, 1997, NEUROSURGERY, V40, P1190, DOI 10.1097/00006123-199706000-00016; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Sener RN, 1997, COMPUT MED IMAG GRAP, V21, P341; SHIH SL, 1993, NEURORADIOLOGY, V35, P619, DOI 10.1007/BF00588410; SUNDERLAND R, 1999, RECENT ADV PAEDIAT, V17; Tzioumi D, 1998, CHILD ABUSE NEGLECT, V22, P1105, DOI 10.1016/S0145-2134(98)00093-3; Wilkins B, 1997, ARCH DIS CHILD, V76, P393, DOI 10.1136/adc.76.5.393; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687	23	22	22	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2002	18	6-7					311	317		10.1007/s00381-002-0616-x			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	588FE	WOS:000177690300009	12172938				2022-02-06	
J	Chiaretti, A; De Benedictis, R; Della Corte, F; Piastra, M; Viola, L; Polidori, G; Di Rocco, C				Chiaretti, A; De Benedictis, R; Della Corte, F; Piastra, M; Viola, L; Polidori, G; Di Rocco, C			The impact of initial management on the outcome of children with severe head injury	CHILDS NERVOUS SYSTEM			English	Article						secondary brain damage; hypoxia; hypotension; Glasgow Outcome Score; pediatric head injury	HYPOTENSION; TRAUMA; CARE	Background: Neurotrauma is one of the most important causes of death in the pediatric age group. Head injury is responsible for both primary and secondary brain damage. The outcome of children with brain injury depends on the nature of the primary damage and on how well secondary brain damage can be limited. Appropriate critical care management at the scene and in hospital can prevent secondary brain damage that would otherwise result from cerebral reactions. Hypoxia and hypotension are major early complications of aggravation of secondary brain damage that are amenable to emergency maneuvers at the scene. In the literature, the influence of initial critical care management and early complications on the outcome of children with severe head injury is not clearly documented. Methods and results: We have prospectively examined the impact of the management at the scene on outcome in 40 children admitted to our Pediatric Intensive Care Unit with severe head injury (Glasgow Coma Scale less than or equal to8). The outcome of these children was assessed using the Glasgow Outcome Score (GOS). The results were evaluated by univariate and multivariate analysis. In our series the length of time before admission to an intensive care unit appears to have influenced the outcome among survivors, while the severity of injury is the only factor statistically associated with early complications (hypoxia and hypotension). With regard to the impact of early complications on outcome, the multivariate analysis showed that hypoxia and hypotension were significantly associated with GOS, independently of the GCS. Conclusion: Our results confirm the need for a precise treatment strategy for the initial management of children with neurotrauma to decrease the incidence of secondary brain damage attributable to hypoxia and hypotension.	Univ Sacred Heart, Pediat Intens Care Unit, I-00168 Rome, Italy; Osped Maggiore La Carita, Dept Anesthesiol, Novara, Italy; Univ Sacred Heart, Dept Pediat Neurosurg, I-00168 Rome, Italy		Chiaretti, A (corresponding author), Univ Sacred Heart, Pediat Intens Care Unit, Largo A Gemelli 8, I-00168 Rome, Italy.		Della Corte, Francesco/ABI-7646-2020	Della Corte, Francesco/0000-0003-1736-2318			Abbate B, 2000, Minerva Pediatr, V52, P623; ADAM EL, 1995, CARE MED, V8, P644; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; Boswell W C, 1995, Air Med J, V14, P125, DOI 10.1016/1067-991X(95)90513-8; BRUCE DA, 1999, PEDIAT NEUROSURGERY, P355; Buntain WL, 1995, MANAGEMENT PEDIAT TR; DADALT L, 1997, RIV ITAL PED, V23, P39; FACCHIN P, 1991, EPIDEMIOLOGIA PREVEN, P23; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; GHAJAR J, 1992, PEDIATR CLIN N AM, V39, P1093; Glasgow JF, 1997, CURR PEDIAT, V7, P187; Gordini G, 1992, Minerva Anestesiol, V58, P217; JENNETT B, 1975, LANCET, V1, P480; Kelly D F, 1995, New Horiz, V3, P453; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Mansfield RT, 1997, CRIT CARE CLIN, V13, P611, DOI 10.1016/S0749-0704(05)70331-6; Meyer P, 1999, CHILD NERV SYST, V15, P732, DOI 10.1007/s003810050462; MORONT ML, 1994, PEDIATR CLIN N AM, V41, P1201; NAKAYAMA DK, 1990, ANN SURG, V211, P218, DOI 10.1097/00000658-199002000-00015; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Rivara FP, 1999, PEDIATRICS, V103, P883; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87	23	22	24	0	0	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	FEB	2002	18	1-2					54	60		10.1007/s00381-001-0533-4			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	534ZR	WOS:000174620100014	11935245				2022-02-06	
J	d'Avella, D; Servadei, F; Scerrati, M; Tomei, G; Brambilla, G; Angileri, FF; Massaro, F; Cristofori, L; Tartara, F; Pozzati, E; Delfini, R; Tomasello, F				d'Avella, D; Servadei, F; Scerrati, M; Tomei, G; Brambilla, G; Angileri, FF; Massaro, F; Cristofori, L; Tartara, F; Pozzati, E; Delfini, R; Tomasello, F			Traumatic intracerebellar hemorrhage: Clinicoradiological analysis of 81 patients	NEUROSURGERY			English	Article; Proceedings Paper	International Conference on Recent Advances in Neurotraumatology (ICRAN 99)	NOV 20-23, 1999	TAIPEI, TAIWAN			head injury; hemorrhagic contusion and hematoma; outcome; posterior fossa; prognostic factors	INJURED ADULT PATIENTS; POSTERIOR-FOSSA; PROGNOSTIC FACTORS; BRAIN INJURY; HEAD-INJURY; HEMATOMAS	OBJECTIVE: We report 81 patients with a traumatic intracerebellar hemorrhagic contusion or hematoma managed between 1996 and 1998 at 13 Italian neurosurgical centers. METHODS: Each center provided data about patients' clinicoradiological findings, management, and outcomes, which were retrospectively reviewed. RESULTS: A poor result occurred in 36 patients (44.4%). Forty-five patients (55.6%) had favorable results. For the purpose of data analysis, patients were divided into two groups according to their admission Glasgow Coma Scale (GCS) scores. In Group 1 (39/81 cases; GCS score, greater than or equal to8), the outcome was favorable in 95% of cases. In Group 2 (42/81 cases; GCS score, <8), the outcome was poor in 81% of cases. Twenty-seven patients underwent posterior fossa surgery. Factors correlating with outcome were GCS score, status of the basal cisterns and the fourth ventricle, associated supratentorial traumatic lesions, mechanism of injury, and intracerebellar clot size. Multivariate analysis showed significant independent prognostic effect only for GCS score (P = 0.000) and the concomitant presence of supratentorial lesions (P = 0.0035). CONCLUSION: This study describes clinicoradiological findings and prognostic factors regarding traumatic cerebellar injury. A general consensus emerged from this analysis that a conservative approach can be considered a viable, safe treatment option for noncomatose patients with intracerebellar clots measuring less than or equal to 3 cm, except when associated with other extradural or subdural posterior fossa focal lesions. Also, a general consensus was reached that surgery should be recommended for all patients with clots larger than 3 cm. The pathogenesis, biomechanics, and optimal management criteria of these rare lesions are still unclear, and larger observational studies are necessary.	Univ Messina, Clin Neurochirurg, Messina, Italy; Osped Bufalini, Div Neurochirurg, Cesena, Italy; IRCCS, Osped Policlin, Clin Neurochirurg, Milan, Italy; Policlin San Matteo, IRCCS, Clin Neurochirurg, I-27100 Pavia, Italy; Osped CTO, Div Neurochirurg, Turin, Italy; Univ Verona, Clin Neurochirurg, I-37100 Verona, Italy; IRCCS, Osped S Raffaele, Clin Neurochirurgia, Milan, Italy; Univ Cattolica Sacro Cuore, Cattedra neurotraumatol, Dipartimento Sci Neurol, Rome, Italy		d'Avella, D (corresponding author), Policlin Univ, Neurosurg Clin, Via Consolare Valeria 1, I-98100 Messina, Italy.		Tartara, Fulvio/ABH-2023-2020; Angileri, Filippo/AAL-4851-2021; Angileri, Filippo/N-8556-2019; Angileri, Filippo Flavio/J-3533-2012	Angileri, Filippo/0000-0002-1107-4115; Angileri, Filippo Flavio/0000-0002-1107-4115; D'AVELLA, Domenico/0000-0001-9077-412X; Tartara, Fulvio/0000-0002-6131-9547; Servadei, Franco/0000-0002-3595-3464			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Bernardi RJ, 1993, BRAIN SURG COMPLICAT, V2, P1931; Cassinari V, 1967, Minerva Neurochir, V11, P230; D'Avella D, 2001, HEAD TRAUMA, P385; DAVELLA D, 1998, ACTA NEUROCHIR SUPP, V71, P410; DUHAIME AC, 1995, NEUROSURGERY, V37, P401, DOI 10.1227/00006123-199509000-00005; Hamasaki T, 1987, No To Shinkei, V39, P1083; Isla A, 1987, J Neurosurg Sci, V31, P67; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Karasawa H, 1997, J NEUROSURG, V86, P629, DOI 10.3171/jns.1997.86.4.0629; KOBAYASHI S, 1994, NEUROSURGERY, V34, P246, DOI 10.1227/00006123-199402000-00006; KOTWICA Z, 1995, ACTA NEUROCHIR, V133, P56, DOI 10.1007/BF01404948; KOZIARSKI A, 1991, ACTA NEUROCHIR, V110, P24, DOI 10.1007/BF01402043; Marshall LF, 1991, J NEUROSURG S, V75, P14; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; NAGATA K, 1991, Neurologia Medico-Chirurgica, V31, P792, DOI 10.2176/nmc.31.792; OLIN MS, 1980, NEUROSURGERY, V7, P271, DOI 10.1227/00006123-198009000-00013; PAPADAKIS N, 1976, JAMA-J AM MED ASSOC, V235, P530, DOI 10.1001/jama.235.5.530; POZZATI E, 1981, NEUROSURGERY, V8, P102, DOI 10.1227/00006123-198101000-00019; POZZATI E, 1982, J NEUROSURG, V56, P691, DOI 10.3171/jns.1982.56.5.0691; SATO K, 1987, Neurological Surgery, V15, P1285; Servadei F, 1997, ACTA NEUROCHIR, V139, P279, DOI 10.1007/BF01808822; Servadei F, 1995, J Neurosurg Sci, V39, P187; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; SERVADEI F, 1995, NEUROSURGERY, V37, P889; SOKOL JH, 1978, SURG NEUROL, V10, P340; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STJOHN JN, 1986, SURG NEUROL, V25, P457, DOI 10.1016/0090-3019(86)90085-6; STONE JL, 1991, NEUROSURGERY, V28, P603, DOI 10.1227/00006123-199104000-00022; TIBBS PA, 1981, SURG NEUROL, V16, P309, DOI 10.1016/0090-3019(81)90068-9; TSAI FY, 1980, J COMPUT ASSIST TOMO, V4, P291, DOI 10.1097/00004728-198006000-00002; TSUBOKAWA T, 1979, Neurologia Medico-Chirurgica, V19, P1127, DOI 10.2176/nmc.19.1127; Vrankovic D, 2000, NEUROSURG REV, V23, P156, DOI 10.1007/PL00011948; WEAVER JP, 1993, BRAIN SURG COMPLICAT, V2, P1351; WRIGHT RL, 1966, J NEUROSURG, V25, P402, DOI 10.3171/jns.1966.25.4.0402; YOKOTA H, 1990, Neurological Surgery, V18, P67; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006; ZUCCARELLO M, 1982, ACTA NEUROCHIR, V62, P79, DOI 10.1007/BF01402212	40	22	23	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JAN	2002	50	1					16	25		10.1097/00006123-200201000-00004			10	Clinical Neurology; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	506AC	WOS:000172946900005	11844230				2022-02-06	
J	Luo, YM; Cao, GD; Pei, W; O'Horo, C; Graham, SH; Chen, J				Luo, YM; Cao, GD; Pei, W; O'Horo, C; Graham, SH; Chen, J			Induction of caspase-activated deoxyribonuclease activity after focal cerebral ischemia and reperfusion	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						apoptosis; caspase-3; caspase-activated deoxyribonuclease; cerebral ischemia; DNA fragmentation	TRAUMATIC BRAIN INJURY; DNA FRAGMENTATION; CELL-DEATH; NEURONAL APOPTOSIS; SPINAL-CORD; INHIBITOR; RATS; CLEAVAGE; PROTEIN; ICAD	Deoxyribonucleic acid fragmentation at nucleosomal junctions is a hallmark of neuronal apoptosis in ischemic brain injury, for which the mechanism is not fully understood. Using the in vitro cell-free apoptosis assay, the authors found that caspase-3-dependent deoxyribonuclease activity caused internucleosomal DNA fragmentation in brain-cell extracts in a rat model of transient focal ischemia. This in vitro deoxyribonuclease activity was completely inhibited by purified inhibitor of caspase-activated deoxyribonuclease protein, the specific endogenous inhibitor of caspase-activated deoxyribonuclease, or by caspase-activated deoxyribonuclease immunodepletion. The induction of the deoxyribonuclease activity was correlated with caspase-3 activation and caspase-3-mediated degradation of inhibitor of caspase-activated deoxyribonuclease. Furthermore, inhibiting caspase-3-like protease activity prevented the endogenous induction of internucleosomal DNA fragmentation in the ischemic brain. These results suggest that caspase-3-dependent caspase-activated deoxyribonuclease activity plays an important role in mediating DNA fragmentation after focal ischemia.	Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Disorders, Pittsburgh, PA 15213 USA; Vet Affiars Pittsburgh Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Pittsburgh, PA USA		Chen, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, S-507,Biomed Sci Tower, Pittsburgh, PA 15213 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38560, NS36736, NS35965] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS035965, R01NS038560, R01NS036736] Funding Source: NIH RePORTER		Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Chen DX, 2000, J BIOL CHEM, V275, P38508, DOI 10.1074/jbc.M003906200; Chen J, 1997, J NEUROCHEM, V69, P232; Chen J, 1998, J NEUROSCI, V18, P4914; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Enari M, 1998, NATURE, V393, P396, DOI 10.1038/30782; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fujimura M, 1999, J NEUROSCI, V19, P3414; Graham SH, 2001, J CEREBR BLOOD F MET, V21, P99, DOI 10.1097/00004647-200102000-00001; LINNIK MD, 1993, STROKE, V24, P2002, DOI 10.1161/01.STR.24.12.2002; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MACMANUS JP, 1995, J CEREBR BLOOD F MET, V15, P728, DOI 10.1038/jcbfm.1995.93; Mukae N, 2000, J BIOL CHEM, V275, P21402, DOI 10.1074/jbc.M909611199; Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123; Namura S, 1998, J NEUROSCI, V18, P3659; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Zhang C, 1999, J NEUROCHEM, V73, P1650, DOI 10.1046/j.1471-4159.1999.0731650.x	20	22	27	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2002	22	1					15	20		10.1097/00004647-200201000-00002			6	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	505TD	WOS:000172930900002	11807389				2022-02-06	
J	Nissley, HM; Schmitter-Edgecombe, M				Nissley, HM; Schmitter-Edgecombe, M			Perceptually based implicit learning in severe closed-head injury patients	NEUROPSYCHOLOGY			English	Article							SELF-PERPETUATING DEVELOPMENT; COMPLEX PROCEDURAL KNOWLEDGE; EXPLICIT MEMORY; DIVIDED ATTENTION; ENCODING BIASES; ACQUISITION; AMNESIA; SYSTEMS; ASSOCIATIONS; INFORMATION	This study suggests that perceptually based implicit learning may either be preserved following a severe closed-head injury (CHI) or recover within the 1st year. Nineteen severe CHI patients and 19 controls searched visual matrices and indicated the quadrant location of a target. Participants were exposed to the following covariation pattern: AAAABAAA. For Covariation A blocks, the matrices systematically co-occurred with a unique location of the target. This relationship was altered for the B block. Despite CHI participants' overall slower response times (RTs), both groups demonstrated the expected decline in RTs across the first 4 Covariation A blocks followed by an increase when the covariation changed. Both groups also exhibited retention of their learning after a 20-min delay. Explicit knowledge tests indicated that participants lacked awareness for the covariation.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03 HD35838-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R03HD035838] Funding Source: NIH RePORTER		ABRAMS M, 1988, J PSYCHOLINGUIST RES, V17, P425; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALLEN R, 1980, COGNITION, V8, P175, DOI 10.1016/0010-0277(80)90011-6; [Anonymous], 1999, SUP PRO BET VERS EXP; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Berry D.C., 1993, IMPLICIT LEARNING TH; BOND MR, 1983, REHABILITATION HEAD, P185; BROOKS DN, 1984, CLOSED HEAD INJURY P; CHAPMAN LJ, 1994, DEV REV, V14, P159, DOI 10.1006/drev.1994.1007; Cleeremans A, 1998, TRENDS COGN SCI, V2, P406, DOI 10.1016/S1364-6613(98)01232-7; COHEN A, 1990, J EXP PSYCHOL LEARN, V16, P17, DOI 10.1037/0278-7393.16.1.17; Cohen J., 2013, STAT POWER ANAL BEHA; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Gabrieli JDE, 1997, PSYCHOL SCI, V8, P326, DOI 10.1111/j.1467-9280.1997.tb00447.x; Golden CJ, 1978, STROOP COLOR WORD TE; GOSHENGOTTSTEIN Y, 1995, J EXP PSYCHOL LEARN, V21, P1229, DOI 10.1037/0278-7393.21.5.1229; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; HARTMAN M, 1989, J EXP PSYCHOL LEARN, V15, P1070, DOI 10.1037/0278-7393.15.6.1070; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; HAYS WL, 1988, STATISTICS; Hendrickx H, 1997, PSYCHOL BELG, V37, P29; HILL T, 1989, J PERS SOC PSYCHOL, V57, P373, DOI 10.1037/0022-3514.57.3.373; HINTZMAN DL, 1990, ANNU REV PSYCHOL, V41, P109, DOI 10.1146/annurev.psych.41.1.109; HOWARD DV, 1992, PSYCHOL AGING, V7, P232, DOI 10.1037/0882-7974.7.2.232; Kaplan E., 1987, MANUAL CALIFORNIA VE; KNOPMAN D, 1991, J CLIN EXP NEUROPSYC, V13, P880, DOI 10.1080/01688639108405105; KNOWLTON BJ, 1992, PSYCHOL SCI, V3, P172, DOI 10.1111/j.1467-9280.1992.tb00021.x; KNOWLTON BJ, 1994, J EXP PSYCHOL LEARN, V20, P79, DOI 10.1037/0278-7393.20.1.79; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEWICKI P, 1989, J EXP PSYCHOL GEN, V118, P323; LEWICKI P, 1986, J EXP PSYCHOL LEARN, V12, P135, DOI 10.1037/0278-7393.12.1.135; LEWICKI P, 1987, J EXP PSYCHOL LEARN, V13, P523, DOI 10.1037/0278-7393.13.4.523; LEWICKI P, 1988, COGNITIVE PSYCHOL, V20, P24, DOI 10.1016/0010-0285(88)90023-0; Lewicki P, 1986, NONCONSCIOUS SOCIAL; MATHEWS RC, 1989, J EXP PSYCHOL LEARN, V15, P1083, DOI 10.1037/0278-7393.15.6.1083; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; Meulemans T, 1997, PSYCHOL BELG, V37, P69; MUTTER SA, 1994, J CLIN EXP NEUROPSYC, V16, P271, DOI 10.1080/01688639408402638; NISSEN MJ, 1989, NEUROPSYCHOLOGIA, V27, P341, DOI 10.1016/0028-3932(89)90023-7; NISSEN MJ, 1987, NEUROLOGY, V37, P789, DOI 10.1212/WNL.37.5.789; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; Reber A. S., 1993, IMPLICIT LEARNING TA; REBER AS, 1991, J EXP PSYCHOL LEARN, V17, P888, DOI 10.1037/0278-7393.17.5.888; REED JM, 1998, HDB IMPLICIT LEARNIN, P261; Reitan R, 1985, HALSTEAD REITAN NEUR; Rosenthal R, 1991, ESSENTIALS BEHAV RES, V2nd; Schmitter-Edgecombe M, 2001, J INT NEUROPSYCH SOC, V7, P615, DOI 10.1017/S1355617701755099; Schmitter-Edgecombe M, 2000, NEUROPSYCHOLOGY, V14, P559; Schmitter-Edgecombe M, 1998, J INT NEUROPSYCH SOC, V4, P144, DOI 10.1017/S1355617798001441; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; Seger C. A., 1998, HDB IMPLICIT LEARNIN, P295; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Smith A., 1991, SYMBOL DIGIT MODALIT; STADLER MA, 1989, J EXP PSYCHOL LEARN, V15, P1061, DOI 10.1037/0278-7393.15.6.1061; STADLER MA, 1995, J EXP PSYCHOL LEARN, V21, P674, DOI 10.1037/0278-7393.21.3.674; STRAYER DL, 1994, PSYCHOL AGING, V9, P589, DOI 10.1037/0882-7974.9.4.589; TEASDALE G, 1974, LANCET, V2, P81; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1981, WECHSLER ADULT INTEL; WEISKRANTZ L, 1987, HUM NEUROBIOL, V6, P93; Willingham DB, 1999, MEM COGNITION, V27, P561, DOI 10.3758/BF03211549; [No title captured]	71	22	22	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JAN	2002	16	1					111	122		10.1037//0894-4105.16.1.111			12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	520RK	WOS:000173794700013	11853352				2022-02-06	
J	Sztriha, L; Gururaj, AK; Bener, A; Nork, M				Sztriha, L; Gururaj, AK; Bener, A; Nork, M			Temporal lobe epilepsy in children: Etiology in a cohort with new-onset seizures	EPILEPSIA			English	Article						temporal lobe epilepsy; childhood; etiology; classification	HIPPOCAMPAL NEURON LOSS; FEBRILE CONVULSIONS; DEVELOPMENTAL MALFORMATIONS; INTRACTABLE EPILEPSY; MESIAL STRUCTURES; ARACHNOID CYSTS; SCLEROSIS; CHILDHOOD; ABNORMALITIES; DIAGNOSIS	Purpose: The aim of this study was to characterize the incidence and etiology of temporal lobe epilepsy (TLE) in a community-based cohort of children with new-onset disease. Methods: A community-based cohort of 30 children with TLE was studied. The patients had new-onset disease before age 14 years between 1995 and 1999. They underwent clinical, EEG, and magnetic resonance imaging investigations. Results: The patients could be divided in three main groups according to likely etiology, as suggested by Harvey et al. (Neurology, 1997;49:960-8). Group 1 consisted of eight (26.7%) children with malformations or long-standing, nonprogressive tumors (developmental TLE). Arachnoid cysts were found in three, dual pathology [cortical dysplasia and hippocampal sclerosis (HS)] in one, and focal cortical dysplasia with glioproliferative changes in one patient. Dysembryoplastic neuroepithelial tumor was responsible for the epilepsy in one, and ganglioglioma, in two children. Group 2 consisted of seven (23.3%) children with a significant antecedent and/or HS. Five children had a significant illness or event before the onset of TLE, including perinatal hypoxic-ischemic encephalopathy in one, encephalitis in one, traumatic brain injury in two, and complex febrile seizures in one. HS was found in the patients with traumatic brain injury and complex febrile seizures in the history in addition to two children without known antecedents. Group 3 comprised 15 (50%) children with no abnormality on neuroimaging and no significant antecedents (cryptogenic TLE). Conclusions: Etiologic differences between children with new-onset TLE may have prognostic implications: children with TLE and significant antecedents/HS arc expected to have the greatest risk of continued seizures and psychological problems.	UAE Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; UAE Univ, Fac Med & Hlth Sci, Dept Community Med, Al Ain, U Arab Emirates; Tawam Hosp, Dept Radiol, Al Ain, U Arab Emirates		Sztriha, L (corresponding author), UAE Univ, Fac Med & Hlth Sci, Dept Pediat, POB 17666, Al Ain, U Arab Emirates.						Arroyo S, 1997, EPILEPSIA, V38, P1098, DOI 10.1111/j.1528-1157.1997.tb01199.x; Bergman DA, 1996, PEDIATRICS, V97, P769; BROCKHAUS A, 1995, EPILEPSIA, V36, P1173, DOI 10.1111/j.1528-1157.1995.tb01059.x; CENDES F, 1993, ANN NEUROL, V34, P795, DOI 10.1002/ana.410340607; CENDES F, 1993, NEUROLOGY, V43, P1083, DOI 10.1212/WNL.43.6.1083; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; ENGEL J, 1998, EPILEPSY COMPREHENSI, P2417; Fernandez G, 1998, NEUROLOGY, V50, P909, DOI 10.1212/WNL.50.4.909; GRATTANSMITH JD, 1993, AM J ROENTGENOL, V161, P1045, DOI 10.2214/ajr.161.5.8273606; Harvey AS, 1997, NEUROLOGY, V49, P960, DOI 10.1212/WNL.49.4.960; HARVEY AS, 1995, PEDIATR NEUROL, V12, P201, DOI 10.1016/0887-8994(95)00022-8; Ho SS, 1998, NEUROLOGY, V50, P748, DOI 10.1212/WNL.50.3.748; Honavar M, 1999, HISTOPATHOLOGY, V34, P342; JACKSON GD, 1993, AM J NEURORADIOL, V14, P753; KUKS JBM, 1993, LANCET, V342, P1391; Kuzniecky R, 1999, NEUROLOGY, V52, P479, DOI 10.1212/WNL.52.3.479; Madsen JR, 1998, PEDIATR NEUROSURG, V28, P261, DOI 10.1159/000028662; Maher J, 1995, BRAIN, V118, P1521, DOI 10.1093/brain/118.6.1521; Mathern GW, 1996, BRAIN, V119, P965, DOI 10.1093/brain/119.3.965; MATHERN GW, 1995, BRAIN, V118, P105, DOI 10.1093/brain/118.1.105; Miller SP, 2000, NEUROLOGY, V54, P1465, DOI 10.1212/WNL.54.7.1465; Morioka T, 1998, EPILEPSIA, V39, P804, DOI 10.1111/j.1528-1157.1998.tb01168.x; Morris HH, 1998, EPILEPSIA, V39, P307, DOI 10.1111/j.1528-1157.1998.tb01378.x; PRAYSON RA, 1995, J NEUROPATH EXP NEUR, V54, P513, DOI 10.1097/00005072-199507000-00005; RAYMOND AA, 1994, NEUROLOGY, V44, P1841, DOI 10.1212/WNL.44.10.1841; VanLandingham KE, 1998, ANN NEUROL, V43, P413, DOI 10.1002/ana.410430403; Wester K, 1999, NEUROSURGERY, V45, P775, DOI 10.1097/00006123-199910000-00008	27	22	24	0	1	BLACKWELL PUBLISHING INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0013-9580			EPILEPSIA	Epilepsia	JAN	2002	43	1					75	80		10.1046/j.1528-1157.2002.24201.x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	527EE	WOS:000174173100012	11879390	Bronze			2022-02-06	
J	Biervert, C; Horvath, E; Fahrig, T				Biervert, C; Horvath, E; Fahrig, T			Semiquantitative expression analysis of ephrine-receptor tyrosine kinase mRNA's in a rat model of traumatic brain injury	NEUROSCIENCE LETTERS			English	Article						ephrine tyrosine kinases; central nervous system lesion model; subdural haematoma; mRNA expression; real-time polymerase chain reaction; housekeeping genes	EPH FAMILY; COMMISSURAL AXONS; PROTEIN; ECK; GUIDANCE; LIGANDS; MICE	The molecular mechanisms involved in recovery of function of the central nervous system (CNS) after injury to the brain are incompletely understood. Here the expression of ephrine (Eph) kinases following traumatic brain injury (subdural haematoma) was analysed in order to find out whether these developmentally regulated genes may be involved in tissue remodelling after brain damage. mRNA was isolated from ipsilateral cortices 7, 18, and 28 days after surgery and semiquantitative reverse transcription-polymerase chain reaction was performed. Most Eph kinases did not show significant regulation at gene expression level during the time course of recovery from acute brain injury but there is some evidence that mRNA of EphB1 might be slightly upregulated. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.	Bayer AG, CNS Res, D-5600 Wuppertal, Germany		Fahrig, T (corresponding author), Aprather Weg 18A, D-42096 Wuppertal, Germany.	thomas.fahrig.tf@bayer-ag.de					BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Eijkenboom M, 2000, NEUROPHARMACOLOGY, V39, P817, DOI 10.1016/S0028-3908(00)00002-2; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gerlai R, 2000, BEHAV BRAIN RES, V108, P133, DOI 10.1016/S0166-4328(99)00139-4; Harrison DC, 2000, MOL BRAIN RES, V75, P143, DOI 10.1016/S0169-328X(99)00305-8; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Krull CE, 1997, CURR BIOL, V7, P571, DOI 10.1016/S0960-9822(06)00256-9; KURODA Y, 1992, NEUROSURGERY, V31, P1062, DOI 10.1227/00006123-199212000-00012; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Moreno-Flores MT, 1999, NEUROSCIENCE, V91, P193, DOI 10.1016/S0306-4522(98)00568-5; MORI T, 1995, MOL BRAIN RES, V29, P325, DOI 10.1016/0169-328X(94)00263-E; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PANDEY A, 1995, SCIENCE, V268, P567, DOI 10.1126/science.7536959; Park S, 1997, EMBO J, V16, P3106, DOI 10.1093/emboj/16.11.3106; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; TANG XX, 1995, GENOMICS, V29, P426, DOI 10.1006/geno.1995.9985; Theil T, 1998, DEVELOPMENT, V125, P443; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Xu QL, 1995, DEVELOPMENT, V121, P4005; Zhou RP, 1998, PHARMACOL THERAPEUT, V77, P151, DOI 10.1016/S0163-7258(97)00112-5	24	22	23	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 23	2001	315	1-2					25	28		10.1016/S0304-3940(01)02312-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	497CH	WOS:000172434800007	11711206				2022-02-06	
J	Sato, S; Iida, H; Hirayama, H; Endo, M; Ohwada, T; Fujii, K				Sato, S; Iida, H; Hirayama, H; Endo, M; Ohwada, T; Fujii, K			Traumatic basilar artery occlusion caused by a fracture of the clivus - Case report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						clivus fracture; basilar artery occlusion		A 56-year-old man presented with a rare traumatic basilar artery occlusion caused by a fracture of the clivus. He fell from the height of 2 meters and immediately fell into a coma. Head computed tomography (CT) revealed an open depressed fracture, an acute epidural hematoma 1 cm thick in the left middle frontal fossa, and a longitudinal fracture of the clivus. Emergency removal of the hematoma was performed with cranioplasty. Head CT 8 hours 50 minutes after injury showed infarctions in the brain stem, cerebellum, and occipital lobes. Cerebral angiography revealed occlusion of the basilar artery in the middle part of the clivus. The patient died after 3 days. Autopsy revealed that the basilar artery was trapped in the clivus fracture site. Vertebrobasilar artery occlusion due to trapping in a clivus fracture has a very poor prognosis. Diagnosis is difficult and generally only confirmed at autopsy. Cerebral angiography is recommended in a patient in a deep coma without massive brain contusion at the early stage of head injury to identify the possibility of vertebrobasilar artery occlusion in a clivus fracture.	Int Goodwill Hosp, Dept Neurosurg, Izumi Ku, Kanagawa 2450006, Japan; Kitasato Univ, Sch Med, Dept Neurosurg, Kanagawa, Japan; Kitasato Univ, Sch Med, Dept Crit Care & Emergency Med, Kanagawa, Japan		Sato, S (corresponding author), Int Goodwill Hosp, Dept Neurosurg, Izumi Ku, 1-28-1 Nishigaoka, Kanagawa 2450006, Japan.						ANTHONY DC, 1987, J NEUROSURG, V66, P929, DOI 10.3171/jns.1987.66.6.0929; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; GUHA A, 1989, CAN J NEUROL SCI, V16, P81, DOI 10.1017/S0317167100028560; JOSLYN JN, 1988, RADIOLOGY, V166, P817, DOI 10.1148/radiology.166.3.3340778; KAPILA A, 1985, J COMPUT ASSIST TOMO, V9, P1142, DOI 10.1097/00004728-198511000-00033; LINDENBERG R, 1966, J NEUROSURG, V24, P908, DOI 10.3171/jns.1966.24.5.0908; LOOP JW, 1964, RADIOLOGY, V83, P36, DOI 10.1148/83.1.36; SATO H, 1990, Neurological Surgery, V18, P1147; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; SIGHTS WP, 1968, J NEUROSURG, V28, P588, DOI 10.3171/jns.1968.28.6.0588	10	22	23	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	NOV	2001	41	11					541	544		10.2176/nmc.41.541			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	492GR	WOS:000172160500010	11758706	Bronze			2022-02-06	
J	Marquardt, TP; Rios-Brown, M; Richburg, T				Marquardt, TP; Rios-Brown, M; Richburg, T			Comprehension and expression of affective sentences in traumatic brain injury	APHASIOLOGY			English	Article; Proceedings Paper	30th Annual Clinical Aphasiology Conference	MAY, 2000	WAIKOLON, HAWAII					The comprehension and production of affective prosody and facial expression was investigated in subjects with traumatic brain injury and matched normal subjects. Performance on tasks designed to assess the ability to recognise affect in congruous, neutral, and ambiguous sentences and the ability to portray emotions in affectively neutral sentences revealed significant impairments for the subjects with traumatic brain injury. Analysis of correct responses to ambiguous sentences found increased reliance of brain-injured subjects on verbal compared to paralinguistic cues in interpreting the emotion of the sentence. The clinical implications of the findings relative to counselling, compensation strategies, and direct intervention for patients with traumatic brain injury are discussed.	Univ Texas, Dept Commun Sci & Disorders, Austin, TX 78712 USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Memphis, Memphis, TN 38152 USA		Marquardt, TP (corresponding author), Univ Texas, Dept Commun Sci & Disorders, Austin, TX 78712 USA.						Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; Borod JC, 1993, NEUROPSYCHOLOGY, V7, P445, DOI DOI 10.1037/0894-4105.7.4.445; Braun C M, 1989, Brain Inj, V3, P345, DOI 10.3109/02699058909004559; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Hartley L. L, 1995, COGNITIVE COMMUNICAT; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; PATTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139; PRIGATANO GP, 1982, J PERCEPTUAL MOTOR S, V54, P859; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th Edn; WEDDELL RA, 1990, NEUROPSYCHOLOGIA, V28, P49, DOI 10.1016/0028-3932(90)90085-3; Ylvisaker M., 1987, COMMUNITY REENTRY HE, P137	14	22	22	0	2	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0268-7038			APHASIOLOGY	Aphasiology	OCT-NOV	2001	15	10-11					1091	1101		10.1080/02687040143000429			11	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	483EW	WOS:000171621600018					2022-02-06	
J	Sylvia, FR; Drake, AI; Wester, DC				Sylvia, FR; Drake, AI; Wester, DC			Transient vestibular balance dysfunction after primary blast injury	MILITARY MEDICINE			English	Article							BOMB EXPLOSION; TERRORIST	Explosive munitions are used routinely in support of military operations. Moreover, service personnel are increasingly being deployed to regions where active conflict, terrorism, and land mines pose significant threats. Despite aggressive protective measures and safety practices, blast injury is an inherent risk. In contrast to secondary and tertiary blast injuries, primary blast injuries are generally limited to the air-filled organs of the respiratory, gastrointestinal, and auditory systems. We report the case of a Marine who entered the back-blast arc of a shoulder-launched multipurpose assault weapon at close range. Despite the magnitude of the blast, he sustained none of the classic findings suggestive of severe primary blast injury. However, he manifested unique vestibular balance abnormalities that precluded his return to full duty for several months. This suggests that personnel who sustain even a mild traumatic brain injury with vestibular manifestations may need prolonged observation and modified duty in certain military occupational specialties.	REIN, Regimental Aid Stn, Marine Div 1, REIN, Camp Pendleton, CA 92055 USA; USN, Ctr Med, Dept Neurol, San Diego, CA 92134 USA; USN, Med Ctr, Dept Def Vestibular Balance Lab, San Diego, CA 92134 USA		Sylvia, FR (corresponding author), REIN, Regimental Aid Stn, Marine Div 1, REIN, Fleet Marine Force,Box 555401, Camp Pendleton, CA 92055 USA.						Benzinger T., 1950, GERMAN AVIATION MED, V2, P1225; BRISMAR B, 1982, J TRAUMA, V22, P216, DOI 10.1097/00005373-198203000-00007; DESAGA H, 1950, GERMAN ACTIVATION ME, P1274; HADDEN WA, 1978, BRIT J SURG, V65, P525, DOI 10.1002/bjs.1800650802; KATZ E, 1989, ANN SURG, V209, P484, DOI 10.1097/00000658-198904000-00016; KERR AG, 1978, PRACTITIONER, V221, P677; Krohn PL, 1942, LANCET, V1, P252; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Mellor S G, 1988, Br J Hosp Med, V39, P536; PAHOR AL, 1981, J LARYNGOL OTOL, V95, P399, DOI 10.1017/S0022215100090873; PHILIPS YY, 1985, 5 INT WOUND BALL S S; PHILLIPS YY, 1986, ANN EMERG MED, V15, P1446, DOI 10.1016/S0196-0644(86)80940-4; Pyper PC, 1982, INJURY, V14, P332; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; ROSSLE R, 1950, GERMAN AVIATION MED, P1260; SCHARDIN H, 1950, GERMAN AVIATION MED, P1207; Wilson JV, 1943, LANCET, V1, P257; ZIV M, 1973, MIL MED, V8, P811	18	22	24	0	1	ASSN MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075			MIL MED	Milit. Med.	OCT	2001	166	10					918	920		10.1093/milmed/166.10.918			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653DG	WOS:000181419500023	11603248				2022-02-06	
J	Cupitt, JM				Cupitt, JM			Prophylaxis against thromboembolism in patients with traumatic brain injury: a survey of UK practice	ANAESTHESIA			English	Article						thrombosis, deep venous; traumatic brain injury; thromboprophylaxis	DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARIN; LOW-DOSE HEPARIN; INTERMITTENT PNEUMATIC COMPRESSION; POSTOPERATIVE INTRACRANIAL HEMORRHAGE; VENA-CAVA FILTERS; VENOUS THROMBOEMBOLISM; NEUROSURGICAL PATIENTS; HIGH-RISK; RANDOMIZED TRIAL	Venous thromboembolism is a major complication associated with traumatic brain injury and is responsible for significant morbidity and mortality. There has been a general reluctance over the years to use anticoagulant prophylaxis for patients with head injury who have suffered intracranial bleeding or for whom intracranial surgery is needed. We conducted a postal questionnaire survey of all neurosurgical centres in the United Kingdom, enquiring about the use of thromboprophylactic methods in the management of patients with traumatic brain injury. A diversity of practice and opinion in the use of such methods was evident from the replies received. The survey highlighted concern about the failure to implement even the most simple means of prophylaxis. The evidence for the use of the various methods of prophylaxis is reviewed.	Hope Hosp, Dept Anaesthesia, Manchester M6 8HD, Lancs, England		Cupitt, JM (corresponding author), Hope Hosp, Dept Anaesthesia, Stott Lane, Manchester M6 8HD, Lancs, England.						Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Agu O, 1999, BRIT J SURG, V86, P992, DOI 10.1046/j.1365-2168.1999.01195.x; BARNETT HG, 1977, J NEUROSURG, V47, P27, DOI 10.3171/jns.1977.47.1.0027; BLACK PM, 1986, NEUROSURGERY, V18, P440, DOI 10.1227/00006123-198604000-00008; Britt LD, 1996, AM J SURG, V172, P13, DOI 10.1016/S0002-9610(96)00079-7; BUCCI MN, 1989, SURG NEUROL, V32, P285, DOI 10.1016/0090-3019(89)90231-0; Burke DT, 1999, J HEAD TRAUMA REHAB, V14, P515, DOI 10.1097/00001199-199910000-00015; CERRATO D, 1978, J NEUROSURG, V49, P378, DOI 10.3171/jns.1978.49.3.0378; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; CLAGETT GP, 1988, ANN SURG, V208, P227, DOI 10.1097/00000658-198808000-00016; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Dickinson LD, 1998, NEUROSURGERY, V43, P1074, DOI 10.1097/00006123-199811000-00039; Erstad BL, 1998, PHARMACOTHERAPY, V18, P1011; FRIM DM, 1992, NEUROSURGERY, V30, P830, DOI 10.1227/00006123-199206000-00002; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; GERSIN K, 1994, J TRAUMA, V37, P205, DOI 10.1097/00005373-199408000-00009; Gosin JS, 1997, ANN VASC SURG, V11, P100, DOI 10.1007/s100169900017; GREEN D, 1994, PHARMACOL REV, V46, P89; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; Hammond FM, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199802000-00007; JOFFE SN, 1975, J NEUROSURG, V42, P201, DOI 10.3171/jns.1975.42.2.0201; KAUFMAN HH, 1983, ANGIOLOGY, V34, P627, DOI 10.1177/000331978303401001; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; KNUDSON MM, 1994, J TRAUMA, V37, P480, DOI 10.1097/00005373-199409000-00025; Langan EM, 1999, J VASC SURG, V30, P484, DOI 10.1016/S0741-5214(99)70075-3; Macdonald RL, 1999, NEUROSURGERY, V45, P245, DOI 10.1097/00006123-199908000-00008; Marion D W, 1991, Neurosurg Clin N Am, V2, P411; Narayan RK, 1996, NEUROTRAUMA; Nurmohamed MT, 1996, THROMB HAEMOSTASIS, V75, P233; Owings JT, 1996, J TRAUMA, V41, P396, DOI 10.1097/00005373-199609000-00004; Paoletti C, 1989, Agressologie, V30, P363; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; SKILLMAN JJ, 1978, SURGERY, V83, P354; Spain DA, 1998, AM SURGEON, V64, P522; SWANN KW, 1984, J NEUROSURG, V61, P1055, DOI 10.3171/jns.1984.61.6.1055; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; TURPIE AGG, 1989, ARCH INTERN MED, V149, P679, DOI 10.1001/archinte.149.3.679; TURPIE AGG, 1977, NEUROLOGY, V27, P435, DOI 10.1212/WNL.27.5.435; VALLADARES JB, 1980, NEUROSURGERY, V6, P138, DOI 10.1227/00006123-198002000-00004; Vanek VW, 1998, AM SURGEON, V64, P1050; Velmahos GC, 1998, J AM COLL SURGEONS, V187, P529, DOI 10.1016/S1072-7515(98)00223-3; Warbel A, 1999, J Neurosci Nurs, V31, P180; WARLOW C, 1972, LANCET, V1, P1305; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Wen DY, 1998, SURG NEUROL, V50, P521, DOI 10.1016/S0090-3019(98)00083-4; ZELIKOVSKI A, 1981, J NEUROSURG, V54, P652, DOI 10.3171/jns.1981.54.5.0652	46	22	22	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	AUG	2001	56	8					780	785					6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	462BD	WOS:000170399000014	11493245				2022-02-06	
J	Ross, GM; Shamovsky, IL; Woo, SB; Post, JI; Vrkljan, PN; Lawrance, G; Solc, M; Dostaler, SM; Neet, KE; Riopelle, RJ				Ross, GM; Shamovsky, IL; Woo, SB; Post, JI; Vrkljan, PN; Lawrance, G; Solc, M; Dostaler, SM; Neet, KE; Riopelle, RJ			The binding of zinc and copper ions to nerve growth factor is differentially affected by pH: implications for cerebral acidosis	JOURNAL OF NEUROCHEMISTRY			English	Article						metalloproteins; neurotrophin; NGF; stroke; transition metal cations; traumatic brain injury	TRK PROTOONCOGENE PRODUCT; P75 NEUROTROPHIN RECEPTOR; ALZHEIMER A-BETA; SUPEROXIDE-DISMUTASE; BASIS-SETS; FACTOR NGF; ISCHEMIA; NEURONS; CULTURE; DISEASE	It has recently been shown that transition metal cations Zn2+ and Cu2+ bind to histidine residues of nerve growth factor (NGF) and other neurotrophins (a family of proteins important for neuronal survival) leading to their inactivation. Experimental data and theoretical considerations indicate that transition metal cations may destabilize the ionic form of histidine residues within proteins, thereby decreasing their pK(a) values. Because the release of transition metal cations and acidification of the local environment represent important events associated with brain injury, the ability of Zn2+ and Cu2+ to bind to neurotrophins in acidic conditions may alter neuronal death following stroke or as a result of traumatic injury. To test the hypothesis that metal ion binding to neurotrophins is influenced by pH, the effects of Zn2+ and Cu2+ on NGF conformation, receptor binding and NGF tyrosine kinase (trkA) receptor signal transduction were examined under conditions mimicking cerebral acidosis (pH range 5.5-7.4). The inhibitory effect of Zn2+ on biological activities of NGF is lost under acidic conditions. Conversely, the binding of Cu2+ to NGF is relatively independent of pH changes within the studied range. These data demonstrate that Cu2+ has greater binding affinity to NGF than Zn2+ at reduced pH, consistent with the higher affinity Of Cu2+ for histidine residues. These findings suggest that cerebral acidosis associated with stroke or traumatic brain injury could neutralize the Zn2+-mediated inactivation of NGF, whereas corresponding pH changes would have little or no influence on the inhibitory effects of Cu2+. The importance of His84 of NGF for transition metal cation binding is demonstrated, confirming the involvement of this residue in metal ion coordination.	Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; Finch Univ Hlth Sci Chicago Med Sch, Dept Biochem & Mol Biol, N Chicago, IL 60064 USA; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada		Ross, GM (corresponding author), Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS036700] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS36700] Funding Source: Medline		Allington C, 2001, CELL DEATH DIFFER, V8, P451, DOI 10.1038/sj.cdd.4400831; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.0.CO;2-8; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Brown RH, 1996, ANN NEUROL, V39, P145, DOI 10.1002/ana.410390202; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chen SH, 2001, EUR J PHARMACOL, V414, P177, DOI 10.1016/S0014-2999(01)00792-0; CHOI DW, 1988, NEUROSCIENCE, V24, P67, DOI 10.1016/0306-4522(88)90312-0; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Danielsen E, 1997, EUR J BIOCHEM, V250, P249, DOI 10.1111/j.1432-1033.1997.0249a.x; DESIDERI A, 1993, ARCH BIOCHEM BIOPHYS, V301, P224; Diederix REM, 2000, BIOCHEMISTRY-US, V39, P9551, DOI 10.1021/bi000648o; FEE JA, 1975, BIOCHIM BIOPHYS ACTA, V412, P26, DOI 10.1016/0005-2795(75)90336-0; Frade JM, 1996, NATURE, V383, P166; FREDERICKSON CJ, 1988, BRAIN RES, V446, P383, DOI 10.1016/0006-8993(88)90899-2; FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kokaia Z, 1998, NEUROSCIENCE, V84, P1113, DOI 10.1016/S0306-4522(97)00579-4; KRISTIAN T, 1994, BRAIN RES, V641, P295, DOI 10.1016/0006-8993(94)90158-9; Kroes SJ, 1996, EUR J BIOCHEM, V240, P342, DOI 10.1111/j.1432-1033.1996.0342h.x; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lynch T, 2000, EXP GERONTOL, V35, P445, DOI 10.1016/S0531-5565(00)00112-1; Maitra R, 2000, NEUROTOX RES, V2, P321, DOI 10.1007/BF03033341; OUYANG YB, 1994, BRAIN RES, V646, P65, DOI 10.1016/0006-8993(94)90058-2; Park JA, 2000, J NEUROSCI, V20, P9096; Remenyi R, 2001, J BIOL INORG CHEM, V6, P23, DOI 10.1007/s007750000178; Ross GM, 1997, NAT MED, V3, P872, DOI 10.1038/nm0897-872; Ross GM, 1998, EUR J NEUROSCI, V10, P890, DOI 10.1046/j.1460-9568.1998.00094.x; ROSS GM, 1999, ENCY MOL BIOL, V3, P1584; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Sedel F, 1999, EUR J NEUROSCI, V11, P3904, DOI 10.1046/j.1460-9568.1999.00814.x; Shamovsky IL, 1999, PROTEIN SCI, V8, P2223; Shamovsky IL, 1999, J AM CHEM SOC, V121, P9797, DOI 10.1021/ja983303q; SLOVITER RS, 1985, BRAIN RES, V330, P150, DOI 10.1016/0006-8993(85)90017-4; SMITH BJ, 1994, CHEM PHYS LETT, V231, P345, DOI 10.1016/0009-2614(94)01273-3; STEVENS WJ, 1992, CAN J CHEM, V70, P612, DOI 10.1139/v92-085; SUTTER A, 1979, J BIOL CHEM, V254, P5972; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Trafton J, 1996, BRAIN RES, V731, P122, DOI 10.1016/0006-8993(96)00488-X; Vornov JJ, 1996, J NEUROCHEM, V67, P2379; Wang W, 1999, NEUROSCI LETT, V259, P115, DOI 10.1016/S0304-3940(98)00929-X; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; White AR, 2001, J NEUROCHEM, V76, P1509, DOI 10.1046/j.1471-4159.2001.00178.x; Woo SB, 1998, PROTEIN SCI, V7, P1006; Woo SB, 1996, J BIOL CHEM, V271, P24433, DOI 10.1074/jbc.271.40.24433; WOODRUFF NR, 1986, BIOCHEMISTRY-US, V25, P7967, DOI 10.1021/bi00372a027; Zhang Y, 2000, INORG CHEM, V39, P3057, DOI 10.1021/ic000036s	54	22	22	0	5	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0022-3042			J NEUROCHEM	J. Neurochem.	AUG	2001	78	3					515	523		10.1046/j.1471-4159.2001.00427.x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	460TZ	WOS:000170325800011	11483654	Bronze			2022-02-06	
J	Barr, WB				Barr, WB			Methodologic issues in neuropsychological testing	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; head injury; assessment; psychometrics	TRAUMATIC BRAIN INJURY; STANDARDIZED ASSESSMENT; FOOTBALL PLAYERS; CONCUSSION	Objective: To familiarize athletic trainers with methodologic issues regarding the development and implementation of neuropsychological tests used in programs for monitoring sport-related cerebral concussion. Data Sources: Knowledge base and MEDLINE and PsychLit searches from 1980-2000 using the terms sports, athletes, concussion, and brain. Data Synthesis: Neuropsychological testing is a proven method for evaluating symptoms of concussion that results from a variety of different causes. These tests have been shown to be effective in evaluating symptoms of subtle cognitive dysfunction in a number of patient groups, Applying these tests in an athletic population has required some procedural modifications, including the use of brief test batteries, collection of preseason baseline data, and evaluation of subtle postconcussive changes in test scores over time. New methods are now being used for improved evaluation of the reliability and validity of neuropsychological tests in athletes. Proper scientific analysis of the psychometric properties of neuropsychological tests and the ultimate value of their use in the sport setting will require years of detailed study on large numbers of athletes with and without symptoms of concussion. Conclusions/Recommendations: Athletic trainers and related personnel need to be aware of the training and methodologic issues associated with neuropsychological testing. Knowledge of the scientific properties of these tests, their advantages, and current limitations will ultimately enhance the athletic trainer's ability to use information from neuropsychological testing in an effective manner.	NYU, Mt Sinai Med Ctr & Hlth Ctr, Comprehens Epilepsy Ctr, Dept Neurol, New York, NY 10016 USA		Barr, WB (corresponding author), NYU, Mt Sinai Med Ctr & Hlth Ctr, Comprehens Epilepsy Ctr, Dept Neurol, 560 1st Ave,Rivergate 4th Floor, New York, NY 10016 USA.	william.barr@med.nyu.edu		Barr, William/0000-0001-7711-7758			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANASTASI A, 1968, PSYCHOLOGICAL TESTIN; BARR W, IN PRESS J INT NEURO; Barr WB, 1997, PSYCHOL ASSESSMENT, V9, P171; Barth JT, 1989, MILD HEAD INJURY, P257; Charter RA, 1999, J CLIN EXP NEUROPSYC, V21, P559, DOI 10.1076/jcen.21.4.559.889; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Franzen M. D., 2000, RELIABILITY VALIDITY; Hinton-Bayre AD, 1999, J CLIN EXP NEUROPSYC, V21, P70, DOI 10.1076/jcen.21.1.70.945; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McFall RM, 1999, ANNU REV PSYCHOL, V50, P215, DOI 10.1146/annurev.psych.50.1.215; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Smith A., 1993, SYMBOL DIGIT MODALIT	20	22	22	0	2	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL-SEP	2001	36	3					297	302					6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	557NC	WOS:000175913800013	12937499				2022-02-06	
J	Sanders, MJ; Dietrich, WD; Green, EJ				Sanders, MJ; Dietrich, WD; Green, EJ			Behavioral, electrophysiological, and histopathological consequences of mild fluid-percussion injury in the rat	BRAIN RESEARCH			English	Article						brain injury; barrel field; parasagittal fluid percussion; water maze; electrophysiology; somatosensory cortex	TRAUMATIC BRAIN INJURY; SOMATOSENSORY EVOKED-POTENTIALS; CORTICAL IMPACT; HEAD-INJURY; LAYER-IV; DYSFUNCTION; DEPRESSION; DEFICITS; MODEL; MOUSE	Metabolic dysfunction in the relay nuclei of the rat vibrissa circuit follows traumatic brain injury (TBI). This study examined the effects of mild (1.4-1.5 atm) parasagittal fluid-percussion injury on the elctrophysiology of this circuit. TBI caused significant reductions in slope and increases in latency of vibrissa-evoked field potentials 3 days after injury. Assessment of open-field swimming revealed an increase in thigmotaxis 2 days after injury. TBI caused mild selective cortical damage and limited axonal swelling at the injury site. Thus mild injury disrupts somatosensory electrophysiology and exploratory behavior. (C) 2001 Elsevier Science B.V. All rights reserved.	Univ Miami, Sch Med, Dept Psychol, Miami, FL 33124 USA; Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33136 USA; Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33136 USA		Sanders, MJ (corresponding author), Univ Calif Los Angeles, Dept Psychol, 1285 Franz Hall,Box 951563, Los Angeles, CA 90095 USA.	msanders@psych.ucla.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL036588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL36588] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30291] Funding Source: Medline		BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; OKUYAMA S, 1993, LIFE SCI, V53, pPL273, DOI 10.1016/0024-3205(93)90603-Z; Perri BR, 1997, J NEUROTRAUM, V14, P15, DOI 10.1089/neu.1997.14.15; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; SHAW NA, 1986, J NEUROL SCI, V74, P257, DOI 10.1016/0022-510X(86)90111-5; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; WALSER H, 1986, J NEUROL, V233, P34, DOI 10.1007/BF00313989; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	20	22	22	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 15	2001	904	1					141	144		10.1016/S0006-8993(01)02424-6			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	447TQ	WOS:000169588900015	11516420				2022-02-06	
J	Donders, J; Zhu, JJ; Tulsky, D				Donders, J; Zhu, JJ; Tulsky, D			Factor index score patterns in the WAIS-III standardization sample	ASSESSMENT			English	Article						WAIS-III; cluster analysis; profile subtypes	TRAUMATIC BRAIN INJURY; VERBAL-LEARNING TEST; WISC-III; SEX-DIFFERENCES; PERFORMANCE; EDUCATION; NORMS; AGE; INTELLIGENCE; ETHNICITY	Representative profile subtypes, based on factor index scores, were examined in the standardization sample of the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III). Two-stage cluster analysis identified five reliable subtypes. Three clusters were differentiated primarily by level of performance across all factor index scores (ranging from below average, to average, to above average). The other two clusters were characterized by distinct patterns of performance, with relative efficacy on the Processing Speed index being the most prominent distinction (ranging from a relative weakness to a relative strength). The clusters did not differ significantly in age, but ethnicity and income covaried directly with level of WAIS-III performance, whereas gender affected differential patterns of performance. Furthermore, education and memory were associated primarily with level and, to a relatively minor degree, pattern of WAIS-III performance. Implications for clinical practice are discussed.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; Psychol Corp, San Antonio, TX USA		Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy SE, Grand Rapids, MI 49503 USA.			Tulsky, David/0000-0002-4335-4509			BORNSTEIN RA, 1988, DEV NEUROPSYCHOL, V4, P17, DOI 10.1080/87565648809540386; Derakshan N, 1998, COGNITION EMOTION, V12, P697; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Donders J, 1996, PSYCHOL ASSESSMENT, V8, P312, DOI 10.1037/1040-3590.8.3.312; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Elliman NA, 1997, PERS INDIV DIFFER, V23, P31, DOI 10.1016/S0191-8869(97)00016-0; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Glutting J. J., 1997, CONT INTELLECTUAL AS, P349; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; KAUFMAN AS, 1999, ESSENTIALS WAIS 3 AS; LECKLITER IN, 1989, J CLIN PSYCHOL, V45, P484, DOI 10.1002/1097-4679(198907)45:4<484::AID-JCLP2270450402>3.0.CO;2-L; MAJERES RL, 1990, INTELLIGENCE, V14, P357, DOI 10.1016/0160-2896(90)90023-M; MANLY J, 2000, ANN C AM PSYCH ASS W; Manly JJ, 1998, NEUROLOGY, V50, P1238, DOI 10.1212/WNL.50.5.1238; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MCDERMOTT PA, 1989, PSYCHOL ASSESSMENT J, V1, P118; Moses JA, 1999, ARCH CLIN NEUROPSYCH, V14, P445, DOI 10.1016/S0887-6177(98)00030-4; Norman MA, 2000, J CLIN EXP NEUROPSYC, V22, P80, DOI 10.1076/1380-3395(200002)22:1;1-8;FT080; *SAS I, 1990, SAS STAT US GUID VER, V0001; SATTLER JM, 1999, ASSESSMENT CHILDREN; Schinka JA, 1998, PSYCHOL ASSESSMENT, V10, P171, DOI 10.1037/1040-3590.10.2.171; SNOW WG, 1990, J CLIN EXP NEUROPSYC, V12, P873, DOI 10.1080/01688639008401028; Stevens J.P., 1992, APPL MULTIVARIATE ST, V2nd; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wechsler, 1997, WECHSLER ADULT INTEL; WECHSLER D, 1997, WAIS3 WAIS3 TECHNICA; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205	32	22	22	0	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911			ASSESSMENT	Assessment	JUN	2001	8	2					193	203		10.1177/107319110100800207			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	537LB	WOS:000174759100007	11428698				2022-02-06	
J	Munte, TF; Radamm, C; Johannes, S; Brabant, G				Munte, TF; Radamm, C; Johannes, S; Brabant, G			Alterations of cognitive functions induced by exogenous application of thyroid hormones in healthy men: A double-blind cross-over study using event-related brain potentials	THYROID			English	Article							CLOSED HEAD-INJURY; VISUAL-SEARCH; ELECTROPHYSIOLOGICAL EVIDENCE; ATTENTION; PARALLEL; THERAPY; DISEASE; MEMORY; P300	The influence of experimentally induced subclinical hyperthyroidism on cognitive functions was tested using exogenous thyroxine or placebo. In a double-blind cross-over design, 24 healthy young men received either 300 mug of levothyroxine or placebo for two consecutive S-week periods. Determination of thyrotropin (TSH), total triiodothyronine (T-3), thyroxine (T-4), and sex hormone binding globulin (SHBG) confirmed the induction of subclinical hyperthyroidism. Three weeks after treatment with placebo or T-4, subjects were tested in two visual search tasks, one requiring the serial scanning of a stimulus array of eight items in order to detect a missing feature (serial task), while the other task allowed the parallel processing of eight items in order to detect an extra feature. Reaction times varied greatly between the tasks while no effect of T-4 medication was revealed on overt search behavior. The late cognitive components of the event-related brain potentials (ERP) were registered during the tasks using a multichannel recording. The late positive component (P300) to target stimuli showed a significant reduction in amplitude in the parallel search task in hyperthyroidism, while for the serial search task a significant frontal negativity was revealed for target stimuli, both suggesting an increased effort to be exerted for the execution of visual search tasks. Thus, short periods of subclinical hyperthyroidism in the range commonly induced in the treatment of thyroid cancer patients induce distinct alterations in brain-electric activity.	Otto Von Guericke Univ, Dept Neuropsychol, D-39106 Magdeburg, Germany; Hannover Med Sch, Dept Clin Endocrinol, D-3000 Hannover, Germany; Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany		Munte, TF (corresponding author), Otto Von Guericke Univ, Dept Neuropsychol, Bldg 24,Univ Pl 2, D-39106 Magdeburg, Germany.		Munte, Thomas/C-2077-2014				BENTE D, 1982, EEG EMG, V13, P1; BRAVERMAN LE, 1991, WERNER INGBARS THYRO, P645; COOPER DS, 1995, J CLIN ENDOCR METAB, V80, P331, DOI 10.1210/jc.80.2.331; Donchin E., 1986, PSYCHOPHYSIOL SYST P, P244; DRATMAN MB, 1983, AM J PHYSIOL, V245, P185; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; HEINZE HJ, 1994, PHARMACOPSYCHIATRY, V27, P224, DOI 10.1055/s-2007-1014309; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LUCK SJ, 1990, PERCEPT PSYCHOPHYS, V48, P603, DOI 10.3758/BF03211606; MACCRIMMON DJ, 1979, PSYCHOSOM MED, V41, P331, DOI 10.1097/00006842-197906000-00007; MANDEL SJ, 1993, ANN INTERN MED, V119, P492, DOI 10.7326/0003-4819-119-6-199309150-00009; Marr D., 1982, VISION COMPUTATIONAL, P428; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Munte TF, 1996, NEUROPSYCHOBIOLOGY, V34, P49, DOI 10.1159/000119291; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; PERRILD H, 1986, ACTA ENDOCRINOL-COP, V112, P185, DOI 10.1530/acta.0.1120185; Plum F., 1987, HDB PHYSL 1 NERVOUS, V5, P519; ROSS DS, 1990, J CLIN ENDOCR METAB, V71, P764, DOI 10.1210/jcem-71-3-764; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; TREISMAN A, 1985, J EXP PSYCHOL GEN, V114, P285, DOI 10.1037/0096-3445.114.3.285; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; ULLMAN S, 1984, COGNITION, V18, P137; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; WHYBROW PC, 1969, ARCH GEN PSYCHIAT, V20, P48; Woods DL., 1990, EVENT RELATED BRAIN, P178	27	22	24	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	1050-7256			THYROID	Thyroid	APR	2001	11	4					385	391		10.1089/10507250152039145			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	429GH	WOS:000168507400013	11349839				2022-02-06	
J	Phillis, JW; Goshgarian, HG				Phillis, JW; Goshgarian, HG			Adenosine and neurotrauma: Therapeutic perspectives	NEUROLOGICAL RESEARCH			English	Article						neurotrauma; cerebroprotection; adenosine receptors; spinal cord injury; cerebral blood flow	SPINAL-CORD HEMISECTION; TRANSIENT FOCAL ISCHEMIA; TRAUMATIC BRAIN INJURY; CEREBRAL-ISCHEMIA; A(2A) RECEPTORS; ADULT-RAT; INTRAVENOUS INFUSIONS; SYSTEMIC THEOPHYLLINE; NERVE ACTIVITIES; AMINOPHYLLINE	Cerebral ischemia studies demonstrating that stimulation of adenosine A(1) receptors by either endogenously released adenosine or the administration of selective receptor agonists causes significant reductions in the morbidity and mortality associated with focal or global brain ischemias have triggered interest in the potential of purinergic therapies for the treatment of traumatic injuries to the brain and spinal cord. Preliminary findings indicate that activation of A(1) adenosine receptors can ameliorate trauma-induced death of central neurons. Other avenues of approach include the administration of agents which elevate local concentrations of adenosine at injury sites by inhibiting its metabolism to inosine by adenosine deaminase, rephosphorylation to adenosine triphosphate by adenosine kinase or re-uptake into adjacent cells. Amplification of the levels of endogenously released adenosine in such a 'site and event specific' fashion has the advantage of largely restricting the effect of such inhibitors to areas of injury-induced adenosine release. Another approach involving purinergic therapy has been applied to the problem of respiratory paralysis following high spinal cord injuries. In this instance, the adenosine antagonist theophylline has been used to enhance residual synaptic drive to spinal respiratory neurons by blocking adenosine Al receptors. Theophylline induced, and maintained, hemidiaphragmatic recovery for prolonged periods after C(2) spinal cord hemisection in rats and may prove to be beneficial in assisting respiration in spinal cord injury patients.	Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Anat, Detroit, MI 48201 USA		Phillis, JW (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	jphillis@med.wayne.edu					AMER SM, 1971, P SOC EXP BIOL MED, V36, P750; Auchampach JA, 1997, CIRC RES, V80, P800; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BERSTRAND H, 1980, EUR J RESP, V109, P37; BRUNS RF, 1990, MOL PHARMACOL, V38, P939; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; CHIANG CH, 1995, EUR RESPIR J, V8, P632; CUNHA RA, 1994, BRAIN RES, V649, P208, DOI 10.1016/0006-8993(94)91066-9; DALY JW, 1985, J MED CHEM, V28, P487, DOI 10.1021/jm00382a018; DELEO J, 1988, NEUROSCI LETT, V84, P307, DOI 10.1016/0304-3940(88)90526-5; Dixon AK, 1996, BRIT J PHARMACOL, V118, P1461, DOI 10.1111/j.1476-5381.1996.tb15561.x; ELDRIDGE FL, 1985, J APPL PHYSIOL, V59, P1428, DOI 10.1152/jappl.1985.59.5.1428; ELDRIDGE FL, 1983, RESP PHYSIOL, V53, P239, DOI 10.1016/0034-5687(83)90070-1; Forbes CD, 1997, INT J CLIN PRACT, V51, P205; FREDHOLM BB, 1994, PHARMACOL REV, V46, P143; GAO Y, 1994, LIFE SCI, V55, pPL61, DOI 10.1016/0024-3205(94)00889-2; Gidday JM, 1996, BRAIN RES, V734, P261, DOI 10.1016/0006-8993(96)00647-6; GOSHGARIAN HG, 1979, EXP NEUROL, V66, P547, DOI 10.1016/0014-4886(79)90201-2; GOSHGARIAN HG, 1986, EXP NEUROL, V93, P440, DOI 10.1016/0014-4886(86)90206-2; GOSHGARIAN HG, 1977, EXP NEUROL, V57, P613, DOI 10.1016/0014-4886(77)90093-0; GOSHGARIAN HG, 2001, J SP CORD MED, V23, P193; Halle JN, 1997, BRAIN RES, V759, P309, DOI 10.1016/S0006-8993(97)00364-8; HEADRICK JP, 1994, J CEREBR BLOOD F MET, V14, P853, DOI 10.1038/jcbfm.1994.107; Hill RJ, 1998, J MOL CELL CARDIOL, V30, P579, DOI 10.1006/jmcc.1997.0621; Jacobson KA, 1998, TRENDS PHARMACOL SCI, V19, P184, DOI 10.1016/S0165-6147(98)01203-6; Jiang N, 1997, EUR J PHARMACOL, V320, P131, DOI 10.1016/S0014-2999(96)00905-3; Kochanek PM, 1997, ACT NEUR S, V70, P109; LAKSHMINARAYAN S, 1978, AM REV RESPIR DIS, V117, P33; LEWIS LJ, 1951, AM J PHYSIOL, V166, P241, DOI 10.1152/ajplegacy.1951.166.2.241; Liang BT, 1998, P NATL ACAD SCI USA, V95, P6995, DOI 10.1073/pnas.95.12.6995; LIN Y, 1992, BRAIN RES, V571, P272, DOI 10.1016/0006-8993(92)90665-V; Lopes LV, 1999, J NEUROPHYSIOL, V82, P3196, DOI 10.1152/jn.1999.82.6.3196; LUNDBERG DB, 1981, J PHARMACOL EXP THER, V217, P215; McAdoo DJ, 2000, BRAIN RES, V854, P152, DOI 10.1016/S0006-8993(99)02333-1; Miller LP, 1996, NEUROSCI LETT, V220, P73, DOI 10.1016/S0304-3940(96)13234-1; MITCHELL HL, 1995, NEUROSURGERY, V36, P1003, DOI 10.1227/00006123-199505000-00017; Monopoli A, 1998, NEUROREPORT, V9, P3955, DOI 10.1097/00001756-199812010-00034; Moreau JL, 1999, BRAIN RES REV, V31, P65, DOI 10.1016/S0165-0173(99)00059-4; MORENO DE, 1992, EXP NEUROL, V116, P219, DOI 10.1016/0014-4886(92)90001-7; MUELLER RA, 1981, J PHARMACOL EXP THER, V218, P593; NACHAZEL J, 1990, EUR RESPIR J, V3, P311; Nantwi KD, 1998, NEUROPHARMACOLOGY, V37, P113, DOI 10.1016/S0028-3908(97)00190-1; Nantwi KD, 1998, BRAIN RES, V789, P126, DOI 10.1016/S0006-8993(98)00024-9; Nantwi KD, 1996, EXP NEUROL, V140, P53, DOI 10.1006/exnr.1996.0114; NEWMAN D, 1994, ISRAEL J MED SCI, V30, P811; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PARKINSON FE, 1997, ROLE ADENOSINE NERVO, P223; PHILLIS J W, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P26; Phillis JW, 1995, BRAIN RES, V705, P79, DOI 10.1016/0006-8993(95)01153-6; PHILLIS JW, 1988, J CEREBR BLOOD F MET, V8, P733, DOI 10.1038/jcbfm.1988.121; PHILLIS JW, 1989, BRAIN RES BULL, V22, P537, DOI 10.1016/0361-9230(89)90107-X; PHILLIS JW, 1997, PRIMER CEREBROVASCUL, P250; Porter W T, 1895, J Physiol, V17, P455; RALL TW, 1999, PHARMACOL BASIS THER, P618; RICHMOND GH, 1949, J APPL PHYSIOL, V2, P16, DOI 10.1152/jappl.1949.2.1.16; RIEGELMAN S, 1980, CHEST, V78, P250, DOI 10.1378/chest.78.2.250; Rosin DL, 1998, J COMP NEUROL, V401, P163; RUDOLPHI K, 1995, NOVEL THERAPIES CNS, P327; RUDOLPHI KA, 1992, CEREBROVAS BRAIN MET, V4, P346; Schubert P, 1997, ANN NY ACAD SCI, V825, P1, DOI 10.1111/j.1749-6632.1997.tb48409.x; Sheardown MJ, 1996, DRUG DEVELOP RES, V39, P108; SIMPSON RE, 1992, J NEUROCHEM, V58, P1683, DOI 10.1111/j.1471-4159.1992.tb10041.x; STJOHN WM, 1987, EXP NEUROL, V96, P279; Von Lubitz DKJE, 1999, EUR J PHARMACOL, V367, P157, DOI 10.1016/S0014-2999(98)00977-7; VONLUBITZ DKJE, 1994, EUR J PHARMACOL, V256, P161, DOI 10.1016/0014-2999(94)90241-0; VonLubitz DKJE, 1995, EUR J PHARMACOL, V287, P295, DOI 10.1016/0014-2999(95)00498-X; VONLUBITZ DKJE, 1988, STROKE, V19, P1133, DOI 10.1161/01.STR.19.9.1133; VONLUBITZ DKJE, 1994, EUR J PHARMACOL, V263, P59, DOI 10.1016/0014-2999(94)90523-1	68	22	23	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					183	189		10.1179/016164101101198316			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200010	11320597				2022-02-06	
J	Oehmichen, M; Meissner, C; Konig, HG				Oehmichen, M; Meissner, C; Konig, HG			Brain injury after survived gunshot to the head: reactive alterations at sites remote from the missile track	FORENSIC SCIENCE INTERNATIONAL			English	Article						gunshot; brain; leukocytes; macrophages; axonal injury	AMYLOID PRECURSOR PROTEIN; TRAUMATIC AXONAL INJURY; PENETRATING GUNSHOTS; WOUNDS; DAMAGE; NEUROPATHOLOGY; INCAPACITATION; CIVILIANS	Gunshot wounds to the brain usually lead to acute respiratory arrest or death after a brief survival period, even in cases involving only slight direct tissue damage. It can be assumed therefore that the damage extends beyond the zone of recognizable destruction and hemorrhages. To determine the true extent of the tissue injury resulting from gunshot wounds to the brain, we carried out microscopic investigations for reactive changes (emigration of leukocytes and macrophages, axonal expression of beta -amyloid precursor protein (beta -APP) in 10 cases of gunshot wound to the narrow channel of the brain with survival times >2 h. Demonstration of leukocytes expressing naphthol AS-D chloroacetate esterase activity in the brain tissue at the border of the missile track established the vitality of the gunshot effect. The presence of macrophages (CD68-epitope) allowed demarcation of a 1-2 mm wide necrotic zone around the permanent cavity. Within this zone and beyond, beta -APP showed an initial increase followed by a decline in the number of injured axons. Three types of beta -APP positive staining could be differentiated. In the immediate vicinity of the missile track beta -APP positive neurons were present at a distance of 2-4 mm from the margin of the permanent cavity (type 1) as a result of primary injured neuronal tissue by the gunshot itself. At longer distances from the narrow channel and the permanent cavity single beta -APP positive axons or axon fragments and two additional types were found; type 2 shows a parallel, wave-like arrangement of the damaged fibers, which suggests that the injury was produced by mechanical acceleration of the brain tissue created by the energy the projectile expended within the brain; irregular aggregation of beta -APP positive axons or axon fragments within a local edema represents type 3, which may be attributed to secondary ischemia or edema. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.	Med Univ Lubeck, Dept Legal Med, D-23562 Lubeck, Germany		Oehmichen, M (corresponding author), Med Univ Lubeck, Dept Legal Med, Kahlhorstr 31-35, D-23562 Lubeck, Germany.	oehmich@rmed.mu-luebeck.de					CARANAT R, 1979, EFFICACITE MUNITIONS; CAREY ME, 1995, NEUROSURG CLIN N AM, V6, P629; CAVALIERE R, 1988, ACTA NEUROCHIR, V94, P133, DOI 10.1007/BF01435866; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; GRAHMICHEN M, 1997, WUNDHEILUNG, P197; KARGER B, 1995, INT J LEGAL MED, V108, P117, DOI 10.1007/BF01844822; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KIRKPATRICK JB, 1988, FORENSIC NEUROPATHOL, P276; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KORDESTANI RK, 1995, NEUROSURG CLIN N AM, V6, P657; Koszyca B, 1998, J NEUROTRAUM, V15, P675, DOI 10.1089/neu.1998.15.675; LEDER LD, 1964, KLIN WOCHENSCHR, V42, P553, DOI 10.1007/BF01486688; NORDSTEDT C, 1988, P NATL ACAD SCI USA, V15, P8910; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Oehmichen M, 1985, Beitr Gerichtl Med, V43, P55; Oehmichen M, 2000, J NEUROTRAUM, V17, P155, DOI 10.1089/neu.2000.17.155; Oehmichen M, 1996, ACTA NEUROPATHOL, V91, P642, DOI 10.1007/s004010050478; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; OEHMICHEN M, 1990, WUNDHEILUNG; OEHMICHEN M, 1992, KOPFSCHUSS SPANNUNGS, P37; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Povlishock JT, 1997, RES LEG MED, V17, P175; Sellier KG, 1994, WOUND BALLISTICS SCI; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D	28	22	25	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738			FORENSIC SCI INT	Forensic Sci.Int.	JAN 15	2001	115	3					189	197		10.1016/S0379-0738(00)00335-2			9	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	378RF	WOS:000165596900004	11074174				2022-02-06	
J	Macmillan, CSA; Andrews, PJD; Easton, VJ				Macmillan, CSA; Andrews, PJD; Easton, VJ			Increased jugular bulb saturation is associated with poor outcome in traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						head injury; jugular bulb venous oxygen saturation; cerebral oxygenation	SEVERE HEAD-INJURY; REPEATED ISCHEMIC INSULTS; VENOUS OXYGEN-SATURATION; INTRACRANIAL HYPERTENSION; INTENSIVE-CARE; OXIMETRY; GERBIL; DESATURATION; VALIDATION; CATHETER	The objective was to compare secondary insults, particularly decreases in jugular bulb oxyhaemoglobin saturation (SjO(2)), during intensive care in patients with "poor" and "good" outcomes 12 months after traumatic brain injury. A prospective observational study of patients' physiological data collected each minute from multimodality monitoring was carried out. Patients had duration of physiological insults quantified as a percentage of their validated monitoring time (once invalid data due to technical reasons were removed). Treatment protocols were designed to minimise secondary insults by maintaining intracranial pressure (ICP) less than 20 mm Hg, and cerebral perfusion pressure (CPP) greater than 70 mm Hg, with prompt correction of hypoxia and pyrexia. Twelve months after injury patients' neurological function was assessed using the Glasgow outcome scale (GOS). A poor outcome was defined as GOS 1 to 3 (group 1) and a good outcome as GOS 4 and 5 (group 2). Seventy five patients (64 male), median age of 34 years (range 15 to 70), were studied. At 12 months 33 patients had a poor outcome (group 1), and 42 a good outcome (group 2). Group 1 spent proportionately more time with SjO(2) greater than 75% compared with group 2 (p<0.05), and more time with SjO(2) below 54% (p<0.04). Group 1 patients also spent proportionately more time with CPP less than 70 mm Hg than group 2 (p<0.04). Patients in group 1 were older (p<0.04) and had a lower postresuscitation Glasgow coma score (p<0.002). There was no difference between the groups for ICP, injury severity score, peripheral pulse saturation, and pyrexia. This study confirms that secondary insults, including an increased SjO(2), occur significantly more in patients with poor outcomes. More research into strategies to reduce the impact of secondary insults, including management of increased SjO(2), is required.	Ninewells Hosp, Dept Anaesthet, Dundee DD1 9SY, Scotland; Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh, Midlothian, Scotland		Macmillan, CSA (corresponding author), Ninewells Hosp, Dept Anaesthet, Dundee DD1 9SY, Scotland.	c.macmillan@dundee.ac.uk					ANDREWS PJD, 1991, BRIT J ANAESTH, V67, P553, DOI 10.1093/bja/67.5.553; ANDREWS PJD, 1997, BAILLIERS CLIN NEURO, V5, P497; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; Cruz J, 1988, Acta Neurochir Suppl (Wien), V42, P35; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; De Deyne C, 1996, Eur J Emerg Med, V3, P69, DOI 10.1097/00063110-199606000-00002; De Deyne C, 1996, YB INTENSIVE CARE EM, P731; GENTLEMAN D, 1990, LANCET, V335, P330, DOI 10.1016/0140-6736(90)90615-C; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GUNN HC, 1995, J NEUROSURG ANESTH, V7, P174, DOI 10.1097/00008506-199507000-00003; Howells T. P., 1995, Journal of Neurotrauma, V12, P471; Jennett B, 1975, Ciba Found Symp, P309; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; LEWIS SB, 1995, ANAESTH INTENS CARE, V23, P307, DOI 10.1177/0310057X9502300307; LYONS C, 1964, ANN SURG, V160, P561, DOI 10.1097/00000658-196410000-00001; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; McKeating EG, 1998, ANESTH ANALG, V86, P759, DOI 10.1097/00000539-199804000-00016; McKeating EG, 1997, BRIT J ANAESTH, V78, P520, DOI 10.1093/bja/78.5.520; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; PLUTA R, 1989, J CEREBR BLOOD F MET, V9, P163, DOI 10.1038/jcbfm.1989.24; Ritter AM, 1996, J CLIN MONITOR, V12, P285, DOI 10.1007/BF02221748; SHEINBERG M, 1992, J NEUROSURG, V76, P212, DOI 10.3171/jns.1992.76.2.0212; Souter MJ, 1996, BRIT J ANAESTH, V76, P744, DOI 10.1093/bja/76.5.744; TOMIDA S, 1987, J CEREBR BLOOD F MET, V7, P773, DOI 10.1038/jcbfm.1987.133; VASS K, 1988, ACTA NEUROPATHOL, V75, P288, DOI 10.1007/BF00690537	28	22	23	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JAN	2001	70	1					101	104		10.1136/jnnp.70.1.101			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	388KC	WOS:000166178800021	11118256	Green Published, Bronze			2022-02-06	
J	McCunn, M; Mirvis, S; Reynolds, HN; Cottingham, C				McCunn, M; Mirvis, S; Reynolds, HN; Cottingham, C			Physician utilization of a portable computed tomography scanner in the intensive care unit	CRITICAL CARE MEDICINE			English	Article						CT scan; portable CT; mobile CT; trauma; diagnostic studies in critical illness; survey; unexpected findings; occult disease	CRITICALLY ILL PATIENTS; INTRAHOSPITAL TRANSPORT; COMPLICATIONS	Objective: To determine the utilization of a portable computed tamography (CT) scanner for critically ill adult patients in an intensive care unit (ICU). Design: survey study and retrospective review. Subjects: Critical care attending staff and fellows and neurosurgery residents. Setting: A university hospital and Level I trauma center with a multitrauma ICU, a neurotrauma ICU, and a neurosurgical ICU. Interventions: We surveyed all physicians who ordered portable CT scans from December 1996 through June 1998. Ordering physicians included critical care attending staff and fellows (anesthesiology, surgery, internal medicine) and neurosurgery residents. Physicians who no longer worked at the institution were contacted by mail or fax. Radiology records were reviewed to determine the actual number and type of scans performed. Measurements and Main Results:The survey response was 100%. Most physicians reported ordering portable head CT scans (97%), followed by chest CT (88%), abdominal CT (78%), and pelvic CT (34%) scans. Analysis of the actual number of scans performed correlated with these reports (511 head, 115 chest, 88 abdomen, and 87 pelvis). The indication for portable CT scans (as opposed to a "fixed" or "stationary" scans) cited most often was patient severity of illness (77%). Patients an extracarporeal support (93%), those with cardiovascular instability (70%), followed by those with respiratory instability (57%) and neurologic instability (40%) were deemed tao ill to transport. If the portable CT scanner was unavailable, however, most physicians (67%) ordered a fixed helical CT scan and the patient was transported to the radiology suite, regardless of medical condition. Conclusions: Access to a portable CT scanner impacts the physician ordering patterns for ICU patients. We found that 100% of surveyed physicians used the portable CT scanner for critically ill patients when the patient was unstable. If the diagnostic study was deemed medically necessary, and the portable scanner was unavailable, most surveyed physicians ordered a "fixed" helical scan and the patient was transported by an experienced transport team for the study. The portable CT offered an alternative and potentially safer means of obtaining diagnostic studies.	Univ Maryland, Sch Med, Dept Crit Care, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Radiol, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		McCunn, M (corresponding author), Univ Maryland, Sch Med, Dept Crit Care, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA.						BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; HURST JM, 1992, J TRAUMA, V33, P582, DOI 10.1097/00005373-199210000-00015; INDECK M, 1988, J TRAUMA, V28, P1020, DOI 10.1097/00005373-198807000-00018; INSEL J, 1986, CRIT CARE MED, V14, P539, DOI 10.1097/00003246-198606000-00004; JASTREMSKI MS, 1993, CRIT CARE MED, V21, P931; MIRVIS S, 1997, EMERG RADIOL, P1; MIRVIS SE, 1987, AM J ROENTGENOL, V148, P685, DOI 10.2214/ajr.148.4.685; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; SZEM JW, 1995, CRIT CARE MED, V23, P1660, DOI 10.1097/00003246-199510000-00009; TAYLOR JO, 1970, LANCET, V2, P1205; WALLEN E, 1995, CRIT CARE MED, V23, P1588, DOI 10.1097/00003246-199509000-00020; WEG JG, 1989, CHEST, V96, P631, DOI 10.1378/chest.96.3.631	12	22	24	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	DEC	2000	28	12					3808	3813		10.1097/00003246-200012000-00008			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	388NB	WOS:000166186200005	11153618				2022-02-06	
J	Quinn, B; Sullivan, SJ				Quinn, B; Sullivan, SJ			The identification by physiotherapists of the physical problems resulting from a mild traumatic brain injury	BRAIN INJURY			English	Article							MINOR HEAD-INJURY; CLINICAL NURSING RESEARCH; DELPHI SURVEY; PRIORITIES; RECOVERY; VARIABLES; SYMPTOMS; ADULTS	In New Zealand, over 9000 people are diagnosed with a traumatic brain injury (TBI) each year, with at least 80% being classified as mild. The cognitive deficits resulting from mild traumatic brain injury (MTBI) have been well documented, but this is not the case for the physical problems. As a result, the physical problems are not well understood and few people with a MTBI are referred for physiotherapy. The aim of this research was to use a modified Delphi Technique to gain consensus amongst physiotherapists working with TBI clients with regard to: (1) The common motor performance problems associated with MTBI; (2) The importance of assessing these motor performance problem; and (3) Whether these motor performance problems should be used in a formal assessment (FA) or included as a screening measure (SM). Following a pilot study to establish face validity and clarity of instructions, a national sample of 52 physiotherapists with a minimum of 1 year's experience working with TBI clients was recruited. In Round 1, 42 physiotherapists listed 424 physical problems which, in their clinical experience, may occur in people with a recent MTBI. A planning committee developed these listed problems into 33 items. In Round 2, these items were then rated by the physiotherapists as to their importance of being included in an assessment. Using 75% consensus criteria, 31 items were deemed as being at least 'important' for inclusion. In Round 3, the physiotherapists were asked whether these items should be used in a FA or used as a SM. Of the 31 items which were retained, seven reached consensus for FA (balance with unstable, reduced or changing base of support; dynamic standing balance; high level balance activities; quality of movement; ballistic activities; gait; proprioception). Five items reached consensus for being used as a SM (attention; behaviour; sport and leisure activities; vocational activities; quality of movement). Consensus of classification was not reached for the remaining 19 items which had previously been identified in Round 2 as being at least 'important' to be assessed. These results form the foundation for the development of an assessment/management protocol for physiotherapists working with adults with MTBI.	Univ Otago, Sch Physiotherapy, Dunedin, New Zealand; HealthCare Otago, ISIS Ctr, Community Rehabil Ctr, Dunedin, New Zealand		Sullivan, SJ (corresponding author), Univ Otago, Sch Physiotherapy, POB 56, Dunedin, New Zealand.	jsullivan@gandalf.otago.ac.nz					Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINKLEY J, 1993, PHYS THER, V73, P138, DOI 10.1093/ptj/73.3.138; BOND S, 1982, J ADV NURS, V7, P565, DOI 10.1111/j.1365-2648.1982.tb00277.x; COUPER MR, 1994, ADV NURS SCI, V7, P72; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; Duffield C, 1989, AUST J ADV NURS, V6, P41; Everett A, 1993, Prof Nurse, V9, P181; Flanagan S, 1999, MT SINAI J MED, V66, P152; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; GRONWALL D, 1974, LANCET, V2, P605; HALL KM, 1994, ARCH PHYSICAL MED RE, V75; HERDMAN SJ, 1993, PHYS MED REHABIL STA, V7, P559; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LINDEMAN CA, 1975, NURS RES, V24, P434, DOI 10.1097/00006199-197511000-00006; Linstone H.A., 1975, DELPHI METHOD TECHNI; MCKENNA HP, 1994, J ADV NURS, V19, P1221, DOI 10.1111/j.1365-2648.1994.tb01207.x; MILESTAPPING C, 1990, PHYS THER, V70, P448, DOI 10.1093/ptj/70.7.448; PILON M, 1995, BRAIN INJURY, V9, P365, DOI 10.3109/02699059509005776; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Schmitz Thomas J., 1994, P97; SWAINE BR, 1993, PHYS THER, V73, P71, DOI 10.1093/ptj/73.2.71; SWAINE BR, 1994, BRAIN INJURY, V8, P323, DOI 10.3109/02699059409150983; Veltman R H, 1993, J Neurosci Nurs, V25, P367; Vitale AE, 1996, BRAIN INJURY, V10, P367, DOI 10.1080/026990596124377; Zasler N., 1993, J HEAD TRAUMA REHAB, V8, P13, DOI 10.1097/00001199-199309000-00004	34	22	24	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2000	14	12					1063	1076					14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	380YW	WOS:000165736100004	11147579				2022-02-06	
J	Salazar, AM; Zitnay, GA; Warden, DL; Schwab, KA				Salazar, AM; Zitnay, GA; Warden, DL; Schwab, KA		DVHIP Study Grp	Defense and Veterans Head Injury Program: Background and overview	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; head injury; military; rehabilitation; TBI disease management; veterans	TRAUMATIC BRAIN INJURY; MILITARY MEDICAL SYSTEM; POLYMERASE; CORTEX; MRI	Traumatic brain injury (TBI) is the principal cause of death and disability for young Americans, with an estimated societal cost of over $39 billion per year. The Defense and Veterans Head injury Program (DVHIP) represents a close collaboration among the Departments of Defense (DoD) and Veterans Affairs (DVA), the Brain Injury Association (BIA), and the International Brain Injury Association (IBIA). Its principal mission is to ensure that military and veteran patients with head injury receive TBI-specific evaluation, treatment, rehabilitation, and follow-up, while at the same time addressing the readiness mission of the military and helping to define optimal care for victims of TBI nationwide. Defense and Veterans Head Injury Program activities can be grouped into three broad classes: (1) TBI education, community service, and primary prevention projects; (2) combined TBI clinical treatment, rehabilitation, and clinical research projects; and (3) clinically linked TBI laboratory research projects. It is thus based on a prudent integration of clinical care and follow-up with programmatic clinical and clinically related laboratory research, TBI prevention, and education. This previously nonexistent clinical infrastructure now offers a valuable base for ongoing TBI clinical research.	Uniformed Serv Univ Hlth Sci, Def & Vet Head Injury Program, Washington, DC USA; Martha Jefferson Hosp, John Jane Brain Injury Ctr, Charlottesville, VA USA; Int Brain Injury Assoc, Charlottesville, VA USA; Walter Reed AMC, Washington, DC 20307 USA; Henry M Jackson Fdn, Rockville, MD USA		Salazar, AM (corresponding author), Uniformed Serv Univ Hlth Sci, Def & Vet Head Injury Program, Washington, DC USA.						BRAVERMAN S, 1999, IN PRESS BRAIN INJUR; CHESNUT R, 1999, AGENCY HLTH CARE POL, V7, P37; Dobi A, 2000, J NEUROSCI, V20, P1073, DOI 10.1523/JNEUROSCI.20-03-01073.2000; GRAFMAN J, 1999, BRAIN INJURY SOURCE, V3, P12; HEALTH NIO, 1999, REPORT CONSENSUS DEV, P245; KOENIG M, 1998, NEUR ABS, V25; KOENING M, 1997, N SCI ABS, V23, P1935; LaPlaca MC, 1999, J NEUROCHEM, V73, P205, DOI 10.1046/j.1471-4159.1999.0730205.x; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; OMMAYA A, 1999, MILITARY MED S; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Rahimi O, 1999, SOMATOSENS MOT RES, V16, P151, DOI 10.1080/08990229970582; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SALAZAR AM, 1999, BRAIN INJ SOURCE, V3, P8; THATCHER R, 1999, BRAIN INJURY SOURCE, V3, P20; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1	19	22	23	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2000	15	5					1081	1091		10.1097/00001199-200010000-00002			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	359DT	WOS:000089596800002	10970929				2022-02-06	
J	Sinal, SH; Petree, AR; Herman-Giddens, M; Rogers, MK; Enand, C; DuRant, RH				Sinal, SH; Petree, AR; Herman-Giddens, M; Rogers, MK; Enand, C; DuRant, RH			Is race or ethnicity a predictive factor in shaken baby syndrome?	CHILD ABUSE & NEGLECT			English	Article							ABUSIVE HEAD TRAUMA; CHILD-ABUSE; INJURY; MECHANISMS	Objective: Previous studies have concluded that shaken baby syndrome occurs more often among Whites than among Blacks. The purpose of this study was to determine whether race is a predictive factor in Shaken Baby Syndrome when population and referral patterns are considered, Methods: A retrospective medical record review of closed head injuries due to child abuse during the time period January 1992 to July 1997 was conducted at three pediatric tertiary care medical centers in North Carolina. Patients included children, ages 0-4 years, identified from medical record reviews and child abuse databases, Only North Carolina residents were included. The specific rates of shaken baby syndrome in Whites versus non-Whites in the referral area were computed. Results: The difference in the rate of shaken baby syndrome from the referral area was not statistically significant among Whites versus non-Whites (26.7/100,000 versus 38.6/100,000, p = .089) Most of the perpetrators were male (68%), and most victims (76%), lived with their mothers and biologic father or mother's boyfriend. Conclusion: Race was not a significant factor in predicting shaken baby syndrome in the referral area studied, and therefore is not a useful factor in targeting groups for intervention. (C) 2000 Elsevier Science Ltd.	Wake Forest Univ, Bowman Gray Sch Med, Brenner Childrens Hosp, Brenner Ctr Child & Adolescent Hlth,Dept Pediat, Winston Salem, NC 27157 USA; Off N Carolina Med Examiner, Chapel Hill, NC USA; Carolinas Med Ctr, Dept Pediat, Charlotte, NC 28203 USA		Sinal, SH (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Pediat, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK007400] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK 7400] Funding Source: Medline		BRENNER SL, 1989, J NATL MED ASSOC, V81, P183; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Guterman NB, 1999, CHILD ABUSE NEGLECT, V23, P863, DOI 10.1016/S0145-2134(99)00062-9; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; HAHN YS, 1983, CHILD BRAIN, V10, P229; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kramer MS, 1988, CLIN EPIDEMIOLOGY BI; SINAL SH, 1987, SOUTHERN MED J, V80, P1505, DOI 10.1097/00007611-198712000-00006; STARLING SP, 1995, PEDIATRICS, V95, P259; TSAI FY, 1980, CT-J COMPUT TOMOGR, V4, P277, DOI 10.1016/0149-936X(80)90020-X; ZIMMERMAN RA, 1979, RADIOLOGY, V130, P687, DOI 10.1148/130.3.687	11	22	23	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134	1873-7757		CHILD ABUSE NEGLECT	Child Abuse Negl.	SEP	2000	24	9					1241	1246		10.1016/S0145-2134(00)00177-0			6	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	352NQ	WOS:000089225100011	11057709				2022-02-06	
J	Swaine, BR; Pless, IB; Friedman, DS; Montes, JL				Swaine, BR; Pless, IB; Friedman, DS; Montes, JL			Effectiveness of a head injury program for children - A preliminary investigation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						rehabilitation; outcome evaluation; head injury; children	TRAUMATIC BRAIN INJURY; FUNCTIONAL INDEPENDENCE MEASURE; EARLY INTERVENTION; REHABILITATION; CARE; PERFORMANCE; AGREEMENT; TEAM; FIM	Objective: The purpose of this study was to investigate whether a more coordinated, comprehensive head injury rehabilitation program provided at a children's trauma center yielded better outcomes than a less coordinated, less comprehensive program. Design: Using a quasi-experimental design, 64 children with head injury admitted to the center and who received rehabilitation services in either 1995 or 1993 were evaluated by using the Functional Independence Measure for children (WeeFIM(TM))/The Functional Independence Measure (FIM(TM)) (e.g., primary outcome measure). Secondary outcomes included "psychosocial adjustment," "return to regular school," and "current problems related to the head injury. Results: No statistically significant differences were found between the groups with respect to mean WeeFIM/FIM scores after controlling for age and injury severity. The 1993 group had poorer scores on the withdrawal subscale of the psychosocial measure (P = 0.02), yet a smaller proportion of these children were enrolled in a special education class (P = 0.02). Conclusions: This study serves as a model for a larger, definitive study of the effectiveness of rehabilitation for children with head injury. The trends suggest that more comprehensive care may lead to better outcomes.	Univ Montreal, Fac Med, Sch Rehabil, Montreal, PQ H3C 3J7, Canada; Montreal Rehabil Inst, Res Ctr, Montreal, PQ, Canada; McGill Montreal Childrens Hosp, Res Inst, Montreal, PQ, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3A 2T5, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 2T5, Canada; Montreal Childrens Hosp, Dept Neurosurg, Montreal, PQ H3H 1P3, Canada		Swaine, BR (corresponding author), Univ Montreal, Fac Med, Sch Rehabil, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.						Achenbach T, 1983, MANUAL CHILD BEHAV C; American Speech and Hearing Association, 1995, ASHA S14, V37, P23; [Anonymous], 1990, ABBR INJ SCAL; ARONOW HU, 1987, J HEAD INJURY REHABI, V2, P24; Bond M R, 1979, Int Rehabil Med, V1, P155; BRUINICKS RH, 1978, BRUINICKS OSERETSKY; Campbell DT., 1966, EXPT QUASIEXPERIMENT; CASEY R, 1986, PEDIATRICS, V78, P497; CHARRON L, 1990, PROGRAMME CADRE READ; Christensen JR, 1997, NEUROREHABILITATION, V9, P105, DOI 10.3233/NRE-1997-9202; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; *COMM ACCR REH FAC, 1993, DIR ACCR ORG SERV PE; *COMM INJ SCAL, 1985, ABBR INJ SCAL; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; COWLEY RS, 1994, J HEAD TRAUMA REHAB, V9, P32; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; DISCALA C, 1992, AM J PHYS MED REHAB, V71, P145, DOI 10.1097/00002060-199206000-00004; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GRANGER CV, 1995, AM J PHYS MED REHAB, V74, P107; GREENSPAN A, 1996, CURR PROB PEDIAT MAY, P170; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; HALEY SM, 1992, ADM MANUAL PEDIAT EV; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALSTEAD LS, 1976, ARCH PHYS MED REHAB, V57, P507; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HIGH WM, 1995, J HEAD TRAUMA REHAB, V10, P14, DOI 10.1097/00001199-199502000-00004; KEITH RA, 1991, ARCH PHYS MED REHAB, V72, P269; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Michaud L. J., 1995, TRAUMATIC HEAD INJUR, P247; MILLS VM, 1988, PHYSICAL REHABILITAT, P495; Morgan T., 1894, J MORPHOL, V9, P1, DOI DOI 10.1002/JMOR.1050090102; MSAIL ME, 1994, CLIN PEDIAT      JUL, P421; MSALL ME, 1994, CLIN PEDIATR, V33, P431, DOI 10.1177/000992289403300709; OTTENBACHER KJ, 1996, DEV MED CHILD NEUROL, V38, P906; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Roberts MA, 1996, BRAIN INJURY, V10, P739, DOI 10.1080/026990596124007; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Smith PM, 1996, ARCH PHYS MED REHAB, V77, P431, DOI 10.1016/S0003-9993(96)90029-5; SPSS, 1997, SPSS BAS 7 5 WIND; *STAT U NY, 1993, GUID UN DAT SET MED; *STAT U NY BUFF, 1993, GUID UN DAT SET MED; Stein REK, 1990, MANUAL PERSONAL ADJU; Swaine BR, 1999, AM J PHYS MED REHAB, V78, P323, DOI 10.1097/00002060-199907000-00006; WALKER DK, 1990, J DEV BEHAV PEDIATR, V11, P116	55	22	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	SEP-OCT	2000	79	5					412	420		10.1097/00002060-200009000-00002			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	354GK	WOS:000089321200002	10994882				2022-02-06	
J	Lendon, CL; Han, BH; Salimi, K; Fagan, AM; Behrens, MI; Muller, MC; Holtzman, DM				Lendon, CL; Han, BH; Salimi, K; Fagan, AM; Behrens, MI; Muller, MC; Holtzman, DM			No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						Alzheimer's disease; culture; injury; murine; transgenic	CENTRAL-NERVOUS-SYSTEM; THROMBIN-CLEAVAGE FRAGMENT; RECEPTOR-RELATED PROTEIN; ONSET ALZHEIMER-DISEASE; TRAUMATIC BRAIN INJURY; AMYLOID-BETA-PEPTIDE; TRANSGENIC MICE; HEAD-INJURY; E EPSILON-4; NEURITE OUTGROWTH	The epsilon 4 allele of apolipoprotein E (apoE) is a genetic risk factor for Alzheimer's disease. Studies also suggest that the epsilon 4 allele may be a risk factor for poor outcome following head trauma, brain haemorrhage and ischaemia. The mechanism by which the presence of an apoE epsilon 4 allele and certain brain injuries act to predispose to Alzheimer's disease and poor outcome following brain injury is unknown. We questioned whether poor outcome after brain injury was due to direct modification by apoE protein and its gene variants of susceptibility to glutamate-mediated excitotoxic injury and apoptosis, mechanisms of cell death which occur following ischaemia and trauma. We investigated the effect of the presence or absence of endogenous murine apoE protein and different apoE isoforms in modification of the survival of murine embryonic cortical neurons exposed to the glutamate agonist, N-methyl-d-aspartic acid (NMDA) or apoptotic insult by staurosporine, and on the amount of brain injury sustained following a hypoxic-ischaemic insult in vivo to the brain of neonatal mice transgenically expressing human apoE epsilon 3 or epsilon 4. Our data provide evidence that apoE does not appear to alter neuronal viability following diverse types of acute neuronal insult, e.g. hypoxic-ischaemic or acute exposure to injurious agents in the models we have examined. This suggests that if apoE does modify the extent of brain damage and recovery after injury, it seems unlikely to be a result of direct or indirect modulation of excitotoxic or apoptotic cell death.	Univ Birmingham, Queen Elizabeth Psychiat Hosp, Dept Psychiat, Birmingham B15 2QZ, W Midlands, England; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Hosp Dr Sotero del Rio, Dept Neurol, Santiago, Chile; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA		Lendon, CL (corresponding author), Univ Birmingham, Queen Elizabeth Psychiat Hosp, Dept Psychiat, Mindelsohn Way, Birmingham B15 2QZ, W Midlands, England.	c.l.lendon@bham.ac.uk	Behrens, Maria I I/I-1083-2013	Behrens, Maria I I/0000-0003-0964-426X	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG013956, R37AG013956] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG-13956] Funding Source: Medline		ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Anderson R, 1998, NEUROSCIENCE, V85, P93, DOI 10.1016/S0306-4522(97)00598-8; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; Buttini M, 1999, J NEUROSCI, V19, P4867; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cheng Y, 1997, ANN NEUROL, V41, P521, DOI 10.1002/ana.410410416; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Fagan AM, 1996, J BIOL CHEM, V271, P30121, DOI 10.1074/jbc.271.47.30121; Ferriero DM, 1996, NEUROBIOL DIS, V3, P64, DOI 10.1006/nbdi.1996.0006; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Holtzman DM, 1998, TRENDS CARDIOVAS MED, V8, P250, DOI 10.1016/S1050-1738(98)00017-6; HOLTZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480, DOI 10.1073/pnas.92.21.9480; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Horsburgh K, 1999, J NEUROPATH EXP NEUR, V58, P227, DOI 10.1097/00005072-199903000-00002; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan J, 1998, J NEUROSCI, V18, P195; KLINGMAN JG, 1990, J NEUROSCI METH, V31, P47, DOI 10.1016/0165-0270(90)90008-4; KOH JY, 1990, BRAIN RES, V533, P315, DOI 10.1016/0006-8993(90)91355-K; LaDu MJ, 1998, J NEUROCHEM, V70, P2070; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Ma JY, 1996, NEUROBIOL AGING, V17, P773; Marques MA, 1996, NEUROREPORT, V7, P2529, DOI 10.1097/00001756-199611040-00025; MASLIAH E, 1994, RES ADV ALZHEIMERS D, P405; MCCALL MR, 1988, J LIPID RES, V29, P1127; McCarron MO, 1998, NEUROSCI LETT, V247, P45, DOI 10.1016/S0304-3940(98)00286-9; MCDONALD JW, 1987, EUR J PHARMACOL, V140, P359, DOI 10.1016/0014-2999(87)90295-0; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Nakai M, 1996, NEUROSCI LETT, V211, P41, DOI 10.1016/0304-3940(96)12716-6; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; PITAS RE, 1987, BIOCHIM BIOPHYS ACTA, V917, P148, DOI 10.1016/0005-2760(87)90295-5; PITAS RE, 1987, J BIOL CHEM, V262, P14352; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; REBECK GW, 1993, NEURON, V11, P575; ROSE K, 1993, IN VITRO BIOL METHOD, P46; Roses AD, 1997, ANN NY ACAD SCI, V826, P200, DOI 10.1111/j.1749-6632.1997.tb48471.x; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Stone DJ, 1997, EXP NEUROL, V143, P313, DOI 10.1006/exnr.1996.6360; Stone DJ, 1998, J NEUROSCI, V18, P3180; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Sun YL, 1998, J NEUROSCI, V18, P3261; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Teter B, 1999, NEUROSCIENCE, V91, P1009, DOI 10.1016/S0306-4522(98)00630-7; Tolar M, 1997, J NEUROSCI, V17, P5678; VANUCCI RC, 1990, PEDIATR RES, V27, P317; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Xu PT, 1996, NEUROBIOL DIS, V3, P229, DOI 10.1006/nbdi.1996.0023; [No title captured]	55	22	23	0	4	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	JUL	2000	12	7					2235	2242		10.1046/j.1460-9568.2000.00113.x			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	336NW	WOS:000088310300005	10947802				2022-02-06	
J	Kita, T; Tanaka, T; Tanaka, N; Kinoshita, Y				Kita, T; Tanaka, T; Tanaka, N; Kinoshita, Y			The role of tumor necrosis factor-alpha in diffuse axonal injury following fluid-percussive brain injury in rats	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						traumatic head injury; diffuse axonal injury; tumor necrosis factor-alpha; beta-amyloid precursor protein; fluid percussion device; glial cell	AMYLOID PRECURSOR PROTEIN; IL-1 RECEPTOR ANTAGONIST; CLOSED-HEAD INJURY; EXPRESSION; PHOSPHORYLATION; PERMEABILITY; MODULATION; DIAGNOSIS; CALIBER; DAMAGE	The immunolocalization of tumor necrosis factor-alpha (TNF alpha) after diffuse axonal injury (DAI) is demonstrated using a midline fluid percussion rat model (moderate brain injury of 1000 mm Hg was generated) and the effects of TNF alpha on the axolemmal permeability using horseradish peroxidase as a tracer. In addition, the accumulation of beta-amyloid precursor protein (beta-APP) was investigated, which has recently been shown to be a reliable marker fur the diagnosis of DAI in cases with fatal head injury. TNF alpha levels in brain tissues from the impact site and the col tex including the corpus callosum, gradually increased during the first 1 h, rose to a maximal elevation at 3 h, gradually decreased at 6 h and decreased further at 24 h. Horseradish peroxidase (HRP) tracer experiments revealed that primary axonal damage appeared as early as 15 min after impact but rapidly recovered and that 1 h after impact, secondary axonal damage occurred in the corpus callosum and the brain stem. By immunoelectron microscopy it was seen that beta-APP accumulated in the axon from 1 h after impact demonstrating that there was functional axonal damage. TNF alpha reactions were detected in the lysosomes of microglia 30 min after impact and 1 h after impact these reactions were mainly detected in the glial cells (such as microglia, astrocytes and oligodendrocytes) in the corpus callosum and the blain stem. It is generally accepted that TNF alpha directly induces primary demyelination and oligodendrocyte apoptosis. Therefore, TNF alpha conveyed from the microglial cells is one cofactor contributing to the formation of the delayed axonal damage observed Lit these sites. The present study suggests that TNF alpha conveyed from the glial cells may contribute to the pathogenic mechanism of DAI formation following fluid percussive brain injury.	Univ Occupat & Environm Hlth, Sch Med, Dept Forens Med, Yahata Nishi Ku, Kitakyushu, Fukuoka 807, Japan; Univ Occupat & Environm Hlth, Sch Med, Dept Neurosurg, Yahata Nishi Ku, Kitakyushu, Fukuoka 807, Japan		Kita, T (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Forens Med, Yahata Nishi Ku, Kitakyushu, Fukuoka 807, Japan.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763			Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Creange A, 1997, EUR CYTOKINE NETW, V8, P145; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; FEDER N, 1971, J CELL BIOL, V51, P339, DOI 10.1083/jcb.51.1.339; Feuerstein GZ, 1997, ANN NY ACAD SCI, V825, P179, DOI 10.1111/j.1749-6632.1997.tb48428.x; Geddes JF, 1997, J CLIN PATHOL, V50, P271, DOI 10.1136/jcp.50.4.271; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; HIRANO A, 1969, J ULTRA MOL STRUCT R, V28, P141, DOI 10.1016/S0022-5320(69)90012-4; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; Ladiwala U, 1998, J NEUROSCI, V18, P1297; Madigan MC, 1996, NEUROL RES, V18, P233; Matsukawa A, 1997, CYTOKINE, V9, P307, DOI 10.1006/cyto.1996.0170; MATSUKAWA A, 1994, IMMUNOL INVEST, V23, P129, DOI 10.3109/08820139409087794; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MERRICK B A, 1992, Applied and Theoretical Electrophoresis, V2, P177; NIXON RA, 1994, J CELL BIOL, V126, P1031, DOI 10.1083/jcb.126.4.1031; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Previtali SC, 1997, AM J PATHOL, V151, P1425; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Yam PS, 1997, BRAIN RES, V760, P150, DOI 10.1016/S0006-8993(97)00290-4; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613	31	22	29	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0937-9827			INT J LEGAL MED	Int. J. Legal Med.	JUN	2000	113	4					221	228		10.1007/s004149900095			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	334WK	WOS:000088208500006	10929238				2022-02-06	
J	Orey, SA; Cragar, DE; Berry, DTR				Orey, SA; Cragar, DE; Berry, DTR			The effects of two motivational manipulations on the neuropsychological performance of mildly head-injured college students	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						malingering; motivation; assessment; head injury	TRAUMATIC BRAIN INJURY; MEMORY DEFICITS; VALIDATION; PROSPECTS; TESTS	Recently much research has focused on the development and utilization of various motivational assessment techniques designed to identifl malingered neuropsychological test performance. Other findings have suggested a strong link between the motivation of the subject and the degree to which the neuropsychological test results validly represent the individual's true level of functioning. However, the majority of the empirical work in this area has focused on only one end of the motivational spectrum, decreased motivation. In order to obtain a more complete assessment of the relationship between motivation and neuropsychological of test results, the present study involved an evaluation of the effects of motivational differences on test performance across three levels of motivation: high, low and standard in 75 head-injured college students. Results supported past research showing significant decreases in test performance by participants given individual financial incentives ($25.00) to perform poorly. Additionally, the sensitivity of several malingering tests to this response set was supported However, no reliable differences were found on neuropsychological or motivational tests between the group given financial incentives ($25.00) to perform well and the standard instruction group. (C) 2000 National Academy of Neuropsychology. Published by Elsevier Science Ltd.	Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA		Berry, DTR (corresponding author), Univ Kentucky, Dept Psychol, 125 Kastle Hall, Lexington, KY 40506 USA.			Locke, Dona/0000-0002-1966-7716			Benton A., 1976, MULTILINGUAL APHASIA; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; FREDERICK R, 1994, PSYCHOL ASSESSMENT, V3, P596; Glass Gene V., 1980, BENEFITS PSYCHOTHERA; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P56; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; Inman TH, 1998, PSYCHOL ASSESSMENT, V10, P128, DOI 10.1037/1040-3590.10.2.128; IVERSON GL, 1991, LAW HUMAN BEHAV, V15, P667, DOI 10.1007/BF01065859; Kaufman AlanS., 1990, ASSESSING ADOLESCENT; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MCCRACKEN LM, 1992, PSYCHOL ASSESSMENT, V4, P235, DOI DOI 10.1037//1040-3590.4.2.235; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rogers R., 1997, CLIN ASSESSMENT MALI; WECHSELR D, 1981, WECHSLER ADULT INTEL; WILLIAMS JM, 1991, MEMORY ASSESSMENT SC; ZIELINSKI JJ, 1994, CLIN PSYCHOL-SCI PR, V1, P169, DOI 10.1111/j.1468-2850.1994.tb00018.x	25	22	22	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2000	15	4					335	348		10.1016/S0887-6177(99)00024-4			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	310KR	WOS:000086827800006	14590230	Bronze			2022-02-06	
J	Koizumi, MS; Lebrao, ML; De Mello-Jorge, MHP; Primerano, V				Koizumi, MS; Lebrao, ML; De Mello-Jorge, MHP; Primerano, V			Morbidity and mortality due to traumatic brain injury in Sao Paulo city, Brazil, 1997	ARQUIVOS DE NEURO-PSIQUIATRIA			Portuguese	Article						epidemiology; morbidity; mortality; head injury	HEAD-INJURY; EPIDEMIOLOGY	There are few epidemiological studies on traumatic brain injury (TBI), and those that allow broad comparative analyses of this problem are even more scarce, due to methodological obstacles. Usually, the studies address head injury (they include the cranial envelopments and content) but are reported as TBI, given the difficulty of mutual exclusion. It is also common for them to be centered at specific severity levels, only for hospitalized victims or according to the external cause, such as traffic accidents. With full respect to these limits, this study had as its objective the estimation of the TBI incidence in patients resident and in-hospital, in the hospital network in the city of Sao Paulo, Brazil, in 1997, as well as the estimation of TBI-caused mortality amongst external causes, at this same time and locale. Data for the study consisted of Ministerio da Saude data on hospital discharges, analyzed based on Autorizacoes de Internacao Hospitalar (AIH) and obituary data on external causes, contained in the Programa de Aprimoramenta das Informacoes de Mortatidade (PROAIM) data base. It was found that 29 717 patients were hospitalized due to lesions and poisoning; of these 3 635 (12%) had TB I; the hospitalization rate was 0.36/1000 pop.;and hospital mortality was 10%. The mortality coefficient due to external causes was 87.3/100 000 pop. Minimum TBI mortality rate is estimated at a minimum of 26.2 and a maximum of 39.3/100 000 pop.	EEUSP, Grp Estudos Neurotrauma, BR-05403000 Sao Paulo, Brazil; Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Sao Paulo, Brazil								Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ANDRADE SM, 1998, THESIS U SAO PAULO; BARROS JL, 1994, ARQ BRAS NEUROCIRURG, V13, P64; Colli BO, 1997, ARQ NEURO-PSIQUIAT, V55, P91, DOI 10.1590/S0004-282X1997000100015; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Emanuelson I, 1997, ACTA PAEDIATR, V86, P730, DOI 10.1111/j.1651-2227.1997.tb08576.x; GAWRYSZEWSKI VP, 1995, THESIS U SAO PAULO; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Henry P C, 1992, J Neurosci Nurs, V24, P311; *IBGE, 1996, CONT POP 1996 MUN SA; JORGE MHP, 1988, THESIS U SAO PAULO; JORGE MM, 1979, THESIS U SAO PAULO S; Kraus JF, 1993, HEAD INJURY, P1; LADEIRA RM, 1995, THESIS U FEDERAL MIN; Levcovitz E., 1993, SIH SUS SISTEMA AIH; Martinez G, 1997, SIGNAL PROCESS-IMAGE, V9, P175, DOI 10.1016/S0923-5965(96)00018-5; Masini M, 1994, J BRAS NEUROCIRURG, V5, P61; MESQUITA MAF, 1998, THESIS U FEDERAL SAO; *ORG MUND SAUD, 1978, CLASS INT DOENC 1975, P475; *ORG MUND SAUD, 1998, CLASS EST INT DOENC, P969; SANTO AH, 1988, THESIS U SAO PAULO S; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Semple PL, 1998, S AFR MED J, V88, P440; SOSIN D, 1989, JAMA-J AM MED ASSOC, V262, P251; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; TIRET L, 1990, INT J EPIDEMIOL, V19, P133, DOI 10.1093/ije/19.1.133	26	22	30	0	3	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2000	58	1					81	89		10.1590/S0004-282X2000000100013			9	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	296HK	WOS:000086018800013	10770871	Green Published, gold, Green Submitted			2022-02-06	
J	Zhao, XR; Newcomb, JK; Pike, BR; Wang, KKW; d'Avella, D; Hayes, RL				Zhao, XR; Newcomb, JK; Pike, BR; Wang, KKW; d'Avella, D; Hayes, RL			Novel characteristics of glutamate-induced cell death in primary septohippocampal cultures: Relationship to calpain and caspase-3 protease activation	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						glutamate; calpain; caspase-3; proteases	TRAUMATIC BRAIN INJURY; CEREBELLAR GRANULE NEURONS; RAT HIPPOCAMPAL-NEURONS; APOPTOTIC CELLS; ALPHA-SPECTRIN; INHIBITORS; NEUROTOXICITY; DEGRADATION; PROTEOLYSIS; BREAKDOWN	Studies examined the phenotypic characteristics of glutamate-induced cell death and their relationship to calpain and caspase-3 activation. Cell viability was assessed by fluorescein diacetate and propidium iodide staining and lactate dehydrogenase release. Calpain and caspase-3 activity was inferred from signature proteolytic fragmentation of alpha-spectrin. Characterization of cell death phenotypes was assessed by Hoechst 33258 and DNA fragmentation assays. Exposure uf septohippocampal cultures to 1.0. 2.0, and 4.0 mmol/L glutamate induced a dose-dependent cell death with an LD50 of 2.0 mmol/L glutamate after 24 hours of incubation. Glutamate treatment induced cell death in neurons and astroglia and produced morphological alterations that differed from necrotic or apoptotic changes observed after maitotoxin or staurosporine exposure. respectively, After glutamate treatment, cell nuclei were enlarged and eccentrically shaped, and aggregated chromatin appeared in a diffusely speckled pattern. Furthermore, no dose of glutamate produced evidence of internucleosomal DNA fragmentation. Incubation with varying doses of glutamate produced calpain and caspase-3 activation. Calpain inhibitor II (N-acetyl-Leu-Leu-methionyl) provided protection only with a narrow dose range, whereas carbobenzoxy-Asp-CH2-OC(O)-2,6-dichlorobenzene (Z-D-DCB; pan-caspase inhibitor) and MK-801 (N-methyl-D-aspartate receptor antagonist) were potently effective across a wider close range. Cycloheximide did not reduce cell death or protease activation.	Univ Florida, Dept Neurosci, Ctr Traumat Brain Injury Studies, Gainesville, FL 32610 USA; Univ Texas, Hlth Sci Ctr, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, Houston, TX USA; Warner Lambert Parke Davis, Parke Davis Pharmaceut Res, Dept Neurosci Therapeut, Ann Arbor, MI 48105 USA; Univ Messina, Policlin Univ, Inst Pharmacol, Messina, Italy		Hayes, RL (corresponding author), Univ Florida, Dept Neurosci, Ctr Traumat Brain Injury Studies, POB 100244,100 Newell Dr,L1-100F, Gainesville, FL 32610 USA.			Wang, Kevin/0000-0002-9343-6473; D'AVELLA, Domenico/0000-0001-9077-412X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS21458, R01 NS38105, R01 NS40182] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021458, R01NS040182] Funding Source: NIH RePORTER		Adamec E, 1998, MOL BRAIN RES, V54, P35, DOI 10.1016/S0169-328X(97)00304-5; Bolton SJ, 1998, EXP NEUROL, V154, P231, DOI 10.1006/exnr.1998.6927; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Carroll FY, 1996, J NEUROSCI RES, V43, P623, DOI 10.1002/(SICI)1097-4547(19960301)43:5<623::AID-JNR12>3.0.CO;2-1; Cebers G, 1997, BRAIN RES BULL, V43, P393, DOI 10.1016/S0361-9230(97)00025-7; CHOI DW, 1987, J NEUROSCI, V7, P357; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Du YS, 1997, P NATL ACAD SCI USA, V94, P11657, DOI 10.1073/pnas.94.21.11657; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; HARRIS AS, 1988, J BIOL CHEM, V263, P15754; Homayoun P, 1997, J NEUROCHEM, V69, P199; Ikeda J, 1996, J NEUROSCI RES, V43, P613; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Kampfl A, 1996, EUR J NEUROSCI, V8, P344, DOI 10.1111/j.1460-9568.1996.tb01218.x; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; KURE S, 1991, BIOCHEM BIOPH RES CO, V179, P39, DOI 10.1016/0006-291X(91)91330-F; LIN JK, 1992, CANCER RES, V52, P385; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MacManus JP, 1997, EXP CELL RES, V233, P310, DOI 10.1006/excr.1997.3558; MANEV H, 1991, J NEUROCHEM, V57, P1288, DOI 10.1111/j.1471-4159.1991.tb08292.x; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; MATYJA E, 1986, EXP NEUROL, V92, P609, DOI 10.1016/0014-4886(86)90303-1; MURPHY EJ, 1994, NEUROBIOLOGY CENTRAL, P28; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; Nath R, 1996, NEUROREPORT, V8, P249, DOI 10.1097/00001756-199612200-00050; Nath R, 1998, J NEUROCHEM, V71, P186; Pike BR, 1998, J NEUROSCI RES, V52, P505, DOI 10.1002/(SICI)1097-4547(19980601)52:5<505::AID-JNR3>3.3.CO;2-Y; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; SASS JB, 1993, J NEUROSCI METH, V47, P115, DOI 10.1016/0165-0270(93)90027-O; SIMAN R, 1988, NEUROSCIENCE, V26, P443; SQUIER MKT, 1994, J CELL PHYSIOL, V159, P229, DOI 10.1002/jcp.1041590206; Wang K K, 1997, Adv Pharmacol, V37, P117; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 1996, ARCH BIOCHEM BIOPHYS, V331, P208, DOI 10.1006/abbi.1996.0300; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Zhao X, 1999, NEUROCHEM RES, V24, P371, DOI 10.1023/A:1020933616351; Zhivotovsky B, 1997, BIOCHEM BIOPH RES CO, V230, P481, DOI 10.1006/bbrc.1996.6016	44	22	27	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2000	20	3					550	562		10.1097/00004647-200003000-00014			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	293AQ	WOS:000085829700014	10724120				2022-02-06	
J	Braun, RM; Botte, MJ				Braun, RM; Botte, MJ			Treatment of shoulder deformity in acquired spasticity	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							CHRONIC HEMIPARETIC PATIENTS; LIMB EXTENSOR SPASTICITY; HEAD-INJURED ADULTS; BOTULINUM TOXIN; HETEROTOPIC OSSIFICATION; PHENOL BLOCKS; BRAIN INJURY; MANAGEMENT; NERVE	Cerebrovascular accidents and traumatic brain injury produce most of the deformities seen in patients with spastic imbalance of the shoulder. A general awareness of the global neurologic defect is required to understand appropriate treatment alternatives. Conservative treatment techniques include early initiation of therapy exercises, Muscle or nerve block treatments may prevent severe shoulder contractures. Diagnostic blocks may help differentiate between deformity caused by spasticity and that caused by fixed soft tissue contracture. Operative release procedures are described, These operations, when combined with appropriate postoperative therapy programs, permit correction of contractures caused by unbalanced muscle forces around the shoulder in patients with severe spasticity who do not respond to conservative care.	Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, San Diego, CA 92103 USA; Univ So Calif, Sch Med, Dept Orthopaed Surg, Los Angeles, CA USA; Univ So Calif, Rancho Los Amigos Med Ctr, Dept Upper Limb Rehabil, Downey, CA 90242 USA; Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, San Diego, CA 92103 USA; Scripps Res Inst, Div Orthopaed Surg, La Jolla, CA 92037 USA; San Diego Vet Affairs Hlth Care Syst, Orthopaed Surg Serv, San Diego, CA USA		Braun, RM (corresponding author), 770 Washington St,Suite 301, San Diego, CA 92103 USA.						ABRAMS RA, 1992, ORTHOPAEDIC REHABILI, P391; AKESON WA, 1992, ORTHOPAEDIC REHABILI, P277; ANDERSON DW, 1980, J NEUROSURG, V53, pS1; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; BAKER LD, 1956, J BONE JOINT SURG AM, V38, P313, DOI 10.2106/00004623-195638020-00007; BLOCH R, 1978, CLIN ORTHOP RELAT R, P10; BODINEFOWLER SC, 1992, ORTHOPAEDIC REHABILI, P295; Botte M J, 1988, Orthop Rev, V17, P637; Botte M J, 1988, Orthop Rev, V17, P891; BOTTE MJ, 1988, J HAND SURG-AM, V13A, P147, DOI 10.1016/0363-5023(88)90220-1; BOTTE MJ, 1987, J HAND SURG-AM, V12A, P639, DOI 10.1016/S0363-5023(87)80227-7; BOTTE MJ, 1989, J HAND SURG-AM, V14, P174, DOI 10.1016/0363-5023(89)90002-6; Botte MJ, 1997, ORTHOPEDICS, V20, P335; BOTTE MJ, 1995, ORTHOPEDICS, V18, P151; BOTTE MJ, 1994, ORTHOPAEDIC KNOWLEDG, P101; BOTTE MJ, 1991, OPERATIVE NERVE REPA, P1415; BOTTE MJ, 1992, ORTHOPAEDIC REHABILI, P337; BOTTE MJ, 1998, SPINE TRAUMA, P639; BOTTE MJ, 1992, ORTHOPAEDIC REHABILI, P427; BOTTE MJ, 1987, J HEAD TRAUMA REHAB, V2, P34; BOTTE MJ, 1992, J MUSCULOSKEL MED, V9, P66; BOTTE MJ, 1987, J HEAD TRAUMA REHAB, V2, P13; BRAUN R, 1971, CALIF MED, V115, P11; BRAUN RM, 1971, J BONE JOINT SURG AM, VA 53, P1307, DOI 10.2106/00004623-197153070-00006; BRAUN RM, 1974, J BONE JOINT SURG AM, VA 56, P466, DOI 10.2106/00004623-197456030-00003; BRAUN RM, 1970, J BONE JOINT SURG AM, VA 52, P907, DOI 10.2106/00004623-197052050-00005; BRAUN RM, 1973, J BONE JOINT SURG AM, VA 55, P580, DOI 10.2106/00004623-197355030-00015; BRAUN RM, 1993, OPERATIVE HAND SURG, P225; BRAUN RM, 1974, CLIN ORTHOP RELAT R, V104, P80; CAPEN DA, 1992, ORTHOPAEDIC REHABILI, P411; DENGLER R, 1992, J NEUROL, V239, P375; GARLAND DE, 1978, CLIN ORTHOP RELAT R, P111; GARLAND DE, 1983, PHYS THER, V63, P2004, DOI 10.1093/ptj/63.12.2004; GARLAND DE, 1979, CLIN ORTHOP RELAT R, P189; GARLAND DE, 1984, ARCH PHYS MED REHAB, V65, P243; GARLAND DE, 1978, ORTHOP CLIN N AM, V9, P291; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1992, ORTHOPAEDIC REHABILI, P453; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1982, CLIN ORTHOP RELAT R, V165, P217; GARLAND DE, 1982, ORTHOPEDIC REHABILIT, P257; HEIDEN JS, 1979, NEURAL TRAUMA, P84; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1321, DOI 10.1136/jnnp.57.11.1321; Hesse S, 1996, STROKE, V27, P455, DOI 10.1161/01.STR.27.3.455; INGLIS AE, 1966, J BONE JOINT SURG AM, VA 48, P847, DOI 10.2106/00004623-196648050-00002; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; Jennett B, 1981, MANAGEMENT HEAD INJU; Keenan M A, 1988, Orthop Rev, V17, P1185; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P806, DOI 10.1016/S0363-5023(87)80075-8; KEENAN MAE, 1990, J HAND SURG-AM, V15A, P607, DOI 10.1016/S0363-5023(09)90023-5; KEENAN MAE, 1987, J BONE JOINT SURG AM, V69A, P1127, DOI 10.2106/00004623-198769080-00003; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P734, DOI 10.1016/S0363-5023(87)80059-X; KEENAN MAE, 1987, J HAND SURG-AM, V12A, P575, DOI 10.1016/S0363-5023(87)80211-3; KEENAN MAE, 1989, J BONE JOINT SURG AM, V71A, P120, DOI 10.2106/00004623-198971010-00018; KEENAN MAE, 1988, CLIN ORTHOP RELAT R, V233, P116; KEENAN MAE, 1992, ORTHOPAEDIC REHABILI, P360; KEENAN MAE, 1993, CONT ORTHOP, V27, P357; KEENAN MAE, 1987, J HEAD TRAUMA REHAB, V2, P62; KEENAN ME, 1993, MANUAL ORTHOPAEDIC S; KOZIN SH, 1993, CLIN ORTHOP RELAT R, P109; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1975, J CHRON DIS, V28, P471, DOI 10.1016/0021-9681(75)90057-0; MACOLLOUGH NC, 1979, INSTR COURSE LECT, V24, P29; Matsumoto N, 1973, STROKE, V4, P20, DOI 10.1161/01.STR.4.1.20; MOONEY V, 1969, CLIN ORTHOP RELAT R, P122; Mooney V, 1969, Clin Orthop Relat Res, V63, P7; MOONEY V, 1967, J BONE JOINT SURG AM, VA 49, P989, DOI 10.2106/00004623-196749050-00018; MOORE TJ, 1991, FOOT ANKLE, V11, P219, DOI 10.1177/107110079101100406; Parise M, 1997, ELECTROMYOGR MOTOR C, V105, P141, DOI 10.1016/S0924-980X(96)96555-8; PERRY J, 1975, INSTRUCTIONAL COURSE, V24, P40; RHOADES ME, 1978, CLIN ORTHOP RELAT R, P104; SIMON DB, 1992, ORTHOPAEDIC REHABILI, P309; WATERS RL, 1978, CLIN ORTHOP RELAT R, V131, P30; WATERS RL, 1978, NEUROLOGICAL ASPECTS, P123; WATERS RL, 1990, CONT ORTHOP, V20, P311; WATERS RL, 1988, OPERATIVE ORTHOPAEDI, P1449; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	85	22	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	NOV	1999		368					54	65					12	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	254XT	WOS:000083640100008	10613153				2022-02-06	
J	Chua, KSG; Kong, KH				Chua, KSG; Kong, KH			Rehabilitation outcome following traumatic brain injury - the Singapore experience	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						closed head injury; Glasgow coma scale; Modified Barthel Index; skull fracture; traumatic brain injury	CLOSED HEAD-INJURY; FUNCTIONAL INDEPENDENCE	The objectives of this study were to define (1) demographic and injury characteristics for acute traumatic brain injury (TBI) patients admitted to rehabilitation; (2) admission and discharge functional status; (3) discharge disposition and vocation status at follow-up. The charts of 80 consecutive TBI admissions (64 males, 16 females) were reviewed. Outcome measures included admission and discharge Modified Barthel Index (MBI) scores, length of rehabilitation stay, discharge disposition and return-to-work status at 1 year post-injury. Fifty-seven (71.3%) of patients were aged 40 years or less. Motor vehicle accidents accounted for 70.0% (56) of injuries. Sixty-one (76.3%) had severe head injuries. Diffuse cerebral oedema was present in 41.3% (33) and 52.5% (42) had intracranial haematoma. Admission and discharge MBI scores were 49.6 +/- 33.7 and 76.9 +/- 25.6 respectively. This difference was significant (P < 0.001). Memory and planning/ organization deficits were present in 68.6% and 70.5% of patients (51 tested). Multiple regression analysis showed that admission MBI score had significant influence on discharge functional outcome (Multiple R 0.66, R-2 0.40, P < 0.001). Seventy-two (90%) were discharge home and 25% (20) returned to work at 1 year post-injury. We conclude that this cohort of TBI patients showed significant improvement in functional status after rehabilitation, and admission functional status had the most impact on discharge functional outcome.	Tan Tock Seng Hosp, Dept Rehabil Med, Singapore 569766, Singapore		Chua, KSG (corresponding author), Tan Tock Seng Hosp, Dept Rehabil Med, 17 Ang Mo Kio Ave 9, Singapore 569766, Singapore.						BEYERL B, 1984, NEUROSURGERY, V15, P257, DOI 10.1227/00006123-198408000-00020; BOND MR, 1990, REHABILITATION ADULT, P59; Bontke C F, 1991, Neurosurg Clin N Am, V2, P473; BRANDSTATER E, 1991, ARCH PHYSICAL MED RE, V74, pS332; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GALBRAITH S, 1976, BRIT J SURG, V63, P138; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1975, LANCET, V1, P480; KAPLAN CP, 1994, ARCH PHYS MED REHAB, V75, P643, DOI 10.1016/0003-9993(94)90186-4; Kolb B, 1985, FUNDAMENTALS HUMAN N; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Miller WG, 1986, NEUROPSYCHOLOGY HDB, P347; Narayan R. K., 1990, REHABILITATION ADULT, P94; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RUFF RM, 1993, BRAIN INJURY, V7, P101, DOI 10.3109/02699059309008164; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; SILVER JM, 1987, AM PSYCHIAT PRESS HD, P179; VARGHESE G, 1992, PHYS MED REH CLIN N, V3, P407; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; 1989, INTERAGENCY HEAD INJ	35	22	23	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	1999	22	3					189	197		10.1097/00004356-199909000-00005			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	244AM	WOS:000083029700005	10839672				2022-02-06	
J	Harmon, KG				Harmon, KG			Assessment and management of concussion in sports	AMERICAN FAMILY PHYSICIAN			English	Article							HEAD-INJURIES; GUIDELINES; RETURN	The most common head injury in sports is concussion. Athletes who Sustain a prolonged:loss of consciousness should be transported immediately to a hospital for further evaluation. Assessment of less severe injuries should include a thorough neurologic examination. The duration of symptoms and the presence of absence of post-traumatic amnesia and loss of consciousness should be noted. To avoid premature return to play, a good understanding of the possible hazards is important. Potential hazards of premature return to play include the possibility of death from second-impact syndrome, permanent neurologic impairment from cumulative trauma, and the postconcussion syndrome.	Univ Washington, Hall Hlth Primary Care Ctr, Sports Med Clin, Seattle, WA 98195 USA		Harmon, KG (corresponding author), Univ Washington, Hall Hlth Primary Care Ctr, Sports Med Clin, Box 354410, Seattle, WA 98195 USA.						Brukner P, 1996, Aust Fam Physician, V25, P1445; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P79; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P83; *COL MED SOC SCH S, 1990, COLO MED, V87, P4; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kelly JP, 1997, NEUROLOGY, V48, P581; LEBLANC KE, 1994, AM FAM PHYSICIAN, V50, P801; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; *NCAA COMM COMP SA, 1994, NCAA SPORTS MED HDB; ROBERTS WO, 1992, PHYSICIAN SPORTSMED, V20, P66, DOI 10.1080/00913847.1992.11710295; SWENSON JE, 1998, P 26 FIMS WORLD C SP; SWENSON JE, 1996, P AMSSM 5 ANN M JUN; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; Young CC, 1997, CLIN J SPORT MED, V7, P196, DOI 10.1097/00042752-199707000-00008	19	22	23	0	1	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	SEP 1	1999	60	3					887	892					6	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	236MV	WOS:000082604100016	10498114				2022-02-06	
J	Bowen, A; Chamberlain, MA; Tennant, A; Neumann, V; Conner, M				Bowen, A; Chamberlain, MA; Tennant, A; Neumann, V; Conner, M			The persistence of mood disorders following traumatic brain injury: a 1 year follow-up	BRAIN INJURY			English	Article							HEAD-INJURY	The study investigated whether the frequency of mood disorders following traumatic brain injury (TBI) increased with time. Consecutive hospital admissions completed the Wimbledon Self-Report Scale at 6 and 12 months post-injury. Scores in the 'borderline/case' range were deemed clinically significant. Seventy-seven of those assessed at 6 months completed the 12 month follow-up. Those lost to follow-up (22) were nor more likely to have been classified 'borderline/case' at: 6 months. They were more likely to have been 'unoccupied' pre-injury (p = 0.002). The frequency of clinically significant disorders did not change significantly, being 39% at 6 months and 35% 1 year post-injury. The majority of subjects (58) maintained the same clinical classification at both assessments. Eight of the 47 (17%) classified 'normal' at 6 months changed to 'borderline/case' at 12 months. However, 11 of the 30 (37%) classified 'borderline/case' at 6 months were 'normal' at 12 months. The direction of change was not statistically significant (p = 0.5). These findings are consistent with previous research. However, the present study examined a larger sample and included a wider range of injury severity, thereby increasing the generalizability of the findings. Also, a broader spectrum of mood disorders was investigated which adds to previous work specifically on depression.	Univ Leeds, Rheumatol & Rehabil Res Unit, Leeds, W Yorkshire, England; Univ Leeds, Sch Psychol, Leeds, W Yorkshire, England		Bowen, A (corresponding author), Univ Manchester, Dept Geriatr Med, Stroke Assoc Therapy Res Unit, Hope Hosp, Clin Sci Bldg, Salford M6 8HD, Lancs, England.		Bowen, Audrey/K-5544-2012; Conner, Mark/N-9063-2013	Bowen, Audrey/0000-0003-4075-1215; Conner, Mark/0000-0002-6229-8143			BOND M, 1984, CLOSED HEAD INJURY P, P146; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; HARRICK L, 1994, BRAIN INJURY, V8, P539; HUGHES D, 1995, TRAUMATIC BRAIN INJU, P66; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; NELSON H, 1976, NATL ADULT READING T; TEASDALE G, 1974, LANCET, V2, P81; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7	12	22	22	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1999	13	7					547	553					7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	215GT	WOS:000081374100007	10462151				2022-02-06	
J	Gofin, R; Adler, B; Hass, T				Gofin, R; Adler, B; Hass, T			Incidence and impact of childhood and adolescent injuries: A population-based study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						disabilities; activity limitations; use of services	CLOSED HEAD-INJURY; PEDIATRIC TRAUMA; YOUNG-ADULTS; CHILDREN; DISABILITY; MORBIDITY	Background: The study of disabilities, use of health services, and absenteeism of parents among 0- to 17-year-old residents of Jerusalem (n = 432) hospitalized for unintentional injuries. Methods: Telephone interviews with parents, 6 months after hospitalization. Disabilities among 4 to 17 year olds were measured by a 25-item scale derived from the International Classification of Impairments, Disabilities, and Handicaps and hy limitations of activities. Results: Six months after the injury, limitations ranged from 8.3% (daily activities) to 19.4% (sport activities), About one in three presented at least one disability in the 25-item scale. All disabilities were present in higher proportions among adolescents. The more severe injuries whether to the head or other parts of the body presented higher percentages of disabilities. Burns and traffic crashes were associated with higher proportions of disabilities than other causes and with more frequent work absenteeism by their parents. Conclusion: A relatively large proportion of children remain with long-term disabilities irrespective of cause and body part injured. Because the sequelae of injuries is multifaceted, rehabilitation should include coordination between health and other services.	Hadassah Med Org, Dept Social Med, Jerusalem, Israel		Gofin, R (corresponding author), Hadassah Univ Hosp, Dept Social Med, IL-91120 Jerusalem, Israel.						ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; *AUSTR I HLTH WELF, 1995, NAT DAT STAND INJ SU; BAKER SP, 1992, INJURY FACT BOOK, P8; Barker M, 1996, ARCH DIS CHILD, V75, P156, DOI 10.1136/adc.75.2.156; BASSON MD, 1991, J TRAUMA, V31, P1363, DOI 10.1097/00005373-199110000-00008; CASEY R, 1986, PEDIATRICS, V78, P497; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; FINGERHUT LA, 1997, HLTH US 1996 97 INJU, P35; *FOR PREV INJ, 1991, SYNAPS SYST NAT PERS; GAHLINGER PM, 1995, COMPUTER PROGRAMS EP, P59; GALLAGHER SS, 1984, AM J PUBLIC HEALTH, V74, P340; GOFIN R, 1995, J CLIN EPIDEMIOL, V48, P977, DOI 10.1016/0895-4356(94)00198-Y; GOFIN R, 1991, ISRAEL J MED SCI, V27, P566; GOFIN R, 1997, INJURIES CHILDREN AD, P48; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; HANVEY L, 1997, SAFETY CANADIAN CHIL, P11; HARRIS BH, 1989, J PEDIATR SURG, V24, P103, DOI 10.1016/S0022-3468(89)80311-2; JAIMOVICH DG, 1991, J TRAUMA, V31, P196; Koelfen W, 1997, EUR J PEDIATR, V156, P230, DOI 10.1007/s004310050590; LEVIN HS, 1979, CHILD BRAIN, V5, P281; Meyer AA, 1998, J TRAUMA, V44, P1, DOI 10.1097/00005373-199801000-00001; MULDER S, 1996, P INT COLL EFF INJ S, V2, P111; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; RUSONIS ES, 1990, MED CLIN N AM, V74, P1311, DOI 10.1016/S0025-7125(16)30518-1; SCOTTJUPP R, 1992, ARCH DIS CHILD, V67, P222, DOI 10.1136/adc.67.2.222; SLATER EJ, 1988, AM J DIS CHILD, V142, P1048, DOI 10.1001/archpedi.1988.02150100042022; TACKET A, 1986, WORLD HLTH STAT Q, V39, P232; WESSON DE, 1989, J TRAUMA, V29, P589, DOI 10.1097/00005373-198905000-00008; *WHO, 1985, TARG HLTH ALL REG OF, P48; World Health Organization, 1978, INT CLASS DIS; World Health Organization, 1980, INT CLASS IMP DIS HA	33	22	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	1999	47	1					15	21		10.1097/00005373-199907000-00004			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	216ZQ	WOS:000081474700003	10421180				2022-02-06	
J	Lammie, GA; Piper, IR; Thomson, D; Brannan, F				Lammie, GA; Piper, IR; Thomson, D; Brannan, F			Neuropathologic characterization of a rodent model of closed head injury - Addition of clinically relevant secondary insults does not significantly potentiate brain damage	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier; closed head injury; axonal injury; neuropathology; rat; trauma model	RAT-BRAIN; SHOCK; MICROGLIA; PROTEINS; STROKE; COMMON; CELLS	We have characterized the early brain pathology in Sprague-Dawley rats subjected to a modified Richmond impact acceleration model of closed head injury (CHI). This model was modified to produce maximal traumatic brain injury (TBI) in the absence of skull fracture, extracerebral or intracerebral hemorrhage, or brain contusion. We then used this model to assess the neuropathologic effects of superimposed secondary insults, which were designed to reflect a clinically relevant combination of hypotension and pyrexia. Acute neuronal injury, blood-brain barrier (BBB) integrity, axonal injury (AI), and glial activation were studied 4 1/2 hours following either CHI (group A), CHI plus secondary insults (group B), secondary insults alone (group C), or sham control injury (group D). There was evidence of limited AI following CHI in the lower medulla and upper cervical cord region, which was not modified by addition of secondary insult. Loss of dendritic microtubule-associated protein MAP2 immunoreactivity proved a reliable marker of acute neuronal damage, which was confined to subimpact and inferolateral cortical locations following CHI and was widespread after secondary insult. The pattern of plasma protein extravasation paralleled that of acute neuronal injury. We found no evidence of microglial activation, either local or generalized, by 4 1/2 hours. However, by this time CHI and secondary insults had combined to produce evidence of subimpact astrocyte activation, which was not apparent with either insult or injury alone. We conclude that in this modified Richmond model of CHI, when combined with secondary insults, there is no convincing potentiation of brain damage with the minor exception of astrocyte activation.	Univ Edinburgh, Western Gen Hosp, Dept Pathol, Neuropathol Lab, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland		Lammie, GA (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Pathol, Neuropathol Lab, Alexander Donald Bldg,Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.						AUER RN, 1984, ACTA NEUROPATHOL, V64, P177, DOI 10.1007/BF00688108; Brown HC, 1998, NEUROPATH APPL NEURO, V24, P177; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GEHRMANN J, 1991, ACTA NEUROPATHOL, V82, P442, DOI 10.1007/BF00293378; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; LEES GJ, 1989, ACTA NEUROPATHOL, V77, P519, DOI 10.1007/BF00687254; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; Sharp FR, 1998, ANN NEUROL, V44, P581, DOI 10.1002/ana.410440402; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; VANDENBRINK WA, 1994, ACT NEUR S, V60, P456; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; WELLS J, 1992, GLIA, V5, P154, DOI 10.1002/glia.440050210; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403	25	22	22	1	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	1999	16	7					603	615		10.1089/neu.1999.16.603			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	220EN	WOS:000081651700005	10447072				2022-02-06	
J	Armengol, CG				Armengol, CG			A multimodal support group with Hispanic traumatic brain injury survivors	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							LATINO HEALTH; STRATEGIES	Objectives: (a) To design and pilot a culturally sensitive and neuropsychologically informed support group addressing barriers to emotional, social, and vocational adjustment among high-level functioning Hispanic/Latino TBI survivors. (b) To determine efficacy through outcome measures. Intervention: Ten-week multimodal, culturally sensitive support group focusing on TBI sequelae education, relaxation techniques, coping skills development, behavioral goal setting and monitoring, and family participation. Participants: Six Spanish-speaking high-level functioning TBI survivors aged 20-42. Setting: Outpatient neuropsychological assessment and treatment center. Outcome measures: Beck Hopelessness Scale; Purpose in Life Test; Perceived Self-Regulatory Ability Inventory. Results: Participants' sense of personal destiny and feelings of hopelessness improved, as evidenced by objective measures and self-report. A telephone interview a year later indicated that gains had been maintained, and most participants were vocationally active. Conclusions: Results underscore the importance of considering linguistic and ethnic factors in developing support groups.	Northeastern Univ, Boston, MA 02115 USA		Armengol, CG (corresponding author), Northeastern Univ, 203 Lake Hall,360 Huntingdon Ave, Boston, MA 02115 USA.						AGUIRREMOLINA M, 1993, PUBLIC HEALTH REP, V108, P559; ARMENGOL CG, 1995, UNPUB PERCEIVED SELF; ARREDONDO P, 1996, THEORY MULTICULTURAL; Baker EA, 1997, HEALTH EDUC BEHAV, V24, P495, DOI 10.1177/109019819702400408; Beck A., 1988, BECK HOPELESSNESS SC; Beck A.T., 1993, COGNITIVE THERAPY SU; COMASDIAZ L, 1993, COUNSELING AM MINORI; CRUMBAUGH CJ, 1988, INT FORUM LOGOTHER J, V11, P76; CRUMBAUGH JC, 1968, J INDIV PSYCHOL, V24, P74; DELGADO JL, 1993, PUBLIC HEALTH REP, V108, P540; DIKMEN SS, 1988, MILD HEAD INJURY; ESLINGER PJ, HEAD INJURY POST CON; ESTRADA AL, 1990, AM J PUBLIC HEALTH, V80, P27, DOI 10.2105/AJPH.80.Suppl.27; GOLDSMITH MF, 1993, JAMA-J AM MED ASSOC, V269, P1604; Guttman D., 1996, LOGOTHERAPY HELPING; HITCHCOCK LS, 1994, J PAIN SYMPTOM MANAG, V9, P312, DOI 10.1016/0885-3924(94)90190-2; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P11; LISHMAN WA, 1998, ORGANIC PSYCHIAT PSY; Lopez-Austin A, 1989, CUERPO HUMANO IDEOLO; LUBUSKO AA, 1994, BRAIN INJURY, V8, P65, DOI 10.3109/02699059409150959; MOES EJ, 1994, PSYCHOTHERAPISTS GUI; NOVELLO AC, 1993, PUBLIC HEALTH REP, V108, P529; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONTERROTO JG, 1990, HDB RACIAL ETHNIC MI; PONTON MO, 1997, NEUROPSYCHOLOGICAL R; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; RIDEOUT E, 1986, J ADV NURS, V11, P429, DOI 10.1111/j.1365-2648.1986.tb01270.x; ROGLER IH, 1993, COUNSELING AM MINORI; Rogler LH, 1989, HISPANICS MENTAL HLT; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; SUE DW, 1996, THEORY MULTICULTURAL; TELLEZVARGAS H, 1991, REV LATINOAMER PSICO, V23, P401; Thoresen CE, 1974, SELF CONTROL POWER P; TORNER JC, 1996, HEAD INJURY POST CON; TRUK DC, 1983, PAIN BEHAV MED COGNI; *US BUR CENS, HISP POP US MARC P20, V444; VASQUEZ MJT, 1995, PSYCHOL INTERVENTION; Walsh KW., 1991, UNDERSTANDING BRAIN; Woodward A M, 1992, J Ment Health Adm, V19, P224, DOI 10.1007/BF02518988; [No title captured]; [No title captured], DOI DOI 10.1037/0894-4105.5.4.253	41	22	22	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1999	14	3					233	246		10.1097/00001199-199906000-00004			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	203XY	WOS:000080734500004	10381976				2022-02-06	
J	Block, GW; Nanson, JL; Lowry, NJ				Block, GW; Nanson, JL; Lowry, NJ			Attention, memory, and language after pediatric ischemic stroke	CHILD NEUROPSYCHOLOGY			English	Article							UNILATERAL BRAIN-LESIONS; CLOSED-HEAD INJURY; CHILDREN	A previous study evaluating receptive language after unilateral brain damage in childhood hypothesized lateralized attention and memory deficits without direct measurement. Our study directly measured attention, memory, and language in order to evaluate empirically the severity and laterality of sequelae. The performances of 11 individuals with a unilateral ischemic-lesion (7 right and 4 left hemisphere) were compared to controls matched on age, sex, and socioeconomic status. Results suggest subtle but persistent. deficits in verbal memory, functional memory, and speed of processing after a lesion to either hemisphere. Lesions sustained before two years of age were associated with the lowest IQ scores. Our findings provide support for a configural representation of language that can to some extent compensate for inefficient or damaged components (Bates, 1994), and the middle-ground lateralization position (Thal et al., 1991) that asserts initial hemispheric specialization with the potential for reorganization.	Univ Saskatchewan, Saskatoon, SK, Canada		Block, GW (corresponding author), Royal Univ Hosp, Alvin Buckwold Child Dev Program, 103 Hosp Dr, Saskatoon, SK S7N 0X0, Canada.						Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; ARAM DM, 1988, NEUROPSYCHOLOGIA, V26, P903, DOI 10.1016/0028-3932(88)90058-9; ARAM DM, 1985, J CLIN EXP NEUROPSYC, V7, P55, DOI 10.1080/01688638508401242; ARAM DM, 1994, NEUROPSYCHOLOGIA, V32, P85, DOI 10.1016/0028-3932(94)90071-X; Aram DM, 1986, DEV NEUROPSYCHOL, V2, P155, DOI 10.1080/87565648609540339; BATES E, 1994, DISCUSS NEUROSCI, V10, P136; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; EISELE JA, 1994, BRAIN LANG, V46, P212, DOI 10.1006/brln.1994.1013; Kalapurackal M, 1994, J Stroke Cerebrovasc Dis, V4, P57, DOI 10.1016/S1052-3057(10)80148-X; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; SATZ P, 1990, BRAIN LANG, V38, P596, DOI 10.1016/0093-934X(90)90139-8; Stiles Joan, 1993, P643; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; WILSON BA, 1993, J CLIN EXP NEUROPSYC, V15, P474, DOI 10.1080/01688639308402572; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	21	22	22	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	JUN	1999	5	2					81	91		10.1076/chin.5.2.81.3169			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	237ME	WOS:000082659500001					2022-02-06	
J	Oehmichen, M; Meissner, C; Schmidt, V; Pedal, I; Konig, HG				Oehmichen, M; Meissner, C; Schmidt, V; Pedal, I; Konig, HG			Pontine axonal injury after brain trauma and nontraumatic hypoxic-ischemic brain damage	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						axonal injury; midbrain; biomechanics; specificity; diffuse axonal injury	AMYLOID PRECURSOR PROTEIN; NONMISSILE HEAD-INJURY; RAT-BRAIN; BETA-APP; HUMANS; MARKER	Experimental studies have shown that diffuse axonal injury is usually induced by positive or negative acceleration mechanisms. In order to determine the reliability of axonal injury (AI) as a marker of this type of traumatic insult, we compared cases of trauma-induced focal cortical hemorrhage without dural involvement (n = 67) with cases of trauma-induced subdural bleeding without cortical hemorrhage (n = 26). Both groups exhibited a wide range of post-traumatic survival times. The injuries in the first group were caused mainly by direct impact to the head, those in the second by acceleration/deceleration mechanisms. The investigations were based primarily on immunohistochemical demonstration of antibodies targeted to beta-amyloid precursor protein (beta-APP) in the pens as a marker of AI and the results were assessed semiquantitatively. No significant differences were found between the two groups. In both groups AI was detected in 80-100% of cases with survival times of more than 3 h and two thirds of all positive cases showed pronounced positivity. Additional comparison of cases of brain death due to mechanical trauma (n = 14) with cases of brain death due to non-mechanical trauma (n = Is) also disclosed no significant intergroup differences. Finally, investigations of the pens in cases of non-traumatic death due to cerebral hypoxia/ischemia (n = 51) demonstrated AI with the same frequency as in the other groups, although the expression tended to be less pronounced. Our results confirm that beta-APP expression in the pens is a reliable indicator of AI but does not discriminate between injuries caused by traumatic strain or shearing mechanisms and secondary damage due to cerebral hypoxia/ischemia or edema. In the large majority of cases with prolonged post-traumatic survival, it can therefore be assumed that Al in the pens is the consequence of primary and/or secondary events or a combination of both, as is common in non-missile head injury survived for more than 90-120 min. Therefore, positive differentiation of the type of biomechanical event based on this criterion alone is not possible.	Univ Lubeck, Dept Legal Med, D-23562 Lubeck, Germany; Univ Halle Wittenberg, Inst Rechtsmed, D-06112 Halle, Germany; Heidelberg Univ, Inst Rechtsmed, D-69115 Heidelberg, Germany; Univ Tubingen, Inst Gerichtliche Med, D-72074 Tubingen, Germany		Oehmichen, M (corresponding author), Univ Lubeck, Dept Legal Med, Kahlhorststr 31-35, D-23562 Lubeck, Germany.						ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BRATZKE H, 1997, CURRENT TOPICS FOREN, V3, P87; DIXON CE, 1991, J NEUROSCI METH, V39, P253; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1987, P 33 STAPP CAR CRASH, P35; GENNARELLI TA, 1981, ACTA NEUROPATHOL B S, V7, P26; Gennarelli TA, 1996, NEUROPATHOL APPL S1, V22, P44; Gentleman S, 1997, RES LEG MED, V17, P161; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Graham DI, 1996, NEUROPATH APPL NEURO, V22, P505, DOI 10.1111/j.1365-2990.1996.tb01125.x; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; JELLINGER K, 1970, J NEUROL SCI, V10, P51, DOI 10.1016/0022-510X(70)90091-2; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1989, CONT ISSUES NEUROLOG, V1, P47; Kita T, 1997, INT J LEGAL MED, V110, P305, DOI 10.1007/s004140050093; KRAULAND W, 1961, QUELLEN AKTUEN CHRON; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MAXWELL WL, 1996, NEUROPATHOL APPL S1, V22, P15; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; MILLER JD, 1978, NEURAL TRAUMA, P173; Oehmichen M, 1997, RES LEG MED, V17, P203; OEHMICHEN M, 1990, WUNDHEILUNG; OEHMICHEN M, 1998, IN PRESS FORENSIC SC; Olsson Y, 1996, NEUROPATH APPL NEURO, V22, P518, DOI 10.1111/j.1365-2990.1996.tb01129.x; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 1997, RES LEG MED, V17, P175; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SIKAL RR, 1969, BIOMETRY, P607; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; UNTERHARNSCHEID.F, 1993, PATHOLOGIE NERVENSYS, V6; Yam PS, 1998, J NEUROTRAUM, V15, P441, DOI 10.1089/neu.1998.15.441	39	22	26	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUN	1999	112	4					261	267		10.1007/s004140050246			7	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	212XU	WOS:000081243600008	10433037				2022-02-06	
J	Gabellec, MM; Crumeyrolle-Arias, M; Le Saux, F; Auriou, N; Jacque, C; Haour, F				Gabellec, MM; Crumeyrolle-Arias, M; Le Saux, F; Auriou, N; Jacque, C; Haour, F			Expression of interleukin-1 genes and interleukin-1 receptors in the mouse brain after hippocampal injury	NEUROSCIENCE RESEARCH			English	Article						central nervous system; brain trauma; interleukin-1 transcripts; interleukin-1 receptor; autoradiography; RT-PCR	TUMOR-NECROSIS-FACTOR; TRANSIENT FOREBRAIN ISCHEMIA; POLYMERASE CHAIN-REACTION; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; ALPHA MESSENGER-RNA; ADULT-RAT BRAIN; BACTERIAL LIPOPOLYSACCHARIDE; TNF-ALPHA; IMMUNOREACTIVE INTERLEUKIN-1-BETA	In order to evaluate the role of IL-1 production in post-traumatic brain, transcripts for IL-1 (alpha, beta, RA) have been quantified following RT-PCR, in hippocampus and cortex after injury of either hippocampus (Hip) or striatum (Stri). Moreover, I-125 IL-1 alpha binding sites have been directly quantified using binding experiments on brain sections and quantitative autoradiography. Under basal conditions, levels of PCR products were very low. On day 1, IL-1RA transcripts only were strongly increased in the hippocampus after Hip-lesions and in cortex after Stri lesion. Transcripts were back to control values on day 7 post-lesion. IL-1 receptor densities in the hippocampus (dentate gyrus) were decreased at day 1 around the site of the lesion (but not on the contralateral side) and were back to controls on day 7 indicating a transient and local IL-1 production in the surroundings of the lesion. No changes were found following Stri lesion. This study provides further evidence of the role of the IL-1 molecules family, notably IL-1RA, in the brain reaction to trauma. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Inst Pasteur, Unite Pharmacol Neuroimmunoendocrinienne, F-75724 Paris, France; Hop La Pitie Salpetriere, INSERM, U495, F-75651 Paris, France; Hop St Antoine, INSERM, U339, F-75571 Paris, France		Gabellec, MM (corresponding author), Inst Pasteur, Unite Pharmacol Neuroimmunoendocrinienne, 28 Rue Dr Roux, F-75724 Paris, France.	mmg@pasteur.fr					BAN E, 1991, NEUROSCIENCE, V43, P21, DOI 10.1016/0306-4522(91)90412-H; BANDTLOW CE, 1990, J CELL BIOL, V111, P1701, DOI 10.1083/jcb.111.4.1701; BRENNEMAN DE, 1992, J NEUROCHEM, V58, P454, DOI 10.1111/j.1471-4159.1992.tb09743.x; BUTTINI M, 1994, MOL BRAIN RES, V23, P126, DOI 10.1016/0169-328X(94)90218-6; Cavaillon JM, 1996, CYTOKINES, P93; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; ERICSSON A, 1995, J COMP NEUROL, V361, P681, DOI 10.1002/cne.903610410; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Gabellec MM, 1996, NEUROIMMUNOMODULAT, V3, P304, DOI 10.1159/000097284; GABELLEC MM, 1995, MOL BRAIN RES, V31, P122, DOI 10.1016/0169-328X(95)00042-Q; Gabellec MM, 1996, J NEUROIMMUNOL, V66, P65, DOI 10.1016/0165-5728(96)00021-5; Gabellec MM, 1997, BRAIN RES PROTOC, V1, P145, DOI 10.1016/S1385-299X(96)00023-2; GATTI S, 1993, BRAIN RES, V624, P291, DOI 10.1016/0006-8993(93)90090-A; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757, DOI 10.1074/jbc.270.23.13757; GRIFFAIS R, 1991, NUCLEIC ACIDS RES, V19, P3887; HAOUR F, 1994, NY ACAD SCI, V747, P324; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Jafarian Tehrani M., 1994, Journal of Neuroimmunology, V53, P91, DOI 10.1016/0165-5728(94)90068-X; Jafarian-Tehrani M, 1998, J NEUROIMMUNOL, V84, P30, DOI 10.1016/S0165-5728(97)00239-7; LAYE S, 1994, MOL BRAIN RES, V27, P157, DOI 10.1016/0169-328X(94)90197-X; LEBLANC P, 1988, NEUROENDOCRINOLOGY, V48, P482, DOI 10.1159/000125053; LECHAN RM, 1990, BRAIN RES, V514, P135, DOI 10.1016/0006-8993(90)90445-H; Marquette C, 1996, J NEUROIMMUNOL, V68, P45, DOI 10.1016/0165-5728(96)00056-2; MARTIN D, 1994, EXP NEUROL, V130, P362, DOI 10.1006/exnr.1994.1215; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; MINAMI M, 1991, BIOCHEM BIOPH RES CO, V176, P593, DOI 10.1016/S0006-291X(05)80225-6; MINAMI M, 1992, J NEUROCHEM, V58, P390, DOI 10.1111/j.1471-4159.1992.tb09324.x; Ohtsuki T, 1996, J CEREBR BLOOD F MET, V16, P1137, DOI 10.1097/00004647-199611000-00007; PARNET P, 1994, MOL BRAIN RES, V27, P63, DOI 10.1016/0169-328X(94)90185-6; REINISCH N, 1994, NEUROSCI LETT, V166, P165, DOI 10.1016/0304-3940(94)90476-6; Relton JK, 1996, EXP NEUROL, V138, P206, DOI 10.1006/exnr.1996.0059; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; ROTHWELL NJ, 1995, TRENDS NEUROSCI, V18, P130, DOI 10.1016/0166-2236(95)93890-A; SCHNEEBERGER C, 1995, PCR METH APPL, V4, P234; SCHOBITZ B, 1994, PROG NEUROBIOL, V44, P397, DOI 10.1016/0301-0082(94)90034-5; SCHULTZBERG M, 1992, PERG S NEUR, V5, P1; SIMS JE, 1994, EUR CYTOKINE NETW, V5, P539; SIMS JE, 1993, P NATL ACAD SCI USA, V90, P6155, DOI 10.1073/pnas.90.13.6155; TAKAO T, 1993, ENDOCRINOLOGY, V132, P1497, DOI 10.1210/en.132.4.1497; Tchelingerian JL, 1996, J NEUROSCI RES, V43, P99, DOI 10.1002/jnr.490430113; TCHELINGERIAN JL, 1993, NEURON, V10, P213, DOI 10.1016/0896-6273(93)90312-F; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; VANDAM AM, 1992, BRAIN RES, V588, P291, DOI 10.1016/0006-8993(92)91588-6; Wang XK, 1997, STROKE, V28, P155, DOI 10.1161/01.STR.28.1.155; Wong ML, 1997, P NATL ACAD SCI USA, V94, P227, DOI 10.1073/pnas.94.1.227; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YABUUCHI K, 1994, MOL BRAIN RES, V27, P27, DOI 10.1016/0169-328X(94)90180-5; YABUUCHI K, 1994, MOL BRAIN RES, V26, P135, DOI 10.1016/0169-328X(94)90084-1; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2	53	22	24	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-0102	1872-8111		NEUROSCI RES	Neurosci. Res.	APR	1999	33	4					251	260		10.1016/S0168-0102(99)00014-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	208ZL	WOS:000081022500001	10401977				2022-02-06	
J	Sarafis, KA; Karatzas, GD; Yotis, CL				Sarafis, KA; Karatzas, GD; Yotis, CL			Ankylosed hips caused by heterotopic ossification after traumatic brain injury: A difficult problem	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						ankylosed hips; heterotopic ossification; traumatic brain injury	BONE-FORMATION	Background: Heterotopic ossifications develop around major joints after severe traumatic brain injury and decrease the range of motion of the joints. Methods: From 1982 to 1994, we operated on 22 ankylosed hips caused by heterotopic ossifications after traumatic brain injury. Our 15 patients had been hospitalized in the intensive care unit for a period of 8 to 57 days. Their preoperative neurologic status was evaluated precisely. Special interest was given also to the accurate estimation of the extent and location of the ectopic bone by using x-rays and computed tomography, as web as to the maturity of the bone by using Tc-99 bone scan and measurements of serum alkaline phosphatase levels. Intraoperatively, we resected as much ectopic bone as was needed to achieve functional range of motion in the hip. Postoperatively, all the patients were administered 100 mg of indomethacin (suppository.) per day for a month, antibiotics, and anticoagulants. They were also exposed to 1,000 cGy of radiation in two equal doses. Results: We achieved a least functional range of motion in 15 of 22 hips. Of the seven hips with poor results, six cases were attributable to the uncontrolled neurologic syndrome and only one poor result was attributable to severe heterotopic ossification recurrence. Wound complications did occur. Conclusion: Ankylosed hips caused by heterotopic ossifications after traumatic brain injury are a difficult problem to manage. Accurate evaluation of the preoperative neurologic status is essential for the desired final outcome and the treatment options.	Asclepie Hosp, Orthopaed Dept 5, GR-16673 Athens, Greece		Sarafis, KA (corresponding author), Asclepie Hosp, Orthopaed Dept 5, 1 Vas Pavlou Str, GR-16673 Athens, Greece.						AN HS, 1987, CLIN ORTHOP RELAT R, V219, P291; AYERS DC, 1991, CLIN ORTHOP RELAT R, P87; BLANE CE, 1981, SKELETAL RADIOL, V7, P21, DOI 10.1007/BF00347167; DAMANSKI M, 1961, J BONE JOINT SURG BR, V43, P286, DOI 10.1302/0301-620X.43B2.286; DEJERINE A, 1991, CLIN ORTHOP RELAT R, P3; DRANE WE, 1989, ASR, V142, P279; FURMAN R, 1970, J BONE JOINT SURG AM, VA 52, P1131, DOI 10.2106/00004623-197052060-00005; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1988, CLIN ORTHOP RELAT R, V233, P86; GARLAND DE, 1989, CLIN ORTHOP RELAT R, V242, P169; GARLAND DE, 1991, CLIN ORTHOP RELAT R, V263, P3; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; HIERTON C, 1983, ACTA ORTHOP SCAND, V54, P58, DOI 10.3109/17453678308992870; HSU JD, 1975, CLIN ORTHOP RELAT R, P165; KJAERSGAARDANDERSEN P, 1986, ACTA ORTHOP SCAND, V57, P12, DOI 10.3109/17453678608993206; MAJOR P, 1980, RADIOLOGY, V136, P797, DOI 10.1148/radiology.136.3.6773108; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; MIELANTS H, 1975, ACTA ORTHOP SCAND, V46, P190, DOI 10.3109/17453677508989207; ORZEL JA, 1985, J NUCL MED, V26, P125; ROBERTS P H, 1968, Journal of Bone and Joint Surgery British Volume, V50B, P70; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539; STOVER SL, 1991, CLIN ORTHOP RELAT R, P71; TIBONE J, 1978, J BONE JOINT SURG AM, V60, P769, DOI 10.2106/00004623-197860060-00007; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142; YOUNG RR, 1987, CLIN ORTHOP RELAT R, V219, P50	28	22	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	1999	46	1					104	109		10.1097/00005373-199901000-00017			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	160DE	WOS:000078214400025	9932691				2022-02-06	
J	Taly, AB; Nair, KPS; Kumar, MV; Jayakumar, PN; Vasudev, MK; Ravishankar, D; Kalaivant, PL; Padankatty, BS; Murali, T				Taly, AB; Nair, KPS; Kumar, MV; Jayakumar, PN; Vasudev, MK; Ravishankar, D; Kalaivant, PL; Padankatty, BS; Murali, T			Heterotopic ossification in non-traumatic myelopathies	SPINAL CORD			English	Article						non-traumatic myelopathies; heterotopic; ossification; spinal cord injury; paraplegia	SPINAL-CORD INJURY; DISODIUM ETIDRONATE; ASSOCIATION; PREVENTION; DIAGNOSIS; THERAPY; BONE	Heterotopic ossification (HO) is an important complication of spinal cord and brain injuries but is rarely reported among patients with non-traumatic myelopathies. In a prospective study on medical problems seven (6.04%) among the 114 subjects with non-traumatic myelopathies had heterotopic ossification had heterotopic ossification. All of them had involvement of hip joints. The co-morbid conditions were: urinary tract infection, seven; spasticity, three; pressure sores, five; and deep venous thrombosis, one. The initial diagnosis was often other than heterotopic ossification. Erythrocyte sedimentation rate and serum alkaline phosphatase levels were elevated in all subjects. Following rest and non-steroidal anti-inflammatory drugs, the range of motion improved in two patients. Heterotopic ossification can occur in patients with non-traumatic myelopathies and has risk factors and clinical features similar to patients with traumatic spinal cord injury. A high index of suspicion about this complication is necessary for early diagnosis and prompt intervention.	Natl Inst Mental Hlth & Neurosci, Dept Neurol Psychiat & Neurol Rehabil, Bangalore 560029, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Neuroradiol, Bangalore 560029, Karnataka, India		Taly, AB (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurol Psychiat & Neurol Rehabil, Bangalore 560029, Karnataka, India.		Taly, Arun/AAV-3517-2021; Nair, Krishnan/AAE-3474-2020	Nair, Krishnan/0000-0002-4004-2315			BANOVAC K, 1993, PARAPLEGIA, V31, P660, DOI 10.1038/sc.1993.106; BIERINGSORENSEN F, 1993, PARAPLEGIA, V31, P513, DOI 10.1038/sc.1993.83; BODLEY R, 1993, PARAPLEGIA, V31, P500, DOI 10.1038/sc.1993.81; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; BUSCHBACHER R, 1992, AM J PHYS MED REHAB, V71, P86, DOI 10.1097/00002060-199204000-00005; BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199; CASSARPULLICINO VN, 1993, PARAPLEGIA, V31, P40, DOI 10.1038/sc.1993.7; COLACHIS SC, 1993, PARAPLEGIA, V31, P507, DOI 10.1038/sc.1993.82; COLACHIS SC, 1993, PARAPLEGIA, V31, P51, DOI 10.1038/sc.1993.8; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; SCHAEFFER MA, 1995, ARCH PHYS MED REHAB, V76, P284, DOI 10.1016/S0003-9993(95)80617-2; SNOECX M, 1995, PARAPLEGIA, V33, P464, DOI 10.1038/sc.1995.101; TALY AB, 1996, 24 ANN NAT C IND ASS	14	22	22	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	1999	37	1					47	49		10.1038/sj.sc.3100751			3	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	161QZ	WOS:000078301600009	10025695	Bronze			2022-02-06	
J	Perlesz, A; O'Loughlan, M				Perlesz, A; O'Loughlan, M			Changes in stress and burden in families seeking therapy following traumatic brain injury: a follow-up study	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						counselling; families; psychosocial outcome; traumatic brain injury	CLOSED HEAD-INJURY; GENERAL HEALTH QUESTIONNAIRE; SOCIAL-ADJUSTMENT; SELF-REPORT; RELATIVES; REHABILITATION; IMPAIRMENT; PATIENT; SAMPLE; POPULATION	The current project is a preliminary investigation of changes in levels of distress, and burden and family and marital adjustment in families following traumatic brain injury (TBI), replicating measures used in the earlier Glasgow, TBI outcome research on relatives' stress and burden. Fifteen families (32 individuals) seeking family counselling in a publicly funded family therapy centre were monitored over a two year period: prior to commencing counselling; 12 months following the commencement of counselling; and 24 months following the commencement of counselling. The most significant and sustained changes in psychosocial outcome were a decrease in distress for both individuals with TBI and their carers as well as a reduction in relatives' burden and strain. Family conflict also reduced, just as family cohesion increased and adjustment within the family unit improved from pre-therapy to the time of follow-up 24 months later. However, reported levels of anger, despite significantly reducing during the first 12 months of the study, actually increased back to their original levels at the 24 month follow-up. Marital adjustment also worsened in the latter half of the study, with couples reporting a similar level of marital adjustment to that which they had experienced prior to counselling. These findings are discussed and recommendations made for more rigorous, controlled, longitudinal studies of the effectiveness of family therapy. It was also recommended that marital couples receive longer-term counselling to address their specific needs, and that the issue of anger be further investigated with a view to either reducing family members' anger, or bearing witness to the legitimacy of their anger in the longer-term, and assisting with anger-management programmes.	Latrobe Univ, Bouverie Ctr, Melbourne, Vic, Australia; Alfred Child & Adolescent Mental Hlth Serv, Melbourne, Vic, Australia		Perlesz, A (corresponding author), Latrobe Univ, Bouverie Ctr, 50 Flemington St,Flemington 3031, Melbourne, Vic, Australia.						*ACQ BRAIN DAM DAT, 1991, REP HEAD INJ IMP PRO, V2; ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; ANDERSONPARENTE JK, 1990, COGNITIVE REHABI JAN, P22; Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; BANJA JD, 1992, J HEAD TRAUMA REHAB, V7, P112; Bech P, 1993, ACTA PSYCHIAT S S372, V87, P1, DOI 10.1111/j.1600-0447.1993.tb03321.x; Bishop DS, 1988, J HEAD TRAUMA REHAB, V3, P16; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brown E.W., 1985, FAMILY SYSTEMS MED, V3, P440, DOI 10.1037/h0089672; COOPER P, 1982, BRIT J PSYCHIAT, V141, P68, DOI 10.1192/bjp.141.1.68; Daniel A., 1983, POWER PRIVILEGE PRES; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; GANS JS, 1983, ARCH PHYS MED REHAB, V64, P176; Gervasio AH, 1997, J HEAD TRAUMA REHAB, V12, P14, DOI 10.1097/00001199-199706000-00003; Goldberg D., 1978, MANUAL GEN HLTH QUES; GORDON WA, 1992, NEUROPSYCHOLOGY, V6, P361; GRIFFITH JL, 1985, FAM SYSTEMS MED, V3, P151; Henry P. W., 1985, FAMILY SYSTEMS MED, V3, P427; HERBERT JT, 1989, J REHABIL, V55, P45; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1990, REHABILITATION ADULT, P3; Kaplan SP, 1991, CLIN NEUROPSYCHOL, V5, P360; KAY T, 1991, HEAD INJURY FAMILY M, P121; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; Kinsella G, 1989, Int Disabil Stud, V11, P9; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LAMONT M, 1993, THESIS LA TROBE U ME; Leathem J, 1996, BRAIN INJURY, V10, P27; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1988, J LEARN DISABIL, V21, P456, DOI 10.1177/002221948802100802; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; LIRA FT, 1983, INT J CLIN NEUROPSYC, V5, P159; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Maitz E.A., 1990, THESIS TEMPLE U PHIL; Maitz E.A., 1991, HEAD INJURY FAMILY M, P65; MALT UF, 1989, ACTA PSYCHIAT SCAND, V80, P103, DOI 10.1111/j.1600-0447.1989.tb05260.x; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; McLaughlin Anne Marie, 1993, Brain Injury, V7, P45, DOI 10.3109/02699059309008155; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; McNair D., 1981, MANUAL PROFILE MOOD; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; Moore A D, 1989, Brain Inj, V3, P171, DOI 10.3109/02699058909004549; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; Moos R.H., 1981, FAMILY ENV SCALE MAN; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PARRY A, 1985, THESIS LA TROBE U ME; Paterson T., 1996, THERAPEUTIC RELATION, P15; PERLESZ A, 1992, AUSTR NZ J FAMILY TH, V13, P145, DOI DOI 10.1002/J.1467-8438.1992.TB00910.X; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P88, DOI 10.1097/00001199-199608000-00011; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; SACHS PR, 1991, TREATING FAMILIES BR; Selvini Palazzoli M., 1980, DIMENSIONS FAMILY TH, P161; Shaw L R, 1990, Brain Inj, V4, P87, DOI 10.3109/02699059009026152; Smith LM, 1995, FAMILY SUPPORT PROGR; *SPSS INC, 1986, SPSS PC PLUS; STAMBROOK M, 1993, ARCH CLIN NEUROPSYCH, V8, P95; Szmukler GI, 1996, SOC PSYCH PSYCH EPID, V31, P149, DOI 10.1007/BF00785761; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TENNANT C, 1977, MED J AUSTRALIA, V2, P392, DOI 10.5694/j.1326-5377.1977.tb114568.x; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEISSMAN MM, 1978, J NERV MENT DIS, V166, P317, DOI 10.1097/00005053-197805000-00002; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; WRATE R, 1987, DISABILITY FAMILY; ZARSKI JJ, 1987, AM J FAM THER, V15, P62; ZEIGLER EA, 1989, COGNITIVE REHABI MAY, P34; ZIMOSTRAD SW, 1989, COGNITIVE REHABI MAY, P26; [No title captured], DOI DOI 10.1080/09602019108520164	83	22	23	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	DEC	1998	21	4					339	354		10.1097/00004356-199812000-00001			16	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	156QN	WOS:000078013700001	9926349				2022-02-06	
J	Atkinson, JLD; Anderson, RE; Murray, MJ				Atkinson, JLD; Anderson, RE; Murray, MJ			The early critical phase of severe head injury: Importance of apnea and dysfunctional respiration	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						fluid percussion head injury; apnea; respiratory dysfunction; severe head injury	TRAUMATIC BRAIN INJURY; MODEL; RAT	Background: Apnea is a known response of concussive head injury. Hypoxic or ischemic brain injury has been documented in a high percentage of severe head injury deaths, The respiratory response after head injury remains poorly defined, however, and its contribution to hypoxic or ischemic mechanisms after severe head injury is unknown. Methods: Eighteen anesthetized but spontaneously breathing rats were subjected to fluid percussion head injury of varying severities. Respiratory rate and volume of air were recorded before and after injury with a Hans Rudolph/Varadyne pneumotach differential pressure transducer and graphically measured, Postmortem inspection of the brains was performed. Results: Apnea and subsequent respiratory dysfunction are directly proportional to the magnitude of energy delivered to the brain. Higher energy results in a dysfunctional or absent respiratory response, probably attributable to failure or disorganized function of the medullary respiratory center. Conclusion: This study for the first time graphically depicts the respiratory response after head injury. Higher energy delivered to the brain directly correlates,vith a markedly abnormal respiratory response that probably contributes significantly to subsequent hypoxic or ischemic brain injury. The absence of the space-occupying hematoma or gross parenchymal disruption suggests that in the clinical setting many of these patients may otherwise have survivable head injury if rescued by early ventilatory assistance.	Mayo Clin & Mayo Fdn, Dept Neurol Surg, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Anesthesiol, Rochester, MN 55905 USA		Atkinson, JLD (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol Surg, 200 1st St SW, Rochester, MN 55905 USA.		Murray, Michael/AAX-2029-2021				Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ANDERSEN BJ, 1988, J NEUROSURG, V68, P601, DOI 10.3171/jns.1988.68.4.0601; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BROWN TH, 1989, GASTROINTEST ENDOSC, V35, P37, DOI 10.1016/S0016-5107(89)72683-3; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GENARELLI TA, 1983, ACTA NEUROCHIR SUPP, V32, P1; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LARSON GM, 1984, AM J SURG, V147, P97, DOI 10.1016/0002-9610(84)90041-2; LEVINE JE, 1979, NEW ENGL J MED, V301, P109; MACIVER IN, 1958, LANCET, V1, P390; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; National Academy of Sciences National Research Council, 1966, ACC DEATH DIS NEGL D; OFFERHAU.J, 1969, CARDIOVASC RES, V3, P433, DOI 10.1093/cvr/3.4.433; RINDER L, 1969, ACTA PHYSIOL SCAND, V76, P352, DOI 10.1111/j.1748-1716.1969.tb04478.x; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SHIOZAKI T, 1993, J NEUROSURG, V78, P501, DOI 10.3171/jns.1993.78.3.0501; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; SIMMONS RL, 1969, ANN SURG, V170, P39, DOI 10.1097/00000658-196907000-00005; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822	26	22	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	1998	45	5					941	945		10.1097/00005373-199811000-00016			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	137UZ	WOS:000076936000018	9820706				2022-02-06	
J	Partrick, DA; Bensard, DD; Moore, EE; Partington, MD; Karrer, FM				Partrick, DA; Bensard, DD; Moore, EE; Partington, MD; Karrer, FM			Driveway crush injuries in young children: A highly lethal, devastating, and potentially preventable event	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	31st Annual Meeting of the Pacific-Association-of-Pediatric-Surgeons	JUN 09-13, 1998	MAUI, HAWAII	Pacific Assoc Pediat Surgeons		trauma; driveway; pedestrian; automobile	PEDESTRIAN INJURIES; PEDIATRIC TRAUMA; UNITED-STATES; HEAD	Background/Purpose: The aim of this study was to investigate driveway-related injuries in children, identify associated risk factors, and evaluate outcome compared with other mechanisms of blunt trauma. Methods:A 6-year review (1991 to 1996) of pediatric (age less than 18 years) pedestrian injuries treated at two urban trauma centers was conducted: one regional pediatric trauma center and one level I trauma center with pediatric commitment. Five hundred twenty-seven children injured in pedestrian accidents were identified from the trauma registry; 51 children (10%) sustained traumatic injuries as a result of being struck in their driveway. Data are reported as mean +/- SEM. Results: Children less than 5 years of age (n = 41) had an injury severity score (ISS) of 12.3 +/- 2.3, 15 (37%) sustained closed head injury, 13 (37%) had torso trauma, 19 (46%) skeletal trauma, and eight (20%) died. Children greater than or equal to 5 years old (n = 10) had an ISS of 10.7 +/- 2.4, three (30%) sustained closed head injury, four (40%) torso trauma, six (60%) skeletal trauma, and none died. In contrast, all other pediatric pedes trian accidents analyzed over the same time period had a mortality rate of only 2% (11 of 476). Conclusions: Pediatric driveway trauma carries a significant risk of head injury and a 10-fold increase in mortality in children under 5 years of age when compared with all other pediatric pedestrian accidents. More emphasis must be placed on injury prevention and public education to prevent this devastating mechanism of injury in these young, vulnerable children. Copyright (C) 1998 by W.B. Saunders Company.	Univ Colorado, Childrens Hosp, Hlth Sci Ctr, Dept Surg, Denver, CO 80218 USA; Denver Hlth Med Ctr, Dept Surg, Denver, CO USA		Bensard, DD (corresponding author), Univ Colorado, Childrens Hosp, Hlth Sci Ctr, Dept Surg, 1950 Ogden St,B-323, Denver, CO 80218 USA.						AGRAN P, 1991, PEDIATRICS, V87, P70; AGRAN PF, 1994, PEDIATRICS, V93, P284; ASHTON SJ, 1982, PEDESTRIAN ACCIDENTS, P169; Baker SP, 1997, J TRAUMA, V42, P369, DOI 10.1097/00005373-199703000-00002; BRISON RJ, 1988, AM J PUBLIC HEALTH, V78, P793, DOI 10.2105/AJPH.78.7.793; CAREY VF, 1993, BRIT MED J, V307, P1086, DOI 10.1136/bmj.307.6912.1086; DUHAIME AC, 1995, NEUROSURGERY, V37, P401, DOI 10.1227/00006123-199509000-00005; FINGERHUT LA, 1988, PUBLIC HEALTH REP, V103, P399; GUYER B, 1990, AM J DIS CHILD, V144, P649, DOI 10.1001/archpedi.1990.02150300047016; HOLMES MJ, 1984, J TRAUMA, V24, P253, DOI 10.1097/00005373-198403000-00012; LESCOHIER I, 1993, PEDIATRICS, V91, P721; PECLET MH, 1990, J PEDIATR SURG, V25, P85, DOI 10.1016/S0022-3468(05)80169-1; RIVARA FP, 1990, AM J DIS CHILD, V144, P692, DOI 10.1001/archpedi.1990.02150300090023; ROBERTS I, 1995, PEDIATRICS, V95, P405; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627	15	22	22	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	NOV	1998	33	11					1712	1715		10.1016/S0022-3468(98)90616-9			4	Pediatrics; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	141FF	WOS:000077131500031	9856902				2022-02-06	
J	Johnson, K; Davis, PK				Johnson, K; Davis, PK			A supported relationships intervention to increase the social integration of persons with traumatic brain injuries	BEHAVIOR MODIFICATION			English	Article							SEVERE HEAD-INJURY; FOLLOW-UP; STUDENTS; PRESCHOOLERS; RECOVERY	A supported relationships intervention was used to increase the integrated social contacts (ISCs) of 3 persons with traumatic brain injury (TBI) who were each matched with 4 community participants. The intervention consisted of asking participants to meet with their matched counterpart to engage in leisure activities once per week for 4 weeks. Additionally, community participants were provided with a brief training session on TBI, were given specific suggestions on interacting with the persons with TBI with whom they were matched, and received weekly phone calls from the researcher. Frequency of ISCs were analyzed with a multiple baseline design across participants. All 3 participants with TBI increased the frequency of ISCs after implementation of the supported relationships intervention and continued to experience mole than baseline levels of ISCs during 8 weeks of follow-up. These data suggest that social integration can be enhanced with a procedure requiring limited staff intervention.	So Illinois Univ, Inst Rehabil, Carbondale, IL 62901 USA		Johnson, K (corresponding author), So Illinois Univ, Inst Rehabil, Carbondale, IL 62901 USA.						BRAUNLINGMCMORR.D, 1992, INNOVATIONS HEAD INJ; BRAUNLINGMCMORROW D, 1986, J REHABIL, V52, P39; BURKE WH, 1990, HEADLINES        SPR, P2; FOREST M, 1992, NATURAL SUPPORTS SCH, P65; HARING TG, 1992, J APPL BEHAV ANAL, V25, P319, DOI 10.1901/jaba.1992.25-319; HARING TG, 1986, J APPL BEHAV ANAL, V19, P159, DOI 10.1901/jaba.1986.19-159; HARING TG, 1991, CRITICAL ISSUES LIVE, P195; JONES CL, 1988, HEAD INJURY GUIDE PA; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; LUFTIG RL, 1988, AM J MENT RETARD, V92, P472; McDonnell J., 1991, SECONDARY PROGRAMS S; MITHAUG DE, 1985, EXCEPT CHILDREN, V51, P397, DOI 10.1177/001440298505100505; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; MORTON MV, 1992, DISS ABSTR INT, V53, P2543; MOUNT B, 1988, ITS NEVER TOO EARLY; Nisbet J., 1992, NATURAL SUPPORTS SCH, P1; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODOM SL, 1986, J APPL BEHAV ANAL, V19, P59, DOI 10.1901/jaba.1986.19-59; ODOM SL, 1985, J APPL BEHAV ANAL, V18, P3, DOI 10.1901/jaba.1985.18-3; Prigatano G. P., 1987, COMMUNITY REENTRY HE, P1; SMULL MW, 1991, CRITICAL ISSUES LIVE, P527; Strully J., 1992, NATURAL SUPPORTS SCH, P165; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VANDERCOOK T, 1989, J ASSOC PERS SEVERE, V14, P205, DOI 10.1177/154079698901400306; WAGNER MT, 1990, INT J CLIN NEUROPSYC, V12, P131; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; ZETLIN AG, 1988, AM J MENT RETARD, V92, P447; [No title captured]	28	22	22	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0145-4455			BEHAV MODIF	Behav. Modificat.	OCT	1998	22	4					502	528		10.1177/01454455980224004			27	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	127AY	WOS:000076329400004	9755649				2022-02-06	
J	Boglioli, LR; Taff, ML; Harleman, G				Boglioli, LR; Taff, ML; Harleman, G			Child homicide caused by commotio cordis	PEDIATRIC CARDIOLOGY			English	Article						commotio cordis; blunt force chest trauma; myocardial concussion; myocardial contusion; sudden cardiac death; cardiac arrhythmia; child abuse; homicide	DEATH	Cardiac concussion, previously known as commotio cordis, occurs in structurally normal hearts without gross or microscopic injury to the myocardium, cardiac valves. or coronary arteries, as opposed to other sports-related deaths known to occur more frequently in structural or congenital heart disease. We describe the sudden cardiac death of a 2-year-old child, who died as a result of a blunt force impact to the chest. A thorough medicolegal investigation was necessary to determine that the child died as a result of foul play.	Lenox Hill Hosp, Cardiol Sect, New York, NY 10021 USA; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; Suffolk Cty Med Examiners Off, Hauppauge, NY 11787 USA		Taff, ML (corresponding author), 511 Hempstead Ave,Suite 2, W Hempstead, NY 11552 USA.						ABRUNZO TJ, 1991, AM J DIS CHILD, V145, P1279, DOI 10.1001/archpedi.1991.02160110071023; BESSON A, 1983, COLOR ATLAS CHEST TR, V1, P86; BROWN GG, 1995, NEUROPSYCHOLOGY, V9, P27, DOI 10.1037/0894-4105.9.1.27; CLINZ W, 1981, CHEST TRAUMA DIAGNOS, P191; DUBROW TJ, 1989, SURGERY, V106, P267; Jackimczyk Kenneth, 1993, Emergency Medicine Clinics of North America, V11, P81; LOWN B, 1969, AM J MED, V46, P705, DOI 10.1016/0002-9343(69)90022-9; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; NIRGIOTIS J G, 1990, Journal of Emergency Medicine, V8, P617, DOI 10.1016/0736-4679(90)90459-9; RODRIGUEZ A, 1990, MANAGEMENT CARDIOTHO, P261; SABBAH HN, 1988, CATHETER CARDIO DIAG, V15, P155, DOI 10.1002/ccd.1810150305; Sadow S H, 1983, Mo Med, V80, P567; Schlomka G, 1932, Z GES EXP MED, V81, P43; SMIRK FH, 1960, AM J CARDIOL, V6, P620, DOI 10.1016/0002-9149(60)90265-4; SYMBAS PN, 1991, CURRENT PROBLEMS CAR, P542; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641	16	22	22	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0172-0643			PEDIATR CARDIOL	Pediatr. Cardiol.	SEP-OCT	1998	19	5					436	438		10.1007/s002469900347			3	Cardiac & Cardiovascular Systems; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Pediatrics	110QF	WOS:000075391300014	9703576				2022-02-06	
J	Kumar, M; Kitchen, ND				Kumar, M; Kitchen, ND			Infective and traumatic aneurysms	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							INTERNAL CAROTID-ARTERY; INTRACRANIAL ANEURYSMS; CEREBRAL-ARTERIES; ENDOCARDITIS; MANAGEMENT; RESOLUTION; WOUNDS; BRAIN	Infectious and traumatic aneurysms are unusual neurological conditions which will rarely present themselves to an individual neurosurgeon. Both, however, require a high index of suspicion, prompt management, and well-defined protocols in order to achieve good outcomes. The prognosis of infectious intracranial aneurysms has improved with the advent of powerful antimicrobacterial chemotherapeutic agents. Prompt and aggressive drug treatment with serial neuroimaging monitoring has enabled the neurosurgeon to identify safely and accurately those patients who will require surgical intervention. Traumatic aneurysms should be considered in any penetrating head injury, especially stab wounds and low velocity missile injuries. Angiography in these instances is warranted and, as most of these aneurysms are false aneurysms, surgical excision or trapping procedures are usually required.	Univ London, Natl Hosp Neurol & Neurosurg, Dept Neurosurg, Inst Neurol, London WC1N 3BG, England		Kitchen, ND (corresponding author), Univ London, Natl Hosp Neurol & Neurosurg, Dept Neurosurg, Inst Neurol, Queen Sq, London WC1N 3BG, England.						AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BALDWINHZ, 1995, NEUROVASCULAR SURG, P777; BARROW DL, 1990, NEUROSURGERY, V27, P562, DOI 10.1227/00006123-199010000-00010; BOHMFALK GL, 1978, J NEUROSURG, V48, P369, DOI 10.3171/jns.1978.48.3.0369; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; CANTU RC, 1966, J NEUROSURG, V25, P189, DOI 10.3171/jns.1966.25.2.0189; Church W, 1869, T PATHOL SOC LOND, V20, P109; Clare C E, 1992, Neurosurg Clin N Am, V3, P551; CROWELL RM, 1995, SURG MANAGEMENT NEUR, P378; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Fearnsides EG, 1916, BRAIN, V39, P224, DOI 10.1093/brain/39.3-4.224; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER AS, 1987, J TRAUMA, V27, P330, DOI 10.1097/00005373-198703000-00021; FRAZEE JG, 1980, J NEUROSURG, V53, P633, DOI 10.3171/jns.1980.53.5.0633; FRIZZELL RT, 1993, NEUROSURGERY, V32, P852, DOI 10.1227/00006123-199305000-00023; HADDAD FS, 1991, NEUROSURGERY, V28, P1; ISHIKAWA M, 1974, SURG NEUROL, V2, P257; Karsner HT., 1947, ACUTE INFLAMMATION A, P16; KEICK CF, 1984, NEUROSURGERY, V60, P42; Kojima Y, 1989, Neurol Med Chir (Tokyo), V29, P202, DOI 10.2176/nmc.29.202; KRAULAND W, 1949, Schweiz Z Pathol Bakteriol, V12, P113; LEAVY LL, 1993, NEUROSURGERY, V32, P532; MAURER JJ, 1961, J NEUROSURG, V18, P837, DOI 10.3171/jns.1961.18.6.0837; MIELKE B, 1981, NEUROSURGERY, V9, P578, DOI 10.1227/00006123-198111000-00017; MOLINARI GF, 1973, NEUROLOGY, V23, P325, DOI 10.1212/WNL.23.4.325; MORAWETZ RB, 1984, NEUROSURGERY, V15, P43, DOI 10.1227/00006123-198407000-00009; NAKATA Y, 1968, ANGIOLOGY, V19, P593, DOI 10.1177/000331976801901003; Ojemann RG, 1995, SURG MANAGEMENT NEUR, P368; ONISHI H, 1989, SURG NEUROL, V31, P149, DOI 10.1016/0090-3019(89)90330-3; Osler W, 1885, LANCET, V1, P505; Osler W, 1885, LANCET, V1, P459; OSLER W, 1885, LANCET, V1, P459; POZZATI E, 1982, J NEUROSURG, V56, P857, DOI 10.3171/jns.1982.56.6.0857; ROUT D, 1984, J NEUROSURG, V60, P1236, DOI 10.3171/jns.1984.60.6.1236; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; SALDAGO AV, 1987, STROKE, V18, P1057; SMITH S, 1829, AM J MED SCI, V4, P237; STEINBERG GK, 1992, NEUROSURGERY, V30, P408, DOI 10.1227/00006123-199203000-00016; TUNKEL AR, 1993, NEUROL CLIN, V11, P419, DOI 10.1016/S0733-8619(18)30161-0; YAMAURA A, 1978, SURG NEUROL, V10, P327; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	43	22	22	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	JUL	1998	9	3					577	+					11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	100WB	WOS:000074837400014	9668189				2022-02-06	
J	Terreni, L; De Simoni, MG				Terreni, L; De Simoni, MG			Role of the brain in interleukin-6 modulation	NEUROIMMUNOMODULATION			English	Article						interleukin-6; opioids; sympathetic nervous system; Alzheimer disease; lipopolysaccharide; interleukin-1 beta	TUMOR-NECROSIS-FACTOR; MESSENGER-RNA EXPRESSION; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; GROWTH-FACTOR; INTRACEREBROVENTRICULAR INJECTION; NEUROTROPHIC FACTOR	High levels of interleukin 6 (IL-6) have been found in the brain tissue or cerebrospinal fluid (CSF) in several CNS disorders including Alzheimer's disease, AIDS dementia complex, multiple sclerois, stroke, Parkinson's disease, traumatic brain injuries, brain tumors and CNS infections. In these diseases, IL-6 is also found in blood showing that CNS conditions can elicit a peripheral immune response. A direct secretion of IL-6 from brain to blood has been shown to be a major mechanism by which the brain activates peripheral metabolic, endocrine and immune responses. However, this communication is not straightforward and other regulatory mechanisms are likely to be there. Several lines of evidence obtained in the laboratory have shown that the brain significantly modulates IL-6 production in the periphery. Evidence will be given that: (i) central inflammatory stimuli efficiently induce peripheral IL-6; (ii) central opioids are effective modulators of peripheral IL-6, and (iii) the sympathetic nervous system represents an inhibitory pathway to peripheral IL-6.	Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy		De Simoni, MG (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.		De Simoni, Maria Grazia/I-6021-2012	De Simoni, Maria Grazia/0000-0001-6695-5297			AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; BARTON BE, 1993, INFECT IMMUN, V61, P1490; BEAMER NB, 1995, ANN NEUROL, V37, P800, DOI 10.1002/ana.410370614; BELLINGER DL, 1992, INT J IMMUNOPHARMACO, V14, P329, DOI 10.1016/0192-0561(92)90162-E; Bertolucci M, 1997, AM J PHYSIOL-REG I, V273, pR956, DOI 10.1152/ajpregu.1997.273.3.R956; Bertolucci M, 1996, NEUROREPORT, V7, P1181, DOI 10.1097/00001756-199604260-00017; BIGLINO A, 1995, EUR J ENDOCRINOL, V133, P173, DOI 10.1530/eje.0.1330173; BOULTON TG, 1994, J BIOL CHEM, V269, P11648; BRETT FM, 1995, J NEUROPATH EXP NEUR, V54, P766, DOI 10.1097/00005072-199511000-00003; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; CARR DJJ, 1991, P SOC EXP BIOL MED, V198, P710; Chai Z, 1996, J EXP MED, V183, P311, DOI 10.1084/jem.183.1.311; Chen GJ, 1997, ENDOCRINOLOGY, V138, P4830, DOI 10.1210/en.138.11.4830; De Luigi A, 1998, NEUROSCIENCE, V83, P1245, DOI 10.1016/S0306-4522(97)00381-3; DEKLOET ER, 1994, PSYCHONEUROENDOCRINO, V19, P121, DOI 10.1016/0306-4530(94)90002-7; DESIMONI MG, 1995, ENDOCRINOLOGY, V136, P897, DOI 10.1210/en.136.3.897; DESIMONI MG, 1993, AM J PHYSIOL, V265, pR739, DOI 10.1152/ajpregu.1993.265.4.R739; DESIMONI MG, 1990, J EXP MED, V171, P1773, DOI 10.1084/jem.171.5.1773; DeSimoni MG, 1997, ENDOCRINOLOGY, V138, P5220, DOI 10.1210/en.138.12.5220; DESIMONI MG, 1992, PATHOPHYSIOLOGY PHAR, P143; DODD J, 1991, PRINCIPLES NEURAL SC, P761; FASSBENDER K, 1994, J NEUROL SCI, V122, P135, DOI 10.1016/0022-510X(94)90289-5; Fattori E, 1995, EUR J NEUROSCI, V7, P2441, DOI 10.1111/j.1460-9568.1995.tb01042.x; Fischer HG, 1997, EUR J IMMUNOL, V27, P1539, DOI 10.1002/eji.1830270633; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; FREIER DO, 1994, J PHARMACOL EXP THER, V270, P1127; Gadient RA, 1995, ANN NY ACAD SCI, V762, P403; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; GANGULI R, 1993, ANN MED, V25, P489, DOI 10.3109/07853899309147317; Goujon E, 1996, MOL BRAIN RES, V36, P53, DOI 10.1016/0169-328X(95)00242-K; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; HSUEH CM, 1992, BRAIN RES, V578, P142, DOI 10.1016/0006-8993(92)90241-Z; HUELL M, 1995, ACTA NEUROPATHOL, V89, P544; IMAMURA K, 1993, ACTA NEUROL SCAND, V87, P281, DOI 10.1111/j.1600-0404.1993.tb05508.x; JONES TH, 1993, CYTOKINE, V5, P531, DOI 10.1016/S1043-4666(05)80001-8; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Loser SV, 1996, N-S ARCH PHARMACOL, V354, P192; Luheshi G, 1996, INT ARCH ALLERGY IMM, V109, P301, DOI 10.1159/000237256; MADDEN KS, 1995, PHYSIOL REV, V75, P77, DOI 10.1152/physrev.1995.75.1.77; MAES M, 1993, PSYCHIAT RES, V49, P11, DOI 10.1016/0165-1781(93)90027-E; MAES M, 1995, EUR ARCH PSY CLIN N, V245, P172, DOI 10.1007/BF02193091; MAIMONE D, 1993, J NEUROIMMUNOL, V47, P55, DOI 10.1016/0165-5728(93)90284-6; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; MASOTTO C, 1992, BRAIN RES BULL, V28, P161, DOI 10.1016/0361-9230(92)90175-W; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MIGNAT C, 1995, LIFE SCI, V56, P793, DOI 10.1016/0024-3205(95)00010-4; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; NAKAFUKU M, 1992, J BIOL CHEM, V267, P19448; Navikas V, 1996, J NEUROIMMUNOL, V64, P63, DOI 10.1016/0165-5728(95)00155-7; Olsson T, 1994, Eur J Neurol, V1, P7, DOI 10.1111/j.1468-1331.1994.tb00045.x; PACIFICI R, 1995, EPILEPSIA, V36, P384, DOI 10.1111/j.1528-1157.1995.tb01013.x; PANERAI AE, 1995, J NEUROIMMUNOL, V58, P71, DOI 10.1016/0165-5728(94)00189-U; PETERSON PK, 1993, BIOCHEM PHARMACOL, V46, P343, DOI 10.1016/0006-2952(93)90508-T; RADULOVIC J, 1994, BRAIN RES, V661, P189, DOI 10.1016/0006-8993(94)91196-7; Romero LI, 1996, AM J PHYSIOL-REG I, V270, pR518, DOI 10.1152/ajpregu.1996.270.3.R518; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; SINGH VK, 1994, MOL NEUROBIOL, V9, P73, DOI 10.1007/BF02816106; Sterneck E, 1996, J NEUROCHEM, V67, P1365; SUNDAR SK, 1989, P NATL ACAD SCI USA, V86, P6398, DOI 10.1073/pnas.86.16.6398; TAIWO YO, 1989, BRAIN RES, V492, P397, DOI 10.1016/0006-8993(89)90928-1; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; Terrazzino S, 1997, LIFE SCI, V61, P695, DOI 10.1016/S0024-3205(97)00534-1; TILG H, 1994, BLOOD, V83, P113; Tilg H, 1997, IMMUNOL TODAY, V18, P428, DOI 10.1016/S0167-5699(97)01103-1; ULICH TR, 1991, AM J PATHOL, V138, P1097; Wagner JA, 1996, J EXP MED, V183, P2417, DOI 10.1084/jem.183.6.2417; WELLER M, 1991, J NEUROL SCI, V104, P215, DOI 10.1016/0022-510X(91)90313-V; WOODROOFE MN, 1993, CYTOKINE, V5, P583, DOI 10.1016/S1043-4666(05)80008-0	72	22	26	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401			NEUROIMMUNOMODULAT	Neuroimmunomodulation	MAY-AUG	1998	5	3-4					214	219		10.1159/000026339			6	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	118EV	WOS:000075826200012	9730688				2022-02-06	
J	Wrightson, P; Gronwall, D				Wrightson, P; Gronwall, D			Mild head injury in New Zealand: incidence of injury and persisting symptoms	NEW ZEALAND MEDICAL JOURNAL			English	Article							BRAIN INJURY	Aims. To define mild head injury and determine its incidence and that of persisting symptoms. Methods. Analysis of an eight week sample of all patients with head injury passing through the Emergency Departments of the four Auckland Hospitals, and of a five year sample of patients attending a clinic for management of symptoms persisting after head injury. Results. Mild head injury was defined by the acute management needed - care out of hospital or not more than 48 hours admission, corresponding reasonably with a definition using post-traumatic amnesia. Incidence in those seen at hospital was 437/10(5) whole population/year for ages 15 and over, and 252/10(5) for ages under 15. Age specific incidences were 1769/10(5)/year for 15 and over, and 2920/10(5) for ages under 15, the major causes being road accidents (RTA) and falls, respectively. For 100 cases seen at hospital approximately 60 were treated by general practitioners alone. Referrals in patients 15 years and over because of persisting symptoms occurred in 58 (95%, CI 3-7), 69% in the first four months and 6% after a year. Referrals were equally likely after RTA, sports injuries and assaults, more frequent after objects striking the head. Older people were marginally more likely to be referred and the probability was significantly greater in women injured in sport and in minor RTA not needing admission to hospital. Conclusions. Mild head injuries are economically important and deserve efficient management.	Auckland Hosp, Dept Neuroserv, Concuss Clin, Auckland, New Zealand		Wrightson, P (corresponding author), 18 Crocus Pl, Auckland 1005, New Zealand.						ALEXANDER MP, 1995, NEUROLOGY, V45, P253; *DEP HLTH NAT HLTH, 1984, HOSP SEL MORB DAT; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1989, MILD HEAD INJURY; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sosin DM, 1996, BRAIN INJURY, V10, P47	9	22	22	0	1	NEW ZEALAND MED ASSN	WELLINGTON	PO BOX 156, WELLINGTON, NEW ZEALAND	0028-8446			NEW ZEAL MED J	N. Z. Med. J.	MAR 27	1998	111	1062					99	101					9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZE579	WOS:000072808200004	9577461				2022-02-06	
J	Carlesimo, GA; Sabbadini, M; Bombardi, P; Di Porto, E; Loasses, A; Caltagirone, C				Carlesimo, GA; Sabbadini, M; Bombardi, P; Di Porto, E; Loasses, A; Caltagirone, C			Retrograde memory deficits in severe closed-head injury patients	CORTEX			English	Article						memory; head trauma; semantic system	HERPES-SIMPLEX ENCEPHALITIS; AUTOBIOGRAPHICAL MEMORY; SEMANTIC MEMORY; REMOTE MEMORY; MAGNETIC-RESONANCE; NONLIVING THINGS; VERBAL MEMORY; TERM-MEMORY; AMNESIA; IMPAIRMENT	A battery of tests evaluating different aspects of retrograde memory (autobiographical, public events, semantic knowledge) was administered to a group of 20 patients who had suffered from a severe closed-head injury (CHI) and who had recovered from the posttraumatic amnesia period and to a group of sex-, age- and education-matched normal controls. Results document a high prevalence of retrograde memory deficits among CHI individuals. The deficit involves both autobiographical and public events memories and extends to early acquired basic and cultural knowledge. The severity of the deficit does not vary according to some kind of temporal gradient or according to a presumed hierarchical or modality organization of the semantic system. However, in the domain of basic knowledge it more severely affects information pertaining to living than nonliving categories of objects. With the exception of a more severe deficit in retrieving autobiographical events occurred in the last year before trauma in a subgroup of patients with focal lesions restricted to the right hemisphere as compared to left lesioned patients, no clear relationship emerges between severity of the retrograde memory deficit and locus of focal cerebral lesions as demonstrated by neuroradiological exams.	IRCCS S Lucia, I-00179 Rome, Italy; Anni Verdi, Rome, Italy; Univ Rome Tor Vergata, Neurol Clin, Rome, Italy		Carlesimo, GA (corresponding author), IRCCS S Lucia, V Ardeatina 306, I-00179 Rome, Italy.		Caltagirone, Carlo/B-4930-2013				ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; Barbarotto R, 1996, ACTA NEUROL SCAND, V93, P272; BASSO A, 1988, J NEUROL NEUROSUR PS, V51, P1201, DOI 10.1136/jnnp.51.9.1201; BATTIG WF, 1969, J EXPT PSYCHOL MON 2, V80; BEATTY WW, 1988, NEUROBIOL AGING, V9, P181, DOI 10.1016/S0197-4580(88)80048-4; BORTOLINI V, 1971, LESSICO FREQUENZE LI; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Capitani Erminio, 1993, Archivio di Psicologia Neurologia e Psichiatria, V54, P457; Carlesimo GA, 1997, CORTEX, V33, P131, DOI 10.1016/S0010-9452(97)80009-3; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; COHEN NJ, 1981, NEUROPSYCHOLOGIA, V19, P337, DOI 10.1016/0028-3932(81)90064-6; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; COLLINS AM, 1970, COGNITION LEARNING M; Costa M, 1989, ARCH PSICOLOGIA NEUR, V50, P735; DAMASIO AR, 1985, ARCH NEUROL-CHICAGO, V42, P252, DOI 10.1001/archneur.1985.04060030070012; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DERENZI E, 1987, CORTEX, V23, P575, DOI 10.1016/S0010-9452(87)80050-3; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; FARAH MJ, 1989, NEUROPSYCHOLOGIA, V27, P193, DOI 10.1016/0028-3932(89)90171-1; Fink GR, 1996, J NEUROSCI, V16, P4275; FLETCHER PC, 1995, BRAIN, V118, P401, DOI 10.1093/brain/118.2.401; FUNNELL E, 1992, COGNITIVE NEUROPSYCH, V9, P135, DOI 10.1080/02643299208252056; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GROSSI D, 1988, CORTEX, V24, P457, DOI 10.1016/S0010-9452(88)80009-1; HILLIS AE, 1991, BRAIN, V114, P2081, DOI 10.1093/brain/114.5.2081; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; Kerlinger F.N., 1973, MULTIPLE REGRESSION; KOPELMAN MD, 1989, NEUROPSYCHOLOGIA, V27, P437, DOI 10.1016/0028-3932(89)90050-X; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Laiacona M., 1993, Archivio di Psicologia Neurologia e Psichiatria, V54, P209; LAIACONA M, 1993, CORTEX, V29, P727, DOI 10.1016/S0010-9452(13)80293-6; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; ROUSSEAUX M, 1984, CORTEX, V20, P575, DOI 10.1016/S0010-9452(84)80060-X; RUSSELL WR, 1971, TRAUMATIC AMNESIA; SAGAR HJ, 1988, BRAIN, V111, P525, DOI 10.1093/brain/111.3.525; SARTORI G, 1988, COGNITIVE NEUROPSYCH, V5, P105, DOI 10.1080/02643298808252928; Shallice T., 1987, COGNITIVE NEUROPSYCH; SILVERI MC, 1988, COGNITIVE NEUROPSYCH, V5, P677, DOI 10.1080/02643298808253278; SILVERI MC, 1991, NEUROLOGY, V41, P545, DOI 10.1212/WNL.41.4.545; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SQUIRE LR, 1978, NEUROPSYCHOLOGIA, V16, P313, DOI 10.1016/0028-3932(78)90025-8; SQUIRE LR, 1975, NEUROPSYCHOLOGIA, V13, P51, DOI 10.1016/0028-3932(75)90047-0; STEWART F, 1992, Q J EXP PSYCHOL-A, V44, P261, DOI 10.1080/02724989243000037; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; Tognoni G., 1987, ITALIAN J NEUROLOG S, V8, P44; TULVING E, 1996, CEREB CORTEX, V3, P79; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1987, BRAIN, V110, P1273, DOI 10.1093/brain/110.5.1273; Wilson JTL, 1989, NEUROPSYCHOLOGY, V3, P255, DOI 10.1037//0894-4105.3.4.255; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; WILSON RS, 1981, CORTEX, V17, P41, DOI 10.1016/S0010-9452(81)80005-6; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P1950	61	22	22	0	8	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	FEB	1998	34	1					1	23		10.1016/S0010-9452(08)70734-2			23	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	ZA672	WOS:000072389500001	9533991				2022-02-06	
J	Pike, BR; Hamm, RJ				Pike, BR; Hamm, RJ			Chronic administration of a partial muscarinic M-1 receptor agonist attenuates decreases in forebrain choline acetyltransferase immunoreactivity following experimental brain trauma	EXPERIMENTAL NEUROLOGY			English	Article							NERVE GROWTH-FACTOR; FACTOR MESSENGER-RNA; CLOSED-HEAD-INJURY; COGNITIVE IMPAIRMENT; NEUROTROPHIC FACTOR; BASAL FOREBRAIN; RAT HIPPOCAMPUS; AGED RATS; ACETYLCHOLINE; EXPRESSION	Lu 25-109-T is a partial muscarinic M-1 receptor agonist with antagonistic effects at presynaptic M-2 autoreceptors and has been shown to improve cognitive function following traumatic brain injury (TBI) in rats. This investigation examined the effects of TBI on basal forebrain choline acetyltransferase immunoreactivity (ChAT-IR) following daily administration of saline or 15 mu mol/kg Lu 25-109-T. Rats received a moderate (2.1 +/- 0.1 atm) level of central fluid percussion TBI or were surgically prepared but not injured and were injected (sc) with saline or drug on Days 1-15 postinjury. Rats were sacrificed following the last daily injection, and sections were collected through the basal forebrain and processed for ChAT-IR. TBI caused a significant reduction in ChAT-IR neuronal density in saline-and Lu 25-109-T-treated rats with a 13% and 5% decrease in the medial septal nucleus (MSN), a 48 and 23% decrease in the vertical limb nucleus of the diagonal band (VDB), and a 51 and 28% decrease in the nucleus basalis magnocellularis (NBM), respectively, However, Lu 25-109-T significantly attenuated the injury-induced reductions in ChAT-IR. Loss in ChAT-IR neuronal density is not thought to result from cell death as parallel cresyl violet-stained sections indicated no decrease in neuronal cell. density in the MSN, VDB, or NBM. These results support the hypothesis that increasing cholinergic tone during the recovery period after TBI will restore cholinergic function impaired by brain trauma. (C) 1997 Academic Press.			Pike, BR (corresponding author), VIRGINIA COMMONWEALTH UNIV, DEPT PSYCHOL, BOX 2018, RICHMOND, VA 23284 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587] Funding Source: Medline		ALBERCH J, 1991, J NEUROCHEM, V57, P1483, DOI 10.1111/j.1471-4159.1991.tb06342.x; AMENTA F, 1994, MECH AGEING DEV, V74, P47, DOI 10.1016/0047-6374(94)90097-3; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; CASTREN E, 1993, EXP NEUROL, V122, P244, DOI 10.1006/exnr.1993.1124; CHOU C-L, 1991, Society for Neuroscience Abstracts, V17, P722; DEKKER AJAM, 1991, NEUROSCI BIOBEHAV R, V15, P299, DOI 10.1016/S0149-7634(05)80008-9; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; DEWITT DS, 1988, ANESTHESIOLOGY REV, V15, P31; Dixon C. E., 1995, Society for Neuroscience Abstracts, V21, P762; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doods Henri N., 1995, Drugs of the Future, V20, P157; DRAVID AR, 1983, ARCH INT PHARMACOD T, V264, P195; GTAY R, 1983, NEUROCI BIOBEHAV REV, V7, P119; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1995, J NEUROTRAUM, V12, P307, DOI 10.1089/neu.1995.12.307; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HEFTI F, 1993, PROG BRAIN RES, V98, P257; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; LAPCHAK PA, 1993, NEUROSCIENCE, V52, P575, DOI 10.1016/0306-4522(93)90407-7; LINDEFORS N, 1992, EXP BRAIN RES, V88, P78, DOI 10.1007/BF02259130; Liu S. J., 1993, Society for Neuroscience Abstracts, V19, P1881; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MEIER E, 1995, LIFE SCI, V56, P1006, DOI 10.1016/0024-3205(95)93724-S; MEIER E, IN PRESS DRUG DEV RE; MESULAM MM, 1983, NEUROSCIENCE, V10, P1185, DOI 10.1016/0306-4522(83)90108-2; Moltzen Ejner K., 1995, Drugs of the Future, V20, P37; NUNZI MG, 1989, PHARMACOPSYCHIATRY, V22, P125, DOI 10.1055/s-2007-1014632; ODELL DM, 1995, J NEUROSURG, V83, P878, DOI 10.3171/jns.1995.83.5.0878; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; PIKE BR, 1997, PHARM BIOCH BEHAV, V57, P1; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; Sinson G., 1995, Society for Neuroscience Abstracts, V21, P2121; SOFRONIEW MV, 1987, BRAIN RES, V411, P310, DOI 10.1016/0006-8993(87)91084-5; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Wiley JL, 1996, BRAIN RES, V716, P47, DOI 10.1016/0006-8993(96)00045-5; WILLIAMS LR, 1991, NEUROBIOL AGING, V12, P39, DOI 10.1016/0197-4580(91)90037-K	42	22	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	1997	147	1					55	65		10.1006/exnr.1997.6582			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XV981	WOS:A1997XV98100007	9294403				2022-02-06	
J	Kordestani, RK; Counelis, GJ; McBride, DQ; Martin, NA				Kordestani, RK; Counelis, GJ; McBride, DQ; Martin, NA			Cerebral arterial spasm after penetrating craniocerebral gunshot wounds: Transcranial doppler and cerebral blood flow findings	NEUROSURGERY			English	Article						cerebral blood flow; head injury; penetrating craniocerebral gunshot wounds; transcranial doppler; traumatic subarachnoid hemorrhage; vasospasm	HEAD-INJURED PATIENTS; COMA DATA-BANK; SUBARACHNOID HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; ANGIOGRAPHIC FINDINGS; TIME COURSE; VASOSPASM; ULTRASOUND; METABOLISM; VELOCITY	OBJECTIVE: The goals of the study were to determine the incidence and time course of cerebral arterial spasm in patients with penetrating craniocerebral gunshot wounds, to study the relationship between vasospasm and subarachnoid hemorrhage (SAH) in these patients, and to evaluate the effects of vasospasm on outcome. METHODS: Thirty-three patients with craniocerebral gunshot wounds underwent computed tomography at admission and then underwent transcranial doppler ultrasonography (TCD). Velocities in the middle cerebral artery and the extracranial internal carotid artery were measured. Vasospasm was defined as a middle cerebral artery velocity greater than 120 cm per second and a hemispheric index (ratio of middle cerebral artery to internal carotid artery velocity) greater than 3. Intravenous xenon-133 cerebral blood flow (CBF) studies were performed for 10 patients. RESULTS: TCD was initiated, on average, 1.1 days after injury; 205 studies (mean, 6.3 studies/patient) were performed 0 to 33 days after injury. TCD showed vasospasm in 14 patients (42.4%). Xenon-133 studies performed within 24 hours of TCD measurements indicating spasm demonstrated normal or low CBF in three of five patients with spasm, ruling out hyperemia as the cause of elevated flow velocities in these three patients. Seven patients had unilateral vasospasm, and seven had bilateral spasm. Vasospasm was most prominent from Days 5 through 11. Vasospasm was distributed across all levels of injury severity, as defined by the Glasgow Coma Scale. Initial computed tomographic scans demonstrated SAH in all 14 patients with vasospasm but in only 9 of 19 without spasm (100 versus 47%, P < 0.0001, binomial distribution probability test). Outcomes for patients with vasospasm were slightly worse than for those without spasm (35.7 versus 47.4% good outcomes, respectively); however, this difference did not reach statistical significance (P = 0.12). CONCLUSION: These findings demonstrate that delayed cerebral arterial spasm is a frequent complication in patients with craniocerebral gunshot wounds and is strongly associated with SAH. The frequency, time course, and severity of spasm are comparable with those observed with aneurysmal SAH and traumatic SAH caused by closed head injury. This study offers new insights into the hemodynamic pathophysiology after gunshot wounds to the brain and suggests that increased vigilance for vasospasm may be of benefit.	UNIV CALIF LOS ANGELES,SCH MED,DIV NEUROSURG,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,CEREBRAL BLOOD FLOW LAB,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,HARBOR MED CTR,TORRANCE,CA 90509					Martin, Neil/0000-0002-6565-4131	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30308] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030308] Funding Source: NIH RePORTER		AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; AGNOLI A, 1969, CEREBRAL BLOOD FLOW, P31; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; BENZEL EC, 1991, NEUROSURGERY, V29, P67, DOI 10.1227/00006123-199107000-00011; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; FISCHER CM, 1980, NEUROSURGERY, V6, P1; Foulkes MA, 1991, J NEUROSURG S, V75, P8, DOI 10.3171/sup.1991.75.1s.00s8; HARDERS AG, 1987, J NEUROSURG, V66, P718, DOI 10.3171/jns.1987.66.5.0718; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; JINKINS JR, 1992, AM J ROENTGENOL, V159, P365, DOI 10.2214/ajr.159.2.1632358; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; KORDESTANI RK, 1995, NEUROSURG CLIN N AM, V6, P657; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Martin N A, 1994, Neurosurg Clin N Am, V5, P607; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; MCBRIDE DQ, 1994, 62 ANN M AM ASS NEUR; MCBRIDE DQ, 1993, 61 ANN M AM ASS NEUR; MILLER JD, 1994, CEREBROVAS BRAIN MET, V6, P31; MUIZELAAR JP, 1989, TXB HEAD INJURY, P221; Newell D W, 1994, Neurosurg Clin N Am, V5, P619; Newell D W, 1990, Neurosurg Clin N Am, V1, P319; Obrist W.D., 1996, NEUROTRAUMA, P471; OBRIST WD, 1990, CEREBROVAS BRAIN MET, V2, P283; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1967, CIRC RES, V20, P124, DOI 10.1161/01.RES.20.1.124; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; SEILER RW, 1986, J NEUROSURG, V64, P594, DOI 10.3171/jns.1986.64.4.0594; SEKHAR LN, 1988, NEUROSURGERY, V22, P813, DOI 10.1227/00006123-198805000-00002; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; SUWANWELA C, 1972, J NEUROSURG, V36, P314, DOI 10.3171/jns.1972.36.3.0314; TEASDALE G, 1974, LANCET, V2, P81; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; Wilkins R H, 1990, Neurosurg Clin N Am, V1, P329; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626	46	22	23	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	AUG	1997	41	2					351	359		10.1097/00006123-199708000-00003			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	XP006	WOS:A1997XP00600010	9257302				2022-02-06	
J	Childers, MK; Holland, D				Childers, MK; Holland, D			Psychomotor agitation following gabapentin use in brain injury	BRAIN INJURY			English	Article							REFLEX SYMPATHETIC DYSTROPHY	Gabapentin, an anticonvulsant structurally related to gamma-aminobutyric acid (GABA) was recently reported to be effective in pain associated with reflex sympathetic dystrophy (RSD) and in pain associated with neuropathy. Yet, to our knowledge, the use of gabapentin for neuropathic pain in the presence of cognitive impairment has not been reported. In this report, we describe two patients (one with a traumatic brain injury, one with a putative acquired brain injury) who presented to a neurorehabilitation unit complaining of pain that was diagnosed as neurologically mediated. Within one week of receiving a daily 900 mg dose of gabapentin, both patients complained of heightened anxiety and restlessness. Correspondingly, each reported a diminution of psychological symptoms within 48 hours of gabapentin cessation. These two cases suggest that gabapentin may cause agitation in cognitive impaired patients. Physicians treating brain-injured patients and prescribing gabapentin for neuropathic pain may wish to closely monitor patients for similar signs of restlessness or anxiety.	UNIV MISSOURI,DEPT PHYS MED & REHABIL,COLUMBIA,MO					Childers, Martin/0000-0003-4754-0883			Bartoszyk G. D., 1986, NEW ANTICONVULSANT D, P147; CHEVILLE A, 1995, AM PAIN SOC 14 ANN S; CHEVILLE AL, 1996, ARCH PHYSICAL MED RE, V77, P939; CHRISTENSEN JA, 1980, J TRAUMA, V20, P166, DOI 10.1097/00005373-198002000-00012; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; JANUS TJ, 1996, IN PRESS J BURN CARE; MELLICK GA, 1995, J PAIN SYMPTOM MANAG, V10, P265, DOI 10.1016/0885-3924(95)00001-F; MELLICK GA, 1995, AM J PAIN MANAGEMENT, V5, P7; MELLICK LB, 1995, AM J EMERG MED, V13, P96, DOI 10.1016/0735-6757(95)90263-5; PARKEDAVIS, 1996, UNPUB PACKAGE INSERT; REIMANN W, 1983, EUR J PHARMACOL, V94, P341, DOI 10.1016/0014-2999(83)90425-9; THURLOW RJ, 1993, EUR J PHARM-MOLEC PH, V247, P341, DOI 10.1016/0922-4106(93)90204-M; WELTY DF, 1993, EPILEPSY RES, V16, P175, DOI 10.1016/0920-1211(93)90078-L; [No title captured]; 1993, NEUROLOGY, V43, P2292	15	22	22	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1997	11	7					537	540		10.1080/713802187			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	XF661	WOS:A1997XF66100006	9210989				2022-02-06	
J	Crown, LA; Hawkins, W				Crown, LA; Hawkins, W			Commotio cordis: Clinical implications of blunt cardiac trauma	AMERICAN FAMILY PHYSICIAN			English	Article							IMPACT	Blunt cardiac trauma can result not only in major structural impairments but also in subtle derangements without an apparent organic defect. Cardiac dysrhythmias, including ventricular fibrillation and sudden cardiac arrest, can occur in both cardiac contusion and cardiac concussion (commotio cordis) and may be fatal. The true incidence of these nonstructural cardiac injuries is unknown. Continuous electrocardiographic monitoring, assessment of cardiac troponin I and transesophageal echocardiograms are important aids in the evaluation of cardiac contusion and concussion.	UNIV TENNESSEE,COLL MED,MEMPHIS,TN								Adams JE, 1996, AM HEART J, V131, P308, DOI 10.1016/S0002-8703(96)90359-2; Cooper A, 1995, Semin Pediatr Surg, V4, P109; Cooper G J, 1989, J R Army Med Corps, V135, P58; Cooper M E, 1995, J Tenn Med Assoc, V88, P351; Daleiden A, 1994, Crit Care Nurs Q, V17, P13; HALE HW, 1957, AM J SURG, V93, P558, DOI 10.1016/0002-9610(57)90510-X; KAPLAN JA, 1993, J TRAUMA, V34, P151, DOI 10.1097/00005373-199301000-00030; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Rosenthal Monica Ann, 1995, Emergency Medicine Clinics of North America, V13, P887; TENZER ML, 1985, J TRAUMA, V25, P620, DOI 10.1097/00005373-198507000-00008; VIANO DC, 1978, J TRAUMA, V18, P452, DOI 10.1097/00005373-197806000-00010; Weiss RL, 1996, CHEST, V109, P73, DOI 10.1378/chest.109.1.73	12	22	24	0	1	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	MAY 15	1997	55	7					2467	2470					4	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XA910	WOS:A1997XA91000010	9166145				2022-02-06	
J	Wilson, BA				Wilson, BA			Semantic memory impairments following non-progressive brain injury: A study of four cases	BRAIN INJURY			English	Article							ALZHEIMERS-DISEASE; VISUAL AGNOSIA; DEMENTIA; APHASIA; COMPREHENSION; KNOWLEDGE; RECOVERY; DEFICIT; ATROPHY	Four brain-injured subjects with semantic memory impairments are described. Two had sustained traumatic head injury and two had herpes simplex virus encephalitis. The study seeks to determine (a) whether subjects with non-progressive brain injury and impaired semantic memory perform similarly to patients with progressive disorders on a semantic memory battery and (b) whether the anatomical lesions of the present group of subjects are similar to those seen in patients with progressive disorders. Results suggests that scores on the semantic memory battery are broadly similar for patients with progressive and non-progressive disorders. Information from magnetic resonance imaging scans supports other findings that the crucial area involved in semantic memory lies in the left temporal neocortex.			Wilson, BA (corresponding author), ADDENBROOKES HOSP,MRC,APPL PSYCHOL UNIT,REHABIL RES GRP,HILLS RD,BOX 58,CAMBRIDGE CB2 2QQ,ENGLAND.						BASSO A, 1988, J NEUROL NEUROSUR PS, V51, P1201, DOI 10.1136/jnnp.51.9.1201; BAYLES KA, 1983, BRAIN LANG, V19, P98, DOI 10.1016/0093-934X(83)90057-3; BUB DN, 1988, COGN NEUROPSYCHOL, V5, P27, DOI 10.1080/02643298808252926; DAVIDOFF J, 1985, CORTEX, V21, P121, DOI 10.1016/S0010-9452(85)80020-4; Elliott C. D., 1983, BRIT ABILITY SCALES; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAFFAN D, 1993, J COGNITIVE NEUROSCI, V5, P118, DOI 10.1162/jocn.1993.5.1.118; HILLIS AE, 1991, BRAIN, V114, P2081, DOI 10.1093/brain/114.5.2081; Hodges J. R, 1995, HDB MEMORY DISORDERS, P167; HODGES JR, 1992, NEUROPSYCHOLOGIA, V30, P301, DOI 10.1016/0028-3932(92)90104-T; HODGES JR, 1992, BRAIN, V115, P1783, DOI 10.1093/brain/115.6.1783; LEITER RG, 1969, EXAMINERS MANUAL LEI; MARTIN A, 1983, BRAIN LANG, V19, P124, DOI 10.1016/0093-934X(83)90059-7; McKenna P., 1983, GRADED NAMING TEST; Nelson H. E, 1982, NATIONAL ADULT READI; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; PATTERSON K, 1992, NEUROPSYCHOLOGIA, V30, P1025, DOI 10.1016/0028-3932(92)90096-5; POECK K, 1988, BRAIN, V111, P151, DOI 10.1093/brain/111.1.151; SACCHETT C, 1992, COGNITIVE NEUROPSYCH, V9, P73, DOI 10.1080/02643299208252053; TYRRELL PJ, 1990, BRAIN, V113, P1321, DOI 10.1093/brain/113.5.1321; Warrington E. K., 1991, VISUAL OBJECT SPACE; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; WILSON BA, 1995, J CLIN EXP NEUROPSYC, V17, P668, DOI 10.1080/01688639508405157; WILSON BA, 1993, CORTEX, V29, P529, DOI 10.1016/S0010-9452(13)80258-4; WILSON BA, 1994, J CLIN EXP NEUROPSYC, V16, P354, DOI 10.1080/01688639408402646; WILSON BA, 1995, BROKEN MEMORIES CASE, P14	27	22	24	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1997	11	4					259	269		10.1080/026990597123566			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	WQ736	WOS:A1997WQ73600003	9134200				2022-02-06	
J	Carlesimo, GA; Sabbadini, M; Loasses, A; Caltagirone, C				Carlesimo, GA; Sabbadini, M; Loasses, A; Caltagirone, C			Forgetting from long-term memory in severe closed-head injury patients: Effect of retrieval conditions and semantic organization	CORTEX			English	Article							ALZHEIMER-TYPE DEMENTIA; KORSAKOFFS SYNDROME; ORGANIC AMNESIA; DAMAGE; RATES; DISEASE	This study was aimed at investigating long-term forgetting in chronic survivors of severe closed-head injury (CHI). For this purpose,performance decay passing from a 30-sec- to a 60-min-delay test in four memory procedures (Free Recall of unrelated stimuli, Free Recall of related stimuli. Cued Recall and y/n Recognition) of 20 CHI and 20 normal controls was analyzed. Comparable 30-sec-delay performances in CHI and control patients were obtained by manipulating exposure times;to study material during the learning phase. Results demonstrated accelerated forgetting in CHI patients in the Free Recall of the related list only. This finding was particularly evident in CHI patients suffering from a focal temporal lobe lesion. These data are discussed in light of retrieval and encoding deficits characterizing memory disorders in CHI patients.			Carlesimo, GA (corresponding author), IRCCS,V ARDEATINA 306,I-00179 ROME,ITALY.		Caltagirone, Carlo/B-4930-2013				ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; BROOKS D N, 1975, Cortex, V11, P329; BUTTERS N, 1988, CLIN NEUROPSYCHOL, V2, P133; CARLESIMO GA, 1992, NEUROPSYCHOL REV, V3, P119, DOI 10.1007/BF01108841; CARLESIMO GA, 1995, CORTEX, V31, P285, DOI 10.1016/S0010-9452(13)80363-2; CARLESIMO GA, 1993, INT J NEUROSCI, V73, P1, DOI 10.3109/00207459308987206; Carlesimo GA, 1995, CORTEX, V31, P735, DOI 10.1016/S0010-9452(13)80024-X; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; ESLINGER PJ, 1986, J NEUROSCI, V6, P3006; FREED DM, 1987, NEUROPSYCHOLOGIA, V25, P461, DOI 10.1016/0028-3932(87)90071-6; GERSHBERG FB, 1995, NEUROPSYCHOLOGIA, V33, P1305, DOI 10.1016/0028-3932(95)00103-A; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; HART RP, 1987, J CONSULT CLIN PSYCH, V55, P101, DOI 10.1037/0022-006X.55.1.101; HUPPERT FA, 1978, NATURE, V275, P317, DOI 10.1038/275317a0; HUPPERT FA, 1979, CORTEX, V15, P385, DOI 10.1016/S0010-9452(79)80065-9; JETTER W, 1986, CORTEX, V22, P229, DOI 10.1016/S0010-9452(86)80047-8; KOPELMAN MD, 1985, NEUROPSYCHOLOGIA, V23, P623, DOI 10.1016/0028-3932(85)90064-8; LARRABEE GJ, 1993, J CLIN EXP NEUROPSYC, V15, P701, DOI 10.1080/01688639308402590; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; MARTONE M, 1986, J CLIN EXP NEUROPSYC, V8, P161, DOI 10.1080/01688638608401309; MCKEE RD, 1992, J NEUROSCI, V12, P3765; MOSS MB, 1986, ARCH NEUROL-CHICAGO, V43, P239, DOI 10.1001/archneur.1986.00520030031008; RAVEN JC, 1949, PROGR MATRICES 1947; REID DB, 1993, J CLIN PSYCHOL, V49, P245, DOI 10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1; Rey A, 1968, REATTIVO FIGURA COMP; Schultz KA, 1986, DEV NEUROPSYCHOL, V2, P77, DOI 10.1080/87565648609540331; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tognoni G., 1987, ITALIAN J NEUROLOG S, V8, P44; VAKIL E, 1992, J CONSULTANT CLIN PS, V5, P802; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; [No title captured], DOI DOI 10.1037/1040-3590.3.1.19	34	22	22	0	2	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	MAR	1997	33	1					131	142		10.1016/S0010-9452(97)80009-3			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	WP883	WOS:A1997WP88300008	9088726				2022-02-06	
J	Lyeth, BG; Gong, QZ; Dhillon, HS; Prasad, MR				Lyeth, BG; Gong, QZ; Dhillon, HS; Prasad, MR			Effects of muscarinic receptor antagonism on the phosphatidylinositol bisphosphate signal transduction pathway after experimental brain injury	BRAIN RESEARCH			English	Article						traumatic brain injury; fluid percussion; phosphatidylinositol bisphosphate; diacylglycerol; free fatty acid; arachidonic acid; scopolamine; muscarinic; rat	INCREASED PROSTAGLANDIN SYNTHESIS; EXPERIMENTAL HEAD-INJURY; EXCITATORY AMINO-ACIDS; REGIONAL LEVELS; RAT; SCOPOLAMINE; LACTATE; METABOLISM; BEHAVIOR; FLUID	Hippocampal levels of fatty acids extracted from phosphatidylinositol 4,5-bisphosphate (PIP,), free fatty acids (FFA), and lactate were measured after central fluid percussion traumatic brain injury (TBI) in rats. At 5 min after injury, there was a decrease in fatty acids extracted from PIP2 suggesting a decrease in PIP2. At the same time point, total FFA increased in saline-treated TBI rats. Levels of arachidonic acid were significantly decreased in PIP2, while at the same time arachidonic and stearic acids increased in FFA in saline-treated TBI rats. No significant alterations in PIP2-derived fatty acids or FFA were observed at 20 min after TBI. Hippocampal concentrations of lactate were significantly elevated at 5 and 20 min after injury in saline-treated rats. In general, these alterations were blunted by preinjury administration of the muscarinic antagonist, scopolamine. These results suggest that the PIP2 signal transduction pathway is activated in the hippocampus at the onset of central fluid percussion TBI and that the enhanced phospholipase C-catalyzed phosphodiestric breakdown of PIP2 is a major mechanism of liberation of FFA in these sites immediately after such injury. The blunting of PIP2 and FFA alterations in animals treated with scopolamine suggests that activation of muscarinic receptors significantly contributes to the phospholipase C (PLC) signal transduction pathophysiology in TBI. The attenuation of lactate accumulation in scopolamine-treated rats suggests that TBI-induced muscarinic receptor activation also contributes to increased glycolytic metabolism and/or ionic imbalances.	UNIV KENTUCKY,CHANDLER MED CTR,DEPT SURG,DIV NEUROSURG,LEXINGTON,KY		Lyeth, BG (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,POB 980693,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 12587, NS 29995, NS 31816] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, P50NS012587, P01NS012587, R55NS031816, R01NS031816] Funding Source: NIH RePORTER		Delahunty TM, 1995, J NEUROTRAUM, V12, P1045, DOI 10.1089/neu.1995.12.1045; DELAHUNTY TM, 1995, NEUROCHEM RES, V20, P335; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DHILLON HS, 1995, BRAIN RES, V698, P100, DOI 10.1016/0006-8993(95)00840-M; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FRANDSEN A, 1993, J NEUROCHEM, V60, P1202, DOI 10.1111/j.1471-4159.1993.tb03278.x; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; JOYCE JN, 1989, J NEUROSCI, V9, P2776; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; KONTOS HA, 1985, CIRC RES, V57, P142, DOI 10.1161/01.RES.57.1.142; KUHR WG, 1988, J CEREBR BLOOD F MET, V8, P130, DOI 10.1038/jcbfm.1988.17; LAPETINA EG, 1987, METHOD ENZYMOL, V141, P176; LYETH BG, 1992, J NEUROTRAUM, V9, pS463; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; MCINTOSH TK, 1987, J NEUROCHEM, V49, P1530; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; PRASAD MR, 1994, J NEUROCHEM, V63, P773; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SEISJO BK, 1988, NEUROCHEM PATHOL, V9, P31; SHOHAMI E, 1987, J CEREBR BLOOD F MET, V7, P58, DOI 10.1038/jcbfm.1987.8; SOMJEN GG, 1984, BRAIN RES, V311, P186, DOI 10.1016/0006-8993(84)91416-1; TZIGARET C, 1993, J NEUROCHEM, V60, P827, DOI 10.1111/j.1471-4159.1993.tb03226.x; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; WEI EP, 1982, J NEUROSURG, V56, P695, DOI 10.3171/jns.1982.56.5.0695; YANG MS, 1985, J NEUROSURG, V63, P617, DOI 10.3171/jns.1985.63.4.0617	42	22	22	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	DEC 2	1996	742	1-2					63	70		10.1016/S0006-8993(96)01002-5			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WC372	WOS:A1996WC37200008	9117422				2022-02-06	
J	Cherney, LR; Halper, AS				Cherney, LR; Halper, AS			Swallowing problems in adults with traumatic brain injury	SEMINARS IN NEUROLOGY			English	Article							DYSPHAGIA				Cherney, LR (corresponding author), NORTHWESTERN UNIV,SCH MED,CHICAGO,IL 60614, USA.						ADAMOVICH BB, 1985, COGNITIVE REHABILITA; AVERYSMITH W, 1994, AM J OCCUP THER, V48, P235, DOI 10.5014/ajot.48.3.235; BROWN G E, 1992, Dysphagia, V7, P138, DOI 10.1007/BF02493445; CHERNEY LR, 1994, CLIN MANAGEMENT DYSP, P49; Cherney LR, 1989, J HEAD TRAUMA REHAB, V4, P42; *CTR FUNCT RES, 1990, GUID US UN DAT SET M; FIELD LH, 1989, BRAIN INJURY, V3, P9; Hagen C, 1981, TOP LANG DIS, V1, P73; Hagen C, 1979, REHABILITATION HEAD; HALPER AS, 1991, CLIN MANAGEMENT COMM, P19; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Lazarus CL, 1989, J HEAD TRAUMA REHAB, V4, P34; Levin HS., 1982, NEUROBEHAVIORAL CONS; LOGEMANN J A, 1990, Dysphagia, V4, P202, DOI 10.1007/BF02407266; LOGEMANN JA, 1995, J SPEECH HEAR RES, V38, P556, DOI 10.1044/jshr.3803.556; NEUMANN S, 1995, DYSPHAGIA, V10, P1, DOI 10.1007/BF00261272; Neumann Stefanie, 1993, Dysphagia, V8, P150, DOI 10.1007/BF02266996; SZEKERES SF, 1985, HEAD INJURY REHABILI, P219; Tippett DC, 1987, DYSPHAGIA, V1, P221; TURPIN R, 1996, 2 ANN MULT BRAIN INJ; WEINSTEIN CJ, 1983, PHYS THER, V12, P1992; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1; YUEN HK, 1992, AM J OCCUP THER, V46, P943, DOI 10.5014/ajot.46.10.943	23	22	25	0	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001	0271-8235			SEMIN NEUROL	Semin. Neurol.	DEC	1996	16	4					349	353		10.1055/s-2008-1040993			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WU475	WOS:A1996WU47500007	9112314				2022-02-06	
J	Etcoff, LM; Kampfer, KM				Etcoff, LM; Kampfer, KM			Practical guidelines in the use of symptom validity and other psychological tests to measure malingering and symptom exaggeration in traumatic brain injury cases	NEUROPSYCHOLOGY REVIEW			English	Article						malingering; symptom validity; neuropsychological; forensic	SIMULATED MEMORY IMPAIRMENT; FORCED-CHOICE METHOD; REY 15-ITEM TEST; FAKE BAD SCALE; HEAD-INJURY; BASE RATES; MMPI-2; PERFORMANCE; DEFICITS; TASK	The detection of malingering or symptom exaggeration has become an essential component in forensic neuropsychological evaluations, particularly in cases involving-personal injury claims. Symptom Validity Tests refer to those measures that can be utilized to detect test performance that is so poor that it is below the level of probability, oftentimes even among brain-damaged populations. This article outlines legal standards for expert testimony in regard to forensic neuropsychological personal injury evaluations. The article provides an outline of specific Symptom Validity Tests and Indicators, and reviews literature supporting test sensitivity and validity. In addition the use of symptom checklists and questionnaires is discussed, as well as the appropriate use of Symptom Validity Tests and Indicators to establish the presence or absence of malingering or symptom exaggeration.									*AM AC NEUR, 1989, ETH PRINC PSYCH COD, V39, P1100; ARNETT PA, 1995, CLIN NEUROPSYCHOL, V9, P17, DOI 10.1080/13854049508402052; BAER RA, 1992, CLIN PSYCHOL REV, V12, P509, DOI 10.1016/0272-7358(92)90069-K; BAGBY RM, 1995, PSYCHOL ASSESSMENT, V7, P84; BAGBY RM, 1994, J PERS ASSESS, V62, P191, DOI 10.1207/s15327752jpa6202_2; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1993, ARCH CLIN NEUROPSYCH, V8, P539, DOI 10.1016/0887-6177(93)90054-5; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; BERRY DTR, 1991, PSYCHOL ASSESSMENT J, V3, P418, DOI DOI 10.1037/1040-3590.3.3.418; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; BINDER LM, 1992, PORTLAND DIGIT RECOG; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BINDER LM, 1993, CLIN NEUROPSYCHOL, V7, P104, DOI DOI 10.1080/13854049308401892; Bolter J. F., 1985, ANN M NAT AC NEUR PH; BROWN S, 1994, AM PSYCH ASS DSM 4 S, V1, P319; Butcher J. N., 1993, MINNESOTA MULTIPHASI; Butcher JN, 1995, PSYCHOL ASSESSMENT, V7, P320, DOI 10.1037/1040-3590.7.3.320; CENTOFANTI C, 1979, SINGLE DOUBLE SIMULT; Cope D., 1993, J HEAD TRAUMA REHAB, V8, P1; Delis DC, 1987, CALIFORNIA VERBAL LE; DOERR HO, 1991, FORENSIC NEUROPSYCHO; DUNN JT, 1993, 13 ANN C NAT AC NEUR; EPSTEIN CM, 1994, NEUROLOGY, V44, P1566, DOI 10.1212/WNL.44.9.1566; FAUST D, 1991, Neuropsychology Review, V2, P205, DOI 10.1007/BF01109045; FAUST D, 1993, ETHICS BEHAV, V3, P359; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; GOLDBERG JO, 1986, J CLIN PSYCHOL, V42, P792, DOI 10.1002/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8; GOLDING SL, 1991, LAW HUMAN BEHAV, V15, P655; GRAHAM JR, 1993, MMPI 2 ASSESSING PER; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; GUILMETTE TJ, 1994, CLIN NEUROPSYCHOL, V8, P283, DOI 10.1080/13854049408404135; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Halstead W.C., 1947, BRAIN INTELLIGENCE; HAYS JR, 1993, PERCEPT MOTOR SKILL, V76, P1331, DOI 10.2466/pms.1993.76.3c.1331; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1995, PSYCHOL ASSESSMENT, V7, P118, DOI 10.1037/1040-3590.7.1.118; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kerlinger F.N., 1973, MULTIPLE REGRESSION; Lamb D.G., 1994, PSYCHOL ASSESSMENT, V6, P8, DOI [https://doi.org/10.1037/1040-3590.6.1.8, DOI 10.1037/1040-3590.6.1.8]; Lee G. P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI DOI 10.1037/1040-3590.4.1.43; Lees-Haley P. R., 1992, FORENSIC REPORTS, V5, P385; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LeesHaley PR, 1996, ARCH CLIN NEUROPSYCH, V11, P45, DOI 10.1016/0887-6177(95)00011-9; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; LEESHALEY PR, 1989, PSYCHOL REP, V65, P1203, DOI 10.2466/pr0.1989.65.3f.1203; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; McCaffrey R. J., 1993, J HEAD TRAUMA REHAB, V8, P38; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MILLIS SR, 1995, CLIN NEUROPSYCHOL, V9, P241, DOI 10.1080/13854049508400486; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; MITTENBERG W, 1993, PSYCHOL ASSESSMENT, V5, P34, DOI DOI 10.1037/1040-3590.5.1.34; Newman R, 1991, Neuropsychol Rev, V2, P241, DOI 10.1007/BF01109047; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; NUWER MR, 1994, NEUROLOGY, V44, P1998, DOI 10.1212/WNL.44.11.1998; OGLOFF JRP, 1990, BEHAV SCI LAW, V8, P27; PANKRATZ L, 1979, J CONSULT CLIN PSYCH, V47, P409, DOI 10.1037/0022-006X.47.2.409; Pankratz L., 1988, CLIN ASSESSMENT MALI, P169; PRIGATANO GP, 1993, J CLIN EXP NEUROPSYC, V15, P537, DOI 10.1080/01688639308402577; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN RM, 1955, J COMP PHYSIOL PSYCH, V48, P474, DOI 10.1037/h0048581; REITAN RM, 1988, TRAUMATIC BRAIN INJU; Rey A., 1964, EXAMEN CLIN PSYCHOL; ROGERS R, 1988, CLIN ASSESSMENT MALI, P19; SBORDONNE RJ, 1991, NEUROPSYCHOLOGY ATTO; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; SHAPIRO DL, 1991, FORENSIC PSYCHOL ASS; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler D, 1987, MEMORY SCALE REVISED; WETTER MW, 1992, PSYCHOL ASSESSMENT, V4, P369, DOI DOI 10.1037/1040-3590.4.3.369; WETTER MW, 1993, PSYCHOL ASSESSMENT, V5, P317, DOI DOI 10.1037/1040-3590.5.3.317; WIGGINS EC, 1988, LAW HUMAN BEHAV, V12, P57, DOI 10.1007/BF01064274; YOUNGJOHN JR, 1995, CLIN NEUROPSYCHOL, V9, P112, DOI 10.1080/13854049508401593	88	22	23	1	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1040-7308	1573-6660		NEUROPSYCHOL REV	Neuropsychol. Rev.	DEC	1996	6	4					171	201		10.1007/BF01874896			31	Psychology, Clinical; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WZ229	WOS:A1996WZ22900001	9159771				2022-02-06	
J	Conoley, JC; Sheridan, SM				Conoley, JC; Sheridan, SM			Pediatric traumatic brain injury: Challenges and interventions for families	JOURNAL OF LEARNING DISABILITIES			English	Article							CLOSED HEAD-INJURY; DISABLED-CHILDREN; CHRONICALLY ILL; CHRONIC ILLNESS; RELATIVES VIEW; SIBLINGS; PREDICTORS; ADOLESCENTS; ADJUSTMENT; DAMAGE	Experiencing a brain injury is a traumatic event not only for the child who is directly affected, but also for his or her family system. Recently, attention has turned toward the potentially deleterious effects of having a child with a traumatic brain injury (TBI) on parents, siblings, and extended family members. Specifically, families of TBI survivors may suffer major psychological, financial, role, and relationship risks. Therefore, treating the child with a brain injury is only one component of a comprehensive recovery program. This article describes common experiences of families following a child's brain injury, and specific strategies that might help families through the recovery/reentry process.	UNIV UTAH, DEPT EDUC PSYCHOL, SALT LAKE CITY, UT 84112 USA								ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BARRY P, 1989, REHABIL PSYCHOL, V34, P83; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Bigler E D, 1989, Brain Inj, V3, P73, DOI 10.3109/02699058909008077; BLACK P, 1969, LATE EFFECTS HEAD IN, P187; BOND MR, 1983, REHABILITATION HEAD, P209; Bragg RM, 1992, J HEAD TRAUMA REHAB, V7, P94; BRESLAU N, 1983, J ABNORM CHILD PSYCH, V11, P379, DOI 10.1007/BF00914246; BRESLAU N, 1982, J ABNORM CHILD PSYCH, V10, P85, DOI 10.1007/BF00915953; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS DN, 1991, BRAIN INJURY, V1, P5; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; CHADWICK O, 1985, DEV MED CHILD NEUROL, V27, P72; CHINITZ SP, 1981, CHILDREN TODAY, V15, P21; DEPOMPEI R, 1989, TOP LANG DISORD, V9, P78, DOI 10.1097/00011363-198903000-00008; DYSON L, 1989, AM J MENT RETARD, V94, P292; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; FERRARI M, 1984, J CHILD PSYCHOL PSYC, V25, P459, DOI 10.1111/j.1469-7610.1984.tb00164.x; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FRANKOWSKI RF, 1985, INJURED CHILD, P20; GARDNER RA, 1973, FAMILY BOOK MINIMAL; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HARVEY DHP, 1984, J CHILD PSYCHOL PSYC, V25, P273, DOI 10.1111/j.1469-7610.1984.tb00149.x; Jackson A, 1991, COUNS PSYCHOL, V4, P355; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kratochwill T. R., 1990, BEHAV CONSULTATION A; Kreutzer J, 1988, J HEAD TRAUMA REHAB, V3, P51, DOI DOI 10.1097/00001199-198812000-00008; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; LAVIGNE JV, 1979, PEDIATRICS, V63, P616; LEAF LE, 1993, BRAIN INJURY, V7, P543, DOI 10.3109/02699059309008182; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1988, J HEAD TRAUMA REHAB, V2, P6; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P527; MARTIN DA, 1988, J LEARN DISABIL, V21, P464, DOI 10.1177/002221948802100803; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCGUIRE TL, 1986, J HEAD TRAUMA REHAB, V1, P1; MILLER L, 1993, AM J FAM THER, V21, P111, DOI 10.1080/01926189308250910; *NAT HEAD INJ FDN, 1985, ED MAN WHAT ED NEED; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; Panting A, 1972, REHABILITATION, V38, P33; PARKE RD, 1986, FAMILIES HANDICAPPED, P101; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; ROSENTHAL M, 1983, REHABILITATION HEAD, P407; Sheridan S.M., 1996, CONJOINT BEHAV CONSU; SHERIDAN SM, 1992, J SCHOOL PSYCHOL, V30, P117, DOI 10.1016/0022-4405(92)90025-Z; SIMEONSSON RJ, 1986, FAMILIES HANDICAPPED, P67; SLATER EJ, 1987, PSYCHIAT ANN, V17, P786, DOI 10.3928/0048-5713-19871201-08; Taylor S C, 1980, Matern Child Nurs J, V9, P109; Testani-Dufour L, 1992, J Neurosci Nurs, V24, P317; WAALAND PK, 1990, COMMUNITY INTEGRATIO, P224; ZARSKI J, 1988, J HEAD TRAUMA REHAB, V3, P31; ZARSKI JJ, 1987, AM J FAM THER, V15, P62	65	22	22	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-2194	1538-4780		J LEARN DISABIL-US	J. Learn. Disabil.	NOV	1996	29	6					662	669		10.1177/002221949602900610			8	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	VU234	WOS:A1996VU23400010	8942310				2022-02-06	
J	Fenton, GW				Fenton, GW			The postconcussional syndrome reappraised	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article; Proceedings Paper	Annual Spring Review Course and Meeting of the American-Medical-EEG-Association	FEB   24, 1996	CHARLESTON, SC	Amer Med EEG Assoc		brainstem auditory evoked potential; electroencephalography; head injury, minor; postconcussional syndrome; quantitative EEG	MINOR HEAD-INJURY; CONCUSSION; SEQUELAE				Fenton, GW (corresponding author), UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT PSYCHIAT,DUNDEE DD1 9SY,SCOTLAND.						Barth JT, 1996, CLIN ELECTROENCEPHAL, V27, P183; Brown G. W., 1978, SOCIAL ORIGINS DEPRE; CHIAPPA KH, 1990, EVOKED POTENTIALS CL; COOPER R, 1965, ELECTROEN CLIN NEURO, V18, P217, DOI 10.1016/0013-4694(65)90088-X; Dow RS, 1944, AM J PSYCHIAT, V101, P174, DOI 10.1176/ajp.101.2.174; DRAKE ME, 1996, AM MED EEG ASS M CHA; DUFFY FH, 1996, CLIN ELECTROENCEPHAL, V27, P104; Duncan-Jones P., 1981, NEUROSIS SOCIAL ENV; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; JOHNSON LC, 1975, BEHAVIOR BRAIN ELECT, P1; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; Levin H.S., 1989, MILD HEAD INJURY; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, P275; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; RIZZO PA, 1983, NEUROPSYCHOBIOLOGY, V9, P78, DOI 10.1159/000117941; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; RUTHERFORD WH, 1977, LANCET, V1, P1; Schoenhuber R, 1983, J Neurosurg Sci, V27, P157; SCHOENHUBER R, 1989, MILD HEAD INJURY, P142; Strauss I, 1934, ARCH NEURO PSYCHIATR, V31, P893, DOI 10.1001/archneurpsyc.1934.02250050011001; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Trimble M.R., 1981, POSTTRAUMATIC NEUROS; WATSON MR, 1995, BRIT J PSYCHIAT, V167, P514, DOI 10.1192/bjp.167.4.514	27	22	23	0	2	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	OCT	1996	27	4					174	182					9	Engineering, Biomedical; Clinical Neurology	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	XA211	WOS:A1996XA21100002	9465280				2022-02-06	
J	Soblosky, JS; Tabor, SL; Matthews, MA; Davidson, JF; Chorney, DA; Carey, ME				Soblosky, JS; Tabor, SL; Matthews, MA; Davidson, JF; Chorney, DA; Carey, ME			Reference memory and allocentric spatial localization deficits after unilateral cortical brain injury in the rat	BEHAVIOURAL BRAIN RESEARCH			English	Article						memory; spatial localization; reference memory; allocentric; parietal cortex; sensorimotor cortex; traumatic brain injury; rat	DORSOMEDIAL PREFRONTAL CORTEX; MEDIAL AGRANULAR CORTEX; PARIETAL CORTEX; HIPPOCAMPAL FUNCTION; POSTERIOR PARIETAL; BILATERAL LESIONS; CAUDATE-NUCLEUS; NEGLECT; ORGANIZATION; DISSOCIATION	Traumatic brain injury (TBI) produces learning and memory impairments in humans. This study investigated the effects of TBI on memory and spatial localization strategies in rats. Prior to TBI, separate groups of rats were trained in an 8-arm radial maze with either all 8 arms baited (Expt. 1) or only 4 of the 8 arms baited (Expt. 2). TBI was produced by a controlled pneumatic impactor striking the entire right sensorimotor cortex of the anesthetized rat. Rats used in Expt. 1 were selected because they did not use a stereotypic response strategy (going to adjacent arms) in performing the maze before injury. After TBI the rats were not different from control rats in the number of working memory (WM) errors made. They did, however, display a distinct propensity to go to adjacent arms, i.e., exhibit stereotypic behavior, with a right-handed (ipsiversive) bias (P<0.005). After TBI, rats which were trained with only 4 of 8 arms baited committed more reference memory (RM) errors than control rats (P<0.05). They did not differ from controls on WM errors. Injured rats took longer to re-attain criteria than controls (P<0.0001). Injured rats also initially displayed a propensity to enter the adjacent arm sequentially before re-attaining criteria. Further analysis indicated that injured rats re-learned the maze with a right-hand bias (P<0.0001). The results of both experiments suggest that after TBI, rats shifted from an allocentric to an egocentric strategy to re-learn the maze. It was suggested that damage to the parietal cortex may have been responsible for both RM errors and the shift away from an allocentric strategy to an egocentric strategy. Possibly, the ipsiversive (right-hand) bias may be the result of a behaviorally or injury-induced neurochemical asymmetry within the motor system.	LOUISIANA STATE UNIV,MED CTR,DEPT ANAT,NEW ORLEANS,LA 70112		Soblosky, JS (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT NEUROSURG,NEUROTRAUMA RES LAB,1542 TULANE AVE,NEW ORLEANS,LA 70112, USA.			Lane, Diane/0000-0001-7313-557X			BENTON AL, 1969, HDB CLIN NEUROLOGY, P212; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; BUTTERS N, 1972, PERCEPT MOTOR SKILL, V34, P27, DOI 10.2466/pms.1972.34.1.27; COOK D, 1988, BEHAV NEURAL BIOL, V49, P332, DOI 10.1016/S0163-1047(88)90338-X; CORWIN JV, 1986, EXP NEUROL, V94, P683, DOI 10.1016/0014-4886(86)90247-5; CORWIN JV, 1994, BEHAV BRAIN RES, V61, P49; CROWNE DP, 1992, BEHAV NEUROSCI, V106, P808, DOI 10.1037/0735-7044.106.5.808; CROWNE DP, 1986, BEHAV BRAIN RES, V22, P227, DOI 10.1016/0166-4328(86)90067-7; DALE RHI, 1986, BEHAV BRAIN RES, V19, P17, DOI 10.1016/0166-4328(86)90043-4; DERENZI E, 1977, J NEUROL NEUROSUR PS, V40, P498, DOI 10.1136/jnnp.40.5.498; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FOREMAN N, 1992, BEHAV NEUROSCI, V106, P529, DOI 10.1037/0735-7044.106.3.529; GLICK SD, 1973, BRIT J PHARMACOL, V4, P316; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HARRELL LE, 1987, BEHAV NEUROSCI, V101, P644, DOI 10.1037/0735-7044.101.5.644; JANIS LS, 1994, BEHAV NEUROSCI, V5, P892; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; JARRARD LE, 1986, HIPPOCAMPUS, V4, P93; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; KESNER RP, 1989, BEHAV NEUROSCI, V103, P956, DOI 10.1037/0735-7044.103.5.956; KESNER RP, 1987, BEHAV NEURAL BIOL, V47, P40, DOI 10.1016/S0163-1047(87)90145-2; KING V, 1990, BEHAV BRAIN RES, V37, P169, DOI 10.1016/0166-4328(90)90092-S; KING VR, 1992, BEHAV BRAIN RES, V50, P53; KING VR, 1993, BEHAV BRAIN RES, V54, P117, DOI 10.1016/0166-4328(93)90070-7; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; LANKE J, 1993, BRAIN RES, V605, P221, DOI 10.1016/0006-8993(93)91744-D; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; PELLEGRINO I, 1979, STEREOTAXIC ATLAS RA; POHL W, 1973, J COMP PHYSIOL PSYCH, V82, P227, DOI 10.1037/h0033922; PYCOCK CJ, 1980, NEUROSCIENCE, V5, P461, DOI 10.1016/0306-4522(80)90048-2; SEMMES J, 1963, BRAIN, V86, P747, DOI 10.1093/brain/86.4.747; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SOBLOSKY JS, IN PRESS BEHAV BRAIN; SWITZER RC, 1991, NEUROSCI BIOBEHAV R, V15, P89, DOI 10.1016/S0149-7634(05)80097-1; VARGO JM, 1988, EXP NEUROL, V102, P199, DOI 10.1016/0014-4886(88)90094-5; YAMAMOTO BK, 1982, LIFE SCI, V30, P2155, DOI 10.1016/0024-3205(82)90289-2; YAMAMOTO BK, 1983, LIFE SCI, V34, P675; ZIMMERBERG B, 1975, BRAIN RES, V86, P335, DOI 10.1016/0006-8993(75)90707-6; ZIMMERBERG B, 1974, SCIENCE, V185, P623, DOI 10.1126/science.185.4151.623; [No title captured]	50	22	22	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	OCT	1996	80	1-2					185	194		10.1016/0166-4328(96)00034-4			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	VM959	WOS:A1996VM95900020	8905142				2022-02-06	
J	Lee, MS; Lee, SB; Kim, WC				Lee, MS; Lee, SB; Kim, WC			Spasmodic dysphonia associated with a left ventrolateral putaminal lesion	NEUROLOGY			English	Article							DYSTONIA	A 34-year-old man presented with a 30-year history of spasmodic dysphonia. He developed a speech disturbance 1 month after a closed head injury due to a fall. Sighing, coughing, and crying were normal. He had a tremor of the right hand when he drew a vertical line. His out-stretched right hand had a minimal dystonic posture with occasional jerks of the fingers. T-1-weighted axial brain MRI study showed a low signal intensity lesion at the putamen; coronal and axial T-2-weighted MRI brain scans showed a high and low signal intensity lesion confined to the middle part of the ventrolateral putamen. Damage to the ventrolateral putamen may have caused abnormal voluntary control of the laryngeal muscles.			Lee, MS (corresponding author), YONSEI UNIV,COLL MED,YOUNGDONG SEVERANCE HOSP,DEPT NEUROL,146-92 DOGOK DONG,SEOUL 120749,SOUTH KOREA.			Lee, Myung Sik/0000-0002-8413-1854			BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BLITZER A, 1988, LARYNGOSCOPE, V98, P636; ISSAC K, 1989, NEUROLOGY, V39, P1642; JANCOVIC J, 1986, ARCH NEUROL-CHICAGO, V43, P866; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; LEE MS, 1994, MOV DISORD, V9, P494; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; Obeso J A, 1988, Adv Neurol, V50, P113; SCHAEFER S, 1985, ANN OTO RHINOL LARYN, V94, P595, DOI 10.1177/000348948509400615; SCHAEFER SD, 1983, LARYNGOSCOPE, V93, P1183	10	22	22	0	3	LITTLE BROWN CO	BOSTON	34 BEACON STREET, BOSTON, MA 02108-1493	0028-3878			NEUROLOGY	Neurology	SEP	1996	47	3					827	828		10.1212/WNL.47.3.827			2	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VG596	WOS:A1996VG59600038	8797490				2022-02-06	
J	Jackowski, MM; Sturr, JF; Taub, HA; Turk, MA				Jackowski, MM; Sturr, JF; Taub, HA; Turk, MA			Photophobia in patients with traumatic brain injury: Uses of light-filtering lenses to enhance contrast sensitivity and reading rate	NEUROREHABILITATION			English	Article						traumatic brain injury; reading rate; contrast sensitivity; light-filtering lenses	VISUAL PERCEPTUAL DYSFUNCTION; HIERARCHICAL MODEL; HEAD-INJURY; SOUND	Patients who have sustained traumatic brain injury (TBI) often experience a new, intense and chronic photophobia. Photophobia, an intolerance to light, is an incompletely understood, subjective symptom, which has bren divided into ocular and central types. Various commercial sources of light-filtering lenses have been developed, which have proven to be successful in diminishing visual symptoms expressed by patients who are photophobic. However, despite the many subjective reports of improved visual performance and comfort with use of these filters, there has been little documentation of actual enhanced visual sensitivity/efficiency. Letter contrast sensitivity (CS) and reading rate were measured in patients with TBI, who, despite good ocular health, experienced significant light intolerance. These patients exhibited up to two fold increases (0.3 log units) in binocular letter contrast sensitivity, as measured with the Pelli-Robson Letter CS Chart, in the presence of selected Coming Photochromic Filters (CPF), as compared to performance in the absence of CPF filters, or to that of similarly treated normal observers. These same patients demonstrated reading rates enhanced up to 39% above that measured in the presence of nearpoint optical correction alone, Reading performance of normal observers was unaffected by similar light filtration. These data provide objective evidence for improvement of visual function provided by light-filtering lenses in patients who become photophobic after TBI. Contrast sensitivity testing and assessment of reading rate add objective criteria for the clinical selection of light-filtering lenses in the treatment of TBI-induced photophobia.	SYRACUSE UNIV,DEPT PSYCHOL,SYRACUSE,NY 13244; CENT NEW YORK RES CORP,NEW YORK,NY; VET ADM MED CTR,PSYCHOL SERV,SYRACUSE,NY 13210; SUNY HLTH SCI CTR,DEPT PHYS MED & REHABIL,SYRACUSE,NY 13210		Jackowski, MM (corresponding author), SUNY HLTH SCI CTR,DEPT OPHTHALMOL,550 HARRISON CTR,SYRACUSE,NY 13202, USA.						BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; DOHN AH, 1991, INVEST OPHTH VIS SCI, V32, P815; HUBER A, 1976, EYE SIGNS BRAIN TUMO; Lebensohn JE, 1934, ARCH OPHTHALMOL-CHIC, V12, P380; LEGGE GE, 1986, CONTRAST POLARITY LO; LIDVALL HE, 1974, ACTA NEUROL SCAND  S, V50, P56; Padula W. V., 1988, BEHAV VISION APPROAC; PADULA WV, 1988, N ENGL J OPTOM   DEC, P16; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; WARREN M, 1993, AM J OCCUP THER, V47, P42, DOI 10.5014/ajot.47.1.42; WARREN M, 1993, AM J OCCUP THER, V47, P55, DOI 10.5014/ajot.47.1.55; WILKINS AJ, 1994, OPHTHAL PHYSL OPT, V14, P365, DOI 10.1111/j.1475-1313.1994.tb00126.x	12	22	22	0	11	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JUN	1996	6	3					193	201		10.1016/1053-8135(96)00165-5			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UK480	WOS:A1996UK48000005	24525771				2022-02-06	
J	Zwaagstra, R; Schmidt, I; Vanier, M				Zwaagstra, R; Schmidt, I; Vanier, M			Recovery of speed of information processing in closed-head-injury patients	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							REACTION-TIME; MODELS	After severe traumatic brain injury, patients almost invariably demonstrate a slowing of reaction time, reflecting a slowing of central information processing. Methodological problems associated with the traditional method for the analysis of longitudinal data (MANOVA) severely complicate studies on cognitive recovery. It is argued that multilevel models are often better suited for the analysis of improvement over time in clinical settings. Multilevel models take into account individual differences in both overall performance level and recovery. These models enable individual predictions for the recovery of speed of information processing. Recovery is modelled in a group of closed-head-injury patients (N = 24). Recovery was predicted by age and severity of injury, as indicated by coma duration. Over a period up to 44 months post trauma, reaction times were found to decrease faster for patients with longer coma duration.	UNIV GRONINGEN,DEPT NEUROPSYCHOL & GERONTOL,GRONINGEN,NETHERLANDS; INST READAPTAT,CTR RECH,MONTREAL,PQ,CANADA		Zwaagstra, R (corresponding author), UNIV GRONINGEN,DEPT STAT & MEASUREMENT THEORY,GROTE KRUISSTR 2-1,NL-9712 TS GRONINGEN,NETHERLANDS.						Bryk, 1992, HIERARCHICAL LINEAR; BRYK AS, 1987, PSYCHOL BULL, V101, P147, DOI 10.1037/0033-2909.101.1.147; DELEEUW J, 1995, J EDUC BEHAV STAT, V20, P171, DOI 10.3102/10769986020002171; Diggle P., 1990, TIME SERIES BIOSTATI; DYE OA, 1975, THESIS OHIO U; FRANCIS DJ, 1991, J CONSULT CLIN PSYCH, V59, P27, DOI 10.1037/0022-006X.59.1.27; GRONWALL DMA, 1974, NEUROPSYCHOLOGICAL E; KREFT IGG, 1994, AM STAT, V48, P324, DOI 10.2307/2684845; MCCULLAGH P, 1989, GEN LINEAR MODELS; MCFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Prosser R. J, 1991, ML3 SOFTWARE 3 LEVEL; SPIKMAN JM, UNPUB RECOVERY ATTEN; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANDERSCHOOT R, 1986, 8632 U GRON DEP NEUR; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452	19	22	22	0	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	1996	18	3					383	393		10.1080/01688639608408995			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	VF466	WOS:A1996VF46600006	8877622				2022-02-06	
J	Armstead, WM				Armstead, WM			Role of vasopressin in altered pial artery responses to dynorphin and beta-endorphin following brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral circulation; newborn; opioids	CEREBRAL BLOOD-FLOW; HYPOTENSIVE NEWBORN PIGS; CEREBROSPINAL-FLUID; ENDOGENOUS OPIOIDS; HEAD-INJURY; CIRCULATION; CATS	Pial artery constriction following fluid percussion brain injury (FPI) is associated with elevated CSF dynorphin and beta-endorphin concentration in newborn pigs. Additionally, dynorphin is a dilator under control conditions and a vasoconstrictor under decreased cerebrovascular tone conditions. Vasopressin contributes to beta-endorphin-induced pial constriction and the constrictor potential for dynorphin. Recently, it has been observed that FPI reverses vasopressin from a dilator to a constrictor. The present study was designed to characterize the effect of FPI on beta-endorphin-induced constriction and the role of vasopressin in that constriction as well as in the reversal of dynorphin's vascular response following FPI. Brain injury of moderate severity (1.9 - 2.3 atm) was produced in anesthetized newborn pigs equipped with a closed cranial window. Dynorphin in physiologic and pharmacologic concentrations (10(-10), 10(-8), 10(-6) M) was reversed from a dilator to a constrictor following FPI (7 +/- 1, 11 +/- 1, and 16 +/- 1 vs -4 +/- 1, -7 +/- 1, and -11 +/- 1% before and after FPI, respectively). Dynorphin-induced vascular changes were accompanied by increased cortical periarachnoid CSF vasopressin and these biochemical changes were potentiated following FPI (24 +/- 4 vs 134 +/- 7 and 53 +/- 7 vs 222 +/- 14 pg/mL for control and dynorphin (10(-6) M) before and after FPI, respectively). In contrast, in animals pretreated with the vasopressin receptor antagonist [1-(beta-mercapto-beta beta-cyclopentamethylene propionic acid) 2-(O-methyl)-Tyr-AVP] (MEAVP, 5 mu g/kg iv), dynorphin-induced constriction following FPI was attenuated (6 +/- 1, 12 +/- 1, and 16 +/- 1, vs -2 +/- 1, -4 +/- 1, and -7 +/- 1% before and after FPI, respectively). Additionally, beta-endorphin-induced pial constriction was potentiated following FPI (-7 +/- 1, -10 +/- 1, -15 +/- 1 vs -10 +/- 1 -15 +/- 2, and -21 +/- 2% for beta-endorphin (10(-10), 10(-8), 10(-6) M) before and after FPI, respectively). beta-endorphin-induced CSF vasopressin release was similarly potentiated following FPI. Further, MEAVP blunted the augmented constrictor responses to beta-endorphin observed following FPI (-5 +/- 1, -9 +/- 1, -14 +/- 1 vs -2 +/- 1, -5 +/- 1, and -8 +/- 1% before and after FPI, respectively). These data indicate that FPI potentiates beta-endorphin-induced pial construction and reverses dynorphin from a dilator to a constrictor. Additionally, these data show that vasopressin contributes to augmented beta-endorphin pial constriction and the reversal of dynorphin's vascular effects following FPI. Further, since CSF dynorphin and beta-endorphin concentrations are increased following FPI, these data suggest that these two opioids contribute to pial artery constriction observed following FPI, at least, in part, via the release of vasopressin.	UNIV PENN,DEPT ANESTHESIA,PHILADELPHIA,PA 19104; UNIV PENN,DEPT PHARMACOL,PHILADELPHIA,PA 19104		Armstead, WM (corresponding author), CHILDRENS HOSP PHILADELPHIA,DEPT ANESTHESIA,34TH ST & CIVIC CTR BLVD,PHILADELPHIA,PA 19104, USA.						ARMSTEAD WM, 1995, BRAIN RES, V689, P183, DOI 10.1016/0006-8993(95)00533-V; ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1991, CIRC RES, V68, P922, DOI 10.1161/01.RES.68.4.922; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; ARMSTEAD WM, 1990, AM J PHYSIOL, V258, pH408, DOI 10.1152/ajpheart.1990.258.2.H408; ARMSTEAD WM, 1989, CIRC RES, V64, P136, DOI 10.1161/01.RES.64.1.136; ARMSTEAD WM, 1992, AM J PHYSIOL, V263, pH1670; ARMSTEAD WM, 1992, J PHARMACOL EXP THER, V260, P1107; ARMSTEAD WM, 1992, AM J PHYSIOL, V262, pH862, DOI 10.1152/ajpheart.1992.262.3.H862; ARMSTEAD WM, 1996, IN PRESS AM J PHYSL; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; COLOMBANI PM, 1985, J PEDIATR SURG, V20, P8, DOI 10.1016/S0022-3468(85)80382-1; EKELUND L, 1974, NEURORADIOLOGY, V7, P209, DOI 10.1007/BF00342700; FIESCHI C, 1972, EUR NEUROL, V8, P192, DOI 10.1159/000114577; HALL ED, 1987, BRAIN RES, V435, P174, DOI 10.1016/0006-8993(87)91599-X; HANKO J, 1981, CEREBRAL MICROCIRCUL, P157; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; KATUSIC ZS, 1984, CIRC RES, V55, P575, DOI 10.1161/01.RES.55.5.575; LASSOFF S, 1980, BRAIN RES, V196, P266, DOI 10.1016/0006-8993(80)90736-2; LLUCH S, 1984, J PHARMACOL EXP THER, V228, P749; MCCULLOUGH D, 1971, J TRAUM, V11, P422, DOI 10.1097/00005373-197105000-00007; MCINTOSH TK, 1992, J NEUROTRAUM, V9, pS201; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1988, NEUR ABSTR, V4, P1152; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PERIYASAMY S, 1990, LIFE SCI, V47, P219, DOI 10.1016/0024-3205(90)90323-J; PERRY DC, 1990, NEUR ABSTR, V16, P242; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; VENTURA C, 1992, CIRC RES, V70, P66, DOI 10.1161/01.RES.70.1.66; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; VINK R, 1990, J NEUROSCI, V10, P3524; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	34	22	22	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	1996	13	3					115	123		10.1089/neu.1996.13.115			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	UD469	WOS:A1996UD46900001	8965321				2022-02-06	
J	Wetter, MW; Deitsch, SE				Wetter, MW; Deitsch, SE			Faking specific disorders and temporal response consistency on the MMPI-2	PSYCHOLOGICAL ASSESSMENT			English	Article							COLLEGE-STUDENTS	The ability of persons faking posttraumatic stress disorder (PTSD) or closed-head injury (CHI) to respond consistently across serial testings on the Minnesota Multiphasic Personality Inventory-2 (MMPI-2; J. Butcher, W. Dahlstrom, J. Graham, A. Tellegen, & B. Kaemmer, 1989) was investigated. Results showed that individuals faking PTSD obtained 2-week test-retest reliability scores comparable to individuals completing the MMPI-2 with standard instructions; individuals faking CHI obtained reliability coefficients significantly lower than individuals faking PTSD. A 3 X 2 (Response Style X Time) analysis of variance indicated that individuals faking a disorder obtained significantly elevated scores on validity scales sensitive to overreporting; no main effect for time was found. Results suggest that test-takers faking specific disorders can describe symptoms consistently on repeated testing and that type of disorder may affect temporal response consistency.			Wetter, MW (corresponding author), UNIV KENTUCKY,DEPT PSYCHOL,KASTLE HALL,LEXINGTON,KY 40506, USA.						ARBISI PA, 1993, 28 ANN S REC DEV MMP; BALDINGER B, 1995, TRIAL, V31, P56; BEE C, 1994, TRIAL, V30, P54; Butcher J.N., 1989, MANUAL RESTANDARIZED; BUTCHER JN, 1990, J PERS ASSESS, V54, P1, DOI 10.1207/s15327752jpa5401&2_1; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; GOUGH HG, 1947, J ABNORM SOC PSYCH, V42, P215, DOI 10.1037/h0063295; GRAHAM JR, 1993, MMPI 2 ASSESSING PER; Lamb D.G., 1994, PSYCHOL ASSESSMENT, V6, P8, DOI [https://doi.org/10.1037/1040-3590.6.1.8, DOI 10.1037/1040-3590.6.1.8]; LEESHALEY P, 1992, AM J FORENSIC PSYCHO, V0010, P00025; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; MATZ PA, 1992, J CLIN PSYCHOL, V48, P330, DOI 10.1002/1097-4679(199205)48:3<330::AID-JCLP2270480310>3.0.CO;2-3; PLATT J, 1986, AM J FORENSIC PSYCH, V4, P29; POPE KS, 1993, MMPI MMPI 2 MMPI A C; ROGERS R, 1993, J PERS ASSESS, V60, P215, DOI 10.1207/s15327752jpa6002_1; Rogers R., 1992, STRUCTURED INTERVIEW; Schretlen D., 1992, PSYCHOL ASSESSMENT, V4, P77, DOI [10.1037/1040-3590.4.1.77, DOI 10.1037/1040-3590.4.1.77]; SCHRETLEN DJ, 1988, CLIN PSYCHOL REV, V8, P451, DOI 10.1016/0272-7358(88)90074-8; WETTER MW, 1993, PSYCHOL ASSESSMENT, V5, P317, DOI DOI 10.1037/1040-3590.5.3.317; ZIELINSKI JJ, 1994, CLIN PSYCHOL-SCI PR, V1, P169, DOI 10.1111/j.1468-2850.1994.tb00018.x; ZISKIN J, 1988, COPING PSYCHIAT PSYC, V2; [No title captured]	23	22	22	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	MAR	1996	8	1					39	47					9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UB448	WOS:A1996UB44800006					2022-02-06	
J	SOUSTIEL, JF; HAFNER, H; CHISTYAKOV, AV; BARZILAI, A; FEINSOD, M				SOUSTIEL, JF; HAFNER, H; CHISTYAKOV, AV; BARZILAI, A; FEINSOD, M			TRIGEMINAL AND AUDITORY-EVOKED RESPONSES IN MINOR HEAD-INJURIES AND POST-CONCUSSION SYNDROME	BRAIN INJURY			English	Article							BRAIN-STEM RESPONSES; POTENTIALS; CONDUCTION; TRAUMA	Forty patients who sustained minor head trauma were investigated by brainstem trigeminal and auditory evoked potentials (BTEP, BAEP) and middle-latency auditory evoked potentials (MLAEP). The patients were evaluated within the first 48 h following their admission and at 3 months after the injury. Outcome was scored at the follow-up examination according to six complaints: failure to resume previous professional activity, headache, memory disorders, dizziness and vertigo, behavioural and emotional disturbances, and other symptoms of a neurological nature. Post-concussion syndrome (PCS) was defined by the presence of four or more of the listed features. All three evoked potential modalities showed significantly increased latencies at the initial assessment, disclosing disseminated axonal damage. Unlike the BTEPs and the BAEPs, the MLAEPs proved to correlate to outcome at 3 months, especially in its psychocognitive aspects. These findings suggest that organic diencephalic-paraventricular primary damage may account for the occurrence of PCS.	TECHNION ISRAEL INST TECHNOL,FAC MED,RAMBAM MAIMONIDES MED CTR,DEPT SURG A,IL-31096 HAIFA,ISRAEL		SOUSTIEL, JF (corresponding author), TECHNION ISRAEL INST TECHNOL,FAC MED,RAMBAM MAIMONIDES MED CTR,DEPT NEUROSURG,IL-31096 HAIFA,ISRAEL.						ADAMS JH, 1982, RECENT ADV NEUROPATH, P165; ALVES WM, 1990, NEUROLOGICAL SURGERY, V4, P2230; ANDERSON DW, 1980, J NEUROSURG, V53, pS1; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; BROWN WJ, 1972, AM J PATHOL, V67, P41; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Cook J B, 1972, Scand J Rehabil Med, V4, P27; DEIBER MP, 1988, ELECTROEN CLIN NEURO, V71, P187, DOI 10.1016/0168-5597(88)90004-4; Gennarelli T, 1982, HEAD INJURY BASIC CL, V1982, P129; GREENBERG RP, 1981, J NEUROSURG, V55, P227, DOI 10.3171/jns.1981.55.2.0227; GRONWALL D, LANCET, V2, P605; HASHIMOTO I, 1982, ELECTROEN CLIN NEURO, V53, P652, DOI 10.1016/0013-4694(82)90141-9; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JENNETT B, 1982, MANAGEMENT HEAD INJU, P253; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; MILLER H, 1961, BRIT MED J, V3, P919; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, V38, P275, DOI 10.1001/archneur.1981.00510050041004; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P179, DOI 10.1016/0013-4694(74)90155-2; PODOSHIN L, 1990, J LARYNGOL OTOL, V104, P191, DOI 10.1017/S0022215100112241; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; RUTHERFORD WH, 1977, LANCET, V1, P1; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; SCHOENHUBER R, 1987, ARCH NEUROL-CHICAGO, V44, P1181, DOI 10.1001/archneur.1987.00520230061015; SCHOENHUBER R, 1988, J NEUROSURG, V68, P724; SOUSTIEL JF, 1993, ELECTROEN CLIN NEURO, V87, P277, DOI 10.1016/0013-4694(93)90180-4; YOUNG B, 1985, NEUROSURGERY, V2, P1688	31	22	23	0	4	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1995	9	8					805	813		10.3109/02699059509008236			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	TH499	WOS:A1995TH49900005	8605513				2022-02-06	
J	RUAN, JS; PRASAD, P				RUAN, JS; PRASAD, P			COUPLING OF A FINITE-ELEMENT HUMAN HEAD MODEL WITH A LUMPED-PARAMETER HYBRID-III DUMMY MODEL - PRELIMINARY-RESULTS	JOURNAL OF NEUROTRAUMA			English	Article; Proceedings Paper	Head Injury 1994 - International Symposium on Head Injury Research	OCT 12-14, 1994	WASHINGTON, D.C.	Natl Highway Traff Safety Adm, Head Injury Res Program, George Washington Univ		BRAIN INJURY; FINITE ELEMENT; IMPACT; SKULL FRACTURE		A skull-brain finite element model of the human head has been coupled with a multilink rigid body model of the Hybrid III dummy, The experimental coupled model is intended to represent anatomically a 50th percentile human to the extent the dummy and the skull-brain model represent a human, It has been verified by simulating several human cadaver head impact tests as well as dummy head ''impacts'' during barrier crashes in an automotive environment, Skull-isostress and brain-isostrain response curves were established based on model calibration of experimental human cadaver tolerance data, The skull-isostress response curve agrees with the JARI Human Head Impact Tolerance Curve for skull fracture, The brain-isostrain response curve predicts a higher G level for concussion than does the JARI concussion curve and the Wayne State Tolerance Curve at the longer time duration range. Barrier crash simulations consist of belted dummies impacting an airbag, a hard and soft steering wheel hub, and no head contact with vehicle interior components. Head impact force, intracranial pressures and strains, skull stress, and head center-of-gravity acceleration were investigated as injury parameters, Head injury criterion (HIC) was also calculated along with these parameters, Preliminary results of the model simulations in those impact conditions are discussed.	FORD MOTOR CO, ADV VEHICLE SYST ENGN, DEARBORN, MI USA								Anzelius A, 1943, ACTA PATH MICROBIO S, V48, P153; CHENG LY, 1990, VEHICLE CRASHWORTHIN, P141; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; DIMASI F, 1991, 12TH P INT TECHN C E, P617; HODGSON VR, 1977, DOTHS1462230 WAYN ST; Hosey R. R., 1982, FINITE ELEMENTS BIOM, P379; HUBBARD RP, 1971, J BIOMECH, V4, P251, DOI 10.1016/0021-9290(71)90031-5; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; LEE ES, 1990, THESIS GEORGIA I TEC; LEE MC, 1987, 31ST STAPP CAR CRASH; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; MELVIN JW, 1969, 11TH P MIDW MECH C, V5, P811; Mendis K, 1992, THESIS OHIO STATE U; NAHUM AM, 1977, 21ST P SATPP CAR CRA; ONO K, 1980, 24TH P STAPP CAR CRA; Patrick LM, 1965, 7TH P STAPP CAR CRAS, P483; PLUCHE R, 1985, HEAD INJURY PREVENTI, P235; PRASAD P, 1985, SAE851246 PAP; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; RUAN JS, 1991, J BIOMECH ENG-T ASME, V113, P276, DOI 10.1115/1.2894885; RUAN JS, 1994, 38TH P STAPP CAR CRA; RUAN JS, 1993, 37TH P STAPP CAR CRA; SHUGAR TA, 1975, J ENG MECH DIV-ASCE, V101, P223; SHUGAR TA, 1977, DOTHS2893550TA REP, V1; Tong P, 1989, 12 INT TECHN C SAF V, P617; UENO K, 1991, CRASHWORTHINESS OCCU, V19, P121; UENO K, 1989, CRASHWORTHINESS OCCU, V13, P123; WARD CC, 1975, 19TH P STAPP CAR CRA; WARD CC, 1978, AVIATION SPACE E JAN, P136; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8	31	22	25	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	1995	12	4					725	734		10.1089/neu.1995.12.725			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	RY920	WOS:A1995RY92000024	8683624				2022-02-06	
J	PETERS, CL; SCOTT, SM				PETERS, CL; SCOTT, SM			COMPARTMENT SYNDROME IN THE FOREARM FOLLOWING FRACTURES OF THE RADIAL HEAD OR NECK IN CHILDREN	JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME			English	Article								A volar compartment syndrome of the forearm was identified following a minimally displaced or angulated fracture of the radial head or neck in three children. The fractures were due to a fail from a bed or from a standing height on an outstretched hand. All three patients had symptoms and signs that were consistent with elevated intracompartmental pressure in the forearm when they were first examined, twelve to twenty-four hours after the injury, and all were managed with an emergency fasciotomy of the forearm. The radial fracture was treated without reduction in the first patient, with manipulative closed reduction in the second patient, and with open reduction and stabilization with Kirschner wires in the third patient. All three patients had a full functional recovery.	PRIMARY CHILDRENS MED CTR,SALT LAKE CITY,UT 84113		PETERS, CL (corresponding author), UNIV UTAH,SCH MED,DIV ORTHOPED SURG,50 N MED DR,SALT LAKE CITY,UT 84132, USA.						EATON RG, 1975, CLIN ORTHOP RELAT R, P58, DOI 10.1097/00003086-197511000-00009; EATON RG, 1965, J BONE JOINT SURG AM, VA 47, P1289; FOWLES JV, 1986, J PEDIATR ORTHOPED, V6, P51; GARBER JN, 1939, J BONE JOINT SURG, V21, P154; GELBERMAN RH, 1981, CLIN ORTHOPAEDICS, V161, P252; HENRIKSON B, 1969, ACTA ORTHOP SCAND, V40, P246, DOI 10.3109/17453676908989505; Henry AK, 1970, EXTENSILE EXPOSURE, P100; HERNANDEZ J, 1986, J PEDIATR ORTHOPED, V6, P627, DOI 10.1097/01241398-198609000-00020; HOLDEN CEA, 1975, CLIN ORTHOP RELAT R, V113, P95; JONES E R L, 1971, Journal of Bone and Joint Surgery British Volume, V53, P429; LINDHAM S, 1979, ACTA ORTHOP SCAND, V50, P79, DOI 10.3109/17453677909024093; MERCHAN ECR, 1991, ORTHOPEDICS, V14, P697; MUBARAK SJ, 1979, J BONE JOINT SURG BR, V61, P285, DOI 10.1302/0301-620X.61B3.479251; MUBARAK SJ, 1976, J BONE JOINT SURG AM, V58, P1016, DOI 10.2106/00004623-197658070-00022; MUBARAK SJ, 1993, COMMUNICATION; NEWMAN JH, 1977, INJURY, V9, P114, DOI 10.1016/0020-1383(77)90004-3; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; Ogden J., 1990, SKELETAL INJURY CHIL, P451; SALTER RB, 1963, J BONE JOINT SURG AM, V45, P587, DOI 10.2106/00004623-196345030-00019; SCULLION JE, 1985, J BONE JOINT SURG BR, V67, P491; SHALL J, 1986, J BONE JOINT SURG AM, V68A, P1451, DOI 10.2106/00004623-198668090-00024; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; VAHVANEN V, 1978, ACTA ORTHOP SCAND, V49, P32, DOI 10.3109/17453677809005720; [No title captured]	24	22	22	0	1	JOURNAL BONE JOINT SURGERY INC	NEEDHAM	20 PICKERING ST, NEEDHAM, MA 02192	0021-9355			J BONE JOINT SURG AM	J. Bone Joint Surg.-Am. vol.	JUL	1995	77A	7					1070	1074		10.2106/00004623-199507000-00014			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	RJ671	WOS:A1995RJ67100014	7608230				2022-02-06	
J	GUALTIERI, CT				GUALTIERI, CT			THE PROBLEM OF MILD BRAIN INJURY	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						BRAIN INJURY; CLOSED HEAD INJURY; MILD BRAIN INJURY; CONCUSSION; POSTCONCUSSION SYNDROME; OUTCOME; DIASCHISIS; SOMATOFORM DISORDER; COMPENSATION NEUROSIS; MALINGERING	MINOR HEAD-INJURY; DIFFUSE AXONAL INJURY; COMPUTERIZED-TOMOGRAPHY; CEREBRAL CONCUSSION; SEQUELAE; SYMPTOMS; SPECT; TIME; IMPAIRMENT; POPULATION	It is estimated that 2,000,000 traumatic brain injuries (TBIs) occur in the U.S.A. each year; 90% are classified as ''mild brain injuries'' (MBIs). The epidemiology, pathophysiology, and diagnosis of MBI and the ''postconcussion syndrome'' (PCS) are reviewed, with particular attention to outcome data and factors that predict outcome. Symptoms of PCS may be quite severe, but severe symptoms are almost invariably transient. Persistent deficits may arise from MBI, but persistent problems are usually mild and are rarely disabling. Catastrophic outcomes related to MBI do occur, in the following situations. (a) What appears to be an MBI is really a severe injury. (b) PCS evolves into a posttraumatic depression that is unrecognized and untreated. (c) A premorbid psychiatric condition is mobilized around the MBI as a focal (but not a causative) event. (d) A patient shows signs of a ''functional'' condition, i.e., conversion disorder (hysteria), somatoform pain disorder, compensation neurosis, or malingering.			GUALTIERI, CT (corresponding author), N CAROLINA NEUROPSYCHIAT CLIN, 500 FRANKLIN SQ, CHAPEL HILL, NC 27514 USA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; AMPHOUX M, 1977, REV MED TRAVAIL, V5, P53; ARCIA E, 1993, BRAIN INJURY, V7, P481, DOI 10.3109/02699059309008175; Azmitia E. C., 1987, PSYCHOPHARMACOLOGY 3, P61; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BARTH JT, 1993, J HEAD TRAUMA REHAB, V8, P1; BELL DS, 1992, MED LEGAL ASSESSMENT; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; BOLLA KI, 1992, ARCH NEUROL-CHICAGO, V49, P1021, DOI 10.1001/archneur.1992.00530340037015; BOURKE RS, 1988, HEAD INJURY; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Carlsson A., 1987, PSYCHOPHARMACOLOGY 3, P39; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cook J B, 1972, Scand J Rehabil Med, V4, P27; Cook J. B, 1969, LATE EFFECTS HEAD IN, P408; CROVITZ HF, 1983, CORTEX, V19, P407, DOI 10.1016/S0010-9452(83)80009-4; Denker P., 1944, NY STATE J MED, V44, P379; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DREIFUSS FE, 1992, EPILEPSIA S, V1, pS7; EAMES P, 1992, J NEUROL NEUROSUR PS, V55, P1046, DOI 10.1136/jnnp.55.11.1046; Eisenberg H.M., 1989, MILD HEAD INJURY, P133; EPSTEIN CM, 1994, NEUROLOGY, V44, P1566, DOI 10.1212/WNL.44.9.1566; EVANS RW, 1992, PHYSICAL MED REHAB C, V3, P427; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; FEE CRA, 1987, ARCH EMERG MED, V4, P159; Frankowski RF, 1985, CENTRAL NERVOUS SYST, P33; Gennarelli T.A., 1986, MECHANISMS SECONDARY, P15; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GIANNOTTA SL, 1987, HEAD INJURY, P464; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GRAY BG, 1992, J NUCL MED, V33, P52; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1989, MILD HEAD INJURY, P153; Gualtieri C. T., 1990, NEUROPSYCHIATRY BEHA; GUALTIERI CT, 1993, PSYCHIATRIC CARE MED, P517; HAYES RL, 1989, MILD HEAD INJURY, P54; HOFF JT, 1989, MILD MODERATE HEAD I; HORN LJ, 1992, REHABILITATION POSTC; JACOBSON SA, 1969, LATE EFFECTS HEAD IN, P35; JAKOBSEN J, 1987, ACTA NEUROL SCAND, V75, P341, DOI 10.1111/j.1600-0404.1987.tb05456.x; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; Jennett B, 1989, MILD HEAD INJURY, P23; KASTE M, 1982, LANCET, V2, P1186; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; KOZOL HL, 1946, ARCH NEURO PSYCHIATR, V56, P245, DOI 10.1001/archneurpsyc.1946.02300200002001; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1989, MILD HEAD INJURY, P8; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; Levin H.S., 1989, MILD HEAD INJURY; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; MACH A, 1989, TRAUMATIC BRAIN INJU, P13; MANDEL S, 1992, MINOR HEAD TRAUMA AS; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MELTZER HY, 1987, PSYCHOPHARMACOLOGY 3, P513; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; NOY P, 1975, NEW DIMENSIONS PSYCH, P162; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; OMMAYA AK, 1969, LANCET, V2, P237; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; RAO N, 1984, ARCH PHYS MED REHAB, V65, P780; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; Ruff R. M., 1989, MILD HEAD INJURY, P176; Rutherford W. H., 1989, MILD HEAD INJURY, P217; RUTHERFORD WH, 1977, LANCET, V1, P1; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; SEKINO H, 1981, Neurologia Medico-Chirurgica, V21, P677; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; STEADMAN JH, 1970, P ROY SOC MED, V63, P23, DOI 10.1177/003591577006300109; STEIN SC, 1993, BRAIN INJURY, V7, P425, DOI 10.3109/02699059309029685; STENGEL E, 1949, RECENT PROG PSYCHIAT, V11, P1; SYMONDS C, 1962, LANCET, V1, P1; Symonds CP, 1943, LANCET, V1, P7; Teuber H-L, 1969, LATE EFFECTS HEAD IN, P13; Trimble M.R., 1981, POSTTRAUMATIC NEUROS; WHITLOCK FA, 1967, ACTA PSYCHIAT SCAND, V43, P144, DOI 10.1111/j.1600-0447.1967.tb11023.x; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950; [No title captured]; [No title captured]	100	22	22	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	APR	1995	8	2					127	136					10	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	QU199	WOS:A1995QU19900007					2022-02-06	
J	WOESSNER, R; CAPLAN, B				WOESSNER, R; CAPLAN, B			AFFECTIVE-DISORDERS FOLLOWING MILD-TO-MODERATE BRAIN INJURY - INTERPRETIVE HAZARDS OF THE SCL-90-R	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						ASSESSMENT; BRAIN INJURY; COGNITIVE IMPAIRMENT; PSYCHOPATHOLOGY	BLUNT HEAD-INJURY; MULTIPLE-SCLEROSIS; RELATIVES VIEW; SPINAL-CORD; SYMPTOMS; PERSONALITY; ADJUSTMENT; MMPI	This article describes an analysis of the Symptom Checklist-90-Revised (SCL-90-R), a self-report measure of emotional distress, demonstrating potentially misleading scale elevations (ie, psychopathology) in data from 23 patients with mild to moderate traumatic brain injury (initial Glasgow Coma Scale score range = 9-15). Average scores were significantly higher than those for the normative control group on 88 of 90 symptoms, seven of nine individual dimensions, and three summary indices. A considerable portion of these elevations was attributable to endorsement of 14 items (15.5%) identified by experts as ''usual consequences'' of traumatic head injury. The Obsessive-Compulsive, Hostility, and Depression scales were especially weighted with brain injury symptoms. These findings corroborate previous reports concerning the hazards of applying to neurological patients psychological instruments that were normed on physically healthy populations. Scores that would indicate pathological abnormality in the latter group may hold substantially different diagnostic significance for the former group. Clinicians should inspect individual responses to self-report questionnaires and seek confirmation from additional sources.	THOMAS JEFFERSON MED COLL,DEPT REHABIL MED,PHILADELPHIA,PA; THOMAS JEFFERSON UNIV HOSP,DEPT REHABIL MED,PHILADELPHIA,PA 19107		WOESSNER, R (corresponding author), MOSS REHABIL HOSP,DEPT PSYCHOL,PHILADELPHIA,PA 19141, USA.						Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; ALFANO DP, 1993, NEUROPSY NEUROPSY BE, V6, P111; ALFANO DP, 1991, NEUROPSYCHOLOGY, V5, P35; ALVES WM, 1989, MILD MODERATE HEAD I; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BROOKS N, 1990, TRAUMATIC BRAIN INJU; Christensen B, 1994, ADV MED PSYCHOTHERAP, V7, P23; Cook J B, 1972, Scand J Rehabil Med, V4, P27; CRIPE LI, 1977, CLIN NEUROPSYCHOL, V2, P492; CYR JJ, 1988, J SOC BEHAV PERS, V3, P245; Derogatis L., 1983, ADM SCORING PROCEDUR, V2nd edn; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN S, 1989, MILD HEAD INJURY; DILLER I, 1994, BRAIN INJURY NEUROPS; GASS CS, 1991, J CLIN PSYCHOL, V17, P253; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GEORGE MS, 1992, BEHAV NEUROL, V5, P3, DOI 10.3233/BEN-1992-5101; GRANT I, 1987, NEUROBEHAVIORAL RECO; GREEN CJ, 1982, HDB CLIN HLTH PSYCHO; HARRINGTON RG, 1994, ASSESS REHABIL EXCEP, V1, P58; Jennett B, 1981, MANAGEMENT HEAD INJU; JENNETT B, 1984, CLOSED HEAD INJURY P; KOZOL HL, 1945, ARCH NEURO PSYCHIATR, V53, P358, DOI 10.1001/archneurpsyc.1945.02300050032004; KRAUS JF, 1993, HEAD INJURY; LEVIN H, 1989, MILD MODERATE HEAD I; LEZAK MD, 1990, J CLIN EXP NEUROPSYC, V12, P50; McCaffrey R. J., 1993, J HEAD TRAUMA REHAB, V8, P38; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; MCMORDIE WR, 1988, CLIN NEUROPSYCHOL, V2, P198; MEYERINK LH, 1988, J CLIN PSYCHOL, V44, P764, DOI 10.1002/1097-4679(198809)44:5<764::AID-JCLP2270440517>3.0.CO;2-Y; MILLER H, 1972, LANCET, V1, P580; MILLER H, 1966, P ROY SOC MED, V59, P257, DOI 10.1177/003591576605900327; MILLER JD, 1990, REHABILITATION ADULT; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; ODONNELL WE, 1984, J CLIN PSYCHOL, V40, P241, DOI 10.1002/1097-4679(198401)40:1<241::AID-JCLP2270400147>3.0.CO;2-6; OHARA C, 1988, COGNITIVE REHABILITA, V6, P26; PAYNE RW, 1985, 9TH MENTAL MEASUREME, V2; Prigatano G. P., 1991, AWARENESS DEFICIT BR; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; SCHMIDT MM, 1990, AUG ANN M AM PSYCH A; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; TATE DG, 1990, REHABIL PSYCHOL, V35, P211, DOI 10.1037/h0079062; TAYLOR GP, 1970, J CONSULT CLIN PSYCH, V35, P183, DOI 10.1037/h0030127; TENNEN H, 1987, TEST CRITIQUES, V3; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	60	22	23	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1995	10	2					78	89		10.1097/00001199-199504000-00009			12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QR039	WOS:A1995QR03900009					2022-02-06	
J	VAKIL, E; TWEEDY, JR				VAKIL, E; TWEEDY, JR			MEMORY FOR TEMPORAL-ORDER AND SPATIAL POSITION INFORMATION - TESTS OF THE AUTOMATIC-EFFORTFUL DISTINCTION	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						EFFORTFUL; AUTOMATIC; SPATIAL; AMNESIA; JUDGMENT TASK; BRAIN INJURY	ELDERLY ADULTS; LOCATION; FREQUENCY; INTENTIONALITY; YOUNG	Information about the temporal and spatial context of events has been postulated by Hasher and Zacks in 1979 to accumulate in memory via processes that are relatively unaffected by subject variables like age and ability, or task variables such as instructions or practice. These ''automatic'' processes have been distinguished from ''effortful'' processes, which are affected by these variables. To evaluate these predictions, we tested memory for temporal order and spatial position in groups of young adults recovering from traumatic brain injuries, normal elderly, and normal young adults, using a design that allowed examination of the effects of practice and instructions. Our results indicate that both traumatic brain injury and aging reduce performance on tasks tapping retention of temporal and spatial information if the subject is asked for a relatively precise estimate of the requested information. These effects tend to disappear when estimation tasks are designed, or errors are analyzed, in a way that allows subjects full credit for only partial information about an item's temporospatial context of presentation. The presence of these task and analysis effects that can eliminate existing differences, calls for reevaluation of those studies in which Hasher and Zacks' criteria for automaticity were satisfied.	GAYLORD HOSP,WALLINGFORD,CT		VAKIL, E (corresponding author), BAR ILAN UNIV,DEPT PSYCHOL,IL-52900 BAR ILAN,ISRAEL.						ATTIG MS, 1981, J GERONTOL, V35, P66; AUDY BC, 1988, B PSYCHONOMIC SOC, V26, P548; AZARI NP, 1989, B PSYCHONOMIC SOC, V27, P203, DOI 10.3758/BF03334584; BUTTERS N, 1975, HIPPOCAMPUS, V2; ELLIS NR, 1991, B PSYCHONOMIC SOC, V29, P28; ELLIS NR, 1989, AM J MENT RETARD, V93, P521; ELLIS NR, 1990, MEM COGNITION, V18, P584, DOI 10.3758/BF03197101; ELLIS NR, 1987, J EXP CHILD PSYCHOL, V44, P401, DOI 10.1016/0022-0965(87)90042-7; HASHER L, 1984, AM PSYCHOL, V39, P1372, DOI 10.1037/0003-066X.39.12.1372; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; HIRST W, 1982, PSYCHOL BULL, V91, P435, DOI 10.1037/0033-2909.91.3.435; HIRST W, 1984, BRAIN COGNITION, V1, P294; HUPPERT FA, 1978, Q J EXP PSYCHOL, V30, P347, DOI 10.1080/14640747808400681; HUPPERT FA, 1976, CORTEX, V12, P3, DOI 10.1016/S0010-9452(76)80024-X; JACOBY LL, 1982, HUMAN MEMORY AMMENSI; Levin H. S., 1989, J CLIN EXP NEUROPSYC, V12, P129; MCCORMACK PD, 1982, J GERONTOL, V37, P80, DOI 10.1093/geronj/37.1.80; MCCORMACK PD, 1981, DEV PSYCHOL, V17, P509; Meudell P, 1982, NORMALITY PATHOLOGY, P203; MOORE TE, 1984, J GERONTOL, V39, P210, DOI 10.1093/geronj/39.2.210; NAVEHBENJAMIN M, 1990, J EXP PSYCHOL LEARN, V16, P117, DOI 10.1037/0278-7393.16.1.117; NAVEHBENJAMIN M, 1988, MEM COGNITION, V16, P437, DOI 10.3758/BF03214224; NAVEHBENJAMIN M, 1987, J EXP PSYCHOL LEARN, V13, P595, DOI 10.1037/0278-7393.13.4.595; PARK DC, 1982, J GERONTOL, V37, P330, DOI 10.1093/geronj/37.3.330; PERLMUTTER M, 1980, J GERONTOL, V36, P59; POSNER MI, 1975, INFORMATION PROCESSI; PZDEK K, 1983, DEV PSYCHOL, V19, P895; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SHIMAMURA AP, 1986, Q J EXP PSYCHOL-A, V38, P619, DOI 10.1080/14640748608401617; SIEMENS L, 1989, AM J PSYCHOL, V1, P53; THORDIKE EL, 1944, TEACHERS BOOK 30000; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; von Wright J M, 1975, J Exp Child Psychol, V20, P181, DOI 10.1016/0022-0965(75)90037-5; Wechsler, 1997, WECHSLER ADULT INTEL; ZACKS RT, 1984, MEM COGNITION, V12, P387, DOI 10.3758/BF03198299; [No title captured]	37	22	23	0	3	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	OCT	1994	7	4					281	288					8	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	PY002	WOS:A1994PY00200006					2022-02-06	
J	GORAJ, B; RIFKINSONMANN, S; LESLIE, DR; LANSEN, TA; KASOFF, SS; TENNER, MS				GORAJ, B; RIFKINSONMANN, S; LESLIE, DR; LANSEN, TA; KASOFF, SS; TENNER, MS			CORRELATION OF INTRACRANIAL-PRESSURE AND TRANSCRANIAL DOPPLER RESISTIVE INDEX AFTER HEAD TRAUMA	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article						HEAD, INJURIES; HEAD, ULTRASOUND; ULTRASOUND, DOPPLER; BRAIN, PRESSURE	CEREBRAL BLOOD-FLOW; BRAIN INJURIES; ULTRASOUND; VELOCITY; HYPERTENSION; ARTERY	PURPOSE: To investigate the usefulness of transcranial Doppler ultrasonography in the evaluation of intracranial pressure changes after head injury. METHODS: Transcranial Doppler examinations and intracranial pressure measurements using intraparenchymal monitors were performed in 12 cases of closed head injury. Twenty-four sets of data, including the Glasgow Coma Scale, intracranial pressure, transcranial Doppler, and carbon dioxide pressure were compared. The side-to-side difference in the resistivity index was also assessed. RESULTS: There was a significant correlation between increased pressure values and resistivity index when comparing measurements from the same side. There was no correlation between carbon dioxide pressure and any transcranial Doppler parameter or intracranial pressure measurement. No significant correlation was found between the resistivity index and the Glasgow Coma Scale. End diastolic velocity was a stronger determinant of resistivity index than peak systolic velocity. CONCLUSION: The relationship of ipsilateral measurements of intracranial pressure to resistivity index is valid. The resistivity index must be analyzed within the context of the particular disease studied, especially with respect to the hemodynamic alterations. Initial findings suggest that intracranial pressure monitoring cannot be replaced by serial transcranial Doppler measurements in the treatment of the patient with acute head injury.	WESTCHESTER CTY MED CTR,NEW YORK MED COLL,DEPT NEUROSURG,VALHALLA,NY 10595; NEW YORK MED COLL,DEPT RADIOL,VALHALLA,NY 10595								AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R., 1986, TRANSCRANIAL DOPPLER, P22, DOI [10.1007/978-3-7091-8864-4_3, DOI 10.1007/978-3-7091-8864-4_3]; Aaslid R., 1986, TRANSCRANIAL DOPPLER, P39; ARCHER LNJ, 1986, PEDIATR RES, V20, P218, DOI 10.1203/00006450-198603000-00004; BADA HS, 1983, J PEDIATR, V100, P191; BECKER DP, 1990, NEUROLOGICAL SURG, P2017; BODE H, 1988, PEDIATRIC APPLICATIO, P115; CHAN KH, 1992, NEUROSURGERY, V30, P697; GILSBACH J, 1986, TRANSCRANIAL DOPPLER, P106; GOH D, 1991, EUR J PEDIATR SURG, V1, P14, DOI 10.1055/s-2008-1042529; HARDERS AG, 1986, NEUROSURGICAL APPL T, P27; Huber P, 1967, Invest Radiol, V2, P17, DOI 10.1097/00004424-196701000-00016; JACKSONPRATT M, 1985, CENTRAL NERVOUS SYST; JENNETT B, 1982, MANAGEMENT HEAD INJU, P111; KLINGELHOFER J, 1988, J NEUROL, V235, P159, DOI 10.1007/BF00314307; LINDEGAARD KF, 1982, TRANSCRANIAL DOPPLER, P67; MAMAROU A, 1982, HEAD INJURY, P115; MAMAROU A, 1992, J NEUROTRAUM, V9, pS327; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; MILES RD, 1987, J ULTRAS MED, V6, P597; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; SANKER P, 1991, CHILD NERV SYST, V7, P391, DOI 10.1007/BF00304204; SAUR JL, 1993, TRANSCRANIAL DOPPLER, P11; SHIGEMORI M, 1990, ACTA NEUROCHIR, V107, P5, DOI 10.1007/BF01402605; SIEBERT JJ, 1989, RADIOLOGY, V171, P155; VRIENS E M, 1989, Ultrasound in Medicine and Biology, V15, P1, DOI 10.1016/0301-5629(89)90125-7; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; WILKINSON HA, 1990, NEUROLOGICAL SURG, P661	30	22	22	1	2	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	AUG	1994	15	7					1333	1339					7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	PB622	WOS:A1994PB62200023	7976946				2022-02-06	
J	MAYR, J; GAISL, M; PURTSCHER, K; NOERES, H; SCHIMPL, G; FASCHING, G				MAYR, J; GAISL, M; PURTSCHER, K; NOERES, H; SCHIMPL, G; FASCHING, G			BABY WALKERS AN UNDERESTIMATED HAZARD FOR OUR CHILDREN	EUROPEAN JOURNAL OF PEDIATRICS			English	Article						BABY WALKER; HEAD INJURY; SKULL FRACTURE; COMPLICATIONS; INJURY PREVENTION	INJURY	Baby walkers (BWs) continue to be a frequent cause of head injuries in young children. A random sample survey of 240 families with children aged 2-6 years revealed a use rate of baby walkers of 55%. Of the children using baby walkers 20% were found to have suffered a BW-related accident. In a retrospective study we reviewed 172 case reports of infants who suffered a BW-related injury between January 1990 and June 1993. We observed 19 skull fractures, 23 concussions of the brain and 125 contusions and lacerations of the head including 4 teeth luxations and 3 fractures or distorsions of the upper extremity. BW-related injuries represent the third most common mode of injury in children aged 7-14 months. We conclude that despite previous warnings BW still represent a frequent cause of severe head injuries in young children. We recommend a general ban on the sale and manufacture of BWs			MAYR, J (corresponding author), GRAZ UNIV,LANDESKRANKENHAUS GRAZ,KINDERCHIRUG KLIN,AUENBRUGGERPLATZ 34,A-8036 GRAZ,AUSTRIA.						BUTERBAUGH L, 1992, 1992 INT M AM MED AS; GLEADHILL DNS, 1987, ARCH DIS CHILD, V62, P491, DOI 10.1136/adc.62.5.491; HOLM VA, 1983, AM J DIS CHILD, V137, P1189, DOI 10.1001/archpedi.1983.02140380049016; JAFFE D, 1991, NEW ENGL J MED, V324, P1477; KAUFFMAN IB, 1977, PERCEPT MOTOR SKILL, V45, P1323, DOI 10.2466/pms.1977.45.3f.1323; PARTINGTON MD, 1991, ANN EMERG MED, V20, P652, DOI 10.1016/S0196-0644(05)82386-8; RIEDER MJ, 1986, PEDIATRICS, V78, P488	7	22	25	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0340-6199			EUR J PEDIATR	Eur. J. Pediatr.	JUL	1994	153	7					531	534		10.1007/s004310050186			4	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	NU967	WOS:A1994NU96700014	7957373				2022-02-06	
J	STEWART, WF; GORDON, B; SELNES, O; BANDEENROCHE, K; ZEGER, S; TUSA, RJ; CELENTANO, DD; SHECHTER, A; LIBERMAN, J; HAIL, C; SIMON, D; LESSER, R; RANDALL, RD				STEWART, WF; GORDON, B; SELNES, O; BANDEENROCHE, K; ZEGER, S; TUSA, RJ; CELENTANO, DD; SHECHTER, A; LIBERMAN, J; HAIL, C; SIMON, D; LESSER, R; RANDALL, RD			PROSPECTIVE-STUDY OF CENTRAL-NERVOUS-SYSTEM FUNCTION IN AMATEUR BOXERS IN THE UNITED-STATES	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						BOXING; CENTRAL NERVOUS SYSTEM; HEAD INJURIES; PROSPECTIVE STUDIES	CHRONIC BRAIN-DAMAGE; MINOR HEAD-INJURY; CONCUSSION; HUMANS	Active amateur boxers from six US cities were studied in 1986-1990 to determine whether changes in central nervous system function over a 2-year interval (as evaluated by tests of perceptual/motor function, attention/concentration, psychomotor speed, memory, visuoconstructional ability, and mental control, measures of ataxia and brainstem auditory evoked potentials, and electroencephalography) were associated with degree of participation in amateur boxing. A total of 484 participants were examined at baseline; 393 (81.2%) were examined 2 years later. At baseline, 22% of the participants had not yet competed in a bout; 9% had never competed in a bout by the second examination. Exposure was defined by number of bouts, sparring-years, and sparring with a professional boxer. Very few statistically significant odds ratios were found between exposure and change in function. Significant tests of trend were found between the total number of bouts incurred before the baseline examination and changes in memory, visuoconstructional ability, and perceptual/motor ability. The significant trends for change in function in the latter two domains were primarily due to performance on the Block Design test, which was common to both test domains. No statistically significant associations were found between more recent bouts (after the baseline visit) and any functional domains, nor between bouts or sparring and any other outcome measures. The significant trends with past bouts, but not more recent bouts, may reflect the need for a long latency period before effects are manifest. Alternatively, given changes in safety practices, the observed association may be related to more severe exposure from bouts that occurred before 1986, when new safety measures were imposed.	JOHNS HOPKINS UNIV HOSP,ZANVYL KRIEGER MIND BRAIN INST,DEPT NEUROL & COGNIT SCI,BALTIMORE,MD; JOHNS HOPKINS UNIV HOSP,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT BIOSTAT,BALTIMORE,MD; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BALTIMORE,MD		STEWART, WF (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,ROOM 6033,615 N WOLFE ST,BALTIMORE,MD 21205, USA.			Zeger, Scott/0000-0001-8907-1603; Hall, Charles/0000-0001-9982-8120	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26450] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026450] Funding Source: NIH RePORTER		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BROOKS N, 1987, J NEUROL NEUROSUR PS, V50, P997, DOI 10.1136/jnnp.50.8.997; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; EGAN JP, 1975, SIGNAL DETECTION THE; FREGLY AR, 1973, ACTA OTO-LARYNGOL, V75, P10, DOI 10.3109/00016487309139631; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ATHLETIC INJURIES HE; GRONWALL D, 1975, LANCET, V2, P995; Hage P, 1983, Phys Sportsmed, V11, P143, DOI 10.1080/00913847.1983.11708665; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JEDLINSKI J, 1970, ACTA MED POL, V12, P443; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; KASTE M, 1982, LANCET, V2, P1186; KLOVE H, 1963, MED CLIN N AM, V47, P1647, DOI 10.1016/S0025-7125(16)33515-5; LAMPERT PW, 1984, JAMA-J AM MED ASSOC, V251, P2676, DOI 10.1001/jama.251.20.2676; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LUNDBERG GD, 1983, JAMA-J AM MED ASSOC, V249, P250, DOI 10.1001/jama.1983.03330260068037; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; Raven J. C., 1960, GUIDE STANDARD PROGR; Rey A, EXAMEN CLIN PSYCHOL; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; Schoenhuber R, 1983, J Neurosurg Sci, V27, P157; SEROL M, 1962, WORLD NEUROL, V3, P351; Smith A., 1982, SYMBOL DIGIT MODALIT; THOMASSEN A, 1979, ACTA NEUROL SCAND, V60, P352, DOI 10.1111/j.1600-0404.1979.tb07661.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Unterharnscheidt F J, 1972, Scand J Rehabil Med, V4, P77; Wechsler D., 1989, WECHSLER ADULT INTEL; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; 1989, USA AMATEUR BOXING F; 1944, MANYAL DIRECTIONS SO; 1983, JAMA-J AM MED ASSOC, V249, P254	41	22	22	0	2	JOHNS HOPKINS UNIV SCHOOL HYGIENE PUB HEALTH	BALTIMORE	111 MARKET PLACE, STE 840, BALTIMORE, MD 21202-6709	0002-9262			AM J EPIDEMIOL	Am. J. Epidemiol.	MAR 15	1994	139	6					573	588		10.1093/oxfordjournals.aje.a117047			16	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	NF396	WOS:A1994NF39600003	8172169				2022-02-06	
J	AXELROD, BN; GOLDMAN, RS; TOMPKINS, LM; JIRON, CC				AXELROD, BN; GOLDMAN, RS; TOMPKINS, LM; JIRON, CC			POOR DIFFERENTIAL PERFORMANCE ON THE WISCONSIN CARD SORTING TEST IN SCHIZOPHRENIA, MOOD DISORDER, AND TRAUMATIC BRAIN INJURY	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article						PERSEVERATION; COGNITIVE PROCESSES; DEPRESSIVE DISORDERS	DORSOLATERAL PREFRONTAL CORTEX; CEREBRAL BLOOD-FLOW; NEUROPSYCHOLOGICAL ASSESSMENT; DYSFUNCTION	The utility of the Wisconsin Card Sorting Test (WCST) to effectively differentiate diagnostic groups was evaluated. Performance on the WCST was contrasted among samples of schizophrenic, mood-disordered, and traumatically brain-injured patients, as well as normal controls. The controls performed significantly better than all three patient groups, without any differentiation among the patient samples. The pattern of performance, over time, also did not differ between the groups. The poor discrimination between the patient groups may provide evidence for multiple cognitive processes being involved in WCST performance (e.g., attention, executive functioning). Consequently, similar WCST performance could result from deficiencies in different cognitive processes.	VET AFFAIRS MED CTR,ANN ARBOR,MI; UNIV MICHIGAN,ANN ARBOR,MI 48109; WINTER HAVEN HOSP,WINTER HAVEN,FL; WAYNE STATE UNIV,DETROIT,MI 48202		AXELROD, BN (corresponding author), VET AFFAIRS MED CTR,PSYCHOL SERV 116B,ALLEN PK,MI 48101, USA.						ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; AXELROD BN, 1992, CLIN NEUROPSYCHOLOGI, V6, P14; BRAFF DL, 1991, ARCH GEN PSYCHIAT, V48, P891; BUTLER M, 1991, PROF PSYCHOL-RES PR, V22, P510, DOI 10.1037/0735-7028.22.6.510; DREWE E A, 1974, Cortex, V10, P159; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; GOLDBERG TE, 1990, ARCH NEUROL-CHICAGO, V47, P418, DOI 10.1001/archneur.1990.00530040062020; GOLDMAN RS, 1992, AM J PSYCHIAT, V149, P1718; GOLDMAN RS, 1991, J NERV MENT DIS, V179, P506; HAALAND KY, 1987, J GERONTOL, V42, P345, DOI 10.1093/geronj/42.3.345; Heaton R.K., 1981, WISCONSIN CARD SORTI; Levin H.S., 1989, MILD HEAD INJURY; MARTIN DJ, 1991, J CLIN PSYCHOL, V47, P684, DOI 10.1002/1097-4679(199109)47:5<684::AID-JCLP2270470509>3.0.CO;2-G; PAULMAN RG, 1990, BIOL PSYCHIAT, V27, P377, DOI 10.1016/0006-3223(90)90549-H; RAO SM, 1987, J CONSULT CLIN PSYCH, V55, P263, DOI 10.1037/0022-006X.55.2.263; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Spitzer R.L., 1978, RES DIAGNOSTIC CRITE; SWEET JJ, 1992, CLIN PSYCHOL REV, V12, P21, DOI 10.1016/0272-7358(92)90090-U; TAYLOR LB, 1979, FUNCTIONAL NEUROSURG; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; [No title captured]; [No title captured]	23	22	22	0	3	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	JAN	1994	7	1					20	24					5	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	NB540	WOS:A1994NB54000002					2022-02-06	
J	SHOHAMI, E; NOVIKOV, M; HOROWITZ, M				SHOHAMI, E; NOVIKOV, M; HOROWITZ, M			LONG-TERM EXPOSURE TO HEAT REDUCES EDEMA FORMATION AFTER CLOSED-HEAD INJURY IN THE RAT	ACTA NEUROCHIRURGICA			English	Article						BBB; HEAD TRAUMA; HEAT ACCLIMATION; BRAIN EDEMA	BRAIN	Cerebral edema is one of the major consequences of head trauma (HT); its evolution may cause secondary ischemia and neuronal damage. In a closed head injury model in rats, we have shown BBB disruption and edema formation during the post traumatic period. We have previously shown that chronic exposure to moderate heat improves clinical outcome of rats subjected to HT. Long term exposure to heat results in the achievement of a stable acclimated state, characterized by a lower metabolic rate and improved heat tolerance. In the present study, we investigated the effect of chronic exposure to heat on edema formation after HT. Rats were held at 24-degrees-C (CON) or 34-degrees-C (ACC) for one month. Injury was then induced under ether anesthesia by a weight drop device. Four or 48 hours later, they were sacrificed for evaluation of BBB integrity (Evans blue, EB, extravasation) or edema formation (specific gravity, SG, or percent water). We found that EB uptake by the contused hemisphere was 6 fold lower in the ACC rats as compared to CON (p < 0.001). Furthermore, edema measured at 48 h by both SG and percent water methods was significantly lower in the acclimated rats (p < 0.01). We suggest that heat acclimation offers protection to rats subjected to head injury, possibly by reduction of plasma proteins extravasation.	HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT PHYSIOL, IL-91010 JERUSALEM, ISRAEL; HEBREW UNIV JERUSALEM, SCH DENT MED, IL-91010 JERUSALEM, ISRAEL		SHOHAMI, E (corresponding author), HADASSAH SCH PHARM, DEPT PHARMACOL, POB 1172, IL-91010 JERUSALEM, ISRAEL.						HADAS H, 1989, INT CONGR SER, V871, P395; HOROWITZ M, 1976, PFLUG ARCH EUR J PHY, V366, P173, DOI 10.1007/BF00585874; LEVI E, 1993, IN PRESS J APPL PHYS; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHAPIRA Y, 1993, IN PRESS J ANASTH AN; SIESJO BK, 1988, CRIT CARE MED, V16, P954, DOI 10.1097/00003246-198810000-00006; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; YOUSEF MK, 1975, AM J PHYSIOL, V229, P427, DOI 10.1152/ajplegacy.1975.229.2.427	9	22	23	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			443	445					3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600121	7976614				2022-02-06	
J	SLIFER, KJ; CATALDO, MD; BABBITT, RL; KANE, AC; HARRISON, KA; CATALDO, MF				SLIFER, KJ; CATALDO, MD; BABBITT, RL; KANE, AC; HARRISON, KA; CATALDO, MF			BEHAVIOR ANALYSIS AND INTERVENTION DURING HOSPITALIZATION FOR BRAIN TRAUMA REHABILITATION	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						BEHAVIOR; BRAIN INJURIES; REHABILITATION	CLOSED HEAD-INJURY; CHILDREN; SEQUELAE; DAMAGE		JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205		SLIFER, KJ (corresponding author), KENNEDY KRIEGER INST,DEPT BEHAV PSYCHOL,707 N BROADWAY,BALTIMORE,MD 21205, USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 24061] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MCH917] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD024061] Funding Source: NIH RePORTER		ALBERTO PA, 1982, APPLIED BEHAVIOR ANA; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BLUMENTHAL JA, 1987, APPLICATIONS BEHAVIO; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; COPPER JO, 1987, APPLIED BEHAVIOR ANA; DIVACK JA, 1985, HEAD INJURY RHEABILI, P352; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerring J P, 1986, Pediatr Rev, V8, P115, DOI 10.1542/pir.8-4-115; GIANUTSAS R, 1987, REHABILITATION PSYCH; GROSS AM, 1990, HDB CLIN BEHAVIORAL; HARSEN M, 1981, BEHAV MODIF, P357; HERSEN M, 1978, SINGLE CASE EXPT DES; HOWARD ME, 1988, J HEAD TRAUMA REHAB, V3, P14; JAFFE KM, 1990, REHABILITATION ADULT, P541; KEDESDY JH, 1988, BEHAVIORAL MED DEV D; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; MACE FC, 1991, RES DEV DISABIL, V12, P155, DOI 10.1016/0891-4222(91)90004-C; MUIR CA, 1983, REHABILITATION HEAD, P381; OREILLY MF, 1990, J APPL BEHAV ANAL, V23, P431, DOI 10.1901/jaba.1990.23-431; PELHAM WE, 1982, BEHAVIORAL MED CLIN, P261; RIMM DC, 1979, BEHAVIOR THERAPY; ROSS AO, 1981, CHILD BEHAVIOR THERA; RUSSO DC, 1982, BEHAVIORAL PEDIATRIC; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; RUTTER M, 1977, J CHILD PSYCHOL PSYC, V18, P1, DOI 10.1111/j.1469-7610.1977.tb00413.x; SLATER EJ, 1988, AM J DIS CHILD, V142, P1048, DOI 10.1001/archpedi.1988.02150100042022; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; WOOD R, 1988, J HEAD TRAUMA REHAB, V3, P53; Zencius A, 1989, Brain Inj, V3, P67, DOI 10.3109/02699058909008076; Zencius A H, 1989, Brain Inj, V3, P199, DOI 10.3109/02699058909004553; ZENCIUS A H, 1991, Brain Injury, V5, P369, DOI 10.3109/02699059109008109	32	22	22	1	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1993	74	8					810	817		10.1016/0003-9993(93)90006-V			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	LR257	WOS:A1993LR25700005	8347066				2022-02-06	
J	SERVADEI, F; VERGONI, G; NASI, MT; STAFFA, G; DONATI, R; ARISTA, A				SERVADEI, F; VERGONI, G; NASI, MT; STAFFA, G; DONATI, R; ARISTA, A			MANAGEMENT OF LOW-RISK HEAD-INJURIES IN AN ENTIRE AREA - RESULTS OF AN 18-MONTH SURVEY	SURGICAL NEUROLOGY			English	Article						MINOR HEAD INJURY; SKULL X-RAY; ASYMPTOMATIC HEMATOMAS; EXTRADURAL HEMATOMAS; BRAIN CONTUSIONS; AVOIDABLE DEATHS	TRAUMATIC INTRACRANIAL HEMATOMA; EXTRADURAL HEMATOMAS; SKULL FRACTURE; CHILDREN; ADULTS; EPIDEMIOLOGY; DETERIORATE; TOMOGRAPHY; COUNTY; TALK	All patients admitted following a minor head injury (GCS is without neurological deficits) during an 18 month period in an entire area were submitted to the same diagnostic and therapeutic protocol. Adult patients were x rayed and in the cases with skull fracture (even asymptomatic), a computed tomographic (CT) scan was performed. Children (below the age of 14) did not routinely receive skull X-rays but were admitted to one of the five regional hospitals where a CT scanner was available 24 hours per day. Neuroradiologic investigations (carried out in over 600 patients) showed posttraumatic lesions in 201 cases; 113 of these patients were transferred to the neurosurgical center. There were 49 patients with extradural hematomas, 41 with brain contusions, 17 with depressed skull fractures, and six with subdural hematomas. Of these 113, 40 patients were operated on (mainly extradural hematomas); surgical indications were based on appearance of clinical deterioration, lesion volume, presence of midline, shift, and/or compressed third ventricle and basal cisterns. In eight cases there was a clinical deterioration to a GCS of 13 or less, in all of these patients, the CT diagnosis (and transfer to a neurosurgical center, preceded the onset of deterioration. All patients admitted to such a center had a good outcome, but a survey of deaths related to head injury in the area revealed two fatalities following minor head injury. The only avoidable death was a patient with multiple brain contusions who developed sudden brain swelling on day 12 posttrauma. We conclude that, even if management mortality is not zero, our protocol is sufficiently safe for the treatment of minor head injury.	OSPED BUFALINI,SERV NEURORADIOL,CESENA,ITALY		SERVADEI, F (corresponding author), OSPED BUFALINI,DIV NEUROSURG,VIA GHIROTTI 286,I-47023 CESENA,ITALY.			Servadei, Franco/0000-0002-3595-3464			ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BRIGGS M, 1984, BRIT MED J, V288, P983; BULLOCK R, 1985, NEUROSURGERY, V16, P602, DOI 10.1227/00006123-198505000-00003; BULLOCK R, 1990, HDB CLIN NEUROLOGY H, V13, P249; CHAN KH, 1990, J NEUROSURG, V72, P189, DOI 10.3171/jns.1990.72.2.0189; COOPER K D, 1983, Neuroepidemiology, V2, P70, DOI 10.1159/000110512; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; EDNA TH, 1983, ACTA CHIR SCAND, V149, P449; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; FISHER RP, 1981, J TRAUMA, V21, P920; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JENNETT B, 1977, LANCET, V1, P873; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLAUBER MR, 1981, AM J EPIDEMIOL, V113, P500, DOI 10.1093/oxfordjournals.aje.a113125; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MANN KS, 1986, CHILD NERV SYST, V2, P258; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; PANG D, 1983, J NEUROSURG, V59, P958, DOI 10.3171/jns.1983.59.6.0958; POZZATI E, 1986, NEUROSURGERY, V18, P696, DOI 10.1227/00006123-198606000-00003; RIMEL RW, 1987, NEUROSURGERY, V21, P51; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; SERVADEI F, 1989, ACTA NEUROCHIR, V96, P39, DOI 10.1007/BF01403493; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; SERVADEI F, 1991, LANCET, V337, P788, DOI 10.1016/0140-6736(91)91403-H; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; VIGOUROUX RD, 1983, ADV NEUROTRAUMATOLOG, P128; VOLLMER DG, 1991, NEUROSURGERY CLIN N, P437	33	22	22	0	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010	0090-3019			SURG NEUROL	Surg. Neurol.	APR	1993	39	4					269	275		10.1016/0090-3019(93)90003-J			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	LD877	WOS:A1993LD87700003	8488443				2022-02-06	
J	RIELLY, JP; BRANDT, ML; MATTOX, KL; POKORNY, WJ				RIELLY, JP; BRANDT, ML; MATTOX, KL; POKORNY, WJ			THORACIC TRAUMA IN CHILDREN	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							EMERGENCY ROOM THORACOTOMY; CHEST TRAUMA	Thirty-seven children were admitted for the treatment of thoracic injuries during a 15-year period. Two thirds suffered blunt trauma. Of these children with blunt injuries, three quarters were male, with a median age of 6 years. Half of all victims of blunt trauma were between the ages of 4 and 6 years, and most were involved in motor vehicle crashes. Thirteen children (35%) were victims of penetrating trauma. Sixty-nine percent were male. The median age was 13 years, with 9 of 13 patients in their teenage years. Injuries were evenly distributed between stab and gunshot wounds. Eight of the 37 patients (22%) required thoracotomy. Fourteen had associated intra-abdominal injuries. Twelve of these patients had injuries that required exploratory laparotomy and two were managed expectantly. There were 27 patients with lung injuries, three quarters of whom were managed with tube thoracostomy alone. Seven children suffered injuries that resulted in their deaths. Six had been struck by a motor vehicle. Four of these six died of closed head injuries. The overall mortality of patients with blunt trauma was 25%.	BAYLOR COLL MED,CORA & WEBB MADING DEPT SURG,HOUSTON,TX 77030								BAKER CC, 1980, J TRAUMA, V20, P848, DOI 10.1097/00005373-198010000-00005; BEALL AC, 1972, J TRAUM, V12, P468, DOI 10.1097/00005373-197206000-00003; BEAVER BL, 1987, J PEDIATR SURG, V22, P19, DOI 10.1016/S0022-3468(87)80007-6; Bellinger S B, 1972, Ann Thorac Surg, V14, P635; Brandt M., 1987, EMERG CARE Q, V3, P45; COSELLI JS, 1984, AM J SURG, V148, P786, DOI 10.1016/0002-9610(84)90438-0; DANNE PD, 1984, J TRAUMA, V24, P796, DOI 10.1097/00005373-198409000-00004; GOLLADAY ES, 1979, J TRAUMA, V19, P526, DOI 10.1097/00005373-197919070-00008; GRAHAM JM, 1979, J TRAUMA, V19, P665, DOI 10.1097/00005373-197909000-00005; JONES KW, 1980, SURG CLIN N AM, V60, P957; LOCICERO J, 1989, SURG CLIN N AM, V69, P15; MATTOX KL, 1974, J THORAC CARDIOV SUR, V68, P886; MATTOX KL, 1984, DISASTER MED, pCH24; MAYFIELD W, 1984, AM J SURG, V148, P162, DOI 10.1016/0002-9610(84)90305-2; OGORMAN RB, 1984, ARCH SURG-CHICAGO, V119, P568; PICKARD LR, 1988, TRAUMA, pCH22; SCHWAITZBERG SD, 1987, EMERG CARE Q, V3, P1; SHIMAZU S, 1983, J TRAUMA, V23, P213, DOI 10.1097/00005373-198303000-00006; SMYTH BT, 1979, J PEDIATR SURG, V14, P41, DOI 10.1016/S0022-3468(79)80574-6; TRUNKEY DD, 1984, CURRENT THERAPY TRAU; VIJ D, 1983, SURGERY, V94, P554; WASHINGTON B, 1985, ANN THORAC SURG, V40, P186; WILSON JM, 1978, ARCH SURG-CHICAGO, V113, P846	23	22	24	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1993	34	3					329	331		10.1097/00005373-199303000-00003			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	KZ702	WOS:A1993KZ70200004	8483169				2022-02-06	
J	MACLAREN, RE; GHOORAHOO, HI; KIRBY, NG				MACLAREN, RE; GHOORAHOO, HI; KIRBY, NG			USE OF AN ACCIDENT AND EMERGENCY DEPARTMENT OBSERVATION WARD IN THE MANAGEMENT OF HEAD-INJURY	BRITISH JOURNAL OF SURGERY			English	Article							INTRACRANIAL HEMATOMA; ADMISSION	The management of 405 patients presenting with head injury to an accident and emergency department was assessed. Sixty-nine patients were admitted, although this number should have been 127 according to current guidelines on the management of head injury. Only three attenders were admitted inappropriately according to these guidelines. An accident and emergency observation ward was open on weekdays only; at weekends, patients with head injury were admitted to a general surgical ward. When the observation ward was open, 51 of the 76 patients (67 per cent) presenting with admission criteria were admitted. When closed, only 15 of the 51 patients (29 per cent) with these criteria were admitted. Guidelines were applied effectively to reduce the number of unnecessary admissions, but there was a significant number of patients with minor head injury who were discharged inappropriately. This number was much reduced when an observation ward was available.			MACLAREN, RE (corresponding author), GUYS HOSP,DEPT ACCID & EMERGENCY,ST THOMAS ST,LONDON SE1 9RT,ENGLAND.						[Anonymous], 1986, REPORT WORKING PARTY; BALLANTYNE E, 1986, IRCS MED SCI-BIOCHEM, V14, P63; CONRAD L, 1985, Journal of Emergency Medicine, V2, P325, DOI 10.1016/0736-4679(85)90285-9; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DALLOS V, 1981, BRIT MED J, V282, P37, DOI 10.1136/bmj.282.6257.37; FOWKES FGR, 1986, BRIT J SURG, V73, P891, DOI 10.1002/bjs.1800731112; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; JONES JJ, 1981, LANCET, V1, P850; Maimaris C, 1991, Health Trends, V23, P33; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; MORGAN WJ, 1981, BRIT MED J, V282, P398; STRANG I, 1978, INJURY, V10, P154; SWANN IJ, 1981, INJURY, V12, P274, DOI 10.1016/0020-1383(81)90200-X; WESTON PAM, 1981, BRIT J SURG, V68, P663, DOI 10.1002/bjs.1800680917; 1984, BMJ, V288, P983	17	22	22	0	0	BLACKWELL SCIENCE LTD	OXFORD	OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL	0007-1323			BRIT J SURG	Br. J. Surg.	FEB	1993	80	2					215	217		10.1002/bjs.1800800230			3	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	KN297	WOS:A1993KN29700024	8443658				2022-02-06	
J	DIGIOVANNA, T; ROSEN, T; FORSETT, R; SIVERTSON, K; KELEN, GD				DIGIOVANNA, T; ROSEN, T; FORSETT, R; SIVERTSON, K; KELEN, GD			SHIPBOARD MEDICINE - A NEW NICHE FOR EMERGENCY-MEDICINE	ANNALS OF EMERGENCY MEDICINE			English	Article								Study objectives: To describe the spectrum of illness that presents to shipboard hospitals and thereby recommend optimal qualifications for the ship's medical personnel. Design: Retrospective review of medical logs from two cruise ships' hospitals. Settings: Two passenger cruise ships, with seven-to-ten day cruises in the Caribbean. Participants: All patients presenting to the ships' hospitals from January 4,1989, to June 10, 1989, on one ship and from October 13, 1990, to November 10, 1990, on another ship. Methods: Analysis of ship medical logs with regard to patient complaint, diagnosis, and treatment. Results: Of 1,547 new patient visits, 12% were related to injuries and 88% to medical problems; 97% of visits were noncritical, and 3% required immediate emergency intervention. Among these were four cardiac arrests, two stab wounds, two serious ocular injuries, one closed-head injury, and one near-drowning. Five patients required endotracheal intubation. Conclusion: There is a sizeable number of visits to ships' hospitals by patients with acute and serious problems of a wide variety. Physicians and nurses with significant emergency training or experience are best qualified to deal with this broad spectrum of patient problems in this isolated environment.	JOHNS HOPKINS UNIV,SCH MED,DEPT EMERGENCY MED,BALTIMORE,MD 21205					Kelen, Gabor/0000-0002-3236-8286				0	22	23	0	4	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	DEC	1992	21	12					1476	1479		10.1016/S0196-0644(05)80065-4			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JZ893	WOS:A1992JZ89300015	1443847				2022-02-06	
J	VRANKOVIC, D; HECIMOVIC, I; SPLAVSKI, B; DMITROVIC, B				VRANKOVIC, D; HECIMOVIC, I; SPLAVSKI, B; DMITROVIC, B			MANAGEMENT OF MISSILE WOUNDS OF THE CEREBRAL DURA-MATER - EXPERIENCE WITH 69 CASES	NEUROCHIRURGIA			English	Article						WAR WOUNDS; DURA MATER; GRAFT; PRIMARY COVERING		Over the period of seven months: from July 1991 to January 1992 sixty-nine patients with penetrating head war-injuries, were admitted in our hospital. Missile wounds of the dura mater require in most cases urgent operative management: watertight closure of the dura defects. However, a dilemma still exists as to the best material to be used to restore the missile dural defects. There are several possibilities: an autologous substitute as periosteum (pericranium) from surrounding, fascia of the temporalis muscle, fascia lata, or allograft transplant as lyophilised cerebral dura mater (lyodura). In the group of 69 patients, 7 were treated conservatively, 13 were treated surgically, but without closing the dural wounds because of their critical condition, and in 45 surgically treated patients the dural defects were covered with 53 transplants: with periosteum in 22 patients but 24 coverings, with fascia of temporalis muscle in 2 patients, with lyodura in 6 patients, with fascia lata in 15 patients but 21 coverings. In 4 patients the dura wounds were sutured by interrupted sutures. The best results were obtained in the fascia lata group.			VRANKOVIC, D (corresponding author), GEN HOSP OSIJEK, DEPT NEUROSURG, J HUTTLER STR 4, OSIJEK 54000, CROATIA.		Dmitrovic, Branko/AAP-4365-2020	Dmitrovic, Branko/0000-0002-5797-8013; Splavski, Bruno/0000-0002-4483-9364				0	22	23	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0028-3819			NEUROCHIRURGIA		SEP	1992	35	5					150	155					6	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JR619	WOS:A1992JR61900004	1436364				2022-02-06	
J	BARKLEY, GL; MORAN, JE; TAKANASHI, Y; TEPLEY, N				BARKLEY, GL; MORAN, JE; TAKANASHI, Y; TEPLEY, N			TECHNIQUES FOR DC MAGNETOENCEPHALOGRAPHY	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						MAGNETOENCEPHALOGRAPHY; NEUROMAGNETISM; DC MAGNETOENCEPHALOGRAPHY; ARTIFACTS; SUPERCONDUCTING QUANTUM INTERFERENCE DEVICE	MIGRAINE	DC shifts are known to occur in association with a number of physiologic phenomena including spreading depression, hypoxia, epilepsy, and hypercapnia and possibly in migraine, closed head injury, and ischemia. Magnetoencephalography (MEG) makes it possible to record these shifts by prolonged DC monitoring of brain activity and offers several advantages over DC EEG and DC electrocorticography. Among the advantages of MEG is its non-invasive nature and the lack of impedance changes at the electrode-tissue interface that produce baseline shifts in DC EEG. In DC MEG measurements, great care must be taken in dealing with a variety of artifactual signals. Environmental noise can be reduced by magnetic shielding and recognized by use of reference magnetometers. Patient-generated artifacts are numerous and can be recognized and limited by a variety of methods.	HENRY FORD HOSP,DEPT NEUROL,DETROIT,MI 48202; OAKLAND UNIV,DEPT PHYS,ROCHESTER,MI 48063								ANTERVO A, 1985, ELECTROEN CLIN NEURO, V61, P247, DOI 10.1016/0013-4694(85)91091-0; BARKLEY GL, 1990, HEADACHE, V30, P428, DOI 10.1111/j.1526-4610.1990.hed3007428.x; Caspers H., 1969, BASIC MECH EPILEPSIE, P375; CHAKKALAKAL DA, 1988, IEEE T BIO-MED ENG, V35, P19, DOI 10.1109/10.1332; COHEN D, 1978, CIRC RES, V36, P414; Fagaly R L, 1990, Adv Neurol, V54, P11; GARDNERMEDWIN AR, 1991, BRAIN RES, V540, P153, DOI 10.1016/0006-8993(91)90502-M; KATILA T, 1981, J APPL PHYS, V52, P2585; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; LEAO AAP, 1944, J NEUROPHYSIOL, V7, P379; LEHMENKUHLER A, 1989, EPILEPSIE, V88, P364; LOKIETEK W, 1974, J BONE JOINT SURG BR, VB 56, P361, DOI 10.1302/0301-620X.56B2.361; MONAKHOV KK, 1962, PHYSIOL BOHEMOSLOV, V11, P269; Okada Y, 1990, Adv Neurol, V54, P133; OKADA YC, 1988, BRAIN RES, V442, P185, DOI 10.1016/0006-8993(88)91450-3; ROMANI G L, 1988, Brain Topography, V1, P5, DOI 10.1007/BF01129335; ROMANI GL, 1982, REV SCI INSTRUM, V53, P1815, DOI 10.1063/1.1136907; SHOENEN J, 1986, CEPHALALGIA, V6, P229; STODIEK SRG, 1987, ADV EPILEPTOL, V16, P123; Tepley N, 1989, Funct Neurol, V4, P321; VANHARREVELD A, 1954, J NEUROPHYSIOL, V17, P505; VRBA J, 1989, ADV BIOMAGNETISM, P733; WELCH KMA, 1990, NEUROL CLIN, V8, P817, DOI 10.1016/S0733-8619(18)30319-0; WILLIAMSON SJ, 1981, J MAGN MAGN MATER, V22, P129, DOI 10.1016/0304-8853(81)90078-0	24	22	22	1	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0736-0258			J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	APR	1991	8	2					189	199		10.1097/00004691-199104000-00006			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FK455	WOS:A1991FK45500006	2050818				2022-02-06	
J	RICHARDS, JS; OSUNA, FJ; JAWORSKI, TM; NOVACK, TA; LELI, DA; BOLL, TJ				RICHARDS, JS; OSUNA, FJ; JAWORSKI, TM; NOVACK, TA; LELI, DA; BOLL, TJ			THE EFFECTIVENESS OF DIFFERENT METHODS OF DEFINING TRAUMATIC BRAIN INJURY IN PREDICTING POSTDISCHARGE ADJUSTMENT IN A SPINAL-CORD INJURY POPULATION	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						ADJUSTMENT; BRAIN INJURIES; SPINAL CORD INJURIES	CLOSED HEAD-INJURY; VALIDATION	Traumatic brain injury (TBI) can occur concomitantly with spinal cord injury (SCI). Much of the initial work in this area has focused on identifying coincidence rates and risk factors; less has focused on possible long-term implications of TBI when it occurs with SCI. In this study, SCI/TBI and neurologically matched SCI-only groups were formed on the basis of clinicians' ratings of neuropsychologic test scores. SCI/TBI and SCI-only groups were also formed using Halstead Category cutoff scores, presence/absence of loss of consciousness, and clinicians' ratings of severity of TBI. Dependent measures assessed an average of two years postinjury measured personal, social, and family adjustment of the individual with SCI and that of a significant other. Loss of consciousness and nonconsensus clinical ratings of presence/absence of TBI predicted postdischarge adjustment poorly. Severity ratings in the moderate to severe range, and Category cutoff scores did have some predictive value, with patients defined as impaired being more likely to report adjustment difficulties or being described as having adjustment difficulties by a significant other. The difficulty of making unequivocal diagnoses of TBI in this population is discussed and implications for future research delineated.	UNIV ALABAMA,BIRMINGHAM,AL 35294		RICHARDS, JS (corresponding author), SPAIN REHABIL CTR,1717 6TH AVE,BIRMINGHAM,AL 35233, USA.						ALEXANDER M, 1980, REHABILITATION I CHI; BERGNER M, 1976, MED CARE, V14, P57, DOI 10.1097/00005650-197601000-00006; BOND MR, 1984, REHABILITATION HEAD, P111; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Colohan A. R. T., 1986, J HEAD TRAUMA REHAB, V1, P13; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF G, 1988, 14TH ANN AM SPIN INJ; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; HARRIS P, 1986, PARAPLEGIA, V5, P215; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LOLLAR D, 1988, 95TH ANN AM PSYCH AS; LONG CJ, 1986, SOUTHERN MED J, V79, P728, DOI 10.1097/00007611-198606000-00020; LUNDHOLM J, 1975, SCAND J REHABIL MED, V7, P97; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OLSON DH, 1986, FAM PROCESS, V25, P337, DOI 10.1111/j.1545-5300.1986.00337.x; PORTER RW, 1973, 19TH P VET ADM SPIN, P188; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; RICHARDS JS, 1986, J REHABIL, V52, P50; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROSENTHALL M, 1984, REHABILITATION HEAD, P202; SCHUENEMAN A, 1982, SCI DIG, V4, P35; SILVER JR, 1980, INJURY, V12, P219, DOI 10.1016/0020-1383(80)90011-X; WAGNER KA, 1984, ASIA ABSTR DIG, P1096; Walker A E, 1972, Scand J Rehabil Med, V4, P5; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0	29	22	22	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	1991	72	5					275	279					5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	FF342	WOS:A1991FF34200002	2009041				2022-02-06	
J	OGAWA, T				OGAWA, T			BLADDER DEFORMITIES IN PATIENTS WITH NEUROGENIC BLADDER DYSFUNCTION	UROLOGIA INTERNATIONALIS			English	Article						NEUROGENIC BLADDER DYSFUNCTION; BLADDER DEFORMITY		231 patients with neurogenic bladder dysfunction were evaluated for bladder deformities. Bladder deformity implies bladder trabeculation and deformity of bladder shape such as pine tree shape. Bladder deformity was judged radiographically at maximum cystometric capacity and classified into grade 0 (none), grade I (mild), grade II (moderate) and grade III (severe). Upper urinary tract deterioration (hydronephrosis and/or reflux) was found in 2% of grade 0, 8% of grade I, 52% of grade II and 62% of grade III. I suggested that bladder deformity was one of the risk factors for upper tract deterioration. High grade deformity (grade II and III) was found more frequently in traumatic spinal cord injury and spinal dysraphism than brain disease. Most patients with low compliance bladder had high grade bladder deformity. The management program including clean intermittent catheterization was effective in preventing bladder deformities.			OGAWA, T (corresponding author), WAKAYAMA ROHSAI HOSP,DEPT UROL,WAKAYAMA,JAPAN.							0	22	22	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0042-1138			UROL INT	Urol.Int.		1991	47			1			59	62		10.1159/000282252			4	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	GD446	WOS:A1991GD44600016	1949379				2022-02-06	
J	SAZBON, L; GROSWASSER, Z				SAZBON, L; GROSWASSER, Z			MEDICAL COMPLICATIONS AND MORTALITY OF PATIENTS IN THE POSTCOMATOSE UNAWARENESS (PC-U) STATE	ACTA NEUROCHIRURGICA			English	Article						VEGETATIVE STATE; APALLIC SYNDROME; POSTCOMATOSE UNAWARENESS; MORTALITY; COMPLICATIONS; ETHICAL PROBLEMS; ECONOMIC ASPECTS	PROLONGED POSTTRAUMATIC UNAWARENESS; VEGETATIVE-STATE; CONSCIOUSNESS; PROGNOSIS	Almost half of all patients with traumatic brain injury who remain unconscious for more than one month will not recover consciousness and will remain in a state of prolonged postcomatose unawareness (PC-U). The aim of this work is to present the survival rate and medical complications of such patients. The survival time of the 62 patients studied ranged from 2 to 115 months, with a median of 15.5 +/- 22 months. Cumulative mortality figures were 15% at 3 months, 40% at 6 months and 60% and the end of the first year. The figures at the end of the second, third and fifth years were 86%, 87% and 94%, respectively. This type of data may aid in decisions regarding the management of these patients. The longer survival with better treatment of patients in a state of PC-U poses severe ethical, medical, legal and economic problems with which society will have to deal.	TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL		SAZBON, L (corresponding author), LOEWENSTEIN HOSP & REHABIL CTR,POB 3,IL-43100 RAANANA,ISRAEL.						BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; GROSWASSER Z, 1990, J NEUROSURG, V72, P81, DOI 10.3171/jns.1990.72.1.0081; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; JENNET B, 1981, MANAGEMENT HEAD INJU, P312; Levy D E, 1978, Ann N Y Acad Sci, V315, P293, DOI 10.1111/j.1749-6632.1978.tb50347.x; NAJENSON T, 1983, 1ST INT C ASS REH CO, P109; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; Sazbon L, 1991, Brain Inj, V5, P1, DOI 10.3109/02699059108998504	9	22	23	0	1	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1991	112	3-4					110	112		10.1007/BF01405137			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GW761	WOS:A1991GW76100008	1776511				2022-02-06	
J	GAIDOLFI, E; VIGNOLO, LA				GAIDOLFI, E; VIGNOLO, LA			CLOSED HEAD-INJURIES OF SCHOOL-AGE CHILDREN - NEUROPSYCHOLOGICAL SEQUELAE IN EARLY ADULTHOOD	ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article											GAIDOLFI, E (corresponding author), UNIV MILAN,CTR NEUROPSICOL,NEUROL CLIN,I-20122 MILAN,ITALY.							0	22	22	0	2	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0392-0461			ITAL J NEUROL SCI	Ital. J. Neurol. Sci.		1980	1	2					65	73					9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JU440	WOS:A1980JU44000001	7338453				2022-02-06	
J	AIRD, RB; STRAIT, LS; ZEALEAR, D; HRENOFF, M				AIRD, RB; STRAIT, LS; ZEALEAR, D; HRENOFF, M			NEUROPHYSIOLOGICAL STUDIES ON CEREBRAL CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																	Aird RB, 1944, J NERV MENT DIS, V99, P501, DOI 10.1097/00005053-194405000-00005; AIRD RB, 1951, J PHARMACOL EXP THER, V103, P136; Aird RB, 1944, ARCH NEURO PSYCHIATR, V51, P54, DOI 10.1001/archneurpsyc.1944.02290250060004; AIRD RB, 1945, RES PUBL ASSOC RES N, V24, P283; BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; Broman T., 1949, PERMEABILITY CEREBRO; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; Dandy WE, 1925, B JOHNS HOPKINS HOSP, V36, P40; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Evans JP, 1943, ARCH NEURO PSYCHIATR, V50, P258, DOI 10.1001/archneurpsyc.1943.02290210036002; EVANS JP, 1950, ACUTE HEAD INJURY, V5; FRIES BA, COMMUNICATION; GREIG ME, 1949, SCIENCE, V110, P237, DOI 10.1126/science.110.2853.237; GROAT RA, 1945, J NEUROSURG, V2, P26, DOI 10.3171/jns.1945.2.1.0026; JASPER H, 1945, RES PUBL ASS NERV ME, V24, P388; Matson DD, 1948, TREATMENT ACUTE CRAN; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; SAUERBRUCH, 1913, VERH DTSCH GES CHIR, V42, P144; SEGERBERG LH, 1949, SURG CLIN N AM, V29, P1301; SPIEGEL EA, 1947, T AM NEUROL ASSOC, P169; SPIEGEL EA, 1946, AM J PHYSIOL, V146, P12, DOI 10.1152/ajplegacy.1946.146.1.12; SPIEGELADOLF M, 1945, FED PROC, V4, P104; SPURLING RG, 1946, SURGICAL TREATMENT N, V17, P27; Strait LA, 1941, J PHARMACOL EXP THER, V73, P363; STROWGER B, COMMUNICATION; TOWER DB, 1948, J CLIN INVEST, V27, P558; WALKER AE, 1945, RES PUBL A NERV MENT, V24, P437; WARD A, 1950, J NEUROSURG, V7, P398, DOI 10.3171/jns.1950.7.5.0398; White JC, 1943, ANN SURG, V119, P619, DOI 10.1097/00000658-194310000-00010; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1946, J NEUROSURG, V3, P157, DOI 10.3171/jns.1946.3.2.0157; WINDLE WF, 1944, FED PROC, V3, P53; [No title captured]	33	22	22	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.		1952	9	4					331	347		10.3171/jns.1952.9.4.0331			17	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UN073	WOS:A1952UN07300002	14946575				2022-02-06	
J	EICHELBERGER, L; KOLLROS, JJ; WALKER, AE				EICHELBERGER, L; KOLLROS, JJ; WALKER, AE			WATER, NITROGEN AND ELECTROLYTE CONTENT OF BRAIN FOLLOWING CEREBRAL CONCUSSION	AMERICAN JOURNAL OF PHYSIOLOGY			English	Article																	Childs A, 1942, AM J PHYSIOL, V137, P384; Darrow DC, 1935, J CLIN INVEST, V14, P266, DOI 10.1172/JCI100674; Eichelberger L, 1944, J BIOL CHEM, V154, P21; Eichelberger L, 1942, J BIOL CHEM, V142, P467; Eichelberger L, 1941, J BIOL CHEM, V140, P467; Gurdjian ES, 1943, SURGERY, V13, P333; LEHMAN EP, 1935, INT CLIN, V3, P180; Manery JF, 1941, AM J PHYSIOL, V132, P0215, DOI 10.1152/ajplegacy.1941.132.1.215; Pilcher C, 1937, ARCH SURG-CHICAGO, V35, P512, DOI 10.1001/archsurg.1937.01190150095009; PILCHER C, 1941, SURG GYNECOL OBSTET, V72, P755; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Wallace GB, 1940, J PHARMACOL EXP THER, V70, P418; WHITE JC, 1943, ANN SURG, V118, P619	13	22	22	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0002-9513			AM J PHYSIOL	Am. J. Physiol.		1949	156	1					129	136		10.1152/ajplegacy.1949.156.1.129			8	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	YB524	WOS:A1949YB52400017	18117583				2022-02-06	
J	LEWIN, W				LEWIN, W			ACUTE SUBDURAL AND EXTRADURAL HAEMATOMA CLOSED HEAD INJURIES - HUNTERIAN LECTURE DELIVERED AT THE ROYAL-COLLEGE-OF-SURGEONS-OF-ENGLAND ON 23RD FEBRUARY, 1949	ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND			English	Article																	BELL C, 1817, SURGICAL OBSERVATION, V1, P466; ERICHSEN JE, 1884, SCI ART SURGERY, V1, P755; Falconer MA, 1942, LANCET, V1, P532; HUNTER J, 1786, WORKS J HUNTER, V1, P486; HUTCHINSON J, 1967, LONDON HOSP REP, V4, P28; Jacobson WHA, 1886, GUYS HOSP REP, V43, P147; Jones FW, 1912, LANCET, V2, P7; LEBEAU J, 1943, UNION MED CAN, V72, P761; MARRIOTT HL, 1947, BRIT MED J, V1, P245, DOI 10.1136/bmj.1.4493.245; Mckenzie KG, 1938, BRIT J SURG, V26, P346, DOI 10.1002/bjs.18002610215; Meyer A, 1920, ARCH NEURO PSYCHIATR, V4, P387, DOI 10.1001/archneurpsyc.1920.02180220036003; Munro D, 1941, ANN SURG, V113, P192, DOI 10.1097/00000658-194102000-00003; Munro D, 1942, NEW ENGL J MED, V227, P87, DOI 10.1056/NEJM194207162270301; MUNRO D, 1938, CRANIOCEREBRAL INJUR; POTT P, 1759, OBSERVATIONS NATURE; Putnam TJ, 1925, ARCH SURG-CHICAGO, V11, P329, DOI 10.1001/archsurg.1925.01120150002001; Reid WL, 1939, J AMER MED ASSOC, V112, P2030, DOI 10.1001/jama.1939.02800200028008; Rowbotham GF, 1942, ACUTE INJURIES HEAD; Traquair HM, 1927, INTRO CLIN PERIMETRY; TROTTER W, 1915, BRIT J SURG, V2, P520	20	22	22	0	0	ROYAL COLL SURGEONS ENGLAND	LONDON	35-43 LINCOLN'S INN FIELDS, LONDON WC2A 3PN, ENGLAND	0035-8843			ANN ROY COLL SURG	Ann. R. Coll. Surg. Engl.		1949	5	4					240	274					35	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	YG614	WOS:A1949YG61400002	18143996				2022-02-06	
J	Moore, EE; Moore, HB; Kornblith, LZ; Neal, MD; Hoffman, M; Mutch, NJ; Schochl, H; Hunt, BJ; Sauaia, A				Moore, Ernest E.; Moore, Hunter B.; Kornblith, Lucy Z.; Neal, Matthew D.; Hoffman, Maureane; Mutch, Nicola J.; Schoechl, Herbert; Hunt, Beverley J.; Sauaia, Angela			Trauma-induced coagulopathy	NATURE REVIEWS DISEASE PRIMERS			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; FRESH-FROZEN PLASMA; QUALITY-OF-LIFE; ENDOTHELIAL GLYCOCALYX DEGRADATION; ADMISSION RAPID THROMBELASTOGRAPHY; DAMAGE CONTROL RESUSCITATION; GOAL-DIRECTED-RESUSCITATION; CHRONIC CRITICAL ILLNESS; DEEP VENOUS THROMBOSIS; RED-BLOOD-CELLS	Uncontrolled haemorrhage is a major preventable cause of death in patients with traumatic injury. Trauma-induced coagulopathy (TIC) describes abnormal coagulation processes that are attributable to trauma. In the early hours of TIC development, hypocoagulability is typically present, resulting in bleeding, whereas later TIC is characterized by a hypercoagulable state associated with venous thromboembolism and multiple organ failure. Several pathophysiological mechanisms underlie TIC; tissue injury and shock synergistically provoke endothelial, immune system, platelet and clotting activation, which are accentuated by the 'lethal triad' (coagulopathy, hypothermia and acidosis). Traumatic brain injury also has a distinct role in TIC. Haemostatic abnormalities include fibrinogen depletion, inadequate thrombin generation, impaired platelet function and dysregulated fibrinolysis. Laboratory diagnosis is based on coagulation abnormalities detected by conventional or viscoelastic haemostatic assays; however, it does not always match the clinical condition. Management priorities are stopping blood loss and reversing shock by restoring circulating blood volume, to prevent or reduce the risk of worsening TIC. Various blood products can be used in resuscitation; however, there is no international agreement on the optimal composition of transfusion components. Tranexamic acid is used in pre-hospital settings selectively in the USA and more widely in Europe and other locations. Survivors of TIC experience high rates of morbidity, which affects short-term and long-term quality of life and functional outcome. Trauma-induced coagulopathy describes alterations in haemostasis (such as fibrinogen depletion, inadequate thrombin generation, impaired platelet function and dysregulated fibrinolysis) that can result in both uncontrolled bleeding and hypercoagulation, leading to venous thromboembolism and multiple organ failure.	[Moore, Ernest E.] Denver Hlth, Ernest E Moore Shock Trauma Ctr, Denver, CO 80204 USA; [Moore, Ernest E.; Moore, Hunter B.; Sauaia, Angela] Univ Colorado Denver, Dept Surg, Aurora, CO 80204 USA; [Kornblith, Lucy Z.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Trauma & Surg Crit Care, San Francisco, CA 94143 USA; [Neal, Matthew D.] Univ Pittsburgh, Med Ctr, Pittsburgh Trauma Res Ctr, Pittsburgh, PA USA; [Hoffman, Maureane] Duke Univ, Sch Med, Durham VA Med Ctr, Transfus Serv, Durham, NC USA; [Mutch, Nicola J.] Univ Aberdeen, Inst Med Sci, Sch Med Med Sci & Nutr, Aberdeen Cardiovasc & Diabet Ctr, Aberdeen, Scotland; [Schoechl, Herbert] Paracelsus Med Univ, Acad Teaching Hosp, AUVA Trauma Ctr Salzburg, Dept Anesthesiol & Intens Care Med, Salzburg, Austria; [Schoechl, Herbert] AUVA Trauma Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [Hunt, Beverley J.] Kings Coll London, London, England; [Sauaia, Angela] Univ Colorado Denver, Colorado Sch Publ Hlth, Aurora, CO USA		Moore, EE (corresponding author), Denver Hlth, Ernest E Moore Shock Trauma Ctr, Denver, CO 80204 USA.; Moore, EE (corresponding author), Univ Colorado Denver, Dept Surg, Aurora, CO 80204 USA.	Ernest.Moore@dhha.org		Hunt, Beverley/0000-0002-4709-0774	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIGMS: 1-6 P50 GM49222, 1-6 T32 GM08315, 1-2 U54 GM 62119, RM1 GM 131968, NHLBI: UM1 HL120877, NIGMS: K23GM130892-01, NIGMS: R35 GM119526, NHLBI R01 HL141080, NHBLI: K99HL1518870]	E.E.M. and A.S. appreciate the generous support from the National Institutes of Health for their inflammation and coagulation research over the past 35 years (NIGMS: 1-6 P50 GM49222, 1-6 T32 GM08315, 1-2 U54 GM 62119, RM1 GM 131968 and NHLBI: UM1 HL120877). H.B.M. acknowledges the generous support from the National Institutes of Health (NHBLI: K99HL1518870) L.Z.K. acknowledges the generous support from the National Institutes of Health for her platelet biology research (NIGMS: K23GM130892-01). M.D.N. acknowledges the generous support by the National Institutes of Health (NIGMS: R35 GM119526 and NHLBI R01 HL141080).	ACS Committee on Trauma, 2014, ACS TQIP MASS TRANSF; Anderson DR, 2019, BLOOD ADV, V3, P3898, DOI 10.1182/bloodadvances.2019000975; Arslan ED, 2015, EUR J TRAUMA EMERG S, V41, P319, DOI 10.1007/s00068-014-0439-y; Baksaas-Aasen K, 2021, INTENS CARE MED, V47, P49, DOI 10.1007/s00134-020-06266-1; Baksaas-Aasen K, 2019, ANN SURG, V270, P1178, DOI 10.1097/SLA.0000000000002825; Ban KC, 2015, SHOCK, V44, P452, DOI 10.1097/SHK.0000000000000452; Barrett CD, 2020, J TRAUMA ACUTE CARE, V89, P991, DOI 10.1097/TA.0000000000002941; Barrett CD, 2017, J TRAUMA ACUTE CARE, V83, P1053, DOI 10.1097/TA.0000000000001685; Benjamin E, 2017, ANN SURG, V266, P463, DOI 10.1097/SLA.0000000000002359; Berlin G, 2019, PLATELETS, V30, P473, DOI 10.1080/09537104.2018.1466387; Berndtson AE, 2016, J TRAUMA ACUTE CARE, V81, P493, DOI 10.1097/TA.0000000000001157; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Black JA, 2020, SEMIN THROMB HEMOST, V46, P215, DOI 10.1055/s-0039-3402426; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bouma BN, 2003, PATHOPHYSIOL HAEMO T, V33, P375, DOI 10.1159/000083832; Brenner A, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2900-4; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P1395, DOI 10.1097/TA.0b013e31825b9f05; Brown LM, 2011, J TRAUMA, V71, pS337, DOI 10.1097/TA.0b013e318227f67c; Butenas S, 1999, BLOOD, V94, P2169, DOI 10.1182/blood.V94.7.2169.419k22_2169_2178; Butler FK Jr., 2018, J SPEC OPER MED, V18, P37; Callcut RA, 2019, J TRAUMA ACUTE CARE, V86, P864, DOI 10.1097/TA.0000000000002205; Cannon WB, 1914, AM J PHYSIOL, V34, P232, DOI 10.1152/ajplegacy.1914.34.2.232; Cap A, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12914; Cap A, 2014, CURR OPIN CRIT CARE, V20, P638, DOI 10.1097/MCC.0000000000000158; Cardenas JC, 2019, SHOCK, V51, P273, DOI 10.1097/SHK.0000000000001160; Cardenas JC, 2014, J TRAUMA ACUTE CARE, V77, P839, DOI 10.1097/TA.0000000000000348; Cardenas JC, 2014, SHOCK, V41, P514, DOI 10.1097/SHK.0000000000000161; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHAKRABARTI R, 1969, J CLIN PATHOL, V22, P659, DOI 10.1136/jcp.22.6.659; Chang R, 2018, SURGERY, V163, P819, DOI 10.1016/j.surg.2017.10.050; Chapman BC, 2013, AM J SURG, V206, P917, DOI 10.1016/j.amjsurg.2013.07.024; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Christensen MC, 2011, J TRAUMA, V70, P1524, DOI 10.1097/TA.0b013e3181f053c2; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Colace TV, 2011, BIOCONJUGATE CHEM, V22, P2104, DOI 10.1021/bc200326v; Coleman JJ, 2015, J AM COLL SURGEONS, V220, P731, DOI 10.1016/j.jamcollsurg.2014.12.032; Coleman JR, 2021, J AM COLL SURGEONS, V232, P709, DOI 10.1016/j.jamcollsurg.2020.12.058; Coleman JR, 2020, ANN SURG, V271, pE128, DOI 10.1097/SLA.0000000000003726; Coleman JR, 2019, AM J SURG, V218, P1065, DOI 10.1016/j.amjsurg.2019.08.024; Coleman JR, 2019, SURGERY, V166, P1122, DOI 10.1016/j.surg.2019.07.014; Coleman JR, 2019, J TRAUMA ACUTE CARE, V87, P1052, DOI 10.1097/TA.0000000000002398; Coleman JR, 2019, J AM COLL SURGEONS, V228, P760, DOI 10.1016/j.jamcollsurg.2019.01.009; Corwin GS, 2020, J EMERG TRAUMA SHOCK, V13, P213, DOI 10.4103/JETS.JETS_45_19; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Cotton BA, 2012, J TRAUMA ACUTE CARE, V72, P1470, DOI 10.1097/TA.0b013e31824d56ad; Cotton BA, 2011, J TRAUMA, V71, P407, DOI 10.1097/TA.0b013e31821e1bf0; Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x; Croce MA, 2002, J TRAUMA, V53, P889, DOI 10.1097/00005373-200211000-00013; Davenport RA, 2017, ANESTHESIOLOGY, V126, P115, DOI 10.1097/ALN.0000000000001428; Deguchi H, 2016, BLOOD, V128, P1870, DOI 10.1182/blood-2016-03-707679; Dias JD, 2019, J THROMB HAEMOST, V17, P984, DOI 10.1111/jth.14447; Diebel ME, 2018, J TRAUMA ACUTE CARE, V84, P75, DOI 10.1097/TA.0000000000001726; Dietch ZC, 2015, SURGERY, V158, P379, DOI 10.1016/j.surg.2015.03.052; Ding N, 2014, CIRC-CARDIOVASC GENE, V7, P615, DOI 10.1161/CIRCGENETICS.113.000398; Ditzel RM, 2020, J TRAUMA ACUTE CARE, V88, P434, DOI 10.1097/TA.0000000000002570; Drake SA, 2020, ANN SURG, V271, P375, DOI 10.1097/SLA.0000000000002999; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Dupuis M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123111; Dyer MR, 2020, TRANSFUSION, V60, P1308, DOI 10.1111/trf.15856; Dyer MR, 2019, J THROMB HAEMOST, V17, P1733, DOI 10.1111/jth.14563; Dyer MR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20479-x; Dzik WH, 2007, TRANSFUSION MED, V17, P367, DOI 10.1111/j.1365-3148.2007.00795.x; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Einersen PM, 2017, J TRAUMA ACUTE CARE, V82, P114, DOI 10.1097/TA.0000000000001270; Engstrom M, 2006, J TRAUMA, V61, P624, DOI 10.1097/01.ta.0000226739.30655.75; Etchill E, 2016, TRANSFUSION, V56, P2478, DOI 10.1111/trf.13755; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; FARSETTI A, 1995, ENDOCRINOLOGY, V136, P5076, DOI 10.1210/en.136.11.5076; Fields AT, 2021, SHOCK, V55, P189, DOI 10.1097/SHK.0000000000001622; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Floccard B, 2012, INJURY, V43, P26, DOI 10.1016/j.injury.2010.11.003; Fox EE, 2017, SHOCK, V47, P567, DOI 10.1097/SHK.0000000000000788; FRANCIS JL, 1994, THROMB RES, V74, P335, DOI 10.1016/0049-3848(94)90149-X; Fraser SR, 2011, BLOOD, V117, P6371, DOI 10.1182/blood-2011-02-333203; Frith D, 2010, J THROMB HAEMOST, V8, P1919, DOI 10.1111/j.1538-7836.2010.03945.x; Gall LS, 2019, ANN SURG, V269, P1184, DOI 10.1097/SLA.0000000000002733; Gando S, 2006, SEMIN THROMB HEMOST, V32, P48, DOI 10.1055/s-2006-933340; Gando S, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.37; Gardner AK, 2019, CRIT CARE MED, V47, P566, DOI 10.1097/CCM.0000000000003655; Gary JL, 2016, J ORTHOP TRAUMA, V30, P294, DOI 10.1097/BOT.0000000000000523; Gee AC, 2008, SHOCK, V29, P334, DOI 10.1097/shk.0b013e3181506ee5; George RL, 2003, SHOCK, V19, P28, DOI 10.1097/00024382-200301000-00006; Gonzalez E, 2017, CRIT CARE CLIN, V33, P119, DOI 10.1016/j.ccc.2016.09.002; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Goolsby C, 2018, J TRAUMA ACUTE CARE, V84, P205, DOI 10.1097/TA.0000000000001732; Gorton HJ, 2000, ANESTH ANALG, V91, P1279, DOI 10.1097/00000539-200011000-00042; Griffin R, 2020, SHOCK, V54, P205, DOI 10.1097/SHK.0000000000001497; Gruen DS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135350; Guyette FX, 2021, JAMA SURG, V156, P11, DOI 10.1001/jamasurg.2020.4350; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haider AH, 2010, J TRAUMA, V69, P537, DOI 10.1097/TA.0b013e3181efc67b; HALT-IT Trial Collaborators, 2020, LANCET, V395, P1927, DOI 10.1016/S0140-6736(20)30848-5; Hamsen U, 2019, ORTHOP REV, V11, P171, DOI 10.4081/or.2019.8214; Haque SF, 2001, ENDOCR J, V48, P33, DOI 10.1507/endocrj.48.33; HARDAWAY RM, 1959, ANN SURG, V150, P261, DOI 10.1097/00000658-195908000-00008; Harr JN, 2015, EUR J TRAUMA EMERG S, V41, P49, DOI 10.1007/s00068-014-0400-0; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Hecht JP, 2021, J TRAUMA ACUTE CARE, V90, P54, DOI 10.1097/TA.0000000000002912; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Henriksen HH, 2017, J SURG RES, V214, P154, DOI 10.1016/j.jss.2017.02.037; HIIPPALA ST, 1995, ANESTH ANALG, V81, P360, DOI 10.1097/00000539-199508000-00026; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Hoffman M, 2013, TRANSFUSION, V53, P1594, DOI 10.1111/trf.12201; Holbrook TL, 2005, J TRAUMA, V59, P1126, DOI 10.1097/01.ta.0000196433.61423.f2; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holcomb JB, 2021, ANN SURG, V273, P395, DOI 10.1097/SLA.0000000000004563; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Holcomb JB, 2011, J TRAUMA, V71, pS318, DOI 10.1097/TA.0b013e318227edbb; Holley MAB, 2013, CHEST, V144, P966, DOI 10.1378/chest.12-2879; Huber D, 2002, BLOOD, V99, P3637, DOI 10.1182/blood.V99.10.3637; Hutchison TN, 2014, J SURG RES, V187, P625, DOI 10.1016/j.jss.2013.11.008; Inaba K, 2013, J AM COLL SURGEONS, V216, P290, DOI 10.1016/j.jamcollsurg.2012.10.017; INNES D, 1964, J CLIN PATHOL, V17, P1, DOI 10.1136/jcp.17.1.1; Itagaki Y, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-0291-9; Ives C, 2012, J AM COLL SURGEONS, V215, P496, DOI 10.1016/j.jamcollsurg.2012.06.005; Jochems D, 2018, INJURY, V49, P1661, DOI 10.1016/j.injury.2018.05.012; Johansson PI, 2012, J THROMB HAEMOST, V10, P207, DOI 10.1111/j.1538-7836.2011.04589.x; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Kalkwarf KJ, 2020, J TRAUMA ACUTE CARE, V89, P716, DOI 10.1097/TA.0000000000002833; Kashuk JL, 2008, J TRAUMA, V65, P261, DOI 10.1097/TA.0b013e31817de3e1; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; KASHUK JL, 1982, J TRAUMA, V22, P672, DOI 10.1097/00005373-198208000-00004; Kelly JM, 2018, ANAESTHESIA, V73, P1103, DOI 10.1111/anae.14297; Kitchen DP, 2010, SEMIN THROMB HEMOST, V36, P757, DOI 10.1055/s-0030-1265292; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Klok FA, 2014, BLOOD REV, V28, P221, DOI 10.1016/j.blre.2014.07.003; Knol HM, 2012, THROMB HAEMOSTASIS, V107, P22, DOI 10.1160/TH11-07-0481; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; Koh EY, 2019, AM J SURG, V218, P501, DOI 10.1016/j.amjsurg.2018.12.022; Kononova O, 2017, BIOCHEMISTRY-US, V56, P1932, DOI 10.1021/acs.biochem.6b01113; Kornblith LZ, 2019, J TRAUMA ACUTE CARE, V87, P1042, DOI 10.1097/TA.0000000000002459; Kornblith LZ, 2019, J THROMB HAEMOST, V17, P852, DOI 10.1111/jth.14450; Kornblith LZ, 2018, J TRAUMA ACUTE CARE, V85, P873, DOI 10.1097/TA.0000000000002025; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kornblith LZ, 2020, J TRAUMA ACUTE CARE, V88, P742, DOI 10.1097/TA.0000000000002681; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, pS83, DOI 10.1097/TA.0000000000000631; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Kutcher ME, 2015, J TRAUMA ACUTE CARE, V78, P516, DOI 10.1097/TA.0000000000000545; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Lee MY, 2017, J THROMB HAEMOST, V15, P2396, DOI 10.1111/jth.13863; Leeper CM, 2020, JAMA SURG, V155, P771, DOI 10.1001/jamasurg.2020.0811; Leeper CM, 2017, ANN SURG, V266, P508, DOI 10.1097/SLA.0000000000002355; Leeper CM, 2017, J TRAUMA ACUTE CARE, V82, P27, DOI 10.1097/TA.0000000000001308; Levy JH, 2012, ANESTH ANALG, V114, P261, DOI 10.1213/ANE.0b013e31822e1853; Li RZ, 2016, J TRAUMA ACUTE CARE, V80, P440, DOI 10.1097/TA.0000000000000915; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Lier H, 2008, J TRAUMA, V65, P951, DOI 10.1097/TA.0b013e318187e15b; Lundy JB, 2013, J TRAUMA ACUTE CARE, V75, pS215, DOI 10.1097/TA.0b013e318299da66; MACFARLANE RG, 1948, BLOOD, V3, P1167, DOI 10.1182/blood.V3.10.1167.1167; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Magnotti LJ, 2008, J AM COLL SURGEONS, V206, P984, DOI 10.1016/j.jamcollsurg.2007.12.038; Magnotti LJ, 2011, J TRAUMA, V70, P391, DOI 10.1097/TA.0b013e31820b5d98; Martini WZ, 2007, ANN SURG, V246, P831, DOI 10.1097/SLA.0b013e3180cc2e94; Martini WZ, 2009, J TRAUMA, V67, P202, DOI 10.1097/TA.0b013e3181a602a7; Martini WZ, 2005, J TRAUMA, V58, P1002, DOI 10.1097/01.TA.0000156246.53383.9F; Marumo M, 2001, THROMB RES, V104, P353, DOI 10.1016/S0049-3848(01)00374-7; McCully SP, 2013, J TRAUMA ACUTE CARE, V75, P947, DOI 10.1097/TA.0b013e3182a9676c; McQuilten ZK, 2017, INJURY, V48, P1074, DOI 10.1016/j.injury.2016.11.021; Meizoso JP, 2017, J AM COLL SURGEONS, V224, P575, DOI 10.1016/j.jamcollsurg.2016.12.018; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Meyer DE, 2018, J TRAUMA ACUTE CARE, V85, P691, DOI 10.1097/TA.0000000000002020; Mira JC, 2017, CRIT CARE MED, V45, P1989, DOI 10.1097/CCM.0000000000002697; Mitra B, 2014, SHOCK, V42, P307, DOI 10.1097/SHK.0000000000000219; Mitrophanov AY, 2020, ANESTH ANALG, V130, P1063, DOI 10.1213/ANE.0000000000004479; Miyata S., 2019, JPN J TRANSFUS CELL, V65, P21; Moore E., 2020, TRAUMA INDUCED COAGU, V2nd, P3; Moore EE, 1996, AM J SURG, V172, P405, DOI 10.1016/S0002-9610(96)00216-4; Moore EE, 2016, TRANSFUSION, V56, pS110, DOI 10.1111/trf.13486; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Moore HB, 2015, J THROMB HAEMOST, V13, P1878, DOI 10.1111/jth.13067; Moore HB, 2020, SEMIN THROMB HEMOST, V46, P189, DOI 10.1055/s-0039-1701016; Moore HB, 2020, J THROMB HAEMOST, V18, P740, DOI 10.1111/jth.14690; Moore HB, 2020, J TRAUMA ACUTE CARE, V88, P588, DOI 10.1097/TA.0000000000002614; Moore HB, 2019, ANESTH ANALG, V129, P762, DOI 10.1213/ANE.0000000000004234; Moore HB, 2019, J AM COLL SURGEONS, V229, P92, DOI 10.1016/j.jamcollsurg.2019.03.015; Moore HB, 2018, LANCET, V392, P283, DOI 10.1016/S0140-6736(18)31553-8; Moore HB, 2017, J SURG RES, V220, P438, DOI 10.1016/j.jss.2017.04.028; Moore HB, 2017, J TRAUMA ACUTE CARE, V83, P1014, DOI 10.1097/TA.0000000000001718; Moore HB, 2017, AM J SURG, V214, P1041, DOI 10.1016/j.amjsurg.2017.08.036; Moore HB, 2017, J AM COLL SURGEONS, V225, P138, DOI 10.1016/j.jamcollsurg.2017.02.018; Moore HB, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.206.206; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Moore HB, 2015, J TRAUMA ACUTE CARE, V79, P897, DOI 10.1097/TA.0000000000000792; Moore HB, 2015, J AM COLL SURGEONS, V220, P872, DOI 10.1016/j.jamcollsurg.2015.01.026; Moore HB, 2015, SHOCK, V43, P39, DOI 10.1097/SHK.0000000000000245; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Morrow GB, 2020, HAEMATOLOGICA, V105, P2824, DOI 10.3324/haematol.2019.230367; Morton AP, 2013, J SURG RES, V179, P5, DOI 10.1016/j.jss.2012.05.054; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Mutch NJ, 2010, J THROMB HAEMOST, V8, P2017, DOI 10.1111/j.1538-7836.2010.03963.x; Myers SP, 2020, ANZ J SURG, V90, P425, DOI 10.1111/ans.15670; Myers SP, 2019, J TRAUMA ACUTE CARE, V86, P20, DOI 10.1097/TA.0000000000002061; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Nadler R, 2020, TRANSFUSION, V60, pS10, DOI 10.1111/trf.15602; Nair PM, 2014, J TRAUMA ACUTE CARE, V77, pS88, DOI 10.1097/TA.0000000000000327; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Nastasi AJ, 2017, J SURG RES, V216, P115, DOI 10.1016/j.jss.2017.04.033; National Blood Authority, 2011, PATIENT BLOOD MANAGE; Neal MD, 2015, J TRAUMA ACUTE CARE, V79, P490, DOI 10.1097/TA.0000000000000793; Neal MD, 2020, BLOOD ADV, V4, P2556, DOI 10.1182/bloodadvances.2019001166; Neal MD, 2012, J TRAUMA ACUTE CARE, V72, P892, DOI 10.1097/TA.0b013e31823d84a7; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Negrier C, 2019, BLOOD REV, V38, DOI 10.1016/j.blre.2019.05.006; Nevin DG, 2017, ANAESTHESIA, V72, P1443, DOI 10.1111/anae.14034; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Norfolk D., 2014, HDB TRANSFUSION MED, V5th, P82; Nunns GR, 2018, SURGERY, V164, P306, DOI 10.1016/j.surg.2018.02.024; Nystrup KB, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-52; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Paffrath T, 2010, INJURY, V41, P97, DOI 10.1016/j.injury.2009.06.010; Park MS, 2017, J TRAUMA ACUTE CARE, V83, P381, DOI 10.1097/TA.0000000000001466; Park MS, 2016, THROMB RES, V144, P40, DOI 10.1016/j.thromres.2016.03.026; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Peltz ED, 2015, J TRAUMA ACUTE CARE, V78, P742, DOI 10.1097/TA.0000000000000589; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Pezold M, 2012, SURGERY, V151, P48, DOI 10.1016/j.surg.2011.06.023; Plautz WE, 2020, TRANSFUSION, V60, pS158, DOI 10.1111/trf.15667; Plotkin AJ, 2008, J TRAUMA, V64, pS64, DOI 10.1097/TA.0b013e318160772d; Prat NJ, 2017, J TRAUMA ACUTE CARE, V83, P373, DOI 10.1097/TA.0000000000001568; Prudovsky I, 2019, J CELL PHYSIOL, V234, P19121, DOI 10.1002/jcp.28603; Pusateri AE, 2020, JAMA SURG, V155, DOI 10.1001/jamasurg.2019.5085; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Reddoch KM, 2014, SHOCK, V41, P54, DOI 10.1097/SHK.0000000000000082; Rizoli SB, 2011, J TRAUMA, V71, pS427, DOI 10.1097/TA.0b013e318232e5ab; Roach REJ, 2014, J THROMB HAEMOST, V12, P1593, DOI 10.1111/jth.12678; Roberts DJ, 2019, J TRAUMA ACUTE CARE, V86, P206, DOI 10.1097/TA.0000000000002099; Roberts DJ, 2018, CAN J SURG, V61, P150, DOI 10.1503/cjs.014116; Roberts I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI [10.3310/HTA17100, 10.3310/hta17100]; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rodriguez EG, 2017, J AM COLL SURGEONS, V225, P419, DOI 10.1016/j.jamcollsurg.2017.05.012; Rondina MT, 2013, CIRC RES, V112, P1506, DOI 10.1161/CIRCRESAHA.113.300512; Rossaint R, 2006, SHOCK, V26, P322, DOI 10.1097/01.shk.0000225403.15722.e9; Rossaint R, 2013, CRIT CARE, V17, DOI 10.1186/cc12579; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Rowell SE, 2020, JAMA-J AM MED ASSOC, V324, P961, DOI 10.1001/jama.2020.8958; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sauaia A., 2021, TRAUMA INDUCED COAGU, V2nd, P13; Savage SA, 2015, J TRAUMA ACUTE CARE, V78, P224, DOI 10.1097/TA.0000000000000502; Schillemans M, 2019, J THROMB HAEMOST, V17, P6, DOI 10.1111/jth.14322; Schlimp CJ, 2014, HAMOSTASEOLOGIE, V34, P29, DOI 10.5482/HAMO-13-07-0038; Schochl H, 2009, J TRAUMA, V67, P125, DOI 10.1097/TA.0b013e31818b2483; Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shackford SR, 2016, J TRAUMA ACUTE CARE, V80, P734, DOI 10.1097/TA.0000000000001009; SHAFTAN GW, 1965, SURGERY, V58, P851; Shakur H, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012964; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shea SM, 2020, TRANSFUSION, V60, pS2, DOI 10.1111/trf.15696; Simao F, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00121; Sobrino Justin, 2013, Proc (Bayl Univ Med Cent), V26, P120; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Sowers MR, 2005, J CLIN ENDOCR METAB, V90, P5942, DOI 10.1210/jc.2005-0591; Spahn DR, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2347-3; Spano PJ, 2020, J TRAUMA ACUTE CARE, V88, P454, DOI 10.1097/TA.0000000000002580; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Spinella PC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02085; Spyropoulos AC, 2020, J THROMB HAEMOST, V18, P1859, DOI 10.1111/jth.14929; Stansbury LG, 2013, TRANSFUSION, V53, P783, DOI 10.1111/j.1537-2995.2012.03828.x; Stark K, 2016, BLOOD, V128, P2435, DOI 10.1182/blood-2016-04-710632; Starr NE, 2020, J TRAUMA ACUTE CARE, V89, P20, DOI 10.1097/TA.0000000000002707; Steele T, 2013, CRIT CARE, V17, DOI 10.1186/cc12756; STEFANINI M, 1954, B NEW YORK ACAD MED, V30, P239; Stein AL, 2019, SCAND J TRAUMA RESUS, V27, DOI 10.1186/s13049-019-0697-0; Stettler GR, 2019, J TRAUMA ACUTE CARE, V87, P582, DOI 10.1097/TA.0000000000002385; Stettler GR, 2018, J SURG RES, V228, P154, DOI 10.1016/j.jss.2018.03.027; STONE HH, 1983, ANN SURG, V197, P532, DOI 10.1097/00000658-198305000-00005; Stortz JA, 2018, SHOCK, V49, P249, DOI 10.1097/SHK.0000000000000981; Strumwasser A, 2016, J TRAUMA ACUTE CARE, V81, P312, DOI 10.1097/TA.0000000000001060; Sumislawski JJ, 2019, J TRAUMA ACUTE CARE, V87, P1082, DOI 10.1097/TA.0000000000002443; Takayama W, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2022-0; Tauber H, 2011, BRIT J ANAESTH, V107, P378, DOI 10.1093/bja/aer158; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Tennent GA, 2007, BLOOD, V109, P1971, DOI 10.1182/blood-2006-08-040956; Teran E, 2002, NITRIC OXIDE-BIOL CH, V7, P217, DOI 10.1016/S1089-8603(02)00105-2; Thorn S, 2021, EUR J TRAUMA EMERG S, V47, P333, DOI 10.1007/s00068-019-01142-0; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Trajano AD, 2014, BMC EMERG MED, V14, DOI 10.1186/1471-227X-14-22; Tweardy DJ, 2006, SHOCK, V26, P386, DOI 10.1097/01.shk.0000227907.56060.2b; vantVeer C, 1997, J BIOL CHEM, V272, P4367, DOI 10.1074/jbc.272.7.4367; Veigas PV, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0308-2; Verni CC, 2019, J TRAUMA ACUTE CARE, V86, P250, DOI 10.1097/TA.0000000000002140; Vigneshwar Navin G, 1800, Ann Surg, V275, pe605, DOI 10.1097/SLA.0000000000004548; Vogel S, 2015, J CLIN INVEST, V125, P4638, DOI 10.1172/JCI81660; Vulliamy P, 2021, PLATELETS, V32, P295, DOI 10.1080/09537104.2020.1718633; Vulliamy P, 2019, P NATL ACAD SCI USA, V116, P17444, DOI 10.1073/pnas.1904978116; Vulliamy P, 2017, J TRAUMA ACUTE CARE, V83, P388, DOI 10.1097/TA.0000000000001520; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639; Weyrich AS, 2004, TRENDS IMMUNOL, V25, P489, DOI 10.1016/j.it.2004.07.003; White NJ, 2016, FREE RADICAL BIO MED, V96, P181, DOI 10.1016/j.freeradbiomed.2016.04.023; Williams J, 2020, J TRAUMA ACUTE CARE, V88, P87, DOI 10.1097/TA.0000000000002498; Wilson RF, 2013, J TRAUMA ACUTE CARE, V74, P45, DOI 10.1097/TA.0b013e3182788fc4; Winthrop AL, 2005, J TRAUMA, V58, P468, DOI 10.1097/01.TA.0000153940.23471.B7; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Wolberg AS, 2004, J TRAUMA, V56, P1221, DOI 10.1097/01.TA.0000064328.97941.FC; Woolley T, 2020, TRANSFUSION, V60, pS52, DOI 10.1111/trf.15658; World Health Organization, 2018, GLOB HLTH EST 2016 D; World Health Organization, 2021, 18 M WHO EXP COMM SE; Wright FL, 2020, J AM COLL SURGEONS, V231, P193, DOI 10.1016/j.jamcollsurg.2020.05.007; Xu X, 2020, J THROMB HAEMOST, V18, P3154, DOI 10.1111/jth.15096; Yazer MH, 2016, J TRAUMA ACUTE CARE, V81, P21, DOI 10.1097/TA.0000000000001100; Zhang JN, 2018, BLOOD, V131, P2001, DOI 10.1182/blood-2017-11-784108; Zipperle J, 2017, J TRAUMA ACUTE CARE, V82, P921, DOI 10.1097/TA.0000000000001410	322	21	21	3	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2056-676X			NAT REV DIS PRIMERS	Nat. Rev. Dis. Primers	APR 29	2021	7	1							30	10.1038/s41572-021-00264-3			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV2EH	WOS:000645651300002	33927200	Bronze, Green Submitted			2022-02-06	
J	Palacios, EM; Owen, JP; Yuh, EL; Wang, MB; Vassar, MJ; Ferguson, AR; Diaz-Arrastia, R; Giacino, JT; Okonkwo, DO; Robertson, CS; Stein, MB; Temkin, N; Jain, S; McCrea, M; MacDonald, CL; Levin, HS; Manley, GT; Mukherjee, P				Palacios, E. M.; Owen, J. P.; Yuh, E. L.; Wang, M. B.; Vassar, M. J.; Ferguson, A. R.; Diaz-Arrastia, R.; Giacino, J. T.; Okonkwo, D. O.; Robertson, C. S.; Stein, M. B.; Temkin, N.; Jain, S.; McCrea, M.; MacDonald, C. L.; Levin, H. S.; Manley, G. T.; Mukherjee, P.		TRACK-TBI Investigators	The evolution of white matter microstructural changes after mild traumatic brain injury: A longitudinal DTI and NODDI study	SCIENCE ADVANCES			English	Article							NEURITE ORIENTATION DISPERSION; OUTCOME PREDICTION; DIFFUSION; MRI; KNOWLEDGE; CHILDREN; ROBUST	Neuroimaging biomarkers that can detect white matter (WM) pathology after mild traumatic brain injury (mTBI) and predict long-term outcome are needed to improve care and develop therapies. We used diffusion tensor imaging (DTI) and neurite orientation dispersion and density imaging (NODDI) to investigate WM microstructure cross-sectionally and longitudinally after mTBI and correlate these with neuropsychological performance. Cross-sectionally, early decreases of fractional anisotropy and increases of mean diffusivity corresponded to WM regions with elevated free water fraction on NODDI. This elevated free water was more extensive in the patient subgroup reporting more early postconcussive symptoms. The longer-term longitudinal WM changes consisted of declining neurite density on NODDI, suggesting axonal degeneration from diffuse axonal injury for which NODDI is more sensitive than DTI. Therefore, NODDI is a more sensitive and specific biomarker than DTI for WM microstructural changes due to mTBI that merits further study for mTBI diagnosis, prognosis, and treatment monitoring.	[Palacios, E. M.; Yuh, E. L.; Wang, M. B.; Mukherjee, P.] UCSF, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Owen, J. P.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Yuh, E. L.; Vassar, M. J.; Ferguson, A. R.; Manley, G. T.; Mukherjee, P.] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Brain & Spinal Cord Injury Ctr, San Francisco, CA 94110 USA; [Vassar, M. J.; Ferguson, A. R.; Manley, G. T.] UCSF, Dept Neurol Surg, San Francisco, CA USA; [Ferguson, A. R.] San Francisco VA Med Ctr, San Francisco, CA USA; [Diaz-Arrastia, R.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Giacino, J. T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Giacino, J. T.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Okonkwo, D. O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Robertson, C. S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Stein, M. B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Stein, M. B.; Jain, S.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Temkin, N.; MacDonald, C. L.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [McCrea, M.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, M.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Levin, H. S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Mukherjee, P.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA		Mukherjee, P (corresponding author), UCSF, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.; Mukherjee, P (corresponding author), Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Brain & Spinal Cord Injury Ctr, San Francisco, CA 94110 USA.; Mukherjee, P (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	pratik.mukherjee@ucsf.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Ferguson, Adam/0000-0001-7102-1608; Robertson, Claudia/0000-0002-8509-678X	U.S. NIH, National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS086090]; U.S. Department of Defense (DoD) TBI Endpoints Development (TED) Initiative [W81XWH-14-2-0176]; NeuroTrauma Sciences LLC; OneMind	The TRACK-TBI study was funded by the U.S. NIH, National Institute of Neurological Disorders and Stroke (NINDS) (grant no.U01 NS086090), the U.S. Department of Defense (DoD) TBI Endpoints Development (TED) Initiative (grant no.W81XWH-14-2-0176), OneMind, and NeuroTrauma Sciences LLC.	Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bigler E. D., 2015, BRAIN NEUROTRAUMA MO; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Billiet T, 2015, NEUROBIOL AGING, V36, P2107, DOI 10.1016/j.neurobiolaging.2015.02.029; Caverzasi E, 2016, J NEUROIMAGING, V26, P494, DOI 10.1111/jon.12359; Cercignani M, 2018, NEUROIMAGE, V182, P117, DOI 10.1016/j.neuroimage.2017.10.052; Chang YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123656; Chen LZ, 2016, NEUROSCI BIOBEHAV R, V68, P838, DOI 10.1016/j.neubiorev.2016.07.022; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Cardoso MGD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00198; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Fukutomi H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48671-7; Jelescu O. I., 2017, FRONT PHYS, V61, P61; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kamagata K, 2017, HUM BRAIN MAPP, V38, P3704, DOI 10.1002/hbm.23628; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kievit RA, 2016, NEUROPSYCHOLOGIA, V91, P186, DOI 10.1016/j.neuropsychologia.2016.08.008; Lerma-Usabiaga G, 2019, NEUROIMAGE, V202, DOI 10.1016/j.neuroimage.2019.116048; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Mah A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182340; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Owen JP, 2016, BRAIN CONNECT, V6, P548, DOI 10.1089/brain.2016.0431; Owen JP, 2015, NEUROIMAGE, V109, P402, DOI 10.1016/j.neuroimage.2015.01.007; Owen JP, 2014, J NEUROSCI, V34, P6214, DOI 10.1523/JNEUROSCI.4495-13.2014; Owen JP, 2013, NEUROIMAGE-CLIN, V2, P844, DOI 10.1016/j.nicl.2013.06.009; Radhakrishnan R, 2016, LANCET PSYCHIAT, V3, P1166, DOI 10.1016/S2215-0366(16)30266-8; Sato K, 2017, ACTA RADIOL OPEN, V6, DOI 10.1177/2058460117703816; Schneider T, 2017, FUNCT NEUROL, V32, P97; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Timmers I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167884; Wang MB, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005550; Xiao M, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00194; Yang YQ, 2015, NEUROPSYCHOLOGIA, V66, P246, DOI 10.1016/j.neuropsychologia.2014.11.020; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang H, 2011, NEUROIMAGE, V56, P1301, DOI 10.1016/j.neuroimage.2011.01.084	48	21	22	3	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	2375-2548			SCI ADV	Sci. Adv.	AUG	2020	6	32							eaaz6892	10.1126/sciadv.aaz6892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NB3YQ	WOS:000560452300004	32821816	gold, Green Published			2022-02-06	
J	Sasaki, Y; Engber, TM; Hughes, RO; Figley, MD; Wu, T; Bosanac, T; Devraj, R; Milbrandt, J; Krauss, R; DiAntonio, A				Sasaki, Yo; Engber, Thomas M.; Hughes, Robert O.; Figley, Matthew D.; Wu, Tong; Bosanac, Todd; Devraj, Rajesh; Milbrandt, Jeffrey; Krauss, Raul; DiAntonio, Aaron			cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons	EXPERIMENTAL NEUROLOGY			English	Article							SERUM NEUROFILAMENT LIGHT; TIR DOMAINS; CELL-DEATH; ACTIVATION; PROTEIN; INJURY; MICE; PREVENTION; PROTECTION; TRIGGERS	SARM1 is the central executioner of pathological axon degeneration, promoting axonal demise in response to axotomy, traumatic brain injury, and neurotoxic chemotherapeutics that induce peripheral neuropathy. SARM1 is an injury-activated NAD+ cleavage enzyme, and this NADase activity is required for the pro-degenerative function of SARM1. At present, SARM1 function is assayed by either analysis of axonal loss, which is far downstream of SARM1 enzymatic activity, or via NAD(+) levels, which are regulated by many competing pathways. Here we explored the utility of measuring cADPR, a product of SARM1-dependent cleavage of NAD(+), as an in cell and in vivo biomarker of SARM1 enzymatic activity. We find that SARM1 is a major producer of cADPR in cultured dorsal root ganglion (DRG) neurons, sciatic nerve, and brain, demonstrating that SARM1 has basal activity in the absence of injury. Following injury, there is a dramatic SARM1-dependent increase in the levels of axonal cADPR that precedes morphological axon degeneration. In vivo, there is also a rapid and large injury-stimulated increase in cADPR in sciatic and optic nerves. The increase in cADPR after injury is proportional to SARM1 gene dosage, suggesting that SARM1 activity is the prime regulator of cADPR levels. The role of cADPR as an important calcium mobilizing agent prompted exploration of its functional contribution to axon degeneration. We used multiple bacterial and mammalian engineered enzymes to manipulate cADPR levels in neurons but found no changes in the time course of axonal degeneration, suggesting that cADPR is unlikely to be an important contributor to the degenerative mechanism. Using cADPR as a SARM1 biomarker, we find that SARM1 can be partially activated by a diverse array of mitochondrial toxins administered at doses that do not induce axon degeneration. Hence, the subcritical activation of SARM1 induced by mitochondrial dysfunction may contribute to the axonal vulnerability common to many neurodegenerative diseases. Finally, we assay levels of both nerve cADPR and plasma neurofilament light chain (NfL) following nerve injury in vivo, and demonstrate that both biomarkers are excellent readouts of SARM1 activity, with cADPR reporting the early molecular changes in the nerve and NfL reporting subsequent axonal breakdown. The identification and characterization of cADPR as a SARM1 biomarker will help identify neurodegenerative diseases in which SARM1 contributes to axonal loss and expedite target validation studies of SARM1-directed therapeutics.	[Sasaki, Yo; Wu, Tong; Milbrandt, Jeffrey] Washington Univ, Genet, St Louis, MO 63110 USA; [Engber, Thomas M.; Hughes, Robert O.; Bosanac, Todd; Devraj, Rajesh; Krauss, Raul] Disarm Therapeut, Cambridge, MA 02142 USA; [Figley, Matthew D.; DiAntonio, Aaron] Washington Univ, Dev Biol, St Louis, MO 63110 USA; [Milbrandt, Jeffrey; DiAntonio, Aaron] Needleman Ctr Neurometab & Axonal Therapeut, St Louis, MO USA		Sasaki, Y; Milbrandt, J (corresponding author), Washington Univ, Genet, St Louis, MO 63110 USA.; Krauss, R (corresponding author), Disarm Therapeut, Cambridge, MA 02142 USA.; DiAntonio, A (corresponding author), Washington Univ, Dev Biol, St Louis, MO 63110 USA.	sasaki@wustl.edu; jmilbrandt@wustl.edu; rkrauss@disarmtx.com; diantonio@wustl.edu		Figley, Matthew/0000-0003-2125-829X; DiAntonio, Aaron/0000-0002-7262-0968	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG013730, NS087632, CA219866]	This work was supported by funds from the National Institutes of Health (AG013730 to J.M. and NS087632 & CA219866 to A.D. and J.M.).	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Benatar M, 2018, ANN NEUROL, V84, P130, DOI 10.1002/ana.25276; Cheng YL, 2019, DIABETES, V68, P2120, DOI 10.2337/db18-1233; DiAntonio A, 2019, PAIN, V160, pS17, DOI 10.1097/j.pain.0000000000001528; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Geisler S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129920; Geisler S, 2019, J EXP MED, V216, P294, DOI 10.1084/jem.20181040; Geisler S, 2016, BRAIN, V139, P3092, DOI 10.1093/brain/aww251; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Gerdts J, 2015, SCIENCE, V348, P453, DOI 10.1126/science.1258366; Gerdts J, 2013, J NEUROSCI, V33, P13569, DOI 10.1523/JNEUROSCI.1197-13.2013; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Guse AH, 2015, BBA-PROTEINS PROTEOM, V1854, P1132, DOI 10.1016/j.bbapap.2014.12.015; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hikosaka K, 2014, J BIOL CHEM, V289, P14796, DOI 10.1074/jbc.M114.554378; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; Khalil M, 2018, NAT REV NEUROL, V14, P577, DOI 10.1038/s41582-018-0058-z; Liu HW, 2018, P NATL ACAD SCI USA, V115, P10654, DOI 10.1073/pnas.1809392115; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Loreto A, 2020, NEUROBIOL DIS, V134, DOI 10.1016/j.nbd.2019.104678; Marion CM, 2019, EXP NEUROL, V321, DOI 10.1016/j.expneurol.2019.113040; Ribeiro JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18393-9; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; Neukomm LJ, 2017, NEURON, V95, P78, DOI 10.1016/j.neuron.2017.06.031; Olsson B, 2019, JAMA NEUROL, V76, P318, DOI 10.1001/jamaneurol.2018.3746; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Sako W, 2015, J NEUROL SCI, V352, P84, DOI 10.1016/j.jns.2015.03.041; Sandelius A, 2018, NEUROLOGY, V90, pE518, DOI 10.1212/WNL.0000000000004932; Sasaki Y, 2016, ELIFE, V5, DOI 10.7554/eLife.19749; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Summers DW, 2020, MOL NEUROBIOL, V57, P1146, DOI 10.1007/s12035-019-01796-2; Summers DW, 2014, J NEUROSCI, V34, P9338, DOI 10.1523/JNEUROSCI.0877-14.2014; Szretter KJ, 2009, J VIROL, V83, P9329, DOI 10.1128/JVI.00836-09; Turkiew E, 2017, J PERIPHER NERV SYST, V22, P162, DOI 10.1111/jns.12219; Vargas ME, 2015, J NEUROSCI, V35, P15026, DOI 10.1523/JNEUROSCI.2484-15.2015; Wan L, 2019, SCIENCE, V365, P799, DOI 10.1126/science.aax1771; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Zhao YJ, 2011, J BIOL CHEM, V286, P22170, DOI 10.1074/jbc.M111.228379; Zhao ZY, 2019, ISCIENCE, V15, P452, DOI 10.1016/j.isci.2019.05.001; Zhu XH, 2018, J MAGN RESON, V292, P155, DOI 10.1016/j.jmr.2018.05.005; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	48	21	21	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUL	2020	329								113252	10.1016/j.expneurol.2020.113252			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LT0MX	WOS:000536772200005	32087251	Green Accepted			2022-02-06	
J	Ovsiew, GP; Resch, ZJ; Nayar, K; Williams, CP; Soble, JR				Ovsiew, Gabriel P.; Resch, Zachary J.; Nayar, Kritika; Williams, Christopher P.; Soble, Jason R.			Not so fast! Limitations of processing speed and working memory indices as embedded performance validity tests in a mixed neuropsychiatric sample	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Performance validity; processing speed; working memory; psychometrics; assessment	TRAUMATIC BRAIN-INJURY; FALSE DISCOVERY RATE; TEST CUTOFF SCORES; CARD SORTING TEST; DIGIT SPAN; MALINGERING DETECTION; INVALID PERFORMANCE; RECOGNITION TRIAL; CROSS-VALIDATION; TEST-II	Introduction Validity indicators embedded within standard neuropsychological tests have received increasing attention as more efficient measures for sampling performance validity throughout an evaluation. This cross-sectional study examined multiple performance validity tests (PVTs) embedded in the Wechsler Adult Intelligence Scale-IV (WAIS-IV) Working Memory (WMI) and Processing Speed (PSI) Indices for detecting invalid test performance. Method This cross-sectional study examined data from a mixed clinical neuropsychiatric sample of 110 patients referred for outpatient evaluation. The sample was composed of 85 patients with valid neuropsychological performance and 25 with invalid performance based on multiple independent criterion PVTs. Among the patients with valid performance, 54% were cognitively impaired, whereas 46% were cognitively unimpaired. Results Among the overall sample, performance on WMI, PSI, and 3/4 constituent subtests (i.e., Digit Span, Symbol Search, Coding) was significantly worse among the invalid group compared to the valid group (eta(2)(p) =.06-.16) with areas under the curve (AUCs) of.67-.76 and 24-32% sensitivity (>= 88% specificity) for identifying invalid performance at cut-scores that maximized accuracy. When the sample was subdivided by cognitive impairment status, AUCs of.68-.87 and 36-56% sensitivity (>= 87% specificity) for detecting invalidity at cut-scores that maximized accuracy were found among those without cognitive impairment. In contrast, for patients with cognitive impairment, Digit Span, Arithmetic, WMI, and Coding were nonsignificant, and AUCs of.66-.67. Further, notably reduced sensitivities of 16-28% (>= 91% specificity) were found for the remaining significant indices. Conclusion Overall, results indicated that embedded WAIS-IV WMI and PSI are useful embedded PVTs in conditions in which cognitive impairment is not expected; however, these embedded PVTs demonstrated questionable utility among patients with cognitive impairment due to poor sensitivity, if adequate specificity is maintained, suggesting limited efficacy among patients with cognitive impairment due to risk of false-positive classification.	[Ovsiew, Gabriel P.; Resch, Zachary J.; Nayar, Kritika; Williams, Christopher P.; Soble, Jason R.] Univ Illinois, Dept Psychiat, Coll Med, 910 S Wood St,MC 913, Chicago, IL 60612 USA; [Resch, Zachary J.; Williams, Christopher P.] Rosalind Franklin Univ Med & Sci, Dept Psychol, N Chicago, IL USA; [Nayar, Kritika] Northwestern Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL USA; [Soble, Jason R.] Univ Illinois, Coll Med, Dept Neurol, Chicago, IL 60612 USA		Ovsiew, GP (corresponding author), Univ Illinois, Dept Psychiat, Coll Med, 910 S Wood St,MC 913, Chicago, IL 60612 USA.	Ovsiew@Outlook.com					Alverson WA, 2019, CLIN NEUROPSYCHOL, V33, P1420, DOI 10.1080/13854046.2019.1599071; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bailey KC, 2018, ARCH CLIN NEUROPSYCH, V33, P895, DOI 10.1093/arclin/acx111; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bondi M. W., 2009, NEUROPSYCHOLOGICAL A, P159; Boone K., 2002, B TEST MANUAL; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Etherton Joseph L, 2006, Spine J, V6, P61, DOI 10.1016/j.spinee.2005.05.382; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fuermaier AB, 2017, TEST MANUAL GRONINGE; Gabel NM, 2019, BRAIN INJURY, V33, P377, DOI 10.1080/02699052.2018.1553311; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Glassmire DM, 2016, ASSESSMENT, V23, P292, DOI 10.1177/1073191115587551; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Gunzler SA, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P567, DOI 10.1007/978-0-387-76978-3_19; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry GK, 2013, CLIN NEUROPSYCHOL, V27, P864, DOI 10.1080/13854046.2013.786758; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lippa SM, 2018, CLIN NEUROPSYCHOL, V32, P391, DOI 10.1080/13854046.2017.1406146; Loring DW, 2008, J INT NEUROPSYCH SOC, V14, P394, DOI 10.1017/S1355617708080582; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; Martin PK, 2020, CLIN NEUROPSYCHOL, V34, P88, DOI 10.1080/13854046.2019.1637027; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers JE, 2014, ARCH CLIN NEUROPSYCH, V29, P224, DOI 10.1093/arclin/acu001; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shura RD, 2020, CLIN NEUROPSYCHOL, V34, P1025, DOI 10.1080/13854046.2019.1635209; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silk-Eglit GM, 2016, ARCH CLIN NEUROPSYCH, V31, P231, DOI 10.1093/arclin/acv108; Soble JR, 2019, APPL NEUROPSYCH-ADUL, V26, P311, DOI 10.1080/23279095.2017.1418744; Soble JR, 2017, PHYS MED REH CLIN N, V28, P339, DOI 10.1016/j.pmr.2016.12.009; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stevens A, 2016, PSYCHIAT RES, V245, P74, DOI 10.1016/j.psychres.2016.08.022; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Webber TA, 2020, ASSESSMENT, V27, P1399, DOI 10.1177/1073191118804874; Webber TA, 2018, CLIN NEUROPSYCHOL, V32, P657, DOI 10.1080/13854046.2017.1415374; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 2008, WECHSLER ADULT INTEL; Willcutt E. G., 2010, PEDIAT NEUROPSYCHOLO, P393; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730; Young JC, 2012, ARCH CLIN NEUROPSYCH, V27, P159, DOI 10.1093/arclin/acr109	66	21	21	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY 27	2020	42	5					473	484		10.1080/13803395.2020.1758635		JUN 2020	12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ME3AD	WOS:000542839500001	32498648				2022-02-06	
J	Bonsack, B; Corey, S; Shear, A; Heyck, M; Cozene, B; Sadanandan, N; Zhang, H; Gonzales-Portillo, B; Sheyner, M; Borlongan, CV				Bonsack, Brooke; Corey, Sydney; Shear, Alex; Heyck, Matt; Cozene, Blaise; Sadanandan, Nadia; Zhang, Henry; Gonzales-Portillo, Bella; Sheyner, Michael; Borlongan, Cesar V.			Mesenchymal stem cell therapy alleviates the neuroinflammation associated with acquired brain injury	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						bone marrow-derived mesenchymal stem cells; clinical trials; inflammation; ischemic stroke; preclinical studies; traumatic brain injury	MARROW STROMAL CELLS; ISCHEMIC-STROKE; NEURONAL DIFFERENTIATION; IN-VITRO; INFLAMMATORY RESPONSE; NEUROLOGICAL DEFICITS; CEREBRAL-ISCHEMIA; CHOROID-PLEXUS; RAT MODEL; T-CELLS	Ischemic stroke and traumatic brain injury (TBI) comprise two particularly prevalent and costly examples of acquired brain injury (ABI). Following stroke or TBI, primary cell death and secondary cell death closely model disease progression and worsen outcomes. Mounting evidence indicates that long-term neuroinflammation extensively exacerbates the secondary deterioration of brain structure and function. Due to their immunomodulatory and regenerative properties, mesenchymal stem cell transplants have emerged as a promising approach to treating this facet of stroke and TBI pathology. In this review, we summarize the classification of cell death in ABI and discuss the prominent role of inflammation. We then consider the efficacy of bone marrow-derived mesenchymal stem/stromal cell (BM-MSC) transplantation as a therapy for these injuries. Finally, we examine recent laboratory and clinical studies utilizing transplanted BM-MSCs as antiinflammatory and neurorestorative treatments for stroke and TBI. Clinical trials of BM-MSC transplants for stroke and TBI support their promising protective and regenerative properties. Future research is needed to allow for better comparison among trials and to elaborate on the emerging area of cell-based combination treatments.	[Bonsack, Brooke; Corey, Sydney; Shear, Alex; Heyck, Matt; Cozene, Blaise; Sadanandan, Nadia; Zhang, Henry; Gonzales-Portillo, Bella; Sheyner, Michael; Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA		Borlongan, CV (corresponding author), Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL 33612 USA.	cborlong@usf.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS090962, R01NS102395, R21NS109575]	Dr Borlongan is funded by National Institutes of Health (NIH) R01NS090962, NIH R01NS102395, and NIH R21NS109575.	Abdullah RH, 2016, J CHEM NEUROANAT, V77, P129, DOI 10.1016/j.jchemneu.2016.07.003; Acosta SA, 2015, STROKE, V46, P2616, DOI 10.1161/STROKEAHA.115.009854; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Al-Qazzaz NK, 2014, NEUROPSYCH DIS TREAT, V10, P1677, DOI 10.2147/NDT.S67184; Alvarez-Viejo M, 2013, TRANSPL P, V45, P434, DOI 10.1016/j.transproceed.2012.05.091; Anbari F, 2014, NEURAL REGEN RES, V9, P919, DOI 10.4103/1673-5374.133133; Appel S H, 2011, Acta Myol, V30, P4; Banerjee S, 2014, STEM CELL TRANSL MED, V3, P1322, DOI 10.5966/sctm.2013-0178; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Borlongan CV, 2008, REGEN MED, V3, P249, DOI 10.2217/17460751.3.3.249; Borlongan CV, 2012, CURR PHARM DESIGN, V18, P3670; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 2000, NEUROREPORT, V11, P923, DOI 10.1097/00001756-200004070-00005; Borlongan CV, 1996, NEUROL RES, V18, P297; Borlongan CV, 1999, LANCET, V353, pSL29; Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074; Cha JM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19211-6; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Cox CS, 2017, STEM CELLS, V35, P1065, DOI 10.1002/stem.2538; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cunningham CJ, 2018, J CEREBR BLOOD F MET, V38, P1276, DOI 10.1177/0271678X18776802; Dabrowska S, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1571-8; Dailey T, 2013, J CLIN MED, V2, P220, DOI 10.3390/jcm2040220; Dang DD, 2018, CNS NEUROSCI THER, V24, P564, DOI 10.1111/cns.12823; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Dela Pena I, 2014, J NEUROSURG SCI, V58, P145; Diamandis T, 2015, STROKE, V46, P588, DOI 10.1161/STROKEAHA.114.007105; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Eckert A, 2015, STEM CELL TRANSL MED, V4, P841, DOI 10.5966/sctm.2014-0184; Emerich DF, 2006, NEUROBIOL DIS, V23, P471, DOI 10.1016/j.nbd.2006.04.014; Faustino J, 2019, J CEREBR BLOOD F MET, V39, P1919, DOI 10.1177/0271678X18817663; Fukumoto Y, 2019, J CEREBR BLOOD F MET, V39, P2144, DOI 10.1177/0271678X18805317; Garcia-Culebras A, 2018, J CEREBR BLOOD F MET, V38, P2150, DOI 10.1177/0271678X18795789; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Greig NH, 2020, CNS NEUROSCI THER, V26, P636, DOI 10.1111/cns.13274; Grotenhuis N, 2016, TISSUE ENG PT A, V22, P1098, DOI [10.1089/ten.tea.2016.0162, 10.1089/ten.TEA.2016.0162]; Gu LJ, 2014, CNS NEUROSCI THER, V20, P67, DOI 10.1111/cns.12160; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Hawthorne AL, 2011, NEUROTHERAPEUTICS, V8, P252, DOI 10.1007/s13311-011-0032-6; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Huang P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42182-1; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Joe IS, 2016, CELL REPROGRAM, V18, P224, DOI 10.1089/cell.2015.0061; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Jung HS, 2016, NEUROSCI LETT, V633, P227, DOI 10.1016/j.neulet.2016.09.032; Kaelber S, 2016, NEURAL REGEN RES, V11, P1575, DOI 10.4103/1673-5374.193231; Kinouchi T, 2018, TRANSL STROKE RES, V9, P306, DOI 10.1007/s12975-017-0577-8; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kong DY, 2017, CELL MOL NEUROBIOL, V37, P303, DOI 10.1007/s10571-016-0370-3; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kurisu K, 2019, J CEREBR BLOOD F MET, V39, P1906, DOI 10.1177/0271678X18817282; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Li D, 2018, CNS NEUROSCI THER, V24, P906, DOI 10.1111/cns.12833; Li GH, 2016, NEURAL REGEN RES, V11, P1015, DOI 10.4103/1673-5374.184506; Li X, 2016, NEUROPSYCH DIS TREAT, V12, P1287, DOI 10.2147/NDT.S104917; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Lippert T, 2019, CNS NEUROSCI THER, V25, P815, DOI 10.1111/cns.13124; Liu HH, 2013, CHINESE MED J-PEKING, V126, P2361, DOI 10.3760/cma.j.issn.0366-6999.20130478; Liu XY, 2019, PAK J MED SCI, V35, P1161, DOI 10.12669/pjms.35.4.311; Liu XF, 2014, PROG NEUROBIOL, V115, P92, DOI 10.1016/j.pneurobio.2013.11.007; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mafi R, 2011, Open Orthop J, V5 Suppl 2, P242, DOI 10.2174/1874325001105010242; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Maiti P, 2019, J CELL MOL MED, V23, P5211, DOI 10.1111/jcmm.14396; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marcet Paul, 2017, Neuroimmunol Neuroinflamm, V4, P82, DOI 10.20517/2347-8659.2017.07; Mashkouri S, 2016, NEURAL REGEN RES, V11, P1379, DOI 10.4103/1673-5374.191197; Meares GP, 2012, GLIA, V60, P771, DOI 10.1002/glia.22307; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morimoto T, 2011, CELL TRANSPLANT, V20, P1049, DOI 10.3727/096368910X544915; Narcisi R, 2016, TISSUE ENG PT A, V22, P1264, DOI 10.1089/ten.tea.2016.0081; Neal EG, 2019, J CEREBR BLOOD F MET, V39, P1750, DOI 10.1177/0271678X18766172; Nguyen TVV, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0371-y; Nishino H, 2000, Prog Brain Res, V127, P461; Onda T, 2008, J CEREBR BLOOD F MET, V28, P329, DOI 10.1038/sj.jcbfm.9600527; Ortega SB, 2015, DISCOV MED, V19, P381; Park DH, 2009, STEM CELLS DEV, V18, P693, DOI 10.1089/scd.2009.0008; Peruzzaro ST, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1383-2; Prasad K, 2014, STROKE, V45, P3618, DOI 10.1161/STROKEAHA.114.007028; Ramos-Cejudo J, 2018, EBIOMEDICINE, V28, P21, DOI 10.1016/j.ebiom.2018.01.021; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rosi Susanna, 2016, Brain Circ, V2, P126, DOI 10.4103/2394-8108.192517; Ryu B, 2019, WEST PAC SURVEILL RE, V10, DOI [10.5365/wpsar.2018.9.3.002, 10.5365/wpsar.2017.8.1.008]; Saporta S, 1997, EXP NEUROL, V146, P299, DOI 10.1006/exnr.1997.6493; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Shahror RA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112624; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Shi YJ, 2017, P NATL ACAD SCI USA, V114, pE1243, DOI 10.1073/pnas.1621174114; Shichinohe H, 2015, NEUROREHAB NEURAL RE, V29, P80, DOI 10.1177/1545968314525856; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Shuai Y, 2016, THERANOSTICS, V6, P1899, DOI 10.7150/thno.15412; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Stonesifer C, 2017, PROG NEUROBIOL, V158, P94, DOI 10.1016/j.pneurobio.2017.07.004; Su E, 2010, DEV NEUROSCI-BASEL, V32, P385, DOI 10.1159/000321342; Subramanian A, 2012, J CELL BIOCHEM, V113, P1886, DOI 10.1002/jcb.24057; Tian CL, 2013, EXP CLIN TRANSPLANT, V11, P176, DOI 10.6002/ect.2012.0053; Toyoshima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127302; Tu J, 2014, GLIA, V62, P106, DOI 10.1002/glia.22590; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; van Velthoven CTJ, 2013, STROKE, V44, P1426, DOI 10.1161/STROKEAHA.111.000326; Wang BY, 2016, J PROTEOME RES, V15, P2407, DOI 10.1021/acs.jproteome.5b01083; Wang JJ, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0193-7; Wang Q, 2016, CLIN NEUROL NEUROSUR, V146, P1, DOI 10.1016/j.clineuro.2016.04.011; Wang Y.L., 2016, MACROMOL BIOSCI, V17, P4; Wei N, 2013, CELL TRANSPLANT, V22, P977, DOI 10.3727/096368912X657251; Xia CF, 2004, HUM GENE THER, V15, P1243, DOI 10.1089/hum.2004.15.1243; Xiang Y, 2014, NEURAL REGEN RES, V9, P243, DOI 10.4103/1673-5374.128215; Yan YH, 2016, LIFE SCI, V166, P131, DOI 10.1016/j.lfs.2016.10.004; Yasuhara T, 2020, CNS NEUROSCI THER, V26, P595, DOI 10.1111/cns.13247; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhong C, 2003, NEUROSCI LETT, V342, P93, DOI 10.1016/S0304-3940(03)00255-6; Zigova T, 1999, EXP NEUROL, V157, P251, DOI 10.1006/exnr.1999.7054; Zimmermann JA, 2017, STEM CELL TRANSL MED, V6, P223, DOI 10.5966/sctm.2016-0044	124	21	21	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JUN	2020	26	6			SI		603	615		10.1111/cns.13378		MAY 2020	13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	LQ8CX	WOS:000529620300001	32356605	gold, Green Published			2022-02-06	
J	Conway, FN; Domingues, M; Monaco, R; Lesnewich, LM; Ray, AE; Alderman, BL; Todaro, SM; Buckman, JF				Conway, Fiona N.; Domingues, Marianne; Monaco, Robert; Lesnewich, Laura M.; Ray, Anne E.; Alderman, Brandon L.; Todaro, Sabrina M.; Buckman, Jennifer F.			Concussion Symptom Underreporting Among Incoming National Collegiate Athletic Association Division I College Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						sport; brain injury; diagnosis; attitude; reporting; safety	SMOKING-CESSATION; EPIDEMIOLOGY; BEHAVIOR; SUPPORT; MANAGEMENT; IMPACT	Objective: Accurate diagnosis of sport-related concussions relies heavily on truthful self-reporting of symptom severity. Previous studies have emphasized lack of knowledge as a factor in symptom nondisclosure. This study sought to examine concussion knowledge and the relationship of knowledge to reasons for symptom nondisclosure. Design: Cross-sectional study. Setting: Data were collected during preparticipation athletic evaluations via electronic survey. Participants: One hundred fifty-six incoming National Collegiate Athletic Association Division I student-athletes. Main Outcome Measures: Survey items included previous concussion diagnosis, concussion fact and symptom knowledge, reasons and situational contexts for nondisclosure, and stakeholder attitudes. Results: Participants, on average, had substantial concussion symptom and fact knowledge. Unexpectedly, participants with higher concussion fact knowledge endorsed more reasons that athletes may hide symptoms. Concussion symptom knowledge was unrelated to reasons for nondisclosure. Athletes believed that symptom reporting was less likely in high-stakes versus low-stakes situations and consistently identified their teammates as holding attitudes that support underreporting and athletic trainers as engaging in behaviors that support player safety. Conclusions: Greater concussion knowledge did not reduce the number of reasons that participants viewed as drivers for concussion nondisclosure. In other words, participants understood why athletes choose to hide symptoms even when they also understood the symptoms, risks, sequelae, and consequences of concussion (and potential harm of nondisclosure). Situational contexts and important stakeholder attitudes also appeared to importantly influence symptom disclosure decisions. A multifaceted approach that goes beyond current educational strategies to addresses situational, social, and athletic pressures may be needed to initiate a widespread cultural shift away from concussion nondisclosure.	[Conway, Fiona N.; Lesnewich, Laura M.; Todaro, Sabrina M.; Buckman, Jennifer F.] Rutgers State Univ, Ctr Alcohol Studies, New Brunswick, NJ USA; [Domingues, Marianne] New York Presbyterian Weill Cornell Med Ctr, Dept Cardiol Crit Care, New York, NY USA; [Monaco, Robert] Atlantic Sports Hlth, Morristown, NJ USA; [Ray, Anne E.] Real Prevent LLC, Clifton, NJ USA; [Alderman, Brandon L.; Buckman, Jennifer F.] Rutgers State Univ, Dept Kinesiol & Hlth, New Brunswick, NJ USA		Buckman, JF (corresponding author), Rutgers State Univ, Rutgers Ctr Alcohol Studies, 607 Allison Rd, Piscataway, NJ 08854 USA.	jbuckman@rutgers.edu		Conway, Fiona/0000-0003-2626-4752	NJ Commission on Brain Injury Research [NJCBIR13IRG028]	J. F. Buckman received a grant from the NJ Commission on Brain Injury Research (NJCBIR13IRG028) to conduct this study. The remaining authors report no conflicts of interest.	Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Center for Disease Control and Prevention, 2016, TYRENDS CURR CIG SMO; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Concannon LG, 2016, PHYS MED REH CLIN N, V27, P513, DOI 10.1016/j.pmr.2015.12.006; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Guskiewicz Kevin, 2014, Neurosurgery, V75 Suppl 4, pS113, DOI 10.1227/NEU.0000000000000494; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Kelly MP, 2016, PUBLIC HEALTH, V136, P109, DOI 10.1016/j.puhe.2016.03.030; Kerr HA, 2014, PEDIATR ANN, V43, pE309, DOI 10.3928/00904481-20141124-10; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; LoGalbo A, 2014, PROG NEUROL SURG, V28, P184, DOI 10.1159/000358779; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lowrey KM., 2015, J BUS TECHNOL LAW, V10, P61; Makdissi Michael, 2015, Neurol Clin Pract, V5, P2, DOI 10.1212/CPJ.0000000000000061; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00035; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Miller MB, 2013, PSYCHOL ADDICT BEHAV, V27, P909, DOI 10.1037/a0031174; National Highway Traffic Safety Administration, 2001, 5 6 REP C EFF OCC PR; Park EW, 2004, ANN FAM MED, V2, P170, DOI 10.1370/afm.64; Peralta R., 2002, GEND ISSUES, V20, P23, DOI [10.1007/s12147-002-0021-5, DOI 10.1007/S12147-002-0021-5]; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; RUSSELL MAH, 1979, BRIT MED J, V2, P231, DOI 10.1136/bmj.2.6184.231; Ryan P, 2009, CLIN NURSE SPEC, V23, P161, DOI 10.1097/NUR.0b013e3181a42373; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shahab L, 2009, ADDICTION, V104, P1792, DOI 10.1111/j.1360-0443.2009.02710.x; Wakefield M, 2003, J HEALTH COMMUN, V8, P229, DOI 10.1080/10810730305686; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Whelan R, 2009, PSYCHOL REC, V59, P247, DOI 10.1007/BF03395661; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	39	21	21	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2020	30	3					203	209		10.1097/JSM.0000000000000557			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	LL1OQ	WOS:000531324800003	32341286	Green Accepted			2022-02-06	
J	Barrett, JP; Henry, RJ; Shirey, KA; Doran, SJ; Makarevich, OD; Ritzel, RM; Meadows, VA; Vogel, SN; Faden, AI; Stoica, BA; Loane, DJ				Barrett, James P.; Henry, Rebecca J.; Shirey, Kari Ann; Doran, Sarah J.; Makarevich, Oleg D.; Ritzel, Rodney M.; Meadows, Victoria A.; Vogel, Stefanie N.; Faden, Alan, I; Stoica, Bogdan A.; Loane, David J.			Interferon-beta Plays a Detrimental Role in Experimental Traumatic Brain Injury by Enhancing Neuroinflammation That Drives Chronic Neurodegeneration	JOURNAL OF NEUROSCIENCE			English	Article						interferon-beta; neurodegeneration; neuroinflammation; neuroprotection; traumatic brain injury; type I interferons	IFN-BETA; GENE-EXPRESSION; HEAD-INJURY; MICROGLIAL ACTIVATION; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; INDUCTION; RISK; DNA; INFLAMMATION	DNA damage and type I interferons (IFNs) contribute to inflammatory responses after traumatic brain injury (TBI). TBI-induced activation of microglia and peripherally-derived inflammatory macrophages may lead to tissue damage and neurological deficits. Here, we investigated the role of IFN-beta in secondary injury after TBI using a controlled cortical impact model in adult male IFN-beta-deficient (IFN-beta(-/-)) mice and assessed post-traumatic neuroinflammatory responses, neuropathology, and long-term functional recovery. TBI increased expression of DNA sensors cyclic GMP-AMP synthase and stimulator of interferon genes in wild-type (WT) mice. IFN-beta and other IFN-related and neuroinflammatory genes were also upregulated early and persistently after TBI. TBI increased expression of proinflammatory mediators in the cortex and hippocampus of WT mice, whereas levels were mitigated in IFN-beta(-/-) mice. Moreover, long-term microglia activation, motor, and cognitive function impairments were decreased in IFN-beta(-/-) TBI mice compared with their injured WT counterparts; improved neurological recovery was associated with reduced lesion volume and hippocampal neurodegeneration in IFN-beta(-/-) mice. Continuous central administration of a neutralizing antibody to the IFN-beta(-/-) receptor (IFNAR) for 3 d, beginning 30 min post-injury, reversed early cognitive impairments in TBI mice and led to transient improvements in motor function. However, anti-IFNAR treatment did not improve long-term functional recovery or decrease TBI neuropathology at 28 d post-injury. In summary, TBI induces a robust neuroinflammatory response that is associated with increased expression of IFN-beta and other IFN-related genes. Inhibition of IFN-beta reduces post-traumatic neuroinflammation and neurodegeneration, resulting in improved neurological recovery. Thus, IFN-beta may be a potential therapeutic target for TBI.	[Barrett, James P.; Henry, Rebecca J.; Doran, Sarah J.; Makarevich, Oleg D.; Ritzel, Rodney M.; Meadows, Victoria A.; Faden, Alan, I; Stoica, Bogdan A.; Loane, David J.] Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA; [Shirey, Kari Ann; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA; [Stoica, Bogdan A.] Univ Maryland, Dept Radiat Oncol, Div Translat Radiat Sci, Sch Med, Baltimore, MD 21201 USA; [Stoica, Bogdan A.] Baltimore VA Med Ctr, Vet Affairs VA Maryland Hlth Care Syst, Baltimore, MD 21201 USA; [Loane, David J.] Trinity Coll Dublin, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland		Barrett, JP (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol & Shock, Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA.	james.barrett@som.umaryland.edu	Loane, David/ABD-5177-2021; STOICA, BOGDAN/H-9782-2013	Loane, David/0000-0003-0393-3503; STOICA, BOGDAN/0000-0002-2501-6434; Henry, Rebecca/0000-0001-8548-1170; Ritzel, Rodney/0000-0002-0160-2930; Barrett, James/0000-0002-0924-9449	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS082308, R01NS037313, R01NS096002, R01NS110756, AI125215]; U.S. Veterans Affairs Grant [1I01 RX001993]; Science Foundation IrelandScience Foundation IrelandEuropean Commission [17/FRL/4860]	This work was supported by National Institutes of Health Grants R01NS082308 (D.J.L.), R01NS037313 (A.I.F.), R01NS096002 (B.A.S.), R01NS110756 (D.J.L./A.I.F./B.A.S.), AI125215 (S.N.V.), U.S. Veterans Affairs Grant 1I01 RX001993 (B.A.S.), and Science Foundation Ireland Grant 17/FRL/4860 (D.J.L.).	Abdullah A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1354-7; Ahyi ANN, 2009, J IMMUNOL, V183, P1598, DOI 10.4049/jimmunol.0803302; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Barrett JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0843-4; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Byrnes AA, 2002, ANN NEUROL, V51, P165, DOI 10.1002/ana.10084; Byrnes KR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-43; Cheng WY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01297; Chin AC, 2019, J NEUROPHYSIOL, V121, P1087, DOI 10.1152/jn.00848.2018; Cox DJ, 2015, GLIA, V63, P812, DOI 10.1002/glia.22786; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Field R, 2010, BRAIN BEHAV IMMUN, V24, P996, DOI 10.1016/j.bbi.2010.04.004; Gok B, 2007, SPINE, V32, P873, DOI 10.1097/01.brs.0000259841.40358.8f; Gunthner R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/731023; Hatesuer B, 2017, J INNATE IMMUN, V9, P145, DOI 10.1159/000450705; Henry RJ, 2019, NEUROTHERAPEUTICS, V16, P216, DOI 10.1007/s13311-018-0665-9; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Karve IP, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0128-15.2016; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Liu JG, 2003, J EXP MED, V198, P1265, DOI 10.1084/jem.20030026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lobo-Silva D, 2017, GLIA, V65, P1439, DOI 10.1002/glia.23172; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Main BS, 2016, GLIA, V64, P1590, DOI 10.1002/glia.23028; Makinde HM, 2020, J SURG RES, V246, P113, DOI 10.1016/j.jss.2019.08.024; Minter MR, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0341-4; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nazmi A, 2019, GLIA, V67, P1254, DOI 10.1002/glia.23592; Owens T, 2014, GLIA, V62, P339, DOI 10.1002/glia.22608; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pinto AK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004086; Pischiutta F, 2018, EXP NEUROL, V300, P167, DOI 10.1016/j.expneurol.2017.11.003; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Sandrow-Feinberg HR, 2010, EXP NEUROL, V223, P439, DOI 10.1016/j.expneurol.2010.01.009; Scheu S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010190; Sen T, 2020, J NEUROSCI, V40, P424, DOI 10.1523/JNEUROSCI.0718-19.2019; Sheikh F, 2014, J LEUKOCYTE BIOL, V96, P591, DOI 10.1189/jlb.2A0414-191R; Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Storek KM, 2015, J IMMUNOL, V194, P3236, DOI 10.4049/jimmunol.1402764; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tanaka T, 2015, GLIA, V63, P595, DOI 10.1002/glia.22770; Taylor JM, 2014, NEUROBIOL AGING, V35, P1012, DOI 10.1016/j.neurobiolaging.2013.10.089; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Walko TD, 2014, SHOCK, V41, P499, DOI 10.1097/SHK.0000000000000160; Wang HC, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2084-z; Xie CL, 2016, INT J MOL MED, V38, P148, DOI 10.3892/ijmm.2016.2583; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	71	21	21	2	9	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474	1529-2401		J NEUROSCI	J. Neurosci.	MAR 11	2020	40	11					2357	2370		10.1523/JNEUROSCI.2516-19.2020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KU6OV	WOS:000519835100016	32029532	Green Published, Bronze			2022-02-06	
J	Ashina, H; Iljazi, A; Al-Khazali, HM; Ashina, S; Jensen, RH; Amin, FM; Ashina, M; Schytz, HW				Ashina, Hakan; Iljazi, Afrim; Al-Khazali, Haidar Muhsen; Ashina, Sait; Jensen, Rigmor Hojland; Amin, Faisal Mohammad; Ashina, Messoud; Winther Schytz, Henrik			Persistent post-traumatic headache attributed to mild traumatic brain injury: Deep phenotyping and treatment patterns	CEPHALALGIA			English	Article						Concussion; head trauma; head injury; clinical management	CHRONIC PAIN; PREVALENCE; MIGRAINE	Objective To investigate clinical characteristics and treatment patterns in persistent post-traumatic headache attributed to mild traumatic brain injury. Methods A total of 100 individuals with persistent post-traumatic headache attributed to mild traumatic brain injury were enrolled between July 2018 and June 2019. Deep phenotyping was performed using a semi-structured interview while allodynia was assessed using the 12-item Allodynia Symptom Checklist. Results In 100 subjects with persistent post-traumatic headache, the mean headache frequency was 25.4 +/- 7.1 days per month. The most common headache phenotype was chronic migraine-like headache (n = 61) followed by combined episodic migraine-like and tension-type-like headache (n = 29) while nine subjects reported "pure" chronic tension-type-like headache. The most frequent trigger factors were stress, lack of sleep, and bright lights. A history of preventive medication use was reported by 63 subjects, of which 79% reported failure of at least one preventive drug, while 19% reported failure of at least four preventive drugs. Cutaneous allodynia was absent in 54% of the subjects, mild in 23%, moderate in 17%, and severe in 6%. Conclusions The headache profile of individuals with persistent post-traumatic headache most often resembled a chronic migraine-like phenotype or a combined episodic migraine-like and tension-type-like headache phenotype. Migraine-specific preventive medications were largely reported to be ineffective. Therefore, there is a pressing need for pathophysiological insights and disease-specific therapies.	[Ashina, Hakan; Iljazi, Afrim; Al-Khazali, Haidar Muhsen; Jensen, Rigmor Hojland; Amin, Faisal Mohammad; Ashina, Messoud; Winther Schytz, Henrik] Univ Copenhagen, Fac Hlth & Med Sci, Rigshosp Glostrup, Danish Headache Ctr,Dept Neurol, Copenhagen, Denmark; [Ashina, Sait] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Comprehens Headache Ctr, Boston, MA 02115 USA; [Ashina, Sait] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Comprehens Headache Ctr, Boston, MA 02115 USA		Schytz, HW (corresponding author), Univ Copenhagen, Danish Headache Ctr, Dept Neurol, Fac Hlth & Med Sci,Rigshosp Glostrup, Valdemar Hansens Vej 5, DK-2600 Glostrup, Denmark.	henrik.winther.schytz.01@regionh.dk	Ashina, Sait/I-1766-2019; Ashina, Sait/AAC-7681-2019	Ashina, Sait/0000-0003-3973-6640; Amin, Faisal Mohammad/0000-0003-3803-3599; Ashina, Messoud/0000-0003-0951-5804; Ashina, Hakan/0000-0002-6268-727X; Schytz, Henrik Winther/0000-0002-6262-2986	Rigshospitalet Research Foundation [F-23340-02]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by a grant from the Rigshospitalet Research Foundation (F-23340-02).	Anthony Michael, 1993, P255; Ashina H, 2019, NAT REV NEUROL, V15, P607, DOI 10.1038/s41582-019-0243-8; Bergman S, 2001, J RHEUMATOL, V28, P1369; CELENTANO DD, 1990, J CLIN EPIDEMIOL, V43, P983, DOI 10.1016/0895-4356(90)90082-Z; Defrin R, 2010, EUR J PAIN, V14, P924, DOI 10.1016/j.ejpain.2010.03.004; Kelman L, 2007, CEPHALALGIA, V27, P394, DOI 10.1111/j.1468-2982.2007.01303.x; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Larsen EL, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-1051-7; Levy D, 2020, CEPHALALGIA, V40, P675, DOI 10.1177/0333102419896368; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lipton RB, 2008, ANN NEUROL, V63, P148, DOI 10.1002/ana.21211; Lipton RB, 2014, HEADACHE, V54, P1661, DOI 10.1111/head.12464; Lucas S, 2018, HEADACHE, V58, P873, DOI 10.1111/head.13311; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Mantyselka PT, 2003, JAMA-J AM MED ASSOC, V290, P2435, DOI 10.1001/jama.290.18.2435; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; OECD and European Observatory on Health Systems and Policies, STAT HLTH EU DENM CO; RASMUSSEN BK, 1992, NEUROLOGY, V42, P1225, DOI 10.1212/WNL.42.6.1225; Russell MB, 1996, CEPHALALGIA, V16, P239, DOI 10.1046/j.1468-2982.1996.1604239.x; Russell MB, 1996, CEPHALALGIA, V16, P156, DOI 10.1046/j.1468-2982.1996.1603156.x; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Voormolen DC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111921; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [10.1001/jama.2013.281053, DOI 10.1001/JAMA.2013.281053]	27	21	21	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2020	40	6					554	564	0333102420909865	10.1177/0333102420909865		FEB 2020	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	LN2BE	WOS:000516901700001	32102546				2022-02-06	
J	Chen, W; Zheng, P; Hong, T; Wang, Y; Liu, N; He, B; Zou, SF; Ren, DB; Duan, J; Zhao, L; Feng, JG				Chen, Wei; Zheng, Ping; Hong, Tao; Wang, Yang; Liu, Ning; He, Bin; Zou, Shufeng; Ren, Dabin; Duan, Jian; Zhao, Lin; Feng, Jiugeng			Astrocytes-derived exosomes induce neuronal recovery after traumatic brain injury via delivering gap junction alpha 1-20 k	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						apoptosis; astrocytes; exosome; GJA1-20 k mitochondria; TBI	TRANSLATION; MOUSE	Astrocytes are more resistant to ischemia and hypoxia in the acute phase of brain injury after traumatic brain injury (TBI). Previous study showed that gap junction alpha 1 (GJA1) phosphorylation can increase the survival of damaged astrocytes. The GJA1-20 k expression in neurons co-culture with astrocytes was positively correlated with exosomes uptake. This study aims to explore the effect of exogenous GJA1-20 k carried by astrocyte-derived exosomes on neurons apoptosis and mitochondrial function after TBI. Astrocytes were co-cultured with the neuron with/without damage from air pressure. Exosomes were isolated, extracted from the culture medium by differential ultra-centrifugation, and verified by electron microscopy. Immunofluorescence staining, tunnel, western blot were employed to detect exosomes marker CD60, apoptosis, and mitochondrial function related protein expression and GJA1-20 k in cell culture. A rat model of hydraulic injury TBI was built, and exosomes was transferred. 2,3,5-Triphenyltetrazolium chloride (TTC) staining and immunohistochemistry staining of Nissl and microtubule associated protein 2 were used to detect the brain damage. A transwell stereo culture model of astrocytes and TBI-like injured neuron was constructed. The exosomes derived from astrocytes promoted the recovery of damaged neuron by in vitro exosome treatment. Compared with GJA1-20 k knockout exosome control group, GJA1-20 k exosomes were uptaken by neuron and downregulated the apoptosis rate and upregulated mitochondrial function to promote neuronal recovery. Finally, the results were validated by TTC staining and damaged tissue sections of rat TBI model. This study contributes to a better understanding of the astrocyte-neuron protection mechanism in TBI and provides a potential new target for the treatment of TBI.	[Chen, Wei; Hong, Tao; Wang, Yang; Zou, Shufeng; Duan, Jian; Feng, Jiugeng] Nanchang Univ, Emergency Trauma Ctr, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Zheng, Ping; He, Bin; Ren, Dabin] Shanghai Univ Med & Hlth Sci, Dept Neurosurg, Peoples Hosp Shanghai Pudong New Area, Shanghai, Peoples R China; [Liu, Ning; Zhao, Lin] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing 330008, Jiangsu, Peoples R China		Feng, JG (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Neurosurg, Nanchang 330008, Jiangxi, Peoples R China.	fengjg_1979@sina.com		Chen, Wei/0000-0001-7438-3241	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81960236, 81701231, 81872058]; Livelihood Project of Pudong new area Science and Technology Commission [PKJ2016-Y31]; Key Research Project of Science and Technology Agency [20192BBGL70022]; Shanghai Nature Science Foundation [19ZR1447400]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81960236, 81701231, 81872058]	National Natural Science Foundation of China, Grant/Award Number: 81960236, 81701231, 81872058; the Livelihood Project of Pudong new area Science and Technology Commission, Grant/Award Number: PKJ2016-Y31; Livelihood Project of Pudong New Area Science and Technology Commission, Grant/Award Number: PKJ2016-Y31; Key Research Project of Science and Technology Agency, Grant/Award Number: 20192BBGL70022; Shanghai Nature Science Foundation, Grant/Award Number: 19ZR1447400; Natural Science Foundation of China, Grant/Award Numbers: 81872058, 81701231, 81960236	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Basheer W, 2016, BBA-MOL CELL RES, V1863, P1848, DOI 10.1016/j.bbamcr.2015.10.015; Basheer WA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121900; Basheer WA, 2017, CIRC RES, V121, P1069, DOI 10.1161/CIRCRESAHA.117.311955; Bell CL., 2018, INT J MOL SCI, V20, pE44; Chen W, 2018, J NEUROPHYSIOL, V119, P305, DOI 10.1152/jn.00654.2017; Chen W, 2017, RESTOR NEUROL NEUROS, V35, P217, DOI 10.3233/RNN-160705; Chen W, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON COMPUTATIONAL ELECTROMAGNETICS (ICCEM), P40, DOI 10.1109/COMPEM.2016.7588630; Chen W, 2015, EXP BRAIN RES, V233, P2823, DOI 10.1007/s00221-015-4352-3; Cheng W., 2017, SCI REP-UK, V7, P1; Fu Y., 2017, FRONT PHYSIOL, V8, P1; Kim SN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07658-y; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Marcus ME, 2013, PHARMACEUTICALS-BASE, V6, P659, DOI 10.3390/ph6050659; Mutschelknaus L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152213; Pecoraro M, 2018, TOXICOL IN VITRO, V47, P120, DOI 10.1016/j.tiv.2017.11.004; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Salat-Canela C, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-31; Sancho M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084666; Slavi N, 2018, P NATL ACAD SCI USA, V115, pE5934, DOI 10.1073/pnas.1803907115; Wang L, 2018, CELL PHYSIOL BIOCHEM, V50, P1535, DOI 10.1159/000494652; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Yin X, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1127-3; Zuo R, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-018-1121-9	25	21	21	4	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	MAR	2020	14	3					412	423		10.1002/term.3002		DEC 2019	12	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Engineering	KW1ME	WOS:000503701800001	31826322				2022-02-06	
J	Bhowmick, S; D'Mello, V; Caruso, D; Abdul-Muneer, PM				Bhowmick, Saurav; D'Mello, Veera; Caruso, Danielle; Abdul-Muneer, P. M.			Traumatic brain injury-induced downregulation of Nrf2 activates inflammatory response and apoptotic cell death	JOURNAL OF MOLECULAR MEDICINE-JMM			English	Article						Traumatic brain injury; Nrf2 signaling; Antioxidant genes; Oxidative stress; Neuroinflammation; Neurodegeneration	NECROSIS-FACTOR-ALPHA; II TYPE-1 RECEPTOR; OXIDATIVE STRESS; ANGIOTENSIN-II; MOUSE MODEL; MATRIX METALLOPROTEINASES; MOLECULAR-MECHANISMS; NRF2-KEAP1 PATHWAY; ENDOTHELIAL-CELLS; DAMAGE	Recent studies from our group and others have demonstrated that oxidative stress, Ca2+ signaling, and neuroinflammation are major mechanisms contributing to post-traumatic neurodegeneration. The present study investigated the mechanisms of regulation of nuclear factor E2-related factor 2 (Nrf2) and its role in regulating antioxidant genes and oxidative stress-induced neuroinflammation and neurodegeneration following TBI. Nrf2 transcriptional system is the major regulator of endogenous defense mechanisms operating within the cells. Wild-type (Nrf2(+/+)) and Nrf2-deficient mice (Nrf2(-/-)) were subjected to 15 psi fluid percussion injury and demonstrated the regulatory role of Nrf2 in the expression antioxidant genes and oxidative stress, neuroinflammation, and cell death. Immunohistochemistry, q-RT-PCR, and western blotting techniques detected downregulation of Nrf2 and antioxidant proteins such as HO-1, GPx1, GSTm1, and NQO1 in mouse brain samples. Further, our study demonstrated that the downregulation of Nrf2 and antioxidant genes in TBI correlated with the induction of free radical-generating enzyme NADPH oxidase 1 and inducible nitric oxide synthase and their corresponding oxidative/nitrosative stress markers 4-hydroxynonenal and 3-nitrotyrosine. The decrease in Nrf2 with subsequent increase in oxidative stress markers led to the activation of MMP3/9, TGF-beta 1, and NF-kB that further led to neuroinflammation and apoptosis. The absence of Nrf2 function in mice resulted in exacerbated brain injury as shown by the increased oxidative stress markers, pro-inflammatory cytokines, and apoptosis markers at 24 h after TBI. In conclusion, this study could establish the significance of Nrf2 in transforming into a novel preventive approach against the pathophysiology of TBI. Key messages center dot Traumatic brain injury impairs Nrf2 signaling in mouse. center dot Nrf2-mediated activation of antioxidant genes are altered after TBI. center dot Impairment of Nrf2 signaling leads to oxidative stress. center dot TBI-induced downregulation of Nrf2 activates MMPs, TGF-beta 1, and NF-kB. center dot Nrf2 regulates neuroinflammation and apoptotic cell death in TB.	[Bhowmick, Saurav; D'Mello, Veera; Caruso, Danielle; Abdul-Muneer, P. M.] Hackensack Meridian Hlth JFK Med Ctr, JFK Neurosci Inst, Lab CNS Injury & Mol Therapy, 65 James St, Edison, NJ 08820 USA		Abdul-Muneer, PM (corresponding author), Hackensack Meridian Hlth JFK Med Ctr, JFK Neurosci Inst, Lab CNS Injury & Mol Therapy, 65 James St, Edison, NJ 08820 USA.	Mohammed.Muneer@hackensackmeridian.org		Abdul-Muneer, P. M/0000-0001-8231-4385	New Jersey Commission on Brain Injury Research [CBIR19PIL010]; Neuroscience Institute at Hackensack Meridian Health JFK Medical Center, Edison, NJ	This work was supported by New Jersey Commission on Brain Injury Research #CBIR19PIL010 and the Neuroscience Institute at Hackensack Meridian Health JFK Medical Center, Edison, NJ to PM Abdul-Muneer.	Abdul-Muneer PM, 2018, MOL NEUROBIOL, V55, P5901, DOI 10.1007/s12035-017-0812-z; Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V62, P291, DOI 10.1016/j.bbi.2017.02.014; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Arimura K, 2012, CURR NEUROVASC RES, V9, P1; Bhakkiyalakshmi E, 2015, PHARMACOL RES, V91, P104, DOI 10.1016/j.phrs.2014.10.004; Bhowmick S, 2019, EXP NEUROL, V317, P260, DOI 10.1016/j.expneurol.2019.03.014; Bhowmick S, 2019, MOL NEUROBIOL, V56, P1124, DOI 10.1007/s12035-018-1132-7; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Ding H, 2017, NEUROCHEM INT, V111, P32, DOI 10.1016/j.neuint.2017.04.016; Dong WW, 2019, EUR J NEUROSCI, V50, P1981, DOI 10.1111/ejn.14399; Elanchezhian R, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.40; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M, 2010, TRAUMATIC BRAIN INJU; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hans VHJ, 1999, NEUROREPORT, V10, P409; Haorah J, 2007, J NEUROCHEM, V101, P566, DOI 10.1111/j.1471-4159.2006.04393.x; Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Howden R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/104308; Ito H, 2001, J HYPERTENS, V19, P591, DOI 10.1097/00004872-200103001-00011; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184; Jain M, 2013, J BIOL CHEM, V288, P770, DOI 10.1074/jbc.M112.431973; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Joshi Gururaj, 2012, Recent Pat CNS Drug Discov, V7, P218; Kaidery NA, 2013, ANTIOXID REDOX SIGN, V18, P139, DOI 10.1089/ars.2011.4491; Kam KY, 2011, MOL CELLS, V31, P209, DOI 10.1007/s10059-011-0028-4; Kanninen K, 2009, P NATL ACAD SCI USA, V106, P16505, DOI 10.1073/pnas.0908397106; Kelly PJ, 2008, STROKE, V39, P100, DOI 10.1161/STROKEAHA.107.488189; Ketsawatsomkron P, 2016, HYPERTENSION, V67, P214, DOI 10.1161/HYPERTENSIONAHA.115.06391; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Krstic J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/654594; Lamle J, 2008, GASTROENTEROLOGY, V134, P1159, DOI 10.1053/j.gastro.2008.01.011; Landmesser U, 2007, ARTERIOSCL THROM VAS, V27, P943, DOI 10.1161/01.ATV.0000258415.32883.bf; Lau LT, 2001, J NEUROTRAUM, V18, P351, DOI 10.1089/08977150151071035; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lu CF, 2016, MOL PHARMACEUT, V13, P4043, DOI 10.1021/acs.molpharmaceut.6b00562; Lu CF, 2015, IUBMB LIFE, V67, P645, DOI 10.1002/iub.1409; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Reisman SA, 2009, TOXICOL SCI, V108, P35, DOI 10.1093/toxsci/kfn267; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rueckschloss U, 2002, ARTERIOSCL THROM VAS, V22, P1845, DOI 10.1161/01.ATV.0000035392.38687.65; Rustenhoven J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0503-0; Sajja RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122358; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Soares HD, 1995, J NEUROSCI, V15, P8223; Steel R, 2012, ACS MED CHEM LETT, V3, P407, DOI 10.1021/ml300041g; Tu JY, 2015, J NEUROSCI, V35, P14727, DOI 10.1523/JNEUROSCI.1304-15.2015; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Xiong WJ, 2015, J CLIN INVEST, V125, P1433, DOI 10.1172/JCI79735	72	21	23	2	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0946-2716	1432-1440		J MOL MED	J. Mol. Med.	DEC	2019	97	12					1627	1641		10.1007/s00109-019-01851-4		NOV 2019	15	Genetics & Heredity; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Research & Experimental Medicine	KQ2NJ	WOS:000498020400001	31758217				2022-02-06	
J	Putukian, M; Echemendia, RJ; Chiampas, G; Dvorak, J; Mandelbaum, B; Lemak, LJ; Kirkendall, D				Putukian, Margot; Echemendia, Ruben J.; Chiampas, George; Dvorak, Jiri; Mandelbaum, Bert; Lemak, Lawrence J.; Kirkendall, Don			Head Injury in Soccer: From Science to the Field; summary of the head injury summit held in April 2017 in New York City, New York	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; SPORTS-RELATED CONCUSSION; PROFESSIONAL RUGBY UNION; FEMALE FOOTBALL PLAYERS; STATES HIGH-SCHOOL; WOMENS SOCCER; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; ELITE FOOTBALL; NECK STRENGTH	There has been an increased focus and awareness of head injury and sport-related concussion (SRC) across all sports from the medical and scientific communities, sports organisations, legislators, the media and the general population. Soccer, in particular, has been a focus of attention due to the popularity of the game, the frequency of SRC and the hypothesised effects of repetitive heading of the ball. Major League Soccer, US Soccer and the National Women's Soccer League jointly hosted a conference entitled, 'Head Injury in Soccer: From Science to the Field', on 21-22 April 2017 in New York City, New York. The mission of this conference was to identify, discuss and disseminate evidence-based science related to the findings and conclusions of the fifth International Conference on Concussion in Sport held by the Concussion in Sport Group and apply them to the sport of soccer. In addition, we reviewed information regarding the epidemiology and mechanism of head injuries in soccer at all levels of play, data regarding the biomechanics and effects of repetitive head impacts and other soccer-specific considerations. We discussed how to release the information raised during the summit to key stakeholders including athletes, parents, coaches and healthcare providers. We identified future areas for research and collaboration to enhance the health and safety of soccer (football) players.	[Putukian, Margot] Princeton Univ, Dept Athlet Med, Princeton, NJ 08544 USA; [Echemendia, Ruben J.] Univ Orthopaed Ctr, Dept Concuss Clin, State Coll, PA USA; [Chiampas, George] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med & Orthoped, Chicago, IL 60611 USA; [Dvorak, Jiri] Swiss Concuss Ctr, Zurich, Switzerland; [Dvorak, Jiri] Schulthess Clin, Dept Spine Unit, Zurich, Switzerland; [Mandelbaum, Bert] Santa Monica Orthopaed & Sports Med Grp, Santa Monica, CA USA; [Lemak, Lawrence J.] Lemak Hlth, Birmingham, AL USA; [Kirkendall, Don] Duke Univ Hlth Syst, Duke Sport Sci Inst, Durham, NC USA		Putukian, M (corresponding author), Princeton Univ, Univ Hlth Serv, Athlet Med, Princeton, NJ 08544 USA.	putukian@princeton.edu		Putukian, Margot/0000-0002-1478-8068			Agel J, 2007, J ATHL TRAINING, V42, P270; Akodu A K, 2012, Afr J Med Med Sci, V41, P423; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Baxter-Johes ADG, 2001, SPORTS MED SPECIFIC, P95; Beaudouin F, 2018, CLIN J SPORT MED, P1; Bible F., 2014, SOCCER BALL SIZES SE; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bjorneboe J, 2013, BRIT J SPORT MED, V47, P508, DOI 10.1136/bjsports-2012-091522; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Chrisman SPD, 2017, CLIN J SPORT MED; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Conley MS, 1997, EUR J APPL PHYSIOL, V75, P443, DOI 10.1007/s004210050186; Conley MS, 1997, J APPL PHYSIOL, V83, P2105, DOI 10.1152/jappl.1997.83.6.2105; Covassin T, 2003, J ATHL TRAINING, V38, P238; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Dick R, 2007, J ATHL TRAINING, V42, P278; Dupont G, 2010, AM J SPORT MED, V38, P1752, DOI 10.1177/0363546510361236; Dvorak J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.034579; Dvorak J, 2011, BRIT J SPORT MED, V45, P626, DOI 10.1136/bjsm.2010.079905; Echemendia RE., 2017, MAJ LEAG SOCC 2017 M; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Eirale C, 2014, J SCI MED SPORT, V17, P34, DOI 10.1016/j.jsams.2013.05.004; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2011, SCAND J MED SCI SPOR, V21, P824, DOI 10.1111/j.1600-0838.2010.01118.x; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Faude O, 2017, SCAND J MED SCI SPOR, V27, P1986, DOI 10.1111/sms.12839; Faude O, 2013, SPORTS MED, V43, P819, DOI 10.1007/s40279-013-0061-x; FIFA, 2007, FIFA BIG COUNT 2006 FIFA BIG COUNT 2006; FITZPATRICK J, 2017, BRIT J SPORT MED, V5; Forbes CR, 2016, APPL NEUROPSYCH-CHIL, V5, P14, DOI 10.1080/21622965.2014.933108; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Geary K, 2014, CLIN J SPORT MED, V24, P502, DOI 10.1097/JSM.0000000000000071; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greydanus DE, 2009, PEDIAT PRACTICE SPOR, P15; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hagglund M, 2009, SCAND J MED SCI SPOR, V19, P819, DOI 10.1111/j.1600-0838.2008.00861.x; Hagglund M, 2009, BRIT J SPORT MED, V43, P483, DOI 10.1136/bjsm.2008.056937; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Hanlon E, 2009, THESIS; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Hartmut G, 2010, CLIN J SPORT MED, V20, P264, DOI 10.1097/JSM.0b013e3181e78e33; Hassabi Mohammad, 2010, Asian J Sports Med, V1, P201; Haywood K., 2014, LIFE SPAN MOTOR DEV, V6th; Hrysomallis C, 2004, J SCI MED SPORT, V7, P156, DOI 10.1016/S1440-2440(04)80005-7; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacobson I, 2007, SCAND J MED SCI SPOR, V17, P84, DOI 10.1111/j.1600-0838.2006.00524.x; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Junge A, 2004, AM J SPORT MED, V32, p80S, DOI 10.1177/0363546503261245; Junge A, 2004, AM J SPORT MED, V32, p23S, DOI 10.1177/0363546503261246; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; Junge A, 2007, BRIT J SPORT MED, V41, pI3, DOI 10.1136/bjsm.2007.036020; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lefebvre C, 1998, ADAPT PHYS ACT Q, V15, P299, DOI 10.1123/apaq.15.4.299; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Lipton ML, 2018, J SCI MED SPORT, V21, P363, DOI 10.1016/j.jsams.2017.08.008; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P205, DOI 10.1097/JSM.0b013e318057518f; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; NCAA, 2017, CONC ED RES SEC CONC; NCAA, 2017, NCAA INJ SURV PROGR; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; O'Kane JW, 2014, PHYSICIAN SPORTSMED, V42, P39, DOI 10.3810/psm.2014.09.2074; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Purcell L., 2005, PAEDIAT CHILD HLTH, V16, P343; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Taubman B, 2016, J CHILD NEUROL, V31, P1555, DOI 10.1177/0883073816664835; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; U.S USSoccer, 2017, SOCC REC 2 REC CONC; United Soccer Coaches, 2017, GET AHEAD SAF SOCC O; Walden M, 2005, SCAND J MED SCI SPOR, V15, P118, DOI 10.1111/j.1600-0838.2004.00393.x; Walden M, 2013, SCAND J MED SCI SPOR, V23, P424, DOI 10.1111/j.1600-0838.2011.01409.x; Walden M, 2007, KNEE SURG SPORT TR A, V15, P1155, DOI 10.1007/s00167-007-0290-3; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Yoon YS, 2004, AM J SPORT MED, V32, p36S, DOI 10.1177/0095399703258781; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2018, J ALZHEIMERS DIS, V66, P37, DOI 10.3233/JAD-180218; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	153	21	21	2	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	NOV	2019	53	21					1332	+		10.1136/bjsports-2018-100232			14	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	JK8GI	WOS:000495077700005	30760457	Bronze			2022-02-06	
J	Campolettano, ET; Gellner, RA; Smith, EP; Bellamkonda, S; Tierney, CT; Crisco, JJ; Jones, DA; Kelley, ME; Urban, JE; Stitzel, JD; Genemaras, A; Beckwith, JG; Greenwald, RM; Maerlender, AC; Brolinson, PG; Duma, SM; Rowson, S				Campolettano, Eamon T.; Gellner, Ryan A.; Smith, Eric P.; Bellamkonda, Srinidhi; Tierney, Casey T.; Crisco, Joseph J.; Jones, Derek A.; Kelley, Mireille E.; Urban, Jillian E.; Stitzel, Joel D.; Genemaras, Amaris; Beckwith, Jonathan G.; Greenwald, Richard M.; Maerlender, Arthur C.; Brolinson, Per Gunnar; Duma, Stefan M.; Rowson, Steven			Development of a Concussion Risk Function for a Youth Population Using Head Linear and Rotational Acceleration	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Biomechanics; Helmet; Risk curve; Mild traumatic brain injury; Football	CHRONIC TRAUMATIC ENCEPHALOPATHY; IMPACT EXPOSURE; FOOTBALL PLAYERS; INJURY; EPIDEMIOLOGY; VALIDATION; KINEMATICS; COLLEGIATE; SEVERITY; CHILDREN	Physical differences between youth and adults, which include incomplete myelination, limited neck muscle development, and a higher head-body ratio in the youth population, likely contribute towards the increased susceptibility of youth to concussion. Previous research efforts have considered the biomechanics of concussion for adult populations, but these known age-related differences highlight the necessity of quantifying the risk of concussion for a youth population. This study adapted the previously developed Generalized Acceleration Model for Brian Injury Threshold (GAMBIT) that combines linear and rotational head acceleration to model the risk of concussion for a youth population with the Generalized Acceleration Model for Concussion in Youth (GAM-CY). Survival analysis was used in conjunction with head impact data collected during participation in youth football to model risk between individuals who sustained medically-diagnosed concussions (n = 15). Receiver operator characteristic curves were generated for peak linear acceleration, peak rotational acceleration, and GAM-CY, all of which were observed to be better injury predictors than random guessing. GAM-CY was associated with an area under the curve of 0.89 (95% confidence interval: 0.82-0.95) when all head impacts experienced by the concussed players were considered. Concussion tolerance was observed to be lower for youth athletes, with average peak linear head acceleration of 62.4 +/- 29.7 g compared to 102.5 +/- 32.7 g for adults and average peak rotational head acceleration of 2609 +/- 1591 rad/s(2) compared to 4412 +/- 2326 rad/s(2). These data provide further evidence of age-related differences in concussion tolerance and may be used for the development of youth-specific protective designs.	[Campolettano, Eamon T.; Gellner, Ryan A.; Duma, Stefan M.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Smith, Eric P.] Virginia Tech, Dept Stat, Blacksburg, VA USA; [Bellamkonda, Srinidhi; Tierney, Casey T.; Crisco, Joseph J.] Brown Univ, Warren Alpert Med Sch, Dept Orthopaed, Providence, RI 02912 USA; [Bellamkonda, Srinidhi; Tierney, Casey T.; Crisco, Joseph J.] Rhode Isl Hosp, Providence, RI USA; [Jones, Derek A.; Kelley, Mireille E.; Urban, Jillian E.; Stitzel, Joel D.] Virginia Tech, Wake Forest Sch Biomed Engn & Sci, Winston Salem, NC USA; [Genemaras, Amaris; Beckwith, Jonathan G.; Greenwald, Richard M.] Simbex, Lebanon, NH USA; [Maerlender, Arthur C.] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE USA; [Brolinson, Per Gunnar] Edward Via Virginia Coll Osteopath Med, Blacksburg, VA USA		Campolettano, ET (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	eamonc@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596; Campolettano, Eamon/0000-0002-0540-1028; Crisco, Joseph/0000-0002-8786-0905	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094410, 1R01NS082453]; National Operating Committee on Standards for Athletic Equipment [1-SAC-2017]	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Numbers R01NS094410 and 1R01NS082453. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institutes of Health. The authors would also like to acknowledge the National Operating Committee on Standards for Athletic Equipment under Award 1-SAC-2017. The authors gratefully acknowledge the youth football teams for their participation in this study.	Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; FARKAS LG, 1992, CLEFT PALATE-CRAN J, V29, P303, DOI 10.1597/1545-1569(1992)029<0303:AGSOTH>2.3.CO;2; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gottschalk AW, 2011, SPORTS MED ARTHROSC, V19, P2, DOI 10.1097/JSA.0b013e31820b95fc; Graham R., 2014, SPORTS RELATED CONCU, P309; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hardy, 2003, P INT RES C BIOM IMP; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Huelke DF, 1998, P ANN C ASS, P93; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Newman J, 2000, P INT RES COUNC BIOM; Newman J. A, 1986, P INT IRCOBI C 1986; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Olvey S. E, 2006, RECOMMENDED STANDARD; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ommaya A.K., 1985, BIOMECHANICS TRAUMA; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Register-Mihalik JK, 2018, J ATHL TRAINING, V53, P768, DOI 10.4085/1062-6050-223-17; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2019, ANN BIOMED ENG; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Shain KS, 2010, CLIN J SPORT MED, V20, P422, DOI 10.1097/JSM.0b013e3181f7db25; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stemper BD, 2018, ANN BIOMED ENG; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Unterharnscheidt FJ., 1971, P 15 STAPP CAR CRASH; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z	53	21	21	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2020	48	1					92	103		10.1007/s10439-019-02382-2		OCT 2019	12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	KI8PN	WOS:000492938200003	31659605	Green Published, hybrid			2022-02-06	
J	Yanuck, SF				Yanuck, Samuel F.			Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders	FRONTIERS IN PSYCHIATRY			English	Article						depression; microglia; neuron; autoimmunity; inflammation; traumatic brain injury; cytokine; excitotoxicity	CENTRAL-NERVOUS-SYSTEM; C-REACTIVE PROTEIN; BLOOD-BRAIN-BARRIER; NF-KAPPA-B; MAJOR DEPRESSIVE DISORDER; PARKINSONS-DISEASE; OXIDATIVE STRESS; ADIPOSE-TISSUE; ENDOTHELIAL DYSFUNCTION; ALZHEIMERS-DISEASE	Errors in neuron-microglial interaction are known to lead to microglial phagocytosis of live neurons and excessive neuronal loss, potentially yielding poorer clinical outcomes. Factors that affect neuron-microglial interaction have the potential to influence the error rate. Clinical comorbidities that unfavorably impact neuron-microglial interaction may promote a higher rate of neuronal loss, to the detriment of patient outcome. This paper proposes that many common, clinically modifiable comorbidities have a common thread, in that they all influence neuron-microglial interactions. Comorbidities like traumatic brain injury, infection, stress, neuroinflammation, loss of neuronal metabolic integrity, poor growth factor status, and other factors, all have the potential to alter communication between neurons and microglia. When this occurs, microglial phagocytosis of live neurons can increase. In addition, microglia can shift into a morphological form in which they express major histocompatibility complex II (MHC-II), allowing them to function as antigen presenting cells that present neuronal debris as antigen to invading T cells. This can increase risk for the development of CNS autoimmunity, or can exacerbate existing CNS autoimmunity. The detrimental influence of these comorbidities has the potential to contribute to the mosaic of factors that determine patient outcome in some CNS pathologies that have neuropsychiatric involvement, including TBI and CNS disorders with autoimmune components, where excessive neuronal loss can yield poorer clinical outcomes. Recognition of the impact of these comorbidities may contribute to an understanding of the common clinical observation that many seemingly disparate factors contribute to the overall picture of case management and clinical outcome in these complex disorders. In a clinical setting, knowing how these comorbidities can influence neuron-microglial interaction can help focus surveillance and care on a broader group of potential therapeutic targets. Accordingly, an interest in the mechanisms underlying the influence of these factors on neuron-microglial interactions is appropriate. Neuronmicroglial interaction is reviewed, and the various mechanisms by which these potential comorbidities influence neuro-microglial interaction are described.	[Yanuck, Samuel F.] Univ N Carolina, Dept Phys Med & Rehabil, Program Integrat Med, Sch Med, Chapel Hill, NC 27515 USA		Yanuck, SF (corresponding author), Univ N Carolina, Dept Phys Med & Rehabil, Program Integrat Med, Sch Med, Chapel Hill, NC 27515 USA.	syanuck@yanuckcenter.com					Aftanas LI, 2018, B EXP BIOL MED+, V165, P195, DOI 10.1007/s10517-018-4128-4; Aharoni R, 2014, J AUTOIMMUN, V54, P81, DOI 10.1016/j.jaut.2014.05.005; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amaral AI, 2013, J INHERIT METAB DIS, V36, P621, DOI 10.1007/s10545-012-9553-3; Andersen K, 2017, J AM SOC NEPHROL, V28, P76, DOI 10.1681/ASN.2015111285; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Ayata P, 2018, NAT NEUROSCI, V21, P1049, DOI 10.1038/s41593-018-0192-3; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barnett ML, 2018, NEUROIMAGE-CLIN, V17, P596, DOI 10.1016/j.nicl.2017.11.017; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Bhattacharjee S, 2018, PARKINSONS DIS-US, V2018, DOI 10.1155/2018/3402983; Bhattacharjee S, 2017, MULT SCLER INT, V2017, DOI 10.1155/2017/3175358; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Butterfield DA, 2019, NAT REV NEUROSCI, V20, P148, DOI 10.1038/s41583-019-0132-6; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cai QX, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00627; Cardoso FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035919; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Carvey PM, 2006, CELL TRANSPLANT, V15, P239, DOI 10.3727/000000006783981990; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chang HS, 2015, BEHAV BRAIN RES, V292, P116, DOI 10.1016/j.bbr.2015.06.005; Chou RC, 2016, CNS DRUGS, V30, P1111, DOI 10.1007/s40263-016-0374-z; Chung G, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00376; Clancy JA, 2014, BRAIN STIMUL, V7, P871, DOI 10.1016/j.brs.2014.07.031; Clarkson BDS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09182-5; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Cole SW, 2008, BRAIN BEHAV IMMUN, V22, P1049, DOI 10.1016/j.bbi.2008.02.006; Combrinck MI, 2002, NEUROSCIENCE, V112, P7, DOI 10.1016/S0306-4522(02)00030-1; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Culmsee C, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00739; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; D'Ignazio L, 2016, FEBS J, V283, P413, DOI 10.1111/febs.13578; Dahl J, 2014, PSYCHONEUROENDOCRINO, V45, P77, DOI 10.1016/j.psyneuen.2014.03.019; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Jong PR, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1458-3; De Virgilio A, 2016, AUTOIMMUN REV, V15, P1005, DOI 10.1016/j.autrev.2016.07.022; Deardorff WJ, 2017, EXPERT REV NEUROTHER, V17, P17, DOI 10.1080/14737175.2016.1200972; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Di Giovangiulio M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00590; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Dong WM, 1998, TOXICOL APPL PHARM, V151, P359, DOI 10.1006/taap.1998.8481; Dooley LN, 2018, NEUROSCI BIOBEHAV R, V94, P219, DOI 10.1016/j.neubiorev.2018.09.006; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Eswarappa M, 2019, BRAIN BEHAV IMMUN, V75, P220, DOI 10.1016/j.bbi.2018.10.012; Eyo UB, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/456857; Feinstein DL, 2016, J NEUROCHEM, V139, P154, DOI 10.1111/jnc.13447; Fernandes A, 2014, CELL MOL LIFE SCI, V71, P3969, DOI 10.1007/s00018-014-1670-8; Fiebich BL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00260; Fisher G, 2011, OBESITY, V19, P1131, DOI 10.1038/oby.2010.310; Ford ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/00001648-200209000-00012; Fricker M, 2012, J NEUROSCI, V32, P2657, DOI 10.1523/JNEUROSCI.4837-11.2012; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Fusco M, 2017, PAIN PRACT, V17, P522, DOI 10.1111/papr.12551; Galloway DA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01575; Galvan A, 2010, HUM BRAIN MAPP, V31, P879, DOI 10.1002/hbm.21029; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Giridharan VV, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00122; Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052; Gomez-Nicola D, 2015, NEUROSCIENTIST, V21, P169, DOI 10.1177/1073858414530512; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greeke EE, 2017, J NEUROL SCI, V380, P236, DOI 10.1016/j.jns.2017.07.047; Grieb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091663; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Harding A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00398; Heilbronn LK, 2001, ARTERIOSCL THROM VAS, V21, P968, DOI 10.1161/01.ATV.21.6.968; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Heninger GR, 1996, PHARMACOPSYCHIATRY, V29, P2, DOI 10.1055/s-2007-979535; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Horsburgh S, 2015, EXERC IMMUNOL REV, V21, P26; Huang M, 2019, BRAIN BEHAV IMMUN, V75, P200, DOI 10.1016/j.bbi.2018.10.007; Huizinga R, 2012, GLIA, V60, P422, DOI 10.1002/glia.22276; Hunter LE, 2019, NEUROBIOL DIS, V123, P122, DOI 10.1016/j.nbd.2018.06.016; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; Inoue T, 2016, J CLIN INVEST, V126, P1939, DOI 10.1172/JCI83658; Jayedi A, 2019, NUTR NEUROSCI, V22, P750, DOI 10.1080/1028415X.2018.1436639; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kao LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168106; Kariuki M, 2016, J PAEDIATR CHILD H, V52, P882, DOI 10.1111/jpc.13239; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Khandaker GM, 2012, SCHIZOPHR RES, V139, P161, DOI 10.1016/j.schres.2012.05.023; Kierdorf K, 2017, J CLIN INVEST, V127, P3201, DOI [10.1172/JCI90602, 10.1172/jci90602]; Kimura K, 2016, CELL REP, V14, P2362, DOI 10.1016/j.celrep.2016.02.032; KLEIN CL, 1994, PATHOBIOLOGY, V62, P90, DOI 10.1159/000163883; Kopschina FP, 2017, J PSYCHOPHARMACOL, V31, P1149, DOI DOI 10.1177/0269881117711708; Kuhlmann CRW, 2009, STROKE, V40, P1458, DOI 10.1161/STROKEAHA.108.535930; Kumar A, 2015, J CHILD NEUROL, V30, P749, DOI 10.1177/0883073814543303; Lacroix S, 1998, BRAIN PATHOL, V8, P625, DOI 10.1111/j.1750-3639.1998.tb00189.x; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Leonard BE, 2018, ACTA NEUROPSYCHIATR, V30, P1, DOI 10.1017/neu.2016.69; Leonard BE, 2014, PROG NEURO-PSYCHOPH, V48, P261, DOI 10.1016/j.pnpbp.2013.10.018; Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.1358; Lin WC, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0749-9; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Liu YJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00451; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Lunnon K, 2011, J IMMUNOL, V186, P7215, DOI 10.4049/jimmunol.0903833; Majkova Z, 2009, TOXICOL APPL PHARM, V237, P1, DOI 10.1016/j.taap.2009.02.016; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; Mangano EN, 2009, NEUROBIOL AGING, V30, P1361, DOI 10.1016/j.neurobiolaging.2007.11.020; Marsland AL, 2017, BRAIN BEHAV IMMUN, V64, P208, DOI 10.1016/j.bbi.2017.01.011; McCaulley Mark E, 2015, Int J Alzheimers Dis, V2015, P515248, DOI 10.1155/2015/515248; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller ZA, 2013, BRAIN, V136, P3461, DOI 10.1093/brain/awt242; Miyauchi T, 2019, HUM PSYCHOPHARM CLIN, V34, DOI 10.1002/hup.2698; Moller P, 2014, MUTAT RES-REV MUTAT, V762, P133, DOI 10.1016/j.mrrev.2014.09.001; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mrowczynski W, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/5413067; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Neniskyte U, 2017, NAT REV NEUROSCI, V18, P658, DOI 10.1038/nrn.2017.110; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Nicklas BJ, 2004, AM J CLIN NUTR, V79, P544; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nocella C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061353; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; O'Connor TG, 2014, J CHILD PSYCHOL PSYC, V55, P615, DOI 10.1111/jcpp.12187; Patrick KL, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00138; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Plaza-Zabala A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030598; Policicchio S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13168-8; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Quan N, 1998, NEUROSCIENCE, V83, P281, DOI 10.1016/S0306-4522(97)00350-3; Quan N, 1997, P NATL ACAD SCI USA, V94, P10985, DOI 10.1073/pnas.94.20.10985; Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0; Raison CL, 2010, ARCH GEN PSYCHIAT, V67, P1211, DOI 10.1001/archgenpsychiatry.2010.161; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rommer PS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01564; Ruskovska T, 2013, J PROTEOMICS, V92, P323, DOI 10.1016/j.jprot.2013.04.002; Santambrogio L, 2001, P NATL ACAD SCI USA, V98, P6295, DOI 10.1073/pnas.111152498; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Schrepf A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04648-0; Semenza G. L., 2007, SCI STKE, DOI DOI 10.1126/STKE.4072007CM8; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Sharma B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00879; Sheehan P, 2019, NEUROSCI LETT, V697, P59, DOI 10.1016/j.neulet.2018.04.013; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; Skaper SD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00072; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Stogsdill JA, 2017, CURR OPIN NEUROBIOL, V42, P1, DOI 10.1016/j.conb.2016.09.016; Strawbridge R, 2017, NEUROPSYCH DIS TREAT, V13, P1245, DOI 10.2147/NDT.S114542; Szepesi Z, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00323; Szic KSV, 2010, BIOCHEM PHARMACOL, V80, P1816, DOI 10.1016/j.bcp.2010.07.029; Temelkova-Kurktschiev T, 2002, METABOLISM, V51, P743, DOI 10.1053/meta.2002.32804; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Thienemann M, 2017, J CHILD ADOL PSYCHOP, V27, P566, DOI 10.1089/cap.2016.0145; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P939, DOI 10.1001/archneurol.2009.153; Uddin MS, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00004; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732, DOI 10.1002/jlb.56.6.732; Urrutia PJ, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00038; van der Hoek TC, 2011, J NEUROL SCI, V310, P220, DOI 10.1016/j.jns.2011.07.007; van Langenberg DR, 2017, UNITED EUR GASTROENT, V5, P579, DOI 10.1177/2050640616663397; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wraith DC, 2012, J CLIN INVEST, V122, P1172, DOI 10.1172/JCI58648; Wu XB, 2016, NEUROSCI LETT, V611, P40, DOI 10.1016/j.neulet.2015.11.030; Yang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078355; Yang SN, 2014, ALLERGY ASTHMA IMMUN, V6, P478, DOI 10.4168/aair.2014.6.6.478; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; You TJ, 2004, J CLIN ENDOCR METAB, V89, P1739, DOI 10.1210/jc.2003-031310; Young JJ, 2014, J AFFECT DISORDERS, V169, P15, DOI 10.1016/j.jad.2014.07.032; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zoppini G, 2006, NUTR METAB CARDIOVAS, V16, P543, DOI 10.1016/j.numecd.2005.09.004	196	21	22	1	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	OCT 3	2019	10								712	10.3389/fpsyt.2019.00712			18	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	JO1EN	WOS:000497328400001	31632307	Green Published, gold			2022-02-06	
J	Davis, GA; Makdissi, M; Bloomfield, P; Clifton, P; Echemendia, RJ; Falvey, EC; Fuller, GW; Green, G; Harcourt, P; Hill, T; McGuirk, N; Meeuwisse, W; Orchard, J; Raftery, M; Sills, AK; Solomon, GS; Valadka, A; McCrory, P				Davis, Gavin A.; Makdissi, Michael; Bloomfield, Paul; Clifton, Patrick; Echemendia, Ruben J.; Falvey, Eanna Cian; Fuller, Gordon Ward; Green, Gary; Harcourt, Peter; Hill, Thomas; McGuirk, Nathan; Meeuwisse, Willem; Orchard, John; Raftery, Martin; Sills, Allen K.; Solomon, Gary S.; Valadka, Alex; McCrory, Paul			International consensus definitions of video signs of concussion in professional sports	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							HOCKEY LEAGUE NHL; MANAGEMENT	Background The use of video to assist professional sporting bodies with the diagnosis of sport-related concussion (SRC) has been well established; however, there has been little consistency across sporting codes with regards to which video signs should be used, and the definitions of each of these signs. Aim The aims of this study were to develop a consensus for the video signs considered to be most useful in the identification of a possible SRC and to develop a consensus definition for each of these video signs across the sporting codes. Methods A brief questionnaire was used to assess which video signs were considered to be most useful in the identification of a possible concussion. Consensus was defined as >90% agreement by respondents. Existing definitions of these video signs from individual sports were collated, and individual components of the definitions were assessed and ranked. A modified Delphi approach was then used to create a consensus definition for each of the video signs. Results Respondents representing seven sporting bodies (Australian Football League, Cricket Australia, Major League Baseball, NFL, NHL, National Rugby League, World Rugby) reached consensus on eight video signs of concussion. Thirteen representatives from the seven professional sports ranked the definition components. Consolidation and refinement of the video signs and their definitions resulted in consensus definitions for six video signs of possible concussion: lying motionless, motor incoordination, impact seizure, tonic posturing, no protective action-floppy and blank/vacant look. Conclusions These video signs and definitions have reached international consensus, are indicated for use by professional sporting bodies and will form the basis for further collaborative research.	[Davis, Gavin A.; Makdissi, Michael] Florey Inst Neurosci & Mental Hlth, Austin Campus, Heidelberg, Vic, Australia; [Davis, Gavin A.] Cabrini Hosp, Neurosurg, Malvern, Vic, Australia; [Makdissi, Michael] La Trobe Sport & Exercise Med Res Ctr, Melbourne, Vic, Australia; [Bloomfield, Paul; McGuirk, Nathan] NRL, Sydney, NSW, Australia; [Clifton, Patrick; Harcourt, Peter] Australian Football League, Melbourne, Vic, Australia; [Echemendia, Ruben J.] Natl Hockey League, Philadelphia, PA USA; [Falvey, Eanna Cian; Raftery, Martin] World Rugby, Dublin, Ireland; [Fuller, Gordon Ward] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Green, Gary; Valadka, Alex] Major League Baseball, New York, NY USA; [Hill, Thomas] Cricket Australia, Melbourne, Vic, Australia; [Meeuwisse, Willem] Natl Hockey League, Calgary, AB, Canada; [Orchard, John] Cricket Australia, Sydney, NSW, Australia; [Sills, Allen K.; Solomon, Gary S.] Natl Football League, New York, NY USA; [McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Melbourne Brain Ctr, Austin Campus, Heidelberg, Vic, Australia		Davis, GA (corresponding author), Cabrini Malvern, Neurosurg, Suite 53,Wattletree Rd, Malvern, Vic 3144, Australia.	gavin.davis@me.com	Orchard, John W/AAY-7216-2020	Orchard, John W/0000-0003-3530-1711; makdissi, michael/0000-0003-0334-7133; McCrory, Paul/0000-0003-4850-0568; Fuller, Gordon Ward/0000-0001-8532-3500; Echemendia, Ruben/0000-0001-6116-8462; Falvey, Eanna/0000-0003-3961-1805; Davis, Gavin/0000-0001-8293-4496			Bruce JM, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-097091; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Davis GA, 2019, BRIT J SPORT MED, V53, P1298; Davis G, 2016, J SCI MED SPORT, V19, P898, DOI 10.1016/j.jsams.2016.02.005; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Gardner AJ, 2018, SPORTS MED OPEN, V4; Gardner AJ, 2017, SPORTS MED OPEN, V3; Gardner AJ, 2017, BRAIN INJURY, V31, P1918, DOI 10.1080/02699052.2017.1358399; Gardner AJ, 2017, INT J SPORTS MED, V38, P71, DOI 10.1055/s-0042-116072; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Makdissi M, 2016, J SCI MED SPORT, V19, P958, DOI 10.1016/j.jsams.2016.02.014; Makdissi M, 2016, J SCI MED SPORT, V19, P859, DOI 10.1016/j.jsams.2016.02.015; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895	18	21	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	OCT	2019	53	20					1264	1267		10.1136/bjsports-2019-100628			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JG2NR	WOS:000491913000006	30954947	Bronze, Green Accepted			2022-02-06	
J	Takahata, K; Kimura, Y; Sahara, N; Koga, S; Shimada, H; Ichise, M; Saito, F; Moriguchi, S; Kitamura, S; Kubota, M; Umeda, S; Niwa, F; Mizushima, J; Morimoto, Y; Funayama, M; Tabuchi, H; Bieniek, KF; Kawamura, K; Zhang, MR; Dickson, DW; Mimura, M; Kato, M; Suhara, T; Higuchi, M				Takahata, Keisuke; Kimura, Yasuyuki; Sahara, Naruhiko; Koga, Shunsuke; Shimada, Hitoshi; Ichise, Masanori; Saito, Fumie; Moriguchi, Sho; Kitamura, Soichiro; Kubota, Manabu; Umeda, Satoshi; Niwa, Fumitoshi; Mizushima, Jin; Morimoto, Yoko; Funayama, Michitaka; Tabuchi, Hajime; Bieniek, Kevin F.; Kawamura, Kazunori; Zhang, Ming-Rong; Dickson, Dennis W.; Mimura, Masaru; Kato, Motoichiro; Suhara, Tetsuya; Higuchi, Makoto			PET-detectable tau pathology correlates with long-term neuropsychiatric outcomes in patients with traumatic brain injury	BRAIN			English	Article						tau; traumatic brain injury (TBI); chronic traumatic encephalopathy (CTE); PET; post-traumatic psychosis	AMYLOID PROTEIN DEPOSITION; HEAD-INJURY; DISEASE; ENCEPHALOPATHY; DISORDERS; TAUOPATHY; PATHOGENESIS; PLAYERS; BINDING; MATTER	Tau deposits is a core feature of neurodegenerative disorder following traumatic brain injury (TBI). Despite ample evidence from post-mortem studies demonstrating exposure to both mild-repetitive and severe TBIs are linked to tau depositions, associations of topology of tau lesions with late-onset psychiatric symptoms due to TBI have not been explored. To address this issue, we assessed tau deposits in long-term survivors of TBI by PET with C-11-PBB3, and evaluated those associations with late-life neuropsychiatric outcomes. PET data were acquired from 27 subjects in the chronic stage following mild-repetitive or severe TBI and 15 healthy control subjects. Among the TBI patients, 14 were diagnosed as having late-onset symptoms based on the criteria of traumatic encephalopathy syndrome. For quantification of tau burden in TBI brains, we calculated C-11-PBB3 binding capacity (cm(3)), which is a summed voxel value of binding potentials (BP*ND) multiplied by voxel volume. Main outcomes of the present study were differences in C-11-PBB3 binding capacity between groups, and the association of regional C-11-PBB3 binding capacity with neuropsychiatric symptoms. To confirm C-11-PBB3 binding to tau deposits in TBI brains, we conducted in vitro PBB3 fluorescence and phospho-tau antibody immunofluorescence labelling of brain sections of chronic traumatic encephalopathy obtained from the Brain Bank. Our results showed that patients with TBI had higher C-11-PBB3 binding capacities in the neocortical grey and white matter segments than healthy control subjects. Furthermore, TBI patients with traumatic encephalopathy syndrome showed higher C-11-PBB3 binding capacity in the white matter segment than those without traumatic encephalopathy syndrome, and regional assessments revealed that subgroup difference was also significant in the frontal white matter. C-11-PBB3 binding capacity in the white matter segment correlated with the severity of psychosis. In vitro assays demonstrated PBB3-positive tau inclusions at the depth of neocortical sulci, confirming C-11-PBB3 binding to tau lesions. In conclusion, increased C-11-PBB3 binding capacity is associated with late-onset neuropsychiatric symptoms following TBI, and a close correlation was found between psychosis and C-11-PBB3 binding capacity in the white matter.	[Takahata, Keisuke; Kimura, Yasuyuki; Sahara, Naruhiko; Shimada, Hitoshi; Ichise, Masanori; Moriguchi, Sho; Kitamura, Soichiro; Kubota, Manabu; Suhara, Tetsuya; Higuchi, Makoto] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Chiba, Japan; [Takahata, Keisuke; Saito, Fumie; Mizushima, Jin; Morimoto, Yoko; Tabuchi, Hajime; Mimura, Masaru; Kato, Motoichiro] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Kimura, Yasuyuki] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan; [Koga, Shunsuke; Bieniek, Kevin F.; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Moriguchi, Sho] Ctr Addict & Mental Hlth, Res Imaging Ctr, Toronto, ON, Canada; [Kitamura, Soichiro; Kawamura, Kazunori] Nara Med Univ, Dept Psychiat, Nara, Japan; [Umeda, Satoshi] Keio Univ, Dept Psychol, Tokyo, Japan; [Niwa, Fumitoshi] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Kyoto, Japan; [Funayama, Michitaka] Japanese Red Cross Ashikaga Hosp, Dept Psychiat, Ashikaga, Tochigi, Japan; [Zhang, Ming-Rong] Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Radiopharmaceut Dev, Chiba, Japan		Takahata, K (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Inage Ku, 4-9-1 Anagawa, Chiba, Chiba 2638555, Japan.	takahata.keisuke@qst.go.jp	Kimura, Yasuyuki/ABC-5158-2020; Koga, Shunsuke/ABE-7206-2020	Kimura, Yasuyuki/0000-0002-7927-9483; Koga, Shunsuke/0000-0001-8868-9700; Niwa, Fumitoshi/0000-0001-5431-5559; Bieniek, Kevin/0000-0003-4922-864X; Takahata, Keisuke/0000-0002-0884-4924	Japan Agency for Medical Research and DevelopmentJapan Agency for Medical Research and Development (AMED) [JP18dm0207007, JP18dm0207018, JP18dk0207026]; JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [JP16K19789]	This study was supported by grants from Grants-in-Aid for Brain Mapping by Integrated Neurotechnologies for Disease Studies (JP18dm0207007 and JP18dm0207018), Research and Development Grants for Dementia (JP18dk0207026) from the Japan Agency for Medical Research and Development. This study was also supported by JSPS KAKENHI Grand Number JP16K19789. H.S., M.R.Z., T.S., and M.H. hold a patent on compounds related to the present report (JP 5422782/EP 12 884 742.3).	ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ALAVI A, 1993, J NUCL MED, V34, P1681; Albano D, 2018, ANN NUCL MED, V32, P532, DOI 10.1007/s12149-018-1274-8; Barrio JR, 2015, P NATL ACAD SCI USA; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bohorquez SS, 2017, ANN M SOC NUCL MED M; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; Bural G, 2015, NUCL MED COMMUN, V36, P1249, DOI 10.1097/MNM.0000000000000394; Deighton S, 2016, SCHIZOPHR RES, P1; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Endo H, 2019, MOVEMENT DISORD, V10, P333; Filley CM, 2016, J NEUROPHYSIOL, V116, P2093, DOI 10.1152/jn.00221.2016; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Garcia-Sierra F, 2000, ACTA NEUROPATHOL, V100, P29, DOI 10.1007/s004010051189; Goland R, 2009, J NUCL MED, V50, P382, DOI 10.2967/jnumed.108.054866; Hashimoto H, 2014, J NUCL MED, V55, P1532, DOI 10.2967/jnumed.114.139550; Hostetler ED, 2016, J NUCL MED, V57, P1599, DOI 10.2967/jnumed.115.171678; Ichise M, 2014, United States Patent, Patent No. [8,652,440 B2, 8652440B2]; Johnson VE, 2014, NATURE, V11, P128; Johnson VE, 2017, ADV NEUROBIOL, V15, P383, DOI 10.1007/978-3-319-57193-5_15; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Khalil MM, 2016, BASIC SCI PET IMAGIN, P303; KIMURA Y, 2015, J NUCL MED, V56, P1; Kimura Y, 2016, EJNMMI RES, V6, DOI 10.1186/s13550-016-0182-y; Koga S, 2017, MOVEMENT DISORD, V32, P884, DOI 10.1002/mds.27013; Larson Steven M., 1999, Clin Positron Imaging, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; Lee P, 2007, INT J RADIAT ONCOL, V69, P328, DOI 10.1016/j.ijrobp.2007.04.036; LoBue C, 2018, J NEUROPSYCH CLIN N, V30, P7, DOI 10.1176/appi.neuropsych.17070145; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Montenigro PH, 2015, BRAIN PATHOL, V25, P304, DOI 10.1111/bpa.12250; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; NG KP, 2017, ALZHEIMERS RES THER, V9, P1; Ni RQ, 2018, J NUCL MED, V59, P960, DOI 10.2967/jnumed.117.201632; Nielsen AS, 2002, SCHIZOPHR RES, V55, P93, DOI 10.1016/S0920-9964(01)00205-5; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ono M, 2017, BRAIN, V140, P764, DOI 10.1093/brain/aww339; Perez-Soriano A, 2017, MOVEMENT DISORD, V32, P1016, DOI 10.1002/mds.27029; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Shimada Hitoshi, 2017, Alzheimers Dement (Amst), V6, P11, DOI 10.1016/j.dadm.2016.12.009; Shinotoh H, 2019, NEUROLOGY, V92, pE136, DOI 10.1212/WNL.0000000000006736; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Southekal S, 2018, J NUCL MED, V59, P944, DOI 10.2967/jnumed.117.200006; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Vanhove Karolien, 2018, Cancer Treat Res Commun, V15, P7, DOI 10.1016/j.ctarc.2017.11.005; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038	65	21	21	2	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	OCT	2019	142		10				3265	3279		10.1093/brain/awz238			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY3MJ	WOS:000504322300034	31504227	Bronze			2022-02-06	
J	Lutgendorf, MA				Lutgendorf, Monica A.			Intimate Partner Violence and Women's Health	OBSTETRICS AND GYNECOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; DOMESTIC VIOLENCE; MENTAL-HEALTH; CARE UTILIZATION; PREVALENCE; PREGNANCY; VETERANS; MULTICOUNTRY; STRANGULATION; INTERVENTION	Intimate partner violence affects 15-71% of women over their lifetime, resulting in significant stress, negative health effects, and negative economic effects. Features include physical and sexual abuse as well as psychological abuse and controlling behaviors such as reproductive coercion or stalking. Intimate partner violence can occur in both heterosexual and same-sex relationships, though the risk may be higher in lesbian, gay, bisexual, transgender, queer, or questioning couples. Pregnancy remains an especially risky time for escalating abuse and also provides a window of opportunity for screening and intervention. Victims experience many consequences of abuse, including physical injuries, traumatic brain injury, and chronic conditions such as headaches, insomnia, pelvic pain, depression, anxiety, and posttraumatic stress disorder. Homicide is an especially devastating consequence, with 40-45% of female victims killed by an intimate partner, and homicide remains an important cause of pregnancy-related death. Routine screening is recommended by the American College of Obstetricians and Gynecologists and the U.S. Preventive Services Task Force, and obstetrician-gynecologists (ob-gyns) should remain vigilant for signs of abuse in their patients. Often the cycle of abuse makes it difficult for women to break free, and ob-gyns should continue to provide supportive care regardless of a woman's readiness to leave an abusive relationship.	[Lutgendorf, Monica A.] Naval Med Ctr San Diego, Div Maternal Fetal Med, Dept Obstet & Gynecol, San Diego, CA 92134 USA		Lutgendorf, MA (corresponding author), Naval Med Ctr San Diego, Div Maternal Fetal Med, Dept Obstet & Gynecol, San Diego, CA 92134 USA.	monica.a.lutgendorf.mil@mail.mil					Agrawal A, 2014, MATERN CHILD HLTH J, V18, P1985, DOI 10.1007/s10995-014-1444-9; American College of Obstetricians and Gynecologists, 2005, SPEC ISS WOM HLTH; [Anonymous], 2015, JOGNN-J OBST GYN NEO, V44, P405, DOI 10.1111/1552-6909.12567; [Anonymous], 2012, Obstet Gynecol, V119, P412, DOI 10.1097/AOG.0b013e318249ff74; [Anonymous], 2017, J OBSTET GYNECOL NEO, V46, pe125; Anyikwa VA, 2016, J EVID-INFORM SOC WO, V13, P484, DOI 10.1080/23761407.2016.1166824; Arkins B, 2016, J PSYCHIATR MENT HLT, V23, P217, DOI 10.1111/jpm.12289; Bianchi AL, 2016, JOGNN-J OBST GYN NEO, V45, P579, DOI 10.1016/j.jogn.2016.02.012; Bonomi AE, 2009, HEALTH SERV RES, V44, P1052, DOI 10.1111/j.1475-6773.2009.00955.x; Breiding M. J., 2015, INTIMATE PARTNER SUR; Brewer NQ, 2018, J AM COLL HEALTH, V66, P1; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Catalano S, FEMALE VICTIMS VIOLE; Chamberlain L, REPROD HLTH PARTNER; Cohen LR, 2013, ADDICT BEHAV, V38, P2325, DOI 10.1016/j.addbeh.2013.03.006; Cook J, 2008, J ROY SOC MED, V101, P358, DOI 10.1258/jrsm.2008.080002; Cooper AD, HOMICIDE TRENDS US 1; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P1678, DOI 10.1001/jama.2018.14741; de Oliveira Fonseca-Machado Mariana, 2014, Invest. educ. enferm, V32, P291, DOI 10.17533/udea.iee.v32n2a12; Dichter ME, 2018, J GEN INTERN MED, V33, P936, DOI 10.1007/s11606-018-4321-1; Dichter ME, 2017, J TRAUMA STRESS, V30, P555, DOI 10.1002/jts.22241; Dichter ME, 2017, AM J PREV MED, V52, P761, DOI 10.1016/j.amepre.2017.01.003; Dichter ME, 2017, PSYCHOL SERV, V14, P246, DOI 10.1037/ser0000132; Durborow N, COMPENDIUM STATE STA; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Feltner C, 2018, JAMA-J AM MED ASSOC, V320, P1699; Foley A, 2015, J EMERG NURS, V41, P89, DOI 10.1016/j.jen.2014.10.013; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gazmararian JA, 1996, JAMA-J AM MED ASSOC, V275, P1915, DOI 10.1001/jama.275.24.1915; Geirisch JM, 09010 VAESP; Gielen AC, 2000, AM J PREV MED, V19, P279, DOI 10.1016/S0749-3797(00)00234-8; Glass N, 2008, J EMERG MED, V35, P329, DOI 10.1016/j.jemermed.2007.02.065; Greene CA, 2018, CHILD ABUSE NEGLECT, V77, P168, DOI 10.1016/j.chiabu.2018.01.012; Haggerty LA, 2011, VIOLENCE VICTIMS, V26, P725, DOI 10.1891/0886-6708.26.6.725; Hanson M, 2010, JOGNN, V39, P363; Khalifeh H, 2015, BRIT J PSYCHIAT, V207, P207, DOI 10.1192/bjp.bp.114.144899; Kimerling R, 2016, J GEN INTERN MED, V31, P888, DOI 10.1007/s11606-016-3701-7; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Latus J, 2007, I AM MISSING DEAD SI, P306; Liebschutz JM, 2012, NEW ENGL J MED, V367, P2071, DOI 10.1056/NEJMp1204278; Lutgendorf MA, 2009, OBSTET GYNECOL, V113, P866, DOI 10.1097/AOG.0b013e31819bdc93; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; McLaughlin J, 2012, CLIN PSYCHOL REV, V32, P677, DOI 10.1016/j.cpr.2012.08.002; Miller E, 2016, CONTRACEPTION, V94, P58, DOI 10.1016/j.contraception.2016.02.009; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; National Center for Injury Prevention and Control, COSTS INTIMATE PARTN; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; O'Campo P, 2011, SOC SCI MED, V72, P855, DOI 10.1016/j.socscimed.2010.12.019; O'Doherty L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007007.pub3; O'Reilly R, 2010, TRAUMA VIOLENCE ABUS, V11, P190, DOI 10.1177/1524838010378298; Pallitto CC, 2013, INT J GYNECOL OBSTET, V120, P3, DOI 10.1016/j.ijgo.2012.07.003; Rabin RF, 2009, AM J PREV MED, V36, P439, DOI 10.1016/j.amepre.2009.01.024; Rezey ML, 2020, J INTERPERS VIOLENCE, V35, P1055, DOI 10.1177/0886260517692334; Shadigian EM, 2005, OBSTET GYNECOL SURV, V60, P183, DOI 10.1097/01.ogx.0000155967.72418.6b; Smith SG, NATL INTIMATE PARTNE; Sparrow K., 2018, TRAUMA VIOLENCE ABUS, DOI 10.1177/1524838018782206; Sprague S, 2012, WOMEN HEALTH, V52, P587, DOI 10.1080/03630242.2012.690840; Stewart DE, 2017, PSYCHIAT CLIN N AM, V40, P321, DOI 10.1016/j.psc.2017.01.009; Sugg N, 2015, MED CLIN N AM, V99, P629, DOI 10.1016/j.mcna.2015.01.012; Tjaden P, EXTENT NATURE CONSEQ; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera E, 2017, BRAIN IMAGING BEHAV, V11, P1664, DOI 10.1007/s11682-016-9643-1; Van Parys AS, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0710-1; Vu NL, 2016, CLIN PSYCHOL REV, V46, P25, DOI 10.1016/j.cpr.2016.04.003; Walters ML, NATL INTIMATE PARTNE; Wood SL, 2011, J CHILD ADOL PS NURS, V24, P223, DOI 10.1111/j.1744-6171.2011.00302.x; World Health Organization UN Office on Drugs and Crime UN Development Programme, GLOB STAT REP VIOL P	68	21	23	2	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7844			OBSTET GYNECOL	Obstet. Gynecol.	SEP	2019	134	3					470	480		10.1097/AOG.0000000000003326			11	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Obstetrics & Gynecology	KK5LL	WOS:000512783100011	31403968	Bronze			2022-02-06	
J	Rosciszewski, G; Cadena, V; Auzmendi, J; Cieri, MB; Lukin, J; Rossi, AR; Murta, V; Villarreal, A; Reines, A; Gomes, FCA; Ramos, AJ				Rosciszewski, Gerardo; Cadena, Vanesa; Auzmendi, Jeronimo; Belen Cieri, Maria; Lukin, Jeronimo; Rossi, Alicia R.; Murta, Veronica; Villarreal, Alejandro; Reines, Analia; Gomes, Flavia C. A.; Javier Ramos, Alberto			Detrimental Effects of HMGB-1 Require Microglial-Astroglial Interaction: Implications for the Status Epilepticus -Induced Neuroinflammation	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						epilepsy; glia; inflammation; seizures; neuronal death	GROUP BOX 1; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; MOBILITY GROUP BOX-1; TOLL-LIKE RECEPTOR; FEBRILE SEIZURES; RAT MODEL; ACTIVATION; RAGE; PROTEIN	Temporal Lobe Epilepsy (TLE) is the most common form of human epilepsy and available treatments with antiepileptic drugs are not disease-modifying therapies. The neuroinflammation, neuronal death and exacerbated plasticity that occur during the silent period, following the initial precipitating event (IPE), seem to be crucial for epileptogenesis. Damage Associated Molecular Patterns (DAMP) such as HMGB-1, are released early during this period concomitantly with a phenomenon of reactive gliosis and neurodegeneration. Here, using a combination of primary neuronal and glial cell cultures, we show that exposure to HMGB-1 induces dendrite loss and neurodegeneration in a glial-dependent manner. In glial cells, loss of function studies showed that HMGB-1 exposure induces NF-kappa B activation by engaging a signaling pathway that involves TLR2, TLR4, and RAGE. In the absence of glial cells, HMGB-1 failed to induce neurodegeneration of primary cultured cortical neurons. Moreover, purified astrocytes were unable to fully respond to HMGB-1 with NF-kappa B activation and required microglial cooperation. In agreement, in vivo HMGB-1 blockage with glycyrrhizin, immediately after pilocarpine-induced status epilepticus (SE), reduced neuronal degeneration, reactive astrogliosis and microgliosis in the long term. We conclude that microglial-astroglial cooperation is required for astrocytes to respond to HMGB-1 and to induce neurodegeneration. Disruption of this HMGB-1 mediated signaling pathway shows beneficial effects by reducing neuroinflammation and neurodegeneration after SE. Thus, early treatment strategies during the latency period aimed at blocking downstream signaling pathways activated by HMGB-1 are likely to have a significant effect in the neuroinflammation and neurodegeneration that are proposed as key factors in epileptogenesis.	[Rosciszewski, Gerardo; Cadena, Vanesa; Auzmendi, Jeronimo; Belen Cieri, Maria; Lukin, Jeronimo; Rossi, Alicia R.; Murta, Veronica; Villarreal, Alejandro; Javier Ramos, Alberto] UBA, Lab Neuropatol Mol, Inst Biol Celular & Neurociencia Prof E Robertis, Fac Med,CONICET, Buenos Aires, DF, Argentina; [Reines, Analia] UBA, Lab Neurofarmacol, Inst Biol Celular & Neurociencia Prof E Robertis, Fac Med,CONICET, Buenos Aires, DF, Argentina; [Gomes, Flavia C. A.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil		Ramos, AJ (corresponding author), UBA, Lab Neuropatol Mol, Inst Biol Celular & Neurociencia Prof E Robertis, Fac Med,CONICET, Buenos Aires, DF, Argentina.	jramos@fmed.uba.ar	Ramos, Alberto Javier/AAR-7796-2020; Murta, Veronica/AAT-5042-2021; Gomes, Flavia/AAX-6354-2021	Ramos, Alberto Javier/0000-0003-4009-6337; Auzmendi, Jeronimo/0000-0002-4819-2713; Villarreal, Alejandro/0000-0001-8624-8119	ANPCYT-FONCYTANPCyTFONCyT [PICT 2015-1451, 2017-2203]; UBACYT; CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); DECIT/MS; IBRO-LARC;  [PICT 2014-2178]	This study was supported by grants from the ANPCYT-FONCYT PICT 2015-1451 and 2017-2203 (AJR), UBACYT (AJR), PICT 2014-2178 (JA), CNPq (FG), and DECIT/MS (FG). GR, VC, and JL are doctoral fellows from CONICET. MC is a doctoral fellow of UBACYT. GR received a research visit grant from IBRO-LARC. AJR, VM, JA, and AV are researchers from CONICET (Argentina).	Alaimo A, 2011, NEUROCHEM INT, V59, P297, DOI 10.1016/j.neuint.2011.06.001; Blume WT, 2006, EPILEPSIA, V47, P71, DOI 10.1111/j.1528-1167.2006.00665.x; Braun M, 2017, BBA-MOL BASIS DIS, V1863, P2614, DOI 10.1016/j.bbadis.2017.05.020; CENDES F, 1993, NEUROLOGY, V43, P1083, DOI 10.1212/WNL.43.6.1083; Choi JY, 2017, P NATL ACAD SCI USA, V114, pE4987, DOI 10.1073/pnas.1702035114; Crack PJ, 2007, IMMUNOL CELL BIOL, V85, P476, DOI 10.1038/sj.icb.7100103; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Diniz LP, 2012, J BIOL CHEM, V287, P41432, DOI 10.1074/jbc.M112.380824; Ellwood KB, 2000, MOL CELL BIOL, V20, P4359, DOI 10.1128/MCB.20.12.4359-4370.2000; Festoff BW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0670-z; Angelo MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107901; Fonken LK, 2016, J NEUROSCI, V36, P7946, DOI 10.1523/JNEUROSCI.1161-16.2016; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Fu L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01325-y; Gao HM, 2011, J NEUROSCI, V31, P1081, DOI 10.1523/JNEUROSCI.3732-10.2011; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gao TL, 2018, BIOCHEM BIOPH RES CO, V497, P430, DOI 10.1016/j.bbrc.2018.02.102; Hamati-Haddad A, 1998, NEUROLOGY, V50, P917, DOI 10.1212/WNL.50.4.917; Haruma J, 2016, SCI REP-UK, V6, DOI 10.1038/srep37755; Hayakawa K, 2008, STROKE, V39, P951, DOI 10.1161/STROKEAHA.107.495820; Kim ID, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0438-8; Kim SW, 2012, NEUROBIOL DIS, V46, P147, DOI 10.1016/j.nbd.2011.12.056; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Li YJ, 2019, J PHARM PHARMACOL, V71, P390, DOI 10.1111/jphp.13040; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Luo L, 2014, CELL MOL NEUROBIOL, V34, P987, DOI 10.1007/s10571-014-0075-4; Luo Lidan, 2013, Exp Neurobiol, V22, P107, DOI 10.5607/en.2013.22.2.107; Majores M, 2007, EPILEPSIA, V48, P4, DOI 10.1111/j.1528-1167.2007.01062.x; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muhammad S, 2008, J NEUROSCI, V28, P12023, DOI 10.1523/JNEUROSCI.2435-08.2008; Ohnishi M, 2014, NEUROCHEM INT, V75, P32, DOI 10.1016/j.neuint.2014.05.007; Ohnishi M, 2011, NEUROPHARMACOLOGY, V61, P975, DOI 10.1016/j.neuropharm.2011.06.026; Okuma Y, 2014, NEUROPHARMACOLOGY, V85, P18, DOI 10.1016/j.neuropharm.2014.05.007; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Parker TM, 2017, BRAIN INJURY, V31, P2, DOI 10.1080/02699052.2016.1217045; Paudel YN, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00628; Pedrazzi M, 2007, J IMMUNOL, V179, P8525, DOI 10.4049/jimmunol.179.12.8525; Qi L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142901; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Qiu JH, 2010, STROKE, V41, P2077, DOI 10.1161/STROKEAHA.110.590463; RACINE RJ, 1972, BRAIN RES, V47, P262, DOI 10.1016/0006-8993(72)90268-5; Rossi AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078516; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Rosciszewski G, 2018, MOL NEUROBIOL, V55, P3875, DOI 10.1007/s12035-017-0618-z; Rossi A, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10040093; Santoro M, 2016, NEUROBIOL DIS, V91, P59, DOI 10.1016/j.nbd.2016.02.018; Sasaki T, 2016, EXP NEUROL, V275, P220, DOI 10.1016/j.expneurol.2015.11.003; Singh V, 2016, ANTIOXID REDOX SIGN, V24, P635, DOI 10.1089/ars.2015.6397; Sun Q, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-106; Tajalli-Nezhad S, 2019, CELL MOL LIFE SCI, V76, P523, DOI 10.1007/s00018-018-2953-2; Takizawa T, 2017, J CEREBR BLOOD F MET, V37, P890, DOI 10.1177/0271678X16647398; Terrando N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00441; Theodore WH, 1999, NEUROLOGY, V52, P132, DOI 10.1212/WNL.52.1.132; Tian XD, 2017, CURR DRUG DELIV, V14, P785, DOI 10.2174/1567201813666160808111933; Venereau E, 2016, PHARMACOL RES, V111, P534, DOI 10.1016/j.phrs.2016.06.031; Verrijdt G, 2002, BIOCHEM J, V361, P97, DOI 10.1042/0264-6021:3610097; Villarreal A, 2014, J NEUROCHEM, V131, P190, DOI 10.1111/jnc.12790; Walker LE, 2017, BIOMARKERS, V22, P635, DOI 10.1080/1354750X.2016.1265003; Walker LE, 2017, J CLIN INVEST, V127, P2118, DOI 10.1172/JCI92001; Wang C, 2016, INFLAMMATION, V39, P1862, DOI 10.1007/s10753-016-0418-z; Wang DL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46243; Wang W, 2016, NEUROSCIENCE, V316, P328, DOI 10.1016/j.neuroscience.2015.11.001; Weber MD, 2015, J NEUROSCI, V35, P316, DOI 10.1523/JNEUROSCI.3561-14.2015; Aviles-Reyes RX, 2010, J NEUROCHEM, V112, P854, DOI 10.1111/j.1471-4159.2009.06535.x; Xiong XX, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0705-5; Yang Qing-Wu, 2010, Front Biosci (Schol Ed), V2, P1081; Yang WH, 2017, NEUROCHEM RES, V42, P1179, DOI 10.1007/s11064-016-2153-0; Zurolo E, 2011, BRAIN, V134, P1015, DOI 10.1093/brain/awr032	71	21	22	0	0	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5102		FRONT CELL NEUROSCI	Front. Cell. Neurosci.	AUG 27	2019	13								380	10.3389/fncel.2019.00380			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IT4PT	WOS:000482843700001	31507379	gold, Green Published			2022-02-06	
J	Kulkarni, P; Morrison, TR; Cai, XZ; Iriah, S; Simon, N; Sabrick, J; Neuroth, L; Ferris, CF				Kulkarni, Praveen; Morrison, Thomas R.; Cai, Xuezhu; Iriah, Sade; Simon, Neal; Sabrick, Julia; Neuroth, Lucas; Ferris, Craig F.			Neuroradiological Changes Following Single or Repetitive Mild TBI	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						Parkinson's disease; dopamine; dementia; hyperconnectivity; microglia activation; cerebellum; suprachiasmatic nucleus (SCN); olfactory system diseases	TRAUMATIC BRAIN-INJURY; STATE FUNCTIONAL CONNECTIVITY; COLLEGIATE FOOTBALL PLAYERS; CEREBRAL GLUCOSE-METABOLISM; DORSAL COLUMN NUCLEI; RESTING-STATE; HEAD-INJURY; CEREBELLAR MODULATION; OLFACTORY DYSFUNCTION; RECOVERY-TIME	Objectives: To test the hypothesis that there are differences in neuroradiological measures between single and repeated mild traumatic brain injury using multimodal MRI. Methods: A closed-head momentum exchange model was used to produce one or three mild head injuries in young adult male rats compared to non-injured, age and weight-matched controls. Six-seven weeks post-injury, rats were studied for deficits in cognitive and motor function. Seven-eight weeks post-injury changes in brain anatomy and function were evaluated through analysis of high resolution T2 weighted images, resting-state BOLD functional connectivity, and diffusion weighted imaging with quantitative anisotropy. Results: Head injuries occurred without skull fracture or signs of intracranial bleeding or contusion. There were no significant differences in cognitive or motors behaviors between experimental groups. With a single mild hit, the affected areas were limited to the caudate/putamen and central amygdala. Rats hit three times showed altered diffusivity in white matter tracts, basal ganglia, central amygdala, brainstem, and cerebellum. Comparing three hits to one hit showed a similar pattern of change underscoring a dose effect of repeated head injury on the brainstem and cerebellum. Disruption of functional connectivity was pronounced with three mild hits. The midbrain dopamine system, hippocampus, and brainstem/cerebellum showed hypoconnectivity. Interestingly, rats exposed to one hit showed enhanced functional connectivity (or hyperconnectivity) across brain sites, particularly between the olfactory system and the cerebellum. Interpretation: Neuroradiological evidence of altered brain structure and function, particularly in striatel and midbrain dopaminergic areas, persists long after mild repetitive head injury. These changes may serve as biomarkers of neurodegeneration and risk for dementia later in life.	[Kulkarni, Praveen; Morrison, Thomas R.; Cai, Xuezhu; Iriah, Sade; Sabrick, Julia; Neuroth, Lucas; Ferris, Craig F.] Northeastern Univ, Ctr Translat NeuroImaging, Boston, MA 02115 USA; [Simon, Neal] Azevan Pharmaceut, Bethlehem, PA USA; [Simon, Neal] Lehigh Univ, Dept Biol Sci, Coll Arts & Sci, Bethlehem, PA 18015 USA		Ferris, CF (corresponding author), Northeastern Univ, Ctr Translat NeuroImaging, Boston, MA 02115 USA.	c.ferris@northeastern.edu		Kulkarni, Praveen/0000-0002-8876-4544	Program Consortium BUILD Award [UL1MD009605/RL5MD009590/TL4MD009635]	This work was funded by the Program Consortium BUILD Award (UL1MD009605/RL5MD009590/TL4MD009635) to CF. This work appeared as a preprint in BioRxiv.	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; ALLEN GI, 1974, PHYSIOL REV, V54, P957, DOI 10.1152/physrev.1974.54.4.957; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Astafiev SV, 2016, NEUROIMAGE-CLIN, V11, P10, DOI 10.1016/j.nicl.2016.01.004; Aumann TD, 1996, J COMP NEUROL, V376, P420; Aumann TD, 1996, J COMP NEUROL, V368, P608, DOI 10.1002/(SICI)1096-9861(19960513)368:4<608::AID-CNE11>3.0.CO;2-D; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bai F, 2009, BIOL PSYCHIAT, V65, P951, DOI 10.1016/j.biopsych.2008.10.017; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Calcagnoli F, 2015, PSYCHONEUROENDOCRINO, V51, P112, DOI 10.1016/j.psyneuen.2014.09.019; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Chen CH, 2014, NAT NEUROSCI, V17, P1767, DOI 10.1038/nn.3868; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; De Beaumont L, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12278; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1992, J NEUROL NEUROSUR PS, V55, P138, DOI 10.1136/jnnp.55.2.138; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; FARZANEH F, 1990, MAGNET RESON MED, V14, P123, DOI 10.1002/mrm.1910140112; Fazio L, 2011, NEUROIMAGE, V54, P2915, DOI 10.1016/j.neuroimage.2010.11.034; Fidan E, 2018, ASN NEURO, V10, DOI 10.1177/1759091418770543; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Gardner RC, 2018, NEUROLOGY, V90, pE1771, DOI 10.1212/WNL.0000000000005522; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Gorges M, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00200; Guilfoyle DN, 2013, J NEUROSCI METH, V214, P144, DOI 10.1016/j.jneumeth.2013.01.019; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; HAINES DE, 1984, BRAIN BEHAV EVOLUT, V24, P198, DOI 10.1159/000121317; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; HEATH RG, 1978, BIOL PSYCHIAT, V13, P501; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hoogenraad FGC, 2000, MAGN RESON IMAGING, V18, P405, DOI 10.1016/S0730-725X(00)00127-2; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Hu X, 2015, MOVEMENT DISORD, V30, P238, DOI 10.1002/mds.26087; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Iannilli E, 2011, RHINOLOGY, V49, P458, DOI 10.4193/Rhino11.110; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jenkins PO, 2018, BRAIN, V141, P797, DOI 10.1093/brain/awx357; Jesmanowicz A, 1998, MAGNET RESON MED, V40, P754, DOI 10.1002/mrm.1910400517; Jonckers E, 2014, MAGN RESON MED, V72, P1103, DOI 10.1002/mrm.24990; KALIL K, 1981, J COMP NEUROL, V195, P25, DOI 10.1002/cne.901950105; Kang D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/394213; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kulkarni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125748; Lanteaume L, 2007, CEREB CORTEX, V17, P1307, DOI 10.1093/cercor/bhl041; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Mainland JD, 2005, J NEUROSCI, V25, P6362, DOI 10.1523/JNEUROSCI.0920-05.2005; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Menon RS, 1997, NMR BIOMED, V10, P179, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<179::AID-NBM463>3.0.CO;2-X; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Onuki Y, 2015, CEREB CORTEX, V25, P313, DOI 10.1093/cercor/bht221; Ordek G, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00197; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pellegrino R, 2017, NEUROSCIENCE, V363, P43, DOI 10.1016/j.neuroscience.2017.07.030; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Poser BA, 2009, NEUROIMAGE, V45, P1162, DOI 10.1016/j.neuroimage.2009.01.007; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Qin Y, 2018, BEHAV BRAIN RES, V340, P41, DOI 10.1016/j.bbr.2016.08.008; Rajesh A, 2017, J NEUROTRAUM, V34, P3280, DOI 10.1089/neu.2017.5047; Richardson JS, 2018, J TELEMED TELECARE, V24, P282, DOI 10.1177/1357633X17696586; Rogers TD, 2011, SYNAPSE, V65, P1204, DOI 10.1002/syn.20960; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170541; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Sackheim AM, 2017, J SURG RES, V213, P100, DOI 10.1016/j.jss.2017.02.016; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Schroeter ML, 2015, J NEUROTRAUM, V32, P1380, DOI 10.1089/neu.2013.3163; Schutter DJL, 2006, NEUROIMAGE, V33, P1227, DOI 10.1016/j.neuroimage.2006.06.055; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith R, 2015, NEUROSCI BIOBEHAV R, V57, P1, DOI 10.1016/j.neubiorev.2015.08.003; SNIDER RS, 1976, J NEUROSCI RES, V2, P133, DOI 10.1002/jnr.490020204; Swisher JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034626; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor KM, 2016, PARKINSONISM RELAT D, V23, P57, DOI 10.1016/j.parkreldis.2015.12.005; Teipel SJ, 2013, MED CLIN N AM, V97, P399, DOI 10.1016/j.mcna.2012.12.013; Teune TM, 2000, PROG BRAIN RES, V124, P141; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Witter L, 2015, CURR OPIN NEUROBIOL, V33, P150, DOI 10.1016/j.conb.2015.03.017; Wortman RC, 2018, ANN CLIN TRANSL NEUR, V5, P1588, DOI 10.1002/acn3.667; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu T, 2009, NEUROSCI LETT, V460, P6, DOI 10.1016/j.neulet.2009.05.046; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zhang Y, 2015, MOVEMENT DISORD, V30, P1229, DOI 10.1002/mds.26251	132	21	21	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5137		FRONT SYST NEUROSCI	Front. Syst. Neurosci.	AUG 2	2019	13								34	10.3389/fnsys.2019.00034			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IN8CR	WOS:000478908700001	31427931	Green Published, gold			2022-02-06	
J	Maiti, P; Peruzzaro, S; Kolli, N; Andrews, M; Al-Gharaibeh, A; Rossignol, J; Dunbar, GL				Maiti, Panchanan; Peruzzaro, Sarah; Kolli, Nivya; Andrews, Melissa; Al-Gharaibeh, Abeer; Rossignol, Julien; Dunbar, Gary L.			Transplantation of mesenchymal stem cells overexpressing interleukin-10 induces autophagy response and promotes neuroprotection in a rat model of TBI	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						autophagy markers; IL-10 overexpressed MSCs; neuroinflammation; TBI	TRAUMATIC BRAIN-INJURY; NEURONAL SURVIVAL; ALZHEIMER-DISEASE; UNITED-STATES; UP-REGULATION; IL-10; DEATH; APOPTOSIS; INHIBITION; MECHANISMS	Autophagy, including mitophagy, is critical for neuroprotection in traumatic brain injury (TBI). Transplantation of mesenchymal stem cells (MSCs) provides neuroprotection and induces autophagy by increasing anti-inflammatory cytokines, such as interleukin-10 (IL-10). To evaluate these effects of IL10 that are released by MSCs, we genetically engineered MSCs to overexpress IL10 and compared their effects to unaltered MSCs following transplantation near the site of induced TBIs in rats. Adult, male Sprague-Dawley rats were divided into four groups: Sham + vehicle, TBI + vehicle, TBI + MSCs-IL-10 and TBI + MSCs-GFP. Thirty-six hours post-TBI, the first two groups received vehicle (Hanks balance salt solution), whereas last two groups were transplanted with MSCs-IL-10 or MSCs-GFP. Three weeks after transplantation, biomarkers for neurodegenerative changes, autophagy, mitophagy, cell death and survival markers were measured. We observed a significant increase in the number of dead cells in the cortex and hippocampus in TBI rats, whereas transplantation of MSCs-IL-10 significantly reduced their numbers in comparison to MSCs alone. MSCs-IL-10 rats had increased autophagy, mitophagy and cell survival markers, along with decreased markers for cell death and neuroinflammation. These results suggest that transplantation of MSCs-IL-10 may be an effective strategy to protect against TBI-induced neuronal damage.	[Maiti, Panchanan; Peruzzaro, Sarah; Kolli, Nivya; Andrews, Melissa; Al-Gharaibeh, Abeer; Rossignol, Julien; Dunbar, Gary L.] Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA; [Maiti, Panchanan; Peruzzaro, Sarah; Kolli, Nivya; Andrews, Melissa; Al-Gharaibeh, Abeer; Rossignol, Julien; Dunbar, Gary L.] Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA; [Maiti, Panchanan; Dunbar, Gary L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA; [Maiti, Panchanan; Dunbar, Gary L.] St Marys Michigan, Field Neurosci Inst, Saginaw, MI USA; [Maiti, Panchanan] Saginaw Valley State Univ, Dept Biol, Saginaw, MI USA; [Maiti, Panchanan] Saginaw Valley State Univ, Brain Res Lab, Saginaw, MI USA; [Rossignol, Julien] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA		Maiti, P; Dunbar, GL (corresponding author), Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA.	maiti1p@cmich.edu; dunba1g@cmich.edu	Rossignol, Julien/I-1013-2019	Rossignol, Julien/0000-0002-8662-0547; Gharaibeh, Abeer/0000-0003-3549-1826	Field Neurosciences Institute, St. Mary's of Michigan; John G. Kulhavi Professorship in Neurosciences; Neuroscience Program at Central Michigan University	Supports came from the Field Neurosciences Institute, St. Mary's of Michigan, the John G. Kulhavi Professorship in Neurosciences and the Neuroscience Program at Central Michigan University.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Amelio I, 2011, BIOCHEM BIOPH RES CO, V414, P277, DOI 10.1016/j.bbrc.2011.09.080; Au AK, 2010, BBA-MOL BASIS DIS, V1802, P918, DOI 10.1016/j.bbadis.2009.10.010; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Chen WQ, 2014, NEURAL REGEN RES, V9, P1210, DOI 10.4103/1673-5374.135329; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cunningham CJ, 2018, J CEREB BLOOD FLOW M; Dang SP, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0245-4; Das G, 2012, COLD SPRING HARB PER, V4, P1; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fontana ACK, 2016, J NEUROTRAUM, V33, P1073, DOI 10.1089/neu.2015.4079; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23525; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hu CX, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-018-1114-8; Kapuy O, 2014, FEBS OPEN BIO, V4, P704, DOI 10.1016/j.fob.2014.07.006; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Lin LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136959; Luo YW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11458-9; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Maiti P, 2007, BRAIN RES, V1175, P1, DOI 10.1016/j.brainres.2007.06.106; Maiti P, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9656719; Maiti P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495091; Maiti P, 2010, J NEUROCHEM, V113, P1252, DOI 10.1111/j.1471-4159.2010.06692.x; Matyas JJ, 2017, CELL TRANSPLANT, V26, P1472, DOI 10.1177/0963689717721214; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Metaxakis A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7050037; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nomoto T, 2009, GENE THER, V16, P383, DOI 10.1038/gt.2008.151; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Patel DM, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/496218; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Peruzzaro ST, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1383-2; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Phinney DG, 2007, CELL CYCLE, V6, P2884, DOI 10.4161/cc.6.23.5095; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Scheibe F, 2012, CELL MOL NEUROBIOL, V32, P567, DOI 10.1007/s10571-012-9798-2; Schlafli AM, 2015, EUR J HISTOCHEM, V59, P137, DOI 10.4081/ejh.2015.2481; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Shin JY, 2014, AUTOPHAGY, V10, P32, DOI 10.4161/auto.26508; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Vizoso FJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091852; Wu TT, 2016, INT J BIOL SCI, V12, P884, DOI 10.7150/ijbs.15194; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	70	21	22	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	AUG	2019	23	8					5211	5224		10.1111/jcmm.14396			14	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	IR6EN	WOS:000481532600034	31162801	Green Published, gold			2022-02-06	
J	Iverson, GL; Luoto, TM; Karhunen, PJ; Castellani, RJ				Iverson, Grant L.; Luoto, Teemu M.; Karhunen, Pekka J.; Castellani, Rudolph J.			Mild Chronic Traumatic Encephalopathy Neuropathology in People With No Known Participation in Contact Sports or History of Repetitive Neurotrauma	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Brain injury; Chronic traumatic encephalopathy; Concussion; Sports	BRAIN-INJURY; ALZHEIMERS-DISEASE; TAU PATHOLOGY; SINGLE; TAUOPATHY; OUTCOMES; TDP-43	It has been asserted that chronic traumatic encephalopathy (CTE) pathology is only present in former athletes and others who have been exposed to repetitive concussions, subconcussive blows, or both. We hypothesized that CTE pathology would be present in men who had no known history of repetitive neurotrauma. Comprehensive medical record reviews and health surveys completed by a family member were available for the 8 men in this case series, none of whom had known exposure to repetitive neurotrauma but 2 of whom had a history of traumatic brain injury (TBI). Postmortem tissue was immunostained for hyperphosphorylated tau (p-tau) to assess for CTE pathology, Braak stage, and aging-related p-tau. The neuropathologist was blind to age, personal history, and clinical history. Six of the 8 cases (75%) showed p-tau in neurons, astrocytes, and cell processes around small blood vessels in an irregular pattern at the depths of the cortical sulci. The changes were focal and limited in terms of overall extent, and some of the cases had a clearer pattern of pathology and some could be considered equivocal. Two of the 8 cases had a history of TBI and one of them showed CTE pathology. Five of the 6 cases with no known history of neurotrauma appeared to meet consensus criteria for CTE. This study adds to the emerging literature indicating that CTE pathology is present in people not known to have experienced multiple concussions or subconcussive blows to the head.	[Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.] MassGeneral Hosp Children Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Univ Tampere, Tampere, Finland; [Karhunen, Pekka J.] Univ Tampere, Fac Med & Life Sci, Dept Forens Med, Tampere, Finland; [Karhunen, Pekka J.] Fimlab Labs, Tampere, Finland; [Karhunen, Pekka J.] Finnish Cardiovasc Res Ctr Tampere, Tampere, Finland; [Castellani, Rudolph J.] Rockefeller Neurosci Inst, Dept Pathol Anat & Lab Med, Morgantown, WV USA; [Castellani, Rudolph J.] Rockefeller Neurosci Inst, Dept Neurosci, Morgantown, WV USA; [Castellani, Rudolph J.] West Virginia Univ, Sch Med, Morgantown, WV 26506 USA		Iverson, GL (corresponding author), Ctr Hlth & Rehabil Res, Dept Phys Med & Rehabil, 79-96 Thirteenth St, Charlestown, MA 02129 USA.	giverson@mgh.harvard.edu	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284	Harvard Integrated Program to Protect and Improve the Health of NFLPA Members; Mooney-Reed Charitable Foundation; Heniz Family Foundation; ImPACT Applications, Inc.; Western Michigan University Homer Stryker MD School of Medicine; ImPACT Applications Systems; Psychological Assessment Resources; CNS Vital Signs	Dr Grant Iverson has been reimbursed by the government, professional scientific bodies, and commercial organizations for discussing or presenting research relating to MTBI and sport-related concussion at meetings, scientific conferences, and symposiums. He has a clinical practice in forensic neuropsychology involving individuals who have sustained mild TBIs (including athletes). He has received honorariums for serving on research panels that provide scientific peer review of programs. He is a coinvestigator, collaborator, or consultant on grants relating to mild TBI funded by the federal government and other organizations. He has received research support from test publishing companies in the past, including ImPACT Applications Systems, Psychological Assessment Resources, and CNS Vital Signs. He has received support from the Harvard Integrated Program to Protect and Improve the Health of NFLPA Members. He serves as a scientific advisor for BioDirection, Inc. He acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, Heniz Family Foundation, and ImPACT Applications, Inc. Dr. Castellani has been reimbursed for travel for speaking at educational programs and has received fees for medicolegal consulting. He has received intramural research funding at Western Michigan University School of Medicine, unrelated to this study. He is subcontracted to the NIH Neurobiobank at the University of Maryland and the Lieber Institute for Brain Development. The neuropathological examinations for this study were funded by Western Michigan University Homer Stryker MD School of Medicine.	Armstrong RA, 2017, NEUROPATH APPL NEURO, V43, P154, DOI 10.1111/nan.12323; Asken BM, 2018, J ORTHOP SPORT PHYS, V48, P672, DOI 10.2519/jospt.2018.0612; Asken BM, 2017, JAMA NEUROL, V74, P1255, DOI 10.1001/jamaneurol.2017.2396; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; HIXSON JE, 1990, J LIPID RES, V31, P545; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Hsu ET, 2018, ACTA NEUROPATHOL, V136, P955, DOI 10.1007/s00401-018-1902-3; Iverson GL, 2018, J ALZHEIMERS DIS, V61, P17, DOI 10.3233/JAD-170654; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Ling H, 2017, NEUROPATH APPL NEURO, V43, P467, DOI 10.1111/nan.12425; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Randolph C, 2018, ARCH CLIN NEUROPSYCH, V33, P644, DOI 10.1093/arclin/acy063; Riley DO, 2015, BRAIN INJURY, V29, P154, DOI 10.3109/02699052.2014.965215; Schwab N, 2018, J ALZHEIMERS DIS, V64, P1067, DOI 10.3233/JAD-180373; Shively SB, 2017, ACTA NEUROPATHOL, V133, P353, DOI 10.1007/s00401-016-1649-7; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193; Zuckerman SL, 2018, J ALZHEIMERS DIS, V66, P37, DOI 10.3233/JAD-180218	58	21	21	2	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUL	2019	78	7					615	625		10.1093/jnen/nlz045			11	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	JI3QO	WOS:000493382600004	31169877	Bronze, Green Published			2022-02-06	
J	Negah, SS; Oliazadeh, P; Jahan-Abad, AJ; Eshaghabadi, A; Samini, F; Ghasemi, S; Asghari, A; Gorji, A				Negah, Sajad Sahab; Oliazadeh, Pardis; Jahan-Abad, Ali Jahanbazi; Eshaghabadi, Arezou; Samini, Fariborz; Ghasemi, Sepideh; Asghari, Amir; Gorji, Ali			Transplantation of human meningioma stem cells loaded on a self-assembling peptide nanoscaffold containing IKVAV improves traumatic brain injury in rats	ACTA BIOMATERIALIA			English	Article						Human stem cells; Brain injury; Cell damage; Cell death; Neuroinflammation	NEURAL STEM/PROGENITOR CELLS; SYNTHETIC PEPTIDE; A-CHAIN; HYDROGEL; DIFFERENTIATION; PROLIFERATION; BIOCOMPATIBILITY; INVOLVEMENT; MIGRATION; RECOVERY	Traumatic brain injury (TBI) can result in permanent brain function impairment due to the poor regenerative ability of neural tissue. Tissue engineering has appeared as a promising approach to promote nerve regeneration and to ameliorate brain damage. The present study was designed to investigate the effect of transplantation of the human meningioma stem-like cells (hMgSCs) seeded in a promising three-dimensional scaffold (RADA4GGSIKVAV; R-GSIK) on the functional recovery of the brain and neuroinflammatory responses following TBI in rats. After induction of TBI, hMgSCs seeded in R-GS1K was transplanted within the injury site and its effect was compared to several control groups. Application of hMgSCs with R-GSIK improved functional recovery after TBI. A significant higher number of hMgSCs was observed in the brain when transplanted with R-GSIK scaffold compared to the control groups. Application of hMgSCs seeded in R-GSIK significantly decreased the lesion volume, reactive gliosis, and apoptosis at the injury site. Furthermore, treatment with hMgSCs seeded in R-GSIK significantly inhibited the expression of Toll-like receptor 4 and its downstream signaling molecules, including interleukin-1 beta and tumor necrosis factor. These data revealed the potential for hMgSCs seeded in R-GS1K to improve the functional recovery of the brain after TBI; possibly via amelioration of inflammatory responses. Statement of significance Tissue engineered scaffolds that mimic the natural extracellular matrix of the brain may modulate stem cell fate and contribute to tissue repair following traumatic brain injury (TB!). Among several scaffolds, self-assembly peptide nanofiber scaffolds markedly promotes cellular behaviors, including cell survival and differentiation. We developed a novel three-dimensional scaffold (RADAI6GGSIKVAV; R-GSIK). Transplantation of the human meningioma stem-like cells seeded in R-GS1K in an animal model of TB1 significantly improved functional recovery of the brain, possibly via enhancement of stem cell survival as well as reduction of the lesion volume, inflammatory process, and reactive gliosis at the injury site. R-GSII( is a suitable microenvironment for human stem cells and could be a potential biomaterial for the reconstruction of the injured brain after TBI. (C) 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Negah, Sajad Sahab; Oliazadeh, Pardis; Gorji, Ali] Mashhad Univ Med Sci, Dept Neurosci, Fac Med, Mashhad, Razavi Khorasan, Iran; [Negah, Sajad Sahab; Oliazadeh, Pardis; Gorji, Ali] Mashhad Univ Med Sci, Neurosci Res Ctr, Mashhad, Razavi Khorasan, Iran; [Negah, Sajad Sahab; Jahan-Abad, Ali Jahanbazi; Eshaghabadi, Arezou; Ghasemi, Sepideh; Gorji, Ali] Khatam Alanbia Hosp, Shefa Neurosci Res Ctr, Tehran, Iran; [Samini, Fariborz] Mashhad Univ Med Sci, Dept Neurosurg, Fac Med, Mashhad, Razavi Khorasan, Iran; [Asghari, Amir] Mashhad Univ Med Sci, Devis Neurocognit Sci Psychiat & Behav Sci Res Ct, Mashhad, Razavi Khorasan, Iran; [Gorji, Ali] Westfalische Wilhelms Univ Munster, Dept Neurosurg, Munster, Germany; [Gorji, Ali] Westfalische Wilhelms Univ Munster, Dept Neurol, Munster, Germany; [Gorji, Ali] Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Domagkstr 11, D-48149 Munster, Germany		Gorji, A (corresponding author), Westfalische Wilhelms Univ Munster, Epilepsy Res Ctr, Domagkstr 11, D-48149 Munster, Germany.	gorjial@uni-muenster.de	Jahan-Abad, Ali Jahanbazi/AAW-3641-2021; Negah, Sajad Sahab/AAQ-5852-2020	Jahan-Abad, Ali Jahanbazi/0000-0001-8629-7762; Gorji, Ali/0000-0002-4557-3270	Iran National Science Foundation (INSF)Iran National Science Foundation (INSF); National Institute for Medical Research (NIMAD) [964650]; German Academic Exchange Service (DAAD)Deutscher Akademischer Austausch Dienst (DAAD) [57348208, 57403633]	This study was supported by the Iran National Science Foundation (INSF), National Institute for Medical Research (NIMAD; 964650), and the German Academic Exchange Service (DAAD; 57348208 and 57403633) to AG.	Agius E, 1996, NEUROSCIENCE, V71, P773, DOI 10.1016/0306-4522(95)00447-5; Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Aligholi H, 2016, BRAIN RES, V1642, P197, DOI 10.1016/j.brainres.2016.03.043; Aligholi H, 2014, J NEUROSCI METH, V225, P81, DOI 10.1016/j.jneumeth.2013.12.008; Cavalcanti BN, 2013, DENT MATER, V29, P97, DOI 10.1016/j.dental.2012.08.002; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Chronopoulou L, 2012, SOFT MATTER, V8, P5784, DOI 10.1039/c2sm25528f; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Cui GH, 2016, MOL NEUROBIOL, V53, P1108, DOI 10.1007/s12035-014-9069-y; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dolecek TA, 2015, CANCER-AM CANCER SOC, V121, P2400, DOI 10.1002/cncr.29379; Fang H, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-27; Farrukh A, 2017, STEM CELL REP, V9, P1432, DOI 10.1016/j.stemcr.2017.09.002; Feng Y, 2017, CELL MOL NEUROBIOL, V37, P155, DOI 10.1007/s10571-016-0356-1; Francis NL, 2016, ACS BIOMATER SCI ENG, V2, P1030, DOI 10.1021/acsbiomaterials.6b00156; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Gong L, 2018, EXP THER MED, V15, P620, DOI 10.3892/etm.2017.5439; Goto S, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00022; Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001; Hassannejad Z., 2018, INJURY; Hu DZ, 2012, J NEURO-ONCOL, V106, P505, DOI 10.1007/s11060-011-0705-3; Hueng DY, 2011, J NEURO-ONCOL, V104, P45, DOI 10.1007/s11060-010-0469-1; Iwasaki M, 2014, BIOMATERIALS, V35, P2617, DOI 10.1016/j.biomaterials.2013.12.019; Jahan-Abad A. J., 2017, MOL NEUROBIOL, P1; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jiang H, 2017, CANCER IMMUNOL IMMUN, V66, P1037, DOI 10.1007/s00262-017-2003-1; Knoblach SM, 2002, J NEUROTRAUM, V19, P1155, DOI 10.1089/08977150260337967; Koss KM, 2016, ACTA BIOMATER, V35, P127, DOI 10.1016/j.actbio.2016.02.001; Leung GKK, 2012, METHOD ENZYMOL, V508, P177, DOI 10.1016/B978-0-12-391860-4.00009-4; Li C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43834; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Lim HY, 2013, INT J ONCOL, V43, P1260, DOI 10.3892/ijo.2013.2053; Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Ludwig PE, 2018, NEURAL REGEN RES, V13, P7, DOI 10.4103/1673-5374.224361; Marshall LF, 2000, HEAD INJURY RECENT P; Meng XE, 2016, MED SCI MONITOR, V22, P284, DOI 10.12659/MSM.894148; Moradi F, 2012, J NEUROSCI RES, V90, P2335, DOI 10.1002/jnr.23120; Negah S. S., 2018, MOL NEUROBIOL, P1; Negah SS, 2018, CELL TISSUE RES, V371, P223, DOI 10.1007/s00441-017-2717-6; Negah SS, 2017, MOL NEUROBIOL, V54, P8050, DOI 10.1007/s12035-016-0295-3; Negah SS, 2016, IRAN J BASIC MED SCI, V19, P1271, DOI 10.22038/ijbms.2016.7907; Pan LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104335; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; SEPHEL GC, 1989, BIOCHEM BIOPH RES CO, V162, P821, DOI 10.1016/0006-291X(89)92384-X; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Su N., 2019, BIOMACROMOLECULES; Tang HL, 2012, INT J MOL SCI, V13, P6424, DOI 10.3390/ijms13056424; TASHIRO K, 1989, J BIOL CHEM, V264, P16174; Theocharidis U, 2014, PROG BRAIN RES, V214, P3, DOI 10.1016/B978-0-444-63486-3.00001-3; Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wang YC, 2013, STROKE, V44, P2545, DOI 10.1161/STROKEAHA.113.001038; Xiong LL, 2018, MOL NEUROBIOL, V55, P2696, DOI 10.1007/s12035-017-0551-1; Yang YH, 2015, ACTA BIOMATER, V21, P55, DOI 10.1016/j.actbio.2015.04.031; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang SC, 2008, PHILOS T R SOC B, V363, P87, DOI 10.1098/rstb.2006.2014; Zhang XM, 2018, CELL PHYSIOL BIOCHEM, V45, P258, DOI 10.1159/000486772; Zou ZW, 2014, J BIOMED MATER RES A, V102, P1286, DOI 10.1002/jbm.a.34804	67	21	21	2	35	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JUL 1	2019	92						132	144		10.1016/j.actbio.2019.05.010			13	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	IF8ZC	WOS:000473380800011	31075516				2022-02-06	
J	Bari, S; Svaldi, DO; Jang, I; Shenk, TE; Poole, VN; Lee, T; Dydak, U; Rispoli, JV; Nauman, EA; Talavage, TM				Bari, Sumra; Svaldi, Diana O.; Jang, Ikbeom; Shenk, Trey E.; Poole, Victoria N.; Lee, Taylor; Dydak, Ulrike; Rispoli, Joseph V.; Nauman, Eric A.; Talavage, Thomas M.			Dependence on subconcussive impacts of brain metabolism in collision sport athletes: an MR spectroscopic study	BRAIN IMAGING AND BEHAVIOR			English	Article						MR spectroscopy; Concussion; Subconcussive injury; Football; Soccer	MAGNETIC-RESONANCE SPECTROSCOPY; CHRONIC TRAUMATIC ENCEPHALOPATHY; APPEARING WHITE-MATTER; DEFAULT MODE NETWORK; HIGH-SCHOOL; COGNITIVE IMPAIRMENT; HEAD IMPACTS; INJURY; CONCUSSION; REPRODUCIBILITY	Long term neurological impairments due to repetitive head trauma are a growing concern for collision sport athletes. American Football has the highest rate of reported concussions among male high school athletes, a position held by soccer for female high school athletes. Recent research has shown that subconcussive events experienced by collision sport athletes can be a further significant source of accrued damage. Collision sport athletes experience hundreds of subconcussive events in a single season, and these largely go uninvestigated as they produce no overt clinical symptoms. Continued participation by these seemingly uninjured athletes is hypothesized to increase susceptibility to diagnoseable brain injury. This study paired magnetic resonance spectroscopy with head impact monitoring to quantify the relationship between metabolic changes and head acceleration event characteristics in high school-aged male football and female soccer collision sport athletes. During the period of exposure to subconcussive events, asymptomatic male (football) collision sport athletes exhibited statistically significant changes in concentrations of glutamate+glutamine (Glx) and total choline containing compounds (tCho) in dorsolateral prefrontal cortex, and female (soccer) collision sport athletes exhibited changes in glutamate+glutamine (Glx) in primary motor cortex. Neurometabolic alterations observed in football athletes during the second half of the season were found to be significantly associated with the average acceleration per head acceleration events, being best predicted by the accumulation of events exceeding 50g. These marked deviations in neurometabolism, in the absence of overt symptoms, raise concern about the neural health of adolescent collision-sport athletes and suggest limiting exposure to head acceleration events may help to ameliorate the risk of subsequent cognitive impairment.	[Bari, Sumra; Jang, Ikbeom; Shenk, Trey E.; Rispoli, Joseph V.; Talavage, Thomas M.] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Svaldi, Diana O.; Poole, Victoria N.; Rispoli, Joseph V.; Nauman, Eric A.; Talavage, Thomas M.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Svaldi, Diana O.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Lee, Taylor; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA; [Dydak, Ulrike] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Talavage, TM (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.; Talavage, TM (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.	tmt@purdue.edu	Rispoli, Joseph Vincent/AAB-1655-2019	Rispoli, Joseph Vincent/0000-0003-4514-3390; Poole, Victoria/0000-0003-0974-2564; Talavage, Thomas/0000-0003-4977-6398; Lee, Taylor/0000-0001-9218-9194	General Electric HealthcareGeneral ElectricGE Healthcare; BrainScope Company, GE-NFL Head Health Initiative	This study was funded in part by General Electric Healthcare and the BrainScope Company, as part of a grant obtained from the GE-NFL Head Health Initiative.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; Auerbach PS, 2016, JAMA-J AM MED ASSOC, V316, P1260, DOI 10.1001/jama.2016.8184; Bailes J, 2015, DEV NEUROPSYCHOL, V40, P59, DOI 10.1080/87565641.2015.1018090; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Batra NA, 2008, BIOL PSYCHIAT, V63, P1178, DOI 10.1016/j.biopsych.2007.10.007; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Belson K, 2015, NY TIMES, pB12; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Breedlove KM., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; DeLellis Stephen M, 2009, J Spec Oper Med, V9, P36; Ding XQ, 2015, MAGN RESON MED, V73, P921, DOI 10.1002/mrm.25208; Dou WQ, 2015, MAGN RESON MATER PHY, V28, P259, DOI 10.1007/s10334-014-0469-9; Endres D, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00367; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2001, J ATHL TRAINING, V36, P228; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; Groger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084081; Gujar SK, 2005, J NEURO-OPHTHALMOL, V25, P217, DOI 10.1097/01.wno.0000177307.21081.81; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hancu L, 2005, NMR BIOMED, V18, P352, DOI 10.1002/nbm.965; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Honaker J, 2011, J STAT SOFTW, V45, P1; Jang I, 2016, 22 ANN M ORG HUM BRA; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Lin Alexander, 2005, NeuroRx, V2, P197, DOI 10.1602/neurorx.2.2.197; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Maudsley AA, 2010, NMR BIOMED, V23, P251, DOI 10.1002/nbm.1445; Maudsley AA, 2015, J NEUROTRAUM, V32, P1056, DOI 10.1089/neu.2014.3505; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; O'Gorman RL, 2011, J MAGN RESON IMAGING, V33, P1262, DOI 10.1002/jmri.22520; Oz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Rasgon NL, 2001, PSYCHIAT RES-NEUROIM, V106, P47, DOI 10.1016/S0925-4927(00)00085-8; Reynolds BB, 2018, BRAIN IMAGING BEHAV, V12, P1332, DOI 10.1007/s11682-017-9790-z; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Schwarz A, 2011, NY TIMES, pD1; Shenk TE, 2015, DEV NEUROPSYCHOL, V40, P63, DOI 10.1080/87565641.2015.1014088; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Svaldi DO, 2016, CEREBROVASCULAR REAC; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Zhang B, 2015, J NEUROIMAGING, V25, P269, DOI 10.1111/jon.12138; Zhu H, 2011, METHODS MOL BIOL, V711, P203, DOI 10.1007/978-1-61737-992-5_9; Zhu XP, 2006, ALZ DIS ASSOC DIS, V20, P77, DOI 10.1097/01.wad.0000213809.12553.fc; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	89	21	21	2	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2019	13	3					735	749		10.1007/s11682-018-9861-9			15	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IA1VV	WOS:000469351500015	29802602				2022-02-06	
J	Huang, WT; Shao, MJ; Liu, H; Chen, J; Hu, J; Zhu, LY; Liu, F; Wang, DX; Zou, YC; Xiong, Y; Wang, X				Huang, Wenting; Shao, Mingjie; Liu, Huan; Chen, Jun; Hu, Jian; Zhu, Liyun; Liu, Fei; Wang, Dongxue; Zou, Yuchi; Xiong, Ye; Wang, Xue			Fibroblast growth factor 21 enhances angiogenesis and wound healing of human brain microvascular endothelial cells by activating PPAR gamma	JOURNAL OF PHARMACOLOGICAL SCIENCES			English	Article						Angiogenesis; Wound healing; FGF21; FGF21/FGFR1/beta-klotho complex; PPAR gamma	IN-VITRO; MECHANISMS; PATHWAY; DISEASE	Angiogenesis of brain microvascular endothelial cells (BMECs) is required in the functional restoration of brain injury, such as traumatic brain injury (TBI) and ischemic stroke. Fibroblast growth factor 21 (FGF21) is an angiogenic molecule that functions through the formation of the FGF21/FGFR1/beta-klotho complex but does not cause carcinogenic events. The current study was to determine whether recombinant human FGF21 (rhFGF21) could promote angiogenesis and scratch wound healing of human brain microvascular endothelial cells (HBMECs) and the possible underlying mechanism. rhFGF21 promoted angiogenesis and migration of HBMECs. The FGFR1 inhibitor PD173074 was applied to demonstrate that rhFGF21 functions through the formation of FGF21/FGFR1/beta-klotho complexes. In addition, the specific PPAR gamma inhibitor GW9662 and PPAR gamma activator rosiglitazone were applied to determine that the role of rhFGF21 in increasing angiogenesis is through the PPAR gamma pathway. In addition, we revealed that the effect of rhFGF21 acts partially through upregulating eNOS expression. In conclusion, our study provides novel evidence that rhFGF21 can enhance the angiogenesis and migration of HBMECs through the formation of the FGF21/FGFR1/beta-klotho complex via PPAR gamma activation and eNOS upregulation, indicating that FGF21 is a potential therapeutic angiogenic agent for the treatment of human brain injury. (C) 2019 The Authors. Production and hosting by Elsevier B. V. on behalf of Japanese Pharmacological Society.	[Huang, Wenting; Shao, Mingjie; Wang, Xue] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou 325035, Zhejiang, Peoples R China; [Liu, Huan; Chen, Jun; Hu, Jian; Zhu, Liyun; Liu, Fei; Wang, Dongxue; Wang, Xue] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Zou, Yuchi; Xiong, Ye] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou 315020, Zhejiang, Peoples R China		Wang, X (corresponding author), Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou 325035, Zhejiang, Peoples R China.; Xiong, Y (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou 315020, Zhejiang, Peoples R China.	xiongye2310@163.com; xinyuw001@163.com			National Undergraduate Training Programs for Innovation and Entrepreneurship [201710343011]; Public Welfare Technology Application Research Foundation of Zhejiang Province [2017C33080]; Wenzhou Municipal Science and Technology Bureau [Y20170686, Y20170224]	This study was supported by the National Undergraduate Training Programs for Innovation and Entrepreneurship (201710343011), the Public Welfare Technology Application Research Foundation of Zhejiang Province (2017C33080), and the Wenzhou Municipal Science and Technology Bureau (Y20170686, Y20170224).	Cao W, 2016, J PHARMACOL SCI, V132, P131, DOI 10.1016/j.jphs.2016.09.003; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chen J, 2018, J NEUROTRAUM, V35, P2091, DOI 10.1089/neu.2017.5271; Domouzoglou EM, 2015, AM J PHYSIOL-HEART C, V309, pH1029, DOI 10.1152/ajpheart.00527.2015; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Iizuka N, 2018, J PHARMACOL SCI, V138, P203, DOI 10.1016/j.jphs.2018.10.004; Jiang F, 2018, J PHARMACOL SCI, V137, P265, DOI 10.1016/j.jphs.2018.07.004; Kim KH, 2015, J ENDOCRINOL, V226, pR1, DOI 10.1530/JOE-15-0160; Kobayashi N, 2008, AM J HYPERTENS, V21, P576, DOI 10.1038/ajh.2008.27; Liu R, 2018, INT IMMUNOPHARMACOL, V57, P72, DOI 10.1016/j.intimp.2018.02.014; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Norton KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep36992; Ouk T, 2013, CURR DRUG TARGETS, V14, P752, DOI 10.2174/1389450111314070005; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Presta M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02327; Semenza GL, 2007, J CELL BIOCHEM, V102, P840, DOI 10.1002/jcb.21523; Villapol S, 2018, CELL MOL NEUROBIOL, V38, P121, DOI 10.1007/s10571-017-0554-5; Wang BT, 2018, J PHARMACOL SCI, V137, P290, DOI 10.1016/j.jphs.2018.07.007; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xu C, 2017, J DIABETES COMPLICAT, V31, P4, DOI 10.1016/j.jdiacomp.2016.10.010; Xu L, 2015, J CELL MOL MED, V19, P92, DOI 10.1111/jcmm.12463; Yang XX, 2018, BIOCONJUGATE CHEM, V29, P287, DOI 10.1021/acs.bioconjchem.7b00588; Yaqoob U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098130; Yu ZY, 2019, MOL NEUROBIOL, V56, P2314, DOI 10.1007/s12035-018-1234-2; Yuan Falei, 2013, Front Biosci (Elite Ed), V5, P517; Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002; Zhu WH, 2014, CAN J PHYSIOL PHARM, V92, P927, DOI 10.1139/cjpp-2014-0227; Zhuang SF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050968	28	21	22	1	6	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	1347-8613	1347-8648		J PHARMACOL SCI	J. Pharmacol. Sci.	JUN	2019	140	2					120	127		10.1016/j.jphs.2019.03.010			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	IM5JO	WOS:000478030400002	31255518	gold			2022-02-06	
J	Kuriakose, M; Younger, D; Ravula, AR; Alay, E; Rao, KVR; Chandra, N				Kuriakose, Matthew; Younger, Daniel; Ravula, Arun Reddy; Alay, Eren; Rao, Kakulavarapu V. Rama; Chandra, Namas			Synergistic Role of Oxidative Stress and Blood-Brain Barrier Permeability as Injury Mechanisms in the Acute Pathophysiology of Blast-induced Neurotrauma	SCIENTIFIC REPORTS			English	Article							NADPH OXIDASE ACTIVITY; MATRIX METALLOPROTEINASES; FLUID PERCUSSION; CLINICAL-TRIALS; APOCYNIN; MATRIX-METALLOPROTEINASE-9; INHIBITOR; EDEMA; NEUROPROTECTION; BIOAVAILABILITY	Blast-induced traumatic brain injury (bTBI) has been recognized as the common mode of neurotrauma amongst military and civilian personnel due to an increased insurgent activity domestically and abroad. Previous studies from our laboratory have identified enhanced blood-brain barrier (BBB) permeability as a significant, sub-acute (four hours post-blast) pathological change in bTBI. We also found that NADPH oxidase (NOX)-mediated oxidative stress occurs at the same time post-blast when the BBB permeability changes. We therefore hypothesized that oxidative stress is a major causative factor in the BBB breakdown in the sub-acute stages. This work therefore examined the role of NOX1 and its downstream effects on BBB permeability in the frontal cortex (a region previously shown to be the most vulnerable) immediately and four hours post-blast exposure. Rats were injured by primary blast waves in a compressed gas-driven shock tube at 180 kPa and the BBB integrity was assessed by extravasation of Evans blue and changes in tight junction proteins (TJPs) as well as translocation of macromolecules from blood to brain and vice versa. NOX1 abundance was also assessed in neurovascular endothelial cells. Blast injury resulted in increased extravasation and reduced levels of TJPs in tissues consistent with our previous observations. NOX1 levels were significantly increased in endothelial cells followed by increased superoxide production within 4 hours of blast. Blast injury also increased the levels/activation of matrix metalloproteinase 3 and 9. To test the role of oxidative stress, rats were administered apocynin, which is known to inhibit the assembly of NOX subunits and arrests its function. We found apocynin completely inhibited dye extravasation as well as restored TJP levels to that of controls and reduced matrix metalloproteinase activation in the sub-acute stages following blast. Together these data strongly suggest that NOX-mediated oxidative stress contributes to enhanced BBB permeability in bTBI through a pathway involving increased matrix metalloproteinase activation.	[Kuriakose, Matthew; Younger, Daniel; Ravula, Arun Reddy; Alay, Eren; Rao, Kakulavarapu V. Rama; Chandra, Namas] New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med CIBM3, Newark, NJ 07102 USA		Rao, KVR; Chandra, N (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Ctr Injury Biomech Mat & Med CIBM3, Newark, NJ 07102 USA.	kakulava@njit.edu; namas.chandra@njit.edu			U. S Army Medical Research and Materiel Command project Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tube [14059001]	This work was supported by U. S Army Medical Research and Materiel Command project Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tube, grant number: 14059001 (PI: Dr. Namas Chandra). Authors gratefully acknowledge Jose Rodrigues, Stephanie Iring, Madison Taylor, and Smit Shah and Madhuvika Murugan for their contributions to this work.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Anter HM, 2018, DRUG DES DEV THER, V12, P2981, DOI 10.2147/DDDT.S176850; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bochicchio GV, 2008, AM SURGEON, V74, P267; Chandasana H, 2015, J CHROMATOGR B, V985, P180, DOI 10.1016/j.jchromb.2015.01.025; Chandra N., 2011, U.S. provisional patent application, Patent No. 61542354; Chandra N, 2017, MIL MED, V182, P105, DOI 10.7205/MILMED-D-16-00144; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; FERNANDEZ V, 1985, ENDOCRINOLOGY, V117, P496, DOI 10.1210/endo-117-2-496; Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683; Gasche Y, 1999, J CEREBR BLOOD F MET, V19, P1020, DOI 10.1097/00004647-199909000-00010; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Hanumegowda UM, 2003, TOXICOL SCI, V76, P237, DOI 10.1093/toxsci/kfg222; Hicks RR, 1997, MOL CHEM NEUROPATHOL, V32, P1, DOI 10.1007/BF02815164; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; JENNER P, 1994, LANCET, V344, P796, DOI 10.1016/S0140-6736(94)92347-7; Jia F, 2010, J NEUROTRAUM, V27, P1059, DOI 10.1089/neu.2009.1067; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kim GW, 2003, J NEUROSCI, V23, P8733; Kim JH, 2013, BRAIN RES, V1499, P163, DOI 10.1016/j.brainres.2013.01.007; Kim SY, 2012, IMMUNOL CELL BIOL, V90, P441, DOI 10.1038/icb.2011.60; Koppula S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/823902; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Kuriakose M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161597; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Ling G. S., 2013, CURRENT OPINION ANES, V24, P124; Loane DJ, 2013, J NEUROTRAUM, V30, P403, DOI 10.1089/neu.2012.2589; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Machado LS, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-56; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mitazaki S, 2016, TOXICOL REP, V3, P357, DOI 10.1016/j.toxrep.2016.02.003; Moore B., 2015, AUSTRALASIAN J PARAM, V4; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Paracatu LC, 2017, MED CHEM, V13, P93, DOI 10.2174/1573406412666160610093216; Parrado-Fernandez C, 2018, J CELL MOL MED, V22, P5151, DOI 10.1111/jcmm.13767; Paterniti I, 2010, J LEUKOCYTE BIOL, V88, P993, DOI 10.1189/jlb.0610322; Qin YY, 2017, FREE RADICAL BIO MED, V104, P333, DOI 10.1016/j.freeradbiomed.2017.01.034; Rama Rao K. V., 2018, J NEUROTRAUMA; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Reijerkerk A, 2006, FASEB J, V20, P2550, DOI 10.1096/fj.06-6099fje; Rochfort KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101815; Rosell A, 2006, STROKE, V37, P1399, DOI 10.1161/01.STR.0000223001.06264.af; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Shetty A, 2014, FRONTIERS CELLULAR N, V8; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang Q, 2008, PHYTOMEDICINE, V15, P496, DOI 10.1016/j.phymed.2007.09.019; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	66	21	21	2	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 22	2019	9								7717	10.1038/s41598-019-44147-w			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HZ1IS	WOS:000468600800011	31118451	gold, Green Published			2022-02-06	
J	Rogers, JM; Duckworth, J; Middleton, S; Steenbergen, B; Wilson, PH				Rogers, Jeffrey M.; Duckworth, Jonathan; Middleton, Sandy; Steenbergen, Bert; Wilson, Peter H.			Elements virtual rehabilitation improves motor, cognitive, and functional outcomes in adult stroke: evidence from a randomized controlled pilot study	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Cognition; Motor activity; Rehabilitation; Stroke; Upper extremity; Virtual reality	TRAUMATIC BRAIN-INJURY; REALITY-BASED REHABILITATION; UPPER EXTREMITY FUNCTION; ARM FUNCTION; BLOCK TEST; INTERNATIONAL CLASSIFICATION; RECOVERY; IMPAIRMENT; VALIDITY; THERAPY	BackgroundVirtual reality technologies show potential as effective rehabilitation tools following neuro-trauma. In particular, the Elements system, involving customized surface computing and tangible interfaces, produces strong treatment effects for upper-limb and cognitive function following traumatic brain injury. The present study evaluated the efficacy of Elements as a virtual rehabilitation approach for stroke survivors.MethodsTwenty-one adults (42-94years old) with sub-acute stroke were randomized to four weeks of Elements virtual rehabilitation (three weekly 30-40min sessions) combined with treatment as usual (conventional occupational and physiotherapy) or to treatment as usual alone. Upper-limb skill (Box and Blocks Test), cognition (Montreal Cognitive Assessment and selected CogState subtests), and everyday participation (Neurobehavioral Functioning Inventory) were examined before and after inpatient training, and one-month later.ResultsEffect sizes for the experimental group (d=1.05-2.51) were larger compared with controls (d=0.11-0.86), with Elements training showing statistically greater improvements in motor function of the most affected hand (p=0.008), and general intellectual status and executive function (p0.001). Proportional recovery was two- to three-fold greater than control participants, with superior transfer to everyday motor, cognitive, and communication behaviors. All gains were maintained at follow-up.ConclusionA course of Elements virtual rehabilitation using goal-directed and exploratory upper-limb movement tasks facilitates both motor and cognitive recovery after stroke. The magnitude of training effects, maintenance of gains at follow-up, and generalization to daily activities provide compelling preliminary evidence of the power of virtual rehabilitation when applied in a targeted and principled manner.Trial registrationthis pilot study was not registered.	[Rogers, Jeffrey M.] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Duckworth, Jonathan] RMIT, Sch Design, Melbourne, Vic, Australia; [Middleton, Sandy] St Vincents Hlth Australia, Nursing Res Inst, Sydney, NSW, Australia; [Middleton, Sandy] Australian Catholic Univ, Sydney, NSW, Australia; [Steenbergen, Bert] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [Wilson, Peter H.] Australian Catholic Univ, Ctr Disabil & Dev Res CeDDR, Melbourne, Vic, Australia; [Wilson, Peter H.] Australian Catholic Univ, Sch Behav & Hlth Sci, Melbourne, Vic, Australia		Rogers, JM (corresponding author), Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia.	jeffrey.rogers@sydney.edu.au	Middleton, Sandy/J-5526-2015; Wilson, Peter H./E-2881-2018	Middleton, Sandy/0000-0002-7201-4394; Wilson, Peter H./0000-0003-3747-0287; Steenbergen, Bert/0000-0001-8863-2624	Prince of Wales Hospital Foundation Research Grant; Australian Catholic University Research Fund Program Grant	This research was supported by a Prince of Wales Hospital Foundation Research Grant awarded to JMR and an Australian Catholic University Research Fund Program Grant awarded to PHW.	Acosta AM, 2011, J REHABIL RES DEV, V48, P431, DOI 10.1682/JRRD.2010.04.0052; Adams ILJ, 2014, NEUROSCI BIOBEHAV R, V47, P225, DOI 10.1016/j.neubiorev.2014.08.011; Al Banna M, 2016, J NEUROL NEUROSUR PS, V87, P161, DOI 10.1136/jnnp-2015-310305; Aminov A, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0370-2; Aminov A, 2017, INT J STROKE, V12, P18; [Anonymous], 2017, STROK AUSTR NO POSTC; [Anonymous], 2017, CLIN GUID STROK MAN; Barker-Collo S, 2012, STROKE, V43, P50, DOI 10.1161/STROKEAHA.111.627182; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Billinger SA, 2014, STROKE, V45, P2532, DOI 10.1161/STR.0000000000000022; Boyd LA, 2003, PHYS THER, V83, P976, DOI 10.1093/ptj/83.11.976; Broeren J, 2008, CEREBROVASC DIS, V26, P289, DOI 10.1159/000149576; Broeren J, 2008, STUD HEALTH TECHNOL, V136, P77; Burton L, 2015, J REHABIL MED, V47, P193, DOI 10.2340/16501977-1930; Cameirao MS, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0127-8; Cameirao MS, 2017, 2017 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION (ICVR); Chen C, 2013, NEUROLOGY, V80, pS27, DOI 10.1212/WNL.0b013e3182762569; Choi JH, 2014, ANN REHABIL MED-ARM, V38, P485, DOI 10.5535/arm.2014.38.4.485; Cohen J, 1988, STAT POWER ANAL BEHA; Crosbie JH, 2012, CLIN REHABIL, V26, P798, DOI 10.1177/0269215511434575; Cumming TB, 2016, INT J STROKE, V11, P968, DOI 10.1177/1747493016669861; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; Cumming TB, 2011, STROKE, V42, P2642, DOI 10.1161/STROKEAHA.111.619486; Cameirao MDS, 2011, RESTOR NEUROL NEUROS, V29, P287, DOI 10.3233/RNN-2011-0599; DESROSIERS J, 1994, ARCH PHYS MED REHAB, V75, P751; Dijkerman C, 2018, CORTEX, V104, P133, DOI 10.1016/j.cortex.2018.06.001; Palma GCD, 2017, TOP STROKE REHABIL, V24, P269, DOI 10.1080/10749357.2016.1250373; Douiri A, 2013, STROKE, V44, P138, DOI 10.1161/STROKEAHA.112.670844; Duckworth Jonathan, 2013, Design, User Experience, and Usability. Health, Learning, Playing, Cultural, and Cross-Cultural User Experience.Second International Conference, DUXU 2013 Held as Part of HCI International 2013. Proceedings. LNCS 8013, P391, DOI 10.1007/978-3-642-39241-2_43; Duckworth J, 2009, SUPERHUMAN REVOULTIO, P120; Duff M, 2013, NEUROREHAB NEURAL RE, V27, P306, DOI 10.1177/1545968312465195; Dunn LE, 2016, CEREBROVASC DIS EXTR, V6, P12, DOI 10.1159/000444149; Edmans JA, 2006, STROKE, V37, P2770, DOI 10.1161/01.STR.0000245133.50935.65; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Faria AL, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00854; Favate AS, 2016, NEUROL CLIN, V34, P967, DOI 10.1016/j.ncl.2016.06.013; Friedly J, 2014, ARCH PHYS MED REHAB, V95, P1419, DOI 10.1016/j.apmr.2014.03.022; Fritz NE, 2015, J NEUROL PHYS THER, V39, P142, DOI 10.1097/NPT.0000000000000090; Fu MJ, 2015, PHYS MED REH CLIN N, V26, P747, DOI 10.1016/j.pmr.2015.06.001; Gamito P, 2017, DISABIL REHABIL, V39, P385, DOI 10.3109/09638288.2014.934925; Green D, 2012, DISABIL REHABIL, V34, P593, DOI 10.3109/09638288.2011.613520; Harrison RA, 2015, CEREBROVASC DIS, V39, P190, DOI 10.1159/000375397; Hatem SM, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00442; Hawe R.L., 2018, STROKE, DOI 10.1161/STROKEAHA.118. 023006; Higgins JPT, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184; Hope TMH, 2019, BRAIN, V142, P15, DOI 10.1093/brain/awy302; Housman SJ, 2009, NEUROREHAB NEURAL RE, V23, P505, DOI 10.1177/1545968308331148; Howard MC, 2017, COMPUT HUM BEHAV, V70, P317, DOI 10.1016/j.chb.2017.01.013; In TS, 2012, J PHYS THER SCI, V24, P339, DOI 10.1589/jpts.24.339; Jo K, 2012, J PHYS THER SCI, V24, P1205; Jokinen H, 2015, EUR J NEUROL, V22, P1288, DOI 10.1111/ene.12743; Kaelin-Lang A, 2005, J NEUROPHYSIOL, V93, P1099, DOI 10.1152/jn.00143.2004; Kalaria RN, 2016, BBA-MOL BASIS DIS, V1862, P915, DOI 10.1016/j.bbadis.2016.01.015; Kim BR, 2011, ANN REHABIL MED-ARM, V35, P450, DOI 10.5535/arm.2011.35.4.450; Kizony R, 2003, J VISUAL COMP ANIMAT, V14, P261, DOI 10.1002/vis.323; Kottink AIR, 2014, GAMES HEALTH J, V3, P184, DOI 10.1089/g4h.2014.0026; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Kwon JS, 2012, NEUROREHABILITATION, V31, P379, DOI 10.3233/NRE-2012-00807; Lai SM, 2002, STROKE, V33, P1840, DOI 10.1161/01.STR.0000019289.15440.F2; LANGE K, 2010, P ICDVRAT CHIL AUG, P249, DOI DOI 10.1007/978-1-4419-5945-4_14; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Laugrand F, 2010, ARCTIC ANTHROPOL, V47, P1; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Leisman G, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00094; Levin MF, 2012, NEUROL THER, V1, DOI 10.1007/s40120-012-0003-9; Lohse KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093318; Maier M, 2019, NEUROREHAB NEURAL RE, V33, P112, DOI 10.1177/1545968318820169; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; McDonald MW, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00135; Merians AS, 2002, PHYS THER, V82, P898, DOI 10.1093/ptj/82.9.898; Meyer S, 2015, STROKE, V46, P1613, DOI 10.1161/STROKEAHA.115.009421; Mitchell AJ, 2017, GEN HOSP PSYCHIAT, V47, P48, DOI 10.1016/j.genhosppsych.2017.04.001; Mullick AA, 2015, RESTOR NEUROL NEUROS, V33, P389, DOI 10.3233/RNN-150510; Mumford N, 2012, BRAIN INJURY, V26, P166, DOI 10.3109/02699052.2011.648706; Mumford N, 2010, BRAIN INJURY, V24, P780, DOI 10.3109/02699051003652807; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nijenhuis SM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0080-y; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302; Reeves M, 2013, STROKE, V44, P3211, DOI 10.1161/STROKEAHA.113.002881; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rogers JM, 2018, NEUROPSYCHOL REV, V28, P285, DOI 10.1007/s11065-018-9378-4; Sakzewski L, 2013, PEDIATRICS; Saposnik G, 2016, LANCET NEUROL, V15, P1019, DOI 10.1016/S1474-4422(16)30121-1; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Saposnik G, 2010, STROKE, V41, P1477, DOI 10.1161/STROKEAHA.110.584979; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Shah N, 2014, GAMES HEALTH J, V3, P13, DOI 10.1089/g4h.2013.0044; Sin H, 2013, AM J PHYS MED REHAB, V92, P871, DOI 10.1097/PHM.0b013e3182a38e40; Standen PJ, 2017, CLIN REHABIL, V31, P340, DOI 10.1177/0269215516640320; Stolwyk RJ, 2018, TOP STROKE REHABIL, V25, P527, DOI 10.1080/10749357.2018.1499301; Subramanian SK, 2015, 2015 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION PROCEEDINGS (ICVR), P38, DOI 10.1109/ICVR.2015.7358582; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Thomas SA, 2006, BRIT J CLIN PSYCHOL, V45, P49, DOI 10.1348/014466505X34183; Tieri G, 2018, EXPERT REV MED DEVIC, V15, P107, DOI 10.1080/17434440.2018.1425613; Tse T, 2013, ARCH PHYS MED REHAB, V94, P177, DOI 10.1016/j.apmr.2012.09.002; Vargus-Adams JN, 2014, J CHILD NEUROL, V29, P1030, DOI 10.1177/0883073814533595; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Vratsistas-Curto A, 2018, CLIN REHABIL, V32, P1098, DOI 10.1177/0269215518778316; Wagle J, 2011, DEMENT GERIATR COGN, V31, P379, DOI 10.1159/000328970; Weiss P, 2006, TXB NEURAL REPAIR RE, p182 197, DOI [10.1017/CBO9780511545078.015, DOI 10.1017/CBO9780511545078.015, DOI 10.1017/CB09780511545078.015]; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; World Health Organization (WHO), 2017, INT CLASS FUNCT DIS; Yin CW, 2014, CLIN REHABIL, V28, P1107, DOI 10.1177/0269215514532851; Zimmerli L, 2013, ARCH PHYS MED REHAB, V94, P1737, DOI 10.1016/j.apmr.2013.01.029	109	21	23	6	23	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	MAY 15	2019	16								56	10.1186/s12984-019-0531-y			13	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology; Rehabilitation	HY3UZ	WOS:000468054200002	31092252	Green Published, gold			2022-02-06	
J	Joseph, JR; Swallow, JS; Wilisey, K; Lapointe, AP; Khalatbari, S; Korley, FK; Oppenlander, ME; Park, P; Szerlip, NJ; Broglio, SP				Joseph, Jacob R.; Swallow, Jennylee S.; Wilisey, Kylene; Lapointe, Andrew P.; Khalatbari, Shokoufeh; Korley, Frederick K.; Oppenlander, Mark E.; Park, Paul; Szerlip, Nicholas J.; Broglio, Steven P.			Elevated markers of brain injury as a result of clinically asymptomatic high-acceleration head impacts in high-school football athletes	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; concussion; subconcussion; biomarker; accelerometry; pediatrics	SERUM NEUROFILAMENT LIGHT; INTRACRANIAL LESIONS; CONCUSSION; MILD; BIOMARKERS; PLAYERS; FLUID; RISK	OBJECTIVE This prospective observational cohort study of high-school football athletes was performed to determine if high-acceleration head impacts (HHIs) that do not result in clinically diagnosed concussion still lead to increases in serum levels of biomarkers indicating traumatic brain injury (TBI) in asymptomatic athletes and to determine the longitudinal profile of these biomarkers over the course of the football season. METHODS Sixteen varsity high-school football athletes underwent baseline neurocognitive testing and blood sampling for the biomarkers tau, ubiquitin C-terminal hydrolase L1 (UCH-L1), neurofilament light protein (NF-L), glial fibrillary acidic protein (GFAP), and spectrin breakdown products (SBDPs). All athletes wore helmet-based accelerometers to measure and record head impact data during all practices and games. At various time points during the season, 6 of these athletes met the criteria for HHI (linear acceleration > 95g and rotational acceleration > 3760 rad/sec(2)); in these athletes a second blood sample was drawn at the end of the athletic event during which the HHI occurred. Five athletes who did not meet the criteria for HHI underwent repeat blood sampling following the final game of the season. In a separate analysis, all athletes who did not receive a diagnosis of concussion during the season (n = 12) underwent repeat neurocognitive testing and blood sampling after the end of the season. RESULTS Total tau levels increased 492.6% +/- 109.8% from baseline to postsession values in athletes who received an HHI, compared with 164% +/- 35% in athletes who did not receive an HHI (p = 0.03). Similarly, UCH-L1 levels increased 738.2% +/- 163.3% in athletes following an HHI, compared with 237.7% +/- 71.9% in athletes in whom there was no HHI (p = 0.03). At the end of the season, researchers found that tau levels had increased 0.6 +/- 0.2 pg/ml (p = 0.003) and UCH-L1 levels had increased 144.3 +/- 56 pg/ml (p = 0.002). No significant elevations in serum NF-L, GFAP, or SBDPs were seen between baseline and end-of-athletic event or end-of-season sampling (for all, p > 0.05). CONCLUSIONS In this pilot study on asymptomatic football athletes, an HHI was associated with increased markers of neuronal (UCH-L1) and axonal (tau) injury when compared with values in control athletes. These same markers were also increased in nonconcussed athletes following the football season.	[Joseph, Jacob R.; Oppenlander, Mark E.; Park, Paul; Szerlip, Nicholas J.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Swallow, Jennylee S.; Lapointe, Andrew P.; Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Wilisey, Kylene] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Khalatbari, Shokoufeh] Univ Michigan, Michigan Inst Clin & Hlth Res, Ann Arbor, MI 48109 USA; [Korley, Frederick K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA		Joseph, JR (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	jojacob@med.umich.edu			American Association of Neurological Surgeons (AANS); Congress of Neurological Surgeons (CNS) Joint Section in Neurotrauma & Critical Care Codman Fellowship	This work was supported by the American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) Joint Section in Neurotrauma & Critical Care Codman Fellowship to Dr. Joseph.	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Forbes JA, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.9.FOCUS12288; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Joseph JR, 2017, WORLD NEUROSURG, V103, P73, DOI 10.1016/j.wneu.2017.03.106; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Li J, 2015, AM J EMERG MED, V33, P1191, DOI 10.1016/j.ajem.2015.05.023; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morris M, 2011, NEURON, V70, P410, DOI 10.1016/j.neuron.2011.04.009; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945; 2010, AM J EMERG MED, V28, P399, DOI DOI 10.1016/J.AJEM.2008.12.025; 1986, J CELL BIOL, V102, P2088; 2005, NEUROSURGERY, V57, P300, DOI DOI 10.1227/01.NEU.0000166663.98616.E4; 1989, SCIENCE, V246, P670	46	21	21	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2019	130	5					1642	1648		10.3171/2017.12.JNS172386			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW0VW	WOS:000466401100028	29966462	Bronze			2022-02-06	
J	Wang, YQ; Mao, J; Wang, X; Lin, Y; Hou, GQ; Zhu, J; Xie, BS				Wang, Yiqin; Mao, Jian; Wang, Xin; Lin, Yong; Hou, Guoqiang; Zhu, Jun; Xie, Baoshu			Genome-wide screening of altered m6A-tagged transcript profiles in the hippocampus after traumatic brain injury in mice	EPIGENOMICS			English	Article						hippocampus; N6-methyladenosine (m6A); traumatic brain injury (TBI)	MESSENGER-RNA; M(6)A; EXPRESSION; METHYLATION	Aim: To systematically profile RNA m6A modification landscape after traumatic brain injury (TBI) in mice. Materials & methods: Expression of m6A-related genes was detected by quantitative real-time PCR (qPCR). Expression and location of METTL3, a key component of m6A methyltransferase complex, were determined by immunostaining. Genome-wide profiling of m6A-tagged transcripts was conducted by m6A-modified RNA immunoprecipitation sequencing (m6A-RIP-seq) and RNA sequencing (RNA-seq). Results: METTL3 was downregulated after TBI. In total, 922 m6A peaks were differentially expressed as determined by m6A-RIP-seq, with 370 upregulated and 552 downregulated. In addition, we identified differentially expressed hypomethylated and hypermethylated mRNA transcripts. Conclusion: Our data provided novel information regarding m6A modification changes in the early period of TBI, which might be promising therapy targets.	[Wang, Yiqin; Zhu, Jun] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom,Rui Jin Hosp, CNRS LIA Hematol & Canc,Sino French Res Ctr Life, Shanghai 200127, Peoples R China; [Mao, Jian; Lin, Yong; Hou, Guoqiang; Xie, Baoshu] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China; [Wang, Xin] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Anesthesiol, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Xie, Baoshu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China		Zhu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom,Rui Jin Hosp, CNRS LIA Hematol & Canc,Sino French Res Ctr Life, Shanghai 200127, Peoples R China.; Xie, BS (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai 200127, Peoples R China.; Xie, BS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou 510080, Guangdong, Peoples R China.	zhuj1966@yahoo.com; clairtree@163.com			Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine [BXJ201824]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81770311]	This research was partly supported by Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine (BXJ201824) and partly supported by National Natural Science Foundation of China (No. 81770311). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Chang MQ, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170166; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Du YZ, 2018, NUCLEIC ACIDS RES, V46, P5195, DOI 10.1093/nar/gky156; Evans LP, 2018, ANN CLIN TRANSL NEUR, V5, P240, DOI 10.1002/acn3.523; Golovina AY, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1160; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li FL, 2016, J BIOMOL SCREEN, V21, P290, DOI 10.1177/1087057115623264; Li MM, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1436-y; Li WB, 2018, ANN CLIN TRANSL NEUR, V5, P552, DOI 10.1002/acn3.552; Li X, 2017, ONCOTARGET, V8, P96103, DOI 10.18632/oncotarget.21726; Majdan M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002331; Mathiyalagan P, 2019, CIRCULATION, V139, P518, DOI 10.1161/CIRCULATIONAHA.118.033794; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McKenna MC, 2015, NEUROCHEM RES, V40, P2527, DOI 10.1007/s11064-015-1600-7; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Prins ML, 2016, J CHILD NEUROL, V31, P28, DOI 10.1177/0883073814549244; Scholler E, 2018, RNA, V24, P499, DOI 10.1261/rna.064063.117; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Tong JY, 2018, FRONT MED-PRC, V12, P481, DOI 10.1007/s11684-018-0654-8; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Visvanathan A, 2018, ONCOGENE, V37, P522, DOI 10.1038/onc.2017.351; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang CX, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004880; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang H, 2018, CELL RES, V28, P1035, DOI 10.1038/s41422-018-0082-y; Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Weng YL, 2018, NEURON, V97, P313, DOI 10.1016/j.neuron.2017.12.036; Xie BS, 2018, J NEUROTRAUM, V35, P1659, DOI 10.1089/neu.2017.5468; Xie BS, 2019, CNS NEUROSCI THER, V25, P465, DOI 10.1111/cns.13069; Yang Y, 2019, J CLIN ENDOCR METAB, V104, P665, DOI 10.1210/jc.2018-00619; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhao BS, 2017, MOL CELL, V67, P903, DOI 10.1016/j.molcel.2017.09.004; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhao XG, 2018, CANCER BIOMARK, V21, P859, DOI 10.3233/CBM-170791; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhou J, 2018, MOL CELL, V69, P636, DOI 10.1016/j.molcel.2018.01.019	42	21	21	3	17	FUTURE MEDICINE LTD	LONDON	UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3 1QB, ENGLAND	1750-1911	1750-192X		EPIGENOMICS-UK	Epigenomics	MAY	2019	11	7					805	819		10.2217/epi-2019-0002			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM5ID	WOS:000478026700007	30882247				2022-02-06	
J	Zhang, LL; Zhang, WJ; Zheng, BB; Tian, NF				Zhang, Lilian; Zhang, Weijiang; Zheng, Binbin; Tian, Naifeng			Sinomenine Attenuates Traumatic Spinal Cord Injury by Suppressing Oxidative Stress and Inflammation via Nrf2 Pathway	NEUROCHEMICAL RESEARCH			English	Article						Sinomenine; Spinal cord injury; Oxidative stress; Inflammation; Nrf2	KEAP1/NRF2 PATHWAY; BRAIN-INJURY; ACTIVATION; INHIBITION; APOPTOSIS; PROTECTS; RECOVERY; MODEL; INVOLVEMENT; CELLS	Traumatic spinal cord injury (SCI) is a devastating condition with few efficacious drugs. Sinomenine, a bioactive alkaloid extracted from medicinal herb, has been used as a treatment of rheumatoid diseases. This present study explored the therapeutic effects of sinomenine on locomotor dysfunction and neuropathology in SCI. Our findings revealed that sinomenine mitigated neurological deficits and enhanced neuronal preservation, paralleled with a reduction of apoptosis. Also, sinomenine significantly reduced inflammatory cytokines and oxidative stress factors. We further examined erythroid-2-related factor 2 (Nrf2) nuclear translocation, which mainly controls the coordinated expression of important antioxidant and detoxification genes. An increase in Nrf2 translocation from cytoplasm to nucleus and Nrf2-mediated transactivation was observed after sinomenine administration. Knocking down Nrf2 by siRNA could counteract sinomenine-mediated anti-oxidant stress and anti-inflammation following H2O2-stimulated and LPS-stimulated PC12 cells. Together, our findings indicated that sinomenine has the potential to be an effective therapeutic agent for SCI by inhibiting inflammation and oxidative stress via Nrf2 activation.	[Zhang, Lilian; Zhang, Weijiang; Tian, Naifeng] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Wenzhou 325000, Zhejiang, Peoples R China; [Zhang, Lilian; Zhang, Weijiang; Tian, Naifeng] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Zhejiang, Peoples R China; [Zhang, Lilian; Zhang, Weijiang; Tian, Naifeng] Zhejiang Prov Key Lab Orthopaed, Wenzhou 325000, Zhejiang, Peoples R China; [Zheng, Binbin] Wenzhou Med Univ, Taizhou Hosp, Dept Orthopaed, Linhai 317000, Zhejiang, Peoples R China		Tian, NF (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Wenzhou 325000, Zhejiang, Peoples R China.; Tian, NF (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Zhejiang, Peoples R China.; Tian, NF (corresponding author), Zhejiang Prov Key Lab Orthopaed, Wenzhou 325000, Zhejiang, Peoples R China.; Zheng, BB (corresponding author), Wenzhou Med Univ, Taizhou Hosp, Dept Orthopaed, Linhai 317000, Zhejiang, Peoples R China.	zbb5161@163.com; tiannaifeng2016@163.com			Science and technology project of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401162]; Public Technology Research Program of Zhejiang Province [LGF18H060011]; Science and Technology Planning Program of Taizhou City [1702KY04]	This work was supported by the Science and technology project of the National Natural Science Foundation of China (NO. 81401162), the Public Technology Research Program of Zhejiang Province (LGF18H060011) and Science and Technology Planning Program of Taizhou City (1702KY04).	Agostini M, 2016, ONCOTARGET, V7, P29881, DOI 10.18632/oncotarget.8935; Cai YF, 2017, ONCOTARGET, V8, P45356, DOI 10.18632/oncotarget.17487; Campolo M, 2013, FASEB J, V27, P4489, DOI 10.1096/fj.13-234716; Chauhan AK, 2016, MOL NEUROBIOL, V53, P5782, DOI 10.1007/s12035-015-9478-6; Chen L, 2016, ONCOTARGET, V7, P54691, DOI 10.18632/oncotarget.10579; Chen XJ, 2016, MOL NEUROBIOL, V53, P1565, DOI 10.1007/s12035-015-9118-1; Cheng P, 2014, NEUROPHARMACOLOGY, V85, P408, DOI 10.1016/j.neuropharm.2014.06.004; Childs EW, 2008, SHOCK, V29, P636, DOI 10.1097/SHK.0b013e318157f524; Choi JY, 2017, ONCOTARGET, V8; Deng J, 2014, PROG NEUROBIOL, V115, P210, DOI 10.1016/j.pneurobio.2014.01.001; Fabrizio FP, 2017, ONCOTARGET, V8, P11187, DOI 10.18632/oncotarget.14492; Fan H, 2017, CELL MOL NEUROBIOL, V37, P1387, DOI 10.1007/s10571-017-0469-1; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Hong JY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588871; Kao CH, 2008, RESUSCITATION, V77, P395, DOI 10.1016/j.resuscitation.2008.01.023; Khayrullina G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0391-8; Kumar H, 2017, MOL NEUROBIOL, V55; Li HT, 2016, MOL NEUROBIOL, V53, P4073, DOI 10.1007/s12035-015-9327-7; Long LH, 2010, ACTA PHARMACOL SIN, V31, P1508, DOI 10.1038/aps.2010.122; Mao L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/238321; Ozdemir US, 2016, MOL NEUROBIOL, V53, P3540, DOI 10.1007/s12035-015-9292-1; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI [10.1186/1742-2094-11-6, 10.1186/s12974-014-0136-0]; Pei JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0870-1; Qin T, 2016, TOXICOL APPL PHARM, V304, P1, DOI 10.1016/j.taap.2016.05.009; Qin T, 2016, FREE RADICAL BIO MED, V92, P90, DOI 10.1016/j.freeradbiomed.2016.01.011; Reigada D, 2015, NEUROSCIENCE, V300, P404, DOI 10.1016/j.neuroscience.2015.05.036; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Shah ZA, 2007, NEUROSCIENCE, V147, P53, DOI 10.1016/j.neuroscience.2007.02.066; Shi H, 2016, J NEUROIMMUNOL, V299, P28, DOI 10.1016/j.jneuroim.2016.08.010; Shukla SM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-117; Smith JR, 2016, BIOMATERIALS, V80, P96, DOI 10.1016/j.biomaterials.2015.11.062; Thompson CD, 2013, J NEUROTRAUM, V30, P1311, DOI 10.1089/neu.2012.2651; Tsai MJ, 2010, NEUROCHEM INT, V57, P867, DOI 10.1016/j.neuint.2010.09.005; Wang AL, 2007, INT IMMUNOPHARMACOL, V7, P1552, DOI 10.1016/j.intimp.2007.07.030; Wu WN, 2011, BRIT J PHARMACOL, V164, P1445, DOI 10.1111/j.1476-5381.2011.01487.x; Xun CH, 2017, EXP THER MED, V14, P431, DOI 10.3892/etm.2017.4505; Yang YQ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00580; Yang Z, 2014, MOL IMMUNOL, V60, P109, DOI 10.1016/j.molimm.2014.03.005; Yin QQ, 2016, BIOCHEM BIOPH RES CO, V477, P881, DOI 10.1016/j.bbrc.2016.06.152; Zhang D, 2017, MOL NEUROBIOL, V54, P3327, DOI 10.1007/s12035-016-9895-1; Zhang Q, 2016, ONCOTARGET, V7, P80872, DOI 10.18632/oncotarget.12645; Zhang R., 2016, MOL NEUROBIOL	42	21	22	1	12	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	APR	2019	44	4					763	775		10.1007/s11064-018-02706-z			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HR2TP	WOS:000462990500003	30603983				2022-02-06	
J	Migueis, GFJ; Fernandes, FAO; Ptak, M; Ratajczak, M; de Sousa, RJA				Migueis, G. F. J.; Fernandes, F. A. O.; Ptak, M.; Ratajczak, M.; Alves de Sousa, R. J.			Detection of bridging veins rupture and subdural haematoma onset using a finite element head model	CLINICAL BIOMECHANICS			English	Article						Biomechanics; Finite elements; Bridging veins; Subdural haematoma; Head model; Damage modeling	INJURY; BIOMECHANICS; BRAIN	Background: One of the most severe traumatic brain injuries, the subdural haematoma, is related to damage and rupture of the bridging veins, generating an abnormal collection of blood between the dura mater and arachnoid mater. Current numerical models of these vessels rely on very simple geometries and material laws, limiting its accuracy and bio-fidelity. Methods: In this work, departing from an existing human head numerical model, a realistic geometry for the bridging veins was developed, devoting special attention to the finite elements type employed. A novel and adequate constitutive model including damage behavior was also successfully implemented. Findings: Results attest that vessel tearing onset was correctly captured, after comparison against experiments on cadavers. Interpretation: Doing so, the model allow to precisely predict the individual influence of kinematic parameters such as the pulse duration, linear and rotational accelerations in promoting vessel tearing.	[Migueis, G. F. J.; Fernandes, F. A. O.; Alves de Sousa, R. J.] Univ Aveiro, Dept Mech Engn, TEMA Ctr Mech Technol & Automat, Aveiro, Portugal; [Ptak, M.] Wroclaw Univ Sci & Technol, Fac Mech Engn, Lukasiewicza 7-9, PL-50371 Wroclaw, Poland; [Ratajczak, M.] Univ Zielona Gora, Fac Mech Engn, Prof Z Szafrana 4, PL-65516 Zielona Gora, Poland		de Sousa, RJA (corresponding author), Univ Aveiro, Campus Santiago, P-3810193 Aveiro, Portugal.	rsousa@ua.pt	de Sousa, Ricardo Alves/E-4405-2010; Fernandes, Fabio A.O./H-2680-2012; Ptak, Mariusz/B-1493-2013; Ratajczak, Monika/AAV-6979-2020	de Sousa, Ricardo Alves/0000-0002-5848-6424; Fernandes, Fabio A.O./0000-0001-9751-8807; Ptak, Mariusz/0000-0001-8081-8336; Ratajczak, Monika/0000-0001-6980-315X	Fundacao para a Cincia e Tecnologia (FCT)Portuguese Foundation for Science and Technology [CEECIND/01192/2017];  [UID/EMS/00481/2013-FCT];  [CENTRO-01-0145-FEDER-022083]	Center of Mechanical Technology and Automation (TEMA, University of Aveiro) is supported by grants UID/EMS/00481/2013-FCT and CENTRO-01-0145-FEDER-022083. Medical images provided by Hospital Sao Joao (Porto, Portugal) are gratefully acknowledged. Fabio Fernandes is supported by individual grant CEECIND/01192/2017, Fundacao para a Cincia e Tecnologia (FCT)	Asiminei A., 2011, P IRCOBI C WARS, P36; Bandak FA, 1997, NATO ADV SCI I E-APP, V332, P53; Besenski N., 2006, IMAGING HEAD INJURIE, P99; Dassault Systemes, 2017, AB AN US MAN; Delye Hans, 2006, Stapp Car Crash J, V50, P625; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P1, DOI 10.1007/978-3-319-89926-8_1; Fernandes FAO, 2018, SPRINGERBR APPL SCI, P41, DOI 10.1007/978-3-319-89926-8_3; Fernandes FAO, 2018, ENG COMPUTATION, V35, P477, DOI 10.1108/EC-09-2016-0321; Fernandes FAO, 2015, P I MECH ENG H, V229, P592, DOI 10.1177/0954411915592906; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2008, THESIS; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Kilic Turker, 2008, Front Neurol Neurosci, V23, P4; Kleiven S., 2002, THESIS; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Li WG, 2016, J MED BIOL ENG, V36, P285, DOI 10.1007/s40846-016-0132-1; LOWENHIELM P, 1978, J BIOENG, V2, P501; Monea AG, 2014, J MECH BEHAV BIOMED, V32, P155, DOI 10.1016/j.jmbbm.2013.12.007; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Nowinski W., 2016, HUMAN BRAIN HEAD NEC; OKA K, 1985, NEUROSURGERY, V17, P711, DOI 10.1227/00006123-198511000-00003; Prantl A., 2013, 2013 SIMULIA COMM C; Ratajczak M, 2016, ACTA BIOENG BIOMECH, V18, P21, DOI 10.5277/ABB-00552-2016-02; Richter M, 2001, J TRAUMA, V51, P949, DOI 10.1097/00005373-200111000-00021; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; Sampei T, 1996, NEUROSURGERY, V38, P971, DOI 10.1097/00006123-199605000-00024; Vignes JR, 2007, J NEUROSURG, V107, P1205, DOI 10.3171/JNS-07/12/1205; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; Zhang L, 2001, Stapp Car Crash J, V45, P369	35	21	21	1	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	MAR	2019	63						104	111		10.1016/j.clinbiomech.2019.02.010			8	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	HW6UZ	WOS:000466827500015	30851565				2022-02-06	
J	Vazquez-Rosa, E; Watson, MR; Sahn, JJ; Hodges, TR; Schroeder, RE; Cintron-Perez, CJ; Shin, MK; Yin, TC; Emery, JL; Martin, SF; Liebl, DJ; Pieper, AA				Vazquez-Rosa, Edwin; Watson, Michael R.; Sahn, James J.; Hodges, Timothy R.; Schroeder, Rachel E.; Cintron-Perez, Coral J.; Shin, Min-Kyoo; Yin, Terry C.; Emery, Josie L.; Martin, Stephen F.; Liebl, Daniel J.; Pieper, Andrew A.			Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury	ACS CHEMICAL NEUROSCIENCE			English	Article						Neuroprotection; traumatic brain injury; blast injury; controlled cortical impact injury; sigma 2R/TMEM97	IDENTIFICATION; INCREASES; PROTEIN; DEATH	Compounds targeting the sigma 2 receptor, which we recently cloned and showed to be identical with transmembrane protein 97 (sigma 2R/TMEM97), are broadly applicable therapeutic agents currently in clinical trials for imaging in breast cancer and for treatment of Alzheimers disease and schizophrenia. These promising applications coupled with our previous observation that the sigma 2R/TMEM97 modulator SAS-0132 has neuroprotective attributes and improves cognition in wild-type mice suggests that modulating sigma 2R/TMEM97 may also have therapeutic benefits in other neurodegenerative conditions such as traumatic brain injury (TBI). Herein, we report that DKR-1677, a novel derivative of SAS-0132 with increased affinity and selectivity for sigma 2R/Tmem97 (K-i = 5.1 nM), is neuroprotective after blast-induced and controlled cortical impact (CCI) TBI in mice. Specifically, we discovered that treatment with DKR-1677 decreases axonal degeneration after blast-induced TBI and enhances survival of cortical neurons and oligodendrocytes after CCI injury. Furthermore, treatment with DKR-1677 preserves cognition in the Morris water maze after blast TBI. Our results support an increasingly broad role for sigma 2R/Tmem97 modulation in neuroprotection and suggest a new approach for treating patients suffering from TBI.	[Vazquez-Rosa, Edwin; Schroeder, Rachel E.; Yin, Terry C.; Emery, Josie L.; Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Psychiat, Radiat Biol Program,Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Vazquez-Rosa, Edwin; Schroeder, Rachel E.; Yin, Terry C.; Emery, Josie L.; Pieper, Andrew A.] Univ Iowa, Carver Coll Med, Dept Free Rad, Radiat Biol Program,Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Watson, Michael R.; Liebl, Daniel J.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Sahn, James J.; Hodges, Timothy R.; Martin, Stephen F.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Vazquez-Rosa, Edwin; Cintron-Perez, Coral J.; Shin, Min-Kyoo; Pieper, Andrew A.] Case Western Reserve Univ, Ctr Geriatr Res Educ & Clin, Louis Stokes Cleveland VAMC,Dept Psychiat, Univ Hosp,Case Med Ctr,Harrington Discovery Inst, Cleveland, OH 44106 USA		Pieper, AA (corresponding author), Univ Iowa, Carver Coll Med, Dept Psychiat, Radiat Biol Program,Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.; Pieper, AA (corresponding author), Univ Iowa, Carver Coll Med, Dept Free Rad, Radiat Biol Program,Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.; Liebl, DJ (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA.; Martin, SF (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.; Pieper, AA (corresponding author), Case Western Reserve Univ, Ctr Geriatr Res Educ & Clin, Louis Stokes Cleveland VAMC,Dept Psychiat, Univ Hosp,Case Med Ctr,Harrington Discovery Inst, Cleveland, OH 44106 USA.	sfmartin@mail.utexas.edu; dliebl@miami.edu; Andrew.Pieper@HarringtonDiscovery.org	Martin, Stephen/U-4676-2019	Pieper, Andrew/0000-0001-6299-6577	Brockman Medical Research Foundation; Titan Neurology Research Fund; Department of Veterans Affairs Merit ReviewUS Department of Veterans Affairs [1IO1BX002444]; Robert A. Welch FoundationThe Welch Foundation [F-0652]; Dell Medical School's Texas Health Catalyst program; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS098740]; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098740] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002444] Funding Source: NIH RePORTER	This work was supported by funds to A.A.P. from the Brockman Medical Research Foundation, from an anonymous donor to the Mary Alice Smith Fund for Neuropsychiatry Research, from the Titan Neurology Research Fund, and from the Department of Veterans Affairs Merit Review 1IO1BX002444. The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government. This work was also supported by the Robert A. Welch Foundation (F-0652) to S.F.M., the Dell Medical School's Texas Health Catalyst program to S.F.M. and J.J.S., NIH/NINDS NS098740 to D.J.L., and the Miami Project to Cure Paralysis to D.J.L.	Alon A, 2017, P NATL ACAD SCI USA, V114, P7160, DOI 10.1073/pnas.1705154114; Bartz F, 2009, CELL METAB, V10, P63, DOI 10.1016/j.cmet.2009.05.009; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Ebrahimi-Fakhari D, 2016, HUM MOL GENET, V25, P3588, DOI 10.1093/hmg/ddw204; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Goldstein L. E., 2012, SCI TRANSL MED, V16; Guo L, 2015, CURR MED CHEM, V22, P989, DOI 10.2174/0929867322666150114163607; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang YS, 2014, MED RES REV, V34, P532, DOI 10.1002/med.21297; Izzo NJ, 2014, PLOS ONE, V9; Mach RH, 2013, J MED CHEM, V56, P7137, DOI 10.1021/jm301545c; Madsen T, 2018, JAMA-J AM MED ASSOC, V320, P580, DOI 10.1001/jama.2018.10211; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Martin S. F., 2015, WO, Patent No. [2015009742 A2, 2015009742]; Minerva Neurosciences Inc., 2014, STUD EV EFF SAF TOL; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Osier N, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070088; Petrov AM, 2016, ACTA NATURAE, V8, P58, DOI 10.32607/20758251-2016-8-1-58-73; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sahn JJ, 2017, ACS CHEM NEUROSCI, V8, P1801, DOI 10.1021/acschemneuro.7b00200; Sahn JJ, 2017, ACS MED CHEM LETT, V8, P455, DOI 10.1021/acsmedchemlett.7b00066; Sahn JJ, 2016, CHEMMEDCHEM, V11, P556, DOI 10.1002/cmdc.201500551; Sahn JJ, 2012, ACS COMB SCI, V14, P496, DOI 10.1021/co300068a; Sanchez-Pulido L, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00439; Scott LL, 2018, NEUROPSYCHOPHARMACOL, V43, P1867, DOI 10.1038/s41386-018-0067-z; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Wager TT, 2010, ACS CHEM NEUROSCI, V1, P420, DOI 10.1021/cn100007x; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Yi BN, 2017, J NEUROCHEM, V140, P561, DOI 10.1111/jnc.13917; Yin TC, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0220-16.2016; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030	35	21	21	1	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	MAR	2019	10	3			SI		1595	1602		10.1021/acschemneuro.8b00543			15	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	HQ2VN	WOS:000462259900065	30421909	Green Accepted			2022-02-06	
J	Zhang, H; Yan, XZ; Li, H; Jin, R; Fu, HF				Zhang, Hong; Yan, Xuzhong; Li, Heng; Jin, Rui; Fu, HongFeng			Real-Time Alarming, Monitoring, and Locating for Non-Hard-Hat Use in Construction	JOURNAL OF CONSTRUCTION ENGINEERING AND MANAGEMENT			English	Article						Non-hard-hat use (NHU); Infrared beam detector; Thermal infrared sensor; Radio-frequency identification (RFID); Web and smartphone application; Cloud server; Internet of Things (IoT); Safety inspection	TRAUMATIC BRAIN-INJURIES; SAFETY; WORKERS; VISION; SYSTEM; IDENTIFICATION; BEHAVIOR	Non-hard-hat use (NHU) is related to many construction accidents, so NHU inspection is crucial to safety management, in which automatic NHU monitoring plays an essential role. Existing computer vision-based NHU inspection methods lack capabilities in identifying workers and helping take real-time action. Previous sensor-based NHU inspection methods require direct skin contact, which would be uncomfortable for workers. In addition, previous sensor-based methods could be deceived by objects other than human heads and could not achieve real-time alarms. This study aims to address these problems by implementing real-time alarming, monitoring, and locating for NHU in construction based on sensor, mobile, web, and cloud techniques. A smart hard-hat system is developed using an Internet of Things (IoT)-based architecture including (1) a hard hat with an infrared beam detector and thermal infrared sensor for nonintrusive NHU detection; (2) radio-frequency identification (RFID) triggers for locating NHU with an average detection error of less than 10 cm; (3) a smartphone application for personalized warnings; (4) a web application for data visualization and alarms for managers; and (5) a cloud sever for data storage and retrieval. The proposed system enables both workers and managers to take timely actions against NHU. The system performance is evaluated in a laboratory test and validated in a field application. It is indicated that the proposed system is accurate and reliable, showing potential to promote safety inspection and supervision in construction.	[Zhang, Hong; Yan, Xuzhong; Fu, HongFeng] Zhejiang Univ, Inst Construct Management, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Heng] Hong Kong Polytech Univ, Dept Bldg & Real Estate, Fac Construct & Environm, Hung Hom,Kowloon, 11 Yuk Choi Rd, Hong Kong 999077, Peoples R China; [Jin, Rui] Zhejiang Construct Engn Grp Co Ltd, 232 Wensan Rd, Hangzhou 310058, Zhejiang, Peoples R China		Yan, XZ (corresponding author), Zhejiang Univ, Inst Construct Management, Coll Civil Engn & Architecture, 866 Yuhangtang Rd, Hangzhou 310058, Zhejiang, Peoples R China.	jgzhangh@zju.edu.cn; 11512075@zju.edu.cn; heng.li@polyu.edu.hk; py255650708@126.com; 21712261@zju.edu.cn	Li, Heng/B-2821-2015	Li, Heng/0000-0002-3187-9041			Ball K, 2010, LABOR HIST-UK, V51, P87, DOI 10.1080/00236561003654776; Barro-Torres S, 2012, COMPUT COMMUN, V36, P42, DOI 10.1016/j.comcom.2012.01.005; Cabahug RR, 2014, MINDANAO J SCI TECHN, V12, P12; Cavazza N, 2009, J SAFETY RES, V40, P277, DOI 10.1016/j.jsr.2009.06.002; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Fang Q, 2018, AUTOMAT CONSTR, V85, P1, DOI 10.1016/j.autcon.2017.09.018; Flin R, 2000, SAFETY SCI, V34, P177, DOI 10.1016/S0925-7535(00)00012-6; Fung IWH, 2014, SAFETY SCI, V65, P70, DOI 10.1016/j.ssci.2013.12.014; Giebe K., 2013, ELIMINATING GAPS PPE; Han S, 2013, AUTOMAT CONSTR, V35, P131, DOI 10.1016/j.autcon.2013.05.001; Han S, 2013, J COMPUT CIVIL ENG, V27, P635, DOI 10.1061/(ASCE)CP.1943-5487.0000279; Hume A., 1995, P INT C BIOM IMP; Jeong BY, 1998, APPL ERGON, V29, P355, DOI 10.1016/S0003-6870(97)00077-X; Kanan R, 2018, AUTOMAT CONSTR, V88, P73, DOI 10.1016/j.autcon.2017.12.033; Kelm A, 2013, AUTOMAT CONSTR, V36, P38, DOI 10.1016/j.autcon.2013.08.009; Kim H, 2018, J COMPUT CIVIL ENG, V32, DOI 10.1061/(ASCE)CP.1943-5487.0000731; Kim J, 2018, AUTOMAT CONSTR, V87, P297, DOI 10.1016/j.autcon.2017.12.016; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; Konstantinou E, 2018, J CONSTR ENG M, V144, DOI 10.1061/(ASCE)CO.1943-7862.0001508; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Levitt R. E., 1987, CONSTRUCTION SAFETY; Li H, 2017, AUTOMAT CONSTR, V80, P95, DOI 10.1016/j.autcon.2017.02.006; Lombardi DA, 2009, ACCIDENT ANAL PREV, V41, P755, DOI 10.1016/j.aap.2009.03.017; Marks ED, 2013, CONSTR MANAG ECON, V31, P636, DOI 10.1080/01446193.2013.783705; Martin-Garin A, 2018, AUTOMAT CONSTR, V87, P201, DOI 10.1016/j.autcon.2017.12.017; Park MW, 2016, AUTOMAT CONSTR, V72, P129, DOI 10.1016/j.autcon.2016.08.039; Park MW, 2015, J CONSTR ENG M, V141, DOI 10.1061/(ASCE)CO.1943-7862.0000974; SangUk Han, 2012, Proceedings of the 2012 Construction Research Congress, P1032; Seo J, 2015, ADV ENG INFORM, V29, P239, DOI 10.1016/j.aei.2015.02.001; Shan Du, 2011, 2011 3rd International Conference on Computer Research and Development (ICCRD 2011), P25, DOI 10.1109/ICCRD.2011.5763846; Shrestha K., 2015, J CONSTRUCTION ENG, V2015, P1; Yan XZ, 2017, ADV ENG INFORM, V34, P152, DOI 10.1016/j.aei.2017.11.001; Yan XZ, 2017, AUTOMAT CONSTR, V74, P2, DOI 10.1016/j.autcon.2016.11.007; Yang J, 2011, ADV ENG INFORM, V25, P736, DOI 10.1016/j.aei.2011.04.001; Zhang Z.P., 2009, THESIS	36	21	21	4	69	ASCE-AMER SOC CIVIL ENGINEERS	RESTON	1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA	0733-9364	1943-7862		J CONSTR ENG M	J. Constr. Eng. Manage.	MAR 1	2019	145	3							04019006	10.1061/(ASCE)CO.1943-7862.0001629			13	Construction & Building Technology; Engineering, Industrial; Engineering, Civil	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Construction & Building Technology; Engineering	HJ6BR	WOS:000457268900005					2022-02-06	
J	Lazaridis, C				Lazaridis, Christos			Withdrawal of Life-Sustaining Treatments in Perceived Devastating Brain Injury: The Key Role of Uncertainty	NEUROCRITICAL CARE			English	Article						Brain injury; Decision-making; Disability; Chronic conditions and rehabilitation; End-of-life issues	TRAUMATIC BRAIN; DECISION-MAKING; HEALTH-CARE; DISABILITY PARADOX; NEUROCRITICAL CARE; DISORDERS; CONSCIOUSNESS; COMMUNICATION; SUPPORT; HEURISTICS	BackgroundWithdrawal of life-sustaining treatment (WOLST) is the leading proximate cause of death in patients with perceived devastating brain injury (PDBI). There are reasons to believe that a potentially significant proportion of WOLST decisions, in this setting, are premature and guided by a number of assumptions that falsely confer a sense of certainty.MethodThis manuscript proposes that these assumptions face serious challenges, and that we should replace unwarranted certainty with an appreciation for the great degree of multi-dimensional uncertainty involved. The article proceeds by offering a taxonomy of uncertainty in PDBI and explores the key role that uncertainty as a cognitive state, may play into how WOLST decisions are reached.ConclusionIn order to properly share decision-making with families and surrogates of patients with PDBI, we will have to acknowledge, understand, and be able to communicate the great degree of uncertainty involved.	[Lazaridis, Christos] Univ Chicago, Dept Neurol, Div Neurocrit Care, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Lazaridis, Christos] Univ Chicago, Dept Neurosurg, Div Neurocrit Care, Chicago, IL 60637 USA; [Lazaridis, Christos] Univ Chicago Med, 5841 S Maryland Ave, Chicago, IL 60637 USA		Lazaridis, C (corresponding author), Univ Chicago Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	lazaridis@uchicago.edu		Lazaridis, Christos/0000-0003-1814-4830			Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Bayne T, 2017, ANN NEUROL, V82, P866, DOI 10.1002/ana.25088; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA, V6th; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bernacki RE, 2014, JAMA INTERN MED, V174, P1994, DOI 10.1001/jamainternmed.2014.5271; Bernat J.L., 2016, AJOB NEUROSCIENCE, V7, P46, DOI DOI 10.1080/21507740.2016.1146367; Bernat JL, 2006, LANCET, V367, P1181, DOI 10.1016/S0140-6736(06)68508-5; Blumenthal-Barby JS, 2016, AM J BIOETHICS, V16, P5, DOI 10.1080/15265161.2016.1159750; Blumenthal-Barby JS, 2015, MED DECIS MAKING, V35, P539, DOI 10.1177/0272989X14547740; Brownstein Michael, 2017, STANFORD ENCY PHILOS; Bruno MA, 2011, BMJ-BRIT MED J, V23; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Chatfield DA, 2018, NURS CRIT CARE, V23, P82, DOI 10.1111/nicc.12290; Cochrane TI, 2009, AM J BIOETHICS, V9, P47, DOI 10.1080/15265160902718857; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Creutzfeldt CJ, 2012, STROKE, V43, P3405, DOI 10.1161/STROKEAHA.112.673376; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Dale CM, 2016, ANN AM THORAC SOC, V13, P1115, DOI 10.1513/AnnalsATS.201511-751OC; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Etkind SN, 2016, POSTGRAD MED J, V92, P412, DOI 10.1136/postgradmedj-2015-133371; Feltz A, 2012, J BIOETHIC INQ, V9, P443, DOI 10.1007/s11673-012-9396-5; Fins JJ, 2015, RIGHTS COME MIND BRA; Fins JJ, 2018, BRAIN INJURY, V32, P670, DOI 10.1080/02699052.2018.1430377; Fins JJ, 2018, CAMB Q HEALTHC ETHIC, V27, P163, DOI 10.1017/S0963180117000329; Gendler TS, 2008, J PHILOS, V105, P634, DOI 10.5840/jphil20081051025; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Granger CV, 2009, AM J PHYS MED REHAB, V88, P755, DOI 10.1097/PHM.0b013e3181aa71a8; Han PKJ, 2011, MED DECIS MAKING, V31, P828, DOI 10.1177/0272989X11393976; Harvey D, 2018, BRIT J ANAESTH, V120, P138, DOI 10.1016/j.bja.2017.10.002; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Holloway RG, 2013, NEUROLOGY, V80, P764, DOI 10.1212/WNL.0b013e318282509c; Hwang DY, 2014, J NEUROSCI NURS, V46, P106, DOI 10.1097/JNN.0000000000000038; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Johnson L. Syd, 2016, AJOB NEUROSCIENCE, V7, P35; Johnson LSM, 2013, AM J BIOETH NEUROSCI, V4, P24; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kennedy Andrew D M, 2003, Health Expect, V6, P255, DOI 10.1046/j.1369-6513.2003.00240.x; KITZINGER J, 2013, SOCIOL HEALTH ILL, V35, P1095, DOI DOI 10.1111/1467-9566.12020; Klein A, 2012, NEUROCRIT CARE, V16, P456, DOI 10.1007/s12028-012-9677-1; Klein C, 2015, BR J PHILOS SCI, V68, P27; Koch PM, 2017, INTENS CARE MED, V43, P1518, DOI 10.1007/s00134-017-4819-8; Kondziella D, 2016, J NEUROL NEUROSUR PS, V87, P485, DOI 10.1136/jnnp-2015-310958; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lind R, 2011, INTENS CARE MED, V37, P1143, DOI 10.1007/s00134-011-2253-x; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; McMahan J, 2002, ETHICS KILLING PROBL, P2002; Mishel M H, 1988, Image J Nurs Sch, V20, P225, DOI 10.1111/j.1547-5069.1988.tb00082.x; MISHEL MH, 1984, RES NURS HEALTH, V7, P163, DOI 10.1002/nur.4770070304; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Muehlschlegel S, 2015, NEUROCRIT CARE, V23, P127, DOI 10.1007/s12028-014-0097-2; Naccache L, 2018, BRAIN, V141, P949, DOI 10.1093/brain/awx324; Nelson WL, 2007, MED DECIS MAKING, V27, P609, DOI 10.1177/0272989x07306780; Norton SA, 2003, AM J CRIT CARE, V12, P548, DOI 10.4037/ajcc2003.12.6.548; Pushkarskaya H, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00325; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Schiff ND, 2016, CURR BIOL, V26, pR572, DOI 10.1016/j.cub.2016.02.027; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Shepherd J, 2016, CONSCIOUSNESS SEVERE; Smithson M, 1999, ORGAN BEHAV HUM DEC, V79, P179, DOI 10.1006/obhd.1999.2844; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Steppacher I, 2016, ANN CLIN TRANSL NEUR, V3, P61, DOI 10.1002/acn3.269; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Verkade MA, 2012, NEUROCRIT CARE, V16, P130, DOI 10.1007/s12028-011-9567-y; WATT DF, 2004, TXB BIOL PSYCHIAT, P00075; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Wilkinson D., 2013, DEATH DISABILITY CAR; Wilkinson D, 2018, MONASH BIOETH REV; Wilkinson D, 2009, THEOR MED BIOETH, V30, P401, DOI 10.1007/s11017-009-9120-6; Williams Bernard, 1985, ETHICS LIMITS PHILOS; Zahuranec DB, 2010, NEUROLOGY, V75, P626, DOI 10.1212/WNL.0b013e3181ed9cc9; Zier LS, 2012, ANN INTERN MED, V156, P360, DOI 10.7326/0003-4819-156-5-201203060-00008	76	21	21	1	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2019	30	1					33	41		10.1007/s12028-018-0595-8			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HJ8LA	WOS:000457449700005	30143963				2022-02-06	
J	Zhao, Q; Yan, T; Li, LL; Chopp, M; Venkat, P; Qian, Y; Li, R; Wu, RX; Li, W; Lu, M; Zhang, TL; Chen, JL				Zhao, Qiang; Yan, Tao; Li, Linlin; Chopp, Michael; Venkat, Poornima; Qian, Yu; Li, Ran; Wu, Ruixia; Li, Wei; Lu, Mei; Zhang, Talan; Chen, Jieli			Immune Response Mediates Cardiac Dysfunction after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain-heart interaction; cardiac dysfunction; immune response; splenectomy; traumatic brain injury	HEART INTERACTION; SPLEEN; FIBROSIS; MICE; CARDIOMYOPATHY; CONTRIBUTES; MONOCYTES; IMPACT; DAMAGE; MODEL	Cardiovascular complications are common after traumatic brain injury (TBI) and are associated with increased morbidity and mortality. In this study, we investigated the possible role of the immune system in mediating cardiac dysfunction post-TBI in mice. Adult male C57BL/6J mice were subjected to a TBI model of controlled cortical impact (CCI) with or without splenectomy (n=20/group). Splenectomy was performed immediately prior to induction of TBI. Cardiac function was measured using echocardiography prior to and after TBI. Neurological and cognitive functional tests and flow cytometry and immunostaining were performed. TBI mice exhibited significant cardiac dysfunction identified by decreased left ventricular ejection fraction and fractional shortening at 3 and 30 days post-TBI. In addition, these mice exhibited significantly increased cardiomyocyte apoptosis, inflammation, and oxidative stress at 3 and 30 days post-TBI, as well as cardiac hypertrophy and fibrosis and ventricular dilatation at 30 days after TBI. TBI mice subjected to splenectomy showed significantly improved cardiac function, and decreased cardiac fibrosis, oxidative stress, cardiomyocyte apoptosis, and infiltration of immune cells and inflammatory factor expression in the heart compared with TBI control mice. TBI mice exhibited severe neurological and cognitive function deficits. However, splenectomy did not improve neurological and cognitive functional outcome after TBI compared with the TBI control group. TBI induces immune cell infiltration and inflammatory factor expression in the heart as well as cardiac dysfunction. Splenectomy decreases heart inflammation and improves cardiac function after TBI. Immune response may contribute to TBI-induced cardiac dysfunction.	[Zhao, Qiang; Yan, Tao; Li, Linlin; Qian, Yu; Li, Ran; Wu, Ruixia; Li, Wei] Tianjin Med Univ Gen Hosp, Dept Geriatr, Tianjin, Peoples R China; [Zhao, Qiang; Yan, Tao; Li, Linlin; Qian, Yu; Li, Ran; Wu, Ruixia; Li, Wei] Minist Educ & Tianjin City, Tianjin Neurol Inst, Key Lab Post Neurotrauma Neurorepair & Regenerat, Neurol, Tianjin, Peoples R China; [Chopp, Michael; Venkat, Poornima; Li, Wei; Chen, Jieli] Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA; [Lu, Mei; Zhang, Talan] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA		Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.; Yan, T (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurol, 154 Anshan Rd, Tianjin 300052, Peoples R China.	yantao78@hotmail.com; jchen4@hfhs.org	Venkat, Poornima/ABF-1558-2020; Yan, Tao/B-2930-2012	Venkat, Poornima/0000-0001-8938-663X; Yan, Tao/0000-0003-3138-4468	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300993, 81571145, 81671144]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [17JCZDJC36100]	This work was supported by the National Natural Science Foundation of China grant 81300993, 81571145, and 81671144 and Tianjin Natural Science Foundation Grant 17JCZDJC36100.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Braunersreuther V, 2013, J MOL CELL CARDIOL, V64, P99, DOI 10.1016/j.yjmcc.2013.09.007; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Chaikittisilpa N, 2018, J NEUROSCI RES, V96, P661, DOI 10.1002/jnr.24100; Chen JL, 2017, TRANSL STROKE RES, V8, P374, DOI 10.1007/s12975-017-0520-z; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Cui X, 2016, STROKE, V47, P214, DOI 10.1161/STROKEAHA.115.011046; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Fujiu K, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0357-x; GALINANES M, 1992, CIRC RES, V71, P1213, DOI 10.1161/01.RES.71.5.1213; GREENHOO.JH, 1969, J NEUROSURG, V30, P521, DOI 10.3171/jns.1969.30.5.0521; Ismahil MA, 2014, CIRC RES, V114, P266, DOI 10.1161/CIRCRESAHA.113.301720; Jiang HM, 2013, AM J HYPERTENS, V26, P1224, DOI 10.1093/ajh/hpt095; Kim E, 2014, J CEREBR BLOOD F MET, V34, P1411, DOI 10.1038/jcbfm.2014.101; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Liu YQ, 2015, INT J CLIN EXP PATHO, V8, P10908; Lunde IG, 2016, CELL TISSUE RES, V365, P539, DOI 10.1007/s00441-016-2454-2; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Manea M M, 2015, J Med Life, V8, P266; Mazzeo AT, 2014, BRIT J ANAESTH, V112, P803, DOI 10.1093/bja/aeu046; Mewhort HEM, 2016, AM J PHYSIOL-HEART C, V310, pH716, DOI 10.1152/ajpheart.00309.2015; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566; Najafipour Hamid, 2014, Iranian Biomedical Journal, V18, P225, DOI 10.6091/ibj.13222.2014; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Qian R, 2015, AM J CARDIOVASC DIS, V5, P72; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tian YK, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0583-0; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Venkat P, 2017, NEUROBIOL AGING, V50, P96, DOI 10.1016/j.neurobiolaging.2016.11.002; Weledji EP, 2014, INT J SURG, V12, P113, DOI 10.1016/j.ijsu.2013.11.017; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zierath D, 2017, STROKE, V48, P497, DOI 10.1161/STROKEAHA.116.016037; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0	46	21	24	2	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					619	629		10.1089/neu.2018.5766			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000459448300012	30045672				2022-02-06	
J	Chen, CH; Zhong, XL; Smith, DK; Tai, WJ; Yang, JJ; Zou, YH; Wang, LL; Sun, JH; Qin, S; Zhang, CL				Chen, Chunhai; Zhong, Xiaoling; Smith, Derek K.; Tai, Wenjiao; Yang, Jianjing; Zou, Yuhua; Wang, Lei-Lei; Sun, Jiahong; Qin, Song; Zhang, Chun-Li			Astrocyte-Specific Deletion of Sox2 Promotes Functional Recovery After Traumatic Brain Injury	CEREBRAL CORTEX			English	Article						brain repair; neural stem cell; reactive gliosis; SOX2; traumatic brain injury	NEURAL STEM-CELLS; CONTROLLED CORTICAL IMPACT; NUCLEAR RECEPTOR TLX; ADULT SPINAL-CORD; REACTIVE ASTROCYTES; SCAR FORMATION; GLIAL PROLIFERATION; SIGNALING PATHWAY; ACTIVATION; EXPRESSION	Injury to the adult brain induces activation of local astrocytes, which serves as a compensatory response that modulates tissue damage and recovery. However, the mechanism governing astrocyte activation during brain injury remains largely unknown. Here we provide in vivo evidence that SOX2, a transcription factor critical for stem cells and brain development, is also required for injury-induced activation of adult cortical astrocytes. Genome-wide chromatin immunoprecipitation-seq analysis of mouse cortical tissues reveals that SOX2 binds to regulatory regions of genes associated with signaling pathways that control glial cell activation, such as Nr2e1, Mmd2, Wnt7a, and Akt2. Astrocyte-specific deletion of Sox2 in adult mice greatly diminishes glial response to controlled cortical impact injury and, most unexpectedly, dampens injury-induced cortical loss and benefits behavioral recovery of mice after injury. Together, these results uncover an essential role of SOX2 in somatic cells under pathological conditions and indicate that SOX2-dependent astrocyte activation could be targeted for functional recovery after traumatic brain injury.	[Chen, Chunhai; Zhong, Xiaoling; Smith, Derek K.; Tai, Wenjiao; Yang, Jianjing; Zou, Yuhua; Wang, Lei-Lei; Sun, Jiahong; Qin, Song; Zhang, Chun-Li] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Chen, Chunhai; Zhong, Xiaoling; Smith, Derek K.; Tai, Wenjiao; Yang, Jianjing; Zou, Yuhua; Wang, Lei-Lei; Sun, Jiahong; Qin, Song; Zhang, Chun-Li] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Chen, Chunhai] Third Mil Med Univ, Dept Occupat Hlth, Chongqing 400038, Peoples R China; [Qin, Song] Fudan Univ, Sch Basic Med Sci, Dept Anat Histol & Embryol, Shanghai 200032, Peoples R China; [Qin, Song] Tongji Univ, Shanghai Peoples Hosp 10, Ctr Neural Injury & Repair, Shanghai 200072, Peoples R China		Qin, S; Zhang, CL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.; Qin, S (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Anat Histol & Embryol, Shanghai 200032, Peoples R China.; Qin, S (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Ctr Neural Injury & Repair, Shanghai 200072, Peoples R China.	sqin@fudan.edu.cn; Chun-Li.Zhang@UTSouthwestern.edu	Qin, Song/AAK-5489-2021	Qin, Song/0000-0002-5569-4324; Chen, Chunhai/0000-0002-7549-213X; Zhong, Xiaoling/0000-0003-2963-4798; Zhang, Chun-Li/0000-0002-2639-4605	Welch FoundationThe Welch Foundation [I-1724]; Texas Institute for Brain Injury and Repair; Decherd Foundation; Kent Waldrep Foundation Center for Basic Research on Nerve Growth and Regeneration; Mobility Foundation; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS070981, NS099073, NS088095, NS092616, NS093502]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81528006]; National Key Basic Research Program of China (973 Program)National Basic Research Program of China [2014CB965001]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [1501219100]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088095, R21NS093502, R01NS070981, R01NS092616, R01NS099073] Funding Source: NIH RePORTER	The work in the Zhang laboratory was supported by Welch Foundation (I-1724), Texas Institute for Brain Injury and Repair, Decherd Foundation, Kent Waldrep Foundation Center for Basic Research on Nerve Growth and Regeneration, Mobility Foundation, National Institutes of Health (NS070981, NS099073, NS088095, NS092616, and NS093502) and National Natural Science Foundation of China (No. 81528006). The work in the Qin laboratory was supported by grants from National Key Basic Research Program of China (973 Program, No. 2014CB965001), National Natural Science Foundation of China (No. 81528006), and Fundamental Research Funds for the Central Universities (No. 1501219100).	Adhikari A, 2011, NEURON, V71, P898, DOI 10.1016/j.neuron.2011.07.027; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Benner EJ, 2013, NATURE, V497, P369, DOI 10.1038/nature12069; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen YC, 2012, NEUROL RES, V34, P390, DOI 10.1179/1743132812Y.0000000027; Chen YC, 2012, BIOCHEM BIOPH RES CO, V420, P397, DOI 10.1016/j.bbrc.2012.03.006; Choi I, 2013, GLIA, V61, P800, DOI 10.1002/glia.22475; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guo FZ, 2011, J NEUROSCI, V31, P11914, DOI 10.1523/JNEUROSCI.1759-11.2011; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Heinrich C, 2014, STEM CELL REP, V3, P1000, DOI 10.1016/j.stemcr.2014.10.007; Huang XT, 2013, J NEUROTRAUM, V30, P2080, DOI 10.1089/neu.2013.2996; Islam MM, 2015, STEM CELL REP, V5, P805, DOI 10.1016/j.stemcr.2015.09.015; Jeong SR, 2012, EXP NEUROL, V233, P312, DOI 10.1016/j.expneurol.2011.10.021; Jin T, 2012, CELL RES, V22, P661, DOI 10.1038/cr.2011.161; Kang P, 2012, NEURON, V74, P79, DOI 10.1016/j.neuron.2012.01.024; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lang HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep13383; Lang HN, 2011, JARO-J ASSOC RES OTO, V12, P151, DOI 10.1007/s10162-010-0244-1; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Lee HJ, 2013, J NEUROSCI RES, V91, P196, DOI 10.1002/jnr.23151; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; Niu WZ, 2013, NAT CELL BIOL, V15, P1164, DOI 10.1038/ncb2843; Niu WZ, 2011, J NEUROSCI, V31, P13816, DOI 10.1523/JNEUROSCI.1038-11.2011; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Qin S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00074; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Shaham O, 2009, DEVELOPMENT, V136, P2567, DOI 10.1242/dev.032888; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Shimozaki K, 2012, J BIOL CHEM, V287, P5969, DOI 10.1074/jbc.M111.290403; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Su ZD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4338; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang LL, 2016, CELL REP, V17, P891, DOI 10.1016/j.celrep.2016.09.038; Wang TW, 2006, J COMP NEUROL, V497, P88, DOI 10.1002/cne.20984; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xie ZF, 2016, CELL MOL NEUROBIOL, V36, P93, DOI 10.1007/s10571-015-0223-5; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang CC, 2012, BRAIN INJURY, V26, P1185, DOI 10.3109/02699052.2012.666374; Yang JL, 2016, GLIA, V64, P1083, DOI 10.1002/glia.22984; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao C, 2015, J NEUROSCI, V35, P11482, DOI 10.1523/JNEUROSCI.3655-14.2015	84	21	22	2	12	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	JAN	2019	29	1					54	69		10.1093/cercor/bhx303			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM5LZ	WOS:000459518500005	29161339	Green Published, Bronze			2022-02-06	
J	He, ZJ; Zang, HX; Zhu, L; Huang, K; Yi, TL; Zhang, S; Cheng, SX				He, Zhijiang; Zang, Hongxin; Zhu, Lei; Huang, Kui; Yi, Tailong; Zhang, Sai; Cheng, Shixiang			An anti-inflammatory peptide and brain-derived neurotrophic factor-modified hyaluronan-methylcellulose hydrogel promotes nerve regeneration in rats with spinal cord injury	INTERNATIONAL JOURNAL OF NANOMEDICINE			English	Article						hyaluronan-methylcellulose hydrogel; anti-inflammatory peptide; neuroprotection; spinal cord injury	CELL-PENETRATING PEPTIDES; NEURAL STEM-CELLS; FUNCTIONAL RECOVERY; GENE-THERAPY; DELIVERY; GROWTH; METHYLPREDNISOLONE; BIOMATERIALS; INFILTRATION; INHIBITION	Background: Traumatic spinal cord injury (SCI) causes neuronal death, demyelination, axonal degeneration, inflammation, glial scar formation, and cystic cavitation resulting in interruption of neural signaling and loss of nerve function. Multifactorial targeted therapy is a promising strategy for SCI. Methods: The anti-inflammatory peptide KAFAKLAARLYRKALARQLGVAA (KAFAK) and brain-derived neurotrophic factor (BDNF)-modified hyaluronan-methylcellulose (HAMC) hydrogel was designed for minimally invasive, localized, and sustained intrathecal protein delivery. The physical and biological characteristics of HAMC-KAFAK/BDNF hydrogel were measured in vitro. SCI model was performed in rats and HAMC-KAFAK/BDNF hydrogel was injected into the injured site of spinal cord. The neuronal regeneration effect was evaluated by inflammatory cytokine levels, behavioral test and histological analysis at 8 weeks post operation. Results: HAMC-KAFAK/BDNF hydrogel showed minimally swelling property and sustained release of the KAFAK and BDNF. HAMC-KAFAK/BDNF hydrogel significantly improved the proliferation of PC12 cells in vitro without cytotoxicity. Significant recovery in both neurological function and nerve tissue morphology in SCI rats were observed in HAMC-KAFAK/BDNF group. HAMC-KAFAK/BDNF group showed significant reduction in proinflammatory cytokines expression and cystic cavitation, decreased glial scar formation, and improved neuronal survival in the rat SCI model compared to HAMC group and SCI group. Conclusion: The HAMC-KAFAK/BDNF hydrogel promotes functional recovery of rats with spinal cord injury by regulating inflammatory cytokine levels and improving axonal regeneration.	[He, Zhijiang; Huang, Kui] Logist Univ, Chinese Peoples Armed Police Force PAP, Tianjin 300309, Peoples R China; [Zang, Hongxin] Chinese Peoples Armed Police Force PAP, Dept Nursing, Characterist Med Ctr, Tianjin 300162, Peoples R China; [Zhu, Lei] Chinese Peoples Armed Police Force PAP, Characterist Med Ctr, Dept Orthopaed, Tianjin 300162, Peoples R China; [Yi, Tailong; Zhang, Sai; Cheng, Shixiang] Chinese Peoples Armed Police Force PAP, Inst TBI & Neurosci, Tianjin Key Lab Neurotrauma Repair, Characterist Med Ctr, 220 ChengLin Rd, Tianjin 300162, Peoples R China		Zhang, S; Cheng, SX (corresponding author), Chinese Peoples Armed Police Force PAP, Inst TBI & Neurosci, Tianjin Key Lab Neurotrauma Repair, Characterist Med Ctr, 220 ChengLin Rd, Tianjin 300162, Peoples R China.	zhangsai718@vip.126.com; shixiangcheng@vip.126.com		Zhu, Lei/0000-0002-6043-7162; cheng, shixiang/0000-0003-4643-2899	National Natural Science Foundation Major Program of ChinaNational Natural Science Foundation of China (NSFC) [81891003]; Science & Technology Program of Tianjin, China [15ZXLCSY00040, 16ZXHLSY00120]; Tianjin Municipal Natural Science FoundationNatural Science Foundation of Tianjin [17JCYBJC25700];  [AWS15J001]	This study was supported by the National Natural Science Foundation Major Program of China (81891003), the Science & Technology Program of Tianjin, China (15ZXLCSY00040, 16ZXHLSY00120), the Technology Research Projects (AWS15J001), and the Tianjin Municipal Natural Science Foundation (17JCYBJC25700).	An YH, 2006, BIOMED MATER, V1, pR38, DOI 10.1088/1748-6041/1/2/R02; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bartlett RL, 2013, NANOMED-NANOTECHNOL, V9, P419, DOI 10.1016/j.nano.2012.09.003; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Brugnano JL, 2011, J CONTROL RELEASE, V155, P128, DOI 10.1016/j.jconrel.2011.05.007; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Coll-Miro M, 2016, P NATL ACAD SCI USA, V113, P1411, DOI 10.1073/pnas.1523212113; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Fouad K, 2009, J NEUROTRAUM, V26, P733, DOI 10.1089/neu.2008.0730; Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015; Haggerty AE, 2013, NEUROSCI BULL, V29, P445, DOI 10.1007/s12264-013-1362-7; Hamers FPT, 2006, J NEUROTRAUM, V23, P537, DOI 10.1089/neu.2006.23.537; Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033; Kramer AS, 2013, CELL TRANSPLANT, V22, P571, DOI 10.3727/096368912X655208; Lacroix S, 2002, J COMP NEUROL, V454, P213, DOI 10.1002/cne.10407; Hong LTA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00583-8; Lin JB, 2016, NANOMED-NANOTECHNOL, V12, P2095, DOI 10.1016/j.nano.2016.05.010; Liu SW, 2017, ACTA BIOMATER, V60, P167, DOI 10.1016/j.actbio.2017.07.024; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Moon YJ, 2012, J NEUROSCI RES, V90, P243, DOI 10.1002/jnr.22734; Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002; Oh JS, 2012, NEUROREPORT, V23, P174, DOI 10.1097/WNR.0b013e32834f4f3a; Orr MB, 2018, NEUROTHERAPEUTICS, V15, P541, DOI 10.1007/s13311-018-0631-6; Pertici V, 2014, BIOMATERIALS, V35, P6248, DOI 10.1016/j.biomaterials.2014.04.020; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Reinhold AK, 2017, PFLUG ARCH EUR J PHY, V469, P123, DOI 10.1007/s00424-016-1920-8; Ritfeld GJ, 2015, CELL TRANSPLANT, V24, P2209, DOI 10.3727/096368915X686201; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Ropper AE, 2017, NEW ENGL J MED, V376, P1358, DOI 10.1056/NEJMra1516539; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Song ZJ, 2018, BIOCHEM BIOPH RES CO, V496, P911, DOI 10.1016/j.bbrc.2018.01.123; Tam RY, 2012, J MATER CHEM, V22, P19402, DOI 10.1039/c2jm33680d; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tsintou M, 2015, NEURAL REGEN RES, V10, P726, DOI 10.4103/1673-5374.156966; Wakao N, 2011, NEUROSCI LETT, V488, P299, DOI 10.1016/j.neulet.2010.11.051; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Xu HL, 2018, INT J NANOMED, V13, P681, DOI 10.2147/IJN.S152246; Xu J, 1998, MOL BRAIN RES, V59, P135, DOI 10.1016/S0169-328X(98)00142-9; Yao SL, 2018, INT J NANOMED, V13, P2883, DOI 10.2147/IJN.S159356; Yong CS, 2001, INT J PHARM, V226, P195, DOI 10.1016/S0378-5173(01)00809-2; Ziemba AM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00245	47	21	26	7	27	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2013			INT J NANOMED	Int. J. Nanomed.		2019	14						721	732		10.2147/IJN.S187854			12	Nanoscience & Nanotechnology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Pharmacology & Pharmacy	HH9OJ	WOS:000456068000002	30705588	Green Published, gold, Green Submitted			2022-02-06	
J	Kleffelgaard, I; Soberg, HL; Tamber, AL; Bruusgaard, KA; Pripp, AH; Sandhaug, M; Langhammer, B				Kleffelgaard, Ingerid; Soberg, Helene Lundgaard; Tamber, Anne-Lise; Bruusgaard, Kari Anette; Pripp, Are Hugo; Sandhaug, Maria; Langhammer, Birgitta			The effects of vestibular rehabilitation on dizziness and balance problems in patients after traumatic brain injury: a randomized controlled trial	CLINICAL REHABILITATION			English	Article						Dizziness; neurological rehabilitation; physical therapy; postural balance; traumatic brain injury	MOBILITY ASSESSMENT-TOOL; HOSPITAL ANXIETY; HEAD-INJURY; CONCUSSION; DISORDERS; VALIDITY; VERTIGO; SYSTEM; SCALE	Objective: To investigate the effects of group-based vestibular rehabilitation in patients with traumatic brain injury. Design: A single-blind randomized controlled trial. Setting: University Hospital (recruitment and baseline assessments) and Metropolitan University (experimental intervention). Subjects: A total of 65 patients (45 women) with mild-to-moderate traumatic brain injury (mean age 39.4 +/- 13.0 years) were randomly assigned to intervention (n = 33) or control group (n = 32). Intervention: Group-based vestibular rehabilitation for eight weeks. Participants were tested at baseline (3.5 +/- 2.1 months after injury) and at two post-intervention follow-ups (2.7 +/- 0.8 and 4.4 +/- 1.0 months after baseline testing). Main measures: Primary outcome: Dizziness Handicap Inventory. Secondary outcome: High-Level Mobility Assessment Tool. Other outcomes: Vertigo Symptom Scale; Rivermead Post-concussion Symptoms Questionnaire; Hospital Anxiety and Depression Scale; and Balance Error Scoring System. Between-group differences were analyzed with a linear mixed-model analysis for repeated measurements. Results: At baseline, no group differences were revealed (personal factors, clinical characteristics and outcome measures). At the first follow-up, statistically significant mean differences in favor of the intervention were found in the primary (-8.7, 95% confidence interval (CI): -16.6 to -0.9) and secondary outcomes (3.7 points, 95% CI: 1.4-6.0). At the second follow-up, no significant between-group differences were found. No significant between-group differences in the other outcomes were found at the two follow-ups. Conclusion: The intervention appeared to speed up recovery for patients with dizziness and balance problems after traumatic brain injury. However, the benefits had dissipated two months after the end of the intervention.	[Kleffelgaard, Ingerid; Soberg, Helene Lundgaard] Oslo Univ Hosp, Dept Phys Med & Rehabil, Postboks 4950, N-0424 Oslo, Norway; [Kleffelgaard, Ingerid; Soberg, Helene Lundgaard; Tamber, Anne-Lise; Bruusgaard, Kari Anette; Pripp, Are Hugo; Langhammer, Birgitta] Oslo Metropolitan Univ, Fac Hlth Sci, Oslo, Norway; [Kleffelgaard, Ingerid] Univ Oslo, Fac Med, Oslo, Norway; [Pripp, Are Hugo] Oslo Univ Hosp, Res Support Serv, Oslo Ctr Biostat & Epidemiol, Oslo, Norway; [Sandhaug, Maria] Statped, Dept Res, Oslo, Norway; [Langhammer, Birgitta] Sunnaas Rehabil Hosp, Nesoddtangen, Norway		Kleffelgaard, I (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Postboks 4950, N-0424 Oslo, Norway.	ingerid.kleffelgard@ous-hf.no	Langhammer, Birgitta/P-1765-2019	Langhammer, Birgitta/0000-0002-9639-0570	Oslo Metropolitan University	We would like to thank all the participants who took part in the study. We thank the physiatrists Nada Andelic, Torgeir Hellstrom and Fredrik Walter Smith who took part in the recruitment of participants to this study. Furthermore, we are grateful to the multidisciplinary traumatic brain injury rehabilitation team at Oslo University Hospital and the colleagues at Oslo Metropolitan University for collaboration and support during the study. We would also like to thank Oslo Metropolitan University for the funding of the study and for providing necessary equipment and facilities for the intervention.	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Arshad Q, 2017, CLIN NEUROL NEUROSUR, V155, P17, DOI 10.1016/j.clineuro.2017.01.021; Bandura A., 1997, SELF EFFICACY EXERCI; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Herdman SJ, 2014, VESTIBULAR REHABILIT; Hilton MP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003162.pub3; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleffelgaard I, 2018, EUR J PHYSIOTHER, V20, P25, DOI 10.1080/21679169.2017.1352020; Kleffelgaard I, 2016, PHYS THER, V96, P839, DOI 10.2522/ptj.20150095; Kleffelgaard I, 2013, PHYS THER, V93, P900, DOI 10.2522/ptj.20120381; Kurre A, 2010, BMC EAR NOSE THROAT, V10, DOI 10.1186/1472-6815-10-3; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Quatman-Yates C, 2016, PHYS THER, V96, P1753, DOI 10.2522/ptj.20150557; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Shumway-Cook A, 2017, MOTOR CONTROL TRANSL, V5th; Tamber AL, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-101; Vikane E, 2017, BRAIN INJURY, V31, P475, DOI 10.1080/02699052.2017.1280852; Wilhelmsen K, 2008, BMC EAR NOSE THROAT, V8, DOI 10.1186/1472-6815-8-2; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2009, INT J THER REHABIL, V16, P370, DOI 10.12968/ijtr.2009.16.7.43046; Yorke A., 2013, ARCH PHYS MED REHAB, V94, P2313, DOI [10.1016/j.apmr.2013.07.007, DOI 10.1016/J.APMR.2013.07.007]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	21	22	0	14	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JAN	2019	33	1					74	84		10.1177/0269215518791274			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	HF8VW	WOS:000454521300009	30056743				2022-02-06	
S	Verkhratsky, A; Ho, MS; Vardjan, N; Zorec, R; Parpura, V		Verkhratsky, A; Ho, MS; Zorec, R; Parpura, V		Verkhratsky, Alexei; Ho, Margaret S.; Vardjan, Nina; Zorec, Robert; Parpura, Vladimir			General Pathophysiology of Astroglia	NEUROGLIA IN NEURODEGENERATIVE DISEASES	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Astrocyte; Neuropathology; Alexander disease; Stroke; Psychiatric diseases; Metabolic diseases; Neurotrauma; Infectious diseases; Systemic	FIBRILLARY ACIDIC PROTEIN; ASTROCYTE GLUTAMINE-SYNTHETASE; DORSOLATERAL PREFRONTAL CORTEX; UP-REGULATES EXPRESSION; GLIAL-CELL DENSITY; REACTIVE ASTROCYTES; ELDERLY-PATIENTS; SENSORINEURAL DEAFNESS; GLUTATHIONE METABOLISM; INFLAMMATORY RESPONSES	Astroglial cells are involved in most if not in all pathologies of the brain. These cells can change the morpho-functional properties in response to pathology or innate changes of these cells can lead to pathologies. Overall pathological changes in astroglia are complex and diverse and often vary with different disease stages. We classify astrogliopathologies into reactive astrogliosis, astrodegeneration with astroglial atrophy and loss of function, and pathological remodelling of astrocytes. Such changes can occur in neurological, neurodevelopmental, metabolic and psychiatric disorders as well as in infection and toxic insults. Mutation in astrocyte-specific genes leads to specific pathologies, such as Alexander disease, which is a leukodystrophy. We discuss changes in astroglia in the pathological context and identify some molecular entities underlying pathology. These entities within astroglia may repent targets for novel therapeutic intervention in the management of brain pathologies.	[Verkhratsky, Alexei] Univ Manchester, Fac Biol Med & Hlth, Oxford Rd, Manchester M13 9PT, Lancs, England; [Verkhratsky, Alexei] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, DK-2200 Copenhagen, Denmark; [Verkhratsky, Alexei] Basque Fdn Sci, Achucarro Ctr Neurosci, Ikerbasque, Bilbao 48011, Spain; [Ho, Margaret S.] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Vardjan, Nina; Zorec, Robert] Univ Ljubljana, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Fac Med, Ljubljana, Slovenia; [Vardjan, Nina; Zorec, Robert] Celica BIOMED, Ljubljana, Slovenia; [Parpura, Vladimir] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA		Verkhratsky, A (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Oxford Rd, Manchester M13 9PT, Lancs, England.; Verkhratsky, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, DK-2200 Copenhagen, Denmark.; Verkhratsky, A (corresponding author), Basque Fdn Sci, Achucarro Ctr Neurosci, Ikerbasque, Bilbao 48011, Spain.	Alexej.Verkhratsky@manchester.ac.uk	Vardjan, Nina/AAP-1496-2021; Zorec, Robert/AAD-7180-2021; Verkhratsky, Alexei/J-4527-2013; Ho, Margaret/K-6310-2017	Zorec, Robert/0000-0002-7478-3875; Verkhratsky, Alexei/0000-0003-2592-9898; Ho, Margaret/0000-0002-2387-7564	National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM123971]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM123971] Funding Source: NIH RePORTER	VP's work is supported by a grant from the National Institute of General Medical Sciences of the National Institutes of Health (R01GM123971). VP is an Honorary Professor at University of Rijeka, Croatia.	Achucarro N., 1910, B GOV HOSP INSANE, V2, P81; Alberdi E, 2013, AGING CELL, V12, P292, DOI 10.1111/acel.12054; Albrecht J, 2010, BIOCHEM PHARMACOL, V80, P1303, DOI 10.1016/j.bcp.2010.07.024; ALEXANDER WS, 1949, BRAIN, V72, P373, DOI 10.1093/brain/72.3.373; Allen JW, 2001, BRAIN RES, V894, P131, DOI 10.1016/S0006-8993(01)01988-6; Alzheimer A, 1910, HISTOLOGISCHE HISTOP, P401; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Andriezen W L, 1893, Br Med J, V2, P227; Armstrong V, 2004, EUR J PHARMACOL, V488, P111, DOI 10.1016/j.ejphar.2004.02.001; Aronica E, 2013, NEUROCHEM INT, V63, P688, DOI 10.1016/j.neuint.2013.01.028; Aronica E, 2011, EPILEPSIA, V52, P1645, DOI 10.1111/j.1528-1167.2011.03115.x; Baker DA, 2008, NEUROPSYCHOPHARMACOL, V33, P1760, DOI 10.1038/sj.npp.1301532; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; Basler T, 2002, INTENS CARE MED, V28, P293, DOI 10.1007/s00134-002-1217-6; Bauer D, 2008, SCHIZOPHR RES, V104, P108, DOI 10.1016/j.schres.2008.06.012; Bauer D, 2010, SCHIZOPHR RES, V117, P92, DOI 10.1016/j.schres.2009.07.025; Bechtholt-Gompf AJ, 2010, NEUROPSYCHOPHARMACOL, V35, P2049, DOI 10.1038/npp.2010.74; Bedner P, 2015, BRAIN, V138, P1208, DOI 10.1093/brain/awv067; Benedetti B, 2011, J PHYSIOL-LONDON, V589, P1159, DOI 10.1113/jphysiol.2010.203224; Bernard R, 2011, MOL PSYCHIATR, V16, P634, DOI 10.1038/mp.2010.44; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Boison D, 2015, NEUROPHARMACOLOGY, V97, P18, DOI 10.1016/j.neuropharm.2015.04.031; Bordey A, 1998, EPILEPSY RES, V32, P286, DOI 10.1016/S0920-1211(98)00059-X; Bowers MS, 2003, EUR J NEUROSCI, V17, P1273, DOI 10.1046/j.1460-9568.2003.02537.x; Bowley MP, 2002, BIOL PSYCHIAT, V52, P404, DOI 10.1016/S0006-3223(02)01404-X; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Braun K, 2009, NEUROSCIENCE, V160, P629, DOI 10.1016/j.neuroscience.2009.02.074; Breslin K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006151; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Burnstock G, 2011, CURR TOP MED CHEM, V11, P973, DOI 10.2174/156802611795347627; Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228; Buttner Andreas, 2006, Forensic Sci Med Pathol, V2, P115, DOI 10.1385/FSMP:2:2:115; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Cao B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4951; Capuani C, 2016, EMBO MOL MED, V8, P967, DOI 10.15252/emmm.201505944; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Cekanaviciute E, 2016, NEUROTHERAPEUTICS, V13, P685, DOI 10.1007/s13311-016-0477-8; Cellot G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00070; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Chepkova AN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40190; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Combes V, 2012, TRENDS PARASITOL, V28, P311, DOI 10.1016/j.pt.2012.05.008; COSTELLO JM, 1977, AUST PAEDIATR J, V13, P114; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; Cullen K M, 1994, Alcohol Alcohol Suppl, V2, P253; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Czeh B, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00056; Czeh B, 2013, EUR NEUROPSYCHOPHARM, V23, P171, DOI 10.1016/j.euroneuro.2012.04.017; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; de Carvalho ACC, 1998, BRAIN RES, V790, P304, DOI 10.1016/S0006-8993(97)01523-0; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Demarque M, 2004, J NEUROSCI, V24, P3289, DOI 10.1523/JNEUROSCI.5338-03.2004; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Dong L, 2015, PSYCHOPHARMACOLOGY B; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Eid T, 2013, NEUROCHEM INT, V63, P670, DOI 10.1016/j.neuint.2013.06.008; El-Hage N, 2011, IMMUNOL INVEST, V40, P498, DOI 10.3109/08820139.2011.561904; Esen N, 2004, J NEUROCHEM, V88, P746, DOI 10.1046/j.1471-4159.2003.02202.x; Esen N, 2007, GLIA, V55, P104, DOI 10.1002/glia.20438; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; FALKAI P, 1986, EUR ARCH PSY CLIN N, V236, P154, DOI 10.1007/BF00380943; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fatemi SH, 2008, SYNAPSE, V62, P501, DOI 10.1002/syn.20519; Fattore L, 2002, NEUROSCIENCE, V110, P1, DOI 10.1016/S0306-4522(01)00598-X; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Ferrer, 2018, NEUROGLIA, V1, P126, DOI [10.3390/neuroglia1010010, DOI 10.3390/NEUROGLIA1010010]; FRANKE H, 1995, ACTA HISTOCHEM, V97, P263, DOI 10.1016/S0065-1281(11)80187-X; Friend DM, 2013, J NEUROCHEM, V125, P566, DOI 10.1111/jnc.12201; Frommann C, 1878, UNTERSUCHUNGEN GEWEB; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144; Giovedi S, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00094; Gleichman AJ, 2014, NEUROSCI LETT, V565, P47, DOI 10.1016/j.neulet.2013.10.055; Gorg B, 2010, GLIA, V58, P691, DOI 10.1002/glia.20955; Gray LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090620; Guilarte TR, 2003, NEUROSCIENCE, V122, P499, DOI 10.1016/S0306-4522(03)00476-7; Gunnarson E, 2005, NEUROSCIENCE, V136, P105, DOI 10.1016/j.neuroscience.2005.07.027; Haack N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105832; Haberle J, 2011, MOL GENET METAB, V103, P89, DOI 10.1016/j.ymgme.2011.02.001; Harvey BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022135; Heming N, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1643-z; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Hinterkeuser S, 2000, EUR J NEUROSCI, V12, P2087, DOI 10.1046/j.1460-9568.2000.00104.x; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Iovino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068408; Jacobs S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-132; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kadoi Y, 1996, CRIT CARE MED, V24, P298, DOI 10.1097/00003246-199602000-00020; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Karlsen AS, 2011, CEREB CORTEX, V21, P2519, DOI 10.1093/cercor/bhr033; Karlsson RM, 2008, BIOL PSYCHIAT, V64, P810, DOI 10.1016/j.biopsych.2008.05.001; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Kelly T, 2010, J NEUROCHEM, V115, P1123, DOI 10.1111/j.1471-4159.2010.07009.x; Kelly T, 2009, GLIA, V57, P921, DOI 10.1002/glia.20817; Kidd SA, 2014, PEDIATRICS, V134, P995, DOI 10.1542/peds.2013-4301; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Koss WA, 2012, BRAIN RES, V1466, P24, DOI 10.1016/j.brainres.2012.05.023; Krencik R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5645; Lanciotti A, 2013, TRANSL NEUROSCI, V4, P144, DOI 10.2478/s13380-013-0118-1; Larsen BR, 2014, GLIA, V62, P608, DOI 10.1002/glia.22629; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Li TF, 2007, NEURON GLIA BIOL, V3, P353, DOI 10.1017/S1740925X0800015X; Li TF, 2008, NEURON GLIA BIOL, V4, P91, DOI 10.1017/S1740925X09990135; Liang CG, 2014, NEUROCHEM RES, V39, P2127, DOI 10.1007/s11064-014-1406-z; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Liu Z, 2015, AMINO ACIDS, V47, P1045, DOI 10.1007/s00726-015-1936-y; LOTHMAN EW, 1976, ELECTROEN CLIN NEURO, V41, P253, DOI 10.1016/0013-4694(76)90118-8; MAKAR TK, 1994, J NEUROCHEM, V62, P45; Marcaggi P, 2001, PROG NEUROBIOL, V64, P157, DOI 10.1016/S0301-0082(00)00043-5; Marin-Valencia I, 2010, MOL GENET METAB, V101, P9, DOI 10.1016/j.ymgme.2010.05.004; Masino SA, 2011, J CLIN INVEST, V121, P2679, DOI 10.1172/JCI57813; MCALPINE D, 1958, LANCET, V2, P629; McGinnis WR, 2004, ALTERN THER HEALTH M, V10, P22; Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012; Miguel-Hidalgo J, 2009, J PSYCHOPHARMACOL, V23, P551, DOI 10.1177/0269881108091074; Miguel-Hidalgo JJ, 2005, ALCOHOL CLIN EXP RES, V29, P766, DOI 10.1097/01.ALC.0000164378.92680.FA; Miguel-Hidalgo JJ, 2006, ALCOHOL CLIN EXP RES, V30, P1845, DOI 10.1111/j.1530-0277.2006.00221.x; Miguel-Hidalgo Jose Javier, 2009, Curr Drug Abuse Rev, V2, P76; Minami T, 1998, ENVIRON TOXICOL PHAR, V5, P35, DOI 10.1016/S1382-6689(97)10004-7; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Montana V, 2014, CURR NEUROPHARMACOL, V12, P324, DOI 10.2174/1570159X12666140903094700; MOODY WJ, 1974, EXP NEUROL, V42, P248, DOI 10.1016/0014-4886(74)90023-5; Moussawi K, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00094; Nedergaard M, 1996, ADV NEUROL, V71, P75; NORENBERG MD, 1987, NEUROCHEM PATHOL, V6, P13, DOI 10.1007/BF02833599; Obara-Michlewska M, 2014, NEUROCHEM INT; Oehmichen M, 1996, ACTA NEUROPATHOL, V91, P642, DOI 10.1007/s004010050478; Ohnuma T, 2000, MOL BRAIN RES, V85, P24, DOI 10.1016/S0169-328X(00)00222-9; Oide T, 2006, NEUROPATH APPL NEURO, V32, P170, DOI 10.1111/j.1365-2990.2006.00710.x; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Orellana JA, 2014, J NEUROCHEM, V128, P752, DOI 10.1111/jnc.12492; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Piva Simone, 2015, Cardiovascular & Hematological Disorders - Drug Targets, V15, P10; Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Qrunfleh AM, 2013, J PSYCHOPHARMACOL, V27, P541, DOI 10.1177/0269881113482529; Quaak I, 2013, INT J ENV RES PUB HE, V10, P3384, DOI 10.3390/ijerph10083384; Rajkowska G, 2002, SCHIZOPHR RES, V57, P127, DOI 10.1016/S0920-9964(02)00339-0; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Reissner KJ, 2010, BEHAV PHARMACOL, V21, P514, DOI 10.1097/FBP.0b013e32833d41b2; Reissner KJ, 2014, PATHOLOGICAL POTENTI; Ren JN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00061; Rintala J, 2001, ALCOHOL, V23, P1, DOI 10.1016/S0741-8329(00)00116-6; Rodriguez JJ, 2016, CURR ALZHEIMER RES, V13, P343, DOI 10.2174/1567205013666160229112911; Rojas DC, 2014, J NEURAL TRANSM, V121, P891, DOI 10.1007/s00702-014-1216-0; Rose CF, 2013, BIOCHEM SOC T, V41, P1518, DOI 10.1042/BST20130237; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Sari Y, 2013, J MOL NEUROSCI, V51, P779, DOI 10.1007/s12031-013-0064-y; Sayre NL, 2014, ADV NEUROBIOL, V11, P121, DOI 10.1007/978-3-319-08894-5_7; Schmitt A, 2009, ACTA NEUROPATHOL, V117, P395, DOI 10.1007/s00401-008-0430-y; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Schwarcz R, 2007, SCHIZOPHRENIA BULL, V33, P652, DOI 10.1093/schbul/sbm030; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Shan D, 2013, SCHIZOPHR RES, V144, P1, DOI 10.1016/j.schres.2012.12.019; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Shulyatnikova T, 2020, NEUROCHEM RES, V45, P83, DOI 10.1007/s11064-019-02743-2; Skowronska M, 2012, NEUROTOX RES, V21, P236, DOI 10.1007/s12640-011-9269-4; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1; Spodenkiewicz Marta, 2016, Biology-Basel, V5, P40, DOI 10.3390/biology5040040; Steinhauser C., 2015, NEUROSCIENCE; Stenzel W, 2004, J NEUROPATH EXP NEUR, V63, P631, DOI 10.1093/jnen/63.6.631; Struys-Ponsar C, 2000, EXP NEUROL, V163, P157, DOI 10.1006/exnr.2000.7355; Suarez I, 2000, DEV NEUROSCI-BASEL, V22, P253, DOI 10.1159/000017449; Suarez-Fernandez MB, 1999, BRAIN RES, V835, P125, DOI 10.1016/S0006-8993(99)01536-X; Sun JD, 2012, NEUROPSYCHOPHARMACOL, V37, P1305, DOI 10.1038/npp.2011.319; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259, DOI 10.1152/jn.1988.59.1.259; Valori CF, 2014, CELL MOL LIFE SCI, V71, P287, DOI 10.1007/s00018-013-1429-7; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Verkhratsky A., 2013, GLIAL PHYSL PATHOPHY; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Verkhratsky A, 2017, BRAIN PATHOL, V27, P629, DOI 10.1111/bpa.12537; Verkhratsky A, 2017, ADV NEUROBIOL, V15, P427, DOI 10.1007/978-3-319-57193-5_17; Verkhratsky A, 2016, PROG NEUROBIOL, V144, P188, DOI 10.1016/j.pneurobio.2015.09.003; Verkhratsky A, 2016, NEUROBIOL DIS, V85, P254, DOI 10.1016/j.nbd.2015.03.025; Verkhratsky A, 2015, NEUROSCIENTIST, V21, P552, DOI 10.1177/1073858414547132; Verkhratsky A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0595; Verkhratsky A, 2014, NEUROSCIENTIST, V20, P576, DOI 10.1177/1073858413510208; Verkhratsky A, 2013, FUTUR NEUROL, V8, P149, DOI 10.2217/fnl.12.90; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Verkhratsky A, 2009, MOL NEUROBIOL, V39, P190, DOI 10.1007/s12035-009-8063-2; Virchow R., 1858, CELLULARPATHOLOGIE I; Wang F, 2015, ACTA PHYSIOL, V214, P261, DOI 10.1111/apha.12500; Wang Y, 2009, EXP NEUROL, V220, P293, DOI 10.1016/j.expneurol.2009.08.034; Weber M, 2013, BRAIN RES, V1500, P72, DOI 10.1016/j.brainres.2012.12.048; Webster MJ, 2001, BRAIN BEHAV IMMUN, V15, P388, DOI 10.1006/brbi.2001.0646; Weng YC, 2007, EXP NEUROL, V204, P433, DOI 10.1016/j.expneurol.2006.12.003; Wilson EH, 2004, INT J PARASITOL, V34, P543, DOI 10.1016/j.ijpara.2003.12.010; Wilson JX, 2000, BRAIN RES, V858, P61, DOI 10.1016/S0006-8993(99)02433-6; Windrem MS, 2017, CELL STEM CELL, V21, P195, DOI 10.1016/j.stem.2017.06.012; Xia M, 2014, SCHIZOPHR RES; Yin ZB, 2007, BRAIN RES, V1131, P1, DOI 10.1016/j.brainres.2006.10.070; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeidan-Chulia F, 2014, NEUROSCI BIOBEHAV R, V38, P160, DOI 10.1016/j.neubiorev.2013.11.008; Zhang L, 2014, NEUROCHEM RES, V39, P2407, DOI 10.1007/s11064-014-1445-5; Zhang L, 2013, NEUROREPORT, V24, P526, DOI 10.1097/WNR.0b013e32836206d1; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhao YX, 2010, NEUROTHERAPEUTICS, V7, P439, DOI 10.1016/j.nurt.2010.07.004; Zorec R, 2019, NEUROSCI LETT, V689, P56, DOI 10.1016/j.neulet.2018.08.003	240	21	22	0	1	SPRINGER-VERLAG SINGAPORE PTE LTD	SINGAPORE	152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE	0065-2598	2214-8019	978-981-13-9913-8; 978-981-13-9912-1	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2019	1175						149	179		10.1007/978-981-13-9913-8_7	10.1007/978-981-13-9913-8		31	Medicine, Research & Experimental; Clinical Neurology; Neurosciences	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Neurosciences & Neurology	BO4IN	WOS:000514285100008	31583588	Green Accepted			2022-02-06	
J	Howe, EI; Andelic, N; Perrin, PB; Roe, C; Sigurdardottir, S; Arango-Lasprilla, JC; Lu, J; Lovstad, M; Forslund, MV				Howe, Emilie I.; Andelic, Nada; Perrin, Paul B.; Roe, Cecilie; Sigurdardottir, Solrun; Arango-Lasprilla, Juan Carlos; Lu, Juan; Lovstad, Marianne; Forslund, Marit Vindal			Employment Probability Trajectories Up To 10 Years After Moderate-To-Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						brain injury; outcome assessment; prospective studies; return to work; rehabilitation	WORKING-AGE INDIVIDUALS; RETURN; REHABILITATION; STABILITY; DISABILITY; PATTERNS	Aims: To examine trajectories of employment probability up to 10 years following moderate-to-severe traumatic brain injury (TBI) and identify significant predictors from baseline socio-demographic and injury characteristics. Methods: A longitudinal observational study followed 97 individuals with moderate-to-severe TBI for their employment status up to 10 years post injury. Participants were enrolled at the Trauma Referral Center in South-Eastern Norway between 2005 and 2007. Socio-demographic and injury characteristics were recorded at baseline. Employment outcomes were assessed at 1, 2, 5, and 10 years. Hierarchical linear modeling (HLM) was used to examine employment status over time and assess the predictors of time, gender, age, relationship status, education, employment pre-injury, occupation, cause of injury, acute Glasgow Coma Scale (GCS) score, duration of post-traumatic amnesia (PTA), CT findings, and injury severity score, as well as the interaction terms between significant predictors and time. Results: The linear trajectory of employment probabilities for the full sample remained at similar to 50% across 1, 2, 5, and 10-years post-injury. Gender (p = 0.016), relationship status (p = 0.002), employment (p < 0.001) and occupational status at injury (p = 0.005), and GCS (p = 0.006) yielded statistically significant effects on employment probability trajectories. Male gender, those in a partnered relationship at the time of injury, individuals who had been employed at the time of injury, those in a white-collar profession, and participants with a higher acute GCS score had significantly higher overall employment probability trajectories across the four time points. The time*gender interaction term was statistically significant (p = 0.002), suggesting that employment probabilities remained fairly stable over time for men, but showed a downward trend for women. The time*employment at injury interaction term was statistically significant (p = 0.003), suggesting that employment probabilities were fairly level over time for those who were employed at injury, but showed an upward trend over time for those who had been unemployed at injury. Conclusion: Overall employment probability trajectories remained relatively stable between 1 and 10 years. Baseline socio-demographic and injury characteristics were predictive of employment trajectories. Regular follow-up is recommended for patients at risk of long-term unemployment.	[Howe, Emilie I.; Andelic, Nada; Roe, Cecilie; Forslund, Marit Vindal] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Howe, Emilie I.; Roe, Cecilie] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Andelic, Nada; Lu, Juan] Univ Oslo, Inst Hlth & Soc, Fac Med, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Oslo, Norway; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Sigurdardottir, Solrun; Lovstad, Marianne] Sunnaas Rehabil Hosp Trust, Dept Res, Nesoddtangen, Norway; [Arango-Lasprilla, Juan Carlos] Cruces Univ Hosp Barakaldo, BioCruces Hlth Res Inst, Baracaldo, Spain; [Arango-Lasprilla, Juan Carlos] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Lu, Juan] Virginia Commonwealth Univ, Dept Family Med & Populat Hlth, Div Epidemiol, Richmond, VA USA; [Lovstad, Marianne] Univ Oslo, Dept Psychol, Oslo, Norway		Howe, EI (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.; Howe, EI (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	emilie.howe@medisin.uio.no		Arango-Lasprilla, Juan Carlos/0000-0002-7184-8311; Andelic, Nada/0000-0002-3719-4406; Lu, Juan/0000-0002-5389-7603	Department of Physical Medicine and Rehabilitation, Oslo University Hospital; Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo; Research Council of NorwayResearch Council of Norway; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002649] Funding Source: NIH RePORTER	The authors would like to thank all the patients for their participation. Special thanks to Nini Hammergren and Svein A. Berntsen for assistance with patient registrations, and Tone Jerstad, neuroradiologist, for the CT assessments. This study was funded by the Department of Physical Medicine and Rehabilitation, Oslo University Hospital, The Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo, and The Research Council of Norway.	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Fraser R, 2006, J VOCAT REHABIL, V25, P141; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Grauwmeijer E, 2012, ARCH PHYS MED REHAB, V93, P993, DOI 10.1016/j.apmr.2012.01.018; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kjeldsberg M, 2013, SCAND J PRIM HEALTH, V31, P36, DOI 10.3109/02813432.2012.751697; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Olsen T, 2005, INT REV PSYCHIATR, V17, P375, DOI 10.1080/09540260500238579; Ose SO, 2013, SINTEF RAPPORT, P1; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Ponsford J, 2020, NEUROPSYCHOL REHABIL, V30, P85, DOI 10.1080/09602011.2018.1453367; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sigurdardottir S, 2020, NEUROPSYCHOL REHABIL, V30, P281, DOI 10.1080/09602011.2018.1462719; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; TEASDALE G, 1974, LANCET, V2, P81; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335	36	21	21	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 5	2018	9								1051	10.3389/fneur.2018.01051			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HC9SP	WOS:000452147400001	30568630	Green Published, gold			2022-02-06	
J	Isokuortti, H; Iverson, GL; Silverberg, ND; Kataja, A; Brander, A; Ohman, J; Luoto, TM				Isokuortti, Harri; Iverson, Grant L.; Silverberg, Noah D.; Kataja, Anneli; Brander, Antti; Ohman, Juha; Luoto, Teemu M.			Characterizing the type and location of intracranial abnormalities in mild traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; head injury; computed tomography; neurodegenerative diseases; common data elements; trauma	CT HEAD RULE; COMMON DATA ELEMENTS; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; COLLABORATING-CENTER; TASK-FORCE; MODERATE; EPIDEMIOLOGY; ADULTS; CLASSIFICATION	OBJECTIVE The incidence of intracranial abnormalities after mild traumatic brain injury (TBI) varies widely across studies. This study describes the characteristics of intracranial abnormalities (acute/preexisting) in a large representative sample of head-injured patients who underwent CT imaging in an emergency department. METHODS CT scans were systematically analyzed/coded in the TBI Common Data Elements framework. Logistic regression modeling was used to quantify risk factors for traumatic intracranial abnormalities in patients with mild TBIs. This cohort included all patients who were treated at the emergency department of the Tampere University Hospital (between 2010 and 2012) and who had undergone head CT imaging after suffering a suspected TBI (n = 3023), including 2766 with mild TBI and a reference group with moderate to severe TBI. RESULTS The most common traumatic lesions seen on CT scans obtained in patients with mild TBIs and those with moderate to severe TBIs were subdural hematomas, subarachnoid hemorrhages, and contusions. Every sixth patient (16.1%) with mild TBI had an intracranial lesion compared with 5 of 6 patients (85.6%) in the group with moderate to severe TBI. The distribution of different types of acute traumatic lesions was similar among mild and moderate/severe TBI groups. Preexisting brain lesions were a more common CT finding among patients with mild TBIs than those with moderate to severe TBIs. Having a past traumatic lesion was associated with increased risk for an acute traumatic lesion but neurodegenerative and ischemic lesions were not. A lower Glasgow Coma Scale score, male sex, older age, falls, and chronic alcohol abuse were associated with higher risk of acute intracranial lesion in patients with mild TBI. CONCLUSIONS These findings underscore the heterogeneity of neuropathology associated with the mild TBI classification. Preexisting brain lesions are common in patients with mild TBI, and the incidence of preexisting lesions increases with age. Acute traumatic lesions are fairly common in patients with mild TBI; every sixth patient had a positive CT scan. Older adults (especially men) who fall represent a susceptible group for acute CT-positive TBI.	[Isokuortti, Harri] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, Tampere, Finland; [Ohman, Juha; Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Iverson, Grant L.; Silverberg, Noah D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] MassGeneral Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.; Silverberg, Noah D.] Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.; Silverberg, Noah D.] Massachusetts Gen Hosp Program, Boston, MA USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Dept Med, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC, Canada		Isokuortti, H (corresponding author), Univ Tampere, Tampere, Finland.	isokuortti@gmail.com	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Iverson, Grant/0000-0001-7348-9570			BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Dunham CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109473; Easter JS, 2017, JAMA-J AM MED ASSOC, V317, P2021, DOI 10.1001/jama.2017.5136; Easter JS, 2013, ACAD EMERG MED, V20, P753, DOI 10.1111/acem.12184; Erly WK, 2002, AM J NEURORADIOL, V23, P103; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huff JS, 2014, AM J EMERG MED, V32, P606, DOI 10.1016/j.ajem.2014.03.010; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Iverson GL, 2000, BRAIN INJURY, V14, P1057; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Temkin NR, 2003, J NEUROTRAUM, V20, P229, DOI 10.1089/089771503321532815; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wu MZ, 2014, RADIOLOGY, V270, P717, DOI 10.1148/radiol.13131114; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	64	21	21	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2018	129	6					1588	1597		10.3171/2017.7.JNS17615			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HE4YU	WOS:000453376800023	29328003	Bronze			2022-02-06	
J	Gerzanich, V; Stokum, JA; Ivanova, S; Woo, SK; Tsymbalyuk, O; Sharma, A; Akkentli, F; Imran, Z; Aarabi, B; Sahuquillo, J; Simard, JM				Gerzanich, Volodymyr; Stokum, Jesse A.; Ivanova, Svetlana; Woo, Seung Kyoon; Tsymbalyuk, Orest; Sharma, Amit; Akkentli, Fatih; Imran, Ziyan; Aarabi, Bizhan; Sahuquillo, Juan; Simard, J. Marc			Sulfonylurea Receptor 1, Transient Receptor Potential Cation Channel Subfamily M Member 4, and KIR6.2:Role in Hemorrhagic Progression of Contusion	JOURNAL OF NEUROTRAUMA			English	Article						brain contusion; brain swelling; glibenclamide; hemorrhagic progression of contusion; K-ATP; SUR1-TRPM4; traumatic brain injury	TRAUMATIC BRAIN-INJURY; K-ATP-CHANNELS; SENSITIVE POTASSIUM CHANNELS; PORE-FORMING SUBUNIT; COMPUTED-TOMOGRAPHY; REACTIVE ASTROCYTES; INSULIN-SECRETION; CEREBRAL EDEMA; DOUBLE-BLIND; GLIBENCLAMIDE	In severe traumatic brain injury (TBI), contusions often are worsened by contusion expansion or hemorrhagic progression of contusion (HPC), which may double the original contusion volume and worsen outcome. In humans and rodents with contusion-TBI, sulfonylurea receptor 1 (SUR1) is upregulated in microvessels and astrocytes, and in rodent models, blockade of SUR1 with glibenclamide reduces HPC. SUR1 does not function by itself, but must co-assemble with either KIR6.2 or transient receptor potential cation channel subfamily M member 4 (TRPM4) to form K-ATP (SUR1-KIR6.2) or SUR1-TRPM4 channels, with the two having opposite effects on membrane potential. Both KIR6.2 and TRPM4 are reportedly upregulated in TBI, especially in astrocytes, but the identity and function of SUR1-regulated channels post-TBI is unknown. Here, we analyzed human and rat brain tissues after contusion-TBI to characterize SUR1, TRPM4, and KIR6.2 expression, and in the rat model, to examine the effects on HPC of inhibiting expression of the three subunits using intravenous antisense oligodeoxynucleotides (AS-ODN). Glial fibrillary acidic protein (GFAP) immunoreactivity was used to operationally define core versus penumbral tissues. In humans and rats, GFAP-negative core tissues contained microvessels that expressed SUR1 and TRPM4, whereas GFAP-positive penumbral tissues contained astrocytes that expressed all three subunits. Forster resonance energy transfer imaging demonstrated SUR1-TRPM4 heteromers in endothelium, and SUR1-TRPM4 and SUR1-KIR6.2 heteromers in astrocytes. In rats, glibenclamide as well as AS-ODN targeting SUR1 and TRPM4, but not KIR6.2, reduced HPC at 24h post-TBI. Our findings demonstrate upregulation of SUR1-TRPM4 and K-ATP after contusion-TBI, identify SUR1-TRPM4 as the primary molecular mechanism that accounts for HPC, and indicate that SUR1-TRPM4 is a crucial target of glibenclamide.	[Gerzanich, Volodymyr; Stokum, Jesse A.; Ivanova, Svetlana; Woo, Seung Kyoon; Tsymbalyuk, Orest; Sharma, Amit; Akkentli, Fatih; Imran, Ziyan; Aarabi, Bizhan; Simard, J. Marc] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Neurotraumatol & Neurosurg Res Unit, Barcelona, Spain; [Sahuquillo, Juan] Univ Autonoma Barcelona, Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain		Simard, JM (corresponding author), Univ Maryland, Sch Med, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@som.umaryland.edu	Sahuquillo, Juan/B-3577-2008	Sahuquillo, Juan/0000-0003-0713-5875	Department of Veterans AffairsUS Department of Veterans Affairs [I01BX002889]; Department of DefenseUnited States Department of Defense [SCI170199]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL082517]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060801, R01NS102589, R01NS105633]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS061934]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL082517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060801, R01NS105633, R01NS102589, R01NS061934] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002889] Funding Source: NIH RePORTER	J.M.S is supported by grants from the Department of Veterans Affairs (I01BX002889), the Department of Defense (SCI170199), the National Heart, Lung and Blood Institute (R01HL082517) and the National Institute of Neurological Disorders and Stroke (NINDS) (R01NS060801; R01NS102589; R01NS105633); V.G. is supported by a grant from NINDS (NS061934).	Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Abu Hamdeh S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25060-0; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; AMMALA C, 1991, BIOCHIM BIOPHYS ACTA, V1092, P347; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; BOKVIST K, 1991, P ROY SOC B-BIOL SCI, V243, P139, DOI 10.1098/rspb.1991.0022; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Castro L, 2019, J NEUROTRAUM, V36, P165, DOI 10.1089/neu.2017.5619; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Fujita A, 2000, PHARMACOL THERAPEUT, V85, P39, DOI 10.1016/S0163-7258(99)00050-9; Galderisi U, 1999, J CELL PHYSIOL, V181, P251, DOI 10.1002/(SICI)1097-4652(199911)181:2<251::AID-JCP7>3.0.CO;2-D; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Gorse K., 2018, J NEUROTRAUMA, pprint; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Griffith CM, 2016, NEUROSCIENCE, V336, P81, DOI 10.1016/j.neuroscience.2016.08.034; Hashiguchi H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184261; Heron-Milhavet L, 2004, MOL CELL NEUROSCI, V25, P585, DOI 10.1016/j.mcn.2003.10.012; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jansen-Olesen I, 2005, EUR J PHARMACOL, V523, P109, DOI 10.1016/j.ejphar.2005.08.028; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jha R.M., 2018, J NEUROL NEUROSURG P; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Katayama Y, 2003, ACTA NEUROCHIR SUPPL, V86, P323; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kurland DB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0599-2; Lamensdorf I, 1999, BRAIN RES, V818, P275, DOI 10.1016/S0006-8993(98)01290-6; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; Marigo V, 2009, MOL CELL ENDOCRINOL, V299, P194, DOI 10.1016/j.mce.2008.11.011; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Mehta RI, 2013, J NEUROPATH EXP NEUR, V72, P871, DOI 10.1097/NEN.0b013e3182a32e40; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Ningaraj NS, 2003, CANCER RES, V63, P8899; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Ploug KB, 2006, EUR J PHARMACOL, V553, P254, DOI 10.1016/j.ejphar.2006.09.053; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Santa N, 2003, STROKE, V34, P1276, DOI 10.1161/01.STR.0000068171.01248.97; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Simard J.M., 2013, J SPINE S, P4; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Soundarapandian MM, 2007, J NEUROCHEM, V103, P1721, DOI 10.1111/j.1471-4159.2007.04963.x; Stokum JA, 2018, GLIA, V66, P108, DOI 10.1002/glia.23231; Sun HS, 2013, ACTA PHARMACOL SIN, V34, P24, DOI 10.1038/aps.2012.138; Sun HS, 2006, J NEUROPHYSIOL, V95, P2590, DOI 10.1152/jn.00970.2005; Szeto V, 2018, ACTA PHARMACOL SIN, V39, P683, DOI 10.1038/aps.2018.10; Thomzig A, 2001, MOL CELL NEUROSCI, V18, P671, DOI 10.1006/mcne.2001.1048; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/NMETH.3995, 10.1038/nmeth.3995]; Vinogradov SV, 2004, BIOCONJUGATE CHEM, V15, P50, DOI 10.1021/bc034164r; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yamada K, 2001, SCIENCE, V292, P1543, DOI 10.1126/science.1059829; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhou M, 2002, MOL BRAIN RES, V101, P23, DOI 10.1016/S0169-328X(02)00137-7; Zhou M, 1999, MOL BRAIN RES, V74, P15, DOI 10.1016/S0169-328X(99)00232-6; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	79	21	21	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1060	1079		10.1089/neu.2018.5986		OCT 2018	20	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6CG	WOS:000446467400001	30160201	hybrid, Green Published			2022-02-06	
J	Batey, M; Hecht, J; Callahan, C; Wahl, W				Batey, Madelyn; Hecht, Jason; Callahan, Cherise; Wahl, Wendy			Direct oral anticoagulants do not worsen traumatic brain injury after low-level falls in the elderly	SURGERY			English	Article							PROTHROMBIN COMPLEX CONCENTRATE; ATRIAL-FIBRILLATION; VITAMIN-K; INTRACEREBRAL HEMORRHAGE; PREINJURY WARFARIN; HEAD-INJURY; MORTALITY; REVERSAL; ASSOCIATION; DABIGATRAN	Background: Falls are now the leading cause of trauma and represent the most common type of trauma in the elderly. The use of anticoagulants is increasing in older patients, but there are little data on outcomes after traumatic brain injury while anticoagulated with direct oral anticoagulants compared with warfarin. We hypothesized that anticoagulated patients would have a greater mortality and complications than nonanticoagulated patients, and patients on direct oral anticoagulants would have more fatal outcomes after low-level falls because of lack of reversal agents. Methods: Patients 65 years or older admitted to level 1-3 trauma centers with 24-hour neurosurgical care were identified through the administrative database of 19 Trinity Health hospitals. Patients with International Classification of Diseases, Ninth Revision, codes consistent with low-level fall and traumatic brain injury from May 2013 through October 2015 were included. Preadmission warfarin or direct oral anticoagulant use was extracted from admission reconciliation of medications in the database. Results: A total of 700 patients met inclusion criteria with 177 on anticoagulants before admission. Anticoagulated patients had more cardiac (P < .001), pulmonary (P < .001), and clotting (P < .02) comorbidities. Warfarin patients had the greatest neurosurgical intervention rate at 18% compared with direct oral anticoagulants (2.8%, P < .02) or nonanticoagulation (11%, P < .02). No difference was identified in overall mortality and mortality after neurosurgical intervention between the nonanticoagulated, warfarin, or direct oral anticoagulant groups. Warfarin patients received more plasma (P < .001) and red cell transfusions (P = .035) with greater intensive care unit stays (P < .001) compared with direct oral anticoagulant or nonanticoagulated patients. With logistic regression, only advancing age (P < .05) and a lesser Glasgow Coma Scale score (P < .01) were associated with greater mortality. Conclusion: Older direct oral anticoagulant patients with traumatic brain injury after low-level fall did not have increased morbidity or mortality compared with those treated with warfarin or who were not treated with anticoagulants. Concerns over the use of direct oral anticoagulant agents in this population may be overstated and deserve more scrutiny. (C) 2018 Elsevier Inc. All rights reserved.	[Batey, Madelyn] Univ Michigan Hlth Syst, Dept Pharm, Ann Arbor, MI USA; [Hecht, Jason; Callahan, Cherise; Wahl, Wendy] St Joseph Mercy Ann Arbor, Dept Pharm, Ann Arbor, MI 48106 USA		Wahl, W (corresponding author), St Joseph Mercy Ann Arbor, Trauma & Surg Crit Care, 5301 E Huron River Dr, Ann Arbor, MI 48106 USA.	wendy.wahl@stjoeshealth.org					Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Burns ER, 2016, J SAFETY RES, V58, P99, DOI 10.1016/j.jsr.2016.05.001; Centers for Disease Control and Prevention, 2017, IMP FACTS FALL; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Dias JD, 2015, ARCH PATHOL LAB MED, V139, P665, DOI 10.5858/arpa.2014-0170-OA; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Feeney JM, 2017, INJURY, V48, P47, DOI 10.1016/j.injury.2016.08.016; Fox BD, 2012, BMJ-BRIT MED J, V345, P1; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; FREDRIKSSON K, 1992, STROKE, V23, P972, DOI 10.1161/01.STR.23.7.972; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Inohara T, 2018, JAMA-J AM MED ASSOC, V319, P463, DOI 10.1001/jama.2017.21917; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kobayashi L, 2017, J TRAUMA ACUTE CARE, V82, P827, DOI 10.1097/TA.0000000000001414; Marzec LN, 2017, J AM COLL CARDIOL, V69, P2475, DOI 10.1016/j.jacc.2017.03.540; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Pollack CV, N ENGL J MED, V373, P511; Popovsky MA, 2006, TRANSFUS APHER SCI, V34, P243, DOI 10.1016/j.transci.2006.01.005; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Teddy P, 2012, J CLIN NEUROSCI, V19, P792, DOI 10.1016/j.jocn.2012.01.024; Yasaka M, 2002, THROMB RES, V108, P25, DOI 10.1016/S0049-3848(02)00402-4	25	21	21	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	OCT	2018	164	4					814	819		10.1016/j.surg.2018.05.060			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	GW3LI	WOS:000446805100031	30098813				2022-02-06	
J	DeGrauw, X; Thurman, D; Xu, LK; Kancherla, V; DeGrauw, T				DeGrauw, Xinyao; Thurman, David; Xu, Likang; Kancherla, Vijaya; DeGrauw, Ton			Epidemiology of traumatic brain injury-associated epilepsy and early use of anti-epilepsy drugs: An analysis of insurance claims data, 2004-2014	EPILEPSY RESEARCH			English	Article						Traumatic brain injury; Epilepsy; Anti-epilepsy drug; Early seizure	LATE POSTTRAUMATIC SEIZURES; CUMULATIVE INCIDENCE; HEAD-INJURY; POPULATION; RISK; ACETAZOLAMIDE; PREVENTION	Background: About 2.8 million TBI-related emergency department visits, hospitalizations and deaths occurred in 2013 in the United States. Post-traumatic epilepsy (PTE) can be a disabling, life-long outcome of TBI. Objectives: The purpose of this study is to address the probability of developing PTE within 9 years after TBI, the risk factors associated with PTE, the prevalence of anti-epileptic drug (AEDs) use, and the effectiveness of using AEDs prophylactically after TBI to prevent the development of PTE. Methods: Using MarketScan((R)) databases covering commercial, Medicare Supplemental, and multi-state Medicaid enrollees from 2004 to 2014, we examined the incidence of early seizures (within seven days after TBI) and cumulative incidence of PTE, the hazard ratios (HR) of PTE by age, gender, TBI severity, early seizure and AED use (carbamazepine, clonazepam, divalproex sodium, gabapentin, lamotrigine, levetiracetam, oxcarbazepine, phenytoin, pregabalin, topiramate, acetazolamide). We used backward selection to build the final Cox proportional hazard model and conducted multivariable survival analysis to obtain estimates of crude and adjusted HR (cHRs, aHRs) of PTE and 95% confidence intervals (CI). Results: The incidence of early seizure among TBI patients in our study was 0.5%. The cumulative incidence of PTE increased from 1.0% in one year to 4.0% in nine years. Most patients with TBI (93%) were not prescribed any AED. Gender was not associated with PTE. The risk of PTE was higher for individuals with older age, early seizures, and more severe TBI. Only individuals using prophylactic acetazolamide had significantly lower risk of PTE (aHR = 0.6, CI 0.4-0.9) compared to those not using any AED. Conclusion: The probability of developing PTE increased within the study period. The risk of developing PTE significantly increased with age, early seizure and TBI severity. Most of the individuals did not receive AED after TBI. There was no evidence suggesting AEDs helped to prevent PTE with the possible exception of acetazolamide. However, further studies may be needed to test the efficacy of acetazolamide in preventing PTE.	[DeGrauw, Xinyao] Snohomish Hlth Dist, 3020 Rucker Ave,Suite 206, Everett, WA 98201 USA; [Thurman, David] Emory Univ, Dept Neurol, 1648 Pierce Dr NE, Atlanta, GA 30307 USA; [Xu, Likang] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, 4700 Buford Highway, Atlanta, GA 30341 USA; [DeGrauw, Xinyao; Kancherla, Vijaya] Emory Univ, Rollins Sch Publ Hlth, 1518 Clifton Rd, Atlanta, GA 30322 USA; [DeGrauw, Ton] Childrens Healthcare Atlanta, 1405 Clifton Rd, Atlanta, GA 30322 USA; [DeGrauw, Ton] Emory Univ, Div Pediat Neurol, 1405 Clifton Rd, Atlanta, GA 30329 USA		DeGrauw, X (corresponding author), Snohomish Hlth Dist, 3020 Rucker Ave,Suite 206, Everett, WA 98201 USA.	xdegrauw@snohd.org		Thurman, David/0000-0002-0533-7062	Intramural CDC HHS [CC999999] Funding Source: Medline		ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Armitage P, 2008, STAT METHODS MED RES; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Baker S., 2012, INJURY RES THEORIES; BICKLER PE, 1988, J APPL PHYSIOL, V65, P422, DOI 10.1152/jappl.1988.65.1.422; Carney N, 2016, NEUROSURGERY; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Dauch WA, 1996, ZBL NEUROCHIR, V57, P190; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Glushakov AV, 2016, METHODS MOL BIOL, V1462, P481, DOI 10.1007/978-1-4939-3816-2_27; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hamidi S, 2015, NEUROPHARMACOLOGY, V95, P377, DOI 10.1016/j.neuropharm.2015.04.015; Harris NG, 2012, J NEUROTRAUM, V29, P1469, DOI 10.1089/neu.2011.2161; Helmers SL, 2015, EPILEPSIA, V56, P942, DOI 10.1111/epi.13001; International League Against Epilepsy C. o. E Prognosis, 1993, EPILEPSIA, V34; Kirmani BF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00032; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Penman AD, 2008, COMPUT METH PROG BIO, V89, P50, DOI 10.1016/j.cmpb.2007.10.004; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Salazar A., 2014, HDB CLIN NEUROL, V128, P525; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Schierhout G., 2012, ANTIEPILEPTIC DRUGS; Sturdivant NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep33330; Szaflarski JP, 2014, NEUROPSYCH DIS TREAT, V10, P1469, DOI 10.2147/NDT.S50421; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thompson K., 2015, PHARM TREATMENTS PRE; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x	35	21	22	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211	1872-6844		EPILEPSY RES	Epilepsy Res.	OCT	2018	146						41	49		10.1016/j.eplepsyres.2018.07.012			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU3HY	WOS:000445168400007	30071385	Green Accepted			2022-02-06	
J	Hubbard, WB; Harwood, CL; Geisler, JG; Vekaria, HJ; Sullivan, PG				Hubbard, W. Brad; Harwood, Christopher L.; Geisler, John G.; Vekaria, Hemendra J.; Sullivan, Patrick G.			Mitochondrial uncoupling prodrug improves tissue sparing, cognitive outcome, and mitochondrial bioenergetics after traumatic brain injury in male mice	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neurotrauma; novel object recognition; oxidative stress; oxygen consumption rate; therapeutics	PERMEABILITY TRANSITION; OXIDATIVE DAMAGE; MOUSE MODEL; CALCIUM; 2,4-DINITROPHENOL; DYSFUNCTION; HOMEOSTASIS; RELEASE; TRANSPORT; INCREASES	Traumatic brain injury (TBI) results in cognitive impairment, which can be long-lasting after moderate to severe TBI. Currently, there are no FDA-approved therapeutics to treat the devastating consequences of TBI and improve recovery. This study utilizes a prodrug of 2,4-dinitrophenol, MP201, a mitochondrial uncoupler with extended elimination time, that was administered after TBI to target mitochondrial dysfunction, a hallmark of TBI. Using a model of cortical impact in male C57/BL6 mice, MP201 (80 mg/kg) was provided via oral gavage 2-hr post-injury and daily afterwards. At 25-hr post-injury, mice were euthanized and the acute rescue of mitochondrial bioenergetics was assessed demonstrating a significant improvement in both the ipsilateral cortex and ipsilateral hippocampus after treatment with MP201. Additionally, oxidative markers, 4-hydroxyneneal and protein carbonyls, were reduced compared to vehicle animals after MP201 administration. At 2-weeks post-injury, mice treated with MP201 post-injury (80 mg/kg; q.d.) displayed significantly increased cortical sparing (p=.0059; 38% lesion spared) and improved cognitive outcome (p=.0133) compared to vehicle-treated mice. Additionally, vehicle-treated mice had significantly lower (p=.0019) CA3 neuron count compared to sham while MP201-treated mice were not significantly different from sham levels. These results suggest that acute mitochondrial dysfunction can be targeted to impart neuroprotection from reactive oxygen species, but chronic administration may have an added benefit in recovery. This study highlights the potential for safe, effective therapy by MP201 to alleviate negative outcomes of TBI.	[Hubbard, W. Brad; Harwood, Christopher L.; Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Coll Med, 800 Rose St,MN 150, Lexington, KY 40506 USA; [Hubbard, W. Brad; Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [Geisler, John G.] Mitochon Pharmaceut Inc, Blue Bell, PA USA; [Sullivan, Patrick G.] Lexington VAMC, Lexington, KY USA		Sullivan, PG (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Coll Med, 800 Rose St,MN 150, Lexington, KY 40506 USA.	patsullivan@uky.edu	Vekaria, Hemendra/AAQ-7450-2020	Vekaria, Hemendra/0000-0001-5945-5235	VA Merit AwardUS Department of Veterans Affairs [1I01BX003405-01A1]; National Science FoundationNational Science Foundation (NSF) [1539068]; NSF EPSCoR Seed [4978/111315]; NCI Cancer CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA177558]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA177558] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003405] Funding Source: NIH RePORTER	VA Merit Award, Grant/Award Number: 1I01BX003405-01A1; National Science Foundation Grant No. 1539068; NSF EPSCoR Seed, Grant/Award Number: 4978/111315; NCI Cancer Center Support, Grant/Award Number: P30 CA177558	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Clond MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061819; Cutting WC, 1933, J AMER MED ASSOC, V101, P193, DOI 10.1001/jama.1933.02740280013006; Davis AR, 2010, J NEUROSCI METH, V189, P84, DOI 10.1016/j.jneumeth.2010.03.012; De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Feng JF, 2012, BRAIN RES, V1469, P144, DOI 10.1016/j.brainres.2012.06.021; Geisler JG, 2011, DIABETOLOGIA, V54, P237, DOI 10.1007/s00125-010-1932-4; Geisler JG, 2017, ALZHEIMERS DEMENT, V13, P582, DOI 10.1016/j.jalz.2016.08.001; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Harris O., 1995, TOXICOLOGICAL PROFIL, P1; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hubbard W. B., 2018, ACUTE NEURONAL INJUR; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Jarmuszkiewicz W, 2004, ACTA BIOCHIM POL, V51, P533; Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Khan RS, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7180632; Korde AS, 2005, J NEUROTRAUM, V22, P1142, DOI 10.1089/neu.2005.22.1142; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Li GM, 2013, NEUROL SCI, V34, P963, DOI 10.1007/s10072-012-1173-z; Liu D, 2015, J NEUROCHEM, V134, P677, DOI 10.1111/jnc.13176; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; da Costa RFM, 2010, J NEUROTRAUM, V27, P829, DOI 10.1089/neu.2009.1189; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Maragos WF, 2003, BRAIN RES, V966, P312, DOI 10.1016/S0006-8993(02)04225-7; Mattiasson G, 2004, CYTOM PART A, V62A, P89, DOI 10.1002/cyto.a.20089; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nicholls DG, 1998, BIOFACTORS, V8, P287, DOI 10.1002/biof.5520080317; Nukala VN, 2006, J NEUROSCI METH, V152, P48, DOI 10.1016/j.jneumeth.2005.08.017; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Pivovarova NB, 2002, J NEUROSCI, V22, P10653; Rizzuto R, 1999, CELL CALCIUM, V26, P193, DOI 10.1054/ceca.1999.0076; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Srodulski S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-30; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Starkov AA, 2002, J NEUROCHEM, V83, P220, DOI 10.1046/j.1471-4159.2002.01153.x; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2003, ANN NEUROL, V53, P711, DOI 10.1002/ana.10543; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924; Vekaria HJ, 2017, NEUROCHEM INT, V109, P117, DOI 10.1016/j.neuint.2017.04.004; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wu B, 2017, EXP NEUROL, V293, P83, DOI 10.1016/j.expneurol.2017.03.020; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	77	21	21	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	OCT	2018	96	10					1677	1688		10.1002/jnr.24271			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GS8WI	WOS:000443994900005	30063076	Green Accepted, Bronze			2022-02-06	
J	Sicard, V; Moore, RD; Ellemberg, D				Sicard, Veronik; Moore, Robert Davis; Ellemberg, Dave			Long-term cognitive outcomes in male and female athletes following sport-related concussions	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Traumatic brain injury; Concussion; Sex differences; Computerized neuropsychological testing; Persistent deficits; Executive functions	TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE ASSESSMENT TOOLS; SEGMENT DYNAMIC STABILIZATION; SEX-DIFFERENCES; BASE-LINE; WORKING-MEMORY; NEUROPSYCHOLOGICAL FUNCTION; GENDER-DIFFERENCES; HEAD ACCELERATION; SOCCER PLAYERS	Despite concussion being a serious public health concern and the increasing participation of female athletes in sport, the comparative long-term outcomes of male and female athletes are poorly understood, potentially limiting the scientific understanding and clinical management of these injuries. We examined whether sex influences the long-term cognitive outcomes in athletes with a history of concussion (HOC; 6+ months from injury). Accordingly, 196 asymptomatic student-athletes participated in the study (98 with a HOC; 98 matched controls). The sample included both male (n = 98) and female athletes (n = 98). Participants completed the Cogstate brief battery, to which we added a 2-Back condition to increase cognitive load. As predicted, the results revealed sex differences on the N-back Task, a measure of executive functions, with female athletes having a HOC responding significantly more slowly than their male counterparts on the 2-Back condition (p = 0.02). Moreover, irrespective of sex, athletes with a HOC were slower and less accurate relative to controls on the N back Task (p = 0.01). Analyses failed to reveal any significant sex or group difference on tasks that measure lower-level cognition (ps > 0.05). The current results reaffirm the presence of subtle, yet long-term alterations in aspects of executive functions following a sport-related concussion. More importantly, our results highlight that female athletes exhibit alterations of greater magnitude than their male counterparts. Therefore, the sex difference observed in the days or weeks following a concussion may persist well into the chronic phase of injury.	[Sicard, Veronik; Ellemberg, Dave] Univ Montreal, Dept Kinesiol, 2100 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada; [Sicard, Veronik; Ellemberg, Dave] Univ Montreal, Ctr Rech Neuropsychol & Cognit, 90 Rue Vincent dIndy, Montreal, PQ H2V 2S9, Canada; [Moore, Robert Davis] Univ South Carolina, Arnold Sch Publ Hlth, 921 Assembly St, Columbia, SC 29208 USA		Ellemberg, D (corresponding author), 2100 Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	veronik.sicard@umontreal.ca; moorerd3@mailbox.sc.edu; dave.ellemberg@umontreal.ca		Sicard, Veronik/0000-0003-2452-934X	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR MOP-102608]	This research was supported by a grant from the Canadian Institutes of Health Research (CIHR MOP-102608) to Dave Ellemberg.	Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Brown DA, 2015, SPORTS MED, V45, P1027, DOI 10.1007/s40279-015-0335-6; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Cromer JA, 2015, CLIN NEUROPSYCHOL, V29, P542, DOI 10.1080/13854046.2015.1054437; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; EMERSON CS, 1992, NEUROREPORT, V3, P957, DOI 10.1097/00001756-199211000-00002; Fratti S, 2017, CLIN NEUROPSYCHOL, V31, P569, DOI 10.1080/13854046.2016.1256435; Gardner A, 2012, APPL NEUROPSYCH-ADUL, V19, P90, DOI 10.1080/09084282.2011.643945; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hammeke TA, 2013, J INT NEUROPSYCH SOC, V19, P863, DOI 10.1017/S1355617713000702; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kumar S, 2009, J NEUROTRAUM, V26, P665, DOI [10.1089/neu.2008.0644, 10.1089/neu.2008-0644]; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Louey AG, 2014, ARCH CLIN NEUROPSYCH, V29, P432, DOI 10.1093/arclin/acu020; Luna B, 2009, ADV CHILD DEV BEHAV, V37, P233, DOI 10.1016/S0065-2407(09)03706-9; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mansell J, 2005, J ATHL TRAINING, V40, P310; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Moore DR, 2016, INT J PSYCHOPHYSIOL, V99, P85, DOI 10.1016/j.ijpsycho.2015.11.010; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Queen RM, 2003, MED SCI SPORT EXER, V35, P2069, DOI 10.1249/01.MSS.0000099081.20125.A5; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Sicard V, 2019, CLIN J SPORT MED, V29, P62, DOI 10.1097/JSM.0000000000000492; Tanveer S, 2017, PEDIAT NEUROL; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; Weiss E, 2003, NEUROSCI LETT, V344, P169, DOI 10.1016/S0304-3940(03)00406-3; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	67	21	21	1	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		3	8		10.1016/j.ijpsycho.2018.03.011			6	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000002	29572188				2022-02-06	
J	He, JC; Liu, H; Zhong, JJ; Guo, ZD; Wu, JC; Zhang, HR; Huang, ZJ; Jiang, L; Li, H; Zhang, ZS; Liu, L; Wu, Y; Qi, LJ; Sun, XC; Cheng, CJ				He, Junchi; Liu, Han; Zhong, Jianjun; Guo, Zongduo; Wu, Jingchuan; Zhang, Hongrong; Huang, Zhijian; Jiang, Li; Li, Hui; Zhang, Zhaosi; Liu, Liu; Wu, Yue; Qi, Lingjun; Sun, Xiaochuan; Cheng, Chongjie			Bexarotene protects against neurotoxicity partially through a PPAR gamma-dependent mechanism in mice following traumatic brain injury	NEUROBIOLOGY OF DISEASE			English	Article						Bexarotene; Traumatic brain injury; Neuron; Astrocyte; Microglia; Peroxisome proliferator-activated receptor; gamma	MICROGLIAL ACTIVATION; INFLAMMATION; POLARIZATION; RECOVERY; NEUROPROTECTION; DIFFERENTIATION; IMPAIRMENT; ASTROCYTES; DAMAGE	Traumatic brain injury (TBI) causes a high rate of mortality and disability worldwide, and there exists almost none effective drugs to protect against TBI. Neurotoxicity occurring after TBI can be derived from microglia and astrocytes, and causes neuronal death and synapse loss. Bexarotene has been demonstrated to protect neurons in CNS diseases. In the present study, we aimed to investigate the potential role of bexarotene in protecting against neurotoxicity after TBI, as well as the underlying mechanism. The controlled cortical impact (CCI) model was established on adult C57BL/6 mice, followed by intraperitoneal administration of bexarotene for 14 consecutive days. We found that bexarotene improved sensorimotor function and cognitive recovery in CCI mice. In addition, bexarotene decreased neuronal death and synapse loss, as well as inhibited apoptotic cascade. Moreover, bexarotene treatment reduced M1 microglia polarization, microglia-derived pro-inflammatory cytokines, and the number of A1 astrocytes after CCI. These effects of bexarotene were partially abolished by T0070907, an antagonist of peroxisome proliferator-activated receptor gamma (PPAR gamma). Additionally, bexarotene enhanced nuclear translocation and transcriptional activity of PPAR gamma. These findings show that bexarotene inhibits neurotoxicity in mice after TBI, at least in part through a PPAR gamma-dependent mechanism.	[He, Junchi; Liu, Han; Zhong, Jianjun; Guo, Zongduo; Wu, Jingchuan; Zhang, Hongrong; Huang, Zhijian; Jiang, Li; Li, Hui; Zhang, Zhaosi; Liu, Liu; Wu, Yue; Qi, Lingjun; Sun, Xiaochuan; Cheng, Chongjie] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Youyi Rd, Chongqing, Peoples R China		Sun, XC; Cheng, CJ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 1 Youyi Rd, Chongqing, Peoples R China.	sunxch1445@qq.com; 358187887@qq.com	Wu, Jingchuan/AAV-7799-2020; He, Junchi/AAD-8482-2019	Wu, Jingchuan/0000-0002-1213-4888; Zhang, Zhaosi/0000-0002-4988-501X; Huang, Zhijian/0000-0002-8241-0761	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159, 81371309]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81601072]	This work was supported by the National Natural Science Foundation of China (grant No. 81571159), the National Natural Science Foundation for Youth of China (No. 81601072), and the National Natural Science Foundation of China (No. 81371309).	Bai P, 2007, J BIOL CHEM, V282, P37738, DOI 10.1074/jbc.M701021200; Cai W, 2018, PROG NEUROBIOL, V163, P27, DOI 10.1016/j.pneurobio.2017.10.002; Certo M, 2015, PHARMACOL RES, V102, P298, DOI 10.1016/j.phrs.2015.10.009; Chen Chun-Jung, 2017, Collection and Research (Taichung), P1, DOI 10.6693/CAR201712_30(1).0001; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Drew PD, 2015, ALCOHOL CLIN EXP RES, V39, P445, DOI 10.1111/acer.12639; Ghosal Kaushik, 2016, Alzheimers Dement (N Y), V2, P110, DOI 10.1016/j.trci.2016.06.001; Han LJ, 2015, STROKE, V46, P2628, DOI 10.1161/STROKEAHA.115.010091; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang ZJ, 2016, J NEUROCHEM, V136, P1017, DOI 10.1111/jnc.13491; Huuskonen MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep33176; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kincheski GC, 2017, BRAIN BEHAV IMMUN, V64, P140, DOI 10.1016/j.bbi.2017.04.007; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu XR, 2016, STROKE, V47, P498, DOI 10.1161/STROKEAHA.115.012079; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marciano DP, 2015, PPAR RES, V2015, DOI 10.1155/2015/254560; Mariani MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep42270; Pan J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0270-3; Pardo L, 2016, GLIA, V64, P853, DOI 10.1002/glia.22969; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Piao C. S., 2017, J CEREB BLOOD FLOW M, DOI 10.1177/0271678X17742792.271678X17742792; Raman P, 2012, J PHARMACOL EXP THER, V342, P816, DOI 10.1124/jpet.112.193003; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Riancho J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00250; Sanz MJ, 2012, J IMMUNOL, V189, P411, DOI 10.4049/jimmunol.1102942; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Savage JC, 2015, J NEUROSCI, V35, P6532, DOI 10.1523/JNEUROSCI.4586-14.2015; Shibata S, 2009, BRAIN RES, V1296, P196, DOI 10.1016/j.brainres.2009.08.015; Teng ZP, 2016, STROKE, V47, P196, DOI 10.1161/STROKEAHA.115.011701; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Zhang HS, 2016, BRAIN RES, V1643, P130, DOI 10.1016/j.brainres.2016.05.003; Zhao J, 2014, J BIOL CHEM, V289, P11282, DOI 10.1074/jbc.M113.526095; Zhao Z, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00293; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033	43	21	22	1	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	SEP	2018	117						114	124		10.1016/j.nbd.2018.06.003			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO8ZO	WOS:000440392100008	29886067				2022-02-06	
J	Nasi, D; Gladi, M; Di Rienzo, A; di Somma, L; Moriconi, E; Iacoangeli, M; Dobran, M				Nasi, Davide; Gladi, Maurizio; Di Rienzo, Alessandro; di Somma, Lucia; Moriconi, Elisa; Iacoangeli, Maurizio; Dobran, Mauro			Risk factors for post-traumatic hydrocephalus following decompressive craniectomy	ACTA NEUROCHIRURGICA			English	Article						Decompressive craniectomy; Post-traumatic hydrocephalus; Traumatic brain injury; Cranioplasty; Ventriculoperitoneal shunt	TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPERTENSION; HYGROMA	Background Post-traumatic hydrocephalus (PTH) is one of the main complications of decompressive craniectomy (DC) after traumatic brain injury (TBI). Then, the recognition of risk factors and subsequent prompt diagnosis and treatment of PTH can improve the outcome of these patients. The purpose of this study was to identify factors associated with the development of PTH requiring surgical treatment in patients undergoing DC for TBI. Methods In this study, we collected the data of 190 patients (149 males and 41 females), who underwent DC for TBI in our Center. Then we analyzed the type of surgical treatment for all patients affected by PTH and the risk factors associated with the development of PTH. Results Post-traumatic hydrocephalus (PTH) developed in 37 patients out of 130 alive 30 days after DC (28.4%). The development of PTH required ventriculoperitoneal shunt (VPS) in 34 patients out of 37 (91.9%), while, in the remaining 3 patients, cerebrospinal fluid hydrodynamic (CSF) disturbances resolved after urgent cranioplasty and temporary external lumbar drain. Multivariate analysis showed that the presence of interhemispheric hygroma (p < 0.001) and delayed cranioplasty (3 months after DC) (p < 0.001) was significantly associated with the need for a VPS or other surgical procedure for PTH. Finally, among the 130 patients alive after 30 days from DC, PTH was associated with unfavorable outcome as measured by the 6-month Glasgow Outcome Scale score (p < 0.0001). Conclusions Our results showed that delayed cranial reconstruction was associated with an increasing rate of PTH after DC. The presence of an interhemispheric hygroma was an independent predictive radiological sign of PTH in decompressed patients for severe TBI.	[Nasi, Davide; Gladi, Maurizio; Di Rienzo, Alessandro; di Somma, Lucia; Moriconi, Elisa; Iacoangeli, Maurizio; Dobran, Mauro] Univ Politecn Marche, Umberto Gen Hosp 1, Dept Neurosurg, Via Conca 71, I-60020 Ancona, Italy		Nasi, D (corresponding author), Univ Politecn Marche, Umberto Gen Hosp 1, Dept Neurosurg, Via Conca 71, I-60020 Ancona, Italy.	davidenasi83@gmail.com		Nasi, Davide/0000-0002-7357-7455			Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P1308, DOI 10.1016/j.clineuro.2012.12.011; De Bonis P, 2010, J NEUROTRAUM, V27, P1965, DOI 10.1089/neu.2010.1425; Di Rienzo A, 2013, NEUROL MED-CHIR, V53, P329, DOI 10.2176/nmc.53.329; di Somma Lucia, 2016, Surg Neurol Int, V7, pS12, DOI 10.4103/2152-7806.173561; Dobran M, 2017, G CHIR, V38, P124, DOI 10.11138/gchir/2017.38.3.124; Dobran M, 2017, Surg Neurol Int, V8, P212, DOI 10.4103/sni.sni_222_17; Dobran M, 2017, BMJ CASE REP, V2017, P2017; Dobran M, 2016, WORLD NEUROSURG, V96, P152, DOI 10.1016/j.wneu.2016.08.100; Halani SH, 2017, NEUROSURGERY, V81, P204, DOI 10.1093/neuros/nyx054; Honeybul S, 2012, J NEUROTRAUM, V29, P1872, DOI 10.1089/neu.2012.2356; Huh PW, 2006, J NEUROSURG, V105, P65, DOI 10.3171/jns.2006.105.1.65; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kaen A, 2010, J NEUROSURG, V113, P1287, DOI 10.3171/2010.4.JNS10132; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Nasi D, 2018, WORLD NEUROSURG, V116, pE543, DOI 10.1016/j.wneu.2018.05.028; Nasi D, 2016, WORLD NEUROSURG, V91, DOI 10.1016/j.wneu.2016.04.041; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Vedantam A, 2018, J NEUROSURG, V128, P1547, DOI 10.3171/2017.1.JNS162721; Waziri A, 2007, NEUROSURGERY, V61, P489, DOI 10.1227/01.NEU.0000290894.85072.37	21	21	22	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2018	160	9					1691	1698		10.1007/s00701-018-3639-0			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GQ7JK	WOS:000441915100004	30054725				2022-02-06	
J	Liou, YJ; Wei, HT; Chen, MH; Hsu, JW; Huang, KL; Bai, YM; Su, TP; Li, CT; Yang, AC; Tsai, SJ; Lin, WC; Chen, TJ				Liou, Ying-Jay; Wei, Han-Ting; Chen, Mu-Hong; Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Su, Tung-Ping; Li, Cheng-Ta; Yang, Albert C.; Tsai, Shih-Jen; Lin, Wei-Chen; Chen, Tzeng-Ji			Risk of Traumatic Brain Injury Among Children, Adolescents, and Young Adults With Attention-Deficit Hyperactivity Disorder in Taiwan	JOURNAL OF ADOLESCENT HEALTH			English	Article						ADHD; Traumatic brain injury; ADHD medications	DEFICIT/HYPERACTIVITY DISORDER; EXECUTIVE FUNCTION; ASSOCIATION; POPULATION; MEDICATION; ADHD; STIMULANT; BEHAVIOR	Purpose: Previous studies suggested that patients with attention-deficit hyperactivity disorder (ADHD) were prone to health-risk behaviors and accidents. However, the relationship of ADHD with the risk of traumatic brain injury (TBI) remained uncertain. Methods: Using the Taiwan National Health Insurance Research Database, 72,181 children (aged 3-11 years), adolescents (12-17 years), and young adults (18-29 years) with ADHD and 72,181 age-/sex matched controls were enrolled between 2001 and 2009, and followed up to the end of 2011 in our study. Those who developed any TBI during the follow-up period were identified. Results: Children, adolescents, and young adults with ADHD had a higher incidence of developing any TBI (9.8% vs. 2.2%, p < .001), such as skull fracture (.2% vs. .1%, p < .001) and concussion (4.3% vs. 1.0%, p < .001), than the controls did. Cox regression analysis with the adjustment of demographic data, psychiatric comorbidities, and ADHD medications showed that ADHD was related to an increased risk of subsequent TBI (hazard ratio: 4.57, 95% confidence interval: 4.31-4.85), and indicated that long-term use of ADHD medication was associated with a reduced likelihood of subsequent TBI (hazard ratio: .93, 95% confidence interval: .87.99). Conclusions: Patients with ADHD had an increased risk of developing any TBI compared with the controls. Long-term use of ADHD medications would reduce this risk. Our findings suggested that the public health government and clinicians should pay more attention to the TBI risk among patients with ADHD, and further indicated the importance of the optimal treatment for ADHD. (C) 2018 Society for Adolescent Health and Medicine. All rights reserved.	[Liou, Ying-Jay; Wei, Han-Ting; Chen, Mu-Hong; Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Su, Tung-Ping; Li, Cheng-Ta; Yang, Albert C.; Tsai, Shih-Jen; Lin, Wei-Chen] Taipei Vet Gen Hosp, Dept Psychiat, 201,Shih Pai Rd,Sec 2, Taipei 11217, Taiwan; [Liou, Ying-Jay; Chen, Mu-Hong; Hsu, Ju-Wei; Huang, Kai-Lin; Bai, Ya-Mei; Su, Tung-Ping; Li, Cheng-Ta; Yang, Albert C.; Tsai, Shih-Jen; Lin, Wei-Chen] Natl Yang Ming Univ, Dept Psychiat, Coll Med, Taipei, Taiwan; [Wei, Han-Ting] Taipei City Hosp, Div Psychiat, Kunming Branch, Taipei, Taiwan; [Wei, Han-Ting] Taipei City Hosp, Branch Linsen Chinese Med & Kunming, Taipei, Taiwan; [Su, Tung-Ping] Cheng Hsin Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Chen, Tzeng-Ji] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan		Liou, YJ; Chen, MH (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, 201,Shih Pai Rd,Sec 2, Taipei 11217, Taiwan.	yjliou@mail2000.com.tw; kremer7119@gmail.com	Chen, TJ/AAH-8430-2021; Tsai, Shih-Jen/AAK-7944-2020; Li, Cheng-Ta/AAI-5759-2021	Tsai, Shih-Jen/0000-0002-9987-022X; Li, Cheng-Ta/0000-0002-0670-1153; Chen, Mu-Hong/0000-0001-6516-1073	Taipei Veterans General HospitalTaipei Veterans General Hospital [V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181]	The study was supported by grant from Taipei Veterans General Hospital (V103E10-001, V104E10-002, V105E10-001-MY2-1, V105A-049, V106B-020, V107B-010, V107C-181). The funding source had no role in any process of our study.	Adeleye AO, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00695; Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Alosco ML, 2014, BRAIN INJURY, V28, P472, DOI 10.3109/02699052.2014.887145; [Anonymous], 1999, JAMA, V282, P974; [Anonymous], 2010, LANCET, V9, P331; Asherson P, 2016, LANCET PSYCHIAT, V3, P568, DOI 10.1016/S2215-0366(16)30032-3; Biederman J, 2015, J NERV MENT DIS, V203, P813, DOI 10.1097/NMD.0000000000000375; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chen MH, 2016, DIABETES CARE, V39, P788, DOI 10.2337/dc15-1807; Chen MH, 2015, BRIT J PSYCHIAT, V206, P302, DOI 10.1192/bjp.bp.113.143610; Chen VCH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173762; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faraone SV, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.20; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gobbo MA, 2014, EUR NEUROPSYCHOPHARM, V24, P1425, DOI 10.1016/j.euroneuro.2014.06.006; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Kieling RR, 2011, EUR PSYCHIAT, V26, P23, DOI 10.1016/j.eurpsy.2010.03.004; Lee SH, 2015, SE ASIAN J TROP MED, V46, P924; Li CT, 2012, BRIT J PSYCHIAT, V200, P45, DOI 10.1192/bjp.bp.110.086983; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Lin JW, 2008, ACT NEUR S, V101, P113; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Mikolajczyk R, 2015, JAMA PEDIATR, V169, P391, DOI 10.1001/jamapediatrics.2014.3275; Nikolas MA, 2016, J CHILD PSYCHOL PSYC, V57, P141, DOI 10.1111/jcpp.12491; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Philip P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138004; Pope CN, 2016, J DEV BEHAV PEDIATR, V37, P702, DOI 10.1097/DBP.0000000000000353; Pope CN, 2017, ACCIDENT ANAL PREV, V98, P123, DOI 10.1016/j.aap.2016.09.030; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Rowland AS, 2018, J CHILD PSYCHOL PSYC, V59, P213, DOI 10.1111/jcpp.12775; Vassallo JL, 2007, BRAIN INJURY, V21, P567, DOI 10.1080/02699050701426832; Wang YP, 2014, AM J PSYCHIAT, V171, P54, DOI 10.1176/appi.ajp.2013.12111467; Wilens TE, 2003, PEDIATRICS, V111, P179, DOI 10.1542/peds.111.1.179	35	21	21	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1054-139X	1879-1972		J ADOLESCENT HEALTH	J. Adolesc. Health	AUG	2018	63	2					233	238		10.1016/j.jadohealth.2018.02.012			6	Psychology, Developmental; Public, Environmental & Occupational Health; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Public, Environmental & Occupational Health; Pediatrics	GR4OQ	WOS:000442593400017	29970331				2022-02-06	
J	Olah, E; Poto, L; Hegyi, P; Szabo, I; Hartmann, P; Solymar, M; Petervari, E; Balasko, M; Habon, T; Rumbus, Z; Tenk, J; Rostas, I; Weinberg, J; Romanovsky, AA; Garami, A				Olah, Emoke; Poto, Laszlo; Hegyi, Peter; Szabo, Imre; Hartmann, Petra; Solymar, Margit; Petervari, Erika; Balasko, Marta; Habon, Tamas; Rumbus, Zoltan; Tenk, Judit; Rostas, Ildiko; Weinberg, Jordan; Romanovsky, Andrej A.; Garami, Andras			Therapeutic Whole-Body Hypothermia Reduces Death in Severe Traumatic Brain Injury if the Cooling Index Is Sufficiently High: Meta-Analyses of the Effect of Single Cooling Parameters and Their Integrated Measure	JOURNAL OF NEUROTRAUMA			English	Article						induced hypothermia; meta-analysis; mortality; thermoregulation; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; TERM MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; FEVER CONTROL; POSTTRAUMATIC HYPOTHERMIA; PREHOSPITAL HYPOTHERMIA; TEMPERATURE MANAGEMENT; CEREBRAL HYPOTHERMIA; AXONAL INJURY; HEAD	Therapeutic hypothermia was investigated repeatedly as a tool to improve the outcome of severe traumatic brain injury (TBI), but previous clinical trials and meta-analyses found contradictory results. We aimed to determine the effectiveness of therapeutic whole-body hypothermia on the deaths of adult patients with severe TBI by using a novel approach of meta-analysis. We searched the PubMed, EMBASE, and Cochrane Library databases from inception to February 2017. The identified human studies were evaluated regarding statistical, clinical, and methodological designs to ensure interstudy homogeneity. We extracted data on TBI severity, body temperature, death, and cooling parameters; then we calculated the cooling index, an integrated measure of therapeutic hypothermia. Forest plot of all identified studies showed no difference in the outcome of TBI between cooled and not cooled patients, but interstudy heterogeneity was high. On the contrary, by meta-analysis of randomized clinical trials that were homogenous with regard to statistical, clinical designs, and precisely reported the cooling protocol, we showed decreased odds ratio for death in therapeutic hypothermia compared with no cooling. As independent factors, milder and longer cooling, and rewarming at <0.25 degrees C/h were associated with better outcome. Therapeutic hypothermia was beneficial only if the cooling index (measure of combination of cooling parameters) was sufficiently high. We conclude that high methodological and statistical interstudy heterogeneity could underlie the contradictory results obtained in previous studies. By analyzing methodologically homogenous studies, we show that cooling improves the outcome of severe TBI, and this beneficial effect depends on certain cooling parameters and on their integrated measure, the cooling index.	[Olah, Emoke; Hegyi, Peter; Solymar, Margit; Petervari, Erika; Balasko, Marta; Rumbus, Zoltan; Tenk, Judit; Rostas, Ildiko; Garami, Andras] Univ Pecs, Inst Translat Med, Med Sch, 12 Szigeti St, H-7624 Pecs, Hungary; [Poto, Laszlo] Univ Pecs, Inst Bioanal, Med Sch, Pecs, Hungary; [Hegyi, Peter; Szabo, Imre] Univ Pecs, Med Sch, Div Gastroenterol, Dept Med 1, Pecs, Hungary; [Hegyi, Peter] Univ Szeged, Hungarian Acad Sci, Momentum Gastroenterol Multidisciplinary Res Grp, Szeged, Hungary; [Hartmann, Petra] Univ Szeged, Inst Surg Res, Szeged, Hungary; [Habon, Tamas] Univ Pecs, Med Sch, Dept Med 1, Dept Cardiol & Angiol, Pecs, Hungary; [Weinberg, Jordan; Romanovsky, Andrej A.] St Josephs Hosp, Trauma Res, Phoenix, AZ USA		Garami, A (corresponding author), Univ Pecs, Inst Translat Med, Med Sch, 12 Szigeti St, H-7624 Pecs, Hungary.	andras.garami@aok.pte.hu	Hartmann, Petra/AAZ-7881-2021; Habon, Tamas/S-9289-2019; Garami, Andras/AAF-8588-2020	Hartmann, Petra/0000-0002-4746-9792; Habon, Tamas/0000-0002-4816-857X; Garami, Andras/0000-0003-2493-0571; Romanovsky, Andrej/0000-0003-3772-8575	National Research, Development and Innovation OfficeNational Research, Development & Innovation Office (NRDIO) - Hungary [FK 124483]; New National Excellence Program of the Hungarian Ministry of Human Capacities [UNKP-17-4-III-PTE-33]; GINOP STAY ALIVE [2.3.2-15-2016-00048]; EFOP LIVE LONGER [3.6.2-16-2017-00006]	This research has been supported by the National Research, Development and Innovation Office (grant FK 124483), the New National Excellence Program of the Hungarian Ministry of Human Capacities (UNKP-17-4-III-PTE-33), GINOP STAY ALIVE (grant 2.3.2-15-2016-00048), and EFOP LIVE LONGER (grant 3.6.2-16-2017-00006).	Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Balvers Kirsten, 2016, J Emerg Trauma Shock, V9, P97, DOI 10.4103/0974-2700.185276; Bramlett HM, 2012, THER HYPOTHERMIA TEM, V2, P14, DOI 10.1089/ther.2012.0002; Bukur M, 2012, J TRAUMA ACUTE CARE, V73, P1195, DOI 10.1097/TA.0b013e31826fc7d9; Bukur M, 2012, J SURG RES, V175, P24, DOI 10.1016/j.jss.2011.07.003; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fay T, 1943, RES PUBL ASSOC RES N, V24, P611; Feng JF, 2010, NEUROSURGERY, V67, P730, DOI 10.1227/01.NEU.0000378023.81727.6E; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Garami A., 2018, ACTA PHYSL OXF, pprint; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hashiguchi N, 2003, J TRAUMA, V55, P1054, DOI 10.1097/01.TA.0000033252.43742.8B; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Hifumi T, 2016, J NEUROTRAUM, V33, P1047, DOI 10.1089/neu.2015.4033; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Lee BH, 2012, CRIT CARE, V16, DOI 10.1186/cc11211; Lee HC, 2010, WORLD NEUROSURG, V74, P654, DOI 10.1016/j.wneu.2010.06.019; Lei J, 2015, CONTEMP CLIN TRIALS, V40, P9, DOI 10.1016/j.cct.2014.11.008; Li PC, 2014, BRAIN INJURY, V28, P1036, DOI 10.3109/02699052.2014.910609; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; Liu YH, 2015, EXP THER MED, V9, P464, DOI 10.3892/etm.2014.2130; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI 10.14306/renhyd.20.2.223; Nichol A, 2015, CRIT CARE RESUSC, V17, P92; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2015, CIRCULATION, V132, P152, DOI 10.1161/CIRCULATIONAHA.115.017350; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; Rincon F, 2014, J NEUROSURG, V121, P950, DOI 10.3171/2014.7.JNS132470; Rumbus Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170152; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Shaefi Shahzad, 2016, Surg Neurol Int, V7, P103, DOI 10.4103/2152-7806.194816; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Smrcka M, 2005, ACT NEUR S, V95, P273; Steiner T, 2001, STROKE, V32, P2833, DOI 10.1161/hs1201.99511; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; Suehiro E, 2015, J NEUROTRAUM, V32, P353, DOI 10.1089/neu.2014.3584; Suehiro E, 2014, J NEUROTRAUM, V31, P315, DOI 10.1089/neu.2013.3057; Tang CH, 2017, J CRIT CARE, V39, P267, DOI 10.1016/j.jcrc.2016.12.012; Taylor CA, 2015, J HEAD TRAUMA REHAB, V30, P150, DOI 10.1097/HTR.0000000000000105; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Westermaier T, 2017, J NEUROL SURG PART A, V78, P397, DOI 10.1055/s-0036-1596057; Yokobori S, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0137-4; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhao WY, 2017, BRAIN RES, V1669, P141, DOI 10.1016/j.brainres.2017.06.006; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zhu YF, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2391-2	73	21	22	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2407	2417		10.1089/neu.2018.5649		JUL 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437231000001	29681213	Green Accepted			2022-02-06	
J	Poulin, A; Imboden, M; Sorba, F; Grazioli, S; Martin-Olmos, C; Rosset, S; Shea, H				Poulin, Alexandre; Imboden, Matthias; Sorba, Francesca; Grazioli, Serge; Martin-Olmos, Cristina; Rosset, Samuel; Shea, Herbert			An ultra-fast mechanically active cell culture substrate	SCIENTIFIC REPORTS			English	Article							DIELECTRIC ELASTOMER ACTUATORS; TRAUMATIC BRAIN-INJURY; IN-VITRO MODEL; STRETCHING DEVICE; MITRAL-VALVE; STRAIN; MECHANOBIOLOGY	We present a mechanically active cell culture substrate that produces complex strain patterns and generates extremely high strain rates. The transparent miniaturized cell stretcher is compatible with live cell microscopy and provides a very compact and portable alternative to other systems. A cell monolayer is cultured on a dielectric elastomer actuator (DEA) made of a 30 mu m thick silicone membrane sandwiched between stretchable electrodes. A potential difference of several kV's is applied across the electrodes to generate electrostatic forces and induce mechanical deformation of the silicone membrane. The DEA cell stretcher we present here applies up to 38% tensile and 12% compressive strain, while allowing real-time live cell imaging. It reaches the set strain in well under 1 ms and generates strain rates as high as 870 s(-1), or 87%/ms. With the unique capability to stretch and compress cells, our ultra-fast device can reproduce the rich mechanical environment experienced by cells in normal physiological conditions, as well as in extreme conditions such as blunt force trauma. This new tool will help solving lingering questions in the field of mechanobiology, including the strain-rate dependence of axonal injury and the role of mechanics in actin stress fiber kinetics.	[Poulin, Alexandre; Imboden, Matthias; Sorba, Francesca; Rosset, Samuel; Shea, Herbert] Ecole Polytech Fed Lausanne, Inst Microengn, CH-2002 Neuchatel, Switzerland; [Sorba, Francesca; Martin-Olmos, Cristina] Swiss Ctr Elect & Microtechnol CSEM, CH-2002 Neuchatel, Switzerland; [Grazioli, Serge] Univ Hosp Geneva, Div Neonatol & Pediat Intens Care Med, CH-1211 Geneva, Switzerland; [Grazioli, Serge] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland; [Rosset, Samuel] Univ Auckland, Bioengn Inst, Auckland 1010, New Zealand		Shea, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Microengn, CH-2002 Neuchatel, Switzerland.	herbert.shea@epfl.ch	Imboden, Matthias/B-5159-2008; Rosset, Samuel/X-9800-2019; Shea, Herbert/C-4744-2008	Imboden, Matthias/0000-0003-4629-4246; Rosset, Samuel/0000-0003-0624-1537; Poulin, Alexandre/0000-0003-0792-9149; Shea, Herbert/0000-0003-3527-3036; Sorba, Francesca/0000-0003-3584-3174	Swiss National Science Foundation (SNSF)Swiss National Science Foundation (SNSF) [CR32I3_166326, 200020_165993, PZ00P2_154900, 205321_153365]; Marie Sklodowska-Curie Action [H2020-MSCA-IF-2015, 701614]; Gertrude von Meissner Foundation [ME10683]	This work was supported by the Swiss National Science Foundation (SNSF) under the grants No. CR32I3_166326, 200020_165993, PZ00P2_154900 and 205321_153365, by the Marie Sklodowska-Curie Action H2020-MSCA-IF-2015 under the grant No. 701614, and by the Gertrude von Meissner Foundation under the grant No. ME10683.	Agrawal A, 2015, J MATER RES, V30, P453, DOI 10.1557/jmr.2014.392; Akbari S, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4793420; Akbari S, 2012, SENSOR ACTUAT A-PHYS, V186, P236, DOI 10.1016/j.sna.2012.01.030; Anderson IA, 2012, J APPL PHYS, V112, DOI 10.1063/1.4740023; Balakrisnan B., 2010, P SOC PHOTO-OPT INS; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; Bidan CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19804-1; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Carpi F, 2005, SMART MATER STRUCT, V14, P1210, DOI 10.1088/0964-1726/14/6/014; Carpi F, 2007, SMART MATER STRUCT, V16, pS300, DOI 10.1088/0964-1726/16/2/S15; Cei D, 2017, BIOINSPIR BIOMIM, V12, DOI 10.1088/1748-3190/12/1/016001; Davis CA, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029016; de Saint-Aubin C. A., 2017, SMART MATER STRUCT, V15; Deguchi S, 2015, AIP ADV, V5, DOI 10.1063/1.4922220; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Huang J, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3699261; Huang YL, 2013, BIOMED MICRODEVICES, V15, P1043, DOI 10.1007/s10544-013-9796-2; Imboden M., 2016, EUROEAP 2016; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Keplinger C, 2012, SOFT MATTER, V8, P285, DOI 10.1039/c1sm06736b; Khalili AA, 2015, INT J MOL SCI, V16, P18149, DOI 10.3390/ijms160818149; Kim DH, 2009, ANNU REV BIOMED ENG, V11, P203, DOI 10.1146/annurev-bioeng-061008-124915; Koh SJA, 2011, J POLYM SCI POL PHYS, V49, P504, DOI 10.1002/polb.22223; Kreutzer J, 2014, MED ENG PHYS, V36, P496, DOI 10.1016/j.medengphy.2013.09.008; Maffli L, 2015, ADV FUNCT MATER, V25, P1656, DOI 10.1002/adfm.201403942; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Marette A, 2017, ADV MATER, V29, DOI 10.1002/adma.201700880; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; O'Halloran A, 2008, J APPL PHYS, V104, DOI 10.1063/1.2981642; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Poulin A., 2018, P SOC PHOTO-OPT INS; Poulin A, 2016, LAB CHIP, V16, P3788, DOI 10.1039/c6lc00903d; Poulin A, 2015, PROC SPIE, V9430, DOI 10.1117/12.2083837; Rizzello G, 2015, J VIB ACOUST, V137, DOI 10.1115/1.4028456; Rosset S, 2016, APPL PHYS REV, V3, DOI 10.1063/1.4963164; Rosset S, 2016, JOVE-J VIS EXP, DOI 10.3791/53423; Rosset S, 2013, APPL PHYS A-MATER, V110, P281, DOI 10.1007/s00339-012-7402-8; Rosset S, 2009, ADV FUNCT MATER, V19, P470, DOI 10.1002/adfm.200801218; Sacks MS, 2002, ANN BIOMED ENG, V30, P1281, DOI 10.1114/1.1529194; Schurmann S, 2016, BIOSENS BIOELECTRON, V81, P363, DOI 10.1016/j.bios.2016.03.015; Seriani S, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4959884; Shian S, 2015, ADV MATER, V27, P6814, DOI 10.1002/adma.201503078; Simmons CS, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054016; Svennersten K, 2011, LAB CHIP, V11, P3287, DOI 10.1039/c1lc20436j; Tremblay D, 2014, BIOTECHNOL LETT, V36, P657, DOI 10.1007/s10529-013-1381-5; van Helvert S, 2018, NAT CELL BIOL, V20, P8, DOI 10.1038/s41556-017-0012-0; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Xu C, 2010, AM J PHYSIOL-HEART C, V299, pH1790, DOI 10.1152/ajpheart.00370.2010	52	21	22	4	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 2	2018	8								9895	10.1038/s41598-018-27915-y			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GL2LX	WOS:000436953900004	29967520	gold, Green Published, Green Submitted			2022-02-06	
J	Blakey, SM; Wagner, HR; Naylor, J; Brancu, M; Lane, I; Sallee, M; Kimbrel, NA; Elbogen, EB				Blakey, Shannon M.; Wagner, H. Ryan; Naylor, Jennifer; Brancu, Mira; Lane, Ilana; Sallee, Meghann; Kimbrel, Nathan A.; Elbogen, Eric B.		VA Mid-Atlantic MIRECC Workgrp	Chronic Pain, TBI, and PTSD in Military Veterans: A Link to Suicidal Ideation and Violent Impulses?	JOURNAL OF PAIN			English	Article						Chronic Pain; traumatic brain injury; posttraumatic stress disorder; suicide; violence	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; STRUCTURED CLINICAL INTERVIEW; MENTAL-HEALTH PROBLEMS; COMORBID CHRONIC PAIN; ABUSE SCREENING-TEST; RISK-FACTORS; RESIDENTIAL-TREATMENT; AFGHANISTAN VETERANS; ALCOHOL-CONSUMPTION	The polytrauma clinical triad refers to the co-occurrence of chronic pain, traumatic brain injury (TBI), and posttraumatic stress disorder (PTSD). Despite research implicating dyadic relationships between these conditions and adverse outcomes, scant research has examined the polytrauma clinical triad's relation to suicide or violence. The present cross-sectional study was designed to examine whether this complex clinical presentation increases risk of suicidal ideation and violent impulses after accounting for other established risk factors. Veterans who served in the military since September 11, 2001 (N = 667) who reported chronic pain completed an interview and self-report battery. Bivariate analyses showed that suicidal ideation and violent impulses both correlated with PTSD, TBI+PTSD, pain intensity and interference, drug abuse, and major depressive disorder (MDD). Multiple regression analyses showed that: 1) race, chronic pain with PTSD, alcohol abuse, and MDD significantly predicted suicidal ideation, 2) pain interference, chronic pain with TBI, chronic pain with PTSD, chronic pain with TBI+PTSD, drug abuse, and MDD significantly predicted violent impulses, and 3) pain interference was a more critical predictor of suicidal and violent ideation than pain intensity. Implications for risk assessment and treatment are discussed. Perspective: This article presents results from a study examining predictors of suicide and violence risk among a sample of post-9/11 U.S. Veterans with chronic pain. Health care professionals should assess for pain interference, TB!, PTSD, depression, and alcohol/drug abuse when conducting risk assessments with this population. (C) 2018 by the American Pain Society	[Blakey, Shannon M.] Univ North Carolina Chapel Hill, Dept Psychol & Neurosci, Davie Hall CB 3270, Chapel Hill, NC 27599 USA; [Wagner, H. Ryan; Naylor, Jennifer; Brancu, Mira; Kimbrel, Nathan A.; Elbogen, Eric B.] Mental Illness Res Educ & Clin Ctr, Vet Affairs Midatlantic, Durham, NC USA; [Wagner, H. Ryan; Naylor, Jennifer; Brancu, Mira; Lane, Ilana; Sallee, Meghann; Kimbrel, Nathan A.; Elbogen, Eric B.] Durham VA Med Ctr, Durham, NC USA; [Wagner, H. Ryan; Naylor, Jennifer; Brancu, Mira; Kimbrel, Nathan A.; Elbogen, Eric B.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA		Blakey, SM (corresponding author), Univ North Carolina Chapel Hill, Dept Psychol & Neurosci, Davie Hall CB 3270, Chapel Hill, NC 27599 USA.	sblakey@unc.edu		Blakey, Shannon/0000-0002-9291-3688	VA Mid-Atlantic Mental Illness Research, Education and Clinical Center; National Center for Complementary and Integrative Health [R34 AT008399-01]; Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardUS Department of Veterans Affairs [1IK2RX000908]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R34AT008399] Funding Source: NIH RePORTER	Preparation of this report was supported by the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center and a grant from National Center for Complementary and Integrative Health (R34 AT008399-01). Dr. Naylor was funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (1IK2RX000908).	Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Babor TF, 2001, MONTEIRO MG ALCOHOL; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Beck AT., 1991, MANUAL BECK SCALE SU; Bohnert ASB, 2014, CLIN J PAIN, V30, P605, DOI 10.1097/AJP.0000000000000011; BONGAR B, 1992, SUICIDE GUIDELINES A; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1097/00000374-199811000-00034; Brancu M, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1570; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Buckenmaier CC, 2013, PAIN MED, V14, P110, DOI 10.1111/j.1526-4637.2012.01516.x; Calati R, 2015, J PSYCHIATR RES, V71, P16, DOI 10.1016/j.jpsychires.2015.09.004; Caldeiro RM, 2008, ADDICTION, V103, P1996, DOI 10.1111/j.1360-0443.2008.02358.x; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; CLEELAND CS, 1991, EFFECT CANC QUALITY; Cochrane-Brink KA, 2000, GEN HOSP PSYCHIAT, V22, P445, DOI 10.1016/S0163-8343(00)00106-7; Cuijpers P, 2014, AM J PSYCHIAT, V171, P453, DOI 10.1176/appi.ajp.2013.13030325; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; Duchnick JJ, 2015, PSYCHOL SERV, V12, P313, DOI 10.1037/ser0000034; Elbogen EB, 2018, PSYCHOL ASSESSMENT, V30, P425, DOI 10.1037/pas0000490; Fazel S, 2015, LANCET PSYCHIAT, V2, P224, DOI 10.1016/S2215-0366(14)00128-X; Finkel EJ, 2014, ADV EXP SOC PSYCHOL, V49, P1, DOI 10.1016/B978-0-12-800052-6.00001-9; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Fishbain DA, 2009, PAIN MED, V10, P573, DOI 10.1111/j.1526-4637.2009.00606.x; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gradus JL, 2015, J TRAUMA STRESS, V28, P361, DOI 10.1002/jts.22021; Guerra VS, 2011, J ANXIETY DISORD, V25, P12, DOI 10.1016/j.janxdis.2010.06.025; Heilbrun K, 2010, INT PERSP FOREN MENT, P1; Helmer DA, 2009, PAIN MED, V10, P1174, DOI 10.1111/j.1526-4637.2009.00723.x; Higgins DM, 2014, PAIN MED, V15, P782, DOI 10.1111/pme.12388; Howe CQ, 2014, GEN HOSP PSYCHIAT, V36, P99, DOI 10.1016/j.genhosppsych.2013.10.003; Ilgen MA, 2013, JAMA PSYCHIAT, V70, P692, DOI 10.1001/jamapsychiatry.2013.908; Ilgen MA, 2010, SUICIDE LIFE-THREAT, V40, P597, DOI 10.1521/suli.2010.40.6.597; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Joiner T.E., 2005, WHY PEOPLE DIE SUICI; Kanzler KE, 2012, PAIN PRACT, V12, P602, DOI 10.1111/j.1533-2500.2012.00542.x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kelley ML, 2013, DRUG ALCOHOL DEPEN, V133, P615, DOI 10.1016/j.drugalcdep.2013.08.002; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; Marshall AD, 2005, CLIN PSYCHOL REV, V25, P862, DOI 10.1016/j.cpr.2005.05.009; Martell C. R., 2010, BEHAV ACTIVATION DEP; Mosher HJ, 2015, J GEN INTERN MED, V30, P597, DOI 10.1007/s11606-014-3143-z; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; O'Mahony S, 2005, J PAIN SYMPTOM MANAG, V29, P446, DOI 10.1016/j.jpainsymman.2004.08.010; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Otis JD, 2009, PAIN MED, V10, P1300, DOI 10.1111/j.1526-4637.2009.00715.x; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P720, DOI 10.1016/j.jpsychires.2010.11.015; Placidi GPA, 2001, BIOL PSYCHIAT, V50, P783, DOI 10.1016/S0006-3223(01)01170-2; Plagge JM, 2013, PAIN MED, V14, P1164, DOI 10.1111/pme.12155; Pompili M, 2013, J NERV MENT DIS, V201, P802, DOI 10.1097/NMD.0b013e3182a21458; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rogers RG, 2001, HDB DIAGNOSTIC STRUC, P103; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Runnals JJ, 2013, PAIN MED, V14, P1529, DOI 10.1111/pme.12208; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schry AR, 2015, PSYCHOL SERV, V12, P384, DOI 10.1037/ser0000053; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; SUMMERS JD, 1991, PAIN, V47, P183, DOI 10.1016/0304-3959(91)90203-A; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Vasterling JJ, 2018, J NEUROPSYCH CLIN N, V30, P91, DOI 10.1176/appi.neuropsych.17090180; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Watkins LE, 2017, J PSYCHIATR RES, V87, P8, DOI 10.1016/j.jpsychires.2016.12.009; Wilder CM, 2016, J ADDICT DIS, V35, P42, DOI 10.1080/10550887.2016.1107264; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	82	21	23	1	9	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	JUL	2018	19	7					797	806		10.1016/j.jpain.2018.02.012			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GM3JD	WOS:000438000000009	29526669	Green Accepted			2022-02-06	
J	Schumacher, DJ; Holmboe, ES; van der Vleuten, C; Busari, JO; Carraccio, C				Schumacher, Daniel J.; Holmboe, Eric S.; van der Vleuten, Cees; Busari, Jamiu O.; Carraccio, Carol			Developing Resident-Sensitive Quality Measures: A Model From Pediatric Emergency Medicine	ACADEMIC MEDICINE			English	Article							PATIENT OUTCOMES; EDUCATION; CARE; PERFORMANCE; IMPROVEMENT; PROGRAMS	Purpose To begin closing the gap with respect to quality measures available for use among residents, the authors sought to identify and develop resident-sensitive quality measures (RSQMs) for use in the pediatric emergency department (PED) setting. Method In May 2016, the authors reviewed National Quality Measures Clearinghouse (NQMC) measures to identify resident-sensitive measures. To create additional measures focused on common, acute illnesses (acute asthma exacerbation, bronchiolitis, closed head injury [CHI]) in the PED, the authors used a nominal group technique (NGT) and Delphi process from September to December 2016. To achieve a local focus for developing these measures, all NGT and Delphi participants were from Cincinnati Children's Hospital Medical Center. Delphi participants rated measures developed through the NGT in two areas: importance of measure to quality care and likelihood that measure represents the work of a resident. Result The review of NQMC measures identified 28 of 183 as being potentially resident sensitive. The NGT produced 67 measures for asthma, 46 for bronchiolitis, and 48 for CHI. These were used in the first round of the Delphi process. After two rounds, 18 measures for asthma, 21 for bronchiolitis, and 21 for CHI met automatic inclusion criteria. In round three, participants categorized the potential final measures by their top 10 and next 5. Conclusions This study describes a template for identifying and developing RSQMs that may promote high-quality care delivery during and following training. Next steps should include implementing and seeking validity evidence for the locally developed measures.	[Schumacher, Daniel J.] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA; [Holmboe, Eric S.] Accreditat Council Grad Med Educ, Milestones Dev & Evaluat, Chicago, IL USA; [van der Vleuten, Cees] Maastricht Univ, Dept Educ Dev & Res, Fac Hlth Med & Life Sci, Educ, Maastricht, Netherlands; [van der Vleuten, Cees] Maastricht Univ, Sch Hlth Profess Educ, Maastricht, Netherlands; [Busari, Jamiu O.] Maastricht Univ, Maastricht, Netherlands; [Busari, Jamiu O.] Maastricht Univ, Med Educ, Maastricht, Netherlands; [Carraccio, Carol] Amer Board Pediat Inc, Competency Based Assessment, Chapel Hill, NC USA		Schumacher, DJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, MLC 2008,3333 Burnet Ave, Cincinnati, OH 45226 USA.	daniel.schumacher@cchmc.org	Busari, Jamiu/C-9425-2018; Busari, JO/AAI-1935-2020	Busari, Jamiu/0000-0002-8616-5564; 	Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center	This study was supported by the Division of Emergency Medicine at Cincinnati Children's Hospital Medical Center.	Agency for Healthcare Research and Quality, SEARCH RES EM DEP; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Bansal N, 2016, JAMA SURG, V151, P111, DOI 10.1001/jamasurg.2015.3637; Berenson R., 2013, ACHIEVING POTENTIAL; Butler JM, 2017, ACAD MED, V92, P984, DOI 10.1097/ACM.0000000000001474; Chen C, 2014, JAMA-J AM MED ASSOC, V312, P2385, DOI 10.1001/jama.2014.15973; Committee on the Governance and Financing of Graduate Medical Education Board on Health Care Services Institute of Medicine., 2014, GRAD MED ED MEETS NA; Cook DA, 2013, ACAD MED, V88, P162, DOI 10.1097/ACM.0b013e31827c3d78; Cordasco KM, 2009, ARE RESIDENCY PROGRA; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Haan CK, 2008, ACAD MED, V83, P574, DOI 10.1097/ACM.0b013e318172318d; Hsu CC, 2007, PRACT ASSESS RES EVA, V12; Humphrey-Murto S, 2017, ACAD MED, V92, P1491, DOI 10.1097/ACM.0000000000001812; Inaba K, 2010, J TRAUMA, V68, P19, DOI 10.1097/TA.0b013e3181b88dfe; Kalet AL, 2010, ACAD MED, V85, P844, DOI 10.1097/ACM.0b013e3181d734a5; Kauvar DS, 2006, J SURG RES, V132, P159, DOI 10.1016/j.jss.2005.11.578; Medicare Payment Advisory Commission, 2009, C IMPR INC MED PROGR; MedPAC (Payment Advisory Commission), 2010, REP C AL INC MED, P103; Mittiga Matthew R, 2010, J Grad Med Educ, V2, P571, DOI 10.4300/JGME-D-10-00106.1; Moreau KA, 2015, MED TEACH, V37, P1060, DOI 10.3109/0142159X.2015.1060307; Phillips DP, 2010, J GEN INTERN MED, V25, P774, DOI 10.1007/s11606-010-1356-3; Resnick AS, 2008, J SURG EDUC, V65, P243, DOI 10.1016/j.jsurg.2008.01.005; Sandars J, 2011, MED TEACH, V33, P875, DOI 10.3109/0142159X.2011.595434; Schon DA., 1983, REFLECTIVE PRACTITIO, V1; Swing SR, 2007, ACAD EMERG MED, V14, P463, DOI 10.1197/j.aem.2006.12.011; van der Leeuw RM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-65; Van Melle E, 2017, ACAD MED, V92, P752, DOI 10.1097/ACM.0000000000001479; Wiest FC, 2002, JAMA-J AM MED ASSOC, V288, P2609, DOI 10.1001/jama.288.20.2609; Yin HS, 2015, J GEN INTERN MED, V30, P1363, DOI 10.1007/s11606-015-3329-z	29	21	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-2446	1938-808X		ACAD MED	Acad. Med.	JUL	2018	93	7					1071	1078		10.1097/ACM.0000000000002093			8	Education, Scientific Disciplines; Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Education & Educational Research; Health Care Sciences & Services	GL5WU	WOS:000437245700030	29215378	Bronze			2022-02-06	
J	Storey, EP; Wiebe, DJ; D'Alonzo, BA; Nixon-Cave, K; Jackson-Coty, J; Goodman, AM; Grady, MF; Master, CL				Storey, Eileen P.; Wiebe, Douglas J.; D'Alonzo, Bernadette A.; Nixon-Cave, Kim; Jackson-Coty, Janet; Goodman, Arlene M.; Grady, Matthew F.; Master, Christina L.			Vestibular Rehabilitation Is Associated With Visuovestibular Improvement in Pediatric Concussion	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						concussion; children; human movement system; vestibular rehabilitation; visuovestibular system	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; HIGH-SCHOOL; FOOTBALL PLAYERS; PROTRACTED RECOVERY; PHYSICAL-THERAPY; NORMATIVE DATA; BALANCE; RELIABILITY	Background and Purpose: Vision and vestibular-related deficits are common after concussion and are associated with prolonged recovery times, substantially impacting the quality of life for children. The utility of targeted vestibular rehabilitation for these deficits in children after concussion is unknown. The purpose of this study was to determine whether active vestibular rehabilitation is associated with an improvement in visuovestibular signs and symptoms in children with concussion. Methods: A retrospective cohort study of children diagnosed with concussion and referred to vestibular rehabilitation between 2012 and 2014 was conducted. Patient-reported symptoms and visuovestibular performance measures were assessed in the medical practice and physical therapy settings. Results: One hundred nine children were included in the study with a mean age of 11.8 (3.4) years. Among this group, 59 (54%) were male and 48 (44%) had a sports-related concussion. Children presented to a pediatric sports medicine office and physical therapy a median of 24 (interquartile range [IQR], 14-42) and 55 (IQR, 39-94) days after injury, respectively. Concussion symptoms decreased from a median of 9 (IQR, 5-13) symptoms at initial evaluation to a median of 0 (IQR, 0-2) symptoms at final assessment. Performance on all visuovestibular tasks improved significantly over the course of therapy except for near point of convergence. For the 45 children who completed the Balance Error Scoring System at both initial and final therapy visits, there was a significant improvement in mean level of performance (P < 0.0001). Characteristics between those who completed a full versus partial course of physical therapy were similar. Discussion and Conclusions: Vestibular rehabilitation in children with concussion is associated with improvement in symptoms as well as visuovestibular performance. This active intervention may benefit children with persistent symptoms after concussion. Future prospective studies are needed to determine the efficacy and optimal postinjury timing of vestibular rehabilitation. Video Abstract available for more insights from the authors (see Supplemental Digital Content 1, available at: http://links.lww.com/JNPT/A208).	[Storey, Eileen P.; Nixon-Cave, Kim; Jackson-Coty, Janet; Grady, Matthew F.; Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Div Orthopaed, 34th & Civ Ctr Blvd,Wood Bldg,2nd Floor, Philadelphia, PA 19104 USA; [Grady, Matthew F.; Master, Christina L.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Goodman, Arlene M.] St Peters Sports Med Inst, Somerset, NJ USA; [Wiebe, Douglas J.; D'Alonzo, Bernadette A.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA		Master, CL (corresponding author), Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Div Orthopaed, 34th & Civ Ctr Blvd,Wood Bldg,2nd Floor, Philadelphia, PA 19104 USA.	masterc@email.chop.edu		D'Alonzo, Bernadette/0000-0002-3760-2158; Master, Christina/0000-0002-6717-4270			Aligene K, 2013, NEUROREHABILITATION, V32, P543, DOI 10.3233/NRE-130876; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Badke MB, 2004, ARCH PHYS MED REHAB, V85, P227, DOI 10.1016/j.apmr.2003.06.006; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Brown KE, 2006, ARCH PHYS MED REHAB, V87, P76, DOI 10.1016/j.apmr.2005.08.003; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Corwin DJ, 2018, BRAIN INJURY, V32, P794, DOI 10.1080/02699052.2018.1458150; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cushman D, 2018, BRAIN INJURY, V32, P569, DOI 10.1080/02699052.2018.1432891; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Faul M, 2010, TRAUMATIC BRAIN INJU; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gaikwad SB, 2018, J NEUROL PHYS THER, V42, P72, DOI 10.1097/NPT.0000000000000216; Gilchrist J, MMWR MORB MORTAL WKL, V60, P1337; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Greenwald BD, 2013, NEUROREHABILITATION, V32, P433, DOI 10.3233/NRE-130865; Gurley JM, 2013, NEUROREHABILITATION, V32, P519, DOI 10.3233/NRE-130874; Hall CD, 2009, OTOLARYNG CLIN N AM, V42, P161, DOI 10.1016/j.otc.2008.09.006; Han BI, 2011, J CLIN NEUROL, V7, P184, DOI 10.3988/jcn.2011.7.4.184; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayes GJ, 1998, OPTOMETRY VISION SCI, V75, P506, DOI 10.1097/00006324-199807000-00019; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kaufman DR, 2014, PHYS THER SPORT, V15, P181, DOI 10.1016/j.ptsp.2013.10.002; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Medeiros IRT, 2005, OTOL NEUROTOL, V26, P699, DOI 10.1097/01.mao.0000169051.69254.85; Moran RN, 2018, AM J SPORT MED, V46, P1475, DOI 10.1177/0363546518756979; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; O'Reilly RC, 2010, OTOL NEUROTOL, V31, P1441, DOI 10.1097/MAO.0b013e3181f20673; Rine RM, 2013, NEUROREHABILITATION, V32, P507, DOI 10.3233/NRE-130873; Scheiman M, 2003, OPTOMETRY VISION SCI, V80, P214, DOI 10.1097/00006324-200303000-00011; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Whitney SL, 2011, NEUROREHABILITATION, V29, P157, DOI 10.3233/NRE-2011-0690; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	51	21	22	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2018	42	3			SI		134	141		10.1097/NPT.0000000000000228			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GL1OM	WOS:000436873100004	29912034				2022-02-06	
J	Tiruvoipati, R; Pilcher, D; Botha, J; Buscher, H; Simister, R; Bailey, M				Tiruvoipati, Ravindranath; Pilcher, David; Botha, John; Buscher, Hergen; Simister, Robert; Bailey, Michael			Association of Hypercapnia and Hypercapnic Acidosis With Clinical Outcomes in Mechanically Ventilated Patients With Cerebral Injury	JAMA NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ARTERIAL CARBON-DIOXIDE; POSTRESUSCITATION PARTIAL-PRESSURE; HOSPITAL CARDIAC-ARREST; SUBARACHNOID HEMORRHAGE; PERMISSIVE HYPERCAPNIA; BLOOD-PH; ISCHEMIA; IMPACT; DEATH	IMPORTANCE Clinical studies investigating the effects of hypercapnia and hypercapnic acidosis in acute cerebral injury are limited. The studies performed so far have mainly focused on the outcomes in relation to the changes in partial pressure of carbon dioxide and pH in isolation and have not evaluated the effects of partial pressure of carbon dioxide and pH in conjunction. OBJECTIVE To review the association of compensated hypercapnia and hypercapnic acidosis during the first 24 hours of intensive care unit admission on hospital mortality in adult mechanically ventilated patients with cerebral injury. DESIGN, SETTING, AND PARTICIPANTS Multicenter, binational retrospective review of patients with cerebral injury (traumatic brain injury, cardiac arrest, and stroke) admitted to 167 intensive care units in Australia and New Zealand between January 2000 and December 2015. Patients were classified into 3 groups based on combination of arterial pH and arterial carbon dioxide (normocapnia and normal pH, compensated hypercapnia, and hypercapnic acidosis) during the first 24 hours of intensive care unit stay. MAIN OUTCOMES AND MEASURES Hospital mortality. RESULTS A total of 30 742 patients (mean age, 55 years; 21 827 men [71%]) were included. Unadjusted hospital mortality rates were highest in patients with hypercapnic acidosis. Multivariable logistic regression analysis and Cox proportional hazards analysis in 3 diagnostic categories showed increased odds of hospital mortality (cardiac arrest odds ratio [OR], 1.51; 95% CI, 1.34-1.71; stroke OR, 1.43; 95% CI, 1.27-1.6; and traumatic brain injury OR, 1.22; 95% CI, 1.06-1.42; P < .001) and hazard ratios (HR) (cardiac arrest HR, 1.23; 95% CI, 1.14-1.34; stroke HR, 1.3; 95% CI, 1.21-1.4; traumatic brain injury HR, 1.13; 95% CI, 1-1.27), in patients with hypercapnic acidosis compared with normocapnia and normal pH. There was no difference in mortality between patients who had compensated hypercapnia compared with patients who had normocapnia and normal pH. In patients with hypercapnic acidosis, the adjusted OR of hospital mortality increased with increasing partial pressure of carbon dioxide, while no such increase was noted in patients with compensated hypercapnia. CONCLUSIONS AND RELEVANCE Hypercapnic acidosis was associated with increased risk of hospital mortality in patients with cerebral injury. Hypercapnia, when compensated to normal pH during the first 24 hours of intensive care unit admission, may not be harmful in mechanically ventilated patients with cerebral injury.	[Tiruvoipati, Ravindranath; Botha, John] Frankston Hosp, Dept Intens Care Med, Frankston, Vic 3199, Australia; [Tiruvoipati, Ravindranath; Botha, John] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Tiruvoipati, Ravindranath; Pilcher, David; Bailey, Michael] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med,Alfred Ctr, Victoria, Melbourne, Vic, Australia; [Pilcher, David; Bailey, Michael] Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Sydney, NSW, Australia; [Pilcher, David] Alfred Hosp, Dept Intens Care, Prahran, Vic, Australia; [Buscher, Hergen] St Vincents Hosp, Dept Intens Care Med, Sydney, NSW, Australia; [Buscher, Hergen] Univ New South Wales, Sydney, NSW, Australia; [Simister, Robert] Univ Coll London Hosp NHS Fdn Trust, Inst Neurol, London, England		Tiruvoipati, R (corresponding author), Frankston Hosp, Dept Intens Care Med, Frankston, Vic 3199, Australia.	travindranath@hotmail.com	Bailey, Michael J/A-4499-2012; Tiruvoipati, Ravindranath/Q-9365-2019; Buscher, Hergen/O-8513-2019	Bailey, Michael J/0000-0002-5551-1401; Buscher, Hergen/0000-0002-4531-6151; Tiruvoipati, Ravindranath/0000-0003-3800-902X			Bennett KS, 2013, CRIT CARE MED, V41, P1534, DOI 10.1097/CCM.0b013e318287f54c; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; CHRISTENSEN MS, 1972, EUR NEUROL, V8, P137, DOI 10.1159/000114566; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Eastwood GM, 2016, RESUSCITATION, V104, P83, DOI 10.1016/j.resuscitation.2016.03.023; Eastwood GM, 2016, RESUSCITATION, V102, P11, DOI 10.1016/j.resuscitation.2016.02.009; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; KATSURA K, 1991, J CEREBR BLOOD F MET, V11, P597, DOI 10.1038/jcbfm.1991.109; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; McKenzie N, 2017, RESUSCITATION, V111, P116, DOI 10.1016/j.resuscitation.2016.09.019; Momiyama Y, 2017, ACUTE MED SURG, V4, P25, DOI 10.1002/ams2.217; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; O'Croinin D, 2005, CRIT CARE, V9, P51, DOI 10.1186/cc2918; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Roberts BW, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-9; Roberts BW, 2013, CIRCULATION, V127, P2107, DOI 10.1161/CIRCULATIONAHA.112.000168; Sathianathan Kushaharan, 2016, World J Crit Care Med, V5, P103, DOI 10.5492/wjccm.v5.i1.103; Schneider AG, 2013, RESUSCITATION, V84, P927, DOI 10.1016/j.resuscitation.2013.02.014; Solaiman O, 2013, J NEUROSURG ANESTH, V25, P254, DOI 10.1097/ANA.0b013e3182806465; Takaki S, 2013, J EMERG MED, V45, P57, DOI 10.1016/j.jemermed.2012.11.095; Tolner EA, 2011, EPILEPSIA, V52, P104, DOI 10.1111/j.1528-1167.2010.02731.x; Vaahersalo J, 2014, CRIT CARE MED, V42, P1463, DOI 10.1097/CCM.0000000000000228; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Westermaier T, 2014, J NEUROSURG, V121, P1056, DOI 10.3171/2014.7.JNS132611; Zhou Q, 2010, ANESTHESIOLOGY, V112, P288, DOI 10.1097/ALN.0b013e3181ca8257	32	21	21	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	JUL	2018	75	7					818	826		10.1001/jamaneurol.2018.0123			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM5DB	WOS:000438149400010	29554187	Bronze, Green Published			2022-02-06	
J	Tolonen, A; Sarkela, MOK; Takala, RSK; Katila, A; Frantzen, J; Posti, JP; Muller, M; van Gils, M; Tenovuo, O				Tolonen, Antti; Sarkela, Mika O. K.; Takala, Riikka S. K.; Katila, Ari; Frantzen, Janek; Posti, Jussi P.; Muller, Markus; van Gils, Mark; Tenovuo, Olli			Quantitative EEG Parameters for Prediction of Outcome in Severe Traumatic Brain Injury: Development Study	CLINICAL EEG AND NEUROSCIENCE			English	Article						traumatic brain injury; continuous electroencephalography; quantitative electroencephalography; prognosis; outcome	SOMATOSENSORY-EVOKED POTENTIALS; PERCENT-ALPHA-VARIABILITY; CONTINUOUS ELECTROENCEPHALOGRAPHY; CONSENSUS STATEMENT; QUANTIFICATION	Monitoring of quantitative EEG (QEEG) parameters in the intensive care unit (ICU) can aid in the treatment of traumatic brain injury (TBI) patients by complementing visual EEG review done by an expert. We performed an explorative study investigating the prognostic value of 59 QEEG parameters in predicting the outcome of patients with severe TBI. Continuous EEG recordings were done on 28 patients with severe TBI in the ICU of Turku University Hospital. We computed a set of QEEG parameters for each patient, and correlated these to patient outcome, measured by dichotomized Glasgow Outcome Scale (GOS) at a follow-up visit between 6 and 12 months, using area under receiver operating characteristic curve (AUC) as a nonlinear correlation measure. For 17 of the 59 QEEG parameters (28.8%), the AUC differed significantly from 0.5, most of these parameters measured EEG power or variability. The best QEEG parameters for outcome prediction were alpha power (AUC = 0.87, P < .01) and variability of the relative fast theta power (AUC = 0.84, P < .01). The results of this study indicate that QEEG parameters provide useful information for predicting outcome in severe TBI. Novel QEEG parameters with potential in outcome prediction were found, the prognostic value of these parameters should be confirmed in later studies. The results also provide further evidence of the usefulness of parameters studied in preexisting studies.	[Tolonen, Antti; van Gils, Mark] VTT Tech Res Ctr Finland Ltd, Tekniikankatu 1,POB 1300, FI-33101 Tampere, Finland; [Sarkela, Mika O. K.; Posti, Jussi P.] GE Healthcare Finland Oy, Helsinki, Finland; [Takala, Riikka S. K.; Katila, Ari; Posti, Jussi P.; Tenovuo, Olli] Univ Turku, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari; Frantzen, Janek; Posti, Jussi P.; Muller, Markus; Tenovuo, Olli] Turku Univ Hosp, Turku, Finland		Tolonen, A (corresponding author), VTT Tech Res Ctr Finland Ltd, Tekniikankatu 1,POB 1300, FI-33101 Tampere, Finland.	antti.tolonen@vtt.fi	Sarkela, Mika/AAJ-6496-2020; Posti, Jussi P./Y-2908-2019	Sarkela, Mika/0000-0001-6817-2093; Posti, Jussi P./0000-0002-5925-5193; van Gils, Mark/0000-0002-0029-1771			[Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; BRICOLO A, 1978, ELECTROEN CLIN NEURO, V45, P211, DOI 10.1016/0013-4694(78)90005-6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carter BG, 2005, INTENS CARE MED, V31, P765, DOI 10.1007/s00134-005-2633-1; Carter BG, 2001, CRIT CARE MED, V29, P178, DOI 10.1097/00003246-200101000-00036; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Dunham CM, 2006, CRIT CARE, V10, DOI 10.1186/cc5097; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Hebb MO, 2007, J NEUROTRAUM, V24, P579, DOI 10.1089/neu.2006.0146; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; INOUYE T, 1991, ELECTROEN CLIN NEURO, V79, P204, DOI 10.1016/0013-4694(91)90138-T; Kaplan PW, 1999, CLIN NEUROPHYSIOL, V110, P205, DOI 10.1016/S1388-2457(98)00046-7; Kirkman Matthew A, 2012, Anesthesiol Clin, V30, P269, DOI 10.1016/j.anclin.2012.05.007; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MOULTON RJ, 1988, CAN J NEUROL SCI, V15, P82, DOI 10.1017/S0317167100027244; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Sarkela Mika, 2002, J Clin Monit Comput, V17, P125, DOI 10.1023/A:1016393904439; Sarkela MOK, 2007, ANESTHESIOLOGY, V107, P928; Steudel W I, 1979, Acta Neurochir Suppl (Wien), V28, P40; Stewart J, 2014, LIVER TRANSPLANT, V20, P1256, DOI 10.1002/lt.23944; Tanner AEJ, 2014, J CLIN NEUROPHYSIOL, V31, P181, DOI 10.1097/WNP.0000000000000049; Thatcher R W, 1991, Ann N Y Acad Sci, V620, P82, DOI 10.1111/j.1749-6632.1991.tb51576.x; van Putten MJAM, 2007, CLIN NEUROPHYSIOL, V118, P2362, DOI 10.1016/j.clinph.2007.07.019; Vespa PM, 2002, J NEUROSURG, V97, P84, DOI 10.3171/jns.2002.97.1.0084; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 2000, J CLIN NEUROPHYSIOL, V17, P473, DOI 10.1097/00004691-200009000-00006; [No title captured]	29	21	25	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1550-0594	2169-5202		CLIN EEG NEUROSCI	Clin. EEG Neurosci.	JUL	2018	49	4					248	257		10.1177/1550059417742232			10	Clinical Neurology; Neurosciences; Neuroimaging; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	GH6DZ	WOS:000433534500004	29172703				2022-02-06	
J	Dreizin, D; Bodanapally, U; Boscak, A; Tirada, N; Issa, G; Nascone, JW; Bivona, L; Mascarenhas, D; O'Toole, RV; Nixon, E; Chen, R; Siegel, E				Dreizin, David; Bodanapally, Uttam; Boscak, Alexis; Tirada, Nikki; Issa, Ghada; Nascone, Jason W.; Bivona, Louis; Mascarenhas, Daniel; O'Toole, Robert V.; Nixon, Erika; Chen, Rong; Siegel, Eliot			CT Prediction Model for Major Arterial Injury after Blunt Pelvic Ring Disruption	RADIOLOGY			English	Article							MULTIDETECTOR CT; ACTIVE EXTRAVASATION; COMPUTED-TOMOGRAPHY; ABDOMINAL-TRAUMA; HEMORRHAGE; FRACTURE; ANGIOGRAPHY; EMBOLIZATION; MANAGEMENT; UPDATE	Purpose: To develop and test a computed tomography (CT)-based predictive model for major arterial injury after blunt pelvic ring disruptions that incorporates semiautomated pelvic hematoma volume quantification. Materials and Methods: A multivariable logistic regression model was developed in patients with blunt pelvic ring disruptions who underwent arterial phase abdominopelvic CT before angiography from 2008 to 2013. Arterial injury at angiography requiring transarterial embolization (TAE) served as the outcome. Areas under the receiver operating characteristic (ROC) curve (AUCs) for the model and for two trauma radiologists were compared in a validation cohort of 36 patients from 2013 to 2015 by using the Hanley-McNeil method. Hematoma volume cutoffs for predicting the need for TAE and probability cutoffs for the secondary outcome of mortality not resulting from closed head injuries were determined by using ROC analysis. Correlation between hematoma volume and transfusion was assessed by using the Pearson coefficient. Results: Independent predictor variables included hematoma volume, intravenous contrast material extravasation, atherosclerosis, rotational instability, and obturator ring fracture. In the validation cohort, the model (AUC, 0.78) had similar performance to reviewers (AUC, 0.69-0.72; P =.40-. 80). A hematoma volume cutoff of 433 mL had a positive predictive value of 87%-100% for predicting major arterial injury requiring TAE. Hematoma volumes correlated with units of packed red blood cells transfused (r = 0.34-0.57; P =.0002-. 0003). Predicted probabilities of 0.64 or less had a negative predictive value of 100% for excluding mortality not resulting from closed head injuries. Conclusion: A logistic regression model incorporating semiautomated hematoma volume segmentation produced objective probability estimates of major arterial injury. Hematoma volumes correlated with 48-hour transfusion requirement, and low predicted probabilities excluded mortality from causes other than closed head injury. (C) RSNA, 2018	[Dreizin, David; Bodanapally, Uttam; Boscak, Alexis; Tirada, Nikki; Issa, Ghada; Nixon, Erika; Chen, Rong; Siegel, Eliot] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Diagnost Radiol & Nucl Med Trauma & Emergenc, 22 S Greene St, Baltimore, MD 21201 USA; [Nascone, Jason W.; Bivona, Louis; Mascarenhas, Daniel; O'Toole, Robert V.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Orthoped,Div Orthoped Traumatol, 22 S Greene St, Baltimore, MD 21201 USA		Dreizin, D (corresponding author), Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Dept Diagnost Radiol & Nucl Med Trauma & Emergenc, 22 S Greene St, Baltimore, MD 21201 USA.	daviddreizin@gmail.com			RSNA Research and Education Foundation [RSCH1605]	D.D. supported by RSNA Research and Education Foundation (RSCH1605).	Anderson SW, 2008, RADIOLOGY, V246, P410, DOI 10.1148/radiol.2462070082; Baghdanian AH, 2016, RADIOGRAPHICS, V36, P872, DOI 10.1148/rg.2016150160; BENMENACHEM Y, 1991, AM J ROENTGENOL, V157, P1005, DOI 10.2214/ajr.157.5.1927786; Blackmore CC, 2006, J TRAUMA, V61, P346, DOI 10.1097/01.ta.0000226151.88369.c9; Blackmore CC, 2003, ARCH SURG-CHICAGO, V138, P504, DOI 10.1001/archsurg.138.5.504; Bohning D, 2011, STAT METHODS MED RES, V20, P541, DOI 10.1177/0962280210374532; Brasel KJ, 2007, J TRAUMA, V62, P1149, DOI 10.1097/TA.0b013e3180479827; Brown CVR, 2005, AM SURGEON, V71, P759; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cullinane DC, 2011, J TRAUMA, V71, P1850, DOI 10.1097/TA.0b013e31823dca9a; Dreizin D, 2016, AM J ROENTGENOL, V207, P1244, DOI 10.2214/AJR.16.16630; Dreizin D, 2016, ABDOM RADIOL, V41, P2203, DOI 10.1007/s00261-016-0822-8; Dreizin D, 2012, RADIOGRAPHICS, V32, P609, DOI 10.1148/rg.323115099; Frevert S, 2008, INJURY, V39, P1290, DOI 10.1016/j.injury.2008.07.004; Hamilton JD, 2008, RADIOGRAPHICS, V28, P1603, DOI 10.1148/rg.286085522; Han K, 2016, KOREAN J RADIOL, V17, P339, DOI 10.3348/kjr.2016.17.3.339; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hosmer DW, 2000, APPL LOGISTIC REGRES, V1, P143, DOI DOI 10.1002/0471722146; Kaatee R, 1996, RADIOLOGY, V199, P637, DOI 10.1148/radiology.199.3.8637979; Kimbrell BJ, 2004, ARCH SURG-CHICAGO, V139, P728, DOI 10.1001/archsurg.139.7.728; Lucey BC, 2007, EMERG RADIOL, V14, P65, DOI [10.1007/s10140-007-0594-0, 10.1007/s10140-007-0600-6]; Miller PR, 2003, J TRAUMA, V54, P437, DOI 10.1097/01.TA.0000053397.33827.DD; Ryan MF, 2004, CAN ASSOC RADIOL J, V55, P160; Sheridan Meghan Kelly, 2002, Emerg Radiol, V9, P188; Soto JA, 2012, RADIOLOGY, V265, P678, DOI 10.1148/radiol.12120354; Spanjersberg WR, 2009, INJURY, V40, P1031, DOI 10.1016/j.injury.2009.06.164; Stephen DJG, 1999, J TRAUMA, V47, P638, DOI 10.1097/00005373-199910000-00006; Tile, 1996, J Am Acad Orthop Surg, V4, P143; TILE M, 1988, J BONE JOINT SURG BR, V70, P1; Willmann JK, 2002, AM J ROENTGENOL, V179, P437, DOI 10.2214/ajr.179.2.1790437; Yoon W, 2004, RADIOGRAPHICS, V24, P1591, DOI 10.1148/rg.246045028	31	21	22	0	5	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0033-8419			RADIOLOGY	Radiology	JUN	2018	287	3					1061	1069		10.1148/radiol.2018170997			9	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	GH7ZM	WOS:000433883400040	29558295	Bronze			2022-02-06	
J	Grassin-Delyle, S; Theusinger, OM; Albrecht, R; Mueller, S; Spahn, DR; Urien, S; Stein, P				Grassin-Delyle, S.; Theusinger, O. M.; Albrecht, R.; Mueller, S.; Spahn, D. R.; Urien, S.; Stein, P.			Optimisation of the dosage of tranexamic acid in trauma patients with population pharmacokinetic analysis	ANAESTHESIA			English	Article						antifibrinolytic agents; pharmacokinetics; tranexamic acid; trauma	FRESH-FROZEN PLASMA; CARDIAC-SURGERY; BLOOD-LOSS; HYPERFIBRINOLYSIS; COAGULOPATHY; PLASMINOGEN; MANAGEMENT; MORTALITY; CHILDREN; RESUSCITATION	Tranexamic acid is used both pre-hospital and in-hospital as an antifibrinolytic drug to treat or prevent hyperfibrinolysis in trauma patients; dosing, however, remains empirical. We aimed to measure plasma levels of tranexamic acid in patients receiving pre-hospital anti-hyperfibrinolytic therapy and to build a population pharmacokinetic model to propose an optimised dosing regimen. Seventy-three trauma patients were enrolled and each received tranexamic acid 1g intravenously pre-hospital. A blood sample was drawn after arrival in the emergency department, and we measured the plasma tranexamic acid concentration using liquid chromatography-mass spectrometry, and modelled the data using non-linear mixed effect modelling. Tranexamic acid was administered at a median (IQR [range]) time of 43 (30-55 [5-135]) min after trauma. Plasma tranexamic acid levels were determined on arrival at hospital, 57 (43-70 [20-148])min after pre-hospital administration of the drug. The measured concentration was 28.7 (21.5-38.5 [8.7-89.0])g.ml(-1). Our subjects had sustained severe trauma; injury severity score 20 (16-29 [5-75]), including penetrating injury in 2.8% and isolated traumatic brain injury in 19.7%. The pharmacokinetics were ascribed a two-compartment open model with body-weight as the main covariate. As tranexamic acid concentrations may fall below therapeutic levels during initial hospital treatment, we propose additional dosing schemes to maintain a specific target blood concentration for as long as required. This is the first study to investigate plasma level and pharmacokinetics of tranexamic acid after pre-hospital administration in trauma patients. Our proposed dosing regimen could be used in subsequent clinical trials to better study efficacy and tolerance profiles with controlled blood concentrations.	[Grassin-Delyle, S.] Univ Paris Saclay, Univ Versailles St Quentin, Plateforme Spectrometrie Masse MasSpecLab, INSERM UMR 1173,UFR Sci Sante Simone Veil,Pharmac, Montigny Le Bretonneux, France; [Grassin-Delyle, S.] Hop Foch, Dept Malad Resp, Pharmacol, Suresnes, France; [Theusinger, O. M.] Univ Hosp Balgrist, Dept Anaesthesiol, Zurich, Switzerland; [Theusinger, O. M.] Univ Zurich, Zurich, Switzerland; [Albrecht, R.; Stein, P.] Rega Rettungsflugwacht Garde Aerienne, Swiss Air Ambulance, Zurich, Switzerland; [Mueller, S.] Schutz & Rettung Zurich, Zurich, Switzerland; [Spahn, D. R.; Stein, P.] Univ Zurich, Inst Anesthesiol, Zurich, Switzerland; [Spahn, D. R.; Stein, P.] Univ Hosp Zurich, Zurich, Switzerland; [Urien, S.] URC Paris Ctr, AP HP, CIC Inserm Necker Cochin 0901, Paris, France; [Urien, S.] Univ Paris 05, Sorbonne Paris Cite, EA 7323, Paris, France		Grassin-Delyle, S (corresponding author), Univ Paris Saclay, Univ Versailles St Quentin, Plateforme Spectrometrie Masse MasSpecLab, INSERM UMR 1173,UFR Sci Sante Simone Veil,Pharmac, Montigny Le Bretonneux, France.; Grassin-Delyle, S (corresponding author), Hop Foch, Dept Malad Resp, Pharmacol, Suresnes, France.	stanislas.grassin-delyle@uvsq.fr	Urien, Saik/G-3240-2013; Grassin-Delyle, Stanislas/AAC-5921-2021	Grassin-Delyle, Stanislas/0000-0001-5747-4432	Swiss National Science Foundation, Berne, SwitzerlandSwiss National Science Foundation (SNSF); Ministry of Health (Gesundheitsdirektion) of the Canton of Zurich, Switzerland for Highly Specialized Medicine; Swiss Society of Anesthesiology and Reanimation (SGAR), Berne, Switzerland; Swiss Foundation for Anesthesia Research, Zurich, Switzerland; Bundesprogramm Chancengleichheit, Berne, Switzerland; CSL Behring, Berne, Switzerland; Vifor SA, Villars-sur-Glane, Switzerland; Novo Nordisk Health Care AG, Zurich, Switzerland; CSL Behring GmbH, Marburg, Germany; LFB Biomedicaments, Courtaboeuf Cedex, France	SD, OT, SU and PS contributed equally to this work. OT has received honoraria or travel support for consulting or lecturing from the following companies: CSL Behring Schweiz, Zurich, Switzerland; Vifor SA, Villars-sur-Glane, Switzerland; Roche Pharma (Switzerland) AG, Reinach, Switzerland; Pentapharm AG, Munchen, Germany; TEM International GmbH, Munchen, Germany; Boehringer Ingelheim (Switzerland); and Octapharma AG Lachen (Switzerland) and Instrumentation Laboratory, Bedford, MA, USA. DS's academic department is receiving grant support from the following: the Swiss National Science Foundation, Berne, Switzerland; the Ministry of Health (Gesundheitsdirektion) of the Canton of Zurich, Switzerland for Highly Specialized Medicine; the Swiss Society of Anesthesiology and Reanimation (SGAR), Berne, Switzerland; the Swiss Foundation for Anesthesia Research, Zurich, Switzerland; Bundesprogramm Chancengleichheit, Berne, Switzerland; CSL Behring, Berne, Switzerland; and Vifor SA, Villars-sur-Glane, Switzerland. DRS was the chair of the ABC Faculty and is the co-chair of the ABC-Trauma Faculty, both of which are managed by Physicians World Europe GmbH, Mannheim, Germany, and sponsored by unrestricted educational grants from Novo Nordisk Health Care AG, Zurich, Switzerland; CSL Behring GmbH, Marburg, Germany; and LFB Biomedicaments, Courtaboeuf Cedex, France. In the past fiveyears, DS has received honoraria or travel support for consulting or lecturing from the following companies and organisations: Danube University of Krems, Austria; US Department of Defense, Washington, USA; European Society of Anesthesiology, Brussels, BE; Baxter AG, Volketswil, Switzerland, Baxter S.p.A., Roma, Italy; Bayer (Schweiz) AG, Zurich, Switzerland; Bayer Pharma AG, Berlin, Germany; B. Braun Melsungen AG, Melsungen, Germany; Boehringer Ingelheim (Schweiz) GmbH, Basel, Switzerland; Bristol-Myers-Squibb, Rueil-Malmaison Cedex, France and Baar, Switzerland; CSL Behring GmbH, Hattersheim am Main, Germany and Berne, Switzerland; Curacyte AG, Munich, Germany; Daiichi Sankyo (Schweiz) AG, Thalwil, Switzerland; Ethicon Biosurgery, Sommerville, New Jersey, USA; Fresenius SE, Bad Homburg v.d.H., Germany; Galenica AG, Bern, Switzerland (including Vifor SA, Villars-sur-Glane, Switzerland); GlaxoSmithKline GmbH & Co. KG, Hamburg, Germany; Haemonetics, Braintree, MA, USA; Janssen-Cilag AG, Baar, Switzerland; Janssen-Cilag EMEA, Beerse, Belgium; LFB Biomedicaments, Courtaboeuf Cedex, France; Merck Sharp & Dohme AG, Luzern, Switzerland; Novo Nordisk A/S, Bagsvard, Denmark; Octapharma AG, Lachen, Switzerland; Oxygen Biotherapeutics, Costa Mesa, CA; PAION Deutschland GmbH, Aachen, Germany; Pharmacosmos A/S, Holbaek, Denmark; Photonics Healthcare B.V., Utrecht, Netherlands; ratiopharm Arzneimittel Vertriebs-GmbH, Vienna, Austria; Roche Diagnostics International Ltd, Reinach, Switzerland; Roche Pharma (Schweiz) AG, Reinach, Switzerland; Sarstedt AG and Co., Sevelen, Switzerland and Numbrecht, Germany; Schering-Plough International, Inc., Kenilworth, New Jersey, USA; Tem International GmbH, Munich, Germany; Verum Diagnostica GmbH, Munich, Germany; Vifor Pharma Deutschland GmbH, Munich, Germany; Vifor Pharma osterreich GmbH, Vienna, Austria; Vifor (International) AG, St. Gallen, Switzerland. PS received honoraria for lecturing by Vifor Pharma (Munich, Germany). SGD, RA, SM and SU have no competing interests to declare.	Anderson BJ, 2008, ANNU REV PHARMACOL, V48, P303, DOI 10.1146/annurev.pharmtox.48.113006.094708; ANDERSSON L, 1968, ANN NY ACAD SCI, V146, P642, DOI 10.1111/j.1749-6632.1968.tb20322.x; [Anonymous], 2011, BRIT MED J, V343, pd3795; Ausset S, 2015, J TRAUMA ACUTE CARE, V78, pS70, DOI 10.1097/TA.0000000000000640; Brecher ME, 1997, TRANSFUSION, V37, P1070, DOI 10.1046/j.1537-2995.1997.371098016448.x; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Bulutcu FS, 2005, PEDIATR ANESTH, V15, P41, DOI 10.1111/j.1460-9592.2004.01366.x; Cardenas JC, 2014, SHOCK, V41, P514, DOI 10.1097/SHK.0000000000000161; Chapman MP, 2016, J TRAUMA ACUTE CARE, V80, P16, DOI 10.1097/TA.0000000000000885; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Dowd NP, 2002, ANESTHESIOLOGY, V97, P390, DOI 10.1097/00000542-200208000-00016; Fabresse N, 2017, J PHARMACEUT BIOMED, V141, P149, DOI 10.1016/j.jpba.2017.04.024; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Gertler R, 2017, BRIT J CLIN PHARMACO, V83, P1745, DOI 10.1111/bcp.13274; Gonzalez EA, 2007, J TRAUMA, V62, P112, DOI 10.1097/01.ta.0000250497.08101.8b; Grassin-Delyle S, 2013, BRIT J ANAESTH, V111, P916, DOI 10.1093/bja/aet255; Grassin-Delyle S, 2013, ANESTHESIOLOGY, V118, P853, DOI 10.1097/ALN.0b013e318283c83a; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; HOYLAERTS M, 1981, BIOCHIM BIOPHYS ACTA, V673, P75; Hunt BJ, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12910; Kashuk JL, 2008, J TRAUMA, V65, P261, DOI 10.1097/TA.0b013e31817de3e1; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Ker K, 2015, COCHRANE DB SYST REV, V5; Ker K, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-3; Kuhn E, 2005, COMPUT STAT DATA AN, V49, P1020, DOI 10.1016/j.csda.2004.07.002; Lin Z, 2016, SEIZURE-EUR J EPILEP, V36, P70, DOI 10.1016/j.seizure.2016.02.011; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; MARKUS G, 1979, J BIOL CHEM, V254, P1211; McCune JS, 2014, CLIN CANCER RES, V20, P754, DOI 10.1158/1078-0432.CCR-13-1960; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Ortmann E, 2013, BRIT J ANAESTH, V111, P549, DOI 10.1093/bja/aet154; Reid RW, 1997, ANESTH ANALG, V84, P990, DOI 10.1097/00000539-199705000-00008; Roberts I, 2017, TRIALS, V18, DOI 10.1186/s13063-016-1750-1; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Schochl H, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12901; Schoemaker RC, 1996, BRIT J CLIN PHARMACO, V42, P283, DOI 10.1046/j.1365-2125.1996.04231.x; Sigaut S, 2014, ANESTHESIOLOGY, V120, P590, DOI 10.1097/ALN.0b013e3182a443e8; SOSLAU G, 1991, AM J HEMATOL, V38, P113, DOI 10.1002/ajh.2830380208; Stein P, 2017, ANAESTHESIA, V72, P1317, DOI 10.1111/anae.13920; Stief T., 2009, HEMOST LAB, V2, P73; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; Syrovets T, 2012, J LEUKOCYTE BIOL, V92, P509, DOI 10.1189/jlb.0212056; Theusinger OM, 2014, BLOOD TRANSFUS-ITALY, V12, P195, DOI 10.2450/2014.0306-13; Theusinger OM, 2011, ANESTH ANALG, V113, P1003, DOI 10.1213/ANE.0b013e31822e183f; Wafaisade A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1322-5; Wesley MC, 2015, ANESTHESIOLOGY, V122, P746, DOI 10.1097/ALN.0000000000000570; Yee BE, 2013, ANESTH ANALG, V117, P767, DOI 10.1213/ANE.0b013e3182a22258; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	49	21	21	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	JUN	2018	73	6					719	729		10.1111/anae.14184			11	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GF4XB	WOS:000431966200009	29411358	Bronze			2022-02-06	
J	Zhang, MH; Zhou, XM; Cui, JZ; Wang, KJ; Feng, Y; Zhang, HA				Zhang, Man-He; Zhou, Xiu-Min; Cui, Jian-Zhong; Wang, Kai-Jie; Feng, Yan; Zhang, Hong-Ao			Neuroprotective effects of dexmedetomidine on traumatic brain injury: Involvement of neuronal apoptosis and HSP70 expression	MOLECULAR MEDICINE REPORTS			English	Article						traumatic brain injury; dexmedetomidine; apoptosis; heat shock proteins; hippocampus; neuron	ISCHEMIA/REPERFUSION INJURY; RATS; ISCHEMIA; PATHOPHYSIOLOGY; HIPPOCAMPUS; PROTECTION; PROPOFOL; MODEL	The aim of the present study was to investigate the protective effect of dexmedetomidine (Dex) on traumatic brain injury (TBI), and further evaluate whether the underlying neuroprotective mechanisms are associated with neurological apoptosis and the expression of 70 kDa heat shock protein (HSP70) in the hippocampus. A total of 90 adult male Sprague-Dawley rats were randomly assigned into 3 groups (n=30/group): Sham, TBI and Dex groups. The rat models of TBI were established using a modified weight-drop device and Dex (15 mu g/kg) was intravenously administered immediately following TBI. The brain edema and neurological function outcomes of TBI were assessed using wet-dry weight analysis and the Neurological Severity Score method. The expression levels of B-cell lymphoma-2 (Bcl-2) and Bcl-2-associated X protein (Bax) in the rat hippocampus were evaluated using immunohistochemical staining and western blot analysis. The protein levels of HSP70 in the hippocampal region were analyzed using western blot analysis. The results of the present study revealed that administration of Dex post-TBI improved brain edema and neurological outcomes, due to the attenuation of the TBI-induced reduction of Bax expression and increase of Bcl-2 and HSP70 expression. In conclusion, the results of the present study suggested that administration of Dex may serve as a neuroprotective agent against brain injury, at least partially via the inhibition of neuronal apoptosis and upregulation of HSP70 expression in the hippocampus.	[Zhang, Man-He; Cui, Jian-Zhong; Feng, Yan] Hebei Med Univ, Dept Surg, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China; [Zhou, Xiu-Min; Wang, Kai-Jie; Zhang, Hong-Ao] Tangshan Workers Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China		Cui, JZ (corresponding author), Hebei Med Univ, Dept Surg, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China.	jzcdoctor@163.com			Natural Science Foundation of Hebei ProvinceNatural Science Foundation of Hebei Province [H2012401071, 2014105079]	The present study was supported by a grant from the Natural Science Foundation of Hebei Province (grant nos. H2012401071 and 2014105079).	Anderson MA, 2014, SEMIN HEMATOL, V51, P219, DOI 10.1053/j.seminhematol.2014.05.008; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Cai Y, 2014, MOL MED REP, V9, P1542, DOI 10.3892/mmr.2014.2034; Cheng G, 2013, MED HYPOTHESES, V80, P115, DOI 10.1016/j.mehy.2012.11.004; Cui CM, 2014, NEUROL SCI, V35, P695, DOI 10.1007/s10072-013-1585-4; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Goyagi T, 2014, BRAIN RES, V1566, P24, DOI 10.1016/j.brainres.2014.04.013; Guler L, 2014, ADV CLIN EXP MED, V23, P683, DOI 10.17219/acem/37214; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; James ML, 2012, ANAESTH INTENS CARE, V40, P949, DOI 10.1177/0310057X1204000605; Jiang LL, 2014, MOL MED REP, V9, P419, DOI 10.3892/mmr.2013.1867; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liao ZX, 2014, BRAIN RES BULL, V107, P69, DOI 10.1016/j.brainresbull.2014.07.001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mangat Halinder S, 2012, Continuum (Minneap Minn), V18, P532, DOI 10.1212/01.CON.0000415426.76524.e1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nasrallah N A, 2016, CHEST, V150, p228A, DOI [10.1016/j.chest.2016.08.241, DOI 10.1016/J.CHEST.2016.08.241]; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Sato A, 2017, YAKUGAKU ZASSHI, V137, P1315, DOI 10.1248/yakushi.17-00131; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Si YN, 2014, EUR REV MED PHARMACO, V18, P1843; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Wang XM, 2013, BRAIN INJURY, V27, P1617, DOI 10.3109/02699052.2013.831130; Wang Z, 2014, NEUROREHABILITATION, V35, P825, DOI 10.3233/NRE-141177; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Xiong B, 2014, BRAIN INJURY, V28, P1003, DOI 10.3109/02699052.2014.888765; Xu XD, 2018, METAB BRAIN DIS, V33, P115, DOI 10.1007/s11011-017-0129-7; Yang NL, 2010, PRACT PREV MED, V17, P243; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005	41	21	24	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JUN	2018	17	6					8079	8086		10.3892/mmr.2018.8898			8	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GJ5AQ	WOS:000435394000076	29693126	Green Published, hybrid, Green Submitted			2022-02-06	
J	Zanier, ER; Zoerle, T; Di Lernia, D; Riva, G				Zanier, Elisa R.; Zoerle, Tommaso; Di Lernia, Daniele; Riva, Giuseppe			Virtual Reality for Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; virtual reality; brain protection; neurorepair; rehabilitation	COGNITIVE REHABILITATION; NEURAL REORGANIZATION; DEFICITS; STROKE	In this perspective, we discuss the potential of virtual reality (VR) in the assessment and rehabilitation of traumatic brain injury, a silent epidemic of extremely high burden and no pharmacological therapy available. VR, endorsed by the mobile and gaming industries, is now available in more usable and cheaper tools allowing its therapeutic engagement both at the bedside and during the daily life at chronic stages after injury with terrific potential for a longitudinal disease modifying effect.	[Zanier, Elisa R.] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy; [Zoerle, Tommaso] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neurosci ICU, Milan, Italy; [Di Lernia, Daniele] Univ Cattolica Sacro Cuore, Dipartimento Psicol, Milan, Italy; [Riva, Giuseppe] Ist Auxol Italiano, Appl Technol Neuropsychol Lab, Milan, Italy; [Riva, Giuseppe] Univ Cattolica Sacro Cuore, Ctr Studi & Ric Psicol Comunicaz, Milan, Italy		Zanier, ER (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy.	elisa.zanier@marionegri.it	Zanier, Elisa/AAA-8095-2020; Riva, Giuseppe/C-5917-2008	Zanier, Elisa/0000-0002-3011-8718; Riva, Giuseppe/0000-0003-3657-106X; Zoerle, Tommaso/0000-0001-8713-8085			Besnard J, 2016, APPL NEUROPSYCH-ADUL, V23, P223, DOI 10.1080/23279095.2015.1048514; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Castelvecchi D, 2016, NATURE, V533, P153, DOI 10.1038/533153a; Cherniack EP, 2011, DISABIL REHABIL-ASSI, V6, P283, DOI 10.3109/17483107.2010.542570; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cuthbert JP, 2014, BRAIN INJURY, V28, P181, DOI 10.3109/02699052.2013.860475; Dahdah MN, 2017, NEUROREHABILITATION, V41, P721, DOI 10.3233/NRE-172183; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dvorkin AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-92; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Miller KJ, 2014, AGE AGEING, V43, P188, DOI 10.1093/ageing/aft194; Orihuela-Espina F, 2013, TOP STROKE REHABIL, V20, P197, DOI 10.1310/tsr2003-197; Parsons TD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00660; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; Robitaille N, 2017, DISABIL REHABIL-ASSI, V12, P758, DOI 10.1080/17483107.2016.1229048; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Saywell N, 2017, CLIN REHABIL, V31, P145, DOI 10.1177/0269215516631384; Schultheis MT, 2001, REHABIL PSYCHOL, V46, P296, DOI 10.1037/0090-5550.46.3.296; Serino S, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00240; Shin H, 2015, J PHYS THER SCI, V27, P2999, DOI 10.1589/jpts.27.2999; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Thengone DJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6113; Wang ZR, 2017, NEURAL REGEN RES, V12, P1823, DOI 10.4103/1673-5374.219043; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; WHO, 2018, NEUR DIS PUBL HLTH C; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Wright WG, 2017, DISABIL REHABIL, V39, P1564, DOI 10.1080/09638288.2016.1226432; Zoerle T, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00354	35	21	22	8	22	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAY 16	2018	9								345	10.3389/fneur.2018.00345			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GG0WP	WOS:000432401500001	29867748	Green Published, gold			2022-02-06	
J	Amyot, F; Kenney, K; Moore, C; Haber, M; Turtzo, LC; Shenouda, C; Silverman, E; Gong, YH; Qu, BX; Harburg, L; Lu, HZY; Wassermann, EM; Diaz-Arrastia, R				Amyot, Franck; Kenney, Kimbra; Moore, Carol; Haber, Margalit; Turtzo, L. Christine; Shenouda, Christian; Silverman, Erika; Gong, Yunhua; Qu, Bao-Xi; Harburg, Leah; Lu, Hanzhang Y.; Wassermann, Eric M.; Diaz-Arrastia, Ramon			Imaging of Cerebrovascular Function in Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; cerebrovascular reactivity; hypercapnia; magnetic resonance imaging-blood oxygen level dependent; neurovascular unit; traumatic brain injury; traumatic cerebrovascular injury	CEREBRAL-BLOOD-FLOW; BIOGENIC-AMINE CONTENT; TRANSCRANIAL DOPPLER; UNITED-STATES; REACTIVITY; CONSEQUENCES; RECOVERY; EPIDEMIOLOGY; HYPOTHERMIA; HYPERCAPNIA	Traumatic cerebrovascular injury (TCVI) is a common pathologic mechanism of traumatic brain injury (TBI) and presents an attractive target for intervention. The aims of this study were to assess cerebral blood flow (CBF) and cerebrovascular reactivity (CVR) using magnetic resonance imaging (MRI) to assess their value as biomarkers of TCVI in chronic TBI, characterize the spatial distribution of TCVI, and assess the relationships between each biomarker and neuropsychological and clinical assessments. Forty-two subjects (27 chronic TBI, 15 age- and gender-matched healthy volunteers) were studied cross-sectionally. CBF was measured by arterial spin labeling and CVR by assessing the MRI-blood oxygen level-dependent signal with hypercapnia challenge. A focused neuropsychological battery adapted from the TBI Common Data Elements and neurobehavioral symptom questionnaires were administered at the time of the imaging session. Chronic TBI subjects showed a significant reduction in mean global, gray matter (GM), and white matter (WM) CVR, compared with healthy volunteers (p<0.001). Mean GM CVR had the greatest effect size (Cohen's d=0.9). CVR maps in chronic TBI subjects showed patchy, multifocal CVR deficits. CBF discriminated poorly between TBI subjects and healthy volunteers and did not correlate with CVR. Mean global CVR correlated best with chronic neurobehavioral symptoms among TBI subjects. Global, GM, and WM CVR are reliable and potentially useful biomarkers of TCVI in the chronic stage after moderate-to-severe TBI. CBF is less useful as biomarker of TCVI. CVR correlates best with chronic TBI symptoms. CVR has potential as a predictive and pharmacodynamic biomarker for interventions targeting TCVI.	[Amyot, Franck; Kenney, Kimbra; Moore, Carol; Qu, Bao-Xi; Harburg, Leah] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Haber, Margalit; Silverman, Erika; Gong, Yunhua; Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Turtzo, L. Christine; Shenouda, Christian] NINDS, Ctr Neurosci & Regenerat Med, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Lu, Hanzhang Y.] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Baltimore, MD USA; [Wassermann, Eric M.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Diaz-Arrastia, R (corresponding author), Univ Penn, Dept Neurol, Perelman Sch Med, Penn Presbyterian Med Ctr, 51 North 39th St, Philadelphia, PA 19104 USA.	Ramon.Diaz-Arrastia@uphs.upenn.edu	Wassermann, Eric M./AAC-9064-2020	Wassermann, Eric M./0000-0003-0628-0210	Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD; Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS; Intramural Research Program of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS002977] Funding Source: NIH RePORTER	Work in the authors' laboratory was supported by the Center for Neuroscience and Regenerative Medicine (CNRM), Uniformed Services University of the Health Sciences (USUHS), Bethesda, MD, by the Military Clinical Neuroscience Center of Excellence (MCNCoE), Department of Neurology, USUHS, and by the Intramural Research Program of the National Institutes of Health. The contents of this paper are solely the responsibility of the authors and do not represent the official views of the Department of Defense, CNRM, MCNCoE, or the National Institutes of Health.	[Anonymous], 2008, GULF WAR HLTH, V7; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Baranova AI, 2008, J NEUROSURG, V109, P502, DOI 10.3171/JNS/2008/109/9/0502; Besancon E, 2008, TRENDS PHARMACOL SCI, V29, P268, DOI 10.1016/j.tips.2008.02.003; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Diomedi M, 2005, NEUROLOGY, V65, P919, DOI 10.1212/01.wnl.0000173835.12308.bb; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00061; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; Faul M, 2010, TRAUMATIC BRAIN INJU; Furuya Y, 2003, NEUROSURGERY, V52, P340, DOI 10.1227/01.NEU.0000043931.83041.AA; Gao GY, 2010, J CEREBR BLOOD F MET, V30, P628, DOI 10.1038/jcbfm.2009.235; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; INOUE M, 1991, J CEREBR BLOOD F MET, V11, P242, DOI 10.1038/jcbfm.1991.56; Kassner Andrea, 2004, Top Magn Reson Imaging, V15, P58, DOI 10.1097/00002142-200402000-00006; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lu H., 2014, JOVE-J VIS EXP, P17; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Menon DK, 2006, CURR OPIN CRIT CARE, V12, P85, DOI 10.1097/01.ccx.0000216572.19062.8f; Mutch WAC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00107; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P200, DOI 10.1038/jcbfm.2010.78; Oda Y, 2011, J CEREBR BLOOD F MET, V31, P1143, DOI 10.1038/jcbfm.2010.208; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; PAPPIUS HM, 1988, J CEREBR BLOOD F MET, V8, P324, DOI 10.1038/jcbfm.1988.67; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Wang JY, 2014, NEUROBIOL DIS, V68, P91, DOI 10.1016/j.nbd.2014.04.014; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; Yezhuvath US, 2012, NEUROBIOL AGING, V33, P75, DOI 10.1016/j.neurobiolaging.2010.02.005; Yezhuvath US, 2009, NMR BIOMED, V22, P779, DOI 10.1002/nbm.1392; Zhu YS, 2013, J CEREBR BLOOD F MET, V33, P1190, DOI 10.1038/jcbfm.2013.66	41	21	21	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1116	1123		10.1089/neu.2017.5114			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000432198500002	29065769	Green Published			2022-02-06	
J	Auxemery, Y				Auxemery, Yann			Post-traumatic psychiatric disorders: PTSD is not the only diagnosis	PRESSE MEDICALE			English	Article							TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSIVE DISORDER; STRESS-DISORDER; PSYCHOTIC SYMPTOMS; ANXIETY DISORDER; COMBAT VETERANS; CHILDHOOD TRAUMA; SOCIAL PHOBIA; COMORBID PTSD; HEALTH	Traumatic events and their consequences are often hidden or minimised by patients for reasons linked to the post-traumatic stress disorder itself (inexpressibility, shame, depressive thoughts, fear of stigmatisation, etc.). Although post-traumatic stress disorder (PTSD) remains the most widely known disorder, chronic post-traumatic psychiatric disorders are many and varied. After a trauma, the practitioner has to check for the different clinical forms of post-traumatic psychological consequences: PTSD is not the only diagnosis. Based on our own clinical experience compared to the international literature, we think necessary to build a didactic classification describing chronic post-traumatic symptoms and syndromes. Post traumatic depressions and bereavement lead to high risk of suicidal crisis and self-harm behaviours. Re-experiencing are felt with anxiety, hyper arousal increases anxious reactivity, and avoidance strategies increase anticipatory anxiety, indicating post-traumatic anxiety disorders (agoraphobia, specific phobia, obsessive compulsive disorder, separation anxiety, social phobia). Characterising an often-severe clinical picture, the co-occurrence of post-traumatic and chronic psychotic symptoms is not unusual (post-traumatic schizophrenia, post-traumatic depression with mood-congruent psychotic features, non-schizophrenic post-traumatic psychotic disorder, and bipolar reaction to trauma). A physical injury occurring at the same time as a traumatic exposure increases the risk of developing post-traumatic stress disorder later which, in turn, afflicts the subjective perception of the physical health (development of somatoform and psychosomatic disorders, comorbidity with a post-concussion syndrome). The trauma may cause a rupture in the biography of a person, also in his/her internal physiological functioning as in his/her social activities (impacts of instinctive functions and behaviours, personality changes, and adjustment difficulties on professional and personal life). Although a nomenclature is necessary for semiological descriptions, a thorough analysis of the patient's general psychological functioning must also be conducted.	[Auxemery, Yann] Hop Instruct Armees Percy, Main Aeromed Ctr, Med Psychol Serv Appl Aeronaut, 101 Ave Henri Barbusse, F-92140 Clamart, France		Auxemery, Y (corresponding author), Hop Instruct Armees Percy, Main Aeromed Ctr, Med Psychol Serv Appl Aeronaut, 101 Ave Henri Barbusse, F-92140 Clamart, France.	Yann.auxemery@hotmail.fr					Ahl R, 2017, INJURY, V48, P101, DOI 10.1016/j.injury.2016.10.041; Alarcon RD, 1999, PSYCHIATRY, V62, P114, DOI 10.1080/00332747.1999.11024860; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1980, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; [Anonymous], 1993, ARCH PHYS MED REHAB, V74, pS8; Auxemery Y, 2017, EUR J TRAUMA DISSOC, V1, P137, DOI 10.1016/j.ejtd.2017.03.002; Auxemery Y, 2015, ENCEPHALE, V41, P346, DOI 10.1016/j.encep.2014.07.005; Auxemery Y, 2015, EVOL PSYCHIATR, V80, P659, DOI 10.1016/j.evopsy.2014.05.001; Auxemery Y, 2014, EVOL PSYCHIATR, V79, P287, DOI 10.1016/j.evopsy.2014.01.002; Auxemery Y, 2012, MED HYPOTHESES, V79, P667, DOI 10.1016/j.mehy.2012.08.005; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Breslau N, 2003, ARCH GEN PSYCHIAT, V60, P289, DOI 10.1001/archpsyc.60.3.289; Brewerton TD, 2017, EAT WEIGHT DISORD-ST, V22, P241, DOI 10.1007/s40519-016-0355-8; Brewin CR, 2003, AM J PSYCHIAT, V160, P783, DOI 10.1176/appi.ajp.160.4.783; Breyer BN, 2016, J TRAUMA STRESS, V29, P229, DOI 10.1002/jts.22097; Briere J, 2005, AM J PSYCHIAT, V162, P2295, DOI 10.1176/appi.ajp.162.12.2295; Calhoun PS, 2007, SCHIZOPHR RES, V91, P210, DOI 10.1016/j.schres.2006.12.011; Chappelle WL, 2014, MIL MED, V179, P63, DOI 10.7205/MILMED-D-13-00501; Crocq L., 1999, PSYCHOL TRAUMAS WAR; David D, 1999, J CLIN PSYCHIAT, V60, P29, DOI 10.4088/JCP.v60n0106; Deb S, 1999, AM J PSYCHIAT, V156, P374; Ducrocq F, 2001, ENCEPHALE, V27, P159; El-Hage W, 2006, PRESSE MED, V35, P1683, DOI 10.1016/S0755-4982(06)74881-3; Etain B, 2017, J PSYCHIATR RES, V84, P73, DOI 10.1016/j.jpsychires.2016.09.022; Etain B, 2013, J CLIN PSYCHIAT, V74, P991, DOI 10.4088/JCP.13m08353; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fostick L, 2012, WORLD J BIOL PSYCHIA, V13, P312, DOI 10.3109/15622975.2011.607848; Fox GC, 1999, BRIT J PSYCHIAT, V174, P560, DOI 10.1192/S0007125000262703; Freeman D, 2013, PSYCHOL MED, V43, P2673, DOI 10.1017/S003329171300038X; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Guina J, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0686-1; Hainsworth C, 2011, J TRAUMA STRESS, V24, P491, DOI 10.1002/jts.20666; Hamner MB, 1998, PSYCHIAT RES, V77, P175, DOI 10.1016/S0165-1781(98)00002-X; Hamner MB, 1999, BIOL PSYCHIAT, V45, P846, DOI 10.1016/S0006-3223(98)00301-1; Harder LH, 2011, J NERV MENT DIS, V199, P940, DOI 10.1097/NMD.0b013e3182392bfb; Hartman D, 2001, POSTGRAD MED J, V77, P244, DOI 10.1136/pmj.77.906.244; Hartung, 2015, INTERVENTIONS IMPROV; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hippocrates, 1923, CORPUS HIPPROCRATICU; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Holterbach L, 2015, ENCEPHALE, V41, P444, DOI 10.1016/j.encep.2015.05.001; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Krakow B, 2000, COMPR PSYCHIAT, V41, P49, DOI 10.1016/S0010-440X(00)90131-7; Lin KH, 2016, OCCUP MED-OXFORD, V66, P514, DOI 10.1093/occmed/kqw036; Lucretius, 1910, RERUM NATURA NATURE; McKinney JM, 2017, J AFFECT DISORDERS, V214, P100, DOI 10.1016/j.jad.2017.03.008; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; Norman SB, 2012, NEUROPHARMACOLOGY, V62, P542, DOI 10.1016/j.neuropharm.2011.04.032; Orr SP, 2000, J AFFECT DISORDERS, V61, P225, DOI 10.1016/S0165-0327(00)00340-2; Orsillo SM, 1996, J TRAUMA STRESS, V9, P235, DOI 10.1007/BF02110658; Ouimette P, 2010, ADDICT BEHAV, V35, P64, DOI 10.1016/j.addbeh.2009.08.009; Pivar IL, 2004, J ANXIETY DISORD, V18, P745, DOI 10.1016/j.janxdis.2003.09.005; POLLOCK DA, 1990, AM J PSYCHIAT, V147, P772; Price M, 2015, J AFFECT DISORDERS, V186, P149, DOI 10.1016/j.jad.2015.06.012; Prigerson HG, 1999, BRIT J PSYCHIAT, V174, P67, DOI 10.1192/bjp.174.1.67; Resnick SG, 2003, J ABNORM PSYCHOL, V112, P415, DOI 10.1037/0021-843X.112.3.415; Reuber M, 2004, J NEUROL NEUROSUR PS, V75, P743, DOI 10.1136/jnnp.2003.013821; Richman H, 1997, Depress Anxiety, V6, P70, DOI 10.1002/(SICI)1520-6394(1997)6:2<70::AID-DA3>3.0.CO;2-9; Roelofs K, 2005, J NERV MENT DIS, V193, P508, DOI 10.1097/01.nmd.0000172472.60197.4d; Roley ME, 2015, J AFFECT DISORDERS, V180, P116, DOI 10.1016/j.jad.2015.04.006; Sareen J, 2005, J TRAUMA STRESS, V18, P313, DOI 10.1002/jts.20040; Sautter FJ, 2002, AM J PSYCHIAT, V159, P1775, DOI 10.1176/appi.ajp.159.10.1775; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seedat S, 2003, J NERV MENT DIS, V191, P675, DOI 10.1097/01.nmd.0000092177.97317.26; Sellbom M, 2009, J TRAUMA STRESS, V22, P471, DOI 10.1002/jts.20452; Sher L, 2005, MED HYPOTHESES, V65, P205, DOI 10.1016/j.mehy.2005.03.014; Silove D, 2010, J TRAUMA STRESS, V23, P169, DOI 10.1002/jts.20490; SOLOMON Z, 1989, PSYCHIATRY, V52, P428, DOI 10.1080/00332747.1989.11024467; Spiegel D, 2000, AM J PSYCHIAT, V157, P1890, DOI 10.1176/appi.ajp.157.11.1890; Sundquist K, 2016, J PSYCHOSOM RES, V86, P60, DOI 10.1016/j.jpsychores.2016.05.007; Swearingen JM, 2017, MIL MED, V182, P258, DOI 10.7205/MILMED-D-16-00107; Tagay S, 2005, J PSYCHOSOM RES, V58, P439, DOI 10.1016/j.jpsychores.2004.09.007; Teng EJ, 2015, J ANXIETY DISORD, V33, P1, DOI 10.1016/j.janxdis.2015.04.002; Tsai J, 2014, J CLIN PSYCHIAT, V75, P276, DOI 10.4088/JCP.13m08466; Vierling V, 2015, PRESSE MED, V44, pE339, DOI 10.1016/j.lpm.2015.04.039; Vogt D, 2017, SOC PSYCH PSYCH EPID, V52, P341, DOI 10.1007/s00127-016-1321-5; Voon V, 2010, BRAIN, V133, P1526, DOI 10.1093/brain/awq054; Waddington A, 2003, ENCEPHALE, V29, P20; World Health Organization, 1993, ICD 10 CLASS MENT BE; Yehuda R, 2015, J SEX MED, V12, P1107, DOI 10.1111/jsm.12856; Zayfert C, 2005, J NERV MENT DIS, V193, P93, DOI 10.1097/01.nmd.0000152795.47479.d9; Zimmerman M, 1999, J CLIN PSYCHIAT, V60, P311, DOI 10.4088/JCP.v60n0508	89	21	23	2	24	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0755-4982	2213-0276		PRESSE MED	Presse Med.	MAY	2018	47	5					423	430		10.1016/j.lpm.2017.12.006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GG1RZ	WOS:000432465900004	29580906				2022-02-06	
J	LoBue, C; Woon, FL; Rossetti, HC; Hynan, LS; Hart, J; Cullum, CM				LoBue, Christian; Woon, Fu L.; Rossetti, Heidi C.; Hynan, Linda S.; Hart, John, Jr.; Cullum, C. Munro			Traumatic Brain Injury History and Progression from Mild Cognitive Impairment to Alzheimer Disease	NEUROPSYCHOLOGY			English	Article						head injury; cognitive decline; mild cognitive impairment; dementia; risk	HEAD-INJURY; RISK-FACTOR; DEMENTIA; PATHOLOGY; ASSOCIATION; PREDICTION; DIAGNOSIS; AGE	Objective: To examine whether history of traumatic brain injury (TBI) is associated with more rapid progression from mild cognitive impairment (MCI) to Alzheimer's disease (AD). Method: Data from 2,719 subjects with MCI were obtained from the National Alzheimer's Coordinating Center. TBI was categorized based on presence (TBI+) or absence (TBI-) of reported TBI with loss of consciousness (LOC) without chronic deficit occurring >1 year prior to diagnosis of MCI. Survival analyses were used to determine if a history of TBI predicted progression from MCI to AD up to 8 years. Random regression models were used to examine whether TBI history also predicted rate of decline on the Clinical Dementia Rating scale Sum of Boxes score (CDR-SB) among subjects who progress to AD. Results: Across 8 years, TBI history was not significantly associated with progression from MCI to a diagnosis of AD in unadjusted (HR = 0.80; 95% CI [0.63, 1.01]; p = .06) and adjusted (p = .15) models. Similarly, a history of TBI was a nonsignificant predictor for rate of decline on CDR-SB among subjects who progressed to AD (b = 0.15, p = .38). MCI was, however, diagnosed a mean of 2.6 years earlier (p < .001) in TBI+ subjects compared with the TBI-group. Conclusions: A history of TBI with LOC was not associated with progression from MCI to AD, but was linked to an earlier age of MCI diagnosis. These findings add to a growing literature suggesting that TBI might reduce the threshold for onset of MCI and certain neurodegenerative conditions, but appears unrelated to progression from MCI to AD.	[LoBue, Christian; Rossetti, Heidi C.; Hynan, Linda S.; Hart, John, Jr.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75208 USA; [Woon, Fu L.] Univ Texas, Dell Med Sch, Seton Brain & Spine Inst, Dept Neurol, Austin, TX USA; [Hynan, Linda S.] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Hynan, Linda S.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Hart, John, Jr.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, Richardson, TX 75083 USA; [Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dept Neurol & Neurotherapeut, Dallas, TX USA; [Cullum, C. Munro] Univ Texas Southwestern Med Ctr Dallas, Dept Neurol Surg, Dallas, TX 75390 USA		LoBue, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75208 USA.	christian.lobue@utsouthwestern.edu	Cullum, C. Munro/AAC-2496-2019; Hynan, Linda S/P-6473-2016	Cullum, C. Munro/0000-0001-9706-5465; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P3012300-19]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG016976, P30AG012300] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health under grant number P3012300-19.	Abisambra JF, 2014, J ALZHEIMERS DIS, V40, P495, DOI 10.3233/JAD-131019; Attems J, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0206-2; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Cedarbaum JM, 2013, ALZHEIMERS DEMENT, V9, pS45, DOI 10.1016/j.jalz.2011.11.002; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Exalto LG, 2014, ALZHEIMERS DEMENT, V10, P562, DOI 10.1016/j.jalz.2013.05.1772; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Farias ST, 2009, ARCH NEUROL-CHICAGO, V66, P1151, DOI 10.1001/archneurol.2009.106; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gilbert M, 2014, INT PSYCHOGERIATR, V26, P1593, DOI 10.1017/S1041610214000842; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Koepsell TD, 2012, NEUROLOGY, V79, P1591, DOI 10.1212/WNL.0b013e31826e26b7; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; LoBue C, 2016, J NEUROL NEUROSUR PS, V87, P817, DOI 10.1136/jnnp-2015-311438; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Nelson PT, 2009, J NEUROPATH EXP NEUR, V68, P1, DOI 10.1097/NEN.0b013e3181919a48; Petersen R C, 2000, Neurologia, V15, P93; Petersen RC, 2005, ARCH NEUROL-CHICAGO, V62, P1160, DOI 10.1001/archneur.62.7.1160; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rodrigue KM, 2012, NEUROLOGY, V78, P387, DOI 10.1212/WNL.0b013e318245d295; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Tyas SL, 2007, AM J EPIDEMIOL, V165, P1231, DOI 10.1093/aje/kwm085; Vos SJB, 2013, NEUROLOGY, V80, P1124, DOI 10.1212/WNL.0b013e318288690c; Xu W, 2015, J NEUROL NEUROSUR PS, V86, P1299, DOI 10.1136/jnnp-2015-310548; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	37	21	22	0	16	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2018	32	4					401	409		10.1037/neu0000431			9	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	GH1GU	WOS:000433151900003	29809031	Bronze, Green Accepted			2022-02-06	
J	Vascak, M; Jin, XT; Jacobs, KM; Povlishock, JT				Vascak, Michal; Jin, Xiaotao; Jacobs, Kimberle M.; Povlishock, John T.			Mild Traumatic Brain Injury Induces Structural and Functional Disconnection of Local Neocortical Inhibitory Networks via Parvalbumin Interneuron Diffuse Axonal Injury	CEREBRAL CORTEX			English	Article						concussion; diffuse axonal injury; excitation/inhibition; fast-spiking; gray matter	AMYLOID PRECURSOR PROTEIN; NONMISSILE HEAD-INJURY; WHITE-MATTER; CEREBRAL-CORTEX; CORTICAL INTERNEURONS; GAMMA-OSCILLATIONS; POSTTRAUMATIC EPILEPSY; COGNITIVE IMPAIRMENT; ANTIGEN RETRIEVAL; NEURONAL CIRCUITS	Diffuse axonal injury (DAI) plays a major role in cortical network dysfunction posited to cause excitatory/inhibitory imbalance after mild traumatic brain injury (mTBI). Current thought holds that white matter (WM) is uniquely vulnerable to DAI. However, clinically diagnosed mTBI is not always associated with WM DAI. This suggests an undetected neocortical pathophysiology, implicating GABAergic interneurons. To evaluate this possibility, we used mild central fluid percussion injury to generate DAI in mice with Cre-driven tdTomato labeling of parvalbumin (PV) intemeurons. We followed tdTomato+ profiles using confocal and electron microscopy, together with patch-clamp analysis to probe for DAI-mediated neocortical GABAergic interneuron disruption. Within 3 h post-mTBI tdTomato+ perisomatic axonal injury (PSAI) was found across somatosensory layers 2-6. The DAI marker amyloid precursor protein colocalized with GAD67 immunoreactivity within tdTomato+ PSAI, representing the majority of GABAergic intemeuron DAI. At 24 h post-mTBI, we used phospho-c-Jun, a surrogate DAI marker, for retrograde assessments of sustaining somas. Via this approach, we estimated DAI occurs in similar to 9% of total tdTomato+ interneurons, representing similar to 14% of pan-neuronal DAI. Patch-clamp recordings of tdTomato+ interneurons revealed decreased inhibitory transmission. Overall, these data show that PV interneuron DAI is a consistent and significant feature of experimental mTBI with important implications for cortical network dysfunction.	[Vascak, Michal; Jin, Xiaotao; Jacobs, Kimberle M.; Povlishock, John T.] Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	john.povlishock@vcuhealth.org	Jacobs, Kimberle/AAW-7526-2020	Vascak, Michal/0000-0001-8916-0796	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077675]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077675] Funding Source: NIH RePORTER	National Institutes of Health (grant NS077675).	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; BAHMANYAR S, 1987, SCIENCE, V237, P77, DOI 10.1126/science.3299701; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Buki A, 2000, J NEUROSCI, V20, P2825; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carlo CN, 2013, P NATL ACAD SCI USA, V110, P1488, DOI 10.1073/pnas.1221398110; Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention (CDC), 2003, C MILD TRAUM BRAIN I; Cesarovic N, 2010, LAB ANIM-UK, V44, P329, DOI 10.1258/la.2010.009085; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Cole JT, 2010, P NATL ACAD SCI USA, V107, P2373, DOI 10.1073/pnas.1000184107; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; Delouche A, 2016, EUR J RADIOL, V85, P25, DOI 10.1016/j.ejrad.2015.11.004; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Doron G, 2014, NEURON, V81, P653, DOI 10.1016/j.neuron.2013.11.032; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Douglas RJ, 2007, CURR BIOL, V17, pR496, DOI 10.1016/j.cub.2007.04.024; ERB DE, 1991, EXP BRAIN RES, V83, P253; Ewald A.J., 2011, COLD SPRING HARBOR P, V6, P174; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fish KN, 2011, CEREB CORTEX, V21, P2450, DOI 10.1093/cercor/bhr007; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gentet LJ, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00052; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Grimm, 2015, VET ANESTHESIA ANALG; Grubb MS, 2010, CURR OPIN NEUROBIOL, V20, P481, DOI 10.1016/j.conb.2010.04.012; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hangya B, 2014, CURR OPIN NEUROBIOL, V26, P117, DOI 10.1016/j.conb.2014.01.007; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Hsieh TH, 2017, CEREB CORTEX, V27, P5509, DOI 10.1093/cercor/bhw318; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Kann O, 2016, NEUROBIOL DIS, V90, P75, DOI 10.1016/j.nbd.2015.08.005; Kann O, 2014, J CEREBR BLOOD F MET, V34, P1270, DOI 10.1038/jcbfm.2014.104; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lazarus MS, 2015, CEREB CORTEX, V25, P1290, DOI 10.1093/cercor/bht322; Lifshitz J, 2016, BRAIN INJURY, V30, P1; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Manning CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038313; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Patel VC, 2017, EXP NEUROL, V289, P85, DOI 10.1016/j.expneurol.2016.12.012; Paterno R, 2016, J NEUROTRAUM, V33, P1645, DOI 10.1089/neu.2015.4107; Perrais D, 2000, EUR J NEUROSCI, V12, P400, DOI 10.1046/j.1460-9568.2000.00957.x; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Povlishock JT, 2001, HEAD TRAUMA, P281; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scholl B, 2015, NEURON, V87, P424, DOI 10.1016/j.neuron.2015.06.030; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Sun JL, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00063, 10.3389/hsys.2015.00063]; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Trachtenberg JT, 2015, NEURON, V87, P247, DOI 10.1016/j.neuron.2015.06.041; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; van der Horn HJ, 2017, J NEUROTRAUM, V34, P1035, DOI 10.1089/neu.2016.4659; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Walhovd KB, 2014, NEUROSCIENCE, V276, P2, DOI 10.1016/j.neuroscience.2014.06.058; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Williams SR, 2008, NAT NEUROSCI, V11, P790, DOI 10.1038/nn.2137; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhou FW, 2009, J NEUROPHYSIOL, V102, P2514, DOI 10.1152/jn.00557.2009	161	21	21	0	11	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	MAY	2018	28	5					1625	1644		10.1093/cercor/bhx058			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GF3XH	WOS:000431890800006	28334184	Green Published, Bronze			2022-02-06	
J	Townsend, JM; Andrews, BT; Feng, Y; Wang, JX; Nudo, RJ; Van Kampen, E; Gehrke, SH; Berkland, CJ; Detamore, MS				Townsend, Jakob M.; Andrews, Brian T.; Feng, Yi; Wang, Jinxi; Nudo, Randolph J.; Van Kampen, Erik; Gehrke, Stevin H.; Berkland, Cory J.; Detamore, Michael S.			Superior calvarial bone regeneration using pentenoate-functionalized hyaluronic acid hydrogels with devitalized tendon particles	ACTA BIOMATERIALIA			English	Article						Bone; Calvarial; Hyaluronic acid; In situ; Hydrogel; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; COLLOIDAL GELS; MATRIX PARTICLES; BIOMATERIALS; CARTILAGE; GELATIN; SCAFFOLDS; BEHAVIOR; DEFECTS	Traumatic brain injury (TBI) is a life-threatening condition defined by internal brain herniation. Severe TBI is commonly treated by a two-stage surgical intervention, where decompressive craniectomy is first conducted to remove a large portion of calvarial bone and allow unimpeded brain swelling. In the second surgery, spaced weeks to months after the first, cranioplasty is performed to restore the cranial bone. Hydrogels with paste-like precursor solutions for surgical placement may potentially revolutionize TBI treatment by permitting a single-stage surgical intervention, capable of being implanted with the initial surgery, remaining pliable during brain swelling, and tuned to regenerate calvarial bone after brain swelling has subsided. The current study evaluated the use of photocrosslinkable pentenoate-functionalized hyaluronic acid (PHA) and non-crosslinking hyaluronic acid (HA) hydrogels encapsulating naturally derived tissue particles of demineralized bone matrix (DBM), devitalized cartilage (DVC), devitalized meniscus (DVM), or devitalized tendon (DVT) for bone regeneration in critical-size rat calvarial defects. All hydrogel precursors exhibited a yield stress for placement and addition of particles increased the average material compressive modulus. The HA-DBM (4-30%), PHA (4%), and PHA-DVT (4-30%) groups had 5 (p < 0.0001), 3.1, and 3.2 (p < 0.05) times greater regenerated bone volume compared to the sham (untreated defect) group, respectively. In vitro cell studies suggested that the PHA-DVT (4-10%) group would have the most desirable performance. Overall, hydrogels containing DVT particles outperformed other materials in terms of bone regeneration in vivo and calcium deposition in vitro. Hydrogels containing DVT will be further evaluated in future rat TBI studies. (C) 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[Townsend, Jakob M.; Detamore, Michael S.] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA; [Andrews, Brian T.] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66160 USA; [Feng, Yi; Wang, Jinxi] Univ Kansas, Med Ctr, Dept Orthoped Surg, Kansas City, KS 66160 USA; [Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, Kansas City, KS 66160 USA; [Van Kampen, Erik; Gehrke, Stevin H.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66047 USA; [Berkland, Cory J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA		Detamore, MS (corresponding author), Univ Oklahoma, 101 David L Boren Blvd, Norman, OK 73019 USA.	Detamore@ou.edu	Townsend, Jakob/AAH-9637-2019; Gehrke, Stevin H/A-5265-2014	Andrews, Brian/0000-0003-3994-6808	Stephenson Graduate Fellowship; National Institute of Dental and Craniofacial Research of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01 DE022472, R03 DE025906]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R03DE025906, R01DE022472] Funding Source: NIH RePORTER	The authors would like to thank Dr. Hong Liu and Dr. Di Wu for help in conducting the mu CT scans. We would like to thank Alysa Crum for creation of the graphical abstract. We would like to recognize funding from the Stephenson Graduate Fellowship. Research reported in the current publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under award number R01 DE022472 and R03 DE025906. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. No industry funding or support was provided for the current study.	Beck EC, 2016, ANN BIOMED ENG, V44, P1863, DOI 10.1007/s10439-015-1547-5; Beck EC, 2016, TISSUE ENG PT A, V22, P665, DOI [10.1089/ten.tea.2015.0546, 10.1089/ten.TEA.2015.0546]; Beck EC, 2015, ANN BIOMED ENG, V43, P2569, DOI 10.1007/s10439-015-1277-8; Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047; Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a; Choy DKS, 2013, TISSUE ENG PT A, V19, P2382, DOI [10.1089/ten.TEA.2012.0733, 10.1089/ten.tea.2012.0733]; Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067; Cunniffe GM, 2015, EUR POLYM J, V72, P464, DOI 10.1016/j.eurpolymj.2015.07.021; Cunniffe GM, 2015, ACTA BIOMATER, V23, P82, DOI 10.1016/j.actbio.2015.05.031; Dennis SC, 2017, LANGMUIR, V33, P206, DOI 10.1021/acs.langmuir.6b03529; Dennis SC, 2015, TISSUE ENG PART B-RE, V21, P247, DOI [10.1089/ten.teb.2014.0419, 10.1089/ten.TEB.2014.0419]; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Gawlitta D, 2015, TISSUE ENG PT A, V21, P694, DOI [10.1089/ten.tea.2014.0117, 10.1089/ten.TEA.2014.0117]; Holloway JL, 2015, MACROMOL BIOSCI, V15, P1218, DOI 10.1002/mabi.201500178; Honeybul S, 2017, J REHABIL MED, V49, P204, DOI 10.2340/16501977-2209; Khader BA, 2016, MAT SCI ENG C-MATER, V66, P315, DOI 10.1016/j.msec.2016.04.101; Ko E, 2016, ACS APPL MATER INTER, V8, P22819, DOI 10.1021/acsami.6b05358; Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lang J, 2016, IDEGGYOGY SZEMLE, V69, P227, DOI 10.18071/isz.69.0227; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Mergy J, 2012, J POLYM SCI POL CHEM, V50, P4019, DOI 10.1002/pola.26201; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Omary R, 2013, J MOL NEUROSCI, V49, P157, DOI 10.1007/s12031-012-9922-2; Oudshoorn MHM, 2007, POLYMER, V48, P1915, DOI 10.1016/j.polymer.2007.01.068; Poldervaart MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177628; Roughley Peter J, 2014, J Exp Orthop, V1, P8, DOI 10.1186/s40634-014-0008-7; Samaniuk JR, 2014, AICHE J, V60, P1523, DOI 10.1002/aic.14329; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Townsend JM, 2017, AAPS J, V19, P703, DOI 10.1208/s12248-017-0045-0; VanKampen E, 2016, CONTROLLING PROTEIN; Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020; Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.tea.2013.0075, 10.1089/ten.TEA.2013.0075]; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025	38	21	21	0	45	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	APR 15	2018	71						148	155		10.1016/j.actbio.2018.02.013			8	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	GE8GN	WOS:000431470300012	29496620	Green Accepted			2022-02-06	
J	Baez-Jurado, E; Vega, GG; Aliev, G; Tarasov, VV; Esquinas, P; Echeverria, V; Barreto, GE				Baez-Jurado, Eliana; Guio Vega, Gina; Aliev, Gjumrakch; Tarasov, Vadim V.; Esquinas, Paula; Echeverria, Valentina; Barreto, George E.			Blockade of Neuroglobin Reduces Protection of Conditioned Medium from Human Mesenchymal Stem Cells in Human Astrocyte Model (T98G) Under a Scratch Assay	MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Scratch assay; Mesenchymal stem cells; Conditioned medium; Adipose tissue; Neuroglobin	TRAUMATIC BRAIN-INJURY; HUMAN BONE-MARROW; IMPROVES SENSORIMOTOR OUTCOMES; OXYGEN-GLUCOSE DEPRIVATION; FIBRILLARY ACIDIC PROTEIN; ESTROGEN-RECEPTOR BETA; MOUSE MODEL; IN-VITRO; ADIPOSE-TISSUE; STROMAL CELLS	Previous studies have indicated that paracrine factors (conditioned medium) increase wound closure and reduce reactive oxygen species in a traumatic brain injury in vitro model. Although the beneficial effects of conditioned medium from human adipose tissue-derived mesenchymal stem cells (hMSCA-CM) have been previously suggested for various neurological diseases, their actions on astrocytic cells are not well understood. In this study, we have explored the effect of hMSCA-CM on human astrocyte model (T98G cells) subjected to scratch assay. Our results indicated that hMSCA-CM improved cell viability, reduced nuclear fragmentation, attenuated the production of reactive oxygen species, and preserved mitochondrial membrane potential and ultrastructural parameters. In addition, hMSCA-CM upregulated neuroglobin in T98G cells and the genetic silencing of this protein prevented the protective action of hMSCA-CM on damaged cells, suggesting that neuroglobin is mediating, at least in part, the protective effect of hMSCA-CM. Overall, this evidence suggests that the use of hMSCA-CM is a promising therapeutic strategy for the protection of astrocytic cells in central nervous system (CNS) pathologies.	[Baez-Jurado, Eliana; Guio Vega, Gina; Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia; [Aliev, Gjumrakch] Russian Acad Sci, Inst Physiol Act Cpds, Chernogolovka 142432, Russia; [Aliev, Gjumrakch] GALLY Int Biomed Res Consulting LLC, San Antonio, TX 78229 USA; [Aliev, Gjumrakch] Univ Atlanta, Sch Hlth Sci & Healthcare Adm, Johns Creek, GA 30097 USA; [Tarasov, Vadim V.] Sechenov First Moscow State Med Univ, Inst Pharm & Translat Med, 2-4 Bolshaya Pirogovskaya St, Moscow 119991, Russia; [Esquinas, Paula] Univ Nacl Colombia, Fac Med Vet & Zootecnia, Bogota, Colombia; [Echeverria, Valentina] Univ San Sebastian, Fac Ciencias Salud, Lientur 1457, Concepcion 4030000, Chile; [Barreto, George E.] Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile		Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, Colombia.; Barreto, GE (corresponding author), Univ Autonoma Chile, Inst Ciencias Biomed, Santiago, Chile.	gsampaio@javeriana.edu.co	Aliev, Gjumrakch/K-7302-2017; Valentina Echeverria Moran, BCh/E-7765-2013; Barreto, George E./AAD-7420-2020; Aliev, Gjumrakch/AAE-7734-2020	Valentina Echeverria Moran, BCh/0000-0003-2393-5418; Barreto, George E./0000-0002-6644-1971; Aliev, Gjumrakch/0000-0001-7373-3182; Tarasov, Vadim Vladimirovic/0000-0002-9394-7994	Vicerrectoria Academica of PUJ; PUJ [6260]	The authors thank Dr. Jorge Andres Afanador and the staff of the cosmetic surgery Clinic DHARA in Bogota - Colombia, for the adipose tissue samples. This work was supported by PUJ grant # 6260 to GEB and scholarship for doctoral studies awarded by the Vicerrectoria Academica of PUJ to Baez-Jurado E.	Acaz-Fonseca E., 2015, GLIA; Aizman I, 2013, STEM CELL TRANSL MED, V2, P223, DOI 10.5966/sctm.2012-0119; Allen JW, 1999, FASEB J, V13, P1875, DOI 10.1096/fasebj.13.13.1875; Amri F, 2017, J NEUROCHEM, V140, P151, DOI 10.1111/jnc.13876; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Baez E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00146; Baglio SR, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00359; Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bankhead P., 2013, ANAL FLUORESCENCE MI; Bertheuil N, 2015, ANN CHIR PLAST ESTH, V60, P94, DOI 10.1016/j.anplas.2014.09.014; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x; Cabezas R, 2015, NEUROTOX RES, V27, P355, DOI 10.1007/s12640-014-9509-5; Cantinieaux D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069515; Chen D, 2016, J NEUROSCI RES; Chen XM, 2015, NEUROSCI LETT, V606, P194, DOI 10.1016/j.neulet.2015.09.002; Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; Duchen MR, 2010, ESSAYS BIOCHEM, V47, P115, DOI [10.1042/BSE0470115, 10.1042/bse0470115]; Egashira Y, 2012, BRAIN RES, V1461, P87, DOI 10.1016/j.brainres.2012.04.033; Eirin A, 2014, GENE, V551, P55, DOI 10.1016/j.gene.2014.08.041; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Fernandez-Fernandez S, 2012, BIOCHEM J, V443, P3, DOI 10.1042/BJ20111943; Fiocchetti M, 2015, J STEROID BIOCHEM, V149, P128, DOI 10.1016/j.jsbmb.2015.02.005; George E, 2011, ROLE ASTROCYTES NEUR; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2016, METHODS MOL BIOL, V1416, P123, DOI 10.1007/978-1-4939-3584-0_7; Gonzalez A, 2007, BRAIN RES, V1178, P28, DOI 10.1016/j.brainres.2007.08.040; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; GRIFFITHS CEM, 1990, J INVEST DERMATOL, V95, pS53, DOI 10.1111/1523-1747.ep12505786; Guerit D, 2014, STEM CELLS DEV, V23, P1195, DOI 10.1089/scd.2013.0463; Guo ZY, 2015, NEURAL REGEN RES, V10, P651, DOI 10.4103/1673-5374.155442; Habersetzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075429; Hao P, 2014, METAB BRAIN DIS, V29, P193, DOI 10.1007/s11011-014-9490-y; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32993; Huang B, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0792-1; Huang WY, 2015, J CELL PHYSIOL, V230, P2461, DOI 10.1002/jcp.24981; HUE L, 1976, BIOCHEM SOC T, V4, P994, DOI 10.1042/bst0040994; Hwang B, 2016, J THORAC CARDIOV SUR, V151, P841, DOI 10.1016/j.jtcvs.2015.11.043; Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159; Jeong SH, 2014, MAR DRUGS, V12, P4602, DOI 10.3390/md12084602; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Kaewsuya P, 2007, ANAL BIOANAL CHEM, V387, P2775, DOI 10.1007/s00216-007-1135-0; Kallakuri S, 2015, J CLIN IMAG SCI, V5, DOI 10.4103/2156-7514.166354; Kemp K, 2010, J NEUROCHEM, V114, P1569, DOI 10.1111/j.1471-4159.2009.06553.x; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim WS, 2008, J DERMATOL SCI, V49, P133, DOI 10.1016/j.jdermsci.2007.08.004; Lattanzi W, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/468705; Lechauve C, 2013, BBA-PROTEINS PROTEOM, V1834, P1772, DOI 10.1016/j.bbapap.2013.04.014; Lee Hyun-Ho, 2015, Korean J Neurotrauma, V11, P44, DOI 10.13004/kjnt.2015.11.2.44; Lee JC, 2016, J PATHOL TRANSL MED, V50, P325, DOI 10.4132/jptm.2015.09.11.r; Li L, 2014, MOL NEUROBIOL, V49, P149, DOI 10.1007/s12035-013-8506-7; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li Y, 2016, J MOL NEUROSCI, V58, P28, DOI 10.1007/s12031-015-0645-z; Liang CM, 2014, CYTOTHERAPY, V16, P1371, DOI 10.1016/j.jcyt.2014.05.015; Lin WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063444; Linero I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107001; Liu YC, 2015, BRAIN INJURY, V29, P651, DOI 10.3109/02699052.2014.1002004; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078514; Mimura J, 2011, J BIOCHEM, V150, P209, DOI 10.1093/jb/mvr065; Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005; Mita T, 2015, BEHAV BRAIN RES, V293, P189, DOI 10.1016/j.bbr.2015.07.043; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Oliva CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024665; Oliveira K, 2015, METAB BRAIN DIS, V30, P1401, DOI 10.1007/s11011-015-9718-5; Ong WK, 2013, INT J BIOCHEM CELL B, V45, P1083, DOI 10.1016/j.biocel.2013.02.013; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Ouyang YB, 2011, MITOCHONDRION, V11, P279, DOI [10.1016/j.mito.2010.10.007, 10.1016/j.mito.2011.09.001]; Park CM, 2016, IN VITRO CELL DEV-AN, V52, P68, DOI 10.1007/s11626-015-9948-1; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Pires AO, 2016, STEM CELLS DEV, V25, P1073, DOI 10.1089/scd.2016.0048; Pischiutta F, 2016, CRIT CARE MED, V44, pE1118, DOI 10.1097/CCM.0000000000001864; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Platas J, 2016, AGING-US, V8, P1703, DOI 10.18632/aging.101007; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qi X, 2016, INT J BIOL SCI, V12, P836, DOI 10.7150/ijbs.14809; Rampelt H, 2016, BIOCH BIOPHYS ACTA; Ren CH, 2015, RESTOR NEUROL NEUROS, V33, P369, DOI 10.3233/RNN-140413; Salgado AJ, 2010, STEM CELLS DEV, V19, P1067, DOI 10.1089/scd.2009.0279; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Sandhir R, 2014, NEUROSCI LETT, V577, P123, DOI 10.1016/j.neulet.2014.06.005; Sasaki S, 2015, J BIOL CHEM, V290, P2303, DOI 10.1074/jbc.M114.581892; Scheibe F, 2012, CELL MOL NEUROBIOL, V32, P567, DOI 10.1007/s10571-012-9798-2; SHAFITZAGARDO B, 1988, GLIA, V1, P346, DOI 10.1002/glia.440010507; Skalnikova HK, 2013, BIOCHIMIE, V95, P2196, DOI 10.1016/j.biochi.2013.07.015; Song M, 2015, J NEUROSCI RES, V93, P973, DOI 10.1002/jnr.23569; Stetler RA, 2013, J CEREBR BLOOD F MET, V33, P22, DOI 10.1038/jcbfm.2012.158; Sun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072926; Taniguchi H, 2016, J VIS EXP; Taylor JM, 2014, NEUROSCI LETT, V577, P125, DOI 10.1016/j.neulet.2014.03.012; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Toro-Urrego N, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00152; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; van Koppen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038746; Walter MNM, 2010, EXP CELL RES, V316, P1271, DOI 10.1016/j.yexcr.2010.02.026; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Wei X, 2009, STEM CELLS, V27, P478, DOI 10.1634/stemcells.2008-0333; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Witte I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.91; Xie BC, 2016, AM J TRANSL RES, V8, P3241; Yalvac ME, 2013, BRAIN BEHAV IMMUN, V32, P122, DOI 10.1016/j.bbi.2013.03.007; Yamazaki H, 2015, NEUROSCI LETT, V609, P53, DOI 10.1016/j.neulet.2015.10.023; Yousefi F, 2016, IMMUNOL LETT, V172, P94, DOI 10.1016/j.imlet.2016.02.016; Yu Z, 2012, NEUROSCIENCE, V218, P235, DOI 10.1016/j.neuroscience.2012.05.054; Yu ZL, 2014, NEUROSCIENCE, V270, P158, DOI 10.1016/j.neuroscience.2014.04.013; Yu ZY, 2016, MOL NEUROBIOL, V53, P3249, DOI 10.1007/s12035-015-9273-4; Yu ZY, 2012, INT J MOL SCI, V13, P6995, DOI 10.3390/ijms13066995; Yuan H, 2016, CELL BIOL INT; Yuan YJ, 2016, CLIN SCI, V130, P2181, DOI 10.1042/CS20160235; Zhang JY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0417-0; Zhao S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-67; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	125	21	21	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2018	55	3					2285	2300		10.1007/s12035-017-0481-y			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY5TG	WOS:000426897800038	28332151				2022-02-06	
J	De Kegel, D; Vastmans, J; Fehervary, H; Depreitere, B; Vander Sloten, J; Famaey, N				De Kegel, Dries; Vastmans, Julie; Fehervary, Heleen; Depreitere, Bart; Vander Sloten, Jos; Famaey, Nele			Biomechanical characterization of human dura mater	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Planar biaxial tensile tests; Dura mater; Constitutive modelling; Gasser-Ogden-Holzapfel model; Ogden model	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; FINITE-ELEMENT-ANALYSIS; INTRACRANIAL-PRESSURE; MECHANICAL-PROPERTIES; SPINAL-CORD; HUMAN HEAD; TISSUE; MENINGES; GLYCEROL	A reliable computational model of the human head is necessary for better understanding of the physical mechanisms of traumatic brain injury (TBI), car-crash investigation, development of protective head gear and advancement of dural replacement materials. The performance and biofidelity of these models depend largely on the material description of the different structures present in the head. One of these structures is the dura mater, the protective layer around the brain. We tested five human dura mater specimens, with samples at different locations, using planar biaxial tests. We describe the resulting stress-strain curves using both the anisotropic Gasser-Ogden-Holzapfel (GOH) model and the isotropic one-term Ogden model. The low-strain section of the curves is also described using a Neo-Hookean formulation. The obtained stress-strain curves reveal highly nonlinear but isotropic behaviour. A significant amount of inter- and intra-specimen variability is noticed, whereby the latter does not seem to be influenced by location. The GOH model achieves the best fit of the individual test data. A simple Neo-Hookean model can only be used with extreme caution, as it does not manage to capture the nonlinear effects present even at low strains.	[De Kegel, Dries; Vastmans, Julie; Fehervary, Heleen; Vander Sloten, Jos; Famaey, Nele] Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium; [Depreitere, Bart] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Neurosurg, Leuven, Belgium		De Kegel, D (corresponding author), Katholieke Univ Leuven, Biomech Sect, Leuven, Belgium.	dries.dekegel@kuleuven.be	Vastmans, Julie/AAP-2906-2020; Fehervary, Heleen/AAG-6014-2019; Depreitere, Bart/AAA-9846-2020	Vastmans, Julie/0000-0001-5415-875X; Depreitere, Bart/0000-0002-7458-0648; Famaey, Nele/0000-0002-7374-8912	Research Foundation Flanders (FWO)FWO [G.0067.13, 1535316N, PDO-012]	This research was funded by a research project, a pre- and post-doctoral fellowship of the Research Foundation Flanders (FWO) (G.0067.13, 1535316N, PDO-012). The authors would like to express their sincerest gratitude to Gracia Umuhire Musigazi, MD, for her help with harvesting the cranial vault dura mater, and to Lotte Vanmol, MSc., for her help with the thickness measurements and the implementation of the filter.	Adeeb N, 2012, CHILD NERV SYST, V28, P827, DOI 10.1007/s00381-012-1744-6; Andersson J., 2013, THESIS, V10; Baeck K, 2013, THESIS; Bashkatov AN, 2003, BIOPHYS J, V85, P3310, DOI 10.1016/S0006-3495(03)74750-X; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Bylski D. I., 1983, J BIOMECH ENG, V105, P71; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chauvet D, 2010, NEUROSURG REV, V33, P287, DOI 10.1007/s10143-010-0261-x; Chen YL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/815981; Clarke A G, 1944, Postgrad Med J, V20, P74; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Ellis H, 2012, SURGERY, V30, P99; Esopenko C, 2015, J NEUROTRAUM, V32, P209, DOI 10.1089/neu.2014.3506; Faul M., 2011, INJURY PREV, V16, P268; Fehervary H, 2016, J MECH BEHAV BIOMED, V61, P135, DOI 10.1016/j.jmbbm.2016.01.011; Fung Y., 1993, BIOMECHANICS; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Gillis J., 2017, OPTISTACK; Haimann MCJ, 1998, J ANAT, V192, P99; HOFFMAN AH, 1984, J BIOMECH, V17, P795, DOI 10.1016/0021-9290(84)90110-6; Holzapfel G. A., 2001, HDB MAT BEHAV MODEL, V3, P1049, DOI DOI 10.1016/13978-012443341-0/50107-1; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; MacManus DB, 2017, ACTA BIOMATER, V57, P384, DOI 10.1016/j.actbio.2017.05.022; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Mao HJ, 2011, J NEUROTRAUM, V28, P2263, DOI 10.1089/neu.2010.1600; Mao HJ, 2011, INT J NUMER METH BIO, V27, P357, DOI 10.1002/cnm.1403; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; MCGARVEY KA, 1984, BIOMATERIALS, V5, P109, DOI 10.1016/0142-9612(84)90011-5; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; O'Leary SA, 2013, J BIOMECH, V46, P1955, DOI 10.1016/j.jbiomech.2013.05.003; OGDEN RW, 1972, J MECH PHYS SOLIDS, V20, P77, DOI 10.1016/0022-5096(72)90032-4; Patel N, 2009, SEMIN ULTRASOUND CT, V30, P559, DOI 10.1053/j.sult.2009.08.006; Protasoni M, 2011, J NEUROSURG, V114, P1723, DOI 10.3171/2010.12.JNS101732; Robertson D, 2014, J MECH BEHAV BIOMED, V40, P234, DOI 10.1016/j.jmbbm.2014.09.006; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Runza M, 1999, ANESTH ANALG, V88, P1317, DOI 10.1097/00000539-199906000-00022; Sacks M. S., 2000, BIAXIAL MECH EVALUAT; Salimi JM, 2014, COMPUT METHOD BIOMEC, V17, P1368, DOI [10.1080/10255842.2012.748755, DOI 10.1080/10255842.2012.748755]; Schafer RW, 2011, IEEE SIGNAL PROC MAG, V28, P111, DOI 10.1109/MSP.2011.941097; Shetye SS, 2014, J MECH BEHAV BIOMED, V34, P146, DOI 10.1016/j.jmbbm.2014.02.014; Standring S., 2008, GRAYS ANATOMY ANATOM, V40th; van Noort R, 1981, Clin Phys Physiol Meas, V2, P197, DOI 10.1088/0143-0815/2/3/003; VANNOORT R, 1981, BIOMATERIALS, V2, P41, DOI 10.1016/0142-9612(81)90086-7; Wilcox Ruth K, 2003, J Orthop Sci, V8, P432, DOI 10.1007/s10776-003-0644-9; Yang King H, 2006, Stapp Car Crash J, V50, P429; Yang ZR, 2015, BRAIN RES, V1602, P160, DOI 10.1016/j.brainres.2014.11.038; Yue XF, 2008, AFR J BIOTECHNOL, V7, P689; Zhang L. Y., 2001, STAPP CAR CRASH J, V45, P1	55	21	21	1	23	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	MAR	2018	79						122	134		10.1016/j.jmbbm.2017.12.023			13	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	FW1PQ	WOS:000425072300015	29294435				2022-02-06	
J	Erdodi, LA; Dunn, AG; Seke, KR; Charron, C; McDermott, A; Enache, A; Maytham, C; Hurtubise, JL				Erdodi, Laszlo A.; Dunn, Alexa G.; Seke, Kristian R.; Charron, Carly; McDermott, Abigail; Enache, Anca; Maytham, Charlotte; Hurtubise, Jessica L.			The Boston Naming Test as a Measure of Performance Validity	PSYCHOLOGICAL INJURY & LAW			English	Article						Boston Naming Test; Performance validity; Embedded validity indicators	TRAUMATIC BRAIN-INJURY; FORCED-CHOICE RECOGNITION; VERBAL-LEARNING TEST; COMPLEX IDEATIONAL MATERIAL; MEMORY-MALINGERING TOMM; CLASSIFICATION ACCURACY; TRIAL 1; INVALID PERFORMANCE; CROSS-VALIDATION; SUSPECT EFFORT	This study was designed to evaluate the potential of the Boston Naming Test (BNT) as a performance validity test (PVT). The classification accuracy of the BNT was examined against several criterion PVTs in a mixed clinical sample of 214 adult outpatients physician referred for neuropsychological assessment. Mean age was 46.7 (SD = 12.5); mean education was 13.5 (SD = 2.5). All participants were native speakers of English. A BNT raw score = 50 produced high specificity (.87-.95), but low and variable sensitivity (.15-.41). Similarly, a T score <= 37 was specific (.87-.95), but not very sensitive (.15-.35) to psychometrically defined non-credible responding. Ipsative analyses (i.e., case-by-case review of individual PVT profiles) suggest that failing these cutoffs was associated with zero false positives when all available PVTs were taken into account. Results are consistent with previous reports that the validity cutoffs on the BNT have high positive predictive power, but low negative predictive power. As such, they are useful in ruling in invalid performance, but they cannot be used to rule it out.	[Erdodi, Laszlo A.; Dunn, Alexa G.; Seke, Kristian R.; Charron, Carly; McDermott, Abigail; Enache, Anca; Maytham, Charlotte; Hurtubise, Jessica L.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Charron, Carly/0000-0001-5647-6903			Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Denning JH, 2014, APPL NEUROPSYCH-ADUL, V21, P269, DOI 10.1080/23279095.2013.811076; Erdodi L. A., 2017, APPL NEUROPSYCHOLOGY; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Goodglass H, 1972, THE ASSESSMENT OF AP; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kaplan E.F., 1978, BOSTON NAMING TEST E; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Larrabee G. J., 2012, FORENSIC NEUROPSYCHO, P117; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; Pearson, 2009, ADV CLIN SOL WAIS 4; Pedraza O, 2009, J INT NEUROPSYCH SOC, V15, P758, DOI 10.1017/S1355617709990361; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Robles L, 2015, J CLIN EXP NEUROPSYC, V37, P614, DOI 10.1080/13803395.2015.1039961; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trueblood W., 1994, J CLIN EXPT NEUROPSY, V4, P697, DOI DOI 10.1080/01688639408402671; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Young G, 2015, PSYCHOL INJ LAW, V8, P188, DOI 10.1007/s12207-015-9232-4	61	21	21	2	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2018	11	1					1	8		10.1007/s12207-017-9309-3			8	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	FX8UX	WOS:000426372200001					2022-02-06	
J	Kerr, WT; Janio, EA; Braesch, CT; Le, JM; Hori, JM; Patel, AB; Gallardo, NL; Bauirjan, J; Chau, AM; Hwang, ES; Davis, EC; Buchard, A; Torres-Barba, D; D'Ambrosio, S; Al Banna, M; Cho, AY; Engel, J; Cohen, MS; Stern, JM				Kerr, Wesley T.; Janio, Emily A.; Braesch, Chelsea T.; Le, Justine M.; Hori, Jessica M.; Patel, Akash B.; Gallardo, Norma L.; Bauirjan, Janar; Chau, Andrea M.; Hwang, Eric S.; Davis, Emily C.; Buchard, Albert; Torres-Barba, David; D'Ambrosio, Shannon; Al Banna, Mona; Cho, Andrew Y.; Engel, Jerome, Jr.; Cohen, Mark S.; Stern, John M.			An objective score to identify psychogenic seizures based on age of onset and history	EPILEPSY & BEHAVIOR			English	Article						Dissociative seizures; Diagnostic score; Logistic regression; Multiple imputation	POSTTRAUMATIC-STRESS-DISORDER; TEMPORAL-LOBE EPILEPSY; NONEPILEPTIC SEIZURES; SYSTEMS QUESTIONNAIRE; TRAUMATIC EVENTS; DIAGNOSTIC DELAY; FOCAL EPILEPSY; BRAIN-INJURY; HEAD-INJURY; CHILDREN	Objective: Psychogenic nonepileptic seizure (PNES) is a common diagnosis after evaluation of medication resistant or atypical seizures with video-electroencephalographic monitoring (VEM), but usually follows a long delay after the development of seizures, during which patients are treated for epilepsy. Therefore, more readily available diagnostic tools are needed for earlier identification of patients at risk for PNES. A tool based on patient reported psychosocial history would be especially beneficial because it could be implemented in the outpatient clinic. Methods: Based on the data from 1375 patients with VEM-confirmed diagnoses, we used logistic regression to compare the frequency of specific patient-reported historical events, demographic information, age of onset, and delay from first seizure until VEM in five mutually exclusive groups of patients: epileptic seizures (ES), PNES, physiologic nonepileptic seizure-like events (PSLE), mixed PNES plus ES, and inconclusive monitoring. To determine the diagnostic utility of this information to differentiate PNES only from ES only, we used multivariate piecewise-linear logistic regression trained using retrospective data from chart review and validated based on data from 246 prospective standardized interviews. Results: The prospective area under the curve of our weighted multivariate piecewise-linear by-sex score was 73%, with the threshold that maximized overall retrospective accuracy resulting in a prospective sensitivity of 74% (95% CI: 70-79%) and prospective specificity of 71% (95% CI: 64-82%). The linear model and piecewise linear without an interaction term for sex had very similar performance statistics. In the multivariate piecewise-linear sex-split predictive model, the significant factors positively associated with ES were history of febrile seizures, current employment or active student status, history of traumatic brain injury (TBI), and longer delay from first seizure until VEM. The significant factors associated with PNES were female sex, older age of onset, mild TBI, and significant stressful events with sexual abuse, in particular, increasing the likelihood of PNES. Delays longer than 20 years, age of onset after 31 years for men, and age of onset after 40 years for women had no additional effect on the likelihood of PNES. Discussion: Our promising results suggest that an objective score has the potential to serve as an early outpatient screening tool to identify patients with greater likelihood of PNES when considered in combination with other factors. In addition, our analysis suggests that sexual abuse, more than other psychological stressors including physical abuse, is more associated with PNES. There was a trend of increasing frequency of PNES for women during childbearing years and plateauing outside those years that was not observed in men. (C) 2017 Elsevier Inc. All rights reserved.	[Kerr, Wesley T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Kerr, Wesley T.; Janio, Emily A.; Braesch, Chelsea T.; Le, Justine M.; Hori, Jessica M.; Patel, Akash B.; Gallardo, Norma L.; Bauirjan, Janar; Chau, Andrea M.; Hwang, Eric S.; Davis, Emily C.; Buchard, Albert; Torres-Barba, David; D'Ambrosio, Shannon; Al Banna, Mona; Cho, Andrew Y.; Engel, Jerome, Jr.; Cohen, Mark S.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Engel, Jerome, Jr.; Cohen, Mark S.; Stern, John M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.; Cohen, Mark S.; Stern, John M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Cohen, Mark S.] Univ Calif Los Angeles, Dept Radiol, Los Angeles, CA USA; [Cohen, Mark S.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Cohen, Mark S.] Univ Calif Los Angeles, Dept Biomed Phys, Los Angeles, CA USA; [Cohen, Mark S.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Cohen, Mark S.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Kerr, Wesley T.] Eisenhower Med Ctr, Dept Internal Med, Rancho Mirage, CA USA		Kerr, WT (corresponding author), Univ Calif Los Angeles, Semel Inst, 760 Westwood Plaza,Room C9-420, Los Angeles, CA 90095 USA.	WesleyTK@UCLA.edu	Cohen, Mark S/C-6610-2011; Kerr, Wesley T/I-6301-2019	Cohen, Mark S/0000-0001-6731-4053; Kerr, Wesley T/0000-0002-5546-5951; Janio, Emily/0000-0002-2221-0805; Stern, John/0000-0002-3549-1642	UCLA-California Institute of Technology Medical Scientist Training Program [NIH T32 GM08042]; Neuroimaging Training Program [NIH T90 DA022768, R90 DA022768, R90 DA023422]; William M. Keck FoundationW.M. Keck Foundation [NS03310, NS080181]; UCLA Departments of Psychiatry & Biobehavioral Sciences and Biomathematics; Eisenhower Medical Center Department of Internal Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS033310, P01NS002808, P20NS080181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R90DA023422, R21DA026109, T90DA022768] Funding Source: NIH RePORTER	The authors thank Kirk Shattuck, Marc Nuwer, and Edward P. Lau for organization support, access to the data, and technical support. This work was supported by the UCLA-California Institute of Technology Medical Scientist Training Program (NIH T32 GM08042), the Neuroimaging Training Program (NIH T90 DA022768, R90 DA022768, & R90 DA023422 to MSC), the William M. Keck Foundation, research grants to JE (NS03310 & NS080181), the UCLA Departments of Psychiatry & Biobehavioral Sciences and Biomathematics, and the Eisenhower Medical Center Department of Internal Medicine.	Adams SJ, 2008, BRIT J PSYCHIAT, V192, P464, DOI 10.1192/bjp.bp.107.046664; Alessi R, 2014, SEIZURE-EUR J EPILEP, V23, P906, DOI 10.1016/j.seizure.2014.07.016; Alessi R, 2013, EPILEPSY BEHAV, V27, P292, DOI 10.1016/j.yebeh.2013.02.003; ALPER K, 1993, NEUROLOGY, V43, P1950, DOI 10.1212/WNL.43.10.1950; Asadi-Pooya A, 2017, NEUROL SCI, V38, P935, DOI 10.1007/s10072-017-2887-8; Asadi-Pooya AA, 2016, J CLIN NEUROSCI, V34, P105, DOI 10.1016/j.jocn.2016.05.037; Badour CL, 2013, J ANXIETY DISORD, V27, P155, DOI 10.1016/j.janxdis.2012.11.002; Baroni G, 2016, SEIZURE-EUR J EPILEP, V37, P35, DOI 10.1016/j.seizure.2016.02.003; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; Begley CE, 2000, EPILEPSIA, V41, P342, DOI 10.1111/j.1528-1157.2000.tb00166.x; Behrouz R, 2006, EPILEPSY BEHAV, V8, P649, DOI 10.1016/j.yebeh.2006.02.003; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Bowman ES, 1996, AM J PSYCHIAT, V153, P57; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cragar DE, 2002, NEUROPSYCHOL REV, V12, DOI 10.1023/A:1015491123070; Dickinson P, 2012, EPILEPSIA, V53, P1679, DOI 10.1111/j.1528-1167.2012.03606.x; Diseth TH, 2005, NORD J PSYCHIAT, V59, P79, DOI 10.1080/08039480510022963; Dixit R, 2013, EPILEPSY BEHAV, V28, P137, DOI 10.1016/j.yebeh.2013.05.004; Duncan R, 2006, EXPERT OPIN DRUG SAF, V5, P609, DOI 10.1517/14740338.5.5.609; Duncan R, 2006, NEUROLOGY, V66, P1644, DOI 10.1212/01.wnl.0000223320.94812.7a; Dworetzky BA, 2005, EPILEPSIA, V46, P1418, DOI 10.1111/j.1528-1167.2005.13004.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; GATES JR, 1985, ARCH NEUROL-CHICAGO, V42, P1183, DOI 10.1001/archneur.1985.04060110065017; Gazzola DM, 2012, EPILEPSY BEHAV, V25, P662, DOI 10.1016/j.yebeh.2012.10.008; Gilbert DL, 2003, NEUROLOGY, V60, P564, DOI 10.1212/01.WNL.0000044152.79316.27; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Haneef Z, 2010, NEUROLOGY, V75, P699, DOI 10.1212/WNL.0b013e3181eee457; Hesdorffer DC, 2012, EPILEPSIA, V53, P1471, DOI 10.1111/j.1528-1167.2012.03567.x; Holmes MD, 2001, EPILEPSY BEHAV, V2, P568, DOI 10.1006/ebeh.2001.0268; Hubsch C, 2010, J NEUROL, V82, P955; Isaac M, 2006, CURR OPIN PSYCHIATR, V19, P61, DOI 10.1097/01.yco.0000194811.83720.69; JEFFERYS JGR, 1995, ITAL J NEUROL SCI, V16, P27, DOI 10.1007/BF02229071; Jones SG, 2010, PSYCHOSOM MED, V72, P487, DOI 10.1097/PSY.0b013e3181d96550; Kallen B, 2014, SEMIN FETAL NEONAT M, V19, P239, DOI 10.1016/j.siny.2014.04.002; Kellinghaus C, 2004, J NEUROL, V251, P704, DOI 10.1007/s00415-004-0406-3; Kerr WT, 2017, EPILEPSIA, V58, P1852, DOI 10.1111/epi.13888; Kerr WT, 2016, SEIZURE-EUR J EPILEP, V40, P123, DOI 10.1016/j.seizure.2016.06.015; Kerr WT, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00031; Kerr WT, 2012, EPILEPSIA, V53, pe189, DOI 10.1111/j.1528-1167.2012.03653.x; KRUMHOLZ A, 1983, NEUROLOGY, V33, P498, DOI 10.1212/WNL.33.4.498; LaFrance WC, 2013, EPILEPSIA, V54, P2005, DOI 10.1111/epi.12356; LaFrance WC, 2013, EPILEPSIA, V54, P53, DOI 10.1111/epi.12106; LaFrance WC, 2006, NEUROLOGY, V66, P1620, DOI 10.1212/01.wnl.0000224953.94807.be; LaFrance WC, 2004, EPILEPSIA, V45, P15, DOI 10.1111/j.0013-9580.2004.452002.x; LANCMAN ME, 1994, J CHILD NEUROL, V9, P404, DOI 10.1177/088307389400900413; Lesser RP, 1996, NEUROLOGY, V46, P1499, DOI 10.1212/WNL.46.6.1499; Magee JA, 2014, EPILEPSY BEHAV, V33, P45, DOI 10.1016/j.yebeh.2014.02.010; Marin-Valencia I, 2014, EPILEPSIA, V55, P970, DOI 10.1111/epi.12650; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; MEIERKORD H, 1991, NEUROLOGY, V41, P1643, DOI 10.1212/WNL.41.10.1643; MILLER ME, 1991, STAT MED, V10, P1213, DOI 10.1002/sim.4780100805; Nagamitsu S, 2011, BRAIN DEV-JPN, V33, P601, DOI 10.1016/j.braindev.2010.10.001; NORRIS FH, 1992, J CONSULT CLIN PSYCH, V60, P409, DOI 10.1037/0022-006X.60.3.409; Oto M, 2005, SEIZURE-EUR J EPILEP, V14, P33, DOI 10.1016/j.seizure.2004.02.008; Pakalnis A, 2000, J CHILD NEUROL, V15, P78, DOI 10.1177/088307380001500202; Patel H, 2007, EPILEPSIA, V48, P2086, DOI 10.1111/j.1528-1167.2007.01200.x; Perez DL, 2016, CNS SPECTRUMS, V21, P239, DOI 10.1017/S109285291600002X; Pittau F, 2009, EPILEPSIA, V50, P41, DOI 10.1111/j.1528-1167.2008.01969.x; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Razvi S, 2012, EPILEPSY BEHAV, V23, P7, DOI 10.1016/j.yebeh.2011.10.009; Reuber M, 2002, NEUROLOGY, V58, P493, DOI 10.1212/WNL.58.3.493; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Robles L, 2015, EPILEPSY BEHAV, V45, P151, DOI 10.1016/j.yebeh.2015.02.003; Rubin D.B., 1987, MULTIPLE IMPUTATION; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Scioli-Salter ER, 2016, PSYCHOL TRAUMA-US, V8, P585, DOI 10.1037/tra0000135; Scott DF, 1982, PSEUDOSEIZURES, P21; Seneviratne U, 2012, EPILEPSIA, V53, pe63, DOI 10.1111/j.1528-1167.2011.03382.x; Seneviratne U, 2010, EPILEPSIA, V51, P1159, DOI 10.1111/j.1528-1167.2010.02560.x; St Louis Erik K, 2016, Continuum (Minneap Minn), V22, P15, DOI 10.1212/CON.0000000000000284; Syed TU, 2008, EPILEPSIA, V49, P898, DOI 10.1111/j.1528-1167.2007.01456.x; Syed TU, 2011, ANN NEUROL, V69, P997, DOI 10.1002/ana.22345; Szabo L, 2012, EPILEPSIA, V53, P565, DOI 10.1111/j.1528-1167.2012.03404.x; Taylor BC, 2017, J NEUROTRAUM, V34, P2567, DOI 10.1089/neu.2016.4910; Tojek TM, 2000, PSYCHOSOMATICS, V41, P221, DOI 10.1176/appi.psy.41.3.221; Valente KD, 2017, PEDIATR NEUROL, V67, P71, DOI 10.1016/j.pediatrneurol.2016.10.021; vanMerode T, 1997, SEIZURE, V6, P311; Vezzani A, 2015, COLD SPRING HARB PER, V6, DOI DOI 10.1101/CSHPERSPECT.A022699; Vincentiis S, 2006, EPILEPSY BEHAV, V8, P294, DOI 10.1016/j.yebeh.2005.08.014; WALCZAK TS, 1995, EPILEPSIA, V36, P1131, DOI 10.1111/j.1528-1157.1995.tb00472.x; Walczak TS, 2001, EPILEPSIA, V42, P804; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x; WILKUS RJ, 1984, EPILEPSIA, V25, P100, DOI 10.1111/j.1528-1157.1984.tb04162.x; Wyllie E, 1999, ARCH PEDIAT ADOL MED, V153, P244	86	21	21	0	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	MAR	2018	80						75	83		10.1016/j.yebeh.2017.11.035			9	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	GA0PK	WOS:000428016400013	29414562	Green Accepted			2022-02-06	
J	Kontos, AP; Collins, MW; Holland, CL; Reeves, VL; Edelman, K; Benso, S; Schneider, W; Okonkwo, D				Kontos, Anthony P.; Collins, Michael W.; Holland, Cyndi L.; Reeves, Valerie L.; Edelman, Kathryn; Benso, Steven; Schneider, Walter; Okonkwo, David			Preliminary Evidence for Improvement in Symptoms, Cognitive, Vestibular, and Oculomotor Outcomes Following Targeted Intervention with Chronic mTBI Patients	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS; CONCUSSION; AFGHANISTAN; MOTOR; BLAST; IRAQ; TBI	Introduction: To determine if targeted, active interventions would improve symptoms and impairment in previously intractable patients with chronic mild traumatic brain injury (mTBI). Materials and Methods: Twenty-six (20 males; 6 females) out of 51 (51%) former military and civilian patients with chronic (1-3 yr) mTBI enrolled in the TEAM traumatic brain injury (TBI) study completed both an initial and 6-mo post-intervention comprehensive mTBI assessment including symptoms (Post-concussion Symptom Scale [PCSS], Dizziness Handicap Inventory [DHI]), cognitive (Immediate Post-concussion Assessment and Cognitive Testing [ImPACT]), vestibular/oculomotor (Vestibular/Ocular Motor Screening [VOMS]), balance (Activities-specific Balance Confidence [ABC] scale, Balance Error Scoring System [BESS]), and cervical (Neck Disability Index [NDI]). Patients were prescribed progressive, targeted interventions and therapies (e.g., behavioral, vestibular, vision, and exertion) that matched their mTBI clinical profile. A series of paired t-tests adjusted for multiple corrections were used to compare pre- and post-intervention assessment scores. Results: Patients demonstrated significant improvement from pre-to post-intervention on total symptoms (t = 2.69, p = 0.01), verbal memory (t = -1.96, p = 0.05), ABC balance score (t = -2.05, p = 0.05), smooth pursuits (t = 2.32, p = 0.04), near-point convergence distance (t = -3.58, p = 0.01), vestibular ocular reflex (t = 2.31, p = 0.03), and visual motion sensitivity (t = 2.43, p = 0.03). Conclusions: Previously recalcitrant patients with chronic complex mTBI demonstrated significant improvement in symptoms, cognitive, vestibular, oculomotor, and balance function following targeted interventions.	[Kontos, Anthony P.; Collins, Michael W.; Reeves, Valerie L.] Univ Pittsburgh, Dept Orthopaed Surg, 4200 5th Ave, Pittsburgh, PA 15260 USA; [Kontos, Anthony P.; Collins, Michael W.; Holland, Cyndi L.] UPMC, Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA; [Edelman, Kathryn; Benso, Steven; Okonkwo, David] Univ Pittsburgh, Dept Neurol Surg, 4200 5th Ave, Pittsburgh, PA 15260 USA; [Schneider, Walter] Univ Pittsburgh, Dept Psychol, 4200 5th Ave, Pittsburgh, PA 15260 USA		Kontos, AP (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, 4200 5th Ave, Pittsburgh, PA 15260 USA.; Kontos, AP (corresponding author), UPMC, Sports Med Concuss Program, 3200 South Water St, Pittsburgh, PA 15203 USA.				Department of DefenseUnited States Department of Defense [W81XWH-14-2-0002]	This research was funded by Department of Defense W81XWH-14-2-0002.	Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Kansagara D., 2013, COMPLICATIONS MILD T; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manners JL, 2016, J NEUROTRAUM, V33, P1796, DOI 10.1089/neu.2015.4245; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	20	21	21	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			333	338		10.1093/milmed/usx172			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GC0JM	WOS:000429463600047	29635578	Bronze			2022-02-06	
J	Moles, A; Heudes, PM; Amelot, A; Cristini, J; Salaud, C; Roualdes, V; Riem, T; Martin, SA; Raoul, S; Terreaux, L; Bord, E; Buffenoir, K				Moles, Alexis; Heudes, Pierre Marie; Amelot, Aymeric; Cristini, Joseph; Salaud, Celine; Roualdes, Vincent; Riem, Tanguy; Martin, Stephane Andre; Raoul, Sylvie; Terreaux, Luc; Bord, Eric; Buffenoir, Kevin			Long-Term Follow-Up Comparative Study of Hydroxyapatite and Autologous Cranioplasties: Complications, Cosmetic Results, Osseointegration	WORLD NEUROSURGERY			English	Article						Autologous; Complication; Cosmetics; Cranioplasty; Hydroxyapatite; Osseointegration	CUSTOM-MADE HYDROXYAPATITE; TRAUMATIC BRAIN-INJURY; LARGE SKULL DEFECT; DECOMPRESSIVE CRANIECTOMY; BONE FLAP; RECONSTRUCTION; IMPLANTATION; PROSTHESIS; EXPERIENCE; RESORPTION	OBJECTIVE: A three-dimensional reconstruction technique using the CustomBone (CB) prosthesis allows custom-made cranioplasty (CP) possessing osseointegration properties owing to its porous hydroxyapatite (HA) composition. This reconstruction technique has replaced less expensive techniques such as subcutaneously preserved autologous bone (SP). Our primary objective was to evaluate complications between CB and SP CP techniques. A secondary objective was to assess cosmetic results and osseointegration of CPs. METHODS: This single-center study comprised patients undergoing delayed CB or SP CP after craniectomy between 2007 and 2014. A prospective interview was conducted to collect all data, including 2-year follow-up clinical and radiologic data. Cosmetic results were assessed by a qualitative score, and osseointegration was assessed by measuring relative fusion at the CP margins. RESULTS: Of 100 patients undergoing CB or SP CP between 2007 and 2014, 92 (CB, n =44; SP, n =48) participated in the prospective interview. No significant difference in complication rates was observed between the 2 groups. The main complication specific to the CB group was fracture of the prosthesis observed in 20.8% patients. A higher rate of good cosmetic results was observed in the CB group (92.5% vs. 74.3%, P = 0.031). In the CB group, 51% of patients demonstrated no signs of bone fusion of the CP. CONCLUSIONS: Although the CB prosthesis is associated with cosmetic advantages, the porous hydroxyapatite composition makes it fragile in the short-term and long-term, and effective osseointegration remains uncertain.	[Moles, Alexis; Amelot, Aymeric; Cristini, Joseph; Salaud, Celine; Roualdes, Vincent; Riem, Tanguy; Martin, Stephane Andre; Raoul, Sylvie; Terreaux, Luc; Bord, Eric; Buffenoir, Kevin] Nantes Univ Hosp, Neurosurg & Neurotraumatol Dept, Nantes, France; [Heudes, Pierre Marie] Nantes Univ Hosp, Dept Neuroradiol, Nantes, France; [Amelot, Aymeric] Hop La Pitie Salpetriere, AP HP, Dept Neurosurg, Paris, France; [Raoul, Sylvie; Buffenoir, Kevin] INSERM, EA3826, Pain Neuromodulat & Qual Life, Nantes, France		Moles, A (corresponding author), Nantes Univ Hosp, Neurosurg & Neurotraumatol Dept, Nantes, France.	alexis.moles@neurochirurgie.fr	Buffenoir, Kevin/ABD-9003-2020				Adetchessi AT, 2012, NEUROCHIRURGIE, V58, P382, DOI 10.1016/j.neuchi.2012.06.001; Beuriat PA, 2016, NEUROCHIRURGIE, V62, P25, DOI 10.1016/j.neuchi.2016.04.003; Brommeland T, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0155-6; Cheng Cheng-Hsin, 2014, Clin Neurol Neurosurg, V124, P85, DOI 10.1016/j.clineuro.2014.06.029; Chibbaro S, 2013, REV NEUROL-FRANCE, V169, P240, DOI 10.1016/j.neurol.2012.06.016; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Frassanito P, 2013, CLIN NEUROL NEUROSUR, V115, P1496, DOI 10.1016/j.clineuro.2012.11.032; Fricia M, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.03.027; Hardy H, 2012, NEUROCHIRURGIE, V58, P25, DOI 10.1016/j.neuchi.2011.09.006; Haute Autorite de Sante, CUSTOMBONE 2014; Honeybul S, 2016, J NEUROSURG, V125, P775, DOI 10.3171/2016.3.JNS1683; Lemee JM, 2013, NEUROCHIRURGIE, V59, P60, DOI 10.1016/j.neuchi.2012.10.138; Lindner D, 2017, J NEUROSURG, V126, P175, DOI 10.3171/2015.10.JNS151245; Lovati AB, 2016, CALCIFIED TISSUE INT, V99, P209, DOI 10.1007/s00223-016-0140-8; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Martini L, 2012, PLAST RECONSTR SURG, V129, p625E, DOI 10.1097/PRS.0b013e318244220d; Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x; Messina G, 2011, ACTA NEUROCHIR, V153, P1717, DOI 10.1007/s00701-011-1014-5; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Shah AM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13561; Sprio S, 2016, J APPL BIOMATER FUNC, V14, pE470, DOI 10.5301/jabfm.5000293; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Staffa G, 2012, J CRANIO MAXILL SURG, V40, pE65, DOI 10.1016/j.jcms.2011.04.014; Stefini R, 2015, J APPL BIOMATER FUNC, V13, pE136, DOI 10.5301/jabfm.5000211; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Wen L, 2015, BRAIN INJURY, V29, P1654, DOI 10.3109/02699052.2015.1075248; Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021; Zanotti B, 2016, J CRANIOFAC SURG, V27, P2061, DOI 10.1097/SCS.0000000000003025; Zanotti B, 2015, ACTA NEUROCHIR, V157, P517, DOI 10.1007/s00701-014-2319-y	31	21	21	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2018	111						E388	E395		10.1016/j.wneu.2017.12.082			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG7WI	WOS:000432908700048	29277595				2022-02-06	
J	Nikolian, VC; Dennahy, IS; Higgins, GA; Williams, AM; Weykamp, M; Georgoff, PE; Eidy, H; Ghandour, MH; Chang, P; Alam, HB				Nikolian, Vahagn C.; Dennahy, Isabel S.; Higgins, Gerald A.; Williams, Aaron M.; Weykamp, Michael; Georgoff, Patrick E.; Eidy, Hassan; Ghandour, Mohamed H.; Chang, Panpan; Alam, Hasan B.			Transcriptomic changes following valproic acid treatment promote neurogenesis and minimize secondary brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Valproic acid; histone deacetylase inhibitor; RNA sequencing; hemorrhage; traumatic brain injury	HEMORRHAGIC-SHOCK; PHARMACOLOGICAL RESUSCITATION; MODEL; RECOVERY; NEURONS; PATHWAY	BACKGROUND Early treatment with valproic acid (VPA) has demonstrated benefit in preclinical models of traumatic brain injury, including smaller brain lesion size, decreased edema, reduced neurologic disability, and faster recovery. Mechanisms underlying these favorable outcomes are not fully understood. We hypothesized that VPA treatment would upregulate genes involved in cell survival and proliferation and downregulate those associated with cell death and the inflammatory response. METHODS Ten female swine were subjected to a protocol of traumatic brain injury and hemorrhagic shock. They were assigned to two groups (n = 5): normal saline (NS; 3x volume of shed blood), or NS + VPA (150 mg/kg). Following 6 hours of observation, brain tissue was harvested to evaluate lesion size and edema. Brain tissue was processed for RNA sequencing. Gene set enrichment and pathway analysis was performed to determine the differential gene expression patterns following injury. RESULTS Animals treated with VPA were noted to have a 46% reduction in brain lesion size and a 57% reduction in ipsilateral brain edema. Valproic acid significantly upregulated genes involved in morphology of the nervous system, neuronal development and neuron quantity. The VPA treatment downregulated pathways related to apoptosis, glial cell proliferation, and neuroepithelial cell differentiation. Ingenuity Pathway Analysis identified VPA as the top upstream regulator of activated transcription, supporting it as a direct cause of these transcriptional changes. Master transcriptional regulator NEUROD1 was also significantly upregulated, suggesting that VPA may induce additional transcription factors. CONCLUSION Administration of VPA attenuated brain lesion size, reduced brain edema, and induced significant changes in the transcriptome of injured brain within 6 hours. Patterns of differential expression were consistent with the proposed neurogenic and prosurvival effects of VPA treatment.	[Nikolian, Vahagn C.; Dennahy, Isabel S.; Williams, Aaron M.; Weykamp, Michael; Georgoff, Patrick E.; Eidy, Hassan; Ghandour, Mohamed H.; Chang, Panpan; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Higgins, Gerald A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Dept Surg, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Higgins, Gerry/0000-0002-0434-1465	US Army Medical Research Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-1-0520]; Frederick A. Coller Society Research Fellowship Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM084127] Funding Source: NIH RePORTER	US Army Medical Research Materiel Command W81XWH-09-1-0520 (Alam, HB); Frederick A. Coller Society Research Fellowship Grant (Nikolian, VC).	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bambakidis T, 2016, J NEUROTRAUM, V33, P1514, DOI 10.1089/neu.2015.4163; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen S, 2014, NEUROCHEM RES, V39, P1621, DOI 10.1007/s11064-014-1241-2; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; de Vries HM, 2014, J TRAUMA ACUTE CARE, V77, P183, DOI 10.1097/TA.0000000000000252; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Delahaye-Duriez A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1097-7; Dobesova Zdena, 2011, 2011 International Conference on Electrical and Control Engineering, P4866, DOI 10.1109/ICECENG.2011.6057428; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Georgoff PE, 2017, CLIN PHARMACOKINET; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Higgins GA, 2017, PHARM RES-DORDR, V34, P1658, DOI 10.1007/s11095-017-2130-6; Imam AM, 2013, SURGERY, V154, P388, DOI 10.1016/j.surg.2013.05.008; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2010, TRANSL STROKE RES, V1, P65, DOI 10.1007/s12975-009-0009-5; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lin T, 2006, SURGERY, V139, P365, DOI 10.1016/j.surg.2005.08.022; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Pucci B, 2000, NEOPLASIA, V2, P291, DOI 10.1038/sj.neo.7900101; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang C, 2014, BRAIN RES, V1555, P1, DOI 10.1016/j.brainres.2014.01.051; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	35	21	21	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2018	84	3					459	465		10.1097/TA.0000000000001765			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	FY1DU	WOS:000426552800008	29251707	Green Accepted			2022-02-06	
J	Suda, S; Aoki, J; Shimoyama, T; Suzuki, K; Sakamoto, Y; Katano, T; Okubo, S; Nito, C; Nishiyama, Y; Mishina, M; Kimura, K				Suda, Satoshi; Aoki, Junya; Shimoyama, Takashi; Suzuki, Kentaro; Sakamoto, Yuki; Katano, Takehiro; Okubo, Seiji; Nito, Chikako; Nishiyama, Yasuhiro; Mishina, Masahiro; Kimura, Kazumi			Stroke-associated infection independently predicts 3-month poor functional outcome and mortality	JOURNAL OF NEUROLOGY			English	Article						Infection; Pneumonia; Prognosis; Stroke	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; PNEUMONIA; CARE	Stroke-associated infection (SAI) is a common and serious complication of stroke. This study aimed to assess the effects of SAI on patient mortality and functional outcome at 3 months after stroke onset. We retrospectively analyzed 809 consecutive patients with acute stroke (517 men and 292 women; median age, 72 years) who were admitted to our department between September 2014 and June 2016. SAI was defined as an infection diagnosed during the hospitalization period. Poor outcome was defined as a modified Rankin Scale (mRS) score of 3-5 or death (mRS score of 6). The effect of SAI on functional outcome was evaluated using a multivariate logistic regression analysis. SAI occurred in 169 patients (20.9%); of these, 106 (62.7%) had pneumonia, 23 (13.6%) had a urinary-tract infection, and 40 (23.7%) had other types of infection. Patients with SAI were older, more likely to be female, had lower body mass indices, had higher stroke severity, and were more likely to have atrial fibrillation and a history of ischemic heart disease than patients without SAI. Poor functional outcome and mortality were more common in patients with SAI than in patients without SAI (poor functional outcome 41.8 vs. 4.8%, mortality 24.3 vs. 3.9%, respectively). After adjusting for age, sex, stroke severity, and various comorbidities, SAI was independently associated with poor functional outcome [odds ratio (OR) 6.88; 95% confidence interval (CI) 3.72-12.73] and mortality (OR 4.45, 95% CI 2.27-8.72) at 3 months after stroke onset. Our results suggest that SAI during the hospitalization period is independently associated with 3-month poor functional outcome and mortality.	[Suda, Satoshi; Aoki, Junya; Shimoyama, Takashi; Suzuki, Kentaro; Sakamoto, Yuki; Katano, Takehiro; Okubo, Seiji; Nito, Chikako; Nishiyama, Yasuhiro; Mishina, Masahiro; Kimura, Kazumi] Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan		Suda, S (corresponding author), Nippon Med Sch, Grad Sch Med, Dept Neurol Sci, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	suda-sa@nms.ac.jp	Mishina, Masahiro/F-3636-2010; a, e c°/AAN-2574-2021	Mishina, Masahiro/0000-0002-8227-0930; , Chikako/0000-0002-0980-5943			Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; Becker KJ, 2014, NEUROCRIT CARE, V21, P140, DOI 10.1007/s12028-013-9899-x; Dasenbrock HH, 2016, WORLD NEUROSURG, V88, P459, DOI 10.1016/j.wneu.2015.10.054; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Doll DN, 2015, BEHAV BRAIN FUNCT, V11, DOI 10.1186/s12993-015-0077-5; Egashira Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-105; Evans A, 2001, LANCET, V358, P1586, DOI 10.1016/S0140-6736(01)06652-1; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Kamel H, 2012, ARCH NEUROL-CHICAGO, V69, P576, DOI 10.1001/archneurol.2011.3590; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kwan J, 2007, ACTA NEUROL SCAND, V115, P331, DOI 10.1111/j.1600-0404.2006.00783.x; Miller CM, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0679-9; Minnerup J, 2010, J NEUROL NEUROSUR PS, V81, P198, DOI 10.1136/jnnp.2009.182394; Popovic N, 2013, J STROKE CEREBROVASC, V22, P424, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.003; Sato K, 2014, J STROKE CEREBROVASC, V23, P2511, DOI 10.1016/j.jstrokecerebrovasdis.2014.02.019; Sehara Y, 2007, J NEUROSCI RES, V85, P2167, DOI 10.1002/jnr.21341; Spratt N, 2003, J CLIN NEUROSCI, V10, P665, DOI 10.1016/j.jocn.2002.12.001; Vargas M, 2006, STROKE, V37, P461, DOI 10.1161/01.STR.0000199138.73365.b3; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9	23	21	33	1	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	FEB	2018	265	2					370	375		10.1007/s00415-017-8714-6			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV6SJ	WOS:000424711600017	29249057				2022-02-06	
J	Johnson, RA; Albright, DL; Marzolf, JR; Bibbo, JL; Yaglom, HD; Crowder, SM; Carlisle, GK; Willard, A; Russell, CL; Grindler, K; Osterlind, S; Wassman, M; Harms, N				Johnson, Rebecca A.; Albright, David L.; Marzolf, James R.; Bibbo, Jessica L.; Yaglom, Hayley D.; Crowder, Sandra M.; Carlisle, Gretchen K.; Willard, Amy; Russell, Cynthia L.; Grindler, Karen; Osterlind, Steven; Wassman, Marita; Harms, Nathan			Effects of therapeutic horseback riding on post-traumatic stress disorder in military veterans	MILITARY MEDICAL RESEARCH			English	Article						Animal-assisted intervention; Coping self-efficacy; Emotion regulation; Military veterans; Post-traumatic stress disorder; Social engagement; Therapeutic horseback riding; Traumatic brain injury	SUBSTANCE USE DISORDERS; MENTAL-HEALTH PROBLEMS; SOLDIERS; PTSD; IRAQ; DEPLOYMENT; SYMPTOMS; CHILDREN; VALIDITY; BEHAVIOR	Background: Large numbers of post-deployment U.S. veterans are diagnosed with post-traumatic stress disorder (PTSD) and/or traumatic brain injury (TBI), leading to an urgent need for effective interventions to reduce symptoms and increase veterans' coping. PTSD includes anxiety, flashbacks, and emotional numbing. The symptoms increase health care costs for stress-related illnesses and can make veterans' civilian life difficult. Methods: We used a randomized wait-list controlled design with repeated measures of U.S. military veterans to address our specific aim to test the efficacy of a 6-week therapeutic horseback riding (THR) program for decreasing PTSD symptoms and increasing coping self-efficacy, emotion regulation, social and emotional loneliness. Fifty-seven participants were recruited and 29 enrolled in the randomized trial. They were randomly assigned to either the horse riding group (n = 15) or a wait-list control group (n = 14). The wait-list control group experienced a 6-week waiting period, while the horse riding group began THR. The wait-list control group began riding after 6 weeks of participating in the control group. Demographic and health history information was obtained from all the participants. PTSD symptoms were measured using the standardized PTSD Checklist-Military Version (PCL-M). The PCL-M as well as other instruments including, The Coping Self Efficacy Scale (CSES), The Difficulties in Emotion Regulation Scale (DERS) and The Social and Emotional Loneliness Scale for Adults-short version (SELSA) were used to access different aspects of individual well-being and the PTSD symptoms. Results: Participants had a statistically significant decrease in PTSD scores after 3 weeks of THR (P <= 0.01) as well as a statistically and clinically significant decrease after 6 weeks of THR (P <= 0.01). Logistic regression showed that participants had a 66.7% likelihood of having lower PTSD scores at 3 weeks and 87.5% likelihood at 6 weeks. Under the generalized linear model(GLM), our ANOVA findings for the coping self-efficacy, emotion regulation, and social and emotional loneliness did not reach statistical significance. The results for coping self-efficacy and emotion regulation trended in the predicted direction. Results for emotional loneliness were opposite the predicted direction. Logistic regression provided validation that outcome effects were caused by riding longer. Conclusion: The findings suggest that THR may be a clinically effective intervention for alleviating PTSD symptoms in military veterans.	[Johnson, Rebecca A.; Crowder, Sandra M.; Carlisle, Gretchen K.] Univ Missouri, Res Ctr Human Anim Interact, Coll Vet Med, Columbia, MO 65211 USA; [Johnson, Rebecca A.] Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65211 USA; [Albright, David L.] Univ Alabama, Sch Social Work, Tuscaloosa, AL 35487 USA; [Marzolf, James R.] Harry S Truman Mem Vet Hosp, Occupat Hlth Serv, Columbia, MO 65211 USA; [Bibbo, Jessica L.] Purdue Univ, Coll Vet Med, Ctr Human Anim Bond, W Lafayette, IN 47907 USA; [Yaglom, Hayley D.] Univ Missouri, Sch Hlth Profess, Columbia, MO 65211 USA; [Willard, Amy; Harms, Nathan] TREE House Greater St Louis, Wentzville, MO 63385 USA; [Russell, Cynthia L.] Univ Missouri, Sch Nursing & Hlth Studies, Kansas City, MO 64108 USA; [Grindler, Karen] Cedar Creek Therapeut Riding Ctr, Columbia, MO 65201 USA; [Osterlind, Steven] Univ Missouri, Sch & Counseling Psychol, Coll Educ, Columbia, MO 65211 USA; [Wassman, Marita] Ride On St Louis, Kimmswick, MO 63053 USA		Johnson, RA (corresponding author), Univ Missouri, Res Ctr Human Anim Interact, Coll Vet Med, Columbia, MO 65211 USA.; Johnson, RA (corresponding author), Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65211 USA.	rajohnson@missouri.edu	Marzolf, James R./AAV-8192-2021; Crowder, Sandra/ABI-8336-2020		University of Missouri Interdisciplinary Center on Aging [n/a] Funding Source: Medline; Horses and Humans Research Foundation [#00040568] Funding Source: Medline		Araujo TB, 2011, BRAZ J PHYS THER, V15, P414, DOI 10.1590/S1413-35552011005000027; Asselin G, 2012, REHABIL NURS, V37, P270, DOI 10.1002/rnj.027; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bandura A, 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI; Biery M.J., 1989, ADAPT PHYS ACT Q, V6, P221, DOI [10.1123/apaq.6.3.221, DOI 10.1123/APAQ.6.3.221]; Bizub AL, 2003, PSYCHIATR REHABIL J, V26, P377, DOI 10.2975/26.2003.377.384; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Cantin A, 2001, MENT HEALTH LEARN, V8, P51; Chandra A, 2010, PEDIATRICS, V125, P16, DOI 10.1542/peds.2009-1180; Chesney MA, 2006, BRIT J HEALTH PSYCH, V11, P421, DOI 10.1348/135910705X53155; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; de Assis MA, 2008, CLINICS, V63, P473, DOI 10.1590/S1807-59322008000400010; Department of Veterans Affairs Department of Defense, 2010, VA DOD CLIN PRACT GU; DiTommaso E, 2004, EDUC PSYCHOL MEAS, V64, P99, DOI 10.1177/0013164403258450; Duncan C., 2014, CANADIAN MILITARY J, V14, P64; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Farias-Tomaszewski S., 2001, Therapeutic Recreation Journal, V35, P250; Foa EB, 1997, ANNU REV PSYCHOL, V48, P449, DOI 10.1146/annurev.psych.48.1.449; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Gewirtz AH, 2010, J CONSULT CLIN PSYCH, V78, P599, DOI 10.1037/a0020571; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Hakanson M, 2009, J BODYW MOV THER, V13, P43, DOI 10.1016/j.jbmt.2007.06.002; Hammer Ann, 2005, Physiotherapy Theory and Practice, V21, P51, DOI 10.1080/09593980590911525; Henriksen J D, 1971, Arch Phys Med Rehabil, V52, P282; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; HOUSE JS, 1994, J HEALTH SOC BEHAV, V35, P213, DOI 10.2307/2137277; International Association of Human-Animal Interactions Organizations, 2014, IAHAIO WHIT PAP; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Johnson RA, 2003, AM BEHAV SCI, V47, P55, DOI 10.1177/0002764203255213; Johnson RA, 2008, ONCOL NURS FORUM, V35, P225, DOI 10.1188/08.ONF.225-232; Johnson RA, 2010, CLIN NURS RES, V19, P387, DOI 10.1177/1054773810373122; Kazdin A. E., 2003, METHODOLOGICAL ISSUE; Kazdin AE., 2003, J CONSTR PSYCHOL, V49, P183; Keaveney SM, 2008, J BUS RES, V61, P444, DOI 10.1016/j.jbusres.2007.07.017; Keren O, 2001, BRAIN INJURY, V15, P633, DOI 10.1080/02699050010009568; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Land Gary, 2002, Occup Ther Health Care, V14, P1, DOI 10.1080/J003v14n01_01; Lanning BA, 2013, J REHABIL RES DEV, V50, pXV, DOI 10.1682/JRRD.2013.07.0159; Lechner HE, 2003, SPINAL CORD, V41, P502, DOI 10.1038/sj.sc.3101492; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Libby DJ, 2012, PSYCHIAT SERV, V63, P1134, DOI 10.1176/appi.ps.201100456; MACKAY-LYONS M, 1988, Physiotherapy Canada, V40, P104; MacLean B, 2011, J REHABIL RES DEV, V48, pIX, DOI 10.1682/JRRD.2011.05.0085; MCLEOD JD, 1990, J HEALTH SOC BEHAV, V31, P162, DOI 10.2307/2137170; Meregillano Gary, 2004, Phys Med Rehabil Clin N Am, V15, P843; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; [National Center for PTSD U. S. Department of Veterans Affairs], 2011, PTSD CHECKL MIL VERS; Nazarian D, 2012, J TRAUMA STRESS, V25, P220, DOI 10.1002/jts.21690; Nesbit R, 2011, PUBLIC ADMIN REV, V71, P67, DOI 10.1111/j.1540-6210.2010.02307.x; Newman Caren L, 2007, Int J Emerg Ment Health, V9, P133; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; Odendaal JSJ, 2003, VET J, V165, P296, DOI 10.1016/S1090-0233(02)00237-X; Otis JD, 2003, J REHABIL RES DEV, V40, P397, DOI 10.1682/JRRD.2003.09.0397; Owens GP, 2012, PSYCHOL TRAUMA-US, V4, P221, DOI 10.1037/a0024251; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Panksepp J, 2005, CONSCIOUS COGN, V14, P30, DOI 10.1016/j.concog.2004.10.004; Payne E, 2016, BEHAV PROCESS, V125, P114, DOI 10.1016/j.beproc.2015.10.004; Pendry P, 2014, J PRIM PREV, V35, P281, DOI 10.1007/s10935-014-0350-7; Schell TL, 2008, NVISIBLE WOUNDS WAR, P93; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Seal KH, 2011, AM PUBLIC HLTH, V116, P93; Silkwood-Sherer D., 2003, PATH INT STRIDES, V9, P14; Stein JY, 2014, J CONSTR PSYCHOL, V7, P122; Strauss JL, 2012, PTSD RES Q, V23, P1; Streeter CC, 2012, MED HYPOTHESES, V78, P571, DOI 10.1016/j.mehy.2012.01.021; Taft CT, 2008, J CONSULT CLIN PSYCH, V76, P648, DOI 10.1037/a0012576; U. S. Census Bureau, 2012, VET 2012 STAT ABSTR; U.S. Department of Veterans Affairs, 2016, PTSD CHECKL DSM 5 PC; U. S. Dept. of Veterans Affairs, 2015, PTSD HIST OV; Ungermann CM, 2001, J ALTERN COMPLEM MED, V17, P1191; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Webster A, 1995, SCI J THERAPEUTIC RI, V1, P333; Wynn GH, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0600-2; Zatzick DF, 1997, AM J PSYCHIAT, V154, P1690, DOI 10.1176/ajp.154.12.1690	76	21	23	2	42	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2095-7467	2054-9369		MILITARY MED RES	MILITARY MED. RES.	JAN 19	2018	5								3	10.1186/s40779-018-0149-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT1SI	WOS:000422916100001	29502529	gold, Green Published			2022-02-06	
J	Chang, R; Holcomb, JB; Johansson, PI; Pati, S; Schreiber, MA; Wade, CE				Chang, Ronald; Holcomb, John B.; Johansson, Par I.; Pati, Shibani; Schreiber, Martin A.; Wade, Charles E.			PLASMA RESUSCITATION IMPROVED SURVIVAL IN A CECAL LIGATION AND PUNCTURE RAT MODEL OF SEPSIS	SHOCK			English	Article						Endothelium; fluid therapy; septic shock	TRAUMATIC BRAIN-INJURY; HEMORRHAGIC-SHOCK; ENDOTHELIAL GLYCOCALYX; FLUID RESUSCITATION; MORTALITY; TRANSFUSION; THERAPY; MULTICENTER; EXPRESSION; PROMMTT	Background: The paradigm shift from crystalloid to plasma resuscitation of traumatic hemorrhagic shock has improved patient outcomes due in part to plasma-mediated reversal of catecholamine and inflammation-induced endothelial injury, decreasing vascular permeability and attenuating organ injury. Since sepsis induces a similar endothelial injury as seen in hemorrhage, we hypothesized that plasma resuscitation would increase 48-h survival in a rat sepsis model. Methods: Adult male Sprague-Dawley rats (375-425 g) were subjected to 35% cecal ligation and puncture (CLP) (t = 0 h). Twenty-two hours post-CLP and prior to resuscitation (t = 22 h), animals were randomized to resuscitation with normal saline (NS, 10 cc/kg/h) or pooled rat fresh frozen plasma (FFP, 3.33 cc/kg/h). Resuscitation under general anesthesia proceeded for the next 6 h (t = 22 h to t = 28 h); lactate was checked every 2 h, and fluid volumes were titrated based on lactate clearance. Blood samples were obtained before (t = 22 h) and after resuscitation (t = 28 h), and at death or study conclusion. Lung specimens were obtained for calculation of wet-to-dry weight ratio. Fisher exact test was used to analyze the primary outcome of 48-h survival. ANOVA with repeated measureswas used to analyze the effect of FFP versus NS resuscitation on blood gas, electrolytes, blood urea nitrogen (BUN), creatinine, interleukin (IL)-6, IL-10, catecholamines, and syndecan-1 (marker for endothelial injury). A two-tailed alpha level of < 0.05 was used for all statistical tests. Results: Thirty-three animals were studied: 14 FFP, 14 NS, and 5 sham. Post-CLP but preresuscitation (t = 22 h) variables between FFP and NS animals were similar and significantly deranged compared with sham animals. FFP significantly increased 48-h survival compared to NS (n = 8 [57%] vs n = 2 [14%]), attenuated the post-resuscitation (t = 28 h) levels of epinephrine (mean 2.2 vs 7.0 ng/mL), norepinephrine, (3.8 vs 8.9 ng/mL), IL-6 (3.8 vs 18.7 ng/mL), and syndecan-1 (21.8 vs 31.0 ng/mL) (all P < 0.05), improved the post-resuscitation PO2 to FiO(2) ratio (353 vs 151), and reduced the pulmonary wet-to-dry weight ratio (5.28 vs 5.94) (all P < 0.05). Conclusion: Compared to crystalloid, plasma resuscitation increased 48-h survival in a rat sepsis model, improved pulmonary function and decreased pulmonary edema, and attenuated markers for inflammation, endothelial injury, and catecholamines.	[Chang, Ronald; Holcomb, John B.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX 77030 USA; [Chang, Ronald; Holcomb, John B.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, McGovern Med Sch, Houston, TX 77030 USA; [Johansson, Par I.] Rigshosp, Capital Reg Blood Bank, Copenhagen, Denmark; [Pati, Shibani] Univ Calif San Francisco, Dept Pathol & Lab Med, San Francisco, CA 94143 USA; [Pati, Shibani] Blood Syst Res Inst, San Francisco, CA USA; [Schreiber, Martin A.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA		Chang, R (corresponding author), 6410 Fannin St,Suite 1100, Houston, TX 77030 USA.	ronald.chang@uth.tmc.edu		Johansson, Par Ingemar/0000-0001-9778-5964; chang, ronald/0000-0002-8947-0054; holcomb, john/0000-0001-8312-9157	T32 fellowship from NIGMS [5T32GM008792]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER	RC is supported by a T32 fellowship (grant no. 5T32GM008792) from NIGMS.	Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Balogh Z, 2013, ARCH SURG-CHICAGO, V138, P637; Bro-Jeppesen J, 2016, RESUSCITATION, V107, P71, DOI 10.1016/j.resuscitation.2016.08.006; Cardenas JC, 2016, SHOCK, V45, P166, DOI 10.1097/SHK.0000000000000504; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Chang R, 2017, CRIT CARE CLIN, V33, P15, DOI 10.1016/j.ccc.2016.08.007; Chang R, 2016, SHOCK, V46, P17, DOI 10.1097/SHK.0000000000000577; Chignalia AZ, 2016, SHOCK, V45, P338, DOI 10.1097/SHK.0000000000000513; COLLINS JA, 1971, ANN SURG, V173, P6, DOI 10.1097/00000658-197101000-00002; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI [10.1007/s00134-004-2210-z, 10.1097/CCM.0b013e31827e83af, 10.1007/s00134-012-2769-8]; Garcia-Alvarez M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0503-3; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Ince C, 2016, SHOCK, V45, P259, DOI 10.1097/SHK.0000000000000473; Jansen TC, 2010, AM J RESP CRIT CARE, V182, P752, DOI 10.1164/rccm.200912-1918OC; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johansen ME, 2015, SEMIN THROMB HEMOST, V41, P16, DOI 10.1055/s-0034-1398377; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Lilley E, 2015, SHOCK, V43, P304, DOI 10.1097/SHK.0000000000000318; MAKHMUDOV RM, 1985, COR VASA, V27, P456; Matsuda A, 2005, SHOCK, V24, P364, DOI 10.1097/01.shk.0000180624.36811.97; Ostrowski SR, 2013, CRIT CARE, V17, DOI 10.1186/cc12532; Peng ZL, 2013, SHOCK, V40, P195, DOI 10.1097/SHK.0b013e31829f91fc; Raghunathan K, 2015, ANESTHESIOLOGY, V123, P1385, DOI 10.1097/ALN.0000000000000861; Rahbar E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0481-5; Robinson BRH, 2013, J TRAUMA ACUTE CARE, V75, pS61, DOI 10.1097/TA.0b013e31828fa408; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Singleton KD, 2003, EUR SURG RES, V35, P486, DOI 10.1159/000073387; Stevens JP, 2007, INTERMEDIATE STAT MO, P57; Torres LN, 2013, J TRAUMA ACUTE CARE, V75, P759, DOI 10.1097/TA.0b013e3182a92514; TRAVERSO LW, 1986, J TRAUMA, V26, P176, DOI 10.1097/00005373-198602000-00015; Wagner EM, 2006, J APPL PHYSIOL, V100, P1224, DOI 10.1152/japplphysiol.01060.2005; Watson JJJ, 2016, SHOCK, V46, P468, DOI 10.1097/SHK.0000000000000663; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515	37	21	21	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JAN	2018	49	1					53	61		10.1097/SHK.0000000000000918			9	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	GB8ED	WOS:000429307300009	28591008	Green Accepted			2022-02-06	
J	Cui, HJ; Tao, L; Li, PF; Ali, Y; Zhou, HJ; Luo, JK; Yang, W; Tao, T				Cui Hanjin; Tao, Liu; Li Pengfei; Ali, Yang; Zhou Huajun; Luo Jiekun; Yang, Wang; Tao, Tang			Altered Long Noncoding RNA and Messenger RNA Expression in Experimental Intracerebral Hemorrhage - a Preliminary Study	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Intracerebral hemorrhage; Long non-coding RNA (lncRNA); Messenger RNA (mRNA); Expression profile	TRAUMATIC BRAIN-INJURY; CELL-DEATH; GROWTH-HORMONE; INFLAMMATORY MEDIATORS; CONSERVATIVE TREATMENT; CEREBRAL-ISCHEMIA; UP-REGULATION; RAT BRAINS; FACTOR-I; RECEPTOR	Background/Aims: Functional recovery in the chronic phase is a difficult problem in intracerebral hemorrhage (ICH) treatment. Long noncoding RNAs (lncRNAs) are demonstrated to be involved in central nervous system (CNS) disorders. However, the roles of lncRNAs in post-ICH injury and repair are poorly understood, especially those that may be attributed to long-term neurological deficit. The present study depicted the lncRNA and messenger RNA (mRNA) profile by microarray at late stage after an experimental ICH. Methods: LncRNA and mRNA microarray was used to first identify differentially expressed genes. Gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to determine bio-functions and signaling pathways, with which differentially expressed genes are most closely related. Quantitative real-time polymerase chain reaction (PCR) was used to validate the results of microarray. Finally, the lncRNA-mRNA co-expression network was constructed to find the interaction of genes. Results: A total of 625 differentially expressed lncRNAs and 826 expressed mRNAs were identified. Altered genes were enriched in mitochondrial matrix, G-protein coupled receptor signaling pathway, and olfactory transduction, which may be associated with ICH-induced pathophysiologic changes in the long term. A co-expression network profile based on 5 validated differentially expressed lncRNAs and 205 interacted mRNAs was composed of 210 nodes and 298 connections. Conclusion: Mitochondrial matrix, reduced G-protein coupled receptor activity, and impaired olfactory transduction may be involved in the sequelae following ICH. Further, these dysregulated lncRNAs and mRNAs may be the promising therapeutic targets to overcome obstacles in functional recovery following ICH. (C) 2018 The Author(s) Published by S. Karger AG, Basel	[Cui Hanjin; Tao, Liu; Li Pengfei; Luo Jiekun; Yang, Wang; Tao, Tang] Cent S Univ, Xiangya Hosp, Inst Integrat Med, Changsha, Hunan, Peoples R China; [Tao, Liu] Xinjiang Med Univ, Tradit Chinese Med Hosp, Dept Gerontol, Urumqi, Peoples R China; [Ali, Yang] Cent S Univ, Xiangya Hosp, Inst Neurol, Changsha, Hunan, Peoples R China; [Ali, Yang] Henan Prov Peoples Hosp, Dept Neurol, Zhengzhou, Henan, Peoples R China; [Zhou Huajun] China Three Gorges Univ, Coll Clin Med Sci 1, Inst Neurol, Yichang, Hubei, Peoples R China		Yang, W; Tao, T (corresponding author), Cent S Univ, Xiangya Hosp, Inst Integrat Med, Changsha, Hunan, Peoples R China.	wangyang_xy87@csu.edu.cn; tangtaotay@csu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81473573, 81173175, 81202625, 81673719, 81603414]; Science Foundation for Young Scientists of Xiangya Hospital, Central South University [2016Q09]	This study was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81473573, 81173175, 81202625, 81673719 and 81603414), Science Foundation for Young Scientists of Xiangya Hospital, Central South University (Grant No. 2016Q09).	Al-Khaled M, 2014, J STROKE CEREBROVASC, V23, P230, DOI 10.1016/j.jstrokecerebrovasdis.2012.12.018; Almeida DV, 2013, TRANSGENIC RES, V22, P75, DOI 10.1007/s11248-012-9627-x; Andersen Grethe, 2007, Ugeskr Laeger, V169, P3376; Arisi GM, 2012, BEHAV BRAIN RES, V227, P356, DOI 10.1016/j.bbr.2011.03.050; Baek H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0280-9; Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Cassidy JM, 2017, TRANSL STROKE RES, V8, P33, DOI 10.1007/s12975-016-0467-5; Castillo C, 2005, ENDOCRINE, V26, P11, DOI 10.1385/ENDO:26:1:011; Cavaliere F, 2001, NEUROCHEM INT, V38, P199, DOI 10.1016/S0197-0186(00)00087-5; Cavaliere F, 2001, NEUROCHEM INT, V38, P189, DOI 10.1016/S0197-0186(00)00088-7; Chen L, 2014, RESTOR NEUROL NEUROS, V32, P533, DOI 10.3233/RNN-140403; Chen Y, 2017, METAB BRAIN DIS, V32, P281, DOI 10.1007/s11011-017-9965-8; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Contreras-Garcia JI, 2012, NEUROSCI LETT, V522, P6, DOI 10.1016/j.neulet.2012.05.050; Cui HJ, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0605-8; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Felberg RA, 2002, ANN NEUROL, V51, P517, DOI 10.1002/ana.10160; Gao YF, 2016, TUMOR BIOL, V37, P14403, DOI 10.1007/s13277-016-5307-4; Goya Y, 2014, EUR NEUROL, V71, P203, DOI 10.1159/000356198; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Han Y, 2016, CELL MOL NEUROBIOL, V36, P1097, DOI 10.1007/s10571-015-0303-6; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Jaako-Movits K, 2005, EUR J NEUROSCI, V22, P2871, DOI 10.1111/j.1460-9568.2005.04481.x; Jeong H, 2010, PLOS ONE, V5; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Kate MP, 2014, J CEREBR BLOOD F MET, V34, P81, DOI 10.1038/jcbfm.2013.164; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kharlamov A, 2002, EXP BRAIN RES, V147, P353, DOI 10.1007/s00221-002-1251-1; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Liu T, 2014, MOL MED REP, V10, P1275, DOI 10.3892/mmr.2014.2351; Majidi S, 2017, WORLD NEUROSURG, V101, P742, DOI 10.1016/j.wneu.2017.03.079; Martoncikova M, 2011, ACTA HISTOCHEM, V113, P326, DOI 10.1016/j.acthis.2010.01.002; Melani A, 2005, NEUROCHEM INT, V47, P442, DOI 10.1016/j.neuint.2005.05.014; Melani A, 2006, J CEREBR BLOOD F MET, V26, P974, DOI 10.1038/sj.jcbfm.9600250; Mendelow AD, 2005, LANCET, V365, P387; Mino M, 2003, NEUROL RES, V25, P839, DOI 10.1179/016164103771953934; Ng SY, 2013, TRENDS GENET, V29, P461, DOI 10.1016/j.tig.2013.03.002; Niimura M, 2006, NEUROSCI LETT, V407, P136, DOI 10.1016/j.neulet.2006.08.060; Park MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23015; Pope K, 2007, NEUROSCI LETT, V422, P13, DOI 10.1016/j.neulet.2007.05.041; Rettberg JR, 2014, FRONT NEUROENDOCRIN, V35, P8, DOI 10.1016/j.yfrne.2013.08.001; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Suzumura A, 2013, CURR PROTEIN PEPT SC, V14, P16, DOI 10.2174/1389203711314010004; Thal SC, 2014, CRIT CARE MED, V42, P129, DOI 10.1097/CCM.0b013e3182a639fd; Tveiten A, 2014, ACTA NEUROL SCAND, V129, P269, DOI 10.1111/ane.12185; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wang CL, 2014, PEPTIDES, V54, P27, DOI 10.1016/j.peptides.2014.01.005; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang JP, 2014, BEHAV BRAIN RES, V265, P171, DOI 10.1016/j.bbr.2014.02.033; Wang MY, 2015, MAGN RESON MED, V74, P42, DOI 10.1002/mrm.25690; Wu H, 2010, NEUROCHEM INT, V57, P248, DOI 10.1016/j.neuint.2010.06.002; Xu Xi, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1437; Yin KJ, 2014, NEUROCHEM INT, V77, P9, DOI 10.1016/j.neuint.2014.03.013; You Y, 2016, BRAIN RES, V1646, P34, DOI 10.1016/j.brainres.2016.04.076; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang Z, 2017, MOL NEUROBIOL, V54, P1874, DOI 10.1007/s12035-016-9785-6; Zhao FY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13850; Zhou HJ, 2010, J NEUROSURG, V113, P820, DOI 10.3171/2010.1.JNS09637; Zweifel C, 2011, BIOMARKERS, V16, P511, DOI 10.3109/1354750X.2011.599074	61	21	22	2	11	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2018	45	3					1284	1301		10.1159/000487464			18	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	FX4HN	WOS:000426033900034	29448258	gold			2022-02-06	
J	Dong, HJ; Li, G; Shang, CZ; Yin, HJ; Luo, YC; Meng, HP; Li, XH; Wang, YL; Lin, L; Zhao, ML				Dong, Huajiang; Li, Gang; Shang, Chongzhi; Yin, Huijuan; Luo, Yuechen; Meng, Huipeng; Li, Xiaohong; Wang, Yali; Lin, Ling; Zhao, Mingliang			Umbilical cord mesenchymal stem cell (UC-MSC) transplantations for cerebral palsy	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Cerebral palsy; umbilical cord; mesenchymal stem cell; transplantation	TRAUMATIC BRAIN-INJURY; STROMAL CELLS; BONE-MARROW; THERAPY; EXOSOMES; RECOVERY; RATS	This study reports a case of a 4-year-old boy patient with abnormalities of muscle tone, movement and motor skills, as well as unstable gait leading to frequent falls. The results of the electroencephalogram (EEG) indicate moderately abnormal EEG, accompanied by irregular seizures. Based on these clinical characteristics, the patient was diagnosed with cerebral palsy (CP) in our hospital. In this study, the patient was treated with umbilical cord mesenchymal stem cell (UC-MSC) transplantation therapy. This patient received UC-MSC transplantation 3 times (5.3*10(7)) in total. After three successive cell transplantations, the patient recovered well and showed obvious improvements in EEG and limb strength, motor function, and language expression. However, the improvement in intelligence quotient (IQ) was less obvious. These results indicate that UC-MSC transplantation is a promising treatment for cerebral palsy.	[Dong, Huajiang; Li, Gang; Meng, Huipeng; Wang, Yali; Lin, Ling] Tianjin Univ, State Key Lab Precis Measurement Technol & Instru, Tianjin, Peoples R China; [Dong, Huajiang; Yin, Huijuan] Chinese Acad Med Sci, Laser Med Lab, Inst Biomed Engn, Tianjin 300192, Peoples R China; [Dong, Huajiang; Yin, Huijuan; Luo, Yuechen] Peking Union Med Coll, Tianjin 300192, Peoples R China; [Shang, Chongzhi; Li, Xiaohong; Zhao, Mingliang] Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China; [Shang, Chongzhi; Li, Xiaohong; Zhao, Mingliang] Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Dept Neurol & Neurosurg, Tianjin, Peoples R China; [Luo, Yuechen] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Wang, Yali] Shulan Hangzhou Hosp, Dongxin Rd 848, Hangzhou, Zhejiang, Peoples R China		Dong, HJ; Lin, L (corresponding author), Tianjin Univ, State Key Lab Precis Measurement Technol & Instru, Tianjin, Peoples R China.; Dong, HJ; Yin, HJ (corresponding author), Chinese Acad Med Sci, Laser Med Lab, Inst Biomed Engn, Tianjin 300192, Peoples R China.; Dong, HJ; Yin, HJ (corresponding author), Peking Union Med Coll, Tianjin 300192, Peoples R China.; Zhao, ML (corresponding author), Tianjin Key Lab Neurotrauma Repair, Tianjin, Peoples R China.; Zhao, ML (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Affiliated Hosp, Dept Neurol & Neurosurg, Tianjin, Peoples R China.; Wang, YL (corresponding author), Shulan Hangzhou Hosp, Dongxin Rd 848, Hangzhou, Zhejiang, Peoples R China.	donghj424@163.com; yinzi490@163.com; wangyali72@163.com; linling@tju.edu.cn; neuro_zhaoml@163.com	Zhao, Mingliang/AAN-1293-2020		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401295, 81401067, 81771352]; Tianjin Research Program of Application Foundation and Advanced Technology [15JCQNJC45200, 16-JCYBJC27600]; PUMC Youth Fund; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [3332015126]	This work was supported by the National Natural Science Foundation of China (81401295, 81401067, 81771352), the Tianjin Research Program of Application Foundation and Advanced Technology (15JCQNJC45200 and 16-JCYBJC27600), the PUMC Youth Fund and the Fundamental Research Funds for the Central Universities (3332015126).	Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Berardis S, 2015, WORLD J GASTROENTERO, V21, P742, DOI 10.3748/wjg.v21.i3.742; Borger V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071450; Ding DC, 2015, CELL TRANSPLANT, V24, P339, DOI 10.3727/096368915X686841; Dong H, 2017, TURK NEUROSURG; Dong HJ, 2017, J CRANIOFAC SURG, V28, P1615, DOI 10.1097/SCS.0000000000003563; El Omar R, 2014, TISSUE ENG PART B-RE, V20, P523, DOI [10.1089/ten.teb.2013.0664, 10.1089/ten.TEB.2013.0664]; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Gulati S., 2017, INDIAN J PEDIAT; Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Jia YX, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0604-4; Komaki M, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0660-9; Li G, 2017, TURK NEUROSURG; Lo Furno D, 2018, J CELL PHYSIOL, V233, P3982, DOI 10.1002/jcp.26192; Lu K, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0563-9; Oh SH, 2015, CYTOTHERAPY, V17, P1090, DOI 10.1016/j.jcyt.2015.04.007; Phinney DG, 2017, STEM CELLS, V35, P851, DOI 10.1002/stem.2575; Savukinas UB, 2016, STEM CELLS, V34, P1437, DOI 10.1002/stem.2357; Wang ZG, 2017, EXP THER MED, V13, P3613, DOI 10.3892/etm.2017.4423; Zhang QH, 2015, AM J TRANSL RES, V7, P2176; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770	23	21	22	0	10	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2018	10	3					901	+					7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GB5IO	WOS:000429097900025	29636880				2022-02-06	
J	Nikolian, VC; Dekker, SE; Bambakidis, T; Higgins, GA; Dennahy, IS; Georgoff, PE; Williams, AM; Andjelkovic, AV; Alam, HB				Nikolian, Vahagn C.; Dekker, Simone E.; Bambakidis, Ted; Higgins, Gerald A.; Dennahy, Isabel S.; Georgoff, Patrick E.; Williams, Aaron M.; Andjelkovic, Anuska V.; Alam, Hasan B.			Improvement of Blood-Brain Barrier Integrity in Traumatic Brain Injury and Hemorrhagic Shock Following Treatment With Valproic Acid and Fresh Frozen Plasma	CRITICAL CARE MEDICINE			English	Article; Proceedings Paper	102nd Annual Clinical Congress and Scientific Forum of the American-College-of-Surgeons (ACS)/Excelsior-Society	OCT 16-20, 2016	Washington, DC	Amer Coll Surg, Excelsior Soc		blood-brain barrier; endothelial permeability; fresh frozen plasma; traumatic brain injury; valproic acid	LARGE ANIMAL-MODEL; LYOPHILIZED PLASMA; PHARMACOLOGICAL RESUSCITATION; TIGHT JUNCTION; EXPRESSION; TRANSFUSION; INHIBITION; DISRUPTION; PHENOTYPE; APOPTOSIS	Objective: Combined traumatic brain injury and hemorrhagic shock are highly lethal. Following injuries, the integrity of the blood-brain barrier can be impaired, contributing to secondary brain insults. The status of the blood-brain barrier represents a potential factor impacting long-term neurologic outcomes in combined injuries. Treatment strategies involving plasma-based resuscitation and valproic acid therapy have shown efficacy in this setting. We hypothesize that a component of this beneficial effect is related to blood-brain barrier preservation. Design: Following controlled traumatic brain injury, hemorrhagic shock, various resuscitation and treatment strategies were evaluated for their association with blood-brain barrier integrity. Analysis of gene expression profiles was performed using Porcine Gene ST 1.1 microarray. Pathway analysis was completed using network analysis tools (Gene Ontology, Ingenuity Pathway Analysis, and Parametric Gene Set Enrichment Analysis). Subjects: Female Yorkshire swine were subjected to controlled traumatic brain injury and 2 hours of hemorrhagic shock (40% blood volume, mean arterial pressure 30-35 mmHg). Interventions: Subjects were resuscitated with 1) normal saline, 2) fresh frozen plasma, 3) hetastarch, 4) fresh frozen plasma + valproic acid, or 5) hetastarch + valproic acid (n = 5 per group). After 6 hours of observation, brains were harvested for evaluation. Measurements and Main Results: Immunofluoroscopic evaluation of the traumatic brain injury site revealed significantly increased expression of tight-junction associated proteins (zona occludin-1, claudin-5) following combination therapy (fresh frozen plasma + valproic acid and hetastarch + valproic acid). The extracellular matrix protein laminin was found to have significantly improved expression with combination therapies. Pathway analysis indicated that valproic acid significantly modulated pathways involved in endothelial barrier function and cell signaling. Conclusions: Resuscitation with fresh frozen plasma results in improved expression of proteins essential for blood-brain barrier integrity. The addition of valproic acid provides significant improvement to these protein expression profiles. This is likely secondary to activation of key pathways related to endothelial functions.	[Nikolian, Vahagn C.; Dekker, Simone E.; Bambakidis, Ted; Dennahy, Isabel S.; Georgoff, Patrick E.; Williams, Aaron M.; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Higgins, Gerald A.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Andjelkovic, Anuska V.] Univ Michigan, Med Sch, Dept Pathol, Ann Arbor, MI USA		Alam, HB (corresponding author), Univ Michigan Hosp, 2920 Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Higgins, Gerry/0000-0002-0434-1465; Dennahy, Isabel/0000-0002-4778-8910	U.S. Army Material and Research Command [W81XWH-09-1-0520]; Massey Foundation grant; Department of DefenseUnited States Department of Defense; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Supported by the U.S. Army Material and Research Command, Contract W81XWH-09-1-0520.; Dr. Higgins received support for article research from a Massey Foundation grant. Dr. Dennahy disclosed off-label product use of valproic acid in traumatic brain injury. Dr. Williams' institution received grant funding from the Department of Defense. Dr. Andjelkovic received support for article research from the National Institutes of Health. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Banjara M, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/8385961; Cartotto R, 2016, CRIT CARE CLIN, V32, P507, DOI 10.1016/j.ccc.2016.06.002; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Chang ZG, 2016, J TRAUMA ACUTE CARE, V81, P512, DOI 10.1097/TA.0000000000001137; Chen S, 2014, NEUROCHEM RES, V39, P1621, DOI 10.1007/s11064-014-1241-2; Corso P, 2015, INJURY PREV, V21, P432, DOI [10.1136/injuryprev-2015-041862, 10.1136/ip.2005.010983rep]; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gautam J, 2016, SCI REP-UK, V6, DOI 10.1038/srep36450; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, HEMATOL-AM SOC HEMAT, P656, DOI 10.1182/asheducation-2013.1.656; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Joannidis M, 2017, INTENS CARE MED, V43, P730, DOI 10.1007/s00134-017-4832-y; Kangwantas K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0495-9; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Kim YJ, 2014, NEUROSCIENCE, V275, P146, DOI 10.1016/j.neuroscience.2014.06.005; Lee TH, 2013, J TRAUMA ACUTE CARE, V75, P369, DOI 10.1097/TA.0b013e31829bb67c; Li YQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/523481; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Pati S, 2010, J TRAUMA, V69, pS55, DOI 10.1097/TA.0b013e3181e453d4; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Reinhold AK, 2017, PFLUG ARCH EUR J PHY, V469, P123, DOI 10.1007/s00424-016-1920-8; Sailliol A, 2013, TRANSFUSION, V53, p65S, DOI 10.1111/trf.12038; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; Wang ZF, 2011, J CEREBR BLOOD F MET, V31, P52, DOI 10.1038/jcbfm.2010.195; Wilson SM, 2012, NAT PROTOC, V7, P1716, DOI 10.1038/nprot.2012.096; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Ying GY, 2016, NEUROSURGERY, V79, P286, DOI 10.1227/NEU.0000000000001264	40	21	22	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JAN	2018	46	1					E59	E66		10.1097/CCM.0000000000002800			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	FW6LU	WOS:000425430600007	29095204				2022-02-06	
J	Rangaprakash, D; Dretsch, MN; Venkataraman, A; Katz, JS; Denney, TS; Deshpande, G				Rangaprakash, D.; Dretsch, Michael N.; Venkataraman, Archana; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna			Identifying disease foci from static and dynamic effective connectivity networks: Illustration in soldiers with trauma	HUMAN BRAIN MAPPING			English	Article						Functional MRI; effective connectivity; dynamic connectivity; disease foci; posttraumatic stress disorder; mild traumatic brain injury; machine learning	POSTTRAUMATIC-STRESS-DISORDER; RESTING-STATE; BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; GRANGER CAUSALITY; PREFRONTAL CORTEX; FMRI DATA; CLASSIFICATION; METAANALYSIS; VARIABILITY	Brain connectivity studies report group differences in pairwise connection strengths. While informative, such results are difficult to interpret since our understanding of the brain relies on region-based properties, rather than on connection information. Given that large disruptions in the brain are often caused by a few pivotal sources, we propose a novel framework to identify the sources of functional disruption from effective connectivity networks. Our approach integrates static and time-varying effective connectivity modeling in a probabilistic framework, to identify aberrant foci and the corresponding aberrant connectomics network. Using resting-state fMRI, we illustrate the utility of this novel approach in U.S. Army soldiers (N=87) with posttraumatic stress disorder (PTSD), mild traumatic brain injury (mTBI) and combat controls. Additionally, we employed machine-learning classification to identify those significant connectivity features that possessed high predictive ability. We identified three disrupted foci (middle frontal gyrus [MFG], insula, hippocampus), and an aberrant prefrontal-subcortical-parietal network of information flow. We found the MFG to be the pivotal focus of network disruption, with aberrant strength and temporal-variability of effective connectivity to the insula, amygdala and hippocampus. These connectivities also possessed high predictive ability (giving a classification accuracy of 81%); and they exhibited significant associations with symptom severity and neurocognitive functioning. In summary, dysregulation originating in the MFG caused elevated and temporally less-variable connectivity in subcortical regions, followed by a similar effect on parietal memory-related regions. This mechanism likely contributes to the reduced control over traumatic memories leading to re-experiencing, hyperarousal and flashbacks observed in soldiers with PTSD and mTBI. Hum Brain Mapp 39:264-287, 2018. (c) 2017 Wiley Periodicals, Inc.	[Rangaprakash, D.; Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, 560 Devall Dr,Suite 266D, Auburn, AL 36849 USA; [Rangaprakash, D.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Dretsch, Michael N.] US Army Aeromed Res Lab, Ft Rucker, AL USA; [Dretsch, Michael N.] HQ TRADOC, Human Dimens Div, Ft Eustis, VA USA; [Venkataraman, Archana] Johns Hopkins Univ, Dept Elect & Comp Engn, Baltimore, MD 21218 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA; [Katz, Jeffrey S.; Denney, Thomas S., Jr.; Deshpande, Gopikrishna] Alabama Adv Imaging Consortium, Birmingham, AL USA		Deshpande, G (corresponding author), Auburn Univ, Dept Elect & Comp Engn, AU MRI Res Ctr, 560 Devall Dr,Suite 266D, Auburn, AL 36849 USA.	gopi@auburn.edu		Denney, Thomas/0000-0002-6695-4777; Rangaprakash, D/0000-0001-9553-1354; Deshpande, Gopikrishna/0000-0001-7471-5357	U.S. Army Medical Research and Materials Command (MRMC) [00007218]	The authors acknowledge financial support for this work from the U.S. Army Medical Research and Materials Command (MRMC) (Grant # 00007218). The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the U.S. Army or the Department of Defense (DoD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the personnel at the TBI clinic and behavioral health clinic, Fort Benning, GA, USA and the US Army Aeromedical Research Laboratory, Fort Rucker, AL, USA, and most of all, the soldiers who participated in the study. The authors thank Julie Rodiek and Wayne Duggan for facilitating data acquisition.	Alba-Ferrara L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028701; Amico E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100012; Bellucci G, 2017, SOC NEUROSCI-UK, V12, P124, DOI 10.1080/17470919.2016.1153518; Berlim MT, 2014, CAN J PSYCHIAT, V59, P487, DOI 10.1177/070674371405900905; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Boly M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125337; Buchel C, 1998, HUM BRAIN MAPP, V6, P403; Cerullo MA, 2012, BIPOLAR DISORD, V14, P175, DOI 10.1111/j.1399-5618.2012.01002.x; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cisler JM, 2014, J PSYCHIATR RES, V48, P47, DOI 10.1016/j.jpsychires.2013.09.013; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deshpande G, 2009, P ISMRM 17 SCI M 200, P3362; Deshpande G, 2015, IEEE T CYBERNETICS, V45, P2668, DOI 10.1109/TCYB.2014.2379621; Deshpande G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00670; Deshpande G, 2012, BRAIN CONNECT, V2, P235, DOI 10.1089/brain.2012.0091; Deshpande G, 2012, BEHAV BRAIN SCI, V35, P148, DOI 10.1017/S0140525X1100149X; Deshpande G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014277; Deshpande G, 2011, NEUROIMAGE, V54, P1043, DOI 10.1016/j.neuroimage.2010.09.024; Deshpande G, 2010, IEEE T BIO-MED ENG, V57, P1446, DOI 10.1109/TBME.2009.2037808; Dickstein B.D., 2014, ASSESSMENT; Dretsch Michael N, 2016, Open Neuroimag J, V10, P111; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Emmert K, 2016, NEUROIMAGE, V124, P806, DOI 10.1016/j.neuroimage.2015.09.042; Feng CL, 2016, HUM BRAIN MAPP, V37, P663, DOI 10.1002/hbm.23057; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Grant MM, 2015, NEUROPSYCHOPHARMACOL, V40, P1782, DOI 10.1038/npp.2015.28; Grant MM, 2014, HUM BRAIN MAPP, V35, P4815, DOI 10.1002/hbm.22514; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Greiser KH, 2009, EUR J EPIDEMIOL, V24, P123, DOI 10.1007/s10654-009-9317-z; Gross J. J., 2014, HDB EMOTION REGULATI; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hall CN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0348; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hansen ECA, 2015, NEUROIMAGE, V105, P525, DOI 10.1016/j.neuroimage.2014.11.001; Hayes JP, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00089; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hutcheson NL, 2015, HUM BRAIN MAPP, V36, P1442, DOI 10.1002/hbm.22714; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Illari P.M., 2011, CAUSALITY SCI CAUSALITY SCI, DOI [10.1093/acprof:oso/9780199574131.001.0001, DOI 10.1093/ACPROF:OSO/9780199574131.001.0001]; Jia H, 2014, BRAIN CONNECT, V4, P741, DOI 10.1089/brain.2014.0300; Jin CF, 2017, HUM BRAIN MAPP, V38, P4479, DOI 10.1002/hbm.23676; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Katwal SB, 2013, NEUROIMAGE, V66, P436, DOI 10.1016/j.neuroimage.2012.10.052; Kennis M, 2015, HUM BRAIN MAPP, V36, P99, DOI 10.1002/hbm.22615; King D. W., 2003, MANUAL DEPLOYMENT RI; Kirchgassner G, 2012, INTRO MODERN TIME SE; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Lacey S, 2014, NEUROPSYCHOLOGIA, V60, P144, DOI 10.1016/j.neuropsychologia.2014.05.008; Lamichhane B, 2014, BRAIN CONNECT, V4, P619, DOI 10.1089/brain.2014.0243; Liu F, 2015, BRAIN TOPOGR, V28, P221, DOI 10.1007/s10548-014-0386-2; Lohmann G, 2012, NEUROIMAGE, V59, P2322, DOI 10.1016/j.neuroimage.2011.09.025; Marquand AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069237; Miller RL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149849; Modinos G, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.53; Oishi K, 2015, ANN NEUROL, V77, P68, DOI 10.1002/ana.24300; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Pinotsis DA, 2013, NEUROIMAGE, V65, P127, DOI 10.1016/j.neuroimage.2012.10.016; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rangaprakash D, 2017, NEUROIMAGE-CLIN, V16, P409, DOI 10.1016/j.nicl.2017.07.016; Rangaprakash D, 2017, DATA BRIEF, V14, P558, DOI 10.1016/j.dib.2017.07.072; Rangaprakash D, 2017, HUM BRAIN MAPP, V38, P2843, DOI 10.1002/hbm.23551; Rangaprakash D., 2015, P ANN M INT SOC MAGN, V23, P4402; Rangaprakash D, 2016, P ANN M INT SOC MAGN, V24, P3740; Rashid B, 2016, NEUROIMAGE, V134, P645, DOI 10.1016/j.neuroimage.2016.04.051; Reiss AL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002225; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Ryali S, 2016, NEUROIMAGE, V132, P398, DOI 10.1016/j.neuroimage.2016.02.067; Ryali S, 2012, NEUROIMAGE, V59, P3852, DOI 10.1016/j.neuroimage.2011.11.054; Ryali S, 2011, NEUROIMAGE, V54, P807, DOI 10.1016/j.neuroimage.2010.09.052; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Sathian K, 2013, J NEUROSCI, V33, P5387, DOI 10.1523/JNEUROSCI.3482-12.2013; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spielberg JM, 2015, BIOL PSYCHIAT, V78, P210, DOI 10.1016/j.biopsych.2015.02.013; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Vapnik V., 2013, NATURE STAT LEARNING; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Venkataraman A, 2013, IEEE T MED IMAGING, V32, P2078, DOI 10.1109/TMI.2013.2272976; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Wang L., 2005, SUPPORT VECTOR MACHI; Weathers F.W, 2015, PTSD CHECKLIST DSM 5; Wen XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067428; Wheelock MD, 2014, NEUROIMAGE, V102, P904, DOI 10.1016/j.neuroimage.2014.08.005; White SF, 2015, NEUROIMAGE-CLIN, V7, P19, DOI 10.1016/j.nicl.2014.11.012; Woo CW, 2015, PAIN, V156, P1379, DOI 10.1097/j.pain.0000000000000223; Wu GR, 2013, MED IMAGE ANAL, V17, P365, DOI 10.1016/j.media.2013.01.003; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yousef M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-144; Zhang J, 2016, BRAIN, V139, P2307, DOI 10.1093/brain/aww143; Zhao SN, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00211; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	109	21	22	1	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JAN	2018	39	1					264	287		10.1002/hbm.23841			24	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FP0IF	WOS:000417282000018	29058357	Green Published			2022-02-06	
J	Wang, HF; Wang, ZQ; Ding, Y; Piao, MH; Feng, CS; Chi, GF; Luo, YN; Ge, PF				Wang, Hai-Feng; Wang, Zong-Qi; Ding, Ye; Piao, Mei-Hua; Feng, Chun-Sheng; Chi, Guang-Fan; Luo, Yi-Nan; Ge, Peng-Fei			Endoplasmic reticulum stress regulates oxygen-glucose deprivation-induced parthanatos in human SH-SY5Y cells via improvement of intracellular ROS	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						endoplasmic reticulum stress; oxygen-glucose deprivation; parthanatos; ROS; SH-SY5Y cells	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; GLIOMA-CELLS; POLY(ADP-RIBOSE) POLYMERASE-1; CEREBRAL-ISCHEMIA; INDUCED APOPTOSIS; NEURONAL DEATH; ER-STRESS; ACTIVATION; PATHWAY	AimsEndoplasmic reticulum (ER) stress has been demonstrated to regulate neuronal death caused by ischemic insults via activation of apoptosis, but it still remains unclear whether ER stress participates in regulation of parthanatos, a new type of programmed cell death characterized by PARP-1 overactivation and intracellular accumulation of PAR polymer. Methodswe used oxygen-glucose deprivation (OGD) and human SH-SY5Y cells to simulate neuronal damage caused by ischemia. ResultsOxygen-glucose deprivation induced time-dependent death in SH-SY5Y cells, which was accompanied with upregulation of PARP-1, accumulation of PAR polymer, decline of mitochondrial membrane potentials and nuclear translocation of AIF. Pharmacological inhibition of PARP-1 with its specific inhibitor 3AB rescued OGD-induced cell death, as well as prevented PAR polymer accumulation, mitochondrial depolarization, and AIF translocation into nucleus. Similar results could be found when PARP-1 was genetically knocked down with SiRNA. These indicated that OGD triggered parthanatos in SH-SY5Y cells. Then, we found inhibition of overproduction of ROS with antioxidant NAC attenuated obviously OGD-induced parthanatos in SH-SY5Y cells, suggesting ROS regulated OGD-induced parthanatos. Additionally, OGD also induced upregulation of ER stress-related proteins. Mitigation of ER stress with chemical chaperone 4-PBA or trehalose suppressed significantly OGD-induced overproduction of ROS, PARP-1 upregulation, PAR polymer accumulation, and nuclear accumulation of AIF, and cell death in SH-SY5Y cells. ConclusionEndoplasmic reticulum stress regulates OGD-induced parthanatos in human SH-SY5Y cells via improvement of intracellular ROS.	[Wang, Hai-Feng; Wang, Zong-Qi; Ding, Ye; Piao, Mei-Hua; Luo, Yi-Nan; Ge, Peng-Fei] Jilin Univ, Dept Neurosurg, Hosp 1, Changchun, Jilin, Peoples R China; [Wang, Zong-Qi; Ding, Ye; Luo, Yi-Nan; Ge, Peng-Fei] Jilin Univ, Res Ctr Neurosci, Hosp 1, Changchun, Jilin, Peoples R China; [Piao, Mei-Hua; Feng, Chun-Sheng] Jilin Univ, Dept Anesthesiol, Hosp 1, Changchun, Jilin, Peoples R China; [Chi, Guang-Fan] Jilin Univ, Key Lab Pathobiol, Minist Educ, Changchun, Jilin, Peoples R China		Ge, PF (corresponding author), Jilin Univ, Dept Neurosurg, Hosp 1, Changchun, Jilin, Peoples R China.; Ge, PF (corresponding author), Jilin Univ, Res Ctr Neurosci, Hosp 1, Changchun, Jilin, Peoples R China.	gepf@jlu.edu.cn			National Nature and Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81372697, 81271215, 81772669, 81771141]; Changbaishan Scholar Project of Jilin Province [2013026]; Scientific Research Foundation of Jilin province [20150414013GH, 20160101127JC]	National Nature and Science Foundation of China, Grant/Award Number: 81372697, 81271215, 81772669 and 81771141; Changbaishan Scholar Project of Jilin Province, Grant/Award Number: 2013026; Scientific Research Foundation of Jilin province, Grant/Award Number: 20150414013GH and 20160101127JC	Akhiani AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089646; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Badiola N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.31; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Chiu LY, 2011, BIOCHEM PHARMACOL, V81, P459, DOI 10.1016/j.bcp.2010.10.016; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416; Ferreiro E, 2012, Int J Cell Biol, V2012, P735206, DOI 10.1155/2012/735206; Gu NB, 2017, BRAIN RES BULL, V130, P27, DOI 10.1016/j.brainresbull.2016.12.006; Guo F, 2013, CELL MOL NEUROBIOL, V33, P443, DOI 10.1007/s10571-013-9911-1; He C, 2014, NEUROSCIENCE, V258, P254, DOI 10.1016/j.neuroscience.2013.11.024; He ZL, 2017, AM J TRANSL RES, V9, P1075; Jin W, 2016, J NEUROL SCI, V366, P8, DOI 10.1016/j.jns.2016.04.038; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kim HR, 2009, J CELL SCI, V122, P1126, DOI 10.1242/jcs.038430; Lee HJ, 2011, ARCH PHARM RES, V34, P1373, DOI 10.1007/s12272-011-0818-4; Lee Y, 2014, BMB REP, V47, P424, DOI 10.5483/BMBRep.2014.47.8.119; Li Y, 2016, MOL NEUROBIOL; Liu H, 1997, J BIOL CHEM, V272, P21751, DOI 10.1074/jbc.272.35.21751; Liu XR, 2014, TRANSL STROKE RES, V5, P692, DOI 10.1007/s12975-014-0359-5; Lu P, 2014, J NEUROSCI, V34, P15975, DOI 10.1523/JNEUROSCI.2499-14.2014; Luo ZF, 2010, TOXICOL APPL PHARM, V246, P49, DOI 10.1016/j.taap.2010.04.005; Ma DD, 2016, CANCER LETT, V371, P194, DOI 10.1016/j.canlet.2015.11.044; Mohammad G, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/510451; Patino P, 2016, NEUROTOXICOLOGY, V57, P61, DOI 10.1016/j.neuro.2016.09.002; Rathnasamy G, 2016, MOL NEUROBIOL, V53, P4713, DOI 10.1007/s12035-015-9389-6; Rubovitch V, 2015, NEUROMOL MED, V17, P58, DOI 10.1007/s12017-015-8340-3; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Su YC, 2016, INT J NEUROSCI, V126, P681, DOI 10.3109/00207454.2015.1059836; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Xin Q, 2014, NEUROCHEM INT, V68, P18, DOI 10.1016/j.neuint.2014.02.001; Yang ZY, 2014, J IMMUNOL, V193, P6114, DOI 10.4049/jimmunol.1400359; Zeeshan HMA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030327; Zhang JL, 2013, J SURG RES, V183, P929, DOI 10.1016/j.jss.2013.02.043; Zhao HW, 2016, CANCER LETT, V374, P136, DOI 10.1016/j.canlet.2016.01.055; Zheng LJ, 2017, MOL NEUROBIOL, V54, P3492, DOI 10.1007/s12035-016-9926-y; Zhong F, 2015, J PHOTOCH PHOTOBIO B, V151, P10, DOI 10.1016/j.jphotobiol.2015.06.016; Zhou ZJ, 2017, CANCER LETT, V390, P77, DOI 10.1016/j.canlet.2017.01.004	41	21	22	5	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	JAN	2018	24	1					29	38		10.1111/cns.12771			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	FQ0XJ	WOS:000418080100003	29045036	Green Published, Bronze			2022-02-06	
J	Wright, DK; O'Brien, TJ; Mychasiuk, R; Shultz, SR				Wright, David K.; O'Brien, Terence J.; Mychasiuk, Richelle; Shultz, Sandy R.			Telomere length and advanced diffusion MRI as biomarkers for repetitive mild traumatic brain injury in adolescent rats	NEUROIMAGE-CLINICAL			English	Article						Biomarker; Concussion; Track weighted imaging; Animal model; Diffusion tensor imaging; MRI	TENSOR IMAGING FINDINGS; WHITE-MATTER; OXIDATIVE STRESS; REDUCES NEUROINFLAMMATION; HYPERPHOSPHORYLATED TAU; PROFESSIONAL FOOTBALL; REPEATED CONCUSSION; SODIUM SELENATE; GENE-EXPRESSION; ANIMAL-MODEL	Mild traumatic brain injuries (mTBI) are of worldwide concern in adolescents of both sexes, and repeated mTBI (RmTBI) may have serious long-term neurological consequences. As such, the study of RmTBI and discovery of objective biomarkers that can help guide medical decisions is an important undertaking. Diffusion-weighted MRI (DWI), which provides markers of axonal injury, and telomere length (TL) are two clinically relevant biomarkers that have been implicated in a number of neurological conditions, and may also be affected by RmTBI. Therefore, this study utilized the lateral impact injury model of RmTBI to investigate changes in diffusion MRI and TL, and how these changes relate to each other. Adolescent male and female rats received either three mTBIs or three sham injuries. The first injury was given on postnatal day 30 (P30), with the repeated injuries separated by four days each. Seven days after the final injury, a sample of ear tissue was collected for TL analysis. Rats were then euthanized and whole brains were collected and fixated for MRI analyses that included diffusion and high-resolution structural sequences. Compared to the sham-injured group, RmTBI rats had significantly shorter TL at seven days post-injury. Analysis of advanced DWI measures found that RmTBI rats had abnormalities in the corpus callosum and cortex at seven days post-injury. Notably, many of the DWI changes were correlated with TL. These findings demonstrate that TL and DWI measurements are changed by RmTBI and may represent clinically applicable biomarkers for this.	[Wright, David K.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3010, Australia; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Wright, David K.; O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia; [O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada		Shultz, SR (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Ctr, 6th Floor,99 Commercial Rd, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021	O'Brien, Terence/0000-0002-7198-8621	Alberta Children's Hospital Foundation; Integrated Concussion Research Program; National Health and Medical Research CouncilNational Health and Medical Research Council of Australia [1087172]	The authors thank the Alberta Children's Hospital Foundation, the Integrated Concussion Research Program and the National Health and Medical Research Council (1087172) for funding. We acknowledge the animal MRI facility at the Florey Institute of Neuroscience and Mental Health, a node of the National Imaging Facility.	Abdullah AI, 2012, MOL NEUROBIOL, V45, P586, DOI 10.1007/s12035-012-8277-6; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Back SA, 2011, ANN NEUROL, V70, P465, DOI 10.1002/ana.22484; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 2004, CARCINOGENESIS, V25, P1083, DOI 10.1093/carcin/bgh185; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calamante F, 2012, NEUROIMAGE, V59, P2494, DOI 10.1016/j.neuroimage.2011.08.099; Cardenas AM, 2017, NEUROIMAGE-CLIN, V15, P200, DOI 10.1016/j.nicl.2017.04.024; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; da Costa L, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00070; Demerath EW, 2004, HUM BIOL, V76, P127, DOI 10.1353/hub.2004.0018; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Eitan E, 2014, TRENDS NEUROSCI, V37, P256, DOI 10.1016/j.tins.2014.02.010; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Gilley D, 2008, MECH AGEING DEV, V129, P27, DOI 10.1016/j.mad.2007.10.010; Guan JZ, 2008, J GERONTOL A-BIOL, V63, P467, DOI 10.1093/gerona/63.5.467; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holland RL, 2016, ADV PRECIS MED, V1, P4, DOI [10.18063/APM.2016.01.007, DOI 10.18063/APM.2016.01.007]; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Klapper W, 2001, MECH AGEING DEV, V122, P695, DOI 10.1016/S0047-6374(01)00223-8; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Mychasiuk R, 2014, BEHAV BRAIN RES, V259, P284, DOI 10.1016/j.bbr.2013.10.048; Mychasiuk R, 2016, EUR J NEUROSCI, V44, P2407, DOI 10.1111/ejn.13360; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Pannek K, 2011, NEUROIMAGE, V55, P133, DOI 10.1016/j.neuroimage.2010.12.010; Panossian LA, 2003, NEUROBIOL AGING, V24, P77, DOI 10.1016/S0197-4580(02)00043-X; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tan XL, 2016, NEUROPHARMACOLOGY, V108, P382, DOI 10.1016/j.neuropharm.2016.05.001; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Willats L, 2014, NEUROIMAGE, V87, P18, DOI 10.1016/j.neuroimage.2013.11.016; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang B, 2010, J NEUROSCI RES, V88, P2859, DOI 10.1002/jnr.22450	78	21	21	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						315	324		10.1016/j.nicl.2018.01.033			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH1NG	WOS:000433169000031	29876252	Green Published, gold			2022-02-06	
J	Xie, GG; Peng, WJ; Li, PF; Xia, Z; Zhong, YY; He, F; Tulake, Y; Feng, DD; Wang, Y; Xing, ZH				Xie, Genggeng; Peng, Weijun; Li, Pengfei; Xia, Zian; Zhong, Yuanyuan; He, Feng; Tulake, Yimingaji; Feng, Dandan; Wang, Yang; Xing, Zhihua			A Network Pharmacology Analysis to Explore the Effect of Astragali Radix-Radix Angelica Sinensis on Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							TRADITIONAL CHINESE MEDICINE; SYSTEMS PHARMACOLOGY; DRUG DISCOVERY; NOGO-A; RAT; EXPRESSION; DECOCTION; RECEPTOR; NEUROPROTECTION; CALYCOSIN	Traumatic brain injury (TBI) is a critical public health and socioeconomic problem worldwide. The herb pair Astragali Radix (AR)-Radix Angelica Sinensis (RAS) is a common prescribed herbal formula or is added to other Chinese medicine prescriptions for traumatic brain injury (TBI) treatment. However, the underlying mechanisms are unclear. In this study, we aimed to explore the active ingredients and action targets of AR-RAS based on the combined methods of network pharmacology prediction and experimental verification. Furthermore, the corresponding potential mechanisms of "multicomponents, multitargets, and multipathways" were disclosed. Methods. A network pharmacology approach including ADME (absorption, distribution, metabolism, and excretion) filter analysis, target prediction, known therapeutic targets collection, Gene Ontology (GO), pathway enrichment analysis, and network construction was used in this study. Further verification experiments were performed to reveal the therapeutic effects of AR-RAS in a rat model of TBI. Results. The comprehensive systematic approach was to successfully identify 14 bioactive ingredients in AR-RAS, while 33 potential targets hit by these ingredients related to TBI. Based on GO annotation analysis, multiple biological processes were significantly regulated by AR-RAS. In addition, 89 novel signaling pathways (P<0.05) underlying the effects of AR-RAS for TBI treatment were identified by DAVID. The neurotrophin signaling pathway was suggested as the major related pathway targeted by AR-RAS to improve axonal growth. The animal experiment confirmed that AR-RAS significantly induced tissue recovery and improved neurological deficits on the 14th day (P<0.01). Treatment with ARRAS markedly reduced the protein and mRNA expression level of NogoA in the hippocampus of TBI rats. Conclusion. Our work illuminates the "multicompounds, multitargets, and multipathways" curative action of AR-RAS in the treatment of TBI by network pharmacology. The animal experiment verifies the effects of AR-RAS on neurological function improvement and axonal outgrowth via downregulation of NogoA expression, providing a theoretical basis for further research on treatment of TBI.	[Xie, Genggeng; Li, Pengfei; Xia, Zian; Zhong, Yuanyuan; Feng, Dandan; Wang, Yang; Xing, Zhihua] Cent S Univ, Xiangya Hosp, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China; [Peng, Weijun] Cent S Univ, Xiangya Hosp 2, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China; [He, Feng] Cent S Univ, Dept Hepatobiliary Surg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Tulake, Yimingaji] Third Div Hosp, Dept Gen Surg, Xinjiang Prod & Construct Corps, Xinjiang 844000, Peoples R China		Wang, Y; Xing, ZH (corresponding author), Cent S Univ, Xiangya Hosp, Inst Integrat Med, Changsha 410008, Hunan, Peoples R China.	wangyang_xy87@csu.edu.cn; xzh_56@163.com	Peng, Weijun/M-5131-2014	Peng, Weijun/0000-0002-4506-0942	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719, 81874409]; Scientific Research Project of Traditional Chinese Medicine of Hunan [201527]	This project was supported by National Natural Science Foundation of China (Nos. 81673719 and 81874409) and Scientific Research Project of Traditional Chinese Medicine of Hunan (No. 201527).	Abdelhalim MAK, 2018, INT J NANOMED, V13, P2821, DOI 10.2147/IJN.S160995; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI 10.1089/neu.2008-0765; Chen ML, 2001, PHARMACEUT RES, V18, P1645, DOI 10.1023/A:1013319408893; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Chen XP, 2013, CHIN J NAT MEDICINES, V11, P577, DOI [10.1016/S1875-5364(13)60067-9, 10.3724/SP.J.1009.2013.00577]; Cheng LL, 2011, FITOTERAPIA, V82, P1128, DOI 10.1016/j.fitote.2011.07.011; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Feng DD, 2017, ONCOTARGET, V8, P94692, DOI 10.18632/oncotarget.21876; Gao JQ, 2014, PHARM BIOL, V52, P1217, DOI 10.3109/13880209.2013.879188; Gao L., 2016, SCI REPORTS, V6; Gong J. L. L. W. L., 2008, CHINESE ARCH TRADITI, V09, P1941; Gu JY, 2011, COMPUT BIOL CHEM, V35, P293, DOI 10.1016/j.compbiolchem.2011.07.003; Hao DC, 2014, DRUG DEVELOP RES, V75, P299, DOI 10.1002/ddr.21214; Huber AB, 2002, J NEUROSCI, V22, P3553; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ip FCF, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1417-1; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Jia Rui-zhe, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P54; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jin XY, 2008, J ETHNOPHARMACOL, V117, P473, DOI 10.1016/j.jep.2008.02.033; Lenffer J, 2006, NUCLEIC ACIDS RES, V34, pD599, DOI 10.1093/nar/gkj152; Li J, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/149762; Li JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15290; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.1016/S1875-5364(13)60037-0, 10.3724/SP.J.1009.2013.00110]; Liang XJ, 2014, MOL BIOSYST, V10, P1014, DOI 10.1039/c3mb70507b; Liu H, 2016, EVID-BASED COMPL ALT, V2016; Mahmood A, 2014, J NEUROSURG, V120, P1147, DOI 10.3171/2013.12.JNS131362; Mahmood A, 2014, BRAIN RES, V1542, P41, DOI 10.1016/j.brainres.2013.10.045; Miao Z. S. F. P., 2013, CHINESE J EXPT TRADI, V02, P163; Pang HQ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00165; Pernet V, 2012, CELL TISSUE RES, V349, P97, DOI 10.1007/s00441-012-1432-6; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ran L., 2008, LISHIZHEN MED MAT ME, V7, P1554, DOI DOI 10.3969/J.ISSN.1008-0805.2008.07.004; Reza A, 2018, BRAIN INJURY, V32, P487, DOI 10.1080/02699052.2018.1429658; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Shahzad M, 2016, CURR DRUG TARGETS, V17, P1331, DOI 10.2174/1389450116666150907104742; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Stelmaschuk S, 2015, J TRAUMA NURS, V22, P194, DOI 10.1097/JTN.0000000000000138; Tao L, 2018, BRAIN RES BULL, V140, P154, DOI 10.1016/j.brainresbull.2018.04.008; Tohda C, 2006, BRIT J PHARMACOL, V149, P532, DOI 10.1038/sj.bjp.0706865; Wang WZ, 2017, BRAIN BEHAV IMMUN, V64, P344, DOI 10.1016/j.bbi.2017.04.019; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xiong DW, 2011, SCI TOTAL ENVIRON, V409, P1444, DOI 10.1016/j.scitotenv.2011.01.015; Xu T., 2017, J CHINESE MED MAT, V09, P2195; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Xu YQ, 2015, CNS NEUROSCI THER, V21, P479, DOI 10.1111/cns.12387; Xu YH, 2011, J ETHNOPHARMACOL, V137, P359, DOI 10.1016/j.jep.2011.05.041; Yadav M, 2018, PHARMACOL REP, V70, P591, DOI 10.1016/j.pharep.2018.01.001; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yang B, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1076-2; Yang JF, 2013, J SURG RES, V182, pE69, DOI 10.1016/j.jss.2012.11.010; Zhao GW, 2014, J ETHNOPHARMACOL, V151, P694, DOI 10.1016/j.jep.2013.11.041; Zhou J., 2017, ONCOTARGET, V8	63	21	21	3	9	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2018	2018								3951783	10.1155/2018/3951783			13	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	HE0NJ	WOS:000452963400001	30596090	Green Published, gold, Green Submitted			2022-02-06	
J	Alosco, ML; Mez, J; Kowall, NW; Stein, TD; Goldstein, LE; Cantu, RC; Katz, DI; Solomon, TM; Kiernan, PT; Murphy, L; Abdolmohammadi, B; Daneshvar, D; Montenigro, PH; Nowinski, CJ; Stern, RA; Mckee, AC				Alosco, Michael L.; Mez, Jesse; Kowall, Neil W.; Stein, Thor D.; Goldstein, Lee E.; Cantu, Robert C.; Katz, Douglas I.; Solomon, Todd M.; Kiernan, Patrick T.; Murphy, Lauren; Abdolmohammadi, Bobak; Daneshvar, Daniel; Montenigro, Philip H.; Nowinski, Christopher J.; Stern, Robert A.; Mckee, Ann C.			Cognitive Reserve as a Modifier of Clinical Expression in Chronic Traumatic Encephalopathy: A Preliminary Examination	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							21ST-CENTURY BRAIN BANKING; EDUCATION; INJURY; PATHOLOGY; DEMENTIA; SPECTRUM; CRITERIA; DISEASE	This study conducted a preliminary examination on cognitive reserve (CR) as a modifier of symptom expression in subjects with autopsy-confirmed chronic traumatic encephalopathy (CTE). The sample included 25 former professional football players neuropathologically diagnosed with CTE stage III or IV. Next of kin interviews ascertained age at cognitive and behavioral/mood symptom onset and demographic/athletic characteristics. Years of education and occupational attainment defined CR. High occupational achievement predicted later age at cognitive (p=0.02) and behavioral/mood (p=0.02) onset. Education was not an individual predictor. These preliminary findings suggest that CR may forestall the clinical manifestation of CTE.	[Alosco, Michael L.; Mez, Jesse; Kowall, Neil W.; Stein, Thor D.; Goldstein, Lee E.; Cantu, Robert C.; Solomon, Todd M.; Kiernan, Patrick T.; Murphy, Lauren; Abdolmohammadi, Bobak; Daneshvar, Daniel; Montenigro, Philip H.; Nowinski, Christopher J.; Stern, Robert A.; Mckee, Ann C.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Alosco, Michael L.; Mez, Jesse; Kowall, Neil W.; Stein, Thor D.; Goldstein, Lee E.; Katz, Douglas I.; Solomon, Todd M.; Kiernan, Patrick T.; Murphy, Lauren; Abdolmohammadi, Bobak; Daneshvar, Daniel; Montenigro, Philip H.; Stern, Robert A.; Mckee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Daneshvar, Daniel] North Shore Med Ctr, Dept Internal Med, Boston, MA USA; [Kowall, Neil W.; Stein, Thor D.; Mckee, Ann C.] VA Boston Healthcare Syst, US Dept Vet Affairs, Boston, MA 02130 USA; [Kowall, Neil W.; Stein, Thor D.; Mckee, Ann C.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Stein, Thor D.; Mckee, Ann C.] Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Biomed Engn, Boston, MA 02215 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Dept Elect & Comp Engn, Boston, MA 02215 USA; [Cantu, Robert C.; Nowinski, Christopher J.] Concuss Legacy Fdn, Boston, MA USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Katz, Douglas I.] Braintree Rehabil Hosp, Braintree, MA USA; [Montenigro, Philip H.; Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA		Mckee, AC (corresponding author), Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA.; Mckee, AC (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.; Mckee, AC (corresponding author), VA Boston Healthcare Syst, US Dept Vet Affairs, Boston, MA 02130 USA.; Mckee, AC (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.; Mckee, AC (corresponding author), Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA.		, Bob/ABA-8507-2020; Kowall, Neil/M-5378-2019	Kowall, Neil/0000-0002-6624-0213; Daneshvar, Daniel/0000-0003-3691-9513; Stein, Thor/0000-0001-6954-4477	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1UO1NS086659-01, R01NS078337, R56NS078337]; Department of DefenseUnited States Department of Defense [W81XWH-13-2-0064]; Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Affairs Biorepository [CSP 501]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP) [13267017]; National Institute of Aging Boston University Framingham Heart Study [R01AG1649]; National Operating Committee on Standards for Athletic Equipment and the Concussion Legacy Foundation; Andlinger Foundation; WWE; NFL; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1F32NS096803-01]; Johnson & Johnson (New Brunswick, N.J.)/Janssen Research & Development, LLC (Raritan, N.J.); Rebiscan, Inc. (Cambridge, Mass.); Ivivi Health Sciences; Mackey-White Committee; NFL Players Association; Avid Radiopharmaceuticals, Inc. (Philadelphia); Athena Diagnostics/Quest Laboratories (Marlborough, Mass.); Amarantus BioScience Holdings, Inc. (San Francisco); Avanir Pharmaceuticals, Inc. (Aliso Viejo, Calif.); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS096803, U01NS093334, R01NS078337, R56NS078337, U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG046377, P30AG019610, P30AG013846] Funding Source: NIH RePORTER	Supported by the National Institute of Neurological Disorders and Stroke (1UO1NS086659-01, R01NS078337, R56NS078337), the Department of Defense (W81XWH-13-2-0064), the Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5), the Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP #13267017), the National Institute of Aging Boston University Framingham Heart Study (R01AG1649), and the National Operating Committee on Standards for Athletic Equipment and the Concussion Legacy Foundation. This work was also supported by unrestricted gifts from the Andlinger Foundation, the WWE, and the NFL. Michael L. Alosco and research reported in this article are supported by the National Institutes of Health under grant 1F32NS096803-01.; Dr. Goldstein is a paid consultant to Johnson & Johnson (New Brunswick, N.J.)/Janssen Research & Development, LLC (Raritan, N.J.), and Rebiscan, Inc. (Cambridge, Mass.); and he has received funding from the WWE and Ivivi Health Sciences. Dr. Nowinski is a member of the Mackey-White Committee of the NFL Players Association and receives fees for speaking at educational programs. Dr. Stern has received research funding from the NFL, the NFL Players Association, and Avid Radiopharmaceuticals, Inc. (Philadelphia); he is a member of the Mackey-White Committee of the NFL Players Association; he is a paid consultant to Athena Diagnostics/Quest Laboratories (Marlborough, Mass.), Amarantus BioScience Holdings, Inc. (San Francisco), and Avanir Pharmaceuticals, Inc. (Aliso Viejo, Calif.); he receives royalties for published neuropsychological tests from Psychological Assessment Resources, Inc. (Lutz, Fla.), as well as compensation from expert legal opinion. Dr. McKee has received funding from the NFL, WWE, and is a member of the Mackey-White Committee of the NFL Players Association. All other authors report no financial relationships with commercial interests.	Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; BARBER R, 1995, J NEUROL NEUROSUR PS, V59, P61, DOI 10.1136/jnnp.59.1.61; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Bennett DA, 2014, ACTA NEUROPATHOL, V127, P137, DOI 10.1007/s00401-013-1226-2; Bernick C, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt177; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Ghaffar O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047206; Harrison SL, 2015, J CLIN EXP NEUROPSYC, V37, P253, DOI 10.1080/13803395.2014.1002759; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Linds AB, 2015, CAN J NEUROL SCI, V42, P389, DOI 10.1017/cjn.2015.266; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montenigro PH, 2016, CUMULATIVE HEAD IMPA; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Richards M, 2003, J CLIN EXP NEUROPSYC, V25, P614, DOI 10.1076/jcen.25.5.614.14581; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2012, LANCET NEUROL, V11, P1006, DOI 10.1016/S1474-4422(12)70191-6; United States Department of Labor, 1991, DICT OCCUPATIONAL TI, VFourth; Vonsattel JPG, 2008, CELL TISSUE BANK, V9, P247, DOI 10.1007/s10561-008-9079-y; Vonsattel JPG, 2008, ACTA NEUROPATHOL, V115, P509, DOI 10.1007/s00401-007-0311-9; Wilson RS, 2013, NEUROLOGY, V80, P1202, DOI 10.1212/WNL.0b013e3182897103; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057; Zahodne LB, 2015, NEUROPSYCHOLOGIA, V77, P260, DOI 10.1016/j.neuropsychologia.2015.09.009	30	21	21	0	89	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	2017	29	1					6	12		10.1176/appi.neuropsych.16030043			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	EP0WO	WOS:000397107600002	27539377	Bronze, Green Accepted			2022-02-06	
J	Campolettano, ET; Bland, ML; Gellner, RA; Sproule, DW; Rowson, B; Tyson, AM; Duma, SM; Rowson, S				Campolettano, Eamon T.; Bland, Megan L.; Gellner, Ryan A.; Sproule, David W.; Rowson, Bethany; Tyson, Abigail M.; Duma, Stefan M.; Rowson, Steven			Ranges of Injury Risk Associated with Impact from Unmanned Aircraft Systems	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Drone; Skull; Brain; Concussion; Cervical spine; Neck	FOOTBALL HELMETS; HEAD; ACCELERATION; CONCUSSION; ACCURACY	Regulations have allowed for increased unmanned aircraft systems (UAS) operations over the last decade, yet operations over people are still not permitted. The objective of this study was to estimate the range of injury risks to humans due to UAS impact. Three commercially-available UAS models that varied in mass (1.2-11 kg) were evaluated to estimate the range of risk associated with UAS-human interaction. Live flight and falling impact tests were conducted using an instrumented Hybrid III test dummy. On average, live flight tests were observed to be less severe than falling impact tests. The maximum risk of AIS 3+ injury associated with live flight tests was 11.6%, while several falling impact tests estimated risks exceeding 50%. Risk of injury was observed to increase with increasing UAS mass, and the larger models tested are not safe for operations over people in their current form. However, there is likely a subset of smaller UAS models that are safe to operate over people. Further, designs which redirect the UAS away from the head or deform upon impact transfer less energy and generate lower risk. These data represent a necessary impact testing foundation for future UAS regulations on operations over people.	[Campolettano, Eamon T.; Bland, Megan L.; Gellner, Ryan A.; Sproule, David W.; Rowson, Bethany; Tyson, Abigail M.; Duma, Stefan M.; Rowson, Steven] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA		Rowson, S (corresponding author), Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.	srowson@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596			Anand S, 2007, ASTM STAND NEWS, V35, P30; AUVSI (Association for Unmanned Vehicle Systems International), 2013, EC IMP UNM AIRCR SYS; Bangash M. Y. H., 2007, TRAUMA TRAUMATIC INJ, P1; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Dalamagkidis K, 2008, PROG AEROSP SCI, V44, P503, DOI 10.1016/j.paerosci.2008.08.001; Duma SM, 2014, J BIOMECH, V47, P1557, DOI 10.1016/j.jbiomech.2013.08.022; Elias B, 2012, PILOTLESS DRONES BAC; Hodgson V. R., 1973, CONCUSSION LEVELS DE, V17; Hodgson V. R., 1970, FRACTURE BEHAV SKULL; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Mertz H. J, 1996, HEAD INJURY RISK ASS; NHTSA, 2012, TRAFF SAF FACTS 2010; Office U. S. G. A., 2015, UNM AER SYST FAA CON; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman E.J., 2003, NEUROSURGERY, V53, P812, DOI [DOI 10.1227/01.N1'17.0000083559.68424.31;, DOI 10.1093/NEUROSURGERY/53.3.799]; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prasad P., 1985, SAE T, V94, P106; Prasad P., 1984, BIOMECHANICAL ANAL H, V28, P25; Ravich T.M., 2009, NDL REV, V85, P597; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sances A, 2002, BIOMED SCI INSTRUM, V38, P459; Walker S W., 2010, INTEGRATING DEP DEFE; Wolf H., 2014, COMP FAA ACTIVITIES, P1	24	21	21	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2017	45	12					2733	2741		10.1007/s10439-017-1921-6			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FN1DS	WOS:000415726200002	28913606	Green Published, hybrid			2022-02-06	
J	Tetlow, AM; Edwards, JD				Tetlow, Amber M.; Edwards, Jerri D.			Systematic Literature Review and Meta-Analysis of Commercially Available Computerized Cognitive Training Among Older Adults	JOURNAL OF COGNITIVE ENHANCEMENT			English	Article						Aging; Cognitive training; Brain fitness; Brain games		Researchers have explored a variety of interventions to improve cognition among older adults. One of which is computerized cognitive training programs. The number of commercially available, cognitive training programs has increased greatly, but scientists debate their value. The purposes of this systematic literature review and meta-analysis were to (1) evaluate the efficacy of commercially available, computerized cognitive training programs to improve cognition in older adults and (2) examine far transfer of training to untrained tasks relevant to everyday functioning. Articles were reviewed if the study (a) included a sample of adults aged 55 and older, (b) used a commercially available, computerized cognitive training program, (c) was a randomized controlled trial, (d) measured cognition as an outcome, and (e) included a sample that was free from health conditions affecting cognitive function (e.g., cancer, stroke, psychiatric conditions, or traumatic brain injury). Effect sizes were calculated using random effect models to determine cognitive training effects for various cognitive domains and far transfer tasks. There were significant small to medium training effects for the cognitive domains of attention (d = 0.651, p < .001), processing speed (d = 0.294, p = .002), and visuospatial memory (d = 0.252, p = 0.016). There was also evidence of far transfer to self-reported measures of everyday function (d = 0.277, p < 0.001). Commercially available computerized cognitive training programs may improve certain cognitive abilities among older adults, who also report improvement on tasks relevant to their everyday lives.	[Tetlow, Amber M.; Edwards, Jerri D.] Univ S Florida, Sch Aging Studies, 13301 Bruce B Downs Blvd,MHC 1300, Tampa, FL 33612 USA		Tetlow, AM (corresponding author), Univ S Florida, Sch Aging Studies, 13301 Bruce B Downs Blvd,MHC 1300, Tampa, FL 33612 USA.	ambertetlow@mail.usf.edu					ABIKOFF H, 1987, J CLIN EXP NEUROPSYC, V9, P435, DOI 10.1080/01688638708405063; Anderson S, 2013, P NATL ACAD SCI USA, V110, P4357, DOI 10.1073/pnas.1213555110; ARENBERG D, 1978, J GERONTOL, V33, P534, DOI 10.1093/geronj/33.4.534; Axelrod Bradley N, 1992, Clin Neuropsychol, V6, P143, DOI 10.1080/13854049208401851; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Ballesteros S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00277; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Berry D.T.R., 1991, CLIN NEUROPSYCHOL, V5, P143, DOI [10.1080/13854049108403298, DOI 10.1080/13854049108403298]; Birren J.E., 1979, BRAIN FUNCTION OLD A, DOI [10.1007/978-3-642-67304-7_3, DOI 10.1007/978-3-642-67304-7_3]; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brehmer Y., 2012, TRAINING INDUCED COG, V72; Brehmer Y, 2011, NEUROIMAGE, V58, P1110, DOI 10.1016/j.neuroimage.2011.06.079; Bridger RS, 2013, ERGONOMICS, V56, P1515, DOI 10.1080/00140139.2013.821172; Buitenweg JIV, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00183; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Centers for Disease Control and Prevention. Trends in aging-United States and worldwide, 2003, MMWR-MORBID MORTAL W, V52, P101; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Cohen J, 1998, STAT POWER ANAL BEHA; Coull JT, 1996, NEUROPSYCHOLOGIA, V34, P1085, DOI 10.1016/0028-3932(96)00029-2; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Deouell LY, 2005, J INT NEUROPSYCH SOC, V11, P697, DOI 10.1017/S13556177050824; Deshpande Prasanna R, 2011, Perspect Clin Res, V2, P137, DOI 10.4103/2229-3485.86879; DIEHL M, 1995, PSYCHOL AGING, V10, P478, DOI 10.1037/0882-7974.10.3.478; Djernes JK, 2006, ACTA PSYCHIAT SCAND, V113, P372, DOI 10.1111/j.1600-0447.2006.00770.x; DUJOVNE BE, 1971, J CLIN PSYCHOL, V27, P351, DOI 10.1002/1097-4679(197107)27:3<351::AID-JCLP2270270313>3.0.CO;2-4; Dulay MF, 2002, CLIN NEUROPSYCHOL, V16, P452, DOI 10.1076/clin.16.4.452.13915; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Edwards J. D., 2013, J GERONTOL B-PSYCHOL; Edwards JD, 2005, J CLIN EXP NEUROPSYC, V27, P529, DOI 10.1080/13803390490515432; Edwards JD, 2005, AGING MENT HEALTH, V9, P262, DOI 10.1080/13607860412331336788; Edwards JD, 2002, GERONTOLOGY, V48, P329, DOI 10.1159/000065259; Ekstrom RB., 1976, MANUAL KIT FACTOR RE; Emery L, 2007, PSYCHOL AGING, V22, P75, DOI 10.1037/0882-7974.22.1.75; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; File T., 2014, COMPUTER INTERNET US; Finn M, 2011, BRAIN IMPAIR, V12, P187; Fowler KS, 2002, J INT NEUROPSYCH SOC, V8, P58, DOI 10.1017/S1355617701020069; Franzen M D, 1987, Arch Clin Neuropsychol, V2, P265, DOI 10.1016/0887-6177(87)90014-X; Gooding AL, 2016, NEUROPSYCHOL REHABIL, V26, P810, DOI 10.1080/09602011.2015.1118389; Greenwood PM, 2016, NEUROPSYCHOLOGY, V30, P742, DOI 10.1037/neu0000235; Groth-Marnat G, 2000, PERCEPT MOTOR SKILL, V90, P522, DOI 10.2466/PMS.90.2.522-526; Haimov I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061390; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Hambrick D. Z., 2014, BRAIN TRAINING DOESN; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Harris Y, 2006, J AM GERIATR SOC, V54, P593, DOI 10.1111/j.1532-5415.2006.00687.x; Heaton RK, 1999, J CLIN EXP NEUROPSYC, V21, P571, DOI 10.1076/jcen.21.4.572.882; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill NTM, 2017, AM J PSYCHIAT, V174, P329, DOI 10.1176/appi.ajp.2016.16030360; Hyer L, 2016, CLIN GERONTOLOGIST, V39, P410, DOI 10.1080/07317115.2015.1120257; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Karbach J, 2009, DEVELOPMENTAL SCI, V12, P978, DOI 10.1111/j.1467-7687.2009.00846.x; Kelly ME, 2014, AGEING RES REV, V15, P28, DOI 10.1016/j.arr.2014.02.004; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Kimbler KJ, 2013, BEHAV SCI-BASEL, V3, P170, DOI 10.3390/bs3010170; LARRABEE GJ, 1983, J CLIN NEUROPSYCHOL, V5, P159, DOI 10.1080/01688638308401162; Lee Y, 2000, J EPIDEMIOL COMMUN H, V54, P123, DOI 10.1136/jech.54.2.123; Lezak MD, 1976, NEUROPSYCHOLOGICAL A; Lo AHY, 2012, J NEUROPSYCHOL, V6, P212, DOI 10.1111/j.1748-6653.2011.02023.x; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; MASUR DM, 1989, J CLIN EXP NEUROPSYC, V11, P615, DOI 10.1080/01688638908400920; Mayas J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092269; MCCARTY SM, 1982, J GERONTOL, V37, P169, DOI 10.1093/geronj/37.2.169; MEFFERD RB, 1966, PSYCHOL REP, V18, P3, DOI 10.2466/pr0.1966.18.1.3; Melby-Lervag M, 2016, PERSPECT PSYCHOL SCI, V11, P512, DOI 10.1177/1745691616635612; Miller KJ, 2013, AM J GERIAT PSYCHIAT, V21, P655, DOI 10.1016/j.jagp.2013.01.077; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; NEWBURGER EC, 2001, HOME COMPUTERS INTER; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; Nieboer A, 2005, SOC INDIC RES, V73, P313, DOI 10.1007/s11205-004-0988-2; O'Brien J, 2011, J VIS, V11, P203, DOI [10.1167/11.11.203, DOI 10.1167/11.11.203]; O'Brien JL, 2013, CLIN NEUROPHYSIOL, V124, P2198, DOI 10.1016/j.clinph.2013.05.012; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; OWEN AM, 1995, NEUROPSYCHOLOGIA, V33, P1, DOI 10.1016/0028-3932(94)00098-A; Owsley C, 2002, GERONTOLOGY, V48, P254, DOI 10.1159/000058360; Park DC, 2014, PSYCHOL SCI, V25, P103, DOI 10.1177/0956797613499592; Peres K, 2008, J AM GERIATR SOC, V56, P37, DOI 10.1111/j.1532-5415.2007.01499.x; Peretz C, 2011, NEUROEPIDEMIOLOGY, V36, P91, DOI 10.1159/000323950; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; Ratner E, 2015, J AM GERIATR SOC, V63, P2614, DOI 10.1111/jgs.2_13825; Raven J, 2000, COGNITIVE PSYCHOL, V41, P1, DOI 10.1006/cogp.1999.0735; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Richardson JTE, 2002, BEHAV RES METH INS C, V34, P69, DOI 10.3758/BF03195425; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Schaie K.W., 1985, MANUAL SCHAIE THURST; Schmiedek F, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00027; Shah T, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.122; Shatil E, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00008; Sheridan LK, 2006, ARCH CLIN NEUROPSYCH, V21, P23, DOI 10.1016/j.acn.2005.07.003; Simons DJ, 2016, PSYCHOL SCI PUBL INT, V17, P103, DOI 10.1177/1529100616661983; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Standford Center on Longevity & Berlin Max Planck Institute for Human Development, 2014, CONS BRAIN TRAIN IND; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Steffens DC, 2006, ARCH GEN PSYCHIAT, V63, P130, DOI 10.1001/archpsyc.63.2.130; Stine-Morrow EAL, 2008, PSYCHOL AGING, V23, P778, DOI 10.1037/a0014341; Strenziok M, 2014, NEUROIMAGE, V85, P1027, DOI 10.1016/j.neuroimage.2013.07.069; Talebi, 2013, INT RES J APPL BASIC, V4, P31, DOI DOI 10.1177/0266242612465454; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Toril P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00206; Tun PA, 1997, J AGING MENTAL HLTH, V18, P47; Uttl B, 2002, ARCH CLIN NEUROPSYCH, V17, P567, DOI 10.1016/S0887-6177(01)00135-4; Valenzuela M, 2009, AM J GERIAT PSYCHIAT, V17, P179, DOI 10.1097/JGP.0b013e3181953b57; Vance D, 2007, REHABIL PSYCHOL, V52, P89, DOI 10.1037/0090-5550.52.1.89; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; WEINBERGER M, 1986, AM J PUBLIC HEALTH, V76, P457, DOI 10.2105/AJPH.76.4.457; Wilde NJ, 2004, J CLIN EXP NEUROPSYC, V26, P539, DOI 10.1080/13803390490496605; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wolinsky FD, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000225; ZELINSKI EM, 2009, NEUROSCIENCE, V27, P455, DOI DOI 10.3233/RNN-2009-0495	127	21	21	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2509-3290	2509-3304		J COGN ENHANCE	J. Cogn. Enhance.	DEC	2017	1	4			SI		559	575		10.1007/s41465-017-0051-2			17	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VJ8HE	WOS:000635180900015					2022-02-06	
J	Peacock, WF; Van Meter, TE; Mirshahi, N; Ferber, K; Gerwien, R; Rao, V; Sair, HI; Diaz-Arrastia, R; Korley, FK				Peacock, W. Frank; Van Meter, Timothy E.; Mirshahi, Nazanin; Ferber, Kyle; Gerwien, Robert; Rao, Vani; Sair, Haris Iqbal; Diaz-Arrastia, Ramon; Korley, Frederick K.			Derivation of a Three Biomarker Panel to improve Diagnosis in Patients with Mild Traumatic Brain injury	FRONTIERS IN NEUROLOGY			English	Article						mild brain injury; mild TBI; biomarker; machine learning; neurogranin; neuron-specific enolase; metallothionein	FIBRILLARY ACIDIC PROTEIN; AMYLOID-BETA; HEAD-INJURY; RECURRENT CONCUSSION; MAGNETIC-RESONANCE; OUTCOME PREDICTION; FOOTBALL PLAYERS; PROGNOSTIC VALUE; AXONAL INJURY; SERUM	Background: Nearly 5 million emergency department (ED) visits for head injury occur each year in the United States, of which <10% of patients show abnormal computed tomography (CT) findings. CT negative patients frequently suffer protracted somatic, behavioral, and neurocognitive dysfunction. Our goal was to evaluate biomarkers to identify mild TBI (mTBI) in patients with suspected head injury. Methods: An observational ED study of head-injured and control patients was conducted at Johns Hopkins University (HeadSMART). Head CT was obtained (ACEP criteria) in patients with Glasgow Coma Scale scores of 13-15 and aged 18-80. Three candidate biomarker proteins, neurogranin (NRGN), neuron-specific enolase (NSE), and metallothionein 3 (MT3), were evaluated by immunoassay (samples <24 h from injury). American Congress of Rehabilitation Medicine (ACRM) criteria were used for diagnosis of mTBI patients for model building. Univariate analysis, logistic regression, and random forest (RF) algorithms were used for data analysis in R. Overall, 662 patients were studied. Statistical models were built using 328 healthy controls and 179 mTBI patients. Results: Median time from injury was 5.9 h (IQR, 4.0; range 0.8-24 h). mTBI patients had elevated NSE, but decreased MT3 versus controls (p < 0.01 for each). NRGN was also elevated but within 2-6 h after injury. In the derivation set, the best model to distinguish mTBI from healthy controls used three markers, age, and sex as covariates (C-statistic = 0.91, sensitivity 98%, specificity 72%). Panel test accuracy was validated with the 155 remaining ACRM+ mTBI patients. Applying the RF model to the ACRM+ mTBI validation set resulted in 78% correctly classified as mTBI (119/153). CT positive and CT negative validation subsets were 91% and 75% correctly classified. In samples taken < 2 h from injury, 100% (10/10) samples classified correctly, indicating that hyperacute testing is possible with these biomarker assays. The model accuracy varied from 72-100% overall, and had greater accuracy with increasing severity, as shown by comparing CT+ with CT-(91% versus 75%), and Injury Severity Score >= 16 versus < 16 (88% versus 72%, respectively). Objective blood tests, detecting NRGN, NSE, and MT3, can be used to identify mTBI, irrespective of neuroimaging findings.	[Peacock, W. Frank] Ben Taub Hosp, Dept Emergency Med, Houston, TX 77030 USA; [Van Meter, Timothy E.; Mirshahi, Nazanin; Ferber, Kyle] ImmunArray Inc, Program Neurol Dis, Richmond, VA USA; [Gerwien, Robert] Gerwien Stat Consulting, Newington, CT USA; [Rao, Vani] Johns Hopkins Bayview Med Ctr, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Sair, Haris Iqbal] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA; [Korley, Frederick K.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA		Peacock, WF (corresponding author), Ben Taub Hosp, Dept Emergency Med, Houston, TX 77030 USA.	william.peacock@bcm.edu			ImmunArray, Inc.	This study was funded by ImmunArray, Inc.	Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Friedland D, 2016, J NEUROL NEUROSUR PS, V87, P1068, DOI 10.1136/jnnp-2015-312193; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kaleka KS, 2016, EXP NEUROL, V277, P115, DOI 10.1016/j.expneurol.2015.12.013; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Kuhn M, 2013, APPL PREDICTIVE MODE, V26; Kurtzke JF, 1993, RINSHO SHINKEIGAKU, V4, P1; Lagares A, 2006, NEUROCIRUGIA, V17, P105; Lange RP, 2014, CANCER INVEST, V32, P423, DOI 10.3109/07357907.2014.933237; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Martinho A, 2010, FEBS J, V277, P3427, DOI 10.1111/j.1742-4658.2010.07749.x; Meric E, 2010, J EMERG MED, V38, P297, DOI 10.1016/j.jemermed.2007.11.032; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Okita Yuho, 2017, Front Neurosci, V11, P114, DOI 10.3389/fnins.2017.00114; PALMITER RD, 1992, P NATL ACAD SCI USA, V89, P6333, DOI 10.1073/pnas.89.14.6333; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Peters ME, 2017, BRAIN INJURY, V31, P370, DOI 10.1080/02699052.2016.1231344; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Rozanski M, 2017, CEREBROVASC DIS, V43, P76, DOI 10.1159/000453460; Rstudio Team, 2016, RSTUDIO INT DEV R; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Sjostedt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130028; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; US EPA, 2000, GUID DAT ASS PRACT M; Wilkinson AA, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0925-6; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yang J, 2015, CLIN BIOCHEM, V48, P843, DOI 10.1016/j.clinbiochem.2015.05.015; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	46	21	21	0	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 30	2017	8								641	10.3389/fneur.2017.00641			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FO1KO	WOS:000416519300003	29250027	Green Published, gold			2022-02-06	
J	Liu, XY; Maurits, NM; Aries, MJH; Czosnyka, M; Ercole, A; Donnelly, J; Cardim, D; Kim, DJ; Dias, C; Cabeleira, M; Smielewski, P				Liu, Xiuyun; Maurits, Natasha M.; Aries, Marcel J. H.; Czosnyka, Marek; Ercole, Ari; Donnelly, Joseph; Cardim, Danilo; Kim, Dong-Joo; Dias, Celeste; Cabeleira, Manuel; Smielewski, Peter			Monitoring of Optimal Cerebral Perfusion Pressure in Traumatic Brain Injured Patients Using a Multi-Window Weighting Algorithm	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; CPPopt; multi-window algorithm; pressure reactivity index; TBI	SEVERE HEAD-INJURY; REACTIVITY; AUTOREGULATION; MANAGEMENT; CHILDREN	Methods to identify an autoregulation guided "optimal'' cerebral perfusion pressure (CPPopt) for traumatic brain injury patients (TBI) have been reported through several studies. An important drawback of existing methodology is that CPPopt can be calculated only in similar to 50-60% of the monitoring time. In this study, we hypothesized that the CPPopt yield and the continuity can be improved significantly through application of a multi-window and weighting calculation algorithm, without adversely affecting preservation of its prognostic value. Data of 526 severe TBI patients admitted between 2003 and 2015 were studied. The multi-window CPPopt calculation was based on automated curve fitting in pressure reactivity index (PRx)-CPP plots using data from 36 increasing length time windows (2-8 h). The resulting matrix of CPPopts was then averaged in a weighted manner. The yield, continuity, and stability of CPPopt were studied. The difference between patients' actual CPP and CPPopt (DCPP) was calculated and the association with outcome was analyzed. Overall, the multi-window method demonstrated more continuous and stable presentation of CPPopt in this cohort. The new method resulted in a mean (+/- SE) CPPopt yield of 94%+/- 2.1%, as opposed to the previous single-window-based CPPopt yield of 51%+/- 0.94%. The stability of CPPopt across the whole monitoring period was significantly improved by using the new algorithm (p < 0.001). The relationship between DCPP according to the multi-window algorithm and outcome was similar to that for CPPopt calculated on the basis of a single window. In conclusion, this study validates the use of a new multi-window and weighting algorithm for significant improvement of CPPopt yield in TBI patients. This methodological improvement is essential for its clinical application in future CPPopt trials.	[Liu, Xiuyun; Aries, Marcel J. H.; Czosnyka, Marek; Ercole, Ari; Donnelly, Joseph; Cardim, Danilo; Cabeleira, Manuel; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab,Dept Clin Neurosci, Hills Rd, Cambridge CB2 0QQ, England; [Maurits, Natasha M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Aries, Marcel J. H.] Maastricht Univ, Med Ctr, Dept Intens Care MJHA, Maastricht, Netherlands; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Kim, Dong-Joo] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Dias, Celeste] San Joao Univ Hosp, Dept Intens Care, Oporto, Portugal		Liu, XY (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab,Dept Clin Neurosci, Hills Rd, Cambridge CB2 0QQ, England.	xl334@cam.ac.uk	Dias, Celeste/AAV-3820-2020; Donnelly, Joseph/N-6803-2019; Dias, Celeste/L-9901-2014; Ercole, Ari/B-6288-2009; Donnelly, Joseph/E-9235-2018; Cardim, Danilo Augusto/B-8447-2012; Liu, Xiuyun/V-4427-2017; Dias, Celeste/AAD-8711-2019	Dias, Celeste/0000-0003-0340-9808; Donnelly, Joseph/0000-0002-6502-8069; Dias, Celeste/0000-0003-0340-9808; Ercole, Ari/0000-0001-8350-8093; Donnelly, Joseph/0000-0002-6502-8069; Cardim, Danilo Augusto/0000-0002-9261-1321; Liu, Xiuyun/0000-0001-9540-4865; Maurits, Natasha/0000-0001-6231-7044	Bill Gates Scholarship (University of Cambridge); Woolf Fisher Trust, New Zealand (Woolf Fisher Scholarship); Cambridge Commonwealth, European AMP; International Trust Scholarship, University of Cambridge; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish	ICM+ Software is licensed by Cambridge Enterprise Ltd., Cambridge, United Kingdom, http://www.neurosurg.cam.ac.uk/icmplus/. Peter Smielewski and Marek Czosnyka have a financial interest in a fraction of the licensing fee. Xiuyun Liu is recipient of a Bill Gates Scholarship (University of Cambridge). Joseph Donnelly is funded by the Woolf Fisher Trust, New Zealand (Woolf Fisher Scholarship). Danilo Cardim is supported by a Cambridge Commonwealth, European & International Trust Scholarship, University of Cambridge. The remaining authors have nothing to disclose.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; JENNETT B, 1975, LANCET, V1, P480; Lang E W, 1995, New Horiz, V3, P400; Lang EW, 2015, J NEUROSURG, V122, P588, DOI 10.3171/2014.10.JNS14602; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Lewis PM, 2015, PEDIATR CRIT CARE ME, V16, P739, DOI 10.1097/PCC.0000000000000471; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	24	21	21	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3081	3088		10.1089/neu.2017.5003			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000003	28486883	Green Submitted			2022-02-06	
J	Wicher, G; Wallenquist, U; Lei, Y; Enoksson, M; Li, XF; Fuchs, B; Abu Hamdeh, S; Marklund, N; Hillered, L; Nilsson, G; Forsberg-Nilsson, K				Wicher, Grzegorz; Wallenquist, Ulrika; Lei, Ying; Enoksson, Mattias; Li, Xiaofei; Fuchs, Barbara; Abu Hamdeh, Sami; Marklund, Niklas; Hillered, Lars; Nilsson, Gunnar; Forsberg-Nilsson, Karin			Interleukin-33 Promotes Recruitment of Microglia/Macrophages in Response to Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						alarmin; glia; microglia; traumatic brain injury; neuroinflammation	INFLAMMATORY RESPONSE; NEUROINTENSIVE CARE; SPINAL-CORD; IL-33; MICRODIALYSIS; EXPRESSION; MACROPHAGES; ACTIVATION; CHEMOKINES; MICROGLIA	Traumatic brain injury (TBI) is a devastating condition, often leading to life-long consequences for patients. Even though modern neurointensive care has improved functional and cognitive outcomes, efficient pharmacological therapies are still lacking. Targeting peripherally derived, or resident inflammatory, cells that are rapid responders to brain injury is promising, but complex, given that the contribution of inflammation to exacerbation versus improved recovery varies with time post-injury. The injury-induced inflammatory response is triggered by release of alarmins, and in the present study we asked whether interleukin-33 (IL-33), an injury-associated nuclear alarmin, is involved in TBI. Here, we used samples from human TBI microdialysate, tissue sections from human TBI, and mouse models of central nervous system injury and found that expression of IL-33 in the brain was elevated from nondetectable levels, reaching a maximum after 72 h in both human samples and mouse models. Astrocytes and oligodendrocytes were the main producers of IL-33. Post-TBI, brains of mice deficient in the IL-33 receptor, ST2, contained fewer microglia/macrophages in the injured region than wild-type mice and had an altered cytokine/chemokine profile in response to injury. These observations indicate that IL-33 plays a role in neuroinflammation with microglia/macrophages being cellular targets for this interleukin post-TBI.	[Wicher, Grzegorz; Wallenquist, Ulrika; Li, Xiaofei; Forsberg-Nilsson, Karin] Uppsala Univ, Rudbeck Lab, Sci Life Lab, Dept Immunol Genet & Pathol, Box 256, S-75185 Uppsala, Sweden; [Lei, Ying; Enoksson, Mattias; Fuchs, Barbara; Nilsson, Gunnar] Karolinska Inst, Immunol & Allergy Unit, Dept Med, Stockholm, Sweden; [Lei, Ying; Enoksson, Mattias; Fuchs, Barbara; Nilsson, Gunnar] Karolinska Univ Hosp, Stockholm, Sweden; [Abu Hamdeh, Sami; Marklund, Niklas; Hillered, Lars] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Li, Xiaofei] Karolinska Inst, Dept Neurosci, Stockholm, Sweden		Wicher, G (corresponding author), Uppsala Univ, Rudbeck Lab, Sci Life Lab, Dept Immunol Genet & Pathol, Box 256, S-75185 Uppsala, Sweden.	Grzegorz.Wicher@igp.uu.se	Forsberg-Nilsson, Karin/D-9604-2019	Forsberg-Nilsson, Karin/0000-0003-0692-6245; Marklund, Niklas/0000-0002-9797-5626; Li, Xiaofei/0000-0002-9991-7534	Swedish Research CouncilSwedish Research CouncilEuropean Commission	This study was supported by grants from the Swedish Research Council.	Akimoto N, 2013, BIOCHEM BIOPH RES CO, V436, P455, DOI 10.1016/j.bbrc.2013.05.126; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chen H, 2015, NEUROSCIENCE, V308, P157, DOI 10.1016/j.neuroscience.2015.09.019; Christophi GP, 2012, CLIN IMMUNOL, V142, P308, DOI 10.1016/j.clim.2011.11.007; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Ekmark-Lewen S, 2010, RESTOR NEUROL NEUROS, V28, P311, DOI 10.3233/RNN-2010-0529; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hudson CA, 2008, J LEUKOCYTE BIOL, V84, P631, DOI 10.1189/jlb.1207830; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Jovanovic IP, 2012, ONCOIMMUNOLOGY, V1, P229, DOI 10.4161/onci.1.2.18131; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Murphy CA, 2002, J IMMUNOL, V169, P7054, DOI 10.4049/jimmunol.169.12.7054; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Wicher G, 2013, NEUROSCI LETT, V555, P171, DOI 10.1016/j.neulet.2013.09.046; Yasuoka S, 2011, BRAIN RES, V1385, P8, DOI 10.1016/j.brainres.2011.02.045	35	21	21	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3173	3182		10.1089/neu.2016.4900			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000013	28490277				2022-02-06	
J	Wright, AD; Smirl, JD; Bryk, K; van Donkelaar, P				Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; van Donkelaar, Paul			A Prospective Transcranial Doppler Ultrasound-Based Evaluation of the Acute and Cumulative Effects of Sport-Related Concussion on Neurovascular Coupling Response Dynamics	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; neurovascular coupling; return-to-play; sport-related concussion; transcranial Doppler ultrasound	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; FOOTBALL PLAYERS; RECOVERY; PERFUSION; EXERCISE; MEMORY; MRI; AUTOREGULATION; ABNORMALITIES	Sport-related concussion has been shown to alter cerebral blood flow (CBF) both acutely and chronically, and may exert cumulative effects across multiple injuries. Such dysfunction may be mediated by trauma-induced deficits to CBF control mechanisms, though our understanding of these effects is limited, including dynamics of neurovascular coupling (NVC) responses (i.e., CBF responses to neurologic demand). A total of 179 junior-level contact sport athletes completed preseason testing; 42 reported never having experienced a concussion (Hx(-)) while 31 had endured three or more (Hx(3+)). A total of 18 athletes suffered concussions during the study period and were re-tested 3 days, 2 weeks, and 1 month post-injury. NVC dynamics were indexed via CBF velocity in the posterior (PCAv) and middle (MCAv) cerebral arteries during cycles of 20 sec eyes closed and 40 sec eyes open to a visual stimulus (reading). Acutely following concussion, peak rate of PCAv increase during the activation phase was delayed by over 50% and PCAv response magnitude was elevated by over 30%, compared with preseason. Response magnitude remained elevated at 2 weeks despite symptom resolution. Independent medical clearance for full return-to-play was inversely related to the magnitude of increase in the NVC response at 3 days post-injury. No post-injury changes were observed in MCAv, blood pressure, or end-tidal carbon dioxide levels during visual stimulation. No NVC metric differences were observed between the Hx-and Hx(3+) groups at preseason. Via multiple potential mechanisms, acute sport-related concussion may induce compensatory alterations in NVC response dynamics that may be related to clinical recovery. Such effects do not appear to be persistent across multiple injuries.	[Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; van Donkelaar, Paul] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Bryk, Kelsey] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA		Wright, AD (corresponding author), Univ British Columbia, Art 180-3333 Univ Way, Kelowna, BC V1V 1V7, Canada.	adwright@alumni.ubc.ca		Smirl, Jonathan/0000-0003-1054-0038	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Canada Foundation for Innovation (CFI)Canada Foundation for Innovation; Mitacs; Vanier Canada Graduate Scholarships program; Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship; Mitacs Accelerate program; Innovations in Wellness fellowship	This research was funded by grants to PvD from the Canadian Institutes for Health Research (CIHR), Canada Foundation for Innovation (CFI), and Mitacs. ADW was supported by the Vanier Canada Graduate Scholarships program and a Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship. JDS was supported by the Mitacs Accelerate program and Innovations in Wellness fellowship.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Azevedo E, 2007, J NEUROL, V254, P236, DOI 10.1007/s00415-006-0338-1; Barlow K., 2016, J NEUROTRAUM, V9, P1; Bishop S, 2017, BRAIN INJURY, P1; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Bryer EJ, 2013, J INT NEUROPSYCH SOC, V19, P751, DOI 10.1017/S1355617713000490; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; Chen BR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000787; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Churchill N., 2016, J NEUROTRAUM, V33, P1; Conroy Deirdre A, 2005, J Circadian Rhythms, V3, P3, DOI 10.1186/1740-3391-3-3; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Elbin RJ, 2012, BRAIN INJURY, V26, P1217, DOI 10.3109/02699052.2012.672788; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ford JH, 2013, J NEUROTRAUM, V30, P1683, DOI 10.1089/neu.2012.2535; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gommer ED, 2014, MED ENG PHYS, V36, P613, DOI 10.1016/j.medengphy.2014.01.006; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Howarth C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00103; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Kostoglou K, 2016, IEEE ENG MED BIO, P696, DOI 10.1109/EMBC.2016.7590797; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2014, J NEUROTRAUM, V31, P189, DOI 10.1089/neu.2013.3069; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Phillips AA, 2016, J CEREBR BLOOD F MET, V36, P647, DOI 10.1177/0271678X15617954; Phillips AA, 2014, J CEREBR BLOOD F MET, V34, P794, DOI 10.1038/jcbfm.2014.3; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rosenegger DG, 2015, MICROCIRCULATION, V22, P197, DOI 10.1111/micc.12184; Rosengarten B, 2003, J NEUROIMAGING, V13, P43, DOI 10.1177/1051228402239716; Rosengarten B, 2001, ULTRASOUND MED BIOL, V27, P1499, DOI 10.1016/S0301-5629(01)00464-1; Saluja RS, 2015, J NEUROTRAUM, V32, P712, DOI 10.1089/neu.2014.3470; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Willie CK, 2011, J NEUROSCI METH, V198, P270, DOI 10.1016/j.jneumeth.2011.03.017; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	61	21	21	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3097	3106		10.1089/neu.2017.5020			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000005	28627298				2022-02-06	
J	Dall'Acqua, P; Johannes, S; Mica, L; Simmen, HP; Glaab, R; Fandino, J; Schwendinger, M; Meier, C; Ulbrich, EJ; Muller, A; Jancke, L; Hanggi, J				Dall'Acqua, Patrizia; Johannes, Sonke; Mica, Ladislav; Simmen, Hans-Peter; Glaab, Richard; Fandino, Javier; Schwendinger, Markus; Meier, Christoph; Ulbrich, Erika Jasmin; Mueller, Andreas; Jancke, Lutz; Hanggi, Jurgen			Prefrontal Cortical Thickening after Mild Traumatic Brain Injury: A One-Year Magnetic Resonance Imaging Study	JOURNAL OF NEUROTRAUMA			English	Article						cortical thickness; group-by-time interaction; longitudinal analysis; mild traumatic brain injury; recovery	GRAY-MATTER ABNORMALITIES; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; LONGITUDINAL CHANGES; THICKNESS; PLASTICITY; VOLUME; SEGMENTATION; ACTIVATION; SYMPTOMS	The objective of this study was to evaluate group-by-time interactions between gray matter morphology of healthy controls and that of patients with mild traumatic brain injury (mTBI) as they transitioned from acute to chronic stages, and to relate these findings to long-term cognitive alterations to identify distinct recovery trajectories between good outcome (GO) and poor outcome (PO). High-resolution T1-weighted magnetic resonance images were acquired in 49 mTBI patients within 7 days and 1 year post-injury and at equivalent times in 49 healthy controls. Using linear mixed-effects models, we performed mass-univariate analyses and associated the results of the interaction with changes in cognitive performance. Morphological alterations indexed by increased or decreased cortical thickness have been expected mainly in frontal, parietal, and temporal brain regions. A significant interaction was found in cortical thickness, spatially restricted to bilateral structures of the prefrontal cortex, showing thickening in mTBI and normal developmental thinning in controls. A discrete thickness increase that can interpreted as the absence of cortical thinning typically seen in the healthy population was associated with cognitive recovery in the GO subgroup, while the exaggerated cortical thickening in the PO patients was linked to worsening cognitive performance. Thickness of the prefrontal cortex is subject to structural alterations during the first year after mTBI. Beside beneficial neuroplasticity, a prolonged state of neuroinflammation for symptomatic patients (maladaptive neuroplasticity) cannot be excluded. If the underlying cellular processes responsible for cortical thickening following mTBI have been determined, brain stimulation or even pharmacological intervention targeting the prefrontal cortex might promote endogenous neural restoration.	[Dall'Acqua, Patrizia; Johannes, Sonke] Bellikon Rehabil Clin, Mutschellenstr 2, CH-5454 Bellikon, Switzerland; [Dall'Acqua, Patrizia; Mueller, Andreas; Jancke, Lutz; Hanggi, Jurgen] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Jancke, Lutz] Univ Zurich, Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland; [Jancke, Lutz] Univ Zurich, Univ Res Prior Program, Dynam Hlth Aging, Zurich, Switzerland; [Mica, Ladislav; Simmen, Hans-Peter] Univ Zurich Hosp, Div Trauma Surg, Zurich, Switzerland; [Ulbrich, Erika Jasmin] Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Glaab, Richard] Kantonsspital Aarau, Dept Traumatol, Aarau, Switzerland; [Fandino, Javier] Kantonsspital Aarau, Dept Neurosurg, Aarau, Switzerland; [Schwendinger, Markus] Baden Cantonal Hosp, Interdisciplinary Emergency Ctr, Baden, Switzerland; [Meier, Christoph] Waid Hosp Zurich, Dept Surg, Zurich, Switzerland; [Mueller, Andreas] Brain & Trauma Fdn Grisons, Chur, Switzerland		Dall'Acqua, P (corresponding author), Bellikon Rehabil Clin, Mutschellenstr 2, CH-5454 Bellikon, Switzerland.	patrizia.dallacqua@rehabellikon.ch		Simmen, Hans-Peter/0000-0002-5201-4549; Hanggi, Jurgen/0000-0001-8124-6018	Research Fund of Swiss Accident (SUVA)	This study was supported by Research Fund of Swiss Accident (SUVA).	Amlien IK, 2016, CEREB CORTEX, V26, P257, DOI 10.1093/cercor/bhu214; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Blakemore SJ, 2012, NEUROIMAGE, V61, P397, DOI 10.1016/j.neuroimage.2011.11.080; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Dennis M, 2013, NEUROSCI BIOBEHAV R, V37, P2760, DOI 10.1016/j.neubiorev.2013.09.010; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Govindarajan K. A., 2016, J NEUROTRAUMA; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Kerr AL, 2011, J COMMUN DISORD, V44, P538, DOI 10.1016/j.jcomdis.2011.04.011; Killgore WDS, 2016, NEUROSCI LETT, V612, P238, DOI 10.1016/j.neulet.2015.12.033; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kolb B, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00015; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Mayer AR, 2015, J NEUROTRAUM, V32, P723, DOI 10.1089/neu.2014.3534; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; Tamnes CK, 2013, NEUROIMAGE, V68, P63, DOI 10.1016/j.neuroimage.2012.11.039; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012; Walhovd K. B., 2016, CEREB CORTEX, P1; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Westlye LT, 2010, NEUROIMAGE, V52, P172, DOI 10.1016/j.neuroimage.2010.03.056; Wierenga LM, 2014, NEUROIMAGE, V87, P120, DOI 10.1016/j.neuroimage.2013.11.010; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	54	21	21	3	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3270	3279		10.1089/neu.2017.5124		OCT 2017	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000414461500001	28847215				2022-02-06	
J	Barbacci, DC; Roux, A; Muller, L; Jackson, SN; Post, J; Baldwin, K; Hoffer, B; Balaban, CD; Schultz, JA; Gouty, S; Cox, BM; Woods, AS				Barbacci, Damon C.; Roux, Aurelie; Muller, Ludovic; Jackson, Shelley N.; Post, Jeremy; Baldwin, Kathrine; Hoffer, Barry; Balaban, Carey D.; Schultz, J. Albert; Gouty, Shawn; Cox, Brian M.; Woods, Amina S.			Mass Spectrometric Imaging of Ceramide Biomarkers Tracks Therapeutic Response in Traumatic Brain Injury	ACS CHEMICAL NEUROSCIENCE			English	Article						Traumatic brain injury; controlled cortical impact; lipids; sphingomyelin; ceramides; mass spectrometry imaging; silver nanoparticles implantation; diffuse axonal injury	EXCITATORY AMINO-ACIDS; FREE FATTY-ACIDS; SPINAL-CORD; RAT-BRAIN; UP-REGULATION; CELL-DEATH; DYNORPHIN; NEUROTOXICITY; MECHANISM; PEPTIDES	Traumatic brain injury (TBI) is a serious public health problem and the leading cause of death in children and young adults. It also contributes to a substantial number of cases of permanent disability. As lipids make up over 50% of the brain mass and play a key role in both membrane structure and cell signaling, their profile is of particular interest. In this study, we show that advanced mass spectrometry imaging (MSI) has sufficient technical accuracy and reproducibility to demonstrate the anatomical distribution of 50 mu m diameter microdomains that show changes in brain ceramide levels in a rat model of controlled cortical impact (CCI) 3 days post injury with and without treatment. Adult male Sprague-Dawley rats received one strike and were euthanized 3 days post trauma. Brain MS images showed increase in ceramides in CCI animals compared to control as well as significant reduction in ceramides in CCI treated animals, demonstrating therapeutic effect of a peptide agonist. The data also suggests the presence of diffuse changes outside of the injured area. These results shed light on the extent of biochemical and structural changes in the brain after traumatic brain injury and could help to evaluate the efficacy of treatments.	[Roux, Aurelie; Muller, Ludovic; Jackson, Shelley N.; Post, Jeremy; Baldwin, Kathrine; Woods, Amina S.] NIH, Struct Biol Unit, Integrat Neurosci Branch, NIDA IRP, Baltimore, MD 21224 USA; [Gouty, Shawn; Cox, Brian M.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Dept Pharmacol, Bethesda, MD 20814 USA; [Barbacci, Damon C.; Schultz, J. Albert] Ionwerks Inc, Houston, TX 77002 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Otolaryngol Neurobiol Commun Sci & Disorders, Pittsburgh, PA 15213 USA; [Balaban, Carey D.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA; [Hoffer, Barry] Univ Hosp Cleveland, Cleveland, OH 44106 USA		Woods, AS (corresponding author), NIH, Struct Biol Unit, Integrat Neurosci Branch, NIDA IRP, Baltimore, MD 21224 USA.		Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844	Department of Defense, Center for Neuroscience and Regenerative Medicine (CNRM), Rockville, MD; National Institute on Drug Abuse, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA); NIH SBIRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R44DA030853-03 5R44DA036263-03]; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000593, ZIADA000594, ZIADA000589, R44DA030853, R44DA036263] Funding Source: NIH RePORTER	This work was supported in part by grants from Department of Defense, Center for Neuroscience and Regenerative Medicine (CNRM), Rockville, MD and the Intramural Research Program of the National Institute on Drug Abuse, NIH. Ionwerks gratefully acknowledges support of this work through NIH SBIR Phase II Grants R44DA030853-03 5R44DA036263-03.	Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Aureli M, 2014, GLYCOCONJUGATE J, V31, P449, DOI 10.1007/s10719-014-9541-y; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BAKSHI R, 1990, J NEUROSCI, V10, P3793, DOI 10.1523/JNEUROSCI.10-12-03793.1990; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; Bjorneras J, 2013, BIOCHEMISTRY-US, V52, P4157, DOI 10.1021/bi4004205; CAUDLE RM, 1988, BRAIN RES, V443, P329, DOI 10.1016/0006-8993(88)91628-9; CONE RI, 1983, J NEUROSCI, V3, P2146; Crowley NA, 2016, CELL REP, V14, P2774, DOI 10.1016/j.celrep.2016.02.069; FADEN AI, 1992, J NEUROSCI, V12, P425; FALLON JH, 1986, J COMP NEUROL, V249, P293, DOI 10.1002/cne.902490302; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hauser KF, 1999, EXP NEUROL, V160, P361, DOI 10.1006/exnr.1999.7235; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; HerreraMarschitz M, 1996, J NEUROCHEM, V66, P1726; Hussain ZM, 2012, J NEUROTRAUM, V29, P1785, DOI 10.1089/neu.2011.2286; Iremonger KJ, 2009, J NEUROSCI, V29, P7349, DOI 10.1523/JNEUROSCI.0381-09.2009; Kim JH, 2011, NEUROSCIENCE, V185, P125, DOI 10.1016/j.neuroscience.2011.04.018; Koetzner L, 2004, J NEUROSCI, V24, P1451, DOI 10.1523/JNEUROSCI.1517-03.2004; Kubota M, 1996, NEUROL RES, V18, P337; Kulkarni M, 2002, J NEUROTRAUM, V19, P965, DOI 10.1089/089771502320317113; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; LEE CH, 1991, J NEUROCHEM, V56, P370, DOI 10.1111/j.1471-4159.1991.tb08161.x; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; Mickley GA, 2006, J AM ASSOC LAB ANIM, V45, P48; Muller L, 2017, J AM SOC MASS SPECTR, V28, P1716, DOI 10.1007/s13361-017-1665-4; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; SKILLING SR, 1992, BRAIN RES, V575, P272, DOI 10.1016/0006-8993(92)90090-V; Solin AV, 2013, B EXP BIOL MED+, V155, P324, DOI 10.1007/s10517-013-2144-y; Sparaco M, 2006, J NEUROSCI RES, V83, P256, DOI 10.1002/jnr.20729; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Tang QB, 2000, J NEUROPHYSIOL, V83, P2610, DOI 10.1152/jn.2000.83.5.2610; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Team RC. R Core Team R, 2016, R LANG ENV STAT COMP; Thon L, 2005, FASEB J, V19, P1945, DOI 10.1096/fj.05-3726com; Tulley JM, 2008, SHOCK, V29, P269, DOI 10.1097/shk.0b013e31811ff60c; WAGNER JJ, 1993, NATURE, V363, P451, DOI 10.1038/363451a0; WANG JQ, 1994, SYNAPSE, V18, P343, DOI 10.1002/syn.890180410; WATSON SJ, 1982, SCIENCE, V218, P1134, DOI 10.1126/science.6128790; Whitehead SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020808; Woodcock J, 2006, IUBMB LIFE, V58, P462, DOI 10.1080/15216540600871118; Woods A, 2001, NEUROCHEM RES, V26, P395, DOI 10.1023/A:1010903215566; Woods AS, 2006, J PROTEOME RES, V5, P1017, DOI 10.1021/pr060016+; Yatsu FM, 1971, STROKE, V2, P587, DOI 10.1161/01.STR.2.6.587; Zhang L, 1997, J NEUROPHYSIOL, V78, P582, DOI 10.1152/jn.1997.78.2.582	55	21	22	1	14	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	OCT	2017	8	10					2266	2274		10.1021/acschemneuro.7b00189			9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	FK4YA	WOS:000413502700021	28745861	Green Accepted			2022-02-06	
J	Gao, L; Smielewski, P; Czosnyka, M; Ercole, A				Gao, Lei; Smielewski, Peter; Czosnyka, Marek; Ercole, Ari			Early Asymmetric Cardio-Cerebral Causality and Outcome after Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						complexity; granger causality; network; outcome; traumatic brain injury	HEART-RATE-VARIABILITY; INTRACRANIAL-PRESSURE; GRANGER CAUSALITY; BAROREFLEX SENSITIVITY; CRITICAL ILLNESS; CONNECTIVITY; COMPLEXITY; DYSFUNCTION; PHYSIOLOGY; NETWORKS	The brain and heart are two vital systems in health and disease, increasingly recognized as a complex, interdependent network with constant information flow in both directions. After severe traumatic brain injury (TBI), the causal, directed interactions between the brain, heart, and autonomic nervous system have not been well established. Novel methods are needed to probe unmeasured, potentially prognostic information in complex biological networks that are not revealed by traditional means. In this study, we examined potential bidirectional causality between intracranial pressure (ICP), mean arterial pressure (MAP), and heart rate (HR) and its relationship to mortality in a 24-h period early post-TBI. We applied Granger causality (GC) analysis to cardio-cerebral monitoring data from 171 severe TBI patients admitted to a single neurocritical care center over a 10-year period. There was significant bidirectional causality between ICP and MAP, MAP and HR, and ICP and HR in the majority of patients (p < 0.01). MAP influenced both ICP and HR to a greater extent (higher GC, p < 0. 00001), but there was no dominant unidirectional causality between ICP and HR (p = 0.85). Those who died had significantly lower GC for ICP causing MAP and HR causing ICP (p = 0.006 and p = 0.004, respectively) and were predictors of mortality independent of age, sex, and traditional intracranial variables (ICP, cerebral perfusion pressure, GCS, and pressure reactivity index). Examining the brain and heart with GC-based features for the first time in severe TBI patients has confirmed strong interdependence and reveals a significant relationship between select causality pairs and mortality. These results support the notion that impaired causal information flow between the cerebrovascular, autonomic, and cardiovascular systems are of central importance in severe TBI.	[Gao, Lei] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA; [Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Div Neurosurg, Cambridge, England; [Ercole, Ari] Univ Cambridge, Dept Anesthesia, Cambridge, England		Gao, L (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA.	lgao4@partners.org	Gao, Lei/AAL-1683-2020; Ercole, Ari/B-6288-2009	Gao, Lei/0000-0003-1476-1460; Ercole, Ari/0000-0001-8350-8093	Academy of Medical SciencesAcademy of Medical Sciences (AMS); MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: researchfish	A.E. acknowledges the financial support of the Academy of Medical Sciences in this work.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrett AB, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041907; Bashan A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1705; Bishop SM, 2012, ANESTHESIOLOGY, V117, P810, DOI 10.1097/ALN.0b013e31826a4aa2; Buchman Timothy G, 2004, Curr Opin Crit Care, V10, P378, DOI 10.1097/01.ccx.0000139369.65817.b6; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Claassen J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149878; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dhamala M, 2008, NEUROIMAGE, V41, P354, DOI 10.1016/j.neuroimage.2008.02.020; Ding M., 2006, HDB TIME SERIES ANAL, V437, P826, DOI DOI 10.1002/9783527609970.CH17; Duggento A, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0185; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Gao L, 2016, J NEUROTRAUM, V33, P2011, DOI 10.1089/neu.2015.4228; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; Henden PL, 2014, J NEUROSURG ANESTH, V26, P50, DOI 10.1097/ANA.0b013e3182a47b62; Hu X, 2007, IEEE T BIO-MED ENG, V54, P1407, DOI 10.1109/TBME.2007.900802; Iberall A.S., 1965, CR2019 NASA; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Jenkins G.E.P.B.G.C.R.G.M., 2008, TIME SERIES ANAL FOR; JENNETT B, 1975, LANCET, V1, P480; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Maeda M, 1998, ACT NEUR S, V71, P293; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Norris PR, 2008, J CRIT CARE, V23, P399, DOI 10.1016/j.jcrc.2007.08.001; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Pollonini L, 2010, BRAIN TOPOGR, V23, P221, DOI 10.1007/s10548-010-0139-9; Porta A, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0517; Porta A, 2012, IEEE T BIO-MED ENG, V59, P832, DOI 10.1109/TBME.2011.2180379; Robinson TG, 1997, STROKE, V28, P1671, DOI 10.1161/01.STR.28.9.1671; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Samuels BC, 2012, INVEST OPHTH VIS SCI, V53, P7328, DOI 10.1167/iovs.12-10632; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Seely AJE, 2000, CRIT CARE MED, V28, P2193, DOI 10.1097/00003246-200007000-00003; Seth A., 2007, SCHOLARPEDIA, V2, P1667, DOI [10.4249/scholarpedia.1667, DOI 10.4249/SCHOLARPEDIA.1667]; Seth AK, 2015, J NEUROSCI, V35, P3293, DOI 10.1523/JNEUROSCI.4399-14.2015; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sykora M, 2016, CRIT CARE MED, V44, P1173, DOI 10.1097/CCM.0000000000001624; Valenza G, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2016.0020; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zouridakis G, 2012, J MECH MED BIOL, V12, DOI 10.1142/S0219519412400064	48	21	21	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2743	2752		10.1089/neu.2016.4787			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700009	28330412	Green Submitted			2022-02-06	
J	Gill, J; Cashion, A; Osier, N; Arcurio, L; Motamedi, V; Dell, KC; Carr, W; Kim, HS; Yun, SJ; Walker, P; Ahlers, S; LoPresti, M; Yarnell, A				Gill, Jessica; Cashion, Ann; Osier, Nicole; Arcurio, Lindsay; Motamedi, Vida; Dell, Kristine C.; Carr, Walter; Kim, Hyung-Suk; Yun, Sijung; Walker, Peter; Ahlers, Stephen; LoPresti, Matthew; Yarnell, Angela			Moderate blast exposure alters gene expression and levels of amyloid precursor protein	NEUROLOGY-GENETICS			English	Article							TRAUMATIC BRAIN-INJURY; AXONAL INJURY; ALZHEIMERS-DISEASE; MESSENGER-RNA; NEUROPROTECTION; MARKER; MODEL	Objective: To explore gene expression after moderate blast exposure (vs baseline) and proteomic changes after moderate- (vs low-) blast exposure.& para;& para;Methods: Military personnel (N = 69) donated blood for quantification of protein level, and peak pressure exposures were detected by helmet sensors before and during a blast training program (10 days total). On day 7, some participants (n = 29) sustained a moderate blast (mean peak pressure = 7.9 psi) and were matched to participants with no/low-blast exposure during the training (n = 40). PAXgene tubes were collected from one training site at baseline and day 10; RNA-sequencing day 10 expression was compared with each participant's own baseline samples to identify genes and pathways differentially expressed in moderate blast-exposed participants. Changes in amyloid precursor protein (APP) from baseline to the day of blast and following 2 days were evaluated. Symptoms were assessed using a self-reported form.& para;& para;Results: We identified 1,803 differentially expressed genes after moderate blast exposure; the most altered network was APP. Significantly reduced levels of peripheral APP were detected the day after the moderate blast exposure and the following day. Protein concentrations correlated with the magnitude of the moderate blast exposure on days 8 and 9. APP concentrations returned to baseline levels 3 days following the blast, likely due to increases in the genetic expression of APP. Onset of concentration problems and headaches occurred after moderate blast.& para;& para;Conclusions: Moderate blast exposure results in a signature biological profile that includes acute APP reductions, followed by genetic expression increases and normalization of APP levels; these changes likely influence neuronal recovery.	[Gill, Jessica] Uniformed Serv Univ Hlth Sci, Intramural Res Program, CNRM Co Director Biomarkers Core, Bethesda, MD 20814 USA; [Cashion, Ann; Osier, Nicole; Arcurio, Lindsay; Motamedi, Vida; Kim, Hyung-Suk; Yun, Sijung] NINR, NIH, Bethesda, MD 20892 USA; [Dell, Kristine C.; LoPresti, Matthew; Yarnell, Angela] Walter Reed Army Inst Res, Silver Spring, MD USA; [Carr, Walter] Army Med Res & Mat Command, Ft Detrick, MD USA; [Walker, Peter; Ahlers, Stephen] Naval Med Res Ctr, Silver Spring, MD USA		Gill, J (corresponding author), Uniformed Serv Univ Hlth Sci, Intramural Res Program, CNRM Co Director Biomarkers Core, Bethesda, MD 20814 USA.	gillj@mail.nih.gov	Osier, Nicole/Q-7913-2017; Gill, Gill M/Q-2020-2017	Osier, Nicole/0000-0002-2903-6774; 	U.S. Navy Bureau of Medicine and Surgery [WUN 603115HP.2380.001.A1304]; National Institutes of Health, Intramural Department of ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000015, ZIANR000030] Funding Source: NIH RePORTER	This study was funded by the National Institutes of Health, Intramural Department of Research, and the U.S. Army Medical Research and Materiel Command and the U.S. Navy Bureau of Medicine and Surgery (WUN 603115HP.2380.001.A1304).	Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Cartagena CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158576; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; del Mar N, 2015, EXP NEUROL, V271, P53, DOI 10.1016/j.expneurol.2015.04.023; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Jiang SD, 2003, AM J MED GENET B, V118B, P99, DOI 10.1002/ajmg.b.10067; Kallakuri S, 2015, J NEUROSCI RURAL PRA, V6, P481, DOI 10.4103/0976-3147.169767; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Livingston WS, 2017, J NEUROTRAUM, V34, P853, DOI 10.1089/neu.2016.4479; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Niederwolfsgruber E, 1998, J GERONTOL A-BIOL, V53, pB186, DOI 10.1093/gerona/53A.3.B186; Padovani A, 2001, NEUROLOGY, V57, P2243, DOI 10.1212/WNL.57.12.2243; Perez-Barcena J, 2008, EUR J ANAESTH, V25, P4; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Shi C, 2014, J STEROID BIOCHEM, V144, P280, DOI 10.1016/j.jsbmb.2014.06.010; SMALL DH, 1994, J NEUROSCI, V14, P2117; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thelin EP, BEHAV BRAIN RES; Van den Heuvel C, 2000, J CLIN NEUROSCI, V7, P140; Verma SK, 2015, NMR BIOMED, V28, P1069, DOI 10.1002/nbm.3351; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f	28	21	21	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2376-7839			NEUROL-GENET	Neurol.-Genet.	OCT	2017	3	5							e186	10.1212/NXG.0000000000000186			9	Genetics & Heredity; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Neurosciences & Neurology	FW1BY	WOS:000425031500010	28975156	Green Published, gold			2022-02-06	
J	Giuliano, S; Talarico, S; Bruno, L; Nicoletti, FB; Ceccotti, C; Belfiore, A				Giuliano, Stefania; Talarico, Serafina; Bruno, Lucia; Nicoletti, Francesco Beniamino; Ceccotti, Claudio; Belfiore, Antonino			Growth hormone deficiency and hypopituitarism in adults after complicated mild traumatic brain injury	ENDOCRINE			English	Article						Growth hormone deficiency in adults; Hypopituitarism; Complicated mild traumatic brain injury; GHD; Cardiovascular risk	ANTERIOR-PITUITARY FUNCTION; QUALITY-OF-LIFE; GH DEFICIENCY; METABOLIC SYNDROME; CARDIOVASCULAR RISK; LIPID PROFILE; LONG-TERM; PREVALENCE; REPLACEMENT; DYSFUNCTION	Traumatic brain injury is considered the main cause of hypopituitarism in adults, and GH deficiency appears to be the most frequent pituitary deficit. Most of the available studies have included all degrees of severity of trauma. We aimed to assess pituitary function and GH deficiency in adult patients at different time lengths after complicated mild TBI according to Glasgow Coma Scale. We also aimed to evaluate whether mild TBI patients with GH deficiency had developed alterations in the glycolipid profile. Forty-eight patients (34 men and 14 women) with complicated mild TBI were included in the study. Twenty-three patients were evaluated at 1 year (Group A) and 25 patients at 5 years or longer after the injury (Group B). All patients underwent basal hormonal evaluation for pituitary function. GH deficiency was investigated by the combined test (GH releasing hormone + arginine). The glycolipid profile was also evaluated. GH deficiency occurred in 8/23 patients (34.7 %) of Group A and in 12/25 patients (48 %) of Group B. In addition, two patients, one in each group, showed evidence of central hypothyroidism. Patients with GH deficiency, especially in Group A, presented a higher frequency of visceral adiposity and adverse metabolic profile as compared to no-GH deficiency patients. Patients examined at 1 year or several years from complicated mild TBI had a similarly high occurrence of isolated GH deficiency, which was associated with visceral adiposity and metabolic alterations. Our findings suggest that patients undergone complicated mild TBI should be evaluated for GH deficiency even after several years from trauma.	[Giuliano, Stefania; Talarico, Serafina; Bruno, Lucia; Nicoletti, Francesco Beniamino; Ceccotti, Claudio; Belfiore, Antonino] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Endocrinol, Campus Univ,Viale Europa, I-88100 Catanzaro, Italy; [Nicoletti, Francesco Beniamino; Ceccotti, Claudio] Pugliese Ciaccio Hosp, Neurosurg Unit, Catanzaro, Italy		Belfiore, A (corresponding author), Magna Graecia Univ Catanzaro, Dept Hlth Sci, Endocrinol, Campus Univ,Viale Europa, I-88100 Catanzaro, Italy.	belfiore@unicz.it	Belfiore, Antonino/B-4652-2011	Belfiore, Antonino/0000-0002-6181-4193	Associazione Italiana per la Ricerca sul Cancro (AIRC)Fondazione AIRC per la ricerca sul cancro [IG 14066/2013]; Merck-SeronoMerck & Company	This work was supported in part by grant IG 14066/2013 to AB from the Associazione Italiana per la Ricerca sul Cancro (AIRC). SG has received financial support for educational programs from Merck-Serono.	Abdu TAM, 2001, CLIN ENDOCRINOL, V55, P209, DOI 10.1046/j.1365-2265.2001.01320.x; Abs R, 2013, EUR J ENDOCRINOL, V168, P297, DOI 10.1530/EJE-12-0807; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Amato MC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/730827; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Bondanelli M, 2010, J CLIN ENDOCR METAB, V95, P4660, DOI 10.1210/jc.2010-0611; Charmandari E, 2014, LANCET, V383, P2152, DOI 10.1016/S0140-6736(13)61684-0; Chaves VE, 2013, ENDOCRINE, V44, P293, DOI 10.1007/s12020-013-9904-3; Colao A, 2002, J CLIN ENDOCR METAB, V87, P1088, DOI 10.1210/jc.87.3.1088; Corneli G, 2007, EUR J ENDOCRINOL, V157, P701, DOI 10.1530/EJE-07-0384; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Di Somma C, 2010, J ENDOCRINOL INVEST, V33, P171, DOI [10.1007/BF03346577, 10.3275/6519]; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Giovannini L, 2015, ENDOCR J, V62, P1037, DOI 10.1507/endocrj.EJ15-0337; Gola M, 2005, J CLIN ENDOCR METAB, V90, P1864, DOI 10.1210/jc.2004-0545; Gotherstrom G, 2007, J CLIN ENDOCR METAB, V92, P1442, DOI 10.1210/jc.2006-1487; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kelestimur F, 2004, J ENDOCRINOL INVEST, V27, pRC28, DOI 10.1007/BF03345299; Kelestimur Fahrettin, 2005, Pituitary, V8, P259, DOI 10.1007/s11102-006-6051-3; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Kreber LA, 2016, J NEUROTRAUM, V33, P1607, DOI 10.1089/neu.2015.4127; Lamberts SWJ, 1998, LANCET, V352, P127; Lissett CA, 2003, CLIN ENDOCRINOL, V59, P773, DOI 10.1046/j.1365-2265.2003.01884.x; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Prodam F, 2013, GROWTH HORM IGF RES, V23, P109, DOI 10.1016/j.ghir.2013.04.001; Reimunde P, 2011, BRAIN INJURY, V25, P65, DOI 10.3109/02699052.2010.536196; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Rizzo M, 2007, EUR J ENDOCRINOL, V156, P361, DOI 10.1530/EJE-06-0652; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2010, PITUITARY, V13, P111, DOI 10.1007/s11102-009-0204-0; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; TEASDALE G, 1974, LANCET, V2, P81; van der Klaauw AA, 2007, EUR J ENDOCRINOL, V156, P455, DOI 10.1530/EJE-06-0699; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuen KCJ, 2016, ENDOCR PRACT, V22, P1235, DOI 10.4158/EP161407.DSCR	52	21	23	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1355-008X	1559-0100		ENDOCRINE	Endocrine	OCT	2017	58	1					115	123		10.1007/s12020-016-1183-3			9	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	FI0AH	WOS:000411580300015	27878771				2022-02-06	
J	Jin, X; Feng, ZY; Mika, V; Li, HY; Viano, DC; Yang, KH				Jin, Xin; Feng, Zhaoying; Mika, Valerie; Li, Haiyan; Viano, David C.; Yang, King H.			The Role of Neck Muscle Activities on the Risk of Mild Traumatic Brain Injury in American Football	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						active muscle response; concussion; neck strength; finite element method	SEGMENT DYNAMIC STABILIZATION; PROFESSIONAL FOOTBALL; HEAD; CONCUSSION; ACCELERATION; BIOMECHANICS; STRENGTH; PLAYERS	Concussion, or mild traumatic brain injury (mTBI), is frequently associated with sports activities. It has generally been accepted that neck strengthening exercises are effective as a preventive strategy for reducing sports-related concussion risks. However, the interpretation of the link between neck strength and concussion risks remains unclear. In this study, a typical helmeted head-to-head impact in American football was simulated using the head and neck complex finite element (FE) model. The impact scenario selected was previously reported in lab-controlled incident reconstructions from high-speed video footages of the National Football League using two head-neck complexes taken from Hybrid III dummies. Four different muscle activation strategies were designed to represent no muscle response, a reactive muscle response, a pre-activation response, and response due to stronger muscle strength. Head kinematics and various head/brain injury risk predictors were selected as response variables to compare the effects of neck muscles on the risk of sustaining the concussion. Simulation results indicated that active responses of neck muscles could effectively reduce the risk of brain injury. Also, anticipatory muscle activation played a dominant role on impact outcomes. Increased neck strength can decrease the time to compress the neck and its effects on reducing brain injury risks need to be further studied.	[Jin, Xin; Feng, Zhaoying; Mika, Valerie; Li, Haiyan; Viano, David C.; Yang, King H.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [Li, Haiyan] Tianjin Univ Sci & Technol, Coll Mech Engn, Tianjin 300222, Peoples R China; [Viano, David C.] Probiomech LLC, Bloomfield Hills, MI 48304 USA		Jin, X (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA.		Mika, Valerie H./AAO-2816-2020		Bioengineering Center, Wayne State University	This study was funded in part by the Bioengineering Center, Wayne State University. The authors also like to show our great appreciation to the Global Human Body Modeling Consortium for providing the whole body model for use in the current study.	Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Conley MS, 1997, J APPL PHYSIOL, V83, P2105, DOI 10.1152/jappl.1997.83.6.2105; Cross KM, 2003, CLIN SPORT MED, V22, P639, DOI 10.1016/S0278-5919(02)00099-6; Delaney Tim, 2015, SOCIOLOGY SPORTS INT, V2nd; Faul M., 2010, CTR DIS CONTR PREV; Fice J. B., 2010, THESIS; Fung Y. C., 1993, BIOMECHANICS MECH PR; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; Holbourn AHS, 1943, LANCET, V2, P438; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Mansell J, 2005, J ATHL TRAINING, V40, P310; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Salmon DM, 2011, AVIAT SPACE ENVIR MD, V82, P978, DOI 10.3357/ASEM.2841.2011; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; van der Horst M, 1997, 973346 SAE; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Zhang L., 2003, IRCOBI C LISB PORT S, P27	24	21	21	0	23	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	OCT	2017	139	10							101002	10.1115/1.4037399			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FK3OU	WOS:000413396200002	28753688				2022-02-06	
J	Kochanek, PM; Wallisch, JS; Bayir, H; Clark, RSB				Kochanek, Patrick M.; Wallisch, Jessica S.; Bayir, Hulya; Clark, Robert S. B.			Pre-clinical models in pediatric traumatic brain injury-challenges and lessons learned	CHILDS NERVOUS SYSTEM			English	Article						Head trauma; Developmental; Immature; Abusive head trauma; Shaken baby syndrome	CONTROLLED CORTICAL IMPACT; SHAKEN BABY SYNDROME; CLOSED-HEAD INJURY; WHITE-MATTER INJURY; INFANT RAT MODEL; AXONAL INJURY; IMMATURE RATS; CALPAIN ACTIVATION; NEONATAL PIG; CHILDREN	Despite the enormity of the problem and the lack of new therapies, research in the pre-clinical arena specifically using pediatric traumatic brain injury (TBI) models is limited. In this review, some of the key models addressing both the age spectrum of pediatric TBI and its unique injury mechanisms will be highlighted. Four topics will be addressed, namely, (1) unique facets of the developing brain important to TBI model development, (2) a description of some of the most commonly used pre-clinical models of severe pediatric TBI including work in both rodents and large animals, (3) a description of the pediatric models of mild TBI and repetitive mild TBI that are relatively new, and finally (4) a discussion of challenges, gaps, and potential future directions to further advance work in pediatric TBI models. This narrative review on the topic of pediatric TBI models was based on review of PUBMED/Medline along with a synthesis of information on key factors in pre-clinical and clinical developmental brain injury that influence TBI modeling. In the contemporary literature, six types of models have been used in rats including weight drop, fluid percussion injury (FPI), impact acceleration, controlled cortical impact (CCI), mechanical shaking, and closed head modifications of CCI. In mice, studies are largely restricted to CCI. In large animals, FPI and rotational injury have been used in piglets and shake injury has also been used in lambs. Most of the studies have been in severe injury models, although more recently, studies have begun to explore mild and repetitive mild injuries to study concussion. Given the emerging importance of TBI in infants and children, the morbidity and mortality that is produced, along with its purported link to the development of chronic neurodegenerative diseases, studies in these models merit greater systematic investigations along with consortium-type approaches and long-term follow-up to translate new therapies to the bedside.	[Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Crit Care Med,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Anesthesiol,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Pediat,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Bioengn,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Clin & Translat Sci,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Wallisch, Jessica S.; Bayir, Hulya; Clark, Robert S. B.] UPMC, Safar Ctr Resuscitat Res, Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Wallisch, Jessica S.; Bayir, Hulya; Clark, Robert S. B.] Univ Pittsburgh, Dept Crit Care Med, Sch Med, 3550 Terrace St,Scaife Hall, Pittsburgh, PA 15261 USA; [Bayir, Hulya; Clark, Robert S. B.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, UPMC,Sch Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Bayir, Hulya] Univ Pittsburgh, Pittsburgh Ctr Free Rad & Antioxidant Hlth, Sch Med, 100 Technol Dr, Pittsburgh, PA 15219 USA		Kochanek, PM (corresponding author), UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Crit Care Med,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kochanek, PM (corresponding author), UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Anesthesiol,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kochanek, PM (corresponding author), UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Pediat,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kochanek, PM (corresponding author), UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Bioengn,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kochanek, PM (corresponding author), UPMC, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Dept Clin & Translat Sci,Safar Ctr Resuscitat Res, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	kochanekpm@ccm.upmc.edu; jessica.wallisch@chp.edu; bayihx@ccm.upmc.edu; clarkrs@ccm.upmc.edu		Wallisch, Jessica/0000-0002-7908-9479	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040686]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER	We thank NICHD T32 HD040686 for the support (JW).	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Anderson RWG, 2014, J BIOMECH, V47, P2578, DOI 10.1016/j.jbiomech.2014.06.002; Armstead WM, 2016, PEDIATR CRIT CARE ME, V17, pe130, DOI 10.1097/PCC.0000000000000603; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Bittigau P, 2003, NEUROTOX RES, V5, P475, DOI 10.1007/BF03033158; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bonnier C, 2002, BRAIN PATHOL, V12, P320; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; CORDOBES F, 1987, CHILD NERV SYST, V3, P235, DOI 10.1007/BF00274055; Curvello V, 2017, PEDIATR RES, V82, P108, DOI 10.1038/pr.2017.83; DAIL WG, 1981, BRAIN RES, V211, P79, DOI 10.1016/0006-8993(81)90068-8; DiLeonardi AM, 2012, J NEUROPATH EXP NEUR, V71, P959, DOI 10.1097/NEN.0b013e31826f5876; Ditelberg JS, 1996, PEDIATR RES, V39, P204, DOI 10.1203/00006450-199602000-00003; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dutschke JK, 2017, APPL IMMUNOHISTO M M, V25, P277, DOI 10.1097/PAI.0000000000000273; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Finnie JW, 2012, J CLIN NEUROSCI, V19, P1159, DOI 10.1016/j.jocn.2011.12.019; Follett PL, 2004, J NEUROSCI, V24, P4412, DOI 10.1523/JNEUROSCI.0477-04.2004; Friess SH, 2007, EXP NEUROL, V204, P234, DOI 10.1016/j.expneurol.2006.10.010; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; GRUNDL PD, 1994, J NEUROTRAUM, V11, P135, DOI 10.1089/neu.1994.11.135; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Hanlon LA, 2017, EXP NEUROL, V290, P1, DOI 10.1016/j.expneurol.2016.12.010; Hanlon LA, 2016, J NEUROPATH EXP NEUR, V75, P214, DOI 10.1093/jnen/nlv021; Hays SR, 2011, CURR NEUROL NEUROSCI, V11, P205, DOI 10.1007/s11910-010-0177-4; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Huh JW, 2006, DEV NEUROSCI-BASEL, V28, P466, DOI 10.1159/000094172; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Jenkins LW, 2016, ROGERS TXB PEDIAT IN, P861; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kochanek P.M., 2011, YOUMANS NEUROLOGICAL, P3300; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kochanek PM, 2015, CRIT CARE MED, V43, P1544, DOI 10.1097/CCM.0000000000001041; Mansfield RT, 1996, J CEREBR BLOOD F MET, V16, P244, DOI 10.1097/00004647-199603000-00009; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prins ML, 2003, DEV BRAIN RES, V140, P93, DOI 10.1016/S0165-3806(02)00588-6; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Robertson CL, 2004, DEV BRAIN RES, V151, P141, DOI 10.1016/j.devbrainres.2004.04.007; Robertson CL, 2015, J BIOENERG BIOMEMBR, V47, P43, DOI 10.1007/s10863-014-9585-5; Sandoz B, 2012, Comput Methods Biomech Biomed Engin, V15 Suppl 1, P293; Shein SL, 2016, PEDIATR CRIT CARE ME, V17, P236, DOI 10.1097/PCC.0000000000000610; Sifringer M, 2007, NEUROBIOL DIS, V25, P614, DOI 10.1016/j.nbd.2006.11.003; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Smith SL, 1998, J NEUROTRAUM, V15, P707, DOI 10.1089/neu.1998.15.707; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Zhou C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3146814; Zou XJ, 2011, NEUROTOXICOL TERATOL, V33, P592, DOI 10.1016/j.ntt.2011.06.003	75	21	21	1	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1693	1701		10.1007/s00381-017-3474-2			9	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900012	29149385	Green Accepted			2022-02-06	
J	Resch, JE; Rach, A; Walton, S; Broshek, DK				Resch, Jacob E.; Rach, Amanda; Walton, Samuel; Broshek, Donna K.			Sport Concussion and the Female Athlete	CLINICS IN SPORTS MEDICINE			English	Article						Neurocognitive; Hormone; Concussion; Sex differences	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; KING-DEVICK TEST; COMPUTERIZED NEUROPSYCHOLOGICAL ASSESSMENT; NEUROCOGNITIVE ASSESSMENT TOOLS; 4TH INTERNATIONAL-CONFERENCE; ERROR SCORING SYSTEM; STATES HIGH-SCHOOL; BASE-LINE; SEX-DIFFERENCES	Sport concussion (SC) has emerged as a major health concern in the medical community and general public owing to increased research and media attention, which has primarily focused on male athletes. Female athletes have an equal, if not increased, susceptibility to SC. An ever-growing body of research continues to compare male and female athletes in terms of SC before and after an injury. Clinicians must be cognizant of this literature to make evidence-based clinical decisions when providing care to female athletes and discern between dated and/or unsupported claims in terms of SC.	[Resch, Jacob E.; Walton, Samuel] Univ Virginia, Dept Kinesiol, 210 Emmet St South, Charlottesville, VA 22904 USA; [Rach, Amanda; Broshek, Donna K.] Univ Virginia, Sch Med, Dept Psychiat & Neurobehav Sci, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA		Resch, JE (corresponding author), Univ Virginia, Dept Kinesiol, 210 Emmet St South, Charlottesville, VA 22904 USA.	jer6x@virginia.edu	Broshek, Donna/ABA-4208-2021	Broshek, Donna/0000-0002-7175-7815; Walton, Samuel/0000-0003-2647-5701			Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; [Anonymous], 2016, INT CONS C CONC SPOR; Arnett P, 2016, SPORTS MED ARTHROSC, V24, P116, DOI 10.1097/JSA.0000000000000123; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown CN, 2007, J ATHL TRAINING, V42, P515; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Cegalis JA, 1991, SOFTWARE TESTING CON; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; De Marco AP, 2016, J CHILD NEUROL, V31, P68, DOI 10.1177/0883073814559645; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; DeMatteo C, 2015, CLIN PEDIATR, V54, P783, DOI 10.1177/0009922814567305; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Fedor A, 2016, APPL NEUROPSYCH-CHIL, V5, P107, DOI 10.1080/21622965.2014.999770; Ferrara Michael S., 2001, J Athl Train, V36, P145; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heinmiller L, 2016, CURR OPIN OPHTHALMOL, V27, P407, DOI 10.1097/ICU.0000000000000296; Horan Lindsay A, 2015, Am Orthopt J, V65, P99, DOI 10.3368/aoj.65.1.99; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King H, 2015, J PHYS ACT HEALTH, V12, P1162, DOI 10.1123/jpah.2014-0356; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mihalik JP, 2009, J SCI MED SPORT, V12, P383, DOI 10.1016/j.jsams.2008.05.003; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MOLLERNIELSEN J, 1989, MED SCI SPORT EXER, V21, P126; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Norman AW, 1997, HORMONES; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Popovic V, 2005, GROWTH HORM IGF RES, V15, P177, DOI 10.1016/j.ghir.2005.02.003; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Randolph C, 2005, J ATHL TRAINING, V40, P139; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Reeser JC, 2015, SPORTS HEALTH, V7, P504, DOI 10.1177/1941738115600143; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Resch JE, 2015, J CHILD NEUROL, V30, P1686, DOI 10.1177/0883073815574335; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Sandel NK, 2017, AM J SPORT MED, V45, P937, DOI 10.1177/0363546516677246; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Scheiman M, 2005, OPTOMETRY VISION SCI, V82, P583, DOI 10.1097/01.opx.0000171331.36871.2f; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneider M, 2008, CLIN ENDOCRINOL, V68, P206, DOI 10.1111/j.1365-2265.2007.03020.x; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; Smith A., 1982, SYMBOL DIGIT MODALIT; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Spreen O, 2006, COMPENDIUM NEUROPSYC; Tanriverdi F, 2015, NEUROPSYCH DIS TREAT, V11, P1835, DOI 10.2147/NDT.S65814; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Viano D. C., 1999, J CRASH PREVENTION I, V1, P35; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Walsh DV, 2016, J NEUROL SCI, V370, P305, DOI 10.1016/j.jns.2016.09.014; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wechlser D., 1997, WECHSLER ADULT INTEL; Wilkins SA, 2014, J NEUROSURG-PEDIATR, V13, P82, DOI 10.3171/2013.10.PEDS13241; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yardt EE, 2008, AM J SPORT MED, V36, P57, DOI 10.1177/0363546507307507; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2014, J NEUROSURG-PEDIATR, V13, P72, DOI 10.3171/2013.9.PEDS13257	159	21	21	0	36	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-5919	1556-228X		CLIN SPORT MED	Clin. Sports Med.	OCT	2017	36	4					717	739		10.1016/j.csm.2017.05.002			23	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FI7CU	WOS:000412154500010	28886824				2022-02-06	
J	Pakkanen, T; Kamarainen, A; Huhtala, H; Silfvast, T; Nurmi, J; Virkkunen, I; Yli-Hankala, A				Pakkanen, Toni; Kamarainen, Antti; Huhtala, Heini; Silfvast, Tom; Nurmi, Jouni; Virkkunen, Ilkka; Yli-Hankala, Arvi			Physician-staffed helicopter emergency medical service has a beneficial impact on the incidence of prehospital hypoxia and secured airways on patients with severe traumatic brain injury	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Prehospital emergency care (MeSH); Emergency medical services (MeSH); Critical care (MeSH); Traumatic brain injury (MeSH); Airway management (MeSH); Endotracheal intubation (MeSH); Patient outcome assessment (MeSH); Glasgow outcome scale (MeSH)	SEVERE HEAD-INJURY; RAPID-SEQUENCE INTUBATION; PRACTICAL SCALE; SURVIVAL; MORTALITY; MANAGEMENT	Background: After traumatic brain injury (TBI), hypotension, hypoxia and hypercapnia have been shown to result in secondary brain injury that can lead to increased mortality and disability. Effective prehospital assessment and treatment by emergency medical service (EMS) is considered essential for favourable outcome. The aim of this study was to evaluate the effect of a physician-staffed helicopter emergency medical service (HEMS) in the treatment of TBI patients. Methods: This was a retrospective cohort study. Prehospital data from two periods were collected: before (EMS group) and after (HEMS group) the implementation of a physician-staffed HEMS. Unconscious prehospital patients due to severe TBI were included in the study. Unconsciousness was defined as a Glasgow coma scale (GCS) score <= 8 and was documented either on-scene, during transportation or by an on-call neurosurgeon on hospital admission. Modified Glasgow Outcome Score (GOS) was used for assessment of six-month neurological outcome and good neurological outcome was defined as GOS 4-5. Results: Data from 181 patients in the EMS group and 85 patients in the HEMS group were available for neurological outcome analyses. The baseline characteristics and the first recorded vital signs of the two cohorts were similar. Good neurological outcome was more frequent in the HEMS group; 42% of the HEMS managed patients and 28% (p = 0.022) of the EMS managed patients had a good neurological recovery. The airway was more frequently secured in the HEMS group (p < 0.001). On arrival at the emergency department, the patients in the HEMS group were less often hypoxic (p = 0.024). In univariate analysis HEMS period, lower age and secured airway were associated with good neurological outcome. Conclusion: The introduction of a physician-staffed HEMS unit resulted in decreased incidence of prehospital hypoxia and increased the number of secured airways. This may have contributed to the observed improved neurological outcome during the HEMS period.	[Pakkanen, Toni; Virkkunen, Ilkka] FinnHEMS Ltd, Res & Dev Unit, Vantaa, Finland; [Pakkanen, Toni; Yli-Hankala, Arvi] Tampere Univ Hosp, Dept Anaesthesia, Tampere, Finland; [Kamarainen, Antti] Tampere Univ Hosp, FinnHEMS 30, Tays Emergency Med Serv, Tampere, Finland; [Huhtala, Heini] Univ Tampere, Fac Social Sci, Tampere, Finland; [Silfvast, Tom] Univ Helsinki, Helsinki Univ Hosp, Dept Anaesthesia & Intens Care, Helsinki, Finland; [Nurmi, Jouni] Helsinki Univ Hosp, Dept Emergency Med & Serv, Helsinki, Finland; [Nurmi, Jouni] Univ Helsinki, Emergency Med, Helsinki, Finland; [Yli-Hankala, Arvi] Univ Tampere, Fac Med & Life Sci, Tampere, Finland		Pakkanen, T (corresponding author), FinnHEMS Ltd, Res & Dev Unit, Vantaa, Finland.; Pakkanen, T (corresponding author), Tampere Univ Hosp, Dept Anaesthesia, Tampere, Finland.	toni.pakkanen@fimnet.fi		Yli-Hankala, Arvi/0000-0002-5029-9181	FinnHEMS ltd, Research and Development Unit	This study was supported by a study grant from FinnHEMS ltd, Research and Development Unit.	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Botker MT, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-12; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Frankema SPG, 2004, BRIT J SURG, V91, P1520, DOI 10.1002/bjs.4756; Garner A, 1999, AUST NZ J SURG, V69, P697, DOI 10.1046/j.1440-1622.1999.01688.x; Haltmeier T, 2016, EUR J TRAUMA EMERG S; Iirola TT, 2006, EUR J EMERG MED, V13, P335, DOI 10.1097/01.mej.0000224429.51623.fb; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; NICHOLL JP, 1995, BRIT MED J, V311, P217, DOI 10.1136/bmj.311.6999.217; Pakkanen T, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0256-x; Ringburg Akkie N, 2009, Air Med J, V28, P298, DOI 10.1016/j.amj.2009.03.007; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Traumatic Brain Injury, TRAUM BRAIN INJ ONL; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008	25	21	21	1	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	SEP 15	2017	25								94	10.1186/s13049-017-0438-1			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FH1UY	WOS:000410926400001	28915898	Green Published, gold			2022-02-06	
J	Mulherkar, S; Firozi, K; Huang, W; Uddin, MD; Grill, RJ; Costa-Mattioli, M; Robertson, C; Tolias, KF				Mulherkar, Shalaka; Firozi, Karen; Huang, Wei; Uddin, Mohammad Danish; Grill, Raymond J.; Costa-Mattioli, Mauro; Robertson, Claudia; Tolias, Kimberley F.			RhoA-ROCK Inhibition Reverses Synaptic Remodeling and Motor and Cognitive Deficits Caused by Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; KINASE INHIBITOR; DENDRITIC SPINES; DORSAL HIPPOCAMPUS; CEREBRAL VASOSPASM; CONDITIONED FEAR; FASUDIL PROTECTS; RANDOMIZED-TRIAL; FAMILY GTPASES; MILD	Traumatic brain injury (TBI) causes extensive neural damage, often resulting in long-term cognitive impairments. Unfortunately, effective treatments for TBI remain elusive. The RhoA-ROCK signaling pathway is a potential therapeutic target since it is activated by TBI and can promote the retraction of dendritic spines/synapses, which are critical for information processing and memory storage. To test this hypothesis, RhoA-ROCK signaling was blocked by RhoA deletion from postnatal neurons or treatment with the ROCK inhibitor fasudil. We found that TBI impairs both motor and cognitive performance and inhibiting RhoA-ROCK signaling alleviates these deficits. Moreover, RhoA-ROCK inhibition prevents TBI-induced spine remodeling and mature spine loss. These data argue that TBI elicits pathological spine remodeling that contributes to behavioral deficits by altering synaptic connections, and RhoA-ROCK inhibition enhances functional recovery by blocking this detrimental effect. As fasudil has been safely used in humans, our results suggest that it could be repurposed to treat TBI.	[Mulherkar, Shalaka; Firozi, Karen; Huang, Wei; Uddin, Mohammad Danish; Costa-Mattioli, Mauro; Tolias, Kimberley F.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Costa-Mattioli, Mauro] Baylor Coll Med, Memory & Brain Res Ctr, Houston, TX 77030 USA; [Grill, Raymond J.] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Robertson, Claudia] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Tolias, Kimberley F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Huang, Wei] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, 733N Broadway, Baltimore, MD 21205 USA; [Grill, Raymond J.] Univ Mississippi, Med Ctr, Dept Neurobiol & Anat Sci, Jackson, MS 39216 USA		Tolias, KF (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Tolias, KF (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	tolias@bcm.edu		Tolias, Kimberley/0000-0002-2092-920X	DoDUnited States Department of Defense [W81XWH0820148]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS062829, 1S10 OD016167, 1U54 HD083092, 5P30HD 024064]; Mission Connect-TIRR Foundation; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [096816]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [076708]; Department of DefenseUnited States Department of Defense [AR120254]; Angelman Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD083092, P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS062829] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD016167] Funding Source: NIH RePORTER	This work was supported by grants from the DoD (W81XWH0820148), the NIH (R01NS062829), and the Mission Connect-TIRR Foundation (K.F.T.) and NIMH (096816), NINDS (076708) and the Department of Defense (AR120254) to M.C.-M. S.M. is supported by an Angelman Syndrome Foundation Postdoctoral fellowship. We received technical assistance from the BCM RNA In Situ Hybridization Core (funded by NIH grants 1S10 OD016167 and 1U54 HD083092), the BCM Pathology Core (funded by NIH grant 5P30HD 024064), and the Neurobehavioral Core (NICHD, U54HD083092). We thank F. Liu and Cheng-lin (Vivian) Shaw for technical help and S. Gaddam and S. Pillai for guidance with surgeries.	Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Antoniadis EA, 2000, BEHAV BRAIN RES, V108, P1, DOI 10.1016/S0166-4328(99)00121-7; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Avalos AM, 2004, J BIOL CHEM, V279, P39139, DOI 10.1074/jbc.M403439200; Barcia C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00809; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bye N, 2016, EXP NEUROL, V279, P86, DOI 10.1016/j.expneurol.2016.02.012; Cappello S, 2012, NEURON, V73, P911, DOI 10.1016/j.neuron.2011.12.030; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Ding J, 2010, J NEUROCHEM, V114, P1619, DOI 10.1111/j.1471-4159.2010.06876.x; Ding J, 2009, BRAIN BEHAV IMMUN, V23, P1083, DOI 10.1016/j.bbi.2009.05.002; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Duman JG, 2015, NEUROSCI LETT, V601, P4, DOI 10.1016/j.neulet.2015.05.034; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Forgione N, 2014, WORLD NEUROSURG, V82, pE535, DOI 10.1016/j.wneu.2013.01.009; Fortin DA, 2012, NEUROSCIENTIST, V18, P326, DOI 10.1177/1073858411407206; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Glenn DE, 2017, DEPRESS ANXIETY, V34, P723, DOI 10.1002/da.22642; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Higley MJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005686; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Huang W, 2013, NAT NEUROSCI, V16, P441, DOI 10.1038/nn.3351; Huentelman MJ, 2009, BEHAV NEUROSCI, V123, P218, DOI 10.1037/a0014260; Ibrahim S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21793; Kaczkurkin AN, 2017, AM J PSYCHIAT, V174, P125, DOI 10.1176/appi.ajp.2016.15121549; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Lai KO, 2013, BBA-MOL BASIS DIS, V1832, P2257, DOI 10.1016/j.bbadis.2013.08.012; Lau CL, 2012, J CELL PHYSIOL, V227, P1199, DOI 10.1002/jcp.22838; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mulherkar S, 2014, DEV BIOL, V394, P39, DOI 10.1016/j.ydbio.2014.08.004; Mulherkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067015; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; O'Shea RD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00050; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Robertson CS, 2012, J NEUROTRAUM, V29, P1156, DOI 10.1089/neu.2011.1827; Sabirzhanova I, 2013, J NEUROTRAUM, V30, P1449, DOI 10.1089/neu.2012.2673; Schallert T, 2000, J CEREBR BLOOD F MET, V20, P1513, DOI 10.1097/00004647-200011000-00001; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; SHIBUYA M, 1992, J NEUROSURG, V76, P571, DOI 10.3171/jns.1992.76.4.0571; Song Y, 2013, CNS NEUROSCI THER, V19, P603, DOI 10.1111/cns.12116; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Tonnesen J, 2014, NAT NEUROSCI, V17, P678, DOI 10.1038/nn.3682; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Wehner Jeanne M, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805cs27; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wu XB, 2016, NEURAL REGEN RES, V11, P23, DOI 10.4103/1673-5374.169601; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yuste R, 2013, ANNU REV NEUROSCI, V36, P429, DOI 10.1146/annurev-neuro-062111-150455; Zhang HF, 2013, NEUROIMMUNOMODULAT, V20, P313, DOI 10.1159/000351221; Zhao JZ, 2006, NEUROL MED-CHIR, V46, P421, DOI 10.2176/nmc.46.421; Zhao JZ, 2011, NEUROL MED-CHIR, V51, P679, DOI 10.2176/nmc.51.679; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029	79	21	21	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 6	2017	7								10689	10.1038/s41598-017-11113-3			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0MI	WOS:000409439900107	28878396	Green Published, gold			2022-02-06	
J	Alice, P; Meghan, L; Elizabeth, B; Alberto, A; Kenji, I; Demetrios, D				Alice, Piccinini; Meghan, Lewis; Elizabeth, Benjamin; Alberto, Aiolfi; Kenji, Inaba; Demetrios, Demetriades			Intracranial pressure monitoring in severe traumatic brain injuries: a closer look at level 1 trauma centers in the United States	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Isolated severe head trauma; ICP monitoring; Level 1 trauma center; Outcomes	SEVERE HEAD-INJURY; OUTCOMES; MORTALITY	Introduction: The Brain Trauma Foundation (BTF) recently updated recommendations for intracranial pressure (ICP) monitoring in severe traumatic brain injury (TBI). The effect of ICP monitoring on outcomes is controversial, and compliance with BTF guidelines is variable. The purpose of this study was to assess both compliance and outcomes at level I trauma centers. Materials and methods: The American College of Surgeons Trauma Quality Improvement Program database was queried for all patients admitted to level I trauma centers with isolated blunt severe TBI (AIS > 3, GCS < 9) who met criteria for ICP monitoring. Patients who had severe extracranial injuries, craniectomy, or death in the first 24 h were excluded. Comparison between groups with and without ICP monitoring was made, analyzing demographics, comorbidities, mechanism of injury, head Abbreviated Injury Scale (AIS), vital signs on admission, head CT scan findings. Outcomes included in-hospital mortality, mechanical ventilation days, intensive care unit (ICU) length of stay, hospital length of stay, systemic complications, and functional independence at discharge. Multivariable analysis was used to identify independent risk factors for each of the outcomes. Results: Overall, 4880 patients were included. ICP monitoring was used in 529 patients (10.8%). Stepwise logistic regression analysis identified ICP monitor placement as an independent risk factor for mortality (OR 1.63; 95% CI 1.28-2.07; p < 0.001), mechanical ventilation (OR 5.74 95% CI 4.42-7.46; p < 0.001), ICU length of stay (OR 4.03; 95% CI 2.94-5.52; p < 0.001), systemic complications (OR 2.78; 95% CI 2.29-3.37; p < 0.001), and decreased functional independence at discharge (OR 1.71 95% CI 1.29-2.26; p < 0.001). Subgroup analysis of patients with head AIS 3, 4, and 5 confirmed that ICP monitors remained an independent risk factor for mortality in both head AIS 4 and 5. Conclusions: Compliance with BTF guidelines for ICP monitoring is low, even at level I trauma centers. In this study, ICP monitoring was associated with poor outcomes, and was found to be an independent risk factor for mortality. Further studies are needed to determine the optimal role of ICP monitoring in the management of severe TBI. (C) 2017 Elsevier Ltd. All rights reserved.	[Alice, Piccinini; Meghan, Lewis; Elizabeth, Benjamin; Alberto, Aiolfi; Kenji, Inaba; Demetrios, Demetriades] Univ Sourhern Calif, Div Trauma Emergency Surg & Surg Crit Care, Los Angeles, CA 90033 USA		Demetrios, D (corresponding author), Univ Southern Calif, Div Trauma & Surg Crit Care, LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	demetria@usc.edu	Aiolfi, Alberto/ABA-7242-2020	Aiolfi, Alberto/0000-0002-7764-6075			Agrawal D, 2016, J NEUROTRAUM, V33, P853, DOI 10.1089/neu.2015.4015; Aiolfi A, J NEUROSURG IN PRESS; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Alkhoury F, 2011, AM SURGEON, V77, P277; Barmparas G, 2012, AM SURGEON, V78, P1166; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney N, 2016, NEUROSURGERY; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Dawes AJ, 2015, J TRAUMA ACUTE CARE, V78, P492, DOI 10.1097/TA.0000000000000559; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Haddad S, 2011, ANAESTH INTENS CARE, V39, P1043, DOI 10.1177/0310057X1103900610; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Lane PL, 2000, CAN J SURG, V43, P442; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; STUART GG, 1983, J NEUROSURG, V59, P601, DOI 10.3171/jns.1983.59.4.0601; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Task Force of the Committee on Trauma American College of Surgeons, 1990, B AM COLL SURG, V75, P20; You WD, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0199-9	22	21	21	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2017	48	9					1944	1950		10.1016/j.injury.2017.04.033			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	FE2LA	WOS:000408046600015	28495204				2022-02-06	
J	Asehnoune, K; Balogh, Z; Citerio, G; Cap, A; Billiar, T; Stocchetti, N; Cohen, MJ; Pelosi, P; Curry, N; Gaarder, C; Gruen, R; Holcomb, J; Hunt, BJ; Juffermans, NP; Maegele, M; Midwinter, M; Moore, FA; O'Dwyer, M; Pittet, JF; Schochl, H; Schreiber, M; Spinella, PC; Stanworth, S; Winfield, R; Brohi, K				Asehnoune, Karim; Balogh, Zsolt; Citerio, Giuseppe; Cap, Andre; Billiar, Timothy; Stocchetti, Nino; Cohen, Mitchell J.; Pelosi, Paolo; Curry, Nicola; Gaarder, Christine; Gruen, Russell; Holcomb, John; Hunt, Beverley J.; Juffermans, Nicole P.; Maegele, Mark; Midwinter, Mark; Moore, Frederick A.; O'Dwyer, Michael; Pittet, Jean-Francois; Schoechl, Herbert; Schreiber, Martin; Spinella, Philip C.; Stanworth, Simon; Winfield, Robert; Brohi, Karim			The research agenda for trauma critical care	INTENSIVE CARE MEDICINE			English	Article						Haemorrhage; Trauma; Shock; Traumatic brain injury; Coagulopathy; Intracranial hypertension	BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; HEMOSTATIC RESUSCITATION; MAJOR HEMORRHAGE; TRANEXAMIC ACID; CLINICAL-TRIAL; COAGULOPATHY; TRANSFUSION; THERAPY; IMPROVEMENT	In this research agenda on the acute and critical care management of trauma patients, we concentrate on the major factors leading to death, namely haemorrhage and traumatic brain injury (TBI). In haemostasis biology, the results of randomised controlled trials have led to the therapeutic focus moving away from the augmentation of coagulation factors (such as recombinant factor VIIa) and towards fibrinogen supplementation and administration of antifibrinolytics such as tranexamic acid. Novel diagnostic techniques need to be evaluated to determine whether an individualised precision approach is superior to current empirical practice. The timing and efficacy of platelet transfusions remain in question, while new blood products need to be developed and evaluated, including whole blood variants, lyophilised products and novel red cell storage modalities. The current cornerstones of TBI management are intracranial pressure control, maintenance of cerebral perfusion pressure and avoidance of secondary insults (such as hypotension, hypoxaemia, hyperglycaemia and pyrexia). Therapeutic hypothermia and decompressive craniectomy are controversial therapies. Further research into these strategies should focus on identifying which subgroups of patients may benefit from these interventions. Prediction of the long-term outcome early after TBI remains challenging. Early magnetic resonance imaging has recently been evaluated for predicting the long-term outcome in mild and severe TBI. Novel biomarkers may also help in outcome prediction and may predict chronic neurological symptoms. For trauma in general, rehabilitation is complex and multidimensional, and the optimal timing for commencement of rehabilitation needs investigation. We propose priority areas for clinical trials in the next 10 years.	[Asehnoune, Karim] CHU Nantes, Hotel Dieu, Dept Anesthesiol & Crit Care Med, F-44000 Nantes, France; [Asehnoune, Karim] Univ Nantes, Lab EA 3826, Nantes, France; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Dept Emergency & Intens Care, Neurointens Care Unit, Monza, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplant, Milan, Italy; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, IRCCS AOU San Martino IST, Genoa, Italy; [Balogh, Zsolt] John Hunter Hosp, Newcastle, NSW, Australia; [Balogh, Zsolt] Univ Newcastle, Newcastle, NSW, Australia; [Billiar, Timothy] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Cap, Andre] US Army Inst Surg Res, San Antonio, TX USA; [Cohen, Mitchell J.] Univ Colorado, Sch Med, Denver Hlth Med Ctr, Aurora, CO USA; [Curry, Nicola] John Radcliffe Hosp, Oxford Univ Hosp NHS Trust, Oxford, England; [Gaarder, Christine] Oslo Univ Hosp, Dept Traumatol, Oslo, Norway; [Gruen, Russell] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Holcomb, John] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX 77030 USA; [Hunt, Beverley J.] Guys & St Thomas NHS Fdn Trust, Dept Haematol, London, England; [Hunt, Beverley J.] Guys & St Thomas NHS Fdn Trust, Dept Pathol, London, England; [Juffermans, Nicole P.] Acad Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [Maegele, Mark] Univ Witten Herdecke, Cologne Merheim Med Ctr, Dept Traumatol & Orthoped Surg, Cologne, Germany; [Midwinter, Mark] Univ Queensland, Rural Clin Sch Bundaberg, Bundaberg, Qld, Australia; [Moore, Frederick A.] Univ Florida, Dept Surg, Gainesville, FL USA; [O'Dwyer, Michael; Brohi, Karim] Queen Mary Univ London, Ctr Trauma Sci, London, England; [Pittet, Jean-Francois] Univ Alabama Birmingham, Dept Anesthesiol, Crit Care Div, Birmingham, AL USA; [Schoechl, Herbert] Paracelsus Med Univ, Acad Teaching Hosp, AUVA Trauma Ctr Salzburg, Dept Anesthesiol & Intens Care Med, Salzburg, Austria; [Schreiber, Martin] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Spinella, Philip C.] Washington Univ St Louis, Sch Med, Dept Pediat, Washington, DC USA; [Stanworth, Simon] John Radcliffe Hosp, NHS Blood & Transplant, Oxford, England; [Winfield, Robert] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA		Asehnoune, K (corresponding author), CHU Nantes, Hotel Dieu, Dept Anesthesiol & Crit Care Med, F-44000 Nantes, France.; Asehnoune, K (corresponding author), Univ Nantes, Lab EA 3826, Nantes, France.	Karim.Asehnoune@chu-nantes.fr	Rocco, Patricia/I-7460-2012; Balogh, Zsolt J/A-2002-2010; Stocchetti, Nino/O-7444-2017; Citerio, Giuseppe/B-1839-2015	Rocco, Patricia/0000-0003-1412-7136; Balogh, Zsolt J/0000-0002-0277-4822; Stocchetti, Nino/0000-0003-3250-6834; Citerio, Giuseppe/0000-0002-5374-3161; holcomb, john/0000-0001-8312-9157; O'Dwyer, Michael J/0000-0003-4038-5745; Pelosi, Paolo/0000-0001-5055-3023			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Asehnoune K, 2017, ANESTHESIOLOGY, V127, P338, DOI 10.1097/ALN.0000000000001725; Asehnoune K, 2017, INTENS CARE MED, V43, P957, DOI 10.1007/s00134-017-4764-6; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Balvers Kirsten, 2015, J Emerg Trauma Shock, V8, P199, DOI 10.4103/0974-2700.166597; Brinck T, 2016, SCAND J SURG, V105, P109, DOI 10.1177/1457496915586650; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cnossen MC, 2021, J NEUROTRAUM, V38, P1072, DOI 10.1089/neu.2015.4121; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Curry N, 2015, BRIT J ANAESTH, V115, P76, DOI 10.1093/bja/aev134; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Giancarelli A, 2016, J SURG RES, V202, P182, DOI 10.1016/j.jss.2015.12.036; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Guiza F, 2015, INTENS CARE MED, V41, P1067, DOI 10.1007/s00134-015-3806-1; Haghbayan H, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0184-x; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hughes NT, 2014, PEDIATR EMERG CARE, V30, P651, DOI 10.1097/PEC.0000000000000217; Hunt BJ, 2015, BRIT J HAEMATOL, V170, P788, DOI 10.1111/bjh.13580; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Innerhofer P, 2017, LANCET HAEMATOL, V4, pE258, DOI 10.1016/S2352-3026(17)30077-7; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Khan S, 2014, J TRAUMA ACUTE CARE, V76, P561, DOI 10.1097/TA.0000000000000146; Khan S, 2013, INJURY, V44, P587, DOI 10.1016/j.injury.2012.09.029; Kroes MCW, 2010, J NEUROSCI, V30, P3959, DOI 10.1523/JNEUROSCI.5469-09.2010; Lamb CM, 2014, BRIT J ANAESTH, V113, P242, DOI 10.1093/bja/aeu233; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Matsumoto J, 2015, DIAGN INTERV IMAG, V96, P687, DOI 10.1016/j.diii.2015.06.001; Moore EE, 2016, TRANSFUSION, V56, pS110, DOI 10.1111/trf.13486; Moore L, 2015, WORLD J SURG, V39, P1397, DOI 10.1007/s00268-015-2977-9; Moreno-Lopez L, 2016, BRAIN INJURY, V30, P1319, DOI 10.1080/02699052.2016.1186839; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NICE, 2016, MAJ TRAUM ASS IN MAN; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Roquilly A, 2016, EUR RESPIR J, V47, P1219, DOI 10.1183/13993003.01314-2015; Roquilly A, 2013, AM J RESP CRIT CARE, V188, P958, DOI 10.1164/rccm.201301-0116OC; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Sauaia A, 2017, CRIT CARE CLIN, V33, P167, DOI 10.1016/j.ccc.2016.08.006; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Simmons JW, 2016, BRIT J ANAESTH, V117, P31, DOI 10.1093/bja/aew328; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stanworth SJ, 2016, BRIT J SURG, V103, P357, DOI 10.1002/bjs.10052; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; van Oostendorp SE, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0301-9; Winearls J, 2016, ANESTH ANALG, V123, P910, DOI 10.1213/ANE.0000000000001516	60	21	22	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	SEP	2017	43	9					1340	1351		10.1007/s00134-017-4895-9			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FE3LF	WOS:000408116700014	28756471				2022-02-06	
J	Benjamin, E; Recinos, G; Aiolfi, A; Inaba, K; Demetriades, D				Benjamin, Elizabeth; Recinos, Gustavo; Aiolfi, Alberto; Inaba, Kenji; Demetriades, Demetrios			Pharmacological Thromboembolic Prophylaxis in Traumatic Brain Injuries Low Molecular Weight Heparin Is Superior to Unfractionated Heparin	ANNALS OF SURGERY			English	Article; Proceedings Paper	137th Annual Meeting of the American-Surgical-Association (ASA)	APR 20-22, 2017	Philadelphia, PA	Amer Surg Assoc		pharmacological prophylaxis; thromboembolic complications; traumatic brain injury	VENOUS THROMBOEMBOLISM; ENOXAPARIN; SAFETY; EFFICACY; EDEMA; THROMBOPROPHYLAXIS; ANTICOAGULATION	Objective: We hypothesized that low molecular weight heparin (LMWH) is superior to unfractionated heparin (UH) for venous thromboembolism (VTE) prophylaxis in patients with severe traumatic brain injuries (TBI). Summary Background Data: Pharmacological VTE prophylaxis with LMWH or UH is the current standard of care in TBI. Clinical work suggests that LMWH may be more effective than UH for VTE prophylaxis in trauma patients. Experimental work shows that heparinoids may have neuroprotective properties. Methods: ACS TQIP database study including patients with blunt severe TBI (AIS >= 3), those that received LMWH or UH VTE prophylaxis. Patients with severe extracranial injuries (AIS >= 3), death within 72 hours, or hospital stay <48 hours were excluded. Demographic and clinical data on admission was collected, as well as head, thorax, and abdomen AIS, and timing of prophylaxis (within 48 hours, 49-72 hours, and >72 hours). Outcomes included VTE complications, mortality, and unplanned return to the operating room. Multivariate analysis was performed to compare outcomes between patients receiving LMWH and UH. Results: Overall, 20,417 patients met the criteria for inclusion in the study, 10,018 (49.1%) received LMWH and 10,399 (50.9%) UH. Multivariate analysis showed that LMWH was an independent protective factor against mortality and thromboembolic complications, regardless of timing of prophylaxis initiation. The type of prophylaxis had no effect on the need for unplanned return to the operating room. Conclusions: LMWH prophylaxis in severe TBI is associated with better survival and lower thromboembolic complications than UH.	[Benjamin, Elizabeth; Recinos, Gustavo; Aiolfi, Alberto; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, Div Acute Care Surg, Dept Surg, Los Angeles, CA USA		Benjamin, E (corresponding author), LAC USC Med Ctr, 2051 Marengo St,Inpatient Tower,C5L 100, Los Angeles, CA 90033 USA.	Elizabeth.Benjamin@med.usc.edu	Benjamin, Elizabeth/AAD-2457-2020; Aiolfi, Alberto/ABA-7242-2020	Aiolfi, Alberto/0000-0002-7764-6075			BARA L, 1993, THROMB RES, V69, P443, DOI 10.1016/0049-3848(93)90233-E; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS32, DOI 10.1089/neu.2007.9991; Byrne JP, 2017, J TRAUMA ACUTE CARE, V82, P252, DOI 10.1097/TA.0000000000001321; Byrne JP, 2016, J AM COLL SURGEONS, V223, p[621, e5]; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Denson K, 2007, AM J SURG, V193, P380, DOI 10.1016/j.amjsurg.2006.12.004; Dudley RR, 2010, J NEUROTRAUM, V27, P2165, DOI 10.1089/neu.2010.1366; Ekeh AP, 2010, J TRAUMA, V68, P912, DOI 10.1097/TA.0b013e3181b21cad; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Frisoli F, 2016, NEUROSURGERY S1, V63, P171; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Jamjoom AAB, 2016, BRIT J NEUROSURG, V30, P240, DOI 10.3109/02688697.2016.1161170; Jamjoom AAB, 2013, J NEUROTRAUM, V30, P503, DOI 10.1089/neu.2012.2584; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Knudson MM, 2004, ANN SURG, V240, P6; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Li S, 2016, J TRAUMAACUTE CARE S, V80, P7; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Galan LAM, 2016, J TRAUMA ACUTE CARE, V81, P567, DOI 10.1097/TA.0000000000001134; Murphy PB, 2016, CAN J SURG, V59, P118, DOI 10.1503/cjs.010815; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Scudday T, 2011, J AM COLL SURGEONS, V213, P53; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; YOUNG E, 1993, THROMB HAEMOSTASIS, V70, P625	29	21	21	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	SEP	2017	266	3					463	469		10.1097/SLA.0000000000002359			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	FD2UR	WOS:000407390800008	28650361				2022-02-06	
J	Howell, DR; Hanson, E; Sugimoto, D; Stracciolini, A; Meehan, WP				Howell, David R.; Hanson, Emily; Sugimoto, Dai; Stracciolini, Andrea; Meehan, William P.			Assessment of the Postural Stability of Female and Male Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						posture; balance; sex; cerebral concussion	ERROR SCORING SYSTEM; GAIT BALANCE CONTROL; YOUNG-ADULTS; PERFORMANCE; CHILDREN; CONCUSSION; ADOLESCENTS; OBESITY; GENDER; INJURY	Objective: Postural stability is often affected by sport-related injuries and subsequently evaluated during postinjury examinations. Intrinsic factors, however, may also affect postural control. We sought to compare the postural control of female and male athletes as measured simultaneously by (1) the modified balance error scoring system (mBESS) and (2) a video-force plate system. Design: Cross-sectional study. Setting: Sports injury prevention center. Participants: Pediatric, adolescent, and young adult athletes who performed mBESS during an injury prevention evaluation. Independent Variables: We compared the postural control of female and male athletes. We also accounted for independent variables associated with postural stability, including age, body mass index, and history of ankle injury, concussion, and migraine headache. Main Outcome Measures: Total errors committed during the mBESS and measurements derived from integrated kinematic and kinetic data obtained by a video-force plate system. Differences between males and females were tested using analysis of covariance. Results: Participants (n = 409) ranged in age from 10 to 29 years (mean = 14.6 +/- 2.8); 60% were female. No significant differences on mBESS were detected between females and males; however, female athletes demonstrated significantly better postural stability on the video-force plate analysis during double-leg (P = 0.03, d = 0.28), single-leg (P < 0.001, d = 0.62), and tandem stances (P < 0.001, d = 0.53) when compared with males. Conclusions: Uninjured female athletes demonstrate better postural stability on video-force plate analysis than their uninjured male counterparts. These findings provide an important information assistive to clinicians during interpretation of postinjury balance tests.	[Howell, David R.; Hanson, Emily; Sugimoto, Dai; Stracciolini, Andrea; Meehan, William P.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; Hanson, Emily; Sugimoto, Dai; Stracciolini, Andrea; Meehan, William P.] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Howell, David R.; Meehan, William P.] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA; [Sugimoto, Dai; Meehan, William P.] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA; [Stracciolini, Andrea; Meehan, William P.] Harvard Med Sch, Dept Pediat, Boston, MA USA		Howell, DR (corresponding author), Micheli Ctr Sports Injury Prevent, ATC, 9 Hope Ave,Suite 100, Waltham, MA 02453 USA.	David.Howell2@childrens.harvard.edu			National Football League Players Association	W. P. Meehan receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and royalties from Wolters Kluwer for working as an author for UpToDate. He is under contract with ABC-Clio publishing for a future book entitled, Concussions, and with Springer International publishing for a future book entitled, Head and Neck Injuries in Young Athletes. His research is funded, in part, by a grant from the National Football League Players Association and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin ProAm Tournament. The remaining authors report no conflicts of interest.	Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Bryant EC, 2005, CLIN BIOMECH, V20, P330, DOI 10.1016/j.clinbiomech.2004.11.006; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Carvalho GF, 2013, HEADACHE, V53, P1116, DOI 10.1111/head.12135; Condon C, 2014, PHYSIOTHER RES INT, V19, P1, DOI 10.1002/pri.1549; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Franjoine MR, 2010, PEDIATR PHYS THER, V22, P350, DOI 10.1097/PEP.0b013e3181f9d5eb; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Iverson GL, 2013, BRAIN INJURY, V27, P596, DOI 10.3109/02699052.2013.772237; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Lee AJY, 2007, J APPL BIOMECH, V23, P173, DOI 10.1123/jab.23.3.173; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Molloy CA, 2003, J AUTISM DEV DISORD, V33, P643, DOI 10.1023/B:JADD.0000006001.00667.4c; Pataky Z, 2014, OBESITY, V22, P56, DOI 10.1002/oby.20514; Paterno MV, 2013, GAIT POSTURE, V38, P136, DOI 10.1016/j.gaitpost.2012.11.001; Ponta ML, 2014, OBES SURG, V24, P1915, DOI 10.1007/s11695-014-1254-6; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Sabin MJ, 2010, J STRENGTH COND RES, V24, P2073, DOI 10.1519/JSC.0b013e3181ddae13; Soltani Narjes, 2014, Asian J Sports Med, V5, P91; Torres Sarina Francescato, 2014, Fisioter. mov., V27, P399, DOI 10.1590/0103-5150.027.003.AO10; Wikstrom EA, 2010, GAIT POSTURE, V31, P407, DOI 10.1016/j.gaitpost.2010.02.004; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Zur O, 2013, RES DEV DISABIL, V34, P1951, DOI 10.1016/j.ridd.2013.03.007	29	21	21	1	31	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2017	27	5					444	449		10.1097/JSM.0000000000000374			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	FG2HS	WOS:000409915300009	27428677				2022-02-06	
J	Rosene, JM; Raksnis, B; Silva, B; Woefel, T; Visich, PS; Dompier, TP; Kerr, ZY				Rosene, John M.; Raksnis, Bryan; Silva, Brie; Woefel, Tyler; Visich, Paul S.; Dompier, Thomas P.; Kerr, Zachary Y.			Comparison of Concussion Rates Between NCAA Division I and Division III Men's and Women's Ice Hockey Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						ice hockey; division differences; concussions; collegiate athletics; NCAA	INJURY SURVEILLANCE SYSTEM; STATES HIGH-SCHOOL; UNITED-STATES; EPIDEMIOLOGY; HELMETS; MECHANISMS; SPORT	Background: Examinations related to divisional differences in the incidence of sports-related concussions (SRC) in collegiate ice hockey are limited. Purpose: To compare the epidemiologic patterns of concussion in National Collegiate Athletic Association (NCAA) ice hockey by sex and division. Study Design: Descriptive epidemiology study. Methods: A convenience sample of men's and women's ice hockey teams in Divisions I and III provided SRC data via the NCAA Injury Surveillance Program during the 2009-2010 to 2014-2015 academic years. Concussion counts, rates, and distributions were examined by factors including injury activity and position. Injury rate ratios (IRRs) and injury proportion ratios (IPRs) with 95% confidence intervals (CIs) were used to compare concussion rates and distributions, respectively. Results: Overall, 415 concussions were reported for men's and women's ice hockey combined. The highest concussion rate was found in Division I men (0.83 per 1000 athlete-exposures [AEs]), followed by Division III women (0.78/1000 AEs), Division I women (0.65/1000 AEs), and Division III men (0.64/1000 AEs). However, the only significant IRR was that the concussion rate was higher in Division I men than Division III men (IRR = 1.29; 95% CI, 1.02-1.65). The proportion of concussions from checking was higher in men than women (28.5% vs 9.4%; IPR = 3.02; 95% CI, 1.63-5.59); however, this proportion was higher in Division I women than Division III women (18.4% vs 1.8%; IPR = 10.47; 95% CI, 1.37-79.75). The proportion of concussions sustained by goalkeepers was higher in women than men (14.2% vs 2.9%; IPR = 4.86; 95% CI, 2.19-10.77), with findings consistent within each division. Conclusion: Concussion rates did not vary by sex but differed by division among men. Checking-related concussions were less common in women than men overall but more common in Division I women than Division III women. Findings highlight the need to better understand the reasons underlying divisional differences within men's and women's ice hockey and the need to develop concussion prevention strategies specific to each athlete population.	[Rosene, John M.; Raksnis, Bryan; Silva, Brie; Woefel, Tyler; Visich, Paul S.; Dompier, Thomas P.; Kerr, Zachary Y.] Univ New England, Biddeford, ME USA; [Rosene, John M.; Raksnis, Bryan; Silva, Brie; Woefel, Tyler; Visich, Paul S.; Dompier, Thomas P.; Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Rosene, John M.; Raksnis, Bryan; Silva, Brie; Woefel, Tyler; Visich, Paul S.; Dompier, Thomas P.; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA		Rosene, JM (corresponding author), Westbrook Coll Hlth Profess, Dept Exercise & Sport Performance, 11 Hills Beach Rd, Biddeford, ME 04005 USA.	jrosene@une.edu			NCAA	One or more of the authors has declared the following potential conflict of interest or source of funding: The National Collegiate Athletic Association (NCAA) Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NCAA.	Abbott K, 2014, CURR SPORT MED REP, V13, P377, DOI 10.1249/JSR.0000000000000102; Agel J, 2007, J ATHL TRAINING, V42, P272; Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2010, CAN J SURG, V53, P319; Bonfield CM, 2015, PHYSICIAN SPORTSMED, V43, P236, DOI 10.1080/00913847.2015.1039922; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kroshus E, 2016, HEALTH COMMUN, P1; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Matic GT, 2015, PHYSICIAN SPORTSMED, V43, P119, DOI 10.1080/00913847.2015.1035210; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Peterson BJ, 2015, J STRENGTH COND RES, V29, P1191, DOI 10.1519/JSC.0000000000000754; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	27	21	21	0	18	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	SEP	2017	45	11					2622	2629		10.1177/0363546517710005			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FF3NP	WOS:000408809800022	28622025				2022-02-06	
J	Roy, D; Vaishnavi, S; Han, DF; Rao, V				Roy, Durga; Vaishnavi, Sandeep; Han, Dingfen; Rao, Vani			Correlates and Prevalence of Aggression at Six Months and One Year After First-Time Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							PHYSICAL AGGRESSION; BEHAVIOR; SCALE; RELIABILITY; RESPONSES	Few studies have examined clinical correlates of aggression after first-time traumatic brain injury (TBI) within the first year after injury. The authors aimed to identify the rates of aggression at 6 and 12 months post-TBI and establish clinical and demographic correlates. A total of 103 subjects with first-time TBI were seen within 12 months postinjury and evaluated for aggression. Post-TBI social functioning and new-onset depression (within 3 months of the TBI) may serve as particularly important predictors for aggression within the first year of TBI, as these factors may afford intervention and subsequent decreased risk of aggression.	[Roy, Durga; Han, Dingfen; Rao, Vani] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Vaishnavi, Sandeep] Neuropsychiat Clin Carolina Partners, Durham, NC USA; [Vaishnavi, Sandeep] Duke Univ, Dept Community & Family Med, Sch Med, Durham, NC USA; [Vaishnavi, Sandeep] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA		Roy, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.	droy4@jhmi.edu			NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23 MH 066894]; Department of DefenseUnited States Department of Defense [W81XWH-13-1-0469]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K23MH066894] Funding Source: NIH RePORTER	Supported by NIMH grant K23 MH 066894 to Dr. Rao and in part by Department of Defense grant W81XWH-13-1-0469 to Dr. Rao.	Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Dyer KFW, 2006, BRAIN INJURY, V20, P1163, DOI 10.1080/02699050601049312; First MB, 1997, COMMUNICATION; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Giles GM, 2007, BRAIN INJURY, V21, P505, DOI 10.1080/02699050701311729; Golden J. C., 1978, STROOP COLOR WORD TE; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Greve KW, 2001, BRAIN INJURY, V15, P255; James AIW, 2013, BRAIN INJURY, V27, P1162, DOI 10.3109/02699052.2013.804200; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kafantaris V, 1996, J NEUROPSYCH CLIN N, V8, P186; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; MCNIEL DE, 1991, AM J PSYCHIAT, V148, P1317; Nelson H.E., 1982, NATL ADULT READING T; Rao V, 2009, J NEUROPSYCH CLIN N, V21, P420, DOI 10.1176/appi.neuropsych.21.4.420; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Schretlen D., 1996, BRIEF TEST ATTENTION; Silver J M, 1991, J Neuropsychiatry Clin Neurosci, V3, pS22; STARR LB, 1983, EXP AGING RES, V9, P101, DOI 10.1080/03610738308258434; Stefan A, 2016, ANN PHYS REHABIL MED, V59, P5, DOI 10.1016/j.rehab.2015.11.002; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; TEASDALE G, 1974, LANCET, V2, P81; Wolfson D, 1985, HALSTEAD REITAN NEUR; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	30	21	21	0	6	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2017	29	4					334	342		10.1176/appi.neuropsych.16050088			9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	FM9CH	WOS:000415390900005	28558481	Green Accepted, Bronze			2022-02-06	
J	Smart, LR; Mangat, HS; Issarow, B; McClelland, P; Mayaya, G; Kanumba, E; Gerber, LM; Wu, X; Peck, RN; Ngayomela, I; Fakhar, M; Stieg, PE; Hartl, R				Smart, Luke R.; Mangat, Halinder S.; Issarow, Benson; McClelland, Paul; Mayaya, Gerald; Kanumba, Emmanuel; Gerber, Linda M.; Wu, Xian; Peck, Robert N.; Ngayomela, Isidore; Fakhar, Malik; Stieg, Philip E.; Hartl, Roger			Severe Traumatic Brain Injury at a Tertiary Referral Center in Tanzania: Epidemiology and Adherence to Brain Trauma Foundation Guidelines	WORLD NEUROSURGERY			English	Article						Adherence; Guidelines; Mortality; Sub-Saharan Africa; Tanzania; Traumatic brain injury	INCOME COUNTRIES; GLOBAL BURDEN; CARE; IMPACT; MANAGEMENT; MORTALITY; REDUCTION; PROGNOSIS; OUTCOMES; DISEASE	BACKGROUND: Severe traumatic brain injury (TBI) is a major cause of death and disability worldwide. Prospective TBI data from sub-Saharan Africa are sparse. This study examines epidemiology and explores management of patients with severe TBI and adherence to Brain Trauma Foundation Guidelines at a tertiary care referral hospital in Tanzania. METHODS: Patients with severe TBI hospitalized at Bugando Medical Centre were recorded in a prospective registry including epidemiologic, clinical, treatment, and outcome data. RESULTS: Between September 2013 and October 2015, 371 patients with TBI were admitted; 33% (115/371) had severe TBI. Mean age was 32.0 years +/- 20.1, and most patients were male (80.0%). Vehicular injuries were the most common cause of injury (65.2%). Approximately half of the patients (47.8%) were hospitalized on the day of injury. Computed tomography of the brain was performed in 49.6% of patients, and 58.3% were admitted to the intensive care unit. Continuous arterial blood pressure monitoring and intracranial pressure monitoring were not performed in any patient. Of patients with severe TBI, 38.3% received hyperosmolar therapy, and 35.7% underwent craniotomy. The 2-week mortality was 34.8%. CONCLUSIONS: Mortality of patients with severe TBI at Bugando Medical Centre, Tanzania, is approximately twice that in high-income countries. Intensive care unit care, computed tomography imaging, and continuous arterial blood pressure and intracranial pressure monitoring are underused or unavailable in the tertiary referral hospital setting. Improving outcomes after severe TBI will require concerted investment in prehospital care and improvement in availability of intensive care unit resources, computed tomography, and expertise in multidisciplinary care.	[Smart, Luke R.; Peck, Robert N.] Dept Internal Med, Mwanza, Tanzania; [Issarow, Benson] Weill Bugando Sch Med, Mwanza, Tanzania; [Mayaya, Gerald; Kanumba, Emmanuel] Bugando Med Ctr, Dept Neurosurg, Mwanza, Tanzania; [Ngayomela, Isidore] Bugando Med Ctr, Dept Orthoped Surg, Mwanza, Tanzania; [Smart, Luke R.; McClelland, Paul; Peck, Robert N.] Weill Cornell Med, Ctr Global Hlth, New York, NY USA; [Mangat, Halinder S.; Fakhar, Malik] Weill Cornell Med, Dept Neurol, New York, NY 10065 USA; [Mangat, Halinder S.; Stieg, Philip E.; Hartl, Roger] Weill Cornell Med, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10065 USA; [Gerber, Linda M.; Wu, Xian] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA		Mangat, HS (corresponding author), Weill Cornell Med, Dept Neurol, New York, NY 10065 USA.; Mangat, HS (corresponding author), Weill Cornell Med, Dept Neurol Surg, Weill Cornell Brain & Spine Ctr, New York, NY 10065 USA.	hsm9001@med.cornell.edu	Mangat, HALINDER/AAN-9153-2020; Smart, Luke R./AAI-1561-2020	Mangat, HALINDER/0000-0003-3426-2001; Smart, Luke R./0000-0003-4083-0060; Peck, Robert/0000-0002-4526-2480	Clinical and Translational Science Center (CTSC), National Center for Advancing Translational Sciences (NCATS) [UL1-TR000457-06]; Leonard & Evelyn Lauder Foundation; Eric Javits Family Foundation; William Beecher Scoville Foundation; Colin McDonald family; National Institutes of Health Fogarty Center [TW009337, K01 TW010281-01]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [D43TW009337, R25TW009337, K01TW010281] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000457] Funding Source: NIH RePORTER	Dr. Linda Gerber and Ms. Xian Wu were supported in part by funds from the Clinical and Translational Science Center (CTSC), National Center for Advancing Translational Sciences (NCATS) grant # UL1-TR000457-06. This work was supported in part by the Leonard & Evelyn Lauder Foundation, Eric Javits Family Foundation, William Beecher Scoville Foundation, Colin McDonald family, and patient donations. L.R.S. received support from the National Institutes of Health Fogarty Center (Grant No. TW009337). R.N.P. received support from the National Institutes of Health Fogarty Center (Grant No. K01 TW010281-01).	Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Brazinova A, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0133-z; Bryan-Hancock C, 2010, INJURY PREV, V16, pA17, DOI 10.1136/ip.2010.029215.61; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Callese TE, 2014, J SURG RES, V190, P104, DOI 10.1016/j.jss.2014.03.029; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Coburger J, 2014, WORLD NEUROSURG, V82, pE1, DOI 10.1016/j.wneu.2012.09.019; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Fatigba HO, 2013, ISRN SURG, V2013; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Geduld H, 2011, EMERG MED J, V28, P794, DOI 10.1136/emj.2010.101683; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Harris OA, 2008, J NEUROSURG, V109, P433, DOI 10.3171/JNS/2008/109/9/0433; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kahamba JF, 2013, WORLD NEUROSURG, V80, P255, DOI 10.1016/j.wneu.2011.07.021; Maier D, 2014, WORLD NEUROSURG, V81, P478, DOI 10.1016/j.wneu.2013.08.014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mitchell KB, 2013, CAN J SURG, V56, P199, DOI 10.1503/cjs.028911; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Staton CA, 2017, INT J INJ CONTROL SA, V24, P69, DOI 10.1080/17457300.2015.1061562; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Wait SD, 2010, WORLD NEUROSURG, V73, P610, DOI 10.1016/j.wneu.2010.06.043; Winkler AS, 2010, WORLD NEUROSURG, V73, P264, DOI 10.1016/j.wneu.2010.03.037; Wong JC, 2016, EUR J NEUROL, V23, P382, DOI 10.1111/ene.12877	38	21	21	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2017	105						238	248		10.1016/j.wneu.2017.05.101			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FH3EJ	WOS:000411027600033	28559070	Green Accepted			2022-02-06	
J	Post, A; Hoshizaki, TB; Gilchrist, MD; Cusimano, MD				Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Cusimano, Michael D.			Peak linear and rotational acceleration magnitude and duration effects on maximum principal strain in the corpus callosum for sport impacts	JOURNAL OF BIOMECHANICS			English	Article						Finite element modelling; Strain; Brain injury; Acceleration; Duration	ACCIDENT RECONSTRUCTION; AXONAL DAMAGE; HEAD; ELEMENT; INJURY; BIOMECHANICS; TISSUE; MODEL	Concussion has been linked to the presence of injurious strains in the brain tissues. Research investigating severe brain injury has reported that strains in the brain may be affected by two parameters: magnitude of the acceleration, and duration of that acceleration. However, little is known how this relationship changes in terms of creating risk for brain injury for magnitudes and durations of acceleration common in sporting environments. This has particular implications for the understanding and prevention of concussive risk of injury in sporting environments. The purpose of this research was to examine the interaction between linear and rotational acceleration and duration on maximum principal strain in the brain tissues for loading conditions incurred in sporting environments. Linear and rotational acceleration loading curves of magnitudes and durations similar to those from impact in sport were used as input to the University College Brain Trauma Model and maximum principal strain (MPS) was measured for the different curves. The results demonstrated that magnitude and duration do have an effect on the strain incurred by the brain tissue. As the duration of the acceleration increases, the magnitude required to achieve strains reflecting a high risk of concussion decreases, with rotational acceleration becoming the dominant contributor. The magnitude required to attain a magnitude of MPS representing risk of brain injury was found to be as low as 2500 rad/s(2) for impacts of 10-15 ms; indicating that interventions to reduce the risk of concussion in sport must consider the duration of the event while reducing the magnitude of acceleration the head incurs. (C) 2017 Elsevier Ltd. All rights reserved.	[Post, Andrew; Cusimano, Michael D.] St Michaels Hosp, Toronto, ON, Canada; [Post, Andrew; Hoshizaki, T. Blaine] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019				Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hitosugi M, 2014, BIOMED RES-TOKYO, V35, P339, DOI 10.2220/biomedres.35.339; Ho J, 2008, THESIS; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T.B., 2016, TRAUMA; Hoshizaki T.B., 2014, J NEUROL NEUROPHYSIO, V5, P181; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Kendall M., 2016, THESIS; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kleiven, 2005, P IRCOBI C PRAG CZEC, P21; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lao Y, 2015, PROC SPIE, V9287, DOI 10.1117/12.2072600; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller R.T., 1998, STAPP CAR CRASH J, P155; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A., 2016, SPORTS ENG; Post A, 2015, ACCIDENT ANAL PREV, V79, P33, DOI 10.1016/j.aap.2015.03.017; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Rousseau P., 2014, THESIS; Ruan J, 1994, THESIS; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Ting W.K., 2016, FRONT NEUROL, V6, P1; Van Lierde C, 2005, THESIS; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Willinger R, 1995, P IRCOBI C; Willinger R., 1992, P INT IRCOBI C BIOM, P179; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yang JK, 2011, COMPUTATIONAL BIOMECHANICS FOR MEDICINE: SOFT TISSUES AND THE MUSCULOSKELETAL SYSTEM, P5, DOI 10.1007/978-1-4419-9619-0_2; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310	53	21	21	1	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	AUG 16	2017	61						183	192		10.1016/j.jbiomech.2017.07.013			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FH9QQ	WOS:000411547200024	28807524				2022-02-06	
J	Bickford, PC; Flowers, A; Grimmig, B				Bickford, Paula C.; Flowers, Antwoine; Grimmig, Bethany			Aging leads to altered microglial function that reduces brain resiliency increasing vulnerability to neurodegenerative diseases	EXPERIMENTAL GERONTOLOGY			English	Article; Proceedings Paper	13th International Symposium on the Neurobiology and Neuroendocrinology of Aging	JUL 17-22, 2016	Bregenz, AUSTRIA	Natl Inst Aging, Orentreich Fdn Advancement Sci, Co Morbid Relat AIDS, European Commiss, 7th Framework Program, Juniper & Pasquale Fdn, Land Vorarlberg & Landeshaupstadt, Univ N Dakota, Sch Med & Hlth Sci, Dept Biomed Sci		Microglia; Polyphenol	COGNITIVE FUNCTION; AGED RATS; PROINFLAMMATORY CYTOKINES; DIETARY SUPPLEMENTATION; PROGENITOR CELLS; STEM-CELLS; INFLAMMATION; NEUROGENESIS; REVERSES; MICE	Aging is the primary risk factor for many neurodegenerative diseases. Thus, understanding the basic biological changes that take place with aging that lead to the brain being less resilient to disease progression of neurodegenerative diseases such as Parkinson's disease or Alzheimer's disease or insults to the brain such as stroke or traumatic brain injuries. Clearly this will not cure the disease per se, yet increasing the ability of the brain to respond to injury could improve long term outcomes. The focus of this review is examining changes in microglia with age and possible therapeutic interventions involving the use of polyphenol rich dietary supplements. Published by Elsevier Inc.	[Bickford, Paula C.] James A Haley Vet Adm Hosp, Res Serv, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Bickford, Paula C.; Flowers, Antwoine; Grimmig, Bethany] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL USA		Bickford, PC (corresponding author), James A Haley Vet Adm Hosp, Res Serv, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	pbickfor@health.usf.edu	Bickford, Paula C/J-5970-2012	Bickford, Paula C/0000-0001-9657-7725	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AG044919]; VA grant [I01BX003421]; Veterans AdministrationUS Department of Veterans Affairs [I01BX003421]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG004418, R36AG051747, R01AG044919] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003421] Funding Source: NIH RePORTER	This work was supported by NIH grants R01AG044919 (PCB), and VA grant I01BX003421 (PCB).; This work was supported by the Veterans Administration (I01BX003421). Content does not represent the views of the Department of Veterans Affairs nor the US Government.	Acosta S, 2010, REJUV RES, V13, P581, DOI 10.1089/rej.2009.1011; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; Bhullar KS, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/891748; Bickford PC, 2015, AGE, V37, DOI 10.1007/s11357-015-9840-7; Bickford PC, 2006, STEM CELLS DEV, V15, P118, DOI 10.1089/scd.2006.15.118; Cho SH, 2015, J NEUROSCI, V35, P807, DOI 10.1523/JNEUROSCI.2939-14.2015; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Fenn AM, 2014, J NEUROSCI, V34, P8904, DOI 10.1523/JNEUROSCI.1146-14.2014; Fenn AM, 2012, BRAIN BEHAV IMMUN, V26, P766, DOI 10.1016/j.bbi.2011.10.003; Flowers A, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0395-4; Gemma C, 2005, EUR J NEUROSCI, V22, P1751, DOI 10.1111/j.1460-9568.2005.04334.x; Gemma C, 2002, J NEUROSCI, V22, P6114; GRANHOLM AC, 1987, BRAIN RES, V423, P71, DOI 10.1016/0006-8993(87)90826-2; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; L'Episcopo F, 2013, J NEUROSCI, V33, P1462, DOI 10.1523/JNEUROSCI.3206-12.2013; Lastres-Becker I, 2012, HUM MOL GENET, V21, P3173, DOI 10.1093/hmg/dds143; Lee DC, 2013, NEUROBIOL AGING, V34, P1610, DOI 10.1016/j.neurobiolaging.2012.12.014; Mayack SR, 2010, NATURE, V463, P495, DOI 10.1038/nature08749; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Moll L, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13917; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Piccin D, 2014, NEUROBIOL AGING, V35, P1669, DOI 10.1016/j.neurobiolaging.2014.01.026; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Small BJ, 2014, REJUV RES, V17, P27, DOI 10.1089/rej.2013.1477; Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898; Turan B, 2012, J BIOENERG BIOMEMBR, V44, P281, DOI 10.1007/s10863-012-9429-0; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang Y, 2005, EXP NEUROL, V193, P75, DOI 10.1016/j.expneurol.2004.12.014; Wilcock D. M., 2012, INT J ALZHEIMERS DIS; Willis L, 2005, CELL TRANSPLANT, V14, P213, DOI 10.3727/000000005783983142; Willis LM, 2010, GLIA, V58, P679, DOI 10.1002/glia.20954; Yasuhara T, 2008, REJUV RES, V11, P201, DOI 10.1089/rej.2007.0608; Zhao X, 2014, J NEUROCHEM	40	21	21	1	19	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0531-5565	1873-6815		EXP GERONTOL	Exp. Gerontol.	AUG	2017	94				SI		4	8		10.1016/j.exger.2017.01.027			5	Geriatrics & Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Geriatrics & Gerontology	EZ1TS	WOS:000404494300002	28163132	Green Accepted			2022-02-06	
J	Glenn, DE; Acheson, DT; Geyer, MA; Nievergelt, CM; Bakermd, DG; Risbrough, VB				Glenn, Daniel E.; Acheson, Dean T.; Geyer, Mark A.; Nievergelt, Caroline M.; Bakermd, Dewleen G.; Risbrough, Victoria B.		MRS-II Team	Fear learning alterations after traumatic brain injury and their role in development of posttraumatic stress symptoms	DEPRESSION AND ANXIETY			English	Article						biological markers; posttraumatic stress disorder; startle; trauma; traumatic brain injury	CONDITIONED FEAR; SEX-DIFFERENCES; POSTCONCUSSIVE SYMPTOMS; ANXIETY DISORDERS; EXTINCTION; PTSD; CONCUSSION; SEQUELAE; RISK; ASSOCIATION	Background: It is unknown how traumatic brain injury (TBI) increases risk for posttraumatic stress disorder (PTSD). One potential mechanism is via alteration of fear-learning processes that could affect responses to trauma memories and cues. We utilized a prospective, longitudinal design to determine if TBI is associated with altered fear learning and extinction, and if fear processing mediates effects of TBI on PTSD symptom change. Methods: Eight hundred fifty two active-duty Marines and Navy Corpsmen were assessed before and after deployment. Assessments included TBI history, PTSD symptoms, combat trauma and deployment stress, and a fear-potentiated startle task of fear acquisition and extinction. Startle response and self-reported expectancy and anxiety served as measures of fear conditioning, and PTSD symptoms were measured with the Clinician-Administered PTSD Scale. Results: Individuals endorsing "multiple hit" exposure (both deployment TBI and a prior TBI) showed the strongest fear acquisition and highest fear expression compared to groups without multiple hits. Extinction did not differ across groups. Endorsing a deployment TBI was associated with higher anxiety to the fear cue compared to those without deployment TBI. The association of deployment TBI with increased postdeployment PTSD symptoms was mediated by postdeployment fear expression when recent prior-TBI exposure was included as a moderator. TBI associations with increased response to threat cues and PTSD symptoms remained when controlling for deployment trauma and postdeployment PTSD diagnosis. Conclusions: Deployment TBI, and multiple-hit TBI in particular, are associated with increases in conditioned fear learning and expression that may contribute to risk for developing PTSD symptoms.	[Glenn, Daniel E.; Acheson, Dean T.; Nievergelt, Caroline M.; Bakermd, Dewleen G.; Risbrough, Victoria B.] San Diego Vet Affairs Hlth Serv, Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr, San Diego, CA 92161 USA; [Glenn, Daniel E.; Acheson, Dean T.; Geyer, Mark A.; Nievergelt, Caroline M.; Bakermd, Dewleen G.; Risbrough, Victoria B.; MRS-II Team] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Geyer, Mark A.] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA		Risbrough, VB (corresponding author), San Diego Vet Affairs Hlth Serv, Ctr Excellence Stress & Mental Hlth, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	vrisbrough@ucsd.edu	Risbrough, Victoria/X-3344-2019; Baker, Dewleen/O-4957-2019	Baker, Dewleen/0000-0002-1736-9838	Navy Bureau of Medicine and Surgery [N62645-11-C-4037]; VA Center of Excellence for Stress and Mental Health; Veterans AffairsUS Department of Veterans Affairs [I01BX002558] Funding Source: NIH RePORTER	Grant sponsor: Navy Bureau of Medicine and Surgery; Contract grant number: N62645-11-C-4037; Grant sponsor: the VA Center of Excellence for Stress and Mental Health.	Acheson D, 2013, PSYCHOPHARMACOLOGY, V229, P199, DOI 10.1007/s00213-013-3099-4; Achesona DT, 2015, PSYCHONEUROENDOCRINO, V51, P495, DOI 10.1016/j.psyneuen.2014.09.030; Alosco M. L., 2015, J HEAD TRAUMA REHAB, V31, P1; Baker DG, 2012, NEUROPHARMACOLOGY, V62, P663, DOI 10.1016/j.neuropharm.2011.02.027; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; BLANCHARD EB, 1995, BEHAV RES THER, V33, P369, DOI 10.1016/0005-7967(94)00067-T; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Briscione MA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00088; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Craske M.G., 2006, FEAR LEARNING BASIC, P217, DOI [10.1037/11474-011, DOI 10.1037/11474-011]; Davies D. R., 2016, FRONT BEHAV NEUROSCI, V10, P1; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fidan E, 2016, J NEUROTRAUM, V33, P641, DOI 10.1089/neu.2015.3958; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Genovese RF, 2013, NEUROSCIENCE, V254, P120, DOI 10.1016/j.neuroscience.2013.09.021; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Grillon C, 2009, BIOL PSYCHIAT, V66, P47, DOI 10.1016/j.biopsych.2008.12.028; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 2016, PSYCHONEUROENDOCRINO, V63, P398, DOI 10.1016/j.psyneuen.2015.02.008; IBM Corp. Released, 2012, IBM SPSS STAT WIND V; Inslicht SS, 2013, J PSYCHIATR RES, V47, P64, DOI 10.1016/j.jpsychires.2012.08.027; Iverson G. L., 2012, REHABILITATION REP, V2012; Jones ME, 2015, NEUROPSYCHOPHARMACOL, V40, P1289, DOI 10.1038/npp.2014.317; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lissek S, 2015, INT J PSYCHOPHYSIOL, V98, P594, DOI 10.1016/j.ijpsycho.2014.11.006; Logue OC, 2016, EXP NEUROL, V277, P227, DOI 10.1016/j.expneurol.2015.12.019; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; Maeng LY, 2015, HORM BEHAV, V76, P106, DOI 10.1016/j.yhbeh.2015.04.002; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Mineka S, 2006, AM PSYCHOL, V61, P10, DOI 10.1037/0003-066X.61.1.10; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Prasad KN, 2015, BRAIN RES, V1599, P103, DOI 10.1016/j.brainres.2014.12.038; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Risbrough V. B., 2016, ELECTROPHYSIOLOGY PS, V28, P1, DOI DOI 10.1007/7854_; Schneider BL, 2016, J NEUROTRAUM, V33, P1614, DOI 10.1089/neu.2015.4190; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shvil E, 2014, NEUROBIOL LEARN MEM, V113, P101, DOI 10.1016/j.nlm.2014.02.003; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vogt D, 2013, J TRAUMA STRESS, V26, P710, DOI 10.1002/jts.21868; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Weathers FW, 2001, DEPRESS ANXIETY, V13, P132, DOI 10.1002/da.1029; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yurgil KA, 2016, J HEAD TRAUMA REHAB, V31, P30, DOI 10.1097/HTR.0000000000000117; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zuckerman SL, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15593	89	21	21	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1091-4269	1520-6394		DEPRESS ANXIETY	Depress. Anxiety	AUG	2017	34	8					723	733		10.1002/da.22642			11	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	FC4TZ	WOS:000406835000007	28489272	Green Submitted			2022-02-06	
J	Lourenco, CF; Ledo, A; Gerhardt, GA; Laranjinha, J; Barbosa, RM				Lourenco, Catia F.; Ledo, Ana; Gerhardt, Greg A.; Laranjinha, Joao; Barbosa, Rui M.			Neurometabolic and electrophysiological changes during cortical spreading depolarization: multimodal approach based on a lactate-glucose dual microbiosensor arrays	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; IN-VIVO; ONLINE MICRODIALYSIS; EXTRACELLULAR GLUCOSE; MICROELECTRODE ARRAYS; MALIGNANT STROKE; DYNAMIC CHANGES; TISSUE PO2; RAT-BRAIN; DEPRESSION	Spreading depolarization (SD) is a slow propagating wave of strong depolarization of neural cells, implicated in several neuropathological conditions. The breakdown of brain homeostasis promotes significant hemodynamic and metabolic alterations, which impacts on neuronal function. In this work we aimed to develop an innovative multimodal approach, encompassing metabolic, electric and hemodynamic measurements, tailored but not limited to study SD. This was based on a novel dualbiosensor based on microelectrode arrays designed to simultaneously monitor lactate and glucose fluctuations and ongoing neuronal activity with high spatial and temporal resolution. In vitro evaluation of dual lactate-glucose microbiosensor revealed an extended linear range, high sensitivity and selectivity, fast response time and low oxygen-, temperature-and pH-dependencies. In anesthetized rats, we measured with the same array a significant drop in glucose concentration matched to a rise in lactate and concurrently with pronounced changes in the spectral profile of LFP-related currents during episodes of mechanically-evoked SD. This occurred along with the stereotypical hemodynamic response of the SD wave. Overall, this multimodal approach successfully demonstrates the capability to monitor metabolic alterations and ongoing electrical activity, thus contributing to a better understanding of the metabolic changes occurring in the brain following SD.	[Lourenco, Catia F.; Ledo, Ana; Laranjinha, Joao; Barbosa, Rui M.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Gerhardt, Greg A.] Univ Kentucky, Ctr Microelectrode Technol, Lexington, KY 40506 USA; [Laranjinha, Joao; Barbosa, Rui M.] Univ Coimbra, Fac Pharm, Coimbra, Portugal		Lourenco, CF; Barbosa, RM (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.; Barbosa, RM (corresponding author), Univ Coimbra, Fac Pharm, Coimbra, Portugal.	cflmarques@uc.pt; rbarbosa@ff.uc.pt	Marques, Catia Lourenco/M-6634-2013; Barbosa, Rui M./U-7117-2019; Ledo, Ana/L-6016-2013	Marques, Catia Lourenco/0000-0002-0514-0198; Barbosa, Rui M./0000-0002-1604-6324; Ledo, Ana/0000-0002-7737-4241	FEDER funds through the Operational Program Competitiveness Factors - COMPETE; FCT - Foundation for Science and TechnologyPortuguese Foundation for Science and Technology [POCI-01-0145-FEDER-007440]; FCTPortuguese Foundation for Science and TechnologyEuropean Commission [SFRH/BPD/82436/2011]	This work was funded by FEDER funds through the Operational Program Competitiveness Factors - COMPETE and national funds by FCT - Foundation for Science and Technology under strategic project POCI-01-0145-FEDER-007440. C.F.L. acknowledges fellowship SFRH/BPD/82436/2011 from FCT. We acknowledge some support from Quanteon, LLC for salary of A.L.	Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Balanca B, 2017, J CEREBR BLOOD F MET, V37, P1670, DOI 10.1177/0271678X16657571; Burmeister JJ, 2008, BIOSENS BIOELECTRON, V23, P1382, DOI 10.1016/j.bios.2007.12.013; Burmeister JJ, 2005, BIOSENS BIOELECTRON, V20, P1772, DOI 10.1016/j.bios.2004.07.003; Chang JC, 2010, BRAIN, V133, P996, DOI 10.1093/brain/awp338; Cornford EM, 2002, EPILEPSIA, V43, P1360, DOI 10.1046/j.1528-1157.2002.01602.x; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Disney AA, 2015, J NEUROSCI METH, V255, P29, DOI 10.1016/j.jneumeth.2015.07.009; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Ferreira NR, 2013, ELECTROANAL, V25, P1757, DOI 10.1002/elan.201300053; Feuerstein D, 2016, J CEREBR BLOOD F MET, V36, P1965, DOI 10.1177/0271678X15612779; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hertle DN, 2016, CLIN NEUROPHYSIOL, V127, P2661, DOI 10.1016/j.clinph.2016.04.026; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Koroleva V I, 2006, Neurosci Behav Physiol, V36, P625, DOI 10.1007/s11055-006-0067-z; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; LAMANNA JC, 1989, METAB BRAIN DIS, V4, P225, DOI 10.1007/BF00999769; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Ledo A, 2017, ANAL CHEM, V89, P1674, DOI 10.1021/acs.analchem.6b03772; Lourenco CF, 2016, SENSOR ACTUAT B-CHEM, V237, P298, DOI 10.1016/j.snb.2016.06.083; Miele M, 1996, J NEUROSCI METH, V70, P15, DOI 10.1016/S0165-0270(96)00094-5; Murphy LJ, 1998, ANAL CHEM, V70, P2928, DOI 10.1021/ac971182r; MURR R, 1994, PFLUG ARCH EUR J PHY, V426, P348, DOI 10.1007/BF00374792; NAIR PK, 1987, STROKE, V18, P616, DOI 10.1161/01.STR.18.3.616; OGUNYEMI AO, 1995, BEHAV NEUROL, V8, P109, DOI 10.3233/BEN-1995-8206; Ostergaard L, 2015, STROKE, V46, P1392, DOI 10.1161/STROKEAHA.114.008077; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Parkin MC, 2003, TRAC-TREND ANAL CHEM, V22, P487, DOI 10.1016/S0165-9936(03)00912-9; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rocchitta G, 2013, ANAL CHEM, V85, P10282, DOI 10.1021/ac402071w; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; Roshchina G. Y., 2014, NEUROSCI BEHAV PHYSL, V44, P134, DOI [10.1007/s11055-014-9887-4, DOI 10.1007/S11055-014-9887-4]; SCHELLER D, 1992, NEUROSCI LETT, V135, P83, DOI 10.1016/0304-3940(92)90141-S; STAMFORD JA, 1984, BRAIN RES, V299, P289, DOI 10.1016/0006-8993(84)90710-8; Taurino I, 2013, ELECTROCHIM ACTA, V93, P72, DOI 10.1016/j.electacta.2013.01.080; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; TOMIDA S, 1989, J CEREBR BLOOD F MET, V9, P79, DOI 10.1038/jcbfm.1989.11; Vasylieva N, 2015, BIOSENS BIOELECTRON, V72, P148, DOI 10.1016/j.bios.2015.05.004; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Viggiano A, 2012, J NEUROSCI METH, V206, P1, DOI 10.1016/j.jneumeth.2012.01.013; Watson C, 2007, RAT BRAIN STEROTAXIC; Weltin A, 2016, ANAL BIOANAL CHEM, V408, P4503, DOI 10.1007/s00216-016-9420-4; Weltin A, 2014, IEEE SENS J, V14, P3345, DOI 10.1109/JSEN.2014.2323220; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Zhang H, 2009, J NEUROSCI METH, V179, P191, DOI 10.1016/j.jneumeth.2009.01.023	50	21	21	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 28	2017	7									10.1038/s41598-017-07119-6			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC1PP	WOS:000406610000015	28754993	Green Published, gold			2022-02-06	
J	Gu, YZ; Jukkola, P; Wang, Q; Esparza, T; Zhao, Y; Brody, D; Gu, C				Gu, Yuanzheng; Jukkola, Peter; Wang, Qian; Esparza, Thomas; Zhao, Yi; Brody, David; Gu, Chen			Polarity of varicosity initiation in central neuron mechanosensation	JOURNAL OF CELL BIOLOGY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRAUMATIC AXONAL INJURY; BRAIN-INJURY; MOLECULAR-MECHANISMS; STRETCH INJURY; TRP CHANNELS; ION-CHANNEL; ANKYRIN-G; PROTEIN; MICE	Little is known about mechanical regulation of morphological and functional polarity of central neurons. In this study, we report that mechanical stress specifically induces varicosities in the axons but not the dendrites of central neurons by activating TRPV4, a Ca2+/Na+-permeable mechanosensitive channel. This process is unexpectedly rapid and reversible, consistent with the formation of axonal varicosities in vivo induced by mechanical impact in a mouse model of mild traumatic brain injury. In contrast, prolonged stimulation of glutamate receptors induces varicosities in dendrites but not in axons. We further show that axonal varicosities are induced by persistent Ca2+ increase, disassembled microtubules (MTs), and subsequently reversible disruption of axonal transport, and are regulated by stable tubulin-only polypeptide, an MT-associated protein. Finally, axonal varicosity initiation can trigger action potentials to antidromically propagate to the soma in retrograde signaling. Therefore, our study demonstrates a new feature of neuronal polarity: axons and dendrites preferentially respond to physical and chemical stresses, respectively.	[Gu, Yuanzheng; Gu, Chen] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Jukkola, Peter; Gu, Chen] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Wang, Qian; Zhao, Yi] Ohio State Univ, Biomed Engn Dept, Columbus, OH 43210 USA; [Esparza, Thomas; Brody, David] Washington Univ, Dept Neurol, St Louis, MO USA		Gu, C (corresponding author), Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.; Gu, C (corresponding author), Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA.	gu.49@osu.edu	Wang, Qian/B-4282-2015; Jukkola, Peter/O-4982-2019	Wang, Qian/0000-0002-9706-2421; Jukkola, Peter/0000-0001-6076-1117	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS062720, R01NS093073, R21AA024873]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS093073, R01NS062720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA024873] Funding Source: NIH RePORTER	This work was supported in part by grants from National Institutes of Health (R01NS062720, R01NS093073, and R21AA024873) to C. Gu.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amack JD, 2012, SCIENCE, V338, P212, DOI 10.1126/science.1223953; Andrieux A, 2002, GENE DEV, V16, P2350, DOI 10.1101/gad.223302; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Baas PW, 2016, CYTOSKELETON, V73, P442, DOI 10.1002/cm.21286; Barry J, 2014, DEV CELL, V28, P117, DOI 10.1016/j.devcel.2013.11.023; Barry J, 2013, J CELL SCI, V126, P2027, DOI 10.1242/jcs.122234; Barsukova AG, 2012, J NEUROSCI, V32, P12028, DOI 10.1523/JNEUROSCI.0408-12.2012; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Bentley M, 2016, NAT REV NEUROSCI, V17, P611, DOI 10.1038/nrn.2016.100; Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108; Beyder A, 2010, J PHYSIOL-LONDON, V588, P4969, DOI 10.1113/jphysiol.2010.199034; Bosc C, 1996, P NATL ACAD SCI USA, V93, P2125, DOI 10.1073/pnas.93.5.2125; Bu W, 2001, ONCOGENE, V20, P3185, DOI 10.1038/sj.onc.1204429; Campas O, 2014, NAT METHODS, V11, P183, DOI [10.1038/NMETH.2761, 10.1038/nmeth.2761]; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Couegnas A, 2007, J NEUROSCI RES, V85, P1515, DOI 10.1002/jnr.21278; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993; Deloulme JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8246; Eastwood SL, 2007, J PSYCHOPHARMACOL, V21, P635, DOI 10.1177/0269881106068825; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fournet V, 2012, J NEUROCHEM, V121, P99, DOI 10.1111/j.1471-4159.2011.07615.x; Franze K, 2009, BIOPHYS J, V97, P1883, DOI 10.1016/j.bpj.2009.07.033; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gardner A, 2012, NAT PROTOC, V7, P1774, DOI 10.1038/nprot.2012.100; Gibson HE, 2008, NEURON, V57, P746, DOI 10.1016/j.neuron.2007.12.027; Gilmour D, 2004, NAT NEUROSCI, V7, P491, DOI 10.1038/nn1235; Grevesse T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09475; Gu C, 2006, NEURON, V52, P803, DOI 10.1016/j.neuron.2006.10.022; Gu YZ, 2014, MOL NEUROBIOL, V50, P339, DOI 10.1007/s12035-014-8654-4; Gu YZ, 2013, J PHYSIOL-LONDON, V591, P2491, DOI 10.1113/jphysiol.2013.251983; Gu YZ, 2012, J BIOL CHEM, V287, P1755, DOI 10.1074/jbc.M111.299305; Gu YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011931; Guillaud L, 1998, J CELL BIOL, V142, P167, DOI 10.1083/jcb.142.1.167; Harrington AW, 2013, NAT REV NEUROSCI, V14, P177, DOI 10.1038/nrn3253; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Jukkola P, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-70; Jukkola PI, 2012, NEUROBIOL DIS, V47, P280, DOI 10.1016/j.nbd.2012.04.012; Kanayama G, 1996, METHOD FIND EXP CLIN, V18, P105; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Koleske AJ, 2013, NAT REV NEUROSCI, V14, P536, DOI 10.1038/nrn3486; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lefevre J, 2011, J BIOL CHEM, V286, P3065, DOI 10.1074/jbc.M110.144089; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Ligon LA, 2003, MOL BIOL CELL, V14, P1405, DOI 10.1091/mbc.E02-03-0155; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MARGOLIS RL, 1986, P NATL ACAD SCI USA, V83, P639, DOI 10.1073/pnas.83.3.639; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Morris CE, 2007, BIOPHYS J, V93, P822, DOI 10.1529/biophysj.106.101246; Namba T, 2015, PHYSIOL REV, V95, P995, DOI 10.1152/physrev.00025.2014; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; PIROLLET F, 1992, BIOCHEMISTRY-US, V31, P8849, DOI 10.1021/bi00152a022; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Richard M, 2009, MOL CELL NEUROSCI, V41, P120, DOI 10.1016/j.mcn.2009.02.004; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Ryskamp DA, 2011, J NEUROSCI, V31, P7089, DOI 10.1523/JNEUROSCI.0359-11.2011; Sanchez C, 2000, PROG NEUROBIOL, V61, P133, DOI 10.1016/S0301-0082(99)00046-5; SERRANO L, 1986, J BIOL CHEM, V261, P7076; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Staal JA, 2007, DEV NEUROBIOL, V67, P1831, DOI 10.1002/dneu.20552; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tseng CY, 2011, J NEUROSCI, V31, P15468, DOI 10.1523/JNEUROSCI.2442-11.2011; van Beuningen SFB, 2016, CURR OPIN NEUROBIOL, V39, P1, DOI 10.1016/j.conb.2016.02.003; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; [王启睿 Wang Qirui], 2013, [空间结构, Spatial Structures], V19, P10; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Xu MX, 2007, J NEUROSCI, V27, P14158, DOI 10.1523/JNEUROSCI.3675-07.2007; Xu MX, 2010, J NEUROSCI, V30, P15987, DOI 10.1523/JNEUROSCI.3565-10.2010; Yang J, 2013, NEURON, V80, P1175, DOI 10.1016/j.neuron.2013.08.034; Zheng Y, 2008, NAT CELL BIOL, V10, P1172, DOI 10.1038/ncb1777; Ziv NE, 1995, J NEUROPHYSIOL, V74, P2625, DOI 10.1152/jn.1995.74.6.2625	87	21	21	0	15	ROCKEFELLER UNIV PRESS	NEW YORK	950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA	0021-9525	1540-8140		J CELL BIOL	J. Cell Biol.	JUL	2017	216	7					2179	2199		10.1083/jcb.201606065			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EZ2TP	WOS:000404563700029	28606925	hybrid, Green Published			2022-02-06	
J	Keret, A; Bennett-Back, O; Rosenthal, G; Gilboa, T; Shweiki, M; Shoshan, Y; Benifla, M				Keret, Amit; Bennett-Back, Odeya; Rosenthal, Guy; Gilboa, Tal; Shweiki, Moatasim; Shoshan, Yigal; Benifla, Mony			Posttraumatic epilepsy: long-term follow-up of children with mild traumatic brain injury	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						posttraumatic epilepsy; mild traumatic brain injury; pediatric neurosurgery; trauma	HEAD-INJURY; YOUNG-ADULTS; SEIZURES; RISK; EPIDEMIOLOGY; COHORT; EPILEPTOGENESIS; PREVALENCE; PREDICTORS; MECHANISMS	OBJECTIVE Posttraumatic epilepsy (PTE) is a known complication of traumatic brain injury (TBI). The true incidence of PTE in children is still uncertain, because most research has been based primarily on adults. This study aimed to determine the true incidence of PTE in a pediatric population with mild TBI (MTBI) and to identify risk factors for the development of epileptic events. METHODS Data were collected from electronic medical records of children 0-17 years of age, who were admitted to a single medical center between 2007 and 2009 with a diagnosis of MTBI. This prospective research consisted of a telephone survey between 2015 and 2016 of children or their caregivers, querying for information about epileptic episodes and current seizure and neurological status. The primary outcome measure was the incidence of epilepsy following TBI, which was defined as 2 unprovoked seizure episodes. Posttraumatic seizure (PTS) was defined as a single, nonrecurrent convulsive episode that occurred > 24 hours following injury. Seizures within 24 hours of the injury were defined as immediate PTS. RESULTS Of 290 children eligible for this study, 191 of them or their caregivers were reached by telephone survey and were included in the analysis. Most injuries (80.6%) were due to falls. Six children had immediate PTS. All children underwent CT imaging; of them, 72.8% demonstrated fractures and 10.5% did not demonstrate acute findings. The mean follow-up was 7.4 years. Seven children (3.7%) experienced PTS; of them, 6 (85.7%) developed epilepsy and 3 (42.9%) developed intractable epilepsy. The overall incidence of epilepsy and intractable epilepsy in this cohort was 3.1% and 1.6%, respectively. None of the children who had immediate PTS developed epilepsy. Children who developed epilepsy spent an average of 2 extra days in the hospital at the time of the injury. The mean time between trauma and onset of seizures was 3.1 years. Immediate PTS was not correlated with PTE. CONCLUSIONS In this analysis of data from medical records and long-term follow-up, MTBI was found to confer increased risk for the development of PTE and intractable PTE, of 4.5 and 8 times higher, respectively. As has been established in adults, these findings confirm that MTBI increases the risk for PTE in the pediatric population.	[Keret, Amit; Shweiki, Moatasim; Benifla, Mony] Hadassah Ein Kerem Med Ctr, Pediat Neurosurg Unit, Jerusalem, Israel; [Rosenthal, Guy; Shweiki, Moatasim; Shoshan, Yigal; Benifla, Mony] Hadassah Ein Kerem Med Ctr, Neurosurg Dept, Jerusalem, Israel; [Bennett-Back, Odeya; Gilboa, Tal] Hadassah Ein Kerem Med Ctr, Pediat Neurol Dept, Jerusalem, Israel		Benifla, M (corresponding author), Hadassah Med Ctr, Dept Neurosurg, POB 12000, IL-91120 Jerusalem, Israel.	beniflam@yahoo.com		Keret, Amit/0000-0002-2242-3632			Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Appleton RE, 2002, J NEUROL NEUROSUR PS, V72, P669, DOI 10.1136/jnnp.72.5.669; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; Del Felice A, 2010, EPILEPSIA, V51, P37, DOI 10.1111/j.1528-1167.2009.02141.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Huguenard AL, 2016, J NEUROSURG-PEDIATR, V17, P476, DOI 10.3171/2015.7.PEDS14723; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jabbari B, 2002, BRAIN INJURY, V16, P463, DOI 10.1080/02699050110102086; Jobst BC, 2015, JAMA-J AM MED ASSOC, V313, P285, DOI 10.1001/jama.2014.17426; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kieslich M, 2001, DISABIL REHABIL, V23, P665; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee ST, 1997, CAN J NEUROL SCI, V24, P40, DOI 10.1017/S0317167100021077; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Matsumoto JH, 2013, EPILEPSY BEHAV, V27, P233, DOI 10.1016/j.yebeh.2013.01.024; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Ratan SK, 1999, PEDIATR NEUROSURG, V30, P127, DOI 10.1159/000028779; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Schmidt D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g254; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983	42	21	22	0	12	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUL	2017	20	1					64	70		10.3171/2017.2.PEDS16585			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EY6IZ	WOS:000404087300009	28474982	Bronze			2022-02-06	
J	Lele, AV; Hoefnagel, AL; Schloemerkemper, N; Wyler, DA; Chaikittisilpa, N; Vavilala, MS; Naik, BI; Williams, JH; Raghavan, LV; Koerner, IP				Lele, Abhijit V.; Hoefnagel, Amie L.; Schloemerkemper, Nina; Wyler, David A.; Chaikittisilpa, Nophanan; Vavilala, Monica S.; Naik, Bhiken I.; Williams, James H.; Raghavan, Lakshmikumar Venkat; Koerner, Ines P.			Perioperative Management of Adult Patients With External Ventricular and Lumbar Drains: Guidelines From the Society for Neuroscience in Anesthesiology and Critical Care	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						external ventricular drain; ventriculostomy; lumbar drain; guidelines; perioperative; management; leveling; transport; checklist; competency	CEREBROSPINAL-FLUID DRAINAGE; THORACOABDOMINAL AORTIC-ANEURYSM; TRAUMATIC BRAIN-INJURY; ASSOCIATION/AMERICAN STROKE ASSOCIATION; TISSUE-PLASMINOGEN ACTIVATOR; CEREBRAL PERFUSION-PRESSURE; RANDOMIZED CONTROLLED-TRIAL; CHRONIC SUBDURAL-HEMATOMA; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE	External ventricular drains and lumbar drains are commonly used to divert cerebrospinal fluid and to measure cerebrospinal fluid pressure. Although commonly encountered in the perioperative setting and critical for the care of neurosurgical patients, there are no guidelines regarding their management in the perioperative period. To address this gap in the literature, The Society for Neuroscience in Anesthesiology & Critical Care tasked an expert group to generate evidence-based guidelines. The document generated targets clinicians involved in perioperative care of patients with indwelling external ventricular and lumbar drains.	[Lele, Abhijit V.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol & Pain Med,Neurocrit Care Serv, Seattle, WA 98104 USA; [Chaikittisilpa, Nophanan] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol & Pediat, Seattle, WA 98104 USA; [Hoefnagel, Amie L.] Univ Florida, Dept Anesthesiol, UF Hlth, Jacksonville, FL USA; [Schloemerkemper, Nina] Univ Calif Davis, Med Ctr, Dept Anesthesiol & Pain Med, Sacramento, CA 95817 USA; [Wyler, David A.] Thomas Jefferson Univ, Jefferson Hosp Neurosci, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Naik, Bhiken I.] Univ Virginia Hlth Syst, Dept Anesthesiol & Neurosurg, Charlottesville, VA USA; [Williams, James H.] Univ North Carolina Chapel Hill, Dept Anesthesiol, N2201 UNC Hosp, Chapel Hill, NC USA; [Raghavan, Lakshmikumar Venkat] Toronto Western Hosp, Dept Anesthesia & Pain Med, Toronto, ON, Canada; [Koerner, Ines P.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Neurosci ICU, Portland, OR USA		Lele, AV (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, Neurocrit Care Serv, 325,9th Ave, Seattle, WA 98104 USA.	abhijit2@uw.edu	Naik, Bhiken/AAH-3831-2019		Mizuho OSI	A.L.H. has received honoraria from Design Science Consulting Inc.; N.S. has received consulting fee from Mizuho OSI. The other authors have no conflicts of interest to disclose.	Abdoh MG, 2012, ACTA NEUROCHIR, V154, P153, DOI 10.1007/s00701-011-1136-9; Acikbas SC, 2002, ACTA NEUROCHIR, V144, P475, DOI 10.1007/s007010200068; Aghamohamadi Davood, 2013, Anesth Pain Med, V2, P159, DOI 10.5812/aapm.6510; Albu S, 2016, CLIN NEUROL NEUROSUR, V142, P43, DOI 10.1016/j.clineuro.2016.01.019; Amato A, 2011, NURS CRIT CARE, V16, P252, DOI 10.1111/j.1478-5153.2010.00444.x; American Society of Anesthesiologists, 2011, GUID PAT CAR AN; American Society of Anesthesiologists, 2015, STAND BAS AN MON; Andrews CM, 2012, NEUROCRIT CARE, V17, P37, DOI 10.1007/s12028-012-9757-2; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; ANDREWS RJ, 1993, NEUROSURGERY, V33, P1052; Antunes P, 2016, ACTA ANAESTH SCAND, V60, P1323, DOI 10.1111/aas.12763; Atkinson RA, 2016, J HOSP INFECT, V92, P263, DOI 10.1016/j.jhin.2015.09.014; Australasian College for Emergency Medicine (ACEM) Australian and New Zealand College of Anaesthetists (ANZCA) College of Intensive Care Medicine of Australia and New Zealand (CICM), 2015, GUID TRANSP CRIT PAT; Bakhsheshian J, 2015, LARYNGOSCOPE, V125, P2245, DOI 10.1002/lary.25379; Basauri LT, 1999, CRIT REV NEUROSURG, V9, P21, DOI 10.1007/s003290050104; Bateman BT, 2013, ANESTH ANALG, V116, P1380, DOI 10.1213/ANE.0b013e318251daed; Bauer DF, 2011, J TRAUMA, V70, P1112, DOI 10.1097/TA.0b013e3181e7c2ae; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Bhargava D, 2013, ACTA NEUROCHIR, V155, P2129, DOI 10.1007/s00701-013-1735-8; Bien AG, 2007, SKULL BASE-INTERD AP, V17, P133, DOI 10.1055/s-2007-970562; Binz DD, 2009, NEUROCRIT CARE, V10, P253, DOI 10.1007/s12028-009-9193-0; Birch AA, 2006, NEUROCRIT CARE, V5, P51, DOI 10.1385/NCC:5:1:51; Bisnaire D, 1997, J Neurosci Nurs, V29, P261; Bloch J, 2003, J NEUROL NEUROSUR PS, V74, P992, DOI 10.1136/jnnp.74.7.992; Bohl MA, 2016, NEUROSURGERY, V79, P296, DOI 10.1227/NEU.0000000000001164; Borire AA, 2015, J NEURO-OPHTHALMOL, V35, P293, DOI 10.1097/WNO.0000000000000239; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P37, DOI DOI 10.1089/NEU.2007.9990; Bruder M, 2015, WORLD NEUROSURG, V84, P1653, DOI 10.1016/j.wneu.2015.07.003; Camacho EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050708; Carney N, 2016, NEUROSURGERY; Center for Professional Practice of Nursing, 2016, ASS MAN EXT VENTR DR; Chai FY, 2013, TURK NEUROSURG, V23, P561, DOI 10.5137/1019-5149.JTN.5724-12.1; Chaikittisilpa N, 2016, NEUROCRIT CARE; Chaney MA, 2006, ANESTH ANALG, V102, P45, DOI 10.1213/01.ane.0000183650.16038.f6; Chatzi M, 2014, CRIT CARE MED, V42, P66, DOI 10.1097/CCM.0b013e31829a70a5; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Cheung AT, 2003, ANN THORAC SURG, V76, P1190, DOI 10.1016/S0003-4975(03)00881-6; Chung DY, 2016, NEUROCRIT CARE; Cinibulak Z, 2016, ACTA NEUROCHIR, V158, P847, DOI 10.1007/s00701-016-2747-y; Civelek E, 2007, TURK NEUROSURG, V17, P289; Cohen-Gadol AA, 2013, INT J SURG CASE REP, V4, P834, DOI 10.1016/j.ijscr.2013.06.014; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Coselli JS, 2002, J VASC SURG, V35, P631, DOI 10.1067/mva.2002.122024; Crowson MG, 2016, ANN OTO RHINOL LARYN, V125, P63, DOI 10.1177/0003489415597917; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 2003, NEUROSURGERY, V52, P619, DOI 10.1227/01.NEU.0000049956.11888.6D; Dagnew E, 2002, NEUROSURGERY, V51, P823, DOI 10.1227/01.NEU.0000024285.50494.83; Dey M, 2015, NEUROSURGERY, V76, P291, DOI 10.1227/NEU.0000000000000624; Dey M, 2012, CURR CARDIOL REP, V14, P754, DOI 10.1007/s11886-012-0316-4; Dey M, 2012, CURR NEUROL NEUROSCI, V12, P24, DOI 10.1007/s11910-011-0231-x; Dimitriou J, 2016, WORLD NEUROSURG, V89, P641, DOI 10.1016/j.wneu.2015.11.037; Doring B L, 1999, J Neurosci Nurs, V31, P80; Drake James M, 2005, Neurosurgery, V56, pE1161; Elvy J, 2008, J ANTIMICROB CHEMOTH, V61, P461, DOI 10.1093/jac/dkm501; Estrera AL, 2003, J THORAC CARDIOV SUR, V126, P1288, DOI 10.1016/S0022-5223(03)00962-0; Estrera AL, 2009, ANN THORAC SURG, V88, P9, DOI 10.1016/j.athoracsur.2009.03.039; Etz CD, 2015, EUR J CARDIO-THORAC, V47, P943, DOI 10.1093/ejcts/ezv142; Evans JM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-222; Fan Jun-Yu, 2004, J Neurosci Nurs, V36, P278; Fanara B, 2010, CRIT CARE, V14, DOI 10.1186/cc9018; Fargen KM, 2016, J NEUROSURG, V124, P1805, DOI 10.3171/2015.5.JNS15299; Farling PA, 2006, RECOMMENDATIONS SAFE; Fields JD, 2006, NEUROLOGY, V67, P1513, DOI 10.1212/01.wnl.0000242889.02957.b6; Flint AC, 2013, NEUROSURGERY, V72, P993, DOI 10.1227/NEU.0b013e31828e8dfd; Foreman PM, 2015, CLIN NEUROL NEUROSUR, V128, P94, DOI 10.1016/j.clineuro.2014.09.026; Fountas KN, 2006, NEUROSURG REV, V29, P14, DOI 10.1007/s10143-005-0423-4; Francel P C, 1992, J Craniofac Surg, V3, P145, DOI 10.1097/00001665-199211000-00006; Fried HI, 2016, NEUROCRIT CARE, V24, P61, DOI 10.1007/s12028-015-0224-8; Ghajar J, 1995, New Horiz, V3, P395; Goodson K, 2008, NEUROCRIT CARE, V8, P247, DOI 10.1007/s12028-007-9017-z; Grady RE, 1999, ANESTH ANALG, V88, P388; Great Ormond Street Hospital for Children, 2015, EXT VENTR DRAIN; Hagel S, 2014, Interdiscip Perspect Infect Dis, V2014, P708531, DOI 10.1155/2014/708531; HASAN D, 1991, STROKE, V22, P190, DOI 10.1161/01.STR.22.2.190; Hellingman CA, 2007, STROKE, V38, P96, DOI 10.1161/01.STR.0000251841.51332.1d; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hepburn-Smith M, 2016, J NEUROSCI NURS, V48, P54, DOI 10.1097/JNN.0000000000000174; Hiratzka LF, 2010, CIRCULATION, V121, pE266, DOI 10.1161/CIR.0b013e3181d4739e; Hirono S, 2015, J NEUROL SURG REP, V76, P83, DOI 10.1055/s-0035-1547369; Hoh BL, 2005, NEUROSURGERY, V57, P845, DOI 10.1227/01.NEU.0000180814.95032.07; Horlocker TT, 2010, REGION ANESTH PAIN M, V35, P64, DOI 10.1097/AAP.0b013e3181c15c70; Howell S, 2008, ANESTH ANALG, V106, P520, DOI 10.1213/ane.0b013e3181606ae5; Hulou MM, 2016, BRIT J NEUROSURG, V30, P438, DOI 10.3109/02688697.2015.1122172; Jacob AK, 2008, ANESTH ANALG, V107, P229, DOI 10.1213/ane.0b013e318174dfbe; Jeong YB, 2009, ACTA ANAESTH SCAND, V53, P1221, DOI 10.1111/j.1399-6576.2009.01984.x; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kalisch B J, 1995, J Neurosci Nurs, V27, P69; KASUYA H, 1991, NEUROSURGERY, V28, P56, DOI 10.1227/00006123-199101000-00009; Kawahara I, 2013, ACTA NEUROCHIR, V155, P1543, DOI 10.1007/s00701-013-1755-4; Kawoos U, 2015, INT J MOL SCI, V16, P28979, DOI 10.3390/ijms161226146; Keong NCH, 2012, NEUROSURGERY, V71, P394, DOI 10.1227/NEU.0b013e318257bebb; Khan NR, 2016, J NEUROSURG-SPINE, V25, P383, DOI 10.3171/2016.1.SPINE151199; Kim GS, 2011, NEUROCRIT CARE, V14, P68, DOI 10.1007/s12028-010-9401-y; Kirkness C J, 2000, J Neurosci Nurs, V32, P271; Kitchen WJ, 2011, BRIT J NEUROSURG, V25, P632, DOI 10.3109/02688697.2011.578770; Kleffmann J, 2016, NEUROCRIT CARE, V25, P440, DOI 10.1007/s12028-016-0274-6; Ko JK, 2014, NEUROL MED-CHIR, V54, P545, DOI 10.2176/nmc.oa.2013-0178; Kocan Mary Jo, 2002, Crit Care Nurse, V22, P70; Komotar RJ, 2005, NEUROSURGERY, V57, P286, DOI 10.1227/01.NEU.0000166661.96546.33; Kosty J, 2013, NEUROSURGERY S, V72; Kosty J, 2013, NEUROSURGERY S, V72; Kosty JA, 2013, ANESTH ANALG, V117, P694, DOI 10.1213/ANE.0b013e31829cc765; Kwon YM, 2015, INT J NEUROSCI, V125, P742, DOI 10.3109/00207454.2015.1012665; Lahner D, 2007, WIEN KLIN WOCHENSCHR, V119, P412, DOI 10.1007/s00508-007-0813-4; Lang EW, 1999, EUR J ANAESTH, V16, P204, DOI 10.1046/j.1365-2346.1999.00442.x; Langan-Fox J, 2000, HUM FACTORS, V42, P242, DOI 10.1518/001872000779656534; Lescot T, 2012, NEUROCHIRURGIE, V58, P235, DOI 10.1016/j.neuchi.2012.03.010; Leverstein-van Hall MA, 2010, J NEUROSURG, V112, P345, DOI 10.3171/2009.6.JNS09223; Leyvi G, 2005, J CARDIOTHOR VASC AN, V19, P392, DOI 10.1053/j.jvca.2005.03.024; Liang HS, 2016, NEUROCRIT CARE, V25, P243, DOI 10.1007/s12028-015-0239-1; Ling E, 2000, ANESTHESIOLOGY, V93, P1115, DOI 10.1097/00000542-200010000-00037; Littlejohns LR, 2009, AACN AANN PROTOCOLS; Lu N, 2012, NEUROCRIT CARE, V16, P368, DOI 10.1007/s12028-011-9659-8; MAGNAES B, 1976, J NEUROSURG, V44, P687, DOI 10.3171/jns.1976.44.6.0687; Makar G, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0525-8; Mancio J, 2014, OXF MED CASE REP, P55, DOI 10.1093/omcr/omu019; Maniker AH, 2006, NEUROSURGERY, V59, P419, DOI 10.1227/01.NEU.0000222817.99752.E6; Manley GT, 2000, J NEUROSURG, V92, P469, DOI 10.3171/jns.2000.92.3.0469; Matsuda H, 2010, ANN THORAC SURG, V90, P561, DOI 10.1016/j.athoracsur.2010.04.067; Mavrocordatos P, 2000, J NEUROSURG ANESTH, V12, P10, DOI 10.1097/00008506-200001000-00003; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Miller C, 2017, J NEUROSURG, V126, P289, DOI 10.3171/2015.12.JNS152341; Mura J, 2013, J NEUROL SURG PART A, V74, P146, DOI 10.1055/s-0032-1330122; Murakami H, 2004, J VASC SURG, V39, P243, DOI 10.1016/j.jvs.2003.07.013; Muralidharan Rajanandini, 2015, Surg Neurol Int, V6, pS271, DOI 10.4103/2152-7806.157620; Muraskin SI, 2007, ANESTH ANALG, V105, P1519, DOI 10.1213/01.ane.0000286081.49295.f3; Narouze S, 2015, REGION ANESTH PAIN M, V40, P182, DOI 10.1097/AAP.0000000000000223; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; Niimura Manabu, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-206654; Nwachuku EL, 2014, NEUROCRIT CARE, V20, P49, DOI 10.1007/s12028-013-9885-3; Olivar H, 2007, CAN J ANAESTH, V54, P829, DOI 10.1007/BF03021711; Olson DM, 2013, J NEUROSURG, V119, P974, DOI 10.3171/2013.6.JNS122403; Paldor I, 2015, J CLIN NEUROSCI, V22, P79, DOI 10.1016/j.jocn.2014.07.006; PAPO I, 1981, ACTA NEUROCHIR, V56, P191, DOI 10.1007/BF01407230; Papson JPN, 2007, ACAD EMERG MED, V14, P574, DOI 10.1197/j.aem.2007.02.034; Park S, 2015, J KOREAN NEUROSURG S, V57, P167, DOI 10.3340/jkns.2015.57.3.167; Park YG, 2011, J KOREAN NEUROSURG S, V50, P317, DOI 10.3340/jkns.2011.50.4.317; Patil V, 2015, STEREOT FUNCT NEUROS, V93, P50, DOI 10.1159/000368906; Petrosoniak A, 2013, CURR OPIN ANESTHESIO, V26, P699, DOI 10.1097/ACO.0000000000000007; Phillips SB, 2014, WORLD NEUROSURG, V82, P739, DOI 10.1016/j.wneu.2013.08.030; Picetti E, 2013, NEUROCRIT CARE, V18, P298, DOI 10.1007/s12028-012-9802-1; Pongudom S, 2011, J MED ASS THAI, V94, P258; Pope W, 1998, J Neurosci Nurs, V30, P185; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Priebe HJ, 2007, BRIT J ANAESTH, V99, P102, DOI 10.1093/bja/aem119; Quenot JP, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-1; Raabe A, 1998, NEUROSURGERY, V42, P74, DOI 10.1097/00006123-199801000-00015; Raabe A, 1998, ACT NEUR S, V71, P59; Rafiq Mirza Faisal Ahmed, 2011, J Ayub Med Coll Abbottabad, V23, P106; Ramakrishna R, 2010, NEUROSURGERY, V67, P110, DOI 10.1227/01.NEU.0000370920.44359.91; Rehman T, 2012, CLIN NEUROL NEUROSUR, V114, P651, DOI 10.1016/j.clineuro.2011.12.040; Remes F, 2013, J NEUROSURG, V119, P1596, DOI 10.3171/2013.6.JNS122126; Riley SP, 2015, J ANESTH, V29, P544, DOI 10.1007/s00540-015-1990-3; Rosenbaum BP, 2014, J CLIN NEUROSCI, V21, P623, DOI 10.1016/j.jocn.2013.09.001; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; Safi HJ, 1996, J VASC SURG, V23, P223, DOI 10.1016/S0741-5214(96)70266-5; Saito K, 2009, NEUROL MED-CHIR, V49, P252, DOI 10.2176/nmc.49.252; Sakowitz OW, 2006, NEUROSURGERY, V58, P137, DOI 10.1227/01.NEU.0000194532.47239.7C; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Salunke P, 2012, NEUROL INDIA, V60, P254, DOI 10.4103/0028-3886.96433; Samadani U, 2003, NEUROSURGERY, V52, P148, DOI 10.1097/00006123-200301000-00019; Sarrafzadeh A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-478; Scheithauer S, 2010, INFECTION, V38, P205, DOI 10.1007/s15010-010-0006-3; Scholz C, 2013, CLIN NEUROL NEUROSUR, V115, P1399, DOI 10.1016/j.clineuro.2013.01.023; Shekhar H, 2016, BRIT J NEUROSURG, V30, P64, DOI 10.3109/02688697.2015.1096903; Simmerman SR, 1997, J NEUROSURG ANESTH, V9, P159, DOI 10.1097/00008506-199704000-00010; Sims-Williams HP, 2014, BRIT J NEUROSURG, V28, P782, DOI 10.3109/02688697.2014.915006; Singh S, 2016, A A CASE REP, V6, P121, DOI 10.1213/XAA.0000000000000230; Sladky John H, 2015, Atlas Oral Maxillofac Surg Clin North Am, V23, P169, DOI 10.1016/j.cxom.2015.05.005; Slazinski T, 2011, CARE PATIENT UNDERGO, P1; Soehle M, 2007, ACTA NEUROCHIR, V149, P575, DOI 10.1007/s00701-007-1149-6; Solter VV, 2014, ACTA CLIN CROAT, V53, P113; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; Stangl AP, 1998, SURG NEUROL, V50, P77, DOI 10.1016/S0090-3019(97)00301-7; Sugrue PA, 2009, J NEUROSURG, V110, P800, DOI 10.3171/2008.5.17568; Sunderland NE, 2016, J NEUROSCI NURS, V48, P274, DOI 10.1097/JNN.0000000000000255; Sussman ES, 2014, J NEUROSURG, V120, P931, DOI 10.3171/2013.12.JNS131685; Tan VES, 2013, ENT-EAR NOSE THROAT, V92, P513, DOI 10.1177/0145561313092010-1112; Tanweer O, 2013, J NEUROSURG, V119, P1309, DOI 10.3171/2013.7.JNS13313; TELISCHI FF, 1995, LARYNGOSCOPE, V105, P219, DOI 10.1288/00005537-199502000-00023; The American Board of Anesthesiology, 2015, PRIM CERT AN; The Royal Children's Hospital Melbourne, 2016, EXT VENTR DRAINS INT; Thompson H J, 2000, Crit Care Nurse, V20, P59; Tiefenthaler W, 2006, ANAESTHESIA, V61, P1208, DOI 10.1111/j.1365-2044.2006.04836.x; Tien DA, 2016, OTOLARYNG CLIN N AM, V49, P119, DOI 10.1016/j.otc.2015.09.007; Ting HYZ, 2014, CAN J ANESTH, V61, P1004, DOI 10.1007/s12630-014-0219-5; TRONNIER V, 1991, ACTA NEUROCHIR, V110, P49, DOI 10.1007/BF01402048; Varelas PN, 2005, NEUROSURGERY, V56, P205, DOI 10.1227/01.neu.0000147973.83688.D8; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Walker CT, 2012, PEDIATR NEUROSURG, V48, P342, DOI 10.1159/000353608; Wang JH, 2014, J MICROBIOL IMMUNOL, V47, P204, DOI 10.1016/j.jmii.2012.08.028; Wang K, 2013, TURK NEUROSURG, V23, P653, DOI 10.5137/1019-5149.JTN.7954-13.0; Wang QP, 2014, NEUROL INDIA, V62, P79, DOI 10.4103/0028-3886.128337; Wang X, 2013, CRIT CARE, V17, DOI 10.1186/cc12608; Warren J, 2004, CRIT CARE MED, V32, P256, DOI 10.1097/01.CCM.0000104917.39204.0A; Weaver KD, 2001, J VASC SURG, V34, P623, DOI 10.1067/mva.2001.117334; Webb A, 2010, NEUROCRIT CARE, V12, P159, DOI 10.1007/s12028-009-9307-8; Weisenberg SH, 2016, J NEUROSURG, V125, P1504, DOI 10.3171/2015.12.JNS151181; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; WILKINSON HA, 1989, NEUROSURGERY, V24, P348, DOI 10.1227/00006123-198903000-00007; Winkler KML, 2013, NEUROCRIT CARE, V18, P161, DOI 10.1007/s12028-013-9816-3; Wong AI, 2016, J NEUROINTERV SURG, V8, P865, DOI 10.1136/neurintsurg-2015-011864; Woodward S, 2002, Br J Nurs, V11, P47; Yasuda T, 2002, PEDIATR NEUROSURG, V36, P22, DOI 10.1159/000048344; Yuan XH, 2014, J CRANIOFAC SURG, V25, P1551, DOI 10.1097/SCS.0000000000000855; Zhao JC, 2015, CLIN NEUROL NEUROSUR, V133, P6, DOI 10.1016/j.clineuro.2015.03.010; Ziai W, 2013, NEUROCRIT CARE, V18, P354, DOI 10.1007/s12028-013-9826-1	209	21	24	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JUL	2017	29	3					191	210		10.1097/ANA.0000000000000407			20	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	EX4UJ	WOS:000403230100001	28169966				2022-02-06	
J	Ma, YB; Matsuwaki, T; Yamanouchi, K; Nishihara, M				Ma, Yanbo; Matsuwaki, Takashi; Yamanouchi, Keitaro; Nishihara, Masugi			Progranulin Protects Hippocampal Neurogenesis via Suppression of Neuroinflammatory Responses Under Acute Immune Stress	MOLECULAR NEUROBIOLOGY			English	Article						Progranulin; Immune stress; Neurogenesis; Microglia; Neuroinflammation	TRAUMATIC BRAIN-INJURY; ADULT NEUROGENESIS; PROGENITOR PROLIFERATION; MICROGLIAL ACTIVATION; HUNTINGTONS-DISEASE; CELL-PROLIFERATION; ROLES; MTOR; EXPRESSION; PHENOTYPE	Immune stress is well known to suppress adult neurogenesis in the hippocampus. We have demonstrated that progranulin (PGRN) has a mitogenic effect on neurogenesis under several experimental conditions. We have also shown that PGRN suppresses excessive neuroinflammatory responses after traumatic brain injury. However, the role of PGRN in modulating neurogenesis under acute immune stress is yet to be elucidated. In the present study, we evaluated the involvement of PGRN in neurogenesis and inflammatory responses in the hippocampus using a lipopolysaccharide (LPS)-induced immune stress model. Treatment of mice with LPS significantly increased the expression of PGRN in activated microglia and decreased neurogenesis in the dentate gyrus of the hippocampus. PGRN deficiency increased CD68-immunoreactive area and exacerbated suppression of neurogenesis following LPS treatment. The expression levels of lysosomal genes including lysozyme M, macrophage expressed gene 1, and cathepsin Z were higher in PGRN-deficient than in wild-type mice, while PGRN deficiency decreased mammalian target of rapamycin (mTOR) mRNA levels, suggesting that PGRN suppresses excessive lysosomal biogenesis by promoting mTOR signaling. LPS treatment also increased the expression of proinflammatory genes such as interleukin (IL)-1 beta, tumor necrosis factor-alpha, and microsomal prostaglandin E synthase-1 (mPGES-1) in the hippocampus, and PGRN deficiency further enhanced gene expression of IL-6 and mPGES-1. These results suggest that PGRN plays a protecting role in hippocampal neurogenesis at least partially by attenuating neuroinflammatory responses during LPS-induced acute immune stress.	[Ma, Yanbo; Matsuwaki, Takashi; Yamanouchi, Keitaro; Nishihara, Masugi] Univ Tokyo, Dept Vet Physiol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan		Nishihara, M (corresponding author), Univ Tokyo, Dept Vet Physiol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	amnishi@mail.ecc.u-tokyo.ac.jp	Yamanouchi, Keitaro/R-5003-2019		JSPS KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23228004]; JSPS Postdoctoral FellowshipMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [26.04906]	This work was partly supported by JSPS KAKENHI (Grant Number 23228004 to MN) and a JSPS Postdoctoral Fellowship for Foreign Researchers (Grant Number 26.04906 to YM).	Anacker C, 2013, P NATL ACAD SCI USA, V110, P8708, DOI 10.1073/pnas.1300886110; Asakura R, 2011, NEUROREPORT, V22, P881, DOI 10.1097/WNR.0b013e32834bf4ca; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Becker JB, 2007, J NEUROSCI, V27, P11851, DOI 10.1523/JNEUROSCI.3565-07.2007; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Cao CY, 1996, BRAIN RES, V733, P263, DOI 10.1016/0006-8993(96)00575-6; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Chiba S, 2007, J REPROD DEVELOP, V53, P297, DOI 10.1262/jrd.18108; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; De Muynck L, 2011, J MOL NEUROSCI, V45, P549, DOI 10.1007/s12031-011-9553-z; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Ek M, 2001, NATURE, V410, P430, DOI 10.1038/35068632; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Foltynie T, 2015, J CLIN INVEST, V125, P978, DOI 10.1172/JCI80822; Gil-Mohapel J, 2011, BRAIN RES, V1406, P84, DOI 10.1016/j.brainres.2011.06.040; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gu ZH, 2013, NEURAL REGEN RES, V8, P2117, DOI 10.3969/j.issn.1673-5374.2013.23.001; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Heberle AM, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970489; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Kleinberger G, 2013, MOL NEUROBIOL, V47, P337, DOI 10.1007/s12035-012-8380-8; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le WD, 2001, J NEUROSCI, V21, P8447, DOI 10.1523/JNEUROSCI.21-21-08447.2001; Lehmann ML, 2013, J NEUROSCI, V33, P2961, DOI 10.1523/JNEUROSCI.3878-12.2013; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Ma YB, 2013, BRAIN RES, V1508, P23, DOI 10.1016/j.brainres.2013.02.042; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Marxreiter F, 2013, CELL MOL LIFE SCI, V70, P459, DOI 10.1007/s00018-012-1062-x; Masocha W, 2009, J NEUROIMMUNOL, V214, P78, DOI 10.1016/j.jneuroim.2009.06.022; Matsuwaki T, 2011, J REPROD DEVELOP, V57, P113, DOI 10.1262/jrd.10-116S; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nedachi T, 2011, NEUROSCIENCE, V185, P106, DOI 10.1016/j.neuroscience.2011.04.037; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; QUAN N, 1994, J NEUROIMMUNOL, V49, P125, DOI 10.1016/0165-5728(94)90188-0; Regensburger M, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/454696; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Suzuki M, 2009, J REPROD DEVELOP, V55, P351, DOI 10.1262/jrd.20249; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; Yu YX, 2009, HIPPOCAMPUS, V19, P1247, DOI 10.1002/hipo.20587	56	21	22	1	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2017	54	5					3717	3728		10.1007/s12035-016-9939-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV9IQ	WOS:000402100100052	27215202				2022-02-06	
J	Yee, MK; Janulewicz, PA; Seichepine, DR; Sullivan, KA; Proctor, SP; Krengel, MH				Yee, Megan K.; Janulewicz, Patricia A.; Seichepine, Daniel R.; Sullivan, Kimberly A.; Proctor, Susan P.; Krengel, Maxine H.			Multiple Mild Traumatic Brain Injuries Are Associated with Increased Rates of Health Symptoms and Gulf War Illness in a Cohort of 1990-1991 Gulf War Veterans	BRAIN SCIENCES			English	Article						mild traumatic brain injury; Gulf War Illness (GWI); chronic multisymptom illness; Gulf War	RECURRENT CONCUSSION; MULTISYMPTOM ILLNESS; COGNITIVE IMPAIRMENT; RISK-FACTORS; DEPRESSION; IMPACT; LIFE; EPIDEMIOLOGY; EXPOSURES	Recent research demonstrated a relation between traumatic brain injury (TBI), health symptoms and diagnosis of Gulf War Illness (GWI) in Gulf War Veterans, but no study has examined the impact of multiple mild TBIs (mTBIs). A total of 229 male Gulf War Veterans from the Ft Devens Cohort were categorized by a number of mTBIs reported. One-way ANOVA and chi-square test of independence were used to test for differences in total reported health symptoms and diagnosis of chronic multisymptom illness (CMI) or Kansas GWI criteria, two of the most common case definitions of GWI. A total of 72 veterans reported no mTBIs (31.4%), 26 reported one mTBI (11.4%), 25 reported two mTBIs (10.9%), and 106 veterans reported sustaining three or more mTBIs (46.3%). Veterans reporting two or more mTBIs (p < 0.01) or three or more mTBIs (p < 0.001) endorsed significantly higher rates of health symptoms than Veterans reporting no mTBIs. Significantly higher rates of CMI (p = 0.035) and Kansas GWI criteria (p < 0.001) were seen in the three or more mTBI group. Results suggest two mTBIs increase risk of health symptoms, but three mTBIs may be the threshold needed to sustain chronic symptom reporting needed for a formal diagnosis. These findings highlight the importance of implementing policies and procedures monitoring head injuries in military personnel.	[Yee, Megan K.] Boston VA Res Inst Inc, Boston, MA 02130 USA; [Janulewicz, Patricia A.; Sullivan, Kimberly A.; Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02118 USA; [Seichepine, Daniel R.] Univ New Hampshire, Neuropsychol Lab, Manchester, NH 03101 USA; [Proctor, Susan P.] US Army Res Inst Environm Med, Mil Performance Div, Natick, MA 01760 USA; [Proctor, Susan P.; Krengel, Maxine H.] VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA; [Krengel, Maxine H.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Krengel, MH (corresponding author), VA Boston Healthcare Syst, Res Serv, Boston, MA 02130 USA.; Krengel, MH (corresponding author), Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA.	meganyee@bu.edu; paj@bu.edu; daniel.seichepine@unh.edu; tty@bu.edu; susan.p.proctor.civ@mail.mil; mhk@bu.edu		Sullivan, Kimberly/0000-0001-7940-6123; Janulewicz Lloyd, Patricia/0000-0002-5299-4946; Krengel, Maxine/0000-0001-7632-590X	Department of Defense GWIRP grantUnited States Department of Defense [GW100046]	Department of Defense GWIRP grant to Krengel GW100046.	Abou-Donia MB, 2017, NEUROTOXICOL TERATOL, V61, P36, DOI 10.1016/j.ntt.2017.03.002; Center for Disease Control, 2003, REP CONGR MILD TRAUM; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Dursa EK, 2016, J OCCUP ENVIRON MED, V58, P41, DOI 10.1097/JOM.0000000000000627; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Institute of Medicine, 2014, CHRON MULT ILLN GULF; Institute of Medicine Gulf War and Health, 2010, UPD HLTH EFF SERV GU; Ismail K, 2011, OCCUP MED-OXFORD, V61, P483, DOI 10.1093/occmed/kqr086; Kelsall HL, 2009, AM J EPIDEMIOL, V170, P1048, DOI 10.1093/aje/kwp238; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Ozakinci G, 2006, ENVIRON HEALTH PERSP, V114, P1553, DOI 10.1289/ehp.9251; Proctor SP, 2001, MIL MED, V166, P510, DOI 10.1093/milmed/166.6.510; Proctor SP, 2001, J OCCUP ENVIRON MED, V43, P259, DOI 10.1097/00043764-200103000-00014; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Research Advisory Committee on Gulf War Veterans' Illnesses (RAC-GWVI), 2013, GULF WAR ILLN HLTH G; Salamon R, 2006, INT J EPIDEMIOL, V35, P479, DOI 10.1093/ije/dyi318; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Smith BN, 2013, J OCCUP ENVIRON MED, V55, P116, DOI 10.1097/JOM.0b013e318270d709; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Sullivan K, 2003, J PSYCHOPATHOL BEHAV, V25, P95, DOI 10.1023/A:1023342915425; Theadom A, 2015, J NEUROTRAUM, V32, P674, DOI 10.1089/neu.2014.3579; VA/DoD, 2014, CLIN PRACT GUID MAN; White RF, 2001, AM J IND MED, V40, P42, DOI 10.1002/ajim.1070; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wolfe J, 1998, AM J IND MED, V33, P104, DOI 10.1002/(SICI)1097-0274(199802)33:2<104::AID-AJIM2>3.0.CO;2-Y; Wolfe J, 2002, J OCCUP ENVIRON MED, V44, P271, DOI 10.1097/00043764-200203000-00015; Yee MK, 2016, J HEAD TRAUMA REHAB, V31, P320, DOI 10.1097/HTR.0000000000000173; 1997, JAMA-J AM MED ASSOC, V277, P238, DOI DOI 10.1001/JAMA.1997.03540270064028	39	21	21	1	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	JUL	2017	7	7							79	10.3390/brainsci7070079			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FD3PH	WOS:000407444400010	28698487	gold, Green Published, Green Submitted			2022-02-06	
J	Bressler, S; Goldberg, H; Shinn-Cunningham, B				Bressler, Scott; Goldberg, Hannah; Shinn-Cunningham, Barbara			Sensory coding and cognitive processing of sound in Veterans with blast exposure	HEARING RESEARCH			English	Article						Blast-induced traumatic brain injury; Selective attention; Envelope following response; Cochlear neuropathy; Hidden hearing loss	TRAUMATIC BRAIN-INJURY; HIDDEN HEARING-LOSS; COCHLEAR NEUROPATHY; INDIVIDUAL-DIFFERENCES; HEAD-INJURY; MILITARY; ATTENTION; SPEECH; NOISE; EEG	Recent anecdotal reports from VA audiology clinics as well as a few published studies have identified a sub-population of Service Members seeking treatment for problems communicating in everyday, noisy listening environments despite having normal to near-normal hearing thresholds. Because of their increased risk of exposure to dangerous levels of prolonged noise and transient explosive blast events, communication problems in these soldiers could be due to either hearing loss (traditional or "hidden") in the auditory sensory periphery or from blast-induced injury to cortical networks associated with attention. We found that out of the 14 blast-exposed Service Members recruited for this study, 12 had hearing thresholds in the normal to near-normal range. A majority of these participants reported having problems specifically related to failures with selective attention. Envelope following responses (EFRs) measuring neural coding fidelity of the auditory brainstem to suprathreshold sounds were similar between blast-exposed and non-blast controls. Blast-exposed subjects performed substantially worse than non-blast controls in an auditory selective attention task in which listeners classified the melodic contour (rising, falling, or "zig-zagging") of one of three simultaneous, competing tone sequences. Salient pitch and spatial differences made for easy segregation of the three concurrent melodies. Poor performance in the blast-exposed subjects was associated with weaker evoked response potentials (ERPs) in frontal EEG channels, as well as a failure of attention to enhance the neural responses evoked by a sequence when it was the target compared to when it was a distractor. These results suggest that communication problems in these listeners cannot be explained by compromised sensory representations in the auditory periphery, but rather point to lingering blast-induced damage to cortical networks implicated in the control of attention. Because all study participants also suffered from post-traumatic disorder (PTSD), follow-up studies are required to tease apart the contributions of PTSD and blast-induced injury on cognitive performance. (C) 2016 Elsevier B.V. All rights reserved.	[Bressler, Scott; Goldberg, Hannah; Shinn-Cunningham, Barbara] Boston Univ, Ctr Computat Neurosci & Neural Technol CompNet, Boston, MA 02215 USA; [Shinn-Cunningham, Barbara] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA		Shinn-Cunningham, B (corresponding author), Ctr Computat Neurosci & Neural Technol, 677 Beacon St, Boston, MA 02215 USA.	shinn@bu.edu		Shinn-Cunningham, Barbara/0000-0002-5096-5914	National Security Science and Engineering Fellowship;  [NIH RO1 DC009477]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC009477, R01DC013825] Funding Source: NIH RePORTER	The authors thank Dr. Yelena Bogdanova, Sarah I(ark, and Vivian Ho at VA Boston Healthcare System, Jamaica Plain Campus for their assistance with subject referrals. This project was supported by NIH RO1 DC009477, and by a National Security Science and Engineering Fellowship to BGSC. The authors declare no competing financial interests.	Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Arciniegas D., 2014, J NEUROPSYCHIATRY CL, V12, P77; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bernstein LR, 2002, J ACOUST SOC AM, V112, P1026, DOI 10.1121/1.1497620; Bharadwaj HM, 2015, J NEUROSCI, V35, P2161, DOI 10.1523/JNEUROSCI.3915-14.2015; Bharadwaj HM, 2014, CLIN NEUROPHYSIOL, V125, P1878, DOI 10.1016/j.clinph.2014.01.011; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Choi I, 2014, HEARING RES, V314, P10, DOI 10.1016/j.heares.2014.04.008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Defense and Veteran Brain Injury Center, 2016, DOD TBI WORLDW NUMB; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demeester K, 2012, EAR HEARING, V33, P615, DOI 10.1097/AUD.0b013e31824e0ba7; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Farmer C.M., 2016, CHARACTERISTICS TREA; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; GOBLICK TJ, 1969, J ACOUST SOC AM, V46, P924, DOI 10.1121/1.1911812; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HINK RF, 1976, PERCEPT PSYCHOPHYS, V20, P236, DOI 10.3758/BF03199449; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoover E.C., 2015, PERSPECT HEAR HEAR D, V19; Krause MO, 2014, BRAIN INJURY, V28, P1473, DOI 10.3109/02699052.2014.920520; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kwok FY, 2008, BRAIN INJURY, V22, P740, DOI 10.1080/02699050802336989; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lobarinas E, 2013, HEARING RES, V302, P113, DOI 10.1016/j.heares.2013.03.012; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Mehraei G, 2016, J NEUROSCI, V36, P3755, DOI 10.1523/JNEUROSCI.4460-15.2016; Mesgarani N, 2012, NATURE, V485, P233, DOI 10.1038/nature11020; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Michalka SW, 2015, NEURON, V87, P882, DOI 10.1016/j.neuron.2015.07.028; Munjal SK, 2010, BRAIN INJURY, V24, P525, DOI 10.3109/02699050903516872; Noble W, 2013, INT J AUDIOL, V52, P409, DOI 10.3109/14992027.2013.781278; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Oleksiak M, 2012, J REHABIL RES DEV, V49, P995, DOI 10.1682/JRRD.2011.01.0001; PICTON TW, 1974, ELECTROEN CLIN NEURO, V36, P191, DOI 10.1016/0013-4694(74)90156-4; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Ruggles D, 2012, CURR BIOL, V22, P1417, DOI 10.1016/j.cub.2012.05.025; Ruggles D, 2011, P NATL ACAD SCI USA, V108, P15516, DOI 10.1073/pnas.1108912108; Ruggles D, 2011, JARO-J ASSOC RES OTO, V12, P395, DOI 10.1007/s10162-010-0254-z; Saunders G.H., 2012, JRRD, V49; Saunders GH, 2015, J REHABIL RES DEV, V52, P343, DOI 10.1682/JRRD.2014.11.0275; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Shaheen LA, 2015, JARO-J ASSOC RES OTO, V16, P727, DOI 10.1007/s10162-015-0539-3; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Shinn-Cunningham Barbara G, 2008, Trends Amplif, V12, P283, DOI 10.1177/1084713808325306; Skoe E, 2010, EAR HEARING, V31, P302, DOI 10.1097/AUD.0b013e3181cdb272; Smetana W.R, 1999, PREDICTING HEARING H; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Taber K., 2007, J NEUROPSYCHIATRY CL, V19; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; Valero MD, 2016, HEARING RES, V332, P29, DOI 10.1016/j.heares.2015.11.005; Viana LM, 2015, HEARING RES, V327, P78, DOI 10.1016/j.heares.2015.04.014; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Zhu L, 2013, J ACOUST SOC AM, V134, P384, DOI 10.1121/1.4807498	76	21	23	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0378-5955	1878-5891		HEARING RES	Hear. Res.	JUN	2017	349				SI		98	110		10.1016/j.heares.2016.10.018			13	Audiology & Speech-Language Pathology; Neurosciences; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Neurosciences & Neurology; Otorhinolaryngology	EW2SB	WOS:000402345200013	27815131	hybrid, Green Accepted			2022-02-06	
J	Krishna, G; Agrawal, R; Zhuang, YM; Ying, Z; Paydar, A; Harris, NG; Royes, LFF; Gomez-Pinilla, F				Krishna, Gokul; Agrawal, Rahul; Zhuang, Yumei; Ying, Zhe; Paydar, Afshin; Harris, Neil G.; Royes, Luiz Fernando F.; Gomez-Pinilla, Fernando			7,8-Dihydroxyflavone facilitates the action exercise to restore plasticity and functionality: Implications for early brain trauma recovery	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						7,8-Dihydroxyflavone; Exercise; Memory; Traumatic brain injury; Functional connectivity; Rehabilitation	SPATIAL MEMORY DEFICITS; TRKB RECEPTOR; AGONIST 7,8-DIHYDROXYFLAVONE; MITOCHONDRIAL BIOGENESIS; COGNITIVE IMPAIRMENT; DOPAMINERGIC-NEURONS; CREB PHOSPHORYLATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; INJURY	Metabolic dysfunction accompanying traumatic brain injury (TBI) severely impairs the ability of injured neurons to comply with functional demands. This limits the success of rehabilitative strategies by compromising brain plasticity and function, and highlights the need for early interventions to promote energy homeostasis. We sought to examine whether the TrkB agonist, 7,8-dihydroxyflavone (7,8-DHF) normalizes brain energy deficits and reestablishes more normal patterns of functional connectivity, while enhancing the effects of exercise during post-TBI period. Moderate fluid percussion injury (FPI) was performed and 7,8-DHF (5 mg/kg, i.p.) was administered in animals subjected to FPI that either had access to voluntary wheel running for 7 days after injury or were sedentary. Compared to sham-injured controls, TBI resulted in reduced hippocampal activation of the BDNF receptor TrkB and associated CREB, reduced levels of plasticity markers GAP-43 and Syn I, as well as impaired memory as indicated by the Barnes maze task. While 7,8-DHF treatment and exercise individually mitigated TBI-induced effects, administration of 7,8-DHF concurrently with exercise facilitated memory performance and augmented levels of markers of cell energy metabolism viz., PGC-1 alpha, COII and AMPK. In parallel to these findings, resting-state functional MRI (fMRI) acquired at 2 weeks after injury showed that 7,8-DHF with exercise enhanced hippocampal functional connectivity, and suggests 7,8-DHF and exercise to promote increases in functional connectivity. Together, these findings indicate that post-injury 7,8-DHF treatment promotes enhanced levels of cell metabolism, synaptic plasticity in combination with exercise increases in brain circuit function that facilitates greater physical rehabilitation after TBI.	[Krishna, Gokul; Agrawal, Rahul; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA; [Zhuang, Yumei; Paydar, Afshin; Harris, Neil G.; Gomez-Pinilla, Fernando] UCLA, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA; [Royes, Luiz Fernando F.] Univ Fed Santa Maria, Ctr Phys Educ & Sports CEFD, Exercise & Biochem Lab, Santa Maria, RS, Brazil		Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, 621 Charles E Young Dr South, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	; Gokul, Krishna/H-3365-2019	Harris, Neil/0000-0002-1965-6750; Agrawal, Rahul/0000-0001-8128-3724; Gokul, Krishna/0000-0001-5869-2204	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050465, NS091222]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050465, R01NS091222] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant NS050465 and NS091222.	Acin-Perez R, 2011, CELL METAB, V13, P712, DOI 10.1016/j.cmet.2011.03.024; Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Arbat-Plana A., 2016, NEUROSCIENCE; Bernard-Gauthier V, 2013, BIOORGAN MED CHEM, V21, P7816, DOI 10.1016/j.bmc.2013.10.012; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Chen L, 2015, J NEUROPATH EXP NEUR, V74, P557, DOI 10.1097/NEN.0000000000000199; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Dachir S, 2014, BRAIN RES, V1555, P78, DOI 10.1016/j.brainres.2014.01.044; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dinocourt C, 2006, EUR J NEUROSCI, V24, P1857, DOI 10.1111/j.1460-9568.2006.05067.x; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Han M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36087; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; He JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34339; Hill JL, 2016, J NEUROCHEM, V139, P106, DOI 10.1111/jnc.13726; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; John JPP, 2009, HIPPOCAMPUS, V19, P731, DOI 10.1002/hipo.20553; Juan WS, 2014, J PINEAL RES, V56, P213, DOI 10.1111/jpi.12114; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Liu CY, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-015-0048-7; Liu X, 2014, J BIOL CHEM, V289, P27571, DOI 10.1074/jbc.M114.562561; Makela J, 2016, NEUROPHARMACOLOGY, V102, P266, DOI 10.1016/j.neuropharm.2015.11.020; Marte A., 2016, MOL NEUROBIOL; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Moro N, 2013, BRAIN RES, V1535, P124, DOI 10.1016/j.brainres.2013.08.044; Porte Y, 2008, NEUROBIOL AGING, V29, P1533, DOI 10.1016/j.neurobiolaging.2007.03.023; Ren Q, 2013, PHARMACOL BIOCHEM BE, V106, P124, DOI 10.1016/j.pbb.2013.03.016; Sanz-Garcia A, 2016, HIPPOCAMPUS, V26, P1179, DOI 10.1002/hipo.22599; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Shama S., 2010, EXP NEUROL, V226, P191; Steiner JL, 2011, J APPL PHYSIOL, V111, P1066, DOI 10.1152/japplphysiol.00343.2011; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Thomason ME, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.055.2009; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Yamada K, 2003, J PHARMACOL SCI, V91, P267; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	53	21	22	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	JUN	2017	1863	6					1204	1213		10.1016/j.bbadis.2017.03.007			10	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EZ4TE	WOS:000404704600005	28315455	Green Accepted, Bronze			2022-02-06	
J	Mantua, J; Henry, OS; Garskovas, NF; Spencer, RMC				Mantua, Janna; Henry, Owen S.; Garskovas, Nolan F.; Spencer, Rebecca M. C.			Mild Traumatic Brain Injury Chronically Impairs Sleep-and Wake-Dependent Emotional Processing	SLEEP			English	Article						Sleep; traumatic brain injury; concussion; memory; emotion	SLOW-WAVE SLEEP; REM-SLEEP; UNITED-STATES; RISK-FACTORS; HEAD-INJURY; MEMORY; DEPRESSION; DISORDERS; AMYGDALA; CONSOLIDATION	Study Objectives: A single traumatic brain injury (TBI), even when mild (ie, concussion), can cause lasting consequences. Individuals with a history of chronic (> 1-year prior) mild TBI have an increased risk of mood disturbances (eg, depression, suicide). This population also has lingering sleep alterations, including poor sleep quality and changes in sleep stage proportions. Given these sleep deficits, we aimed to test whether sleep-dependent emotional memory consolidation is reduced in this population. We utilized a mild TBI group (3.7 +/- 2.9 years post injury) and an uninjured (non-TBI) population. Methods: Participants viewed negative and neutral images both before and after a 12-hour period containing sleep ("Sleep" group) or an equivalent period of time spent awake ("Wake" group). Participants rated images for valence/arousal at both sessions, and memory recognition was tested at session two. Results: The TBI group had less rapid eye movement (REM), longer REM latency, and more sleep complaints. Sleep-dependent memory consolidation of nonemotional images was present in all participants. However, consolidation of negative images was only present in the non-TBI group. A lack of differentiation between the TBI Sleep and Wake groups was due to poor performance in the sleep group and, unexpectedly, enhanced performance in the wake group. Additionally, although the non-TBI participants habituated to negative images over a waking period, the TBI participants did not. Conclusions: We propose disrupted sleep-and wake-dependent emotional processing contributes to poor emotional outcomes following chronic, mild TBI. This work has broad implications, as roughly one-third of the US population will sustain a mild TBI during their lifetime.	[Mantua, Janna; Spencer, Rebecca M. C.] Dept Psychol & Brain Sci, Neuroscience & Behav Program, Amherst, MA USA; [Henry, Owen S.] Commonwealth Honors Coll, Dept Psychol & Brain Sci, Amherst, MA USA; [Garskovas, Nolan F.; Spencer, Rebecca M. C.] Univ Massachusetts, Dept Psychol & Brain Sci, 135 Hicks Way,Tobin 419, Amherst, MA 01003 USA		Spencer, RMC (corresponding author), Univ Massachusetts, Dept Psychol & Brain Sci, 135 Hicks Way,Tobin 419, Amherst, MA 01003 USA.	rspencer@psych.umass.edu		Henry, Owen/0000-0002-2266-7768	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG040133]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040133] Funding Source: NIH RePORTER	This work was supported in part by National Institutes of Health [grant no. R01 AG040133].	Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Arbour C, 2015, SLEEP MED, V16, P534, DOI 10.1016/j.sleep.2014.12.002; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Baker JM, 2014, BRAIN INJURY, V28, P51, DOI 10.3109/02699052.2013.857787; Baran B, 2016, J COGNITIVE NEUROSCI, V28, P792, DOI 10.1162/jocn_a_00938; Baran B, 2012, J NEUROSCI, V32, P1035, DOI 10.1523/JNEUROSCI.2532-11.2012; Battistone M, 2008, APPL NEUROPSYCHOL, V15, P69, DOI 10.1080/09084280801917863; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Benedict C, 2009, FASEB J, V23, P3629, DOI 10.1096/fj.08-122853; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Boyle J, 2006, CURR MED RES OPIN, V22, P1343, DOI 10.1185/030079906X112660; BROOKS D N, 1974, Cortex, V10, P224; BROOKS D N, 1975, Cortex, V11, P329; Broughton RJ, 1989, SLEEP ALERTNESS CHRO; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cairney SA, 2014, SLEEP, V37, P701, DOI 10.5665/sleep.3572; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; Corsi-Cabrera M, 2016, J SLEEP RES, V25, P576, DOI 10.1111/jsr.12415; Cowdin N, 2014, EXP BRAIN RES, V232, P1479, DOI 10.1007/s00221-014-3857-5; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ficca G, 2000, BEHAV BRAIN RES, V112, P159, DOI 10.1016/S0166-4328(00)00177-7; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gerberding JLBS, 2003, CTR DIS CONTR PREV, P9; GILES DE, 1988, J AFFECT DISORDERS, V14, P51, DOI 10.1016/0165-0327(88)90071-7; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Grima N, 2016, J CLIN SLEEP MED, V12, P419, DOI 10.5664/jcsm.5598; Groch S, 2011, PSYCHONEUROENDOCRINO, V36, P1342, DOI 10.1016/j.psyneuen.2011.03.006; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haboubi NHJ, 2001, DISABIL REHABIL, V23, P635; Hazlett EA, 2012, BIOL PSYCHIAT, V72, P448, DOI 10.1016/j.biopsych.2012.03.027; Hendler T, 2001, CELL MOL NEUROBIOL, V21, P733, DOI 10.1023/A:1015156222101; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; Jones BJ, 2016, NEUROBIOL AGING, V45, P178, DOI 10.1016/j.neurobiolaging.2016.05.019; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lang P.J., 2008, INT AFFECTIVE PICTUR, DOI 10.1016/j.epsr.2006.03.016; Lara-Carrasco J, 2009, J SLEEP RES, V18, P178, DOI 10.1111/j.1365-2869.2008.00709.x; LEDOUX JE, 1993, BEHAV BRAIN RES, V58, P69, DOI 10.1016/0166-4328(93)90091-4; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mantua J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00328; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mellman TA, 2002, AM J PSYCHIAT, V159, P1696, DOI 10.1176/appi.ajp.159.10.1696; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Millman RP, 2005, PEDIATRICS, V115, P1774, DOI 10.1542/peds.2005-0772; Modarres Mo H., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P59, DOI 10.1016/j.nbscr.2016.06.001; Pace-Schott EF, 2011, NEUROBIOL LEARN MEM, V95, P24, DOI 10.1016/j.nlm.2010.10.006; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Payne JD, 2008, PSYCHOL SCI, V19, P781, DOI 10.1111/j.1467-9280.2008.02157.x; Payne JD, 2015, EMOTION, V15, P176, DOI 10.1037/a0038683; Ponsford JL, 2013, NEUROREHAB NEURAL RE, V27, P613, DOI 10.1177/1545968313481283; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rizvi SJ, 2013, J AFFECT DISORDERS, V151, P573, DOI 10.1016/j.jad.2013.06.050; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Silver JM, 2005, TXB TRAUMATIC BRAIN, V293, DOI [10.1001/jama.293.17.2161-a, DOI 10.1001/JAMA.293.17.2161-A]; Sonni A, 2015, NEUROBIOL AGING, V36, P2272, DOI 10.1016/j.neurobiolaging.2015.03.010; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; St Jacques PL, 2009, PSYCHOL SCI, V20, P74, DOI 10.1111/j.1467-9280.2008.02258.x; Teasdale JD, 1988, COGNITION EMOTION, V2, P247, DOI 10.1080/02699938808410927; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; van Noordt S, 2011, BRAIN INJURY, V25, P707, DOI 10.3109/02699052.2011.580312; Vandekerckhove M, 2010, SLEEP MED REV, V14, P219, DOI 10.1016/j.smrv.2010.01.002; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wagner U, 2002, PSYCHOSOM MED, V64, P627, DOI 10.1097/01.PSY.0000021940.35402.51; Walker MP, 2009, PSYCHOL BULL, V135, P731, DOI 10.1037/a0016570; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wechsler D., 2008, WECHSLER ADULT INTEL, P1; Wilson JK, 2012, NEUROBIOL AGING, V33, P991, DOI 10.1016/j.neurobiolaging.2011.06.029	77	21	21	2	18	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	JUN	2017	40	6							zsx062	10.1093/sleep/zsx062			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FA6VR	WOS:000405583100008	28460124	Green Published, Bronze			2022-02-06	
J	Stefani, MA; Modkovski, R; Hansel, G; Zimmer, ER; Kopczynski, A; Muller, AP; Strogulski, NR; Rodolphi, MS; Carteri, RK; Schmidt, AP; Oses, JP; Smith, DH; Portela, LV				Stefani, Marco A.; Modkovski, Rafael; Hansel, Gisele; Zimmer, Eduardo R.; Kopczynski, Afonso; Muller, Alexandre P.; Strogulski, Nathan R.; Rodolphi, Marcelo S.; Carteri, Randhall K.; Schmidt, Andre P.; Oses, Jean P.; Smith, Douglas H.; Portela, Luis V.			Elevated glutamate and lactate predict brain death after severe head trauma	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							EXCITATORY AMINO-ACIDS; NEUROTROPHIC FACTOR; INJURY; BIOMARKERS; RELEASE; GLUCOSE; MILD; BDNF; MICRODIALYSIS; RECEPTORS	Objective: Clinical neurological assessment is challenging for severe traumatic brain injury (TBI) patients in the acute setting. Waves of neurochemical abnormalities that follow TBI may serve as fluid biomarkers of neurological status. We assessed the cerebrospinal fluid (CSF) levels of glutamate, lactate, BDNF, and GDNF, to identify potential prognostic biomarkers of neurological outcome. Methods: This cross-sectional study was carried out in a total of 20 consecutive patients (mean [SD] age, 29 [13] years; M/ F, 9: 1) with severe TBI Glasgow Coma Scale <= 8 and abnormal computed tomography scan on admission. Patients were submitted to ventricular drainage and had CSF collected between 2 and 4 h after hospital admission. Patients were then stratified according to two clinical outcomes: deterioration to brain death (nonsurvival, n = 6) or survival (survival, n = 14), within 3 days after hospital admission. Received: 23 February 2017; Accepted: 31 March 2017 CSF levels of brain-derived substances were compared between nonsurvival and survival groups. Clinical and neurological parameters were also assessed. Results: Glutamate and lactate are significantly increased in nonsurvival relative to survival patients. We tested the accuracy of both biomarkers to discriminate patient outcome. Setting a cutoff of > 57.75, glutamate provides 80.0% of sensitivity and 84.62% of specificity (AUC: 0.8214, 95% CL: 54.55-98.08%; and a cutoff of > 4.65, lactate has 100% of sensitivity and 85.71% of specificity (AUC: 0.8810, 95% CL: 54.55-98.08%). BDNF and GDNF did not discriminate poor outcome. Interpretation: This early study suggests that glutamate and lactate concentrations at hospital admission accurately predict death within 3 days after severe TBI.	[Stefani, Marco A.; Modkovski, Rafael] Univ Fed Rio Grande do Sul, Lab Neuroanat, Dept Morphol Sci, Porto Alegre, RS, Brazil; [Hansel, Gisele; Zimmer, Eduardo R.; Kopczynski, Afonso; Strogulski, Nathan R.; Rodolphi, Marcelo S.; Carteri, Randhall K.; Schmidt, Andre P.; Portela, Luis V.] Univ Fed Rio Grande do Sul, Lab Neurotrauma, Dept Biochem, Postgrad Program Biochem, Porto Alegre, RS, Brazil; [Zimmer, Eduardo R.] Pontifical Catholic Univ Rio Grande Sul PUCRS, Brain Inst Rio Grande Sul BraIns, Porto Alegre, RS, Brazil; [Muller, Alexandre P.] Univ South Santa Catarina UNESC, Lab Exercise Biochem & Physiol, Criciuma, SC, Brazil; [Oses, Jean P.] Univ Catolica Pelotas, Grad Program Hlth & Behav, Pelotas, RS, Brazil; [Smith, Douglas H.] Univ Penn, Penn Ctr Brain Injury & Repair, Perelman Sch Med, Philadelphia, PA 19104 USA; [Smith, Douglas H.] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA		Portela, LV (corresponding author), Univ Fed Rio Grande do Sul, Dept Biochem, ICBS, 2600 Ramiro Barcelos St, BR-90035003 Porto Alegre, RS, Brazil.	roskaportela@gmail.com	Carteri, Randhall/A-9015-2017; Oses, Jean Pierre/E-2534-2013; Hansel, Gisele/A-9150-2015; Zimmer, Eduardo R Rigon/I-2932-2015; Carvalho, Afonso/O-8654-2018; Portela, Luis V/I-3410-2014; STEFANI, MARCO ANTONIO/C-3993-2013; Carteri, Randhall/AAN-9871-2021	Carteri, Randhall/0000-0003-4124-9470; Hansel, Gisele/0000-0001-5048-1293; Zimmer, Eduardo R Rigon/0000-0002-5349-0053; STEFANI, MARCO ANTONIO/0000-0002-4728-8764; Carteri, Randhall/0000-0003-4124-9470; Strogulski, Nathan/0000-0003-2166-2137	Coordenacao de Aperfeicoamento de Pessoal de Nivel SuperiorCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [PNPD 1663]; Fundacao de Amparo a Pesquisa do Estado do Rio Grande do SulFundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [1010267]; Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [4011645/2012-6, 5465346/2014-6]	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior PNPD 1663, Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul 1010267, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico 4011645/2012-6, 5465346/2014-6	Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Black IB, 1999, J NEUROBIOL, V41, P108, DOI 10.1002/(SICI)1097-4695(199910)41:1<108::AID-NEU14>3.0.CO;2-U; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Farrand AQ, 2015, NEUROBIOL AGING, V36, P1569, DOI 10.1016/j.neurobiolaging.2014.11.017; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Koura SS, 1998, ACT NEUR S, V71, P244; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Lazaridis C, 2014, NEUROCRIT CARE, V21, P345, DOI 10.1007/s12028-014-0007-7; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Robinet C, 2010, J CEREBR BLOOD F MET, V30, P286, DOI 10.1038/jcbfm.2009.208; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Schmidt AP, 2009, PHARMACOL BIOCHEM BE, V91, P549, DOI 10.1016/j.pbb.2008.09.009; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Simon D, 2016, BRAIN INJURY, V30, P23, DOI 10.3109/02699052.2015.1077993; Thelin EP, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00159; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zauner A, 1996, ACT NEUR S, V67, P40; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	39	21	25	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	JUN	2017	4	6					392	402		10.1002/acn3.416			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB2PI	WOS:000405985300004	28589166	Green Published, gold			2022-02-06	
J	Scheenen, ME; van der Horn, HJ; de Koning, ME; van der Naalt, J; Spikman, JM				Scheenen, Myrthe E.; van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje; Spikman, Jacoba M.			Stability of coping and the role of self-efficacy in the first year following mild traumatic brain injury	SOCIAL SCIENCE & MEDICINE			English	Article						Mild traumatic brain injury; Coping; Stability; Self-efficacy	QUALITY-OF-LIFE; GLASGOW OUTCOME SCALE; SOCIAL SUPPORT; BREAST-CANCER; STRATEGIES; PERSONALITY; VALIDITY; STRESS; STYLES; HEALTH	Background and aims: Coping, the psychological adaptation to stressors and serious life events, has been found to have a great influence on the development and persistence of posttraumatic complaints. Coping has received much attention for having been found to be modifiable in treatment following mild traumatic brain injury (mTBI) and for its potential to identify the Patients who are at risk of suffering from long-term complaints. Currently, coping styles are assumed to be stable over time. Although interventions to facilitate adaptive coping are given at different time intervals after the injury, little is known about spontaneous changes in preferred strategies over time following mTBI. This study aimed to investigate the stability of different coping styles over a one-year period following mTBI (at two weeks', six and twelve months' post-injury) and to investigate the relation between coping styles and feelings of self-efficacy. Methods: We included 425 mTBI patients (Glasgow Coma Scale [GCS] score 13-15) admitted to three Level-1 trauma centers in the Netherlands as part of a prospective follow-up study. All participants filled out The Utrecht Coping List (UCL) to determine their position on seven coping subscales. Results: Most coping styles showed a decrease over time, except for positive reframing, which showed a decrease and then increased. Interestingly, the passive coping style was found to stabilize over time within the year after injury. High feelings of self-efficacy were related to a high active coping style (r = 0.36), and low feelings of self-efficacy with passive coping (r =-032). Conclusions: These results hold important possibilities for the use of the passive coping strategy as an inclusion criterion for intervention studies and an entry point for treatment itself. Considering the intertwinement of coping with self-efficacy, improving feelings of self-efficacy could form an effective part of an intervention to improve outcome. (C) 2017 Elsevier Ltd. All rights reserved.	[Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	m.e.scheenen@umcg.nl; h.j.van.der.horn@umcg.nl; m.e.de.koning@umcg.nl; j.van.der.naalt@umcg.nl; j.m.spikman@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation (Hersenstichting Nederland) [PS2012-06]; Dutch Brain Foundation	This study is funded by the Dutch Brain Foundation (PS2012-06) (Hersenstichting Nederland). The Dutch Brain Foundation is a charitable foundation that supports projects that promote recovery and quality of life of TBI patients in the Netherlands. The funders did not peer review the study, and had no role in study design, data collection, decision to publish or preparation of the article.	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bandura A., 1994, SELF EFFICACY, P71; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Bonanno George A, 2010, Psychol Sci Public Interest, V11, P1, DOI 10.1177/1529100610387086; BROWN GK, 1987, PAIN, V31, P53, DOI 10.1016/0304-3959(87)90006-6; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2006, BRAIN COGNITION, V60, P214; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; DeLongis A, 2005, J PERS, V73, P1633, DOI 10.1111/j.1467-6494.2005.00361.x; Eisenbarth, 2012, N AM J PSYCHOL, V14, P485, DOI DOI 10.1037/t03473-000; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Folkman S, 2004, ANNU REV PSYCHOL, V55, P745, DOI 10.1146/annurev.psych.55.090902.141456; Folkman S., 1984, STRESS; Geyer S, 2015, SOC SCI MED, V135, P92, DOI 10.1016/j.socscimed.2015.04.027; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE43, DOI 10.1097/HTR.0b013e318292fb00; HEIM E, 1993, J PSYCHOSOM RES, V37, P523, DOI 10.1016/0022-3999(93)90008-4; IBM Corp, 2016, IBM SPSS STAT WINDOW; Kendall E, 2001, BRAIN IMPAIR, V2, P81; King C. A., 2008, THESIS; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Luszczynska A, 2005, J PSYCHOL, V139, P439, DOI 10.3200/JRLP.139.5.439-457; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Nielsen MB, 2014, SCAND J PSYCHOL, V55, P142, DOI 10.1111/sjop.12103; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Regier NG, 2015, AGING MENT HEALTH, V19, P1113, DOI 10.1080/13607863.2014.1003286; Scholten AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110905; Schophaus M., 2000, SELF EFFICACY RAW DA; SCHREURS PJG, 1984, GEDRAG GEZOND, V12, P101; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Schwarzer R., 2013, RESILIENCE CHILDREN, P139, DOI [DOI 10.1007/978-1-4614-4939-3_10, 10.1007/978-1-46144939-3_10]; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Taylor SE, 2007, ANNU REV CLIN PSYCHO, V3, P377, DOI 10.1146/annurev.clinpsy.3.022806.091520; TEASDALE G, 1974, LANCET, V2, P81; Tomberg T, 2007, BRAIN INJURY, V21, P479, DOI 10.1080/02699050701311737; Verhage F., 1964, THESIS; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	49	21	21	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0277-9536	1873-5347		SOC SCI MED	Soc. Sci. Med.	MAY	2017	181						184	190		10.1016/j.socscimed.2017.03.025			7	Public, Environmental & Occupational Health; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Biomedical Social Sciences	EU7JL	WOS:000401211000021	28381344	Green Published			2022-02-06	
J	Ivanov, I; Fernandez, C; Mitsis, EM; Dickstein, DL; Wong, E; Tang, CY; Simantov, J; Bang, C; Moshier, E; Sano, M; Elder, GA; Hazlett, EA				Ivanov, Iliyan; Fernandez, Corey; Mitsis, Effie M.; Dickstein, Dara L.; Wong, Edmund; Tang, Cheuk Y.; Simantov, Jessie; Bang, Charlene; Moshier, Erin; Sano, Mary; Elder, Gregory A.; Hazlett, Erin A.			Blast exposure, White Matter integrity, and cognitive Function in iraq and afghanistan combat Veterans	FRONTIERS IN NEUROLOGY			English	Article						adult brain injury; diffusion tensor imaging; magnetic resonance imaging; cognitive function; military injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; DIFFUSION-TENSOR; POSTCONCUSSION SYMPTOMS; SERVICE MEMBERS; PTSD SYMPTOMS; MILD; ABNORMALITIES; TRACTOGRAPHY; SEQUELAE	The long-term effects of blast exposure are a major health concern for combat veterans returning from the recent conflicts in Iraq and Afghanistan. We used an optimized diffusion tensor imaging tractography algorithm to assess white matter (WM) fractional anisotropy (FA) in blast-exposed Iraq and Afghanistan veterans (n= 40) scanned on average 3.7 years after deployment/trauma exposure. Veterans diagnosed with a blast-related mild traumatic brain injury (mTBI) were compared to combat veterans with blast exposure but no TBI diagnosis. Blast exposure was associated with decreased FA in several WM tracts. However, total blast exposure did not correlate well with neuropsychological testing performance and there were no differences in FA based on mTBI diagnosis. Yet, veterans with mTBI performed worse on every neurocognitive test administered. Multiple linear regression across all blast-exposed veterans using a six-factor prediction model indicated that the amount of blast exposure accounted for 11-15% of the variability in composite FA scores such that as blast exposure increased, FA decreased. Education accounted for 10% of the variability in composite FA scores and 25-32% of FA variability in the right cingulum, such that as level of education increased, FA increased. Total blast exposure, age, and education were significant predictors of FA in the left cingulum. We did not find any effect of post-traumatic stress disorder on cognition or composite FA. In summary, our findings suggest that greater total blast exposure is a contributing factor to poor WM integrity. While FA was not associated with neurocognitive performance, we hypothesize that FA changes in the cingulum in veterans with multiple combat exposures and no head trauma prior to deployment may represent a marker of vulnerability for future deficits. Future work needs to examine this longitudinally.	[Ivanov, Iliyan; Fernandez, Corey; Mitsis, Effie M.; Bang, Charlene; Sano, Mary; Elder, Gregory A.; Hazlett, Erin A.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Fernandez, Corey; Sano, Mary; Hazlett, Erin A.] James J Peters Vet Affairs Med Ctr, Res & Dev, Bronx, NY 10468 USA; [Mitsis, Effie M.; Simantov, Jessie; Bang, Charlene] James J Peters Vet Affairs Med Ctr, Rehabil Med Serv, Bronx, NY USA; [Dickstein, Dara L.] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Dickstein, Dara L.; Hazlett, Erin A.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA; [Wong, Edmund; Tang, Cheuk Y.] Icahn Sch Med Mt Sinai, Dept Radiol, Translat & Mol Imaging Inst, New York, NY 10029 USA; [Simantov, Jessie] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Moshier, Erin] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Elder, Gregory A.] James J Peters Vet Affairs Med Ctr, Neurol Serv, Bronx, NY USA; [Hazlett, Erin A.] James J Peters Vet Affairs Med, Mental Illness Res Educ & Clin Ctr MIRECC VISN 2, Bronx, NY 10468 USA		Hazlett, EA (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Hazlett, EA (corresponding author), James J Peters Vet Affairs Med Ctr, Res & Dev, Bronx, NY 10468 USA.; Hazlett, EA (corresponding author), Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, Friedman Brain Inst, New York, NY 10029 USA.; Hazlett, EA (corresponding author), James J Peters Vet Affairs Med, Mental Illness Res Educ & Clin Ctr MIRECC VISN 2, Bronx, NY 10468 USA.	erin.hazlett@mssm.edu	Dickstein, Dara/AAH-6603-2020	Tang, Cheuk Ying/0000-0002-9828-0092; Fernandez, Corey/0000-0003-3901-5552	Veteran's Affairs (VA) Merit Awards [I01CX000190, I01CX000261]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005138] Funding Source: NIH RePORTER	This research was funded by Veteran's Affairs (VA) Merit Awards (I01CX000190 to EMM and I01CX000261 to EH).	Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2012, NEUROSCI LETT, V509, P1, DOI 10.1016/j.neulet.2011.12.009; Carpenter DM, 2008, NEUROREPORT, V19, P1369, DOI 10.1097/WNR.0b013e32830abc35; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Davenport ND, 2015, HUM BRAIN MAPP, V36, P1053, DOI 10.1002/hbm.22685; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; De Palma RG., 2015, BRAIN NEUROTRAUMA MO; Delis D.C., 2000, CALIFORNIA VERBAL LE; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Elwood RW, 1995, NEUROPSYCHOL REV, V5, P173, DOI 10.1007/BF02214761; Geary EK, 2011, J INT NEUROPSYCH SOC, V17, P709, DOI 10.1017/S1355617711000646; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Golden C, 2000, NEUROPSYCHOLOGICAL I; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hayes JP, 2012, NEUROCASE, V18, P258, DOI 10.1080/13554794.2011.588181; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, AM J NEURORADIOL, V26, P719; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lin YC, 2014, BRAIN TOPOGR, V27, P393, DOI 10.1007/s10548-013-0346-2; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Matthews SC, 2012, PSYCHIAT RES-NEUROIM, V204, P149, DOI 10.1016/j.pscychresns.2012.04.018; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Mori S, 1999, J NEUROPHYSIOL, V82, P290, DOI 10.1152/jn.1999.82.1.290; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Nandipati Sirisha, 2012, Curr Aging Sci, V5, P131; Noble KG, 2013, DEVELOPMENTAL SCI, V16, P653, DOI 10.1111/desc.12077; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Post JB, 2012, AM J NEPHROL, V35, P120, DOI 10.1159/000334871; Rueda MR, 2005, P NATL ACAD SCI USA, V102, P14931, DOI 10.1073/pnas.0506897102; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; UDDO M, 1993, J PSYCHOPATHOL BEHAV, V15, P43, DOI 10.1007/BF00964322; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Warden DL, 2009, NEUROIMAGE, V47, pT152, DOI 10.1016/j.neuroimage.2009.01.060; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; YEHUDA R, 1995, AM J PSYCHIAT, V152, P137	73	21	21	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 21	2017	8								127	10.3389/fneur.2017.00127			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET0UI	WOS:000399979100001	28484418	Green Published, gold			2022-02-06	
J	Cheah, CF; Kofler, M; Schiefecker, AJ; Beer, R; Klug, G; Pfausler, B; Helbok, R				Cheah, Chun Fai; Kofler, Mario; Schiefecker, Alois Josef; Beer, Ronny; Klug, Gert; Pfausler, Bettina; Helbok, Raimund			Takotsubo Cardiomyopathy in Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Myocardial dysfunction; Takotsubo cardiomyopathy; Monitoring; Echocardiography	NEUROGENIC STUNNED MYOCARDIUM; TAKO-TSUBO CARDIOMYOPATHY; SUBARACHNOID HEMORRHAGE; HEART-FAILURE; STRESS; FEATURES; OUTCOMES	Takotsubo cardiomyopathy (TC) is a well-known complication after aneurysmal subarachnoid hemorrhage and has been rarely described in patients with traumatic brain injury (TBI). Case report and review of literature. Here, we report a 73-year-old woman with mild traumatic brain injury (TBI) presenting in cardiogenic shock. Takotsubo cardiomyopathy (TC) was diagnosed by repeated echocardiography. Cardiovascular support by inotropic agents led to hemodynamic stabilization after initiation of levosimendan. Cardiac function fully recovered within 21 days. We performed an in-depth literature review and identified 16 reported patients with TBI and TC. Clinical course and characteristics are discussed in the context of our patient. Takotsubo cardiomyopathy is under-recognized after TBI and may negatively impact outcome if left untreated.	[Cheah, Chun Fai; Kofler, Mario; Schiefecker, Alois Josef; Beer, Ronny; Pfausler, Bettina; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria; [Cheah, Chun Fai] Hosp Pulau Pinang, Dept Neurol, Jalan Residensi, Georgetown 10990, Pulau Pinang, Malaysia; [Klug, Gert] Med Univ Innsbruck, Univ Clin Internal Med 3, Cardiol & Angiol, Anichstr 35, A-6020 Innsbruck, Austria		Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Anichstr 35, A-6020 Innsbruck, Austria.	Raimund.Helbok@tirol-kliniken.at	Helbok, Raimund/AAA-8361-2021	Klug, Gert/0000-0002-4737-0979	University of Innsbruck; Medical University of Innsbruck	Paul Rhomberg, MD, Department of Neuroradiology, Medical University of Innsbruck Anichstrasse 35, 6020 Innsbruck, Austria provided neuroimaging data. Open access funding provided by University of Innsbruck and Medical University of Innsbruck.	Bahloul M, 2006, AM J CRIT CARE, V15, P462; Bailen MR, 2003, J CRIT CARE, V18, P245, DOI 10.1016/j.jcrc.2003.10.008; Banki N, 2006, J NEUROSURG, V105, P15, DOI 10.3171/jns.2006.105.1.15; Bonacchi M, 2015, INTERACT CARDIOV TH, V20, P365, DOI 10.1093/icvts/ivu421; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; Deleu D, 2007, SAUDI MED J, V28, P283; Divekar A, 2006, PEDIATR CARDIOL, V27, P376, DOI 10.1007/s00246-005-1263-2; Finsterer J, 2014, INT J CARDIOL, V177, P322, DOI 10.1016/j.ijcard.2014.08.101; Hasanin A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0246-z; Hong J, 2014, ANN PEDIAT CHILD HLT, V2, P1029; Kilbourn KJ, 2013, CLIN NEUROL NEUROSUR, V115, P909, DOI 10.1016/j.clineuro.2012.09.006; Krishnamoorthy V, 2013, CASE REP ANAESTHESIO, V2013, P1; Krpata DM, 2013, J PEDIATR SURG, V48, P876, DOI 10.1016/j.jpedsurg.2013.01.042; Lee VH, 2006, J NEUROSURG, V105, P264, DOI 10.3171/jns.2006.105.2.264; Lyon AR, 2008, NAT CLIN PRACT CARD, V5, P22, DOI 10.1038/ncpcardio1066; Lyon AR, 2016, EUR J HEART FAIL, V18, P8, DOI 10.1002/ejhf.424; Marechaux S, 2009, EUR J ECHOCARDIOGR, V10, P332, DOI 10.1093/ejechocard/jen250; Palac Robert T, 2003, Prog Transplant, V13, P42; Parissis JT, 2009, HEART FAIL REV, V14, P265, DOI 10.1007/s10741-008-9128-4; Park JH, 2005, CHEST, V128, P296, DOI 10.1378/chest.128.1.296; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Riera M, 2010, J TRAUMA, V68, P13; Samol A, 2011, INJURY EXTRA, V42, P54; Santoro F, 2013, CARDIOVASC THER, V31, pE133, DOI 10.1111/1755-5922.12047; Taccone FS, 2013, INTENS CARE MED, V39, P1497, DOI 10.1007/s00134-013-2945-5; Templin C, 2015, NEW ENGL J MED, V373, P929, DOI 10.1056/NEJMoa1406761; Vergez M, 2009, RESUSCITATION, V80, P1074, DOI 10.1016/j.resuscitation.2009.05.021; Wippermann J, 2008, ASIAN CARDIOVASC THO, V16, P30; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	31	21	22	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					284	291		10.1007/s12028-016-0334-y			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300018	28000134	Green Published			2022-02-06	
J	Chen, C; Shi, JX; Stanley, RM; Sribnick, EA; Groner, JI; Xiang, H				Chen, Cheng; Shi, Junxin; Stanley, Rachel M.; Sribnick, Eric A.; Groner, Jonathan I.; Xiang, Henry			US Trends of ED Visits for Pediatric Traumatic Brain Injuries: Implications for Clinical Trials	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						pediatric; traumatic brain injury; emergency department	CHILDREN	Our goal in this paper was to use the 2006-2013 Nationwide Emergency Department Sample (NEDS) database to describe trends of annual patient number, patient demographics and hospital characteristics of pediatric traumatic brain injuries (TBI) treated in U.S. emergency departments (EDs); and to use the same database to estimate the available sample sizes for various clinical trials of pediatric TBI cases. National estimates of patient demographics and hospital characteristics were calculated for pediatric TBI. Simulation analyses assessed the potential number of pediatric TBI cases from randomly selected hospitals for inclusion in future clinical trials under different scenarios. Between 2006 and 2013, the NEDS database estimated that of the 215,204,932 children who visited the ED, 6,089,930 (2.83%) had a TBI diagnosis. During the study period in the US EDs, pediatric TBI patients increased by 34.1%. Simulation analyses suggest that hospital EDs with annual TBI ED visits >1000, Levels I and II Trauma Centers, pediatric hospitals, and teaching hospitals will likely provide ample cases for pediatric TBI studies. However, recruiting severe pediatric TBI cases for clinical trials from a limited number of hospital EDs will be challenging due to small sample sizes. Pediatric TBI-related ED visits in the U.S. increased by over 30% from 2006 to 2013. Including unspecified head injury cases with ICD-9-CM code 959.01 would significantly change the national estimates and demographic patterns of pediatric TBI cases. Future clinical trials of children with TBI should conduct a careful feasibility assessment to estimate their sample size and study power in selected study sites.	[Chen, Cheng; Shi, Junxin; Stanley, Rachel M.; Sribnick, Eric A.; Groner, Jonathan I.; Xiang, Henry] Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, 700 Childrens Dr, Columbus, OH 43205 USA; [Chen, Cheng; Shi, Junxin; Groner, Jonathan I.; Xiang, Henry] Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA; [Stanley, Rachel M.; Xiang, Henry] Ohio State Univ, Dept Pediat, Coll Med, 370 West 9th Ave, Columbus, OH 43210 USA; [Stanley, Rachel M.] Ohio State Univ, Dept Neurosurg, Coll Med, 370 West 9th Ave, Columbus, OH 43210 USA; [Sribnick, Eric A.] Ohio State Univ, Dept Surg, Coll Med, 370 West 9th Ave, Columbus, OH 43210 USA; [Groner, Jonathan I.] Nationwide Childrens Hosp, Div Emergency Med, Columbus, OH 43205 USA		Xiang, H (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Pediat Trauma Res, 700 Childrens Dr, Columbus, OH 43205 USA.; Xiang, H (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Injury Res & Policy, 700 Childrens Dr, Columbus, OH 43205 USA.; Xiang, H (corresponding author), Ohio State Univ, Dept Pediat, Coll Med, 370 West 9th Ave, Columbus, OH 43210 USA.	Cheng.Chen@nationwidechildrens.org; Junxin.Shi@nationwidechildrens.org; Rachel.Stanley@nationwidechildrens.org; Eric.Sribnick@nationwidechildrens.org; Jonathan.Groner@nationwidechildrens.org; Henry.Xiang@nationwidechildrens.org	Sribnick, Eric/AAH-6693-2020		Agency for Healthcare Research and Quality (AHRQ)United States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01/HS2426301]; Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) [R40/MC29448]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [R01HS024263] Funding Source: NIH RePORTER	An abstract of this study was presented at the International Conference on Pediatrics Acquired Brain Injury, 16-18 September 2015, Liverpool, UK. This research was funded by grants from the Agency for Healthcare Research and Quality (AHRQ) (R01/HS2426301) and the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) (R40/MC29448: Emergency Medical Care of Severely Injured U.S. Children). The conclusions are those of the author and should not be construed as the official position of the funding agencies. Melody L. Davis is acknowledged for her efforts in editing the text during the revision of the manuscript.	[Anonymous], SEARCH FOR STUD; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Centers for Disease Control and Prevention, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, C TRAUM BRAIN INJ US; Chan V, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0031-x; Cook Alan, 2014, J Trauma Acute Care Surg, V76, P47, DOI 10.1097/TA.0b013e3182ab0d5d; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Coronado V. G., 2007, Morbidity and Mortality Weekly Report, V56, P167; Kohn MA, 2004, ACAD EMERG MED, V11, P1, DOI 10.1197/S1069-656(03)00578-5; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marr A., CENTRAL NERVOUS SYST; Natale JE, 2006, DEV NEUROSCI-BASEL, V28, P276, DOI 10.1159/000094154; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Smith NA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0346; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; The Clinical Trials Subcommittee, DES COND CLIN TRIALS; U.S. Census Bureau, ANN EST RES POP SEX; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Verger K, 2000, BRAIN INJURY, V14, P495; WHO, INT CLASS DIS ICD	23	21	21	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1661-7827	1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	APR	2017	14	4							414	10.3390/ijerph14040414			13	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	EY6PG	WOS:000404105100078	28406438	Green Submitted, Green Published, gold			2022-02-06	
J	Topolovec-Vranic, J; Schuler, A; Gozdzik, A; Somers, J; Bourque, PE; Frankish, CJ; Jbilou, J; Pakzad, S; Lazgare, LIP; Hwang, SW				Topolovec-Vranic, Jane; Schuler, Andree; Gozdzik, Agnes; Somers, Julian; Bourque, Paul-Emile; Frankish, C. James; Jbilou, Jalila; Pakzad, Sarah; Lazgare, Luis Ivan Palma; Hwang, Stephen W.			The high burden of traumatic brain injury and comorbidities amongst homeless adults with mental illness	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Brain injuries; Homeless persons; Mental disorders; Psychiatric diagnosis; Health care delivery; Comorbidity	POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; HEAD-INJURY; COMMUNITY; POPULATION; PREVALENCE; CHALLENGES; MANAGEMENT; SERVICES; SEIZURES	Objective: characterize the prevalence of self-reported head injury with loss of consciousness (LOC) and associated demographic, clinical and service use factors in a sample of homeless adults with mental illness. Method: Participants in the At Home/Chez Soi study were interviewed at the time of study enrollment regarding their history of head injuries, mental and physical health diagnoses and justice system and healthcare interactions. Sociodemographic and clinical data were also collected. Results: Over half of the 2088 study respondents (52.6%, n = 1098) reported a history of head injury with a LOC, which was associated with several demographic, clinical and service use variables in this population. With respect to specific mental health conditions, a history of head injury with LOC was associated with higher odds of current depression (OR = 2.18, CI: 1.83-2.60), manic episode or hypomanic episode (OR = 1.91, CI: 1.45-2.50), PTSD (OR = 2.98, CI: 2.44-3.65), panic disorder (OR = 2.37, CI:1.91-2.93), mood disorder (OR = 1.78, CI: 1.40-2.26) and alcohol (OR = 2.09, CI: 1.75-2.49) and drug (OR = 1.73, CI: 1.46-2.06) misuse disorders, but reduced odds of having diagnosis of a psychotic disorder (OR = 0.63, CI: 0.53-0.76). A history of head injury with LOC was also associated with increased use of variety of services, including family medicine (OR = 1.33, CI: 1.12-1.59), criminal justice system (OR = 1.50, CI: 1.25-1.80) and the emergency department (OR = 1.03, CI: 1.01-1.05). Conclusions: Amongst homeless adults with mental illness having a history of head injuries with LOC was independently associated with various adverse outcomes. These individuals constitute a high-risk group who may benefit from specialized services. (C) 2016 Elsevier Ltd. All rights reserved.	[Topolovec-Vranic, Jane] St Michaels Hosp, Trauma & Neurosurg Program, Toronto, ON, Canada; [Topolovec-Vranic, Jane] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Schuler, Andree; Gozdzik, Agnes; Lazgare, Luis Ivan Palma; Hwang, Stephen W.] St Michaels Hosp, Ctr Urban Hlth Solut, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Somers, Julian] Simon Fraser Univ, Fac Hlth Sci, Somers Res Grp, Vancouver, BC, Canada; [Bourque, Paul-Emile; Jbilou, Jalila; Pakzad, Sarah] Univ Moncton, Sch Psychol, Moncton, NB, Canada; [Frankish, C. James] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Hwang, Stephen W.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy,Management & Evaluat, Dept Med,Div Gen Internal Med, Toronto, ON, Canada		Hwang, SW (corresponding author), St Michaels Hosp, Ctr Urban Hlth Solut, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada.	hwangs@smh.ca	Topolovec-Vranic, Jane/A-5293-2013; Hwang, Stephen/D-2297-2011	Topolovec-Vranic, Jane/0000-0001-7695-4212; Hwang, Stephen/0000-0002-1276-1101	Health Canada via the Mental Health Commission of Canada (MHCC)	This research has been made possible through a financial contribution from Health Canada via the Mental Health Commission of Canada (MHCC). The authors, writing for the At Home/Chez Soi investigators, thank Jayne Barker (2008-2011), PhD, Cameron Keller (2011-2012), and Catharine Hume (2012-present) MHCC At Home/Chez Soi National Project Leads, Paula Goering, PhD, the National Research Lead, the National Research Team, the five site research teams, the Site Coordinators, the numerous service and housing providers, as well as people with lived experience, who have contributed to this project and the research.	Amen DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129659; Andersen J, 2014, DISABIL REHABIL, V36, P2210, DOI 10.3109/09638288.2014.895870; Aubry T, 2016, PSYCHIAT SERV, V67, P275, DOI 10.1176/appi.ps.201400587; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Barnes SM, 2015, J HEALTH CARE POOR U, V26, P92, DOI 10.1353/hpu.2015.0010; Beghi M, 2013, NEUROPSYCH DIS TREAT, V9, P1725, DOI 10.2147/NDT.S40213; Blackmer J, 1999, BRAIN INJURY, V13, P627; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Currie LB, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-404; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Faul M, 2010, TRAUMATIC BRAIN INJU; Gagnon A, 2016, DISABIL REHABIL, V38, P433, DOI 10.3109/09638288.2015.1044035; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Hwang SW, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-73; Hwang SW, 2008, CMAJ, V179, P179; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jaycox L., 2008, INVISIBLE WOUNDS WAR; Kelly G, 2008, BRAIN INJURY, V22, P457, DOI 10.1080/02699050802060647; Kessler RC, 2004, BIOL PSYCHIAT, V56, P730, DOI 10.1016/j.biopsych.2004.06.034; Lasry Oliver, 2016, CMAJ Open, V4, pE249, DOI 10.9778/cmajo.20150105; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; Lucas S, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0520-1; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, P1986, DOI 10.2105/AJPH.2014.302087; McAllister TW, 1997, COMMUNITY MENT HLT J, V33, P341, DOI 10.1023/A:1025055426260; McMillan TM, 2015, J NEUROTRAUM, V32, P116, DOI 10.1089/neu.2014.3387; Neufeld MY, 1999, EPILEPSY RES, V34, P123, DOI 10.1016/S0920-1211(98)00105-3; NINDS Common Data Elements Team, 2012, TBI CDES V3 DEF TRAU; O'Callaghan A, 2012, BRAIN INJURY, V26, P1599, DOI 10.3109/02699052.2012.698788; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; RUSSELLJONES DL, 1989, J NEUROL NEUROSUR PS, V52, P659, DOI 10.1136/jnnp.52.5.659; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Schofield PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132558; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Stergiopoulos V, 2015, JAMA-J AM MED ASSOC, V313, P905, DOI 10.1001/jama.2015.1163; Svoboda T, 2014, EMERG MED J, V31, P571, DOI 10.1136/emermed-2012-201761; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; To MJ, 2015, J HEAD TRAUMA REHAB, V30, P270, DOI 10.1097/HTR.0000000000000044; Topolovec-Vranic J., 2013, TRAUMATIC BRAIN INJU, P4; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; U.S. Department of Veterans Affairs, 2010, VA CONS C PRACT REC; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	58	21	21	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	APR	2017	87						53	60		10.1016/j.jpsychires.2016.12.004			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EO8WK	WOS:000396971000008	28006664				2022-02-06	
J	Xu, X; Lv, HY; Xia, Z; Fan, R; Zhang, CH; Wang, Y; Wang, DS				Xu, Xia; Lv, Huiying; Xia, Zian; Fan, Rong; Zhang, Chunhu; Wang, Yang; Wang, Dongsheng			Rhein exhibits antioxidative effects similar to Rhubarb in a rat model of traumatic brain injury	BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article						Rhein; Rhubarb; Traumatic brain injury; Oxidative stress; Neuroprotective effect	TRADITIONAL CHINESE MEDICINE; OXIDATIVE STRESS	Background: The brain is secondarily harmed by pathological, physiological, and biological reactions that are caused by traumatic brain injury (TBI). Rhein, a significant composition of Rhubarb, is a well-known traditional Chinese treatment method and has a strong oxidation-resisting characteristic, but Rhein's mechanism remains unclear. Methods: This study aimed to identify Rhein in the brain tissues of TBI model of rats, and confirm whether Rhein induced an antioxidative effect similar to its parent medicine, Rhubarb. First, the ultra performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was applied to identify Rhein in the brain tissue of the controlled cortical impact (CCI) rats after intra-gastric administration of Rhubarb. Further, for the purpose of calculating the oxidant stress of the CCI rats, the malondialdehyde (MDA), catalase (CAT), superoxide dismutase (SOD), and glutathione disulfide (GSSG), as well as the proportion of glutathione (GSH)/GSSG were measured in the brain tissues. Results: The results showed that Rhein was absorbed in the brain tissues of CCI rats. Rhubarb and rhein elevated the SOD, CAT activities, GSH level, and GSH/GSSG ratio, and diminished the MDA and GSSG levels. Conclusion: The data demonstrated that Rhubarb and Rhein had the potential to be used as a neuroprotective drug for TBI, and that Rhein induced an antioxidative effect similar to its parent medicine, Rhubarb.	[Xu, Xia; Xia, Zian; Fan, Rong; Zhang, Chunhu; Wang, Yang; Wang, Dongsheng] Ctr South Univ, Inst Integrad Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410008, Peoples R China; [Lv, Huiying] Hunan Acad Agr Sci, Hunan Agr Product Processing Inst, Hunan Food Test & Analys Ctr, Changsha 410125, Peoples R China		Wang, Y; Wang, DS (corresponding author), Ctr South Univ, Inst Integrad Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410008, Peoples R China.	wangyang_xy87@163.com; wdsh66@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81303074, 81673719, 81373554, 81173198]	This project was supported by the National Natural Science Foundation of China (Nos. 81303074, 81673719, 81373554 and 81173198).	Anglada JM, 2015, ACCOUNTS CHEM RES, V48, P575, DOI 10.1021/ar500412p; Ashraf A, 2015, PAK J BOT, V47, P367; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Bas O, 2007, NEUROCHEM INT, V50, P548, DOI 10.1016/j.neuint.2006.11.005; Bounda GA, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/329831; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dincel GC, 2016, INT J IMMUNOPATH PH, V29, P226, DOI 10.1177/0394632016638668; Doulames VM, 2015, FRONT BEHAV NEUROSCI, V9, DOI [10.3389/fnbeh.2015.00369, 10.3389/fnbeh.2015.00275]; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Duan YQ, 2013, FOOD FUNCT, V4, P1252, DOI 10.1039/c3fo60116a; Gan L, 2015, BIOMED ENVIRON SCI, V28, P148, DOI 10.3967/bes2015.019; Gao D, 2016, MOLECULES, V21, DOI 10.3390/molecules21030298; Giustarini D, 2016, J CHROMATOGR B, V1019, P21, DOI 10.1016/j.jchromb.2016.02.015; Hu F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14012; Jia D, 2014, J MOL NEUROSCI, V53, P271, DOI 10.1007/s12031-013-0217-z; Jiang BP, 2014, BRAIN RES, V1586, P1, DOI 10.1016/j.brainres.2014.08.001; Khalaj L, 2013, BRAIN RES, V1527, P117, DOI 10.1016/j.brainres.2013.06.041; Laskowski R.A., 2015, FRONTIERS NEUROENGIN; Lecoq AL, 2015, ANN ENDOCRINOL-PARIS, V76, pS10, DOI 10.1016/S0003-4266(16)30003-8; Li M, 2015, CHINESE MED J-PEKING, V128, P1072, DOI 10.4103/0366-6999.155094; Li WJ, 2011, LIFE SCI, V88, P713, DOI 10.1016/j.lfs.2011.02.010; Liang YZ, 2004, J CHROMATOGR B, V812, P53, DOI 10.1016/j.jchromb.2004.08.041; Lu K, 2015, MOL MED REP, V12, P2689, DOI 10.3892/mmr.2015.3693; Miyamoto K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379206; Moghbelinejad S, 2014, TOXICOL LETT, V224, P108, DOI 10.1016/j.toxlet.2013.10.010; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Omrani H, 2015, ADV PHARM BULL, V5, P283, DOI 10.15171/apb.2015.039; Ribas GS, 2014, GENE, V533, P469, DOI 10.1016/j.gene.2013.10.017; Sarkar S, 2014, ECOTOX ENVIRON SAFE, V107, P1, DOI 10.1016/j.ecoenv.2014.05.012; Shia CS, 2009, PLANTA MED, V75, P1386, DOI 10.1055/s-0029-1185725; Sun DQ, 2009, CHEM-BIOL INTERACT, V179, P110, DOI 10.1016/j.cbi.2008.11.014; Sun K, 2015, ACTA PHARM SIN B, V5, P8, DOI 10.1016/j.apsb.2014.11.002; Sun WJ, 2017, SPECTROCHIM ACTA A, V171, P72, DOI 10.1016/j.saa.2016.07.039; Tang Yu-ping, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P152; Tejada S, 2007, BRAIN RES BULL, V71, P372, DOI 10.1016/j.brainresbull.2006.10.005; Toklu HZ, 2015, FRONTIERS NEUROENGIN; Toyama T, 2014, NAT PROD COMMUN, V9, P1755; Tu QY, 2013, INT J BIOL MACROMOL, V60, P268, DOI 10.1016/j.ijbiomac.2013.05.035; Wang D, 2012, MOLECULES, V17, P9803, DOI 10.3390/molecules17089803; Wang JB, 2008, J PHARMACEUT BIOMED, V47, P765, DOI 10.1016/j.jpba.2008.03.011; Wang QS, 2005, NEUROCHEM RES, V30, P1387, DOI 10.1007/s11064-005-8391-1; Wang Y., 2012, J VIBRATION SHOCK, V9, P9, DOI DOI 10.7150/IJMS.4970]; Wang Y, 2016, MOL MED REP, V14, P3690, DOI 10.3892/mmr.2016.5720; Wang Zhi-peng, 2003, Zhongguo Zhongyao Zazhi, V28, P974; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yang B, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1076-2; Yu XL, 2015, FOOD FUNCT, V6, P3296, DOI 10.1039/c5fo00500k; Yu YH, 2015, PHARMACOL BIOCHEM BE, V133, P122, DOI 10.1016/j.pbb.2015.03.020; Zeraatpishe A, 2015, ASIAN J SPORTS MED, V4; ZHANG W, 2015, INT J ANTENN PROPAG, V2015, P1, DOI DOI 10.1145/2820783.2820823.10; Zhang YQ, 2008, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON ELECTRONIC COMMERCE AND SECURITY, P3, DOI 10.1109/ISECS.2008.227; Zhong XF, 2012, MOL MED REP, V5, P1261, DOI 10.3892/mmr.2012.793	52	21	22	6	31	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1472-6882			BMC COMPLEM ALTERN M	BMC Complement. Altern. Med.	MAR 7	2017	17								140	10.1186/s12906-017-1655-x			9	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	EN8TV	WOS:000396273600001	28264680	gold, Green Published			2022-02-06	
J	Bellerose, J; Bernier, A; Beaudoin, C; Gravel, J; Beauchamp, MH				Bellerose, Jenny; Bernier, Annie; Beaudoin, Cindy; Gravel, Jocelyn; Beauchamp, Miriam H.			Long-Term Brain-Injury-Specific Effects Following Preschool Mild TBI: A Study of Theory of Mind	NEUROPSYCHOLOGY			English	Article						concussion; pediatric; social cognition; theory of mind; traumatic brain injury	SOCIAL-EMOTIONAL BEHAVIOR; FALSE-BELIEF; MIDDLE CHILDHOOD; NEUROCOGNITIVE OUTCOMES; INDIVIDUAL-DIFFERENCES; EXECUTIVE FUNCTIONS; HEAD-INJURY; CHILDREN; ADOLESCENTS; RECOVERY	Objective: A previous study conducted by our group found theory of mind (ToM) differences in preschool children who sustained mild traumatic brain injury (mTBI) compared with typically developing peers, 6 months postinjury. The goals of the current longitudinal study were to determine whether these findings are the result of a brain-injury-specific effect or rather a general-injury effect, to examine the long-term evolution of ToM skills following preschool mTBI, as well as to investigate the links between ToM abilities and general social functioning. Method: Seventy-two children who sustained mTBI between the ages of 18 and 60 months were evaluated 6 and 18 months postinjury on ToM tasks including desires and emotions reasoning and false belief understanding. They were compared with 58 participants who sustained an orthopedic injury (OI) and 83 typically developing children (TDC). Results: The 3 groups did not differ on demographic and baseline characteristics. The mTBI group obtained poorer scores relative to both comparison groups on the desires and emotions reasoning task, both at 6 and 18 months injury. No correlations were found between injury characteristics and ToM performance. For the mTBI group, associations were found between ToM performance and global social competence. Conclusion: These findings suggest a brain-injury-specific effect that persists in the long-term following mTBI in preschool children.	[Bellerose, Jenny; Bernier, Annie; Beaudoin, Cindy; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Bellerose, Jenny; Beaudoin, Cindy; Gravel, Jocelyn; Beauchamp, Miriam H.] St Justine Hosp Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca		Gravel, Jocelyn/0000-0001-5901-4990			Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2013, J INT NEUROPSYCH SOC, V19, P539, DOI 10.1017/S1355617712001543; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Astington J. W., 2003, INDIVIDUAL DIFFERENC, P13; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baron-Cohen S., 2000, UNDERSTANDING OTHER, P3, DOI DOI 10.1093/ACPROF:OSO/9780199692972.001.0001; Bayley N., 2005, BAYLEY SCALES INFANT; Bellerose J.S., 2011, BRAIN MAPPING NEURAL, P181; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Benson JE, 2013, DEV PSYCHOL, V49, P1615, DOI 10.1037/a0031056; Bianco F, 2016, J EXP CHILD PSYCHOL, V149, P41, DOI 10.1016/j.jecp.2015.11.006; Blair C, 2002, AM PSYCHOL, V57, P111, DOI 10.1037//0003-066X.57.2.111; Blakemore SJ, 2004, NEUROREPORT, V15, P119, DOI 10.1097/00001756-200401190-00024; BONADIO WA, 1989, AM J DIS CHILD, V143, P1061, DOI 10.1001/archpedi.1989.02150210095025; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Brooks R, 2015, J EXP CHILD PSYCHOL, V130, P67, DOI 10.1016/j.jecp.2014.09.010; Brosseau-Liard P, 2015, BRIT J DEV PSYCHOL, V33, P464, DOI 10.1111/bjdp.12107; Ciurea A V, 2011, J Med Life, V4, P234; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Dennis M, 2012, J INT NEUROPSYCH SOC, V18, P908, DOI 10.1017/S1355617712000756; Dennis M, 2009, J CLIN EXP NEUROPSYC, V31, P835, DOI 10.1080/13803390802572419; Devine RT, 2014, CHILD DEV, V85, P1777, DOI 10.1111/cdev.12237; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Donders J, 2007, J HEAD TRAUMA REHAB, V22, P296, DOI 10.1097/01.HTR.0000290974.01872.82; Fahie CM, 2003, J APPL DEV PSYCHOL, V24, P51, DOI 10.1016/S0193-3973(03)00024-8; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Hughes C, 1998, J CHILD PSYCHOL PSYC, V39, P981, DOI 10.1017/S0021963098003059; Hughes C, 2007, J CHILD PSYCHOL PSYC, V48, P1025, DOI 10.1111/j.1469-7610.2007.01806.x; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P96, DOI 10.1016/j.jecp.2010.07.012; Im-Bolter N, 2016, J EXP CHILD PSYCHOL, V149, P98, DOI 10.1016/j.jecp.2015.12.006; Jones DE, 2015, AM J PUBLIC HEALTH, V105, P2283, DOI 10.2105/AJPH.2015.302630; Kaldoja ML, 2015, J CHILD NEUROL, V30, P860, DOI 10.1177/0883073814544705; Kaldoja ML, 2012, BRAIN INJURY, V26, P1005, DOI 10.3109/02699052.2012.660516; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kochanek PM, 2006, DEV NEUROSCI-BASEL, V28, P244, DOI 10.1159/000094151; Ladd GW, 1999, ANNU REV PSYCHOL, V50, P333, DOI 10.1146/annurev.psych.50.1.333; Lagattuta KH, 2005, CHILD DEV, V76, P713, DOI 10.1111/j.1467-8624.2005.00873.x; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1998, BRAIN INJURY, V12, P41; Miller Scott, 2012, THEORY MIND PRESCHOO; Mink D, 2014, INFANT BEHAV DEV, V37, P66, DOI 10.1016/j.infbeh.2013.12.001; Mitchell P., 1994, CHILDRENS EARLY UNDE, P331; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Noppens R, 2004, EXP TOXICOL PATHOL, V56, P113, DOI 10.1016/j.etp.2004.04.005; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; PARKER JG, 1987, PSYCHOL BULL, V102, P357, DOI 10.1037/0033-2909.102.3.357; Pears KC, 2003, SOC DEV, V12, P1, DOI 10.1111/1467-9507.00219; Razza RA, 2009, J APPL DEV PSYCHOL, V30, P332, DOI 10.1016/j.appdev.2008.12.020; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sariaslan A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002103; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Snodgrass C, 2006, BRAIN INJURY, V20, P825, DOI 10.1080/02699050600832585; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Turkstra LS, 2004, NEUROREHABILITATION, V19, P245; Walz NC, 2010, J NEUROPSYCHOL, V4, P181, DOI 10.1348/174866410X488788; Wang M. C., 2009, NEUROTRAUMA CRITICAL, P87; Wechsler D., 2002, WECHSLER PRESCHOOL P; Wellman HM, 2011, CHILD DEV, V82, P780, DOI 10.1111/j.1467-8624.2011.01583.x; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	87	21	21	1	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2017	31	3					229	241		10.1037/neu0000341			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	EN4UY	WOS:000396003600001	28114784				2022-02-06	
J	De Blasio, D; Fumagalli, S; Longhi, L; Orsini, F; Palmioli, A; Stravalaci, M; Vegliante, G; Zanier, ER; Bernardi, A; Gobbi, M; De Simoni, MG				De Blasio, Daiana; Fumagalli, Stefano; Longhi, Luca; Orsini, Franca; Palmioli, Alessandro; Stravalaci, Matteo; Vegliante, Gloria; Zanier, Elisa R.; Bernardi, Anna; Gobbi, Marco; De Simoni, Maria-Grazia			Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Inflammation; brain trauma; behavior (rodent); mannose-binding lectin inhibitor; neuroregeneration; brain recovery	ISCHEMIA-REPERFUSION INJURY; INNATE IMMUNITY; COMPLEMENT-SYSTEM; MICE BRAIN; C1-INHIBITOR; CELLS; NEUROPROTECTION; FICOLINS; THERAPY; DISEASE	Mannose-binding lectin is present in the contusion area of traumatic brain-injured patients and in that of traumatic brain-injured mice, where mannose-binding lectin-C exceeds mannose-binding lectin-A. The reduced susceptibility to traumatic brain injury of mannose-binding lectin double knock-out mice (mannose-binding lectin(-/-)) when compared to wild type mice suggests that mannose-binding lectin may be a therapeutic target following traumatic brain injury. Here, we evaluated the effects of a multivalent glycomimetic mannose-binding lectin ligand, Polyman9, following traumatic brain injury in mice. Invitro surface plasmon resonance assay indicated that Polyman9 dose-dependently inhibits the binding to immobilized mannose residues of plasma mannose-binding lectin-C selectively over that of mannose-binding lectin-A. Male C57Bl/6 mice underwent sham/controlled cortical impact traumatic brain injury and intravenous treatment with Polyman9/saline. Ex-vivo surface plasmon resonance studies confirmed that Polyman9 effectively reduces the binding of plasma mannose-binding lectin-C to immobilized mannose residues. Invivo studies up to four weeks post injury, showed that Polyman9 induces significant improvement in sensorimotor deficits (by neuroscore and beam walk), promotes neurogenesis (73% increase in doublecortin immunoreactivity), and astrogliosis (28% increase in glial fibrillary acid protein). Polyman9 administration in brain-injured mannose-binding lectin(-/-) mice had no effect on post-traumatic brain-injured functional deficits, suggestive of the specificity of its neuroprotective effects. The neurobehavioral efficacy of Polyman9 implicates mannose-binding lectin-C as a novel therapeutic target for traumatic brain injury.	[De Blasio, Daiana; Fumagalli, Stefano; Orsini, Franca; Stravalaci, Matteo; Vegliante, Gloria; Zanier, Elisa R.; Gobbi, Marco; De Simoni, Maria-Grazia] Ist Ric Farmacol Mario Negri, IRCCS, Milan, Italy; [De Blasio, Daiana; Fumagalli, Stefano] Osped Maggiore Policlin, Fdn IRCCS CaGranda, Dept Anesthesia & Crit Care Med, Milan, Italy; [Longhi, Luca] Azienda Socio Sanit Terr Papa Giovanni XXIII, Dept Anesthesia & Crit Care Med, Neurosurg Intens Care Unit, Bergamo, Italy; [Palmioli, Alessandro; Bernardi, Anna] Univ Milan, Dept Chem, Milan, Italy		De Simoni, MG (corresponding author), Mario Negri Inst Pharmacol Res, Lab Inflammat & Nervous Syst, Dept Neurosci, IRCCS, Via G La Masa 19, I-20156 Milan, Italy.	desimoni@marionegri.it	Fumagalli, Stefano/I-3097-2019; De Simoni, Maria Grazia/I-6021-2012; Stravalaci, Matteo/AAB-8963-2019; Palmioli, Alessandro/A-8695-2013; Longhi, Luca/AAF-9903-2021; Vegliante, Gloria/ABF-9054-2021; Zanier, Elisa/AAA-8095-2020; Gobbi, Marco/J-2638-2016; Bernardi, Anna/A-1167-2012	De Simoni, Maria Grazia/0000-0001-6695-5297; Stravalaci, Matteo/0000-0002-5636-4204; Palmioli, Alessandro/0000-0002-5287-1663; Longhi, Luca/0000-0001-9894-8788; Vegliante, Gloria/0000-0002-7563-0889; Zanier, Elisa/0000-0002-3011-8718; Gobbi, Marco/0000-0003-1014-6225; Bernardi, Anna/0000-0002-1258-2007; Fumagalli, Stefano/0000-0003-3598-6263; Orsini, Franca/0000-0001-7415-9936	Fondazione CariploFondazione Cariplo [2012-0590]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Financial support including Drs De Blasio and Fumagalli fellowship was provided by Fondazione Cariplo (grant number 2012-0590).	Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; De Simoni MG, 2004, AM J PATHOL, V164, P1857, DOI 10.1016/S0002-9440(10)63744-3; Endo Y, 2015, INT REV CEL MOL BIO, V316, P49, DOI 10.1016/bs.ircmb.2015.01.003; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Hansen S, 2000, J IMMUNOL, V164, P2610, DOI 10.4049/jimmunol.164.5.2610; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; KAWASAKI N, 1983, J BIOCHEM, V94, P937, DOI 10.1093/oxfordjournals.jbchem.a134437; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Pischiutta F, 2014, NEUROPHARMACOLOGY, V79, P119, DOI 10.1016/j.neuropharm.2013.11.001; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Storini C, 2005, NEUROBIOL DIS, V19, P10, DOI 10.1016/j.nbd.2004.11.001; Stravalaci M, 2016, J BIOMOL SCREEN, V21, P749, DOI 10.1177/1087057116637563; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Varga N, 2014, BIOMATERIALS, V35, P4175, DOI 10.1016/j.biomaterials.2014.01.014; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, DISCOV MED, V10, P434; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Yongqing T, 2011, BIOCHIM BIOPHYS ACTA, V1824, P253; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Zanier ER, 2014, NEUROTHERAPEUTICS, V11, P679, DOI 10.1007/s13311-014-0277-y; Zanier ER, 2011, CRIT CARE MED, V39, P2501, DOI 10.1097/CCM.0b013e31822629ba; ZIPURSKY A, 1965, CAN J PHYSIOL PHARM, V43, P289, DOI 10.1139/y65-028	44	21	21	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAR	2017	37	3					938	950		10.1177/0271678X16647397			13	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	EL5KQ	WOS:000394660400017	27165013	Green Published, Bronze			2022-02-06	
J	Langdon, R; DiSabella, MT				Langdon, Raquel; DiSabella, Marc T.			Pediatric Headache: An Overview	CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE			English	Article							IDIOPATHIC INTRACRANIAL HYPERTENSION; PSEUDOTUMOR CEREBRI SYNDROME; MEDICATION-OVERUSE HEADACHE; TRAUMATIC BRAIN-INJURY; QUALITY STANDARDS SUBCOMMITTEE; TENSION-TYPE HEADACHE; ACADEMY-OF-NEUROLOGY; POSTTRAUMATIC HEADACHES; DIAGNOSTIC-CRITERIA; DOUBLE-BLIND	Headache represents the most common neurologic disorder in the general population including children and is increasingly being recognized as a major source of morbidity in youth related to missed school days and activities. In this article, we take a holistic approach to the child presenting with headache with a focus on the detailed headache history, physical and neurologic examinations, and diagnostic evaluation of these patients. Clinical presentations and classification schema of multiple primary and secondary headache types in children are discussed using the International Headache Criteria (IHCD-3) as a guide, and a summary provided of the various treatment modalities employed for pediatric headache including lifestyle modifications, behavioral techniques, and abortive and preventive medications.	[Langdon, Raquel; DiSabella, Marc T.] Childrens Natl Med Ctr, Ctr Neurosci & Behav Hlth, Washington, DC 20010 USA		Langdon, R (corresponding author), Childrens Natl Med Ctr, Ctr Neurosci & Behav Hlth, Washington, DC 20010 USA.						Abend NS, 2010, SEMIN PEDIATR NEUROL, V17, P123, DOI 10.1016/j.spen.2010.04.001; Aitken LA, 2009, PEDIATR NEUROL, V40, P449, DOI 10.1016/j.pediatrneurol.2009.01.003; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Arnautovic A, 2015, J NEUROSURG-PEDIATR, V15, P161, DOI 10.3171/2014.10.PEDS14295; Babcock L, 2012, ARCH PEDIAT ADOLESC, V167, P156; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Blume HK, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0516-x; Blume HK, 2012, PEDIATR REV, V33, P562, DOI 10.1542/pir.33-12-562; Boukje de Vries, 2015, CEPHALALGIA; Brousseau DC, 2004, ANN EMERG MED, V43, P256, DOI 10.1016/S0196-0644(03)00716-9; Cady RK, 2002, NEUROLOGY, V58, pS10, DOI 10.1212/WNL.58.9_suppl_6.S10; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chiang CC, 2016, CEPHALALGIA, V36, P371, DOI 10.1177/0333102415593088; Condo M, 2009, J HEADACHE PAIN, V10, P361, DOI 10.1007/s10194-009-0142-2; Cuvellier JC, 2008, ARCH PEDIATRIE, V15, P1805, DOI 10.1016/j.arcped.2008.09.017; DiFazio M, 2015, CLIN PEDIAT PHILA; Dipasquale V, 2015, J PEDIATR NEUROL, V13, P58, DOI 10.1055/s-0035-1555157; Dooley JM, 2009, PAED CHILD HEALT-CAN, V14, P24, DOI 10.1093/pch/14.1.24; Fokoloros C, 2015, J PEDIATR NEUROL, V13, P16, DOI 10.1055/s-0035-1555147; Friedman DI, 2013, NEUROLOGY, V81, P1159, DOI 10.1212/WNL.0b013e3182a55f17; Friedman DI, 2004, J NEURO-OPHTHALMOL, V24, P138, DOI 10.1097/00041327-200406000-00009; Gallelli Luca, 2005, J Headache Pain, V6, P277, DOI 10.1007/s10194-005-0206-x; Gelfand AA, 2012, NEUROLOGY, V79, P1392, DOI 10.1212/WNL.0b013e31826c1b7b; Gini G, 2014, HEADACHE, V54, P976, DOI 10.1111/head.12344; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza Christopher C, 2014, Continuum (Minneap Minn), V20, P1545, DOI 10.1212/01.CON.0000458975.78766.11; Goadsby PJ, 1997, NEUROL CLIN, V15, P27, DOI 10.1016/S0733-8619(05)70293-0; Goh KY, 1997, J NEURO-OPHTHALMOL, V17, P86; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hamalainen ML, 1997, NEUROLOGY, V48, P103, DOI 10.1212/WNL.48.1.103; Hamel E, 1999, CAN J NEUROL SCI, V26, pS2; Hering-Hanit R, 2003, CEPHALALGIA, V23, P332, DOI 10.1046/j.1468-2982.2003.00576.x; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; Hershey AD, 2005, HEADACHE, V45, P1288, DOI 10.1111/j.1526-4610.2005.00260.x; Hershey AD, 2000, HEADACHE, V40, P539, DOI 10.1046/j.1526-4610.2000.00085.x; Hershey AD, 2014, SINUS HEADACHE NASAL, P172; Hershey AD, 2013, HEADACHE, V53, P799, DOI 10.1111/head.12105; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Holroyd KA, 2006, SEMIN NEUROL, V26, P199, DOI 10.1055/s-2006-939920; Jensen R, 1999, CEPHALALGIA, V19, P602, DOI 10.1046/j.1468-2982.1999.019006602.x; Johnson KJ, 2014, CANCER EPIDEM BIOMAR, V23, P2716, DOI 10.1158/1055-9965.EPI-14-0207; Kabbouche MA, 2009, DIAGNOSTIC TESTING C; Kacperski J, 2016, HEADACHE, V56, P36, DOI 10.1111/head.12737; Kesler A, 2002, J CHILD NEUROL, V17, P745, DOI 10.1177/08830738020170101401; Kirkwood MW, 2012, NEUROPSYCHOLOGY, V26, P304; Klapper J, 2001, HEADACHE, V41, P981, DOI 10.1046/j.1526-4610.2001.01192.x; Kristoffersen ES, 2014, J PAIN RES, V7, P367, DOI 10.2147/JPR.S46071; Kroner-Herwig B, 2012, HEADACHE, V52, P1387, DOI 10.1111/j.1526-4610.2012.02210.x; Kroner-Herwig B, 2010, EUR J PAIN, V14, P951, DOI 10.1016/j.ejpain.2010.02.010; Krogh AB, 2015, CEPHALALGIA; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher Jeffrey S, 2014, Continuum (Minneap Minn), V20, P1552, DOI 10.1212/01.CON.0000458974.78766.58; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lee MJ, 2016, J HEADACHE PAIN, V17, DOI [10.1186/s10194-016-0662-5, 10.1186/s10194-016-0615-z]; Lewis D, 2004, NEUROLOGY, V63, P2215, DOI 10.1212/01.WNL.0000147332.41993.90; Lewis DW, 2009, NEUROL CLIN, V27, P481, DOI 10.1016/j.ncl.2008.11.003; Lewis DW, 2002, NEUROLOGY, V59, P490, DOI 10.1212/WNL.59.4.490; Lim M, 2005, ARCH DIS CHILD, V90, P206, DOI 10.1136/adc.2003.039305; Limbrick DD, 2014, J NEUROSURG-PEDIATR, V14, P30, DOI 10.3171/2014.7.PEDS14324; Linder SL, 2005, PEDIATR ANN, V34, P442, DOI 10.3928/0090-4481-20050601-08; Lipton R. B., 2015, NEUROLOGY, V21, P1118, DOI [10.1212/CON.000000000000021626252595, DOI 10.1212/CON.0000000000000216]; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McVige JW, 2014, NEUROL CLIN, V32, P95, DOI 10.1016/j.ncl.2013.07.002; Medina LS, 1997, RADIOLOGY, V202, P819, DOI 10.1148/radiology.202.3.9051039; Mokri Bahram, 2015, Continuum (Minneap Minn), V21, P1086, DOI 10.1212/CON.0000000000000193; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; OLESEN J, 1990, ANN NEUROL, V28, P791, DOI 10.1002/ana.410280610; Orr SL, 2014, CEPHALALGIA, V34, P568, DOI 10.1177/0333102413519512; Pacheva I, 2012, INT J CLIN PRACT, V66, P1168, DOI 10.1111/ijcp.12024; Papetti L, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0480-5; Persico AM, 2015, NEUROGENETICS, V16, P77, DOI 10.1007/s10048-014-0433-x; Piazza F, 2012, HEADACHE, V52, P1506, DOI 10.1111/j.1526-4610.2012.02221.x; Pinchefsky E, 2015, PEDIATR NEUROL, V52, P263, DOI 10.1016/j.pediatrneurol.2014.10.013; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Reiter PD, 2005, HEADACHE, V45, P899, DOI 10.1111/j.1526-4610.2005.05158.x; Rogers DL, 2014, PEDIATR CLIN N AM, V61, P579, DOI 10.1016/j.pcl.2014.03.004; Romanello S, 2013, JAMA-J AM MED ASSOC, V309, P1607, DOI 10.1001/jama.2013.747; Schobitz Erik, 2006, Curr Pain Headache Rep, V10, P391, DOI 10.1007/s11916-006-0066-3; Schwedt TJ, 2006, HEADACHE, V46, P387, DOI 10.1111/j.1526-4610.2006.00371.x; Schwedt Todd J, 2015, Continuum (Minneap Minn), V21, P1058, DOI 10.1212/CON.0000000000000201; Seeger TA, 2015, J CHILD NEUROL, V30, P1142, DOI 10.1177/0883073814553973; Serdaroglu G, 2002, HEADACHE, V42, P819, DOI 10.1046/j.1526-4610.2002.02186.x; Sheldon CA, 2015, J PEDIATR NEUROL, V13, P8, DOI 10.1055/s-0035-1555145; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Soiberman U, 2011, CHILD NERV SYST, V27, P1913, DOI 10.1007/s00381-011-1470-5; Stafstrom CE, 2002, PEDIATRICS, V109, P460, DOI 10.1542/peds.109.3.460; Standridge SM, 2010, PEDIATR NEUROL, V43, P377, DOI 10.1016/j.pediatrneurol.2010.08.001; Straube A, 2013, DTSCH ARZTEBL INT, V110, P811, DOI 10.3238/arztebl.2013.0811; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Vinchon M, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-18; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Wilson Maria-Carmen B, 2006, Curr Pain Headache Rep, V10, P387, DOI 10.1007/s11916-006-0065-4; Winner P, 2005, HEADACHE, V45, P1304, DOI 10.1111/j.1526-4610.2005.00262.x; Wu YW, 1999, NEUROLOGY, V53, P1271, DOI 10.1212/WNL.53.6.1271	99	21	21	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1538-5442	1538-3199		CURR PROB PEDIATR AD	Curr. Probl. Pediatr. Adolesc. Health Care	MAR	2017	47	3					44	65		10.1016/j.cppeds.2017.01.002			22	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	ER8JI	WOS:000399065400002	28366491				2022-02-06	
J	Schiller, RM; van den Bosch, GE; Muetzel, RL; Smits, M; Dudink, J; Tibboel, D; Ijsselstijn, H; White, T				Schiller, Raisa M.; van den Bosch, Gerbrich E.; Muetzel, Ryan L.; Smits, Marion; Dudink, Jeroen; Tibboel, Dick; Ijsselstijn, Hanneke; White, Tonya			Neonatal critical illness and development: white matter and hippocampus alterations in school-age neonatal extracorporeal membrane oxygenation survivors	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; POPULATION; NEPSY; ECMO	AIM To examine the neurobiology of long-term neuropsychological deficits after neonatal extracorporeal membrane oxygenation (ECMO). METHOD This cross-sectional study assessed white matter integrity and hippocampal volume of ECMO survivors (8-15y) and healthy children (8-17y) using diffusion tensor imaging (DTI) and structural magnetic resonance imaging (MRI) respectively. Neuropsychological outcome was evaluated in ECMO survivors. Included clinical predictors of white matter integrity: age start ECMO, ECMO duration, highest oxygenation index before ECMO, highest mean airway pressure, and mechanical ventilation duration. RESULTS ECMO survivors (n=23) had lower global fractional anisotropy than healthy children (n=54) (patients=0.368; comparison group=0.381; p=0.018), but similar global mean diffusivity (p=0.410). ECMO survivors had lower fractional anisotropy in the left cingulum bundle (ECMO survivors=0.345; comparison group=0.399; p<0.001) and higher mean diffusivity in a region of the left parahippocampal cingulum (patients=0.916; comparison group=0.871; p<0.001). Higher global mean diffusivity predicted worse verbal memory in ECMO survivors (n=17) (beta=-0.74, p=0.008). ECMO survivors (n= 23) had smaller bilateral hippocampal volume than healthy children (n= 43) (left, p<0.001; right, p<0.001) and this was related to worse verbal memory (left, beta=0.65, p=0.018; right, beta=0.71, p=0.006). INTERPRETATION Neonatal ECMO survivors are at risk for long-term brain alterations, which may partly explain long-term neuropsychological impairments. Neuroimaging may contribute to better risk stratification of long-term impairments.	[Schiller, Raisa M.; van den Bosch, Gerbrich E.; Tibboel, Dick; Ijsselstijn, Hanneke] Erasmus MC Sophia Childrens Hosp, Intens Care & Dept Pediat Surg, Rotterdam, Netherlands; [Schiller, Raisa M.; Muetzel, Ryan L.; White, Tonya] Erasmus MC Sophia Childrens Hosp, Dept Child & Adolescent Psychiatry Psychol, NL-3000 CB Rotterdam, Netherlands; [Smits, Marion; Dudink, Jeroen; White, Tonya] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Dudink, Jeroen] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands		White, T (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Child & Adolescent Psychiatry Psychol, NL-3000 CB Rotterdam, Netherlands.	t.white@erasmusmc.nl	Smits, Marion/E-4795-2011; van den Bosch, Gerbrich/AAP-4158-2020; Muetzel, Ryan/AAA-8730-2022; White, Tonya/AAU-2226-2021; Smits, Marion/AAB-3985-2019	Muetzel, Ryan/0000-0003-3215-1287; White, Tonya/0000-0003-0271-1896; Smits, Marion/0000-0001-5563-2871; Dudink, Jeroen/0000-0003-0446-3646	Dutch Research Council: ZonMw Priority Medicines for Children [40-4150098.9020]; Sophia Stichting Wetenschappelijk Onderzoek (SSWO) [S14-21]; ZonMwNetherlands Organization for Health Research and Development [TOP 91211021]	This study was supported by the Dutch Research Council: ZonMw Priority Medicines for Children grant 40-4150098.9020 and the Sophia Stichting Wetenschappelijk Onderzoek (SSWO): S14-21. A component of the neuroimaging infrastructure was supported through a ZonMw TOP 91211021 to TW. We thank Joost van Rosmalen (PhD) from the department of Biostatistics (Erasmus MC, Rotterdam, the Netherlands) for statistical input and advice. The authors have stated that they had no interests which may be perceived as posing a conflict or bias.	Allison P, 1999, LOGISTIC REGRESSION; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brooks BL, 2010, CHILD NEUROPSYCHOL, V16, P80, DOI 10.1080/09297040903146966; Cohen J., 2013, STAT POWER ANAL BEHA; Cooper JM, 2015, CEREB CORTEX, V25, P1469, DOI 10.1093/cercor/bht332; de Groot M, 2015, ALZHEIMERS DEMENT, V11, P321, DOI 10.1016/j.jalz.2014.06.011; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Eichenbaum H, 1997, SCIENCE, V277, P330, DOI 10.1126/science.277.5324.330; Extracorporeal Life Support Organization, 2016, ECLS REG REP INT SUM; Madderom MJ, 2016, CRIT CARE MED, V44, P1182, DOI 10.1097/CCM.0000000000001626; Madderom MJ, 2013, INTENS CARE MED, V39, P1584, DOI 10.1007/s00134-013-2973-1; McNally H, 2006, PEDIATRICS, V117, pE845, DOI 10.1542/peds.2005-1167; Muetzel RL, 2015, NEUROIMAGE, V119, P119, DOI 10.1016/j.neuroimage.2015.06.014; Polito A, 2013, INTENS CARE MED, V39, P1594, DOI 10.1007/s00134-013-2985-x; Raets MMA, 2013, PEDIATR CRIT CARE ME, V14, P884, DOI 10.1097/PCC.0b013e3182a555ac; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; Stinnett TA, 2002, J PSYCHOEDUC ASSESS, V20, P66, DOI 10.1177/073428290202000105; STOLAR CJH, 1991, J PEDIATR SURG, V26, P563, DOI 10.1016/0022-3468(91)90708-2; Strang J.D., 1983, CHILD NEUROPSYCHOLOG; van den Bosch GE, 2015, PEDIATR CRIT CARE ME, V16, P652, DOI 10.1097/PCC.0000000000000474; van Heijst AFJ, 2014, SEMIN PERINATOL, V38, P104, DOI 10.1053/j.semperi.2013.11.008; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; White T, 2013, EUR J EPIDEMIOL, V28, P99, DOI 10.1007/s10654-013-9768-0; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110	25	21	21	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	MAR	2017	59	3					304	310		10.1111/dmcn.13309			7	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	EP3ZM	WOS:000397320200016	27873310	Bronze, Green Submitted			2022-02-06	
J	Gao, HB; Han, ZL; Bai, RJ; Huang, S; Ge, XT; Chen, FL; Lei, P				Gao, Huabin; Han, Zhaoli; Bai, Ruojing; Huang, Shan; Ge, Xintong; Chen, Fanglian; Lei, Ping			The accumulation of brain injury leads to severe neuropathological and neurobehavioral changes after repetitive mild traumatic brain injury	BRAIN RESEARCH			English	Article						Traumatic brain injury; Neurodegeneration; Neuroinflammation; Neurobehavioral	CONTROLLED CORTICAL IMPACT; CLINICAL MANAGEMENT; HEAD-INJURY; ENCEPHALOPATHY; DEFICITS; RATS; VULNERABILITY; CONCUSSION; MICROGLIA; SINGLE	Traumatic brain injury (TBI) is a major public health problem with long-term neurobehavioral sequela. The evidences have revealed that TBI is a risk factor for later development of neurodegenerative disease and both the single and repetitive brain injury can lead to the neurodegeneration. But whether the effects of accumulation play an important role in the neurodegenerative disease is still unknown. We utilized the Sprague Dawley (SD) rats to develop the animal models of repetitive mild TBI and single mild TBI in order to detect the neurobehavioral changes. The results of neurobehavioral test revealed that the repetitive mild TBI led to more severe behavioral injuries than the single TBI. There were more activated microglia cells and astrocytes in the repetitive mild TBI group than the single TBI group. In consistent with this, the levels of TNF-alpha and IL-6 were higher and the expression of IL-10 was lower in the repetitive mild TBI group compared with the single TBI group. The expression of amyloid precursor protein (APP) increased in the repetitive TBI group detected by ELISA and western blot. But the levels of total tau (Tau-5) and P-tau (ser202) seem no different between the two groups in most time point. In conclusion, repetitive mild TBI could lead to more severe neurobehavioral impairments and the effects of accumulation may be associated with the increased inflammation in the brain. (C) 2016 Elsevier B.V. All rights reserved.	[Gao, Huabin; Huang, Shan; Ge, Xintong; Chen, Fanglian; Lei, Ping] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Han, Zhaoli; Bai, Ruojing; Lei, Ping] Tianjin Med Univ, Gen Hosp, Tianjin Inst Geriatr, Tianjin 300052, Peoples R China		Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Anshan Rd 154, Tianjin 300052, Peoples R China.	leiping1974@163.com	Ge, Xintong/X-4889-2019	Ge, Xintong/0000-0001-7153-952X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471252, 81501055]; Tianjin Municipal Science and Technology Commission [13JCYBJC23700]	This work was supported by grants from the National Natural Science Foundation of China (grant nos. 81471252 and 81501055), Tianjin Municipal Science and Technology Commission natural fund Project (13JCYBJC23700).	Abisambra JF, 2014, J ALZHEIMERS DIS, V40, P495, DOI 10.3233/JAD-131019; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2010, NEUROL RES, V32, P1097, DOI 10.1179/016164110X12681290831162; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Semple BD, 2015, NEUROBIOL DIS, V74, P263, DOI 10.1016/j.nbd.2014.12.003; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Washington P. M., 2015, EXP NEUROL; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Zhao YD, 2001, WORLD J SURG, V25, P1202; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	37	21	21	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 15	2017	1657						1	8		10.1016/j.brainres.2016.11.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL9DI	WOS:000394919200001	27923640				2022-02-06	
J	Peron, S; Droguerre, M; Debarbieux, F; Ballout, N; Benoit-Marand, M; Francheteau, M; Brot, S; Rougon, G; Jaber, M; Gaillard, A				Peron, Sophie; Droguerre, Marine; Debarbieux, Franck; Ballout, Nissrine; Benoit-Marand, Marianne; Francheteau, Maureen; Brot, Sebastien; Rougon, Genevieve; Jaber, Mohamed; Gaillard, Afsaneh			A Delay between Motor Cortex Lesions and Neuronal Transplantation Enhances Graft Integration and Improves Repair and Recovery	JOURNAL OF NEUROSCIENCE			English	Article						cortical injury; delay; functional recovery; neuroanatomical repair; transplantation	EMBRYONIC STEM-CELLS; SCANNING-ELECTRON-MICROSCOPE; ENDOTHELIAL GROWTH-FACTOR; FRONTAL-CORTEX; SPINAL-CORD; CORTICAL-NEURONS; CEREBRAL-CORTEX; FORELIMB MOVEMENTS; STAIRCASE TEST; ADULT-RATS	We previously reported that embryonic motor cortical neurons transplanted immediately after lesions in the adult mouse motor cortex restored damaged motor cortical pathways. A critical barrier hindering the application of transplantation strategies for a wide range of traumatic injuries is the determination of a suitable time window for therapeutic intervention. Here, we report that a 1 week delay between the lesion and transplantation significantly enhances graft vascularization, survival, and proliferation of grafted cells. More importantly, the delay dramatically increases the density of projections developed by grafted neurons and improves functional repair and recovery as assessed by intravital dynamic imaging and behavioral tests. These findings open new avenues in cell transplantation strategies as they indicate successful brain repair may occur following delayed transplantation.	[Peron, Sophie; Droguerre, Marine; Ballout, Nissrine; Benoit-Marand, Marianne; Francheteau, Maureen; Brot, Sebastien; Jaber, Mohamed; Gaillard, Afsaneh] Univ Poitiers, Cellular Therapies Brain Dis Grp, Expt & Clin Neurosci Lab, IINSERM,U1084, 1 Rue Georges Bonnet,BP 633, F-86022 Poitiers, France; [Peron, Sophie; Droguerre, Marine; Ballout, Nissrine; Benoit-Marand, Marianne; Francheteau, Maureen; Brot, Sebastien; Jaber, Mohamed; Gaillard, Afsaneh] Univ Poitiers, U1084, F-86073 Poitiers, France; [Debarbieux, Franck; Rougon, Genevieve] Fac Med Marseille, Inst Neurosci Timone, CNRS, UMR 7289,ImaPath, F-13005 Marseille, France; [Debarbieux, Franck; Rougon, Genevieve] Aix Marseille Univ, F-13284 Marseille 07, France; [Jaber, Mohamed] CHU Poitiers, F-86021 Poitiers, France		Gaillard, A (corresponding author), Univ Poitiers, Cellular Therapies Brain Dis Grp, Expt & Clin Neurosci Lab, IINSERM,U1084, 1 Rue Georges Bonnet,BP 633, F-86022 Poitiers, France.	afsaneh.gaillard@univ-poitiers.fr	BALLOUT, Nissrine/ABG-2754-2020	Droguerre, Marine/0000-0002-3570-0635; Peron, Sophie/0000-0002-7167-4585; Benoit-Marand, Marianne/0000-0002-1380-5401; Jaber, Mohamed/0000-0003-2536-1913; BROT, Sebastien/0000-0002-4373-2135; ROUGON, Genevieve/0000-0003-1316-8200	Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME); Fonds Europeen de Developpement Regional (FEDER)European Commission [33552]; Contrat de Plan Etat-region (CPER 5); Agence Nationale de la Recherche (ANR)French National Research Agency (ANR)	This work was funded by grants from the Institut pour la Recherche sur la Moelle Epiniere et l'Encephale (IRME), Fonds Europeen de Developpement Regional (FEDER) No 33552 and Contrat de Plan Etat-region (CPER 5) to A.G. and Agence Nationale de la Recherche (ANR) to F.D. We thank the staff of Image'UP platform (University of Poitiers).	[Anonymous], NATURE; Baird AL, 2001, BRAIN RES BULL, V54, P243, DOI 10.1016/S0361-9230(00)00457-3; Ballout N, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00055; Bartholdi D, 1997, EUR J NEUROSCI, V9, P2549, DOI 10.1111/j.1460-9568.1997.tb01684.x; Bessert DA, 1999, J HISTOCHEM CYTOCHEM, V47, P693, DOI 10.1177/002215549904700511; Bouet V, 2007, EXP NEUROL, V203, P555; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Casper D, 2003, EXP NEUROL, V184, P785, DOI 10.1016/S0014-4886(03)00336-4; Chen YJ, 2016, CELL STEM CELL, V18, P817, DOI 10.1016/j.stem.2016.03.014; EBRAHIMIGAILLARD A, 1995, NEUROSCIENCE, V64, P49, DOI 10.1016/0306-4522(94)00396-M; Falkner S, 2016, NATURE, V539, P248, DOI 10.1038/nature20113; Fenrich KK, 2012, J PHYSIOL-LONDON, V590, P3665, DOI 10.1113/jphysiol.2012.230532; FINGER S, 1989, EXP NEUROL, V104, P1, DOI 10.1016/0014-4886(89)90001-0; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gaillard A, 2000, CEREB CORTEX, V10, P443, DOI 10.1093/cercor/10.5.443; Gaillard A, 1998, ADV ANAT EMBRYOL CEL, V148, P1; Gaillard A, 2007, NAT NEUROSCI, V10, P1294, DOI 10.1038/nn1970; Gaillard A, 2011, TRENDS NEUROSCI, V34, P124, DOI 10.1016/j.tins.2011.01.003; Gaillard A, 2007, CELL ADHES MIGR, V1, P161, DOI 10.4161/cam.1.4.5274; Gaillard A, 2009, NEUROBIOL DIS, V35, P477, DOI 10.1016/j.nbd.2009.07.003; Gaillard F, 2004, NEUROSCIENCE, V126, P631, DOI 10.1016/j.neuroscience.2004.04.011; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gaspard N, 2009, CELL CYCLE, V8, P2491, DOI 10.4161/cc.8.16.9276; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Harris NG, 2010, J NEUROTRAUM, V27, P1971, DOI 10.1089/neu.2010.1470; KESSLAK JP, 1986, EXP NEUROL, V94, P615, DOI 10.1016/0014-4886(86)90241-4; KOLB B, 1988, BEHAV NEURAL BIOL, V50, P193, DOI 10.1016/S0163-1047(88)90881-3; KOLB B, 1994, BRAIN RES, V647, P15, DOI 10.1016/0006-8993(94)91393-5; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; MANTHORPE M, 1983, BRAIN RES, V267, P47, DOI 10.1016/0006-8993(83)91038-7; MAYER E, 1992, EUR J NEUROSCI, V4, P119, DOI 10.1111/j.1460-9568.1992.tb00858.x; Michelsen KA, 2015, NEURON, V85, P982, DOI 10.1016/j.neuron.2015.02.001; MIYOSHI Y, 1995, BRAIN RES, V681, P131, DOI 10.1016/0006-8993(95)00304-9; MIYOSHI Y, 1995, EXP NEUROL, V131, P69, DOI 10.1016/0014-4886(95)90009-8; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nag S, 2002, J NEUROPATH EXP NEUR, V61, P778, DOI 10.1093/jnen/61.9.778; NEAFSEY EJ, 1989, BRAIN RES, V493, P33, DOI 10.1016/0006-8993(89)90997-9; NIETOSAMPEDRO M, 1984, P NATL ACAD SCI-BIOL, V81, P6250, DOI 10.1073/pnas.81.19.6250; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olson L, 1982, ADV CELLULAR NEUROBI, V4, P407; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Pinaudeau C, 2000, EUR J NEUROSCI, V12, P2486, DOI 10.1046/j.1460-9568.2000.00148.x; PLUMET J, 1993, RESTOR NEUROL NEUROS, V6, P9, DOI 10.3233/RNN-1993-6102; Riolobos AS, 2001, NEUROBIOL LEARN MEM, V75, P274, DOI 10.1006/nlme.2000.3979; Roome RB, 2014, J NEUROSCI METH, V233, P34, DOI 10.1016/j.jneumeth.2014.05.014; Santos-Torres J, 2009, J NEUROTRAUM, V26, P1593, DOI 10.1089/neu.2008.0702; Senatorov VV, 1991, J NEURAL TRANSPLANT, V2, P125; Skold MK, 2005, J NEUROTRAUMA, V22, P353; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Thompson LH, 2009, EUR J NEUROSCI, V30, P625, DOI 10.1111/j.1460-9568.2009.06878.x; Ueno M, 2011, EXP NEUROL, V230, P280, DOI 10.1016/j.expneurol.2011.05.006; Whishaw IQ, 2004, J NEUROTRAUM, V21, P1584, DOI 10.1089/neu.2004.21.1584; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; BRAIN RES; NAT NEUROSCI	57	21	21	0	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	FEB 15	2017	37	7					1820	1834		10.1523/JNEUROSCI.2936-16.2017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EL2DU	WOS:000394431100015	28087762	Green Published, Bronze			2022-02-06	
J	van Essen, TA; de Ruiter, GCW; Kho, KH; Peul, WC				van Essen, Thomas A.; de Ruiter, Godard C. W.; Kho, Kuan H.; Peul, Wilco C.			Neurosurgical Treatment Variation of Traumatic Brain Injury: Evaluation of Acute Subdural Hematoma Management in Belgium and The Netherlands	JOURNAL OF NEUROTRAUMA			English	Article						ASDH; TBI; treatment variation	QUALITY-OF-LIFE; DECOMPRESSIVE CRANIECTOMY; HEAD-INJURY; CLINICAL ARTICLE; CARE MANAGEMENT; CONSORTIUM; TRIALS; EPIDEMIOLOGY; NEUROTRAUMA; POPULATION	Several recent global traumatic brain injury (TBI) initiatives rely on practice variation in diagnostic and treatment methods to answer effectiveness questions. One of these scientific dilemmas, the surgical management of the traumatic acute subdural hematoma (ASDH) might be variable among countries, among centers within countries, and even among neurosurgeons within a center, and hence be amenable for a comparative effectiveness study. The aim of our questionnaire, therefore, was to explore variations in treatment for ASDH among neurosurgeons in similar centers in a densely populated geographical area. An online questionnaire, involving treatment decisions on six case vignettes of ASDH, was sent to 93 neurosurgeons in The Netherlands and Belgium. Clinical and radiological variables differed per case. Sixty neurosurgeons filled out the questionnaire (response rate 65%). For case vignettes with severe TBI and an ASDH, there was a modest variation in the decision to evacuate the hematoma and a large variation in the decision to combine the evacuation with a decompressive craniectomy. The main reasons for operating were "neurological condition'' and "mass effect.'' For ASDH and mild/moderate TBI, there was large variation in the decision of whether to operate or not, whereas "hematoma size'' was the predominant motivation for surgery. Significant inter-center variation for the decision to evacuate the hematoma was observed (p = 0.01). Most pronounced was that 1 out of 7 (14%) neurosurgeons in one region chose a surgical strategy compared with 9 out of 10 (90%) in another region for the same scenario. In conclusion, variation exists in the neurosurgical management of TBI within an otherwise homogeneous setting. This variation supports the methodology of the international Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) initiative, and shaped the Dutch Neurotraumatology Quality Registry (Net-QuRe) initiative.	[van Essen, Thomas A.; Peul, Wilco C.] Leiden Univ, Med Ctr, Dept Neurosurg, Neurosurg Cooperat Holland, Leiden, Netherlands; [van Essen, Thomas A.; de Ruiter, Godard C. W.; Peul, Wilco C.] Med Ctr Haaglanden, Neurosurg Cooperat Holland, Dept Neurosurg, The Hague, Netherlands; [Kho, Kuan H.] Med Spectrum Twente, Dept Neurosurg, Enschede, Netherlands; [Kho, Kuan H.] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium		van Essen, TA (corresponding author), Albinusdreef 2,J-11-R-83, NL-2333 ZA Leiden, Netherlands.	T.A.van_Essen@lumc.nl	Kho, Kuan H/D-3263-2013; de Ruiter, Godard/ABC-4074-2020	Kho, Kuan H/0000-0002-1834-0922; Van Essen, Thomas/0000-0003-4657-5283	European UnionEuropean Commission [602150]; Hersenstichting Nederland (Dutch Brain Foundation) for Neurotraumatology Quality Registry (Net-QuRe)	The authors thank Dr. Johannes Van Loon and Prof. dr. Bart Depreitere (neurosurgeons, Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium) for their involvement in case selection, all Dutch and Belgian neurosurgeons who participated in filling out the questionnaire, and Dr. Carmen L. Vleggeert-Lankamp (neurosurgeon, Department of Neurosurgery, Leiden University Medical Center, Leiden, The Netherlands) for critical appraisal of the first draft of our manuscript. This work was supported by The European Union seventh Framework Program (grant 602150) for Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) and Hersenstichting Nederland (Dutch Brain Foundation) for Neurotraumatology Quality Registry (Net-QuRe).	Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Brattheim BJ, 2012, EUR J VASC ENDOVASC, V44, P267, DOI 10.1016/j.ejvs.2012.04.029; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Gregson BA, 2003, STROKE, V34, P2593, DOI 10.1161/01.STR.0000097491.82104.F3; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Honeybul S, 2013, J NEUROSURG, V119, P1566, DOI 10.3171/2013.8.JNS13857; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kahneman D., 2012, THINKING FAST SLOW; Kelly ML, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1319; Kolias AG, 2012, ACTA NEUROCHIR, V154, P1563, DOI 10.1007/s00701-012-1349-6; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marion DW, 2006, NEUROSURGERY, V58, P655; MATHEW P, 1993, ACTA NEUROCHIR, V121, P100, DOI 10.1007/BF01809258; Mendelow A. D., 2015, J NEUROTRAUMA; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nijboer JMM, 2010, INJURY, V41, P52, DOI 10.1016/j.injury.2009.05.030; Peul W. C., 2014, J NEUROTRAUM, V31, pA1; Rayan N, 2012, J TRAUMA ACUTE CARE, V72, P585, DOI 10.1097/TA.0b013e318243da4d; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Servadei F, 2007, CURR OPIN CRIT CARE, V13, P163, DOI 10.1097/MCC.0b013e32807f2a94; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tallon JM, 2008, CAN J SURG, V51, P339; Timmons SD, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.6.FOCUS1296; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	44	21	21	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					881	889		10.1089/neu.2016.4495			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200016	27393190	Green Submitted			2022-02-06	
J	Janak, JC; Orman, JA; Soderdahl, DW; Hudak, SJ				Janak, Judson C.; Orman, Jean A.; Soderdahl, Douglas W.; Hudak, Steven J.			Epidemiology of Genitourinary Injuries among Male US Service Members Deployed to Iraq and Afghanistan: Early Findings from the Trauma Outcomes and Urogenital Health (TOUGH) Project	JOURNAL OF UROLOGY			English	Article						urogenital system; wounds and injuries; blast injuries; penis; organ transplantation	SEXUAL DYSFUNCTION; COMBAT; AMPUTATION; MANAGEMENT; IMPACT	Purpose: In this study we report the number, nature and severity of genitourinary injuries among male U.S. service members deployed to Operations Iraqi Freedom and Enduring Freedom. Materials and Methods: This retrospective cross-sectional study of the Department of Defense Trauma Registry used ICD-9-CM codes to identify service members with genitourinary injuries, and used Abbreviated Injury Scale codes to determine injury severity, genitourinary organs injured and comorbid injuries. Results: From October 2001 to August 2013, 1,367 male U.S. service members sustained 1 or more genitourinary injuries. The majority of injuries involved the external genitalia (1,000, 73.2%), including the scrotum (760, 55.6%), testes (451, 33.0%), penis (423, 31%) and/or urethra (125, 9.1%). Overall more than a third of service members with genitourinary injury sustained at least 1 severe genitourinary injury (502, 36.7%). Loss of 1 or both testes was documented in 146 men, including 129 (9.4%) unilateral orchiectomies and 17 (1.2%) bilateral orchiectomies. Common comorbid injuries included traumatic brain injury (549, 40.2%), pelvic fracture (341, 25.0%), colorectal injury (297, 21.7%) and lower extremity amputations (387, 28.7%). Conclusions: An unprecedented number of U.S. service members sustained genitourinary injury while deployed to Operation Iraqi Freedom/Operation Enduring Freedom. Further study is needed to describe the long-term impact of genitourinary injury and determine the potential need for novel treatments to improve sexual, urinary and/or reproductive function among service members with severe genital injury.	[Janak, Judson C.; Orman, Jean A.] JBSA, US Army Inst Surg Res, Ft Sam Houston, TX USA; [Soderdahl, Douglas W.; Hudak, Steven J.] JBSA, San Antonio Mil Med Ctr, Ft Sam Houston, TX USA		Hudak, SJ (corresponding author), JBSA, San Antonio Mil Med Ctr, Dept Surg, Urol Clin, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.	Steven.J.Hudak2.mil@mail.mil					Banti M, 2016, J TRAUMA ACUTE CARE, V80, P131, DOI 10.1097/TA.0000000000000864; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Cosgrove DJ, 2002, UROLOGY, V60, P881, DOI 10.1016/S0090-4295(02)01899-X; Davendra M Sharma, 2013, J R Army Med Corps, V159 Suppl 1, pi1; Doukas WC, 2013, J BONE JOINT SURG AM, V95A, P138, DOI 10.2106/JBJS.K.00734; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Feltman R, 2014, WASHINGTON POST; Ficke JR, 2012, J TRAUMA ACUTE CARE, V73, pS520, DOI 10.1097/TA.0b013e31827559da; Fleming Mark, 2012, J Surg Orthop Adv, V21, P32; Frappell-Cooke W, 2013, J ROY ARMY MED CORPS, V159, P52, DOI 10.1136/jramc-2013-000028; Grady D., 2015, NY TIMES; Han JS, 2013, J MENS HEALTH, V10, P124, DOI 10.1089/jomh.2013.1504; Harvey-Kelly KF, 2011, J UROLOGY, V185, P2027, DOI 10.1016/j.juro.2011.01.076; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Hudak SJ, 2005, UROLOGY, V65, P1041, DOI 10.1016/j.urology.2004.11.031; Kime P, 2016, MILITARY TIMES  0131; Kime P, 2016, ARMY TIMES; Melcer T, 2010, MIL MED, V175, P147, DOI 10.7205/MILMED-D-09-00120; Nicol MN, 2016, DAILY MAIL; Paquette EL, 2007, J UROLOGY, V177, P2196, DOI 10.1016/j.juro.2007.01.132; Penn-Barwell JG, 2014, INJURY, V45, P1105, DOI 10.1016/j.injury.2014.01.025; Rees PM, 2007, LANCET, V369, P512, DOI 10.1016/S0140-6736(07)60238-4; Schmidt MS, 2016, NY TIMES; Serkin FB, 2010, J TRAUMA, V69, pS175, DOI 10.1097/TA.0b013e3181e45cd1; Sharma DM, 2013, J ROY ARMY MED CORPS, V159, P57, DOI 10.1136/jramc-2013-000029; Sharma DM, 2013, J ROY ARMY MED CORPS, V159, P18, DOI 10.1136/jramc-2013-000023; Sorensen MD, 2008, J TRAUMA, V65, P1045, DOI 10.1097/TA.0b013e3181896192; Wilcox Sherrie L, 2015, GENITOURINARY TRAUMA; Williamson GM, 1996, J SEX RES, V33, P221, DOI 10.1080/00224499609551838	29	21	22	2	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5347	1527-3792		J UROLOGY	J. Urol.	FEB	2017	197	2					414	419		10.1016/j.juro.2016.08.005			6	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	EH8YT	WOS:000392059300059	27506692				2022-02-06	
J	Lynall, RC; Zukowski, LA; Plummer, P; Mihalik, JP				Lynall, Robert C.; Zukowski, Lisa A.; Plummer, Prudence; Mihalik, Jason P.			Reliability and validity of the protokinetics movement analysis software in measuring center of pressure during walking	GAIT & POSTURE			English	Article						Gait; Functional movement; Movement assessment; Dynamic balance	GAITRITE(R) WALKWAY SYSTEM; BALANCE CONTROL; GAIT; PARAMETERS; QUANTIFICATION; CONCUSSION	Our purpose was to determine the validity and test-retest reliability of the Protokinetics Movement Analysis Software (PKMAS) in measuring center of pressure (COP) during walking as compared to a force plate gold standard. Twenty-five healthy participants (14 females, 11 males; age 20.0 +/- 1.5 years) completed 2 testing sessions approximately 5 days apart (mean = 5.5 +/- 1.1 days). In each session, participants completed 16 total trials across a 6 m walkway: 8 trials walking on a ProtoKinetics Zeno Walkway using PKMAS and 8 trials walking over 2 force plates arranged in an offset tandem pattern. COP path length (cm) and speed (cm/s) were calculated from data averaged across the 8 trials on a given device for a given foot. Intraclass correlation coefficients (ICC 2, k) were computed to determine between session reliability. Pearson correlation coefficients (r) and Bland-Altman plots were produced between the PKMAS and force plate outcomes for session 1 to determine validity. The PKMAS demonstrated excellent reliability (ICC 2, k >= 0.962) for all COP measures. Pearson correlation coefficients between PKMAS and force plates were >= 0.75 for all outcome variables. Bland-Altman plots and 95% levels of agreement revealed a bias where the PKMAS appeared to underestimate COP path length and speed by approximately 4 cm and 6 cm/s, respectively. After correcting for bias, our findings suggest the PKMAS is a reliable tool to measure COP in healthy people during gait. Using the PKMAS with the ProtoKinetics Zeno Walkway may allow for more efficient investigation of dynamic balance variables during functional movement tasks. (C) 2016 Elsevier B.V. All rights reserved.	[Lynall, Robert C.; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Dept Exercise & Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Lynall, Robert C.; Plummer, Prudence; Mihalik, Jason P.] Univ North Carolina Chapel Hill, Sch Med, Dept Allied Hlth Sci, Human Movement Sci Curriculum, Chapel Hill, NC USA; [Zukowski, Lisa A.; Plummer, Prudence] Univ North Carolina Chapel Hill, Sch Med, Dept Allied Hlth Sci, Div Phys Therapy, Chapel Hill, NC USA; [Mihalik, Jason P.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA		Lynall, RC (corresponding author), Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA.	rlynall@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640			Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Buesing C, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0062-0; Cho MK, 2015, GAIT POSTURE, V42, P73, DOI 10.1016/j.gaitpost.2015.04.009; Dames KD, 2015, GAIT POSTURE, V42, P122, DOI 10.1016/j.gaitpost.2015.04.017; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; Gribble PA, 2012, J ATHL TRAINING, V47, P339, DOI 10.4085/1062-6050-47.3.08; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Jian Y., 1993, GAIT POSTURE, V1, P9, DOI [10.1016/0966-6362(93)90038-3, DOI 10.1016/0966-6362(93)90038-3]; Menz HB, 2004, GAIT POSTURE, V20, P20, DOI 10.1016/S0966-6362(03)00068-7; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Roemmich RT, 2012, GAIT POSTURE, V36, P340, DOI 10.1016/j.gaitpost.2012.01.018; van der Krogt M.M., 2015, J BIOMECH; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Xu H, 2015, GAIT POSTURE, V42, P110, DOI 10.1016/j.gaitpost.2015.04.015	15	21	21	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0966-6362	1879-2219		GAIT POSTURE	Gait Posture	FEB	2017	52						308	311		10.1016/j.gaitpost.2016.12.023			4	Neurosciences; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics; Sport Sciences	EQ3XS	WOS:000398007900052	28033577				2022-02-06	
J	Weickenmeier, J; Butler, CAM; Young, PG; Goriely, A; Kuhl, E				Weickenmeier, J.; Butler, C. A. M.; Young, P. G.; Goriely, A.; Kuhl, E.			The mechanics of decompressive craniectomy: Personalized simulations	COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING			English	Article						Neuromechanics; Neurosurgery; Finite element analysis; Decompressive craniectomy; Hemicraniectomy	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL; TISSUE; HEAD; ACCURATE	Decompressive craniectomy is a traditional but controversial surgical procedure that removes part of the skull to allow an injured and swollen brain to expand outward. Recent studies suggest that mechanical strain is associated with its undesired, high failure rates. However, the precise strain fields induced by the craniectomy are unknown. Here we create a personalized craniectomy model from magnetic resonance images to quantify the strains during a decompressive craniectomy using finite element analysis. We swell selected regions of the brain and remove part of the skull to allow the brain to bulge outward and release the intracranical swelling pressure. Our simulations reveal three potential failure mechanisms associated with the procedure: axonal stretch in the center of the bulge, axonal compression at the edge of the craniectomy, and axonal shear around the opening. Strikingly, for a swelling of only 10%, axonal strain, compression, and shear reach local maxima of up to 30%, and exceed the reported functional and morphological damage thresholds of 18% and 21%. Our simulations suggest that a collateral craniectomy with the skull opening at the side of swelling is less invasive than a contralateral craniectomy with the skull opening at the opposite side: It induces less deformation, less rotation, smaller strains, and a markedly smaller midline shift. Our computational craniectomy model can help quantify brain deformation, tissue strain, axonal stretch, and shear with the goal to identify high-risk regions for brain damage on a personalized basis. While computational modeling is beyond clinical practice in neurosurgery today, simulations of neurosurgical procedures have the potential to rationalize surgical process parameters including timing, location, and size, and provide standardized guidelines for clinical decision making and neurosurgical planning. (C) 2016 Elsevier B.V. All rights reserved.	[Weickenmeier, J.; Kuhl, E.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Butler, C. A. M.] Simpleware Ltd, Bradninch Hall,Castle St, Exeter EX4 3PL, Devon, England; [Young, P. G.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Goriely, A.] Univ Oxford, Math Inst, Oxford, England; [Kuhl, E.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA		Kuhl, E (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	ekuhl@stanford.edu	Kuhl, Ellen/G-4444-2011	Kuhl, Ellen/0000-0002-6283-935X; Weickenmeier, Johannes/0000-0003-1889-5976	Wolfson/Royal Society Merit AwardRoyal Society of London; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 HL119578]	The authors thank Allan L. Reiss and his group for providing the MRI scans. This work was supported by the Wolfson/Royal Society Merit Award to Alain Goriely and by the National Institutes of Health grant U01 HL119578 to Ellen Kuhl.	[Anonymous], 2014, AB 6 14 AN US MAN SI; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Budday S., 2016, MECH CHARACTER UNPUB; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Budday S, 2014, J MECH PHYS SOLIDS, V72, P75, DOI 10.1016/j.jmps.2014.07.010; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cotton RT, 2016, COMPUT METHOD BIOMEC, V19, P101, DOI 10.1080/10255842.2014.994118; de Rooij R, 2016, APPL MECH REV, V68, DOI 10.1115/1.4032436; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Fletcher T.L., MODELLING BRAI UNPUB; Fletcher TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110408; Fletcher TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102131; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Gao CP, 2008, ACTA NEUROCHIR SUPPL, V102, P279, DOI 10.1007/978-3-211-85578-2_52; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Goriely A., 2016, PHYS REV LE IN PRESS; Goriely A, 2015, ADV APPL MECH, V48, P79, DOI 10.1016/bs.aams.2015.10.002; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Holland MA, 2015, ANN BIOMED ENG, V43, P1640, DOI 10.1007/s10439-015-1312-9; Holzapfel GA., 2000, NONLINEAR SOLID MECH; Hu JW, 2007, J NEUROSURG, V106, P164, DOI 10.3171/jns.2007.106.1.164; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Jones H.R., 2013, NETTER COLLECTION 1, V7; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kocher T, 1901, HIRNERSCHUTTERUNG HI; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Komotar R., 2011, AM ASS NEUROLOG SURG; Lang GE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0123; Lejeune E, 2016, SOFT MATTER, V12, P5613, DOI 10.1039/c6sm00526h; Li XG, 2013, J CLIN NEUROSCI, V20, P509, DOI 10.1016/j.jocn.2012.04.019; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Mooney M, 1940, J APPL PHYS, V11, P582, DOI 10.1063/1.1712836; Ogden R.W., 1972, P ROY SOC LOND A MAT, V326; Ploch CC, 2016, WORLD NEUROSURG, V90, P668, DOI 10.1016/j.wneu.2016.02.081; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; RIVLIN RS, 1948, PHILOS TR R SOC S-A, V241, P379, DOI 10.1098/rsta.1948.0024; Saggar M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10894; Sahuquillo J, 2013, CURR OPIN CRIT CARE, V19, P101, DOI 10.1097/MCC.0b013e32835eba1a; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tagliaferri F, 2012, ACTA NEUROCHIR, V154, P919, DOI 10.1007/s00701-012-1318-0; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; van den Bedem H, 2015, BIOPHYS J, V109, P2215, DOI 10.1016/j.bpj.2015.10.020; von Holst H, 2014, ACTA NEUROCHIR, V156, P1961, DOI 10.1007/s00701-014-2195-5; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Weickenmeier J, 2016, ACTA BIOMATER, V42, P265, DOI 10.1016/j.actbio.2016.07.040; Weickenmeier J, 2016, J MECH PHYS SOLIDS, V96, P572, DOI 10.1016/j.jmps.2016.08.009; Wright RM, 2011, BIOMECH MODEL MECHAN, V11, P245; Young PG, 2008, PHILOS T R SOC A, V366, P3155, DOI 10.1098/rsta.2008.0090	52	21	22	0	8	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0045-7825	1879-2138		COMPUT METHOD APPL M	Comput. Meth. Appl. Mech. Eng.	FEB 1	2017	314				SI		180	195		10.1016/j.cma.2016.08.011			16	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Mathematics; Mechanics	EI8UF	WOS:000392782900011		Green Accepted, Green Submitted			2022-02-06	
J	Nitkiewicz, J; Borjabad, A; Morgello, S; Murray, J; Chao, W; Emdad, L; Fisher, PB; Potash, MJ; Volsky, DJ				Nitkiewicz, Jadwiga; Borjabad, Alejandra; Morgello, Susan; Murray, Jacinta; Chao, Wei; Emdad, Luni; Fisher, Paul B.; Potash, Mary Jane; Volsky, David J.			HIV induces expression of complement component C3 in astrocytes by NF-kappa B-dependent activation of interleukin-6 synthesis	JOURNAL OF NEUROINFLAMMATION			English	Article						HIV; HAND; Complement component C3; Astrocytes; IL-6; Neurodegeneration; NF-kappa B; HIV-associated dementia; Brain tissue	HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; SIV-INFECTED MONKEYS; NEUROCOGNITIVE DISORDERS; PRODUCTIVE INFECTION; ALZHEIMERS-DISEASE; GENE-EXPRESSION; MICROGLIA; MICE	Background: Abnormal activation of the complement system contributes to some central nervous system diseases but the role of complement in HIV-associated neurocognitive disorder (HAND) is unclear. Methods: We used real-time PCR and immunohistochemistry to detect complement expression in postmortem brain tissue from HAND patients and controls. To further investigate the basis for viral induction of gene expression in the brain, we studied the effect of HIV on C3 expression by astrocytes, innate immune effector cells, and targets of HIV. Human fetal astrocytes (HFA) were infected with HIV in culture and cellular pathways and factors involved in signaling to C3 expression were elucidated using pharmacological pathway inhibitors, antisense RNA, promoter mutational analysis, and fluorescence microscopy. Results: We found significantly increased expression of complement components including C3 in brain tissues from patients with HAND and C3 was identified by immunocytochemistry in astrocytes and neurons. Exposure of HFA to HIV in culture-induced C3 promoter activity, mRNA expression, and protein production. Use of pharmacological inhibitors indicated that induction of C3 expression by HIV requires NF-kappa B and protein kinase signaling. The relevance of NF-kappa B regulation to C3 induction was confirmed through detection of NF-kappa B translocation into nuclei and inhibition through overexpression of the physiological NF-kappa B inhibitor, I-kappa B alpha. C3 promoter mutation analysis revealed that the NF-kappa B and SP binding sites are dispensable for the induction by HIV, while the proximal IL-1 beta/IL-6 responsive element is essential. HIV-treated HFA secreted IL-6, exogenous IL-6 activated the C3 promoter, and anti-IL-6 antibodies blocked HIV activation of the C3 promoter. The activation of IL-6 transcription by HIV was dependent upon an NF-kappa B element within the IL-6 promoter. Conclusions: These results suggest that HIV activates C3 expression in primary astrocytes indirectly, through NF-kappa B-dependent induction of IL-6, which in turn activates the C3 promoter. HIV induction of C3 and IL-6 in astrocytes may contribute to HIV-mediated inflammation in the brain and cognitive dysfunction.	[Nitkiewicz, Jadwiga; Borjabad, Alejandra; Chao, Wei; Potash, Mary Jane; Volsky, David J.] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Morgello, Susan; Murray, Jacinta] Icahn Sch Med Mt Sinai, Dept Neurol, Manhattan HIV Brain Bank, New York, NY 10029 USA; [Emdad, Luni; Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, VCU Massey Canc Ctr, Sch Med,VCU Inst Mol Med, Richmond, VA 23298 USA; [Nitkiewicz, Jadwiga] PSI CRO, Wisniowy Business Pk C,1 Sierpnia 6A, PL-02134 Warsaw, Poland; [Volsky, David J.] Dept Med, Div Infect Dis, 1468 Madison Ave,Annenberg Bldg,21st Floor, New York, NY 10029 USA		Volsky, DJ (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA.; Volsky, DJ (corresponding author), Dept Med, Div Infect Dis, 1468 Madison Ave,Annenberg Bldg,21st Floor, New York, NY 10029 USA.	David.Volsky@mssm.edu			PHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R21 MH 086372, R01 MH 083627, R01 DA 017618, R01 DA 037611, R01 MH 104145, U01 MH 100931]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH104145, U24MH100931, R21MH086372, R01MH083627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA037611, R01DA017618] Funding Source: NIH RePORTER	Funding was supplied by PHS grants to DJV: R21 MH 086372, R01 MH 083627, R01 DA 017618, R01 DA 037611, R01 MH 104145 and to SM: U01 MH 100931.	Abassi M, 2017, J NEUROVIROL, V23, P369, DOI 10.1007/s13365-016-0505-9; ACHIM CL, 1993, J CLIN INVEST, V91, P2769, DOI 10.1172/JCI116518; ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Baccam M, 2003, J IMMUNOL, V170, P3099, DOI 10.4049/jimmunol.170.6.3099; Barnum SR, 1996, GLIA, V18, P107, DOI 10.1002/(SICI)1098-1136(199610)18:2<107::AID-GLIA3>3.0.CO;2-Y; Blatteis CM, 2004, FRONT BIOSCI-LANDMRK, V9, P915, DOI 10.2741/1297; Borjabad A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002213; Brouillette MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155766; Bruder C, 2004, MOL IMMUNOL, V40, P949, DOI 10.1016/j.molimm.2003.10.016; Canki M, 2001, J VIROL, V75, P7925, DOI 10.1128/JVI.75.17.7925-7933.2001; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Clements JE, 2002, J INFECT DIS, V186, P905, DOI 10.1086/343768; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Depboylu C, 2005, NEUROBIOL DIS, V20, P12, DOI 10.1016/j.nbd.2005.01.030; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fitting S, 2010, J PROTEOME RES, V9, P1795, DOI 10.1021/pr900926n; Harezlak J, 2011, AIDS, V25, P625, DOI 10.1097/QAD.0b013e3283427da7; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hong S, 2016, CURR OPIN NEUROBIOL, V36, P128, DOI 10.1016/j.conb.2015.12.004; Hong SZ, 2015, BRAIN BEHAV IMMUN, V45, P1, DOI 10.1016/j.bbi.2014.10.008; Hu WT, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0277-8; Jongen PJH, 2000, ACTA NEUROL SCAND, V101, P116, DOI 10.1034/j.1600-0404.2000.101002116.x; Kamat A, 2012, JAIDS-J ACQ IMM DEF, V60, P234, DOI 10.1097/QAI.0b013e318256f3bc; Kim SY, 2003, J NEUROCHEM, V86, P1458, DOI 10.1046/j.1471-4159.2003.01958.x; Kim SY, 2004, J NEUROIMMUNOL, V157, P17, DOI 10.1016/j.jneuroim.2004.08.032; Komotar RJ, 2008, ADV EXP MED BIOL, V632, P23, DOI 10.1007/978-0-387-78952-1_2; Li JL, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-31; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; Liu FM, 2014, J NEUROVIROL, V20, P184, DOI 10.1007/s13365-014-0243-9; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Mankowski JL, 2004, J NEUROIMMUNOL, V157, P66, DOI 10.1016/j.jneuroim.2004.08.031; Mastellos DC, 2016, IMMUNOBIOLOGY, V221, P1046, DOI 10.1016/j.imbio.2016.06.013; Mateen FJ, 2012, NEUROLOGY, V79, P1873, DOI 10.1212/WNL.0b013e318271f7b8; Mayilyan KR, 2008, DRUG NEWS PERSPECT, V21, P200, DOI 10.1358/dnp.2008.21.4.1213349; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Morgan BP, 2015, EXPERT REV CLIN IMMU, V11, P1109, DOI 10.1586/1744666X.2015.1074039; Nookala AR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0214-3; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pendyala G, 2009, J PROTEOME RES, V8, P2253, DOI 10.1021/pr800854t; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Price RW, 2014, SEMIN NEUROL, V34, P7, DOI 10.1055/s-0034-1372337; Quintana A, 2007, NEUROIMMUNOMODULAT, V14, P139, DOI 10.1159/000110637; REBOUL J, 1989, J NEUROL SCI, V89, P243, DOI 10.1016/0022-510X(89)90026-9; Roberts ES, 2004, J NEUROIMMUNOL, V157, P81, DOI 10.1016/j.jneuroim.2004.08.030; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Russell D.W., 2001, MOL CLONING LAB MANU; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Sordillo PP, 2016, BRAIN INJURY, V1-11; Speth C, 2004, J NEUROIMMUNOL, V151, P45, DOI 10.1016/j.jneuroim.2004.02.013; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; Speth C, 2001, J VIROL, V75, P2604, DOI 10.1128/JVI.75.6.2604-2516.2001; Spudich S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007120; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Su ZZ, 2002, ONCOGENE, V21, P3592, DOI 10.1038/sj.onc.1205445; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Thompson KA, 2011, AM J PATHOL, V179, P1623, DOI 10.1016/j.ajpath.2011.06.039; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Winkler JM, 2012, J NEUROIMMUNE PHARM, V7, P372, DOI 10.1007/s11481-012-9344-5; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076	73	21	23	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JAN 26	2017	14								23	10.1186/s12974-017-0794-9			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	EP1LD	WOS:000397145500001	28122624	Green Published, gold			2022-02-06	
J	Rubovitch, V; Zilberstein, Y; Chapman, J; Schreiber, S; Pick, CG				Rubovitch, Vardit; Zilberstein, Yael; Chapman, Joab; Schreiber, Shaul; Pick, Chaim G.			Restoring GM1 ganglioside expression ameliorates axonal outgrowth inhibition and cognitive impairments induced by blast traumatic brain injury	SCIENTIFIC REPORTS			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NOGO-A; NEURITE OUTGROWTH; MOUSE MODEL; REGENERATION; PLASTICITY; GROWTH; MEMORY; MILD	Blast induced traumatic brain injury (B-TBI) may cause various degrees of cognitive and behavioral disturbances but the exact brain pathophysiology involved is poorly understood. It was previously suggested that ganglioside alteration on the axon surface as well as axonal regenerating inhibitors (ARIs) such as myelin associated glycoprotein (MAG) were involved in axonal outgrowth inhibition (AOI), leading to brain damage. GM1 ganglioside content in the brain was significantly reduced while GD1 ganglioside was not affected. The axonal regeneration was also reduced as seen by the phosphorylated NF-H expression. Moreover, B-TBI induced a significant elevation in MAG expression in the brains of the injured mice. The blast injured mice exhibited a significant decline in spatial memory as seen by the Y-maze test. In addition, the injured mice showed pronounced damage to the visual memory (as evaluated by the Novel object recognition test). A single low dose of GM1 (2 mg/kg; IP), shortly after the injury, prevented both the cognitive and the cellular changes in the brains of the injured mice. These results enlighten part of the complicated mechanism that underlies the damage induced by B-TBI and may also suggest a potential new treatment strategy for brain injuries.	[Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Zilberstein, Yael] Tel Aviv Univ, Sackler Fac Med, Sackler Cellular & Mol Imaging Ctr, IL-69978 Tel Aviv, Israel; [Chapman, Joab] Chaim Sheba Med Ctr, J Sagol Neurosci Ctr, Dept Neurol, Ramat Gan, Israel; [Chapman, Joab] Tel Aviv Univ, Sackler Sch Med, Dept Neurol, Tel Aviv, Israel; [Chapman, Joab; Schreiber, Shaul; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Psychiat, IL-64239 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Univ, Sackler Sch Med, Dept Psychiat, Tel Aviv, Israel		Rubovitch, V (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.	rubovitc@post.tau.ac.il	Chapman, Joab/E-4598-2010; Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693			Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Buss A, 2005, ACTA NEUROPATHOL, V110, P113, DOI 10.1007/s00401-004-0942-z; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; Gao L, 2015, FRONT BIOSCI-LANDMRK, V20, P763, DOI 10.2741/4335; Gotow Takahiro, 2000, Medical Electron Microscopy, V33, P173, DOI 10.1007/s007950000019; Guzik-Kornacka A, 2016, BRAIN STRUCT FUNCT, V221, P317, DOI 10.1007/s00429-014-0909-3; Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053; Kusumi A, 2012, MOL BIOL CELL, V23, P3925, DOI 10.1091/mbc.E12-02-0159; Lee S, 2014, BIOL OPEN, V3, P974, DOI 10.1242/bio.20149779; Li L, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150898, 10.1371/journal.pone.0144219]; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; McKerracher L, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00051; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mori K, 2012, J PHYS CHEM B, V116, P5111, DOI 10.1021/jp207881k; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Noel A, 2015, EXP NEUROL, V271, P308, DOI 10.1016/j.expneurol.2015.06.021; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Pernet V, 2012, CELL DEATH DIFFER, V19, P1096, DOI 10.1038/cdd.2011.191; Petrasek T, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00090; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Schnaar R L, 2003, Prog Mol Subcell Biol, V32, P125; Schnaar RL, 2016, J MOL BIOL, V428, P3325, DOI 10.1016/j.jmb.2016.05.020; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; SCHNEIDER JS, 1989, EXP NEUROL, V105, P177, DOI 10.1016/0014-4886(89)90117-9; Schreiber Shaul, 2007, Am J Disaster Med, V2, P307; Schwab JM, 2005, LANCET, V365, P2055, DOI 10.1016/S0140-6736(05)66699-8; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Tweedie D, 2016, ALZHEIMERS DEMENT, V12, P34, DOI 10.1016/j.jalz.2015.07.489; Vinson M, 2001, J BIOL CHEM, V276, P20280, DOI 10.1074/jbc.M100345200; Vyas AA, 2005, J BIOL CHEM, V280, P16305, DOI 10.1074/jbc.M500250200; Vyas AA, 2002, P NATL ACAD SCI USA, V99, P8412, DOI 10.1073/pnas.072211699; Yuan AD, 2012, J CELL SCI, V125, P3257, DOI 10.1242/jcs.104729; Zemmar A, 2014, J NEUROSCI, V34, P8685, DOI 10.1523/JNEUROSCI.3817-13.2014	43	21	22	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 23	2017	7								41269	10.1038/srep41269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI6VX	WOS:000392636500001	28112258	Green Published, gold			2022-02-06	
J	Bagnato, S; Boccagni, C; Sant'Angelo, A; Fingelkurts, AA; Fingelkurts, AA; Galardi, G				Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Fingelkurts, Alexander A.; Fingelkurts, Andrew A.; Galardi, Giuseppe			Longitudinal Assessment of Clinical Signs of Recovery in Patients with Unresponsive Wakefulness Syndrome after Traumatic or Nontraumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						Coma Recovery Scale Revised; disorders of consciousness; MCS; TBI; vegetative state	MINIMALLY CONSCIOUS STATE; DISORDERS	Although clinical examination is the gold standard for differential diagnosis between unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS), clinical signs denoting the first occurrence of conscious behavior in patients with UWS have not been clarified. In this prospective single-center cohort study, 31 consecutive patients with UWS after traumatic brain injury (TBI) (17 patients) or non-TBI were assessed with the Coma Recovery Scale Revised (CRS-R) at admission to a rehabilitation department and after 1, 2, 3, 6, and 12 months. Of the 21 patients who recovered consciousness during the study, 90.5% recovered consciousness within the first 3 months. At the first diagnosis of emergence from UWS, 52.4% of patients showed signs of awareness in only one CRS-R subscale. In particular, 42.9% of patients showed conscious behaviors on the visual CRS-R subscale (23.8% showed visual fixation and 19.1% showed visual pursuit), and 9.5% showed conscious behaviors on the motor CRS-R subscale (half showed localization to a noxious stimulus and half showed object manipulation). Moreover, 23.8% of patients had conscious behaviors on two CRS subscales, always involving the visual and motor CRS-R subscales. The remaining patients showed conscious behaviors on more than two CRS-R subscales. In conclusion, visual fixation and visual pursuit are the commonest early clinical signs denoting MCS. When emerging from UWS, patients with TBI often showed more signs of consciousness and had higher CRS-R scores than patients with non-TBI.	[Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Neurophysiol, I-90015 Cefalu, PA, Italy; [Bagnato, Sergio; Boccagni, Cristina; Sant'Angelo, Antonino; Galardi, Giuseppe] Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, I-90015 Cefalu, PA, Italy; [Fingelkurts, Alexander A.; Fingelkurts, Andrew A.] BM Sci Brain & Mind Technol Res Ctr, Espoo, Finland		Bagnato, S (corresponding author), Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Neurophysiol, I-90015 Cefalu, PA, Italy.; Bagnato, S (corresponding author), Fdn Ist San Raffaele G Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, I-90015 Cefalu, PA, Italy.	sergiobagnato@gmail.com	Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887			Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Estraneo A, 2015, CLIN REHABIL, V29, P803, DOI 10.1177/0269215514556002; Fingelkurts Alexander A, 2013, Suppl Clin Neurophysiol, V62, P81; Fingelkurts Alexander A, 2007, Cogn Process, V8, P183, DOI 10.1007/s10339-007-0175-x; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Royal College of Physicians, 2013, PROL DIS CONSC NAT C; Royal College of Physicians, 2003, PERM VEG STAT GUID D; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218	11	21	21	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					535	539		10.1089/neu.2016.4418			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800029					2022-02-06	
J	Ahmed, OH; Hall, EE				Ahmed, Osman Hassan; Hall, Eric E.			"It was only a mild concussion": Exploring the description of sports concussion in online news articles	PHYSICAL THERAPY IN SPORT			English	Article						Concussion; Sports medicine; Media; Internet	HIGH-SCHOOL; KNOWLEDGE TRANSFER; INFLUENCING POLICY; RUGBY PLAYERS; MEDIA; EDUCATION; LEAGUE; MANAGEMENT; AWARENESS; PROGRAM	Background/aims: Concussion is widely discussed in online sports news articles, but the terms used to report this injury vary. This study aimed to use a systematic search strategy and explore the description of sports concussion in online sports news articles. Methods: A systematic approach was employed to obtain online articles related to sports concussion from four sports associated with concussion (hockey, football, soccer, and rugby). Included articles were evaluated for the descriptors used in relation to concussion and possible consequences associated with concussion. Data was analysed to determine trends between each sport as well between the countries of origin of the articles. Results: From 200 articles retrieved, 153 were included for analysis. The terms "Head injury" (30.1%) and "Brain injury" (20.9%) were most used to describe a concussive injury, and the most frequently mentioned consequence of concussion was "Chronic Traumatic Encephalopathy" (15%). Modifiers which potentially play down the importance of the injury were noted in 9.8% of the articles, with journalists the primary source of these terms. Conclusions: The variability in reporting of concussion by online news articles may limit the transmission of correct concussion information to the public. To improve the consistency of this reporting, the "Media Concussion Checklist" was developed. (C) 2016 The Authors. Published by Elsevier Ltd.	[Ahmed, Osman Hassan] Bournemouth Univ, Fac Hlth & Social Sci, Royal London House, Bournemouth BH1 3LT, Dorset, England; [Ahmed, Osman Hassan] Poole Hosp NHS Fdn Trust, Dept Physiotherapy, Poole, Dorset, England; [Ahmed, Osman Hassan] FA Ctr Disabil Football Res, St Georges Pk, Burton Upon Trent, England; [Hall, Eric E.] Elan Univ, Dept Exercise Sci, Elon, NC USA		Ahmed, OH (corresponding author), Bournemouth Univ, Fac Hlth & Social Sci, Royal London House, Bournemouth BH1 3LT, Dorset, England.	osman.hassan.ahmed@gmail.com					Ahmed OH, 2014, PM&R, V6, P1071, DOI 10.1016/j.pmrj.2014.08.945; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Asplund CA, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1381; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bikhchandani S, 1998, J ECON PERSPECT, V12, P151, DOI 10.1257/jep.12.3.151; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Burns J., 2014, NY TIMES; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chapman S, 2014, J HEALTH COMMUN, V19, P260, DOI 10.1080/10810730.2013.811327; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Croker J. M. B., 2015, COMMUNICATION; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Geller G, 2002, JAMA-J AM MED ASSOC, V287, P773, DOI 10.1001/jama.287.6.773; Goff S., 2015, WASHINGTON POST; Gollust SE, 2012, SOC SCI MED, V74, P1544, DOI 10.1016/j.socscimed.2012.01.021; Ho SS, 2008, INT J PUBLIC OPIN R, V20, P171, DOI 10.1093/ijpor/edn017; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Maese R., 2014, WASHINGTON POST; Mc Fie S., 2015, CLIN J SPORTS MED; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McLellan TL, 2011, BRIT J SPORT MED, V45, P993, DOI 10.1136/bjsm.2011.083618; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140, DOI 10.1097/JSM.0b013e31803212ae; McNamee M, 2014, SPORT ETHICS PHILOS, V8, P113, DOI 10.1080/17511321.2014.946269; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; Petersen A, 2001, SOC SCI MED, V52, P1255, DOI 10.1016/S0277-9536(00)00229-X; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; Sharp David J, 1800, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Sullivan SJ, 2012, PHYS THER SPORT, V13, P209, DOI 10.1016/j.ptsp.2011.10.004; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Yengo-Kahn AM, 2016, AM J SPORT MED, V44, P801, DOI 10.1177/0363546515580313	39	21	21	2	9	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	JAN	2017	23						7	13		10.1016/j.ptsp.2016.07.003			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	EJ5ML	WOS:000393262200002	27639135	Green Accepted, hybrid			2022-02-06	
J	French, CJ; Glassford, NJ; Gantner, D; Higgins, AM; Cooper, DJ; Nichol, A; Skrifvars, MB; Imberger, G; Presneill, J; Bailey, M; Bellomo, R				French, Craig J.; Glassford, Neil J.; Gantner, Dashiell; Higgins, Alisa M.; Cooper, David James; Nichol, Alistair; Skrifvars, Markus B.; Imberger, Georgina; Presneill, Jeffrey; Bailey, Michael; Bellomo, Rinaldo			Erythropoiesis-stimulating Agents in Critically Ill Trauma Patients A Systematic Review and Meta-analysis	ANNALS OF SURGERY			English	Article						critical illness; epoetin alfa; erythropoiesis-stimulating agents; trauma	RECOMBINANT-HUMAN-ERYTHROPOIETIN; ISCHEMIA-REPERFUSION INJURY; TRIAL SEQUENTIAL-ANALYSIS; BRAIN-INJURY; DOUBLE-BLIND; EPOETIN-ALPHA; TRANSFUSION; PROTECTS; RECOVERY; EFFICACY	Objective: To perform a meta-analysis of all relevant randomized controlled trials assessing the effect of erythropoiesis-stimulating agents (ESAs) in critically ill trauma patients. Background: ESAs have effects beyond erythropoiesis. The administration of the ESA epoetin alfa to critically ill trauma patients has been associated with a reduction in mortality. Methods: We performed a systematic review and meta-analysis with trial sequential analysis. We searched Medline, Medline in Process, and other nonindexed citations, EMBASE, and the Cochrane Database from inception until September 9, 2015, for randomized controlled trials comparing ESAs to placebo (or no ESA). Results: We identified 9 eligible studies that randomly assigned 2607 critically ill patients after trauma to an ESA or placebo (or no ESA). Compared with placebo (or no ESA), ESA therapy was associated with a substantial reduction in mortality [risk ratio (RR) 0.63, 95% confidence interval (CI) 0.49-0.79, P = 0.0001, I-2 = 0%). In patients with traumatic brain injury, ESA therapy did not increase the number of patients surviving with moderate disability or good recovery (RR 1.00, 95% CI 0.88-1.15, P = 0.95, I-2 = 0%). With the dosing regimens employed in the included studies, ESA therapy did not increase the risk of lower limb proximal deep venous thrombosis (RR 0.97, 95% CI 0.72-1.29, P = 0.78, I-2 = 0%). Conclusions: The administration of ESAs to critically ill trauma patients is associated with a significant improvement in mortality without an increase in the rate of lower limb proximal deep venous thrombosis. Given the worldwide public health significance of these findings research to validate or refute them is required.	[French, Craig J.; Gantner, Dashiell; Imberger, Georgina] Western Hlth, Dept Anaesthesia, Gordon St, Melbourne, Vic, Australia; [French, Craig J.; Gantner, Dashiell; Imberger, Georgina] Western Hlth, Dept Intens Care, Gordon St, Melbourne, Vic, Australia; [Glassford, Neil J.; Bellomo, Rinaldo] Austin Hosp, Dept Intens Care, Melbourne, Vic, Australia; [French, Craig J.; Glassford, Neil J.; Gantner, Dashiell; Higgins, Alisa M.; Cooper, David James; Nichol, Alistair; Skrifvars, Markus B.; Presneill, Jeffrey; Bailey, Michael; Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Cooper, David James] The Alfred, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] St Vincents Univ Hosp, Dublin, Ireland; [Presneill, Jeffrey] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [French, Craig J.; Bellomo, Rinaldo] Univ Melbourne, Melbourne, Vic, Australia; [Skrifvars, Markus B.] Helsinki Univ Hosp, Div Intens Care, Dept Anesthesiol Intens Care & Pain Med, Helsinki, Finland; [Skrifvars, Markus B.] Univ Helsinki, Helsinki, Finland		French, CJ (corresponding author), Western Hlth, Dept Intens Care, Gordon St, Footscray, Vic 3011, Australia.	Craig.French@wh.org.au	Higgins, Alisa/AAM-8088-2020; French, Craig/ABF-5087-2020; Cooper, D. James/G-7961-2013; Bailey, Michael J/A-4499-2012	Higgins, Alisa/0000-0001-8295-7559; French, Craig/0000-0003-1363-9711; Cooper, D. James/0000-0002-5872-9051; Bailey, Michael J/0000-0002-5551-1401; Bellomo, Rinaldo/0000-0002-1650-8939; Glassford, Neil/0000-0003-1647-3745; Nichol, Alistair/0000-0002-4689-1238; Nichol, Alistair Dualta/0000-0002-4771-5615			Abrishamkar S, 2012, J RES MED SCI, V17, P51; Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Calvillo L, 2003, P NATL ACAD SCI USA, V100, P4802, DOI 10.1073/pnas.0630444100; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Corwin HL, 2014, J TRAUMA ACUTE CARE, V77, P774, DOI 10.1097/TA.0000000000000442; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; [Герасимов Лев Владимирович Gerasimov L.V.], 2012, [Общая реаниматология, Obshchaya reanimatologiya], VVIII, P11; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hojman P, 2009, CYTOKINE, V45, P154, DOI 10.1016/j.cyto.2008.12.005; Joyeux-Faure M, 2012, FUND CLIN PHARMACOL, V26, P761, DOI 10.1111/j.1472-8206.2011.00992.x; Kaukonen KM, 2014, CRIT CARE RESUSC, V16, P255; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Luchette FA, 2012, AM J SURG, V203, P508, DOI 10.1016/j.amjsurg.2011.08.006; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Menon DK, 2015, LANCET, V386, P2452, DOI 10.1016/S0140-6736(15)00387-6; MIYAKE T, 1977, J BIOL CHEM, V252, P5558; Napolitano LM, 2008, J TRAUMA, V65, P285, DOI 10.1097/TA.0b013e31817f2c6e; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nirula R, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/209848; Ogunshola Omolara O, 2013, Methods Mol Biol, V982, P13, DOI 10.1007/978-1-62703-308-4_2; Ozawa T, 2010, CIRC J, V74, P1415, DOI 10.1253/circj.CJ-10-0109; Peden M., 2002, INJURY CHART BOOK GR; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sepodes B, 2006, TRANSPL INT, V19, P919, DOI 10.1111/j.1432-2277.2006.00366.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Solling C, 2011, ACTA ANAESTH SCAND, V55, P185, DOI 10.1111/j.1399-6576.2010.02369.x; Solling C, 2012, BASIC CLIN PHARMACOL, V110, P113, DOI 10.1111/j.1742-7843.2011.00820.x; Thorlund K, 2011, USER MANUAL TRIAL SE; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Turner RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059202; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wu HW, 2006, EUR J CARDIO-THORAC, V29, P902, DOI 10.1016/j.ejcts.2006.02.036; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	40	21	21	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	JAN	2017	265	1					54	62		10.1097/SLA.0000000000001746			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	EH9QS	WOS:000392106500017	27070933				2022-02-06	
J	Geytenbeek, M; Fleming, J; Doig, E; Ownsworth, T				Geytenbeek, Megan; Fleming, Jennifer; Doig, Emmah; Ownsworth, Tamara			The occurrence of early impaired self-awareness after traumatic brain injury and its relationship with emotional distress and psychosocial functioning	BRAIN INJURY			English	Article						Metacognition; brain injury; severity; outcome; depression; stress	ANXIETY STRESS SCALES; PSYCHOMETRIC PROPERTIES; REHABILITATION; DEPRESSION; DEFICITS; TRANSITION; ADJUSTMENT; OUTCOMES; HOME; SEVERITY	Objective: To describe the occurrence of impaired self-awareness (ISA) after traumatic brain Injury (TBI) and its association with emotional distress and psychosocial functioning following discharge. Design: Prospective cohort design with data collection at discharge and 1-, 3- and 6-month follow-up. Participants: 81 adults with TBI. Measures: Self-awareness was measured using a discrepancy score generated from the Mayo-Portland Adaptability Index (MPAI-4) Ability subscale, and significant other's ratings of Item 20 on the MPAI-4. Other measures were the Depression Anxiety Stress Scale-21 and Sydney Psychosocial and Reintegration Scale. Results: The discrepancy score method identified more cases of ISA than the single-item rating by significant others. Using discrepancy scores, the occurrence of ISA was 69.1% at discharge, and for those remaining in the study 6 months later, it was 54.3%. Better self-awareness was associated with greater anxiety at discharge, and stress at discharge, 3 and 6 months later, and better psychosocial functioning at all time points. Participants with ISA had significantly poorer relationships at 6 months post-discharge after controlling for injury severity. Conclusion: Whilst self-awareness is associated with greater stress in patients with TBI, It is also associated with better outcomes, Indicating the Importance of targeting ISA In rehabilitation.	[Geytenbeek, Megan; Fleming, Jennifer; Doig, Emmah] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Geytenbeek, Megan; Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld, Australia; [Ownsworth, Tamara] Griffith Univ, Menzies Hlth Inst Queensland, Mt Gravatt, Qld, Australia		Fleming, J (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	j.fleming@uq.edu.au	Doig, Emmah/AAG-6674-2021; Ownsworth, Tamara/ABB-6961-2021	Doig, Emmah/0000-0002-7020-053X; Ownsworth, Tamara/0000-0003-1835-7094; Fleming, Jennifer/0000-0002-5603-2410	Acquired Brain Injury Outreach Service; Australian Research Council Linkage ProjectAustralian Research Council [LP0776294]; Department of Communities, Disability Services; NHMRC Postdoctoral Research Fellowship - Centre Research Excellence in Traumatic Brain Injury RecoveryNational Health and Medical Research Council of Australia [APP1023043]	The authors report no conflicts of interest. The project was funded by an Australian Research Council Linkage Project (LP0776294) with the Department of Communities, Disability Services and the Acquired Brain Injury Outreach Service as industry partners. Emmah Doig was in receipt of a NHMRC Postdoctoral Research Fellowship funded by the Centre Research Excellence in Traumatic Brain Injury Recovery (APP1023043).	ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Clare L, 2011, DEMENT GERIATR COGN, V31, P317, DOI 10.1159/000327356; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; De Wolf A, 2010, QUAL LIFE RES, V19, P1185, DOI 10.1007/s11136-010-9685-6; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fleming J, 1999, OCCUP THER J RES, V19, P3, DOI 10.1177/153944929901900101; Fleming J., 2006, BRAIN IMPAIR, V7, P83, DOI [https://doi.org/10.1375/brim.7.2.83, DOI 10.1375/BRIM.7.2.83, 10.1375/brim.7.2.83]; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Jones SJ., 2008, BRIT J OCCUP THER, V71, P44, DOI DOI 10.1177/030802260807100202; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kervick RB, 2005, BRAIN INJURY, V19, P881, DOI 10.1080/02699050400025273; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; McBrinn J, 2008, BRAIN INJURY, V22, P765, DOI 10.1080/02699050802372208; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Nalder E, 2012, J REHABIL MED, V44, P837, DOI 10.2340/16501977-1033; Nalder E, 2012, J HEAD TRAUMA REHAB, V27, P143, DOI 10.1097/HTR.0b013e3182168fb1; Newman AC, 2000, BRAIN INJURY, V14, P333; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth TL, 2008, NEUROPSYCHOL REHABIL, V18, P692, DOI 10.1080/09602010701595136; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Portney LG, 2009, FDN CLIN RES APPL PR, P451; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Simmond M., 2003, OCCUP THER J RES, V66, P447, DOI [10.1177/030802260306601003, DOI 10.1177/030802260306601003]; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Tabachnick B.G., 2007, USING MULTIVARIATE S, V5th, P60; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Vanderploeg RD, 2007, J REHABIL RES DEV, V44, P937, DOI 10.1682/JRRD.2006.12.0163; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Wallace CA, 2000, BRAIN INJURY, V14, P549; Wise K, 2005, BRAIN INJURY, V19, P765, DOI 10.1080/0269905050019977	64	21	21	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1791	1798		10.1080/02699052.2017.1346297			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500010	29058497				2022-02-06	
